Citrus Sinensis ID: 047719

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590------
Protein Sequence
FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQDSFFAVEFDTSFDPSLGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGSAIYTVDRWRFKTFESYPSGNPIDVIDEGDCLTCYPEDAGYNGSYSDVDKRKAKIAETALEVGGLVTFVFTVVAIVGIISCFLIKKKRHDGRSKEDHVCTVQRVPMRLALTDIKQATLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEAPLPLLPVKKPTVNIRSVFPEASELIDSGGDHSPGFDDSLWMTPRSRFS
Secondary Structure (PSIPRED)
ccccccccEEEEEEEEEEEEEcccccccccEEEEEEccccccccccccccccccccccccccEEEEEccccccccccccccccEEEEEccEEEEEEcccccccEEEcccccEEEEEEEEcccEEEEEEEEccccccccccEEEEEcccccccccEEEEEEEccccccEEEEEEEEEEEccccccccccccccccccccccccccccccccccccccccccEEEEEEEEHHHHHHHHHHHHHHHHHHHHHEEEccccccccccccccccccccEEEHHHHHHHHcccccccccccccccEEEEEEcccccEEEEEEEEccccccccHHHHHHHHHHHHccccccccccccEEEccccEEEEEEEccccccHHHHccccccccccccHHHHHHHHHHHHHHHHHcccccccEEEEccccccccccccccccccccccccccccccccccccccccccccccccEEccHHEEEEHHccccccccccccHHHHHHHHHHcccccccccccccccccHHHHHHHHHHHHHcccccccccccHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccccccccEcEEEEEEEEEcEcccccccccEEEEEEEccccccccccHHcEEEcccccccccEEEEEEEccccHHHccccccEEEEEEcccccccccccccccEEEcccccEEEEEEEccccEEEEEEcccccccccccEEEEEEccHHHHcccEEEEEEcccccccEEEEEEEEEEccccccccccHHccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccHHHHHHHHccccccccEccccccEEEEEEcccccEEEEEEEccccHHHccHHHHHHHHHHHHHHHHHHcHHHHHHHHcccccEEEEEEccccccHHHHHcccccccccccHHHHHHHHHHHHHHHHHHHHHHcEEEEcccccHHHEEEcccccEEEccccccEEEEcHHHccHHHHHccccccccHHHHHHHEEHEEHccccccccccHHHHHHHHHHHHcccHHHHccHHHcccccHHHHHHHHHHccccccccccccccHHHHHHHHcccccccccccccccccHHHHHHccccccccccccccccccccccccccccc
Coil and Loop (DISEMBL)
fldpktnttasfscrfsfsiipsplcafgdgFAFLITSnadsfgndngymglpgpvlspqdsffavefdtsfdpslgdingnhigidISSVISFVSVDAlsrgidlksgrhITTWIEYRDSLKLIRVWAgysqirppspliIAQIDLSKQFKDYMHVGfsaangqgsaiytvdrwrfktfesypsgnpidvidegdcltcypedagyngsysdvDKRKAKIAETALEVGGLVTFVFTVVAIVGIISCFLIKkkrhdgrskedhvctvqrvpmrlaLTDIKQATLgfnknrivgegasatvykgslpsggavavkrfekpnrvecarnpfttefaTMAGCLRHKNLVQLqgwccegneLVLVYEylpngsldkilhnnsssSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNaklgdfeatipagtmgylapeyvysgvpsektdvySFGVVALEVaagkspvdndgcvIVDWVWNLrkkgklldaADFRLRGKFNRKEMERMLMVGLscvhpnhekrpsVKEAARILkgeaplpllpvkkptvnirsvfpeaselidsggdhspgfddslwmtprsrfs
Flexible Loop (DISEMBL)
fldpktnttasfscRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQDSFFAVEFDTSFDPSLGDINGNHIGIDISSVISFVSVDALSrgidlksgrhittwiEYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFsaangqgsaIYTVDRWRFKTFESYPSGNPIDVIDEGDCLTCYPEDAGYNGSYSDVDKRKAKIAETalevgglvTFVFTVVAIVGIISCFLIkkkrhdgrskedhvctvqrvpmrlALTDIKQATLGFNKNRIVGEGASAtvykgslpsggavavkrfekpnrvecarNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVaagkspvdndgCVIVDWVWNLrkkgklldaadfrlrGKFNRKEMERMLMVGlscvhpnhekRPSVKEAARILKgeaplpllpvkkptVNIRSVFPEASElidsggdhspgfddslwmtprsrfs
Low Complexity Region (SEG)
FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQDSFFAVEFDTSFDPSLgdingnhigidissvisfvsvDALSRGIDLKSGRHITTWIEYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGSAIYTVDRWRFKTFESYPSGNPIDVIDEGDCLTCYPEDAGYNGSYSDVDKRKAKIAETALEvgglvtfvftvvAIVGIISCFLIKKKRHDGRSKEDHVCTVQRVPMRLALTDIKQATLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEAplpllpVKKPTVNIRSVFPEASELIDSGGDHSPGFDDSLWMTPRSRFS
Disordered region (IsUnstruct)
**********SFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQDSFFAVEFDTSFDPSLGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGSAIYTVDRWRFKTFESYPSGNPIDVIDEGDCLTCYPEDAGYNGSYSDVDKRKAKIAETALEVGGLVTFVFTVVAIVGIISCFLIKKKRHDG**KEDHVCTVQRVPMRLALTDIKQATLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSL************VLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVH**********************PLLPV***TVNIR*********************************
Disordered Region (DISOPRED)
*****TNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFG**NGYMGLPGPVLSPQDSFFAVEFDTSFDPSLGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGSAIYTVDRWRFKTFESYPSGNPI*V********************************TALEVGGLVTFVFTVVAIVGIISCFLIKKKRHD*********TVQRVPMRLALTDIKQATLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFE***********FTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEAPLPLLPVKKPTVN***********************************
Disordered Region (DISEMBL)
FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQDSFFAVEFDTSFDPSLGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGSAIYTVDRWRFKTFESYPSGNPIDVIDEGDCLTCYPEDAGYNGSYSDVDKRKAKIAETALEVGGLVTFVFTVVAIVGIISCFLIKKK**********VCTVQRVPMRLALTDIKQATLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEAPLPLLPVKKPTVNIRSVFPEASELIDSGGDHSPGFDDSLWMTPRSRFS
Disordered Region (DISPRO)
*****TNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQDSFFAVEFDTSFDPSLGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGSAIYTVDRWRFKTFESYPSGNPIDVIDEGDCLTCY****************KAKIAETALEVGGLVTFVFTVVAIVGIISCFLIKKKRHDGRSKEDHVCTVQRVPMRLALTDIKQATLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEAPLPLLPVKKPTVNIRSVFPEA***************************
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQDSFFAVEFDTSFDPSLGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGSAIYTVDRWRFKTFESYPSGNPIDVIDEGDCLTCYPEDAGYNGSYSDVDKRKAKIAETALEVGGLVTFVFTVVAIVGIISCFLIKKKRHDGRSKEDHVCTVQRVPMRLALTDIKQATLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEAPLPLLPVKKPTVNIRSVFPEASELIDSGGDHSPGFDDSLWMTPRSRFS
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	596	2.2.26 [Sep-21-2011]
Q9FHX3	691	L-type lectin-domain cont	yes	no	0.971	0.837	0.576	0.0
Q9FHG4	681	Probable L-type lectin-do	no	no	0.922	0.807	0.397	1e-119
Q9LFH9	715	L-type lectin-domain cont	no	no	0.885	0.738	0.391	1e-106
Q9LYX1	711	L-type lectin-domain cont	no	no	0.912	0.765	0.383	1e-105
Q9M2S4	684	L-type lectin-domain cont	no	no	0.872	0.760	0.359	1e-82
O80939	675	L-type lectin-domain cont	no	no	0.880	0.777	0.335	2e-79
Q9FIF0	694	Putative L-type lectin-do	no	no	0.879	0.755	0.342	3e-77
O81292	674	L-type lectin-domain cont	no	no	0.890	0.787	0.336	2e-76
Q66GN2	691	Lectin-domain containing	no	no	0.874	0.753	0.348	3e-76
Q9FIF1	674	Probable L-type lectin-do	no	no	0.895	0.792	0.336	4e-76

>sp|Q9FHX3|LRKS6_ARATH L-type lectin-domain containing receptor kinase S.6 OS=Arabidopsis thaliana GN=LECRKS6 PE=2 SV=1

 Score =  669 bits (1727), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 361/626 (57%), Positives = 441/626 (70%), Gaps = 47/626 (7%)

Query: 1   FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQ 60
           FL+P TNTTASFSCRFSFSII SP C FGDGFAFLITSNADSF   NG++GLP    +P 
Sbjct: 83  FLEPSTNTTASFSCRFSFSIIASPSCPFGDGFAFLITSNADSFVFSNGFLGLP----NPD 138

Query: 61  DSFFAVEFDTSFDPSLGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRD 120
           DSF AVEFDT FDP  GDIN NH+GID+SS+ S  SVDA+S+G DLKSG+ +  WIEY D
Sbjct: 139 DSFIAVEFDTRFDPVHGDINDNHVGIDVSSIFSVSSVDAISKGFDLKSGKKMMAWIEYSD 198

Query: 121 SLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAAN-GQGSAIYTVDRWRFKT 179
            LKLIRVW GYS+++P SP++  QIDLS + K+YMHVGFSA+N G GSA++ V+RW+F+T
Sbjct: 199 VLKLIRVWVGYSRVKPTSPVLSTQIDLSGKVKEYMHVGFSASNAGIGSALHIVERWKFRT 258

Query: 180 FESYPSG-NPIDVIDEGDCLTCY------PEDAGYNGSYSDVDKRKAKIAETALEVGGLV 232
           F S+       +   + +CL C       P++    G    V     KI   +L + GL 
Sbjct: 259 FGSHSDAIQEEEEEKDEECLVCSGEVSENPKEIHRKGFNFRVTVVGLKIPVWSL-LPGLA 317

Query: 233 TFVFTVVAIVGIISCFLIKKKRHDGRSKEDHVCTVQRVPMRLALTDIKQATLGFNKNRIV 292
             V  V  IV  + C    KKR     + D    + R+P RL+L +IK AT GFN+N IV
Sbjct: 318 AIVILVAFIVFSLIC---GKKRIS--EEADSNSGLVRMPGRLSLAEIKSATSGFNENAIV 372

Query: 293 GEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWC 352
           G+GASATVY+GS+PS G+VAVKRF++ +  +C RNPFTTEF TM G LRHKNLVQ QGWC
Sbjct: 373 GQGASATVYRGSIPSIGSVAVKRFDREHWPQCNRNPFTTEFTTMTGYLRHKNLVQFQGWC 432

Query: 353 CEGNELVLVYEYLPNGSLDKILHNNSSSS-----IVLSWEKRLNIVLGVASALSYLHEEC 407
            EG E  LV+EYLPNGSL + LH   SS      IVLSW++R+NI+LGVASAL+YLHEEC
Sbjct: 433 SEGTETALVFEYLPNGSLSEFLHKKPSSDPSEEIIVLSWKQRVNIILGVASALTYLHEEC 492

Query: 408 ERQIIHRDVKACNILLDAEFNAKLGDF---------------EATIPAGTMGYLAPEYVY 452
           ERQIIHRDVK CNI+LDAEFNAKLGDF                AT+PAGTMGYLAPEYVY
Sbjct: 493 ERQIIHRDVKTCNIMLDAEFNAKLGDFGLAEIYEHSALLAGRAATLPAGTMGYLAPEYVY 552

Query: 453 SGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFN 512
           +GVPSEKTDVYSFGVV LEV  G+ PV +DG V+VD +W+  + GK+LD AD  LR +F+
Sbjct: 553 TGVPSEKTDVYSFGVVVLEVCTGRRPVGDDGAVLVDLMWSHWETGKVLDGADIMLREEFD 612

Query: 513 RKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEAPLPLLPVKKPTVNIRSVFPEASEL 572
            +EMER+LMVG+ C HP+ EKRP VK+A RI++GEAPLP+LP ++P + IR    EA E+
Sbjct: 613 AEEMERVLMVGMVCAHPDSEKRPRVKDAVRIIRGEAPLPVLPARRPLLRIRPA-NEAEEM 671

Query: 573 IDSG--GDHSPGFDDSLWMTPRSRFS 596
           I  G  G+  P      WMTP+S FS
Sbjct: 672 IVDGLVGEDLP------WMTPKSHFS 691

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9FHG4|LRKS7_ARATH Probable L-type lectin-domain containing receptor kinase S.7 OS=Arabidopsis thaliana GN=LECRKS7 PE=2 SV=1

 Score =  429 bits (1102), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 234/588 (39%), Positives = 344/588 (58%), Gaps = 38/588 (6%)

Query: 1   FLDPKTNTTASFSCRFSFSII---PSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVL 57
           F DP +NTTASFS  FSF++    P P  A GDG AF ++ + D+ G+  GY+GL     
Sbjct: 80  FYDPDSNTTASFSTHFSFTVQNLNPDPTSA-GDGLAFFLSHDNDTLGSPGGYLGLVNSSQ 138

Query: 58  SPQDSFFAVEFDTSFDPSLGDINGNHIGIDISSVISFVSVDAL-SRGIDLKSGRHITTWI 116
             ++ F A+EFDT  DP   D NGNHIG+D+ S+ S  + D L S  IDLKSG+ IT+WI
Sbjct: 139 PMKNRFVAIEFDTKLDPHFNDPNGNHIGLDVDSLNSISTSDPLLSSQIDLKSGKSITSWI 198

Query: 117 EYRDSLKLIRVWAGYSQ-----IRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGSAIYT 171
           +Y++ L+L+ V+  Y+       +P  PL+   IDLS      M+VGFS +    + I+ 
Sbjct: 199 DYKNDLRLLNVFLSYTDPVTTTKKPEKPLLSVNIDLSPFLNGEMYVGFSGSTEGSTEIHL 258

Query: 172 VDRWRFKTFESYPSGNPIDVIDEGDCLTCYPEDAGYNGSYSDVDKRKAKIAETALEVGGL 231
           ++ W FKT    P      V  + + L    + +  N     +  +K +     L +G  
Sbjct: 259 IENWSFKTSGFLP------VRSKSNHLHNVSDSSVVNDDPVVIPSKKRRHRHN-LAIGLG 311

Query: 232 VTFVFTVVAIVGIISCFLIKKKRHDGRSKEDHVCTVQRVPMRLALTDIKQATLGFNKNRI 291
           ++    +   + +   F +KK +     KE     +  +    +  ++  AT GF+ +R+
Sbjct: 312 ISCPVLICLALFVFGYFTLKKWKSVKAEKELKTELITGL-REFSYKELYTATKGFHSSRV 370

Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G GA   VY+    S G ++  +  + N  E  +  F  E + +A CLRHKNLVQLQGW
Sbjct: 371 IGRGAFGNVYRAMFVSSGTISAVKRSRHNSTE-GKTEFLAELSIIA-CLRHKNLVQLQGW 428

Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSS-SIVLSWEKRLNIVLGVASALSYLHEECERQ 410
           C E  EL+LVYE++PNGSLDKIL+  S + ++ L W  RLNI +G+ASALSYLH ECE+Q
Sbjct: 429 CNEKGELLLVYEFMPNGSLDKILYQESQTGAVALDWSHRLNIAIGLASALSYLHHECEQQ 488

Query: 411 IIHRDVKACNILLDAEFNAKLGDFE------------ATIPAGTMGYLAPEYVYSGVPSE 458
           ++HRD+K  NI+LD  FNA+LGDF             +T+ AGTMGYLAPEY+  G  +E
Sbjct: 489 VVHRDIKTSNIMLDINFNARLGDFGLARLTEHDKSPVSTLTAGTMGYLAPEYLQYGTATE 548

Query: 459 KTDVYSFGVVALEVAAGKSPVDND-----GCVIVDWVWNLRKKGKLLDAADFRLRGKFNR 513
           KTD +S+GVV LEVA G+ P+D +        +VDWVW L  +G++L+A D RL+G+F+ 
Sbjct: 549 KTDAFSYGVVILEVACGRRPIDKEPESQKTVNLVDWVWRLHSEGRVLEAVDERLKGEFDE 608

Query: 514 KEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEAPLPLLPVKKPTVN 561
           + M+++L+VGL C HP+  +RPS++   +IL  E     +P  KPT++
Sbjct: 609 EMMKKLLLVGLKCAHPDSNERPSMRRVLQILNNEIEPSPVPKMKPTLS 656

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LFH9|LRK81_ARATH L-type lectin-domain containing receptor kinase VIII.1 OS=Arabidopsis thaliana GN=LECRK81 PE=1 SV=1

 Score =  385 bits (990), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 229/585 (39%), Positives = 330/585 (56%), Gaps = 57/585 (9%)

Query: 27  AFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQDSFFAVEFDTSFDPSLGDINGNHIGI 86
           + G G AF+I+ +A+S G   G +GL GP  S    F AVEFDT  D    DIN NH+G 
Sbjct: 97  SIGGGLAFVISPDANSIGIAGGSLGLTGPNGS-GSKFVAVEFDTLMDVDFKDINSNHVGF 155

Query: 87  DISSVISFVSVDALSRGIDLKSGRHITTWIEYRDSLKLIRVWAGYSQIRPPSPLIIAQID 146
           D++ V+S VS D  +  IDLKSG  I +WIEY    ++  V   YS ++P  P++   +D
Sbjct: 156 DVNGVVSSVSGDLGTVNIDLKSGNTINSWIEYDGLTRVFNVSVSYSNLKPKVPILSFPLD 215

Query: 147 LSKQFKDYMHVGFSAANGQGSAIYTVDRWRFKTFESY----------PSGNPIDVIDEGD 196
           L +   D+M VGFS +    + I++++ W F +              P  N ++   + +
Sbjct: 216 LDRYVNDFMFVGFSGSTQGSTEIHSIEWWSFSSSFGSSLGSGSGSPPPRANLMN--PKAN 273

Query: 197 CLTCYPEDAGYNGSYSDVDKRKAKIA-------------ETALEVGGLVTF-VFTVVAIV 242
            +   P  A    S +       ++              E    + G+VT   F +    
Sbjct: 274 SVKSPPPLASQPSSSAIPISSNTQLKTSSSSSCHSRFCKENPGTIAGVVTAGAFFLALFA 333

Query: 243 GIISCFLIKKKRHDGRSKEDHVCTVQRVPMRLALTDIKQATLGFNKNRIVGEGASATVYK 302
           G +     KK +   RS +     + + P   +  ++K  T  FN++RI+G GA   VY+
Sbjct: 334 GALFWVYSKKFKRVERS-DSFASEIIKAPKEFSYKELKAGTKNFNESRIIGHGAFGVVYR 392

Query: 303 GSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV 361
           G LP +G  VAVKR    ++ +  +N F +E + + G LRH+NLV+LQGWC E  E++LV
Sbjct: 393 GILPETGDIVAVKRCSHSSQDK--KNEFLSELSII-GSLRHRNLVRLQGWCHEKGEILLV 449

Query: 362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNI 421
           Y+ +PNGSLDK L     S   L W+ R  I+LGVASAL+YLH ECE Q+IHRDVK+ NI
Sbjct: 450 YDLMPNGSLDKALF---ESRFTLPWDHRKKILLGVASALAYLHRECENQVIHRDVKSSNI 506

Query: 422 LLDAEFNAKLGDF------------EATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVA 469
           +LD  FNAKLGDF            EAT+ AGTMGYLAPEY+ +G  SEKTDV+S+G V 
Sbjct: 507 MLDESFNAKLGDFGLARQIEHDKSPEATVAAGTMGYLAPEYLLTGRASEKTDVFSYGAVV 566

Query: 470 LEVAAGKSPVDNDGCV----------IVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERM 519
           LEV +G+ P++ D  V          +V+WVW L K+GK+  AAD RL GKF+  EM R+
Sbjct: 567 LEVVSGRRPIEKDLNVQRHNVGVNPNLVEWVWGLYKEGKVSAAADSRLEGKFDEGEMWRV 626

Query: 520 LMVGLSCVHPNHEKRPSVKEAARILKGEAPLPLLPVKKPTVNIRS 564
           L+VGL+C HP+   RP+++   ++L GEA +P++P  +PT++  +
Sbjct: 627 LVVGLACSHPDPAFRPTMRSVVQMLIGEADVPVVPKSRPTMSFST 671

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LYX1|LRK82_ARATH L-type lectin-domain containing receptor kinase VIII.2 OS=Arabidopsis thaliana GN=LECRK82 PE=2 SV=1

 Score =  383 bits (984), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 227/592 (38%), Positives = 328/592 (55%), Gaps = 48/592 (8%)

Query: 1   FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQ 60
           F  P+T + ASF+  FSFS+      + G G AF+I+ + D  G+  G++GL     S  
Sbjct: 84  FRHPETKSPASFTTYFSFSVTNLNPSSIGGGLAFVISPDEDYLGSTGGFLGLTEETGS-G 142

Query: 61  DSFFAVEFDTSFDPSLGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRD 120
             F AVEFDT  D    D+NGNH+G+D+++V+S    D  +  IDLKSG  + +WI Y  
Sbjct: 143 SGFVAVEFDTLMDVQFKDVNGNHVGLDLNAVVSAAVADLGNVDIDLKSGNAVNSWITYDG 202

Query: 121 SLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGSAIYTVDRW----- 175
           S +++ V+  YS ++P SP++   +DL +   D M VGFS +    + I++VD W     
Sbjct: 203 SGRVLTVYVSYSNLKPKSPILSVPLDLDRYVSDSMFVGFSGSTQGSTEIHSVDWWSFSSS 262

Query: 176 ------RFKTFESYPSGNPIDVIDEGDCLTCYPEDAGYNGSYSDVDKRKAKIAETALEVG 229
                       + P  +           T   + A  + S  +   +K+  A     V 
Sbjct: 263 FEESSESPPPMPNSPPPSSPSSSITPSLSTVRRKTADPSSSCRNKLCKKSPAA-----VA 317

Query: 230 GLVTFVFTVVAIVGIISCFLIKKKRHDGRSKEDHVCTVQRVPMRLALTDIKQATLGFNKN 289
           G+VT     +A+   +  ++  KK    R  E     + + P      ++K AT  F+ +
Sbjct: 318 GVVTAGAFFLALFAGVIIWVYSKKIKYTRKSESLASEIMKSPREFTYKELKLATDCFSSS 377

Query: 290 RIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           R++G GA  TVYKG L  SG  +A+KR    + +      F +E  ++ G LRH+NL++L
Sbjct: 378 RVIGNGAFGTVYKGILQDSGEIIAIKRC---SHISQGNTEFLSEL-SLIGTLRHRNLLRL 433

Query: 349 QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE 408
           QG+C E  E++L+Y+ +PNGSLDK L+    S   L W  R  I+LGVASAL+YLH+ECE
Sbjct: 434 QGYCREKGEILLIYDLMPNGSLDKALYE---SPTTLPWPHRRKILLGVASALAYLHQECE 490

Query: 409 RQIIHRDVKACNILLDAEFNAKLGDF------------EATIPAGTMGYLAPEYVYSGVP 456
            QIIHRDVK  NI+LDA FN KLGDF            +AT  AGTMGYLAPEY+ +G  
Sbjct: 491 NQIIHRDVKTSNIMLDANFNPKLGDFGLARQTEHDKSPDATAAAGTMGYLAPEYLLTGRA 550

Query: 457 SEKTDVYSFGVVALEVAAGKSPVDNDG----------CVIVDWVWNLRKKGKLLDAADFR 506
           +EKTDV+S+G V LEV  G+ P+                +VDWVW L ++GKLL A D R
Sbjct: 551 TEKTDVFSYGAVVLEVCTGRRPITRPEPEPGLRPGLRSSLVDWVWGLYREGKLLTAVDER 610

Query: 507 LRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEAPLPLLPVKKP 558
           L  +FN +EM R++MVGL+C  P+   RP+++   +IL GEA +P +P+ KP
Sbjct: 611 L-SEFNPEEMSRVMMVGLACSQPDPVTRPTMRSVVQILVGEADVPEVPIAKP 661

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M2S4|LRKS4_ARATH L-type lectin-domain containing receptor kinase S.4 OS=Arabidopsis thaliana GN=LECRKS4 PE=1 SV=1

 Score =  308 bits (788), Expect = 1e-82,   Method: Compositional matrix adjust.
 Identities = 205/571 (35%), Positives = 307/571 (53%), Gaps = 51/571 (8%)

Query: 7   NTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGN-DNGYMGLPGPV-LSPQDSFF 64
           N   SFS  F+ +++P  +   G G AF IT   D  G+  + Y+GL     ++    FF
Sbjct: 79  NRALSFSTSFAIAMVPEFVTLGGHGLAFAITPTPDLRGSLPSQYLGLLNSSRVNFSSHFF 138

Query: 65  AVEFDTSFDPSLGDINGNHIGIDISSVISFVSV-------DALSRGIDLKSGRHITTWIE 117
           AVEFDT  D    DIN NH+GIDI+S+ S +S        ++  + + L  GR I  WI+
Sbjct: 139 AVEFDTVRDLEFEDINDNHVGIDINSMESSISTPAGYFLANSTKKELFLDGGRVIQAWID 198

Query: 118 YRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGSAIYTVDRWRF 177
           Y  + K + V       +P   L+   +DLS    D M+VGFSA+ G  ++ + +  W F
Sbjct: 199 YDSNKKRLDVKLSPFSEKPKLSLLSYDVDLSSVLGDEMYVGFSASTGLLASSHYILGWNF 258

Query: 178 KTFESYPSGNPIDVIDEGDCLTCYPEDAGYNGSYSDVDKRKAKIAETALEVGGLVTFVFT 237
                  SG    +      L   P         S + KRK K     L V  L + +  
Sbjct: 259 NM-----SGEAFSL-----SLPSLPRIP------SSIKKRKKKRQSLILGVSLLCSLL-- 300

Query: 238 VVAIVGIISCFLIKKKRHDGRSKEDHVCTVQRVPMRLALTDIKQATLGFNKNRIVGEGAS 297
           + A++   S F+++K + + R +E     +   P R +  ++K+AT GF    ++G G  
Sbjct: 301 IFAVLVAASLFVVRKVKDEDRVEE---WELDFGPHRFSYRELKKATNGFGDKELLGSGGF 357

Query: 298 ATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGN 356
             VYKG LP S   VAVKR    +R +  R  F +E +++ G LRH+NLVQL GWC   +
Sbjct: 358 GKVYKGKLPGSDEFVAVKRISHESR-QGVRE-FMSEVSSI-GHLRHRNLVQLLGWCRRRD 414

Query: 357 ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDV 416
           +L+LVY+++PNGSLD  L + +   ++L+W++R  I+ GVAS L YLHE  E+ +IHRD+
Sbjct: 415 DLLLVYDFMPNGSLDMYLFDENPE-VILTWKQRFKIIKGVASGLLYLHEGWEQTVIHRDI 473

Query: 417 KACNILLDAEFNAKLGDF------------EATIPAGTMGYLAPEYVYSGVPSEKTDVYS 464
           KA N+LLD+E N ++GDF             AT   GT GYLAPE   SG  +  TDVY+
Sbjct: 474 KAANVLLDSEMNGRVGDFGLAKLYEHGSDPGATRVVGTFGYLAPELTKSGKLTTSTDVYA 533

Query: 465 FGVVALEVAAGKSPVDNDG----CVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERML 520
           FG V LEVA G+ P++        V+VDWVW+  + G + D  D RL G+F+ +E+  ++
Sbjct: 534 FGAVLLEVACGRRPIETSALPEELVMVDWVWSRWQSGDIRDVVDRRLNGEFDEEEVVMVI 593

Query: 521 MVGLSCVHPNHEKRPSVKEAARILKGEAPLP 551
            +GL C + + E RP++++    L+ + P P
Sbjct: 594 KLGLLCSNNSPEVRPTMRQVVMYLEKQFPSP 624

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O80939|LRK41_ARATH L-type lectin-domain containing receptor kinase IV.1 OS=Arabidopsis thaliana GN=LECRK41 PE=1 SV=1

 Score =  296 bits (759), Expect = 2e-79,   Method: Compositional matrix adjust.
 Identities = 195/582 (33%), Positives = 304/582 (52%), Gaps = 57/582 (9%)

Query: 1   FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNAD-SFGNDNGYMGLPGPVLSP 59
           F D    T +SFS  F F+I        G G AF++  NA   +GN + Y+GL     + 
Sbjct: 74  FKDSPNGTVSSFSTSFVFAIHSQIAILSGHGIAFVVAPNASLPYGNPSQYIGLFNLANNG 133

Query: 60  QDS--FFAVEFDTSFDPSLGDINGNHIGIDISSVISFVSVDA-------LSRGIDLKSGR 110
            ++   FAVE DT       D N NH+GIDI+S+ S  S  A         + + L S +
Sbjct: 134 NETNHVFAVELDTILSTEFNDTNDNHVGIDINSLKSVQSSPAGYWDEKGQFKNLTLISRK 193

Query: 111 HITTWIEYRDSLKLIRV-WAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGSAI 169
            +  W++Y      I V  A +++ +P  PL+ A  DLS      M+VGFS+A G   + 
Sbjct: 194 PMQVWVDYDGRTNKIDVTMAPFNEDKPTRPLVTAVRDLSSVLLQDMYVGFSSATGSVLSE 253

Query: 170 YTVDRWRFKTFESYPSGNPIDVIDEGDCLTCYPEDAGYNGSYSDVDKRKAKIAETALEVG 229
           + +  W F   E  P   P+        L+  P+          + + + K      ++G
Sbjct: 254 HYILGWSFGLNEKAP---PL-------ALSRLPK----------LPRFEPKRISEFYKIG 293

Query: 230 GLVTFVFTVVAIVGIISCFLIKKKRHDGRSKEDHVCTVQRVPMRLALTDIKQATLGFNKN 289
             +  +F + + + ++ C++++++R      E+      +   R    D+  AT GF + 
Sbjct: 294 MPLISLFLIFSFIFLV-CYIVRRRRKFAEELEEWEKEFGK--NRFRFKDLYYATKGFKEK 350

Query: 290 RIVGEGASATVYKGSLPSGG-AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
            ++G G   +VYKG +P     +AVKR    +R       F  E  ++ G + H+NLV L
Sbjct: 351 GLLGTGGFGSVYKGVMPGTKLEIAVKRVSHESR--QGMKEFVAEIVSI-GRMSHRNLVPL 407

Query: 349 QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE 408
            G+C    EL+LVY+Y+PNGSLDK L+N  +  + L+W++R+ ++LGVAS L YLHEE E
Sbjct: 408 LGYCRRRGELLLVYDYMPNGSLDKYLYN--TPEVTLNWKQRIKVILGVASGLFYLHEEWE 465

Query: 409 RQIIHRDVKACNILLDAEFNAKLGDF------------EATIPAGTMGYLAPEYVYSGVP 456
           + +IHRDVKA N+LLD E N +LGDF            + T   GT+GYLAPE+  +G  
Sbjct: 466 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGSDPQTTHVVGTLGYLAPEHTRTGRA 525

Query: 457 SEKTDVYSFGVVALEVAAGKSPVD-----NDGCVIVDWVWNLRKKGKLLDAADFRLRGKF 511
           +  TDV++FG   LEVA G+ P++     ++  ++VDWV+ L  KG +L A D  +  + 
Sbjct: 526 TMATDVFAFGAFLLEVACGRRPIEFQQETDETFLLVDWVFGLWNKGDILAAKDPNMGSEC 585

Query: 512 NRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEAPLPLL 553
           + KE+E +L +GL C H +   RPS+++    L+G+A LP L
Sbjct: 586 DEKEVEMVLKLGLLCSHSDPRARPSMRQVLHYLRGDAKLPEL 627

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FIF0|LRK22_ARATH Putative L-type lectin-domain containing receptor kinase II.2 OS=Arabidopsis thaliana GN=LECRK22 PE=3 SV=3

 Score =  289 bits (740), Expect = 3e-77,   Method: Compositional matrix adjust.
 Identities = 197/576 (34%), Positives = 293/576 (50%), Gaps = 52/576 (9%)

Query: 16  FSFSIIPSPLCAFGDGFAFLITSNAD--SFGNDNGYMGLPGPVL--SPQDSFFAVEFDTS 71
           F F+I P  L   G G AF++    D    G+   Y+GL         ++   AVE DT+
Sbjct: 88  FVFAIFP--LLGDGQGMAFVVAPFMDIRYSGDAASYLGLFNRKNDNKTENHILAVELDTN 145

Query: 72  FDPSLGDINGNHIGIDISSVIS--------FVSVDALSRGIDLKSGRHITTWIEYRDSLK 123
             P   + + NH+GIDI+S+IS        F   +  +    L S + I  WI+Y  + K
Sbjct: 146 SSPEAIEDSDNHVGIDINSIISEDSANASYFSGTEGKNISFRLASEKSILVWIDYNGTEK 205

Query: 124 LIRVWAG------------YSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGSAIYT 171
           L+ V                S I+P  PL+   I++S+ F   M VGFS + G   +   
Sbjct: 206 LLNVTVAPVPTPKPALPYLSSSIKPRKPLLSRFINISEIFNGTMFVGFSGSTGTVKSDQY 265

Query: 172 VDRWRFKTFESYPSGNPIDVIDEGDCLTCYPEDAGYNGSYSDVDKRKAKIAETALEVGGL 231
           +  W FK      S +   ++D  +                     ++K ++  + +   
Sbjct: 266 ILGWSFKKGGQAESLDLSKILDPPNRPPPPSSPPPPPPPPPTPPTSRSKDSKNIIIICVT 325

Query: 232 VTFVFTVVAIVGIISCFLIKKKRHDGRSKEDHVCTVQRVPMRLALTDIKQATLGFNKNRI 291
           VT +  ++ + G +  +L KKK++   ++       +  P R +  ++ +A  GF +NR+
Sbjct: 326 VTSIAFLLMLGGFL--YLYKKKKY---AEVLEHWENEYSPQRYSFRNLYKAIRGFRENRL 380

Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G    VYKG LPSG  +AVKR    +  E     +  E A+M G LRHKNLVQL G+
Sbjct: 381 LGAGGFGKVYKGELPSGTQIAVKRVY--HNAEQGMKQYAAEIASM-GRLRHKNLVQLLGY 437

Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
           C    EL+LVY+Y+PNGSLD  L N +     L+W +R+NI+ GVASAL YLHEE E+ +
Sbjct: 438 CRRKGELLLVYDYMPNGSLDDYLFNKNKLK-DLTWSQRVNIIKGVASALLYLHEEWEQVV 496

Query: 412 IHRDVKACNILLDAEFNAKLGDF------------EATIPAGTMGYLAPEYVYSGVPSEK 459
           +HRD+KA NILLDA+ N +LGDF            +AT   GT+GY+APE    GV + K
Sbjct: 497 LHRDIKASNILLDADLNGRLGDFGLARFHDRGENLQATRVVGTIGYMAPELTAMGVATTK 556

Query: 460 TDVYSFGVVALEVAAGKSPVDND----GCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKE 515
           TD+Y+FG   LEV  G+ PV+ D       ++ WV    K+  L+D  D +L G F  KE
Sbjct: 557 TDIYAFGSFILEVVCGRRPVEPDRPPEQMHLLKWVATCGKRDTLMDVVDSKL-GDFKAKE 615

Query: 516 MERMLMVGLSCVHPNHEKRPSVKEAARILKGEAPLP 551
            + +L +G+ C   N E RPS++   + L+G A +P
Sbjct: 616 AKLLLKLGMLCSQSNPESRPSMRHIIQYLEGNATIP 651

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81292|LRK43_ARATH L-type lectin-domain containing receptor kinase IV.3 OS=Arabidopsis thaliana GN=LECRK43 PE=2 SV=1

 Score =  287 bits (734), Expect = 2e-76,   Method: Compositional matrix adjust.
 Identities = 196/582 (33%), Positives = 308/582 (52%), Gaps = 51/582 (8%)

Query: 1   FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSN-ADSFGNDNGYMGLPGPVLSP 59
           F D   +T +SFS  F   I        G G AF I  N   S    + Y+GL     + 
Sbjct: 76  FKDSPNDTVSSFSTTFVIGIYSGIPTISGHGMAFFIAPNPVLSSAMASQYLGLFSSTNNG 135

Query: 60  QDS--FFAVEFDTSFDPSLGDINGNHIGIDISSVISFVSV-----DALSR--GIDLKSGR 110
            D+    AVEFDT  +P   D N NH+GI+I+S+ S  S      D +++   + L S +
Sbjct: 136 NDTNHILAVEFDTIMNPEFDDTNDNHVGININSLTSVKSSLVGYWDEINQFNNLTLISRK 195

Query: 111 HITTWIEYRDSLKLIRV-WAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGSAI 169
            +  W++Y D    I V  A + +++P   L+    DLS  F   M++GFSAA G   + 
Sbjct: 196 RMQVWVDYDDRTNQIDVTMAPFGEVKPRKALVSVVRDLSSVFLQDMYLGFSAATGYVLSE 255

Query: 170 YTVDRWRFKTFESYPSGNPIDVIDEGDCLTCYPEDAGYNGSYSDVDKRKAKIAETALEVG 229
           + V  W F       +  P+        L+  P+     G  S     K ++   +L   
Sbjct: 256 HFVFGWSFMV--KGKTAPPL-------TLSKVPKFPRV-GPTSLQRFYKNRMPLFSL--- 302

Query: 230 GLVTFVFTVVAIVGIISCFLIKKKRHDGRSKEDHVCTVQRVPMRLALTDIKQATLGFNKN 289
            L+  V  VV+++ ++  F+++++R      ED      +   RL   D+  AT GF   
Sbjct: 303 -LLIPVLFVVSLIFLVR-FIVRRRRKFAEEFEDWETEFGK--NRLRFKDLYYATKGFKDK 358

Query: 290 RIVGEGASATVYKGSLPSGGA-VAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
            ++G G    VY+G +P+    +AVKR    +R       F  E  ++ G + H+NLV L
Sbjct: 359 DLLGSGGFGRVYRGVMPTTKKEIAVKRVSNESR--QGLKEFVAEIVSI-GRMSHRNLVPL 415

Query: 349 QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE 408
            G+C   +EL+LVY+Y+PNGSLDK L++     + L W++R N+++GVAS L YLHEE E
Sbjct: 416 LGYCRRRDELLLVYDYMPNGSLDKYLYD--CPEVTLDWKQRFNVIIGVASGLFYLHEEWE 473

Query: 409 RQIIHRDVKACNILLDAEFNAKLGDF------------EATIPAGTMGYLAPEYVYSGVP 456
           + +IHRD+KA N+LLDAE+N +LGDF            + T   GT GYLAP++V +G  
Sbjct: 474 QVVIHRDIKASNVLLDAEYNGRLGDFGLARLCDHGSDPQTTRVVGTWGYLAPDHVRTGRA 533

Query: 457 SEKTDVYSFGVVALEVAAGKSPVD-----NDGCVIVDWVWNLRKKGKLLDAADFRLRGKF 511
           +  TDV++FGV+ LEVA G+ P++     ++  ++VD V+    +G +LDA D  L   +
Sbjct: 534 TTATDVFAFGVLLLEVACGRRPIEIEIESDESVLLVDSVFGFWIEGNILDATDPNLGSVY 593

Query: 512 NRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEAPLPLL 553
           +++E+E +L +GL C H + + RP++++  + L+G+A LP L
Sbjct: 594 DQREVETVLKLGLLCSHSDPQVRPTMRQVLQYLRGDATLPDL 635

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q66GN2|LRK64_ARATH Lectin-domain containing receptor kinase VI.4 OS=Arabidopsis thaliana GN=LECRK64 PE=2 SV=1

 Score =  286 bits (732), Expect = 3e-76,   Method: Compositional matrix adjust.
 Identities = 203/582 (34%), Positives = 293/582 (50%), Gaps = 61/582 (10%)

Query: 6   TNTTA-SFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGND-NGYMGLPGPVLSPQDS- 62
           TNTT  SFS  F F I  S     G GF F ++   +    D   YMGL         S 
Sbjct: 83  TNTTVRSFSTSFIFIIPSSSTSNGGFGFTFTLSPTPNRTDADPEQYMGLLNERNDGNSSN 142

Query: 63  -FFAVEFDT--SFDPSLGDINGNHIGIDISSVIS--------FVSVDALSRGIDLKSGRH 111
             FAVEFDT   F      I GNHIG++ +S+ S        F + D+      L SG  
Sbjct: 143 HVFAVEFDTVQGFKDGTNRI-GNHIGLNFNSLSSDVQEPVAYFNNNDSQKEEFQLVSGEP 201

Query: 112 ITTWIEYRDSLKLIR--VWAGYSQIRPPSPLIIAQI-DLSKQFKDYMHVGFSAA---NGQ 165
           I  +++Y    K +   V+      +P  PLI  ++  LS    D M VGF+AA   +GQ
Sbjct: 202 IQVFLDYHGPTKTLNLTVYPTRLGYKPRIPLISREVPKLSDIVVDEMFVGFTAATGRHGQ 261

Query: 166 GSAIYTVDRWRFKTFESYPSGNPIDVIDEGDCLTCYPEDAGYNGSYSDVDKRKAKIAETA 225
            SA Y +  W F +   +P    +D+           +  GYNG                
Sbjct: 262 SSAHYVMG-WSFASGGEHPLAAMLDISQLPPPPPNKAKKRGYNG---------------- 304

Query: 226 LEVGGLVTFVFTVVAIVGIISCFLIKKKRHDGRSKEDHVCTVQRV--PMRLALTDIKQAT 283
            +V  L+  + TV++I+ ++    +  K+   R +++ +     +  P R    D+ +AT
Sbjct: 305 -KVIALIVALSTVISIMLVLLFLFMMYKK---RMQQEEILEDWEIDHPHRFRYRDLYKAT 360

Query: 284 LGFNKNRIVGEGASATVYKGSL-PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRH 342
            GF +NR+VG G    VY+G++  S   +AVK+   PN ++  R  F  E  ++ G LRH
Sbjct: 361 EGFKENRVVGTGGFGIVYRGNIRSSSDQIAVKKI-TPNSMQGVRE-FVAEIESL-GRLRH 417

Query: 343 KNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNN-SSSSIVLSWEKRLNIVLGVASALS 401
           KNLV LQGWC   N+L+L+Y+Y+PNGSLD +L++    S  VLSW  R  I  G+AS L 
Sbjct: 418 KNLVNLQGWCKHRNDLLLIYDYIPNGSLDSLLYSKPRRSGAVLSWNARFQIAKGIASGLL 477

Query: 402 YLHEECERQIIHRDVKACNILLDAEFNAKLGDFE------------ATIPAGTMGYLAPE 449
           YLHEE E+ +IHRDVK  N+L+D++ N +LGDF              T+  GT+GY+APE
Sbjct: 478 YLHEEWEQIVIHRDVKPSNVLIDSDMNPRLGDFGLARLYERGSQSCTTVVVGTIGYMAPE 537

Query: 450 YVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRG 509
              +G  S  +DV++FGV+ LE+ +G+ P D+    I DWV  L+  G++L A D RL  
Sbjct: 538 LARNGNSSSASDVFAFGVLLLEIVSGRKPTDSGTFFIADWVMELQASGEILSAIDPRLGS 597

Query: 510 KFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEAPLP 551
            ++  E    L VGL C H   E RP ++   R L  +  +P
Sbjct: 598 GYDEGEARLALAVGLLCCHHKPESRPLMRMVLRYLNRDEDVP 639

Involved in negative regulation of abscisic acid response in seed germination.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FIF1|LRK21_ARATH Probable L-type lectin-domain containing receptor kinase II.1 OS=Arabidopsis thaliana GN=LECRK21 PE=2 SV=1

 Score =  286 bits (731), Expect = 4e-76,   Method: Compositional matrix adjust.
 Identities = 205/609 (33%), Positives = 303/609 (49%), Gaps = 75/609 (12%)

Query: 19  SIIPSPLCAFGDGFAFLITSNAD--SFGNDNGYMGLPGPVLSPQDS--FFAVEFDTSFDP 74
           +I P     +G G AF+++   D  S G+ N  +G+       + +   FAVE DT+ + 
Sbjct: 91  AIFPLQKSTYGHGMAFVVSPTKDLRSNGSANSNLGIFNRANDNKTATHIFAVELDTNQNS 150

Query: 75  SLGDINGNHIGIDISSVISFVSVDA----LSRG----IDLKSGRHITTWIEYRDSLKLIR 126
              D  GN +GIDI+S++S  S DA      +G    + L SG+ I  WI+Y    K++ 
Sbjct: 151 ESFDKGGNDVGIDINSIVSVESADASYFNARKGKNISLPLASGKSILVWIDYDGIEKVLN 210

Query: 127 VWAGYSQ------------IRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGSAIYTVDR 174
           V     Q            I+P  PL+   I+LS+ F + M+VGFS + G   +   +  
Sbjct: 211 VTLAPVQTPKPDSPYFSSFIKPKVPLLSRSINLSEIFTETMYVGFSGSTGSIKSNQYILG 270

Query: 175 WRFKTFESYPSGNPIDVIDEGDCLTCYPEDAGYNGSYSDVDKRKAKIAETALEVGGLVTF 234
           W FK       G   + +D        P    +                   EV G    
Sbjct: 271 WSFK------QGGKAESLDISRLSNPPPSPKRF----------------PLKEVLGATIS 308

Query: 235 VFTVVAIVGIISCFLIKKKRHDGRSKEDHVCTVQRVPMRLALTDIKQATLGFNKNRIVGE 294
               + + GI+  +L KKK++    ++      +  P R +   + +AT GF +N+++G 
Sbjct: 309 TIAFLTLGGIV--YLYKKKKYAEVLEQ---WEKEYSPQRYSFRILYKATKGFRENQLLGA 363

Query: 295 GASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE 354
           G    VYKG LPSG  +AVKR    +  E     +  E A+M G LRHKNLV L G+C  
Sbjct: 364 GGFGKVYKGILPSGTQIAVKRVY--HDAEQGMKQYVAEIASM-GRLRHKNLVHLLGYCRR 420

Query: 355 GNELVLVYEYLPNGSLDKIL-HNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIH 413
             EL+LVY+Y+PNGSLD  L H N      L+W +R+NI+ GVASAL YLHEE E+ ++H
Sbjct: 421 KGELLLVYDYMPNGSLDDYLFHKNKLKD--LTWSQRVNIIKGVASALLYLHEEWEQVVLH 478

Query: 414 RDVKACNILLDAEFNAKLGDF------------EATIPAGTMGYLAPEYVYSGVPSEKTD 461
           RD+KA NILLDA+ N KLGDF            EAT   GT+GY+APE    GV +  TD
Sbjct: 479 RDIKASNILLDADLNGKLGDFGLARFHDRGVNLEATRVVGTIGYMAPELTAMGVTTTCTD 538

Query: 462 VYSFGVVALEVAAGKSPVDNDG----CVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEME 517
           VY+FG   LEV  G+ PVD D      ++V WV +  K+  L D  D +L   F  +E +
Sbjct: 539 VYAFGAFILEVVCGRRPVDPDAPREQVILVKWVASCGKRDALTDTVDSKLI-DFKVEEAK 597

Query: 518 RMLMVGLSCVHPNHEKRPSVKEAARILKGEAPLPLLPVKKPTVNIRSVFPEA-SELIDSG 576
            +L +G+ C   N E RPS+++  + L+G   +P +      + I ++  E  +++  + 
Sbjct: 598 LLLKLGMLCSQINPENRPSMRQILQYLEGNVSVPAISFGTVALGIPNISHETVTQMTTTS 657

Query: 577 GDHSPGFDD 585
              +  F+D
Sbjct: 658 SSANFSFED 666

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	596
224085089	677	predicted protein [Populus trichocarpa]	0.991	0.872	0.652	0.0
225463883	698	PREDICTED: L-type lectin-domain containi	0.996	0.851	0.639	0.0
255570340	696	kinase, putative [Ricinus communis] gi|2	0.937	0.803	0.655	0.0
356534061	685	PREDICTED: L-type lectin-domain containi	0.991	0.862	0.599	0.0
357443743	666	Cysteine-rich receptor-like protein kina	0.963	0.861	0.597	0.0
449462190	770	PREDICTED: L-type lectin-domain containi	0.998	0.772	0.6	0.0
449506975	672	PREDICTED: L-type lectin-domain containi	0.998	0.885	0.6	0.0
297791869	689	lectin protein kinase family protein [Ar	0.983	0.850	0.579	0.0
15238300	691	concanavalin A-like lectin kinase-like p	0.971	0.837	0.576	0.0
225461937	679	PREDICTED: probable L-type lectin-domain	0.953	0.836	0.405	1e-122

>gi|224085089|ref|XP_002307486.1| predicted protein [Populus trichocarpa] gi|222856935|gb|EEE94482.1| predicted protein [Populus trichocarpa]

 Score =  812 bits (2097), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 398/610 (65%), Positives = 477/610 (78%), Gaps = 19/610 (3%)

Query: 1   FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQ 60
           FLDP TNTTASF CRFSFSII SPLC+ GDG AFLITSNADSF    GYMGLP P L+PQ
Sbjct: 71  FLDPITNTTASFFCRFSFSIIRSPLCSSGDGMAFLITSNADSFSLSKGYMGLPEPALNPQ 130

Query: 61  DSFFAVEFDTSFDPSLGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRD 120
           DSF AVEFDTS DPSLGDI+ NHIGID ++++SF ++DA+S GIDL+SGR IT WIEY D
Sbjct: 131 DSFIAVEFDTSCDPSLGDISSNHIGIDANTIVSFAAIDAVSVGIDLQSGRQITAWIEYSD 190

Query: 121 SLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGSAIYTVDRWRFKTF 180
           S KLI+VW  Y Q+RPPSP+++AQ+DLS+ FK+YMHVGFSA+NGQGSA++ VD WRFKT+
Sbjct: 191 SSKLIQVWVSYFQVRPPSPILVAQVDLSEHFKEYMHVGFSASNGQGSAVHIVDHWRFKTY 250

Query: 181 ESYPSGNPIDVIDEGDCLTCYPEDAGYNGSYSDVDKRKAKIAETALEVGGLVTFVFTVVA 240
            +  S  P D  D+GDCL CYPE+  YN      +  K K+ E AL +GGL  F  +++ 
Sbjct: 251 ATLSSVTPRDTSDKGDCLMCYPENPMYNYGPGTQNGWKKKLLEMALGLGGLAAFTVSLIV 310

Query: 241 IVGIISCFLIKK-KRHDGRSKEDHVCTVQRVPMRLALTDIKQATLGFNKNRIVGEGASAT 299
           ++ +I  F IKK K   GR+KE     + RVP RL++T+I+ AT+GF+++RI+G+GASAT
Sbjct: 311 VLFVIIFFAIKKGKGVGGRTKEGR---INRVPRRLSITEIRTATMGFHRSRIIGQGASAT 367

Query: 300 VYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELV 359
           V+KG L S G+VAVKRF++   +ECARNPF TEFATM GCLRH+NLVQLQGWCCEG  L 
Sbjct: 368 VFKGYLSSCGSVAVKRFDQAG-IECARNPFITEFATMVGCLRHENLVQLQGWCCEGTVLA 426

Query: 360 LVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKAC 419
           LVYEYLPNGSL+++LH NSSS+I L W++R+NIVLGVASALSYLHEECERQIIHRDVKAC
Sbjct: 427 LVYEYLPNGSLNEVLHKNSSSAIFLLWKQRVNIVLGVASALSYLHEECERQIIHRDVKAC 486

Query: 420 NILLDAEFNAKLGDF-------------EATIPAGTMGYLAPEYVYSGVPSEKTDVYSFG 466
           NILLDAEFNAKLGDF              ATIPAGT GYLAPEYVY GVPS K+DVYSFG
Sbjct: 487 NILLDAEFNAKLGDFGLAEVYEHSSVMRAATIPAGTTGYLAPEYVYYGVPSVKSDVYSFG 546

Query: 467 VVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSC 526
           VV LEVA GK PVD+ G V+VD VW+  +KGKL++AAD +L G FN  E+ERMLMVGLSC
Sbjct: 547 VVMLEVATGKRPVDDVGAVLVDRVWSFWEKGKLIEAADSKLVGMFNTLEVERMLMVGLSC 606

Query: 527 VHPNHEKRPSVKEAARILKGEAPLPLLPVKKPTVNIRSVFPEAS-ELIDSGGDHSPGFDD 585
           VHPNHE RP+VKEAA IL+G+APLP+LP +KP V  +SV  E S E ++  GD+SP  DD
Sbjct: 607 VHPNHEMRPTVKEAAVILRGQAPLPVLPQRKPAVGFQSVLSEDSDETLNLAGDNSPCTDD 666

Query: 586 SLWMTPRSRF 595
             WMTPR+ F
Sbjct: 667 VTWMTPRTSF 676

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225463883|ref|XP_002263711.1| PREDICTED: L-type lectin-domain containing receptor kinase S.6-like [Vitis vinifera]

 Score =  794 bits (2050), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 390/610 (63%), Positives = 473/610 (77%), Gaps = 16/610 (2%)

Query: 1   FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQ 60
           FLD +TNT ASFS RFSFSIIPSPLC FGDG AFLITSN   F   +GY+GLP P LS Q
Sbjct: 89  FLDSRTNTPASFSSRFSFSIIPSPLCRFGDGMAFLITSNGGYFSLSDGYLGLPEP-LSTQ 147

Query: 61  DSFFAVEFDTSFDPSLGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRD 120
           DSF A+EFDTSF+PSLGDINGNH+GID+++++SF SVD++S+GIDLKSG+ +T WIEYRD
Sbjct: 148 DSFVAIEFDTSFNPSLGDINGNHVGIDVNTIVSFASVDSVSQGIDLKSGKEMTAWIEYRD 207

Query: 121 SLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGSAIYTVDRWRFKTF 180
           + K+IRVW G S +RPP PL++AQIDLS+ FK++MHVGFSA+NG GSA + V+RWRFKTF
Sbjct: 208 AEKIIRVWVGNSPVRPPRPLLVAQIDLSRHFKEFMHVGFSASNGPGSAGHIVNRWRFKTF 267

Query: 181 ESYPSGNPIDVIDEGDCLTCYPEDAGYNGSYSDVDKRKAKIAETALEVGGLVTFVFTVVA 240
              PS  P+D  ++GDC  C PE++    +  D+     +I E AL +GGL   V  ++ 
Sbjct: 268 GFIPSAIPMDAAEDGDCFMCAPENSNAKRNPFDLHIGSLEIKEMALGLGGLTAVVLAMIV 327

Query: 241 IVGIISCFLIKKKRHDGRSKEDHVCTVQRVPMRLALTDIKQATLGFNKNRIVGEGASATV 300
           I+ II C + KK+    RS+ED  C +Q  PMR +L +I  AT+GFNK RI+GEGAS+TV
Sbjct: 328 ILIIIFCLIRKKRLGIRRSQEDQSCRIQTAPMRFSLAEINSATMGFNKKRIIGEGASSTV 387

Query: 301 YKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVL 360
           Y+G LPS GAVAVKRF + NR++   +PFT EF T+  CLRH NLVQL GWCCEGNE +L
Sbjct: 388 YQGFLPSVGAVAVKRFTQTNRIDYCSDPFTNEFVTVGDCLRHANLVQLIGWCCEGNEFLL 447

Query: 361 VYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACN 420
           +YEYLPNGSLDK+LH N  S   L+WE+RLNIVLGVASAL+YLHEECERQIIHRDVKA N
Sbjct: 448 IYEYLPNGSLDKVLHKNIKSGSSLTWEQRLNIVLGVASALTYLHEECERQIIHRDVKASN 507

Query: 421 ILLDAEFNAKLGDF-------------EATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGV 467
           I+LD+EFNAKLGDF             EATIPAGTMGYLAPEYV  GVP+EKTDVYSFGV
Sbjct: 508 IMLDSEFNAKLGDFGLAEIYEHSSITREATIPAGTMGYLAPEYVCYGVPTEKTDVYSFGV 567

Query: 468 VALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCV 527
           V LE+A G+ PVD+D  V++DWVW+LR+KG L+ AADFRL G+FNR EMERMLMVGLSC 
Sbjct: 568 VMLELATGRKPVDDDRSVLLDWVWDLREKGTLMLAADFRLMGRFNRVEMERMLMVGLSCA 627

Query: 528 HPNHEKRPSVKEAARILKGEAPLPLLPVKKPTVNIRSVFPEASE-LIDSGG-DHSPGFDD 585
           HPNH+KRP+VK+AARIL+GEAPLP LP +KPT   +   PEAS+ ++D GG D +P  DD
Sbjct: 628 HPNHKKRPTVKKAARILRGEAPLPTLPARKPTPRPQHSLPEASQRIMDLGGDDENPSLDD 687

Query: 586 SLWMTPRSRF 595
           + WMTPRS F
Sbjct: 688 APWMTPRSHF 697

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255570340|ref|XP_002526129.1| kinase, putative [Ricinus communis] gi|223534506|gb|EEF36205.1| kinase, putative [Ricinus communis]

 Score =  788 bits (2034), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 377/575 (65%), Positives = 454/575 (78%), Gaps = 16/575 (2%)

Query: 1   FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQ 60
           FLD  T+  ASFSCRFSFSII SPLC+FGDG AFLITSNA+SF   NGYMGLPGP L+PQ
Sbjct: 88  FLDSTTSIPASFSCRFSFSIIKSPLCSFGDGMAFLITSNAESFSLSNGYMGLPGPALNPQ 147

Query: 61  DSFFAVEFDTSFDPSLGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRD 120
           DSF AVEFDTSFDP L DING+HIGID+++V+SF SVDALS GIDLKSG+ +  WIEY D
Sbjct: 148 DSFVAVEFDTSFDPFLSDINGDHIGIDVNTVVSFASVDALSNGIDLKSGKQMIAWIEYSD 207

Query: 121 SLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGSAIYTVDRWRFKTF 180
             KLI+VW   SQ RPP+P++ A++DLS+ FK++MHVGF+A+NGQGSA++ +D WRFKT+
Sbjct: 208 IAKLIQVWVSDSQNRPPNPILEARVDLSENFKEFMHVGFTASNGQGSAVHLIDHWRFKTY 267

Query: 181 ESYPSGNPIDVIDEGDCLTCYPEDAGYNGSYSDVDKRKAKIAETALEVGGLVTFVFTVVA 240
            S P+   +   +  DC  CY ED+  NG  +++D++  K+ E AL +GGL  F+ ++  
Sbjct: 268 WSAPAATNVQASEGEDCFLCYLEDSSENGDPTNLDEKTNKMKEIALGLGGLAAFILSIAL 327

Query: 241 IVGIISCFLIKKKR--HDGRSKEDHVCTVQRVPMRLALTDIKQATLGFNKNRIVGEGASA 298
           I+ II  F+I+KKR     R+KE      +  P R ++ +IK AT+GF++NRI+GEGASA
Sbjct: 328 ILAIIFLFVIRKKRVVFGRRTKEGQFFIHKGGPTRFSIVEIKAATMGFHRNRIIGEGASA 387

Query: 299 TVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNEL 358
           TVYKGSLP  GAVAVKRF K   +EC RNPF TEFAT+ GCL+H NLVQLQGWCCE +EL
Sbjct: 388 TVYKGSLPDLGAVAVKRFNK-TEIECCRNPFITEFATIVGCLKHNNLVQLQGWCCEESEL 446

Query: 359 VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKA 418
           VLVYEYLPNGSL KILHNN+SSS  LSW++R+NI LGVASALSYLHEE ERQIIHRDVK 
Sbjct: 447 VLVYEYLPNGSLAKILHNNTSSSNFLSWKQRMNIALGVASALSYLHEESERQIIHRDVKT 506

Query: 419 CNILLDAEFNAKLGDF-------------EATIPAGTMGYLAPEYVYSGVPSEKTDVYSF 465
           CNI+LD EFNAKLGDF             EATIPAGTMGYLAPEYVYSGVPS KTDVYSF
Sbjct: 507 CNIMLDEEFNAKLGDFGLAEVYEHSSSTREATIPAGTMGYLAPEYVYSGVPSVKTDVYSF 566

Query: 466 GVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLS 525
           GVV LEVA GK PVD+DG V+VDWVW   ++GKL++AAD +L+GKFN  EM+RML+VGL 
Sbjct: 567 GVVVLEVATGKRPVDDDGTVLVDWVWGFWEQGKLIEAADSKLKGKFNGAEMQRMLLVGLC 626

Query: 526 CVHPNHEKRPSVKEAARILKGEAPLPLLPVKKPTV 560
           CVHPNHE+RP++KEAA+ILKGEAPLP+LP +KP V
Sbjct: 627 CVHPNHEERPTIKEAAKILKGEAPLPVLPSRKPKV 661

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356534061|ref|XP_003535576.1| PREDICTED: L-type lectin-domain containing receptor kinase S.6-like [Glycine max]

 Score =  734 bits (1896), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 372/621 (59%), Positives = 461/621 (74%), Gaps = 30/621 (4%)

Query: 1   FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQ 60
           FLDP+TN+TASFSCRFSFSI+ SP C   DG AFLI S+       +GYMGLP    S  
Sbjct: 68  FLDPQTNSTASFSCRFSFSILSSPSCPSADGLAFLIASSTHFPTLSSGYMGLP---SSSF 124

Query: 61  DSFFAVEFDTSFDPSLGDINGNHIGIDISSVIS-FVSVDALSRGIDLKSGRHITTWIEYR 119
            SFFAVEFDT+F P LGDIN NH+ +D++S+ S F SVDA SRG+DLKSG+ IT W+EYR
Sbjct: 125 SSFFAVEFDTAFHPFLGDINDNHVAVDVNSLASSFASVDAASRGVDLKSGKIITAWVEYR 184

Query: 120 DSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGSAIYTVDRWRFKT 179
            +++++RVW GYS  RPP+P++  QIDLS++ +D+MHVGF+A+NG+GS+++ V  W+FKT
Sbjct: 185 HAMRMVRVWIGYSSTRPPTPILATQIDLSERLEDFMHVGFTASNGEGSSVHLVHHWQFKT 244

Query: 180 FESYPSGNPIDVIDEGDCLTCYPEDA-----GYNGSYSDVDKRKAKIAETALEVGGLVTF 234
           F        +DV++EGDC  CY  D+     G + S  D  +R+ KI E AL + GL  F
Sbjct: 245 FGYDDDSRSMDVVEEGDCFLCYEGDSTGKREGSSMSNKDDIERRKKIGEMALGLAGLTAF 304

Query: 235 VFTVVAIVGIISCFLIKKK---RHDGRSKEDHVCTVQ--RVPMRLALTDIKQATLGFNKN 289
           V + +A + ++  FL K K   R   + ++   C  Q  +VP RL+L+DIK AT+GFN++
Sbjct: 305 VVSGLAAMVVVCVFLTKNKACIRKKNKEEQGQSCRFQTSKVPTRLSLSDIKSATMGFNRD 364

Query: 290 RIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQ 349
           R+VGEGASA VYKG LP GG VAVKRFE+ N ++C  NPF TEFATM G LRHKNLVQL+
Sbjct: 365 RLVGEGASAKVYKGYLPFGGDVAVKRFERDNGLDCLHNPFATEFATMVGYLRHKNLVQLK 424

Query: 350 GWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECER 409
           GWCCEGNELVLVYE+LPNGSL+K+LH N +SSIVLSW++RLNIVLGVASAL+YLHEECER
Sbjct: 425 GWCCEGNELVLVYEFLPNGSLNKVLHRNFNSSIVLSWQQRLNIVLGVASALTYLHEECER 484

Query: 410 QIIHRDVKACNILLDAEFNAKLGDF-------------EATIPAGTMGYLAPEYVYSGVP 456
           QIIHRDVK CNI+LDA+F AKLGDF             +ATIPAGTMGYLAPEYVYSGVP
Sbjct: 485 QIIHRDVKTCNIMLDADFTAKLGDFGLAEVYEHSSSTRDATIPAGTMGYLAPEYVYSGVP 544

Query: 457 SEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEM 516
           + KTDVYSFGVV LEVA G+ PV++DG V+VD+VW L  K KL++AAD RL GKF+ KEM
Sbjct: 545 TVKTDVYSFGVVVLEVATGRKPVEDDGTVVVDFVWGLWGKRKLIEAADPRLMGKFDEKEM 604

Query: 517 ERMLMVGLSCVHPNHEKRPSVKEAARILKGEAPLPLLPVKKPTVNIRSVFP--EASELID 574
           ERML+VGL CVHP++EKRP V+EA RILK EAPLPLLP  KP V IR + P  + SE   
Sbjct: 605 ERMLLVGLLCVHPDYEKRPRVREATRILKKEAPLPLLPTSKPRVRIRPICPDDDTSEAQS 664

Query: 575 SGGDHSPGFDDSLWMTPRSRF 595
              D     DD+ ++TPRS+F
Sbjct: 665 VVADWLST-DDAPYLTPRSQF 684

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357443743|ref|XP_003592149.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] gi|355481197|gb|AES62400.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula]

 Score =  722 bits (1864), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 367/614 (59%), Positives = 452/614 (73%), Gaps = 40/614 (6%)

Query: 1   FLDPKTNTTASFSCRFSFSIIPSPLCAFG-DGFAFLITSNADSFGNDNGYMGLPGPVLSP 59
           FLDP TN+TASFSCRFSFSI+ SP C    DG AFLI+S  D     NGYMGLP    S 
Sbjct: 73  FLDPLTNSTASFSCRFSFSILSSPSCPSSSDGIAFLISSTTDFSSLSNGYMGLPH---SD 129

Query: 60  QDSFFAVEFDTSFDPSLGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYR 119
           QDS+FAVEFDTSFDPSLGDINGNH+GID+ SV+SF S D LSR IDLKSG+ I  WIEYR
Sbjct: 130 QDSYFAVEFDTSFDPSLGDINGNHVGIDLGSVVSFASADLLSRRIDLKSGKIINAWIEYR 189

Query: 120 DSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGSAIYTVDRWRFKT 179
           D +K++RVW  YS  RPP+P+I + IDLS++FK++MHVGFSA+NG+GS+I+ V  W+FKT
Sbjct: 190 DDMKMVRVWVSYSSTRPPTPIIASFIDLSERFKEFMHVGFSASNGKGSSIHLVHHWQFKT 249

Query: 180 FESYPSGNPIDVIDEGDCLTCYPEDAGYNGSYSDVDKRKAKIAETALEVGGLVTFVFTVV 239
                S  P+D ++EGDC  CY  D+                 + AL +GG+  FV    
Sbjct: 250 LSYSHSVGPMDNVEEGDCFLCYAGDS-----------------KIALGIGGITAFVVGSA 292

Query: 240 AIVGIISCFLIKKKR----HDGRSKEDHVCTVQRVPMRLALTDIKQATLGFNKNRIVGEG 295
             + ++ C LIK+KR       R  +       +VP++L+L++I  AT+GFN++R+VGEG
Sbjct: 293 LALIVVICVLIKRKRGGVIRKIREGQSSRFQTNKVPVKLSLSEITSATMGFNRDRLVGEG 352

Query: 296 ASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG 355
           ASA VYKGSLP GG VAVKRFEK + ++   NPF TEFATM GCLRHKNLVQL+GWCCEG
Sbjct: 353 ASAKVYKGSLPFGGDVAVKRFEKIDELDRLHNPFATEFATMVGCLRHKNLVQLKGWCCEG 412

Query: 356 NELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRD 415
           NELVLVYEYLPNGSLDK+LH N SSS VLSW++R+NI+LGVA+AL+YLHEECERQIIHRD
Sbjct: 413 NELVLVYEYLPNGSLDKVLHRNLSSSFVLSWKQRVNIILGVAAALTYLHEECERQIIHRD 472

Query: 416 VKACNILLDAEFNAKLGDF-------------EATIPAGTMGYLAPEYVYSGVPSEKTDV 462
           VK CNI+LD +FNAKLGDF             +ATIPAGTMGYLAPEYVYSGVP+ KTDV
Sbjct: 473 VKTCNIMLDVDFNAKLGDFGLAEVYEHSSSTRDATIPAGTMGYLAPEYVYSGVPTVKTDV 532

Query: 463 YSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMV 522
           YSFGVV +EVA G+ PV +DG VI D+VW+L +K +L++AAD +L G+F+  EMERML+V
Sbjct: 533 YSFGVVIIEVATGRKPVADDGTVIGDYVWSLWEKNRLVEAADPKLMGEFDVIEMERMLLV 592

Query: 523 GLSCVHPNHEKRPSVKEAARILKGEAPLPLLPVKKPTVNIRSVFP-EASELIDSGGDHSP 581
           GL CVHP++EKRP V++AAR++K EAPLPLLP  KP V I  V P +  E  D  GD   
Sbjct: 593 GLVCVHPDYEKRPRVRDAARMIKKEAPLPLLPTTKPWVRIMPVCPNDTPETQDVVGDWVS 652

Query: 582 GFDDSLWMTPRSRF 595
             D++ ++TPRS+F
Sbjct: 653 N-DEAPYLTPRSQF 665

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449462190|ref|XP_004148824.1| PREDICTED: L-type lectin-domain containing receptor kinase S.6-like [Cucumis sativus]

 Score =  700 bits (1806), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 369/615 (60%), Positives = 447/615 (72%), Gaps = 20/615 (3%)

Query: 1   FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQ 60
           FLD  TN++ASFS RFS SI+P+PLC+F DGFAFLI S+ +SF   N ++ LP P  S  
Sbjct: 155 FLDSSTNSSASFSSRFSLSILPTPLCSFPDGFAFLIASDPESFTLSNSHIPLPNPSHSSP 214

Query: 61  DSFFAVEFDTSFDPSLGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRD 120
            SF AVEFDT+FD +LGDIN NH+G++++S  S  SVD  S GI LK+GR IT WIEYRD
Sbjct: 215 FSFIAVEFDTNFDSNLGDINDNHLGLNVNSPTSLTSVDFRSHGIVLKNGRKITAWIEYRD 274

Query: 121 SLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGSAIYTVDRWRFKTF 180
             K IRVW GYSQ RP +PL+ A +DLSKQFK++M+VGFSA+NGQGSA++ VDRW+F+TF
Sbjct: 275 DSKTIRVWVGYSQTRPVNPLLAAPMDLSKQFKEFMYVGFSASNGQGSALFIVDRWQFRTF 334

Query: 181 ESYPSGNPIDVIDEG-DCLTCYPEDAGY-NGSYSDVDKRKAKIAETALEVGGLVTFVFTV 238
              PS +P+D I+EG  C  C  ED    N  + D  +R+ K  E +L  GGL  F  + 
Sbjct: 335 GLLPSLSPVDTINEGAGCFMCSSEDLNSDNSRFVDASERRKKSGEMSLVFGGLAAFACSG 394

Query: 239 VAIVGIISCFLIKKKRHD-GRSKE-DHVCTVQ--RVPMRLALTDIKQATLGFNKNRIVGE 294
             I+G +S  LIKK R    R +E D  C V+  R+P RL+L +IK AT+GFN+NR+VGE
Sbjct: 395 ALILGFVSYTLIKKLRSRVCRGREIDRTCLVKMNRIPTRLSLGEIKLATMGFNQNRVVGE 454

Query: 295 GASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE 354
           G SATVYKGSLPSG  VAVKRFE+        NPF TEFATM GCLRHKNLVQL GWCCE
Sbjct: 455 GGSATVYKGSLPSGVEVAVKRFEQGMANNRLPNPFATEFATMVGCLRHKNLVQLHGWCCE 514

Query: 355 GNELVLVYEYLPNGSLDKILHNNS-SSSIVLSWEKRLNIVLGVASALSYLHEECERQIIH 413
            NELVLVYEYL NGSL K+LH  S +S  V+ W+KR++IVLGVASAL+YLHEECERQIIH
Sbjct: 515 ANELVLVYEYLANGSLAKLLHETSPNSQFVIPWKKRVSIVLGVASALTYLHEECERQIIH 574

Query: 414 RDVKACNILLDAEFNAKLGDFE-------------ATIPAGTMGYLAPEYVYSGVPSEKT 460
           RDVK CNILLDA+ NAKLGDF              ATIPAGTMGYLAPEY+Y GVP+ KT
Sbjct: 575 RDVKTCNILLDADLNAKLGDFGLAEVYEHSSLTRIATIPAGTMGYLAPEYLYYGVPTVKT 634

Query: 461 DVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERML 520
           DVYSFGVV LEVA+GK PVD  G V+VDW+W L     L++AAD RL G ++  EMERML
Sbjct: 635 DVYSFGVVILEVASGKRPVDEGGMVLVDWIWVLWGVRSLIEAADPRLMGNYDVVEMERML 694

Query: 521 MVGLSCVHPNHEKRPSVKEAARILKGEAPLPLLPVKKPTVNIRSVFPEASELIDSGGDHS 580
           MVGL CVHPN+EKRP+VKEA RIL+GEAPLP+LP++KP V IR +  +  E +++     
Sbjct: 695 MVGLFCVHPNNEKRPTVKEAVRILRGEAPLPVLPLRKPMVGIRPILSDDFEDLENPCSDY 754

Query: 581 PGFDDSLWMTPRSRF 595
             F++  WMTP+S F
Sbjct: 755 IAFEEPAWMTPKSEF 769

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449506975|ref|XP_004162899.1| PREDICTED: L-type lectin-domain containing receptor kinase S.6-like [Cucumis sativus]

 Score =  697 bits (1800), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 369/615 (60%), Positives = 447/615 (72%), Gaps = 20/615 (3%)

Query: 1   FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQ 60
           FLD  TN++ASFS RFS SI+P+PLC+F DGFAFLI S+ +SF   N ++ LP P  S  
Sbjct: 57  FLDSSTNSSASFSSRFSLSILPTPLCSFPDGFAFLIASDPESFTLSNSHIPLPNPSHSSP 116

Query: 61  DSFFAVEFDTSFDPSLGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRD 120
            SF AVEFDT+FD +LGDIN NH+G++++S  S  SVD  S GI LK+GR IT WIEYRD
Sbjct: 117 FSFIAVEFDTNFDSNLGDINDNHLGLNVNSPTSLTSVDFRSHGIVLKNGRKITAWIEYRD 176

Query: 121 SLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGSAIYTVDRWRFKTF 180
             K IRVW GYSQ RP +PL+ A +DLSKQFK++M+VGFSA+NGQGSA++ VDRW+F+TF
Sbjct: 177 DSKTIRVWVGYSQTRPVNPLLAAPMDLSKQFKEFMYVGFSASNGQGSALFIVDRWQFRTF 236

Query: 181 ESYPSGNPIDVIDEG-DCLTCYPEDAGY-NGSYSDVDKRKAKIAETALEVGGLVTFVFTV 238
              PS +P+D I+EG  C  C  ED    N  + D  +R+ K  E +L  GGL  F  + 
Sbjct: 237 GLLPSLSPVDTINEGAGCFMCSSEDLNSDNSRFVDASERRKKSGEMSLVFGGLAAFACSG 296

Query: 239 VAIVGIISCFLIKKKRHD-GRSKE-DHVCTVQ--RVPMRLALTDIKQATLGFNKNRIVGE 294
             I+G +S  LIKK R    R +E D  C V+  R+P RL+L +IK AT+GFN+NR+VGE
Sbjct: 297 ALILGFVSYTLIKKLRSRVCRGREIDRTCLVKMNRIPTRLSLGEIKLATMGFNQNRVVGE 356

Query: 295 GASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE 354
           G SATVYKGSLPSG  VAVKRFE+        NPF TEFATM GCLRHKNLVQL GWCCE
Sbjct: 357 GGSATVYKGSLPSGVEVAVKRFEQGMANNRLPNPFATEFATMVGCLRHKNLVQLHGWCCE 416

Query: 355 GNELVLVYEYLPNGSLDKILHNNS-SSSIVLSWEKRLNIVLGVASALSYLHEECERQIIH 413
            NELVLVYEYL NGSL K+LH  S +S  V+ W+KR++IVLGVASAL+YLHEECERQIIH
Sbjct: 417 ANELVLVYEYLANGSLAKLLHETSPNSQFVIPWKKRVSIVLGVASALTYLHEECERQIIH 476

Query: 414 RDVKACNILLDAEFNAKLGDFE-------------ATIPAGTMGYLAPEYVYSGVPSEKT 460
           RDVK CNILLDA+ NAKLGDF              ATIPAGTMGYLAPEY+Y GVP+ KT
Sbjct: 477 RDVKTCNILLDADLNAKLGDFGLAEVYEHSSLTRIATIPAGTMGYLAPEYLYYGVPTVKT 536

Query: 461 DVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERML 520
           DVYSFGVV LEVA+GK PVD  G V+VDW+W L     L++AAD RL G ++  EMERML
Sbjct: 537 DVYSFGVVILEVASGKRPVDEGGMVLVDWIWVLWGVRSLIEAADPRLMGNYDVVEMERML 596

Query: 521 MVGLSCVHPNHEKRPSVKEAARILKGEAPLPLLPVKKPTVNIRSVFPEASELIDSGGDHS 580
           MVGL CVHPN+EKRP+VKEA RIL+GEAPLP+LP++KP V IR +  +  E +++     
Sbjct: 597 MVGLFCVHPNNEKRPTVKEAVRILRGEAPLPVLPLRKPMVGIRPILSDDFEDLENPCSDY 656

Query: 581 PGFDDSLWMTPRSRF 595
             F++  WMTP+S F
Sbjct: 657 IAFEEPAWMTPKSEF 671

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297791869|ref|XP_002863819.1| lectin protein kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297309654|gb|EFH40078.1| lectin protein kinase family protein [Arabidopsis lyrata subsp. lyrata]

 Score =  676 bits (1745), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 358/618 (57%), Positives = 438/618 (70%), Gaps = 32/618 (5%)

Query: 1   FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQ 60
           FL+P TNTTASFSCRFSFSII SP C FGDGFAFLITSNADSF   NG++GLP    +P 
Sbjct: 82  FLEPSTNTTASFSCRFSFSIISSPSCPFGDGFAFLITSNADSFVFSNGFLGLP----NPD 137

Query: 61  DSFFAVEFDTSFDPSLGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRD 120
           DSF AVEFDT FDP  GDIN NH+GID++S+ S  SVDA+S+G DLKSGR +  WIEY D
Sbjct: 138 DSFIAVEFDTGFDPGHGDINDNHVGIDVNSIFSVASVDAISKGFDLKSGREMMAWIEYSD 197

Query: 121 SLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAAN-GQGSAIYTVDRWRFKT 179
            LKLIRVW GYS+++P SP++  QIDLS + K+YMHVGFSA+N G GSA++ V+RW+F T
Sbjct: 198 VLKLIRVWVGYSRVKPTSPVLSTQIDLSGKVKEYMHVGFSASNAGVGSALHIVERWKFTT 257

Query: 180 FESYPSGNPIDVIDEGDCLTCYPED-AGYNGSYSDVDKRKAKIAETALEVGGLVTFVFTV 238
           FES+      +   + +CL C  E      G +      +  +    +    L+  +  +
Sbjct: 258 FESHSDAIQEEEEKDEECLVCSGEVFENPMGIHRKGFDFRVSVVGFKIPFWSLLPGMAAI 317

Query: 239 VAIVGIISCFLIKKKRHDGRSKEDHVCTVQRVPMRLALTDIKQATLGFNKNRIVGEGASA 298
           V +V  I   LI  K+       D    + R+P RL+L +IK AT GFN+N IVG+GASA
Sbjct: 318 VILVAFIVFSLISGKKRISEGA-DTNSGINRMPGRLSLAEIKSATSGFNENTIVGQGASA 376

Query: 299 TVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNEL 358
           TVY+GS+PS G+VAVKRF++ +  +C RNPFTTEF TM G LRHKNLVQ QGWC EG E 
Sbjct: 377 TVYRGSIPSIGSVAVKRFDRDHWPQCNRNPFTTEFTTMTGYLRHKNLVQFQGWCSEGTET 436

Query: 359 VLVYEYLPNGSLDKILHNNSSSS-----IVLSWEKRLNIVLGVASALSYLHEECERQIIH 413
            LV+EYLPNGSL + LH   SS      IVLSW++R+NI+LGVASAL+YLHEECERQIIH
Sbjct: 437 ALVFEYLPNGSLSEFLHKKPSSDPSEEFIVLSWKQRVNIILGVASALTYLHEECERQIIH 496

Query: 414 RDVKACNILLDAEFNAKLGDF---------------EATIPAGTMGYLAPEYVYSGVPSE 458
           RDVK CNI+LDAEFNAKLGDF                AT+PAGTMGYLAPEYVY+GVPSE
Sbjct: 497 RDVKTCNIMLDAEFNAKLGDFGLAEIYEHSALLAGRAATLPAGTMGYLAPEYVYTGVPSE 556

Query: 459 KTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMER 518
           KTDVYSFGVV LEV  G+ PV +DG V+VD +W+L + GK+LD AD  LR +F+  EMER
Sbjct: 557 KTDVYSFGVVVLEVCTGRRPVGDDGTVLVDLMWSLWETGKVLDGADIMLREEFDAGEMER 616

Query: 519 MLMVGLSCVHPNHEKRPSVKEAARILKGEAPLPLLPVKKPTVNIRSVFPEASELIDSGGD 578
           +LMVG+ C HP+ EKRP VKEA RI++GEAPLP+LP ++P + IRS   EA E+I  G  
Sbjct: 617 VLMVGMVCAHPDCEKRPRVKEAVRIIRGEAPLPVLPARRPLLRIRSA-TEAEEMIADG-- 673

Query: 579 HSPGFDDSLWMTPRSRFS 596
              G +D  WMTP+S FS
Sbjct: 674 --LGREDLTWMTPKSHFS 689

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15238300|ref|NP_199027.1| concanavalin A-like lectin kinase-like protein [Arabidopsis thaliana] gi|75333882|sp|Q9FHX3.1|LRKS6_ARATH RecName: Full=L-type lectin-domain containing receptor kinase S.6; Short=LecRK-S.6; Flags: Precursor gi|9757957|dbj|BAB08445.1| receptor lectin kinase-like protein [Arabidopsis thaliana] gi|91806974|gb|ABE66214.1| lectin protein kinase family protein [Arabidopsis thaliana] gi|332007387|gb|AED94770.1| concanavalin A-like lectin kinase-like protein [Arabidopsis thaliana]

 Score =  669 bits (1727), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 361/626 (57%), Positives = 441/626 (70%), Gaps = 47/626 (7%)

Query: 1   FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQ 60
           FL+P TNTTASFSCRFSFSII SP C FGDGFAFLITSNADSF   NG++GLP    +P 
Sbjct: 83  FLEPSTNTTASFSCRFSFSIIASPSCPFGDGFAFLITSNADSFVFSNGFLGLP----NPD 138

Query: 61  DSFFAVEFDTSFDPSLGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRD 120
           DSF AVEFDT FDP  GDIN NH+GID+SS+ S  SVDA+S+G DLKSG+ +  WIEY D
Sbjct: 139 DSFIAVEFDTRFDPVHGDINDNHVGIDVSSIFSVSSVDAISKGFDLKSGKKMMAWIEYSD 198

Query: 121 SLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAAN-GQGSAIYTVDRWRFKT 179
            LKLIRVW GYS+++P SP++  QIDLS + K+YMHVGFSA+N G GSA++ V+RW+F+T
Sbjct: 199 VLKLIRVWVGYSRVKPTSPVLSTQIDLSGKVKEYMHVGFSASNAGIGSALHIVERWKFRT 258

Query: 180 FESYPSG-NPIDVIDEGDCLTCY------PEDAGYNGSYSDVDKRKAKIAETALEVGGLV 232
           F S+       +   + +CL C       P++    G    V     KI   +L + GL 
Sbjct: 259 FGSHSDAIQEEEEEKDEECLVCSGEVSENPKEIHRKGFNFRVTVVGLKIPVWSL-LPGLA 317

Query: 233 TFVFTVVAIVGIISCFLIKKKRHDGRSKEDHVCTVQRVPMRLALTDIKQATLGFNKNRIV 292
             V  V  IV  + C    KKR     + D    + R+P RL+L +IK AT GFN+N IV
Sbjct: 318 AIVILVAFIVFSLIC---GKKRIS--EEADSNSGLVRMPGRLSLAEIKSATSGFNENAIV 372

Query: 293 GEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWC 352
           G+GASATVY+GS+PS G+VAVKRF++ +  +C RNPFTTEF TM G LRHKNLVQ QGWC
Sbjct: 373 GQGASATVYRGSIPSIGSVAVKRFDREHWPQCNRNPFTTEFTTMTGYLRHKNLVQFQGWC 432

Query: 353 CEGNELVLVYEYLPNGSLDKILHNNSSSS-----IVLSWEKRLNIVLGVASALSYLHEEC 407
            EG E  LV+EYLPNGSL + LH   SS      IVLSW++R+NI+LGVASAL+YLHEEC
Sbjct: 433 SEGTETALVFEYLPNGSLSEFLHKKPSSDPSEEIIVLSWKQRVNIILGVASALTYLHEEC 492

Query: 408 ERQIIHRDVKACNILLDAEFNAKLGDF---------------EATIPAGTMGYLAPEYVY 452
           ERQIIHRDVK CNI+LDAEFNAKLGDF                AT+PAGTMGYLAPEYVY
Sbjct: 493 ERQIIHRDVKTCNIMLDAEFNAKLGDFGLAEIYEHSALLAGRAATLPAGTMGYLAPEYVY 552

Query: 453 SGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFN 512
           +GVPSEKTDVYSFGVV LEV  G+ PV +DG V+VD +W+  + GK+LD AD  LR +F+
Sbjct: 553 TGVPSEKTDVYSFGVVVLEVCTGRRPVGDDGAVLVDLMWSHWETGKVLDGADIMLREEFD 612

Query: 513 RKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEAPLPLLPVKKPTVNIRSVFPEASEL 572
            +EMER+LMVG+ C HP+ EKRP VK+A RI++GEAPLP+LP ++P + IR    EA E+
Sbjct: 613 AEEMERVLMVGMVCAHPDSEKRPRVKDAVRIIRGEAPLPVLPARRPLLRIRPA-NEAEEM 671

Query: 573 IDSG--GDHSPGFDDSLWMTPRSRFS 596
           I  G  G+  P      WMTP+S FS
Sbjct: 672 IVDGLVGEDLP------WMTPKSHFS 691

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225461937|ref|XP_002268825.1| PREDICTED: probable L-type lectin-domain containing receptor kinase S.7-like [Vitis vinifera]

 Score =  445 bits (1144), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 247/609 (40%), Positives = 355/609 (58%), Gaps = 41/609 (6%)

Query: 1   FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQ 60
           F D ++NTTASFS RFSFSI      ++GDG AF ++   ++ G+  GY+GL       +
Sbjct: 80  FFDSESNTTASFSTRFSFSITNVNPSSYGDGLAFFLSPENETLGSPGGYLGLVNSSQLTK 139

Query: 61  DSFFAVEFDTSFDPSLGDINGNHIGIDISSVISFVSVD-ALSRGIDLKSGRHITTWIEYR 119
           + F AVEFDT  DP   D N NH+G+DI S+ S  + D  L   IDLKSG+ IT WIEY+
Sbjct: 140 NRFVAVEFDTRLDPHFNDPNDNHVGLDIDSLNSMKTADPVLDENIDLKSGKSITAWIEYK 199

Query: 120 DSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGSAIYTVDRWRFKT 179
           +    ++V+   S+ +P  P++I  IDLS+  K+  +VGFSA+    + ++ ++ W FKT
Sbjct: 200 NDQMKLKVFLSSSRSKPERPVLIVDIDLSEYLKELKYVGFSASTEGSTELHLIENWSFKT 259

Query: 180 FESYPSGN-----PIDVIDEGDCLTCYPEDAGYNGSYSDVDKRKAKIAETALEVGGLVTF 234
           F   P+       P +V D  + +   P  A      SD   +  K       + G V F
Sbjct: 260 FGLVPAPPRLHFPPHNVSD--NTVMIPPPSA-----VSDSGNKGHKRLGLGFGIAGPVFF 312

Query: 235 VFTVVAIVGIISCFLIKKKRHDGRSKEDHVCTVQRVPMRLALTDIKQATLGFNKNRIVGE 294
              V+++ G +S     KK    R ++     +   P   +  ++K AT GF+ +RI+G 
Sbjct: 313 CI-VLSVFGYVSM----KKWRGMRWEKSFKADILAGPREFSYKELKGATKGFHSSRIIGN 367

Query: 295 GASATVYKGSLPSGGAV-AVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCC 353
           GA  TVYK    + G + AVKR +  +     ++ F  E + +A CLRHKNLVQLQGWC 
Sbjct: 368 GAFGTVYKAFFITTGTISAVKRSKHSHE---GKSEFLAELSIIA-CLRHKNLVQLQGWCV 423

Query: 354 EGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIH 413
           E  +L+LVYE++PNGSLDK+L+  S    +L W  R NI++G+AS L+YLH+ECE+Q+IH
Sbjct: 424 EKGDLLLVYEFMPNGSLDKMLYQESEEGTLLKWSHRYNIIVGMASVLTYLHQECEQQVIH 483

Query: 414 RDVKACNILLDAEFNAKLGDFE------------ATIPAGTMGYLAPEYVYSGVPSEKTD 461
           RD+K  NI+LD  FNA+LGDF             +T+ AGTMGYLAPEY+  G  +EKTD
Sbjct: 484 RDIKTSNIMLDGNFNARLGDFGLARLMDHDKSPVSTLTAGTMGYLAPEYLQYGKATEKTD 543

Query: 462 VYSFGVVALEVAAGKSPVDNDG-----CVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEM 516
           V+S+GVV LEVA G+ P++ D        +VDWVW L  +G +L+AAD RL  +F  +EM
Sbjct: 544 VFSYGVVILEVACGRRPIEKDTDSQKMMNLVDWVWGLYSQGNILEAADKRLNREFKEEEM 603

Query: 517 ERMLMVGLSCVHPNHEKRPSVKEAARILKGEAPLPLLPVKKPTVNIRSVFP-EASELIDS 575
            ++L+VGLSC +P+   RPS++   +IL  EA   L+P  KP++      P    +++  
Sbjct: 604 RKLLLVGLSCANPDCNVRPSMRRVLQILNDEAEPLLVPRMKPSLTFSLSLPLSIDDIVSD 663

Query: 576 GGDHSPGFD 584
           G DH    D
Sbjct: 664 GEDHRKSLD 672

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	596
TAIR|locus:2165740	691	AT5G42120 [Arabidopsis thalian	0.711	0.613	0.545	1.7e-187
TAIR|locus:2083986	715	AT3G53380 [Arabidopsis thalian	0.796	0.664	0.368	1.7e-107
TAIR|locus:2143528	711	AT5G03140 [Arabidopsis thalian	0.786	0.659	0.368	7.4e-103
TAIR|locus:2162212	681	AT5G55830 [Arabidopsis thalian	0.788	0.690	0.388	1.2e-83
TAIR|locus:2099941	684	AT3G55550 [Arabidopsis thalian	0.545	0.475	0.384	7.6e-72
TAIR|locus:2097613	693	AT3G08870 [Arabidopsis thalian	0.459	0.395	0.413	1.4e-68
TAIR|locus:2149795	688	LECRKA4.2 "lectin receptor kin	0.870	0.754	0.343	1.9e-67
TAIR|locus:2149780	682	LECRKA4.1 "lectin receptor kin	0.874	0.763	0.336	5.8e-66
TAIR|locus:2138381	686	AT4G04960 [Arabidopsis thalian	0.508	0.441	0.364	9.8e-66
TAIR|locus:2149810	691	LECRKA4.3 "lectin receptor kin	0.862	0.743	0.340	2e-65

TAIR|locus:2165740 AT5G42120 [Arabidopsis thaliana (taxid:3702)]

 Score = 1171 (417.3 bits), Expect = 1.7e-187, Sum P(2) = 1.7e-187
 Identities = 244/447 (54%), Positives = 301/447 (67%)

Query:     1 FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQ 60
             FL+P TNTTASFSCRFSFSII SP C FGDGFAFLITSNADSF   NG++GLP    +P 
Sbjct:    83 FLEPSTNTTASFSCRFSFSIIASPSCPFGDGFAFLITSNADSFVFSNGFLGLP----NPD 138

Query:    61 DSFFAVEFDTSFDPSLXXXXXXXXXXXXXXXXXXXXXDALSRGIDLKSGRHITTWIEYRD 120
             DSF AVEFDT FDP                       DA+S+G DLKSG+ +  WIEY D
Sbjct:   139 DSFIAVEFDTRFDPVHGDINDNHVGIDVSSIFSVSSVDAISKGFDLKSGKKMMAWIEYSD 198

Query:   121 SLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAAN-GQGSAIYTVDRWRFKT 179
              LKLIRVW GYS+++P SP++  QIDLS + K+YMHVGFSA+N G GSA++ V+RW+F+T
Sbjct:   199 VLKLIRVWVGYSRVKPTSPVLSTQIDLSGKVKEYMHVGFSASNAGIGSALHIVERWKFRT 258

Query:   180 FESYPSG--NPIDVIDEGDCLTCYPEDAGYNGSYSDVDKRKAKIAETALEXXXXXXXXXX 237
             F S+        +  DE +CL C  E    + +  ++ ++      T +           
Sbjct:   259 FGSHSDAIQEEEEEKDE-ECLVCSGE---VSENPKEIHRKGFNFRVTVVGLKIPVWSLLP 314

Query:   238 XXAIVGIISCFLI-----KKKRHDGRSKEDHVCTVQRVPMRLALTDIKQATLGFNKNRIV 292
               A + I+  F++      KKR     + D    + R+P RL+L +IK AT GFN+N IV
Sbjct:   315 GLAAIVILVAFIVFSLICGKKRIS--EEADSNSGLVRMPGRLSLAEIKSATSGFNENAIV 372

Query:   293 GEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWC 352
             G+GASATVY+GS+PS G+VAVKRF++ +  +C RNPFTTEF TM G LRHKNLVQ QGWC
Sbjct:   373 GQGASATVYRGSIPSIGSVAVKRFDREHWPQCNRNPFTTEFTTMTGYLRHKNLVQFQGWC 432

Query:   353 CEGNELVLVYEYLPNGSLDKILHNNSSSS-----IVLSWEKRLNIVLGVASALSYLHEEC 407
              EG E  LV+EYLPNGSL + LH   SS      IVLSW++R+NI+LGVASAL+YLHEEC
Sbjct:   433 SEGTETALVFEYLPNGSLSEFLHKKPSSDPSEEIIVLSWKQRVNIILGVASALTYLHEEC 492

Query:   408 ERQIIHRDVKACNILLDAEFNAKLGDF 434
             ERQIIHRDVK CNI+LDAEFNAKLGDF
Sbjct:   493 ERQIIHRDVKTCNIMLDAEFNAKLGDF 519

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2083986 AT3G53380 [Arabidopsis thaliana (taxid:3702)]

 Score = 769 (275.8 bits), Expect = 1.7e-107, Sum P(2) = 1.7e-107
 Identities = 190/516 (36%), Positives = 273/516 (52%)

Query:     1 FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQ 60
             F  P T+   SFS  FSFSI      + G G AF+I+ +A+S G   G +GL GP  S  
Sbjct:    71 FRQPGTHFPTSFSSFFSFSITNVNPSSIGGGLAFVISPDANSIGIAGGSLGLTGPNGSGS 130

Query:    61 DSFFAVEFDTSFDPSLXXXXXXXXXXXXXXXXXXXXXDALSRGIDLKSGRHITTWIEYRD 120
               F AVEFDT  D                        D  +  IDLKSG  I +WIEY  
Sbjct:   131 -KFVAVEFDTLMDVDFKDINSNHVGFDVNGVVSSVSGDLGTVNIDLKSGNTINSWIEYDG 189

Query:   121 SLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGSAIYTVDRWRFKT- 179
               ++  V   YS ++P  P++   +DL +   D+M VGFS +    + I++++ W F + 
Sbjct:   190 LTRVFNVSVSYSNLKPKVPILSFPLDLDRYVNDFMFVGFSGSTQGSTEIHSIEWWSFSSS 249

Query:   180 FESY---PSGNP---IDVID-EGDCLTCYPEDAGYNGSYSDVDKRKAKIAETALEXXXXX 232
             F S     SG+P    ++++ + + +   P  A    S +       ++  ++       
Sbjct:   250 FGSSLGSGSGSPPPRANLMNPKANSVKSPPPLASQPSSSAIPISSNTQLKTSSSSSCHSR 309

Query:   233 XXXXXXXAIVGIISC------------FLIKKKRHDGRSKEDHVCT-VQRVPMRLALTDI 279
                     I G+++             F +  K+     + D   + + + P   +  ++
Sbjct:   310 FCKENPGTIAGVVTAGAFFLALFAGALFWVYSKKFKRVERSDSFASEIIKAPKEFSYKEL 369

Query:   280 KQATLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAG 338
             K  T  FN++RI+G GA   VY+G LP +G  VAVKR    ++ +  +N F +E + + G
Sbjct:   370 KAGTKNFNESRIIGHGAFGVVYRGILPETGDIVAVKRCSHSSQDK--KNEFLSELSII-G 426

Query:   339 CLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVAS 398
              LRH+NLV+LQGWC E  E++LVY+ +PNGSLDK L     S   L W+ R  I+LGVAS
Sbjct:   427 SLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFE---SRFTLPWDHRKKILLGVAS 483

Query:   399 ALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF------------EATIPAGTMGYL 446
             AL+YLH ECE Q+IHRDVK+ NI+LD  FNAKLGDF            EAT+ AGTMGYL
Sbjct:   484 ALAYLHRECENQVIHRDVKSSNIMLDESFNAKLGDFGLARQIEHDKSPEATVAAGTMGYL 543

Query:   447 APEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDND 482
             APEY+ +G  SEKTDV+S+G V LEV +G+ P++ D
Sbjct:   544 APEYLLTGRASEKTDVFSYGAVVLEVVSGRRPIEKD 579

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=ISS

TAIR|locus:2143528 AT5G03140 [Arabidopsis thaliana (taxid:3702)]

 Score = 751 (269.4 bits), Expect = 7.4e-103, Sum P(2) = 7.4e-103
 Identities = 184/500 (36%), Positives = 261/500 (52%)

Query:     1 FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQ 60
             F  P+T + ASF+  FSFS+      + G G AF+I+ + D  G+  G++GL     S  
Sbjct:    84 FRHPETKSPASFTTYFSFSVTNLNPSSIGGGLAFVISPDEDYLGSTGGFLGLTEETGSGS 143

Query:    61 DSFFAVEFDTSFDPSLXXXXXXXXXXXXXXXXXXXXXDALSRGIDLKSGRHITTWIEYRD 120
               F AVEFDT  D                        D  +  IDLKSG  + +WI Y  
Sbjct:   144 -GFVAVEFDTLMDVQFKDVNGNHVGLDLNAVVSAAVADLGNVDIDLKSGNAVNSWITYDG 202

Query:   121 SLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGSA-IYTVDRWRFKT 179
             S +++ V+  YS ++P SP++   +DL +   D M VGFS +  QGS  I++VD W F +
Sbjct:   203 SGRVLTVYVSYSNLKPKSPILSVPLDLDRYVSDSMFVGFSGST-QGSTEIHSVDWWSFSS 261

Query:   180 -FESY---PSGNPIDVIDEGDCLTCYPEDAGYNGSYSDVDKR-KAKIAET--ALEXXXXX 232
              FE     P   P          +  P  +      +D     + K+ +   A       
Sbjct:   262 SFEESSESPPPMPNSPPPSSPSSSITPSLSTVRRKTADPSSSCRNKLCKKSPAAVAGVVT 321

Query:   233 XXXXXXXAIVGIISCFLIKKKRHDGRSKEDHVCTVQRVPMRLALTDIKQATLGFNKNRIV 292
                       G+I     KK ++  R  E     + + P      ++K AT  F+ +R++
Sbjct:   322 AGAFFLALFAGVIIWVYSKKIKYT-RKSESLASEIMKSPREFTYKELKLATDCFSSSRVI 380

Query:   293 GEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
             G GA  TVYKG L  SG  +A+KR    + +      F +E + + G LRH+NL++LQG+
Sbjct:   381 GNGAFGTVYKGILQDSGEIIAIKRC---SHISQGNTEFLSELS-LIGTLRHRNLLRLQGY 436

Query:   352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
             C E  E++L+Y+ +PNGSLDK L+ + ++   L W  R  I+LGVASAL+YLH+ECE QI
Sbjct:   437 CREKGEILLIYDLMPNGSLDKALYESPTT---LPWPHRRKILLGVASALAYLHQECENQI 493

Query:   412 IHRDVKACNILLDAEFNAKLGDF------------EATIPAGTMGYLAPEYVYSGVPSEK 459
             IHRDVK  NI+LDA FN KLGDF            +AT  AGTMGYLAPEY+ +G  +EK
Sbjct:   494 IHRDVKTSNIMLDANFNPKLGDFGLARQTEHDKSPDATAAAGTMGYLAPEYLLTGRATEK 553

Query:   460 TDVYSFGVVALEVAAGKSPV 479
             TDV+S+G V LEV  G+ P+
Sbjct:   554 TDVFSYGAVVLEVCTGRRPI 573

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=ISS

TAIR|locus:2162212 AT5G55830 [Arabidopsis thaliana (taxid:3702)]

 Score = 838 (300.0 bits), Expect = 1.2e-83, P = 1.2e-83
 Identities = 196/505 (38%), Positives = 276/505 (54%)

Query:     1 FLDPKTNTTASFSCRFSFSII---PSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVL 57
             F DP +NTTASFS  FSF++    P P  A GDG AF ++ + D+ G+  GY+GL     
Sbjct:    80 FYDPDSNTTASFSTHFSFTVQNLNPDPTSA-GDGLAFFLSHDNDTLGSPGGYLGLVNSSQ 138

Query:    58 SPQDSFFAVEFDTSFDPSLXXXXXXXXXXXXXXXXXXXXXDAL-SRGIDLKSGRHITTWI 116
               ++ F A+EFDT  DP                       D L S  IDLKSG+ IT+WI
Sbjct:   139 PMKNRFVAIEFDTKLDPHFNDPNGNHIGLDVDSLNSISTSDPLLSSQIDLKSGKSITSWI 198

Query:   117 EYRDSLKLIRVWAGYSQI-----RPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGSAIYT 171
             +Y++ L+L+ V+  Y+       +P  PL+   IDLS      M+VGFS +    + I+ 
Sbjct:   199 DYKNDLRLLNVFLSYTDPVTTTKKPEKPLLSVNIDLSPFLNGEMYVGFSGSTEGSTEIHL 258

Query:   172 VDRWRFKTFESYPSGNPIDVIDEGDCLTCYPEDAGYNGSYSDVDKRKAKIAETALEXXXX 231
             ++ W FKT     SG  + V  + + L    + +  N     +  +K +           
Sbjct:   259 IENWSFKT-----SGF-LPVRSKSNHLHNVSDSSVVNDDPVVIPSKKRRHRHNLAIGLGI 312

Query:   232 XXXXXXXXAIVGIISCFLIKKKRHDGRSKEDHVCTVQRVPMRLALTDIKQATLGFNKNRI 291
                     A+  +   F +KK +     KE     +  +    +  ++  AT GF+ +R+
Sbjct:   313 SCPVLICLALF-VFGYFTLKKWKSVKAEKELKTELITGL-REFSYKELYTATKGFHSSRV 370

Query:   292 VGEGASATVYKGSLPSGGAV-AVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQG 350
             +G GA   VY+    S G + AVKR  + N  E  +  F  E + +A CLRHKNLVQLQG
Sbjct:   371 IGRGAFGNVYRAMFVSSGTISAVKR-SRHNSTE-GKTEFLAELSIIA-CLRHKNLVQLQG 427

Query:   351 WCCEGNELVLVYEYLPNGSLDKILHNNSSS-SIVLSWEKRLNIVLGVASALSYLHEECER 409
             WC E  EL+LVYE++PNGSLDKIL+  S + ++ L W  RLNI +G+ASALSYLH ECE+
Sbjct:   428 WCNEKGELLLVYEFMPNGSLDKILYQESQTGAVALDWSHRLNIAIGLASALSYLHHECEQ 487

Query:   410 QIIHRDVKACNILLDAEFNAKLGDFE------------ATIPAGTMGYLAPEYVYSGVPS 457
             Q++HRD+K  NI+LD  FNA+LGDF             +T+ AGTMGYLAPEY+  G  +
Sbjct:   488 QVVHRDIKTSNIMLDINFNARLGDFGLARLTEHDKSPVSTLTAGTMGYLAPEYLQYGTAT 547

Query:   458 EKTDVYSFGVVALEVAAGKSPVDND 482
             EKTD +S+GVV LEVA G+ P+D +
Sbjct:   548 EKTDAFSYGVVILEVACGRRPIDKE 572

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000226 "microtubule cytoskeleton organization" evidence=RCA

GO:0000911 "cytokinesis by cell plate formation" evidence=RCA

TAIR|locus:2099941 AT3G55550 [Arabidopsis thaliana (taxid:3702)]

 Score = 589 (212.4 bits), Expect = 7.6e-72, Sum P(2) = 7.6e-72
 Identities = 135/351 (38%), Positives = 203/351 (57%)

Query:   212 SDVDKRKAKIAETALEXXXXXXXXXXXXAIVGIISCFLIKKKRHDGRSKEDHVCTVQRVP 271
             S + KRK K    +L             A++   S F+++K + + R +E     +   P
Sbjct:   277 SSIKKRKKK--RQSLILGVSLLCSLLIFAVLVAASLFVVRKVKDEDRVEE---WELDFGP 331

Query:   272 MRLALTDIKQATLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFT 330
              R +  ++K+AT GF    ++G G    VYKG LP S   VAVKR    +R +  R  F 
Sbjct:   332 HRFSYRELKKATNGFGDKELLGSGGFGKVYKGKLPGSDEFVAVKRISHESR-QGVRE-FM 389

Query:   331 TEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRL 390
             +E +++ G LRH+NLVQL GWC   ++L+LVY+++PNGSLD  L + +   ++L+W++R 
Sbjct:   390 SEVSSI-GHLRHRNLVQLLGWCRRRDDLLLVYDFMPNGSLDMYLFDENPE-VILTWKQRF 447

Query:   391 NIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFE------------ATI 438
              I+ GVAS L YLHE  E+ +IHRD+KA N+LLD+E N ++GDF             AT 
Sbjct:   448 KIIKGVASGLLYLHEGWEQTVIHRDIKAANVLLDSEMNGRVGDFGLAKLYEHGSDPGATR 507

Query:   439 PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGC----VIVDWVWNLR 494
               GT GYLAPE   SG  +  TDVY+FG V LEVA G+ P++        V+VDWVW+  
Sbjct:   508 VVGTFGYLAPELTKSGKLTTSTDVYAFGAVLLEVACGRRPIETSALPEELVMVDWVWSRW 567

Query:   495 KKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK 545
             + G + D  D RL G+F+ +E+  ++ +GL C + + E RP++++    L+
Sbjct:   568 QSGDIRDVVDRRLNGEFDEEEVVMVIKLGLLCSNNSPEVRPTMRQVVMYLE 618

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2097613 AT3G08870 [Arabidopsis thaliana (taxid:3702)]

 Score = 569 (205.4 bits), Expect = 1.4e-68, Sum P(2) = 1.4e-68
 Identities = 120/290 (41%), Positives = 167/290 (57%)

Query:   271 PMRLALTDIKQATLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFT 330
             P R    D+  AT  F ++ I+G G    VY+G+L S G +AVK+    N ++  R  F 
Sbjct:   353 PHRFRYRDLYLATKKFKESEIIGTGGFGIVYRGNLSSSGPIAVKKITS-NSLQGVRE-FM 410

Query:   331 TEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSS-SSIVLSWEKR 389
              E  ++ G L HKNLV LQGWC   NEL+L+Y+Y+PNGSLD +L+     + IVL W+ R
Sbjct:   411 AEIESL-GRLGHKNLVNLQGWCKHKNELLLIYDYIPNGSLDSLLYQTPRRNGIVLPWDVR 469

Query:   390 LNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF------------EAT 437
               I+ G+AS L YLHEE E+ ++HRDVK  N+L+D + NAKLGDF            + T
Sbjct:   470 FEIIKGIASGLLYLHEEWEQIVVHRDVKPSNVLIDEDMNAKLGDFGLARLYERGTLTQTT 529

Query:   438 IPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKG 497
                GT+GY+APE   +G  S  +DV++FGV+ LE+  G  P + +   + DWV      G
Sbjct:   530 KIVGTLGYMAPELTRNGKGSTASDVFAFGVLLLEIVCGNKPTNAENFFLADWVMEFHTNG 589

Query:   498 KLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE 547
              +L   D  L   FN +E +  L+VGL C H   + RPS++   R L GE
Sbjct:   590 GILCVVDQNLGSSFNGREAKLALVVGLLCCHQKPKFRPSMRMVLRYLNGE 639

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2149795 LECRKA4.2 "lectin receptor kinase a4.1" [Arabidopsis thaliana (taxid:3702)]

 Score = 685 (246.2 bits), Expect = 1.9e-67, P = 1.9e-67
 Identities = 198/577 (34%), Positives = 289/577 (50%)

Query:     6 TNTTA-SFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNG-YMGLPGPVLSPQDS- 62
             TN+T  SFS  F F IIP+     G GF F ++   D  G ++  Y+GL         + 
Sbjct:    81 TNSTIRSFSTSFVFVIIPTSSSNGGFGFTFTLSPTPDRTGAESAQYLGLLNKANDGNSTN 140

Query:    63 -FFAVEFDT--SFDPSLXXXXXXXXXXXXXXXXXXXX------XDALSRGID--LKSGRH 111
               FAVEFDT   F                               +  +R  D  L+SG  
Sbjct:   141 HVFAVEFDTVQGFKDGADRTGNHIGLNFNSLTSDVQEPVVYYDNEDPNRKEDFPLQSGDP 200

Query:   112 ITTWIEYRDSLKLIR--VWAGYSQIRPPSPLIIAQID-LSKQFKDYMHVGFSAANG--QG 166
             I   ++Y    + +   V+    + RP  PLI   +  LS+  ++ M+VGF+AA G  Q 
Sbjct:   201 IRAILDYDGPTQTLNLTVYPANLKSRPVRPLISRPVPKLSQIVQEEMYVGFTAATGRDQS 260

Query:   167 SAIYTVDRWRFKTFESYPSGNPIDVIDEGDCLTCYPEDAGYNGSYSDVDKRKAKIAETAL 226
             SA Y +  W F +     + + +D+++         +  GYN   S V    A I   AL
Sbjct:   261 SAHYVMG-WSFSSGGDLLTEDTLDLLELPRPPPNTAKKRGYN---SQV---LALIV--AL 311

Query:   227 EXXXXXXXXXXXXAIVGIISCFLIKKKR-HDGRSKEDHVCTVQRVPMRLALTDIKQATLG 285
                           ++ ++  F++ KKR   G   ED    +   P RL   D+  AT G
Sbjct:   312 SGVTVI--------LLALLFFFVMYKKRLQQGEVLEDW--EINH-PHRLRYKDLYAATDG 360

Query:   286 FNKNRIVGEGASATVYKGSL--PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHK 343
             F +NRIVG G   TV++G+L  PS   +AVK+   PN ++  R  F  E  ++ G LRHK
Sbjct:   361 FKENRIVGTGGFGTVFRGNLSSPSSDQIAVKKIT-PNSMQGVRE-FIAEIESL-GRLRHK 417

Query:   344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNS-SSSIVLSWEKRLNIVLGVASALSY 402
             NLV LQGWC + N+L+L+Y+Y+PNGSLD +L++    S +VLSW  R  I  G+AS L Y
Sbjct:   418 NLVNLQGWCKQKNDLLLIYDYIPNGSLDSLLYSRPRQSGVVLSWNARFKIAKGIASGLLY 477

Query:   403 LHEECERQIIHRDVKACNILLDAEFNAKLGDF------------EATIPAGTMGYLAPEY 450
             LHEE E+ +IHRD+K  N+L++ + N +LGDF              T+  GT+GY+APE 
Sbjct:   478 LHEEWEKVVIHRDIKPSNVLIEDDMNPRLGDFGLARLYERGSQSNTTVVVGTIGYMAPEL 537

Query:   451 VYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGK 510
               +G  S  +DV++FGV+ LE+ +G+ P D+    + DWV  L  +G++L A D RL   
Sbjct:   538 ARNGKSSSASDVFAFGVLLLEIVSGRRPTDSGTFFLADWVMELHARGEILHAVDPRLGFG 597

Query:   511 FNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE 547
             ++  E    L+VGL C H     RPS++   R L G+
Sbjct:   598 YDGVEARLALVVGLLCCHQRPTSRPSMRTVLRYLNGD 634

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=IMP

GO:0009845 "seed germination" evidence=IMP

GO:0010200 "response to chitin" evidence=RCA

TAIR|locus:2149780 LECRKA4.1 "lectin receptor kinase a4.1" [Arabidopsis thaliana (taxid:3702)]

 Score = 671 (241.3 bits), Expect = 5.8e-66, P = 5.8e-66
 Identities = 193/574 (33%), Positives = 280/574 (48%)

Query:     6 TNTTA-SFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNG-YMGLPGPVLS--PQD 61
             TN T  SFS  F F IIPS     G GF F ++         +  Y+G+     +  P++
Sbjct:    86 TNVTIRSFSTSFVFVIIPSSSSNKGFGFTFTLSPTPYRLNAGSAQYLGVFNKENNGDPRN 145

Query:    62 SFFAVEFDT---SFDPSLXXXXXXXXXXXXXXXXXXXX------XDALSRGID--LKSGR 110
               FAVEFDT   S D +                            D  ++  D  L+SG 
Sbjct:   146 HVFAVEFDTVQGSRDDNTDRIGNDIGLNYNSRTSDLQEPVVYYNNDDHNKKEDFQLESGN 205

Query:   111 HITTWIEYRDSLKLIRVWAGYSQI--RPPSPLIIAQID-LSKQFKDYMHVGFSAANGQG- 166
              I   +EY  + +++ V    +++  +P  PLI   +  L +  ++ M+VGF+A+ G+G 
Sbjct:   206 PIQALLEYDGATQMLNVTVYPARLGFKPTKPLISQHVPKLLEIVQEEMYVGFTASTGKGQ 265

Query:   167 SAIYTVDRWRFKTFESYPSGNPIDVIDEGDCLTCYPEDAGYNGSYSDVDKRKAKIAETAL 226
             S+ + V  W F +    P     DV+   +     P  A   G  S V      ++   L
Sbjct:   266 SSAHYVMGWSFSSGGERPIA---DVLILSELPPPPPNKAKKEGLNSQVIVMIVALSAVML 322

Query:   227 EXXXXXXXXXXXXAIVGIISCFLIKKKRHDGRSKEDHVCTVQRVPMRLALTDIKQATLGF 286
                           ++ ++  F +  K+  G+ +      +   P RL   D+  AT GF
Sbjct:   323 --------------VMLVLLFFFVMYKKRLGQEETLEDWEIDH-PRRLRYRDLYVATDGF 367

Query:   287 NKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLV 346
              K  I+G G   TV+KG LP+   +AVK+    +R +  R  F  E  ++ G LRHKNLV
Sbjct:   368 KKTGIIGTGGFGTVFKGKLPNSDPIAVKKIIPSSR-QGVRE-FVAEIESL-GKLRHKNLV 424

Query:   347 QLQGWCCEGNELVLVYEYLPNGSLDKILHN-NSSSSIVLSWEKRLNIVLGVASALSYLHE 405
              LQGWC   N+L+L+Y+Y+PNGSLD +L+     S  VLSW  R  I  G+AS L YLHE
Sbjct:   425 NLQGWCKHKNDLLLIYDYIPNGSLDSLLYTVPRRSGAVLSWNARFQIAKGIASGLLYLHE 484

Query:   406 ECERQIIHRDVKACNILLDAEFNAKLGDF------------EATIPAGTMGYLAPEYVYS 453
             E E+ +IHRDVK  N+L+D++ N +LGDF            E T   GT+GY+APE   +
Sbjct:   485 EWEKIVIHRDVKPSNVLIDSKMNPRLGDFGLARLYERGTLSETTALVGTIGYMAPELSRN 544

Query:   454 GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNR 513
             G PS  +DV++FGV+ LE+  G+ P D+    +VDWV  L   G++L A D RL   ++ 
Sbjct:   545 GNPSSASDVFAFGVLLLEIVCGRKPTDSGTFFLVDWVMELHANGEILSAIDPRLGSGYDG 604

Query:   514 KEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE 547
              E    L VGL C H     RPS++   R L GE
Sbjct:   605 GEARLALAVGLLCCHQKPASRPSMRIVLRYLNGE 638

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009737 "response to abscisic acid stimulus" evidence=IEP

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA;IMP

GO:0009845 "seed germination" evidence=IMP

GO:0042742 "defense response to bacterium" evidence=IMP

GO:0052033 "pathogen-associated molecular pattern dependent induction by symbiont of host innate immune response" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2138381 AT4G04960 [Arabidopsis thaliana (taxid:3702)]

 Score = 538 (194.4 bits), Expect = 9.8e-66, Sum P(2) = 9.8e-66
 Identities = 120/329 (36%), Positives = 193/329 (58%)

Query:   240 AIVGIISCFLIKKKRHDGRSK---EDHVCTVQRVPMRLALTDIKQATLGFNKNRIVGEGA 296
             A+VG++   +++K+    R +   ED    ++  P R+   +I+  T GF++  ++G G 
Sbjct:   300 ALVGLVLFAVVRKRLERARKRALMEDW--EMEYWPHRIPYEEIESGTKGFDEKNVIGIGG 357

Query:   297 SATVYKGSLPSGGA-VAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCC-E 354
             +  VYKG L  G   VAVKR  + +  +  R  F  E +++ G L+H+NLV L+GWC  E
Sbjct:   358 NGKVYKGLLQGGVVEVAVKRISQESS-DGMRE-FVAEISSL-GRLKHRNLVSLRGWCKKE 414

Query:   355 GNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHR 414
                 +LVY+Y+ NGSLD+ +  N      LS E+R+ I+ GVAS + YLHE  E +++HR
Sbjct:   415 VGSFMLVYDYMENGSLDRWIFENDEKITTLSCEERIRILKGVASGILYLHEGWESKVLHR 474

Query:   415 DVKACNILLDAEFNAKLGDF------------EATIPAGTMGYLAPEYVYSGVPSEKTDV 462
             D+KA N+LLD +   +L DF              T   GT GYLAPE V +G  S +TDV
Sbjct:   475 DIKASNVLLDRDMIPRLSDFGLARVHGHEQPVRTTRVVGTAGYLAPEVVKTGRASTQTDV 534

Query:   463 YSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRL---RGKFNR-KEMER 518
             +++G++ LEV  G+ P++     ++DWVW L ++G++L+  D ++   +G      E ER
Sbjct:   535 FAYGILVLEVMCGRRPIEEGKKPLMDWVWGLMERGEILNGLDPQMMMTQGVTEVIDEAER 594

Query:   519 MLMVGLSCVHPNHEKRPSVKEAARILKGE 547
             +L +GL C HP+  KRPS+++  ++ +G+
Sbjct:   595 VLQLGLLCAHPDPAKRPSMRQVVQVFEGD 623

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2149810 LECRKA4.3 "lectin receptor kinase a4.3" [Arabidopsis thaliana (taxid:3702)]

 Score = 666 (239.5 bits), Expect = 2.0e-65, P = 2.0e-65
 Identities = 196/575 (34%), Positives = 280/575 (48%)

Query:     6 TNTTA-SFSCRFSFSIIPSPLCAFGD-GFAFLITSNADSFGND-NGYMGLPGPVLSPQDS 62
             TNTT  SFS  F F IIPS   + G  GF F ++   +    D   YMGL         S
Sbjct:    83 TNTTVRSFSTSFIF-IIPSSSTSNGGFGFTFTLSPTPNRTDADPEQYMGLLNERNDGNSS 141

Query:    63 --FFAVEFDT--SFDPS-------LXXXXXXXXXXXXXXXXXXXXXDALSRGIDLKSGRH 111
                FAVEFDT   F          +                     D+      L SG  
Sbjct:   142 NHVFAVEFDTVQGFKDGTNRIGNHIGLNFNSLSSDVQEPVAYFNNNDSQKEEFQLVSGEP 201

Query:   112 ITTWIEYRDSLKLIRVWAGYSQI--RPPSPLIIAQID-LSKQFKDYMHVGFSAA---NGQ 165
             I  +++Y    K + +    +++  +P  PLI  ++  LS    D M VGF+AA   +GQ
Sbjct:   202 IQVFLDYHGPTKTLNLTVYPTRLGYKPRIPLISREVPKLSDIVVDEMFVGFTAATGRHGQ 261

Query:   166 GSAIYTVDRWRFKTFESYPSGNPIDVIDEGDCLTCYPEDAGYNGSYSDVDKRKAKIAETA 225
              SA Y +  W F +   +P    +D+           +  GYNG      K  A I   A
Sbjct:   262 SSAHYVMG-WSFASGGEHPLAAMLDISQLPPPPPNKAKKRGYNG------KVIALIV--A 312

Query:   226 LEXXXXXXXXXXXXAIVGIISCFLIKKKRHDGRSKEDHVCTVQRV--PMRLALTDIKQAT 283
             L              ++ ++  F++ KKR     +++ +     +  P R    D+ +AT
Sbjct:   313 LSTVISI--------MLVLLFLFMMYKKR----MQQEEILEDWEIDHPHRFRYRDLYKAT 360

Query:   284 LGFNKNRIVGEGASATVYKGSLPSGG-AVAVKRFEKPNRVECARNPFTTEFATMAGCLRH 342
              GF +NR+VG G    VY+G++ S    +AVK+   PN ++  R  F  E  ++ G LRH
Sbjct:   361 EGFKENRVVGTGGFGIVYRGNIRSSSDQIAVKKIT-PNSMQGVRE-FVAEIESL-GRLRH 417

Query:   343 KNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSS-SSIVLSWEKRLNIVLGVASALS 401
             KNLV LQGWC   N+L+L+Y+Y+PNGSLD +L++    S  VLSW  R  I  G+AS L 
Sbjct:   418 KNLVNLQGWCKHRNDLLLIYDYIPNGSLDSLLYSKPRRSGAVLSWNARFQIAKGIASGLL 477

Query:   402 YLHEECERQIIHRDVKACNILLDAEFNAKLGDFE------------ATIPAGTMGYLAPE 449
             YLHEE E+ +IHRDVK  N+L+D++ N +LGDF              T+  GT+GY+APE
Sbjct:   478 YLHEEWEQIVIHRDVKPSNVLIDSDMNPRLGDFGLARLYERGSQSCTTVVVGTIGYMAPE 537

Query:   450 YVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRG 509
                +G  S  +DV++FGV+ LE+ +G+ P D+    I DWV  L+  G++L A D RL  
Sbjct:   538 LARNGNSSSASDVFAFGVLLLEIVSGRKPTDSGTFFIADWVMELQASGEILSAIDPRLGS 597

Query:   510 KFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARIL 544
              ++  E    L VGL C H   E RP ++   R L
Sbjct:   598 GYDEGEARLALAVGLLCCHHKPESRPLMRMVLRYL 632

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=IMP

GO:0009845 "seed germination" evidence=IMP

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9FHX3	LRKS6_ARATH	2, ., 7, ., 1, 1, ., 1	0.5766	0.9714	0.8379	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.946
3rd Layer	2.7.11	0.963

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: fgenesh4_pg.C_LG_V001074 hypothetical protein (677 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	596
cd06899	236	cd06899, lectin_legume_LecRK_Arcelin_ConA, legume	5e-57
pfam00139	231	pfam00139, Lectin_legB, Legume lectin domain	4e-53
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	4e-46
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-40
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	7e-40
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	4e-37
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	7e-37
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	9e-36
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	4e-34
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-29
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-28
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	4e-26
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	6e-26
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-23
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-23
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-23
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	6e-22
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-21
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-21
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	4e-21
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-20
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-20
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-20
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	4e-20
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	4e-20
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-19
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-19
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-19
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	5e-19
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	5e-19
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	6e-19
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-18
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-18
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-18
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-18
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-18
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	6e-18
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	7e-18
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	8e-18
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-17
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-17
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-17
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	4e-17
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-16
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-16
cd01951	223	cd01951, lectin_L-type, legume lectins	3e-16
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-16
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-16
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	4e-16
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	4e-16
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	9e-16
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	9e-16
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-15
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-15
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-15
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-15
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-15
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-15
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-15
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	6e-15
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	8e-15
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	9e-15
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-14
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-14
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-14
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-14
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-14
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-14
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-14
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-14
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-14
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	3e-14
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-14
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-14
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	3e-14
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	3e-14
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-14
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	5e-14
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	5e-14
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	6e-14
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	9e-14
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-13
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-13
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-13
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-13
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-13
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-13
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-13
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-13
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-13
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-13
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-13
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	4e-13
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	4e-13
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	8e-13
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	9e-13
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	9e-13
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-12
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-12
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-12
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-12
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-12
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-12
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-12
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	3e-12
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	4e-12
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	5e-12
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	5e-12
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	6e-12
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	6e-12
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	6e-12
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	6e-12
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	6e-12
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	7e-12
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	8e-12
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	8e-12
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	9e-12
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	9e-12
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-11
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-11
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-11
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-11
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-11
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-11
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-11
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	2e-11
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-11
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-11
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	3e-11
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	4e-11
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	4e-11
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	5e-11
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	6e-11
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	6e-11
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	6e-11
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	8e-11
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	8e-11
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	8e-11
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-10
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-10
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-10
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-10
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-10
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-10
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-10
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-10
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-10
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	3e-10
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-10
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-10
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	3e-10
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	5e-10
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	5e-10
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	7e-10
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	8e-10
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-09
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-09
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-09
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-09
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-09
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-09
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-09
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-09
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-09
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	3e-09
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	4e-09
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	4e-09
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	4e-09
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	4e-09
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	4e-09
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	5e-09
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	5e-09
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	5e-09
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	5e-09
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	6e-09
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	7e-09
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	8e-09
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	8e-09
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	9e-09
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-08
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-08
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-08
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-08
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-08
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-08
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-08
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-08
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	4e-08
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	6e-08
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	7e-08
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	8e-08
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	8e-08
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	8e-08
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	9e-08
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	9e-08
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-07
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-07
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-07
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-07
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-07
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-07
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-07
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-07
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-07
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-07
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	3e-07
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-07
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-07
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	4e-07
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	4e-07
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	6e-07
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	6e-07
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	7e-07
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	8e-07
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	8e-07
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	9e-07
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	9e-07
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	9e-07
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-06
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-06
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-06
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-06
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-06
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-06
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-06
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-06
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-06
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-06
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-06
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-06
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-06
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-06
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	3e-06
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	3e-06
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	4e-06
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	4e-06
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	4e-06
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	5e-06
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	5e-06
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	5e-06
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	6e-06
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	6e-06
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	7e-06
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	7e-06
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	8e-06
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	9e-06
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-05
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-05
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-05
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-05
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-05
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-05
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-05
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-05
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-05
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	3e-05
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-05
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	4e-05
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	4e-05
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	4e-05
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	4e-05
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	6e-05
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	6e-05
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	7e-05
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-04
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-04
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	1e-04
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-04
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-04
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-04
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-04
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	4e-04
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	4e-04
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	5e-04
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	5e-04
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	7e-04
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	8e-04
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	0.001
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	0.002
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	0.002
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	0.003
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	0.003
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	0.004
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	0.004

>gnl|CDD|173887 cd06899, lectin_legume_LecRK_Arcelin_ConA, legume lectins, lectin-like receptor kinases, arcelin, concanavalinA, and alpha-amylase inhibitor

 Score =  191 bits (487), Expect = 5e-57
 Identities = 65/184 (35%), Positives = 93/184 (50%), Gaps = 4/184 (2%)

Query: 1   FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGND-NGYMGLPGP--VL 57
             D  T   ASFS  FSFSI P      GDG AF +            GY+GL       
Sbjct: 52  LWDSTTGKVASFSTSFSFSITPPNPSLGGDGLAFFLAPTDSLPPASSGGYLGLFNSSNNG 111

Query: 58  SPQDSFFAVEFDTSFDPSLGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIE 117
           +  +   AVEFDT  +P  GD + NH+GID++S++S  +      G  LKSG+ +  WI+
Sbjct: 112 NSSNHIVAVEFDTFQNPEFGDPDDNHVGIDVNSLVSVKAGYWDDDGGKLKSGKPMQAWID 171

Query: 118 YRDSLKLIRVWAGYSQIRPP-SPLIIAQIDLSKQFKDYMHVGFSAANGQGSAIYTVDRWR 176
           Y  S K + V   YS +  P  PL+   +DLSK   + ++VGFSA+ G  + ++ +  W 
Sbjct: 172 YDSSSKRLSVTLAYSGVAKPKKPLLSYPVDLSKVLPEEVYVGFSASTGLLTELHYILSWS 231

Query: 177 FKTF 180
           F + 
Sbjct: 232 FSSN 235

This alignment model includes the legume lectins (also known as agglutinins), the arcelin (also known as phytohemagglutinin-L) family of lectin-like defense proteins, the LecRK family of lectin-like receptor kinases, concanavalinA (ConA), and an alpha-amylase inhibitor. Arcelin is a major seed glycoprotein discovered in kidney beans (Phaseolus vulgaris) that has insecticidal properties and protects the seeds from predation by larvae of various bruchids. Arcelin is devoid of monosaccharide binding properties and lacks a key metal-binding loop that is present in other members of this family. Phytohaemagglutinin (PHA) is a lectin found in plants, especially beans, that affects cell metabolism by inducing mitosis and by altering the permeability of the cell membrane to various proteins. PHA agglutinates most mammalian red blood cell types by binding glycans on the cell surface. Medically, PHA is used as a mitogen to trigger cell division in T-lymphocytes and to activate latent HIV-1 from human peripheral lymphocytes. Plant L-type lectins are primarily found in the seeds of leguminous plants where they constitute about 10% of the total soluble protein of the seed extracts. They are synthesized during seed development several weeks after flowering and transported to the vacuole where they become condensed into specialized vesicles called protein bodies. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded sheet and homotetramers occur by a back-to-back association of these homodimers. Though L-type lectins exhibit both sequence and structural similarity to one another, their carbohydrate binding specificities differ widely. Length = 236

>gnl|CDD|215744 pfam00139, Lectin_legB, Legume lectin domain

 Score =  180 bits (460), Expect = 4e-53
 Identities = 67/182 (36%), Positives = 94/182 (51%), Gaps = 5/182 (2%)

Query: 1   FLDPKTNTTASFSCRFSFSIIPSPL-CAFGDGFAFLITSNADSFG-NDNGYMGLPGP--V 56
             D  T   ASFS  F F+I   P     GDG AF +  +    G +  GY+GL      
Sbjct: 51  LWDSSTGKVASFSTSFVFAIKNIPKSTNGGDGLAFFLAPSGTQPGASSGGYLGLFNSSNN 110

Query: 57  LSPQDSFFAVEFDTSFDPSLGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWI 116
            +  +   AVEFDT  +P   DI+ NH+GID++S+IS  S  A    +DL SG+ I  WI
Sbjct: 111 GNSSNHIVAVEFDTFLNPEFNDIDDNHVGIDVNSIISVASESASFVPLDLNSGKPIQVWI 170

Query: 117 EYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGSAIYTVDRWR 176
           +Y  S K + V   Y   +P  PL+ A +DLS    ++++VGFSA+ G  +  + V  W 
Sbjct: 171 DYDGSSKRLSVTLAYP-NKPKRPLLSASVDLSTVLPEWVYVGFSASTGGATESHYVLSWS 229

Query: 177 FK 178
           F 
Sbjct: 230 FS 231

Length = 231

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  162 bits (413), Expect = 4e-46
 Identities = 76/280 (27%), Positives = 106/280 (37%), Gaps = 51/280 (18%)

Query: 286 FNKNRIVGEGASATVYKGSLPSGG-AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           +   R +G G+  TVYK      G  VAVK  +K +           E   +   L H N
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILR-RLSHPN 59

Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           +V+L     + + L LV EY   G L   L         LS ++   I L +   L YLH
Sbjct: 60  IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRG----GPLSEDEAKKIALQILRGLEYLH 115

Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTMGYLAPEYVYS 453
                 IIHRD+K  NILLD     K+ DF             T   GT  Y+APE V  
Sbjct: 116 ---SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPE-VLL 171

Query: 454 GVP--SEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLL----------- 500
           G      K DV+S GV+  E+  GK P   +  +    +        L            
Sbjct: 172 GGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSE 231

Query: 501 DAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEA 540
           +A D           +++ L       + +  KRP+ +E 
Sbjct: 232 EAKDL----------IKKCL-------NKDPSKRPTAEEI 254

Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  146 bits (371), Expect = 1e-40
 Identities = 78/267 (29%), Positives = 106/267 (39%), Gaps = 66/267 (24%)

Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQG 350
           +GEG   TVY      +G  VA+K  +K +           E   +   L H N+V+L G
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDS-SSLLEELLREIEILK-KLNHPNIVKLYG 58

Query: 351 WCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQ 410
              + N L LV EY   GSL  +L  N      LS ++ L I+L +   L YLH      
Sbjct: 59  VFEDENHLYLVMEYCEGGSLKDLLKENEG---KLSEDEILRILLQILEGLEYLH---SNG 112

Query: 411 IIHRDVKACNILLDA-EFNAKLGDF-----------EATIPAGTMGYLAPEYVYSGVP-S 457
           IIHRD+K  NILLD+     KL DF                 GT  Y+APE +      S
Sbjct: 113 IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYS 172

Query: 458 EKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEME 517
           EK+D++S GV+  E               +  + +L                      + 
Sbjct: 173 EKSDIWSLGVILYE---------------LPELKDL----------------------IR 195

Query: 518 RMLMVGLSCVHPNHEKRPSVKEAARIL 544
           +ML         + EKRPS KE    L
Sbjct: 196 KML-------QKDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  145 bits (369), Expect = 7e-40
 Identities = 73/275 (26%), Positives = 112/275 (40%), Gaps = 47/275 (17%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           +     +GEG+   VY      +G  VA+K  +K    +        E   +   L+H N
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRER-ILREIKILK-KLKHPN 58

Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           +V+L     + ++L LV EY   G L  +L         LS ++    +  + SAL YLH
Sbjct: 59  IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGR----LSEDEARFYLRQILSALEYLH 114

Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF----------EATIPAGTMGYLAPEYVYSG 454
               + I+HRD+K  NILLD + + KL DF          + T   GT  Y+APE V  G
Sbjct: 115 S---KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPE-VLLG 170

Query: 455 VP-SEKTDVYSFGVVALEVAAGKSPVDNDG------CVIVDWVWNLRKKGKLL--DAADF 505
               +  D++S GV+  E+  GK P   D         I             +  +A D 
Sbjct: 171 KGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDL 230

Query: 506 RLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEA 540
                     + ++L         + EKR + +EA
Sbjct: 231 ----------IRKLL-------VKDPEKRLTAEEA 248

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  138 bits (350), Expect = 4e-37
 Identities = 82/282 (29%), Positives = 127/282 (45%), Gaps = 46/282 (16%)

Query: 290 RIVGEGASATVYKGSLPSGG----AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           + +GEGA   VYKG L         VAVK   K +  E  R  F  E   M   L H N+
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTL-KEDASEEERKDFLKEARVMKK-LGHPNV 58

Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNN-----SSSSIVLSWEKRLNIVLGVASAL 400
           V+L G C E   L LV EY+  G L   L  +     S     LS +  L+  + +A  +
Sbjct: 59  VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118

Query: 401 SYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMG-----YLA 447
            YL     ++ +HRD+ A N L+  +   K+ DF        +      T G     ++A
Sbjct: 119 EYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMA 175

Query: 448 PEYVYSGVPSEKTDVYSFGVVALEVAA-GKSP---VDNDGCVIVDWVWNLRKKGKLLDAA 503
           PE +  G+ + K+DV+SFGV+  E+   G +P   + N+   +++++    +KG  L   
Sbjct: 176 PESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE--VLEYL----RKGYRLP-- 227

Query: 504 DFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK 545
               + ++   E+   LM  LSC   + E RP+  E    L+
Sbjct: 228 ----KPEYCPDELYE-LM--LSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  137 bits (348), Expect = 7e-37
 Identities = 83/278 (29%), Positives = 118/278 (42%), Gaps = 44/278 (15%)

Query: 288 KNRIVGEGASATVYKGSL-PSGGA----VAVKRFEKPNRVECARNPFTTEFATMAGCLRH 342
             + +GEGA   VYKG L   GG     VAVK   K +  E     F  E   M   L H
Sbjct: 3   LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTL-KEDASEQQIEEFLREARIMRK-LDH 60

Query: 343 KNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
            N+V+L G C E   L +V EY+  G L   L  N      LS    L+  L +A  + Y
Sbjct: 61  PNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP---KLSLSDLLSFALQIARGMEY 117

Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGTMG---YLAPEY 450
           L     +  IHRD+ A N L+      K+ DF         +     G      ++APE 
Sbjct: 118 LE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPES 174

Query: 451 VYSGVPSEKTDVYSFGVVALEVAA-GKSP---VDNDGCVIVDWVWNLRKKGKLLDAADFR 506
           +  G  + K+DV+SFGV+  E+   G+ P   + N+   +++++    K G  L      
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNE--EVLEYL----KNGYRLP----- 223

Query: 507 LRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARIL 544
            +      E+   LM  L C   + E RP+  E   IL
Sbjct: 224 -QPPNCPPEL-YDLM--LQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  134 bits (340), Expect = 9e-36
 Identities = 86/279 (30%), Positives = 121/279 (43%), Gaps = 45/279 (16%)

Query: 288 KNRIVGEGASATVYKGSLPSGGA-----VAVKRFEKPNRVECARNPFTTEFATMAGCLRH 342
             + +GEGA   VYKG+L   G      VAVK   K +  E     F  E   M   L H
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL-KEDASEQQIEEFLREARIMRK-LDH 60

Query: 343 KNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
            N+V+L G C E   L++V EY+P G L   L  N      LS    L+  L +A  + Y
Sbjct: 61  PNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPK--ELSLSDLLSFALQIARGMEY 118

Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGTMG---YLAPEY 450
           L     +  IHRD+ A N L+      K+ DF         +     G      ++APE 
Sbjct: 119 LE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPES 175

Query: 451 VYSGVPSEKTDVYSFGVVALEVAA-GKSP---VDNDGCVIVDWVWNLRKKGKLLDAADFR 506
           +  G  + K+DV+SFGV+  E+   G+ P   + N    +++++    KKG        R
Sbjct: 176 LKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNA--EVLEYL----KKGY-------R 222

Query: 507 LRGKFN-RKEMERMLMVGLSCVHPNHEKRPSVKEAARIL 544
           L    N   E+   LM  L C   + E RP+  E   IL
Sbjct: 223 LPKPPNCPPEL-YKLM--LQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  129 bits (328), Expect = 4e-34
 Identities = 66/212 (31%), Positives = 95/212 (44%), Gaps = 27/212 (12%)

Query: 286 FNKNRIVGEGASATVYKGSL-----PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCL 340
               + +GEGA   VYKG+L      +   VAVK   K    E  R  F  E + M   L
Sbjct: 1   LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTL-KEGASEEEREEFLEEASIMKK-L 58

Query: 341 RHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASAL 400
            H N+V+L G C +G  L +V EY+P G L   L  +      L+ +  L + L +A  +
Sbjct: 59  SHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEK---LTLKDLLQMALQIAKGM 115

Query: 401 SYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYL-----A 447
            YL     +  +HRD+ A N L+      K+ DF        +        G L     A
Sbjct: 116 EYLE---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMA 172

Query: 448 PEYVYSGVPSEKTDVYSFGVVALEVAA-GKSP 478
           PE +  G  + K+DV+SFGV+  E+   G+ P
Sbjct: 173 PESLKDGKFTSKSDVWSFGVLLWEIFTLGEQP 204

Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  117 bits (296), Expect = 1e-29
 Identities = 58/217 (26%), Positives = 88/217 (40%), Gaps = 44/217 (20%)

Query: 288 KNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLV 346
           +  ++G G+  +VY      +G  +AVK  E     E        E   ++  L+H N+V
Sbjct: 4   RGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSS-LQHPNIV 62

Query: 347 QLQGWCC--EGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLN----------IVL 394
           +  G     E N L +  EY+  GSL  +L              +L           I+ 
Sbjct: 63  RYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKF----------GKLPEPVIRKYTRQILE 112

Query: 395 GVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEA-------------TIPAG 441
           G    L+YLH      I+HRD+K  NIL+D++   KL DF                   G
Sbjct: 113 G----LAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRG 165

Query: 442 TMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSP 478
           T  ++APE +         D++S G   +E+A GK P
Sbjct: 166 TPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  114 bits (287), Expect = 1e-28
 Identities = 63/205 (30%), Positives = 92/205 (44%), Gaps = 34/205 (16%)

Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQG 350
           +G+G    VYK     +G  VA+K        +  +     E   +  C +H N+V+  G
Sbjct: 8   IGKGGFGEVYKARHKRTGKEVAIKVI--KLESKEKKEKIINEIQILKKC-KHPNIVKYYG 64

Query: 351 WCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLN------IVLGVASALSYLH 404
              + +EL +V E+   GSL  +L          S  + L       +   +   L YLH
Sbjct: 65  SYLKKDELWIVMEFCSGGSLKDLLK---------STNQTLTESQIAYVCKELLKGLEYLH 115

Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF------EATIP----AGTMGYLAPEYVYSG 454
                 IIHRD+KA NILL ++   KL DF        T       GT  ++APE V +G
Sbjct: 116 SN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPE-VING 171

Query: 455 VP-SEKTDVYSFGVVALEVAAGKSP 478
            P   K D++S G+ A+E+A GK P
Sbjct: 172 KPYDYKADIWSLGITAIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  110 bits (274), Expect = 4e-26
 Identities = 70/334 (20%), Positives = 107/334 (32%), Gaps = 28/334 (8%)

Query: 285 GFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKP-NRVECARNPFTTEFATMAGCLRHK 343
            +   R +GEG+   VY         VA+K   K           F  E   +A      
Sbjct: 1   SYRILRKLGEGSFGEVYLARDRK--LVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
           N+V+L  +  +   L LV EY+  GSL+ +L         LS  + L I+  + SAL YL
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKG-PLSESEALFILAQILSALEYL 117

Query: 404 HEECERQIIHRDVKACNILLDAE-FNAKLGDF-----------------EATIPAGTMGY 445
           H    + IIHRD+K  NILLD +    KL DF                   +   GT GY
Sbjct: 118 H---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174

Query: 446 LAPEYVYSGV---PSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDA 502
           +APE +        S  +D++S G+   E+  G  P + +                   +
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234

Query: 503 ADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEAPLPLLPVKKPTVNI 562
               L         +    +    +  + + R S                       +  
Sbjct: 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKP 294

Query: 563 RSVFPEASELIDSGGDHSPGFDDSLWMTPRSRFS 596
               P    L  S        +         +  
Sbjct: 295 DDSAPLRLSLPPSLEALISSLNSLAISGSDLKLD 328

Length = 384

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  106 bits (267), Expect = 6e-26
 Identities = 62/202 (30%), Positives = 93/202 (46%), Gaps = 24/202 (11%)

Query: 291 IVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQ 349
           ++G GA   VYKG +L +G  VA+K+       E A      E   +   L+H N+V+  
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKN-LKHPNIVKYI 65

Query: 350 GWCCEGNELVLVYEYLPNGSLDKILHNNS--SSSIVLSWEKRLNIVLGVASALSYLHEEC 407
           G     + L ++ EY  NGSL +I+        S+V  +      V  V   L+YLHE+ 
Sbjct: 66  GSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVY------VYQVLQGLAYLHEQ- 118

Query: 408 ERQIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTMGYLAPEYVYSGVP 456
              +IHRD+KA NIL   +   KL DF           +     GT  ++APE +     
Sbjct: 119 --GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGA 176

Query: 457 SEKTDVYSFGVVALEVAAGKSP 478
           S  +D++S G   +E+  G  P
Sbjct: 177 STASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  100 bits (251), Expect = 1e-23
 Identities = 77/290 (26%), Positives = 129/290 (44%), Gaps = 50/290 (17%)

Query: 277 TDIKQATLGFNKNRIVGEGASATVYKGSLPSGG----AVAVKRFEKPNRVECARNPFTTE 332
            D    T+     +++G G    V +G L   G     VA+K   K    +  R  F TE
Sbjct: 1   IDPSYVTI----EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL-KAGSSDKQRLDFLTE 55

Query: 333 FATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNI 392
            A++ G   H N+++L+G   +   ++++ EY+ NGSLDK L  N       +  + + +
Sbjct: 56  -ASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGK---FTVGQLVGM 111

Query: 393 VLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGTM 443
           + G+AS + YL E      +HRD+ A NIL+++    K+ DF         EAT    T 
Sbjct: 112 LRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYT--TK 166

Query: 444 G------YLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKK 496
           G      + APE +     +  +DV+SFG+V  EV + G+ P            W++  +
Sbjct: 167 GGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERP-----------YWDMSNQ 215

Query: 497 GKLLDAAD--FRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARIL 544
             ++ A +  +RL    +       LM  L C   +  +RP+  +    L
Sbjct: 216 -DVIKAVEDGYRLPPPMDCPSALYQLM--LDCWQKDRNERPTFSQIVSTL 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 99.4 bits (248), Expect = 3e-23
 Identities = 70/210 (33%), Positives = 96/210 (45%), Gaps = 35/210 (16%)

Query: 292 VGEGASATVYKG-SLPSGGAVAVKR--FEK-PNRVECARNPFTTEFATMAGCLRHKNLVQ 347
           +G GA+A VY    LP+   VA+KR   EK    V+  R     E   M+ C  H N+V+
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRK----EVQAMSQC-NHPNVVK 63

Query: 348 LQGWCCEGNELVLVYEYLPNGS-LDKILHNNSSSSIVLSWEKRLNIVL-GVASALSYLHE 405
                  G+EL LV  YL  GS LD +  +     +    E  +  VL  V   L YLH 
Sbjct: 64  YYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLD---EAIIATVLKEVLKGLEYLHS 120

Query: 406 ECERQIIHRDVKACNILLDAEFNAKLGDFEA----------------TIPAGTMGYLAPE 449
                 IHRD+KA NILL  + + K+ DF                  T   GT  ++APE
Sbjct: 121 N---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTF-VGTPCWMAPE 176

Query: 450 YVYSGVP-SEKTDVYSFGVVALEVAAGKSP 478
            +        K D++SFG+ A+E+A G +P
Sbjct: 177 VMEQVHGYDFKADIWSFGITAIELATGAAP 206

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 99.1 bits (248), Expect = 3e-23
 Identities = 57/202 (28%), Positives = 88/202 (43%), Gaps = 18/202 (8%)

Query: 290 RIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           + +G+G+   VY       G    +K  +  N  E  R     E   +   L H N+++ 
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILK-KLNHPNIIKY 64

Query: 349 QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE 408
                E  +L +V EY   G L + +            E+ L+  + +  AL YLH    
Sbjct: 65  YESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS--- 121

Query: 409 RQIIHRDVKACNILLDAEFNAKLGDF------EATIPA-----GTMGYLAPEYVYSGVP- 456
           R+I+HRD+K  NI L +    KLGDF       +T+       GT  YL+PE +    P 
Sbjct: 122 RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPE-LCQNKPY 180

Query: 457 SEKTDVYSFGVVALEVAAGKSP 478
           + K+D++S G V  E+   K P
Sbjct: 181 NYKSDIWSLGCVLYELCTLKHP 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 95.5 bits (238), Expect = 6e-22
 Identities = 72/270 (26%), Positives = 110/270 (40%), Gaps = 49/270 (18%)

Query: 293 GEGASATVYKGS-LPSGGAVAVKRFE-KPNRVECARNPFTTEFATMAGCLRHKNLVQLQG 350
           G G S  V K    P+G  +AVK    + N     +     E   +  C     +V   G
Sbjct: 10  GAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAI--QKQILRELDILHKC-NSPYIVGFYG 66

Query: 351 WCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLN------IVLGVASALSYLH 404
                 ++ +  EY+  GSLDKIL            + R+       I + V   L+YLH
Sbjct: 67  AFYNNGDISICMEYMDGGSLDKILK---------EVQGRIPERILGKIAVAVLKGLTYLH 117

Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGTMGYLAPEYVYSGV 455
           E+   +IIHRDVK  NIL+++    KL DF          A    GT  Y+APE +    
Sbjct: 118 EK--HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGND 175

Query: 456 PSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKG------KLLDAADFRLRG 509
            S K+D++S G+  +E+A G+ P             N    G       +++    RL  
Sbjct: 176 YSVKSDIWSLGLSLIELATGRFPYPP---------ENDPPDGIFELLQYIVNEPPPRLPS 226

Query: 510 KFNRKEMERMLMVGLSCVHPNHEKRPSVKE 539
                + +  + +   C+  +  +RPS KE
Sbjct: 227 GKFSPDFQDFVNL---CLIKDPRERPSYKE 253

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 94.4 bits (235), Expect = 1e-21
 Identities = 64/196 (32%), Positives = 94/196 (47%), Gaps = 19/196 (9%)

Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G+G    V  G    G  VAVK  +       A   F  E + M   LRH NLVQL G 
Sbjct: 14  IGKGEFGDVMLGDY-RGQKVAVKCLK---DDSTAAQAFLAEASVMTT-LRHPNLVQLLGV 68

Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
             +GN L +V EY+  GSL   L +   + I L   ++L   L V   + YL    E+  
Sbjct: 69  VLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITL--AQQLGFALDVCEGMEYLE---EKNF 123

Query: 412 IHRDVKACNILLDAEFNAKLGDF------EATIPAGTM--GYLAPEYVYSGVPSEKTDVY 463
           +HRD+ A N+L+  +  AK+ DF           +G +   + APE +     S K+DV+
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWTAPEALREKKFSTKSDVW 183

Query: 464 SFGVVALEVAA-GKSP 478
           SFG++  E+ + G+ P
Sbjct: 184 SFGILLWEIYSFGRVP 199

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 93.1 bits (232), Expect = 3e-21
 Identities = 63/206 (30%), Positives = 96/206 (46%), Gaps = 25/206 (12%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F+    +GEG+  +VYK     +G  VA+K       VE        E + +  C     
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP----VEEDLQEIIKEISILKQC-DSPY 59

Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           +V+  G   +  +L +V EY   GS+  I+     ++  L+ E+   I+      L YLH
Sbjct: 60  IVKYYGSYFKNTDLWIVMEYCGAGSVSDIM---KITNKTLTEEEIAAILYQTLKGLEYLH 116

Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDFE-ATIPAGTMG----------YLAPEYVYS 453
                + IHRD+KA NILL+ E  AKL DF  +     TM           ++APE V  
Sbjct: 117 S---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPE-VIQ 172

Query: 454 GVP-SEKTDVYSFGVVALEVAAGKSP 478
            +  + K D++S G+ A+E+A GK P
Sbjct: 173 EIGYNNKADIWSLGITAIEMAEGKPP 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 93.6 bits (233), Expect = 4e-21
 Identities = 64/211 (30%), Positives = 88/211 (41%), Gaps = 27/211 (12%)

Query: 290 RIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNP-----FTTEFATMAGCLRHKN 344
             +GEGA  +V K  L + G +   +      +    NP        E      C +   
Sbjct: 7   SRLGEGAGGSVTKCRLKNTGMIFALKT-----ITTDPNPDLQKQILRELEINKSC-KSPY 60

Query: 345 LVQLQGWCCE--GNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRL-NIVLGVASALS 401
           +V+  G   +   + + +  EY   GSLD I          +  EK L  I   V   LS
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIG-EKVLGKIAESVLKGLS 119

Query: 402 YLHEECERQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGTMGYLAPEYVY 452
           YLH    R+IIHRD+K  NILL  +   KL DF          A    GT  Y+APE + 
Sbjct: 120 YLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSFYMAPERIQ 176

Query: 453 SGVPSEKTDVYSFGVVALEVAAGKSPVDNDG 483
               S  +DV+S G+  LEVA  + P   +G
Sbjct: 177 GKPYSITSDVWSLGLTLLEVAQNRFPFPPEG 207

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 96.5 bits (240), Expect = 1e-20
 Identities = 85/335 (25%), Positives = 144/335 (42%), Gaps = 47/335 (14%)

Query: 235 VFTVVAIVGIISCFLIKKKRHDGRS-----KEDHVCTVQ----RVPMRLALTDIKQATLG 285
            F V+A+V     F+   +  +         ED    +Q    +V   + + DI  +   
Sbjct: 638 AFLVLALVAFGFVFI---RGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSL-- 692

Query: 286 FNKNRIVGEGASATVYKGSLPSGGA-VAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
             +  ++  G     YKG     G    VK     N +       ++E A M G L+H N
Sbjct: 693 -KEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP------SSEIADM-GKLQHPN 744

Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           +V+L G C       L++EY+   +L ++L N       LSWE+R  I +G+A AL +LH
Sbjct: 745 IVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLH 797

Query: 405 EECERQIIHRDVKACNILLDAEFNAKL---------GDFEATIPAGTMGYLAPEYVYSGV 455
             C   ++  ++    I++D +    L          D +  I +    Y+APE   +  
Sbjct: 798 CRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISSA---YVAPETRETKD 854

Query: 456 PSEKTDVYSFGVVALEVAAGKSPVDNDGCV---IVDWVWNLRKKGKLLDAADFRLRGK-- 510
            +EK+D+Y FG++ +E+  GKSP D +  V   IV+W         L    D  +RG   
Sbjct: 855 ITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVS 914

Query: 511 FNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK 545
            N+ E+  ++ + L C   +   RP   +  + L+
Sbjct: 915 VNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949

Length = 968

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 91.0 bits (226), Expect = 3e-20
 Identities = 63/219 (28%), Positives = 100/219 (45%), Gaps = 35/219 (15%)

Query: 290 RIVGEGASATVYKGSLPSGGA------VAVKRFEKPNRVECARNPFTTEFATMAGCLRHK 343
           R +GEGA   V+ G             VAVK   K      AR  F  E A +    +H+
Sbjct: 11  RELGEGAFGKVFLGECYHLEPENDKELVAVKTL-KETASNDARKDFERE-AELLTNFQHE 68

Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNS----------SSSIVLSWEKRLNIV 393
           N+V+  G C EG+  ++V+EY+ +G L+K L ++           S    L+  + L I 
Sbjct: 69  NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128

Query: 394 LGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT----------IPAGTM 443
           + +AS + YL     +  +HRD+   N L+  +   K+GDF  +          +   TM
Sbjct: 129 VQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTM 185

Query: 444 ---GYLAPEYVYSGVPSEKTDVYSFGVVALEV-AAGKSP 478
               ++ PE +     + ++DV+SFGVV  E+   GK P
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 90.4 bits (224), Expect = 3e-20
 Identities = 65/212 (30%), Positives = 108/212 (50%), Gaps = 31/212 (14%)

Query: 288 KNRIVGEGASATVYKGSLPSGG----AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHK 343
           K +++G G    V++G L   G    AVA+K   KP   E  R  F +E A++ G   H 
Sbjct: 9   KQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTL-KPGYTEKQRQDFLSE-ASIMGQFSHH 66

Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKIL--HNNSSSSIVLSWEKRLNIVLGVASALS 401
           N+++L+G   +    +++ EY+ NG+LDK L  H+   SS  L     + ++ G+A+ + 
Sbjct: 67  NIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL-----VGMLRGIAAGMK 121

Query: 402 YLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT-----IPAGT---------MGYLA 447
           YL    +   +HRD+ A NIL+++    K+ DF  +      P GT         + + A
Sbjct: 122 YL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTA 178

Query: 448 PEYVYSGVPSEKTDVYSFGVVALEVAA-GKSP 478
           PE +     +  +DV+SFG+V  EV + G+ P
Sbjct: 179 PEAIAYRKFTSASDVWSFGIVMWEVMSFGERP 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 90.5 bits (225), Expect = 4e-20
 Identities = 59/203 (29%), Positives = 90/203 (44%), Gaps = 29/203 (14%)

Query: 290 RIVGEGASATVYKGSL-PSGGA----VAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           + +GEG    V      P G      VAVK     +  E  R+ F  E   +   L H+N
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL-NHSGEEQHRSDFEREIEILRT-LDHEN 67

Query: 345 LVQLQGWCCE--GNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
           +V+ +G C +  G  L L+ EYLP+GSL   L  +      ++ ++ L     +   + Y
Sbjct: 68  IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ---INLKRLLLFSSQICKGMDY 124

Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDFE-ATIPAGTMGYL-------------AP 448
           L     ++ IHRD+ A NIL+++E   K+ DF  A +      Y              AP
Sbjct: 125 LGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAP 181

Query: 449 EYVYSGVPSEKTDVYSFGVVALE 471
           E + +   S  +DV+SFGV   E
Sbjct: 182 ECLRTSKFSSASDVWSFGVTLYE 204

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 90.3 bits (225), Expect = 4e-20
 Identities = 66/207 (31%), Positives = 95/207 (45%), Gaps = 38/207 (18%)

Query: 292 VGEGASATVYKG-SLPSGGAVAVK--RFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           +GEGAS  VYK     +G  VA+K  R  K N+          E   M  C +H N+V  
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMRLRKQNK-----ELIINEILIMKDC-KHPNIVDY 80

Query: 349 QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLN------IVLGVASALSY 402
                 G+EL +V EY+  GSL  I+  N           R+N      +   V   L Y
Sbjct: 81  YDSYLVGDELWVVMEYMDGGSLTDIITQN---------FVRMNEPQIAYVCREVLQGLEY 131

Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDF--EATIPA---------GTMGYLAPEYV 451
           LH    + +IHRD+K+ NILL  + + KL DF   A +           GT  ++APE +
Sbjct: 132 LHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVI 188

Query: 452 YSGVPSEKTDVYSFGVVALEVAAGKSP 478
                  K D++S G++ +E+A G+ P
Sbjct: 189 KRKDYGPKVDIWSLGIMCIEMAEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 88.6 bits (220), Expect = 1e-19
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 26/208 (12%)

Query: 286 FNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           F   R +G G    V++G   +   VA+K  +  +     +  F  E   +   LRHK+L
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD--LLKQQDFQKEVQALKR-LRHKHL 64

Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
           + L   C  G  + ++ E +  GSL   L   S    VL     +++   VA  ++YL E
Sbjct: 65  ISLFAVCSVGEPVYIITELMEKGSLLAFL--RSPEGQVLPVASLIDMACQVAEGMAYLEE 122

Query: 406 ECERQIIHRDVKACNILLDAEFNAKLGDF--------------EATIPAGTMGYLAPEYV 451
              +  IHRD+ A NIL+  +   K+ DF              +  IP     + APE  
Sbjct: 123 ---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIP---YKWTAPEAA 176

Query: 452 YSGVPSEKTDVYSFGVVALEVAA-GKSP 478
             G  S K+DV+SFG++  E+   G+ P
Sbjct: 177 SHGTFSTKSDVWSFGILLYEMFTYGQVP 204

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 87.6 bits (218), Expect = 2e-19
 Identities = 71/274 (25%), Positives = 116/274 (42%), Gaps = 44/274 (16%)

Query: 286 FNKNRIVGEGASATVYKGSL-PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
             + +++G+G+S  VYK    P+G   A+K+       E  R     E  T+  C     
Sbjct: 3   LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEE-FRKQLLRELKTLRSC-ESPY 60

Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNI---VLG-----V 396
           +V+  G   +  E+ +V EY+  GSL  +L            +K   I   VL      +
Sbjct: 61  VVKCYGAFYKEGEISIVLEYMDGGSLADLL------------KKVGKIPEPVLAYIARQI 108

Query: 397 ASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--EATIPA---------GTMGY 445
              L YLH +  R IIHRD+K  N+L++++   K+ DF     +           GT+ Y
Sbjct: 109 LKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTY 166

Query: 446 LAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADF 505
           ++PE +     S   D++S G+  LE A GK P    G     + + L +   + D    
Sbjct: 167 MSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG--QPSF-FELMQ--AICDGPPP 221

Query: 506 RLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKE 539
            L  +    E    +    +C+  + +KRPS  E
Sbjct: 222 SLPAEEFSPEFRDFIS---ACLQKDPKKRPSAAE 252

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 87.2 bits (216), Expect = 3e-19
 Identities = 69/219 (31%), Positives = 103/219 (47%), Gaps = 31/219 (14%)

Query: 287 NKNRIVGEGASATVYKGSLPSGGAV-AVKR--FEKPNRVECARNPFTTEFATMAGCLRHK 343
             N+I G+G+   V+K    +   V A+K+    K NR E  R     E A +   L   
Sbjct: 4   ILNKI-GKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRRE--REEAIDE-ARVLAKLDSS 59

Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIV--LSWEKRLNIVLGVASALS 401
            +++      +  +L +V EY  NG L K+L       +     W   + I+LG    L+
Sbjct: 60  YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----LA 115

Query: 402 YLHEECERQIIHRDVKACNILLDAEFNAKLGD------------FEATIPAGTMGYLAPE 449
           +LH    ++I+HRD+K+ N+ LDA  N K+GD            F  TI  GT  YL+PE
Sbjct: 116 HLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTI-VGTPYYLSPE 171

Query: 450 YVYSGVPSEKTDVYSFGVVALEVAAGKSP--VDNDGCVI 486
                  +EK+DV++ GVV  E   GK P   +N G +I
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALI 210

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 87.1 bits (216), Expect = 5e-19
 Identities = 72/280 (25%), Positives = 122/280 (43%), Gaps = 48/280 (17%)

Query: 286 FNKNRIVGEGASATVYKGS-LPSGG----AVAVKRFEKPNRVECARNPFTTEFATMAGCL 340
             K +++G GA  TVYKG  +P G      VA+K   +    + A      E   MA   
Sbjct: 9   LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPK-ANKEILDEAYVMASV- 66

Query: 341 RHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSS---SSIVLSWEKRLNIVLGVA 397
            H ++V+L G  C  +++ L+ + +P G L   + N+     S  +L+W  +      +A
Sbjct: 67  DHPHVVRLLG-ICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IA 119

Query: 398 SALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTM--G 444
             +SYL E   ++++HRD+ A N+L+    + K+ DF           E     G +   
Sbjct: 120 KGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIK 176

Query: 445 YLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDN-DGCVIVDWVWNLRKKGKLLDA 502
           ++A E +   + + K+DV+S+GV   E+   G  P +      I D    L +KG+ L  
Sbjct: 177 WMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPD----LLEKGERLPQ 232

Query: 503 ADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR 542
                   +       M++V   C   + E RP+ KE   
Sbjct: 233 PPICTIDVY-------MVLV--KCWMIDAESRPTFKELIN 263

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 86.7 bits (215), Expect = 5e-19
 Identities = 66/275 (24%), Positives = 117/275 (42%), Gaps = 46/275 (16%)

Query: 285 GFNKNRIVGEGASATVYKGSLPSGGAV-AVKRFEKPNRVECARNPFTTEFATMAGCLRHK 343
            F   + +G+G+  +VYK    S     A+K  +  +  +  R     E   +A  + H 
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILAS-VNHP 59

Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
           N++  +    +GN+L +V EY P G L K +        ++  ++   I + +   L  L
Sbjct: 60  NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119

Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDFE-ATIPAGTMG--------YLAPEYVYSG 454
           HE   ++I+HRD+K+ NILL A    K+GD   + +    M         Y+APE V+ G
Sbjct: 120 HE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPE-VWKG 175

Query: 455 VP-SEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFR---LRGK 510
            P S K+D++S G +  E+A    P +                 +     D R    RGK
Sbjct: 176 RPYSYKSDIWSLGCLLYEMATFAPPFE----------------AR--SMQDLRYKVQRGK 217

Query: 511 FNR------KEMERMLMVGLSCVHPNHEKRPSVKE 539
           +        ++++  +    S +    + RP+  +
Sbjct: 218 YPPIPPIYSQDLQNFIR---SMLQVKPKLRPNCDK 249

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 86.5 bits (214), Expect = 6e-19
 Identities = 64/217 (29%), Positives = 99/217 (45%), Gaps = 29/217 (13%)

Query: 286 FNKNRIVGEGASATVYKGSLPSGGAVAVKRFE-KPNRVECARNPFTT--EFATMAGCLRH 342
           + K  ++G+GA  TVY G    G  +AVK+ E   + V  A   +    E   +   L+H
Sbjct: 2   WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61

Query: 343 KNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHN-NSSSSIVLSWEKRLNIVLGVASALS 401
            N+VQ  G C + N + +  E++P GS+  IL+        V     +  I+ GVA    
Sbjct: 62  VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK-QILDGVA---- 116

Query: 402 YLHEECERQIIHRDVKACNILLDAEFNAKLGDFE-----ATIPA------------GTMG 444
           YLH  C   ++HRD+K  N++L      KL DF      A +              GT  
Sbjct: 117 YLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPY 173

Query: 445 YLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDN 481
           ++APE +       K+D++S G    E+A GK P+ +
Sbjct: 174 WMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLAS 210

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 85.8 bits (213), Expect = 1e-18
 Identities = 63/203 (31%), Positives = 90/203 (44%), Gaps = 22/203 (10%)

Query: 289 NRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
            R +G G    V+ G+      VAVK   KP     +   F  E   M   LRH  LVQL
Sbjct: 11  ERKLGAGQFGEVWMGTWNGTTKVAVKTL-KPG--TMSPEAFLQEAQIMKK-LRHDKLVQL 66

Query: 349 QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE 408
              C E   + +V EY+  GSL   L +     + L   + +++   +A  ++YL     
Sbjct: 67  YAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRL--PQLVDMAAQIAEGMAYLE---S 121

Query: 409 RQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVP 456
           R  IHRD+ A NIL+      K+ DF         E T   G    + + APE    G  
Sbjct: 122 RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRF 181

Query: 457 SEKTDVYSFGVVALE-VAAGKSP 478
           + K+DV+SFG++  E V  G+ P
Sbjct: 182 TIKSDVWSFGILLTEIVTYGRVP 204

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 85.6 bits (212), Expect = 1e-18
 Identities = 72/279 (25%), Positives = 123/279 (44%), Gaps = 36/279 (12%)

Query: 285 GFNKNRIVGEGASATVYKG-SLPSGGAVAVKR---FE---KPNRVECARNPFTTEFATMA 337
            F   + +G+G  + VYK   L  G  VA+K+   FE      R +C +         + 
Sbjct: 3   NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKE------IDLL 56

Query: 338 GCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVA 397
             L H N+++      E NEL +V E    G L +++ +      ++         + + 
Sbjct: 57  KQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC 116

Query: 398 SALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-------EATIPA----GTMGYL 446
           SAL ++H    ++I+HRD+K  N+ + A    KLGD          T  A    GT  Y+
Sbjct: 117 SALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYM 173

Query: 447 APEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFR 506
           +PE ++    + K+D++S G +  E+AA +SP   D         NL    K ++  D+ 
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-------NLYSLCKKIEKCDYP 226

Query: 507 LRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK 545
                +  E  R L+    C++P+ EKRP +    ++ K
Sbjct: 227 PLPADHYSEELRDLVSR--CINPDPEKRPDISYVLQVAK 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 84.9 bits (210), Expect = 2e-18
 Identities = 66/218 (30%), Positives = 104/218 (47%), Gaps = 37/218 (16%)

Query: 288 KNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVE--CAR-----NPFTTEFATMAGC 339
           K  ++G G+  +VY G +  SG  +AVK+ E P+       R     +    E A +   
Sbjct: 4   KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKE- 62

Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRL--NIVLGVA 397
           L+H+N+VQ  G   + + L +  EY+P GS+  +L+N  +      +E+ L  N V  + 
Sbjct: 63  LQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGA------FEETLVRNFVRQIL 116

Query: 398 SALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF------EATIPAGTMG------- 444
             L+YLH    R IIHRD+K  NIL+D +   K+ DF      EA   +           
Sbjct: 117 KGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQ 173

Query: 445 ----YLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSP 478
               ++APE V     + K D++S G + +E+  GK P
Sbjct: 174 GSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 84.8 bits (210), Expect = 2e-18
 Identities = 76/278 (27%), Positives = 118/278 (42%), Gaps = 56/278 (20%)

Query: 288 KNRIVGEGASATVYKG-SLPSGGAVAVKRF----EKPNRVECARNPFTTEFATMAGCLRH 342
           K  ++G G+  +VY+G +L  G   AVK      +     E  +     E A ++  L+H
Sbjct: 4   KGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQ-LEQEIALLSK-LQH 61

Query: 343 KNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSS--SSIVLSWEKRLNIVLGVASAL 400
            N+VQ  G   E + L +  E +P GSL K+L    S    ++  + ++  I+LG    L
Sbjct: 62  PNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQ--ILLG----L 115

Query: 401 SYLHEECERQIIHRDVKACNILLDAEFNAKLGDF----------EATIPAGTMGYLAPEY 450
            YLH+   R  +HRD+K  NIL+D     KL DF           A    G+  ++APE 
Sbjct: 116 EYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEV 172

Query: 451 VYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKL--------LD 501
           +   G      D++S G   LE+A GK P        V  V+ + +  +L         +
Sbjct: 173 IAQQGGYGLAADIWSLGCTVLEMATGKPPWSQ--LEGVAAVFKIGRSKELPPIPDHLSDE 230

Query: 502 AADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKE 539
           A DF L+                 C+  +   RP+  E
Sbjct: 231 AKDFILK-----------------CLQRDPSLRPTAAE 251

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 84.8 bits (210), Expect = 3e-18
 Identities = 64/225 (28%), Positives = 104/225 (46%), Gaps = 44/225 (19%)

Query: 288 KNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNR------------VECARNPFTTEFA 334
           K  ++G+G    VY   ++ +G  +AVK+ E P              V+  R+    E  
Sbjct: 5   KGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRS----EIE 60

Query: 335 TMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNS--SSSIVLSWEKRLNI 392
           T+   L H N+VQ  G+      L +  EY+P GS+   L         +V  + ++   
Sbjct: 61  TLKD-LDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQ--- 116

Query: 393 VLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-------------EATIP 439
              V   L+YLH    + I+HRD+KA N+L+DA+   K+ DF             +    
Sbjct: 117 ---VLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSM 170

Query: 440 AGTMGYLAPEYV--YSGVPSEKTDVYSFGVVALEVAAGKSPVDND 482
            G++ ++APE +  YS   S K D++S G V LE+ AG+ P  ++
Sbjct: 171 QGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE 215

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 83.5 bits (207), Expect = 6e-18
 Identities = 60/210 (28%), Positives = 89/210 (42%), Gaps = 35/210 (16%)

Query: 292 VGEGASATVYKG-SLPSGGAVAVK--RFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           +G G    VY   +L +G  +AVK  R +  +           E   +   L+H NLV+ 
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPK--TIKEIADEMKVLEL-LKHPNLVKY 64

Query: 349 QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNI-VLGVASALSYLHEEC 407
            G      ++ +  EY   G+L+++L +          E  + +  L +   L+YLH   
Sbjct: 65  YGVEVHREKVYIFMEYCSGGTLEELLEHGRILD-----EHVIRVYTLQLLEGLAYLHSH- 118

Query: 408 ERQIIHRDVKACNILLDAEFNAKLGDF-------EATIPAGTMG--------YLAPEYVY 452
              I+HRD+K  NI LD     KLGDF         T   G           Y+APE V 
Sbjct: 119 --GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPE-VI 175

Query: 453 SGVPSE----KTDVYSFGVVALEVAAGKSP 478
           +G   +      D++S G V LE+A GK P
Sbjct: 176 TGGKGKGHGRAADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 83.5 bits (206), Expect = 7e-18
 Identities = 62/203 (30%), Positives = 89/203 (43%), Gaps = 23/203 (11%)

Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G    V+ G       VA+K   +    E     F  E   M   L H  LVQL G 
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE---EDFIEEAQVMMK-LSHPKLVQLYGV 67

Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
           C E + + LV+E++ +G L   L          S E  L + L V   ++YL       +
Sbjct: 68  CTERSPICLVFEFMEHGCLSDYLRAQRGK---FSQETLLGMCLDVCEGMAYLESSN---V 121

Query: 412 IHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVPSEK 459
           IHRD+ A N L+      K+ DF         + T   GT   + + +PE       S K
Sbjct: 122 IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSK 181

Query: 460 TDVYSFGVVALEV-AAGKSPVDN 481
           +DV+SFGV+  EV + GK+P +N
Sbjct: 182 SDVWSFGVLMWEVFSEGKTPYEN 204

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 83.4 bits (206), Expect = 8e-18
 Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 31/217 (14%)

Query: 288 KNRIVGEGASATVYKG-SLPSGGAVAVKR--FEKPNRVECAR--NPFTTEFATMAGCLRH 342
           K + +G GA ++ Y+   + +G  +AVK+  + +    E          E   MA  L H
Sbjct: 4   KGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMAR-LNH 62

Query: 343 KNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
            +++++ G  CE +   L  E++  GS+  +L    +    +       ++ G    LSY
Sbjct: 63  PHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRG----LSY 118

Query: 403 LHEECERQIIHRDVKACNILLDAE-FNAKLGDFEATIP---------------AGTMGYL 446
           LHE    QIIHRDVK  N+L+D+     ++ DF A                   GT+ ++
Sbjct: 119 LHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175

Query: 447 APEYVYSGVPSEKT-DVYSFGVVALEVAAGKSPVDND 482
           APE V  G    ++ DV+S G V +E+A  K P + +
Sbjct: 176 APE-VLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAE 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 82.5 bits (204), Expect = 1e-17
 Identities = 65/221 (29%), Positives = 95/221 (42%), Gaps = 37/221 (16%)

Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASA 399
           L H NLVQL G C +   + +V EY+ NG L   L         L  E  L++   V  A
Sbjct: 56  LSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKG---KLGTEWLLDMCSDVCEA 112

Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLA 447
           + YL        IHRD+ A N L+  +   K+ DF         + T   GT   + +  
Sbjct: 113 MEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAP 169

Query: 448 PEYVYSGVPSEKTDVYSFGVVALEV-AAGKSPVDNDGCVIVDWVWNLRKKGKLLD--AAD 504
           PE       S K+DV+SFGV+  EV + GK P +                 ++++  +A 
Sbjct: 170 PEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYER------------FSNSEVVESVSAG 217

Query: 505 FRL-RGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARIL 544
           +RL R K    E+  ++    SC H   E RP+ K+    L
Sbjct: 218 YRLYRPKLAPTEVYTIMY---SCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 82.9 bits (205), Expect = 2e-17
 Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 42/215 (19%)

Query: 292 VGEGASATVYKGSL--PSGG----AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           +GEGA   VYKG L  P+      +VA+K  ++    +  +  F  E   M+  L+H N+
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPK-VQQEFRQEAELMSD-LQHPNI 70

Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIV------------LSWEKRLNIV 393
           V L G C +     +++EYL +G L + L  NS  S V            L     L+I 
Sbjct: 71  VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130

Query: 394 LGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF----------------EAT 437
           + +A+ + YL        +HRD+ A N L+      K+ DF                ++ 
Sbjct: 131 IQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSL 187

Query: 438 IPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEV 472
           +P   M    PE +  G  + ++D++SFGVV  E+
Sbjct: 188 LPVRWM---PPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 81.9 bits (203), Expect = 3e-17
 Identities = 53/226 (23%), Positives = 88/226 (38%), Gaps = 48/226 (21%)

Query: 290 RIVGEGASATVYKGSLPSGGA-VAVKRFEKP-----NRVECARNPFTTEFATMAGCLRHK 343
           +I+GEG+ +TV            A+K  +K       +V+        E   +     H 
Sbjct: 7   KIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYV----KIEKEVLTRLNGHP 62

Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
            +++L     +   L  V EY PNG L + +    S    L  +        +  AL YL
Sbjct: 63  GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGS----LDEKCTRFYAAEILLALEYL 118

Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF----------------------EATIPA- 440
           H    + IIHRD+K  NILLD + + K+ DF                      ++ I   
Sbjct: 119 HS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175

Query: 441 --------GTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSP 478
                   GT  Y++PE +      + +D+++ G +  ++  GK P
Sbjct: 176 RRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 80.9 bits (200), Expect = 4e-17
 Identities = 64/199 (32%), Positives = 87/199 (43%), Gaps = 28/199 (14%)

Query: 292 VGEGASATVYKG--SLPSGG--AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQ 347
           +G G   +V KG   + SG    VAVK   K   +   +  F  E + MA  L H  +V+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTL-KQEHIAAGKKEFLREASVMAQ-LDHPCIVR 60

Query: 348 LQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC 407
           L G  C+G  L+LV E  P G L K L       +         +   VA  ++YL E  
Sbjct: 61  LIG-VCKGEPLMLVMELAPLGPLLKYLKKRREIPVS----DLKELAHQVAMGMAYL-ESK 114

Query: 408 ERQIIHRDVKACNILLDAEFNAKLGDF---EATIP------AGTMG-----YLAPEYVYS 453
               +HRD+ A N+LL     AK+ DF    A         A T G     + APE +  
Sbjct: 115 --HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172

Query: 454 GVPSEKTDVYSFGVVALEV 472
           G  S K+DV+S+GV   E 
Sbjct: 173 GKFSSKSDVWSYGVTLWEA 191

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 79.1 bits (196), Expect = 2e-16
 Identities = 50/157 (31%), Positives = 66/157 (42%), Gaps = 24/157 (15%)

Query: 340 LRHKNLVQLQGWCC--EGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLG-V 396
           + H  +V+L          +L LV EY P G L   L      S     E+R       +
Sbjct: 50  INHPFIVKL--HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFS-----EERARFYAAEI 102

Query: 397 ASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTMGY 445
             AL YLH      II+RD+K  NILLDA+ + KL DF                 GT  Y
Sbjct: 103 VLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEY 159

Query: 446 LAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDND 482
           LAPE +      +  D +S GV+  E+  GK P   +
Sbjct: 160 LAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAE 196

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 78.9 bits (195), Expect = 2e-16
 Identities = 38/111 (34%), Positives = 51/111 (45%), Gaps = 13/111 (11%)

Query: 396 VASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF----------EATIPAGTMGY 445
           +  AL YLH    + IIHRD+K  NILLD + +  + DF            T  +GT GY
Sbjct: 109 IVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGY 165

Query: 446 LAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKK 496
           +APE +     S   D +S GV A E   GK P       I D +   ++ 
Sbjct: 166 MAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET 216

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173886 cd01951, lectin_L-type, legume lectins

 Score = 77.9 bits (192), Expect = 3e-16
 Identities = 42/180 (23%), Positives = 68/180 (37%), Gaps = 22/180 (12%)

Query: 9   TASFSCRFSFSIIPSPLCAFGDGFAFLITSNADS------FGNDNGYMGLPGPVLSPQDS 62
           +  F+  F F +  +      DG AF++ ++          G   GY G+          
Sbjct: 53  SKDFTTTFKFYL-GTKGTNGADGIAFVLQNDPAGALGGGGGGGGLGYGGIGN-------- 103

Query: 63  FFAVEFDTSFDPSLGDINGNHIGIDISSVISFVSVDALSRGIDLKSGR----HITT-WIE 117
             AVEFDT  +    D NGNHI ID++      +  A S G           +  T  I 
Sbjct: 104 SVAVEFDTYKNDDNNDPNGNHISIDVNGN-GNNTALATSLGSASLPNGTGLGNEHTVRIT 162

Query: 118 YRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGSAIYTVDRWRF 177
           Y  +   + V+         S  I   +DL +      + GF+A+ G  + ++ +  W F
Sbjct: 163 YDPTTNTLTVYLDNGST-LTSLDITIPVDLIQLGPTKAYFGFTASTGGLTNLHDILNWSF 221

The L-type (legume-type) lectins are a highly diverse family of carbohydrate binding proteins that generally display no enzymatic activity toward the sugars they bind. This family includes arcelin, concanavalinA, the lectin-like receptor kinases, the ERGIC-53/VIP36/EMP46 type1 transmembrane proteins, and an alpha-amylase inhibitor. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded sheet and homotetramers occur by a back-to-back association of these homodimers. Though L-type lectins exhibit both sequence and structural similarity to one another, their carbohydrate binding specificities differ widely. Length = 223

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 79.1 bits (196), Expect = 3e-16
 Identities = 72/317 (22%), Positives = 117/317 (36%), Gaps = 98/317 (30%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARN--PFTTEFATMAGC--- 339
           + K   +GEG    VYK  +  +G  VA+K+     R+E  +   P T     +      
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKI----RMENEKEGFPITA----IREIKLL 52

Query: 340 --LRHKNLVQLQGWCCE--GNELVLVYEYLPNGSLDKILHNNS---SSSIVLSWEKRLNI 392
             LRH N+V+L+          + +V+EY+ +  L  +L +     + S +  + K+L  
Sbjct: 53  QKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQL-- 109

Query: 393 VLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF------EATIPAG----- 441
                  L YLH      I+HRD+K  NIL++ +   KL DF           A      
Sbjct: 110 ----LEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRV 162

Query: 442 -TMGYLAPE-------YVYSGVPSEKTDVYSFGVVALEVAAGK----------------- 476
            T+ Y  PE       Y        + D++S G +  E+  GK                 
Sbjct: 163 ITLWYRPPELLLGATRY------GPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFE 216

Query: 477 ---SPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERM----------LMVG 523
              SP D       +W   +    KL    + + +  + R+  E            L+  
Sbjct: 217 LCGSPTDE------NW-PGVS---KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDK 266

Query: 524 LSCVHPNHEKRPSVKEA 540
           L  + P  +KR S  +A
Sbjct: 267 LLTLDP--KKRISADQA 281

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 79.2 bits (195), Expect = 3e-16
 Identities = 63/206 (30%), Positives = 98/206 (47%), Gaps = 29/206 (14%)

Query: 292 VGEGASATVYKG-SLPSGGAVAVKRF---EKPNRVECARNPFTTEFATMAGCLRHKNLVQ 347
           +G+GAS TVY    + +G  VA+K+    ++P + E   N    E   M    +H N+V 
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKK-ELIIN----EILVMRE-NKHPNIVN 80

Query: 348 LQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC 407
                  G+EL +V EYL  GSL  ++         ++   R         AL +LH   
Sbjct: 81  YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFLHS-- 133

Query: 408 ERQIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTMGYLAPEYVYSGVP 456
             Q+IHRD+K+ NILL  + + KL DF           + +   GT  ++APE V     
Sbjct: 134 -NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 192

Query: 457 SEKTDVYSFGVVALEVAAGKSPVDND 482
             K D++S G++A+E+  G+ P  N+
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNE 218

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 78.7 bits (195), Expect = 4e-16
 Identities = 62/211 (29%), Positives = 91/211 (43%), Gaps = 35/211 (16%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTT--EFATMAGCLRH 342
           + K   +GEG    VYK     +G  VA+K+    N  E    P T   E + +   L+H
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEE--GIPSTALREISLLKE-LKH 57

Query: 343 KNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
            N+V+L        +L LV+EY     L K L       +  +  K   I+  +   L+Y
Sbjct: 58  PNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGP-LSPNLIKS--IMYQLLRGLAY 113

Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDF----EATIPAG-------TMGYLAPEYV 451
            H     +I+HRD+K  NIL++ +   KL DF       IP         T+ Y APE +
Sbjct: 114 CHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEIL 170

Query: 452 -----YS-GVPSEKTDVYSFGVVALEVAAGK 476
                YS  V     D++S G +  E+  GK
Sbjct: 171 LGSKHYSTAV-----DIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 78.1 bits (192), Expect = 4e-16
 Identities = 68/213 (31%), Positives = 104/213 (48%), Gaps = 27/213 (12%)

Query: 276 LTDIKQATLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFAT 335
           L ++++ TLG     I+GEG    V +G   +G  VAVK      + +     F  E A 
Sbjct: 2   LLNLQKLTLG----EIIGEGEFGAVLQGEY-TGQKVAVKNI----KCDVTAQAFLEETAV 52

Query: 336 MAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLG 395
           M   L HKNLV+L G     N L +V E +  G+L   L     + + +   + L   L 
Sbjct: 53  MTK-LHHKNLVRLLGVILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVI--QLLQFSLD 108

Query: 396 VASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGTMG---------YL 446
           VA  + YL     ++++HRD+ A NIL+  +  AK+ DF      G+MG         + 
Sbjct: 109 VAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDF-GLARVGSMGVDNSKLPVKWT 164

Query: 447 APEYVYSGVPSEKTDVYSFGVVALEV-AAGKSP 478
           APE +     S K+DV+S+GV+  EV + G++P
Sbjct: 165 APEALKHKKFSSKSDVWSYGVLLWEVFSYGRAP 197

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 77.1 bits (190), Expect = 9e-16
 Identities = 69/273 (25%), Positives = 120/273 (43%), Gaps = 40/273 (14%)

Query: 290 RIVGEGASATVYKGSLPSGGAVAVK--RFEKPNRVECARNPFTTEFATMAGCLRHKNLVQ 347
             +G+G    VYKG L     VAVK  R   P  +   +  F  E A +     H N+V+
Sbjct: 1   EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDL---KRKFLQE-AEILKQYDHPNIVK 56

Query: 348 LQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC 407
           L G C +   + +V E +P GSL   L    +    L+ +K L + L  A+ + YL  + 
Sbjct: 57  LIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNR---LTVKKLLQMSLDAAAGMEYLESKN 113

Query: 408 ERQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGT----MGYLAPEYVYSG 454
               IHRD+ A N L+      K+ DF           T+  G     + + APE +  G
Sbjct: 114 ---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYG 170

Query: 455 VPSEKTDVYSFGVVALEV-AAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRL-RGKFN 512
             + ++DV+S+G++  E  + G +P             + ++  + +++  +R+   +  
Sbjct: 171 RYTSESDVWSYGILLWETFSLGDTPYPG---------MSNQQTRERIESG-YRMPAPQLC 220

Query: 513 RKEMERMLMVGLSCVHPNHEKRPSVKEAARILK 545
            +E+ R+++    C   + E RPS  E    L+
Sbjct: 221 PEEIYRLML---QCWAYDPENRPSFSEIYNELQ 250

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 77.3 bits (190), Expect = 9e-16
 Identities = 76/276 (27%), Positives = 120/276 (43%), Gaps = 45/276 (16%)

Query: 290 RIVGEGASATVYKG--SLPSGGA--VAVKRFEKPNRVECA---RNPFTTEFATMAGCLRH 342
           RI+G G    + +G   LPS     VA+       R  C+   R  F  E  T+ G   H
Sbjct: 11  RILGTGRFGELCRGCLKLPSKRELPVAIHTL----RAGCSDKQRRGFLAEALTL-GQFDH 65

Query: 343 KNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
            N+V+L+G    GN +++V EY+ NG+LD  L  +      L   + + ++ G+AS + Y
Sbjct: 66  SNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ---LVAGQLMGMLPGLASGMKY 122

Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDF----EATIPA--GTMG------YLAPEY 450
           L    E   +H+ + A  +L++++   K+  F    E    A   TM       + APE 
Sbjct: 123 L---SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEA 179

Query: 451 VYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAAD-FRLR 508
           +     S  +DV+SFG+V  EV + G+ P            W++  +  +    D FRL 
Sbjct: 180 IQYHHFSSASDVWSFGIVMWEVMSYGERP-----------YWDMSGQDVIKAVEDGFRLP 228

Query: 509 GKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARIL 544
              N   +   LM  L C      +RP   +   IL
Sbjct: 229 APRNCPNLLHQLM--LDCWQKERGERPRFSQIHSIL 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 77.8 bits (191), Expect = 1e-15
 Identities = 78/306 (25%), Positives = 132/306 (43%), Gaps = 48/306 (15%)

Query: 286 FNKNRIVGEGASATVYKGS-LPSGGAVAVKR--FEKPNRVECARNPFTTEFATMAGCLRH 342
           + +   +G+GAS TV+    + +G  VA+K+   +K  + E   N    E   M   L++
Sbjct: 21  YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIIN----EILVMKE-LKN 75

Query: 343 KNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
            N+V        G+EL +V EYL  GSL  ++     +   +   +   +      AL +
Sbjct: 76  PNIVNFLDSFLVGDELFVVMEYLAGGSLTDVV-----TETCMDEAQIAAVCRECLQALEF 130

Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTMGYLAPEYV 451
           LH     Q+IHRD+K+ N+LL  + + KL DF           + +   GT  ++APE V
Sbjct: 131 LHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 187

Query: 452 YSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFR--LRG 509
                  K D++S G++A+E+  G+ P  N+  +   ++       +L +        R 
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRD 247

Query: 510 KFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEAPLPLLPVKKPTVNIRSVFPEA 569
             NR            C+  + EKR S KE  +        P L + KP  ++  +   A
Sbjct: 248 FLNR------------CLEMDVEKRGSAKELLQ-------HPFLKLAKPLSSLTPLILAA 288

Query: 570 SELIDS 575
            E + S
Sbjct: 289 KEAMKS 294

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 77.0 bits (189), Expect = 1e-15
 Identities = 68/266 (25%), Positives = 126/266 (47%), Gaps = 28/266 (10%)

Query: 286 FNKNRIVGEGASATVYKGS-LPSGGAVAVKRFEKPNRVEC-ARNPFTTEFATMAGCLRHK 343
           F   + +G G  + VY+ + L  G  VA+K+ +  + ++  AR     E   +   L H 
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQ-LNHP 62

Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
           N+++      E NEL +V E    G L +++ +      ++  +      + + SAL ++
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122

Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGD------FEATIPA-----GTMGYLAPEYVY 452
           H    R+++HRD+K  N+ + A    KLGD      F +   A     GT  Y++PE ++
Sbjct: 123 HS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179

Query: 453 SGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADF-RLRGKF 511
               + K+D++S G +  E+AA +SP   D         NL    K ++  D+  L    
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-------MNLYSLCKKIEQCDYPPLPSDH 232

Query: 512 NRKEMERMLMVGLSCVHPNHEKRPSV 537
             +E+ +++ +   C++P+ EKRP +
Sbjct: 233 YSEELRQLVNM---CINPDPEKRPDI 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 76.8 bits (189), Expect = 1e-15
 Identities = 76/270 (28%), Positives = 115/270 (42%), Gaps = 44/270 (16%)

Query: 288 KNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPN-RVECARNPFTTEFATMAGCLRHKNL 345
           K+++ G G    VY+G        VAVK  ++    VE     F  E A M   ++H NL
Sbjct: 11  KHKL-GGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE----EFLKEAAVMKE-IKHPNL 64

Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSS---IVLSWEKRLNIVLGVASALSY 402
           VQL G C       ++ E++  G+L   L   +      +VL     L +   ++SA+ Y
Sbjct: 65  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAMEY 119

Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEY 450
           L    ++  IHRD+ A N L+      K+ DF           T  AG    + + APE 
Sbjct: 120 LE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 176

Query: 451 VYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRG 509
           +     S K+DV++FGV+  E+A  G SP      + +  V+ L +KG       +R+  
Sbjct: 177 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG---IDLSQVYELLEKG-------YRMER 226

Query: 510 KFNRKEMERMLMVGLSCVHPNHEKRPSVKE 539
                     LM   +C   N   RPS  E
Sbjct: 227 PEGCPPKVYELM--RACWQWNPSDRPSFAE 254

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 77.1 bits (190), Expect = 1e-15
 Identities = 65/209 (31%), Positives = 105/209 (50%), Gaps = 35/209 (16%)

Query: 292 VGEGASATV---YKGSLPSGGAVAVKRFE--KPNRVECARNPFTTEFATMAGCLRHKNLV 346
           +GEG++  V      S  +G  VAVK+ +  K  R E   N    E   M    +H N+V
Sbjct: 27  IGEGSTGIVCIATDKS--TGRQVAVKKMDLRKQQRRELLFN----EVVIMRD-YQHPNIV 79

Query: 347 QLQGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
           ++      G+EL +V E+L  G+L D + H        ++ E+   + L V  ALS+LH 
Sbjct: 80  EMYSSYLVGDELWVVMEFLEGGALTDIVTHTR------MNEEQIATVCLAVLKALSFLHA 133

Query: 406 ECERQIIHRDVKACNILLDAEFNAKLGDF------EATIP-----AGTMGYLAPEYVYSG 454
              + +IHRD+K+ +ILL ++   KL DF         +P      GT  ++APE V S 
Sbjct: 134 ---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPE-VISR 189

Query: 455 VP-SEKTDVYSFGVVALEVAAGKSPVDND 482
           +P   + D++S G++ +E+  G+ P  N+
Sbjct: 190 LPYGTEVDIWSLGIMVIEMVDGEPPYFNE 218

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 77.4 bits (190), Expect = 1e-15
 Identities = 62/221 (28%), Positives = 104/221 (47%), Gaps = 38/221 (17%)

Query: 290 RIVGEGASATVYKGSL----PSGGA--VAVKRFEKPNRVECARNPFTTEFATMAGCLRHK 343
           R +GEGA   V+        P+     VAVK  + P     AR  F  E A +   L+H+
Sbjct: 11  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL--AARKDFQRE-AELLTNLQHE 67

Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIV------------LSWEKRLN 391
           ++V+  G C +G+ L++V+EY+ +G L+K L  +   +++            L   + L+
Sbjct: 68  HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127

Query: 392 IVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT----------IPAG 441
           I   +AS + YL     +  +HRD+   N L+ A    K+GDF  +          +   
Sbjct: 128 IASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 184

Query: 442 TM---GYLAPEYVYSGVPSEKTDVYSFGVVALEV-AAGKSP 478
           TM    ++ PE +     + ++DV+SFGV+  E+   GK P
Sbjct: 185 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 76.4 bits (188), Expect = 2e-15
 Identities = 61/213 (28%), Positives = 95/213 (44%), Gaps = 33/213 (15%)

Query: 287 NKNRIV-GEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           N  R+V G+G    VY    L +   +A+K  E P R      P   E A +   L+H+N
Sbjct: 10  NGERVVLGKGTYGIVYAARDLSTQVRIAIK--EIPERDSRYVQPLHEEIA-LHSYLKHRN 66

Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHN-----NSSSSIVLSWEKRLNIVLGVASA 399
           +VQ  G   E     +  E +P GSL  +L +       +   ++ + K+      +   
Sbjct: 67  IVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQ------ILEG 120

Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNA-KLGDFEATI------PA-----GTMGYLA 447
           L YLH+    QI+HRD+K  N+L++      K+ DF  +       P      GT+ Y+A
Sbjct: 121 LKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMA 177

Query: 448 PEYVYSGVP--SEKTDVYSFGVVALEVAAGKSP 478
           PE +  G        D++S G   +E+A GK P
Sbjct: 178 PEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 76.3 bits (188), Expect = 2e-15
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 34/213 (15%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVK--RFEKPN-RVECARNPFTTEFATMAGCLR 341
           + +  ++G GA   VY+G  +P+G  VA+K    + P+  V         E A ++  LR
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVS----DIQREVALLSQ-LR 57

Query: 342 H---KNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVL-GVA 397
                N+ +  G   +G  L ++ EY   GS+  ++     +      EK +++++  V 
Sbjct: 58  QSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIA------EKYISVIIREVL 111

Query: 398 SALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTMGYL 446
            AL Y+H+     +IHRD+KA NIL+    N KL DF           + +   GT  ++
Sbjct: 112 VALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWM 168

Query: 447 APEYVYSGVPSE-KTDVYSFGVVALEVAAGKSP 478
           APE +  G   + K D++S G+   E+A G  P
Sbjct: 169 APEVITEGKYYDTKADIWSLGITIYEMATGNPP 201

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 75.0 bits (185), Expect = 6e-15
 Identities = 61/204 (29%), Positives = 90/204 (44%), Gaps = 28/204 (13%)

Query: 292 VGEGASATVYKG-SLPSGGAVAVK--RFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           +G G    VYK   + +G  VA+K  + E  +  E  +     E + +  C RH N+V  
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQ----EISMLKEC-RHPNIVAY 65

Query: 349 QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE 408
            G     ++L +V EY   GSL  I          LS  +   +       L+YLHE   
Sbjct: 66  FGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGP---LSELQIAYVCRETLKGLAYLHE--- 119

Query: 409 RQIIHRDVKACNILLDAEFNAKLGDF--EATIPA---------GTMGYLAPEYV---YSG 454
              IHRD+K  NILL  + + KL DF   A + A         GT  ++APE       G
Sbjct: 120 TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKG 179

Query: 455 VPSEKTDVYSFGVVALEVAAGKSP 478
               K D+++ G+ A+E+A  + P
Sbjct: 180 GYDGKCDIWALGITAIELAELQPP 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 75.1 bits (185), Expect = 8e-15
 Identities = 69/284 (24%), Positives = 115/284 (40%), Gaps = 54/284 (19%)

Query: 291 IVGEGASATVYKGSL------PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
            +GEGA   V K              VAVK   K +  E   +   +E   M    +HKN
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHKN 77

Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNN------SSSSIVLSWEKRLNIV----- 393
           ++ L G C +   L +V EY  +G+L   L         +S       E+ L        
Sbjct: 78  IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137

Query: 394 -LGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF----------------EA 436
              VA  + +L     ++ IHRD+ A N+L+  +   K+ DF                  
Sbjct: 138 AYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNG 194

Query: 437 TIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALE-VAAGKSPVDNDGCVIVDWVWNLRK 495
            +P   M   APE ++  V + ++DV+SFGV+  E    G SP      + V+ ++ L K
Sbjct: 195 RLPVKWM---APEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG---IPVEELFKLLK 248

Query: 496 KGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKE 539
           +G  ++      + +   +E+  ++     C H    +RP+ K+
Sbjct: 249 EGYRME------KPQNCTQELYHLM---RDCWHEVPSQRPTFKQ 283

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 74.2 bits (182), Expect = 9e-15
 Identities = 66/204 (32%), Positives = 93/204 (45%), Gaps = 31/204 (15%)

Query: 290 RIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARN-----PFTTEFATMAGCLRHKN 344
           + +G+G    V  G    G  VAVK         C +N      F  E + M   LRH N
Sbjct: 12  QTIGKGEFGDVMLGDY-RGNKVAVK---------CIKNDATAQAFLAEASVMTQ-LRHSN 60

Query: 345 LVQLQGWCCEGN-ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
           LVQL G   E    L +V EY+  GSL   L +   S  VL  +  L   L V  A+ YL
Sbjct: 61  LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS--VLGGDCLLKFSLDVCEAMEYL 118

Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGT--------MGYLAPEYVYSGV 455
                   +HRD+ A N+L+  +  AK+ DF  T  A +        + + APE +    
Sbjct: 119 EAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKK 175

Query: 456 PSEKTDVYSFGVVALEVAA-GKSP 478
            S K+DV+SFG++  E+ + G+ P
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGRVP 199

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 74.3 bits (183), Expect = 1e-14
 Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 38/213 (17%)

Query: 290 RIVGEGASATVYKG---SLPSGGA---VAVKR-FEKPNRVECARNPFTTEFATMAGCLRH 342
           R +G+G+   VY+G    +  G     VA+K   E  +  E  R  F  E + M     H
Sbjct: 12  RELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRE--RIEFLNEASVMKEFNCH 69

Query: 343 KNLVQLQGWCCEGNELVLVYEYLPNGSLDKILH------NNSSSSIVLSWEKRLNIVLGV 396
            ++V+L G    G   ++V E +  G L   L        N+      + +K + +   +
Sbjct: 70  -HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEI 128

Query: 397 ASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT----------------IPA 440
           A  ++YL     ++ +HRD+ A N ++  +   K+GDF  T                +P 
Sbjct: 129 ADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185

Query: 441 GTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVA 473
             M   APE +  GV + K+DV+SFGVV  E+A
Sbjct: 186 RWM---APESLKDGVFTTKSDVWSFGVVLWEMA 215

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 74.0 bits (182), Expect = 1e-14
 Identities = 59/205 (28%), Positives = 91/205 (44%), Gaps = 28/205 (13%)

Query: 290 RIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQ 349
           R +G G    V++G   +   VAVK   KP  ++     F  E   M   LRH  L+QL 
Sbjct: 12  RKLGAGQFGEVWEGLWNNTTPVAVKTL-KPGTMD--PKDFLAEAQIMKK-LRHPKLIQLY 67

Query: 350 GWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECER 409
             C     + +V E +  GSL + L   +  ++ L   + +++   VAS ++YL     +
Sbjct: 68  AVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKL--PQLIDMAAQVASGMAYLE---AQ 122

Query: 410 QIIHRDVKACNILLDAEFNAKLGDF---------------EATIPAGTMGYLAPEYVYSG 454
             IHRD+ A N+L+      K+ DF                A  P   + + APE     
Sbjct: 123 NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFP---IKWTAPEAALYN 179

Query: 455 VPSEKTDVYSFGVVALE-VAAGKSP 478
             S K+DV+SFG++  E V  G+ P
Sbjct: 180 RFSIKSDVWSFGILLTEIVTYGRMP 204

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 73.8 bits (181), Expect = 2e-14
 Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 27/208 (12%)

Query: 290 RIVGEGASATVYKGSLPSGG----AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           +++G G    V  G L   G     VA+K   K    E  R  F +E A++ G   H N+
Sbjct: 10  KVIGAGEFGEVCSGRLKLPGKREIPVAIKTL-KAGYTEKQRRDFLSE-ASIMGQFDHPNI 67

Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
           + L+G   +   +++V EY+ NGSLD  L  +     V+   + + ++ G+AS + YL  
Sbjct: 68  IHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVI---QLVGMLRGIASGMKYL-- 122

Query: 406 ECERQIIHRDVKACNILLDAEFNAKLGDF----------EA--TIPAGTMG--YLAPEYV 451
             +   +HRD+ A NIL+++    K+ DF          EA  T   G +   + APE +
Sbjct: 123 -SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 181

Query: 452 YSGVPSEKTDVYSFGVVALEVAA-GKSP 478
                +  +DV+S+G+V  EV + G+ P
Sbjct: 182 AYRKFTSASDVWSYGIVMWEVMSYGERP 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 73.9 bits (181), Expect = 2e-14
 Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 23/203 (11%)

Query: 292 VGEGASATV-YKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQG 350
           +GEG++  V       SG  VAVK  +   R +  R     E   M    +H+N+V++  
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDL--RKQQRRELLFNEVVIMRD-YQHQNVVEMYK 85

Query: 351 WCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQ 410
               G EL ++ E+L  G+L  I+     S   L+ E+   +   V  AL YLH +    
Sbjct: 86  SYLVGEELWVLMEFLQGGALTDIV-----SQTRLNEEQIATVCESVLQALCYLHSQ---G 137

Query: 411 IIHRDVKACNILLDAEFNAKLGDF------EATIP-----AGTMGYLAPEYVYSGVPSEK 459
           +IHRD+K+ +ILL  +   KL DF         +P      GT  ++APE +       +
Sbjct: 138 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTE 197

Query: 460 TDVYSFGVVALEVAAGKSPVDND 482
            D++S G++ +E+  G+ P  +D
Sbjct: 198 VDIWSLGIMVIEMVDGEPPYFSD 220

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 73.9 bits (182), Expect = 2e-14
 Identities = 69/290 (23%), Positives = 117/290 (40%), Gaps = 57/290 (19%)

Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQG 350
           VGEGA   V K  +  +G  VA+K+F++    E  +     E   +   LRH+N+V L+ 
Sbjct: 9   VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQ-LRHENIVNLKE 67

Query: 351 WCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQ 410
                  L LV+EY+    L+ +  +       L  +   + +  +  A++Y H      
Sbjct: 68  AFRRKGRLYLVFEYVERTLLELLEASPGG----LPPDAVRSYIWQLLQAIAYCHS---HN 120

Query: 411 IIHRDVKACNILLDAEFNAKLGD--FEATIPAG----------TMGYLAPEYVYSGVPSE 458
           IIHRD+K  NIL+      KL D  F   + A           T  Y APE +       
Sbjct: 121 IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYG 180

Query: 459 K-TDVYSFGVVALEVAAGKS--PVDNDGCVIVDWVWNLRKK-GKLLDA--ADF------- 505
           K  DV++ G +  E+  G+   P D+D    +D ++ ++K  G L  +    F       
Sbjct: 181 KPVDVWAIGCIMAELLDGEPLFPGDSD----IDQLYLIQKCLGPLPPSHQELFSSNPRFA 236

Query: 506 ---------------RLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEA 540
                          R  GK +   ++ +     +C+  + ++R +  E 
Sbjct: 237 GVAFPEPSQPESLERRYPGKVSSPALDFL----KACLRMDPKERLTCDEL 282

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 73.2 bits (180), Expect = 2e-14
 Identities = 62/216 (28%), Positives = 96/216 (44%), Gaps = 45/216 (20%)

Query: 291 IVGE---GASATVYKGSLPSGGAVAVKR---FEKPNRVECARNPFTTEFATMAGCLRHKN 344
           I+GE   GA   VYK      G  A  +    E    +E     F  E   ++ C +H N
Sbjct: 9   IIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELE----DFMVEIDILSEC-KHPN 63

Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLN------IVLGVAS 398
           +V L       N+L ++ E+   G+LD         SI+L  E+ L       +   +  
Sbjct: 64  IVGLYEAYFYENKLWILIEFCDGGALD---------SIMLELERGLTEPQIRYVCRQMLE 114

Query: 399 ALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP-----------AGTMGYLA 447
           AL++LH     ++IHRD+KA NILL  + + KL DF  +              GT  ++A
Sbjct: 115 ALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMA 171

Query: 448 PEYV----YSGVPSE-KTDVYSFGVVALEVAAGKSP 478
           PE V    +   P + K D++S G+  +E+A  + P
Sbjct: 172 PEVVACETFKDNPYDYKADIWSLGITLIELAQMEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 73.5 bits (181), Expect = 2e-14
 Identities = 47/208 (22%), Positives = 84/208 (40%), Gaps = 27/208 (12%)

Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKP--NRVECARNPFTTEFATMAGCLRHKNLVQL 348
           +GEG    VYK     +G  VA+K+ +    +           E   +   L H N+++L
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTA--LREIKLLK-ELNHPNIIKL 63

Query: 349 QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE 408
                   +L LV+E++ +  L K++ +       L      + +  +   L++ H    
Sbjct: 64  LDVFRHKGDLYLVFEFM-DTDLYKLIKDRQR---GLPESLIKSYLYQLLQGLAFCHSH-- 117

Query: 409 RQIIHRDVKACNILLDAEFNAKLGDF----EATIPAGTMG-------YLAPEYVY-SGVP 456
             I+HRD+K  N+L++ E   KL DF        P            Y APE +      
Sbjct: 118 -GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGY 176

Query: 457 SEKTDVYSFGVVALEVAAGKS--PVDND 482
           S   D++S G +  E+ + +   P  ++
Sbjct: 177 STPVDIWSVGCIFAELLSRRPLFPGKSE 204

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 62/204 (30%), Positives = 103/204 (50%), Gaps = 25/204 (12%)

Query: 292 VGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQG 350
           +GEG++  V   +   +G  VAVK+ +   R +  R     E   M     H+N+V +  
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDL--RKQQRRELLFNEVVIMRD-YHHENVVDMYN 86

Query: 351 WCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQ 410
               G+EL +V E+L  G+L  I+ +       ++ E+   + L V  ALSYLH +    
Sbjct: 87  SYLVGDELWVVMEFLEGGALTDIVTHTR-----MNEEQIATVCLSVLRALSYLHNQ---G 138

Query: 411 IIHRDVKACNILLDAEFNAKLGDF------EATIP-----AGTMGYLAPEYVYSGVP-SE 458
           +IHRD+K+ +ILL ++   KL DF         +P      GT  ++APE V S +P   
Sbjct: 139 VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPE-VISRLPYGT 197

Query: 459 KTDVYSFGVVALEVAAGKSPVDND 482
           + D++S G++ +E+  G+ P  N+
Sbjct: 198 EVDIWSLGIMVIEMIDGEPPYFNE 221

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 73.5 bits (181), Expect = 3e-14
 Identities = 56/217 (25%), Positives = 91/217 (41%), Gaps = 32/217 (14%)

Query: 292 VGEGASATVYK-GSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQG 350
           +GEGA   V+K     +G  VA+K+           N    E   +  C +H  +V+L  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQAC-QHPYVVKLLD 66

Query: 351 WCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQ 410
               G+  VLV EY+P   L ++L +     +  +  K    +L     ++Y+H      
Sbjct: 67  VFPHGSGFVLVMEYMP-SDLSEVLRD-EERPLPEAQVKSYMRML--LKGVAYMHAN---G 119

Query: 411 IIHRDVKACNILLDAEFNAKLGDF------------EATIPAGTMGYLAPEYVYSGVP-- 456
           I+HRD+K  N+L+ A+   K+ DF              +    T  Y APE +Y G    
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLY-GARKY 178

Query: 457 SEKTDVYSFGVVALEVAAGKSPV---DND----GCVI 486
               D+++ G +  E+  G SP+   +ND      V 
Sbjct: 179 DPGVDLWAVGCIFAELLNG-SPLFPGENDIEQLAIVF 214

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 73.6 bits (180), Expect = 3e-14
 Identities = 62/221 (28%), Positives = 104/221 (47%), Gaps = 26/221 (11%)

Query: 274 LALTDIKQATLGFNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTE 332
           +++ D K+    F K   +G+GAS TVY    + +G  VA+K+     + +  +     E
Sbjct: 12  VSVGDPKKKYTRFEK---IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK--KELIINE 66

Query: 333 FATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNI 392
              M    ++ N+V        G+EL +V EYL  GSL  ++     +   +   +   +
Sbjct: 67  ILVMREN-KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAV 120

Query: 393 VLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAG 441
                 AL +LH     Q+IHRD+K+ NILL  + + KL DF           + +   G
Sbjct: 121 CRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVG 177

Query: 442 TMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDND 482
           T  ++APE V       K D++S G++A+E+  G+ P  N+
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 73.1 bits (180), Expect = 3e-14
 Identities = 57/221 (25%), Positives = 93/221 (42%), Gaps = 39/221 (17%)

Query: 340 LRHKNLVQLQGWCC-EGNELV-LVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVA 397
           L+H N+V+         N+ + +V EY   G L +++         +  E    I+  + 
Sbjct: 56  LKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLL 115

Query: 398 SALSYLH--EECERQIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTMG 444
            AL   H   +    ++HRD+K  NI LDA  N KLGDF            A    GT  
Sbjct: 116 LALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPY 175

Query: 445 YLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAAD 504
           Y++PE +      EK+D++S G +  E+ A   P                 + +L  A+ 
Sbjct: 176 YMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP--------------FTARNQLQLASK 221

Query: 505 FRLRGKFNR------KEMERMLMVGLSCVHPNHEKRPSVKE 539
            +  GKF R       E+  ++    S ++ + +KRPS +E
Sbjct: 222 IK-EGKFRRIPYRYSSELNEVIK---SMLNVDPDKRPSTEE 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 73.5 bits (180), Expect = 3e-14
 Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 23/203 (11%)

Query: 292 VGEGASATVYKGSLPSGGA-VAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQG 350
           +GEG++  V   ++ S G  VAVK+ +   R +  R     E   M    +H+N+V++  
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDL--RKQQRRELLFNEVVIMRD-YQHENVVEMYN 84

Query: 351 WCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQ 410
               G+EL +V E+L  G+L  I+ +       ++ E+   + L V  ALS LH +    
Sbjct: 85  SYLVGDELWVVMEFLEGGALTDIVTHTR-----MNEEQIAAVCLAVLKALSVLHAQ---G 136

Query: 411 IIHRDVKACNILLDAEFNAKLGDF------EATIP-----AGTMGYLAPEYVYSGVPSEK 459
           +IHRD+K+ +ILL  +   KL DF         +P      GT  ++APE +       +
Sbjct: 137 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPE 196

Query: 460 TDVYSFGVVALEVAAGKSPVDND 482
            D++S G++ +E+  G+ P  N+
Sbjct: 197 VDIWSLGIMVIEMVDGEPPYFNE 219

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 73.1 bits (179), Expect = 3e-14
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 30/211 (14%)

Query: 288 KNRIVGEGASATVYKGS-LPSGGAVAVKRFEKPNRVECARNPFT--TEFATMAGCLRHKN 344
           K +++G G   TV+KG  +P G ++ +    K  +    R  F   T+     G L H  
Sbjct: 11  KLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAY 70

Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           +V+L G  C G  L LV +  P GSL   +  +  S   L  ++ LN  + +A  + YL 
Sbjct: 71  IVRLLG-ICPGASLQLVTQLSPLGSLLDHVRQHRDS---LDPQRLLNWCVQIAKGMYYLE 126

Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF----------------EATIPAGTMGYLAP 448
           E     ++HR++ A NILL ++   ++ DF                E   P   + ++A 
Sbjct: 127 EHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTP---IKWMAL 180

Query: 449 EYVYSGVPSEKTDVYSFGVVALEVAA-GKSP 478
           E +  G  + ++DV+S+GV   E+ + G  P
Sbjct: 181 ESILFGRYTHQSDVWSYGVTVWEMMSYGAEP 211

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 73.5 bits (180), Expect = 3e-14
 Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 30/214 (14%)

Query: 291 IVGEGASATVYKGSLPSGGA---VAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQ 347
           ++GEG    V K  +   G     A+KR ++    +  R+ F  E   +     H N++ 
Sbjct: 14  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD-FAGELEVLCKLGHHPNIIN 72

Query: 348 LQGWCCEGNELVLVYEYLPNGSL------DKILHNNSSSSI------VLSWEKRLNIVLG 395
           L G C     L L  EY P+G+L       ++L  + + +I       LS ++ L+    
Sbjct: 73  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132

Query: 396 VASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-----EATIPAGTMG-----Y 445
           VA  + YL    ++Q IHRD+ A NIL+   + AK+ DF     +      TMG     +
Sbjct: 133 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW 189

Query: 446 LAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSP 478
           +A E +   V +  +DV+S+GV+  E+ + G +P
Sbjct: 190 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 223

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 72.6 bits (179), Expect = 3e-14
 Identities = 46/136 (33%), Positives = 69/136 (50%), Gaps = 19/136 (13%)

Query: 354 EGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIH 413
           +G++L ++ EY   GS   +L         +++     I+  V   L YLHEE     IH
Sbjct: 70  KGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAF-----ILREVLLGLEYLHEE---GKIH 121

Query: 414 RDVKACNILLDAEFNAKLGDF------EATIP-----AGTMGYLAPEYVYSGVPSEKTDV 462
           RD+KA NILL  E + KL DF       +T+       GT  ++APE +      EK D+
Sbjct: 122 RDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADI 181

Query: 463 YSFGVVALEVAAGKSP 478
           +S G+ A+E+A G+ P
Sbjct: 182 WSLGITAIELAKGEPP 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 72.2 bits (177), Expect = 5e-14
 Identities = 57/209 (27%), Positives = 101/209 (48%), Gaps = 29/209 (13%)

Query: 291 IVGEGASATVYKGSLPSGGA----VAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLV 346
           ++G G    V +G L   G     VA+K   K    E  R  F +E A++ G   H N++
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTL-KSGYTEKQRRDFLSE-ASIMGQFDHPNII 68

Query: 347 QLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEE 406
            L+G   +   ++++ E++ NG+LD  L  N     V+   + + ++ G+A+ + YL   
Sbjct: 69  HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVI---QLVGMLRGIAAGMKYL--- 122

Query: 407 CERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGT--------MGYLAPEY 450
            E   +HRD+ A NIL+++    K+ DF        + + P  T        + + APE 
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA 182

Query: 451 VYSGVPSEKTDVYSFGVVALEVAA-GKSP 478
           +     +  +DV+S+G+V  EV + G+ P
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMSYGERP 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 72.3 bits (177), Expect = 5e-14
 Identities = 61/218 (27%), Positives = 102/218 (46%), Gaps = 37/218 (16%)

Query: 292 VGEGASATVYKGS----LPSGGA--VAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           +GEGA   V+       LP      VAVK  ++ +  E AR  F  E A +   L+H+++
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESARQDFQRE-AELLTVLQHQHI 69

Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEK-----------RLNIVL 394
           V+  G C EG  L++V+EY+ +G L++ L ++   + +L+  +            L I  
Sbjct: 70  VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129

Query: 395 GVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT----------IPAGTM- 443
            +AS + YL        +HRD+   N L+      K+GDF  +          +   TM 
Sbjct: 130 QIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 186

Query: 444 --GYLAPEYVYSGVPSEKTDVYSFGVVALEV-AAGKSP 478
              ++ PE +     + ++D++SFGVV  E+   GK P
Sbjct: 187 PIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 71.7 bits (176), Expect = 6e-14
 Identities = 48/158 (30%), Positives = 76/158 (48%), Gaps = 25/158 (15%)

Query: 332 EFATMAGCLRHKNLVQLQGWC-CEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRL 390
           E A++   L HK+LV+L G C  + N +V   EY+  G LD  LH    +++ L W  +L
Sbjct: 50  ETASLMSQLSHKHLVKLYGVCVRDENIMVE--EYVKFGPLDVFLHRE-KNNVSLHW--KL 104

Query: 391 NIVLGVASALSYLHEECERQIIHRDVKACNILL----DAEFN---AKLGDFEATIPAGTM 443
           ++   +ASAL YL    +++++H +V   NIL+      E      KL D    I   + 
Sbjct: 105 DVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSR 161

Query: 444 GY-------LAPEYVYSGV--PSEKTDVYSFGVVALEV 472
                    +APE + +G    +   D +SFG   LE+
Sbjct: 162 EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEI 199

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 71.4 bits (175), Expect = 9e-14
 Identities = 62/210 (29%), Positives = 100/210 (47%), Gaps = 28/210 (13%)

Query: 288 KNRIVGEGASATVYKG-SLPSGGAVAVKRFE-KPNRVECAR--NPFTTEFATMAGCLRHK 343
           + +++G+GA   VY    + +G  +AVK+    P+  E  +  N    E   +   L+H+
Sbjct: 6   RGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKN-LQHE 64

Query: 344 NLVQLQGWCCEGNELVLVY-EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
            +VQ  G C   +E + ++ EY+P GS+   L    + +  ++ +    I+ GV     Y
Sbjct: 65  RIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVE----Y 119

Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDFEA-----TIPA---------GTMGYLAP 448
           LH      I+HRD+K  NIL D+  N KLGDF A     TI +         GT  +++P
Sbjct: 120 LHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176

Query: 449 EYVYSGVPSEKTDVYSFGVVALEVAAGKSP 478
           E +       K DV+S G   +E+   K P
Sbjct: 177 EVISGEGYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 71.3 bits (175), Expect = 1e-13
 Identities = 75/266 (28%), Positives = 107/266 (40%), Gaps = 49/266 (18%)

Query: 307 SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG--NELVLVYEY 364
           +G  VAVK+ +  +  E  R+ F  E   +   L+H N+V+ +G C       L LV EY
Sbjct: 32  TGEVVAVKKLQ-HSTAEHLRD-FEREIEILKS-LQHDNIVKYKGVCYSAGRRNLRLVMEY 88

Query: 365 LPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLD 424
           LP GSL   L  +      L   K L     +   + YL     ++ +HRD+   NIL++
Sbjct: 89  LPYGSLRDYLQKHRER---LDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVE 142

Query: 425 AEFNAKLGDFEAT--IPAGTMGYL------------APEYVYSGVPSEKTDVYSFGVVAL 470
           +E   K+GDF  T  +P     Y             APE +     S  +DV+SFGVV  
Sbjct: 143 SENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 202

Query: 471 EV----AAGKSPV---------DNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEME 517
           E+        SP          D  G +IV  +  L K    L A              E
Sbjct: 203 ELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPP--------GCPAE 254

Query: 518 -RMLMVGLSCVHPNHEKRPSVKEAAR 542
              +M    C + +  +RPS  E A 
Sbjct: 255 IYAIM--KECWNNDPSQRPSFSELAL 278

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 71.0 bits (174), Expect = 1e-13
 Identities = 80/282 (28%), Positives = 114/282 (40%), Gaps = 43/282 (15%)

Query: 279 IKQATLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAG 338
           I  + L F K   +G G    V+ G   +   VA+K   +    E     F  E   M  
Sbjct: 1   INPSELTFMKE--LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSE---EDFIEEAKVMMK 55

Query: 339 CLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVAS 398
            L H  LVQL G C +   L +V E++ NG L   L         LS +  L++   V  
Sbjct: 56  -LSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQG---KLSKDMLLSMCQDVCE 111

Query: 399 ALSYLHEECERQ-IIHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGY 445
            + YL    ER   IHRD+ A N L+ +    K+ DF         E T  +G    + +
Sbjct: 112 GMEYL----ERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKW 167

Query: 446 LAPEYVYSGVPSEKTDVYSFGVVALEV-AAGKSPVDNDGCV-IVDWVWNLRKKGKLLDAA 503
             PE       S K+DV+SFGV+  EV   GK P +      +V+ +           + 
Sbjct: 168 SPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMI-----------SR 216

Query: 504 DFRL-RGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARIL 544
            FRL R K     +  ++    SC H   E RP+  E  R +
Sbjct: 217 GFRLYRPKLASMTVYEVMY---SCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 71.3 bits (175), Expect = 1e-13
 Identities = 36/104 (34%), Positives = 54/104 (51%), Gaps = 16/104 (15%)

Query: 392 IVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF----------EATIPAG 441
           I + +  AL YLH +    +IHRDVK  N+L++     KL DF            TI AG
Sbjct: 108 IAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAG 165

Query: 442 TMGYLAPEYVYSGVPSE----KTDVYSFGVVALEVAAGKSPVDN 481
              Y+APE +   +  +    K+DV+S G+  +E+A G+ P D+
Sbjct: 166 CKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 71.6 bits (175), Expect = 1e-13
 Identities = 57/216 (26%), Positives = 100/216 (46%), Gaps = 31/216 (14%)

Query: 290 RIVGEGASATVYKGSL----PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           R +GEGA   V+        P    + V      +  + AR  F  E A +   L+H+++
Sbjct: 11  RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHRE-AELLTNLQHEHI 69

Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIV---------LSWEKRLNIVLGV 396
           V+  G C EG+ L++V+EY+ +G L+K L  +   +++         L+  + L+I   +
Sbjct: 70  VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129

Query: 397 ASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT----------IPAGTM--- 443
           A+ + YL     +  +HRD+   N L+      K+GDF  +          +   TM   
Sbjct: 130 AAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 186

Query: 444 GYLAPEYVYSGVPSEKTDVYSFGVVALEV-AAGKSP 478
            ++ PE +     + ++DV+S GVV  E+   GK P
Sbjct: 187 RWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 70.7 bits (173), Expect = 1e-13
 Identities = 66/273 (24%), Positives = 116/273 (42%), Gaps = 44/273 (16%)

Query: 286 FNKNRIVGEGASATVY--KGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHK 343
           + K R+VG GA   V+  +        V +K+       +  R     E   +   L H 
Sbjct: 2   YEKIRVVGRGAFGIVHLCRR-KADQKLVIIKQIPVEQMTKDERLAAQNECQVLK-LLSHP 59

Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
           N+++      E   L++V EY P G+L + +    +S  +L  +  L+  + +  AL ++
Sbjct: 60  NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNS--LLDEDTILHFFVQILLALHHV 117

Query: 404 HEECERQIIHRDVKACNILLDAEFN-AKLGDF----------EATIPAGTMGYLAPEYVY 452
           H    + I+HRD+K  NILLD      K+GDF          +A    GT  Y++PE   
Sbjct: 118 HT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCE 174

Query: 453 SGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRL-RGKF 511
               ++K+D+++ G V  E+A+ K   +                   L A   ++  G F
Sbjct: 175 GKPYNQKSDIWALGCVLYELASLKRAFE----------------AANLPALVLKIMSGTF 218

Query: 512 N----RKEME-RMLMVGLSCVHPNHEKRPSVKE 539
                R   + R L++ +  + P+  KRP + +
Sbjct: 219 APISDRYSPDLRQLILSMLNLDPS--KRPQLSQ 249

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 72.2 bits (177), Expect = 1e-13
 Identities = 57/212 (26%), Positives = 92/212 (43%), Gaps = 42/212 (19%)

Query: 290 RIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
             +G GA  TVYK    P+G   A+K     N  +  R     E   +   + H N+V+ 
Sbjct: 80  NRIGSGAGGTVYKVIHRPTGRLYALKVIYG-NHEDTVRRQICREIEILRD-VNHPNVVKC 137

Query: 349 QGWCCEGNELVLVYEYLPNGSLD--KILHNNSSSSIVLSWEKRL-NIVLGVASALSYLHE 405
                   E+ ++ E++  GSL+   I             E+ L ++   + S ++YLH 
Sbjct: 138 HDMFDHNGEIQVLLEFMDGGSLEGTHIAD-----------EQFLADVARQILSGIAYLHR 186

Query: 406 ECERQIIHRDVKACNILLDAEFNAKLGDF-------EATIP----AGTMGYLAPEYV--- 451
              R I+HRD+K  N+L+++  N K+ DF       +   P     GT+ Y++PE +   
Sbjct: 187 ---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTD 243

Query: 452 -----YSGVPSEKTDVYSFGVVALEVAAGKSP 478
                Y G      D++S GV  LE   G+ P
Sbjct: 244 LNHGAYDGYAG---DIWSLGVSILEFYLGRFP 272

Length = 353

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 71.0 bits (174), Expect = 1e-13
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 35/203 (17%)

Query: 356 NELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRD 415
           N + +  E++  GSLD+I          +  E    I + V   L+YL+     +I+HRD
Sbjct: 76  NNICMCMEFMDCGSLDRIYKKGGP----IPVEILGKIAVAVVEGLTYLYNV--HRIMHRD 129

Query: 416 VKACNILLDAEFNAKLGDFE---------ATIPAGTMGYLAPEYVYSGVPSEKTDVYSFG 466
           +K  NIL+++    KL DF          A    GT  Y++PE +  G  + K+DV+S G
Sbjct: 130 IKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLG 189

Query: 467 VVALEVAAGK-----SPVDNDGCV----IVDWVWNL-RKKGKLLDAADFRLRGKFNRKEM 516
           +  +E+A GK     S +D+DG      I+D +  + ++    L ++DF        +++
Sbjct: 190 ISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDF-------PEDL 242

Query: 517 ERMLMVGLSCVHPNHEKRPSVKE 539
              +     C+  +  +RP+ ++
Sbjct: 243 RDFVDA---CLLKDPTERPTPQQ 262

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 70.7 bits (173), Expect = 1e-13
 Identities = 75/277 (27%), Positives = 117/277 (42%), Gaps = 43/277 (15%)

Query: 279 IKQATLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAG 338
           I    L F K   +G G    V  G       VA+K  ++ +  E   + F  E   M  
Sbjct: 1   IDPKDLTFLKE--LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMK 55

Query: 339 CLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVAS 398
            L H+ LVQL G C +   + +V EY+ NG L   L  +          + L +   V  
Sbjct: 56  -LSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKR---FQPSQLLEMCKDVCE 111

Query: 399 ALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYL 446
            ++YL     +Q IHRD+ A N L+D +   K+ DF         E T   G+   + + 
Sbjct: 112 GMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS 168

Query: 447 APEYVYSGVPSEKTDVYSFGVVALEV-AAGKSPVDN-DGCVIVDWVWNLRKKGKLLDAAD 504
            PE +     S K+DV++FGV+  EV + GK P +  +    V+ V           +  
Sbjct: 169 PPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKV-----------SQG 217

Query: 505 FRLRGKFNRKEM--ERMLMVGLSCVHPNHEKRPSVKE 539
            RL     R  +  E++  +  SC H   E+RP+ ++
Sbjct: 218 LRLY----RPHLASEKVYAIMYSCWHEKAEERPTFQQ 250

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 70.6 bits (173), Expect = 2e-13
 Identities = 71/270 (26%), Positives = 110/270 (40%), Gaps = 50/270 (18%)

Query: 302 KGSLPSGG--AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELV 359
           KG    GG   V VK  +K  + E  ++ F  E   M   L HKN+V+L G C E     
Sbjct: 27  KGIEEEGGETLVLVKALQK-TKDENLQSEFRRE-LDMFRKLSHKNVVRLLGLCREAEPHY 84

Query: 360 LVYEYLPNGSLDKILHNNSSSSIV-----LSWEKRLNIVLGVASALSYLHEECERQIIHR 414
           ++ EY   G L + L    S         LS ++++ +   +A  + +L      + +HR
Sbjct: 85  MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHR 141

Query: 415 DVKACNILLDAEFNAKLGDF---------------EATIPAGTMGYLAPEYVYSGVPSEK 459
           D+ A N L+ ++   K+                   A IP   + +LAPE V     S K
Sbjct: 142 DLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIP---LRWLAPEAVQEDDFSTK 198

Query: 460 TDVYSFGVVALEV-AAGKSP---VDNDGCVIVDWVWNLRKKGKL-LDAADFRLRGKFNRK 514
           +DV+SFGV+  EV   G+ P   + ++  +      N  + GKL L   +          
Sbjct: 199 SDVWSFGVLMWEVFTQGELPFYGLSDEEVL------NRLQAGKLELPVPE---------G 243

Query: 515 EMERMLMVGLSCVHPNHEKRPSVKEAARIL 544
              R+  +   C   N + RPS  E    L
Sbjct: 244 CPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 70.9 bits (173), Expect = 2e-13
 Identities = 61/221 (27%), Positives = 104/221 (47%), Gaps = 26/221 (11%)

Query: 274 LALTDIKQATLGFNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTE 332
           +++ D K+    F K   +G+GAS TVY    + +G  VA+++     + +  +     E
Sbjct: 13  VSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINE 67

Query: 333 FATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNI 392
              M    ++ N+V        G+EL +V EYL  GSL  ++     +   +   +   +
Sbjct: 68  ILVMREN-KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAV 121

Query: 393 VLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAG 441
                 AL +LH     Q+IHRD+K+ NILL  + + KL DF           + +   G
Sbjct: 122 CRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVG 178

Query: 442 TMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDND 482
           T  ++APE V       K D++S G++A+E+  G+ P  N+
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 70.3 bits (172), Expect = 3e-13
 Identities = 47/151 (31%), Positives = 72/151 (47%), Gaps = 28/151 (18%)

Query: 340 LRHKNLVQLQGWCCEGNE--LVLVYEYLPNGSLDKIL--HNNSSSSIVLSWEKRLNIVLG 395
           L H+N+V+ +G C E     L L+ EY+P GSL   L  H  + + ++L  ++       
Sbjct: 63  LYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQ------- 115

Query: 396 VASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT--IPAGTMGY-------- 445
           +   ++YLH +     IHRD+ A N+LLD +   K+GDF     +P G   Y        
Sbjct: 116 ICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 172

Query: 446 ----LAPEYVYSGVPSEKTDVYSFGVVALEV 472
                A E +     S  +DV+SFGV   E+
Sbjct: 173 PVFWYAVECLKENKFSYASDVWSFGVTLYEL 203

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 70.2 bits (172), Expect = 4e-13
 Identities = 72/274 (26%), Positives = 118/274 (43%), Gaps = 47/274 (17%)

Query: 290 RIVGEGA-----SATVYKGSLPSGGA--VAVKRFEKPNRVECARNPFTTEFATMAGCLRH 342
           + +G GA      AT Y G   S     VAVK   KP      R    +E   M+    H
Sbjct: 41  KTLGAGAFGKVVEATAY-GLSKSDAVMKVAVKML-KPTAHSSEREALMSELKIMSHLGNH 98

Query: 343 KNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
           +N+V L G C  G  ++++ EY   G L   L     S   L+ E  L+    VA  +++
Sbjct: 99  ENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRES--FLTLEDLLSFSYQVAKGMAF 156

Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDF----------------EATIPAGTMGYL 446
           L     +  IHRD+ A N+LL      K+ DF                 A +P   M   
Sbjct: 157 L---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWM--- 210

Query: 447 APEYVYSGVPSEKTDVYSFGVVALEV-AAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADF 505
           APE +++ V + ++DV+S+G++  E+ + G +P    G  +    + L K+G       +
Sbjct: 211 APESIFNCVYTFESDVWSYGILLWEIFSLGSNPY--PGMPVDSKFYKLIKEG-------Y 261

Query: 506 RL-RGKFNRKEMERMLMVGLSCVHPNHEKRPSVK 538
           R+ + +    E+  ++    +C   +  KRP+ K
Sbjct: 262 RMAQPEHAPAEIYDIMK---TCWDADPLKRPTFK 292

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 69.6 bits (171), Expect = 4e-13
 Identities = 60/217 (27%), Positives = 92/217 (42%), Gaps = 41/217 (18%)

Query: 291 IVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQ 349
           ++GEG    VYK     +G  VA+K     + +E        E+  +     H N+    
Sbjct: 13  VIGEGTYGKVYKARHKKTGQLVAIKIM---DIIEDEEEEIKEEYNILRKYSNHPNIATFY 69

Query: 350 G------WCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLN------IVLGVA 397
           G           ++L LV E    GS+  ++        +    KRL       I+    
Sbjct: 70  GAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKG------LRKKGKRLKEEWIAYILRETL 123

Query: 398 SALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF------EATIPA-----GTMGYL 446
             L+YLHE    ++IHRD+K  NILL      KL DF      ++T+       GT  ++
Sbjct: 124 RGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWM 180

Query: 447 APEYV---YSGVPS--EKTDVYSFGVVALEVAAGKSP 478
           APE +        S   ++DV+S G+ A+E+A GK P
Sbjct: 181 APEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 68.9 bits (169), Expect = 8e-13
 Identities = 40/104 (38%), Positives = 53/104 (50%), Gaps = 16/104 (15%)

Query: 392 IVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF----------EATIPAG 441
           + + +  AL YL E+    +IHRDVK  NILLDA  N KL DF            T  AG
Sbjct: 119 MTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAG 176

Query: 442 TMGYLAPEYVYSGVPSEK----TDVYSFGVVALEVAAGKSPVDN 481
              Y+APE +    P+ K     DV+S G+  +E+A G+ P  N
Sbjct: 177 CAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 68.6 bits (168), Expect = 9e-13
 Identities = 59/211 (27%), Positives = 81/211 (38%), Gaps = 36/211 (17%)

Query: 290 RIVGEGASATVYKGSL------PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHK 343
           R +G GA   VY+G             VAVK   +    E   + F  E   M+    H+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCS-EQDESDFLMEALIMSK-FNHQ 69

Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKIL---HNNSSSSIVLSWEKRLNIVLGVASAL 400
           N+V+L G   E     ++ E +  G L   L            L+ +  L     VA   
Sbjct: 70  NIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGC 129

Query: 401 SYLHEECERQIIHRDVKACNILLDAEFN---AKLGDF----------------EATIPAG 441
            YL E      IHRD+ A N LL  +     AK+ DF                 A +P  
Sbjct: 130 KYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIK 186

Query: 442 TMGYLAPEYVYSGVPSEKTDVYSFGVVALEV 472
            M    PE    G+ + KTDV+SFGV+  E+
Sbjct: 187 WM---PPEAFLDGIFTSKTDVWSFGVLLWEI 214

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 68.5 bits (168), Expect = 9e-13
 Identities = 48/129 (37%), Positives = 60/129 (46%), Gaps = 26/129 (20%)

Query: 369 SLD---KILHNNSSSSI---VLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNIL 422
           SLD   K ++    S I   +L       I +    AL+YL EE   +IIHRDVK  NIL
Sbjct: 88  SLDKFYKYVYEVLKSVIPEEILG-----KIAVATVKALNYLKEEL--KIIHRDVKPSNIL 140

Query: 423 LDAEFNAKLGDF----------EATIPAGTMGYLAPEYVYSGVPSE---KTDVYSFGVVA 469
           LD   N KL DF            T  AG   Y+APE +          ++DV+S G+  
Sbjct: 141 LDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITL 200

Query: 470 LEVAAGKSP 478
            EVA GK P
Sbjct: 201 YEVATGKFP 209

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 47/155 (30%), Positives = 75/155 (48%), Gaps = 17/155 (10%)

Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASA 399
           ++H N+V       E   L +V EY   G L K +  N    ++ S ++ L+  + ++  
Sbjct: 56  MKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRI--NRQRGVLFSEDQILSWFVQISLG 113

Query: 400 LSYLHEECERQIIHRDVKACNILLDAE-FNAKLGDFE-----------ATIPAGTMGYLA 447
           L ++H+   R+I+HRD+K+ NI L      AKLGDF            A    GT  YL+
Sbjct: 114 LKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLS 170

Query: 448 PEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDND 482
           PE   +   + KTD++S G V  E+   K P + +
Sbjct: 171 PEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 68.0 bits (166), Expect = 2e-12
 Identities = 54/182 (29%), Positives = 87/182 (47%), Gaps = 24/182 (13%)

Query: 307 SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE--GNELVLVYEY 364
           +G  VAVK   KP            E   +   L H+N+V+ +G C E  GN + L+ E+
Sbjct: 32  TGEQVAVKSL-KPESGGNHIADLKKEIEILRN-LYHENIVKYKGICTEDGGNGIKLIMEF 89

Query: 365 LPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLD 424
           LP+GSL + L  N +    ++ +++L   + +   + YL     RQ +HRD+ A N+L++
Sbjct: 90  LPSGSLKEYLPRNKNK---INLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVE 143

Query: 425 AEFNAKLGDFEATIPAGT--------------MGYLAPEYVYSGVPSEKTDVYSFGVVAL 470
           +E   K+GDF  T    T              + + APE +        +DV+SFGV   
Sbjct: 144 SEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLY 203

Query: 471 EV 472
           E+
Sbjct: 204 EL 205

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 67.6 bits (165), Expect = 2e-12
 Identities = 55/200 (27%), Positives = 91/200 (45%), Gaps = 23/200 (11%)

Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G    V+ G       VA+K   K   +      F  E A +   L+H  LV+L   
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSL-KQGSMSPE--AFLAE-ANLMKQLQHPRLVRLYAV 69

Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
             +   + ++ EY+ NGSL   L   +   I L+  K +++   +A  ++++     +  
Sbjct: 70  VTQ-EPIYIITEYMENGSLVDFL--KTPEGIKLTINKLIDMAAQIAEGMAFIER---KNY 123

Query: 412 IHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVPSEK 459
           IHRD++A NIL+      K+ DF         E T   G    + + APE +  G  + K
Sbjct: 124 IHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 183

Query: 460 TDVYSFGVVALE-VAAGKSP 478
           +DV+SFG++  E V  G+ P
Sbjct: 184 SDVWSFGILLTEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 67.4 bits (164), Expect = 2e-12
 Identities = 57/216 (26%), Positives = 98/216 (45%), Gaps = 30/216 (13%)

Query: 284 LGFNKNRIVGEGASATVYKG-SLPSGGAVAVKRFE-KPNRVECARNPFTTEFA-TMAGCL 340
           + + + +++G+GA   VY    + +G  +A K+ +  P   E ++     E    +   L
Sbjct: 2   INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL 61

Query: 341 RHKNLVQLQGWCCEGNE--LVLVYEYLPNGSLDKIL--HNNSSSSIVLSWEKRLNIVLGV 396
           +H+ +VQ  G   +  E  L +  EY+P GS+   L  +   + S+   + ++      +
Sbjct: 62  QHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQ------I 115

Query: 397 ASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT--------------IPAGT 442
              +SYLH      I+HRD+K  NIL D+  N KLGDF A+                 GT
Sbjct: 116 LEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGT 172

Query: 443 MGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSP 478
             +++PE +       K DV+S G   +E+   K P
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 59/214 (27%), Positives = 91/214 (42%), Gaps = 30/214 (14%)

Query: 291 IVGEGASATVYKGSLPSGG---AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQ 347
           ++GEG    V +  +   G     A+K   K    E     F  E   +     H N++ 
Sbjct: 9   VIGEGNFGQVIRAMIKKDGLKMNAAIKML-KEFASENDHRDFAGELEVLCKLGHHPNIIN 67

Query: 348 LQGWCCEGNELVLVYEYLPNGSL------------DKILHNNSSSSIVLSWEKRLNIVLG 395
           L G C     L +  EY P G+L            D        ++  L+ ++ L     
Sbjct: 68  LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127

Query: 396 VASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-----EATIPAGTMG-----Y 445
           VA+ + YL    E+Q IHRD+ A N+L+     +K+ DF     E      TMG     +
Sbjct: 128 VATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRW 184

Query: 446 LAPEYVYSGVPSEKTDVYSFGVVALE-VAAGKSP 478
           +A E +   V + K+DV+SFGV+  E V+ G +P
Sbjct: 185 MAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTP 218

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 67.0 bits (164), Expect = 3e-12
 Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 40/206 (19%)

Query: 292 VGEGASATVYKG-SLPSGG---AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQ 347
           +G+G+   V +G    SGG    VAVK   K +++    + F  E A M   L H+NL++
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCL-KSDKLSDIMDDFLKEAAIMHS-LDHENLIR 60

Query: 348 LQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRL-NIVLGVASALSYLHEE 406
           L G     + L++V E  P GSL   L  ++    ++S    L +  + +A+ + YL   
Sbjct: 61  LYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLIS---TLCDYAVQIANGMRYLES- 115

Query: 407 CERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGTMGYL-------------------- 446
             ++ IHRD+ A NILL ++   K+GDF      G M  L                    
Sbjct: 116 --KRFIHRDLAARNILLASDDKVKIGDF------GLMRALPQNEDHYVMEEHLKVPFAWC 167

Query: 447 APEYVYSGVPSEKTDVYSFGVVALEV 472
           APE + +   S  +DV+ FGV   E+
Sbjct: 168 APESLRTRTFSHASDVWMFGVTLWEM 193

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 67.0 bits (163), Expect = 3e-12
 Identities = 55/202 (27%), Positives = 93/202 (46%), Gaps = 22/202 (10%)

Query: 290 RIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQ 349
           + +G G    V+ G   +   VAVK   KP  +      F  E A +   L+H  LV+L 
Sbjct: 12  KKLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSV--QAFLEE-ANLMKTLQHDKLVRLY 67

Query: 350 GWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECER 409
               +   + ++ EY+  GSL   L ++    ++L   K ++    +A  ++Y+     +
Sbjct: 68  AVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLP--KLIDFSAQIAEGMAYIE---RK 122

Query: 410 QIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVPS 457
             IHRD++A N+L+      K+ DF         E T   G    + + APE +  G  +
Sbjct: 123 NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 182

Query: 458 EKTDVYSFGVVALEVAA-GKSP 478
            K+DV+SFG++  E+   GK P
Sbjct: 183 IKSDVWSFGILLYEIVTYGKIP 204

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 67.3 bits (164), Expect = 3e-12
 Identities = 61/236 (25%), Positives = 95/236 (40%), Gaps = 38/236 (16%)

Query: 271 PMRLALTDIKQATLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFT 330
              L L  +   T  +     +G+G    VYK +    G++A  +   P  +        
Sbjct: 9   SSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDP--ISDVDEEIE 66

Query: 331 TEFATMAGCLRHKNLVQLQGWC-----CEGNELVLVYEYLPNGSLDKILHNNSSSSIVLS 385
            E+  +     H N+V+  G         G +L LV E    GS+ +++        +L 
Sbjct: 67  AEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKG------LLI 120

Query: 386 WEKRLN------IVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT-- 437
             +RL+      I+ G    L +LH     +IIHRDVK  NILL  E   KL DF  +  
Sbjct: 121 CGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQ 177

Query: 438 ---------IPAGTMGYLAPEYV-----YSGVPSEKTDVYSFGVVALEVAAGKSPV 479
                       GT  ++APE +     Y      + DV+S G+ A+E+  G  P+
Sbjct: 178 LTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 66.8 bits (163), Expect = 4e-12
 Identities = 45/131 (34%), Positives = 67/131 (51%), Gaps = 18/131 (13%)

Query: 363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNIL 422
           EY+  GSLDK+     ++  +     R  I   V   L +L EE    IIHRDVK  N+L
Sbjct: 79  EYMDAGSLDKLYAGGVATEGIPEDVLR-RITYAVVKGLKFLKEE--HNIIHRDVKPTNVL 135

Query: 423 LDAEFNAKLGDF------EATIPAGTMG---YLAPEYVYSGVPSE------KTDVYSFGV 467
           ++     KL DF       A++    +G   Y+APE + SG P++      ++DV+S G+
Sbjct: 136 VNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGL 195

Query: 468 VALEVAAGKSP 478
             LE+A G+ P
Sbjct: 196 SILEMALGRYP 206

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 66.4 bits (162), Expect = 5e-12
 Identities = 55/215 (25%), Positives = 93/215 (43%), Gaps = 30/215 (13%)

Query: 290 RIVGEGASATVYKGSL----PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           +I+GEG   +V +G L     S   VAVK  +           F +E A M     H N+
Sbjct: 5   KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKD-FDHPNV 63

Query: 346 VQLQGWCCEGNEL------VLVYEYLPNGSLDKILHNN--SSSSIVLSWEKRLNIVLGVA 397
           ++L G C E + L      +++  ++ +G L   L  +        L  +  L  ++ +A
Sbjct: 64  MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIA 123

Query: 398 SALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-------------EATIPAGTMG 444
             + YL     R  IHRD+ A N +L  +    + DF             +  I    + 
Sbjct: 124 LGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 180

Query: 445 YLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSP 478
           ++A E +   V + K+DV++FGV   E+A  G++P
Sbjct: 181 WIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 66.3 bits (162), Expect = 5e-12
 Identities = 61/213 (28%), Positives = 90/213 (42%), Gaps = 29/213 (13%)

Query: 289 NRIVGEGASATVYKG--SLPSGG--AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
            R +GEG    VY+G    P     AVAVK   K       R  F  E   M     H +
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTC-KNCTSPSVREKFLQEAYIMRQ-FDHPH 68

Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           +V+L G     N + +V E  P G L   L  N  S   L     +     +++AL+YL 
Sbjct: 69  IVKLIG-VITENPVWIVMELAPLGELRSYLQVNKYS---LDLASLILYSYQLSTALAYLE 124

Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF------------EATIPAGTMGYLAPEYVY 452
               ++ +HRD+ A N+L+ +    KLGDF            +A+     + ++APE + 
Sbjct: 125 S---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESIN 181

Query: 453 SGVPSEKTDVYSFGVVALEVAA-GKSP---VDN 481
               +  +DV+ FGV   E+   G  P   V N
Sbjct: 182 FRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN 214

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 66.0 bits (161), Expect = 6e-12
 Identities = 53/207 (25%), Positives = 90/207 (43%), Gaps = 22/207 (10%)

Query: 292 VGEGASATVYKGSLPSGGA--VAVKR--FEKPNRVECARN------PFTTEFATMAGCLR 341
           +G GA   VYK    + G   +A+K      P   +  R          +E   +   LR
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 342 HKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALS 401
           H N+V+      E + L +V + +    L +  ++        + E+  NI + +  AL 
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127

Query: 402 YLHEECERQIIHRDVKACNILLDAEFNAKLGDF----------EATIPAGTMGYLAPEYV 451
           YLH+E  ++I+HRD+   NI+L  +    + DF          + T   GT+ Y  PE V
Sbjct: 128 YLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIV 185

Query: 452 YSGVPSEKTDVYSFGVVALEVAAGKSP 478
            +    EK DV++FG +  ++   + P
Sbjct: 186 KNEPYGEKADVWAFGCILYQMCTLQPP 212

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 66.6 bits (162), Expect = 6e-12
 Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 38/210 (18%)

Query: 292 VGEGASATVYKGSLPSGGAVAV-KRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQG 350
           +G+GA   VYK      GA+A  K  E  +  E     +  E   +A C  H  +V+L G
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL--EDYMVEIEILATC-NHPYIVKLLG 76

Query: 351 WCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLN------IVLGVASALSYLH 404
                 +L ++ E+ P G++D         +I+L  ++ L       I   +  AL YLH
Sbjct: 77  AFYWDGKLWIMIEFCPGGAVD---------AIMLELDRGLTEPQIQVICRQMLEALQYLH 127

Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDFEATIP-----------AGTMGYLAPEYVYS 453
                +IIHRD+KA N+LL  + + KL DF  +              GT  ++APE V  
Sbjct: 128 S---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMC 184

Query: 454 GVPSE-----KTDVYSFGVVALEVAAGKSP 478
               +     K D++S G+  +E+A  + P
Sbjct: 185 ETMKDTPYDYKADIWSLGITLIEMAQIEPP 214

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 66.6 bits (162), Expect = 6e-12
 Identities = 62/213 (29%), Positives = 103/213 (48%), Gaps = 34/213 (15%)

Query: 290 RIVGEGASATVYKGS-LPSGGAV----AVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           +++G GA  TVYKG  +P G  V    A+K   +    + A   F  E   MA  + H +
Sbjct: 13  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPK-ANVEFMDEALIMAS-MDHPH 70

Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILH---NNSSSSIVLSWEKRLNIVLGVASALS 401
           LV+L G C     + LV + +P+G L   +H   +N  S ++L+W       + +A  + 
Sbjct: 71  LVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMM 123

Query: 402 YLHEECERQIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTM--GYLAP 448
           YL E   R+++HRD+ A N+L+ +  + K+ DF           E     G M   ++A 
Sbjct: 124 YLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMAL 180

Query: 449 EYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVD 480
           E ++    + ++DV+S+GV   E+   G  P D
Sbjct: 181 ECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 66.4 bits (162), Expect = 6e-12
 Identities = 53/158 (33%), Positives = 73/158 (46%), Gaps = 29/158 (18%)

Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLN------IV 393
           LRH N ++ +G     +   LV EY             S+S I+   +K L       I 
Sbjct: 72  LRHPNTIEYKGCYLREHTAWLVMEYCLG----------SASDILEVHKKPLQEVEIAAIC 121

Query: 394 LGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-EATI--PA----GTMGYL 446
            G    L+YLH       IHRD+KA NILL      KL DF  A++  PA    GT  ++
Sbjct: 122 HGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFVGTPYWM 178

Query: 447 APEYVYS---GVPSEKTDVYSFGVVALEVAAGKSPVDN 481
           APE + +   G    K DV+S G+  +E+A  K P+ N
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 66.2 bits (161), Expect = 6e-12
 Identities = 54/204 (26%), Positives = 86/204 (42%), Gaps = 20/204 (9%)

Query: 286 FNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           F K   +G+G+   VYKG       V   +       E        E   ++ C     +
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYI 64

Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
            +  G   +G +L ++ EYL  GS   +L         ++      I+  +   L YLH 
Sbjct: 65  TRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIA-----TILREILKGLDYLHS 119

Query: 406 ECERQIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTMGYLAPEYVYSG 454
           E   + IHRD+KA N+LL  + + KL DF           +     GT  ++APE +   
Sbjct: 120 E---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS 176

Query: 455 VPSEKTDVYSFGVVALEVAAGKSP 478
               K D++S G+ A+E+A G+ P
Sbjct: 177 AYDFKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 66.6 bits (162), Expect = 7e-12
 Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 20/208 (9%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F+  R +G G+   VY    + +   VA+K+     +    +     +       LRH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKI-LHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
            +Q +G     +   LV EY    + D + +H      + ++      +  G    L+YL
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA-----AVTHGALQGLAYL 131

Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF-EATI--PA----GTMGYLAPEYVYS--- 453
           H      +IHRDVKA NILL      KLGDF  A+I  PA    GT  ++APE + +   
Sbjct: 132 HSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEVILAMDE 188

Query: 454 GVPSEKTDVYSFGVVALEVAAGKSPVDN 481
           G    K DV+S G+  +E+A  K P+ N
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPPLFN 216

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 66.2 bits (162), Expect = 8e-12
 Identities = 62/250 (24%), Positives = 99/250 (39%), Gaps = 52/250 (20%)

Query: 246 SCFLIKKKRHDGRSKEDHVCTVQRVPMRLALTDIKQATLGFNKNRIVGEGASATVYKGSL 305
                 +K  +G+  E H+C          L D  +     N N      A A V     
Sbjct: 5   QPLNFVEKLGEGQFGEVHLCEADG------LQDFSEKAFAENDN------ADAPVL---- 48

Query: 306 PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYL 365
                VAVK   +P+  + AR  F  E   ++  L   N+ +L G C     L ++ EY+
Sbjct: 49  -----VAVK-VLRPDASDNAREDFLKEVKILSR-LSDPNIARLLGVCTVDPPLCMIMEYM 101

Query: 366 PNGSLDKILH-------NNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKA 418
            NG L++ L          + +S  LS+   L +   +AS + YL        +HRD+  
Sbjct: 102 ENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLAT 158

Query: 419 CNILLDAEFNAKLGDF----------------EATIPAGTMGYLAPEYVYSGVPSEKTDV 462
            N L+   +  K+ DF                 A +P   + ++A E V  G  + K+DV
Sbjct: 159 RNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLP---IRWMAWESVLLGKFTTKSDV 215

Query: 463 YSFGVVALEV 472
           ++FGV   E+
Sbjct: 216 WAFGVTLWEI 225

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 65.4 bits (159), Expect = 8e-12
 Identities = 64/265 (24%), Positives = 119/265 (44%), Gaps = 26/265 (9%)

Query: 286 FNKNRIVGEGASATVYKGS-LPSGGAVAVKRFEKPNRVEC-ARNPFTTEFATMAGCLRHK 343
           F   + +G G  + VY+ + L     VA+K+ +    ++  AR     E   +   L H 
Sbjct: 4   FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQ-LNHP 62

Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
           N+++      E NEL +V E    G L +++        ++         + + SA+ ++
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122

Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGD------FEATIPA-----GTMGYLAPEYVY 452
           H    R+++HRD+K  N+ + A    KLGD      F +   A     GT  Y++PE ++
Sbjct: 123 HS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179

Query: 453 SGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFN 512
               + K+D++S G +  E+AA +SP   D         NL    + ++  D+      +
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-------MNLFSLCQKIEQCDYPPLPTEH 232

Query: 513 RKEMERMLMVGLSCVHPNHEKRPSV 537
             E  R L+    C++P+ ++RP +
Sbjct: 233 YSEKLRELVS--MCIYPDPDQRPDI 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 65.8 bits (160), Expect = 9e-12
 Identities = 50/188 (26%), Positives = 86/188 (45%), Gaps = 36/188 (19%)

Query: 311 VAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSL 370
           VAVK   + +  + ARN F  E   M+  L++ N+++L G C   + L ++ EY+ NG L
Sbjct: 47  VAVKML-RADVTKTARNDFLKEIKIMSR-LKNPNIIRLLGVCVSDDPLCMITEYMENGDL 104

Query: 371 DKIL----------HNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACN 420
           ++ L          H N+  S+  S    L + + +AS + YL        +HRD+   N
Sbjct: 105 NQFLSQREIESTFTHANNIPSV--SIANLLYMAVQIASGMKYL---ASLNFVHRDLATRN 159

Query: 421 ILLDAEFNAKLGDF----------------EATIPAGTMGYLAPEYVYSGVPSEKTDVYS 464
            L+   +  K+ DF                 A +P   + ++A E +  G  +  +DV++
Sbjct: 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLP---IRWMAWESILLGKFTTASDVWA 216

Query: 465 FGVVALEV 472
           FGV   E+
Sbjct: 217 FGVTLWEM 224

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 65.5 bits (159), Expect = 9e-12
 Identities = 59/201 (29%), Positives = 93/201 (46%), Gaps = 25/201 (12%)

Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G+G    V+ G+      VA+K   KP  +  +   F  E   M   LRH+ LVQL   
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTM--SPEAFLQEAQVMKK-LRHEKLVQLYAV 69

Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECER-Q 410
             E   + +V EY+  GSL   L       + L   + +++   +AS ++Y+    ER  
Sbjct: 70  VSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQIASGMAYV----ERMN 122

Query: 411 IIHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVPSE 458
            +HRD++A NIL+      K+ DF         E T   G    + + APE    G  + 
Sbjct: 123 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 182

Query: 459 KTDVYSFGVVALEVAA-GKSP 478
           K+DV+SFG++  E+   G+ P
Sbjct: 183 KSDVWSFGILLTELTTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 65.2 bits (159), Expect = 1e-11
 Identities = 71/275 (25%), Positives = 113/275 (41%), Gaps = 54/275 (19%)

Query: 290 RIVGEGA--SATVYK----GSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHK 343
           R++G+GA   AT+Y+     SL     V + R  +  R + A N    E   ++  L+H 
Sbjct: 6   RVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRD-ALN----EIVILS-LLQHP 59

Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
           N++       + N L++  EY   G+L DKI+        +   E  L  +  + SA+SY
Sbjct: 60  NIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQ---LFEEEMVLWYLFQIVSAVSY 116

Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTMGYLAPEYV 451
           +H+     I+HRD+K  NI L      KLGDF            A    GT  Y++PE  
Sbjct: 117 IHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELC 173

Query: 452 YSGVP-SEKTDVYSFGVVALEVAAGKSPVDNDG----CV-IVDWVWNLRKKGKLLDAADF 505
             GV  + K+D+++ G V  E+   K   D        V IV   +         +    
Sbjct: 174 -QGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSE---- 228

Query: 506 RLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEA 540
                        ++ +  S +  + EKRP+  E 
Sbjct: 229 -------------LISLVHSLLQQDPEKRPTADEV 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 64.9 bits (158), Expect = 1e-11
 Identities = 61/214 (28%), Positives = 90/214 (42%), Gaps = 39/214 (18%)

Query: 290 RIVGEGASATVYKGSL-----PSGGA--VAVKRFEKPNRVECARNPFTTEFATMAGCLRH 342
             +G GA   VY+G+      P  G   VAVK   K    +  +  F  E   M     H
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQ-EKKEFLKEAHLM-SNFNH 58

Query: 343 KNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHN---NSSSSIVLSWEKRLNIVLGVASA 399
            N+V+L G C       ++ E +  G L   L +         +L+ ++ L+I L VA  
Sbjct: 59  PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118

Query: 400 LSYLHEECERQIIHRDVKACNILL-----DAEFNAKLGDF----------------EATI 438
             YL +      IHRD+ A N L+     DA+   K+GDF                E  +
Sbjct: 119 CVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL 175

Query: 439 PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEV 472
           P   M   APE +  G  + ++DV+SFGV+  E+
Sbjct: 176 PVRWM---APESLLDGKFTTQSDVWSFGVLMWEI 206

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 65.1 bits (158), Expect = 2e-11
 Identities = 52/204 (25%), Positives = 86/204 (42%), Gaps = 20/204 (9%)

Query: 286 FNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           F K   +G+G+   V+KG       V   +       E        E   ++ C     +
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYV 64

Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
            +  G   +G +L ++ EYL  GS   +L         ++      ++  +   L YLH 
Sbjct: 65  TKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIA-----TMLKEILKGLDYLHS 119

Query: 406 ECERQIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTMGYLAPEYVYSG 454
           E   + IHRD+KA N+LL  + + KL DF           +     GT  ++APE +   
Sbjct: 120 E---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQS 176

Query: 455 VPSEKTDVYSFGVVALEVAAGKSP 478
               K D++S G+ A+E+A G+ P
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 64.9 bits (159), Expect = 2e-11
 Identities = 56/211 (26%), Positives = 91/211 (43%), Gaps = 48/211 (22%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECAR---NP-------FTTEFA 334
           + K + +GEG  A VYK     +G  VA+K+  K    + A+   N           E  
Sbjct: 2   YEKGKKLGEGTYAVVYKARDKETGRIVAIKKI-KLGERKEAKDGINFTALREIKLLQE-- 58

Query: 335 TMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVL 394
                L+H N++ L       + + LV+E++    L+K++ + S   IVL+     + +L
Sbjct: 59  -----LKHPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKS---IVLTPADIKSYML 109

Query: 395 GVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTM 443
                L YLH      I+HRD+K  N+L+ ++   KL DF           + T    T 
Sbjct: 110 MTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTR 166

Query: 444 GYLAPEYVY------SGVPSEKTDVYSFGVV 468
            Y APE ++       GV     D++S G +
Sbjct: 167 WYRAPELLFGARHYGVGV-----DMWSVGCI 192

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 64.7 bits (157), Expect = 2e-11
 Identities = 58/213 (27%), Positives = 93/213 (43%), Gaps = 28/213 (13%)

Query: 291 IVGEGASATVYKGSLPSGGAV--AVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           ++GEG    V K  +   G    A  +  K    +     F  E   +     H N++ L
Sbjct: 2   VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61

Query: 349 QGWCCEGNELVLVYEYLPNGSL------------DKILHNNSSSSIVLSWEKRLNIVLGV 396
            G C     L L  EY P+G+L            D      +S++  LS ++ L+    V
Sbjct: 62  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121

Query: 397 ASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-----EATIPAGTMG-----YL 446
           A  + YL +   +Q IHRD+ A NIL+   + AK+ DF     +      TMG     ++
Sbjct: 122 ARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWM 178

Query: 447 APEYVYSGVPSEKTDVYSFGVVALEVAA-GKSP 478
           A E +   V +  +DV+S+GV+  E+ + G +P
Sbjct: 179 AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 211

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 65.1 bits (159), Expect = 2e-11
 Identities = 49/157 (31%), Positives = 71/157 (45%), Gaps = 24/157 (15%)

Query: 341 RHKNLVQLQGWCC--EGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVAS 398
           +H  L QL    C    + L  V EY+  G L  + H   S        +       +  
Sbjct: 54  KHPFLTQL--HSCFQTKDRLFFVMEYVNGGDL--MFHIQRSG--RFDEPRARFYAAEIVL 107

Query: 399 ALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF----EATIPA-------GTMGYLA 447
            L +LHE   R II+RD+K  N+LLD+E + K+ DF    E  +         GT  Y+A
Sbjct: 108 GLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIA 164

Query: 448 PEYVYSGVP-SEKTDVYSFGVVALEVAAGKSPVDNDG 483
           PE + S  P     D ++ GV+  E+ AG+SP + D 
Sbjct: 165 PE-ILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD 200

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 64.3 bits (156), Expect = 2e-11
 Identities = 67/277 (24%), Positives = 116/277 (41%), Gaps = 42/277 (15%)

Query: 286 FNKNRIVGEGASATVYKGS-LPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F    +VG G    VYKG  + +G   A+K  +     E        E   +     H+N
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE---EEIKQEINMLKKYSHHRN 64

Query: 345 LVQLQGWCCEGN------ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVAS 398
           +    G   + N      +L LV E+   GS+  ++ N   +++   W     I   +  
Sbjct: 65  IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILR 122

Query: 399 ALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP-----------AGTMGYLA 447
            LS+LH+    ++IHRD+K  N+LL      KL DF  +              GT  ++A
Sbjct: 123 GLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMA 179

Query: 448 PEYVYSGVPSE-----KTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDA 502
           PE +      +     K+D++S G+ A+E+A G  P+ +        +  +R    +   
Sbjct: 180 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD--------MHPMRALFLIPRN 231

Query: 503 ADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKE 539
              RL+ K   K+ +  +    SC+  NH +RP+ ++
Sbjct: 232 PAPRLKSKKWSKKFQSFIE---SCLVKNHSQRPTTEQ 265

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 64.1 bits (156), Expect = 2e-11
 Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 33/208 (15%)

Query: 292 VGEGASATVYKGSLPSGG--------AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHK 343
           +G+G    ++KG     G         V +K  +K +R   + + F  E A+M   L HK
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHR-NYSESFF--EAASMMSQLSHK 59

Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
           +LV   G C  G+E ++V EY+  GSLD  L  N  + I +SW  +L +   +A AL +L
Sbjct: 60  HLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKN-KNLINISW--KLEVAKQLAWALHFL 116

Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGD---FEATIPAGTMGYLAPEYVYSGVP---- 456
               ++ + H +V A N+LL  E + K G+    + + P  ++  L  E +   +P    
Sbjct: 117 E---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPP 173

Query: 457 ---------SEKTDVYSFGVVALEVAAG 475
                    S   D +SFG    E+ +G
Sbjct: 174 ECIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 64.7 bits (157), Expect = 2e-11
 Identities = 60/255 (23%), Positives = 104/255 (40%), Gaps = 42/255 (16%)

Query: 311 VAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSL 370
           VAVK   K +  E   +   +E   M    +HKN++ L G C +   L ++ EY   G+L
Sbjct: 50  VAVKML-KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 108

Query: 371 DKILHN------------NSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKA 418
            + L                     ++++  ++    VA  + YL     ++ IHRD+ A
Sbjct: 109 REYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAA 165

Query: 419 CNILLDAEFNAKLGDFEATIPAGTMGY-------------LAPEYVYSGVPSEKTDVYSF 465
            N+L+      K+ DF        + Y             +APE ++  V + ++DV+SF
Sbjct: 166 RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 225

Query: 466 GVVALEV-AAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGL 524
           GV+  E+   G SP      + V+ ++ L K+G  +D                 + M+  
Sbjct: 226 GVLMWEIFTLGGSPYPG---IPVEELFKLLKEGHRMDKP---------ANCTNELYMMMR 273

Query: 525 SCVHPNHEKRPSVKE 539
            C H     RP+ K+
Sbjct: 274 DCWHAIPSHRPTFKQ 288

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 66.4 bits (162), Expect = 3e-11
 Identities = 57/198 (28%), Positives = 88/198 (44%), Gaps = 35/198 (17%)

Query: 307 SGGAVAVK--RFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL--QGWCCEGNELVLVY 362
           +G  VA+K  R + P   E  R  F  E A  A  L H N+V L   G       L  V+
Sbjct: 2   TGHEVAIKLLRTDAPEE-EHQRARFRRETALCAR-LYHPNIVALLDSG-EAPPGLLFAVF 58

Query: 363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNIL 422
           EY+P  +L ++L  +      L   +   ++L V  AL+  H    + I+HRD+K  NI+
Sbjct: 59  EYVPGRTLREVLAADG----ALPAGETGRLMLQVLDALACAHN---QGIVHRDLKPQNIM 111

Query: 423 L---DAEFNAKLGDF-------------EATIPA-----GTMGYLAPEYVYSGVPSEKTD 461
           +       +AK+ DF              AT+       GT  Y APE +     +  +D
Sbjct: 112 VSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSD 171

Query: 462 VYSFGVVALEVAAGKSPV 479
           +Y++G++ LE   G+  V
Sbjct: 172 LYAWGLIFLECLTGQRVV 189

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 64.2 bits (156), Expect = 3e-11
 Identities = 68/300 (22%), Positives = 123/300 (41%), Gaps = 63/300 (21%)

Query: 289 NRIVGEGASATVYKGS------LPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRH 342
            + +GEG    V K +            VAVK   K N          +EF  +   + H
Sbjct: 5   GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKML-KENASSSELRDLLSEFNLLKQ-VNH 62

Query: 343 KNLVQLQGWCCEGNELVLVYEYLPNGSLDKILH--------------NNSSSSIVLSWEK 388
            ++++L G C +   L+L+ EY   GSL   L               N +SS +    E+
Sbjct: 63  PHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDER 122

Query: 389 RLNI------VLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT----- 437
            L +         ++  + YL    E +++HRD+ A N+L+      K+ DF  +     
Sbjct: 123 ALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYE 179

Query: 438 -----------IPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALE-VAAGKSPVDNDGCV 485
                      IP   + ++A E ++  + + ++DV+SFGV+  E V  G +P      +
Sbjct: 180 EDSYVKRSKGRIP---VKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG---I 233

Query: 486 IVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK 545
             + ++NL K G  ++  +            E M  + L+C     +KRP+  + ++ L+
Sbjct: 234 APERLFNLLKTGYRMERPE---------NCSEEMYNLMLTCWKQEPDKRPTFADISKELE 284

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 63.3 bits (154), Expect = 4e-11
 Identities = 47/173 (27%), Positives = 83/173 (47%), Gaps = 22/173 (12%)

Query: 311 VAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSL 370
           + + +     R E  +     E A ++  ++H N+VQ Q    E   L +V +Y   G L
Sbjct: 33  INISKMSPKEREESRK-----EVAVLSN-MKHPNIVQYQESFEENGNLYIVMDYCEGGDL 86

Query: 371 DKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAK 430
            K +  N+   ++   ++ L+  + +  AL ++H+   R+I+HRD+K+ NI L  +   K
Sbjct: 87  YKKI--NAQRGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIK 141

Query: 431 LGDFE-----------ATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEV 472
           LGDF            A    GT  YL+PE   +   + K+D+++ G V  E+
Sbjct: 142 LGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEM 194

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 64.3 bits (156), Expect = 4e-11
 Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 18/204 (8%)

Query: 286 FNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           F K   +G G    V+K S    G +  ++          RN    E   +  C     +
Sbjct: 7   FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYI 65

Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIV-LGVASALSYLH 404
           V   G      E+ +  E++  GSLD++L            E+ L  V + V   L+YL 
Sbjct: 66  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP-----EQILGKVSIAVIKGLTYLR 120

Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGTMGYLAPEYVYSGV 455
           E+   +I+HRDVK  NIL+++    KL DF          A    GT  Y++PE +    
Sbjct: 121 EK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTH 178

Query: 456 PSEKTDVYSFGVVALEVAAGKSPV 479
            S ++D++S G+  +E+A G+ P+
Sbjct: 179 YSVQSDIWSMGLSLVEMAIGRYPI 202

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 63.1 bits (153), Expect = 5e-11
 Identities = 64/210 (30%), Positives = 94/210 (44%), Gaps = 30/210 (14%)

Query: 290 RIVGEGASATVYKG-SLPSGGAVAVKRFE-KPNRVECAR--NPFTTEFATMAGCLRHKNL 345
           +++G GA   VY      +G  +AVK+    P+  E ++  N    E   +   LRH  +
Sbjct: 8   KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLK-NLRHDRI 66

Query: 346 VQLQGWCC---EGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
           VQ  G C    E  +L +  EY+P GS+   L    + +  ++      I+ GV    SY
Sbjct: 67  VQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGV----SY 121

Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDFEA-----TI---------PAGTMGYLAP 448
           LH      I+HRD+K  NIL D+  N KLGDF A     TI           GT  +++P
Sbjct: 122 LHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSP 178

Query: 449 EYVYSGVPSEKTDVYSFGVVALEVAAGKSP 478
           E +       K DV+S     +E+   K P
Sbjct: 179 EVISGEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 63.6 bits (155), Expect = 6e-11
 Identities = 42/134 (31%), Positives = 70/134 (52%), Gaps = 17/134 (12%)

Query: 356 NELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRL-NIVLGVASALSYLHEECERQIIHR 414
            E+ +  E++  GSLD++L    +  I    E  L  I + V   L+YL E+   +I+HR
Sbjct: 72  GEISICMEHMDGGSLDQVL--KKAGRIP---ENILGKISIAVLRGLTYLREK--HKIMHR 124

Query: 415 DVKACNILLDAEFNAKLGDFE---------ATIPAGTMGYLAPEYVYSGVPSEKTDVYSF 465
           DVK  NIL+++    KL DF          A    GT  Y++PE +     + ++D++S 
Sbjct: 125 DVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSL 184

Query: 466 GVVALEVAAGKSPV 479
           G+  +E+A G+ P+
Sbjct: 185 GLSLVEMAIGRYPI 198

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 63.1 bits (153), Expect = 6e-11
 Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 28/209 (13%)

Query: 290 RIVGEGASATVYKG-SLPSGGAVAVKRFE-KPNRVECAR--NPFTTEFATMAGCLRHKNL 345
           +++G+GA   VY      +G  +AVK+ +  P   E ++  N    E   +   L H+ +
Sbjct: 8   KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL-HERI 66

Query: 346 VQLQGWCCEGNE--LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
           VQ  G   +  E  L +  E++P GS+   L +  + +  ++ +    I+ GV    SYL
Sbjct: 67  VQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGV----SYL 122

Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDFEA-----TI---------PAGTMGYLAPE 449
           H      I+HRD+K  NIL D+  N KLGDF A     TI           GT  +++PE
Sbjct: 123 HSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPE 179

Query: 450 YVYSGVPSEKTDVYSFGVVALEVAAGKSP 478
            +       K D++S G   +E+   K P
Sbjct: 180 VISGEGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 63.9 bits (155), Expect = 6e-11
 Identities = 52/197 (26%), Positives = 85/197 (43%), Gaps = 16/197 (8%)

Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G    V K      G +  ++          RN    E   +  C     +V   G 
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGA 71

Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
                E+ +  E++  GSLD++L         +  E    + + V   L+YL E+   QI
Sbjct: 72  FYSDGEISICMEHMDGGSLDQVLKEAKR----IPEEILGKVSIAVLRGLAYLREK--HQI 125

Query: 412 IHRDVKACNILLDAEFNAKLGDF---------EATIPAGTMGYLAPEYVYSGVPSEKTDV 462
           +HRDVK  NIL+++    KL DF          A    GT  Y++PE +     S ++D+
Sbjct: 126 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDI 185

Query: 463 YSFGVVALEVAAGKSPV 479
           +S G+  +E+A G+ P+
Sbjct: 186 WSMGLSLVELAIGRYPI 202

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 63.1 bits (153), Expect = 8e-11
 Identities = 49/153 (32%), Positives = 74/153 (48%), Gaps = 19/153 (12%)

Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKI-LHNNSSSSIVLSWEKRLNIVLGVAS 398
           L+H N ++ +G   + +   LV EY    + D + +H      + ++      I  G   
Sbjct: 78  LKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA-----AITHGALQ 132

Query: 399 ALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-EATI--PA----GTMGYLAPEYV 451
            L+YLH      +IHRD+KA NILL      KL DF  A+   PA    GT  ++APE +
Sbjct: 133 GLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGTPYWMAPEVI 189

Query: 452 YS---GVPSEKTDVYSFGVVALEVAAGKSPVDN 481
            +   G    K DV+S G+  +E+A  K P+ N
Sbjct: 190 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 222

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 62.8 bits (152), Expect = 8e-11
 Identities = 52/204 (25%), Positives = 83/204 (40%), Gaps = 20/204 (9%)

Query: 286 FNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           F K   +G+G+   V+KG       V   +       E        E   ++ C     +
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYV 64

Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
            +  G   +  +L ++ EYL  GS   +L         ++      I+  +   L YLH 
Sbjct: 65  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA-----TILREILKGLDYLHS 119

Query: 406 ECERQIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTMGYLAPEYVYSG 454
           E   + IHRD+KA N+LL      KL DF           +     GT  ++APE +   
Sbjct: 120 E---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS 176

Query: 455 VPSEKTDVYSFGVVALEVAAGKSP 478
               K D++S G+ A+E+A G+ P
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 62.9 bits (153), Expect = 8e-11
 Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 48/223 (21%)

Query: 290 RIVGEGASATVYK----GSLPSGG--AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHK 343
           R +G+GA   V++    G LP      VAVK  ++    +  +  F  E A MA    H 
Sbjct: 11  RDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD-MQADFQREAALMAE-FDHP 68

Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNS-----SSS-------------IVLS 385
           N+V+L G C  G  + L++EY+  G L++ L + S     S S             + LS
Sbjct: 69  NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128

Query: 386 WEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT-------- 437
             ++L I   VA+ ++YL    ER+ +HRD+   N L+      K+ DF  +        
Sbjct: 129 CTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 185

Query: 438 --------IPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEV 472
                   IP   + ++ PE ++    + ++DV+++GVV  E+
Sbjct: 186 YKASENDAIP---IRWMPPESIFYNRYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 62.0 bits (150), Expect = 1e-10
 Identities = 76/287 (26%), Positives = 121/287 (42%), Gaps = 53/287 (18%)

Query: 290 RIVGEGASATVYKGSLPSGGAVAVKRFEKPNRV------ECARNPFTTEFATMAGCLRHK 343
           R +G+G+   VY+G      A  V + E   RV      E A      EF   A  ++  
Sbjct: 12  RELGQGSFGMVYEGI-----AKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF 66

Query: 344 N---LVQLQGWCCEGNELVLVYEYLPNGSLDKILHN------NSSSSIVLSWEKRLNIVL 394
           N   +V+L G   +G   +++ E +  G L   L +      N+      S +K + +  
Sbjct: 67  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAG 126

Query: 395 GVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT--------IPAGTMG-- 444
            +A  ++YL+     + +HRD+ A N ++  +F  K+GDF  T           G  G  
Sbjct: 127 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 183

Query: 445 ---YLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLL 500
              +++PE +  GV +  +DV+SFGVV  E+A   + P      +  + V     +G LL
Sbjct: 184 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG---MSNEQVLRFVMEGGLL 240

Query: 501 DAADFRLRGKFNRKEM--ERMLMVGLSCVHPNHEKRPSVKEAARILK 545
           D  D       N  +M  E M M    C   N + RPS  E    +K
Sbjct: 241 DKPD-------NCPDMLFELMRM----CWQYNPKMRPSFLEIISSIK 276

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 63/262 (24%), Positives = 109/262 (41%), Gaps = 54/262 (20%)

Query: 317 EKPNRV-------------ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE 363
           EKPNRV             E   +   +E   M    +HKN++ L G C +   L ++ E
Sbjct: 45  EKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVE 104

Query: 364 YLPNGSLDKILHNNSSSSI------------VLSWEKRLNIVLGVASALSYLHEECERQI 411
           Y   G+L + L       +             LS++  ++    VA  + YL     ++ 
Sbjct: 105 YASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKC 161

Query: 412 IHRDVKACNILLDAEFNAKLGDF-------------EATIPAGTMGYLAPEYVYSGVPSE 458
           IHRD+ A N+L+  +   K+ DF             + T     + ++APE ++  + + 
Sbjct: 162 IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTH 221

Query: 459 KTDVYSFGVVALEV-AAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEME 517
           ++DV+SFGV+  E+   G SP      V V+ ++ L K+G  +D                
Sbjct: 222 QSDVWSFGVLLWEIFTLGGSPYPG---VPVEELFKLLKEGHRMDKPS---------NCTN 269

Query: 518 RMLMVGLSCVHPNHEKRPSVKE 539
            + M+   C H    +RP+ K+
Sbjct: 270 ELYMMMRDCWHAVPSQRPTFKQ 291

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 62.0 bits (150), Expect = 2e-10
 Identities = 58/209 (27%), Positives = 91/209 (43%), Gaps = 36/209 (17%)

Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G+GA   VYK      G +A  +     + E     +  E   +A C  H N+V+L   
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVID-TKSEEELEDYMVEIDILASC-DHPNIVKLLDA 70

Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLN------IVLGVASALSYLHE 405
               N L ++ E+   G++D         +++L  E+ L       +      AL+YLHE
Sbjct: 71  FYYENNLWILIEFCAGGAVD---------AVMLELERPLTEPQIRVVCKQTLEALNYLHE 121

Query: 406 ECERQIIHRDVKACNILLDAEFNAKLGDFEATIP-----------AGTMGYLAPEYVYSG 454
               +IIHRD+KA NIL   + + KL DF  +              GT  ++APE V   
Sbjct: 122 N---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCE 178

Query: 455 VPSE-----KTDVYSFGVVALEVAAGKSP 478
              +     K DV+S G+  +E+A  + P
Sbjct: 179 TSKDRPYDYKADVWSLGITLIEMAQIEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 55/200 (27%), Positives = 89/200 (44%), Gaps = 20/200 (10%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F K   +GEG    VYK  +  +G  VA+K+       E   +    E + +   L H N
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE-LNHPN 60

Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           +V+L       N+L LV+E+L +  L K +  +  S I L   K  + +  +   L++ H
Sbjct: 61  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIK--SYLFQLLQGLAFCH 117

Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG-----------TMGYLAPEYVY- 452
                +++HRD+K  N+L++ E   KL DF      G           T+ Y APE +  
Sbjct: 118 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 174

Query: 453 SGVPSEKTDVYSFGVVALEV 472
               S   D++S G +  E+
Sbjct: 175 CKYYSTAVDIWSLGCIFAEM 194

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 58/214 (27%), Positives = 99/214 (46%), Gaps = 25/214 (11%)

Query: 278 DIKQATLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMA 337
           +I + +L   K   +G G    V+  +      VAVK   KP  +      F  E A + 
Sbjct: 2   EIPRESLKLEKK--LGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVE--AFLAE-ANVM 55

Query: 338 GCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVA 397
             L+H  LV+L     +   + ++ E++  GSL   L ++  S   L   K ++    +A
Sbjct: 56  KTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIA 112

Query: 398 SALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGY 445
             ++++ +   R  IHRD++A NIL+ A    K+ DF         E T   G    + +
Sbjct: 113 EGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKW 169

Query: 446 LAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSP 478
            APE +  G  + K+DV+SFG++ +E+   G+ P
Sbjct: 170 TAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 61.9 bits (150), Expect = 2e-10
 Identities = 66/259 (25%), Positives = 109/259 (42%), Gaps = 62/259 (23%)

Query: 246 SCFLIKKKRHDGRSKEDHVCTVQRVPMRLALTDIKQATLGFNKNRIVGEGASATVYKG-S 304
              L K+K  +G+  E H+C V   P  L        TL F  N          V KG  
Sbjct: 5   GHLLFKEKLGEGQFGEVHLCEVVN-PQDLP-------TLQFPFN----------VRKGRP 46

Query: 305 LPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEY 364
           L     VAVK   +P+  + ARN F  E   ++  L+  N+++L G C + + L ++ EY
Sbjct: 47  L----LVAVKIL-RPDANKNARNDFLKEVKILSR-LKDPNIIRLLGVCVDEDPLCMITEY 100

Query: 365 LPNGSLDKILHNN---------------SSSSIVLSWEKRLNIVLGVASALSYLHEECER 409
           + NG L++ L ++               +     +S+   L++ L +AS + YL      
Sbjct: 101 MENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSL 157

Query: 410 QIIHRDVKACNILLDAEFNAKLGDF----------------EATIPAGTMGYLAPEYVYS 453
             +HRD+   N L+      K+ DF                 A +P   + ++A E +  
Sbjct: 158 NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLP---IRWMAWECILM 214

Query: 454 GVPSEKTDVYSFGVVALEV 472
           G  +  +DV++FGV   E+
Sbjct: 215 GKFTTASDVWAFGVTLWEI 233

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 61/201 (30%), Positives = 92/201 (45%), Gaps = 25/201 (12%)

Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G    V+ G+      VAVK   KP  +  +   F  E   M   LRH  LVQL   
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTL-KPGTM--SPESFLEEAQIMKK-LRHDKLVQLYAV 69

Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECER-Q 410
             E   + +V EY+  GSL   L +    ++ L     +++   VA+ ++Y+    ER  
Sbjct: 70  VSE-EPIYIVTEYMSKGSLLDFLKDGEGRALKLP--NLVDMAAQVAAGMAYI----ERMN 122

Query: 411 IIHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVPSE 458
            IHRD+++ NIL+      K+ DF         E T   G    + + APE    G  + 
Sbjct: 123 YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 182

Query: 459 KTDVYSFGVVALE-VAAGKSP 478
           K+DV+SFG++  E V  G+ P
Sbjct: 183 KSDVWSFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 61.9 bits (150), Expect = 2e-10
 Identities = 64/255 (25%), Positives = 106/255 (41%), Gaps = 42/255 (16%)

Query: 311 VAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSL 370
           VAVK   K N  +       +E   M    +HKN++ L G C +   L ++ EY   G+L
Sbjct: 47  VAVKML-KDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNL 105

Query: 371 DKILHNN------------SSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKA 418
            + L                     LS++  ++    VA  + YL     R+ IHRD+ A
Sbjct: 106 REFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAA 162

Query: 419 CNILLDAEFNAKLGDFEATIPAGTMGY-------------LAPEYVYSGVPSEKTDVYSF 465
            N+L+  +   K+ DF        + Y             +APE ++  V + ++DV+SF
Sbjct: 163 RNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSF 222

Query: 466 GVVALEV-AAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGL 524
           G++  E+   G SP      + V+ ++ L ++G  +D          N      MLM   
Sbjct: 223 GILMWEIFTLGGSPYPG---IPVEELFKLLREGHRMDKPS-------NCTHELYMLM--R 270

Query: 525 SCVHPNHEKRPSVKE 539
            C H    +RP+ K+
Sbjct: 271 ECWHAVPTQRPTFKQ 285

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 61.0 bits (148), Expect = 3e-10
 Identities = 56/198 (28%), Positives = 83/198 (41%), Gaps = 23/198 (11%)

Query: 291 IVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQ 349
           I+G G   TVYK   L +   +AVK       VE  +    +E   +  C     ++   
Sbjct: 8   ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQ-IMSELEILYKC-DSPYIIGFY 65

Query: 350 GWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECER 409
           G     N + +  E++  GSLD           VL       I + V   L+YL      
Sbjct: 66  GAFFVENRISICTEFMDGGSLDVY---RKIPEHVLG-----RIAVAVVKGLTYL---WSL 114

Query: 410 QIIHRDVKACNILLDAEFNAKLGDFE---------ATIPAGTMGYLAPEYVYSGVPSEKT 460
           +I+HRDVK  N+L++     KL DF          A    GT  Y+APE +        +
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYGIHS 174

Query: 461 DVYSFGVVALEVAAGKSP 478
           DV+S G+  +E+A G+ P
Sbjct: 175 DVWSLGISFMELALGRFP 192

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 61.6 bits (150), Expect = 3e-10
 Identities = 65/214 (30%), Positives = 94/214 (43%), Gaps = 39/214 (18%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARN--PFTT--EFATMAGCL 340
           F K   +GEG    VY+     SG  VA+K+     R++  R+  P ++  E  T+   L
Sbjct: 9   FEKLNRIGEGTYGIVYRARDTTSGEIVALKKV----RMDNERDGIPISSLREI-TLLLNL 63

Query: 341 RHKNLVQLQGWCCEGNEL---VLVYEYLPNGSLDKILHNNS---SSSIVLSWEKRLNIVL 394
           RH N+V+L+     G  L    LV EY     L  +L N     S S V        ++L
Sbjct: 64  RHPNIVELKE-VVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKC------LML 115

Query: 395 GVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT----IPAGTMG------ 444
            +   L YLHE     IIHRD+K  N+LL  +   K+ DF       +PA  M       
Sbjct: 116 QLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTL 172

Query: 445 -YLAPEYVY-SGVPSEKTDVYSFGVVALEVAAGK 476
            Y APE +      +   D+++ G +  E+ A K
Sbjct: 173 WYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 61.6 bits (149), Expect = 3e-10
 Identities = 68/299 (22%), Positives = 120/299 (40%), Gaps = 46/299 (15%)

Query: 310 AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGS 369
            VAVK   K +  +   +   +E   M    +HKN++ L G C +   L ++ EY   G+
Sbjct: 46  TVAVKML-KDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGN 104

Query: 370 LDKILHNNSSSSI------------VLSWEKRLNIVLGVASALSYLHEECERQIIHRDVK 417
           L + L       +             L+++  ++    VA  + YL     ++ IHRD+ 
Sbjct: 105 LREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLA 161

Query: 418 ACNILLDAEFNAKLGDFEATIPAGTMGY-------------LAPEYVYSGVPSEKTDVYS 464
           A N+L+  +   K+ DF        + Y             +APE ++  V + ++DV+S
Sbjct: 162 ARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 221

Query: 465 FGVVALEV-AAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVG 523
           FGV+  E+   G SP      + V+ ++ L K+G  +D                 + M+ 
Sbjct: 222 FGVLLWEIFTLGGSPYPG---IPVEELFKLLKEGHRMDKP---------ANCTHELYMIM 269

Query: 524 LSCVHPNHEKRPSVKEAA----RILKGEAPLPLLPVKKPTVNIRSVFPEASELIDSGGD 578
             C H    +RP+ K+      R+L   +    L +  P        P++     SG D
Sbjct: 270 RECWHAVPSQRPTFKQLVEDLDRVLTVTSTDEYLDLSVPFEQYSPGCPDSPSSCSSGDD 328

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 60.7 bits (148), Expect = 3e-10
 Identities = 46/152 (30%), Positives = 59/152 (38%), Gaps = 46/152 (30%)

Query: 356 NELVLVYEYLPNGSLDKILHN----------NSSSSIVLSWEKRLNIVLGVASALSYLHE 405
             L LV EYLP G L  +L N             + IVL              AL YLH 
Sbjct: 66  KNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVL--------------ALEYLHS 111

Query: 406 ECERQIIHRDVKACNILLDAEFNAKLGDF----------EATIPA---------GTMGYL 446
                IIHRD+K  NIL+D+  + KL DF          +  +           GT  Y+
Sbjct: 112 N---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168

Query: 447 APEYVYSGVPSEKTDVYSFGVVALEVAAGKSP 478
           APE +     S+  D +S G +  E   G  P
Sbjct: 169 APEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 61.8 bits (150), Expect = 3e-10
 Identities = 38/108 (35%), Positives = 51/108 (47%), Gaps = 16/108 (14%)

Query: 384 LSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP---- 439
           L  E+ + I   +  AL+YLH    R IIHRDVK  NI LD   NA LGDF A       
Sbjct: 182 LPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238

Query: 440 ---------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSP 478
                    +GT+   +PE +       KTD++S G+V  E++     
Sbjct: 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286

Length = 392

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 60.5 bits (147), Expect = 5e-10
 Identities = 60/209 (28%), Positives = 97/209 (46%), Gaps = 29/209 (13%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           + K   +GEG    VYKG +  +G  VA+K+    +  E   +    E + +   L+H N
Sbjct: 2   YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKE-LQHPN 60

Query: 345 LVQLQGWCCEGNELVLVYEYLP---NGSLDKILHNNS-SSSIVLSWEKRLNIVLGVASAL 400
           +V LQ    + + L L++E+L       LD +       + +V S+  +  I+ G+    
Sbjct: 61  IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQ--ILQGIL--- 115

Query: 401 SYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT----IP-------AGTMGYLAPE 449
            + H    R+++HRD+K  N+L+D +   KL DF       IP         T+ Y APE
Sbjct: 116 -FCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPE 171

Query: 450 YVYSGVP--SEKTDVYSFGVVALEVAAGK 476
            V  G P  S   D++S G +  E+A  K
Sbjct: 172 -VLLGSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 60.2 bits (146), Expect = 5e-10
 Identities = 74/280 (26%), Positives = 114/280 (40%), Gaps = 53/280 (18%)

Query: 290 RIVGEGASATVYKGSL----PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           R++G+G    VY G+L          AVK   +   +E     F  E   M     H N+
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQ-FLKEGIIMKD-FSHPNV 58

Query: 346 VQLQGWCC--EGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
           + L G C   EG+ LV V  Y+ +G L   + + + +  V   +  +   L VA  + YL
Sbjct: 59  LSLLGICLPSEGSPLV-VLPYMKHGDLRNFIRSETHNPTV---KDLIGFGLQVAKGMEYL 114

Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF------------------EATIPAGTMGY 445
                ++ +HRD+ A N +LD  F  K+ DF                   A +P   M  
Sbjct: 115 ---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWM-- 169

Query: 446 LAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADF 505
            A E + +   + K+DV+SFGV+  E+    +P   D    VD            D   +
Sbjct: 170 -ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD----VD----------SFDITVY 214

Query: 506 RLRGKFNRKEM---ERMLMVGLSCVHPNHEKRPSVKEAAR 542
            L+G+   +     + +  V LSC HP  E RP+  E   
Sbjct: 215 LLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVS 254

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 60.1 bits (146), Expect = 7e-10
 Identities = 46/156 (29%), Positives = 76/156 (48%), Gaps = 25/156 (16%)

Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHN----NSSSSIVLSWEKRLNIVLG 395
           + H  +++L     +   L ++ EY+P G L   L N    ++S+ +  + E        
Sbjct: 58  VSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASE-------- 109

Query: 396 VASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGTMGYL 446
           +  AL YLH    ++I++RD+K  NILLD E + KL DF           T+  GT  YL
Sbjct: 110 IVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTL-CGTPEYL 165

Query: 447 APEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDND 482
           APE + S   ++  D ++ G++  E+  G  P  +D
Sbjct: 166 APEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDD 201

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 60.1 bits (145), Expect = 8e-10
 Identities = 58/208 (27%), Positives = 92/208 (44%), Gaps = 20/208 (9%)

Query: 286 FNKNRIVGEGASATVY-KGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F   R +G G+   VY    + +   VA+K+     +    +     +       ++H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKI-LHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
            ++ +G     +   LV EY    + D + +H      + ++      I  G    L+YL
Sbjct: 87  SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA-----AITHGALQGLAYL 141

Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF-EATI--PA----GTMGYLAPEYVYS--- 453
           H      +IHRD+KA NILL      KL DF  A+I  PA    GT  ++APE + +   
Sbjct: 142 HSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVGTPYWMAPEVILAMDE 198

Query: 454 GVPSEKTDVYSFGVVALEVAAGKSPVDN 481
           G    K DV+S G+  +E+A  K P+ N
Sbjct: 199 GQYDGKVDVWSLGITCIELAERKPPLFN 226

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 59.7 bits (145), Expect = 1e-09
 Identities = 48/216 (22%), Positives = 84/216 (38%), Gaps = 41/216 (18%)

Query: 290 RIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGC--LRHKNLVQ 347
           +   +     + K   P+   VAVK+    N   C++         +     L+H N++ 
Sbjct: 8   KCFEDLMIVHLAKHK-PTNTLVAVKKI---NLDSCSKEDLKLLQQEIITSRQLQHPNILP 63

Query: 348 LQGWCCEGNELVLVYEYLPNGSLDKILHNN-----SSSSIVLSWEKRLNIVLGVASALSY 402
                   +EL +V   +  GS + +L  +        +I         I+  V +AL Y
Sbjct: 64  YVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF-------ILKDVLNALDY 116

Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP------------------AGTMG 444
           +H +     IHR VKA +ILL  +    L     ++                      + 
Sbjct: 117 IHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP 173

Query: 445 YLAPEYVYSGVP--SEKTDVYSFGVVALEVAAGKSP 478
           +L+PE +   +   +EK+D+YS G+ A E+A G  P
Sbjct: 174 WLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 59.3 bits (143), Expect = 1e-09
 Identities = 58/213 (27%), Positives = 95/213 (44%), Gaps = 38/213 (17%)

Query: 292 VGEGASATVYKGSL--PSGG----AVAVKRFEKPNRVECA-RNPFTTEFATMAGCLRHKN 344
           +GE     VYKG L   + G    AVA+K  +  ++ E   R  F  E A M   L+H N
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLK--DKAEGPLREEFKHE-AMMRSRLQHPN 69

Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKR------------LNI 392
           +V L G   +   L +++ Y  +  L + L   S  S V S +              ++I
Sbjct: 70  IVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHI 129

Query: 393 VLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGD---FEATIPAG---TMG-- 444
           V  +A+ + +L       ++H+D+   N+L+  + N K+ D   F     A     MG  
Sbjct: 130 VTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNS 186

Query: 445 -----YLAPEYVYSGVPSEKTDVYSFGVVALEV 472
                +++PE +  G  S  +D++S+GVV  EV
Sbjct: 187 LLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEV 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 59.3 bits (144), Expect = 1e-09
 Identities = 57/203 (28%), Positives = 90/203 (44%), Gaps = 30/203 (14%)

Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARN--PFTT--EFATMAGCLRHKNLV 346
           +GEG    VYK     +G  VA+K+     R+E      P T   E + +   L H N+V
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKI----RLETEDEGVPSTAIREISLLKE-LNHPNIV 61

Query: 347 QLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEE 406
           +L       N+L LV+E+L    LD   + +SS    L      + +  +   ++Y H  
Sbjct: 62  RLLDVVHSENKLYLVFEFL---DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS- 117

Query: 407 CERQIIHRDVKACNILLDAEFNAKLGDFEAT----IPAG-------TMGYLAPEYVYSGV 455
              +++HRD+K  N+L+D E   KL DF       +P         T+ Y APE +  G 
Sbjct: 118 --HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPE-ILLGS 174

Query: 456 PSEKT--DVYSFGVVALEVAAGK 476
               T  D++S G +  E+   +
Sbjct: 175 RQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 58.8 bits (142), Expect = 1e-09
 Identities = 63/206 (30%), Positives = 90/206 (43%), Gaps = 29/206 (14%)

Query: 292 VGEGASATVYKG---SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           +G G   TV KG      S   VAVK  +  N     ++    E   M   L +  +V++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQ-LDNPYIVRM 61

Query: 349 QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRL-NIVLGVASALSYLHEEC 407
            G  CE    +LV E    G L+K L  N   +     EK +  +V  V+  + YL E  
Sbjct: 62  IG-ICEAESWMLVMELAELGPLNKFLQKNKHVT-----EKNITELVHQVSMGMKYLEET- 114

Query: 408 ERQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGTMG-----YLAPEYVYS 453
               +HRD+ A N+LL  +  AK+ DF         E    A T G     + APE +  
Sbjct: 115 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNY 172

Query: 454 GVPSEKTDVYSFGVVALEV-AAGKSP 478
              S K+DV+SFGV+  E  + G+ P
Sbjct: 173 YKFSSKSDVWSFGVLMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 59.0 bits (143), Expect = 1e-09
 Identities = 37/112 (33%), Positives = 54/112 (48%), Gaps = 18/112 (16%)

Query: 387 EKRLNIVLG-VASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF----------- 434
           E  + + +  +  AL +LH+     II+RD+K  NILLD+E +  L DF           
Sbjct: 104 ESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE 160

Query: 435 -EATIPAGTMGYLAPEYVYSGVP--SEKTDVYSFGVVALEVAAGKSPVDNDG 483
             A    GT+ Y+APE +  G     +  D +S GV+  E+  G SP   DG
Sbjct: 161 ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDG 212

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 58.9 bits (143), Expect = 2e-09
 Identities = 63/218 (28%), Positives = 89/218 (40%), Gaps = 47/218 (21%)

Query: 292 VGEGASATVYK-GSLPSGGAVAVKRFEKPNRVECARNPFTTEFAT----MAGCLRHKNLV 346
           +GEG+   V+K  +  +G  VA+K+F     VE   +P   + A     M   L+H NLV
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKF-----VESEDDPVIKKIALREIRMLKQLKHPNLV 63

Query: 347 QLQGWCCEGNELVLVYEYLPN---GSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
            L        +L LV+EY  +     L+K         I         I+     A+++ 
Sbjct: 64  NLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIK-------KIIWQTLQAVNFC 116

Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTMGYLAPEYVY 452
           H+      IHRDVK  NIL+  +   KL DF           + T    T  Y APE + 
Sbjct: 117 HKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLV 173

Query: 453 S----GVPSEKTDVYSFGVVALEVAA------GKSPVD 480
                G P    DV++ G V  E+        GKS VD
Sbjct: 174 GDTQYGPP---VDVWAIGCVFAELLTGQPLWPGKSDVD 208

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 58.1 bits (140), Expect = 3e-09
 Identities = 56/218 (25%), Positives = 102/218 (46%), Gaps = 31/218 (14%)

Query: 276 LTDIKQATLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFAT 335
           L ++ Q + G     +V EG +  + KG   +   VAVK   +   +   R  F  E + 
Sbjct: 11  LRELGQGSFG-----MVYEGNARDIIKGEAET--RVAVKTVNESASLR-ERIEFLNEASV 62

Query: 336 MAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHN------NSSSSIVLSWEKR 389
           M G   H ++V+L G   +G   ++V E + +G L   L +      N+      + ++ 
Sbjct: 63  MKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 121

Query: 390 LNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT--------IPAG 441
           + +   +A  ++YL+    ++ +HRD+ A N ++  +F  K+GDF  T           G
Sbjct: 122 IQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKG 178

Query: 442 TMG-----YLAPEYVYSGVPSEKTDVYSFGVVALEVAA 474
             G     ++APE +  GV +  +D++SFGVV  E+ +
Sbjct: 179 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 58.1 bits (140), Expect = 3e-09
 Identities = 70/287 (24%), Positives = 123/287 (42%), Gaps = 53/287 (18%)

Query: 290 RIVGEGASATVYKGSLPSGGA---VAVKRFEKPNRVECARNPFTTEFATMAGCLR---HK 343
           + +GEG   +V +G L    +   VAVK  +      C R+    +F + A C++   H 
Sbjct: 5   KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKI---AICTRSEME-DFLSEAVCMKEFDHP 60

Query: 344 NLVQLQGWCCEGNEL------VLVYEYLPNGSLDKILHNN--SSSSIVLSWEKRLNIVLG 395
           N+++L G C +  E       V++  ++ +G L   L  +        L  +  +  +  
Sbjct: 61  NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120

Query: 396 VASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-------------EATIPAGT 442
           +AS + YL     +  IHRD+ A N +L+   N  + DF             +  I    
Sbjct: 121 IASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMP 177

Query: 443 MGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSP---VDNDGCVIVDWVWNLRKKGK 498
           + ++A E +   V + K+DV+SFGV   E+A  G++P   V+N    I D+   LR+  +
Sbjct: 178 VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE--IYDY---LRQGNR 232

Query: 499 LLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK 545
           L    D           ++ +  +  SC   N + RPS +     L+
Sbjct: 233 LKQPPDC----------LDGLYSLMSSCWLLNPKDRPSFETLRCELE 269

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 58.1 bits (140), Expect = 3e-09
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 26/200 (13%)

Query: 292 VGEGASATVYKG-SLPSGGAVAVK--RFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           +GEG  ATV+KG S  +   VA+K  R E      C          ++   L+H N+V L
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCT----AIREVSLLKNLKHANIVTL 68

Query: 349 QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE 408
                    L LV+EYL +  L + L N  +   ++S       +  +   LSY H+   
Sbjct: 69  HDIIHTERCLTLVFEYLDS-DLKQYLDNCGN---LMSMHNVKIFMFQLLRGLSYCHK--- 121

Query: 409 RQIIHRDVKACNILLDAEFNAKLGDF----EATIPAG-------TMGYLAPEYVYSGVP- 456
           R+I+HRD+K  N+L++ +   KL DF      ++P         T+ Y  P+ +      
Sbjct: 122 RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEY 181

Query: 457 SEKTDVYSFGVVALEVAAGK 476
           S   D++  G +  E+A G+
Sbjct: 182 STPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 58.5 bits (142), Expect = 3e-09
 Identities = 52/164 (31%), Positives = 71/164 (43%), Gaps = 33/164 (20%)

Query: 337 AGCLRHKNLVQLQGWCCEGNELV-LVYEYLPNGSLDKILHNNSSSSIVLSWEKRLN---- 391
           A   RH  LV L   C +  + V  V EY   G L   +H +  S      E R      
Sbjct: 56  ANSERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFS------EPRAVFYAA 108

Query: 392 -IVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF------------EATI 438
            +VLG    L YLHE    +I++RD+K  N+LLD E   K+ DF             +T 
Sbjct: 109 CVVLG----LQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTF 161

Query: 439 PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDND 482
             GT  +LAPE +     +   D +  GV+  E+  G+SP   D
Sbjct: 162 -CGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGD 204

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 57.3 bits (138), Expect = 4e-09
 Identities = 52/199 (26%), Positives = 87/199 (43%), Gaps = 32/199 (16%)

Query: 291 IVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLR---HKNLVQ 347
           ++G+G    V+KG+L     VAVK  +     E        +F + A  L+   H N+V+
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCK-----EDLPQELKIKFLSEARILKQYDHPNIVK 56

Query: 348 LQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC 407
           L G C +   + +V E +P G     L         L  ++ +   L  A+ ++YL    
Sbjct: 57  LIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDE---LKTKQLVKFALDAAAGMAYLES-- 111

Query: 408 ERQIIHRDVKACNILLDAEFNAKLGDFEAT---------------IPAGTMGYLAPEYVY 452
            +  IHRD+ A N L+      K+ DF  +               IP   + + APE + 
Sbjct: 112 -KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP---IKWTAPEALN 167

Query: 453 SGVPSEKTDVYSFGVVALE 471
            G  S ++DV+S+G++  E
Sbjct: 168 YGRYSSESDVWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 57.9 bits (140), Expect = 4e-09
 Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 30/203 (14%)

Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQG 350
           +GEG  ATVYKG +  +G  VA+K     +  E   +    E + M   L+H+N+V+L  
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEI-HLDAEEGTPSTAIREISLMKE-LKHENIVRLHD 65

Query: 351 WCCEGNELVLVYEYLPNGSLDKILHNNSSS-----SIVLSWEKRLNIVLGVASALSYLHE 405
                N+L+LV+EY+ +  L K +  +        + V S+  +L         +++ HE
Sbjct: 66  VIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQL------LKGIAFCHE 118

Query: 406 ECERQIIHRDVKACNILLDAEFNAKLGDFEAT----IPAG-------TMGYLAPEYVY-S 453
               +++HRD+K  N+L++     KL DF       IP         T+ Y AP+ +  S
Sbjct: 119 N---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGS 175

Query: 454 GVPSEKTDVYSFGVVALEVAAGK 476
              S   D++S G +  E+  G+
Sbjct: 176 RTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 57.8 bits (140), Expect = 4e-09
 Identities = 56/216 (25%), Positives = 96/216 (44%), Gaps = 37/216 (17%)

Query: 291 IVGEGASATVYKGSL--PSGG---AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           ++ EG    ++ G L     G    V VK   K +  E        E   + G L H+N+
Sbjct: 13  LLQEGTFGRIFYGILIDEKPGKEEEVFVKTV-KDHASEIQVTLLLQESCLLYG-LSHQNI 70

Query: 346 VQLQGWCCEGNELVLV-YEYLPNGSLDKIL----HNNSSSSIVLSWEKRLNIVLGVASAL 400
           + +   C E  E   V Y Y+  G+L   L       +++   LS ++ +++ + +A  +
Sbjct: 71  LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGM 130

Query: 401 SYLHEECERQIIHRDVKACNILLDAEFNAK-----------------LGDFEATIPAGTM 443
           SYLH+   R +IH+D+ A N ++D E   K                 LGD E       +
Sbjct: 131 SYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENR----PV 183

Query: 444 GYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSP 478
            ++A E + +   S  +DV+SFGV+  E+   G++P
Sbjct: 184 KWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 58.1 bits (140), Expect = 4e-09
 Identities = 60/204 (29%), Positives = 85/204 (41%), Gaps = 20/204 (9%)

Query: 290 RIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNP--FTTEFATMAGCLRHKNLVQ 347
           R++G G+ A V    L     +   +  K   V    +     TE         H  LV 
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60

Query: 348 LQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC 407
           L       + L  V EY+  G L  + H        L  E        ++ AL+YLHE  
Sbjct: 61  LHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRK--LPEEHARFYSAEISLALNYLHE-- 114

Query: 408 ERQIIHRDVKACNILLDAEFNAKLGDF----EATIPA-------GTMGYLAPEYVYSGVP 456
            R II+RD+K  N+LLD+E + KL D+    E   P        GT  Y+APE +     
Sbjct: 115 -RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY 173

Query: 457 SEKTDVYSFGVVALEVAAGKSPVD 480
               D ++ GV+  E+ AG+SP D
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 57.7 bits (139), Expect = 4e-09
 Identities = 58/233 (24%), Positives = 96/233 (41%), Gaps = 36/233 (15%)

Query: 275 ALTDIKQATLG-----FNKNRIVGEGASATVYKGS-LPSGGAVAVKRFEKPNRVECARNP 328
           +L DI  + L      F    +VG G    VYKG  + +G   A+K     +  E     
Sbjct: 2   SLDDIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVM---DVTEDEEEE 58

Query: 329 FTTEFATMAGCLRHKNLVQLQGWCCE------GNELVLVYEYLPNGSLDKILHNNSSSSI 382
              E   +     H+N+    G   +       ++L LV E+   GS+  ++ N   +++
Sbjct: 59  IKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNAL 118

Query: 383 VLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP--- 439
              W     I   +   L++LH     ++IHRD+K  N+LL      KL DF  +     
Sbjct: 119 KEDWIAY--ICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 173

Query: 440 --------AGTMGYLAPEYVYSGVPSEKT-----DVYSFGVVALEVAAGKSPV 479
                    GT  ++APE +      + T     D++S G+ A+E+A G  P+
Sbjct: 174 TVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 58.7 bits (142), Expect = 5e-09
 Identities = 57/218 (26%), Positives = 98/218 (44%), Gaps = 34/218 (15%)

Query: 289 NRIVGEGASATV-YKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGC-----LR- 341
           +R++G GA+ TV     +  G   AVK  +     E  +N    E   +  C     ++ 
Sbjct: 37  SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKC 96

Query: 342 HKNLVQLQGWCCEGNE-----LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGV 396
           H++  +        N      + LV +Y   G L + + + + ++      +   + + V
Sbjct: 97  HEDFAKKD----PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQV 152

Query: 397 ASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF------EATIP-------AGTM 443
             A+ ++H    + +IHRD+K+ NILL +    KLGDF       AT+         GT 
Sbjct: 153 LLAVHHVHS---KHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTP 209

Query: 444 GYLAPEYVYSGVP-SEKTDVYSFGVVALEVAAGKSPVD 480
            Y+APE ++   P S+K D++S GV+  E+   K P D
Sbjct: 210 YYVAPE-IWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246

Length = 496

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 57.4 bits (139), Expect = 5e-09
 Identities = 71/289 (24%), Positives = 118/289 (40%), Gaps = 63/289 (21%)

Query: 291 IVGEGASATVYK-GSLPSGGAVAVKRFEKPNRVECARNPFTTEFAT----MAGCLRHKNL 345
           +VGEG+   V K     +G  VA+K+F     +E   +    + A     M   LRH+NL
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKF-----LESEDDKMVKKIAMREIRMLKQLRHENL 62

Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
           V L         L LV+E++ +  LD +    +     L   +    +  +   + + H 
Sbjct: 63  VNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG----LDESRVRKYLFQILRGIEFCHS 118

Query: 406 ECERQIIHRDVKACNILLDAEFNAKLGD--FEATIPAG---------TMGYLAPEYVYSG 454
                IIHRD+K  NIL+      KL D  F  T+ A          T  Y APE +   
Sbjct: 119 H---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGD 175

Query: 455 VPSEK-TDVYSFGVVALEVAAGKS--PVDNDGCVIVDWVWNLRKK-GKLLDAADFRLRGK 510
               +  D+++ G +  E+  G+   P D+D    +D ++++ K  G L+     R +  
Sbjct: 176 TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD----IDQLYHIIKCLGNLIP----RHQEI 227

Query: 511 FNR------------KEMERM---------LMVGL--SCVHPNHEKRPS 536
           F +            KE+E +         L++ L   C+  + + RPS
Sbjct: 228 FQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPS 276

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 57.5 bits (139), Expect = 5e-09
 Identities = 30/93 (32%), Positives = 47/93 (50%), Gaps = 13/93 (13%)

Query: 396 VASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF----------EATIPAGTMGY 445
           +   L +LH+   R+I++RD+K  N+LLD   N ++ D           +    AGT GY
Sbjct: 104 IICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGY 160

Query: 446 LAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSP 478
           +APE +   V     D ++ G    E+ AG+SP
Sbjct: 161 MAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 57.1 bits (138), Expect = 5e-09
 Identities = 51/137 (37%), Positives = 63/137 (45%), Gaps = 26/137 (18%)

Query: 355 GNELVLVYEYLPNG---SLDKILHNNSSSSIVLSWEKRL--NIVLGVASALSYLHEECER 409
            + L LV EYL  G   SL K L       +   W K+    +VLGV      LH+   R
Sbjct: 69  KDYLYLVMEYLNGGDCASLIKTL-----GGLPEDWAKQYIAEVVLGV----EDLHQ---R 116

Query: 410 QIIHRDVKACNILLDAEFNAKLGDF-------EATIPAGTMGYLAPEYVYSGVPSEK-TD 461
            IIHRD+K  N+L+D   + KL DF       E     GT  YLAPE    GV  +K +D
Sbjct: 117 GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPDYLAPE-TILGVGDDKMSD 175

Query: 462 VYSFGVVALEVAAGKSP 478
            +S G V  E   G  P
Sbjct: 176 WWSLGCVIFEFLFGYPP 192

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 57.2 bits (138), Expect = 6e-09
 Identities = 62/212 (29%), Positives = 94/212 (44%), Gaps = 36/212 (16%)

Query: 290 RIVGEGASATVYKGSLPSGGAV-AVKRFEK-----PNRVECARNPFTTEFATMAGCLRHK 343
           R++G+G+   V    L   G + AVK  +K      + VEC      TE   ++    H 
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECT----MTEKRILSLARNHP 56

Query: 344 NLVQLQGWCC--EGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLG-VASAL 400
            L QL  +CC    + L  V E++  G L  + H   S       E R       + SAL
Sbjct: 57  FLTQL--YCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFD---EARARFYAAEITSAL 109

Query: 401 SYLHEECERQIIHRDVKACNILLDAEFNAKLGDF------------EATIPAGTMGYLAP 448
            +LH+   + II+RD+K  N+LLD E + KL DF             +T   GT  Y+AP
Sbjct: 110 MFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTF-CGTPDYIAP 165

Query: 449 EYVYSGVPSEKTDVYSFGVVALEVAAGKSPVD 480
           E +   +     D ++ GV+  E+  G +P +
Sbjct: 166 EILQEMLYGPSVDWWAMGVLLYEMLCGHAPFE 197

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 57.1 bits (138), Expect = 7e-09
 Identities = 56/191 (29%), Positives = 85/191 (44%), Gaps = 31/191 (16%)

Query: 358 LVLVYEYLPNGSLDKILHNNSSSSIVLSWEK--RLNIVLGVASALSYLHEECERQIIHRD 415
           L  V EYL  G L  + H  SS     +  +     I+ G    L +LH+   + II+RD
Sbjct: 71  LFFVMEYLNGGDL--MFHIQSSGRFDEARARFYAAEIICG----LQFLHK---KGIIYRD 121

Query: 416 VKACNILLDAEFNAKLGDF-----------EATIPAGTMGYLAPEYVYSGVPSEKTDVYS 464
           +K  N+LLD + + K+ DF           +A+   GT  Y+APE +     +E  D +S
Sbjct: 122 LKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWS 181

Query: 465 FGVVALEVAAGKSPVDNDG------CVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMER 518
           FGV+  E+  G+SP   +        ++ D     R   K  +A D  L   F R   +R
Sbjct: 182 FGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISK--EAKDC-LSKLFERDPTKR 238

Query: 519 MLMVGLSCVHP 529
           + + G    HP
Sbjct: 239 LGVDGDIRQHP 249

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 56.8 bits (137), Expect = 8e-09
 Identities = 59/230 (25%), Positives = 95/230 (41%), Gaps = 39/230 (16%)

Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLG--VA 397
           L H N++Q  G C E    +LV E+ P G L   L +N      ++ +K +   +   VA
Sbjct: 52  LNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMA-QKDVLQRMACEVA 110

Query: 398 SALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-------------EATIPAGTMG 444
           S L +LH+      IH D+   N  L A+ + K+GD+                  A  + 
Sbjct: 111 SGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR 167

Query: 445 YLAPEYVYS-------GVPSEKTDVYSFGVVALEVA-AGKSPVDN--DGCVIVDWVWNLR 494
           +LAPE V            ++K++++S GV   E+  A   P  +  D  V+   V   R
Sbjct: 168 WLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVV---R 224

Query: 495 KKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARIL 544
           ++   L      L  K++ +  E M    L       E RP+ +E   +L
Sbjct: 225 EQDIKLPKPQLDL--KYSDRWYEVMQFCWLD-----PETRPTAEEVHELL 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 57.1 bits (138), Expect = 8e-09
 Identities = 37/93 (39%), Positives = 51/93 (54%), Gaps = 14/93 (15%)

Query: 399 ALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF----EATIPA-------GTMGYLA 447
           AL++LHE   R II+RD+K  N+LLDAE + KL D+    E   P        GT  Y+A
Sbjct: 108 ALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIA 164

Query: 448 PEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVD 480
           PE +         D ++ GV+  E+ AG+SP D
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 56.6 bits (136), Expect = 9e-09
 Identities = 57/212 (26%), Positives = 90/212 (42%), Gaps = 36/212 (16%)

Query: 292 VGEGASATVYKGSLPSGGA-----VAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLV 346
           +GE A   +YKG L   G      VA+K  +  N  +     F  E + MA  L H N+V
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQ-QWGEFQQEASLMAE-LHHPNIV 70

Query: 347 QLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIV-------------LSWEKRLNIV 393
            L G   +   + +++EYL  G L + L   S  S V             L     L+I 
Sbjct: 71  CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130

Query: 394 LGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGTMGY-------- 445
           + +A+ + YL        +H+D+ A NIL+  + + K+ D   +    +  Y        
Sbjct: 131 IQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187

Query: 446 -----LAPEYVYSGVPSEKTDVYSFGVVALEV 472
                + PE +  G  S  +D++SFGVV  E+
Sbjct: 188 LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 56.8 bits (137), Expect = 1e-08
 Identities = 47/186 (25%), Positives = 81/186 (43%), Gaps = 33/186 (17%)

Query: 311 VAVKRF-EKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGS 369
           VAVK   E  N+   ARN F  E   M+  L+  N+++L   C   + L ++ EY+ NG 
Sbjct: 49  VAVKMLREDANK--NARNDFLKEIKIMSR-LKDPNIIRLLAVCITSDPLCMITEYMENGD 105

Query: 370 LDKILHNN-------SSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNIL 422
           L++ L  +        +  + +S+   + +   +AS + YL        +HRD+   N L
Sbjct: 106 LNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCL 162

Query: 423 LDAEFNAKLGDF----------------EATIPAGTMGYLAPEYVYSGVPSEKTDVYSFG 466
           +   +  K+ DF                 A +P   M +   E +  G  +  +DV++FG
Sbjct: 163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSW---ESILLGKFTTASDVWAFG 219

Query: 467 VVALEV 472
           V   E+
Sbjct: 220 VTLWEI 225

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 56.5 bits (136), Expect = 1e-08
 Identities = 53/200 (26%), Positives = 91/200 (45%), Gaps = 26/200 (13%)

Query: 292 VGEGASATVYKG-SLPSGGAVAVK--RFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           +GEG  ATV+KG S  +   VA+K  R E      C          ++   L+H N+V L
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCT----AIREVSLLKDLKHANIVTL 69

Query: 349 QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE 408
                    L LV+EYL +  L + + +  +   ++S       +  +   L+Y H    
Sbjct: 70  HDIVHTDKSLTLVFEYL-DKDLKQYMDDCGN---IMSMHNVKIFLYQILRGLAYCHR--- 122

Query: 409 RQIIHRDVKACNILLDAEFNAKLGDF----EATIPAG-------TMGYLAPEYVY-SGVP 456
           R+++HRD+K  N+L++     KL DF      ++P         T+ Y  P+ +  S   
Sbjct: 123 RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEY 182

Query: 457 SEKTDVYSFGVVALEVAAGK 476
           S + D++  G +  E+A+G+
Sbjct: 183 STQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 56.5 bits (136), Expect = 1e-08
 Identities = 58/217 (26%), Positives = 102/217 (47%), Gaps = 34/217 (15%)

Query: 286 FNKNRIVGEGASATVYKGS-LPSGG----AVAVKRFEKPNRVECARNPFTTEFATMAGCL 340
           F K +++G GA  TVYKG  +P G      VA+K   +    + A      E   MA  +
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-ANKEILDEAYVMAS-V 66

Query: 341 RHKNLVQLQGWCCEGNELVLVYEYLPNGSL-DKILHN--NSSSSIVLSWEKRLNIVLGVA 397
            + ++ +L G C   + + L+ + +P G L D +  +  N  S  +L+W       + +A
Sbjct: 67  DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 119

Query: 398 SALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGT--MG 444
             ++YL E   R+++HRD+ A N+L+    + K+ DF           E     G   + 
Sbjct: 120 KGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIK 176

Query: 445 YLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVD 480
           ++A E +   + + ++DV+S+GV   E+   G  P D
Sbjct: 177 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 58/201 (28%), Positives = 89/201 (44%), Gaps = 25/201 (12%)

Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G+G    V+ G+      VA+K   KP  +      F  E   M   LRH  LV L   
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTL-KPGTM--MPEAFLQEAQIMKK-LRHDKLVPLYAV 69

Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECER-Q 410
             E   + +V E++  GSL   L       + L   + +++   +A  ++Y+    ER  
Sbjct: 70  VSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLP--QLVDMAAQIADGMAYI----ERMN 122

Query: 411 IIHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVPSE 458
            IHRD++A NIL+      K+ DF         E T   G    + + APE    G  + 
Sbjct: 123 YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 182

Query: 459 KTDVYSFGVVALE-VAAGKSP 478
           K+DV+SFG++  E V  G+ P
Sbjct: 183 KSDVWSFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 56/206 (27%), Positives = 88/206 (42%), Gaps = 31/206 (15%)

Query: 292 VGEGASATVYKGSLPSGG---AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           +G G    VYK    + G   A+ V + E        +     E   M  C +H N+V  
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQ----EIIMMKDC-KHSNIVAY 71

Query: 349 QGWCCEGNELVLVYEYLPNGSLDKILH-NNSSSSIVLSWEKRLNIVLGVASALSYLHEEC 407
            G     ++L +  E+   GSL  I H     S   +++  R  +       L YLH + 
Sbjct: 72  FGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLHSKG 126

Query: 408 ERQIIHRDVKACNILLDAEFNAKLGDF--EATIPA---------GTMGYLAPEYV---YS 453
           +   +HRD+K  NILL    + KL DF   A I A         GT  ++APE       
Sbjct: 127 K---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERK 183

Query: 454 GVPSEKTDVYSFGVVALEVAAGKSPV 479
           G  ++  D+++ G+ A+E+A  + P+
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQPPM 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 55.6 bits (135), Expect = 2e-08
 Identities = 47/209 (22%), Positives = 87/209 (41%), Gaps = 43/209 (20%)

Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLR--------- 341
           +G+G   +VY   +  +G  VA+K+ +K              F +   C+          
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMKKK-------------FYSWEECMNLREVKSLRK 53

Query: 342 ---HKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVAS 398
              H N+V+L+    E +EL  V+EY+  G+L +++ +        S     +I+  +  
Sbjct: 54  LNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKG--KPFSESVIRSIIYQILQ 110

Query: 399 ALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF------EATIP----AGTMGYLAP 448
            L+++H+       HRD+K  N+L+      K+ DF       +  P      T  Y AP
Sbjct: 111 GLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAP 167

Query: 449 EYV-YSGVPSEKTDVYSFGVVALEVAAGK 476
           E +  S   S   D+++ G +  E+   +
Sbjct: 168 EILLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 46/136 (33%), Positives = 65/136 (47%), Gaps = 18/136 (13%)

Query: 356 NELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRD 415
           + L LV EY+  G L  + H        L  E        +  AL++LHE   R II+RD
Sbjct: 69  SRLFLVIEYVNGGDL--MFHMQRQRK--LPEEHARFYAAEICIALNFLHE---RGIIYRD 121

Query: 416 VKACNILLDAEFNAKLGDF----EATIPA-------GTMGYLAPEYVYSGVPSEKTDVYS 464
           +K  N+LLDA+ + KL D+    E   P        GT  Y+APE +         D ++
Sbjct: 122 LKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWA 181

Query: 465 FGVVALEVAAGKSPVD 480
            GV+  E+ AG+SP D
Sbjct: 182 LGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 43/154 (27%), Positives = 69/154 (44%), Gaps = 20/154 (12%)

Query: 342 HKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALS 401
           H N+V+L G C +   + +V E +  G     L         L  ++ + +V   A+ + 
Sbjct: 52  HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPR---LKVKELIQMVENAAAGME 108

Query: 402 YLHEECERQIIHRDVKACNILLDAEFNAKLGDF------EATIPAGTMG-------YLAP 448
           YL  +     IHRD+ A N L+  +   K+ DF      E  + A T G       + AP
Sbjct: 109 YLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAP 165

Query: 449 EYVYSGVPSEKTDVYSFGVVALEV-AAGKSPVDN 481
           E +  G  S ++DV+SFG++  E  + G  P  N
Sbjct: 166 EALNYGRYSSESDVWSFGILLWEAFSLGAVPYAN 199

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 54.6 bits (131), Expect = 4e-08
 Identities = 48/156 (30%), Positives = 74/156 (47%), Gaps = 21/156 (13%)

Query: 332 EFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLN 391
           E A+M   + HK++V L G C    E ++V E++  G LD  +H  S    VL+   +  
Sbjct: 53  ETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSD---VLTTPWKFK 109

Query: 392 IVLGVASALSYLHEECERQIIHRDVKACNILLDAE-FNAKLGDF----EATIPAGTMG-- 444
           +   +ASALSYL    ++ ++H +V   NILL  E  + + G F    +  IP   +   
Sbjct: 110 VAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQ 166

Query: 445 -------YLAPEYVY-SGVPSEKTDVYSFGVVALEV 472
                  ++APE V  S   S   D +SFG    E+
Sbjct: 167 ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 54.5 bits (131), Expect = 6e-08
 Identities = 35/98 (35%), Positives = 48/98 (48%), Gaps = 14/98 (14%)

Query: 396 VASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTMG 444
           V  AL +LH      +I+RD+K  NILLDAE + KL DF             T   GT  
Sbjct: 105 VTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPD 161

Query: 445 YLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDND 482
           Y+APE +         D ++ GV+  E+ AG+ P + D
Sbjct: 162 YIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEAD 199

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 54.5 bits (131), Expect = 7e-08
 Identities = 49/183 (26%), Positives = 80/183 (43%), Gaps = 44/183 (24%)

Query: 384 LSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--------- 434
           L+ E  ++    VA  + +L     R+ IHRD+ A NILL      K+ DF         
Sbjct: 170 LTLEDLISYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD 226

Query: 435 -------EATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEV-AAGKSP-----VDN 481
                  +A +P   + ++APE ++  V + ++DV+SFGV+  E+ + G SP     +D 
Sbjct: 227 PDYVRKGDARLP---LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE 283

Query: 482 DGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAA 541
           + C          K+G  + A ++             +  + L C H N E RP+  E  
Sbjct: 284 EFC-------RRLKEGTRMRAPEY---------ATPEIYSIMLDCWHNNPEDRPTFSELV 327

Query: 542 RIL 544
            IL
Sbjct: 328 EIL 330

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 54.0 bits (130), Expect = 8e-08
 Identities = 33/96 (34%), Positives = 50/96 (52%), Gaps = 14/96 (14%)

Query: 396 VASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF----EATIP-------AGTMG 444
           +A  L +LH    + II+RD+K  N++LDAE + K+ DF    E            GT  
Sbjct: 110 IAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPD 166

Query: 445 YLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVD 480
           Y+APE +      +  D ++FGV+  E+ AG+ P D
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 55.2 bits (133), Expect = 8e-08
 Identities = 54/217 (24%), Positives = 87/217 (40%), Gaps = 42/217 (19%)

Query: 290 RIVGEGASATVYKGSLPS-GGAVAVKRF-EKPNRVECARNPFTTEFATMAGCLRHKNLVQ 347
           R++G+G    VY    P     VA+K+  E  +     +  F  E A +A  L H  +V 
Sbjct: 8   RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLRE-AKIAADLIHPGIVP 66

Query: 348 LQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC 407
           +   C +G+ +     Y+   +L  +L +      +    K L     V + LS  H+ C
Sbjct: 67  VYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESL---SKELAEKTSVGAFLSIFHKIC 123

Query: 408 E-------RQIIHRDVKACNILL-------------------------DAEFNAKLGDF- 434
                   + ++HRD+K  NILL                         D + + +   + 
Sbjct: 124 ATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183

Query: 435 EATIPA---GTMGYLAPEYVYSGVPSEKTDVYSFGVV 468
             TIP    GT  Y+APE +     SE TD+Y+ GV+
Sbjct: 184 SMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVI 220

Length = 932

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 53.7 bits (130), Expect = 8e-08
 Identities = 32/93 (34%), Positives = 46/93 (49%), Gaps = 15/93 (16%)

Query: 396 VASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGTMGYL 446
           V  AL YLH      I++RD+K  N+LLD++   K+ DF           T+  GT  YL
Sbjct: 110 VVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTL-CGTPEYL 165

Query: 447 APEYVYSGVPSEKT-DVYSFGVVALEVAAGKSP 478
           APE +       K  D ++ G++  E+ AG  P
Sbjct: 166 APE-IILSKGYGKAVDWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 53.4 bits (128), Expect = 9e-08
 Identities = 47/161 (29%), Positives = 76/161 (47%), Gaps = 31/161 (19%)

Query: 332 EFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLN 391
           E A++   + H +L  + G C  G+E ++V E++ +G LD  L       + ++W  ++ 
Sbjct: 65  ETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAW--KIT 121

Query: 392 IVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP------------ 439
           +   +ASALSYL    ++ ++H +V A NILL     A+LG  E T P            
Sbjct: 122 VAQQLASALSYLE---DKNLVHGNVCAKNILL-----ARLGLAEGTSPFIKLSDPGVSFT 173

Query: 440 -------AGTMGYLAPEYVYSGVP-SEKTDVYSFGVVALEV 472
                     + ++APE V  G   S   D +SFG   LE+
Sbjct: 174 ALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 53.4 bits (129), Expect = 9e-08
 Identities = 33/98 (33%), Positives = 45/98 (45%), Gaps = 15/98 (15%)

Query: 396 VASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEA-----------TIPAGTMG 444
           V  A  YLH    R II+RD+K  N+LLD+    KL DF             T   GT  
Sbjct: 102 VVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTF-CGTPE 157

Query: 445 YLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDND 482
           Y+APE + +       D +S G++  E+  G+ P   D
Sbjct: 158 YVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGED 195

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 56/200 (28%), Positives = 91/200 (45%), Gaps = 26/200 (13%)

Query: 292 VGEGASATVYKG-SLPSGGAVAVK--RFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           +GEG  ATVYKG S  +   VA+K  R E      C          ++   L+H N+V L
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCT----AIREVSLLKDLKHANIVTL 69

Query: 349 QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE 408
                    L LV+EYL +  L + L ++  +SI +   K    +  +   L+Y H    
Sbjct: 70  HDIIHTEKSLTLVFEYL-DKDLKQYL-DDCGNSINMHNVKLF--LFQLLRGLNYCHR--- 122

Query: 409 RQIIHRDVKACNILLDAEFNAKLGDF----EATIPAG-------TMGYLAPEYVYSGVP- 456
           R+++HRD+K  N+L++     KL DF      +IP         T+ Y  P+ +      
Sbjct: 123 RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDY 182

Query: 457 SEKTDVYSFGVVALEVAAGK 476
           S + D++  G +  E++ G+
Sbjct: 183 STQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 59/206 (28%), Positives = 92/206 (44%), Gaps = 31/206 (15%)

Query: 292 VGEGASATVYKG-SLPSGGAVAVK--RFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           VG G    VYK  +L +G   AVK  + E  +     +     E   +  C +H N+V  
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQ----EIFMVKEC-KHCNIVAY 71

Query: 349 QGWCCEGNELVLVYEYLPNGSLDKILH-NNSSSSIVLSWEKRLNIVLGVASALSYLHEEC 407
            G      +L +  EY   GSL  I H     S + +++  R  +       L+YLH   
Sbjct: 72  FGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLHS-- 124

Query: 408 ERQIIHRDVKACNILLDAEFNAKLGDF------EATIPA-----GTMGYLAPEYVY---S 453
            +  +HRD+K  NILL    + KL DF       ATI       GT  ++APE      +
Sbjct: 125 -KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKN 183

Query: 454 GVPSEKTDVYSFGVVALEVAAGKSPV 479
           G  ++  D+++ G+ A+E+A  + P+
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQPPM 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 53.3 bits (128), Expect = 1e-07
 Identities = 43/159 (27%), Positives = 70/159 (44%), Gaps = 30/159 (18%)

Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLG---VASALS 401
           + QLQ    + + L LV EY P G L  +L+          +E + +  +    +A  + 
Sbjct: 63  IPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNR---------YEDQFDEDMAQFYLAELVL 113

Query: 402 YLHEECERQIIHRDVKACNILLDAEFNAKLGDF------------EATIPAGTMGYLAPE 449
            +H   +   +HRD+K  N+L+D   + KL DF             + +P GT  Y+APE
Sbjct: 114 AIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPE 173

Query: 450 YVYSGVPSEKT------DVYSFGVVALEVAAGKSPVDND 482
            + +     K       D +S GV+A E+  G+SP    
Sbjct: 174 VLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG 212

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 47/152 (30%), Positives = 67/152 (44%), Gaps = 17/152 (11%)

Query: 341 RHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASAL 400
           RH  L  L+      + L  V EY   G L    H   S   V S ++       + SAL
Sbjct: 53  RHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFH--LSRERVFSEDRARFYGAEIVSAL 108

Query: 401 SYLHEECERQIIHRDVKACNILLDAEFNAKLGDF---------EATIPA--GTMGYLAPE 449
            YLH E  + +++RD+K  N++LD + + K+ DF          AT+    GT  YLAPE
Sbjct: 109 DYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPE 166

Query: 450 YVYSGVPSEKTDVYSFGVVALEVAAGKSPVDN 481
            +         D +  GVV  E+  G+ P  N
Sbjct: 167 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 198

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 53.3 bits (128), Expect = 2e-07
 Identities = 35/94 (37%), Positives = 49/94 (52%), Gaps = 14/94 (14%)

Query: 396 VASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA-----------GTMG 444
           +A AL +LH      II+RD+K  NILLD E + KL DF  +  +           GT+ 
Sbjct: 107 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVE 163

Query: 445 YLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSP 478
           Y+APE V     ++  D +SFGV+  E+  G  P
Sbjct: 164 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 53.0 bits (127), Expect = 2e-07
 Identities = 56/208 (26%), Positives = 86/208 (41%), Gaps = 32/208 (15%)

Query: 290 RIVGEGASATVYKGSLP-SGGAVAVKRFEKP-----NRVECARNPFTTEFATMAGCLRHK 343
           +++G+G+   V+   L  +    A+K  +K      + VEC       E   ++    H 
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECT----MVEKRVLSLAWEHP 56

Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEK--RLNIVLGVASALS 401
            L  L         L  V EYL  G L  + H  S     L         I+ G    L 
Sbjct: 57  FLTHLYCTFQTKENLFFVMEYLNGGDL--MFHIQSCHKFDLPRATFYAAEIICG----LQ 110

Query: 402 YLHEECERQIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTMGYLAPEY 450
           +LH    + I++RD+K  NILLD + + K+ DF           +     GT  Y+APE 
Sbjct: 111 FLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEI 167

Query: 451 VYSGVPSEKTDVYSFGVVALEVAAGKSP 478
           +     +   D +SFGV+  E+  G+SP
Sbjct: 168 LLGQKYNTSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 45/161 (27%), Positives = 72/161 (44%), Gaps = 26/161 (16%)

Query: 334 ATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSL-DKILHNNS---SSSIVLSWEKR 389
           A +   ++H N+V  +        L +V EY   G L  KI            +L W   
Sbjct: 49  AVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW--F 106

Query: 390 LNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFE-----------ATI 438
           + + LGV     ++HE   ++++HRD+K+ NI L      KLGDF            A  
Sbjct: 107 VQMCLGV----QHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT 159

Query: 439 PAGTMGYLAPEYVYSGVP-SEKTDVYSFGVVALEVAAGKSP 478
             GT  Y+ PE ++  +P + K+D++S G +  E+   K P
Sbjct: 160 YVGTPYYVPPE-IWENMPYNNKSDIWSLGCILYELCTLKHP 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 52.4 bits (126), Expect = 2e-07
 Identities = 49/159 (30%), Positives = 69/159 (43%), Gaps = 42/159 (26%)

Query: 293 GEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTT--EFATMAGCLRHKNLVQLQ 349
           GEG+ ATVYKG S  +G  VA+K   +    E A  PFT   E + +   L+H N+V L 
Sbjct: 14  GEGSYATVYKGRSKLTGQLVALKEI-RLEHEEGA--PFTAIREASLLKD-LKHANIVTLH 69

Query: 350 GWCCEGNELVLVYEYL-----------PNGSLDKILHNNSSSSIVLSWEKRLNIVL---G 395
                   L LV+EYL             G     L  +             N+ L    
Sbjct: 70  DIIHTKKTLTLVFEYLDTDLKQYMDDCGGG-----LSMH-------------NVRLFLFQ 111

Query: 396 VASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF 434
           +   L+Y H   +R+++HRD+K  N+L+      KL DF
Sbjct: 112 LLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADF 147

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 51.9 bits (124), Expect = 3e-07
 Identities = 45/154 (29%), Positives = 69/154 (44%), Gaps = 27/154 (17%)

Query: 340 LRHKNLVQL-QGWCCEGNELVLVYEYLPNGSLDKILHNNSS----SSIVLSWEKRLNIVL 394
           L+H N+V   + W  E   L +V  +   G L   L          + V+ W       +
Sbjct: 56  LKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEW------FV 109

Query: 395 GVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTM 443
            +A AL YLHE+    I+HRD+K  N+ L      K+GD             A+   GT 
Sbjct: 110 QIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTP 166

Query: 444 GYLAPEYVYSGVP-SEKTDVYSFGVVALEVAAGK 476
            Y++PE ++S  P + K+DV++ G    E+A  K
Sbjct: 167 YYMSPE-LFSNKPYNYKSDVWALGCCVYEMATLK 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 51.9 bits (124), Expect = 3e-07
 Identities = 38/141 (26%), Positives = 65/141 (46%), Gaps = 21/141 (14%)

Query: 353 CEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQII 412
           CE   L+LV E    G L+K L   S     ++    + ++  V+  + YL     +  +
Sbjct: 64  CEAEALMLVMEMASGGPLNKFL---SGKKDEITVSNVVELMHQVSMGMKYLEG---KNFV 117

Query: 413 HRDVKACNILLDAEFNAKLGDF---------EATIPAGTMG-----YLAPEYVYSGVPSE 458
           HRD+ A N+LL  +  AK+ DF         ++   A + G     + APE +     S 
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSS 177

Query: 459 KTDVYSFGVVALEV-AAGKSP 478
           ++DV+S+G+   E  + G+ P
Sbjct: 178 RSDVWSYGITMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 52.3 bits (125), Expect = 3e-07
 Identities = 47/152 (30%), Positives = 66/152 (43%), Gaps = 18/152 (11%)

Query: 341 RHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASAL 400
           RH  L  L+      + L  V EY   G L    H   S   V + E+       + SAL
Sbjct: 53  RHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFH--LSRERVFTEERARFYGAEIVSAL 108

Query: 401 SYLHEECERQIIHRDVKACNILLDAEFNAKLGDF---------EATIPA--GTMGYLAPE 449
            YLH    R +++RD+K  N++LD + + K+ DF          AT+    GT  YLAPE
Sbjct: 109 EYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 165

Query: 450 YVYSGVPSEKTDVYSFGVVALEVAAGKSPVDN 481
            +         D +  GVV  E+  G+ P  N
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 52.2 bits (125), Expect = 3e-07
 Identities = 44/161 (27%), Positives = 70/161 (43%), Gaps = 21/161 (13%)

Query: 334 ATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLP--NGSLDKILHNNSSSSIVLSWEKRLN 391
           A +   + H ++++++     G    +V   LP  +  L   L   S     L  ++ L 
Sbjct: 108 AMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRP---LPIDQALI 161

Query: 392 IVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-EATIP---------AG 441
           I   +   L YLH +   +IIHRDVK  NI ++      +GD   A  P         AG
Sbjct: 162 IEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAG 218

Query: 442 TMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDND 482
           T+   APE +     + K D++S G+V  E+ A  S +  D
Sbjct: 219 TVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFED 259

Length = 357

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 51.9 bits (124), Expect = 3e-07
 Identities = 29/96 (30%), Positives = 46/96 (47%), Gaps = 13/96 (13%)

Query: 396 VASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF----------EATIPAGTMGY 445
           +   + +LH      I++RD+K  N+LLD + N +L D             T  AGT GY
Sbjct: 104 ITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGY 160

Query: 446 LAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDN 481
           +APE +     S   D ++ G    E+ AG++P  +
Sbjct: 161 MAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKD 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 51.7 bits (124), Expect = 4e-07
 Identities = 33/92 (35%), Positives = 47/92 (51%), Gaps = 11/92 (11%)

Query: 399 ALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-------EATIP-AGTMGYLAPEY 450
           A  YLH    + II+RD+K  N+LLD + + K+ DF       + T    GT  YLAPE 
Sbjct: 130 AFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLCGTPEYLAPEV 186

Query: 451 VYSGVPSEKTDVYSFGVVALEVAAGKSPVDND 482
           + S    +  D ++ GV+  E  AG  P  +D
Sbjct: 187 IQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD 218

Length = 329

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 51.6 bits (123), Expect = 4e-07
 Identities = 59/209 (28%), Positives = 93/209 (44%), Gaps = 34/209 (16%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVK--RFEKPNRVECARNPFTT-EFATMAGCLR 341
           + K   +GEG+ ATVYKG S  +G  VA+K  R +     E    PFT    A++   L+
Sbjct: 7   YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQ-----EEEGTPFTAIREASLLKGLK 61

Query: 342 HKNLVQLQGWCCEGNELVLVYEYLPNG---SLDKILHNNSSSSIVLSWEKRLNIVLGVAS 398
           H N+V L         L LV+EY+       +DK        ++ L        +  +  
Sbjct: 62  HANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKL-------FLFQLLR 114

Query: 399 ALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF----EATIPAG-------TMGYLA 447
            LSY+H+   R I+HRD+K  N+L+      KL DF      ++P+        T+ Y  
Sbjct: 115 GLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRP 171

Query: 448 PEYVYSGVP-SEKTDVYSFGVVALEVAAG 475
           P+ +      S   D++  G + +E+  G
Sbjct: 172 PDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 51.1 bits (122), Expect = 6e-07
 Identities = 56/204 (27%), Positives = 89/204 (43%), Gaps = 29/204 (14%)

Query: 292 VGEGASATVYKG-SLPSGGAVAVK--RFEKPNRVECARNPFTT-EFATMAGCLRHKNLVQ 347
           +GEG+ ATVYKG S  +G  VA+K    +    V     PFT    A++   L+H N+V 
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVISMKTEEGV-----PFTAIREASLLKGLKHANIVL 67

Query: 348 LQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC 407
           L         L  V+EY+     D   +       +  +  RL  +  +   L+Y+H   
Sbjct: 68  LHDIIHTKETLTFVFEYM---HTDLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAYIHG-- 121

Query: 408 ERQIIHRDVKACNILLDAEFNAKLGDF----EATIPAG-------TMGYLAPEYVYSGVP 456
            + I+HRD+K  N+L+      KL DF      +IP+        T+ Y  P+ +     
Sbjct: 122 -QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATD 180

Query: 457 -SEKTDVYSFGVVALEVAAGKSPV 479
            S   D++  G + +E+  G  P 
Sbjct: 181 YSSALDIWGAGCIFIEMLQG-QPA 203

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 50.8 bits (121), Expect = 6e-07
 Identities = 73/274 (26%), Positives = 117/274 (42%), Gaps = 46/274 (16%)

Query: 288 KNRIVGEGASATVYKGS-LPSGG----AVAVKRFEKPNRVECARNPFTTEFATMAGCLRH 342
           K +++G GA  TVYKG  +P G      VA+K   + N    A      E   MAG +  
Sbjct: 11  KVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVL-RENTSPKANKEILDEAYVMAG-VGS 68

Query: 343 KNLVQLQGWCCEGNELVLVYEYLPNGSL-DKILHNNS--SSSIVLSWEKRLNIVLGVASA 399
             + +L G C   + + LV + +P G L D +  N     S  +L+W       + +A  
Sbjct: 69  PYVCRLLGICLT-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAKG 121

Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGT--MGYL 446
           +SYL E    +++HRD+ A N+L+ +  + K+ DF           E     G   + ++
Sbjct: 122 MSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWM 178

Query: 447 APEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADF 505
           A E +     + ++DV+S+GV   E+   G  P D             R+   LL+  + 
Sbjct: 179 ALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG---------IPAREIPDLLEKGE- 228

Query: 506 RLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKE 539
           RL           M+MV   C   + E RP  +E
Sbjct: 229 RLPQPPICTIDVYMIMV--KCWMIDSECRPRFRE 260

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 51.1 bits (122), Expect = 7e-07
 Identities = 57/221 (25%), Positives = 86/221 (38%), Gaps = 50/221 (22%)

Query: 290 RIVGEGASATVYKGSLPSGGA-VAVKRFEKP-----NRVEC-----------ARNPFTTE 332
           +++G+G+   V    L   G   AVK  +K      + VEC             NPF T 
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 333 FATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNI 392
                    H               L  V E+L  G L   + +     +  +      I
Sbjct: 61  LYCTFQTKEH---------------LFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEI 105

Query: 393 VLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAG 441
           V G    L +LH    + II+RD+K  N++LD + + K+ DF            A+   G
Sbjct: 106 VCG----LQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCG 158

Query: 442 TMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDND 482
           T  Y+APE +     +   D +SFGV+  E+  G+SP   D
Sbjct: 159 TPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD 199

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 51.1 bits (122), Expect = 8e-07
 Identities = 38/107 (35%), Positives = 51/107 (47%), Gaps = 16/107 (14%)

Query: 390 LNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-EATIP--------- 439
           L I   V  A+ YLHE    +IIHRD+KA NI ++   +  LGDF  A  P         
Sbjct: 185 LAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY 241

Query: 440 --AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGK-SPVDNDG 483
             AGT+   APE +         D++S G+V  E+A    S  + DG
Sbjct: 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDG 288

Length = 391

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 50.6 bits (121), Expect = 8e-07
 Identities = 56/205 (27%), Positives = 88/205 (42%), Gaps = 21/205 (10%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           + K   +GEG    VYK     +   +A+K+       E   +    E + +   ++H N
Sbjct: 4   YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKE-MQHGN 62

Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           +V+LQ        L LV+EYL    LD   H +SS     +       +  +   ++Y H
Sbjct: 63  IVRLQDVVHSEKRLYLVFEYL---DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH 119

Query: 405 EECERQIIHRDVKACNILLDAEFNA-KLGDFEAT----IPAG-------TMGYLAPEYVY 452
                +++HRD+K  N+L+D   NA KL DF       IP         T+ Y APE + 
Sbjct: 120 S---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILL 176

Query: 453 -SGVPSEKTDVYSFGVVALEVAAGK 476
            S   S   D++S G +  E+   K
Sbjct: 177 GSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 50.3 bits (121), Expect = 9e-07
 Identities = 45/156 (28%), Positives = 72/156 (46%), Gaps = 22/156 (14%)

Query: 291 IVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARN--PFTT--EFATMAGCLR--HK 343
            +GEGA  TVYK   L +G  VA+K+     RV  +    P +T  E A +       H 
Sbjct: 6   EIGEGAYGTVYKARDLNTGRFVALKKV----RVPLSEEGIPLSTLREIALLKQLESFEHP 61

Query: 344 NLVQL----QGWCCEGN-ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVAS 398
           N+V+L     G   +   +L LV+E++ +  L   L         L  E   +++  +  
Sbjct: 62  NIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKP--GLPPETIKDLMRQLLR 118

Query: 399 ALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF 434
            + +LH      I+HRD+K  NIL+ ++   K+ DF
Sbjct: 119 GVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADF 151

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 50.8 bits (121), Expect = 9e-07
 Identities = 49/179 (27%), Positives = 80/179 (44%), Gaps = 44/179 (24%)

Query: 383 VLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-------- 434
           VL+ E  +     VA  + +L     R+ IHRD+ A NILL      K+ DF        
Sbjct: 175 VLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 231

Query: 435 --------EATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEV-AAGKSP-----VD 480
                   +A +P   + ++APE ++  V + ++DV+SFGV+  E+ + G SP     +D
Sbjct: 232 DPDYVRKGDARLP---LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 288

Query: 481 NDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKE 539
            + C  +       K+G  + A D      +   EM + +   L C H    +RP+  E
Sbjct: 289 EEFCRRL-------KEGTRMRAPD------YTTPEMYQTM---LDCWHGEPSQRPTFSE 331

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 50.8 bits (121), Expect = 9e-07
 Identities = 47/152 (30%), Positives = 66/152 (43%), Gaps = 18/152 (11%)

Query: 341 RHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASAL 400
           RH  L  L+      + L  V EY+  G L    H   S   V S ++       + SAL
Sbjct: 53  RHPFLTSLKYSFQTKDRLCFVMEYVNGGEL--FFH--LSRERVFSEDRTRFYGAEIVSAL 108

Query: 401 SYLHEECERQIIHRDVKACNILLDAEFNAKLGDF----EATIPAGTMG-------YLAPE 449
            YLH     +I++RD+K  N++LD + + K+ DF    E    A TM        YLAPE
Sbjct: 109 DYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPE 165

Query: 450 YVYSGVPSEKTDVYSFGVVALEVAAGKSPVDN 481
            +         D +  GVV  E+  G+ P  N
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 50.9 bits (122), Expect = 1e-06
 Identities = 67/232 (28%), Positives = 93/232 (40%), Gaps = 55/232 (23%)

Query: 286 FNKNRIVGEGA-----------SATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFA 334
           F+  +++G GA           S  VY   L S       +FE   R + A   F  E  
Sbjct: 45  FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLS-------KFEMIKRSDSAF--FWEERD 95

Query: 335 TMAGCLRHKN---LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEK--R 389
            MA    H N   +VQL     +   L +V EY+P G L  ++   S+  I   W +   
Sbjct: 96  IMA----HANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM---SNYDIPEKWARFYT 148

Query: 390 LNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI----------- 438
             +VL    AL  +H       IHRDVK  N+LLD   + KL DF   +           
Sbjct: 149 AEVVL----ALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCD 201

Query: 439 -PAGTMGYLAPEYVYS----GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV 485
              GT  Y++PE + S    G    + D +S GV   E+  G +P   D  V
Sbjct: 202 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 253

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 14/98 (14%)

Query: 396 VASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF----EATIPA-------GTMG 444
           ++  L +LH    R II+RD+K  N++LD+E + K+ DF    E  +         GT  
Sbjct: 110 ISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPD 166

Query: 445 YLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDND 482
           Y+APE +      +  D +++GV+  E+ AG+ P D +
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE 204

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 50.8 bits (121), Expect = 1e-06
 Identities = 60/218 (27%), Positives = 89/218 (40%), Gaps = 35/218 (16%)

Query: 290 RIVGEGASATV----YKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           +++G GA   V    +K S        + +FE   R + A   F  E   +        +
Sbjct: 49  KVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSA---FFWEERDIMAFANSPWV 105

Query: 346 VQLQGWCCEGNE--LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
           VQL  +C   ++  L +V EY+P G L  ++ N     +   W K       V  AL  +
Sbjct: 106 VQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSN---YDVPEKWAKFYTA--EVVLALDAI 158

Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDFEATI------------PAGTMGYLAPEYV 451
           H      +IHRDVK  N+LLD   + KL DF   +              GT  Y++PE +
Sbjct: 159 HS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVL 215

Query: 452 YS----GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV 485
            S    G    + D +S GV   E+  G +P   D  V
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV 253

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 64/218 (29%), Positives = 92/218 (42%), Gaps = 35/218 (16%)

Query: 290 RIVGEGASATVY----KGSLPSGGAVAVKRFEKPNRVECARNPFTTEFA-TMAGCLRHKN 344
           +++G GA   V+         SG   A+K  +K   V+ A+   TTE   T    L H  
Sbjct: 6   KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAK---TTEHTRTERQVLEHIR 62

Query: 345 ----LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLG-VASA 399
               LV L        +L L+ +Y+  G L   L            E+ + I  G +  A
Sbjct: 63  QSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK-----EQEVQIYSGEIVLA 117

Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF------------EATIPAGTMGYLA 447
           L +LH+     II+RD+K  NILLD+  +  L DF             A    GT+ Y+A
Sbjct: 118 LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMA 174

Query: 448 PEYVYSGVP--SEKTDVYSFGVVALEVAAGKSPVDNDG 483
           P+ V  G     +  D +S GV+  E+  G SP   DG
Sbjct: 175 PDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDG 212

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 49.5 bits (118), Expect = 1e-06
 Identities = 44/148 (29%), Positives = 67/148 (45%), Gaps = 34/148 (22%)

Query: 342 HKNLVQLQGWC-----CEGNEL-VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLG 395
           H + ++   +C     CEG +L   + E    G   K L  N     V  W   + ++LG
Sbjct: 68  HASFLERDAFCIITEYCEGRDLDCKLEELKHTG---KTLSENQ----VCEW--FIQLLLG 118

Query: 396 VASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFE-----------ATIPAGTMG 444
           V     Y+H+   R+I+HRD+KA NI L      K+GDF            AT   GT  
Sbjct: 119 V----HYMHQ---RRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFTGTPY 170

Query: 445 YLAPEYVYSGVPSEKTDVYSFGVVALEV 472
           Y++PE +       K+D++S G +  E+
Sbjct: 171 YMSPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 45/171 (26%), Positives = 74/171 (43%), Gaps = 44/171 (25%)

Query: 396 VASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF----------------EATIP 439
           VA  + +L     R+ IHRD+ A NILL      K+ DF                 A +P
Sbjct: 183 VARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239

Query: 440 AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEV-AAGKSP-----VDNDGCVIVDWVWNL 493
              + ++APE ++  V + ++DV+SFGV+  E+ + G SP     ++ + C         
Sbjct: 240 ---LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFC--------- 287

Query: 494 RKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARIL 544
               +L D    R+R   N       +M  L+C   + ++RP+      IL
Sbjct: 288 ---QRLKDGT--RMRAPENATPEIYRIM--LACWQGDPKERPTFSALVEIL 331

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 54/213 (25%), Positives = 86/213 (40%), Gaps = 34/213 (15%)

Query: 292 VGEGASATVYK-GSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQG 350
           +G+G    V+K  +  +G   AVK  +  + ++        E+  +     H N+V+  G
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID---EEIEAEYNILKALSDHPNVVKFYG 82

Query: 351 W-----CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLN---IVLGVASALSY 402
                    G++L LV E    GS+  ++         L   +R+    I   +  AL  
Sbjct: 83  MYYKKDVKNGDQLWLVLELCNGGSVTDLVKG------FLKRGERMEEPIIAYILHEALMG 136

Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT-----------IPAGTMGYLAPEYV 451
           L      + IHRDVK  NILL  E   KL DF  +              GT  ++APE +
Sbjct: 137 LQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVI 196

Query: 452 -----YSGVPSEKTDVYSFGVVALEVAAGKSPV 479
                       + DV+S G+ A+E+  G  P+
Sbjct: 197 ACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 50.3 bits (120), Expect = 1e-06
 Identities = 43/136 (31%), Positives = 60/136 (44%), Gaps = 21/136 (15%)

Query: 356 NELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLG-VASALSYLHEECERQIIHR 414
           ++L LV +Y+  G L   L      S     E R    +  +  AL +LH+     I++R
Sbjct: 69  SDLYLVTDYMSGGELFWHLQKEGRFS-----EDRAKFYIAELVLALEHLHKY---DIVYR 120

Query: 415 DVKACNILLDAEFNAKLGDFEATIP-----------AGTMGYLAPEYVYSGVPSEK-TDV 462
           D+K  NILLDA  +  L DF  +              GT  YLAPE +       K  D 
Sbjct: 121 DLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDF 180

Query: 463 YSFGVVALEVAAGKSP 478
           +S GV+  E+  G SP
Sbjct: 181 WSLGVLVFEMCCGWSP 196

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 50.2 bits (120), Expect = 2e-06
 Identities = 42/159 (26%), Positives = 70/159 (44%), Gaps = 27/159 (16%)

Query: 365 LPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLD 424
             + S D     ++  S  L  +  L     VA  + +L     +  IHRDV A N+LL 
Sbjct: 190 SSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLT 246

Query: 425 AEFNAKLGDF----------------EATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVV 468
               AK+ DF                 A +P   M   APE ++  V + ++DV+S+G++
Sbjct: 247 DGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWM---APESIFDCVYTVQSDVWSYGIL 303

Query: 469 ALEV-AAGKSPVDNDGCVIVDW-VWNLRKKGKLLDAADF 505
             E+ + GKSP      ++V+   + + K+G  +   DF
Sbjct: 304 LWEIFSLGKSPYPG---ILVNSKFYKMVKRGYQMSRPDF 339

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 49.6 bits (119), Expect = 2e-06
 Identities = 46/152 (30%), Positives = 69/152 (45%), Gaps = 19/152 (12%)

Query: 293 GEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTT--EFATMAGCLRHKNLVQLQ 349
           GEG    VYK   + +G  VA+K+    N  +    P T   E   +   L+H N+V L 
Sbjct: 17  GEGTFGEVYKARQIKTGRVVALKKILMHNEKDGF--PITALREI-KILKKLKHPNVVPLI 73

Query: 350 GWCCE-----GNELVLVYEYLP--NGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
               E       +   VY   P  +  L  +L N S   + L+  +    +L +   ++Y
Sbjct: 74  DMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPS---VKLTESQIKCYMLQLLEGINY 130

Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDF 434
           LHE     I+HRD+KA NIL+D +   K+ DF
Sbjct: 131 LHEN---HILHRDIKAANILIDNQGILKIADF 159

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 49.8 bits (119), Expect = 2e-06
 Identities = 36/95 (37%), Positives = 47/95 (49%), Gaps = 16/95 (16%)

Query: 396 VASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTMG 444
           +ASAL YLH      II+RD+K  NILLD++ +  L DF             +   GT  
Sbjct: 105 IASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPE 161

Query: 445 YLAPEYVYSGVPSEKT-DVYSFGVVALEVAAGKSP 478
           YLAPE V    P ++T D +  G V  E+  G  P
Sbjct: 162 YLAPE-VLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 49.8 bits (119), Expect = 2e-06
 Identities = 58/231 (25%), Positives = 94/231 (40%), Gaps = 54/231 (23%)

Query: 288 KNRIVGEGASATVYKG-SLPSGGAVAVKRF---EKPNRVECARN-------PFTT--EFA 334
           K   +GEG    V K     +G  VA+K+    E  N V   R         FTT  E  
Sbjct: 13  KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72

Query: 335 TMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVL 394
            M   ++H+N++ L     EG+ + LV + +    L K++       I L+  +   I+L
Sbjct: 73  IMNE-IKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRK----IRLTESQVKCILL 126

Query: 395 GVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-------------------- 434
            + + L+ LH+      +HRD+   NI ++++   K+ DF                    
Sbjct: 127 QILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDET 183

Query: 435 -----EATIPAGTMGYLAPEYVYSGVPSEK----TDVYSFGVVALEVAAGK 476
                E T    T+ Y APE +     +EK     D++S G +  E+  GK
Sbjct: 184 MQRREEMTSKVVTLWYRAPELLMG---AEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 49.4 bits (118), Expect = 2e-06
 Identities = 48/156 (30%), Positives = 71/156 (45%), Gaps = 28/156 (17%)

Query: 339 CLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNN-----SSSSIVLSWEKRLNIV 393
            ++H  +V L      G +L L+ EYL  G L   L         ++   LS      I 
Sbjct: 56  AVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS-----EIS 110

Query: 394 LGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIP---AGT 442
           L    AL +LH++    II+RD+K  NILLDA+ + KL DF        E T+     GT
Sbjct: 111 L----ALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGT 163

Query: 443 MGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSP 478
           + Y+APE +      +  D +S G +  ++  G  P
Sbjct: 164 IEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 49.1 bits (117), Expect = 3e-06
 Identities = 29/94 (30%), Positives = 47/94 (50%), Gaps = 14/94 (14%)

Query: 396 VASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP-----------AGTMG 444
           + S L +LH+   R+II+RD+K  N+LLD + N ++ D    +            AGT G
Sbjct: 106 IISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPG 162

Query: 445 YLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSP 478
           ++APE +         D ++ GV   E+ A + P
Sbjct: 163 FMAPELLQGEEYDFSVDYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 48.8 bits (116), Expect = 3e-06
 Identities = 50/199 (25%), Positives = 86/199 (43%), Gaps = 21/199 (10%)

Query: 291 IVGEGASATVYK-GSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQ 349
           +VGEGA   V K     +   VA+K+F+     E  +     E   M   L+ +N+V+L+
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLREL-KMLRTLKQENIVELK 66

Query: 350 GWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECER 409
                  +L LV+EY+    L+ +L    +       EK  + +  +  A+ + H+    
Sbjct: 67  EAFRRRGKLYLVFEYVEKNMLE-LLEEMPNGVPP---EKVRSYIYQLIKAIHWCHKN--- 119

Query: 410 QIIHRDVKACNILLDAEFNAKLGDF------------EATIPAGTMGYLAPEYVYSGVPS 457
            I+HRD+K  N+L+      KL DF              T    T  Y +PE +      
Sbjct: 120 DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYG 179

Query: 458 EKTDVYSFGVVALEVAAGK 476
           +  D++S G +  E++ G+
Sbjct: 180 KAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 48.9 bits (117), Expect = 3e-06
 Identities = 44/169 (26%), Positives = 61/169 (36%), Gaps = 19/169 (11%)

Query: 356 NELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRD 415
             L L  EY+P G    +L+N    S       R  +      A+  LHE      IHRD
Sbjct: 74  EYLYLAMEYVPGGDFRTLLNNLGVLS---EDHARFYMAEMFE-AVDALHE---LGYIHRD 126

Query: 416 VKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGV 467
           +K  N L+DA  + KL DF         A    G+  Y+APE +         D +S G 
Sbjct: 127 LKPENFLIDASGHIKLTDFGLSKGIVTYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGC 186

Query: 468 VALEVAAGKSPVDNDGCVIVDWVW-NLRKKGKLLDAADFRLRGKFNRKE 515
           +  E   G  P         +  W NL+   + L    +         E
Sbjct: 187 MLYEFLCGFPPFSGST---PNETWENLKYWKETLQRPVYDDPRFNLSDE 232

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 48.8 bits (116), Expect = 4e-06
 Identities = 30/98 (30%), Positives = 51/98 (52%), Gaps = 14/98 (14%)

Query: 396 VASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTMG 444
           +A  L +LH    + II+RD+K  N++LD+E + K+ DF                 GT  
Sbjct: 110 IAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPD 166

Query: 445 YLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDND 482
           Y+APE +      +  D ++FGV+  E+ AG++P + +
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 204

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 48.6 bits (116), Expect = 4e-06
 Identities = 53/211 (25%), Positives = 87/211 (41%), Gaps = 41/211 (19%)

Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQG 350
           +GEG   TV+K  +  +   VA+KR    +  E   +    E   +   L+HKN+V+L  
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKE-LKHKNIVRLYD 66

Query: 351 WCCEGNELVLVYEYLP----------NGSLDKILHNNSSSSIVLSWEKRLNIVLGVASAL 400
                 +L LV+EY            NG +D          IV S+  +L         L
Sbjct: 67  VLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDP--------EIVKSFMFQL------LKGL 112

Query: 401 SYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG-----------TMGYLAPE 449
           ++ H      ++HRD+K  N+L++     KL DF      G           T+ Y  P+
Sbjct: 113 AFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPD 169

Query: 450 YVYSG-VPSEKTDVYSFGVVALEVAAGKSPV 479
            ++   + S   D++S G +  E+A    P+
Sbjct: 170 VLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 48.8 bits (116), Expect = 4e-06
 Identities = 62/204 (30%), Positives = 88/204 (43%), Gaps = 24/204 (11%)

Query: 290 RIVGEGASATVYKGSLPSGGAV-AVKRFEKPNRVECA-RNPFTTEFATMAGCLRHKNLVQ 347
           +++G+G+   V      S G+  AVK  +K   ++   +N    E   +   L+H  LV 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 348 LQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLG-VASALSYLHEE 406
           L        +L  V +Y+  G L    H       +   E R       VASA+ YLH  
Sbjct: 61  LHYSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFL---EPRARFYAAEVASAIGYLHSL 115

Query: 407 CERQIIHRDVKACNILLDAEFNAKLGDF----EATIP-------AGTMGYLAPEYVYSGV 455
               II+RD+K  NILLD++ +  L DF    E   P        GT  YLAPE V    
Sbjct: 116 ---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPE-VLRKE 171

Query: 456 PSEKT-DVYSFGVVALEVAAGKSP 478
           P ++T D +  G V  E+  G  P
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 48.4 bits (115), Expect = 5e-06
 Identities = 55/201 (27%), Positives = 84/201 (41%), Gaps = 28/201 (13%)

Query: 292 VGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTT--EFATMAGC--LRHKNLV 346
           +G GA  TVYK   P SG  VA+K        +    P +T  E A +       H N+V
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGL--PLSTVREVALLKRLEAFDHPNIV 65

Query: 347 QLQGWCCEGN-----ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALS 401
           +L   C         ++ LV+E++     D   + +      L  E   +++      L 
Sbjct: 66  RLMDVCATSRTDRETKVTLVFEHVDQ---DLRTYLDKVPPPGLPAETIKDLMRQFLRGLD 122

Query: 402 YLHEECERQIIHRDVKACNILLDAEFNAKLGDF---------EATIP-AGTMGYLAPEYV 451
           +LH  C   I+HRD+K  NIL+ +    KL DF          A  P   T+ Y APE +
Sbjct: 123 FLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVL 179

Query: 452 YSGVPSEKTDVYSFGVVALEV 472
                +   D++S G +  E+
Sbjct: 180 LQSTYATPVDMWSVGCIFAEM 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 48.7 bits (116), Expect = 5e-06
 Identities = 32/97 (32%), Positives = 47/97 (48%), Gaps = 14/97 (14%)

Query: 396 VASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF---------EATIPA--GTMG 444
           + SAL YLH      +++RD+K  N++LD + + K+ DF          AT+    GT  
Sbjct: 104 IVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 160

Query: 445 YLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDN 481
           YLAPE +         D +  GVV  E+  G+ P  N
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 47.9 bits (115), Expect = 5e-06
 Identities = 43/156 (27%), Positives = 67/156 (42%), Gaps = 29/156 (18%)

Query: 342 HKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALS 401
           + N ++L          VL+ +Y+ +G L  +L         LS  +   I+  +  AL+
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK----LSEAEVKKIIRQLVEALN 123

Query: 402 YLHEECERQIIHRDVKACNILLD-AEFNAKLGDF-----EATIPA---GTMGYLAPE--- 449
            LH+     IIH D+K  N+L D A+    L D+       T P+   GT+ Y +PE   
Sbjct: 124 DLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT-PSCYDGTLDYFSPEKIK 179

Query: 450 ---YVYSGVPSEKTDVYSFGVVALEVAAGKSPVDND 482
              Y  S       D ++ GV+  E+  GK P   D
Sbjct: 180 GHNYDVS------FDWWAVGVLTYELLTGKHPFKED 209

Length = 267

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 48.2 bits (115), Expect = 6e-06
 Identities = 51/265 (19%), Positives = 106/265 (40%), Gaps = 36/265 (13%)

Query: 291 IVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQG 350
           ++ E    ++YKG   +   V ++ F+K ++        T         +   N++++ G
Sbjct: 27  LIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG 85

Query: 351 WCCEGNE----LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEE 406
           +  +  +    L L+ EY   G L ++L         LS++ +L++ +     L  L++ 
Sbjct: 86  FIIDIVDDLPRLSLILEYCTRGYLREVLDKEKD----LSFKTKLDMAIDCCKGLYNLYKY 141

Query: 407 CERQIIHRDVKACNILLDAEFNAKL--GDFEATIPA------GTMGYLAPEY---VYSGV 455
             +   ++++ + + L+   +  K+     E  + +        M Y + +    ++S  
Sbjct: 142 TNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEY 199

Query: 456 PSEKTDVYSFGVVALEVAAGKSPVDN-DGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRK 514
            + K D+YS GVV  E+  GK P +N     I D + N     KL       ++      
Sbjct: 200 -TIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEA- 257

Query: 515 EMERMLMVGLSCVHPNHEKRPSVKE 539
                      C   +  KRP++KE
Sbjct: 258 -----------CTSHDSIKRPNIKE 271

Length = 283

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 48.0 bits (114), Expect = 6e-06
 Identities = 32/97 (32%), Positives = 50/97 (51%), Gaps = 17/97 (17%)

Query: 392 IVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLG------DFEATIP---AGT 442
           I+LG    L ++H    R +++RD+K  NILLD   + ++       DF    P    GT
Sbjct: 106 IILG----LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGT 158

Query: 443 MGYLAPEYVYSGVPSEKT-DVYSFGVVALEVAAGKSP 478
            GY+APE +  GV  + + D +S G +  ++  G SP
Sbjct: 159 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 48.0 bits (115), Expect = 7e-06
 Identities = 27/79 (34%), Positives = 43/79 (54%), Gaps = 9/79 (11%)

Query: 356 NELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRD 415
            ++ LV+EY+     +  LH    ++I+    KR  I+  +  AL Y+H      +IHRD
Sbjct: 82  KDIYLVFEYM-----ETDLHAVIRANILEDVHKRY-IMYQLLKALKYIHS---GNVIHRD 132

Query: 416 VKACNILLDAEFNAKLGDF 434
           +K  NILL+++   KL DF
Sbjct: 133 LKPSNILLNSDCRVKLADF 151

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 48.1 bits (114), Expect = 7e-06
 Identities = 51/207 (24%), Positives = 87/207 (42%), Gaps = 28/207 (13%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           + + + +G GA   V        G  VAVK+  +P + +        E   +  C+ HKN
Sbjct: 23  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLK-CVNHKN 81

Query: 345 LVQL------QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVAS 398
           ++ L      Q    E  ++ LV E L + +L +++H        L  E+   ++  +  
Sbjct: 82  IISLLNVFTPQKSLEEFQDVYLVME-LMDANLCQVIHME------LDHERMSYLLYQMLC 134

Query: 399 ALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG----------TMGYLAP 448
            + +LH      IIHRD+K  NI++ ++   K+ DF     A           T  Y AP
Sbjct: 135 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAP 191

Query: 449 EYVYSGVPSEKTDVYSFGVVALEVAAG 475
           E +      E  D++S G +  E+  G
Sbjct: 192 EVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 47.7 bits (113), Expect = 8e-06
 Identities = 38/135 (28%), Positives = 61/135 (45%), Gaps = 38/135 (28%)

Query: 396 VASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--EATIP--------AGTMGY 445
           +   L  LH+E   +I++RD+K  NILLD   + ++ D      +P         GT+GY
Sbjct: 111 ICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGY 167

Query: 446 LAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADF 505
           +APE V +   +   D ++ G +  E+ AG+SP               RKK         
Sbjct: 168 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ------------RKK--------- 206

Query: 506 RLRGKFNRKEMERML 520
               K  R+E+ER++
Sbjct: 207 ----KIKREEVERLV 217

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 47.7 bits (114), Expect = 9e-06
 Identities = 33/160 (20%), Positives = 64/160 (40%), Gaps = 28/160 (17%)

Query: 292 VGEGASATVYKG---SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGC--------L 340
           +G G    VYK    +   G   A+K+F+                 + + C        L
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGD--------KEQYTGISQSACREIALLREL 59

Query: 341 RHKNLVQLQGWCCEGNE--LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVAS 398
           +H+N+V L     E  +  + L+++Y  +     I  +  +  + +      +++  + +
Sbjct: 60  KHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILN 119

Query: 399 ALSYLHEECERQIIHRDVKACNILLDAEFNA----KLGDF 434
            + YLH      ++HRD+K  NIL+  E       K+GD 
Sbjct: 120 GVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 47.3 bits (112), Expect = 1e-05
 Identities = 31/97 (31%), Positives = 49/97 (50%), Gaps = 17/97 (17%)

Query: 392 IVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLG------DFEATIP---AGT 442
           I+LG    L ++H    R +++RD+K  NILLD   + ++       DF    P    GT
Sbjct: 106 IILG----LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGT 158

Query: 443 MGYLAPEYVYSGVPSEKT-DVYSFGVVALEVAAGKSP 478
            GY+APE +  G   + + D +S G +  ++  G SP
Sbjct: 159 HGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 47.1 bits (113), Expect = 1e-05
 Identities = 36/154 (23%), Positives = 65/154 (42%), Gaps = 21/154 (13%)

Query: 290 RIVGEGASATVYKG-SLPSGGAVAVKRFEKP--NRVECARNPFTTEFATMAGCLRHKNLV 346
           + +G GA   V       +G  VA+K+      + ++  R         +   LRH+N++
Sbjct: 6   KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKR---ILREIKLLRHLRHENII 62

Query: 347 QL------QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASAL 400
            L             N++ +V E +    L K++     S   L+ +     +  +   L
Sbjct: 63  GLLDILRPPSPEDF-NDVYIVTELMET-DLHKVIK----SPQPLTDDHIQYFLYQILRGL 116

Query: 401 SYLHEECERQIIHRDVKACNILLDAEFNAKLGDF 434
            YLH      +IHRD+K  NIL+++  + K+ DF
Sbjct: 117 KYLHSA---NVIHRDLKPSNILVNSNCDLKICDF 147

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 47.3 bits (112), Expect = 1e-05
 Identities = 41/138 (29%), Positives = 62/138 (44%), Gaps = 17/138 (12%)

Query: 396 VASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF----EATIPAGTMG------- 444
           +ASAL YLH      I++RD+K  NILLD++ +  L DF    E     GT         
Sbjct: 105 IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPE 161

Query: 445 YLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPV-DNDGCVIVDWVWN--LRKKGKLLD 501
           YLAPE ++        D +  G V  E+  G  P    +   + D + N  L+ K  + +
Sbjct: 162 YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITN 221

Query: 502 AADFRLRGKFNRKEMERM 519
           +A   L G   +   +R+
Sbjct: 222 SARHLLEGLLQKDRTKRL 239

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 47.3 bits (112), Expect = 1e-05
 Identities = 43/144 (29%), Positives = 60/144 (41%), Gaps = 24/144 (16%)

Query: 358 LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVK 417
           L +V EY+P G L  ++ N     +   W +       V  AL  +H       IHRDVK
Sbjct: 118 LYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTA--EVVLALDAIHS---MGFIHRDVK 169

Query: 418 ACNILLDAEFNAKLGDFEATI------------PAGTMGYLAPEYVYS----GVPSEKTD 461
             N+LLD   + KL DF   +              GT  Y++PE + S    G    + D
Sbjct: 170 PDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECD 229

Query: 462 VYSFGVVALEVAAGKSPVDNDGCV 485
            +S GV   E+  G +P   D  V
Sbjct: 230 WWSVGVFLYEMLVGDTPFYADSLV 253

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 46.5 bits (110), Expect = 2e-05
 Identities = 59/221 (26%), Positives = 93/221 (42%), Gaps = 39/221 (17%)

Query: 292 VGEGASATVYKG-SLPSGGA-VAVKRFEKPNRVECARN--PFTT--EFATMAG--CLRHK 343
           +GEGA   V+K   L +GG  VA+KR     RV+      P +T  E A +       H 
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRV----RVQTGEEGMPLSTIREVAVLRHLETFEHP 64

Query: 344 NLVQLQGWCC-----EGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVAS 398
           N+V+L   C         +L LV+E++     D   + +      +  E   +++  +  
Sbjct: 65  NVVRLFDVCTVSRTDRETKLTLVFEHVDQ---DLTTYLDKVPEPGVPTETIKDMMFQLLR 121

Query: 399 ALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF----------EATIPAGTMGYLAP 448
            L +LH     +++HRD+K  NIL+ +    KL DF            T    T+ Y AP
Sbjct: 122 GLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 178

Query: 449 EYVYSGVPSEKTDVYSFGVVALE------VAAGKSPVDNDG 483
           E +     +   D++S G +  E      +  G S VD  G
Sbjct: 179 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG 219

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 47.0 bits (111), Expect = 2e-05
 Identities = 29/101 (28%), Positives = 51/101 (50%), Gaps = 16/101 (15%)

Query: 384 LSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP---- 439
           L  + R  I+  +  A+ Y+H+   +++IHRD+K  NI L+ +    LGDF   +P    
Sbjct: 265 LLKQTR-AIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKE 320

Query: 440 --------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEV 472
                    GT+   +PE +      E TD++S G++ L++
Sbjct: 321 REAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDM 361

Length = 501

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 46.5 bits (110), Expect = 2e-05
 Identities = 48/202 (23%), Positives = 82/202 (40%), Gaps = 41/202 (20%)

Query: 309 GAVAVKRFEKPNRVECAR--NPFTTEFATMAGCLRHKNLVQLQGWCC----------EGN 356
           G VAV + +   R+   +  N +         C R +  V + G C           + N
Sbjct: 15  GEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDEN 74

Query: 357 ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLG---VASALSYLHEECERQIIH 413
            L LV +Y   G L  +L           +E RL   +    +A  +  +H   +   +H
Sbjct: 75  YLYLVMDYYVGGDLLTLLSK---------FEDRLPEDMARFYIAEMVLAIHSIHQLHYVH 125

Query: 414 RDVKACNILLDAEFNAKLGDF------------EATIPAGTMGYLAPEYVYS-----GVP 456
           RD+K  N+LLD   + +L DF            ++++  GT  Y++PE + +     G  
Sbjct: 126 RDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKY 185

Query: 457 SEKTDVYSFGVVALEVAAGKSP 478
             + D +S GV   E+  G++P
Sbjct: 186 GPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 46.5 bits (110), Expect = 2e-05
 Identities = 42/141 (29%), Positives = 67/141 (47%), Gaps = 22/141 (15%)

Query: 357 ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLG-VASALSYLHEECERQIIHRD 415
           +L L+ +Y+  G +   L+   + S     E  +    G +  AL +LH+     I++RD
Sbjct: 79  KLHLILDYVSGGEMFTHLYQRDNFS-----EDEVRFYSGEIILALEHLHK---LGIVYRD 130

Query: 416 VKACNILLDAEFNAKLGDF-----------EATIP-AGTMGYLAPEYVYS-GVPSEKTDV 462
           +K  NILLD+E +  L DF           E T    GT+ Y+APE +   G   +  D 
Sbjct: 131 IKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDW 190

Query: 463 YSFGVVALEVAAGKSPVDNDG 483
           +S G++  E+  G SP   +G
Sbjct: 191 WSLGILIFELLTGASPFTLEG 211

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 46.5 bits (110), Expect = 2e-05
 Identities = 51/203 (25%), Positives = 80/203 (39%), Gaps = 17/203 (8%)

Query: 286 FNKNRIVGEGASATVYKGSLPSGG--AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHK 343
           FN  R +G G+   V   +  +     VA+KRFEK   ++  +         +   + H 
Sbjct: 32  FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHP 91

Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
             V L G   + + L LV E++  G     L  N      +       IVL       YL
Sbjct: 92  FCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVL----IFEYL 147

Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGV 455
                  I++RD+K  N+LLD +   K+ DF              GT  Y+APE + +  
Sbjct: 148 QS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLCGTPEYIAPEILLNVG 204

Query: 456 PSEKTDVYSFGVVALEVAAGKSP 478
             +  D ++ G+   E+  G  P
Sbjct: 205 HGKAADWWTLGIFIYEILVGCPP 227

Length = 340

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 46.4 bits (110), Expect = 3e-05
 Identities = 34/90 (37%), Positives = 48/90 (53%), Gaps = 18/90 (20%)

Query: 398 SALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEA--------TIP-----AGTMG 444
           SA+ Y+H E    IIHRD+K  N+L++   +  LGDF A        + P     AGT+ 
Sbjct: 271 SAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVD 327

Query: 445 YLAPEYVYSGVP-SEKTDVYSFGVVALEVA 473
             APE V +G P +   D++S G+V  E A
Sbjct: 328 TNAPE-VLAGDPYTPSVDIWSAGLVIFEAA 356

Length = 461

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 46.2 bits (109), Expect = 3e-05
 Identities = 38/130 (29%), Positives = 60/130 (46%), Gaps = 16/130 (12%)

Query: 356 NELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRD 415
           ++L+L+ EY   G L+K +       +     +   +   +  AL  +H    R+++HRD
Sbjct: 138 DKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRD 194

Query: 416 VKACNILLDAEFNAKLGDFE-------------ATIPAGTMGYLAPEYVYSGVPSEKTDV 462
           +K+ NI L      KLGDF              A+   GT  YLAPE       S+K D+
Sbjct: 195 LKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADM 254

Query: 463 YSFGVVALEV 472
           +S GV+  E+
Sbjct: 255 WSLGVILYEL 264

Length = 478

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 45.8 bits (108), Expect = 4e-05
 Identities = 45/182 (24%), Positives = 79/182 (43%), Gaps = 27/182 (14%)

Query: 311 VAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL------QGWCCEGNELVLVYEY 364
           VA+K+  +P + +        E   M  C+ HKN++ L      Q    E  ++ +V E 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMK-CVNHKNIIGLLNVFTPQKSLEEFQDVYIVME- 109

Query: 365 LPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLD 424
           L + +L +++       + L  E+   ++  +   + +LH      IIHRD+K  NI++ 
Sbjct: 110 LMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVK 160

Query: 425 AEFNAKLGDFEATIPAGTMGYLAPEYV--YSGVPS--------EKTDVYSFGVVALEVAA 474
           ++   K+ DF     AGT   + P  V  Y   P         E  D++S G +  E+  
Sbjct: 161 SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIK 220

Query: 475 GK 476
           G 
Sbjct: 221 GG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 45.8 bits (108), Expect = 4e-05
 Identities = 52/204 (25%), Positives = 86/204 (42%), Gaps = 32/204 (15%)

Query: 292 VGEGASATV---YKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           +G GA   V   Y   L     VA+K+  +P + +        E   M  C+ HKN++ L
Sbjct: 25  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMK-CVNHKNIISL 81

Query: 349 ------QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
                 Q    E  ++ LV E L + +L +++       + L  E+   ++  +   + +
Sbjct: 82  LNVFTPQKSLEEFQDVYLVME-LMDANLCQVIQ------MELDHERMSYLLYQMLCGIKH 134

Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG----------TMGYLAPEYVY 452
           LH      IIHRD+K  NI++ ++   K+ DF     AG          T  Y APE + 
Sbjct: 135 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 191

Query: 453 SGVPSEKTDVYSFGVVALEVAAGK 476
                E  D++S G +  E+   K
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 45.8 bits (108), Expect = 4e-05
 Identities = 33/94 (35%), Positives = 43/94 (45%), Gaps = 14/94 (14%)

Query: 396 VASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTMG 444
           +ASAL YLH      I++RD+K  NILLD++ +  L DF             T   GT  
Sbjct: 105 IASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPE 161

Query: 445 YLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSP 478
           YLAPE +         D +  G V  E+  G  P
Sbjct: 162 YLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 45.2 bits (107), Expect = 4e-05
 Identities = 31/89 (34%), Positives = 45/89 (50%), Gaps = 13/89 (14%)

Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--EATIP--------AGTMGYLAPE 449
           L  LH E   +I++RD+K  NILLD   + ++ D      IP         GT+GY+APE
Sbjct: 115 LEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPE 171

Query: 450 YVYSGVPSEKTDVYSFGVVALEVAAGKSP 478
            V +   +   D +  G +  E+  GKSP
Sbjct: 172 VVKNERYTFSPDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 45.3 bits (107), Expect = 6e-05
 Identities = 54/202 (26%), Positives = 91/202 (45%), Gaps = 27/202 (13%)

Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNRVEC-ARNPFTTEFATMAGCLRHKN---LV 346
           VG GA  +V       +G  VA+K+  +P + E  A+  +     T+   ++H+N   L+
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRE--LTLLKHMQHENVIGLL 80

Query: 347 QLQGWCCEGNELVLVYEYLP--NGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
            +      G+E    Y  +P     L KI+ +       LS +K   +V  +   L Y+H
Sbjct: 81  DVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHP------LSEDKVQYLVYQMLCGLKYIH 134

Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGVP 456
                 IIHRD+K  N+ ++ +   K+ DF        E T    T  Y APE + + + 
Sbjct: 135 SA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILNWMH 191

Query: 457 SEKT-DVYSFGVVALEVAAGKS 477
             +T D++S G +  E+  GK+
Sbjct: 192 YNQTVDIWSVGCIMAEMLTGKT 213

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 44.9 bits (107), Expect = 6e-05
 Identities = 62/226 (27%), Positives = 96/226 (42%), Gaps = 56/226 (24%)

Query: 289 NRIVGEGASATVYKG-SLPSGGAVAVKR--FEKPNRVECARNPFTT--EFATMAGCLRHK 343
           NRI  EG    VY+     +G  VA+K+   EK    E    P T+  E   +   L+H 
Sbjct: 11  NRI-EEGTYGVVYRARDKKTGEIVALKKLKMEK----EKEGFPITSLREINILLK-LQHP 64

Query: 344 NLVQLQGWCCEGNELV---------LVYEYLPNGSLD-KILHNNSSSSIVLSWEKRLNIV 393
           N+V ++       E+V         +V EY+ +   D K L        + S  K   ++
Sbjct: 65  NIVTVK-------EVVVGSNLDKIYMVMEYVEH---DLKSLMETMKQPFLQSEVK--CLM 112

Query: 394 LGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGT 442
           L + S +++LH+     I+HRD+K  N+LL+     K+ DF             T    T
Sbjct: 113 LQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVT 169

Query: 443 MGYLAPEYVYSGVP--SEKTDVYSFGVVALE------VAAGKSPVD 480
           + Y APE +  G    S   D++S G +  E      +  GKS +D
Sbjct: 170 LWYRAPE-LLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID 214

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 44.9 bits (106), Expect = 7e-05
 Identities = 46/199 (23%), Positives = 80/199 (40%), Gaps = 38/199 (19%)

Query: 306 PSGGAVAVKRFEKPNRVECARNPFTTEFAT---MAGCLRHKNLVQLQGWCCEGNELVLVY 362
           P+G  V V+R      +E   N   T       ++    H N+V  +      NEL +V 
Sbjct: 23  PTGEYVTVRRIN----LEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT 78

Query: 363 EYLPNGSLDKIL---HNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKAC 419
            ++  GS   ++     +  S + +++     I+ GV  AL Y+H       +HR VKA 
Sbjct: 79  SFMAYGSAKDLICTHFMDGMSELAIAY-----ILQGVLKALDYIHH---MGYVHRSVKAS 130

Query: 420 NILLDAEFNAKLGDFEATIP------------------AGTMGYLAPEYVYSGVP--SEK 459
           +IL+  +    L    + +                      + +L+PE +   +     K
Sbjct: 131 HILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAK 190

Query: 460 TDVYSFGVVALEVAAGKSP 478
           +D+YS G+ A E+A G  P
Sbjct: 191 SDIYSVGITACELANGHVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 44.2 bits (105), Expect = 1e-04
 Identities = 52/199 (26%), Positives = 81/199 (40%), Gaps = 18/199 (9%)

Query: 290 RIVGEGASATVYKGSLPSGGA-VAVKRFEKP-NRVECARNPFTTEFATMAGCLRHKNLVQ 347
             VG GA   V        G  VA+K+  +P      A+  +  E   +   + H+N++ 
Sbjct: 21  SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR-ELRLLK-HMDHENVIG 78

Query: 348 LQGWCCEGNELVLVYE-YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEE 406
           L       + L    + YL    +   L+N       LS +    +V  +   L Y+H  
Sbjct: 79  LLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQ-KLSDDHIQFLVYQILRGLKYIHSA 137

Query: 407 CERQIIHRDVKACNILL--DAEFN------AKLGDFEATIPAGTMGYLAPEYVYSGVPSE 458
               IIHRD+K  NI +  D E        A+  D E T    T  Y APE + + +   
Sbjct: 138 ---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYN 194

Query: 459 KT-DVYSFGVVALEVAAGK 476
           +T D++S G +  E+  GK
Sbjct: 195 QTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 44.2 bits (104), Expect = 1e-04
 Identities = 28/93 (30%), Positives = 44/93 (47%), Gaps = 13/93 (13%)

Query: 396 VASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--EATIP--------AGTMGY 445
           +   L  LH E     ++RD+K  NILLD   + ++ D      IP         GT+GY
Sbjct: 111 ILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGY 167

Query: 446 LAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSP 478
           +APE + +   +   D +  G +  E+  G+SP
Sbjct: 168 MAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 44.2 bits (104), Expect = 1e-04
 Identities = 46/194 (23%), Positives = 80/194 (41%), Gaps = 28/194 (14%)

Query: 306 PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYL 365
           P+G  V V+  +  N  E        E   ++   RH N++        G+ L ++  ++
Sbjct: 23  PTGTLVTVRITDLENCTEEHLKALQNE-VVLSHFFRHPNIMTSWTVFTTGSWLWVISPFM 81

Query: 366 PNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDA 425
             GS + +L         +S     NI+ G    L+YLH+      IHR++KA +IL+  
Sbjct: 82  AYGSANSLLKTYFPEG--MSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISG 136

Query: 426 EFNAKLG-------------------DFEATIPAGTMGYLAPEYVYSGVP--SEKTDVYS 464
           +    L                    DF        + +L+PE +   +   + K+D+YS
Sbjct: 137 DGLVSLSGLSHLYSLVRNGQKAKVVYDF-PQFSTSVLPWLSPELLRQDLYGYNVKSDIYS 195

Query: 465 FGVVALEVAAGKSP 478
            G+ A E+A G+ P
Sbjct: 196 VGITACELATGRVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 43.8 bits (104), Expect = 1e-04
 Identities = 52/213 (24%), Positives = 87/213 (40%), Gaps = 39/213 (18%)

Query: 293 GEGASATVYKG-SLPSGGAVAVKRFEKP-NRVECARNPFTTEFATMAGCLRHKNLVQLQG 350
           GEG  + V K  S  +G   A+K  +K    +E   N    E   +     H N+++L  
Sbjct: 8   GEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN--LREIQALRRLSPHPNILRL-- 63

Query: 351 WCCE------GNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
              E         L LV+E L + +L +++         L  ++  + +  +  +L ++H
Sbjct: 64  --IEVLFDRKTGRLALVFE-LMDMNLYELIKGRKRP---LPEKRVKSYMYQLLKSLDHMH 117

Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDFEA----------TIPAGTMGYLAPE-YVYS 453
                 I HRD+K  NIL+  +   KL DF +          T    T  Y APE  +  
Sbjct: 118 R---NGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTD 173

Query: 454 GVPSEKTDVYSFGVVALEVAA------GKSPVD 480
           G    K D+++ G V  E+ +      G + +D
Sbjct: 174 GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD 206

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 43.9 bits (103), Expect = 2e-04
 Identities = 43/202 (21%), Positives = 88/202 (43%), Gaps = 30/202 (14%)

Query: 362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNI 421
           Y+   +  +  +L ++ S    L+    L+    VA  + +L     +  +HRD+ A N+
Sbjct: 214 YKGSNDSEVKNLLSDDGSEG--LTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNV 268

Query: 422 LLDAEFNAKLGDF---------EATIPAGT----MGYLAPEYVYSGVPSEKTDVYSFGVV 468
           LL      K+ DF            +  G+    + ++APE ++  + +  +DV+S+G++
Sbjct: 269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGIL 328

Query: 469 ALEV-AAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCV 527
             E+ + G +P    G ++    +N  K G  +   D         +E+  +++    C 
Sbjct: 329 LWEIFSLGGTPY--PGMIVDSTFYNKIKSGYRMAKPDHA------TQEVYDIMV---KCW 377

Query: 528 HPNHEKRPSVKEAARILKGEAP 549
           +   EKRPS    + I++   P
Sbjct: 378 NSEPEKRPSFLHLSDIVESLLP 399

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 43.0 bits (101), Expect = 2e-04
 Identities = 30/96 (31%), Positives = 46/96 (47%), Gaps = 4/96 (4%)

Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLN-IVLGVAS 398
           L+H NL+Q  G C E    +LV E+ P G L   L +   + ++      L  +   +A 
Sbjct: 52  LQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIAL 111

Query: 399 ALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF 434
            L +LH+      IH D+   N LL A+   K+GD+
Sbjct: 112 GLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDY 144

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 44.1 bits (104), Expect = 2e-04
 Identities = 30/79 (37%), Positives = 39/79 (49%), Gaps = 7/79 (8%)

Query: 356 NELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRD 415
           N + LV EYL  G +  +LH           E  +  +  VA AL YLH      IIHRD
Sbjct: 77  NNVYLVMEYLIGGDVKSLLHIYG----YFDEEMAVKYISEVALALDYLHRH---GIIHRD 129

Query: 416 VKACNILLDAEFNAKLGDF 434
           +K  N+L+  E + KL DF
Sbjct: 130 LKPDNMLISNEGHIKLTDF 148

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 42.6 bits (100), Expect = 3e-04
 Identities = 50/222 (22%), Positives = 92/222 (41%), Gaps = 36/222 (16%)

Query: 286 FNKNRIVGEGASATVYKGSLP----SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLR 341
           F   R++G+G   +V +  L     S   VAVK      + +   +    EF   A C++
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML----KADIFSSSDIEEFLREAACMK 56

Query: 342 ---HKNLVQLQGWCCEGNEL------VLVYEYLPNGSLDKILHNN--SSSSIVLSWEKRL 390
              H N+++L G              +++  ++ +G L   L  +        L  +  +
Sbjct: 57  EFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLV 116

Query: 391 NIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--EATIPAGT------ 442
             ++ +AS + YL     +  IHRD+ A N +L+      + DF     I +G       
Sbjct: 117 RFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGC 173

Query: 443 -----MGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSP 478
                + +LA E +   V +  +DV++FGV   E+   G++P
Sbjct: 174 ASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 42.8 bits (101), Expect = 4e-04
 Identities = 55/206 (26%), Positives = 91/206 (44%), Gaps = 32/206 (15%)

Query: 290 RIVGEGASATVYKG-SLPSGGAVAVKRFEKP-NRVECARNPFTTEFATMAGCLRHKNLVQ 347
           + +G GA   V       +G  VA+K+  +P   V  A+  +  E   M   + HKN++ 
Sbjct: 22  KPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYR-ELVLMK-LVNHKNIIG 79

Query: 348 L------QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALS 401
           L      Q    E  ++ LV E L + +L +++       + L  E+   ++  +   + 
Sbjct: 80  LLNVFTPQKSLEEFQDVYLVME-LMDANLCQVIQ------MDLDHERMSYLLYQMLCGIK 132

Query: 402 YLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGT---MG-------YLAPEYV 451
           +LH      IIHRD+K  NI++ ++   K+ DF     AGT   M        Y APE V
Sbjct: 133 HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE-V 188

Query: 452 YSGVP-SEKTDVYSFGVVALEVAAGK 476
             G+   E  D++S G +  E+  G 
Sbjct: 189 ILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 42.3 bits (100), Expect = 4e-04
 Identities = 47/211 (22%), Positives = 84/211 (39%), Gaps = 38/211 (18%)

Query: 290 RIVGEGASATVYKG-SLPSGGAVAVKR---FEKPNRVECARNPFTTEFATMAGCLRHKNL 345
             +GEGA   V      P+G  VA+K+   FE      C R   T     +    +H+N+
Sbjct: 11  SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQ--TFCQR---TLREIKILRRFKHENI 65

Query: 346 VQLQ-----GWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASAL 400
           + +            N++ +V E +    L K++      +  LS +     +  +   L
Sbjct: 66  IGILDIIRPPSFESFNDVYIVQELMET-DLYKLI-----KTQHLSNDHIQYFLYQILRGL 119

Query: 401 SYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-------EATIPAGTMG-------YL 446
            Y+H      ++HRD+K  N+LL+   + K+ DF             G +        Y 
Sbjct: 120 KYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYR 176

Query: 447 APEYVYSGVPSEKT-DVYSFGVVALEVAAGK 476
           APE + +     K  D++S G +  E+ + +
Sbjct: 177 APEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 41.9 bits (98), Expect = 5e-04
 Identities = 28/89 (31%), Positives = 44/89 (49%), Gaps = 13/89 (14%)

Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--EATIP--------AGTMGYLAPE 449
           L  L  E   +I++RD+K  NILLD   + ++ D      IP         GT+GY+APE
Sbjct: 115 LEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPE 171

Query: 450 YVYSGVPSEKTDVYSFGVVALEVAAGKSP 478
            + +   +   D +  G +  E+  G+SP
Sbjct: 172 VINNEKYTFSPDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 42.2 bits (99), Expect = 5e-04
 Identities = 33/115 (28%), Positives = 56/115 (48%), Gaps = 23/115 (20%)

Query: 381 SIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF------ 434
            + L  E  L+    VA  +S+L     +  IHRD+ A NILL      K+ DF      
Sbjct: 208 ELALDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDI 264

Query: 435 ----------EATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEV-AAGKSP 478
                      A +P   + ++APE +++ V + ++DV+S+G++  E+ + G SP
Sbjct: 265 RNDSNYVVKGNARLP---VKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 41.4 bits (97), Expect = 7e-04
 Identities = 26/100 (26%), Positives = 48/100 (48%), Gaps = 13/100 (13%)

Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKIL-----HNNSSSSIVLSWEKRLNIVL 394
           L+H N++Q  G C E    +LV+EY   G L   L     H  +S  ++L       +  
Sbjct: 52  LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ-----RMAC 106

Query: 395 GVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF 434
            +A+ ++++H+      +H D+   N  L ++   K+GD+
Sbjct: 107 EIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDY 143

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 41.5 bits (97), Expect = 8e-04
 Identities = 50/201 (24%), Positives = 87/201 (43%), Gaps = 26/201 (12%)

Query: 292 VGEGASATV-YKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQG 350
           VG GA  TV       +G  VA+K+  +P + E        E   +   ++H+N++ L  
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKH-MKHENVIGLLD 81

Query: 351 WCC------EGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
                      ++  LV  ++    L K++ +       LS ++   +V  +   L Y+H
Sbjct: 82  VFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEK-----LSEDRIQFLVYQMLKGLKYIH 135

Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGVP 456
                 IIHRD+K  N+ ++ +   K+ DF        E T    T  Y APE + + + 
Sbjct: 136 AA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTRWYRAPEVILNWMH 192

Query: 457 SEKT-DVYSFGVVALEVAAGK 476
             +T D++S G +  E+  GK
Sbjct: 193 YTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 40.8 bits (95), Expect = 0.001
 Identities = 47/202 (23%), Positives = 82/202 (40%), Gaps = 41/202 (20%)

Query: 309 GAVAVKRFEKPNRVECAR--NPFTTEFATMAGCLRHKNLVQLQG---WCC-------EGN 356
           G VAV + +  ++V   +  N +         C R +  V + G   W         + N
Sbjct: 15  GEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDEN 74

Query: 357 ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLG---VASALSYLHEECERQIIH 413
            L LV +Y   G L  +L           +E RL   +    +A  +  +    +   +H
Sbjct: 75  NLYLVMDYYVGGDLLTLLSK---------FEDRLPEDMARFYLAEMVIAIDSVHQLHYVH 125

Query: 414 RDVKACNILLDAEFNAKLGDF------------EATIPAGTMGYLAPEYVYS-----GVP 456
           RD+K  NIL+D   + +L DF            ++++  GT  Y++PE + +     G  
Sbjct: 126 RDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKY 185

Query: 457 SEKTDVYSFGVVALEVAAGKSP 478
             + D +S GV   E+  G++P
Sbjct: 186 GPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 40.5 bits (95), Expect = 0.002
 Identities = 47/160 (29%), Positives = 72/160 (45%), Gaps = 29/160 (18%)

Query: 291 IVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTT--EFATMAGCLRHKNLVQ 347
            +GEG    VYK     +G  VA+K+    N  E    P T   E   +   L H+N+V 
Sbjct: 14  QIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGF--PITAIREIKILRQ-LNHRNIVN 70

Query: 348 LQGWCCEGNELV----------LVYEYLPN---GSLDKILHNNSSSSIVLSWEKRLNIVL 394
           L+    +  + +          LV+EY+ +   G L+  L + S   I  S+ K+L    
Sbjct: 71  LKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK-SFMKQL---- 125

Query: 395 GVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF 434
                L+Y H+   +  +HRD+K  NILL+ +   KL DF
Sbjct: 126 --LEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADF 160

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 40.1 bits (94), Expect = 0.002
 Identities = 24/84 (28%), Positives = 41/84 (48%), Gaps = 17/84 (20%)

Query: 412 IHRDVKACNILLDAEFNAKLGDF------------EATIPAGTMGYLAPEYVYS-----G 454
           +HRD+K  N+LLD   + +L DF            ++ +  GT  Y++PE + +     G
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKG 183

Query: 455 VPSEKTDVYSFGVVALEVAAGKSP 478
               + D +S GV   E+  G++P
Sbjct: 184 RYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 39.5 bits (92), Expect = 0.003
 Identities = 29/91 (31%), Positives = 43/91 (47%), Gaps = 14/91 (15%)

Query: 399 ALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTMGYLA 447
           AL  LH+     +I+RD+K  NILLD + +  L DF           +     GT  YLA
Sbjct: 105 ALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLA 161

Query: 448 PEYVYSGVPSEKTDVYSFGVVALEVAAGKSP 478
           PE +     ++  D ++ GV+  E+  G  P
Sbjct: 162 PELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 39.6 bits (93), Expect = 0.003
 Identities = 46/164 (28%), Positives = 60/164 (36%), Gaps = 49/164 (29%)

Query: 356 NELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRD 415
             L LV EY+P G L  +L       +      R  I   V  AL  +H+      IHRD
Sbjct: 74  EHLYLVMEYMPGGDLMNLL---IRKDVFPEETARFYIAELVL-ALDSVHK---LGFIHRD 126

Query: 416 VKACNILLDAEFNAKLGDF----------------------------------------E 435
           +K  NIL+DA+ + KL DF                                         
Sbjct: 127 IKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVR 186

Query: 436 ATIPAGTMGYLAPEYVYSGVP-SEKTDVYSFGVVALEVAAGKSP 478
           A    GT  Y+APE V  G P   + D +S GV+  E+  G  P
Sbjct: 187 ANSTVGTPDYIAPE-VLRGTPYGLECDWWSLGVILYEMLYGFPP 229

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 39.7 bits (93), Expect = 0.004
 Identities = 32/117 (27%), Positives = 52/117 (44%), Gaps = 13/117 (11%)

Query: 340 LRHKNLVQLQGWCC-----EGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVL 394
           L H+N++ ++           N++ +VYE +     D  LH    SS  LS +     + 
Sbjct: 61  LDHENVIAIKDIMPPPHREAFNDVYIVYELM-----DTDLHQIIRSSQTLSDDHCQYFLY 115

Query: 395 GVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGTMGYLAPEYV 451
            +   L Y+H      ++HRD+K  N+LL+A  + K+ DF         G    EYV
Sbjct: 116 QLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYV 169

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 39.0 bits (91), Expect = 0.004
 Identities = 55/228 (24%), Positives = 89/228 (39%), Gaps = 60/228 (26%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARN--PFTTEFATMAGCLRH 342
           + K   +GEG    VYK     +G  VA+K+     R+E      P T         LR 
Sbjct: 3   YEKLEKIGEGTYGKVYKARDKNTGKLVALKK----TRLEMDEEGIPPTA--------LRE 50

Query: 343 KNLVQLQGWC-----------CEGNE----LVLVYEYLPNGSLDKIL-------HNNSSS 380
            +L+Q+                E       L LV+EYL +  L K +            +
Sbjct: 51  ISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPA 109

Query: 381 SIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNA-KLGDF----E 435
             + S+  +L  + GVA    + H+     ++HRD+K  N+L+D +    K+ D      
Sbjct: 110 KTIKSFMYQL--LKGVA----HCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160

Query: 436 ATIPAG-------TMGYLAPEYVYSGVP-SEKTDVYSFGVVALEVAAG 475
            +IP         T+ Y APE +      S   D++S G +  E++  
Sbjct: 161 FSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	596
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd06899	236	lectin_legume_LecRK_Arcelin_ConA legume lectins, l	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
PF00139	236	Lectin_legB: Legume lectin domain; InterPro: IPR00	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.98
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.98
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.98
cd01951	223	lectin_L-type legume lectins. The L-type (legume-t	99.98
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.98
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.98
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.98
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.98
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.96
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.96
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.96
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.96
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.96
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.95
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.95
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.95
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.94
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.93
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.93
KOG1152	772	consensus Signal transduction serine/threonine kin	99.93
PLN00181	793	protein SPA1-RELATED; Provisional	99.93
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.92
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.92
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.92
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.91
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.91
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.91
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.9
PRK09188	365	serine/threonine protein kinase; Provisional	99.87
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.85
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.84
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.82
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.8
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.8
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.8
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.79
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.78
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.78
PRK12274	218	serine/threonine protein kinase; Provisional	99.77
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.76
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.76
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.76
PRK10345	210	hypothetical protein; Provisional	99.74
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.74
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.72
smart00090	237	RIO RIO-like kinase.	99.68
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.68
PRK14879	211	serine/threonine protein kinase; Provisional	99.67
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.67
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.65
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.61
cd07308	218	lectin_leg-like legume-like lectins: ERGIC-53, ERG	99.58
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.57
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.54
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.51
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.51
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.45
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.4
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.37
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.26
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.22
cd06902	225	lectin_ERGIC-53_ERGL ERGIC-53 and ERGL type 1 tran	99.17
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.15
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.12
cd06901	248	lectin_VIP36_VIPL VIP36 and VIPL type 1 transmembr	99.1
KOG1243	690	consensus Protein kinase [General function predict	99.03
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.02
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.99
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.86
KOG3087	229	consensus Serine/threonine protein kinase [General	98.79
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.66
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.66
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.66
PF03388	229	Lectin_leg-like: Legume-like lectin family; InterP	98.59
cd06903	215	lectin_EMP46_EMP47 EMP46 and EMP47 type 1 transmem	98.57
COG4248	637	Uncharacterized protein with protein kinase and he	98.54
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.47
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.46
PRK09902	216	hypothetical protein; Provisional	98.21
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.21
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.19
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.13
KOG3838	497	consensus Mannose lectin ERGIC-53, involved in gly	98.1
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	97.91
KOG3839	351	consensus Lectin VIP36, involved in the transport	97.79
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.79
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.76
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	97.73
PF01636	239	APH: Phosphotransferase enzyme family This family	97.7
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.67
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.65
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.64
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.53
PLN02876	822	acyl-CoA dehydrogenase	97.48
PRK10593	297	hypothetical protein; Provisional	97.24
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.18
cd06900	255	lectin_VcfQ VcfQ bacterial pilus biogenesis protei	97.17
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.15
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.11
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	96.81
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	96.8
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	96.75
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	96.74
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	96.49
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	96.38
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.26
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	96.25
PRK05231	319	homoserine kinase; Provisional	96.07
PLN02756	418	S-methyl-5-thioribose kinase	95.98
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	95.25
PLN02236	344	choline kinase	95.21
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	94.92
KOG1236	565	consensus Predicted unusual protein kinase [Genera	94.88
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	94.81
KOG2268	465	consensus Serine/threonine protein kinase [Signal	94.38
KOG1093	725	consensus Predicted protein kinase (contains TBC a	94.2
PRK12396	409	5-methylribose kinase; Reviewed	93.88
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	93.43
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	93.42

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-56  Score=469.37  Aligned_cols=275  Identities=44%  Similarity=0.785  Sum_probs=247.5

Q ss_pred             cccccCHHHHHHHhcCCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeec
Q 047719          270 VPMRLALTDIKQATLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQ  349 (596)
Q Consensus       270 ~~~~~~~~el~~at~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~  349 (596)
                      ....|++.||+.||++|+..++||+|+||.||+|.+.+|..||||++.......  ..+|.+|+..+.+ ++|||||+|+
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~-l~H~Nlv~Ll  137 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSR-LRHPNLVKLL  137 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhc-CCCcCcccEE
Confidence            456799999999999999999999999999999999999999999885433221  5569999966655 8999999999


Q ss_pred             ceeeeCC-eEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCc
Q 047719          350 GWCCEGN-ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFN  428 (596)
Q Consensus       350 g~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~  428 (596)
                      |||.+.+ +.+||||||++|+|.++|+.....  +|+|.+|++||.++|+||+|||+.+.++||||||||+|||||++++
T Consensus       138 GyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~  215 (361)
T KOG1187|consen  138 GYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFN  215 (361)
T ss_pred             EEEecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCC
Confidence            9999999 599999999999999999986543  7999999999999999999999999889999999999999999999


Q ss_pred             eEEccCCCcc---c---------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCC----ChhHHHHHHH
Q 047719          429 AKLGDFEATI---P---------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDND----GCVIVDWVWN  492 (596)
Q Consensus       429 ~kl~Dfg~~~---~---------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~----~~~~~~~~~~  492 (596)
                      +||+|||++.   .         .||.+|+|||++..+..|.|+|||||||+|+||+||+.+.+..    ...+++|.+.
T Consensus       216 aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~  295 (361)
T KOG1187|consen  216 AKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKP  295 (361)
T ss_pred             EEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHH
Confidence            9999999753   1         6899999999999999999999999999999999999988753    2358999999


Q ss_pred             HHhcCCchhhcccccc-CcCCH-HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Q 047719          493 LRKKGKLLDAADFRLR-GKFNR-KEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEAP  549 (596)
Q Consensus       493 ~~~~~~~~~~~d~~l~-~~~~~-~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~~~  549 (596)
                      ....+.+.+++|+++. ..++. +++.++..++++|++.+|++||+|.||+++|+....
T Consensus       296 ~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  296 LLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             HHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence            9999999999999987 67765 789999999999999999999999999999965443

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-46  Score=389.63  Aligned_cols=242  Identities=34%  Similarity=0.520  Sum_probs=202.1

Q ss_pred             cceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCC-eEEEEEecCCC
Q 047719          289 NRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGN-ELVLVYEYLPN  367 (596)
Q Consensus       289 ~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~-~~~lV~E~~~~  367 (596)
                      .+.||+|+||+||+|.++....||||++..........++|.+|+..|.+ ++|||||+++|+|.+.. .++||||||++
T Consensus        46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~-l~HpNIV~f~G~~~~~~~~~~iVtEy~~~  124 (362)
T KOG0192|consen   46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSR-LRHPNIVQFYGACTSPPGSLCIVTEYMPG  124 (362)
T ss_pred             hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHh-CCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence            35599999999999999655559999997655444446789999966655 99999999999999988 79999999999


Q ss_pred             CCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCC-eEEccCCCCceeecCCC-ceEEccCCCcc-------
Q 047719          368 GSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQ-IIHRDVKACNILLDAEF-NAKLGDFEATI-------  438 (596)
Q Consensus       368 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~-ivHrDlkp~NiLl~~~~-~~kl~Dfg~~~-------  438 (596)
                      |+|.++|+...  ...++|..+++++.|||+||.|||+   .+ ||||||||+||||+.++ ++||+|||+++       
T Consensus       125 GsL~~~l~~~~--~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~  199 (362)
T KOG0192|consen  125 GSLSVLLHKKR--KRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKT  199 (362)
T ss_pred             CcHHHHHhhcc--cCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeeccccc
Confidence            99999998841  3469999999999999999999999   66 99999999999999997 99999999763       


Q ss_pred             ----cCCCcccCCccccc--cCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCC
Q 047719          439 ----PAGTMGYLAPEYVY--SGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFN  512 (596)
Q Consensus       439 ----~~gt~~y~aPE~~~--~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  512 (596)
                          ..||+.|||||.+.  ...|+.|+|||||||+||||+||+.||.....  ..........+         .+...+
T Consensus       200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~--~~~~~~v~~~~---------~Rp~~p  268 (362)
T KOG0192|consen  200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP--VQVASAVVVGG---------LRPPIP  268 (362)
T ss_pred             cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH--HHHHHHHHhcC---------CCCCCC
Confidence                35899999999999  56999999999999999999999999987643  11121222222         223333


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          513 RKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       513 ~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                      ......+..|+..||+.||++||++.+++..|+..
T Consensus       269 ~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~  303 (362)
T KOG0192|consen  269 KECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESI  303 (362)
T ss_pred             ccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence            34566778888899999999999999999999854

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-46  Score=388.10  Aligned_cols=239  Identities=29%  Similarity=0.449  Sum_probs=204.9

Q ss_pred             ccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecCCC
Q 047719          288 KNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPN  367 (596)
Q Consensus       288 ~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  367 (596)
                      ..+.||+|.||.||.|.++....||+|.++..   ....+.|.+|++.|.+ ++|+|||+|+|+|...+.+|||||||++
T Consensus       210 l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~---~m~~~~f~~Ea~iMk~-L~H~~lV~l~gV~~~~~piyIVtE~m~~  285 (468)
T KOG0197|consen  210 LIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG---SMSPEAFLREAQIMKK-LRHEKLVKLYGVCTKQEPIYIVTEYMPK  285 (468)
T ss_pred             HHHHhcCCccceEEEEEEcCCCcccceEEecc---ccChhHHHHHHHHHHh-CcccCeEEEEEEEecCCceEEEEEeccc
Confidence            34789999999999999988889999999653   2344678999988876 9999999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcccCC------
Q 047719          368 GSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG------  441 (596)
Q Consensus       368 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~~g------  441 (596)
                      |+|.+||+...  ...+...+.+.++.|||+||+||++   +++|||||.++||||+++..+||+|||+++..+      
T Consensus       286 GsLl~yLr~~~--~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~  360 (468)
T KOG0197|consen  286 GSLLDYLRTRE--GGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA  360 (468)
T ss_pred             CcHHHHhhhcC--CCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCCCceee
Confidence            99999999733  3358889999999999999999999   999999999999999999999999999998642      


Q ss_pred             ------CcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHH
Q 047719          442 ------TMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRK  514 (596)
Q Consensus       442 ------t~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  514 (596)
                            ...|.|||.+..++++.|||||||||+||||+| |+.||.....  .+          +.+.++...+-..+..
T Consensus       361 ~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn--~e----------v~~~le~GyRlp~P~~  428 (468)
T KOG0197|consen  361 SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN--EE----------VLELLERGYRLPRPEG  428 (468)
T ss_pred             cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH--HH----------HHHHHhccCcCCCCCC
Confidence                  356999999999999999999999999999999 9999987532  11          2222333334445556


Q ss_pred             HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          515 EMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       515 ~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                      +...+.+||..||+.+|++|||++.+...|+..
T Consensus       429 CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~  461 (468)
T KOG0197|consen  429 CPDEVYELMKSCWHEDPEDRPTFETLREVLEDF  461 (468)
T ss_pred             CCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence            777889999999999999999999988888754

>cd06899 lectin_legume_LecRK_Arcelin_ConA legume lectins, lectin-like receptor kinases, arcelin, concanavalinA, and alpha-amylase inhibitor

Probab=100.00  E-value=2e-44  Score=355.99  Aligned_cols=180  Identities=36%  Similarity=0.581  Sum_probs=164.0

Q ss_pred             CCCCCCCcccceEEEEEEEEecCCCCCCCCeEEEEEecCCC-CCCCCCCccCCCCCC-CC-CCCceEEEEeeCccCCCCC
Q 047719            1 FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNAD-SFGNDNGYMGLPGPV-LS-PQDSFFAVEFDTSFDPSLG   77 (596)
Q Consensus         1 ~~~~~~~~~asF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~-~~~~~~~~lG~~~~~-~~-~~~~~~AVEfDt~~~~~~~   77 (596)
                      |||+.+++++||+|+|+|.|.+.+...+||||||||+|.+. +.+..|+|||+++.. ++ ..++.|||||||++|.+++
T Consensus        52 l~~~~~~~~~sFst~F~F~i~~~~~~~~gdGlAF~i~~~~~~~~~~~G~~lG~~~~~~~~~~~~~~vAVEFDT~~n~~~~  131 (236)
T cd06899          52 LWDSTTGKVASFSTSFSFSITPPNPSLGGDGLAFFLAPTDSLPPASSGGYLGLFNSSNNGNSSNHIVAVEFDTFQNPEFG  131 (236)
T ss_pred             eecCCCCCceeEEEEEEEEEEcCCCCCCCCeEEEEEecCCCCCCCCCcceeeeecCCCCCCcccceEEEEeecccCcccC
Confidence            68999999999999999999987777889999999999877 456899999999887 33 3789999999999999888


Q ss_pred             CCCCCeeEEecCCccccccccCCCCCcccCCCceEEEEEEEcCCccEEEEEEeeCC-CCCCCCeEEEeecCcccCCCceE
Q 047719           78 DINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRDSLKLIRVWAGYSQ-IRPPSPLIIAQIDLSKQFKDYMH  156 (596)
Q Consensus        78 d~~~~Hvgid~ns~~s~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~-~~~~~p~l~~~vdl~~~l~~~~~  156 (596)
                      ||++||||||+|++.|..+..+......|.+|+.++|||+||+.+++|+|++.... .+|..|+|+..+||+.+|+++||
T Consensus       132 D~~~nHigIdvn~~~S~~~~~~~~~~~~l~~g~~~~v~I~Y~~~~~~L~V~l~~~~~~~~~~~~ls~~vdL~~~l~~~~~  211 (236)
T cd06899         132 DPDDNHVGIDVNSLVSVKAGYWDDDGGKLKSGKPMQAWIDYDSSSKRLSVTLAYSGVAKPKKPLLSYPVDLSKVLPEEVY  211 (236)
T ss_pred             CCCCCeEEEEcCCcccceeeccccccccccCCCeEEEEEEEcCCCCEEEEEEEeCCCCCCcCCEEEEeccHHHhCCCceE
Confidence            99999999999999998887776556678999999999999999999999999844 48889999999999999999999


Q ss_pred             EEEEeecCCccceeeeeeeeeecc
Q 047719          157 VGFSAANGQGSAIYTVDRWRFKTF  180 (596)
Q Consensus       157 vGFsastg~~~~~~~i~~Wsf~~~  180 (596)
                      ||||||||...|.|+|++|+|+++
T Consensus       212 vGFSasTG~~~~~h~i~sWsF~s~  235 (236)
T cd06899         212 VGFSASTGLLTELHYILSWSFSSN  235 (236)
T ss_pred             EEEEeEcCCCcceEEEEEEEEEcC
Confidence            999999999999999999999975

This alignment model includes the legume lectins (also known as agglutinins), the arcelin (also known as phytohemagglutinin-L) family of lectin-like defense proteins, the LecRK family of lectin-like receptor kinases, concanavalinA (ConA), and an alpha-amylase inhibitor. Arcelin is a major seed glycoprotein discovered in kidney beans (Phaseolus vulgaris) that has insecticidal properties and protects the seeds from predation by larvae of various bruchids. Arcelin is devoid of monosaccharide binding properties and lacks a key metal-binding loop that is present in other members of this family. Phytohaemagglutinin (PHA) is a lectin found in plants, especially beans, that affects cell metabolism by inducing mitosis and by altering the permeability of the cell membrane to various proteins. PHA agglutinates most mammalian red blood cell types by bindin

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=3.3e-45  Score=397.35  Aligned_cols=248  Identities=29%  Similarity=0.437  Sum_probs=208.6

Q ss_pred             CCCccceeecCCceEEEEEEcCC------CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeE
Q 047719          285 GFNKNRIVGEGASATVYKGSLPS------GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNEL  358 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~~------g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~  358 (596)
                      +....+.||+|.||+||+|....      ...||||.++.. ...+.+.+|.+|++.+ ..++|||||+|+|.|.+++.+
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~-a~~~~~~dF~REaeLl-a~l~H~nIVrLlGVC~~~~P~  564 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK-AENQARQDFRREAELL-AELQHPNIVRLLGVCREGDPL  564 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc-ccHHHHHHHHHHHHHH-HhccCCCeEEEEEEEccCCee
Confidence            34445889999999999997532      457999999743 3445778999999555 559999999999999999999


Q ss_pred             EEEEecCCCCCHHHHhhhCCCC----------CcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCc
Q 047719          359 VLVYEYLPNGSLDKILHNNSSS----------SIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFN  428 (596)
Q Consensus       359 ~lV~E~~~~gsL~~~l~~~~~~----------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~  428 (596)
                      |+|+|||..|+|.+||......          +.+|+..+.+.||.|||.||+||-+   +.+|||||..+|+||.++..
T Consensus       565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge~l~  641 (774)
T KOG1026|consen  565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGENLV  641 (774)
T ss_pred             EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CcccccchhhhhceeccceE
Confidence            9999999999999999765321          2348899999999999999999999   99999999999999999999


Q ss_pred             eEEccCCCcccC-------------CCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHH
Q 047719          429 AKLGDFEATIPA-------------GTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLR  494 (596)
Q Consensus       429 ~kl~Dfg~~~~~-------------gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~  494 (596)
                      |||+|||+++..             -..+|||||.+..+++|.+||||||||+|||+++ |+.||.+-..   +-|.+..
T Consensus       642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn---~EVIe~i  718 (774)
T KOG1026|consen  642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN---QEVIECI  718 (774)
T ss_pred             EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch---HHHHHHH
Confidence            999999998653             1368999999999999999999999999999999 9999976422   2233444


Q ss_pred             hcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Q 047719          495 KKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEAP  549 (596)
Q Consensus       495 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~~~  549 (596)
                      ..+++.         ..++.....+..||+.||+.+|++||+++||...|+....
T Consensus       719 ~~g~lL---------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~  764 (774)
T KOG1026|consen  719 RAGQLL---------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ  764 (774)
T ss_pred             HcCCcc---------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence            555443         3455677889999999999999999999999999987654

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2e-44  Score=358.70  Aligned_cols=245  Identities=28%  Similarity=0.405  Sum_probs=200.6

Q ss_pred             cCHHHHHHHhcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeeccee
Q 047719          274 LALTDIKQATLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWC  352 (596)
Q Consensus       274 ~~~~el~~at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~  352 (596)
                      .++.||+.       .+.||+|..|+|||+.++ ++..+|+|++.. ......+++..+|++.+.. .+||+||.++|.|
T Consensus        76 i~~~dle~-------~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~-~~~~~~~~Qi~rEl~il~~-~~spyIV~~ygaF  146 (364)
T KOG0581|consen   76 ISLSDLER-------LGVLGSGNGGTVYKVRHKPTGKIYALKVILL-NIDPALQKQILRELEILRS-CQSPYIVGFYGAF  146 (364)
T ss_pred             cCHHHhhh-------hhhcccCCCcEEEEEEEcCCCeEEEEEeecc-cCCHHHHHHHHHHHHHHhh-CCCCCeeeEeEEE
Confidence            45555543       478999999999999876 488899999953 3334566788999977776 6999999999999


Q ss_pred             eeCC-eEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEE
Q 047719          353 CEGN-ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKL  431 (596)
Q Consensus       353 ~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl  431 (596)
                      ...+ ++.|+||||.+|||++++...+    .+++...-+|+.+|++||.|||++  ++||||||||+||||+..|.+||
T Consensus       147 ~~~~~~isI~mEYMDgGSLd~~~k~~g----~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKi  220 (364)
T KOG0581|consen  147 YSNGEEISICMEYMDGGSLDDILKRVG----RIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKI  220 (364)
T ss_pred             EeCCceEEeehhhcCCCCHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEe
Confidence            9999 5999999999999999998753    488999999999999999999974  89999999999999999999999


Q ss_pred             ccCCCcc---------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCCh---hHHHHHHHHHhcCCc
Q 047719          432 GDFEATI---------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGC---VIVDWVWNLRKKGKL  499 (596)
Q Consensus       432 ~Dfg~~~---------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~---~~~~~~~~~~~~~~~  499 (596)
                      ||||.+.         .+||..|||||.+.+..|+.++||||||+.++|+++|+.|+.....   ...+.+.....+   
T Consensus       221 cDFGVS~~lvnS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~---  297 (364)
T KOG0581|consen  221 CDFGVSGILVNSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDE---  297 (364)
T ss_pred             ccccccHHhhhhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcC---
Confidence            9999653         4699999999999999999999999999999999999999987422   122212111111   


Q ss_pred             hhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          500 LDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       500 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                         ..+++...   .....+..++-.|+++||.+||+++|+++
T Consensus       298 ---ppP~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  298 ---PPPRLPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             ---CCCCCCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence               11122221   24456778888999999999999999987

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-42  Score=363.26  Aligned_cols=240  Identities=27%  Similarity=0.409  Sum_probs=200.9

Q ss_pred             cCCCccceeecCCceEEEEEEc-CCCCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSL-PSGGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      ..|...++||+|||+.||+++. ..|+.||+|++.+.... ...++...+||+. -+.++|||||+++++|.+..+.|||
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeI-Hr~L~HpnIV~f~~~FEDs~nVYiv   96 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEI-HRSLKHPNIVQFYHFFEDSNNVYIV   96 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHH-HHhcCCCcEEeeeeEeecCCceEEE
Confidence            5688899999999999999987 67999999999764332 3345668889854 4559999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc---
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI---  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---  438 (596)
                      .|+|++|+|..+++.+.    ++++.++..++.||+.||.|||+   .+|+|||||..|+||++++++||+|||++.   
T Consensus        97 LELC~~~sL~el~Krrk----~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le  169 (592)
T KOG0575|consen   97 LELCHRGSLMELLKRRK----PLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLE  169 (592)
T ss_pred             EEecCCccHHHHHHhcC----CCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeec
Confidence            99999999999998543    69999999999999999999999   899999999999999999999999999874   


Q ss_pred             --------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCc
Q 047719          439 --------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGK  510 (596)
Q Consensus       439 --------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  510 (596)
                              .+||+.|+|||++....++..+||||+||+||-|+.|++||+...  +.+-. .....      .+.    .
T Consensus       170 ~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~--vkety-~~Ik~------~~Y----~  236 (592)
T KOG0575|consen  170 YDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT--VKETY-NKIKL------NEY----S  236 (592)
T ss_pred             CcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch--HHHHH-HHHHh------cCc----c
Confidence                    369999999999999999999999999999999999999998752  11111 11111      111    1


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HH
Q 047719          511 FNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR--IL  544 (596)
Q Consensus       511 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L  544 (596)
                      ++........+|+...+++||.+|||+++|++  ++
T Consensus       237 ~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff  272 (592)
T KOG0575|consen  237 MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFF  272 (592)
T ss_pred             cccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence            22234455667778889999999999999987  55

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-42  Score=347.39  Aligned_cols=192  Identities=31%  Similarity=0.460  Sum_probs=172.9

Q ss_pred             hcCCCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      ..+|...+.||+|+||.||+|+++. +..||||.+.+........+.+..|+..+.. ++|||||+|++++..++.+|||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLke-l~H~nIV~l~d~~~~~~~i~lV   87 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKE-LKHPNIVRLLDCIEDDDFIYLV   87 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHh-cCCcceeeEEEEEecCCeEEEE
Confidence            3467778889999999999998764 8899999998765455566678889966654 9999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCC------CceEEccCC
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAE------FNAKLGDFE  435 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~------~~~kl~Dfg  435 (596)
                      ||||.+|+|.+||+..+    .+++.....++.|||.||++||+   ++||||||||+||||+..      -.+||+|||
T Consensus        88 MEyC~gGDLs~yi~~~~----~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG  160 (429)
T KOG0595|consen   88 MEYCNGGDLSDYIRRRG----RLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFG  160 (429)
T ss_pred             EEeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccc
Confidence            99999999999999875    48999999999999999999999   999999999999999765      468999999


Q ss_pred             Ccc----------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCC
Q 047719          436 ATI----------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDND  482 (596)
Q Consensus       436 ~~~----------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~  482 (596)
                      +++          .+|++.|||||++..++|+.|+|+||.|++|||+++|+.||+..
T Consensus       161 fAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~  217 (429)
T KOG0595|consen  161 FARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE  217 (429)
T ss_pred             hhhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence            875          46999999999999999999999999999999999999999864

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-44  Score=378.58  Aligned_cols=257  Identities=25%  Similarity=0.416  Sum_probs=217.3

Q ss_pred             ccCHHHHHHHhcCC---------CccceeecCCceEEEEEEcCC----CCEEEEEEeecCCchhcccchHHHHHHHHHhc
Q 047719          273 RLALTDIKQATLGF---------NKNRIVGEGASATVYKGSLPS----GGAVAVKRFEKPNRVECARNPFTTEFATMAGC  339 (596)
Q Consensus       273 ~~~~~el~~at~~f---------~~~~~LG~G~fG~Vy~~~~~~----g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~  339 (596)
                      .++|+|--+|...|         .++++||.|.||.||+|+++-    ...||||.++. ...+.++.+|+.|. .+.+.
T Consensus       609 P~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~-GytekqrrdFL~EA-sIMGQ  686 (996)
T KOG0196|consen  609 PHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKA-GYTEKQRRDFLSEA-SIMGQ  686 (996)
T ss_pred             CccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeecc-CccHHHHhhhhhhh-hhccc
Confidence            45677766666555         346899999999999998864    34799999974 34566778999999 45566


Q ss_pred             cCCCceeeecceeeeCCeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCC
Q 047719          340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKAC  419 (596)
Q Consensus       340 l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~  419 (596)
                      .+||||++|.|+.......+||+|||+||+|+.||+.+.+   .+.+.+...++++||.||.||.+   .++|||||.++
T Consensus       687 FdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DG---qftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAAR  760 (996)
T KOG0196|consen  687 FDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDG---QFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAAR  760 (996)
T ss_pred             CCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCC---ceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhh
Confidence            9999999999999999999999999999999999998763   48999999999999999999999   99999999999


Q ss_pred             ceeecCCCceEEccCCCcccC------------C--CcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCCh
Q 047719          420 NILLDAEFNAKLGDFEATIPA------------G--TMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGC  484 (596)
Q Consensus       420 NiLl~~~~~~kl~Dfg~~~~~------------g--t~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~  484 (596)
                      |||++.+..+|++|||+++..            |  ..+|.|||.+..+++|.+||||||||+|||+++ |.+||-+..+
T Consensus       761 NILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN  840 (996)
T KOG0196|consen  761 NILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN  840 (996)
T ss_pred             heeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch
Confidence            999999999999999998643            1  257999999999999999999999999999999 9999865322


Q ss_pred             hHHHHHHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Q 047719          485 VIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEAP  549 (596)
Q Consensus       485 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~~~  549 (596)
                                  .++...+....+...+.++...+.+||+.|||+|-.+||.+.+|+..|.+...
T Consensus       841 ------------QdVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr  893 (996)
T KOG0196|consen  841 ------------QDVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR  893 (996)
T ss_pred             ------------HHHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence                        22334444445555566778889999999999999999999999999986543

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-43  Score=339.56  Aligned_cols=248  Identities=25%  Similarity=0.345  Sum_probs=202.2

Q ss_pred             CCccceeecCCceEEEEEE-cCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecce-eeeCCe-EEEEE
Q 047719          286 FNKNRIVGEGASATVYKGS-LPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW-CCEGNE-LVLVY  362 (596)
Q Consensus       286 f~~~~~LG~G~fG~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~-~~~~~~-~~lV~  362 (596)
                      |...++||+|.||+|||+. +.+|..||.|.+.-.......++....|+..+ +.++|||||+++++ +.++.+ ++|||
T Consensus        21 y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lL-kQL~HpNIVqYy~~~f~~~~evlnivm   99 (375)
T KOG0591|consen   21 YQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLL-KQLNHPNIVQYYAHSFIEDNEVLNIVM   99 (375)
T ss_pred             HHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHH-HhcCCchHHHHHHHhhhccchhhHHHH
Confidence            5566899999999999995 55799999999986666666778899999555 55999999999994 555555 89999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCC-CeEEccCCCCceeecCCCceEEccCCCcc---
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECER-QIIHRDVKACNILLDAEFNAKLGDFEATI---  438 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~-~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---  438 (596)
                      |||..|+|..+++.-......+++..++++..|++.||.++|..+.+ -|+||||||.||+|+.+|.+||+|||+++   
T Consensus       100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~  179 (375)
T KOG0591|consen  100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS  179 (375)
T ss_pred             HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence            99999999999987666667799999999999999999999995543 38999999999999999999999999754   


Q ss_pred             --------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCc
Q 047719          439 --------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGK  510 (596)
Q Consensus       439 --------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  510 (596)
                              .+||+.||+||.+....|+.||||||+||++|||+.-++||.++.  +... .+....++..         .
T Consensus       180 s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n--~~~L-~~KI~qgd~~---------~  247 (375)
T KOG0591|consen  180 SKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN--LLSL-CKKIEQGDYP---------P  247 (375)
T ss_pred             chhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc--HHHH-HHHHHcCCCC---------C
Confidence                    369999999999999999999999999999999999999998762  2211 1222222221         1


Q ss_pred             CC-HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          511 FN-RKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       511 ~~-~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                      .+ .-....+..|+..|+..||+.||+.-.+++.+..
T Consensus       248 ~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  248 LPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             CcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence            22 3455677888899999999999985555554443

>PF00139 Lectin_legB: Legume lectin domain; InterPro: IPR001220 Legume lectins are one of the largest lectin families with more than 70 lectins reported

Probab=100.00  E-value=4e-42  Score=340.55  Aligned_cols=178  Identities=36%  Similarity=0.570  Sum_probs=157.2

Q ss_pred             CCCCCCCcccceEEEEEEEEecC--CCCCCCCeEEEEEecCCC-CCCCCCCccCCCCCC-CCC-CCceEEEEeeCccCCC
Q 047719            1 FLDPKTNTTASFSCRFSFSIIPS--PLCAFGDGFAFLITSNAD-SFGNDNGYMGLPGPV-LSP-QDSFFAVEFDTSFDPS   75 (596)
Q Consensus         1 ~~~~~~~~~asF~t~F~f~i~~~--~~~~~g~G~aF~l~~~~~-~~~~~~~~lG~~~~~-~~~-~~~~~AVEfDt~~~~~   75 (596)
                      |||..+++++||+|+|+|.|...  ....+||||||||+|++. +.++.|++||+.+.. ++. .++.|||||||++|++
T Consensus        51 l~d~~~~~~~sF~t~F~f~i~~~~~~~~~~~dGlAFvi~~~~~~~~~~~g~~lG~~~~~~~~~~~~~~vAVEFDT~~N~~  130 (236)
T PF00139_consen   51 LWDSTTGNVASFSTSFSFSITNGPGSSNNGGDGLAFVIQPDPNLPGGSSGGYLGLFNSSTDGNGINNSVAVEFDTYKNPE  130 (236)
T ss_dssp             SBETTTTEBEEEEEEEEEEEEESSSSSSS-BEEEEEEEEETTSSTTTSSGGGTTTSSSSSTTGGGGCEEEEEEETSTCGG
T ss_pred             EeCCCCcceeeeeeEEEEEEeccCCCCccCCCceEEEEecCcccccCCCCCccCccccccCCCccCcEEEEEEeeeeccc
Confidence            69999999999999999999643  567789999999999887 455689999998876 343 6889999999999999


Q ss_pred             CCCCCCCeeEEecCCccccccccCC---CCCcccCCCceEEEEEEEcCCccEEEEEEeeCCCCCCCCeEEEeecCcccCC
Q 047719           76 LGDINGNHIGIDISSVISFVSVDAL---SRGIDLKSGRHITTWIEYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFK  152 (596)
Q Consensus        76 ~~d~~~~Hvgid~ns~~s~~~~~~~---~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~l~~~vdl~~~l~  152 (596)
                      ++||++||||||+|++.|..+.++.   ....+|.+|+.++|||+||+.+++|+|++.....+|..|+|+..+||+.+|+
T Consensus       131 ~~d~~~nHIgI~~n~~~s~~~~~~~~~~~~~~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~~~l~~~vdL~~~l~  210 (236)
T PF00139_consen  131 YNDPDDNHIGIDVNSVVSNKTASAGYYSSPSFSLSDGKWHTVWIDYDASTKRLSVYLDDNSSKPSSPVLSVNVDLSAVLP  210 (236)
T ss_dssp             GTTTSSSEEEEEESSSSESEEEE----EEEEHHHGTTSEEEEEEEEETTTTEEEEEEEETTTTSEEEEEEEE--HHHHSC
T ss_pred             ccccCCCEEEEECCCCcccccccccccccccccccCCcEEEEEEEEcCCccEEEEEEecccCCCcceeEEEEEchHHhcC
Confidence            9999999999999999998886654   3467899999999999999999999999998767888999999999999999


Q ss_pred             CceEEEEEeecCCccceeeeeeeeee
Q 047719          153 DYMHVGFSAANGQGSAIYTVDRWRFK  178 (596)
Q Consensus       153 ~~~~vGFsastg~~~~~~~i~~Wsf~  178 (596)
                      ++||||||||||...|.|.|++|+|+
T Consensus       211 ~~v~vGFsasTG~~~~~h~I~sW~F~  236 (236)
T PF00139_consen  211 EQVYVGFSASTGGSYQTHDILSWSFS  236 (236)
T ss_dssp             SEEEEEEEEEESSSSEEEEEEEEEEE
T ss_pred             CCcEEEEEeecCCCcceEEEEEEEeC
Confidence            99999999999999999999999996

Leguminous plant lectins resemble each other in their physicochemical properties although they differ in their carbohydrate specificities. They consist of two or four subunits with relative molecular mass of 30 kDa and each subunit has one carbohydrate-binding site. The interaction with sugars requires tightly bound calcium and manganese ions. The structural similarities of these lectins are reported by the primary structural analyses and X-ray crystallographic studies. X-ray studies have shown that the folding of the polypeptide chains in the region of the carbohydrate-binding sites is also similar, despite differences in the primary sequences. The carbohydrate-binding sites of these lectins consist of two conserved amino acids on beta pleated sheets. One of these loops contains transition metals, calcium and manganese, which keep the amino acid residues of the sugar-binding site at the required positions. Amino acid sequences of this loop play an important role in the carbohydrate-binding specificities of these lectins. These lectins bind either glucose/mannose or galactose. The exact function of legume lectins is not known but they may be involved in the attachment of nitrogen-fixing bacteria to legumes and in the protection against pathogens. Some legume lectins are proteolytically processed to produce two chains, beta (which corresponds to the N-terminal) and alpha (C-terminal) (IPR000985 from INTERPRO). The lectin concanavalin A (conA) from jack bean is exceptional in that the two chains are transposed and ligated (by formation of a new peptide bond). The N terminus of mature conA thus corresponds to that of the alpha chain and the C terminus to the beta chain.; GO: 0005488 binding; PDB: 1VLN_B 2GDF_C 2JE9_C 2JEC_C 1DGL_B 2P37_B 2CWM_A 2P34_D 2OW4_A 3IPV_B ....

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.1e-42  Score=343.63  Aligned_cols=241  Identities=26%  Similarity=0.328  Sum_probs=196.3

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcc-----cchHHHHHHHHHhccCCCceeeecceeeeCCe
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECA-----RNPFTTEFATMAGCLRHKNLVQLQGWCCEGNE  357 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~-----~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~  357 (596)
                      +.|...+.||+|+||.|-+|..+ +|+.||||.+++.....+.     .....+|++.|.+ ++|||||++++++...+.
T Consensus       172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkk-L~HP~IV~~~d~f~~~ds  250 (475)
T KOG0615|consen  172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKK-LSHPNIVRIKDFFEVPDS  250 (475)
T ss_pred             ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHh-cCCCCEEEEeeeeecCCc
Confidence            34667899999999999999654 5999999999865443322     2234588877765 999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCC---CceEEccC
Q 047719          358 LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAE---FNAKLGDF  434 (596)
Q Consensus       358 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~---~~~kl~Df  434 (596)
                      .|+|||||.+|+|.+++-.+.    .+.+..-..+++|++.|+.|||+   +||+||||||+|||+..+   ..+||+||
T Consensus       251 ~YmVlE~v~GGeLfd~vv~nk----~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItDF  323 (475)
T KOG0615|consen  251 SYMVLEYVEGGELFDKVVANK----YLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITDF  323 (475)
T ss_pred             eEEEEEEecCccHHHHHHhcc----ccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEeccc
Confidence            999999999999999998765    36777778899999999999999   999999999999999766   78999999


Q ss_pred             CCcc----------cCCCcccCCccccccCC---CCCccceeehhHHHHHHHhCCCCCCCCChh--HHHHHHHHHhcCCc
Q 047719          435 EATI----------PAGTMGYLAPEYVYSGV---PSEKTDVYSFGVVALEVAAGKSPVDNDGCV--IVDWVWNLRKKGKL  499 (596)
Q Consensus       435 g~~~----------~~gt~~y~aPE~~~~~~---~t~~sDV~SfGvll~El~tG~~p~~~~~~~--~~~~~~~~~~~~~~  499 (596)
                      |++.          .+||+.|.|||++.+..   +..+.|+||+||+||-+++|.+||++.-..  +.    +....++.
T Consensus       324 GlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~----eQI~~G~y  399 (475)
T KOG0615|consen  324 GLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLK----EQILKGRY  399 (475)
T ss_pred             chhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHH----HHHhcCcc
Confidence            9874          46999999999998643   345889999999999999999999874221  21    11222221


Q ss_pred             hhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          500 LDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       500 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                            ........+..++.++|+.+++..||++|||+.|+++
T Consensus       400 ------~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  400 ------AFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             ------cccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence                  1122344567788999999999999999999999987

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-42  Score=339.52  Aligned_cols=233  Identities=26%  Similarity=0.305  Sum_probs=191.1

Q ss_pred             hcCCCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCchhc-ccchHHHHHHHHHhccCCCceeeecceeeeCCeEEE
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRVEC-ARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVL  360 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~-~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~l  360 (596)
                      .+.|...++||+|+||+||.++..+ ++.+|+|++++....+. ......+|..++.+ ++||.||+|+..|++.+.+||
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~-v~hPFiv~l~ysFQt~~kLyl  102 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSK-IKHPFIVKLIYSFQTEEKLYL  102 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHh-CCCCcEeeeEEecccCCeEEE
Confidence            4568899999999999999997655 88999999987655443 33446677755555 999999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc--
Q 047719          361 VYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI--  438 (596)
Q Consensus       361 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~--  438 (596)
                      |+||+.||.|..+|++.+    .+++..+.-.+.+|+.||.|||+   .+||||||||+|||||++|+++|+|||++.  
T Consensus       103 Vld~~~GGeLf~hL~~eg----~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~  175 (357)
T KOG0598|consen  103 VLDYLNGGELFYHLQREG----RFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKED  175 (357)
T ss_pred             EEeccCCccHHHHHHhcC----CcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence            999999999999999765    48888899999999999999999   999999999999999999999999999864  


Q ss_pred             ---------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccC
Q 047719          439 ---------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRG  509 (596)
Q Consensus       439 ---------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  509 (596)
                               .+||+.|||||.+.+..|+..+|+||+||++|||++|.+||...+  ...+........ +      ...+
T Consensus       176 ~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~--~~~~~~~I~~~k-~------~~~p  246 (357)
T KOG0598|consen  176 LKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED--VKKMYDKILKGK-L------PLPP  246 (357)
T ss_pred             ccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc--HHHHHHHHhcCc-C------CCCC
Confidence                     379999999999999999999999999999999999999998753  222222222211 0      1111


Q ss_pred             cCCHHHHHHHHHHHHHcCCCCCCCCC
Q 047719          510 KFNRKEMERMLMVGLSCVHPNHEKRP  535 (596)
Q Consensus       510 ~~~~~~~~~l~~l~~~C~~~dp~~RP  535 (596)
                      .   -......+++...++.||++|-
T Consensus       247 ~---~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  247 G---YLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             c---cCCHHHHHHHHHHhccCHHHhc
Confidence            1   1233445556677899999996

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-41  Score=353.03  Aligned_cols=251  Identities=26%  Similarity=0.424  Sum_probs=203.0

Q ss_pred             HHhcCCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEE
Q 047719          281 QATLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVL  360 (596)
Q Consensus       281 ~at~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~l  360 (596)
                      ...+.+.....||+|.||+||+|.+-  ..||||++..........+.|.+|+..+.+ -+|.||+-+.|||..+.. .|
T Consensus       389 Ip~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkk-TRH~NIlLFMG~~~~p~~-AI  464 (678)
T KOG0193|consen  389 IPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKK-TRHENILLFMGACMNPPL-AI  464 (678)
T ss_pred             cCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhh-cchhhheeeehhhcCCce-ee
Confidence            33344556789999999999999983  469999998777777788899999976655 999999999999998877 99


Q ss_pred             EEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc-
Q 047719          361 VYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP-  439 (596)
Q Consensus       361 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~-  439 (596)
                      |+.+|++-+|+.||+...   ..++..+.++|+.|||+||.|||.   ++|||||||..||+|.+++.|||+|||+... 
T Consensus       465 iTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk  538 (678)
T KOG0193|consen  465 ITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLATVK  538 (678)
T ss_pred             eehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccceeee
Confidence            999999999999999764   358999999999999999999999   9999999999999999999999999998642 


Q ss_pred             ------------CCCcccCCcccccc---CCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhcc
Q 047719          440 ------------AGTMGYLAPEYVYS---GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAAD  504 (596)
Q Consensus       440 ------------~gt~~y~aPE~~~~---~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d  504 (596)
                                  .|...|||||++..   ..|+..+|||||||++|||+||..||........  +|.. ..|.+  ..|
T Consensus       539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI--ifmV-GrG~l--~pd  613 (678)
T KOG0193|consen  539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI--IFMV-GRGYL--MPD  613 (678)
T ss_pred             eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe--EEEe-ccccc--Ccc
Confidence                        36778999999975   4689999999999999999999999984322111  1111 11111  011


Q ss_pred             ccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Q 047719          505 FRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEAP  549 (596)
Q Consensus       505 ~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~~~  549 (596)
                      ..   ....+..+.|.+|...||..++++||.+.+|+..|+...+
T Consensus       614 ~s---~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  614 LS---KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             ch---hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence            10   1122345577788889999999999999999997775543

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-39  Score=335.65  Aligned_cols=251  Identities=25%  Similarity=0.366  Sum_probs=203.9

Q ss_pred             CCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEec
Q 047719          285 GFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEY  364 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~  364 (596)
                      .....++||+|-||.|.++....+..||||+++.. .....+++|..|++.|.+ ++|||||+|+|.|..++.+++|+||
T Consensus       539 ~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~-a~~~~r~~F~kEIkiLsq-LkhPNIveLvGVC~~DePicmI~EY  616 (807)
T KOG1094|consen  539 RLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPD-ATKNARNDFLKEIKILSR-LKHPNIVELLGVCVQDDPLCMITEY  616 (807)
T ss_pred             heehhhhhcCcccceeEEEEecCceEEEEeecCcc-cchhHHHHHHHHHHHHhc-cCCCCeeEEEeeeecCCchHHHHHH
Confidence            34556899999999999999977899999999754 334457899999988877 7999999999999999999999999


Q ss_pred             CCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcccC----
Q 047719          365 LPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA----  440 (596)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~~----  440 (596)
                      |++|+|.+||..+...  .+.-...++|+.|||+||+||.+   .++|||||.++|||+|.++++||+|||+++..    
T Consensus       617 mEnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~  691 (807)
T KOG1094|consen  617 MENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD  691 (807)
T ss_pred             HhcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccccccCC
Confidence            9999999999877422  24555677899999999999999   89999999999999999999999999988631    


Q ss_pred             ---------CCcccCCccccccCCCCCccceeehhHHHHHHHh--CCCCCCCCC-hhHHHHHHHHHhcCCchhhcccccc
Q 047719          441 ---------GTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA--GKSPVDNDG-CVIVDWVWNLRKKGKLLDAADFRLR  508 (596)
Q Consensus       441 ---------gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t--G~~p~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l~  508 (596)
                               -..+|||||.+..+++|.+||||+||++|||+++  ...||+.-. +..++-.-.+...+..      ...
T Consensus       692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~------~~~  765 (807)
T KOG1094|consen  692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGR------QVV  765 (807)
T ss_pred             ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCc------cee
Confidence                     2468999999999999999999999999999866  788997632 2233222222222111      111


Q ss_pred             CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Q 047719          509 GKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEA  548 (596)
Q Consensus       509 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~~  548 (596)
                      ...+.-+...++++++.||..+.++||+++++...|+...
T Consensus       766 l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~  805 (807)
T KOG1094|consen  766 LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA  805 (807)
T ss_pred             ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence            2223345567789999999999999999999999987643

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2.4e-40  Score=346.62  Aligned_cols=250  Identities=26%  Similarity=0.386  Sum_probs=196.2

Q ss_pred             hcCCCccceeecCCceEEEEEEc------CCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCC
Q 047719          283 TLGFNKNRIVGEGASATVYKGSL------PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGN  356 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~  356 (596)
                      .++|...++||+|+||.||+|..      ..+..||||++.... .......+.+|+..+....+||||++++++|...+
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            45688889999999999999963      235689999986432 22334568889977776449999999999987654


Q ss_pred             -eEEEEEecCCCCCHHHHhhhCCCC-------------------------------------------------------
Q 047719          357 -ELVLVYEYLPNGSLDKILHNNSSS-------------------------------------------------------  380 (596)
Q Consensus       357 -~~~lV~E~~~~gsL~~~l~~~~~~-------------------------------------------------------  380 (596)
                       .+++||||+++|+|.+++......                                                       
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence             689999999999999999753210                                                       


Q ss_pred             ---CcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc-------------CCCcc
Q 047719          381 ---SIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP-------------AGTMG  444 (596)
Q Consensus       381 ---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~-------------~gt~~  444 (596)
                         ...+++.+++.++.||++||+|||+   .+|+||||||+|||++.++.+||+|||++..             .++..
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence               1348889999999999999999999   8999999999999999999999999997642             23567


Q ss_pred             cCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHHHHHHHHHHH
Q 047719          445 YLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVG  523 (596)
Q Consensus       445 y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~  523 (596)
                      |+|||.+.+..++.++|||||||+||||++ |+.||......  +........+...     .    .+......+.+++
T Consensus       242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~--~~~~~~~~~~~~~-----~----~~~~~~~~l~~li  310 (338)
T cd05102         242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN--EEFCQRLKDGTRM-----R----APENATPEIYRIM  310 (338)
T ss_pred             ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc--HHHHHHHhcCCCC-----C----CCCCCCHHHHHHH
Confidence            999999999999999999999999999997 99999764321  1111111121111     1    1112334677899


Q ss_pred             HHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          524 LSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       524 ~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                      ..||+.||++|||+.|+++.|+..
T Consensus       311 ~~cl~~dp~~RPs~~el~~~l~~~  334 (338)
T cd05102         311 LACWQGDPKERPTFSALVEILGDL  334 (338)
T ss_pred             HHHccCChhhCcCHHHHHHHHHHH
Confidence            999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=6e-39  Score=380.83  Aligned_cols=252  Identities=28%  Similarity=0.499  Sum_probs=207.0

Q ss_pred             hcCCCccceeecCCceEEEEEEc-CCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          283 TLGFNKNRIVGEGASATVYKGSL-PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      ...|...++||+|+||.||+|.. .++..||||++.....      ....|++.+. .++|||||+++|+|.+....|+|
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~l~-~l~HpnIv~~~~~~~~~~~~~lv  761 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS------IPSSEIADMG-KLQHPNIVKLIGLCRSEKGAYLI  761 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc------ccHHHHHHHh-hCCCCCcceEEEEEEcCCCCEEE
Confidence            34577889999999999999986 4689999999853221      1123454554 48999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCc----
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT----  437 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~----  437 (596)
                      ||||++|+|.++++.       ++|.++.+++.|||+||+|||..+.++|+||||||+||+++.++..++. |+..    
T Consensus       762 ~Ey~~~g~L~~~l~~-------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~  833 (968)
T PLN00113        762 HEYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC  833 (968)
T ss_pred             EeCCCCCcHHHHHhc-------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc
Confidence            999999999999962       8899999999999999999997666899999999999999999888775 4322    


Q ss_pred             ---ccCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCC---ChhHHHHHHHHHhcCCchhhccccccC--
Q 047719          438 ---IPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDND---GCVIVDWVWNLRKKGKLLDAADFRLRG--  509 (596)
Q Consensus       438 ---~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~---~~~~~~~~~~~~~~~~~~~~~d~~l~~--  509 (596)
                         ...||..|||||++.+..++.++|||||||++|||+||+.||+..   ...+.+|+.............|+.+..  
T Consensus       834 ~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  913 (968)
T PLN00113        834 TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDV  913 (968)
T ss_pred             cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCC
Confidence               235779999999999999999999999999999999999998642   235667776655555555555655543  


Q ss_pred             cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Q 047719          510 KFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEAP  549 (596)
Q Consensus       510 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~~~  549 (596)
                      ..+.++...+.+++.+||+.||++||+|+||++.|+....
T Consensus       914 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        914 SVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            3456777889999999999999999999999999987543

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-40  Score=374.23  Aligned_cols=245  Identities=28%  Similarity=0.449  Sum_probs=203.4

Q ss_pred             CCccceeecCCceEEEEEEcCC--CC----EEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEE
Q 047719          286 FNKNRIVGEGASATVYKGSLPS--GG----AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELV  359 (596)
Q Consensus       286 f~~~~~LG~G~fG~Vy~~~~~~--g~----~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~  359 (596)
                      -...+.||+|.||.||+|.+.+  |.    .||||.+.+. .+.+...+|++|...|.+ ++|||||+++|.|.+....+
T Consensus       694 v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~-f~HpNiv~liGv~l~~~~~~  771 (1025)
T KOG1095|consen  694 VTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSK-FDHPNIVSLIGVCLDSGPPL  771 (1025)
T ss_pred             eEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhc-CCCcceeeEEEeecCCCCcE
Confidence            3456899999999999998754  43    4999999753 345567789999966655 99999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhhCCC---CCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCC
Q 047719          360 LVYEYLPNGSLDKILHNNSS---SSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEA  436 (596)
Q Consensus       360 lV~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~  436 (596)
                      |++|||++|+|..||++.+.   ....|...+.+.++.|||+|+.||++   +++|||||.++|+||++...+||+|||+
T Consensus       772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFGl  848 (1025)
T KOG1095|consen  772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFGL  848 (1025)
T ss_pred             EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccch
Confidence            99999999999999997632   23468899999999999999999999   9999999999999999999999999999


Q ss_pred             cccC---------C----CcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhh
Q 047719          437 TIPA---------G----TMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDA  502 (596)
Q Consensus       437 ~~~~---------g----t~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  502 (596)
                      ++..         |    ...|||||.+..+.+|.|+|||||||+|||++| |..||......-  ........++    
T Consensus       849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~--v~~~~~~ggR----  922 (1025)
T KOG1095|consen  849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE--VLLDVLEGGR----  922 (1025)
T ss_pred             hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH--HHHHHHhCCc----
Confidence            8631         2    357999999999999999999999999999999 999998754311  1111223331    


Q ss_pred             ccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          503 ADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       503 ~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                            -..+..+...+.+||..||+.+|++||++..+++.+...
T Consensus       923 ------L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i  961 (1025)
T KOG1095|consen  923 ------LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAI  961 (1025)
T ss_pred             ------cCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhh
Confidence                  233445667788999999999999999999999977654

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-40  Score=343.49  Aligned_cols=230  Identities=27%  Similarity=0.463  Sum_probs=194.5

Q ss_pred             ccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecCCC
Q 047719          288 KNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPN  367 (596)
Q Consensus       288 ~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  367 (596)
                      +.+-||+|+.|-||+|++ .++.||||+++.-+         ..+|..|.+ ++|+||+.+.|+|.....+|||||||+.
T Consensus       128 ELeWlGSGaQGAVF~Grl-~netVAVKKV~elk---------ETdIKHLRk-LkH~NII~FkGVCtqsPcyCIiMEfCa~  196 (904)
T KOG4721|consen  128 ELEWLGSGAQGAVFLGRL-HNETVAVKKVRELK---------ETDIKHLRK-LKHPNIITFKGVCTQSPCYCIIMEFCAQ  196 (904)
T ss_pred             hhhhhccCcccceeeeec-cCceehhHHHhhhh---------hhhHHHHHh-ccCcceeeEeeeecCCceeEEeeecccc
Confidence            347899999999999999 67899999985321         235656655 9999999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc---------
Q 047719          368 GSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI---------  438 (596)
Q Consensus       368 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---------  438 (596)
                      |-|+..|+...    ++.......+..+||.||.|||.   +.|||||||+-||||..+..+||+|||.+.         
T Consensus       197 GqL~~VLka~~----~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkM  269 (904)
T KOG4721|consen  197 GQLYEVLKAGR----PITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKM  269 (904)
T ss_pred             ccHHHHHhccC----ccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhh
Confidence            99999998765    47788899999999999999999   899999999999999999999999999764         


Q ss_pred             -cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHHHHH
Q 047719          439 -PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEME  517 (596)
Q Consensus       439 -~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  517 (596)
                       .+||..|||||++.....+.|+|||||||+||||+||..||.+-+..-+  +|   .      +-.-.+....+..+.+
T Consensus       270 SFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI--Iw---G------VGsNsL~LpvPstcP~  338 (904)
T KOG4721|consen  270 SFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI--IW---G------VGSNSLHLPVPSTCPD  338 (904)
T ss_pred             hhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee--EE---e------ccCCcccccCcccCch
Confidence             4699999999999999999999999999999999999999986432111  11   1      1111233345556667


Q ss_pred             HHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          518 RMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       518 ~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                      -+..|+..||+..|..||++++++..|+-
T Consensus       339 GfklL~Kqcw~sKpRNRPSFrqil~HldI  367 (904)
T KOG4721|consen  339 GFKLLLKQCWNSKPRNRPSFRQILLHLDI  367 (904)
T ss_pred             HHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence            78888899999999999999999999863

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.6e-40  Score=319.24  Aligned_cols=247  Identities=25%  Similarity=0.313  Sum_probs=192.9

Q ss_pred             CCCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          285 GFNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      .|+...++|+|+||.|||++.++ |+.||||++..+.....-.+-.++|+ .|++.++|+|+|.|+.+|.+++.++||+|
T Consensus         3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREI-rmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREI-RMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHH-HHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            45667889999999999999876 99999999976555444555678898 55556999999999999999999999999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc----
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP----  439 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~----  439 (596)
                      ||+. ++.+-|.....   .++.....+++.|++.|+.|+|+   +++|||||||+||||+.++.+||||||.++.    
T Consensus        82 ~~dh-TvL~eLe~~p~---G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p  154 (396)
T KOG0593|consen   82 YCDH-TVLHELERYPN---GVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP  154 (396)
T ss_pred             ecch-HHHHHHHhccC---CCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence            9987 55555554432   37888999999999999999999   8999999999999999999999999997653    


Q ss_pred             -------CCCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHH-HhcCCc-----------
Q 047719          440 -------AGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNL-RKKGKL-----------  499 (596)
Q Consensus       440 -------~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~-~~~~~~-----------  499 (596)
                             +.|.+|.|||++.+ -+|+..+||||.||++.||++|.+-|.+...  ++.+... ..-|.+           
T Consensus       155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SD--iDQLy~I~ktLG~L~prhq~iF~~N  232 (396)
T KOG0593|consen  155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSD--IDQLYLIRKTLGNLIPRHQSIFSSN  232 (396)
T ss_pred             cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcch--HHHHHHHHHHHcccCHHHHHHhccC
Confidence                   35789999999987 6899999999999999999999999987543  1111110 011111           


Q ss_pred             ---hhhcccc------ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          500 ---LDAADFR------LRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       500 ---~~~~d~~------l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                         ..+.-+.      +...++ ....-+++++..|++.||.+|++-+|++.
T Consensus       233 ~~F~Gv~lP~~~~~epLe~k~p-~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  233 PFFHGVRLPEPEHPEPLERKYP-KISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             CceeeeecCCCCCccchhhhcc-cchHHHHHHHHHHhcCCccccccHHHHhc
Confidence               1110010      111121 23447889999999999999999998864

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-40  Score=350.47  Aligned_cols=245  Identities=31%  Similarity=0.409  Sum_probs=201.8

Q ss_pred             cceeecCCceEEEEEEcCC--C---CEEEEEEeecC-CchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          289 NRIVGEGASATVYKGSLPS--G---GAVAVKRFEKP-NRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       289 ~~~LG~G~fG~Vy~~~~~~--g---~~vAvK~l~~~-~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      .++||+|+||.||+|.+..  +   ..||||..+.+ ........+|++|.+.|.+ ++|||||+++|++....+++|||
T Consensus       162 ~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~-l~H~NVVr~yGVa~~~~Pl~ivm  240 (474)
T KOG0194|consen  162 GKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQ-LNHPNVVRFYGVAVLEEPLMLVM  240 (474)
T ss_pred             cceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHh-CCCCCEEEEEEEEcCCCccEEEE
Confidence            4899999999999998753  2   23899998753 3556678899999977766 99999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcccC--
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA--  440 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~~--  440 (596)
                      |+|+||+|.+||+....   .++..+++.++.+.|.||+|||+   .++|||||.++|||++.++.+||+|||++...  
T Consensus       241 El~~gGsL~~~L~k~~~---~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~  314 (474)
T KOG0194|consen  241 ELCNGGSLDDYLKKNKK---SLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ  314 (474)
T ss_pred             EecCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCccccccCCcc
Confidence            99999999999998753   58999999999999999999999   99999999999999999999999999997643  


Q ss_pred             ---------CCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChh-HHHHHHHHHhcCCchhhccccccC
Q 047719          441 ---------GTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCV-IVDWVWNLRKKGKLLDAADFRLRG  509 (596)
Q Consensus       441 ---------gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~-~~~~~~~~~~~~~~~~~~d~~l~~  509 (596)
                               -...|+|||.+..+.++.++|||||||++||+++ |..||.+.... +..++   ...+         .+.
T Consensus       315 ~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI---~~~~---------~r~  382 (474)
T KOG0194|consen  315 YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKI---VKNG---------YRM  382 (474)
T ss_pred             eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHH---HhcC---------ccC
Confidence                     2367999999999999999999999999999999 89999875432 11111   1111         111


Q ss_pred             cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCC
Q 047719          510 KFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEAPLPL  552 (596)
Q Consensus       510 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~~~~p~  552 (596)
                      ..+......+..++..||..+|++||+|.++.+.|+.......
T Consensus       383 ~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  383 PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence            2222344555666679999999999999999999986654433

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-39  Score=336.02  Aligned_cols=241  Identities=24%  Similarity=0.350  Sum_probs=195.8

Q ss_pred             HhcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccc-hHHHHHHHHHhccCCCceeeecceeeeCCeEE
Q 047719          282 ATLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARN-PFTTEFATMAGCLRHKNLVQLQGWCCEGNELV  359 (596)
Q Consensus       282 at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~-~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~  359 (596)
                      ...+|..++.||.|+|++|++|+.. .++.||||++.+.....+... -...|-..|..+-.||.|++|+..|++...+|
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY  150 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY  150 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence            3456888899999999999999765 489999999976544433322 23445445555348999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc-
Q 047719          360 LVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI-  438 (596)
Q Consensus       360 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~-  438 (596)
                      +|+||+++|+|.++|+..+    .|++.....++.+|+.||+|||+   .|||||||||+|||||.|+++||+|||.+. 
T Consensus       151 FvLe~A~nGdll~~i~K~G----sfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~  223 (604)
T KOG0592|consen  151 FVLEYAPNGDLLDLIKKYG----SFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKI  223 (604)
T ss_pred             EEEEecCCCcHHHHHHHhC----cchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeecccccc
Confidence            9999999999999999865    48889999999999999999999   999999999999999999999999998542 


Q ss_pred             -----------------------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHh
Q 047719          439 -----------------------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRK  495 (596)
Q Consensus       439 -----------------------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~  495 (596)
                                             .+||..|.+||++..+..++.+|+|+|||+||+|+.|++||.+..+.+.-   +   
T Consensus       224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliF---q---  297 (604)
T KOG0592|consen  224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIF---Q---  297 (604)
T ss_pred             CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHH---H---
Confidence                                   35999999999999999999999999999999999999999876543220   0   


Q ss_pred             cCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          496 KGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       496 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                        + ...++..+...++    +.+.+|+.+.+..||++|+|.++|-+
T Consensus       298 --k-I~~l~y~fp~~fp----~~a~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  298 --K-IQALDYEFPEGFP----EDARDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             --H-HHHhcccCCCCCC----HHHHHHHHHHHccCccccccHHHHhh
Confidence              0 0112222233333    45566667778999999999999877

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-39  Score=329.34  Aligned_cols=242  Identities=26%  Similarity=0.420  Sum_probs=193.6

Q ss_pred             cCCCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCC--eEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGN--ELVL  360 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~--~~~l  360 (596)
                      .++...+.||+|+||.||++...+ |...|||.+...+...  .+.+.+|+..+.+ ++|||||+++|......  .+++
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~--~~~l~~Ei~iL~~-l~~p~IV~~~G~~~~~~~~~~~i   93 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT--SESLEREIRILSR-LNHPNIVQYYGSSSSRENDEYNI   93 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh--HHHHHHHHHHHHh-CCCCCEEeeCCccccccCeeeEe
Confidence            345667899999999999998765 8999999986542221  4557889866655 88999999999855544  6999


Q ss_pred             EEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecC-CCceEEccCCCcc-
Q 047719          361 VYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDA-EFNAKLGDFEATI-  438 (596)
Q Consensus       361 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~-~~~~kl~Dfg~~~-  438 (596)
                      .|||+++|+|.+++...+.   .|++..+...+.||++||+|||+   ++++||||||+||||+. ++.+||+|||++. 
T Consensus        94 ~mEy~~~GsL~~~~~~~g~---~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~  167 (313)
T KOG0198|consen   94 FMEYAPGGSLSDLIKRYGG---KLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKK  167 (313)
T ss_pred             eeeccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCccccc
Confidence            9999999999999998753   49999999999999999999998   99999999999999999 7999999999543 


Q ss_pred             -------------cCCCcccCCccccccC-CCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhcc
Q 047719          439 -------------PAGTMGYLAPEYVYSG-VPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAAD  504 (596)
Q Consensus       439 -------------~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d  504 (596)
                                   ..||+.|||||++..+ ....++|||||||++.||+||++||... ....+++.........     
T Consensus       168 ~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~~~~~~~~~ig~~~~~-----  241 (313)
T KOG0198|consen  168 LESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-FEEAEALLLIGREDSL-----  241 (313)
T ss_pred             cccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-cchHHHHHHHhccCCC-----
Confidence                         3589999999999864 3346999999999999999999999863 1122222222222211     


Q ss_pred             ccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 047719          505 FRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARIL  544 (596)
Q Consensus       505 ~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L  544 (596)
                          +.++........+++..|++.||++|||++++++..
T Consensus       242 ----P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp  277 (313)
T KOG0198|consen  242 ----PEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP  277 (313)
T ss_pred             ----CCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence                133344555667777899999999999999998843

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.5e-39  Score=330.70  Aligned_cols=242  Identities=19%  Similarity=0.288  Sum_probs=193.8

Q ss_pred             CccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhc-ccchHHHHHHHHHhccCCCceeeecceeee----CCeEEEE
Q 047719          287 NKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVEC-ARNPFTTEFATMAGCLRHKNLVQLQGWCCE----GNELVLV  361 (596)
Q Consensus       287 ~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~-~~~~~~~E~~~l~~~l~H~niv~l~g~~~~----~~~~~lV  361 (596)
                      .....||+|++|.||+|.+ +|+.||||+++....... ..+.+.+|+..+.+ ++|||||+++|++.+    ....++|
T Consensus        23 ~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~nIv~~~g~~~~~~~~~~~~~lv  100 (283)
T PHA02988         23 YTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRR-IDSNNILKIYGFIIDIVDDLPRLSLI  100 (283)
T ss_pred             CCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHh-cCCCCEEEEeeeEEecccCCCceEEE
Confidence            3347899999999999998 788999999965432221 13567789966655 999999999999877    3578999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc---
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI---  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---  438 (596)
                      |||+++|+|.+++....    .++|...+.++.+++.||.|||+.  .+++||||||+|||++.++.+||+|||++.   
T Consensus       101 ~Ey~~~g~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~  174 (283)
T PHA02988        101 LEYCTRGYLREVLDKEK----DLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILS  174 (283)
T ss_pred             EEeCCCCcHHHHHhhCC----CCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhc
Confidence            99999999999998653    488999999999999999999972  478899999999999999999999999864   


Q ss_pred             -----cCCCcccCCcccccc--CCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcC
Q 047719          439 -----PAGTMGYLAPEYVYS--GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKF  511 (596)
Q Consensus       439 -----~~gt~~y~aPE~~~~--~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  511 (596)
                           ..|+..|+|||.+.+  ..++.++|||||||++|||++|+.||.....  .+........+..     .    ..
T Consensus       175 ~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~--~~~~~~i~~~~~~-----~----~~  243 (283)
T PHA02988        175 SPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT--KEIYDLIINKNNS-----L----KL  243 (283)
T ss_pred             cccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHhcCCC-----C----CC
Confidence                 347889999999976  6899999999999999999999999986532  1111111111110     1    11


Q ss_pred             CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          512 NRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       512 ~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                      +......+.+++.+||+.||++|||++|+++.|+..
T Consensus       244 ~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~  279 (283)
T PHA02988        244 PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY  279 (283)
T ss_pred             CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence            112344677888999999999999999999998753

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=3.1e-39  Score=307.14  Aligned_cols=261  Identities=25%  Similarity=0.347  Sum_probs=204.3

Q ss_pred             CCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          285 GFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      .|...++||+|.||.||+|+.. +|+.||||+++..+..+......++|+..+. .++|+||+.|+++|-..+.+.||+|
T Consensus         3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lq-el~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQ-ELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHH-HccCcchhhhhhhccCCCceEEEEE
Confidence            4666789999999999999754 5999999999876555555567899996664 5999999999999999999999999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcccCC--
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG--  441 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~~g--  441 (596)
                      ||+. +|+..+++..   ..++..+...++.++.+||+|||+   +.|+||||||.|+|++++|.+||+|||+++..|  
T Consensus        82 fm~t-dLe~vIkd~~---i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p  154 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDKN---IILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSP  154 (318)
T ss_pred             eccc-cHHHHhcccc---cccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence            9976 9999998764   468999999999999999999999   899999999999999999999999999987654  


Q ss_pred             ---------CcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCCh-hHHHHHHHHHhcC---------Cchh
Q 047719          442 ---------TMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGC-VIVDWVWNLRKKG---------KLLD  501 (596)
Q Consensus       442 ---------t~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~-~~~~~~~~~~~~~---------~~~~  501 (596)
                               |.+|.|||++.+ ..|+...|+||.|||+.||+-|.+-|.++.+ .....+......+         .+.+
T Consensus       155 ~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpd  234 (318)
T KOG0659|consen  155 NRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPD  234 (318)
T ss_pred             CcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccccc
Confidence                     678999999987 5799999999999999999999988876532 1111111111111         1111


Q ss_pred             hc------cccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhcCCCCCCCCC
Q 047719          502 AA------DFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKGEAPLPLLPV  555 (596)
Q Consensus       502 ~~------d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~~~~~~p~~p~  555 (596)
                      ..      .+.+..-+ .......++|+..++..||.+|+++.|+++  .+.. .|.|.+|.
T Consensus       235 Y~~~~~~P~~~~~~lf-~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~-~P~pt~~~  294 (318)
T KOG0659|consen  235 YVKIQQFPKPPLNNLF-PAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS-LPLPTPPS  294 (318)
T ss_pred             HHHHhcCCCCcccccc-ccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc-CCCCCChh
Confidence            11      11111112 234455688999999999999999999987  3433 45555443

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.3e-38  Score=328.38  Aligned_cols=251  Identities=22%  Similarity=0.326  Sum_probs=194.9

Q ss_pred             cCCCccceeecCCceEEEEEEcCC-----------------CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCcee
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPS-----------------GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLV  346 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~-----------------g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv  346 (596)
                      ..|...+.||+|+||.||++.+++                 +..||+|.+.... ......++.+|+..+.+ ++||||+
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~-l~h~niv   82 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSR-LKDPNII   82 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhh-cCCCCee
Confidence            457778999999999999997532                 3369999986432 23345678899966655 8999999


Q ss_pred             eecceeeeCCeEEEEEecCCCCCHHHHhhhCCC---------------CCcccCHHHHHHHHHHHHHHHHHHHhccCCCe
Q 047719          347 QLQGWCCEGNELVLVYEYLPNGSLDKILHNNSS---------------SSIVLSWEKRLNIVLGVASALSYLHEECERQI  411 (596)
Q Consensus       347 ~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~i  411 (596)
                      ++++++.+.+..++||||+++|+|.+++.....               ....++|..++.++.||+.||+|||+   .+|
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i  159 (304)
T cd05096          83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNF  159 (304)
T ss_pred             EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCc
Confidence            999999999999999999999999999965321               11347889999999999999999999   899


Q ss_pred             EEccCCCCceeecCCCceEEccCCCccc-------------CCCcccCCccccccCCCCCccceeehhHHHHHHHh--CC
Q 047719          412 IHRDVKACNILLDAEFNAKLGDFEATIP-------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA--GK  476 (596)
Q Consensus       412 vHrDlkp~NiLl~~~~~~kl~Dfg~~~~-------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t--G~  476 (596)
                      +||||||+|||++.++.+||+|||++..             .++..|+|||.+..+.++.++|||||||++|||++  +.
T Consensus       160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~  239 (304)
T cd05096         160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE  239 (304)
T ss_pred             cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence            9999999999999999999999997642             23668999999988899999999999999999987  55


Q ss_pred             CCCCCCCh-hHHHHHHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 047719          477 SPVDNDGC-VIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK  545 (596)
Q Consensus       477 ~p~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~  545 (596)
                      .||..... .....+.......... .     ....+......+.+++.+||+.||++|||+++|.+.|+
T Consensus       240 ~p~~~~~~~~~~~~~~~~~~~~~~~-~-----~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         240 QPYGELTDEQVIENAGEFFRDQGRQ-V-----YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCCCcCCHHHHHHHHHHHhhhcccc-c-----cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            67765322 2222222211111100 0     00011123356788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-40  Score=334.07  Aligned_cols=246  Identities=22%  Similarity=0.341  Sum_probs=196.8

Q ss_pred             CCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccC-CCceeeecceeeeCC-eEEEE
Q 047719          285 GFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLR-HKNLVQLQGWCCEGN-ELVLV  361 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~-H~niv~l~g~~~~~~-~~~lV  361 (596)
                      +|...++||.|.||.||+|+.. .|+.||||++++...+ .++-.-++|+..+.+ ++ |||||+|.+.+.+.+ .+|+|
T Consensus        11 RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~k-ln~hpniikL~Evi~d~~~~L~fV   88 (538)
T KOG0661|consen   11 RYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRK-LNPHPNIIKLKEVIRDNDRILYFV   88 (538)
T ss_pred             HHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHh-cCCCCcchhhHHHhhccCceEeee
Confidence            4566789999999999999754 5899999999765443 222235789988877 66 999999999999988 99999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc--
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP--  439 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~--  439 (596)
                      ||||+. +|++.++++.   ..+++..+..|+.||++||+|+|.   +|+.|||+||+|||+..+..+||+|||+++.  
T Consensus        89 fE~Md~-NLYqLmK~R~---r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~  161 (538)
T KOG0661|consen   89 FEFMDC-NLYQLMKDRN---RLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREVR  161 (538)
T ss_pred             HHhhhh-hHHHHHhhcC---CcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEecccccccccc
Confidence            999965 9999999873   479999999999999999999999   9999999999999999999999999999864  


Q ss_pred             --------CCCcccCCccccc-cCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHh-----------c-CC
Q 047719          440 --------AGTMGYLAPEYVY-SGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRK-----------K-GK  498 (596)
Q Consensus       440 --------~gt~~y~aPE~~~-~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~-----------~-~~  498 (596)
                              +.|.+|.|||++. .+.|+.+.|+||+|||++|+.+-++.|.+..+  .|.++....           + -.
T Consensus       162 SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE--~Dqi~KIc~VLGtP~~~~~~eg~~  239 (538)
T KOG0661|consen  162 SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASE--IDQIYKICEVLGTPDKDSWPEGYN  239 (538)
T ss_pred             cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcH--HHHHHHHHHHhCCCccccchhHHH
Confidence                    4688999999876 57899999999999999999999999987543  111111110           1 01


Q ss_pred             chhhccccc--------cCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          499 LLDAADFRL--------RGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       499 ~~~~~d~~l--------~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      +...+..++        ..-.+ ......++++..|+..||.+|||+.|+++
T Consensus       240 La~~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~  290 (538)
T KOG0661|consen  240 LASAMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQ  290 (538)
T ss_pred             HHHHhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence            111111111        11122 25567788889999999999999999988

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-38  Score=322.27  Aligned_cols=253  Identities=28%  Similarity=0.374  Sum_probs=199.6

Q ss_pred             cCCCccceeecCCceEEEEEEc-CCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSL-PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      +.|+..++||.|..++||+|.. +.++.||||++..++-. .....+.+|+..|. .++||||++++..|..+.++|+||
T Consensus        26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~-~~ld~l~kE~~~ms-l~~HPNIv~~~~sFvv~~~LWvVm  103 (516)
T KOG0582|consen   26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN-NDLDALRKEVQTMS-LIDHPNIVTYHCSFVVDSELWVVM  103 (516)
T ss_pred             cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh-hhHHHHHHHHHHhh-hcCCCCcceEEEEEEecceeEEee
Confidence            4577889999999999999965 46899999999754433 23667889996665 599999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCc-----
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT-----  437 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~-----  437 (596)
                      .||.+||+.+.++..-..  .+++..+..|++++++||.|||+   +|.||||||+.||||+++|.+||+|||.+     
T Consensus       104 pfMa~GS~ldIik~~~~~--Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~  178 (516)
T KOG0582|consen  104 PFMAGGSLLDIIKTYYPD--GLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFD  178 (516)
T ss_pred             hhhcCCcHHHHHHHHccc--cccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence            999999999999876432  38899999999999999999999   99999999999999999999999999642     


Q ss_pred             ----------ccCCCcccCCcccccc--CCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccc
Q 047719          438 ----------IPAGTMGYLAPEYVYS--GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADF  505 (596)
Q Consensus       438 ----------~~~gt~~y~aPE~~~~--~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~  505 (596)
                                ..+||+.|||||+++.  ..|+.|+||||||++..||++|..||..... ..-....+........  ..
T Consensus       179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP-mkvLl~tLqn~pp~~~--t~  255 (516)
T KOG0582|consen  179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP-MKVLLLTLQNDPPTLL--TS  255 (516)
T ss_pred             cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh-HHHHHHHhcCCCCCcc--cc
Confidence                      2369999999999654  5699999999999999999999999986532 1111112222211111  01


Q ss_pred             cccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhc
Q 047719          506 RLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKG  546 (596)
Q Consensus       506 ~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~~  546 (596)
                      .+..+........+.+++..|++.||++|||++++++  +++.
T Consensus       256 ~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~  298 (516)
T KOG0582|consen  256 GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKK  298 (516)
T ss_pred             cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhh
Confidence            1111112223346777888999999999999999987  4443

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.5e-38  Score=328.73  Aligned_cols=238  Identities=24%  Similarity=0.312  Sum_probs=192.1

Q ss_pred             HhcCCCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCchhccc-chHHHHHHHHHhccCCCceeeecceeeeCCeEE
Q 047719          282 ATLGFNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRVECAR-NPFTTEFATMAGCLRHKNLVQLQGWCCEGNELV  359 (596)
Q Consensus       282 at~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~-~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~  359 (596)
                      ..++|....+||+|+||.||+++.++ |..+|+|+++++....... .-.+.|-..|.. ..+++||+|+..|++...+|
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~-~ds~~vVKLyYsFQD~~~LY  217 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAE-VDSPWVVKLYYSFQDKEYLY  217 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhh-cCCCcEEEEEEEecCCCeeE
Confidence            45679999999999999999998765 8999999998765443332 234555544444 89999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc
Q 047719          360 LVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP  439 (596)
Q Consensus       360 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~  439 (596)
                      |||||+|||++..+|....    .|++......+.+++.|+..||+   .|+|||||||+|+|||..|++||+|||++..
T Consensus       218 LiMEylPGGD~mTLL~~~~----~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~g  290 (550)
T KOG0605|consen  218 LIMEYLPGGDMMTLLMRKD----TLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTG  290 (550)
T ss_pred             EEEEecCCccHHHHHHhcC----cCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccch
Confidence            9999999999999998765    58889999999999999999999   9999999999999999999999999986421


Q ss_pred             ----------------------------------------------------------CCCcccCCccccccCCCCCccc
Q 047719          440 ----------------------------------------------------------AGTMGYLAPEYVYSGVPSEKTD  461 (596)
Q Consensus       440 ----------------------------------------------------------~gt~~y~aPE~~~~~~~t~~sD  461 (596)
                                                                                +||+.|||||++.+..|+..+|
T Consensus       291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cD  370 (550)
T KOG0605|consen  291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECD  370 (550)
T ss_pred             hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcccc
Confidence                                                                      2899999999999999999999


Q ss_pred             eeehhHHHHHHHhCCCCCCCCCh-----hHHHHHHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCC
Q 047719          462 VYSFGVVALEVAAGKSPVDNDGC-----VIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPS  536 (596)
Q Consensus       462 V~SfGvll~El~tG~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs  536 (596)
                      +||+|||+|||+.|.+||..+..     .+..|...+....              ......+..+|+.+|+. ||++|-.
T Consensus       371 wWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~--------------~~~~s~eA~DLI~rll~-d~~~RLG  435 (550)
T KOG0605|consen  371 WWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE--------------EVDLSDEAKDLITRLLC-DPENRLG  435 (550)
T ss_pred             HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC--------------cCcccHHHHHHHHHHhc-CHHHhcC
Confidence            99999999999999999987653     2233332221111              01112456667777777 9999986


Q ss_pred             ---HHHHHH
Q 047719          537 ---VKEAAR  542 (596)
Q Consensus       537 ---~~ev~~  542 (596)
                         ++||-+
T Consensus       436 ~~G~~EIK~  444 (550)
T KOG0605|consen  436 SKGAEEIKK  444 (550)
T ss_pred             cccHHHHhc
Confidence               555543

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=6.4e-39  Score=340.81  Aligned_cols=249  Identities=25%  Similarity=0.366  Sum_probs=195.7

Q ss_pred             hcCCCccceeecCCceEEEEEEc------CCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCC
Q 047719          283 TLGFNKNRIVGEGASATVYKGSL------PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGN  356 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~  356 (596)
                      .++|...+.||+|+||.||+|..      ..+..||||+++.... ......+.+|+..+....+||||++++++|...+
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~  112 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLGACTVGG  112 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence            44678889999999999999963      2356899999864322 2234567889977766338999999999999999


Q ss_pred             eEEEEEecCCCCCHHHHhhhCCC---------------------------------------------------------
Q 047719          357 ELVLVYEYLPNGSLDKILHNNSS---------------------------------------------------------  379 (596)
Q Consensus       357 ~~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------  379 (596)
                      ..++||||+++|+|.+++.....                                                         
T Consensus       113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (375)
T cd05104         113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG  192 (375)
T ss_pred             cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence            99999999999999999975321                                                         


Q ss_pred             --------------CCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcccC-----
Q 047719          380 --------------SSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA-----  440 (596)
Q Consensus       380 --------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~~-----  440 (596)
                                    ....++|..++.++.||++||+|||+   .+++||||||+|||++.++.+||+|||++...     
T Consensus       193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  269 (375)
T cd05104         193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN  269 (375)
T ss_pred             eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence                          01247899999999999999999999   89999999999999999999999999976421     


Q ss_pred             --------CCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcC
Q 047719          441 --------GTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKF  511 (596)
Q Consensus       441 --------gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  511 (596)
                              ++..|+|||.+.+..++.++|||||||++|||++ |..||....... . .......+...         ..
T Consensus       270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-~-~~~~~~~~~~~---------~~  338 (375)
T cd05104         270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-K-FYKMIKEGYRM---------LS  338 (375)
T ss_pred             ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-H-HHHHHHhCccC---------CC
Confidence                    3456999999999999999999999999999998 889987542111 1 11111111110         01


Q ss_pred             CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          512 NRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       512 ~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                      +......+.+|+.+||+.||++||++.||++.|+.
T Consensus       339 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         339 PECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence            11123467788899999999999999999999985

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.5e-39  Score=328.20  Aligned_cols=250  Identities=24%  Similarity=0.328  Sum_probs=194.8

Q ss_pred             CCCccceeecCCceEEEEEEc-CCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeC--CeEEEE
Q 047719          285 GFNKNRIVGEGASATVYKGSL-PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG--NELVLV  361 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~--~~~~lV  361 (596)
                      .|+..++||+|.||.||||+. .+|+.||+|+++.+...+....-..+||.+|. .++||||++|.+...+.  +.+|||
T Consensus       118 ~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr-~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  118 SFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILR-RLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHH-hcCCCcccceeeEEEecCCceEEEE
Confidence            355568899999999999975 46999999999876655555555678996655 59999999999998887  689999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc--
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP--  439 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~--  439 (596)
                      +|||++ +|.-++...   ...++..++..++.|++.||+|||.   ++|+|||||.+|||||.+|.+||+|||+++.  
T Consensus       197 FeYMdh-DL~GLl~~p---~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~  269 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSSP---GVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFYT  269 (560)
T ss_pred             Eecccc-hhhhhhcCC---CcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeecc
Confidence            999988 899888764   3469999999999999999999999   9999999999999999999999999998763  


Q ss_pred             ----------CCCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCCh-hHHHHHHHHH--------hcCCc
Q 047719          440 ----------AGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGC-VIVDWVWNLR--------KKGKL  499 (596)
Q Consensus       440 ----------~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~-~~~~~~~~~~--------~~~~~  499 (596)
                                +-|++|.|||++.+ ..|+.+.|+||.||||.||++|++.|.+..+ ....-+..+.        ...++
T Consensus       270 ~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kL  349 (560)
T KOG0600|consen  270 PSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKL  349 (560)
T ss_pred             CCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccC
Confidence                      35789999999987 4799999999999999999999999988643 1122222221        11122


Q ss_pred             hhhccccccCcCCH-------HHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          500 LDAADFRLRGKFNR-------KEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       500 ~~~~d~~l~~~~~~-------~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ...........+..       ......++|+-..+..||.+|.|+.++++
T Consensus       350 P~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  350 PHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             CcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            21111111111111       12245566777788899999999999976

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=7.3e-39  Score=323.80  Aligned_cols=243  Identities=26%  Similarity=0.391  Sum_probs=195.8

Q ss_pred             cCCCccceeecCCceEEEEEEcC----CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP----SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELV  359 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~  359 (596)
                      .+|...+.||+|+||.||+|.+.    .+..||+|.++.... ......+.+|+..+.. ++||||+++++++...+..+
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~   82 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS-DKQRRGFLAEALTLGQ-FDHSNIVRLEGVITRGNTMM   82 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC-HHHHHHHHHHHHHHhc-CCCCCcCeEEEEEecCCCcE
Confidence            45778899999999999999753    356899999865322 2334568889866655 89999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc
Q 047719          360 LVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP  439 (596)
Q Consensus       360 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~  439 (596)
                      +||||+++|+|.+++....   ..++|.+++.++.|++.||+|||+   .+++||||||+|||++.++.+|++|||....
T Consensus        83 lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~  156 (266)
T cd05064          83 IVTEYMSNGALDSFLRKHE---GQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQE  156 (266)
T ss_pred             EEEEeCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCccccc
Confidence            9999999999999998643   258999999999999999999999   8999999999999999999999999986432


Q ss_pred             ------------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhcccc
Q 047719          440 ------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADFR  506 (596)
Q Consensus       440 ------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~  506 (596)
                                  .++..|+|||.+.+..++.++|||||||++||+++ |+.||......  +.... ...+..       
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--~~~~~-~~~~~~-------  226 (266)
T cd05064         157 DKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--DVIKA-VEDGFR-------  226 (266)
T ss_pred             ccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHH-HHCCCC-------
Confidence                        23568999999999999999999999999999875 99999764321  11111 111111       


Q ss_pred             ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          507 LRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       507 l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                        ...+......+.+++..||+.+|++||+++++.+.|+.
T Consensus       227 --~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~  264 (266)
T cd05064         227 --LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK  264 (266)
T ss_pred             --CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence              11122334567788899999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=4.9e-39  Score=331.90  Aligned_cols=237  Identities=27%  Similarity=0.346  Sum_probs=200.4

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      ++|...+.||+|+||.||||+.+ +.+.||+|.+.+..+.+...+...+|++++.+ ++|||||.++.||....++++|+
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~-lkHpniv~m~esfEt~~~~~vVt   80 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRS-LKHPNIVEMLESFETSAHLWVVT   80 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHh-cCCcchhhHHHhhcccceEEEEe
Confidence            35677789999999999999765 47899999998877777777789999966655 99999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc---
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP---  439 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~---  439 (596)
                      ||+.+ +|..+|....    .+++..+..++.++..||.|||+   .+|+|||+||+||||+..+.+|+||||+++.   
T Consensus        81 e~a~g-~L~~il~~d~----~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~  152 (808)
T KOG0597|consen   81 EYAVG-DLFTILEQDG----KLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMST  152 (808)
T ss_pred             hhhhh-hHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhccc
Confidence            99977 9999998765    49999999999999999999999   9999999999999999999999999997643   


Q ss_pred             --------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcC
Q 047719          440 --------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKF  511 (596)
Q Consensus       440 --------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  511 (596)
                              .||+-|||||++.++.|+..+|+||+||+|||+++|++||-..  .+...+.....+..           ..
T Consensus       153 ~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~--si~~Lv~~I~~d~v-----------~~  219 (808)
T KOG0597|consen  153 NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR--SITQLVKSILKDPV-----------KP  219 (808)
T ss_pred             CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH--HHHHHHHHHhcCCC-----------CC
Confidence                    5999999999999999999999999999999999999999654  23333322222211           11


Q ss_pred             CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          512 NRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       512 ~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      +......+..+....++.||.+|.+-.+++.
T Consensus       220 p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  220 PSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             cccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            2234455566666778999999999988876

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.8e-39  Score=327.24  Aligned_cols=238  Identities=36%  Similarity=0.557  Sum_probs=187.3

Q ss_pred             ccceeecCCceEEEEEEcC-----CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          288 KNRIVGEGASATVYKGSLP-----SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       288 ~~~~LG~G~fG~Vy~~~~~-----~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      ..+.||.|.||.||+|.+.     .+..|+||.++. .......+++.+|+..+.+ ++||||++++|+|...+..++|+
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~-l~h~ni~~~~g~~~~~~~~~lv~   80 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRK-LRHPNIVKLYGFCIENEPLFLVM   80 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHT-HSBTTBE-EEEEEESSSSEEEEE
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeeccccccc-ccccccccccccccccccccccc
Confidence            3578999999999999876     256899999954 2233346789999977766 69999999999999888899999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcccC--
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA--  440 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~~--  440 (596)
                      ||+++|+|.++|....  ...+++.+++.|+.||++||+|||+   .+++|+||+++|||+++++.+||+|||+....  
T Consensus        81 e~~~~g~L~~~L~~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~  155 (259)
T PF07714_consen   81 EYCPGGSLDDYLKSKN--KEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISE  155 (259)
T ss_dssp             E--TTEBHHHHHHHTC--TTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred             cccccccccccccccc--ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence            9999999999999872  2358999999999999999999999   89999999999999999999999999876543  


Q ss_pred             -----------CCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhcccccc
Q 047719          441 -----------GTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLR  508 (596)
Q Consensus       441 -----------gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  508 (596)
                                 +...|+|||.+....++.++||||||+++|||++ |+.|+.....  .+..... ..+....       
T Consensus       156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~--~~~~~~~-~~~~~~~-------  225 (259)
T PF07714_consen  156 KSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN--EEIIEKL-KQGQRLP-------  225 (259)
T ss_dssp             SSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH--HHHHHHH-HTTEETT-------
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccc-cccccce-------
Confidence                       4567999999999889999999999999999999 7899876532  2222222 2222211       


Q ss_pred             CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 047719          509 GKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARIL  544 (596)
Q Consensus       509 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L  544 (596)
                        .+......+..++..||+.+|++||+|+++++.|
T Consensus       226 --~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  226 --IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             --SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             --eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence              1122345577888999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.4e-38  Score=325.20  Aligned_cols=242  Identities=21%  Similarity=0.264  Sum_probs=192.9

Q ss_pred             CCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          285 GFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      .|...+.||+|+||.||++... +|+.||||.+.+.... ......+.+|+..+.. ++|+||+++++++.+.+..++||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~-l~~~~iv~~~~~~~~~~~~~lv~   79 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEK-VNSRFVVSLAYAYETKDALCLVL   79 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHh-cCCCcEEEEEEEEccCCeEEEEE
Confidence            3667789999999999999764 6899999998654322 1233456788866654 89999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc----
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI----  438 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~----  438 (596)
                      ||+++|+|.+++....  ...+++..+..++.|++.||+|||+   .+++||||||+|||+++++.+||+|||++.    
T Consensus        80 e~~~~g~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~  154 (285)
T cd05631          80 TIMNGGDLKFHIYNMG--NPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE  154 (285)
T ss_pred             EecCCCcHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence            9999999999887543  2358999999999999999999999   899999999999999999999999999764    


Q ss_pred             ------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhH-HHHHHHHHhcCCchhhccccccCcC
Q 047719          439 ------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVI-VDWVWNLRKKGKLLDAADFRLRGKF  511 (596)
Q Consensus       439 ------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~-~~~~~~~~~~~~~~~~~d~~l~~~~  511 (596)
                            ..||..|+|||.+.+..++.++|||||||++|||++|+.||....... .+-+.......          ...+
T Consensus       155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~----------~~~~  224 (285)
T cd05631         155 GETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKED----------QEEY  224 (285)
T ss_pred             CCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcc----------cccC
Confidence                  247899999999999999999999999999999999999998643211 11111111100          1112


Q ss_pred             CHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHH
Q 047719          512 NRKEMERMLMVGLSCVHPNHEKRPS-----VKEAAR  542 (596)
Q Consensus       512 ~~~~~~~l~~l~~~C~~~dp~~RPs-----~~ev~~  542 (596)
                      +......+.+|+..||+.||++||+     ++++++
T Consensus       225 ~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         225 SEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             CccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            2233456778889999999999997     777765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.1e-38  Score=338.73  Aligned_cols=249  Identities=24%  Similarity=0.362  Sum_probs=195.4

Q ss_pred             hcCCCccceeecCCceEEEEEEcC------CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCC
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLP------SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGN  356 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~  356 (596)
                      .++|...+.||+|+||.||++...      ++..||||+++..... .....+.+|+..+....+|+|||+++++|...+
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~  115 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT-DEREALMSELKILSHLGQHKNIVNLLGACTHGG  115 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH-HHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence            446888899999999999998632      2457999999654322 234567889877766338999999999999999


Q ss_pred             eEEEEEecCCCCCHHHHhhhCCC---------------------------------------------------------
Q 047719          357 ELVLVYEYLPNGSLDKILHNNSS---------------------------------------------------------  379 (596)
Q Consensus       357 ~~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------  379 (596)
                      ..++||||+++|+|.++++....                                                         
T Consensus       116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (374)
T cd05106         116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS  195 (374)
T ss_pred             CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence            99999999999999999864321                                                         


Q ss_pred             ---------CCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc-----------
Q 047719          380 ---------SSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP-----------  439 (596)
Q Consensus       380 ---------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~-----------  439 (596)
                               ....+++.++++++.||++||+|||+   ++++||||||+|||+++++.+||+|||++..           
T Consensus       196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~  272 (374)
T cd05106         196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG  272 (374)
T ss_pred             cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence                     01247889999999999999999999   8999999999999999999999999997642           


Q ss_pred             --CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHHHH
Q 047719          440 --AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEM  516 (596)
Q Consensus       440 --~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  516 (596)
                        .++..|||||.+....++.++|||||||++|||++ |+.||....... . .......+.         ....+....
T Consensus       273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~-~~~~~~~~~---------~~~~~~~~~  341 (374)
T cd05106         273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-K-FYKMVKRGY---------QMSRPDFAP  341 (374)
T ss_pred             CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-H-HHHHHHccc---------CccCCCCCC
Confidence              13457999999998899999999999999999997 999997642111 0 111111110         001111123


Q ss_pred             HHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          517 ERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       517 ~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                      ..+.+++..||+.||++|||+.+|++.|+.
T Consensus       342 ~~l~~li~~cl~~dp~~RPs~~~l~~~l~~  371 (374)
T cd05106         342 PEIYSIMKMCWNLEPTERPTFSQISQLIQR  371 (374)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            567788889999999999999999999975

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-39  Score=338.40  Aligned_cols=240  Identities=28%  Similarity=0.390  Sum_probs=204.9

Q ss_pred             CCCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          285 GFNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      +....++||-|-||.||.|.|+. ...||||.++.+   ....++|+.|...|.. ++|||+|+|+|+|.....+|||+|
T Consensus       268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED---tMeveEFLkEAAvMKe-ikHpNLVqLLGVCT~EpPFYIiTE  343 (1157)
T KOG4278|consen  268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKE-IKHPNLVQLLGVCTHEPPFYIITE  343 (1157)
T ss_pred             heeeeeccCCCcccceeeeeeeccceeeehhhhhhc---chhHHHHHHHHHHHHh-hcCccHHHHhhhhccCCCeEEEEe
Confidence            44567899999999999999976 678999999643   3456789999977765 999999999999999999999999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcccC---
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA---  440 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~~---  440 (596)
                      ||.+|+|.+||++....  .++-.-.+.++.||++||+||..   +.+|||||.++|+|+.++..+|++|||+++..   
T Consensus       344 fM~yGNLLdYLRecnr~--ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD  418 (1157)
T KOG4278|consen  344 FMCYGNLLDYLRECNRS--EVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGD  418 (1157)
T ss_pred             cccCccHHHHHHHhchh--hcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhhcCC
Confidence            99999999999987643  36667788999999999999998   99999999999999999999999999987542   


Q ss_pred             ------C---CcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhccccccCc
Q 047719          441 ------G---TMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGK  510 (596)
Q Consensus       441 ------g---t~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  510 (596)
                            |   ...|.|||.+....++.|+|||+|||+||||.| |..||.+-+.   ..++.+.+++-         +.+
T Consensus       419 TYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl---SqVY~LLEkgy---------RM~  486 (1157)
T KOG4278|consen  419 TYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYGLLEKGY---------RMD  486 (1157)
T ss_pred             ceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH---HHHHHHHhccc---------ccc
Confidence                  2   357999999999999999999999999999999 9999987532   22344444442         333


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 047719          511 FNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK  545 (596)
Q Consensus       511 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~  545 (596)
                      -+..+...+..||+.||+.+|.+||+++|+.+.++
T Consensus       487 ~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafE  521 (1157)
T KOG4278|consen  487 GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFE  521 (1157)
T ss_pred             CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHH
Confidence            45566778999999999999999999999998775

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-39  Score=333.11  Aligned_cols=238  Identities=28%  Similarity=0.406  Sum_probs=198.9

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      ..|....+||+|.-|.||.+... +++.||||++....  ....+-.++|+..|.. .+|+|||.++..+..++++++||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~--Q~~keLilnEi~Vm~~-~~H~NiVnfl~Sylv~deLWVVM  349 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK--QPKKELLLNEILVMRD-LHHPNIVNFLDSYLVGDELWVVM  349 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEecc--CCchhhhHHHHHHHHh-ccchHHHHHHHHhcccceeEEEE
Confidence            34667789999999999999654 58899999996543  3344557899977776 99999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc----
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI----  438 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~----  438 (596)
                      |||++|+|.+.+....     +++.++..|+.++++||+|||.   ++|+|||||..|||++.++.+||+|||++.    
T Consensus       350 Eym~ggsLTDvVt~~~-----~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~  421 (550)
T KOG0578|consen  350 EYMEGGSLTDVVTKTR-----MTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE  421 (550)
T ss_pred             eecCCCchhhhhhccc-----ccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence            9999999999998653     8999999999999999999999   999999999999999999999999999764    


Q ss_pred             -------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcC
Q 047719          439 -------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKF  511 (596)
Q Consensus       439 -------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  511 (596)
                             .+||+.|||||.+....|++|.||||||++++||+-|++||-.+.....-|+  ....+..        ....
T Consensus       422 ~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyL--Ia~ng~P--------~lk~  491 (550)
T KOG0578|consen  422 EQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL--IATNGTP--------KLKN  491 (550)
T ss_pred             ccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHH--HhhcCCC--------CcCC
Confidence                   3599999999999999999999999999999999999999976543332222  1122211        1122


Q ss_pred             CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          512 NRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       512 ~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      +......+.++..+|++.|+++||++.|+++
T Consensus       492 ~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  492 PEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             ccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence            2344456677778999999999999999987

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=8.8e-38  Score=319.08  Aligned_cols=250  Identities=20%  Similarity=0.263  Sum_probs=192.1

Q ss_pred             CCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          285 GFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      +|...+.||+|+||.||+++.. +++.||||++............+.+|+..+. .++|+||+++++++...+..++|||
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLR-TLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHH-hCCCccccchhhhEecCCEEEEEEe
Confidence            5788899999999999999876 4789999999755444444556788886554 5999999999999999999999999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc----
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP----  439 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~----  439 (596)
                      |++++.|..+....    ..+++..+..++.|++.||.|||+   .+++||||||+|||++.++.+||+|||++..    
T Consensus        81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  153 (287)
T cd07848          81 YVEKNMLELLEEMP----NGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG  153 (287)
T ss_pred             cCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence            99987776554432    248899999999999999999999   8999999999999999999999999997632    


Q ss_pred             --------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChh--HHH-----------HHHHHHhcCC
Q 047719          440 --------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV--IVD-----------WVWNLRKKGK  498 (596)
Q Consensus       440 --------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~--~~~-----------~~~~~~~~~~  498 (596)
                              .||..|+|||.+.+..++.++|||||||++|||++|+.||......  +..           +.........
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07848         154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR  233 (287)
T ss_pred             ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence                    4788999999999888999999999999999999999999764321  000           0000000000


Q ss_pred             chhhcccccc------CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          499 LLDAADFRLR------GKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       499 ~~~~~d~~l~------~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ......+...      ..+.......+.+++.+|++.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0000000000      0001112345888999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-38  Score=318.82  Aligned_cols=251  Identities=26%  Similarity=0.376  Sum_probs=188.8

Q ss_pred             CCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHH--HHHhccCCCceeeecceeeeCC----eE
Q 047719          285 GFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFA--TMAGCLRHKNLVQLQGWCCEGN----EL  358 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~--~l~~~l~H~niv~l~g~~~~~~----~~  358 (596)
                      .....++||+|+||.||||.+ +++.||||++..     +..+.|.+|-.  .+. .++|+||+++++.-....    ++
T Consensus       211 pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~-----~~kqs~~~Ek~Iy~lp-~m~h~nIl~Fi~~ekr~t~~~~ey  283 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPE-----QEKQSFQNEKNIYSLP-GMKHENILQFIGAEKRGTADRMEY  283 (534)
T ss_pred             chhhHHHhhcCccceeehhhc-cCceeEEEecCH-----HHHHHHHhHHHHHhcc-CccchhHHHhhchhccCCccccce
Confidence            344568899999999999999 569999999953     23345666643  233 378999999999877665    89


Q ss_pred             EEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhcc------CCCeEEccCCCCceeecCCCceEEc
Q 047719          359 VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC------ERQIIHRDVKACNILLDAEFNAKLG  432 (596)
Q Consensus       359 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~------~~~ivHrDlkp~NiLl~~~~~~kl~  432 (596)
                      +||+||.++|+|.+||..+.     ++|....+|+..+++||+|||++.      +++|+|||||++||||.+|+++.|+
T Consensus       284 wLVt~fh~kGsL~dyL~~nt-----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIa  358 (534)
T KOG3653|consen  284 WLVTEFHPKGSLCDYLKANT-----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIA  358 (534)
T ss_pred             eEEeeeccCCcHHHHHHhcc-----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEee
Confidence            99999999999999999874     999999999999999999999864      6789999999999999999999999


Q ss_pred             cCCCcc-------------cCCCcccCCccccccCC------CCCccceeehhHHHHHHHhCCCCCCC--C---------
Q 047719          433 DFEATI-------------PAGTMGYLAPEYVYSGV------PSEKTDVYSFGVVALEVAAGKSPVDN--D---------  482 (596)
Q Consensus       433 Dfg~~~-------------~~gt~~y~aPE~~~~~~------~t~~sDV~SfGvll~El~tG~~p~~~--~---------  482 (596)
                      |||++.             .+||.+|||||++.+..      .-.+.||||+|.+||||++...-+..  .         
T Consensus       359 DFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~  438 (534)
T KOG3653|consen  359 DFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEA  438 (534)
T ss_pred             ccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhH
Confidence            999864             35999999999997642      22478999999999999997643321  0         


Q ss_pred             ----ChhHHHHHHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCC
Q 047719          483 ----GCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEAPLP  551 (596)
Q Consensus       483 ----~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~~~~p  551 (596)
                          ...+-+.......+.....+.+....    ...+..+.+.+-.||+.||+.|.|+.=|.+.+.....+.
T Consensus       439 evG~hPt~e~mq~~VV~kK~RP~~p~~W~~----h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~  507 (534)
T KOG3653|consen  439 EVGNHPTLEEMQELVVRKKQRPKIPDAWRK----HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW  507 (534)
T ss_pred             HhcCCCCHHHHHHHHHhhccCCCChhhhhc----CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence                01111111111111111122221111    134667778888999999999999888877766554433

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.2e-38  Score=326.87  Aligned_cols=245  Identities=24%  Similarity=0.252  Sum_probs=194.7

Q ss_pred             CCCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          285 GFNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      +|...+.||+|+||.||+|.... ++.||||++.+.... ......+..|+..+.. ++||||+++++++......|+||
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~-~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTT-TKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHh-CCCCCCccEEEEEEcCCEEEEEE
Confidence            57888999999999999998764 889999999753221 1234457788866554 88999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc----
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI----  438 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~----  438 (596)
                      ||+++|+|.+++....    .+++.....++.||+.||.|||+   .+++||||||+|||++.++.+||+|||++.    
T Consensus        81 e~~~g~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~  153 (333)
T cd05600          81 EYVPGGDFRTLLNNLG----VLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT  153 (333)
T ss_pred             eCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence            9999999999997643    48899999999999999999999   899999999999999999999999999764    


Q ss_pred             ----cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHH
Q 047719          439 ----PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRK  514 (596)
Q Consensus       439 ----~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  514 (596)
                          ..||+.|+|||.+.+..++.++|||||||++|||++|+.||......  +................   .......
T Consensus       154 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~---~~~~~~~  228 (333)
T cd05600         154 YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN--ETWENLKYWKETLQRPV---YDDPRFN  228 (333)
T ss_pred             ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHH--HHHHHHHhccccccCCC---CCccccc
Confidence                35899999999999989999999999999999999999999764321  11111111111111000   0000012


Q ss_pred             HHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          515 EMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       515 ~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ....+.+++..|++.+|.+||+++++++
T Consensus       229 ~s~~~~~li~~~l~~~~~rr~s~~~ll~  256 (333)
T cd05600         229 LSDEAWDLITKLINDPSRRFGSLEDIKN  256 (333)
T ss_pred             cCHHHHHHHHHHhhChhhhcCCHHHHHh
Confidence            3455677888999999999999999986

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-38  Score=305.56  Aligned_cols=192  Identities=30%  Similarity=0.380  Sum_probs=170.5

Q ss_pred             CCCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCchhcccch-HHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          285 GFNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRVECARNP-FTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~-~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      +|+..+.||.|+||+|.+++.+. |..+|+|++++.........+ ..+|. .+++.+.||++++|++.|.+.+.+||||
T Consensus        45 dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk-~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   45 DFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEK-RVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHH-HHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            57778999999999999998764 889999999765544433333 34554 5566699999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc----
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI----  438 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~----  438 (596)
                      ||+++|.|..+|+..+    .++.....-++.||+.||+|||+   ..|++|||||+|||||.+|.+||.|||.+.    
T Consensus       124 eyv~GGElFS~Lrk~~----rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~  196 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKSG----RFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG  196 (355)
T ss_pred             eccCCccHHHHHHhcC----CCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence            9999999999999865    48899999999999999999999   999999999999999999999999999764    


Q ss_pred             ----cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCCh
Q 047719          439 ----PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGC  484 (596)
Q Consensus       439 ----~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~  484 (596)
                          .+||+.|+|||.+....+..++|.|||||++|||++|.+||.....
T Consensus       197 rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~  246 (355)
T KOG0616|consen  197 RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP  246 (355)
T ss_pred             cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence                4799999999999999999999999999999999999999987543

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.2e-38  Score=330.53  Aligned_cols=247  Identities=25%  Similarity=0.358  Sum_probs=204.0

Q ss_pred             CCCccceeecCCceEEEEEEcC-CCCEEEEEEeecC-CchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          285 GFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKP-NRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~-~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      -|..++.||+|+-|.|-+|++. +|+.+|||++.+. ...+.......+|+ .+++++.|||+++|++.+.++.++|||.
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEI-viMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREI-VIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhh-HHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            4667789999999999999875 5999999999765 33333445577888 4556799999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc----
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI----  438 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~----  438 (596)
                      ||+++|.|.++|-..+    +|++.+..++..||..|+.|+|.   .+|+||||||+|+|||.++++||+|||++.    
T Consensus        92 Eyv~gGELFdylv~kG----~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~  164 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRKG----PLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVP  164 (786)
T ss_pred             EecCCchhHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccC
Confidence            9999999999998765    48899999999999999999999   899999999999999999999999999864    


Q ss_pred             ------cCCCcccCCccccccCCC-CCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcC
Q 047719          439 ------PAGTMGYLAPEYVYSGVP-SEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKF  511 (596)
Q Consensus       439 ------~~gt~~y~aPE~~~~~~~-t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  511 (596)
                            .+|++.|.|||.+.+.+| +.++||||.|||||-|+||+.||+++.  +...+. ....|..          +.
T Consensus       165 gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN--ir~LLl-KV~~G~f----------~M  231 (786)
T KOG0588|consen  165 GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN--IRVLLL-KVQRGVF----------EM  231 (786)
T ss_pred             CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc--HHHHHH-HHHcCcc----------cC
Confidence                  479999999999999887 789999999999999999999999653  222121 1222221          12


Q ss_pred             CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhcCCCCCC
Q 047719          512 NRKEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKGEAPLPL  552 (596)
Q Consensus       512 ~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~~~~~~p~  552 (596)
                      +.....++.+|+.+++..||++|.|++||++  +|.+-..+|.
T Consensus       232 Ps~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~  274 (786)
T KOG0588|consen  232 PSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPS  274 (786)
T ss_pred             CCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCCh
Confidence            2334455667778899999999999999998  6776655543

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=5.4e-38  Score=315.21  Aligned_cols=239  Identities=28%  Similarity=0.366  Sum_probs=194.2

Q ss_pred             CCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEec
Q 047719          285 GFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEY  364 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~  364 (596)
                      .|...+.||+|+||.||++.+.++..+|+|.+....   .....+.+|+..+. .++||||++++++|......++||||
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~iv~e~   80 (256)
T cd05114           5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA---MSEEDFIEEAKVMM-KLSHPKLVQLYGVCTQQKPLYIVTEF   80 (256)
T ss_pred             HcEEeeEecCCcCceEEEEEeccCceEEEEecccCC---ccHHHHHHHHHHHH-HCCCCCceeEEEEEccCCCEEEEEEc
Confidence            467778999999999999998888899999985332   22356888986665 49999999999999999999999999


Q ss_pred             CCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc-----
Q 047719          365 LPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP-----  439 (596)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~-----  439 (596)
                      +++|+|.+++.....   .++|..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||.+..     
T Consensus        81 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~  154 (256)
T cd05114          81 MENGCLLNYLRQRQG---KLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE  154 (256)
T ss_pred             CCCCcHHHHHHhCcc---CCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCc
Confidence            999999999976432   48899999999999999999999   8999999999999999999999999997642     


Q ss_pred             -------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcC
Q 047719          440 -------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKF  511 (596)
Q Consensus       440 -------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  511 (596)
                             .++..|+|||.+....++.++||||||+++|||++ |+.||.....  .+.+.........          ..
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~--~~~~~~i~~~~~~----------~~  222 (256)
T cd05114         155 YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN--YEVVEMISRGFRL----------YR  222 (256)
T ss_pred             eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHCCCCC----------CC
Confidence                   13457999999988889999999999999999999 8999976432  1111111111110          00


Q ss_pred             CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 047719          512 NRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK  545 (596)
Q Consensus       512 ~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~  545 (596)
                      +......+.+++.+||+.+|++||+++++++.|.
T Consensus       223 ~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         223 PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            1112346788999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=7.4e-38  Score=320.13  Aligned_cols=252  Identities=24%  Similarity=0.268  Sum_probs=187.8

Q ss_pred             CCCccceeecCCceEEEEEEcC--CCCEEEEEEeecCCchhcccchHHHHHHHHHh--ccCCCceeeecceeee-----C
Q 047719          285 GFNKNRIVGEGASATVYKGSLP--SGGAVAVKRFEKPNRVECARNPFTTEFATMAG--CLRHKNLVQLQGWCCE-----G  355 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~--~l~H~niv~l~g~~~~-----~  355 (596)
                      +|...+.||+|+||.||+|...  ++..||||+++.....+.....+.+|+..+..  .++||||++++++|..     .
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            5778899999999999999763  36789999987544333333456667655433  2479999999999863     4


Q ss_pred             CeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCC
Q 047719          356 NELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFE  435 (596)
Q Consensus       356 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg  435 (596)
                      ..+++||||++ ++|.+++.....  ..+++..+..++.||+.||+|||+   .+++||||||+|||++.++.+||+|||
T Consensus        82 ~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T cd07862          82 TKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFG  155 (290)
T ss_pred             CcEEEEEccCC-CCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEcccc
Confidence            56899999996 699999976532  348899999999999999999999   899999999999999999999999999


Q ss_pred             Ccc----------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCCh-hHHHHHHHHHhcCCchh---
Q 047719          436 ATI----------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGC-VIVDWVWNLRKKGKLLD---  501 (596)
Q Consensus       436 ~~~----------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~-~~~~~~~~~~~~~~~~~---  501 (596)
                      ++.          ..||..|+|||.+....++.++|||||||++|||++|++||..... .....+..........+   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~  235 (290)
T cd07862         156 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR  235 (290)
T ss_pred             ceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchh
Confidence            753          2478899999999888899999999999999999999999986532 11111111100000000   


Q ss_pred             ---hcccccc--C-----cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          502 ---AADFRLR--G-----KFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       502 ---~~d~~l~--~-----~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                         .....+.  .     ....+....+.+++.+|++.||++|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         236 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence               0000000  0     000112345678899999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-37  Score=324.78  Aligned_cols=241  Identities=25%  Similarity=0.356  Sum_probs=195.1

Q ss_pred             HHhcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCch---hcccchHHHHHHHHHhccC-CCceeeecceeeeC
Q 047719          281 QATLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRV---ECARNPFTTEFATMAGCLR-HKNLVQLQGWCCEG  355 (596)
Q Consensus       281 ~at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~---~~~~~~~~~E~~~l~~~l~-H~niv~l~g~~~~~  355 (596)
                      ....+|...+.||+|+||+|++|... ++..||||.+.+....   ....+...+|+..+.. ++ ||||++++.++...
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~-~~~HpnI~~l~ev~~t~   92 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRR-LRSHPNIIRLLEVFATP   92 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHH-hccCCCEeEEEEEEecC
Confidence            34567888999999999999999654 5899999987654221   1233445578866655 66 99999999999999


Q ss_pred             CeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCC-CceEEccC
Q 047719          356 NELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAE-FNAKLGDF  434 (596)
Q Consensus       356 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~-~~~kl~Df  434 (596)
                      ..+|+||||+.+|+|.+++.+..    .+.+.+...+..|++.|++|||+   ++|+||||||+|+|+|.+ +++||+||
T Consensus        93 ~~~~ivmEy~~gGdL~~~i~~~g----~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DF  165 (370)
T KOG0583|consen   93 TKIYIVMEYCSGGDLFDYIVNKG----RLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDF  165 (370)
T ss_pred             CeEEEEEEecCCccHHHHHHHcC----CCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEecc
Confidence            99999999999999999999843    48889999999999999999999   999999999999999999 99999999


Q ss_pred             CCcc-----------cCCCcccCCccccccCC-C-CCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchh
Q 047719          435 EATI-----------PAGTMGYLAPEYVYSGV-P-SEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLD  501 (596)
Q Consensus       435 g~~~-----------~~gt~~y~aPE~~~~~~-~-t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~  501 (596)
                      |++.           .+||+.|+|||++.+.. | ..++||||+||+||-|++|+.||++...  ...... ...+.   
T Consensus       166 G~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~--~~l~~k-i~~~~---  239 (370)
T KOG0583|consen  166 GLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV--PNLYRK-IRKGE---  239 (370)
T ss_pred             ccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH--HHHHHH-HhcCC---
Confidence            9764           35899999999999866 7 4899999999999999999999987432  111111 11111   


Q ss_pred             hccccccCcCCHHH-HHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          502 AADFRLRGKFNRKE-MERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       502 ~~d~~l~~~~~~~~-~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                         .    .++... ...+..|+.+|+++||.+|+++.+++.
T Consensus       240 ---~----~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  240 ---F----KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             ---c----cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence               1    111112 556778888999999999999999985

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=6.3e-38  Score=319.29  Aligned_cols=245  Identities=27%  Similarity=0.436  Sum_probs=197.1

Q ss_pred             CCCccceeecCCceEEEEEEcCC------CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeE
Q 047719          285 GFNKNRIVGEGASATVYKGSLPS------GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNEL  358 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~~------g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~  358 (596)
                      +|...+.||+|+||.||+|....      ...||+|.+.... ......++.+|+..+.. ++||||+++++++......
T Consensus         6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~-l~h~~i~~~~~~~~~~~~~   83 (283)
T cd05048           6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSD-LQHPNIVCLLGVCTKEQPT   83 (283)
T ss_pred             HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHh-cCCcccceEEEEEcCCCce
Confidence            56777999999999999997643      2579999986432 22334568889866655 8999999999999999999


Q ss_pred             EEEEecCCCCCHHHHhhhCCCC------------CcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCC
Q 047719          359 VLVYEYLPNGSLDKILHNNSSS------------SIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAE  426 (596)
Q Consensus       359 ~lV~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~  426 (596)
                      +++|||+++|+|.+++......            ...+++...+.++.|++.||+|||+   .+++||||||+||+++++
T Consensus        84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~  160 (283)
T cd05048          84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEG  160 (283)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCC
Confidence            9999999999999999764321            1358899999999999999999999   899999999999999999


Q ss_pred             CceEEccCCCccc-------------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHH
Q 047719          427 FNAKLGDFEATIP-------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWN  492 (596)
Q Consensus       427 ~~~kl~Dfg~~~~-------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~  492 (596)
                      +.+||+|||++..             .++..|+|||.+....++.++|||||||++|||++ |..||.+....  + ...
T Consensus       161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~--~-~~~  237 (283)
T cd05048         161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ--E-VIE  237 (283)
T ss_pred             CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH--H-HHH
Confidence            9999999997642             24567999999988899999999999999999998 99998764321  1 111


Q ss_pred             HHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          493 LRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       493 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                      ....+..         ...+......+.+|+.+||+.||++||++.||++.|+.
T Consensus       238 ~i~~~~~---------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         238 MIRSRQL---------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHcCCc---------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            1111111         11223345678889999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=6.5e-38  Score=315.37  Aligned_cols=242  Identities=24%  Similarity=0.375  Sum_probs=196.2

Q ss_pred             cCCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      ++|...++||+|+||.||+|...++..||+|.+....   ...+.+.+|+..+.+ ++|+||+++++.+...+..+++||
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~e   81 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT---MSVQAFLEEANLMKT-LQHDKLVRLYAVVTKEEPIYIITE   81 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc---hhHHHHHHHHHHHHh-CCCCCeeeEEEEEcCCCCcEEEEe
Confidence            4577789999999999999998788899999985432   234567888866554 899999999999999999999999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcccC---
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA---  440 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~~---  440 (596)
                      |+++|+|.+++....  ...+++.+++.++.|+++||+|||+   .+++||||||+||+++.++.+||+|||.+...   
T Consensus        82 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05072          82 YMAKGSLLDFLKSDE--GGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN  156 (261)
T ss_pred             cCCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence            999999999997653  2358899999999999999999999   89999999999999999999999999876432   


Q ss_pred             ---------CCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhccccccCc
Q 047719          441 ---------GTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGK  510 (596)
Q Consensus       441 ---------gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  510 (596)
                               ++..|+|||.+....++.++|||||||++|||++ |+.||......  +..... .....     ..... 
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~-~~~~~-----~~~~~-  227 (261)
T cd05072         157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--DVMSAL-QRGYR-----MPRME-  227 (261)
T ss_pred             ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--HHHHHH-HcCCC-----CCCCC-
Confidence                     3457999999988889999999999999999998 99999764321  111111 11110     01111 


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          511 FNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       511 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                         .....+.+++.+|++.+|++||+++++.+.|+.
T Consensus       228 ---~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         228 ---NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             ---CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence               223457788999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=3e-37  Score=311.43  Aligned_cols=251  Identities=23%  Similarity=0.335  Sum_probs=201.8

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCc-hhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNR-VECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      .+|...+.||+|+||.||+|... +++.||||.+..... .......+.+|+..+. .++||||+++++++...+..++|
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLK-QLNHPNVIKYLDSFIEDNELNIV   80 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHH-hCCCcceeeeeeeEEECCeEEEE
Confidence            46888899999999999999865 589999998864222 2233446788886555 48999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc---
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI---  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---  438 (596)
                      +||+++|+|.+++.........+++..++.++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||.+.   
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~  157 (267)
T cd08228          81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence            99999999999986543333458889999999999999999999   899999999999999999999999999654   


Q ss_pred             --------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCc
Q 047719          439 --------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGK  510 (596)
Q Consensus       439 --------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  510 (596)
                              ..|+..|+|||.+.+..++.++|+||||+++|||++|+.||.........+........ .        ...
T Consensus       158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~-~--------~~~  228 (267)
T cd08228         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCD-Y--------PPL  228 (267)
T ss_pred             chhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCC-C--------CCC
Confidence                    24778899999998888999999999999999999999998764433333222221111 0        111


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          511 FNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       511 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                      ........+.+++.+||+.+|++||++++|++.|++.
T Consensus       229 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         229 PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence            1223446678889999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-37  Score=323.08  Aligned_cols=232  Identities=21%  Similarity=0.239  Sum_probs=185.9

Q ss_pred             eecCCceEEEEEEcC-CCCEEEEEEeecCCc-hhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecCCCCC
Q 047719          292 VGEGASATVYKGSLP-SGGAVAVKRFEKPNR-VECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGS  369 (596)
Q Consensus       292 LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  369 (596)
                      ||+|+||.||++... +++.||+|++.+... .......+.+|+..+.+ ++||||+++++++...+..|+||||+++|+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~   79 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQ-VNCPFIVPLKFSFQSPEKLYLVLAFINGGE   79 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHh-CCCCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence            799999999999875 478999999964322 22334457778866654 899999999999999999999999999999


Q ss_pred             HHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc----------
Q 047719          370 LDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP----------  439 (596)
Q Consensus       370 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~----------  439 (596)
                      |.+++....    .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++..          
T Consensus        80 L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~  152 (312)
T cd05585          80 LFHHLQREG----RFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT  152 (312)
T ss_pred             HHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCcccc
Confidence            999997643    48899999999999999999999   8999999999999999999999999997642          


Q ss_pred             -CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHHHHHH
Q 047719          440 -AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMER  518 (596)
Q Consensus       440 -~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~  518 (596)
                       .||+.|+|||.+.+..++.++|||||||++|||++|+.||.....  .......... .          ..++......
T Consensus       153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~--~~~~~~~~~~-~----------~~~~~~~~~~  219 (312)
T cd05585         153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV--NEMYRKILQE-P----------LRFPDGFDRD  219 (312)
T ss_pred             ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH--HHHHHHHHcC-C----------CCCCCcCCHH
Confidence             489999999999998999999999999999999999999976432  1111111111 0          0112223345


Q ss_pred             HHHHHHHcCCCCCCCCCCHHHHHHHH
Q 047719          519 MLMVGLSCVHPNHEKRPSVKEAARIL  544 (596)
Q Consensus       519 l~~l~~~C~~~dp~~RPs~~ev~~~L  544 (596)
                      +.+++..|++.||++||++..+.+.|
T Consensus       220 ~~~li~~~L~~dp~~R~~~~~~~e~l  245 (312)
T cd05585         220 AKDLLIGLLSRDPTRRLGYNGAQEIK  245 (312)
T ss_pred             HHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence            67788899999999998654444443

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=5.5e-38  Score=326.86  Aligned_cols=232  Identities=25%  Similarity=0.283  Sum_probs=188.1

Q ss_pred             ceeecCCceEEEEEEcC-CCCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecCCC
Q 047719          290 RIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPN  367 (596)
Q Consensus       290 ~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  367 (596)
                      +.||+|+||.||++... +|+.||||++++.... ......+.+|+..+. .++||||+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~-~l~hp~i~~~~~~~~~~~~~~lv~e~~~~   79 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQ-NTRHPFLTALKYSFQTHDRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHH-hCCCCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999765 5889999999753221 223345677875554 48999999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc--------
Q 047719          368 GSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP--------  439 (596)
Q Consensus       368 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~--------  439 (596)
                      |+|.+++....    .+++.....++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++..        
T Consensus        80 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  152 (323)
T cd05571          80 GELFFHLSRER----VFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATM  152 (323)
T ss_pred             CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcc
Confidence            99999997653    48899999999999999999999   8999999999999999999999999997542        


Q ss_pred             ---CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHHHH
Q 047719          440 ---AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEM  516 (596)
Q Consensus       440 ---~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  516 (596)
                         .||+.|+|||.+.+..++.++|||||||++|||++|+.||.......  .. .......      .    .++....
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~--~~-~~~~~~~------~----~~p~~~~  219 (323)
T cd05571         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LF-ELILMEE------I----RFPRTLS  219 (323)
T ss_pred             cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH--HH-HHHHcCC------C----CCCCCCC
Confidence               48999999999999999999999999999999999999997643211  01 1111111      1    1122233


Q ss_pred             HHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 047719          517 ERMLMVGLSCVHPNHEKRP-----SVKEAAR  542 (596)
Q Consensus       517 ~~l~~l~~~C~~~dp~~RP-----s~~ev~~  542 (596)
                      ..+.+++.+|++.||++||     ++.++++
T Consensus       220 ~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         220 PEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             HHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            4567788899999999999     7888865

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-38  Score=333.65  Aligned_cols=235  Identities=26%  Similarity=0.329  Sum_probs=194.0

Q ss_pred             HHhcCCCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCchh-cccchHHHHHHHHHhccCCCceeeecceeeeCCeE
Q 047719          281 QATLGFNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRVE-CARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNEL  358 (596)
Q Consensus       281 ~at~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~-~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~  358 (596)
                      ..-++|...++||+|+||+|+++.++. ++.+|||++++..... ...+..+.|..++...-+||.|+.|+.+|++++++
T Consensus       365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l  444 (694)
T KOG0694|consen  365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL  444 (694)
T ss_pred             ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence            345679999999999999999998764 7899999998765433 33445566665554445799999999999999999


Q ss_pred             EEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCc-
Q 047719          359 VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT-  437 (596)
Q Consensus       359 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~-  437 (596)
                      |.||||+.||++..+.+..     .+++..+.-++..|+.||.|||+   ++||+||||..|||||.+|.+||+|||++ 
T Consensus       445 ~fvmey~~Ggdm~~~~~~~-----~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcK  516 (694)
T KOG0694|consen  445 FFVMEYVAGGDLMHHIHTD-----VFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCK  516 (694)
T ss_pred             EEEEEecCCCcEEEEEecc-----cccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEeccccccc
Confidence            9999999999965555533     48999999999999999999999   99999999999999999999999999875 


Q ss_pred             ----------ccCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCCh-hHHHHHHHHHhcCCchhhcccc
Q 047719          438 ----------IPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGC-VIVDWVWNLRKKGKLLDAADFR  506 (596)
Q Consensus       438 ----------~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~-~~~~~~~~~~~~~~~~~~~d~~  506 (596)
                                +.+||+.|||||.+.+..|+..+|+|||||+||||+.|+.||.++++ .+.+   .....          
T Consensus       517 e~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~Fd---sI~~d----------  583 (694)
T KOG0694|consen  517 EGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFD---SIVND----------  583 (694)
T ss_pred             ccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH---HHhcC----------
Confidence                      45799999999999999999999999999999999999999997643 2211   11100          


Q ss_pred             ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCH
Q 047719          507 LRGKFNRKEMERMLMVGLSCVHPNHEKRPSV  537 (596)
Q Consensus       507 l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~  537 (596)
                       ...|+.-...+.+.|+...+..+|++|..+
T Consensus       584 -~~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  584 -EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             -CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence             123455556677778888899999999976

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=5.5e-38  Score=327.78  Aligned_cols=238  Identities=24%  Similarity=0.288  Sum_probs=192.5

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      .+|...+.||+|+||.||+|... +++.||||++.+.... ......+.+|+..+.+ ++||||+++++++.+.+..|+|
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~-l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILME-LSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHh-CCCCCCCcEEEEEEcCCEEEEE
Confidence            45778899999999999999876 4889999999653221 1234457788866654 8999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc---
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI---  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---  438 (596)
                      |||+++|+|.+++....    .+++.....++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++.   
T Consensus        97 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  169 (329)
T PTZ00263         97 LEFVVGGELFTHLRKAG----RFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP  169 (329)
T ss_pred             EcCCCCChHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence            99999999999998654    47888899999999999999999   899999999999999999999999999764   


Q ss_pred             -----cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCH
Q 047719          439 -----PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNR  513 (596)
Q Consensus       439 -----~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  513 (596)
                           ..||+.|+|||.+.+..++.++|||||||++|||++|+.||......  +.. .....+..          .++.
T Consensus       170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--~~~-~~i~~~~~----------~~p~  236 (329)
T PTZ00263        170 DRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF--RIY-EKILAGRL----------KFPN  236 (329)
T ss_pred             CCcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH--HHH-HHHhcCCc----------CCCC
Confidence                 34889999999999988999999999999999999999999764321  111 11111111          1111


Q ss_pred             HHHHHHHHHHHHcCCCCCCCCCC-----HHHHHH
Q 047719          514 KEMERMLMVGLSCVHPNHEKRPS-----VKEAAR  542 (596)
Q Consensus       514 ~~~~~l~~l~~~C~~~dp~~RPs-----~~ev~~  542 (596)
                      .....+.+++..||+.||++||+     +++++.
T Consensus       237 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        237 WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            12245678889999999999997     677664

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2.2e-37  Score=323.25  Aligned_cols=236  Identities=27%  Similarity=0.321  Sum_probs=188.9

Q ss_pred             ceeecCCceEEEEEEcC-CCCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecCCC
Q 047719          290 RIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPN  367 (596)
Q Consensus       290 ~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  367 (596)
                      +.||+|+||.||++... +++.||+|++++.... ......+..|+..+.+..+||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            47999999999999865 4789999999754322 223345667776666666899999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc---------
Q 047719          368 GSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI---------  438 (596)
Q Consensus       368 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---------  438 (596)
                      |+|..++....    .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++.         
T Consensus        81 ~~L~~~~~~~~----~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~  153 (329)
T cd05618          81 GDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT  153 (329)
T ss_pred             CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcc
Confidence            99999987653    48899999999999999999999   899999999999999999999999999764         


Q ss_pred             --cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCC------hhHHHHHHHHHhcCCchhhccccccCc
Q 047719          439 --PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDG------CVIVDWVWNLRKKGKLLDAADFRLRGK  510 (596)
Q Consensus       439 --~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~------~~~~~~~~~~~~~~~~~~~~d~~l~~~  510 (596)
                        ..||..|+|||.+.+..++.++|||||||++|||++|+.||....      ....+++.........          .
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~----------~  223 (329)
T cd05618         154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----------R  223 (329)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC----------C
Confidence              247899999999999999999999999999999999999995311      1122333332222111          1


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCC------HHHHHH
Q 047719          511 FNRKEMERMLMVGLSCVHPNHEKRPS------VKEAAR  542 (596)
Q Consensus       511 ~~~~~~~~l~~l~~~C~~~dp~~RPs------~~ev~~  542 (596)
                      ++......+.+++.+|++.||++||+      ++++++
T Consensus       224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05618         224 IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  261 (329)
T ss_pred             CCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence            22223455678889999999999998      456543

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=4.5e-38  Score=345.15  Aligned_cols=248  Identities=23%  Similarity=0.318  Sum_probs=199.5

Q ss_pred             HHHHhcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCC-
Q 047719          279 IKQATLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGN-  356 (596)
Q Consensus       279 l~~at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~-  356 (596)
                      ++...++|...+.||+|+||+||++... +|+.||||++............+.+|+..+.. ++|+|+++++..+.... 
T Consensus        27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~-~~h~~iv~~~~~~~~~~~  105 (496)
T PTZ00283         27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLN-CDFFSIVKCHEDFAKKDP  105 (496)
T ss_pred             ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhc-CCCCcEEEeecceecccc
Confidence            3344568999999999999999999754 68999999997655444455667888866654 89999999988765432 


Q ss_pred             -------eEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCce
Q 047719          357 -------ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNA  429 (596)
Q Consensus       357 -------~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~  429 (596)
                             .+++||||+++|+|.++|.........+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+
T Consensus       106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~v  182 (496)
T PTZ00283        106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLV  182 (496)
T ss_pred             cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCE
Confidence                   3789999999999999998654444568999999999999999999999   899999999999999999999


Q ss_pred             EEccCCCcc-------------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhc
Q 047719          430 KLGDFEATI-------------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKK  496 (596)
Q Consensus       430 kl~Dfg~~~-------------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~  496 (596)
                      ||+|||++.             ..||+.|+|||.+.+..++.++|||||||++|||++|+.||.....  .+.+.... .
T Consensus       183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~--~~~~~~~~-~  259 (496)
T PTZ00283        183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM--EEVMHKTL-A  259 (496)
T ss_pred             EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHh-c
Confidence            999999753             2488999999999999999999999999999999999999976532  12221111 1


Q ss_pred             CCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          497 GKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       497 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      +..         ...+......+..++..||+.||++||++.++++
T Consensus       260 ~~~---------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~  296 (496)
T PTZ00283        260 GRY---------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN  296 (496)
T ss_pred             CCC---------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence            111         1112223456778889999999999999999876

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=9.1e-38  Score=314.97  Aligned_cols=241  Identities=27%  Similarity=0.374  Sum_probs=196.1

Q ss_pred             CCCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          285 GFNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      +|...+.||+|+||.||+|...+ ++.||+|++....   ....++.+|+..+.. ++|+||++++++|......++|||
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~e   82 (263)
T cd05052           7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKE-IKHPNLVQLLGVCTREPPFYIITE   82 (263)
T ss_pred             HeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHh-CCCCChhheEEEEcCCCCcEEEEE
Confidence            46677899999999999998754 8899999985432   234568889866655 899999999999999999999999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcccC---
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA---  440 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~~---  440 (596)
                      |+++++|.+++....  ...+++..++.++.|+++||+|||+   .+++||||||+||++++++.+||+|||.+...   
T Consensus        83 ~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~  157 (263)
T cd05052          83 FMTYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  157 (263)
T ss_pred             eCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence            999999999997654  2358999999999999999999999   89999999999999999999999999976432   


Q ss_pred             ---------CCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhccccccCc
Q 047719          441 ---------GTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGK  510 (596)
Q Consensus       441 ---------gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  510 (596)
                               ++..|+|||.+.+..++.++|||||||++|||++ |..|+.....  .+. +......         ....
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--~~~-~~~~~~~---------~~~~  225 (263)
T cd05052         158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQV-YELLEKG---------YRME  225 (263)
T ss_pred             eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHH-HHHHHCC---------CCCC
Confidence                     2457999999988899999999999999999998 9999976432  111 1111111         1111


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          511 FNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       511 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                      .+......+.+++.+||+.+|++||++.++++.|+.
T Consensus       226 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~  261 (263)
T cd05052         226 RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET  261 (263)
T ss_pred             CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence            122234567788899999999999999999999874

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=8e-38  Score=317.86  Aligned_cols=248  Identities=25%  Similarity=0.387  Sum_probs=196.2

Q ss_pred             HhcCCCccceeecCCceEEEEEEcC------CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeC
Q 047719          282 ATLGFNKNRIVGEGASATVYKGSLP------SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG  355 (596)
Q Consensus       282 at~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~  355 (596)
                      .+++|+..+.||+|+||.||+|...      .+..||||++..... .....++.+|+..+. .++|+||+++++++.+.
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~-~l~~~~iv~~~~~~~~~   81 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS-MRERIEFLNEASVMK-EFNCHHVVRLLGVVSQG   81 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC-HHHHHHHHHHHHHHH-hCCCCCeeeEEEEEcCC
Confidence            4567888999999999999998643      246799999854322 223456888886554 48999999999999999


Q ss_pred             CeEEEEEecCCCCCHHHHhhhCCCC------CcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCce
Q 047719          356 NELVLVYEYLPNGSLDKILHNNSSS------SIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNA  429 (596)
Q Consensus       356 ~~~~lV~E~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~  429 (596)
                      ...++||||+++|+|.+++......      ...+++..++.++.|++.||+|||+   .+++||||||+||++++++.+
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~  158 (277)
T cd05062          82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTV  158 (277)
T ss_pred             CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCE
Confidence            9999999999999999999764321      2346889999999999999999999   899999999999999999999


Q ss_pred             EEccCCCccc-------------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHh
Q 047719          430 KLGDFEATIP-------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRK  495 (596)
Q Consensus       430 kl~Dfg~~~~-------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~  495 (596)
                      ||+|||++..             .++..|+|||.+..+.++.++|||||||++|||++ |..||......  ... ....
T Consensus       159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~--~~~-~~~~  235 (277)
T cd05062         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE--QVL-RFVM  235 (277)
T ss_pred             EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHH-HHHH
Confidence            9999997642             23567999999998889999999999999999999 78898754321  111 1111


Q ss_pred             cCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          496 KGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       496 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                      ......         .+......+.+++.+|++.+|++|||+.|+++.|+.
T Consensus       236 ~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         236 EGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             cCCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            111111         112233567889999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=9.7e-38  Score=333.67  Aligned_cols=252  Identities=26%  Similarity=0.363  Sum_probs=198.1

Q ss_pred             HhcCCCccceeecCCceEEEEEEcCC------CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeC
Q 047719          282 ATLGFNKNRIVGEGASATVYKGSLPS------GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG  355 (596)
Q Consensus       282 at~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~  355 (596)
                      ...+|...++||+|+||.||+|....      +..||||++..... ....+.+.+|+..+.+.-.|||||+++++|.+.
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~  113 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR-SSEKQALMSELKIMTHLGPHLNIVNLLGACTKS  113 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence            35577888999999999999997521      34699999964322 233456889997776633599999999999999


Q ss_pred             CeEEEEEecCCCCCHHHHhhhCCC--------------------------------------------------------
Q 047719          356 NELVLVYEYLPNGSLDKILHNNSS--------------------------------------------------------  379 (596)
Q Consensus       356 ~~~~lV~E~~~~gsL~~~l~~~~~--------------------------------------------------------  379 (596)
                      ...||||||+++|+|.++|.....                                                        
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (400)
T cd05105         114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE  193 (400)
T ss_pred             CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence            999999999999999999875321                                                        


Q ss_pred             ------------------------------------CCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceee
Q 047719          380 ------------------------------------SSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILL  423 (596)
Q Consensus       380 ------------------------------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl  423 (596)
                                                          ....+++.+++.++.||++||+|||+   .+++||||||+|||+
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill  270 (400)
T cd05105         194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLL  270 (400)
T ss_pred             hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEE
Confidence                                                01247889999999999999999999   899999999999999


Q ss_pred             cCCCceEEccCCCccc-------------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHH
Q 047719          424 DAEFNAKLGDFEATIP-------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDW  489 (596)
Q Consensus       424 ~~~~~~kl~Dfg~~~~-------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~  489 (596)
                      +.++.+||+|||++..             .++..|+|||.+.+..++.++|||||||++|||++ |..||......  ..
T Consensus       271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~--~~  348 (400)
T cd05105         271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD--ST  348 (400)
T ss_pred             eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh--HH
Confidence            9999999999997642             24567999999998899999999999999999997 99998753211  11


Q ss_pred             HHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Q 047719          490 VWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEA  548 (596)
Q Consensus       490 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~~  548 (596)
                      .......+.         ....+......+.+++.+||+.+|++||++.+|.+.|+...
T Consensus       349 ~~~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         349 FYNKIKSGY---------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             HHHHHhcCC---------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence            111111111         11112233456788999999999999999999999998643

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=3.4e-37  Score=321.99  Aligned_cols=251  Identities=25%  Similarity=0.318  Sum_probs=195.0

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      ++|...+.||+|+||.||++... ++..||+|.+.... .......+.+|+..+.. ++||||+++++++...+..++||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~lv~   82 (331)
T cd06649           5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHE-CNSPYIVGFYGAFYSDGEISICM   82 (331)
T ss_pred             ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHH-CCCCCCCeEEEEEEECCEEEEEe
Confidence            57888899999999999999876 48889999986432 22334568889866655 89999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc----
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI----  438 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~----  438 (596)
                      ||+++|+|.+++....    .+++..+..++.|++.||.|||+.  .+|+||||||+|||++.++.+||+|||++.    
T Consensus        83 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  156 (331)
T cd06649          83 EHMDGGSLDQVLKEAK----RIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (331)
T ss_pred             ecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence            9999999999997653    488999999999999999999982  469999999999999999999999999764    


Q ss_pred             -----cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChh-HHHHHHHHHhcC--C------------
Q 047719          439 -----PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV-IVDWVWNLRKKG--K------------  498 (596)
Q Consensus       439 -----~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~-~~~~~~~~~~~~--~------------  498 (596)
                           ..||..|+|||.+.+..++.++|||||||++|||++|+.||...... +..........+  .            
T Consensus       157 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (331)
T cd06649         157 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPP  236 (331)
T ss_pred             cccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccc
Confidence                 24889999999999889999999999999999999999999754321 111100000000  0            


Q ss_pred             ----------------chhhccccc---cCc-CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          499 ----------------LLDAADFRL---RGK-FNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       499 ----------------~~~~~d~~l---~~~-~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                                      ..+..+...   ... ........+.+++.+||+.||++|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~  300 (331)
T cd06649         237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMN  300 (331)
T ss_pred             cccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                            000000000   000 00112346788999999999999999999987

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-37  Score=313.43  Aligned_cols=243  Identities=27%  Similarity=0.420  Sum_probs=196.6

Q ss_pred             cCCCccceeecCCceEEEEEEcCC----CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPS----GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELV  359 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~  359 (596)
                      ++|...+.||+|+||.||+|.+..    ...||||.++... ......+|.+|+..+.. ++|+||+++++++...+..+
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~   81 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQ-FDHPNIIRLEGVVTKSRPVM   81 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHh-CCCCCcceEeEEEecCCceE
Confidence            468888999999999999998743    3579999986433 23344568889866654 89999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc
Q 047719          360 LVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP  439 (596)
Q Consensus       360 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~  439 (596)
                      +||||+++++|.+++.....   .+++..++.++.|++.||+|||+   .+++||||||+|||+++++.+||+|||++..
T Consensus        82 iv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~  155 (266)
T cd05033          82 IITEYMENGSLDKFLRENDG---KFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRR  155 (266)
T ss_pred             EEEEcCCCCCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhc
Confidence            99999999999999976532   58999999999999999999999   8999999999999999999999999997653


Q ss_pred             C-------------CCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhccc
Q 047719          440 A-------------GTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADF  505 (596)
Q Consensus       440 ~-------------gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~  505 (596)
                      .             ++..|+|||.+.+..++.++||||||+++|||++ |..||......  + ...........     
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--~-~~~~~~~~~~~-----  227 (266)
T cd05033         156 LEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--D-VIKAVEDGYRL-----  227 (266)
T ss_pred             ccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH--H-HHHHHHcCCCC-----
Confidence            2             3467999999998899999999999999999998 99998653221  1 11111111100     


Q ss_pred             cccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          506 RLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       506 ~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                          ..+......+.+++.+|++.+|++||+++|+++.|+.
T Consensus       228 ----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~  264 (266)
T cd05033         228 ----PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK  264 (266)
T ss_pred             ----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence                1112234567889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-37  Score=312.67  Aligned_cols=243  Identities=26%  Similarity=0.377  Sum_probs=198.2

Q ss_pred             hcCCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      ..+|...+.||+|+||.||+|...+++.||+|.++...   ...+++.+|+..+.+ ++|+||+++++++...+..++||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~   80 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT---MDPKDFLAEAQIMKK-LRHPKLIQLYAVCTLEEPIYIVT   80 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc---ccHHHHHHHHHHHHH-CCCCCccceeEEEecCCCeeeee
Confidence            34578889999999999999998778899999986432   234568889866655 89999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcccC--
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA--  440 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~~--  440 (596)
                      ||+++++|.+++....  ...+++..+..++.|++.||.|||+   .+++||||||+||++++++.+||+|||++...  
T Consensus        81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05068          81 ELMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKE  155 (261)
T ss_pred             ecccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence            9999999999997654  2358999999999999999999999   89999999999999999999999999876432  


Q ss_pred             -------C---CcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhccccccC
Q 047719          441 -------G---TMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRG  509 (596)
Q Consensus       441 -------g---t~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  509 (596)
                             |   +..|+|||.+.+..++.++||||||+++|||++ |+.||......  . +........         ..
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~-~~~~~~~~~---------~~  223 (261)
T cd05068         156 DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA--E-VLQQVDQGY---------RM  223 (261)
T ss_pred             CcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH--H-HHHHHHcCC---------CC
Confidence                   2   246999999998899999999999999999999 99999764321  1 111111110         01


Q ss_pred             cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          510 KFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       510 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                      ..+......+.+++.+|++.+|++||++.++.+.|+.
T Consensus       224 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         224 PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            1112234567888999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=7.8e-38  Score=324.57  Aligned_cols=244  Identities=25%  Similarity=0.393  Sum_probs=192.9

Q ss_pred             cCCCccceeecCCceEEEEEEcCC-CC----EEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPS-GG----AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNEL  358 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~----~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~  358 (596)
                      .+|...+.||+|+||.||+|.+.. +.    .||||+++... .....+++..|+..+. .++||||++++|+|... ..
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~-~l~h~niv~~~g~~~~~-~~   83 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMA-SVDNPHVCRLLGICLTS-TV   83 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC-CHHHHHHHHHHHHHHH-hCCCCCCCeEEEEEcCC-Cc
Confidence            458888999999999999998643 33    48999986432 2234456888886554 48999999999999865 57


Q ss_pred             EEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc
Q 047719          359 VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI  438 (596)
Q Consensus       359 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~  438 (596)
                      ++|+||+++|+|.+++....   ..+++..++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++.
T Consensus        84 ~~v~e~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~  157 (316)
T cd05108          84 QLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAK  157 (316)
T ss_pred             eeeeecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccc
Confidence            89999999999999998653   248899999999999999999999   899999999999999999999999999875


Q ss_pred             cC-------------CCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhcc
Q 047719          439 PA-------------GTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAAD  504 (596)
Q Consensus       439 ~~-------------gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d  504 (596)
                      ..             ++..|+|||.+....++.++|||||||++|||++ |+.||.+....  ++ ......+...    
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~--~~-~~~~~~~~~~----  230 (316)
T cd05108         158 LLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EI-SSILEKGERL----  230 (316)
T ss_pred             cccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--HH-HHHHhCCCCC----
Confidence            32             2457999999999999999999999999999998 99999764321  11 1111111110    


Q ss_pred             ccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Q 047719          505 FRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEA  548 (596)
Q Consensus       505 ~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~~  548 (596)
                           ..+......+..++..||+.+|.+||++.++++.|....
T Consensus       231 -----~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~  269 (316)
T cd05108         231 -----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  269 (316)
T ss_pred             -----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                 001112345678889999999999999999999887544

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.3e-37  Score=309.84  Aligned_cols=240  Identities=25%  Similarity=0.351  Sum_probs=196.9

Q ss_pred             CCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          285 GFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      +|...+.||+|+||.||++... ++..|++|.+...........++.+|+..+.. ++|||++++++++.+.+..++|||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAK-LDSSYIIRYYESFLDKGKLNIVME   79 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHh-cCCCCeehheeeeccCCEEEEEEE
Confidence            4677789999999999999875 58899999986544344456678889866554 899999999999999999999999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc----
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP----  439 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~----  439 (596)
                      |+++++|.+++....  ...+++..++.++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||.+..    
T Consensus        80 ~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~  154 (256)
T cd08529          80 YAENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN  154 (256)
T ss_pred             eCCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence            999999999998753  2358999999999999999999998   8999999999999999999999999986532    


Q ss_pred             -------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCC
Q 047719          440 -------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFN  512 (596)
Q Consensus       440 -------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  512 (596)
                             .|+..|+|||++.+..++.++|+|||||++|||++|+.||......  ... .....+.         .....
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~-~~~~~~~---------~~~~~  222 (256)
T cd08529         155 TNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG--ALI-LKIIRGV---------FPPVS  222 (256)
T ss_pred             cchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH--HHH-HHHHcCC---------CCCCc
Confidence                   4678899999999888999999999999999999999999765321  111 1111111         11122


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          513 RKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       513 ~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ......+.+++.+||+.+|++||++.++++
T Consensus       223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  252 (256)
T cd08529         223 QMYSQQLAQLIDQCLTKDYRQRPDTFQLLR  252 (256)
T ss_pred             cccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence            234456788999999999999999999876

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4e-37  Score=321.69  Aligned_cols=254  Identities=23%  Similarity=0.320  Sum_probs=190.1

Q ss_pred             CCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeC-----CeE
Q 047719          285 GFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG-----NEL  358 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~-----~~~  358 (596)
                      .|...+.||+|+||.||+|... ++..||||++............+.+|+..+.. ++||||+++++++...     ...
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~-l~hpniv~~~~~~~~~~~~~~~~~   79 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRL-LRHPDIVEIKHIMLPPSRREFKDI   79 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHh-CCCCCEeeecceEeccCCCCCceE
Confidence            3677899999999999999865 58999999986433333334567889866654 8999999999988643     358


Q ss_pred             EEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc
Q 047719          359 VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI  438 (596)
Q Consensus       359 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~  438 (596)
                      |+||||+. ++|.+++....    .+++..+..++.||++||.|||+   .+|+||||||+|||++.++.+||+|||++.
T Consensus        80 ~lv~e~~~-~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~  151 (338)
T cd07859          80 YVVFELME-SDLHQVIKAND----DLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLAR  151 (338)
T ss_pred             EEEEecCC-CCHHHHHHhcc----cCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCcccc
Confidence            99999995 69999997653    48999999999999999999999   899999999999999999999999999754


Q ss_pred             c--------------CCCcccCCcccccc--CCCCCccceeehhHHHHHHHhCCCCCCCCCh-hHHHHHHHHHhcC----
Q 047719          439 P--------------AGTMGYLAPEYVYS--GVPSEKTDVYSFGVVALEVAAGKSPVDNDGC-VIVDWVWNLRKKG----  497 (596)
Q Consensus       439 ~--------------~gt~~y~aPE~~~~--~~~t~~sDV~SfGvll~El~tG~~p~~~~~~-~~~~~~~~~~~~~----  497 (596)
                      .              .||..|+|||.+.+  ..++.++|||||||++|||++|+.||..... .....+.......    
T Consensus       152 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  231 (338)
T cd07859         152 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPET  231 (338)
T ss_pred             ccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            2              47889999999875  6789999999999999999999999976432 1111111110000    


Q ss_pred             -------C---chhhccccccCcCC---HHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhcC
Q 047719          498 -------K---LLDAADFRLRGKFN---RKEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKGE  547 (596)
Q Consensus       498 -------~---~~~~~d~~l~~~~~---~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~~~  547 (596)
                             .   ..............   ......+.+++..|++.||++|||++|+++  ++++.
T Consensus       232 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~  296 (338)
T cd07859         232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGL  296 (338)
T ss_pred             HHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhc
Confidence                   0   00000000000000   011245678889999999999999999986  44443

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=8.9e-37  Score=316.84  Aligned_cols=232  Identities=24%  Similarity=0.291  Sum_probs=185.4

Q ss_pred             ceeecCCceEEEEEEcCC-CCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecCCC
Q 047719          290 RIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPN  367 (596)
Q Consensus       290 ~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  367 (596)
                      ++||+|+||.||+|...+ ++.||||++++.... ......+..|...+....+||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            469999999999998754 789999999753221 222334556665665557899999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc---------
Q 047719          368 GSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI---------  438 (596)
Q Consensus       368 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---------  438 (596)
                      |+|.+++....    .+++.....++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++.         
T Consensus        81 g~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~  153 (316)
T cd05592          81 GDLMFHIQSSG----RFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA  153 (316)
T ss_pred             CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcc
Confidence            99999997653    48889999999999999999999   899999999999999999999999999764         


Q ss_pred             --cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHHHH
Q 047719          439 --PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEM  516 (596)
Q Consensus       439 --~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  516 (596)
                        ..||..|+|||.+.+..++.++|||||||++|||++|+.||......  +........           ...++....
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~--~~~~~i~~~-----------~~~~~~~~~  220 (316)
T cd05592         154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED--ELFDSILND-----------RPHFPRWIS  220 (316)
T ss_pred             ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHcC-----------CCCCCCCCC
Confidence              24799999999999889999999999999999999999999865421  111111111           011122223


Q ss_pred             HHHHHHHHHcCCCCCCCCCCHH-HHH
Q 047719          517 ERMLMVGLSCVHPNHEKRPSVK-EAA  541 (596)
Q Consensus       517 ~~l~~l~~~C~~~dp~~RPs~~-ev~  541 (596)
                      ..+.+++..||+.||++||++. +++
T Consensus       221 ~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         221 KEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             HHHHHHHHHHccCCHHHcCCChHHHH
Confidence            4566788899999999999875 453

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-38  Score=321.75  Aligned_cols=237  Identities=25%  Similarity=0.292  Sum_probs=192.3

Q ss_pred             CCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          285 GFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      +|...+.||+|+||.||++... +++.||+|++...... ......+.+|+..+. .++||||+++++++.+....++||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLK-EVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHH-hCCCCcHhhhHhhhccCCeEEEEE
Confidence            5778899999999999999875 5889999999643221 123445778885554 499999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc----
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI----  438 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~----  438 (596)
                      ||+++|+|.+++....    .+++.....++.||+.||+|||+   ++++||||||+|||++.++.+||+|||++.    
T Consensus        81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  153 (291)
T cd05612          81 EYVPGGELFSYLRNSG----RFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD  153 (291)
T ss_pred             eCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence            9999999999998654    48899999999999999999999   899999999999999999999999999754    


Q ss_pred             ----cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHH
Q 047719          439 ----PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRK  514 (596)
Q Consensus       439 ----~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  514 (596)
                          ..||+.|+|||.+.+..++.++|||||||++|||++|+.||......  ...... ..+..          .++..
T Consensus       154 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~--~~~~~i-~~~~~----------~~~~~  220 (291)
T cd05612         154 RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF--GIYEKI-LAGKL----------EFPRH  220 (291)
T ss_pred             CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHH-HhCCc----------CCCcc
Confidence                34889999999999888999999999999999999999999765321  111111 11110          11122


Q ss_pred             HHHHHHHHHHHcCCCCCCCCCC-----HHHHHH
Q 047719          515 EMERMLMVGLSCVHPNHEKRPS-----VKEAAR  542 (596)
Q Consensus       515 ~~~~l~~l~~~C~~~dp~~RPs-----~~ev~~  542 (596)
                      ....+.+++.+|++.||.+||+     ++++++
T Consensus       221 ~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  253 (291)
T cd05612         221 LDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN  253 (291)
T ss_pred             CCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence            2345678889999999999995     777665

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=6.5e-38  Score=315.18  Aligned_cols=244  Identities=28%  Similarity=0.414  Sum_probs=199.8

Q ss_pred             HhcCCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          282 ATLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       282 at~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      +..+|...+.||.|+||.||+|...++..+|+|.+.....  .....+..|+..+. .++|+||+++++++......++|
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~lv   80 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL--LKQQDFQKEVQALK-RLRHKHLISLFAVCSVGEPVYII   80 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch--hhHHHHHHHHHHHh-cCCCcchhheeeeEecCCCeEEE
Confidence            3456778899999999999999988899999999864332  23446788886655 48999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc--
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP--  439 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~--  439 (596)
                      |||+++++|.+++....  ...+++.+++.++.||+.||.|||+   ++++|+||||+||++++++.+||+|||.+..  
T Consensus        81 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~  155 (261)
T cd05148          81 TELMEKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIK  155 (261)
T ss_pred             EeecccCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcC
Confidence            99999999999998654  2358999999999999999999999   8999999999999999999999999987643  


Q ss_pred             ---------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCCh-hHHHHHHHHHhcCCchhhcccccc
Q 047719          440 ---------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGC-VIVDWVWNLRKKGKLLDAADFRLR  508 (596)
Q Consensus       440 ---------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~  508 (596)
                               .++..|+|||.+....++.++||||||+++|||++ |+.||..... .....   .. .+         ..
T Consensus       156 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~---~~-~~---------~~  222 (261)
T cd05148         156 EDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQ---IT-AG---------YR  222 (261)
T ss_pred             CccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH---HH-hC---------Cc
Confidence                     24567999999988889999999999999999998 8999976432 11111   11 11         01


Q ss_pred             CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          509 GKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       509 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                      ...+......+.+++.+||+.||.+|||++++++.|+.
T Consensus       223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         223 MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence            11122334567788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=8e-37  Score=307.91  Aligned_cols=250  Identities=25%  Similarity=0.366  Sum_probs=204.0

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      ++|...+.||+|+||.||+|... +|+.||+|.++..... ......+.+|+..+.+ ++|+|++++++++...+..++|
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~-~~~~~i~~~~~~~~~~~~~~lv   80 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQ-LDHPNVIKYLASFIENNELNIV   80 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHh-CCCCCeeeeeeeeecCCeEEEE
Confidence            57888899999999999999876 6899999998643322 2235578889866655 8999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc---
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI---  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---  438 (596)
                      |||+++|+|.+++.........+++.+++.++.+++.||+|||+   .+++||||||+||+++.++.++|+|||.+.   
T Consensus        81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~  157 (267)
T cd08224          81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence            99999999999997654334568999999999999999999999   899999999999999999999999998653   


Q ss_pred             --------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCc
Q 047719          439 --------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGK  510 (596)
Q Consensus       439 --------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  510 (596)
                              ..++..|+|||.+.+..++.++|||||||++|||++|+.||........+....... +..         ..
T Consensus       158 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~---------~~  227 (267)
T cd08224         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEK-CDY---------PP  227 (267)
T ss_pred             CCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhc-CCC---------CC
Confidence                    247788999999988889999999999999999999999997654333322221111 111         11


Q ss_pred             CCH-HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          511 FNR-KEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       511 ~~~-~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                      .+. .....+.+++.+||+.+|++||++.+|++.|+..
T Consensus       228 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         228 LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence            111 3345677888999999999999999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-37  Score=338.10  Aligned_cols=243  Identities=26%  Similarity=0.307  Sum_probs=201.0

Q ss_pred             CCccceeecCCceEEEEEEcCCC-CEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecce-eee------CCe
Q 047719          286 FNKNRIVGEGASATVYKGSLPSG-GAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW-CCE------GNE  357 (596)
Q Consensus       286 f~~~~~LG~G~fG~Vy~~~~~~g-~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~-~~~------~~~  357 (596)
                      ....++|.+|||+.||.+....+ ..||+|++...  .+...+...+||..|..+-.|+|||.+++. ...      .-+
T Consensus        39 v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E  116 (738)
T KOG1989|consen   39 VTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE  116 (738)
T ss_pred             EEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence            44568999999999999988765 99999998643  456677889999888886669999999993 322      136


Q ss_pred             EEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCc
Q 047719          358 LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT  437 (596)
Q Consensus       358 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~  437 (596)
                      .+|+||||++|+|-+++..+...  .|++.++++|+.++++|+++||. +.++|||||||.+||||+.+++.||||||.+
T Consensus       117 vllLmEyC~gg~Lvd~mn~Rlq~--~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSa  193 (738)
T KOG1989|consen  117 VLLLMEYCKGGSLVDFMNTRLQT--RLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSA  193 (738)
T ss_pred             EEeehhhccCCcHHHHHHHHHhc--cCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCccccc
Confidence            89999999999999999876532  39999999999999999999998 6788999999999999999999999999975


Q ss_pred             cc--------------------CCCcccCCccccc---cCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHH
Q 047719          438 IP--------------------AGTMGYLAPEYVY---SGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLR  494 (596)
Q Consensus       438 ~~--------------------~gt~~y~aPE~~~---~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~  494 (596)
                      ..                    .-|+.|.|||++.   +...++|+|||||||+||-|+....||+..+.          
T Consensus       194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----------  263 (738)
T KOG1989|consen  194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----------  263 (738)
T ss_pred             ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----------
Confidence            42                    2588999999874   56789999999999999999999999987532          


Q ss_pred             hcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Q 047719          495 KKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEA  548 (596)
Q Consensus       495 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~~  548 (596)
                           ..++.-.....-.......+..|+..||++||.+||++-+|+..+...+
T Consensus       264 -----laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~  312 (738)
T KOG1989|consen  264 -----LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELA  312 (738)
T ss_pred             -----eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHh
Confidence                 1222222222223467889999999999999999999999998776543

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.3e-37  Score=311.70  Aligned_cols=245  Identities=24%  Similarity=0.397  Sum_probs=194.7

Q ss_pred             CCccceeecCCceEEEEEEcCC----CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCe----
Q 047719          286 FNKNRIVGEGASATVYKGSLPS----GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNE----  357 (596)
Q Consensus       286 f~~~~~LG~G~fG~Vy~~~~~~----g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~----  357 (596)
                      |...+.||+|+||.||+|....    +..||||+++...........+.+|+..+.. ++|+||+++++++.....    
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~~~   79 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKD-FDHPNVMKLIGVCFEASSLQKI   79 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHh-CCCCCeeeEEeeeccCCccccC
Confidence            4567899999999999997643    3679999987544444445678889866655 899999999999876554    


Q ss_pred             --EEEEEecCCCCCHHHHhhhCCC--CCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEcc
Q 047719          358 --LVLVYEYLPNGSLDKILHNNSS--SSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGD  433 (596)
Q Consensus       358 --~~lV~E~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~D  433 (596)
                        .++++||+++|+|..++.....  ....+++.....++.|++.||+|||+   .+++||||||+||++++++.+||+|
T Consensus        80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~d  156 (273)
T cd05035          80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVAD  156 (273)
T ss_pred             cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECC
Confidence              7999999999999999965421  22358999999999999999999999   8999999999999999999999999


Q ss_pred             CCCccc-------------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCc
Q 047719          434 FEATIP-------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKL  499 (596)
Q Consensus       434 fg~~~~-------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~  499 (596)
                      ||.+..             .++..|+|||.+....++.++|||||||++|||++ |..||......  +..... ..+..
T Consensus       157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~--~~~~~~-~~~~~  233 (273)
T cd05035         157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH--EIYDYL-RHGNR  233 (273)
T ss_pred             ccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHH-HcCCC
Confidence            998643             13467999999988889999999999999999999 88998764321  111111 11111


Q ss_pred             hhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          500 LDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       500 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                               ...+......+.+++.+||+.||++||++.|+++.|+.
T Consensus       234 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~  271 (273)
T cd05035         234 ---------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN  271 (273)
T ss_pred             ---------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence                     11122334578888899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.7e-37  Score=315.52  Aligned_cols=245  Identities=27%  Similarity=0.452  Sum_probs=196.8

Q ss_pred             cCCCccceeecCCceEEEEEEcCC------CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCe
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPS------GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNE  357 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~  357 (596)
                      +.|...+.||+|+||.||+|...+      +..||||.++.... ......+.+|+..+.. ++|+||+++++++.....
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~~~   82 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTN-FQHENIVKFYGVCTEGDP   82 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHHHHHHHHHHHHHHh-cCCCCchheeeEEecCCC
Confidence            457778999999999999997633      47899999864332 2244678889866554 899999999999999999


Q ss_pred             EEEEEecCCCCCHHHHhhhCCC----------CCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCC
Q 047719          358 LVLVYEYLPNGSLDKILHNNSS----------SSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEF  427 (596)
Q Consensus       358 ~~lV~E~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~  427 (596)
                      .++||||+++++|.+++.....          ....+++.++..++.|++.||.|||+   .+++||||||+||+++.++
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~  159 (280)
T cd05049          83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDL  159 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCC
Confidence            9999999999999999976531          12357899999999999999999999   8999999999999999999


Q ss_pred             ceEEccCCCccc-------------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHH
Q 047719          428 NAKLGDFEATIP-------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNL  493 (596)
Q Consensus       428 ~~kl~Dfg~~~~-------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~  493 (596)
                      .+||+|||++..             .++..|+|||.+.++.++.++|||||||++|||++ |..||......  +.+...
T Consensus       160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~--~~~~~~  237 (280)
T cd05049         160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE--EVIECI  237 (280)
T ss_pred             eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHH
Confidence            999999997642             13567999999999999999999999999999999 99998654321  111111


Q ss_pred             HhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 047719          494 RKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK  545 (596)
Q Consensus       494 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~  545 (596)
                       ..+...         ..+......+.+++..||+.||++||+++||++.|+
T Consensus       238 -~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         238 -TQGRLL---------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             -HcCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence             111111         111223456788899999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.9e-37  Score=311.62  Aligned_cols=235  Identities=26%  Similarity=0.357  Sum_probs=188.6

Q ss_pred             eeecCCceEEEEEEc---CCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecCCC
Q 047719          291 IVGEGASATVYKGSL---PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPN  367 (596)
Q Consensus       291 ~LG~G~fG~Vy~~~~---~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  367 (596)
                      .||+|+||.||+|.+   .++..+|+|+++.........+++..|+..+. .++|+||+++++++. ....++||||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~-~~~~~lv~e~~~~   79 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQ-QLDNPYIVRMIGICE-AESWMLVMELAEL   79 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHH-hCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence            589999999999964   34788999998654433344567888886555 489999999999885 4567999999999


Q ss_pred             CCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcccC-------
Q 047719          368 GSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA-------  440 (596)
Q Consensus       368 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~~-------  440 (596)
                      |+|.+++....    .+++..+..++.|++.||+|||+   ++++||||||+|||++.++.+||+|||.+...       
T Consensus        80 ~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~  152 (257)
T cd05116          80 GPLNKFLQKNK----HVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY  152 (257)
T ss_pred             CcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCee
Confidence            99999997543    48899999999999999999999   89999999999999999999999999976422       


Q ss_pred             -------CCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCC
Q 047719          441 -------GTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFN  512 (596)
Q Consensus       441 -------gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  512 (596)
                             ++..|+|||.+....++.++|||||||++|||++ |+.||......  ++.... ..+...         ..+
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~i-~~~~~~---------~~~  220 (257)
T cd05116         153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--EVTQMI-ESGERM---------ECP  220 (257)
T ss_pred             eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHH-HCCCCC---------CCC
Confidence                   2368999999988889999999999999999998 99999764321  122111 121111         111


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          513 RKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       513 ~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                      ......+.+++.+||+.||++||++.+|.+.|+.
T Consensus       221 ~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         221 QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence            2233557789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=8.7e-37  Score=316.89  Aligned_cols=232  Identities=22%  Similarity=0.270  Sum_probs=186.4

Q ss_pred             ceeecCCceEEEEEEcC-CCCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecCCC
Q 047719          290 RIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPN  367 (596)
Q Consensus       290 ~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  367 (596)
                      ++||+|+||.||++... +|+.||+|++++.... +.....+..|...+....+||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999876 4889999999753221 223344666776666667999999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc---------
Q 047719          368 GSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI---------  438 (596)
Q Consensus       368 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---------  438 (596)
                      |+|.+++....    .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++.         
T Consensus        81 g~L~~~i~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  153 (316)
T cd05620          81 GDLMFHIQDKG----RFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA  153 (316)
T ss_pred             CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCce
Confidence            99999997653    48889999999999999999999   899999999999999999999999999753         


Q ss_pred             --cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHHHH
Q 047719          439 --PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEM  516 (596)
Q Consensus       439 --~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  516 (596)
                        ..||..|+|||.+.+..++.++|||||||++|||++|+.||......  ...... ...      .+.    ++....
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~--~~~~~~-~~~------~~~----~~~~~~  220 (316)
T cd05620         154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED--ELFESI-RVD------TPH----YPRWIT  220 (316)
T ss_pred             eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHHH-HhC------CCC----CCCCCC
Confidence              24899999999999999999999999999999999999999765321  111111 111      011    111123


Q ss_pred             HHHHHHHHHcCCCCCCCCCCHH-HHH
Q 047719          517 ERMLMVGLSCVHPNHEKRPSVK-EAA  541 (596)
Q Consensus       517 ~~l~~l~~~C~~~dp~~RPs~~-ev~  541 (596)
                      ..+.+++..|++.||++||++. ++.
T Consensus       221 ~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         221 KESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             HHHHHHHHHHccCCHHHcCCChHHHH
Confidence            4566788899999999999984 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=6e-37  Score=319.82  Aligned_cols=232  Identities=26%  Similarity=0.277  Sum_probs=187.6

Q ss_pred             ceeecCCceEEEEEEcC-CCCEEEEEEeecCCc-hhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecCCC
Q 047719          290 RIVGEGASATVYKGSLP-SGGAVAVKRFEKPNR-VECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPN  367 (596)
Q Consensus       290 ~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  367 (596)
                      +.||+|+||.||++... +++.||||++.+... .......+.+|+..+ +.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l-~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~   79 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVL-KNTRHPFLTSLKYSFQTKDRLCFVMEYVNG   79 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHH-HhCCCCCCcceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999765 589999999975322 122344677788555 458999999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc---------
Q 047719          368 GSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI---------  438 (596)
Q Consensus       368 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---------  438 (596)
                      |+|.+++....    .+++.++..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++.         
T Consensus        80 g~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~  152 (328)
T cd05593          80 GELFFHLSRER----VFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATM  152 (328)
T ss_pred             CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCccccc
Confidence            99999997643    48899999999999999999999   899999999999999999999999999753         


Q ss_pred             --cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHHHH
Q 047719          439 --PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEM  516 (596)
Q Consensus       439 --~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  516 (596)
                        ..||+.|+|||.+.+..++.++|||||||++|||++|+.||......  ....... ..      +..+    +....
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~--~~~~~~~-~~------~~~~----p~~~~  219 (328)
T cd05593         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFELIL-ME------DIKF----PRTLS  219 (328)
T ss_pred             ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH--HHHHHhc-cC------CccC----CCCCC
Confidence              24889999999999889999999999999999999999999764321  1111110 00      1111    12223


Q ss_pred             HHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 047719          517 ERMLMVGLSCVHPNHEKRP-----SVKEAAR  542 (596)
Q Consensus       517 ~~l~~l~~~C~~~dp~~RP-----s~~ev~~  542 (596)
                      ..+.+++.+|++.||++||     ++.|+++
T Consensus       220 ~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  250 (328)
T cd05593         220 ADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR  250 (328)
T ss_pred             HHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence            4567788899999999997     8888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=7.2e-37  Score=319.88  Aligned_cols=192  Identities=28%  Similarity=0.404  Sum_probs=167.7

Q ss_pred             hcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      .++|...+.||+|+||.||++... ++..+|+|.+.... .......+.+|++.+.. ++|+||++++++|.+++..++|
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~lv   81 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHE-CNSPYIVGFYGAFYSDGEISIC   81 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHH-CCCCcccceeEEEEECCEEEEE
Confidence            357888899999999999999876 47889999886432 22334568889866655 8999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc---
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI---  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---  438 (596)
                      |||+++|+|.+++....    .+++.....++.+++.||.|||+.  .+++||||||+|||++.++.+||+|||++.   
T Consensus        82 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~  155 (333)
T cd06650          82 MEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  155 (333)
T ss_pred             EecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence            99999999999997643    478899999999999999999972  479999999999999999999999999764   


Q ss_pred             ------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCC
Q 047719          439 ------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDND  482 (596)
Q Consensus       439 ------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~  482 (596)
                            ..||..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~  205 (333)
T cd06650         156 DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP  205 (333)
T ss_pred             hhccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence                  24788999999999888999999999999999999999999754

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.9e-37  Score=310.30  Aligned_cols=236  Identities=24%  Similarity=0.346  Sum_probs=190.1

Q ss_pred             ceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecCCCC
Q 047719          290 RIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNG  368 (596)
Q Consensus       290 ~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  368 (596)
                      +.||+|+||.||+|... +++.||+|.+.... .......+.+|+..+. .++|+||++++++|......++||||++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILK-QYSHPNIVRLIGVCTQKQPIYIVMELVQGG   78 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHH-hCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence            46999999999999875 58899999885332 2234456888886554 489999999999999999999999999999


Q ss_pred             CHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcccC--------
Q 047719          369 SLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA--------  440 (596)
Q Consensus       369 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~~--------  440 (596)
                      +|.+++....   ..+++..++.++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++...        
T Consensus        79 ~L~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  152 (252)
T cd05084          79 DFLTFLRTEG---PRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST  152 (252)
T ss_pred             cHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCccccccccccc
Confidence            9999997543   248899999999999999999999   89999999999999999999999999976431        


Q ss_pred             -----CCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHH
Q 047719          441 -----GTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRK  514 (596)
Q Consensus       441 -----gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  514 (596)
                           .+..|+|||.+.++.++.++|||||||++|||++ |..||.......   ........         .....+..
T Consensus       153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~---~~~~~~~~---------~~~~~~~~  220 (252)
T cd05084         153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ---TREAIEQG---------VRLPCPEL  220 (252)
T ss_pred             CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH---HHHHHHcC---------CCCCCccc
Confidence                 1345999999998889999999999999999998 888886532211   11111111         11112223


Q ss_pred             HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 047719          515 EMERMLMVGLSCVHPNHEKRPSVKEAARILK  545 (596)
Q Consensus       515 ~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~  545 (596)
                      ....+.+++.+|++.+|++|||+.++.+.|+
T Consensus       221 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         221 CPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            3456788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=3.5e-37  Score=328.27  Aligned_cols=241  Identities=22%  Similarity=0.249  Sum_probs=188.0

Q ss_pred             CCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          285 GFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      .|...+.||+|+||+||+|... +++.||||++.+.... ......+.+|+..+. .++|+||+++++++.+.+.+|+||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~-~l~h~~iv~l~~~~~~~~~~~lv~   80 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILA-EADNEWVVKLYYSFQDKDNLYFVM   80 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHH-hcCCCCeeeeEEEEecCCEEEEEE
Confidence            4777899999999999999764 4889999999653322 223445778886554 489999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc----
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI----  438 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~----  438 (596)
                      ||+++|+|.+++....    .+++..+..++.||+.||+|||+   .+|+||||||+||||+.++.+||+|||++.    
T Consensus        81 E~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~  153 (381)
T cd05626          81 DYIPGGDMMSLLIRME----VFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRW  153 (381)
T ss_pred             ecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCccccc
Confidence            9999999999997653    48888999999999999999999   899999999999999999999999999742    


Q ss_pred             ------------------------------------------------------cCCCcccCCccccccCCCCCccceee
Q 047719          439 ------------------------------------------------------PAGTMGYLAPEYVYSGVPSEKTDVYS  464 (596)
Q Consensus       439 ------------------------------------------------------~~gt~~y~aPE~~~~~~~t~~sDV~S  464 (596)
                                                                            ..||..|+|||.+.+..++.++||||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS  233 (381)
T cd05626         154 THNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWS  233 (381)
T ss_pred             ccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceee
Confidence                                                                  25899999999999888999999999


Q ss_pred             hhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHHHHHHHHHHHH--HcCCCCCCCCCCHHHHHH
Q 047719          465 FGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGL--SCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       465 fGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~--~C~~~dp~~RPs~~ev~~  542 (596)
                      |||++|||++|+.||........  .............   .....++.+    +.+++.  .|+..++..||+++|++.
T Consensus       234 lG~il~elltG~~Pf~~~~~~~~--~~~i~~~~~~~~~---~~~~~~s~~----~~dli~~ll~~~~~~~~R~~~~~~l~  304 (381)
T cd05626         234 VGVILFEMLVGQPPFLAPTPTET--QLKVINWENTLHI---PPQVKLSPE----AVDLITKLCCSAEERLGRNGADDIKA  304 (381)
T ss_pred             hhhHHHHHHhCCCCCcCCCHHHH--HHHHHccccccCC---CCCCCCCHH----HHHHHHHHccCcccccCCCCHHHHhc
Confidence            99999999999999976432111  1111110000000   001122332    333333  377778888999999977

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=5.3e-37  Score=319.09  Aligned_cols=228  Identities=25%  Similarity=0.289  Sum_probs=184.8

Q ss_pred             ceeecCCceEEEEEEcC-CCCEEEEEEeecCCc-hhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecCCC
Q 047719          290 RIVGEGASATVYKGSLP-SGGAVAVKRFEKPNR-VECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPN  367 (596)
Q Consensus       290 ~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  367 (596)
                      ++||+|+||.||++... +++.||||++.+... .......+..|+..+....+||||+++++++...+.+|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999875 488999999965322 1223345667776776656899999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc---------
Q 047719          368 GSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI---------  438 (596)
Q Consensus       368 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---------  438 (596)
                      |+|.+++....    .+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++.         
T Consensus        81 g~L~~~i~~~~----~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~  153 (320)
T cd05590          81 GDLMFHIQKSR----RFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT  153 (320)
T ss_pred             chHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcc
Confidence            99999997654    48899999999999999999999   899999999999999999999999999753         


Q ss_pred             --cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHHHH
Q 047719          439 --PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEM  516 (596)
Q Consensus       439 --~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  516 (596)
                        ..||+.|+|||.+.+..++.++|||||||++|||++|+.||......  +..... .....          ..+....
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~--~~~~~i-~~~~~----------~~~~~~~  220 (320)
T cd05590         154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED--DLFEAI-LNDEV----------VYPTWLS  220 (320)
T ss_pred             cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH--HHHHHH-hcCCC----------CCCCCCC
Confidence              24889999999999889999999999999999999999999865321  111111 11111          1111223


Q ss_pred             HHHHHHHHHcCCCCCCCCCCH
Q 047719          517 ERMLMVGLSCVHPNHEKRPSV  537 (596)
Q Consensus       517 ~~l~~l~~~C~~~dp~~RPs~  537 (596)
                      ..+.+++..|++.||++||++
T Consensus       221 ~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         221 QDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             HHHHHHHHHHcccCHHHCCCC
Confidence            456778889999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=2.2e-37  Score=311.16  Aligned_cols=239  Identities=27%  Similarity=0.388  Sum_probs=193.2

Q ss_pred             CCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEec
Q 047719          285 GFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEY  364 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~  364 (596)
                      +|...+.||+|+||.||+|...++..+|||.+.....   ...++.+|+..+. .++||||++++++|.+....++||||
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd05113           5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMM-KLSHEKLVQLYGVCTKQRPIYIVTEY   80 (256)
T ss_pred             HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc---cHHHHHHHHHHHh-cCCCCCeeeEEEEEccCCCcEEEEEc
Confidence            4666789999999999999887777899999864322   2356888986665 48999999999999999999999999


Q ss_pred             CCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc-----
Q 047719          365 LPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP-----  439 (596)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~-----  439 (596)
                      +++|+|.+++.....   .+++..++.++.||+.||+|||+   .+++|+||||+||+++.++.+||+|||.+..     
T Consensus        81 ~~~~~l~~~i~~~~~---~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~  154 (256)
T cd05113          81 MSNGCLLNYLREHGK---RFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE  154 (256)
T ss_pred             CCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCc
Confidence            999999999976532   48999999999999999999999   8999999999999999999999999987542     


Q ss_pred             -------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcC
Q 047719          440 -------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKF  511 (596)
Q Consensus       440 -------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  511 (596)
                             .++..|+|||.+....++.++|||||||++|||++ |+.||......  +..... ..+...         ..
T Consensus       155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~-~~~~~~---------~~  222 (256)
T cd05113         155 YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS--ETVEKV-SQGLRL---------YR  222 (256)
T ss_pred             eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHH-hcCCCC---------CC
Confidence                   13467999999988889999999999999999999 99998754321  111111 111110         01


Q ss_pred             CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 047719          512 NRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK  545 (596)
Q Consensus       512 ~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~  545 (596)
                      +......+.+++.+||+.+|++||++.++++.|+
T Consensus       223 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         223 PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            1112356788889999999999999999998764

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-37  Score=312.28  Aligned_cols=249  Identities=27%  Similarity=0.348  Sum_probs=187.4

Q ss_pred             CCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHH-hccCCCceeeecceeeeCC----eEE
Q 047719          285 GFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMA-GCLRHKNLVQLQGWCCEGN----ELV  359 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~-~~l~H~niv~l~g~~~~~~----~~~  359 (596)
                      .....+.||+|.||.||+|.+ .|+.||||++..  .   ++..+.+|-++.. ..++|+||+.+++.-..+.    +++
T Consensus       212 qI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~s--r---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw  285 (513)
T KOG2052|consen  212 QIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSS--R---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW  285 (513)
T ss_pred             eeEEEEEecCccccceeeccc-cCCceEEEEecc--c---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence            345568999999999999999 688999999942  2   2334555543322 2489999999998765543    699


Q ss_pred             EEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhcc-----CCCeEEccCCCCceeecCCCceEEccC
Q 047719          360 LVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC-----ERQIIHRDVKACNILLDAEFNAKLGDF  434 (596)
Q Consensus       360 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~-----~~~ivHrDlkp~NiLl~~~~~~kl~Df  434 (596)
                      ||++|.++|||+|||...     .++-...++++..+|.||+|||.+.     ++.|.|||||+.|||+..++.+.|+|+
T Consensus       286 LvTdYHe~GSL~DyL~r~-----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL  360 (513)
T KOG2052|consen  286 LVTDYHEHGSLYDYLNRN-----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  360 (513)
T ss_pred             EeeecccCCcHHHHHhhc-----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence            999999999999999875     4889999999999999999999864     678999999999999999999999999


Q ss_pred             CCcc---------------cCCCcccCCccccccCC------CCCccceeehhHHHHHHHhCC----------CCCCCC-
Q 047719          435 EATI---------------PAGTMGYLAPEYVYSGV------PSEKTDVYSFGVVALEVAAGK----------SPVDND-  482 (596)
Q Consensus       435 g~~~---------------~~gt~~y~aPE~~~~~~------~t~~sDV~SfGvll~El~tG~----------~p~~~~-  482 (596)
                      |++.               .+||.+|||||++....      .-..+||||||.++||++...          .||.+- 
T Consensus       361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V  440 (513)
T KOG2052|consen  361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV  440 (513)
T ss_pred             eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence            9863               36999999999986532      124699999999999997632          455431 


Q ss_pred             --ChhHHHHHHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Q 047719          483 --GCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEA  548 (596)
Q Consensus       483 --~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~~  548 (596)
                        +....+ +....-..++...++.   .-.+.+.+..|.+|+..||..+|..|-|+-.+-+.|....
T Consensus       441 p~DPs~ee-MrkVVCv~~~RP~ipn---rW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~  504 (513)
T KOG2052|consen  441 PSDPSFEE-MRKVVCVQKLRPNIPN---RWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS  504 (513)
T ss_pred             CCCCCHHH-HhcceeecccCCCCCc---ccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence              111111 1111111111111111   1234578889999999999999999999988877776544

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=5.9e-37  Score=319.13  Aligned_cols=232  Identities=25%  Similarity=0.272  Sum_probs=186.4

Q ss_pred             ceeecCCceEEEEEEcC-CCCEEEEEEeecCCc-hhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecCCC
Q 047719          290 RIVGEGASATVYKGSLP-SGGAVAVKRFEKPNR-VECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPN  367 (596)
Q Consensus       290 ~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  367 (596)
                      +.||+|+||.||++... +|..||+|++.+... .......+.+|+..+. .++||||+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~-~l~hp~i~~~~~~~~~~~~~~lv~E~~~~   79 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ-NTRHPFLTALKYAFQTHDRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHH-hCCCCCCcceeeEEecCCEEEEEEeCCCC
Confidence            46999999999999865 589999999965322 1223345667875554 48999999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc---------
Q 047719          368 GSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI---------  438 (596)
Q Consensus       368 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---------  438 (596)
                      |+|..++....    .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++.         
T Consensus        80 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~  152 (323)
T cd05595          80 GELFFHLSRER----VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM  152 (323)
T ss_pred             CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCcc
Confidence            99999997653    48899999999999999999999   899999999999999999999999998643         


Q ss_pred             --cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHHHH
Q 047719          439 --PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEM  516 (596)
Q Consensus       439 --~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  516 (596)
                        ..||..|+|||.+.+..++.++|||||||++|||++|+.||.......  ..... ....      ..+    +....
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~--~~~~~-~~~~------~~~----p~~~~  219 (323)
T cd05595         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--LFELI-LMEE------IRF----PRTLS  219 (323)
T ss_pred             ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH--HHHHH-hcCC------CCC----CCCCC
Confidence              248899999999999999999999999999999999999997643211  01111 1111      111    11223


Q ss_pred             HHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 047719          517 ERMLMVGLSCVHPNHEKRP-----SVKEAAR  542 (596)
Q Consensus       517 ~~l~~l~~~C~~~dp~~RP-----s~~ev~~  542 (596)
                      ..+.+++..|++.||++||     ++.++++
T Consensus       220 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         220 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             HHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            4567788899999999998     7888765

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=5.1e-37  Score=321.82  Aligned_cols=238  Identities=22%  Similarity=0.287  Sum_probs=191.8

Q ss_pred             cCCCccceeecCCceEEEEEEcCC--CCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPS--GGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVL  360 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~--g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~l  360 (596)
                      ++|...+.||+|+||.||+|....  +..||+|++.+.... ......+.+|+..+ ..++||||+++++++.+.+..|+
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l-~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKIL-NYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHH-HhCCCCCCcceEEEEEeCCEEEE
Confidence            357888999999999999997543  368999998643221 22334577888555 45899999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc--
Q 047719          361 VYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI--  438 (596)
Q Consensus       361 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~--  438 (596)
                      ||||+++|+|.+++....    .+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||++.  
T Consensus       109 v~Ey~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~  181 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRNK----RFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV  181 (340)
T ss_pred             EEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence            999999999999998654    48899999999999999999999   899999999999999999999999999764  


Q ss_pred             ------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCC
Q 047719          439 ------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFN  512 (596)
Q Consensus       439 ------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  512 (596)
                            ..||+.|+|||.+.+..++.++|||||||++|||++|+.||.......   .......+..      .    ++
T Consensus       182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~---~~~~i~~~~~------~----~p  248 (340)
T PTZ00426        182 DTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL---IYQKILEGII------Y----FP  248 (340)
T ss_pred             CCCcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH---HHHHHhcCCC------C----CC
Confidence                  258899999999998889999999999999999999999998654321   1111111110      1    11


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 047719          513 RKEMERMLMVGLSCVHPNHEKRP-----SVKEAAR  542 (596)
Q Consensus       513 ~~~~~~l~~l~~~C~~~dp~~RP-----s~~ev~~  542 (596)
                      ......+.+++.+|++.||++|+     +++++++
T Consensus       249 ~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~  283 (340)
T PTZ00426        249 KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE  283 (340)
T ss_pred             CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence            11223456788899999999995     8888866

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-37  Score=310.58  Aligned_cols=238  Identities=29%  Similarity=0.372  Sum_probs=193.2

Q ss_pred             CCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEec
Q 047719          285 GFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEY  364 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~  364 (596)
                      +|...+.||+|+||.||++...++..+|+|.+.+...   ....+.+|+..+.. ++|+||+++++++...+..++||||
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM---SEDDFIEEAKVMMK-LSHPNLVQLYGVCTKQRPIFIVTEY   80 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC---CHHHHHHHHHHHHh-CCCCCEEEEEEEEcCCCceEEEEec
Confidence            4667789999999999999887777899999854322   23457888865554 8999999999999999999999999


Q ss_pred             CCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcccC----
Q 047719          365 LPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA----  440 (596)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~~----  440 (596)
                      +++++|.+++.....   .++|..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||.+...    
T Consensus        81 ~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~  154 (256)
T cd05059          81 MANGCLLNYLRERKG---KLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ  154 (256)
T ss_pred             CCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceeccccc
Confidence            999999999986532   58999999999999999999999   89999999999999999999999999976421    


Q ss_pred             --------CCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcC
Q 047719          441 --------GTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKF  511 (596)
Q Consensus       441 --------gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  511 (596)
                              ++..|+|||.+.+..++.++|||||||++|||++ |+.||......  +...... ..         .....
T Consensus       155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~-~~---------~~~~~  222 (256)
T cd05059         155 YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS--EVVESVS-AG---------YRLYR  222 (256)
T ss_pred             ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH--HHHHHHH-cC---------CcCCC
Confidence                    2346999999998899999999999999999999 89999754321  1111111 11         00111


Q ss_pred             CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 047719          512 NRKEMERMLMVGLSCVHPNHEKRPSVKEAARIL  544 (596)
Q Consensus       512 ~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L  544 (596)
                      +......+.+++.+||+.+|++|||+.|+++.|
T Consensus       223 ~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         223 PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            122345688899999999999999999999987

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=3e-37  Score=314.61  Aligned_cols=245  Identities=27%  Similarity=0.405  Sum_probs=194.0

Q ss_pred             CCCccceeecCCceEEEEEEc-----CCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEE
Q 047719          285 GFNKNRIVGEGASATVYKGSL-----PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELV  359 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~-----~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~  359 (596)
                      +|+..+.||+|+||.||+|..     ..+..||+|.+..... ......+.+|+..+. .++|+||+++++++......|
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~   83 (283)
T cd05090           6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN-PQQWGEFQQEASLMA-ELHHPNIVCLLGVVTQEQPVC   83 (283)
T ss_pred             hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCC-HHHHHHHHHHHHHHh-hCCCCCeeeEEEEEecCCceE
Confidence            466778999999999999974     2467899999864322 233456888886555 489999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhhCCC-------------CCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCC
Q 047719          360 LVYEYLPNGSLDKILHNNSS-------------SSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAE  426 (596)
Q Consensus       360 lV~E~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~  426 (596)
                      +||||+++++|.+++.....             ....+++.+.+.++.|++.||+|||+   ++++||||||+|||++++
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~  160 (283)
T cd05090          84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQ  160 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCC
Confidence            99999999999999964321             12358899999999999999999999   899999999999999999


Q ss_pred             CceEEccCCCcccC-------------CCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHH
Q 047719          427 FNAKLGDFEATIPA-------------GTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWN  492 (596)
Q Consensus       427 ~~~kl~Dfg~~~~~-------------gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~  492 (596)
                      +.+||+|||++...             ++..|+|||.+.+..++.++|||||||++|||++ |..||......   .+..
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~---~~~~  237 (283)
T cd05090         161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ---EVIE  237 (283)
T ss_pred             CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHH
Confidence            99999999976432             3456999999988889999999999999999999 99998654321   1111


Q ss_pred             HHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          493 LRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       493 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                      ........         ..+......+.+++.+|++.||++||++.++.+.|+.
T Consensus       238 ~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         238 MVRKRQLL---------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            11111111         1111223467778889999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.9e-37  Score=339.55  Aligned_cols=239  Identities=23%  Similarity=0.267  Sum_probs=191.8

Q ss_pred             CCccceeecCCceEEEEEEcC-C-CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          286 FNKNRIVGEGASATVYKGSLP-S-GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       286 f~~~~~LG~G~fG~Vy~~~~~-~-g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      |...+.||+|+||.||++... + +..||+|.+....  ......+.+|+..+. .++|||||+++++|...+..|||||
T Consensus        69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~--~~~~~~~~~E~~~l~-~l~Hpniv~~~~~~~~~~~~~lv~E  145 (478)
T PTZ00267         69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND--ERQAAYARSELHCLA-ACDHFGIVKHFDDFKSDDKLLLIME  145 (478)
T ss_pred             EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC--HHHHHHHHHHHHHHH-hCCCCCEeEEEEEEEECCEEEEEEE
Confidence            777899999999999999654 3 5788998774332  223345677886655 4999999999999999999999999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc----
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP----  439 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~----  439 (596)
                      |+++|+|.++|........++++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++..    
T Consensus       146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~  222 (478)
T PTZ00267        146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS  222 (478)
T ss_pred             CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence            999999999987643334468899999999999999999999   8999999999999999999999999997532    


Q ss_pred             ---------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCc
Q 047719          440 ---------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGK  510 (596)
Q Consensus       440 ---------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  510 (596)
                               .||+.|+|||.+.+..++.++|||||||++|||++|+.||.....  .+....... +...         .
T Consensus       223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~--~~~~~~~~~-~~~~---------~  290 (478)
T PTZ00267        223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ--REIMQQVLY-GKYD---------P  290 (478)
T ss_pred             cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHh-CCCC---------C
Confidence                     388999999999999999999999999999999999999976432  111111111 1110         1


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          511 FNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       511 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      .+......+.+++..||+.||++||++++++.
T Consensus       291 ~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        291 FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            11122345778889999999999999998864

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=6.8e-37  Score=323.88  Aligned_cols=192  Identities=25%  Similarity=0.340  Sum_probs=167.4

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      ++|+..+.||+|+||+||++... +++.||||++.+.... ......+..|+..+. .++|+||+++++.+.+...+|+|
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~-~~~~~~iv~~~~~~~~~~~~~lv   79 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILV-EADSLWVVKMFYSFQDKLNLYLI   79 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHH-hCCCCCcceEEEEEecCCeEEEE
Confidence            36788899999999999999765 4889999999653222 222345667775554 48999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc---
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI---  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---  438 (596)
                      |||+++|+|.+++....    .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++.   
T Consensus        80 ~E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~  152 (363)
T cd05628          80 MEFLPGGDMMTLLMKKD----TLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK  152 (363)
T ss_pred             EcCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence            99999999999998653    48899999999999999999999   899999999999999999999999999753   


Q ss_pred             -------------------------------------------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhC
Q 047719          439 -------------------------------------------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAG  475 (596)
Q Consensus       439 -------------------------------------------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG  475 (596)
                                                                 .+||+.|+|||.+.+..++.++|||||||++|||++|
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G  232 (363)
T cd05628         153 KAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG  232 (363)
T ss_pred             ccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhC
Confidence                                                       2589999999999998999999999999999999999


Q ss_pred             CCCCCCCC
Q 047719          476 KSPVDNDG  483 (596)
Q Consensus       476 ~~p~~~~~  483 (596)
                      +.||....
T Consensus       233 ~~Pf~~~~  240 (363)
T cd05628         233 YPPFCSET  240 (363)
T ss_pred             CCCCCCCC
Confidence            99997643

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.8e-37  Score=324.94  Aligned_cols=249  Identities=27%  Similarity=0.385  Sum_probs=194.8

Q ss_pred             cCCCccceeecCCceEEEEEEcC------CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeC-C
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP------SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG-N  356 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~-~  356 (596)
                      ++|...+.||+|+||.||+|...      .++.||+|+++.... ......+..|+..+.+..+|+||++++++|... .
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT-ASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC-HHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            35778899999999999999642      246899999864322 223456778887776644899999999988754 5


Q ss_pred             eEEEEEecCCCCCHHHHhhhCCCC--------------------------------------------------------
Q 047719          357 ELVLVYEYLPNGSLDKILHNNSSS--------------------------------------------------------  380 (596)
Q Consensus       357 ~~~lV~E~~~~gsL~~~l~~~~~~--------------------------------------------------------  380 (596)
                      .++++|||+++|+|.+++......                                                        
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            689999999999999999653210                                                        


Q ss_pred             -CcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc-------------CCCcccC
Q 047719          381 -SIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP-------------AGTMGYL  446 (596)
Q Consensus       381 -~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~-------------~gt~~y~  446 (596)
                       ...++|..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++..             .++..|+
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence             1258999999999999999999999   8999999999999999999999999997643             2356799


Q ss_pred             CccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHH
Q 047719          447 APEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLS  525 (596)
Q Consensus       447 aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~  525 (596)
                      |||++.+..++.++|||||||++|||++ |+.||......  +........+...         ..+......+.+++.+
T Consensus       243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~--~~~~~~~~~~~~~---------~~~~~~~~~~~~l~~~  311 (337)
T cd05054         243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID--EEFCRRLKEGTRM---------RAPEYATPEIYSIMLD  311 (337)
T ss_pred             CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc--HHHHHHHhccCCC---------CCCccCCHHHHHHHHH
Confidence            9999999999999999999999999998 99999753211  1111111111111         1112234567888999


Q ss_pred             cCCCCCCCCCCHHHHHHHHhcC
Q 047719          526 CVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       526 C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                      ||+.+|++||++.|+++.|+..
T Consensus       312 cl~~~p~~RPs~~ell~~l~~~  333 (337)
T cd05054         312 CWHNNPEDRPTFSELVEILGDL  333 (337)
T ss_pred             HccCChhhCcCHHHHHHHHHHH
Confidence            9999999999999999999854

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.3e-36  Score=316.54  Aligned_cols=236  Identities=25%  Similarity=0.338  Sum_probs=186.9

Q ss_pred             CCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCch-hcccchHHHHHHHH--HhccCCCceeeecceeeeCCeEEEE
Q 047719          286 FNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRV-ECARNPFTTEFATM--AGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       286 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l--~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      |...+.||+|+||.||++... +++.||||++++.... ....+.+..|+..+  .+.++||||+++++++...+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            456789999999999999865 5889999999753221 12233455555433  2457899999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc---
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI---  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---  438 (596)
                      |||+++|+|..++...     .+++..+..++.||+.||.|||+   .+++||||||+|||++.++.+||+|||++.   
T Consensus        81 ~E~~~~~~L~~~~~~~-----~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~  152 (324)
T cd05589          81 MEYAAGGDLMMHIHTD-----VFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM  152 (324)
T ss_pred             EcCCCCCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence            9999999999988653     38999999999999999999999   899999999999999999999999999753   


Q ss_pred             --------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCc
Q 047719          439 --------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGK  510 (596)
Q Consensus       439 --------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  510 (596)
                              ..|+..|+|||.+.+..++.++|||||||++|||++|+.||......  +.........       .    .
T Consensus       153 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~--~~~~~i~~~~-------~----~  219 (324)
T cd05589         153 GFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE--EVFDSIVNDE-------V----R  219 (324)
T ss_pred             CCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCC-------C----C
Confidence                    24789999999999989999999999999999999999999865321  1111111111       0    1


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 047719          511 FNRKEMERMLMVGLSCVHPNHEKRP-----SVKEAAR  542 (596)
Q Consensus       511 ~~~~~~~~l~~l~~~C~~~dp~~RP-----s~~ev~~  542 (596)
                      ++......+.+++.+|++.||++||     ++.++++
T Consensus       220 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         220 YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence            1112234567788999999999999     4666554

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=3.3e-37  Score=315.44  Aligned_cols=247  Identities=26%  Similarity=0.437  Sum_probs=196.8

Q ss_pred             cCCCccceeecCCceEEEEEEcC------CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCe
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP------SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNE  357 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~  357 (596)
                      .+|...+.||+|+||+||++...      ++..+|+|.+....  ......+.+|+..+.+ ++|+||++++++|.....
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~   81 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--DNARKDFHREAELLTN-LQHEHIVKFYGVCVEGDP   81 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC--HHHHHHHHHHHHHHHh-CCCCCcceEEEEEecCCc
Confidence            46778899999999999999742      24569999985432  3345568889866655 899999999999999999


Q ss_pred             EEEEEecCCCCCHHHHhhhCCC---------CCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCc
Q 047719          358 LVLVYEYLPNGSLDKILHNNSS---------SSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFN  428 (596)
Q Consensus       358 ~~lV~E~~~~gsL~~~l~~~~~---------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~  428 (596)
                      .++||||+++++|.+++.....         ....+++..++.++.|++.||+|||+   .+++||||||+|||+++++.
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~  158 (288)
T cd05093          82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLL  158 (288)
T ss_pred             cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCc
Confidence            9999999999999999975431         12348999999999999999999999   89999999999999999999


Q ss_pred             eEEccCCCcccC-------------CCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHH
Q 047719          429 AKLGDFEATIPA-------------GTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLR  494 (596)
Q Consensus       429 ~kl~Dfg~~~~~-------------gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~  494 (596)
                      +||+|||.+...             ++..|+|||.+.+..++.++|||||||++|||++ |..||......  +.. ...
T Consensus       159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~--~~~-~~i  235 (288)
T cd05093         159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--EVI-ECI  235 (288)
T ss_pred             EEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHH-HHH
Confidence            999999976421             3567999999998899999999999999999999 99998754321  111 111


Q ss_pred             hcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Q 047719          495 KKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEA  548 (596)
Q Consensus       495 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~~  548 (596)
                      ..+....     ....    ....+.+++.+||+.+|.+|||++++.+.|+...
T Consensus       236 ~~~~~~~-----~~~~----~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~  280 (288)
T cd05093         236 TQGRVLQ-----RPRT----CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA  280 (288)
T ss_pred             HcCCcCC-----CCCC----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence            1111111     1111    2345788999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.7e-37  Score=316.47  Aligned_cols=248  Identities=28%  Similarity=0.459  Sum_probs=197.4

Q ss_pred             cCCCccceeecCCceEEEEEEcC------CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCe
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP------SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNE  357 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~  357 (596)
                      .+|...+.||+|+||.||+|...      ++..+++|.+....  ....+.+.+|+..+.+ ++|+||+++++++.....
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~   81 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTN-LQHEHIVKFYGVCGDGDP   81 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhc-CCCCCcceEEEEEccCCc
Confidence            34677789999999999999742      34569999985332  2334568888866655 899999999999999999


Q ss_pred             EEEEEecCCCCCHHHHhhhCCC------------CCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecC
Q 047719          358 LVLVYEYLPNGSLDKILHNNSS------------SSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDA  425 (596)
Q Consensus       358 ~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~  425 (596)
                      .++||||+++++|.+++.....            ....++|..++.++.||+.||+|||+   .+++||||||+|||++.
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~  158 (291)
T cd05094          82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGA  158 (291)
T ss_pred             eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEcc
Confidence            9999999999999999976431            12348999999999999999999999   89999999999999999


Q ss_pred             CCceEEccCCCccc-------------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHH
Q 047719          426 EFNAKLGDFEATIP-------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVW  491 (596)
Q Consensus       426 ~~~~kl~Dfg~~~~-------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~  491 (596)
                      ++.+||+|||++..             .++..|+|||.+....++.++|||||||++|||+| |+.||......  + ..
T Consensus       159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~-~~  235 (291)
T cd05094         159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT--E-VI  235 (291)
T ss_pred             CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--H-HH
Confidence            99999999997632             24567999999998899999999999999999999 99998654321  1 11


Q ss_pred             HHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Q 047719          492 NLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEAP  549 (596)
Q Consensus       492 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~~~  549 (596)
                      .....+....         ........+.+++.+||+.+|++||++++|++.|+....
T Consensus       236 ~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         236 ECITQGRVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             HHHhCCCCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence            1112221111         111233567889999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=3.1e-37  Score=316.00  Aligned_cols=250  Identities=26%  Similarity=0.393  Sum_probs=198.4

Q ss_pred             HhcCCCccceeecCCceEEEEEEcCC------CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeC
Q 047719          282 ATLGFNKNRIVGEGASATVYKGSLPS------GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG  355 (596)
Q Consensus       282 at~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~  355 (596)
                      ..++|...+.||+|+||.||++....      ...+|+|++..... .....++.+|+..+.+..+|+||+++++++...
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   88 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE   88 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC-HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence            34567788999999999999997532      36799999864322 233456888987666533899999999999999


Q ss_pred             CeEEEEEecCCCCCHHHHhhhCC------------CCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceee
Q 047719          356 NELVLVYEYLPNGSLDKILHNNS------------SSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILL  423 (596)
Q Consensus       356 ~~~~lV~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl  423 (596)
                      +..+++|||+++|+|.+++....            .....+++..++.++.|++.||+|||+   .+++||||||+|||+
T Consensus        89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~  165 (293)
T cd05053          89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLV  165 (293)
T ss_pred             CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEE
Confidence            99999999999999999997532            123468999999999999999999998   899999999999999


Q ss_pred             cCCCceEEccCCCccc-------------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHH
Q 047719          424 DAEFNAKLGDFEATIP-------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDW  489 (596)
Q Consensus       424 ~~~~~~kl~Dfg~~~~-------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~  489 (596)
                      +.++.+||+|||.+..             .++..|+|||.+....++.++|||||||++|||++ |..||......  + 
T Consensus       166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~-  242 (293)
T cd05053         166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE--E-  242 (293)
T ss_pred             cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH--H-
Confidence            9999999999997642             13467999999988899999999999999999998 99998754321  1 


Q ss_pred             HHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          490 VWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       490 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                      +......+.         ....+......+.+++.+|++.+|++|||+.|+++.|+..
T Consensus       243 ~~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~  291 (293)
T cd05053         243 LFKLLKEGY---------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM  291 (293)
T ss_pred             HHHHHHcCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence            111111111         1112223345678899999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=6.3e-37  Score=319.75  Aligned_cols=236  Identities=27%  Similarity=0.325  Sum_probs=188.5

Q ss_pred             ceeecCCceEEEEEEcC-CCCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecCCC
Q 047719          290 RIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPN  367 (596)
Q Consensus       290 ~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  367 (596)
                      ++||+|+||.||++... +++.||||++++.... ......+..|...+....+||||+++++++.+...+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999865 4889999999754322 223345667776666645899999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc---------
Q 047719          368 GSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI---------  438 (596)
Q Consensus       368 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---------  438 (596)
                      |+|.+++....    .+++..+..++.||+.||+|||+   .+++||||||+|||++.++.+||+|||++.         
T Consensus        81 g~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~  153 (329)
T cd05588          81 GDLMFHMQRQR----KLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT  153 (329)
T ss_pred             CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCCCcc
Confidence            99999987643    48999999999999999999999   899999999999999999999999999753         


Q ss_pred             --cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCC------hhHHHHHHHHHhcCCchhhccccccCc
Q 047719          439 --PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDG------CVIVDWVWNLRKKGKLLDAADFRLRGK  510 (596)
Q Consensus       439 --~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~------~~~~~~~~~~~~~~~~~~~~d~~l~~~  510 (596)
                        ..||..|+|||.+.+..++.++|||||||++|||++|+.||+..+      ....++..+.......      .+   
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~~---  224 (329)
T cd05588         154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI------RI---  224 (329)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC------CC---
Confidence              248899999999999999999999999999999999999996321      1122333332222211      11   


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCC------HHHHHH
Q 047719          511 FNRKEMERMLMVGLSCVHPNHEKRPS------VKEAAR  542 (596)
Q Consensus       511 ~~~~~~~~l~~l~~~C~~~dp~~RPs------~~ev~~  542 (596)
                       +......+.+++.+|++.||++||+      ++++++
T Consensus       225 -p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         225 -PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             -CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence             1122345677888999999999997      667654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=3.6e-37  Score=311.72  Aligned_cols=244  Identities=25%  Similarity=0.396  Sum_probs=191.7

Q ss_pred             CccceeecCCceEEEEEEcCCC-C--EEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeC------Ce
Q 047719          287 NKNRIVGEGASATVYKGSLPSG-G--AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG------NE  357 (596)
Q Consensus       287 ~~~~~LG~G~fG~Vy~~~~~~g-~--~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~------~~  357 (596)
                      ...+.||+|+||.||+|....+ .  .||+|.++...........+.+|+..+.. ++|+||++++++|...      ..
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKE-FDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHh-CCCCCcceEEEEEccCCcccCCCC
Confidence            4568899999999999987653 2  69999986544344445678888866655 8999999999987542      24


Q ss_pred             EEEEEecCCCCCHHHHhhhCC--CCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCC
Q 047719          358 LVLVYEYLPNGSLDKILHNNS--SSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFE  435 (596)
Q Consensus       358 ~~lV~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg  435 (596)
                      .+++|||+++|+|.+++....  .....+++.....++.|++.||+|||+   ++|+||||||+|||+++++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCC
Confidence            789999999999999985332  123358999999999999999999999   899999999999999999999999999


Q ss_pred             Cccc-------------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchh
Q 047719          436 ATIP-------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLD  501 (596)
Q Consensus       436 ~~~~-------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~  501 (596)
                      ++..             .++..|+|||.+....++.++|||||||++|||++ |+.||......  + .......+....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~-~~~~~~~~~~~~  234 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS--E-IYDYLRQGNRLK  234 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH--H-HHHHHHcCCCCC
Confidence            7643             23457999999998899999999999999999999 88999764321  1 111222221111


Q ss_pred             hccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          502 AADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       502 ~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                               ........+.+++.+||+.+|++|||+.++++.|+.
T Consensus       235 ---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~  270 (272)
T cd05075         235 ---------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK  270 (272)
T ss_pred             ---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence                     111233457889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=5.3e-37  Score=326.20  Aligned_cols=240  Identities=23%  Similarity=0.272  Sum_probs=186.4

Q ss_pred             CCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          285 GFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      .|...+.||+|+||.||++... +++.||||++.+.... ......+.+|+..+. .++|+||+++++.+.+.+.+|+||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~-~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILA-EADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHH-hCCCCCcceEEEEEEcCCEEEEEE
Confidence            5788899999999999999865 4889999998643221 123345677875554 599999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc----
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI----  438 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~----  438 (596)
                      ||+++|+|.+++....    .+++.....++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++.    
T Consensus        81 E~~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~  153 (376)
T cd05598          81 DYIPGGDMMSLLIRLG----IFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  153 (376)
T ss_pred             eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence            9999999999997653    47888889999999999999999   899999999999999999999999999742    


Q ss_pred             --------------------------------------------------cCCCcccCCccccccCCCCCccceeehhHH
Q 047719          439 --------------------------------------------------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVV  468 (596)
Q Consensus       439 --------------------------------------------------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvl  468 (596)
                                                                        ..||+.|||||++.+..++.++|||||||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi  233 (376)
T cd05598         154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  233 (376)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence                                                              258999999999999899999999999999


Q ss_pred             HHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCC---CHHHHHH
Q 047719          469 ALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRP---SVKEAAR  542 (596)
Q Consensus       469 l~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RP---s~~ev~~  542 (596)
                      +|||++|+.||......  +.............   ......++.    .+.+++.+|+ .+|.+|+   ++.|+++
T Consensus       234 lyell~G~~Pf~~~~~~--~~~~~i~~~~~~~~---~~~~~~~s~----~~~~li~~l~-~~p~~R~~~~t~~ell~  300 (376)
T cd05598         234 LYEMLVGQPPFLADTPA--ETQLKVINWETTLH---IPSQAKLSR----EASDLILRLC-CGAEDRLGKNGADEIKA  300 (376)
T ss_pred             eeehhhCCCCCCCCCHH--HHHHHHhccCcccc---CCCCCCCCH----HHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence            99999999999865321  11111111110000   001112222    2334444444 4999999   8888876

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=8.6e-37  Score=318.68  Aligned_cols=242  Identities=24%  Similarity=0.305  Sum_probs=189.8

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      ++|...+.||+|+||.||++... +++.||||++++.... ......+..|+. +.+.++|+||+++++++.+....++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~-i~~~~~~~~i~~~~~~~~~~~~~~lv   79 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERD-ILSISNSPWIPQLQYAFQDKDNLYLV   79 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHH-HHHhCCCCCCcceeeEEecCCeEEEE
Confidence            36888899999999999999765 5889999999754321 223344666664 44558999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc---
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI---  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---  438 (596)
                      |||+++|+|.+++....   ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++.   
T Consensus        80 ~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  153 (330)
T cd05601          80 MEYQPGGDLLSLLNRYE---DQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLT  153 (330)
T ss_pred             ECCCCCCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECC
Confidence            99999999999998752   248899999999999999999999   899999999999999999999999999763   


Q ss_pred             ---------cCCCcccCCccccc------cCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhc
Q 047719          439 ---------PAGTMGYLAPEYVY------SGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAA  503 (596)
Q Consensus       439 ---------~~gt~~y~aPE~~~------~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  503 (596)
                               ..||..|+|||.+.      ...++.++|||||||++|||++|+.||.....  .................
T Consensus       154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~--~~~~~~i~~~~~~~~~~  231 (330)
T cd05601         154 ANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS--AKTYNNIMNFQRFLKFP  231 (330)
T ss_pred             CCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH--HHHHHHHHcCCCccCCC
Confidence                     24788999999986      45678999999999999999999999976432  11111221111111110


Q ss_pred             cccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          504 DFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       504 d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      +       .......+.+|+..|++ +|++||+++++++
T Consensus       232 ~-------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         232 E-------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             C-------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            0       01123445667778887 9999999999875

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2.7e-37  Score=321.34  Aligned_cols=233  Identities=24%  Similarity=0.290  Sum_probs=187.4

Q ss_pred             ceeecCCceEEEEEEcCC-CCEEEEEEeecCCc-hhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecCCC
Q 047719          290 RIVGEGASATVYKGSLPS-GGAVAVKRFEKPNR-VECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPN  367 (596)
Q Consensus       290 ~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~-~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  367 (596)
                      ++||+|+||.||+|.... ++.||||++.+... .......+..|...+....+||||+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            469999999999998754 78999999965322 1223345667776666556899999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc--------
Q 047719          368 GSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP--------  439 (596)
Q Consensus       368 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~--------  439 (596)
                      |+|..++....    .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++..        
T Consensus        81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  153 (321)
T cd05591          81 GDLMFQIQRSR----KFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT  153 (321)
T ss_pred             CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCCccc
Confidence            99999997654    48899999999999999999999   8999999999999999999999999997542        


Q ss_pred             ---CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHHHH
Q 047719          440 ---AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEM  516 (596)
Q Consensus       440 ---~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  516 (596)
                         .||..|+|||.+.+..++.++|||||||++|||++|+.||......  +....... ...      .    ++....
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~--~~~~~i~~-~~~------~----~p~~~~  220 (321)
T cd05591         154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED--DLFESILH-DDV------L----YPVWLS  220 (321)
T ss_pred             cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH--HHHHHHHc-CCC------C----CCCCCC
Confidence               3789999999999889999999999999999999999999865321  11111111 110      0    111122


Q ss_pred             HHHHHHHHHcCCCCCCCCC-------CHHHHHH
Q 047719          517 ERMLMVGLSCVHPNHEKRP-------SVKEAAR  542 (596)
Q Consensus       517 ~~l~~l~~~C~~~dp~~RP-------s~~ev~~  542 (596)
                      ..+.+++..|++.||++||       +++++++
T Consensus       221 ~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         221 KEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             HHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence            4567788899999999999       7777765

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=3.8e-37  Score=320.56  Aligned_cols=233  Identities=22%  Similarity=0.279  Sum_probs=188.1

Q ss_pred             CCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          285 GFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      +|...+.||+|+||.||+|... +++.||||++.+.... ......+..|...+....+|++|+++++++...+.+++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4677899999999999999865 4789999999753321 2223345666666665557999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc---
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP---  439 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~---  439 (596)
                      ||+++|+|.+++....    .+++.++..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++..   
T Consensus        81 E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~  153 (323)
T cd05616          81 EYVNGGDLMYQIQQVG----RFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW  153 (323)
T ss_pred             cCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence            9999999999997653    48899999999999999999999   8999999999999999999999999997642   


Q ss_pred             --------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcC
Q 047719          440 --------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKF  511 (596)
Q Consensus       440 --------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  511 (596)
                              .||+.|+|||.+.+..++.++|||||||++|||++|+.||......  ....... ...          ..+
T Consensus       154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~--~~~~~i~-~~~----------~~~  220 (323)
T cd05616         154 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--ELFQSIM-EHN----------VAY  220 (323)
T ss_pred             CCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH--HHHHHHH-hCC----------CCC
Confidence                    4789999999999999999999999999999999999999865421  1111111 111          111


Q ss_pred             CHHHHHHHHHHHHHcCCCCCCCCCCH
Q 047719          512 NRKEMERMLMVGLSCVHPNHEKRPSV  537 (596)
Q Consensus       512 ~~~~~~~l~~l~~~C~~~dp~~RPs~  537 (596)
                      +......+.+++.+|++.+|++|++.
T Consensus       221 p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         221 PKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             CCcCCHHHHHHHHHHcccCHHhcCCC
Confidence            22234566788899999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-37  Score=322.30  Aligned_cols=241  Identities=25%  Similarity=0.285  Sum_probs=192.4

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchh-cccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVE-CARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~-~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      ++|...+.||+|+||.||++... +++.||||++.+..... .....+..|+..+. .++|+||+++++++.+.+..++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~-~~~~~~i~~~~~~~~~~~~~~lv   79 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILA-DADSPWIVKLYYSFQDEEHLYLV   79 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHH-hcCCCCccchhhheecCCeEEEE
Confidence            36788899999999999999875 58999999997543222 23445677775554 48999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc---
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI---  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---  438 (596)
                      |||+++|+|.+++....    .+++..+..++.||+.||+|||+   .+++||||||+|||++.++.+||+|||++.   
T Consensus        80 ~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~  152 (350)
T cd05573          80 MEYMPGGDLMNLLIRKD----VFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMN  152 (350)
T ss_pred             EcCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCc
Confidence            99999999999998753    48899999999999999999999   999999999999999999999999998653   


Q ss_pred             -------------------------------------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCC
Q 047719          439 -------------------------------------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDN  481 (596)
Q Consensus       439 -------------------------------------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~  481 (596)
                                                           ..||..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~  232 (350)
T cd05573         153 KAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYS  232 (350)
T ss_pred             ccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCC
Confidence                                                 2378899999999999999999999999999999999999986


Q ss_pred             CChhHHHHHHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCC-HHHHHH
Q 047719          482 DGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPS-VKEAAR  542 (596)
Q Consensus       482 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs-~~ev~~  542 (596)
                      ....  ..............   ......    ....+.+++..|++ ||.+||+ ++++++
T Consensus       233 ~~~~--~~~~~i~~~~~~~~---~p~~~~----~~~~~~~li~~ll~-dp~~R~~s~~~ll~  284 (350)
T cd05573         233 DTLQ--ETYNKIINWKESLR---FPPDPP----VSPEAIDLICRLLC-DPEDRLGSFEEIKS  284 (350)
T ss_pred             CCHH--HHHHHHhccCCccc---CCCCCC----CCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence            5421  11111111000000   000011    23456677788997 9999999 999987

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=4.1e-37  Score=316.21  Aligned_cols=248  Identities=25%  Similarity=0.383  Sum_probs=194.9

Q ss_pred             cCCCccceeecCCceEEEEEEcCC-CC--EEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPS-GG--AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVL  360 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~--~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~l  360 (596)
                      ++|...++||+|+||.||+|...+ +.  .+++|.++... .....+.+.+|+..+.+..+||||+++++++...+..++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l   80 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA-SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI   80 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC-CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence            467788999999999999998754 33  47888885322 223345688898777664489999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhCCC------------CCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCc
Q 047719          361 VYEYLPNGSLDKILHNNSS------------SSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFN  428 (596)
Q Consensus       361 V~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~  428 (596)
                      |+||+++|+|.+++.....            ....+++..++.++.|++.||+|||+   .+++||||||+|||+++++.
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~  157 (297)
T cd05089          81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLA  157 (297)
T ss_pred             EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCe
Confidence            9999999999999976431            11248899999999999999999999   89999999999999999999


Q ss_pred             eEEccCCCcccC----------CCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcC
Q 047719          429 AKLGDFEATIPA----------GTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKG  497 (596)
Q Consensus       429 ~kl~Dfg~~~~~----------gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~  497 (596)
                      +||+|||++...          .+..|+|||.+....++.++|||||||++|||++ |+.||.....  .+.. .....+
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~--~~~~-~~~~~~  234 (297)
T cd05089         158 SKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC--AELY-EKLPQG  234 (297)
T ss_pred             EEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--HHHH-HHHhcC
Confidence            999999976421          2456999999988889999999999999999998 9999976432  1111 111111


Q ss_pred             CchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          498 KLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       498 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                               .....+......+.+++..||+.+|.+||+++++++.|+..
T Consensus       235 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  275 (297)
T cd05089         235 ---------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRM  275 (297)
T ss_pred             ---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                     11111122334677889999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=3.4e-37  Score=313.94  Aligned_cols=244  Identities=28%  Similarity=0.386  Sum_probs=189.1

Q ss_pred             CCCccceeecCCceEEEEEEcC-CCC----EEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEE
Q 047719          285 GFNKNRIVGEGASATVYKGSLP-SGG----AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELV  359 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~-~g~----~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~  359 (596)
                      +|...+.||+|+||.||+|.+. ++.    .+++|.+... .......++..|+..+ ..++||||+++++++. ....+
T Consensus         8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l-~~l~h~~iv~~~~~~~-~~~~~   84 (279)
T cd05111           8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAM-GSLDHAYIVRLLGICP-GASLQ   84 (279)
T ss_pred             hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHH-hcCCCCCcceEEEEEC-CCccE
Confidence            5667789999999999999864 344    4778877432 1122334566666454 4589999999999885 45678


Q ss_pred             EEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc
Q 047719          360 LVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP  439 (596)
Q Consensus       360 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~  439 (596)
                      +++||+++|+|.+++....   ..++|..++.++.||+.||+|||+   .+++||||||+|||+++++.+||+|||.+..
T Consensus        85 ~i~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~  158 (279)
T cd05111          85 LVTQLSPLGSLLDHVRQHR---DSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADL  158 (279)
T ss_pred             EEEEeCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCcccee
Confidence            9999999999999998643   248999999999999999999999   8999999999999999999999999997642


Q ss_pred             -------------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhccc
Q 047719          440 -------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADF  505 (596)
Q Consensus       440 -------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~  505 (596)
                                   .++..|+|||.+.++.++.++|||||||++|||++ |+.||.+......   ......+....  .+
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~---~~~~~~~~~~~--~~  233 (279)
T cd05111         159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV---PDLLEKGERLA--QP  233 (279)
T ss_pred             ccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHHHCCCcCC--CC
Confidence                         24568999999998899999999999999999998 9999976532211   11112221111  01


Q ss_pred             cccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Q 047719          506 RLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEAP  549 (596)
Q Consensus       506 ~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~~~  549 (596)
                         ..    ....+.+++..||+.+|++|||+.|+++.|+....
T Consensus       234 ---~~----~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         234 ---QI----CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             ---CC----CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence               11    12345778889999999999999999998876443

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.9e-37  Score=318.96  Aligned_cols=229  Identities=26%  Similarity=0.297  Sum_probs=184.7

Q ss_pred             ceeecCCceEEEEEEc----CCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecC
Q 047719          290 RIVGEGASATVYKGSL----PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYL  365 (596)
Q Consensus       290 ~~LG~G~fG~Vy~~~~----~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~  365 (596)
                      +.||+|+||.||++..    .+|+.||+|++.+..........+..|+..+. .++||||+++++++...+..|+||||+
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILA-EVNHPFIVKLHYAFQTEGKLYLILDFL   80 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHH-hCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence            5799999999999864    35789999999754333333445677885554 489999999999999999999999999


Q ss_pred             CCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc------
Q 047719          366 PNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP------  439 (596)
Q Consensus       366 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~------  439 (596)
                      ++|+|.+++....    .+++..+..++.||++||+|||+   .+|+||||||+|||++.++.+||+|||++..      
T Consensus        81 ~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~  153 (318)
T cd05582          81 RGGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK  153 (318)
T ss_pred             CCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC
Confidence            9999999997643    48999999999999999999999   8999999999999999999999999997532      


Q ss_pred             -----CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHH
Q 047719          440 -----AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRK  514 (596)
Q Consensus       440 -----~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  514 (596)
                           .||..|+|||.+....++.++|||||||++|||++|+.||......  +...... ....          ..+..
T Consensus       154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~--~~~~~i~-~~~~----------~~p~~  220 (318)
T cd05582         154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK--ETMTMIL-KAKL----------GMPQF  220 (318)
T ss_pred             ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH--HHHHHHH-cCCC----------CCCCC
Confidence                 4788999999999888999999999999999999999999765321  1111111 1110          11122


Q ss_pred             HHHHHHHHHHHcCCCCCCCCCCHHH
Q 047719          515 EMERMLMVGLSCVHPNHEKRPSVKE  539 (596)
Q Consensus       515 ~~~~l~~l~~~C~~~dp~~RPs~~e  539 (596)
                      ....+.+++.+|++.||++||++.+
T Consensus       221 ~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         221 LSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            2345677888999999999999555

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1e-36  Score=307.45  Aligned_cols=250  Identities=24%  Similarity=0.351  Sum_probs=199.8

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCc-hhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNR-VECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      .+|...+.||+|+||.||++... ++..+|||.+..... ......++.+|+..+.. ++|+||+++++++.+.+..+++
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~-~~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQ-LNHPNVIKYYASFIEDNELNIV   80 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHH-ccCCchhhhhheeEeCCeEEEE
Confidence            35777899999999999999854 689999998864322 22334578888865554 8999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc---
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI---  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---  438 (596)
                      |||+++++|.+++.........+++..++.++.||+.||+|||+   .+++|+||||+||+++.++.++|+|||.+.   
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd08229          81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence            99999999999997543334468999999999999999999999   899999999999999999999999998643   


Q ss_pred             --------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCc
Q 047719          439 --------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGK  510 (596)
Q Consensus       439 --------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  510 (596)
                              ..|+..|+|||.+.+..++.++||||||+++|||++|..||................      ...+.   .
T Consensus       158 ~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------~~~~~---~  228 (267)
T cd08229         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ------CDYPP---L  228 (267)
T ss_pred             cCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhc------CCCCC---C
Confidence                    247788999999988889999999999999999999999997543222221111110      00011   1


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          511 FNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       511 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                      ........+.+++.+||+.+|++||||.+|++.++.
T Consensus       229 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~  264 (267)
T cd08229         229 PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKR  264 (267)
T ss_pred             CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence            112234567788889999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=4.8e-37  Score=316.78  Aligned_cols=247  Identities=26%  Similarity=0.389  Sum_probs=194.4

Q ss_pred             cCCCccceeecCCceEEEEEEcCC-CC--EEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPS-GG--AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVL  360 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~--~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~l  360 (596)
                      ++|...+.||+|+||.||+|.... +.  .+|+|++... ........+.+|+..+.+..+|+||+++++++...+..++
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            467778999999999999998643 44  4688877532 2233445678898777664489999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhCCC------------CCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCc
Q 047719          361 VYEYLPNGSLDKILHNNSS------------SSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFN  428 (596)
Q Consensus       361 V~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~  428 (596)
                      ||||+++|+|.+++.....            ....+++.+++.++.|++.||+|||+   .+++||||||+|||++.++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCc
Confidence            9999999999999976431            12358899999999999999999998   89999999999999999999


Q ss_pred             eEEccCCCccc----------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcC
Q 047719          429 AKLGDFEATIP----------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKG  497 (596)
Q Consensus       429 ~kl~Dfg~~~~----------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~  497 (596)
                      +||+|||++..          .++..|+|||.+....++.++|||||||++|||+| |..||......  +..... ..+
T Consensus       163 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~~-~~~  239 (303)
T cd05088         163 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--ELYEKL-PQG  239 (303)
T ss_pred             EEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH--HHHHHH-hcC
Confidence            99999998642          13567999999988889999999999999999998 99999754321  111111 111


Q ss_pred             CchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          498 KLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       498 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                               .....+......+.+++.+||+.+|++||+++++++.|+.
T Consensus       240 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~  279 (303)
T cd05088         240 ---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR  279 (303)
T ss_pred             ---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence                     0111111223457788999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3.3e-37  Score=320.08  Aligned_cols=233  Identities=23%  Similarity=0.309  Sum_probs=186.5

Q ss_pred             ceeecCCceEEEEEEcCC-CCEEEEEEeecCCc-hhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecCCC
Q 047719          290 RIVGEGASATVYKGSLPS-GGAVAVKRFEKPNR-VECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPN  367 (596)
Q Consensus       290 ~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~-~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  367 (596)
                      +.||+|+||.||+|.... ++.||||++++... .+.....+..|...+...++||||+++++++.+.+.+++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            469999999999998754 78999999975321 1222344566766666657999999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc--------
Q 047719          368 GSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP--------  439 (596)
Q Consensus       368 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~--------  439 (596)
                      |+|.+++....    .+++.+...++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++..        
T Consensus        81 g~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  153 (316)
T cd05619          81 GDLMFHIQSCH----KFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT  153 (316)
T ss_pred             CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCce
Confidence            99999997643    48899999999999999999999   8999999999999999999999999997542        


Q ss_pred             ---CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHHHH
Q 047719          440 ---AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEM  516 (596)
Q Consensus       440 ---~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  516 (596)
                         .||..|+|||.+.+..++.++|||||||++|||++|+.||......  +...... ..      .+.    ++....
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--~~~~~i~-~~------~~~----~~~~~~  220 (316)
T cd05619         154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE--ELFQSIR-MD------NPC----YPRWLT  220 (316)
T ss_pred             eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH--HHHHHHH-hC------CCC----CCccCC
Confidence               3789999999999889999999999999999999999999765321  1111111 11      011    111223


Q ss_pred             HHHHHHHHHcCCCCCCCCCCHH-HHHH
Q 047719          517 ERMLMVGLSCVHPNHEKRPSVK-EAAR  542 (596)
Q Consensus       517 ~~l~~l~~~C~~~dp~~RPs~~-ev~~  542 (596)
                      ..+.+++.+|++.||++||++. ++.+
T Consensus       221 ~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         221 REAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             HHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            4566788899999999999997 5543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-37  Score=313.58  Aligned_cols=242  Identities=22%  Similarity=0.264  Sum_probs=193.0

Q ss_pred             CCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchh-cccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          285 GFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVE-CARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~-~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      +|...++||+|+||+||++... +++.||||++....... .....+.+|+..+. .++|+||+++++++.....+++||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~   79 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILE-KVNSRFVVSLAYAYETKDALCLVL   79 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHH-hcCCCCEeeeeeeecCCCeEEEEE
Confidence            3677899999999999999864 58899999996433221 22345677886554 489999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc---
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP---  439 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~---  439 (596)
                      ||+++|+|.+++....  ...+++..+..++.|++.||.|||+   .+++||||||+||++++++.++|+|||++..   
T Consensus        80 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  154 (285)
T cd05605          80 TLMNGGDLKFHIYNMG--NPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE  154 (285)
T ss_pred             eccCCCcHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence            9999999999987543  2358999999999999999999999   8999999999999999999999999997542   


Q ss_pred             -------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhH-HHHHHHHHhcCCchhhccccccCcC
Q 047719          440 -------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVI-VDWVWNLRKKGKLLDAADFRLRGKF  511 (596)
Q Consensus       440 -------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~-~~~~~~~~~~~~~~~~~d~~l~~~~  511 (596)
                             .|+..|+|||.+.+..++.++|||||||++|||++|+.||....... ...+......          ....+
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~----------~~~~~  224 (285)
T cd05605         155 GETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKE----------DQEEY  224 (285)
T ss_pred             CCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhh----------ccccc
Confidence                   47889999999998889999999999999999999999998643211 1111111100          01122


Q ss_pred             CHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 047719          512 NRKEMERMLMVGLSCVHPNHEKRP-----SVKEAAR  542 (596)
Q Consensus       512 ~~~~~~~l~~l~~~C~~~dp~~RP-----s~~ev~~  542 (596)
                      +......+.+++..|++.||++||     +++++++
T Consensus       225 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         225 SEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             CcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence            233445677888999999999999     7778755

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.1e-36  Score=311.63  Aligned_cols=250  Identities=25%  Similarity=0.315  Sum_probs=189.7

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      .+|...+.||+|+||.||+|... ++..||+|+++.... ......+.+|+..+. .++||||+++++++...+..++||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~lv~   82 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLK-NLKHANIVTLHDIIHTERCLTLVF   82 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHH-hCCCCCEeeEEEEEcCCCeEEEEE
Confidence            35778899999999999999765 588999999864332 223345778886665 489999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc----
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI----  438 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~----  438 (596)
                      ||+++ +|.+++....   ..+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||++.    
T Consensus        83 e~~~~-~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~  155 (288)
T cd07871          83 EYLDS-DLKQYLDNCG---NLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSV  155 (288)
T ss_pred             eCCCc-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccC
Confidence            99974 9999987643   247889999999999999999999   899999999999999999999999999753    


Q ss_pred             -------cCCCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCCh-hHHHHHHHHHhcC------------
Q 047719          439 -------PAGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGC-VIVDWVWNLRKKG------------  497 (596)
Q Consensus       439 -------~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~-~~~~~~~~~~~~~------------  497 (596)
                             ..++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... .............            
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07871         156 PTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNE  235 (288)
T ss_pred             CCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccch
Confidence                   236888999998875 5689999999999999999999999976532 1111111111000            


Q ss_pred             CchhhccccccCc----CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          498 KLLDAADFRLRGK----FNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       498 ~~~~~~d~~l~~~----~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      .......+.....    ........+.+++.+|++.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            0000000000000    00012245678889999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=3.5e-37  Score=314.13  Aligned_cols=237  Identities=22%  Similarity=0.242  Sum_probs=187.4

Q ss_pred             eecCCceEEEEEEcC-CCCEEEEEEeecCCchh-cccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecCCCCC
Q 047719          292 VGEGASATVYKGSLP-SGGAVAVKRFEKPNRVE-CARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGS  369 (596)
Q Consensus       292 LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~-~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  369 (596)
                      ||+|+||+||++... +++.||+|++.+..... .....+..|+..+. .++|+||+++.+++......++||||+++|+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~-~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~   79 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILA-KVHSRFIVSLAYAFQTKTDLCLVMTIMNGGD   79 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHH-hCCCCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence            699999999999765 58899999986433221 22345677875554 4899999999999999999999999999999


Q ss_pred             HHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc----------
Q 047719          370 LDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP----------  439 (596)
Q Consensus       370 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~----------  439 (596)
                      |..++.........+++..+..++.||+.||+|||+   .+|+||||||+||+++.++.+||+|||++..          
T Consensus        80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~  156 (280)
T cd05608          80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKG  156 (280)
T ss_pred             HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccc
Confidence            999886543334468999999999999999999999   8999999999999999999999999997632          


Q ss_pred             -CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHH-HHHHHHHhcCCchhhccccccCcCCHHHHH
Q 047719          440 -AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIV-DWVWNLRKKGKLLDAADFRLRGKFNRKEME  517 (596)
Q Consensus       440 -~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~-~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  517 (596)
                       .||..|+|||.+.+..++.++|||||||++|||++|+.||........ ..........          ...++.....
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~  226 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND----------SVTYPDKFSP  226 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc----------CCCCcccCCH
Confidence             478899999999999999999999999999999999999976432111 0000000000          0112223345


Q ss_pred             HHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 047719          518 RMLMVGLSCVHPNHEKRP-----SVKEAAR  542 (596)
Q Consensus       518 ~l~~l~~~C~~~dp~~RP-----s~~ev~~  542 (596)
                      .+.+++..|++.||++||     +++++++
T Consensus       227 ~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         227 ASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             HHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            677888899999999999     6677765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=6.8e-37  Score=312.03  Aligned_cols=251  Identities=25%  Similarity=0.373  Sum_probs=192.7

Q ss_pred             CccceeecCCceEEEEEEc-----CCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeC--CeEE
Q 047719          287 NKNRIVGEGASATVYKGSL-----PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG--NELV  359 (596)
Q Consensus       287 ~~~~~LG~G~fG~Vy~~~~-----~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~--~~~~  359 (596)
                      ...+.||+|+||+||++..     .++..||+|.++.... ......+.+|+..+.. ++||||++++++|...  ...+
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~-l~h~~i~~~~~~~~~~~~~~~~   84 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG-QQNTSGWKKEINILKT-LYHENIVKYKGCCSEQGGKGLQ   84 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC-hHHHHHHHHHHHHHHh-CCCCCEeeEEEEEecCCCceEE
Confidence            6678999999999988642     3477899999864322 2344567889866654 8999999999998764  3689


Q ss_pred             EEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc
Q 047719          360 LVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP  439 (596)
Q Consensus       360 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~  439 (596)
                      +||||+++|+|.+++...     .+++.+++.++.|++.||.|||+   .+++||||||+|||+++++.+||+|||++..
T Consensus        85 lv~e~~~~~~l~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~  156 (283)
T cd05080          85 LIMEYVPLGSLRDYLPKH-----KLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKA  156 (283)
T ss_pred             EEecCCCCCCHHHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccc
Confidence            999999999999999764     38999999999999999999999   8999999999999999999999999997643


Q ss_pred             C--------------CCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHH---hcCCchhh
Q 047719          440 A--------------GTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLR---KKGKLLDA  502 (596)
Q Consensus       440 ~--------------gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~---~~~~~~~~  502 (596)
                      .              ++..|+|||.+....++.++|||||||++|||++|+.|+........+......   ....+.+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd05080         157 VPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIEL  236 (283)
T ss_pred             cCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhh
Confidence            2              345699999998888999999999999999999999998653221111100000   00011111


Q ss_pred             ccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          503 ADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       503 ~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                      .+.......+......+.+++..||+.+|++|||++++++.|+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~  281 (283)
T cd05080         237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM  281 (283)
T ss_pred             hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence            111111122223446788899999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=5.7e-37  Score=319.22  Aligned_cols=229  Identities=25%  Similarity=0.296  Sum_probs=184.9

Q ss_pred             ceeecCCceEEEEEEcC-CCCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecCCC
Q 047719          290 RIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPN  367 (596)
Q Consensus       290 ~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  367 (596)
                      +.||+|+||+||+|... +|+.||||++.+.... ......+..|...+.+.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999875 5899999999653221 122344566665666679999999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc---------
Q 047719          368 GSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI---------  438 (596)
Q Consensus       368 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---------  438 (596)
                      |+|.+++....    .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++.         
T Consensus        81 g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  153 (323)
T cd05575          81 GELFFHLQRER----SFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTT  153 (323)
T ss_pred             CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcc
Confidence            99999997653    48889999999999999999999   899999999999999999999999999753         


Q ss_pred             --cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHHHH
Q 047719          439 --PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEM  516 (596)
Q Consensus       439 --~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  516 (596)
                        ..||+.|+|||.+.+..++.++|||||||++|||++|+.||.....  .+....... ..      ..+...    ..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~--~~~~~~i~~-~~------~~~~~~----~~  220 (323)
T cd05575         154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT--AEMYDNILN-KP------LRLKPN----IS  220 (323)
T ss_pred             ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH--HHHHHHHHc-CC------CCCCCC----CC
Confidence              2488999999999998999999999999999999999999976432  111111111 11      111122    23


Q ss_pred             HHHHHHHHHcCCCCCCCCCCHH
Q 047719          517 ERMLMVGLSCVHPNHEKRPSVK  538 (596)
Q Consensus       517 ~~l~~l~~~C~~~dp~~RPs~~  538 (596)
                      ..+.+++.+|++.||++||+++
T Consensus       221 ~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         221 VSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             HHHHHHHHHHhhcCHHhCCCCC
Confidence            4567788899999999999874

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=6.8e-37  Score=299.28  Aligned_cols=273  Identities=24%  Similarity=0.290  Sum_probs=202.7

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeee--CCeEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE--GNELVL  360 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~--~~~~~l  360 (596)
                      ++|...+.|++|.||.||+|+.. +++.||+|+++-+...+.---..++||..+++ .+|||||.+-.+..-  -+.+|+
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~-~~H~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLK-ARHPNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHh-cCCCCeeeeEEEEeccccceeee
Confidence            34667789999999999999875 48899999997554333222346899977766 889999999887654  357999


Q ss_pred             EEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcccC
Q 047719          361 VYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA  440 (596)
Q Consensus       361 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~~  440 (596)
                      |||||+. +|...+....   .++...+..-+..|+++|++|||.   ..|+|||||++|+|+...|.+||+|||+++..
T Consensus       155 VMe~~Eh-DLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y  227 (419)
T KOG0663|consen  155 VMEYVEH-DLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREY  227 (419)
T ss_pred             eHHHHHh-hHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhh
Confidence            9999987 9999998764   468889999999999999999999   89999999999999999999999999998765


Q ss_pred             C-----------CcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCCh-hHHHHHHHHHhcCCc--------
Q 047719          441 G-----------TMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGC-VIVDWVWNLRKKGKL--------  499 (596)
Q Consensus       441 g-----------t~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~-~~~~~~~~~~~~~~~--------  499 (596)
                      |           |.+|.|||++.+ ..|+...|+||+|||+.||+++++-|.+... ...+-+.++...+.-        
T Consensus       228 gsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~  307 (419)
T KOG0663|consen  228 GSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSE  307 (419)
T ss_pred             cCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccc
Confidence            4           568999999987 5699999999999999999999999987643 222222222221111        


Q ss_pred             hhhc---------cccccCcCCHH-HHHHHHHHHHHcCCCCCCCCCCHHHHHHH-HhcCCCCCCCCCCCCcccccc
Q 047719          500 LDAA---------DFRLRGKFNRK-EMERMLMVGLSCVHPNHEKRPSVKEAARI-LKGEAPLPLLPVKKPTVNIRS  564 (596)
Q Consensus       500 ~~~~---------d~~l~~~~~~~-~~~~l~~l~~~C~~~dp~~RPs~~ev~~~-L~~~~~~p~~p~~~~~~~~~~  564 (596)
                      ...+         -..++..+... ..+.-++|....+..||++|-|++|.++. .-.+.|.|..|...|.+..++
T Consensus       308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P~~~Pt~P~k~  383 (419)
T KOG0663|consen  308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDPSMFPTWPAKS  383 (419)
T ss_pred             cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCChhhcCCCcccc
Confidence            1111         00112222211 23556677777889999999999998761 122445555555444444443

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=3.5e-37  Score=320.92  Aligned_cols=233  Identities=23%  Similarity=0.269  Sum_probs=186.1

Q ss_pred             CCCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCc-hhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          285 GFNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNR-VECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~-~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      +|...+.||+|+||.||+|.... ++.||||++.+... .......+..|...+...-+|++|+++++++...+.+|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            46778999999999999998654 78999999975322 12234456777766655334567889999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc---
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP---  439 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~---  439 (596)
                      ||+++|+|.+++....    .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++..   
T Consensus        81 E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05587          81 EYVNGGDLMYHIQQVG----KFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF  153 (324)
T ss_pred             cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence            9999999999997653    48899999999999999999999   8999999999999999999999999997542   


Q ss_pred             --------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcC
Q 047719          440 --------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKF  511 (596)
Q Consensus       440 --------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  511 (596)
                              .||..|+|||++.+..++.++|||||||++|||++|+.||......  +...... ...          ..+
T Consensus       154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--~~~~~i~-~~~----------~~~  220 (324)
T cd05587         154 GGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED--ELFQSIM-EHN----------VSY  220 (324)
T ss_pred             CCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHH-cCC----------CCC
Confidence                    4899999999999999999999999999999999999999765321  1111111 110          111


Q ss_pred             CHHHHHHHHHHHHHcCCCCCCCCCCH
Q 047719          512 NRKEMERMLMVGLSCVHPNHEKRPSV  537 (596)
Q Consensus       512 ~~~~~~~l~~l~~~C~~~dp~~RPs~  537 (596)
                      +......+.+++.+|++.||++||+.
T Consensus       221 ~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         221 PKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             CCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence            12233456788889999999999976

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-37  Score=326.20  Aligned_cols=241  Identities=24%  Similarity=0.289  Sum_probs=189.0

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      ++|...+.||+|+||.||++... +++.||||++.+.... ......+.+|+..+. .++|+||+++++++.+....|+|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~-~l~h~~iv~~~~~~~~~~~~~lv   79 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILA-EADNPWVVKLYYSFQDENYLYLI   79 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHH-hCCCCCCcceEEEEEcCCeEEEE
Confidence            36888899999999999999875 5889999999653221 122344667875554 48999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc---
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI---  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---  438 (596)
                      |||+++|+|.+++....    .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++.   
T Consensus        80 ~E~~~~g~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  152 (364)
T cd05599          80 MEYLPGGDMMTLLMKKD----TFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK  152 (364)
T ss_pred             ECCCCCcHHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceecc
Confidence            99999999999998653    48899999999999999999999   899999999999999999999999999753   


Q ss_pred             ----------------------------------------------cCCCcccCCccccccCCCCCccceeehhHHHHHH
Q 047719          439 ----------------------------------------------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEV  472 (596)
Q Consensus       439 ----------------------------------------------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El  472 (596)
                                                                    ..||+.|+|||++....++.++|||||||++|||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el  232 (364)
T cd05599         153 KSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM  232 (364)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHh
Confidence                                                          2489999999999988999999999999999999


Q ss_pred             HhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHH
Q 047719          473 AAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPS---VKEAAR  542 (596)
Q Consensus       473 ~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs---~~ev~~  542 (596)
                      ++|+.||......  +................   ...+    ...+.+++..|+. +|.+|++   ++|+++
T Consensus       233 ~~G~~Pf~~~~~~--~~~~~i~~~~~~~~~~~---~~~~----s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         233 LVGYPPFCSDNPQ--ETYRKIINWKETLQFPD---EVPL----SPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             hcCCCCCCCCCHH--HHHHHHHcCCCccCCCC---CCCC----CHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            9999999865321  11111111110000000   0011    2344556667776 8999998   888866

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=4.6e-37  Score=314.52  Aligned_cols=246  Identities=24%  Similarity=0.408  Sum_probs=195.4

Q ss_pred             CCCccceeecCCceEEEEEEcC------CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeE
Q 047719          285 GFNKNRIVGEGASATVYKGSLP------SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNEL  358 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~  358 (596)
                      +|...+.||+|+||.||+|...      ....+|+|.+..... ......+.+|+..+. .++||||+++++.|...+..
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~   78 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS-SSELRDLLSEFNLLK-QVNHPHVIKLYGACSQDGPL   78 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC-HHHHHHHHHHHHHHh-hCCCCCEeeEEEEEecCCCc
Confidence            3667789999999999999752      235789998864332 223456888986555 48999999999999999999


Q ss_pred             EEEEecCCCCCHHHHhhhCCC--------------------CCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCC
Q 047719          359 VLVYEYLPNGSLDKILHNNSS--------------------SSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKA  418 (596)
Q Consensus       359 ~lV~E~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp  418 (596)
                      ++|+||+++|+|.+++.....                    ....+++..++.++.|++.||+|||+   .+++||||||
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp  155 (290)
T cd05045          79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAA  155 (290)
T ss_pred             EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhh
Confidence            999999999999999875321                    12358899999999999999999998   8999999999


Q ss_pred             CceeecCCCceEEccCCCccc-------------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCCh
Q 047719          419 CNILLDAEFNAKLGDFEATIP-------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGC  484 (596)
Q Consensus       419 ~NiLl~~~~~~kl~Dfg~~~~-------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~  484 (596)
                      +|||+++++.+||+|||.+..             .++..|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus       156 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~  235 (290)
T cd05045         156 RNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP  235 (290)
T ss_pred             heEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence            999999999999999997642             24568999999988889999999999999999999 9999976432


Q ss_pred             hHHHHHHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          485 VIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       485 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                         ..+++......         ....+......+.+++..|++.+|++||++.|+++.|+..
T Consensus       236 ---~~~~~~~~~~~---------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~  286 (290)
T cd05045         236 ---ERLFNLLKTGY---------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM  286 (290)
T ss_pred             ---HHHHHHHhCCC---------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence               11222222211         1111122335677889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-37  Score=327.25  Aligned_cols=241  Identities=23%  Similarity=0.240  Sum_probs=187.9

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCc-hhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNR-VECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      ++|...+.||+|+||.||++... +++.||||++.+... .......+.+|+..+. .++|||||++++++.+....|+|
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~-~l~hp~iv~~~~~~~~~~~~~lv   79 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLA-ESDSPWVVSLYYSFQDAQYLYLI   79 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHH-hCCCCCcceEEEEEEcCCeeEEE
Confidence            36788899999999999999765 588999999864322 1223445777886554 48999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc---
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI---  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---  438 (596)
                      |||+++|+|.+++....    .+++.....++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++.   
T Consensus        80 ~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~  152 (377)
T cd05629          80 MEFLPGGDLMTMLIKYD----TFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFH  152 (377)
T ss_pred             EeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeecccccccc
Confidence            99999999999997643    47888999999999999999999   899999999999999999999999999763   


Q ss_pred             -------------------------------------------------------cCCCcccCCccccccCCCCCcccee
Q 047719          439 -------------------------------------------------------PAGTMGYLAPEYVYSGVPSEKTDVY  463 (596)
Q Consensus       439 -------------------------------------------------------~~gt~~y~aPE~~~~~~~t~~sDV~  463 (596)
                                                                             ..||+.|+|||.+.+..++.++|||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw  232 (377)
T cd05629         153 KQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWW  232 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeE
Confidence                                                                   2589999999999988999999999


Q ss_pred             ehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCC---CCCHHHH
Q 047719          464 SFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEK---RPSVKEA  540 (596)
Q Consensus       464 SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~---RPs~~ev  540 (596)
                      ||||++|||++|+.||......  +...............+.   ..+    ...+.+++..|++ +|.+   ||++.|+
T Consensus       233 SlGvil~elltG~~Pf~~~~~~--~~~~~i~~~~~~~~~p~~---~~~----s~~~~dli~~lL~-~~~~r~~r~~~~~~  302 (377)
T cd05629         233 SLGAIMFECLIGWPPFCSENSH--ETYRKIINWRETLYFPDD---IHL----SVEAEDLIRRLIT-NAENRLGRGGAHEI  302 (377)
T ss_pred             ecchhhhhhhcCCCCCCCCCHH--HHHHHHHccCCccCCCCC---CCC----CHHHHHHHHHHhc-CHhhcCCCCCHHHH
Confidence            9999999999999999765321  111111111111111000   011    2345566677776 6665   4699888


Q ss_pred             HH
Q 047719          541 AR  542 (596)
Q Consensus       541 ~~  542 (596)
                      ++
T Consensus       303 l~  304 (377)
T cd05629         303 KS  304 (377)
T ss_pred             hc
Confidence            77

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=7e-37  Score=305.64  Aligned_cols=236  Identities=26%  Similarity=0.386  Sum_probs=191.8

Q ss_pred             ceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecCCCCC
Q 047719          290 RIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGS  369 (596)
Q Consensus       290 ~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  369 (596)
                      ++||+|+||.||+|...++..+|+|++..... ......+.+|+..+.. ++|+||++++++|...+..++||||+++++
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   78 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLP-QELKIKFLSEARILKQ-YDHPNIVKLIGVCTQRQPIYIVMELVPGGD   78 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCC-HHHHHHHHHHHHHHHh-CCCCCcCeEEEEEecCCccEEEEECCCCCc
Confidence            36899999999999988889999999864332 2233467888866654 899999999999999999999999999999


Q ss_pred             HHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc----------
Q 047719          370 LDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP----------  439 (596)
Q Consensus       370 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~----------  439 (596)
                      |.+++....   ..+++..++.++.|++.+|.|||+   .+++||||||+||+++.++.+||+|||++..          
T Consensus        79 L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~  152 (250)
T cd05085          79 FLSFLRKKK---DELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSG  152 (250)
T ss_pred             HHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccccccccCC
Confidence            999997543   247899999999999999999999   8999999999999999999999999997642          


Q ss_pred             --CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHHHH
Q 047719          440 --AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEM  516 (596)
Q Consensus       440 --~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  516 (596)
                        .++..|+|||++.++.++.++|||||||++||+++ |..||......  . .......+.         ....+....
T Consensus       153 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~--~-~~~~~~~~~---------~~~~~~~~~  220 (250)
T cd05085         153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ--Q-AREQVEKGY---------RMSCPQKCP  220 (250)
T ss_pred             CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH--H-HHHHHHcCC---------CCCCCCCCC
Confidence              23456999999998899999999999999999999 99999764321  1 111111111         111122234


Q ss_pred             HHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 047719          517 ERMLMVGLSCVHPNHEKRPSVKEAARILK  545 (596)
Q Consensus       517 ~~l~~l~~~C~~~dp~~RPs~~ev~~~L~  545 (596)
                      ..+.+++.+|++.+|++||++.|+.+.|.
T Consensus       221 ~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         221 DDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             HHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            67888999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=4.8e-37  Score=312.24  Aligned_cols=247  Identities=26%  Similarity=0.341  Sum_probs=195.2

Q ss_pred             HhcCCCccceeecCCceEEEEEEcCC------CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeC
Q 047719          282 ATLGFNKNRIVGEGASATVYKGSLPS------GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG  355 (596)
Q Consensus       282 at~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~  355 (596)
                      ++++|...+.||+|+||.||+|.+.+      +..||+|.+.... .......+..|+..+. .++|+||+++++++.+.
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~   81 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMS-KFNHQNIVRLIGVSFER   81 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHH-hCCCCCEeeEEEEEccC
Confidence            35678888999999999999997743      4678999875322 2233456888886555 48999999999999999


Q ss_pred             CeEEEEEecCCCCCHHHHhhhCCC---CCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCC---ce
Q 047719          356 NELVLVYEYLPNGSLDKILHNNSS---SSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEF---NA  429 (596)
Q Consensus       356 ~~~~lV~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~---~~  429 (596)
                      ...++||||+++++|.+++.....   ....++|..++.++.||+.||+|||+   .+++||||||+|||++.++   .+
T Consensus        82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~  158 (277)
T cd05036          82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVA  158 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcce
Confidence            999999999999999999976532   12358999999999999999999999   8999999999999998764   59


Q ss_pred             EEccCCCcccC-------------CCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHh
Q 047719          430 KLGDFEATIPA-------------GTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRK  495 (596)
Q Consensus       430 kl~Dfg~~~~~-------------gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~  495 (596)
                      ||+|||++...             .+..|+|||.+.+..++.++|||||||++|||++ |+.||......  +.......
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~--~~~~~~~~  236 (277)
T cd05036         159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ--EVMEFVTG  236 (277)
T ss_pred             EeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHc
Confidence            99999986432             2356999999998899999999999999999997 99999764321  11111111


Q ss_pred             cCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 047719          496 KGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK  545 (596)
Q Consensus       496 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~  545 (596)
                      ..          ....+......+.+++.+|++.+|++||++.+|++.|+
T Consensus       237 ~~----------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         237 GG----------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             CC----------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            11          11112223456788899999999999999999999885

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2.3e-37  Score=326.23  Aligned_cols=235  Identities=23%  Similarity=0.379  Sum_probs=182.8

Q ss_pred             CCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEec
Q 047719          286 FNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEY  364 (596)
Q Consensus       286 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~  364 (596)
                      |...+.||+|+||.||++... +++.||||++.... .......+.+|+..+.. ++|+||+++++++...+.+++||||
T Consensus        76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRD-VNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHh-CCCCCcceeeeEeccCCeEEEEEec
Confidence            344578999999999999865 58999999986432 22334568888866654 8999999999999999999999999


Q ss_pred             CCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc------
Q 047719          365 LPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI------  438 (596)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~------  438 (596)
                      +++|+|.+..        ...+..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++.      
T Consensus       154 ~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~  222 (353)
T PLN00034        154 MDGGSLEGTH--------IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM  222 (353)
T ss_pred             CCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence            9999986532        25567788999999999999999   899999999999999999999999999753      


Q ss_pred             -----cCCCcccCCcccccc-----CCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhcccccc
Q 047719          439 -----PAGTMGYLAPEYVYS-----GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLR  508 (596)
Q Consensus       439 -----~~gt~~y~aPE~~~~-----~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  508 (596)
                           ..||..|+|||.+..     ...+.++|||||||++|||++|+.||.....  .+|........ .      ...
T Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~--~~~~~~~~~~~-~------~~~  293 (353)
T PLN00034        223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ--GDWASLMCAIC-M------SQP  293 (353)
T ss_pred             ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--ccHHHHHHHHh-c------cCC
Confidence                 258899999998743     2345689999999999999999999974321  11211111000 0      000


Q ss_pred             CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          509 GKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       509 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ..........+.+++.+||+.||++||++.|+++
T Consensus       294 ~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~  327 (353)
T PLN00034        294 PEAPATASREFRHFISCCLQREPAKRWSAMQLLQ  327 (353)
T ss_pred             CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1112233456788889999999999999999987

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.3e-38  Score=294.78  Aligned_cols=241  Identities=26%  Similarity=0.359  Sum_probs=199.2

Q ss_pred             hcCCCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEE
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVL  360 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~l  360 (596)
                      -++|+.++.||+|.||.||.|+.+. +-.||+|++.++... .+...++.+|+ .+...++||||+++++|+.+....||
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREi-EIqs~L~hpnilrlY~~fhd~~riyL   99 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREI-EIQSHLRHPNILRLYGYFHDSKRIYL   99 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhhee-EeecccCCccHHhhhhheeccceeEE
Confidence            3568899999999999999998765 678999999765432 23455778888 44555999999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCc---
Q 047719          361 VYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT---  437 (596)
Q Consensus       361 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~---  437 (596)
                      ++||.++|+|...|++..  ...++......++.|+|.||.|+|.   ++||||||||+|+|++.++..||+|||-+   
T Consensus       100 ilEya~~gel~k~L~~~~--~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~  174 (281)
T KOG0580|consen  100 ILEYAPRGELYKDLQEGR--MKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHA  174 (281)
T ss_pred             EEEecCCchHHHHHHhcc--cccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence            999999999999999654  2358888889999999999999999   99999999999999999999999999965   


Q ss_pred             ------ccCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcC
Q 047719          438 ------IPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKF  511 (596)
Q Consensus       438 ------~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  511 (596)
                            ..+||..|++||+..+..++...|+|++|++.||++.|.+||+....   +   ..+.+-   ..++.    .+
T Consensus       175 p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~---~---etYkrI---~k~~~----~~  241 (281)
T KOG0580|consen  175 PSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH---S---ETYKRI---RKVDL----KF  241 (281)
T ss_pred             CCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh---H---HHHHHH---HHccc----cC
Confidence                  34699999999999999999999999999999999999999986421   0   111111   11111    22


Q ss_pred             CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          512 NRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       512 ~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      +......+.+++..|+..+|.+|.+..|+++
T Consensus       242 p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  242 PSTISGGAADLISRLLVKNPIERLALTEVMD  272 (281)
T ss_pred             CcccChhHHHHHHHHhccCccccccHHHHhh
Confidence            2334456678888999999999999999876

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.9e-36  Score=312.21  Aligned_cols=251  Identities=23%  Similarity=0.280  Sum_probs=189.2

Q ss_pred             hcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      .++|...+.||+|+||.||+|... +++.||||++..... ......+.+|+..+.. ++||||+++++++.+....++|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~lv   81 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKG-LKHANIVLLHDIIHTKETLTLV   81 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc-cccchhHHHHHHHHhh-CCCCCcCeEEEEEecCCeEEEE
Confidence            356888899999999999999876 588999999864332 2223356778866654 8999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc---
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI---  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---  438 (596)
                      |||++ ++|.+++....   ..+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++.   
T Consensus        82 ~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  154 (303)
T cd07869          82 FEYVH-TDLCQYMDKHP---GGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKS  154 (303)
T ss_pred             EECCC-cCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence            99995 68888887543   247889999999999999999999   899999999999999999999999999753   


Q ss_pred             --------cCCCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCChhH--HHHHHHHHhcCCc------hh
Q 047719          439 --------PAGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVI--VDWVWNLRKKGKL------LD  501 (596)
Q Consensus       439 --------~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~--~~~~~~~~~~~~~------~~  501 (596)
                              ..||..|+|||.+.+ ..++.++|||||||++|||++|+.||.+.....  .............      ..
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (303)
T cd07869         155 VPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHS  234 (303)
T ss_pred             CCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhh
Confidence                    246788999998865 457899999999999999999999998643211  1111111100000      00


Q ss_pred             --hccc-cccCcCCH---------HHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          502 --AADF-RLRGKFNR---------KEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       502 --~~d~-~l~~~~~~---------~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                        ..++ ......+.         .....+.+++..|++.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence              0000 00000000         01235667888999999999999999976

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=4.3e-37  Score=321.23  Aligned_cols=241  Identities=24%  Similarity=0.251  Sum_probs=188.0

Q ss_pred             CCCccceeecCCceEEEEEEc----CCCCEEEEEEeecCCch--hcccchHHHHHHHHHhccCCCceeeecceeeeCCeE
Q 047719          285 GFNKNRIVGEGASATVYKGSL----PSGGAVAVKRFEKPNRV--ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNEL  358 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~----~~g~~vAvK~l~~~~~~--~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~  358 (596)
                      +|...+.||+|+||.||++..    .++..||+|++.+....  ....+.+..|+..+....+|+||+++++++...+.+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            467789999999999999864    35789999999643221  122345677776666544699999999999999999


Q ss_pred             EEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc
Q 047719          359 VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI  438 (596)
Q Consensus       359 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~  438 (596)
                      ++||||+++|+|.+++....    .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++.
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~  153 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD----NFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSK  153 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence            99999999999999997653    48899999999999999999999   899999999999999999999999999764


Q ss_pred             c------------CCCcccCCccccccC-CCCCccceeehhHHHHHHHhCCCCCCCCCh-hHHHHHHHHHhcCCchhhcc
Q 047719          439 P------------AGTMGYLAPEYVYSG-VPSEKTDVYSFGVVALEVAAGKSPVDNDGC-VIVDWVWNLRKKGKLLDAAD  504 (596)
Q Consensus       439 ~------------~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~El~tG~~p~~~~~~-~~~~~~~~~~~~~~~~~~~d  504 (596)
                      .            .||..|+|||.+.+. .++.++|||||||++|||++|+.||..... .....+......      .+
T Consensus       154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~------~~  227 (332)
T cd05614         154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK------CD  227 (332)
T ss_pred             cccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc------CC
Confidence            2            488999999998765 478999999999999999999999975321 111111111111      11


Q ss_pred             ccccCcCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 047719          505 FRLRGKFNRKEMERMLMVGLSCVHPNHEKRP-----SVKEAAR  542 (596)
Q Consensus       505 ~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RP-----s~~ev~~  542 (596)
                      +.    ++......+.+++.+|++.||++||     +++++++
T Consensus       228 ~~----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         228 PP----FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             CC----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            11    1122334567788899999999999     6667765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.2e-36  Score=316.44  Aligned_cols=229  Identities=26%  Similarity=0.304  Sum_probs=184.4

Q ss_pred             ceeecCCceEEEEEEcC-CCCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecCCC
Q 047719          290 RIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPN  367 (596)
Q Consensus       290 ~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  367 (596)
                      ++||+|+||.||++... +++.||+|++.+.... ......+..|+..+.+.++||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999875 4889999999653221 223345666765666779999999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc--------
Q 047719          368 GSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP--------  439 (596)
Q Consensus       368 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~--------  439 (596)
                      |+|..++....    .+++.....++.||++||.|||+   .+|+||||||+|||++.++.+||+|||++..        
T Consensus        81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  153 (321)
T cd05603          81 GELFFHLQRER----CFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT  153 (321)
T ss_pred             CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcc
Confidence            99999987643    47888889999999999999999   8999999999999999999999999997542        


Q ss_pred             ---CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHHHH
Q 047719          440 ---AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEM  516 (596)
Q Consensus       440 ---~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  516 (596)
                         .||..|+|||.+.+..++.++|||||||++|||++|+.||...+..  ......... .          ...+....
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~~~-~----------~~~~~~~~  220 (321)
T cd05603         154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS--QMYDNILHK-P----------LQLPGGKT  220 (321)
T ss_pred             ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH--HHHHHHhcC-C----------CCCCCCCC
Confidence               4788999999999888999999999999999999999999765321  111111111 0          01122233


Q ss_pred             HHHHHHHHHcCCCCCCCCCCHH
Q 047719          517 ERMLMVGLSCVHPNHEKRPSVK  538 (596)
Q Consensus       517 ~~l~~l~~~C~~~dp~~RPs~~  538 (596)
                      ..+.+++.+|++.||++||+..
T Consensus       221 ~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         221 VAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             HHHHHHHHHHccCCHhhcCCCC
Confidence            4577888999999999999753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.1e-36  Score=316.47  Aligned_cols=233  Identities=26%  Similarity=0.319  Sum_probs=188.3

Q ss_pred             ceeecCCceEEEEEEcCC-CCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecCCC
Q 047719          290 RIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPN  367 (596)
Q Consensus       290 ~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  367 (596)
                      +.||+|+||+||++.... ++.||||++++.... ......+..|+..+....+||||+++++++...+.+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            469999999999998764 789999999754221 223345667776665545899999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc---------
Q 047719          368 GSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI---------  438 (596)
Q Consensus       368 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---------  438 (596)
                      |+|..++....    .+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++.         
T Consensus        81 ~~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  153 (318)
T cd05570          81 GDLMFHIQRSG----RFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT  153 (318)
T ss_pred             CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcc
Confidence            99999997653    48999999999999999999999   899999999999999999999999999753         


Q ss_pred             --cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHHHH
Q 047719          439 --PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEM  516 (596)
Q Consensus       439 --~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  516 (596)
                        ..||..|+|||.+.+..++.++|||||||++|||++|+.||......  ...... .....          .++....
T Consensus       154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~--~~~~~i-~~~~~----------~~~~~~~  220 (318)
T cd05570         154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED--ELFQSI-LEDEV----------RYPRWLS  220 (318)
T ss_pred             cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH--HHHHHH-HcCCC----------CCCCcCC
Confidence              24789999999999999999999999999999999999999765321  111111 11110          1112233


Q ss_pred             HHHHHHHHHcCCCCCCCCCCH-----HHHHH
Q 047719          517 ERMLMVGLSCVHPNHEKRPSV-----KEAAR  542 (596)
Q Consensus       517 ~~l~~l~~~C~~~dp~~RPs~-----~ev~~  542 (596)
                      ..+.+++.+||+.||++||++     .++++
T Consensus       221 ~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         221 KEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             HHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            467788899999999999999     77765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=6.3e-37  Score=318.89  Aligned_cols=232  Identities=25%  Similarity=0.329  Sum_probs=186.1

Q ss_pred             ceeecCCceEEEEEEc----CCCCEEEEEEeecCCch--hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          290 RIVGEGASATVYKGSL----PSGGAVAVKRFEKPNRV--ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       290 ~~LG~G~fG~Vy~~~~----~~g~~vAvK~l~~~~~~--~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      +.||+|+||.||++..    ..++.||||++++....  ......+.+|+..+. .++||||+++++++..++..|+|||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~-~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILE-AVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHH-hCCCCchhceeeEEecCCeEEEEEe
Confidence            6799999999999975    34789999999653221  122334667875554 5999999999999999999999999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc-----
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI-----  438 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~-----  438 (596)
                      |+++|+|.+++....    .+.+..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++.     
T Consensus        81 ~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  153 (323)
T cd05584          81 YLSGGELFMHLEREG----IFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE  153 (323)
T ss_pred             CCCCchHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC
Confidence            999999999997654    47788889999999999999999   899999999999999999999999999753     


Q ss_pred             ------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCC
Q 047719          439 ------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFN  512 (596)
Q Consensus       439 ------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  512 (596)
                            ..||..|+|||++.+..++.++|||||||++|||++|+.||......  ....... .+..          ..+
T Consensus       154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~--~~~~~~~-~~~~----------~~~  220 (323)
T cd05584         154 GTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK--KTIDKIL-KGKL----------NLP  220 (323)
T ss_pred             CCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH--HHHHHHH-cCCC----------CCC
Confidence                  24889999999999888999999999999999999999999765321  1111111 1110          111


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 047719          513 RKEMERMLMVGLSCVHPNHEKRP-----SVKEAAR  542 (596)
Q Consensus       513 ~~~~~~l~~l~~~C~~~dp~~RP-----s~~ev~~  542 (596)
                      ......+.+++.+|++.+|++||     +++++++
T Consensus       221 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         221 PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            12234567888999999999999     7887765

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=7.1e-37  Score=324.42  Aligned_cols=245  Identities=24%  Similarity=0.265  Sum_probs=186.9

Q ss_pred             HHHhcCCCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCchh-cccchHHHHHHHHHhccCCCceeeecceeeeCCe
Q 047719          280 KQATLGFNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRVE-CARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNE  357 (596)
Q Consensus       280 ~~at~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~-~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~  357 (596)
                      ....++|...+.||+|+||.||++.... ++.||+|++.+..... .....+.+|+ .+.+.++||||+++++++.+...
T Consensus        39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~-~i~~~~~hp~iv~~~~~~~~~~~  117 (370)
T cd05621          39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEER-DIMAFANSPWVVQLFCAFQDDKY  117 (370)
T ss_pred             CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHH-HHHHhCCCCCEeeEEEEEEcCCE
Confidence            3345678889999999999999998764 7899999986432222 2223455666 44456999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCc
Q 047719          358 LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT  437 (596)
Q Consensus       358 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~  437 (596)
                      .|+||||+++|+|.+++...     .+++.....++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~~-----~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a  189 (370)
T cd05621         118 LYMVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTC  189 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccc
Confidence            99999999999999999754     37888899999999999999999   89999999999999999999999999975


Q ss_pred             c------------cCCCcccCCccccccC----CCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchh
Q 047719          438 I------------PAGTMGYLAPEYVYSG----VPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLD  501 (596)
Q Consensus       438 ~------------~~gt~~y~aPE~~~~~----~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~  501 (596)
                      .            ..||+.|+|||.+...    .++.++|||||||++|||++|+.||.....  ...............
T Consensus       190 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~--~~~~~~i~~~~~~~~  267 (370)
T cd05621         190 MKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL--VGTYSKIMDHKNSLN  267 (370)
T ss_pred             eecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH--HHHHHHHHhCCcccC
Confidence            3            2489999999998753    378999999999999999999999976532  111111111111111


Q ss_pred             hccccccCcCCHHHHHHHHHHHHHcCCCCCC--CCCCHHHHHH
Q 047719          502 AADFRLRGKFNRKEMERMLMVGLSCVHPNHE--KRPSVKEAAR  542 (596)
Q Consensus       502 ~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~--~RPs~~ev~~  542 (596)
                      .       .........+.+++..|++.++.  .||++.|+++
T Consensus       268 ~-------p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~  303 (370)
T cd05621         268 F-------PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQ  303 (370)
T ss_pred             C-------CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhc
Confidence            0       01111234455666777775544  3889999877

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1e-36  Score=306.57  Aligned_cols=240  Identities=25%  Similarity=0.390  Sum_probs=193.9

Q ss_pred             CCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEec
Q 047719          285 GFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEY  364 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~  364 (596)
                      +|...+.||+|+||.||++...++..+|+|.+.....   ....+.+|+..+.+ ++|+|++++++++. ....+++|||
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~---~~~~~~~E~~~l~~-l~~~~i~~~~~~~~-~~~~~lv~e~   81 (260)
T cd05070           7 SLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM---SPESFLEEAQIMKK-LRHDKLVQLYAVVS-EEPIYIVTEY   81 (260)
T ss_pred             HhhhhheeccccCceEEEEEecCCceeEEEEecCCCC---CHHHHHHHHHHHHh-cCCCceEEEEeEEC-CCCcEEEEEe
Confidence            5677789999999999999988888999999864332   23468889866655 89999999999875 4568999999


Q ss_pred             CCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc-----
Q 047719          365 LPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP-----  439 (596)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~-----  439 (596)
                      +++++|.+++....  ...+++.+++.++.|++.||+|||+   .+++||||||+||++++++.++|+|||.+..     
T Consensus        82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05070          82 MSKGSLLDFLKDGE--GRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             cCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence            99999999998643  2348999999999999999999999   8999999999999999999999999987542     


Q ss_pred             -------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcC
Q 047719          440 -------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKF  511 (596)
Q Consensus       440 -------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  511 (596)
                             .++..|+|||.+....++.++||||||+++|||++ |..||.....  .+....... .         .....
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--~~~~~~~~~-~---------~~~~~  224 (260)
T cd05070         157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN--REVLEQVER-G---------YRMPC  224 (260)
T ss_pred             cccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHHc-C---------CCCCC
Confidence                   13457999999988889999999999999999999 8999976432  111111111 1         01112


Q ss_pred             CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          512 NRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       512 ~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                      +......+.+++.+|++.+|++|||++++.++|+.
T Consensus       225 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         225 PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            22334568889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=8.3e-37  Score=308.53  Aligned_cols=245  Identities=26%  Similarity=0.426  Sum_probs=195.8

Q ss_pred             hcCCCccceeecCCceEEEEEEcCC-C---CEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeE
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLPS-G---GAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNEL  358 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~~-g---~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~  358 (596)
                      +++|+..+.||+|+||.||+|.... +   ..+|+|+++... ......++..|+..+ +.++|+|++++.+++...+..
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~~~~~   81 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIM-GQFSHHNIIRLEGVVTKFKPA   81 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHH-hcCCCCCeeEEEEEEccCCCc
Confidence            3467788999999999999998753 3   379999986432 223345688888555 458999999999999999999


Q ss_pred             EEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc
Q 047719          359 VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI  438 (596)
Q Consensus       359 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~  438 (596)
                      ++||||+++++|.+++....   ..+++.++..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++.
T Consensus        82 ~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~  155 (268)
T cd05063          82 MIITEYMENGALDKYLRDHD---GEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSR  155 (268)
T ss_pred             EEEEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccce
Confidence            99999999999999997643   248999999999999999999999   899999999999999999999999999764


Q ss_pred             cC--------------CCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhc
Q 047719          439 PA--------------GTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAA  503 (596)
Q Consensus       439 ~~--------------gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  503 (596)
                      ..              .+..|+|||.+....++.++|||||||++|||++ |+.||.....  .++..... .+.     
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~--~~~~~~i~-~~~-----  227 (268)
T cd05063         156 VLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN--HEVMKAIN-DGF-----  227 (268)
T ss_pred             ecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH--HHHHHHHh-cCC-----
Confidence            22              1346999999988889999999999999999998 9999965432  11221211 110     


Q ss_pred             cccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          504 DFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       504 d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                          ......+....+.+++.+||+.+|++||++.+|++.|++.
T Consensus       228 ----~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         228 ----RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             ----CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                1111112345678999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=9.7e-37  Score=307.58  Aligned_cols=241  Identities=25%  Similarity=0.381  Sum_probs=193.9

Q ss_pred             cCCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      ..|...++||+|+||.||+|...++..||+|++.....   ....+.+|+..+.. ++|+||+++++.+.+ ...++|||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~---~~~~~~~E~~~l~~-l~~~~i~~~~~~~~~-~~~~lv~e   80 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKK-LRHEKLVQLYAVVSE-EPIYIVTE   80 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc---CHHHHHHHHHHHHh-CCCCCcceEEEEECC-CCcEEEEE
Confidence            45778899999999999999887777899999864322   23468888866554 899999999998754 56899999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc----
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP----  439 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~----  439 (596)
                      |+++|+|.+++....  ...+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||.+..    
T Consensus        81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~  155 (262)
T cd05071          81 YMSKGSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN  155 (262)
T ss_pred             cCCCCcHHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence            999999999998643  2347899999999999999999999   8999999999999999999999999987642    


Q ss_pred             --------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhccccccCc
Q 047719          440 --------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGK  510 (596)
Q Consensus       440 --------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  510 (596)
                              .++..|+|||...+..++.++|||||||++|||++ |..||......  + .........         ...
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~--~-~~~~~~~~~---------~~~  223 (262)
T cd05071         156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--E-VLDQVERGY---------RMP  223 (262)
T ss_pred             ccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH--H-HHHHHhcCC---------CCC
Confidence                    23457999999988899999999999999999999 88898764321  1 111111110         011


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          511 FNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       511 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                      ...+....+.+++..|++.+|++||++.+++++|+.
T Consensus       224 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~  259 (262)
T cd05071         224 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED  259 (262)
T ss_pred             CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence            123345667899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.2e-37  Score=310.82  Aligned_cols=245  Identities=26%  Similarity=0.382  Sum_probs=195.7

Q ss_pred             cCCCccceeecCCceEEEEEEcCC------CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCe
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPS------GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNE  357 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~  357 (596)
                      ++|...+.||+|+||.||+|....      +..||+|.+.... .......+.+|+..+.. ++|+||+++++++.....
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~-~~~~~i~~~~~~~~~~~~   83 (277)
T cd05032           6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKE-FNCHHVVRLLGVVSTGQP   83 (277)
T ss_pred             HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHh-CCCCceeEEEEEEcCCCC
Confidence            467778999999999999997642      3689999985432 22234567888866655 899999999999999999


Q ss_pred             EEEEEecCCCCCHHHHhhhCCCC------CcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEE
Q 047719          358 LVLVYEYLPNGSLDKILHNNSSS------SIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKL  431 (596)
Q Consensus       358 ~~lV~E~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl  431 (596)
                      .++||||+++|+|.+++......      ...++|..++.++.|++.||.|||+   .+++||||||+|||++.++.+||
T Consensus        84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl  160 (277)
T cd05032          84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEE
Confidence            99999999999999999764321      1247899999999999999999998   89999999999999999999999


Q ss_pred             ccCCCccc-------------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcC
Q 047719          432 GDFEATIP-------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKG  497 (596)
Q Consensus       432 ~Dfg~~~~-------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~  497 (596)
                      +|||++..             .++..|+|||.+..+.++.++|||||||++||+++ |+.||.......  . ......+
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~-~~~~~~~  237 (277)
T cd05032         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE--V-LKFVIDG  237 (277)
T ss_pred             CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH--H-HHHHhcC
Confidence            99997532             24678999999988889999999999999999998 999997543211  1 1111111


Q ss_pred             CchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 047719          498 KLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK  545 (596)
Q Consensus       498 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~  545 (596)
                      ....         .+......+.+++..||+.+|++|||+.++++.|+
T Consensus       238 ~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         238 GHLD---------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             CCCC---------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            1111         11122457788999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=4.4e-37  Score=326.08  Aligned_cols=243  Identities=25%  Similarity=0.281  Sum_probs=189.2

Q ss_pred             HhcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchh-cccchHHHHHHHHHhccCCCceeeecceeeeCCeEE
Q 047719          282 ATLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVE-CARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELV  359 (596)
Q Consensus       282 at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~-~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~  359 (596)
                      ...+|...+.||+|+||.||++... +++.||+|++.+..... .....+..|+..+ +.++||||+++++++.+....|
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il-~~~~h~~iv~~~~~~~~~~~~~  119 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIM-AHANSEWIVQLHYAFQDDKYLY  119 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHH-HhCCCCCcceEEEEEecCCEEE
Confidence            3457888899999999999999875 48899999996432222 2223456677555 4589999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc-
Q 047719          360 LVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI-  438 (596)
Q Consensus       360 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~-  438 (596)
                      +||||+++|+|.+++...     .++......++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++. 
T Consensus       120 lv~Ey~~gg~L~~~l~~~-----~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~  191 (370)
T cd05596         120 MVMEYMPGGDLVNLMSNY-----DIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMK  191 (370)
T ss_pred             EEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceee
Confidence            999999999999999754     27778888899999999999999   899999999999999999999999998753 


Q ss_pred             -----------cCCCcccCCccccccC----CCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhc
Q 047719          439 -----------PAGTMGYLAPEYVYSG----VPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAA  503 (596)
Q Consensus       439 -----------~~gt~~y~aPE~~~~~----~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  503 (596)
                                 ..||+.|+|||.+...    .++.++|||||||++|||++|+.||......  ..............  
T Consensus       192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--~~~~~i~~~~~~~~--  267 (370)
T cd05596         192 MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--GTYSKIMDHKNSLT--  267 (370)
T ss_pred             ccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH--HHHHHHHcCCCcCC--
Confidence                       2488999999998653    4789999999999999999999999865321  11111111110000  


Q ss_pred             cccccCcCCHHHHHHHHHHHHHcCCCCCCC--CCCHHHHHH
Q 047719          504 DFRLRGKFNRKEMERMLMVGLSCVHPNHEK--RPSVKEAAR  542 (596)
Q Consensus       504 d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~--RPs~~ev~~  542 (596)
                         ...  .......+.+++..|++.+|.+  ||+++|+++
T Consensus       268 ---~~~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~  303 (370)
T cd05596         268 ---FPD--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKS  303 (370)
T ss_pred             ---CCC--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence               000  0112345667888999988987  999999976

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=8.2e-37  Score=325.49  Aligned_cols=191  Identities=24%  Similarity=0.321  Sum_probs=166.0

Q ss_pred             CCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          285 GFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      .|...++||+|+||.||+|... +++.||||++.+.... ......+.+|+..+ +.++|+|||++++.+.+.+.+|+||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il-~~~~h~~iv~~~~~~~~~~~~~lv~   80 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDIL-AEADNEWVVRLYYSFQDKDNLYFVM   80 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHH-HhCCCCcCCeEEEEEEeCCEEEEEE
Confidence            4778899999999999999765 5889999999643221 22334567787555 4589999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc----
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI----  438 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~----  438 (596)
                      ||+++|+|.+++....    .+++.....++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++.    
T Consensus        81 E~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~  153 (382)
T cd05625          81 DYIPGGDMMSLLIRMG----IFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  153 (382)
T ss_pred             eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCccccc
Confidence            9999999999997653    47888889999999999999999   899999999999999999999999999742    


Q ss_pred             ------------------------------------------------------cCCCcccCCccccccCCCCCccceee
Q 047719          439 ------------------------------------------------------PAGTMGYLAPEYVYSGVPSEKTDVYS  464 (596)
Q Consensus       439 ------------------------------------------------------~~gt~~y~aPE~~~~~~~t~~sDV~S  464 (596)
                                                                            ..||+.|+|||++.+..++.++||||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS  233 (382)
T cd05625         154 THDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS  233 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEe
Confidence                                                                  24889999999999989999999999


Q ss_pred             hhHHHHHHHhCCCCCCCCC
Q 047719          465 FGVVALEVAAGKSPVDNDG  483 (596)
Q Consensus       465 fGvll~El~tG~~p~~~~~  483 (596)
                      |||+||||++|+.||....
T Consensus       234 lGvil~elltG~~Pf~~~~  252 (382)
T cd05625         234 VGVILYEMLVGQPPFLAQT  252 (382)
T ss_pred             chHHHHHHHhCCCCCCCCC
Confidence            9999999999999998653

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.3e-36  Score=305.87  Aligned_cols=241  Identities=24%  Similarity=0.385  Sum_probs=194.5

Q ss_pred             cCCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      +.|...++||+|+||.||+|...+++.||+|.+.....   ....+.+|+..+. .++|+|++++++++. .+..+++||
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~---~~~~~~~E~~~l~-~l~h~~i~~~~~~~~-~~~~~~v~e   80 (260)
T cd05067           6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM---SPEAFLAEANLMK-QLQHPRLVRLYAVVT-QEPIYIITE   80 (260)
T ss_pred             HHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC---cHHHHHHHHHHHH-hcCCcCeeeEEEEEc-cCCcEEEEE
Confidence            45777899999999999999988899999999864332   2346888885554 589999999998864 567899999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc----
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP----  439 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~----  439 (596)
                      |+++++|.+++....  ...+++.+++.++.|++.||+|||+   .+++||||||+||+++.++.++|+|||++..    
T Consensus        81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05067          81 YMENGSLVDFLKTPE--GIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDN  155 (260)
T ss_pred             cCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence            999999999997644  2358999999999999999999998   8999999999999999999999999987642    


Q ss_pred             --------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhccccccCc
Q 047719          440 --------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGK  510 (596)
Q Consensus       440 --------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  510 (596)
                              .++..|+|||.+....++.++||||||+++|||++ |+.||.....  .+..... .....         ..
T Consensus       156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~-~~~~~---------~~  223 (260)
T cd05067         156 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN--PEVIQNL-ERGYR---------MP  223 (260)
T ss_pred             CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh--HHHHHHH-HcCCC---------CC
Confidence                    23467999999988889999999999999999999 9999975432  1111111 11110         11


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          511 FNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       511 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                      .+......+.+++.+|++.+|++||+++++...|+.
T Consensus       224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         224 RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            111223468889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-36  Score=307.71  Aligned_cols=241  Identities=27%  Similarity=0.401  Sum_probs=189.5

Q ss_pred             ceeecCCceEEEEEEcCC-CC--EEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecCC
Q 047719          290 RIVGEGASATVYKGSLPS-GG--AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLP  366 (596)
Q Consensus       290 ~~LG~G~fG~Vy~~~~~~-g~--~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~~  366 (596)
                      ++||+|+||.||+|...+ +.  .+|+|.++... .......+..|+..+.+..+||||++++++|...+..++||||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~   79 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP   79 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC-CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence            468999999999998754 43  57888885322 223345678898777663389999999999999999999999999


Q ss_pred             CCCHHHHhhhCCC------------CCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccC
Q 047719          367 NGSLDKILHNNSS------------SSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF  434 (596)
Q Consensus       367 ~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Df  434 (596)
                      +|+|.+++.....            ....+++.+++.++.|++.||+|||+   .+++||||||+|||+++++.+||+||
T Consensus        80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~df  156 (270)
T cd05047          80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADF  156 (270)
T ss_pred             CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCC
Confidence            9999999976431            12348899999999999999999998   89999999999999999999999999


Q ss_pred             CCccc----------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhc
Q 047719          435 EATIP----------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAA  503 (596)
Q Consensus       435 g~~~~----------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  503 (596)
                      |++..          ..+..|+|||++....++.++|||||||++|||++ |+.||.....  .+..... ....     
T Consensus       157 gl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~--~~~~~~~-~~~~-----  228 (270)
T cd05047         157 GLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--AELYEKL-PQGY-----  228 (270)
T ss_pred             CCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH--HHHHHHH-hCCC-----
Confidence            98631          13456999999988889999999999999999997 9999965421  1111111 1110     


Q ss_pred             cccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          504 DFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       504 d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                          ....+......+.+++..||+.+|.+|||+.++++.|+.
T Consensus       229 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~  267 (270)
T cd05047         229 ----RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR  267 (270)
T ss_pred             ----CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence                001111223467789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2.2e-36  Score=309.97  Aligned_cols=252  Identities=24%  Similarity=0.341  Sum_probs=196.9

Q ss_pred             hcCCCccceeecCCceEEEEEEcCC-----------------CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCce
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLPS-----------------GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL  345 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~~-----------------g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~ni  345 (596)
                      ..+|...+.||+|+||.||++...+                 +..||+|++..... .....++.+|+..+.+ ++|+||
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~-l~~~~i   81 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS-DNAREDFLKEVKILSR-LSDPNI   81 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC-HHHHHHHHHHHHHHHh-cCCCCE
Confidence            3467888999999999999987543                 24589999864432 2345578889866655 899999


Q ss_pred             eeecceeeeCCeEEEEEecCCCCCHHHHhhhCCCC-------CcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCC
Q 047719          346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSS-------SIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKA  418 (596)
Q Consensus       346 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp  418 (596)
                      ++++++|..++..++|+||+++++|.+++......       ...+++..++.++.|++.||+|||+   .+++||||||
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp  158 (296)
T cd05051          82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLAT  158 (296)
T ss_pred             eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccch
Confidence            99999999999999999999999999999765421       1258999999999999999999999   8999999999


Q ss_pred             CceeecCCCceEEccCCCccc-------------CCCcccCCccccccCCCCCccceeehhHHHHHHHh--CCCCCCCCC
Q 047719          419 CNILLDAEFNAKLGDFEATIP-------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA--GKSPVDNDG  483 (596)
Q Consensus       419 ~NiLl~~~~~~kl~Dfg~~~~-------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t--G~~p~~~~~  483 (596)
                      +||+++.++.++|+|||.+..             .++..|+|||.+....++.++|||||||++|||++  |..||....
T Consensus       159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~  238 (296)
T cd05051         159 RNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT  238 (296)
T ss_pred             hceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence            999999999999999997642             24567999999988889999999999999999998  677876532


Q ss_pred             h-hHHHHHHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 047719          484 C-VIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK  545 (596)
Q Consensus       484 ~-~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~  545 (596)
                      . .................      ....+......+.+++.+|++.||++|||+.|+++.|+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         239 DQQVIENAGHFFRDDGRQI------YLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             hHHHHHHHHhccccccccc------cCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            1 22222222111111100      01111122356888999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=5.9e-37  Score=312.31  Aligned_cols=244  Identities=24%  Similarity=0.337  Sum_probs=192.1

Q ss_pred             CCccceeecCCceEEEEEEcCC------CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEE
Q 047719          286 FNKNRIVGEGASATVYKGSLPS------GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELV  359 (596)
Q Consensus       286 f~~~~~LG~G~fG~Vy~~~~~~------g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~  359 (596)
                      |...+.||+|+||.||+|...+      +..||||+++.... ......+..|+..+ ..++||||+++++++......+
T Consensus         7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~-~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE-GPLREEFKHEAMMR-SRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC-HHHHHHHHHHHHHH-hcCCCCCcCeEEEEEcCCCceE
Confidence            4556889999999999997532      46899999964322 22334577777444 5599999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhhCCC------------CCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCC
Q 047719          360 LVYEYLPNGSLDKILHNNSS------------SSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEF  427 (596)
Q Consensus       360 lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~  427 (596)
                      +++||+++++|.+++.....            ....+++..++.++.|++.||.|||+   .+++||||||+|||+++++
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~  161 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKL  161 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCC
Confidence            99999999999999963211            12358899999999999999999999   8999999999999999999


Q ss_pred             ceEEccCCCccc-------------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHH
Q 047719          428 NAKLGDFEATIP-------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNL  493 (596)
Q Consensus       428 ~~kl~Dfg~~~~-------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~  493 (596)
                      .+||+|||++..             .+++.|+|||.+..+.++.++|||||||++|||++ |..||.....  .++....
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--~~~~~~i  239 (283)
T cd05091         162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--QDVIEMI  239 (283)
T ss_pred             ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHH
Confidence            999999997532             23568999999988889999999999999999998 8888876432  1222121


Q ss_pred             HhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          494 RKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       494 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                      . .+..         ..++.+....+..++..||+.+|++||++++|++.|+.
T Consensus       240 ~-~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         240 R-NRQV---------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             H-cCCc---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            1 1111         11122334557788999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=5e-37  Score=319.89  Aligned_cols=233  Identities=25%  Similarity=0.280  Sum_probs=186.3

Q ss_pred             ceeecCCceEEEEEEcC-CCCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecCCC
Q 047719          290 RIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPN  367 (596)
Q Consensus       290 ~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  367 (596)
                      +.||+|+||.||++... ++..||+|++.+.... ......+..|++.+. .++||||+++++++...+.+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~-~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   79 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ-NSRHPFLTALKYSFQTHDRLCFVMEYANG   79 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHH-hCCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999764 5889999999753221 223345667775554 48999999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc---------
Q 047719          368 GSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI---------  438 (596)
Q Consensus       368 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---------  438 (596)
                      |+|.+++....    .+++..+..++.||+.||+|||+.  .+|+||||||+|||++.++.+||+|||++.         
T Consensus        80 ~~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~  153 (325)
T cd05594          80 GELFFHLSRER----VFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM  153 (325)
T ss_pred             CcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccc
Confidence            99999997653    489999999999999999999962  689999999999999999999999999753         


Q ss_pred             --cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHHHH
Q 047719          439 --PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEM  516 (596)
Q Consensus       439 --~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  516 (596)
                        ..||..|+|||.+.+..++.++|||||||++|||++|+.||......  ... .......      ..+...    ..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~--~~~-~~i~~~~------~~~p~~----~~  220 (325)
T cd05594         154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLF-ELILMEE------IRFPRT----LS  220 (325)
T ss_pred             ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH--HHH-HHHhcCC------CCCCCC----CC
Confidence              24889999999999889999999999999999999999999764321  111 1111110      111112    23


Q ss_pred             HHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 047719          517 ERMLMVGLSCVHPNHEKRP-----SVKEAAR  542 (596)
Q Consensus       517 ~~l~~l~~~C~~~dp~~RP-----s~~ev~~  542 (596)
                      ..+.+++.+|++.||++|+     ++.++++
T Consensus       221 ~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         221 PEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             HHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence            4567788899999999997     8998875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.3e-36  Score=315.21  Aligned_cols=231  Identities=27%  Similarity=0.303  Sum_probs=185.3

Q ss_pred             ceeecCCceEEEEEEcC-CCCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecCCC
Q 047719          290 RIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPN  367 (596)
Q Consensus       290 ~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  367 (596)
                      ++||+|+||+||++... +++.||+|++++.... ......+..|+..+.+..+|+||+++++++.....+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            47999999999999865 4789999999754322 223445677876666655899999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc---------
Q 047719          368 GSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI---------  438 (596)
Q Consensus       368 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---------  438 (596)
                      |+|..++....    .+++..+..++.||+.||+|||+   .+++||||||+|||++.++.+||+|||++.         
T Consensus        81 ~~L~~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  153 (327)
T cd05617          81 GDLMFHMQRQR----KLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT  153 (327)
T ss_pred             CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCce
Confidence            99999987643    48999999999999999999999   899999999999999999999999999754         


Q ss_pred             --cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCC----hhHHHHHHHHHhcCCchhhccccccCcCC
Q 047719          439 --PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDG----CVIVDWVWNLRKKGKLLDAADFRLRGKFN  512 (596)
Q Consensus       439 --~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~----~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  512 (596)
                        ..||..|+|||.+.+..++.++|||||||++|||++|+.||....    ....++..+.......      .    .+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~------~----~p  223 (327)
T cd05617         154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI------R----IP  223 (327)
T ss_pred             ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC------C----CC
Confidence              248899999999999999999999999999999999999996421    1122233332222111      1    11


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCH
Q 047719          513 RKEMERMLMVGLSCVHPNHEKRPSV  537 (596)
Q Consensus       513 ~~~~~~l~~l~~~C~~~dp~~RPs~  537 (596)
                      ......+.+++.+|++.||++||++
T Consensus       224 ~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         224 RFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             CCCCHHHHHHHHHHhccCHHHcCCC
Confidence            1223456678889999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.7e-36  Score=315.64  Aligned_cols=233  Identities=22%  Similarity=0.279  Sum_probs=187.1

Q ss_pred             CCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          285 GFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      +|+..+.||+|+||.||++... +|+.||||++.+.... ......+..|...+....+|++|+++++++...+.+|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            3677799999999999999765 5889999999753221 2233456677766655456788899999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc---
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP---  439 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~---  439 (596)
                      ||+++|+|.+++....    .+++.++..++.||+.||+|||+   .+++||||||+|||++.++.+||+|||++..   
T Consensus        81 Ey~~~g~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~  153 (323)
T cd05615          81 EYVNGGDLMYHIQQVG----KFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV  153 (323)
T ss_pred             cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence            9999999999997653    48999999999999999999999   8999999999999999999999999997542   


Q ss_pred             --------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcC
Q 047719          440 --------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKF  511 (596)
Q Consensus       440 --------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  511 (596)
                              .||..|+|||.+.+..++.++|||||||++|||++|+.||......  ........ ..          ..+
T Consensus       154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--~~~~~i~~-~~----------~~~  220 (323)
T cd05615         154 DGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED--ELFQSIME-HN----------VSY  220 (323)
T ss_pred             CCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHHh-CC----------CCC
Confidence                    3889999999999888999999999999999999999999865321  11111111 11          011


Q ss_pred             CHHHHHHHHHHHHHcCCCCCCCCCCH
Q 047719          512 NRKEMERMLMVGLSCVHPNHEKRPSV  537 (596)
Q Consensus       512 ~~~~~~~l~~l~~~C~~~dp~~RPs~  537 (596)
                      +......+.+++.+|++.+|++|++.
T Consensus       221 p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         221 PKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             CccCCHHHHHHHHHHcccCHhhCCCC
Confidence            12233456778889999999999974

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=8.8e-37  Score=310.53  Aligned_cols=248  Identities=24%  Similarity=0.360  Sum_probs=197.7

Q ss_pred             hcCCCccceeecCCceEEEEEEcCC-----CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeee-CC
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLPS-----GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE-GN  356 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~~-----g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~-~~  356 (596)
                      .++|...+.||+|+||.||+|...+     +..|++|++... ........+.+|+..+.+ ++|+||+++++++.. ..
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~-l~h~ni~~~~~~~~~~~~   82 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYG-LSHQNILPILHVCIEDGE   82 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHh-CCCCCCCeEEEEEecCCC
Confidence            4578888999999999999998755     678999998633 233345667888866655 899999999999876 46


Q ss_pred             eEEEEEecCCCCCHHHHhhhCCCC----CcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEc
Q 047719          357 ELVLVYEYLPNGSLDKILHNNSSS----SIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLG  432 (596)
Q Consensus       357 ~~~lV~E~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~  432 (596)
                      ..++++||+++|+|.+++......    ...+++.+++.++.|++.||+|||+   .+++||||||+||++++++.+||+
T Consensus        83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~  159 (280)
T cd05043          83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKIT  159 (280)
T ss_pred             CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEEC
Confidence            789999999999999999765322    1458999999999999999999998   899999999999999999999999


Q ss_pred             cCCCccc-------------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCC
Q 047719          433 DFEATIP-------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGK  498 (596)
Q Consensus       433 Dfg~~~~-------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~  498 (596)
                      |||++..             .++..|+|||.+....++.++|||||||++||+++ |+.||.....  .++.... ..+.
T Consensus       160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~-~~~~  236 (280)
T cd05043         160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--FEMAAYL-KDGY  236 (280)
T ss_pred             CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--HHHHHHH-HcCC
Confidence            9998742             24567999999988889999999999999999999 9999976432  1111111 1111


Q ss_pred             chhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          499 LLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       499 ~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                      .     ..    ........+.+++.+||+.+|++|||+.++++.|+..
T Consensus       237 ~-----~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~  276 (280)
T cd05043         237 R-----LA----QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF  276 (280)
T ss_pred             C-----CC----CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            0     00    1111234678899999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-36  Score=303.90  Aligned_cols=241  Identities=31%  Similarity=0.441  Sum_probs=197.0

Q ss_pred             cCCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      ++|...+.||+|+||.||++.. .|+.||||.+.....   ..+++.+|+..+.. ++|+||+++++++......++|||
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~~~~~~v~e   80 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST---AAQAFLAEASVMTT-LRHPNLVQLLGVVLQGNPLYIVTE   80 (256)
T ss_pred             hhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh---HHHHHHHHHHHHHh-cCCcceeeeEEEEcCCCCeEEEEE
Confidence            4577789999999999999987 478999999964332   45568889865554 899999999999999999999999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcccC---
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA---  440 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~~---  440 (596)
                      |+++++|.+++.....  ..++|..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||.+...   
T Consensus        81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~  155 (256)
T cd05039          81 YMAKGSLVDYLRSRGR--AVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG  155 (256)
T ss_pred             ecCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEcccccccccccc
Confidence            9999999999986542  258999999999999999999999   89999999999999999999999999976532   


Q ss_pred             -----CCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHH
Q 047719          441 -----GTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRK  514 (596)
Q Consensus       441 -----gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  514 (596)
                           ++..|+|||.+..+.++.++||||||+++||+++ |+.||......  + +........         ....+..
T Consensus       156 ~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~-~~~~~~~~~---------~~~~~~~  223 (256)
T cd05039         156 QDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--D-VVPHVEKGY---------RMEAPEG  223 (256)
T ss_pred             cccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH--H-HHHHHhcCC---------CCCCccC
Confidence                 3567999999988889999999999999999998 99999764321  1 111111110         1111122


Q ss_pred             HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          515 EMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       515 ~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                      ....+.+++.+|++.+|++||+++|+++.|+.
T Consensus       224 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         224 CPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             CCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence            34567888999999999999999999999974

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-38  Score=317.03  Aligned_cols=241  Identities=27%  Similarity=0.363  Sum_probs=196.6

Q ss_pred             CCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          285 GFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      .|+..++||+|.||.||||... .++.||+|++..... +...++..+|+..+.+ .+++||.+++|.+..+..++++||
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~-~deIediqqei~~Ls~-~~~~~it~yygsyl~g~~LwiiMe   91 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA-EDEIEDIQQEISVLSQ-CDSPNITEYYGSYLKGTKLWIIME   91 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhhc-chhhHHHHHHHHHHHh-cCcchHHhhhhheeecccHHHHHH
Confidence            4666789999999999999865 488999999975433 3345567788866655 899999999999999999999999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc-----
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI-----  438 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~-----  438 (596)
                      ||.+|++.+.|+...    .+++....-|+.++..||.|||.   .+.+|||||+.|||+..+|.+||+|||.+.     
T Consensus        92 y~~gGsv~~lL~~~~----~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~  164 (467)
T KOG0201|consen   92 YCGGGSVLDLLKSGN----ILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNT  164 (467)
T ss_pred             HhcCcchhhhhccCC----CCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeech
Confidence            999999999998764    34777777889999999999999   899999999999999999999999998652     


Q ss_pred             ------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCC
Q 047719          439 ------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFN  512 (596)
Q Consensus       439 ------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  512 (596)
                            .+||+.|||||++....|+.|+||||||++.+||++|.+|+.....            .+++-.+.....+.+.
T Consensus       165 ~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP------------mrvlflIpk~~PP~L~  232 (467)
T KOG0201|consen  165 VKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP------------MRVLFLIPKSAPPRLD  232 (467)
T ss_pred             hhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc------------ceEEEeccCCCCCccc
Confidence                  4699999999999988999999999999999999999999976421            1111111111122222


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhc
Q 047719          513 RKEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKG  546 (596)
Q Consensus       513 ~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~~  546 (596)
                      ......+.+++-.|++.||+.||++.++++  +++.
T Consensus       233 ~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~  268 (467)
T KOG0201|consen  233 GDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR  268 (467)
T ss_pred             cccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence            234456778888999999999999999986  4544

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1e-36  Score=317.60  Aligned_cols=230  Identities=25%  Similarity=0.288  Sum_probs=185.0

Q ss_pred             ceeecCCceEEEEEEcC-CCCEEEEEEeecCCc-hhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecCCC
Q 047719          290 RIVGEGASATVYKGSLP-SGGAVAVKRFEKPNR-VECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPN  367 (596)
Q Consensus       290 ~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  367 (596)
                      ++||+|+||+||++... +|+.||||++.+... .......+..|...+.+.++||||+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999764 588999999965322 1223345666765666679999999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc--------
Q 047719          368 GSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP--------  439 (596)
Q Consensus       368 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~--------  439 (596)
                      |+|..++....    .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++..        
T Consensus        81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~  153 (325)
T cd05604          81 GELFFHLQRER----SFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT  153 (325)
T ss_pred             CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCc
Confidence            99999987643    48899999999999999999999   8999999999999999999999999997542        


Q ss_pred             ---CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHHHH
Q 047719          440 ---AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEM  516 (596)
Q Consensus       440 ---~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  516 (596)
                         .||..|+|||.+.+..++.++|||||||++|||++|+.||......  +....... ..+      .+...    ..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--~~~~~~~~-~~~------~~~~~----~~  220 (325)
T cd05604         154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA--EMYDNILH-KPL------VLRPG----AS  220 (325)
T ss_pred             ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH--HHHHHHHc-CCc------cCCCC----CC
Confidence               4889999999999999999999999999999999999999765321  11111111 110      11112    23


Q ss_pred             HHHHHHHHHcCCCCCCCCCCHHH
Q 047719          517 ERMLMVGLSCVHPNHEKRPSVKE  539 (596)
Q Consensus       517 ~~l~~l~~~C~~~dp~~RPs~~e  539 (596)
                      ..+.+++..|++.+|++||++++
T Consensus       221 ~~~~~ll~~ll~~~p~~R~~~~~  243 (325)
T cd05604         221 LTAWSILEELLEKDRQRRLGAKE  243 (325)
T ss_pred             HHHHHHHHHHhccCHHhcCCCCC
Confidence            45667888999999999998864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.5e-36  Score=310.52  Aligned_cols=250  Identities=24%  Similarity=0.383  Sum_probs=196.1

Q ss_pred             HhcCCCccceeecCCceEEEEEEcC------CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeC
Q 047719          282 ATLGFNKNRIVGEGASATVYKGSLP------SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG  355 (596)
Q Consensus       282 at~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~  355 (596)
                      ...+|...+.||+|+||.||+|...      .+..||+|.+...... .....+.+|+..+. .++|+||+++++++.+.
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~   81 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL-RERIEFLNEASVMK-GFTCHHVVRLLGVVSKG   81 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCH-HHHHHHHHHHHHHH-hCCCCCeeeEEEEEcCC
Confidence            3457888899999999999999643      2457999998643322 22345777876554 48999999999999999


Q ss_pred             CeEEEEEecCCCCCHHHHhhhCCC------CCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCce
Q 047719          356 NELVLVYEYLPNGSLDKILHNNSS------SSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNA  429 (596)
Q Consensus       356 ~~~~lV~E~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~  429 (596)
                      ...++||||+++|+|.+++.....      ....+++..+..++.|++.||.|||+   ++++||||||+|||+++++.+
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~  158 (288)
T cd05061          82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTV  158 (288)
T ss_pred             CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcE
Confidence            999999999999999999975321      12345778899999999999999999   899999999999999999999


Q ss_pred             EEccCCCccc-------------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHh
Q 047719          430 KLGDFEATIP-------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRK  495 (596)
Q Consensus       430 kl~Dfg~~~~-------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~  495 (596)
                      ||+|||++..             .++..|+|||.+.++.++.++|||||||++|||++ |..||.....  .+...... 
T Consensus       159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~--~~~~~~~~-  235 (288)
T cd05061         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN--EQVLKFVM-  235 (288)
T ss_pred             EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHH-
Confidence            9999997642             23567999999998899999999999999999999 7889865422  11111111 


Q ss_pred             cCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Q 047719          496 KGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEA  548 (596)
Q Consensus       496 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~~  548 (596)
                      .+...         ..+......+.+++.+|++.+|++|||+.++++.|+...
T Consensus       236 ~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         236 DGGYL---------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             cCCCC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            11110         111122357888999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-36  Score=304.22  Aligned_cols=235  Identities=29%  Similarity=0.431  Sum_probs=189.0

Q ss_pred             ceeecCCceEEEEEEcCC----CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecC
Q 047719          290 RIVGEGASATVYKGSLPS----GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYL  365 (596)
Q Consensus       290 ~~LG~G~fG~Vy~~~~~~----g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~  365 (596)
                      ++||+|+||.||+|.+..    +..+|+|.+...... ....++.+|+..+.. +.|+|||++++++. ....++||||+
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~-~~~~~~v~e~~   77 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQ-LDHPCIVRLIGVCK-GEPLMLVMELA   77 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHh-cCCCCeeeEEEEEc-CCceEEEEEeC
Confidence            469999999999997532    268999998654432 344568888866654 89999999999876 45689999999


Q ss_pred             CCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcccC-----
Q 047719          366 PNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA-----  440 (596)
Q Consensus       366 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~~-----  440 (596)
                      ++|+|.+++....    .+++..++.++.|++.||+|||+   .+++|+||||+|||++.++.+||+|||.+...     
T Consensus        78 ~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~  150 (257)
T cd05060          78 PLGPLLKYLKKRR----EIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD  150 (257)
T ss_pred             CCCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence            9999999998654    48999999999999999999999   89999999999999999999999999876421     


Q ss_pred             ---------CCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCCh-hHHHHHHHHHhcCCchhhccccccC
Q 047719          441 ---------GTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGC-VIVDWVWNLRKKGKLLDAADFRLRG  509 (596)
Q Consensus       441 ---------gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~~  509 (596)
                               ++..|+|||.+....++.++|||||||++|||++ |+.||..... .+..+.    ......         
T Consensus       151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~----~~~~~~---------  217 (257)
T cd05060         151 YYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAML----ESGERL---------  217 (257)
T ss_pred             ccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH----HcCCcC---------
Confidence                     2357999999998899999999999999999998 9999976432 122211    111110         


Q ss_pred             cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          510 KFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       510 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                      ..+......+.+++.+||+.+|++||++.++++.|+..
T Consensus       218 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         218 PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence            11122335677899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-37  Score=289.63  Aligned_cols=250  Identities=24%  Similarity=0.287  Sum_probs=201.3

Q ss_pred             hcCCCccceeecCCceEEEEEE-cCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCC-----
Q 047719          283 TLGFNKNRIVGEGASATVYKGS-LPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGN-----  356 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~-----  356 (596)
                      .++|.+.+.||+|||..||+++ +.++..+|+|++.-..  .++.+..++|+ .+.++++|||++++++++..+.     
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEi-d~~rkf~s~~vl~l~dh~l~~~~D~~~   96 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREI-DNHRKFNSPNVLRLVDHQLREEKDGKH   96 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHH-HHHHhhCCcchHHHHHHHHHhhccCce
Confidence            3467788999999999999997 4468899999996443  45566788898 5556699999999999987644     


Q ss_pred             eEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCC
Q 047719          357 ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEA  436 (596)
Q Consensus       357 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~  436 (596)
                      ..||+++|...|||.+.+.........+++.+.+.|..+|++||++||+. .+++.||||||.|||+.+.+.++|.|||.
T Consensus        97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS  175 (302)
T KOG2345|consen   97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGS  175 (302)
T ss_pred             eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccC
Confidence            49999999999999999988765566799999999999999999999983 34599999999999999999999999997


Q ss_pred             cccC--------------------CCcccCCccccc---cCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHH
Q 047719          437 TIPA--------------------GTMGYLAPEYVY---SGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNL  493 (596)
Q Consensus       437 ~~~~--------------------gt~~y~aPE~~~---~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~  493 (596)
                      +...                    .|..|.|||++.   +...+.++|||||||+||+|+.|..||+..          .
T Consensus       176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~----------~  245 (302)
T KOG2345|consen  176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI----------Y  245 (302)
T ss_pred             ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH----------h
Confidence            6542                    588999999886   356789999999999999999999999752          1


Q ss_pred             HhcCCchhhcc-ccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          494 RKKGKLLDAAD-FRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       494 ~~~~~~~~~~d-~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                      ...+.+.-++. ..+...-.....+.+.+++.+|++.||.+||++.+++..++.
T Consensus       246 ~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~  299 (302)
T KOG2345|consen  246 QQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDD  299 (302)
T ss_pred             hcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence            12233222211 122222222356778889999999999999999999988764

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.6e-36  Score=316.06  Aligned_cols=232  Identities=24%  Similarity=0.282  Sum_probs=184.7

Q ss_pred             ceeecCCceEEEEEEcC-CCCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecCCC
Q 047719          290 RIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPN  367 (596)
Q Consensus       290 ~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  367 (596)
                      +.||+|+||.||++... +++.||+|++.+.... ......+..|...+.+.++|+||+++++++...+..|+||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999875 4788999999653221 122334556665566668999999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc---------
Q 047719          368 GSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI---------  438 (596)
Q Consensus       368 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---------  438 (596)
                      |+|.+++....    .+.+.....++.||++||+|||+   .+|+||||||+|||++.++.+||+|||++.         
T Consensus        81 ~~L~~~~~~~~----~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~  153 (325)
T cd05602          81 GELFYHLQRER----CFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTT  153 (325)
T ss_pred             CcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCc
Confidence            99999997643    37788888999999999999999   899999999999999999999999999753         


Q ss_pred             --cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHHHH
Q 047719          439 --PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEM  516 (596)
Q Consensus       439 --~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  516 (596)
                        ..||+.|+|||.+.+..++.++|||||||++|||++|+.||.....  .+.........       .....    ...
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~i~~~~-------~~~~~----~~~  220 (325)
T cd05602         154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT--AEMYDNILNKP-------LQLKP----NIT  220 (325)
T ss_pred             ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH--HHHHHHHHhCC-------cCCCC----CCC
Confidence              2488999999999999999999999999999999999999976432  11111111110       01111    223


Q ss_pred             HHHHHHHHHcCCCCCCCCCCHHHHH
Q 047719          517 ERMLMVGLSCVHPNHEKRPSVKEAA  541 (596)
Q Consensus       517 ~~l~~l~~~C~~~dp~~RPs~~ev~  541 (596)
                      ..+.+++.+|++.||.+||++.+.+
T Consensus       221 ~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         221 NSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             HHHHHHHHHHcccCHHHCCCCCCCH
Confidence            4567778899999999999876543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.3e-36  Score=314.05  Aligned_cols=248  Identities=25%  Similarity=0.360  Sum_probs=196.8

Q ss_pred             cCCCccceeecCCceEEEEEEcC--------CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeC
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP--------SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG  355 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~--------~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~  355 (596)
                      .+|...+.||+|+||.||++...        +...+|+|.+.... ......++..|+..+....+|+||++++++|...
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            45788899999999999999642        23469999986432 2333456788887666534899999999999999


Q ss_pred             CeEEEEEecCCCCCHHHHhhhCCC------------CCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceee
Q 047719          356 NELVLVYEYLPNGSLDKILHNNSS------------SSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILL  423 (596)
Q Consensus       356 ~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl  423 (596)
                      +..++||||+++|+|.+++.....            ....++|.+++.++.|++.||+|||+   .+++||||||+|||+
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheEE
Confidence            999999999999999999986532            12358999999999999999999998   899999999999999


Q ss_pred             cCCCceEEccCCCcccC-------------CCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHH
Q 047719          424 DAEFNAKLGDFEATIPA-------------GTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDW  489 (596)
Q Consensus       424 ~~~~~~kl~Dfg~~~~~-------------gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~  489 (596)
                      +.++.+||+|||.+...             ++..|+|||.+.+..++.++|||||||++|||++ |..||.....  .+.
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~--~~~  251 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--EEL  251 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH--HHH
Confidence            99999999999976421             2357999999988889999999999999999998 8889865432  121


Q ss_pred             HHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          490 VWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       490 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                      .... .....         ...+......+.+++..|++.+|++||+|.++++.|+..
T Consensus       252 ~~~~-~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~  299 (307)
T cd05098         252 FKLL-KEGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  299 (307)
T ss_pred             HHHH-HcCCC---------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence            1111 11111         111222345677888999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.2e-36  Score=304.32  Aligned_cols=240  Identities=23%  Similarity=0.366  Sum_probs=192.6

Q ss_pred             CCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEec
Q 047719          285 GFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEY  364 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~  364 (596)
                      +|...+.||+|+||.||++....+..+|+|++....   .....+.+|+..+.+ ++|+|++++++++. ....++||||
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~---~~~~~~~~E~~~l~~-l~h~~i~~~~~~~~-~~~~~~v~e~   81 (260)
T cd05069           7 SLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT---MMPEAFLQEAQIMKK-LRHDKLVPLYAVVS-EEPIYIVTEF   81 (260)
T ss_pred             HeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC---ccHHHHHHHHHHHHh-CCCCCeeeEEEEEc-CCCcEEEEEc
Confidence            467778999999999999998777789999885432   223467888866554 89999999999875 4568999999


Q ss_pred             CCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc-----
Q 047719          365 LPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP-----  439 (596)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~-----  439 (596)
                      +++|+|.+++....  ...++|..+..++.|++.||+|||+   .+++|+||||+||++++++.++|+|||.+..     
T Consensus        82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05069          82 MGKGSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             CCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence            99999999997643  2348899999999999999999999   8999999999999999999999999997642     


Q ss_pred             -------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcC
Q 047719          440 -------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKF  511 (596)
Q Consensus       440 -------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  511 (596)
                             .++..|+|||......++.++|||||||++|||++ |+.||......  +..... ....         ....
T Consensus       157 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~-~~~~---------~~~~  224 (260)
T cd05069         157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR--EVLEQV-ERGY---------RMPC  224 (260)
T ss_pred             ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHH-HcCC---------CCCC
Confidence                   13457999999988899999999999999999999 89999764321  111111 1110         0111


Q ss_pred             CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          512 NRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       512 ~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                      +......+.+++.+||+.+|++||+++++.++|+.
T Consensus       225 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         225 PQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            22334567888899999999999999999999874

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-37  Score=328.50  Aligned_cols=242  Identities=29%  Similarity=0.410  Sum_probs=198.3

Q ss_pred             CccceeecCCceEEEEEEc-CCC----CEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          287 NKNRIVGEGASATVYKGSL-PSG----GAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       287 ~~~~~LG~G~fG~Vy~~~~-~~g----~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      ...++||+|+||+||||.+ ++|    -+||||++... .......+++.|...|.+ ++||||++|+|+|.... +.||
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~-t~~~~s~e~LdeAl~mas-ldHpnl~RLLgvc~~s~-~qlv  775 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF-TSPKASIELLDEALRMAS-LDHPNLLRLLGVCMLST-LQLV  775 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeecc-CCchhhHHHHHHHHHHhc-CCCchHHHHhhhcccch-HHHH
Confidence            4468999999999999965 444    37999998643 334455678889877766 99999999999998876 8999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcccC-
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA-  440 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~~-  440 (596)
                      ++|||.|+|.+|++.++.   .+.....+.+..|||+||.|||.   +.++||||.++|||+.+-..+||.|||++... 
T Consensus       776 tq~mP~G~LlDyvr~hr~---~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~  849 (1177)
T KOG1025|consen  776 TQLMPLGCLLDYVREHRD---NIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLA  849 (1177)
T ss_pred             HHhcccchHHHHHHHhhc---cccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence            999999999999998653   57888999999999999999998   99999999999999999999999999986532 


Q ss_pred             ------------CCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhccccc
Q 047719          441 ------------GTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRL  507 (596)
Q Consensus       441 ------------gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  507 (596)
                                  -.+.|||-|.+....+++++|||||||.+||++| |..|+++...   +-+..+.+.+.         
T Consensus       850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~---~eI~dlle~ge---------  917 (1177)
T KOG1025|consen  850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA---EEIPDLLEKGE---------  917 (1177)
T ss_pred             cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH---HHhhHHHhccc---------
Confidence                        2356899999999999999999999999999999 9999987532   11222223332         


Q ss_pred             cCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Q 047719          508 RGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEAP  549 (596)
Q Consensus       508 ~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~~~  549 (596)
                      +...++-....+..++.+||..|+..||+++++...+.+-+.
T Consensus       918 RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar  959 (1177)
T KOG1025|consen  918 RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR  959 (1177)
T ss_pred             cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence            223344556778889999999999999999999887765443

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-36  Score=310.87  Aligned_cols=251  Identities=22%  Similarity=0.332  Sum_probs=193.8

Q ss_pred             cCCCccceeecCCceEEEEEEcCC---------------CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeee
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPS---------------GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL  348 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~---------------g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l  348 (596)
                      ++|...+.||+|+||.||++....               ...||+|.++... .......+.+|++.+.+ ++|+|++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~-l~h~~i~~~   82 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSR-LKNPNIIRL   82 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHh-CCCCCcCeE
Confidence            467888999999999999987532               2358999986432 23344568889876655 999999999


Q ss_pred             cceeeeCCeEEEEEecCCCCCHHHHhhhCCC--------CCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCc
Q 047719          349 QGWCCEGNELVLVYEYLPNGSLDKILHNNSS--------SSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACN  420 (596)
Q Consensus       349 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~N  420 (596)
                      ++++......++||||+++++|.+++.....        ....++|..++.++.|++.||+|||+   .+++||||||+|
T Consensus        83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~N  159 (295)
T cd05097          83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRN  159 (295)
T ss_pred             EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhh
Confidence            9999999999999999999999999965421        11247899999999999999999999   899999999999


Q ss_pred             eeecCCCceEEccCCCccc-------------CCCcccCCccccccCCCCCccceeehhHHHHHHHh--CCCCCCCCCh-
Q 047719          421 ILLDAEFNAKLGDFEATIP-------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA--GKSPVDNDGC-  484 (596)
Q Consensus       421 iLl~~~~~~kl~Dfg~~~~-------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t--G~~p~~~~~~-  484 (596)
                      |+++.++.+||+|||++..             .++..|+|||.+..+.++.++|||||||++|||++  |..||..... 
T Consensus       160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~  239 (295)
T cd05097         160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE  239 (295)
T ss_pred             EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence            9999999999999997642             13567999999998899999999999999999998  5667765321 


Q ss_pred             hHHHHHHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 047719          485 VIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK  545 (596)
Q Consensus       485 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~  545 (596)
                      ...............      ......+......+.+++.+||+.+|++||+|.+|++.|+
T Consensus       240 ~~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         240 QVIENTGEFFRNQGR------QIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             HHHHHHHHhhhhccc------cccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            121111111111100      0000111122357889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2e-36  Score=312.16  Aligned_cols=247  Identities=24%  Similarity=0.375  Sum_probs=195.9

Q ss_pred             hcCCCccceeecCCceEEEEEEc------CCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCC
Q 047719          283 TLGFNKNRIVGEGASATVYKGSL------PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGN  356 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~  356 (596)
                      .++|...+.||+|+||.||++..      ..+..||||+++.... ......+.+|+..+.+..+|+||++++++|...+
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  112 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH-SSEREALMSELKIMSHLGNHENIVNLLGACTIGG  112 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC-hHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence            34688889999999999999963      1245799999864322 2234568889876665338999999999999999


Q ss_pred             eEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCC
Q 047719          357 ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEA  436 (596)
Q Consensus       357 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~  436 (596)
                      ..++||||+++|+|.++++....  ..+++.++..++.|++.||+|||+   ++++|+||||+|||++.++.+||+|||+
T Consensus       113 ~~~lv~e~~~~~~L~~~i~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~  187 (302)
T cd05055         113 PILVITEYCCYGDLLNFLRRKRE--SFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGL  187 (302)
T ss_pred             ceEEEEEcCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCcc
Confidence            99999999999999999986442  238999999999999999999999   8999999999999999999999999997


Q ss_pred             ccc-------------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhh
Q 047719          437 TIP-------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDA  502 (596)
Q Consensus       437 ~~~-------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  502 (596)
                      +..             .++..|+|||.+....++.++|||||||++|||++ |..||......  +-.......+.    
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~--~~~~~~~~~~~----  261 (302)
T cd05055         188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD--SKFYKLIKEGY----  261 (302)
T ss_pred             cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch--HHHHHHHHcCC----
Confidence            642             23467999999998899999999999999999998 99998754321  00111111111    


Q ss_pred             ccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          503 ADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       503 ~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                           ....+......+.+++.+|++++|++||++.|+++.|+.
T Consensus       262 -----~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~  300 (302)
T cd05055         262 -----RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK  300 (302)
T ss_pred             -----cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence                 001111223567889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.3e-36  Score=324.96  Aligned_cols=249  Identities=24%  Similarity=0.378  Sum_probs=195.9

Q ss_pred             hcCCCccceeecCCceEEEEEEcC------CCCEEEEEEeecCCchhcccchHHHHHHHHHhccC-CCceeeecceeeeC
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLP------SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLR-HKNLVQLQGWCCEG  355 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~-H~niv~l~g~~~~~  355 (596)
                      .++|...+.||+|+||.||+|.+.      .+..||||+++..... .....+..|+..+.+ +. |||||+++++|...
T Consensus        36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~-l~~H~niv~~~~~~~~~  113 (401)
T cd05107          36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS-SEKQALMSELKIMSH-LGPHLNIVNLLGACTKG  113 (401)
T ss_pred             HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh-hHHHHHHHHHHHHHh-cCCCCCeEEEEEEEccC
Confidence            345677899999999999999853      2468999999654322 233468889877766 65 99999999999999


Q ss_pred             CeEEEEEecCCCCCHHHHhhhCCC--------------------------------------------------------
Q 047719          356 NELVLVYEYLPNGSLDKILHNNSS--------------------------------------------------------  379 (596)
Q Consensus       356 ~~~~lV~E~~~~gsL~~~l~~~~~--------------------------------------------------------  379 (596)
                      +..++||||+++|+|.++++....                                                        
T Consensus       114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (401)
T cd05107         114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ  193 (401)
T ss_pred             CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence            999999999999999999975421                                                        


Q ss_pred             --------------------------------------CCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCce
Q 047719          380 --------------------------------------SSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNI  421 (596)
Q Consensus       380 --------------------------------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~Ni  421 (596)
                                                            ....++|...+.++.||+.||+|||+   .+++||||||+||
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~Ni  270 (401)
T cd05107         194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNV  270 (401)
T ss_pred             cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcceE
Confidence                                                  11247888899999999999999998   8999999999999


Q ss_pred             eecCCCceEEccCCCccc-------------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHH
Q 047719          422 LLDAEFNAKLGDFEATIP-------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIV  487 (596)
Q Consensus       422 Ll~~~~~~kl~Dfg~~~~-------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~  487 (596)
                      |+++++.+||+|||++..             .++..|+|||.+....++.++|||||||++|||++ |+.||.....  .
T Consensus       271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~--~  348 (401)
T cd05107         271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM--N  348 (401)
T ss_pred             EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc--h
Confidence            999999999999998642             24567999999998889999999999999999998 8999865321  1


Q ss_pred             HHHHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          488 DWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       488 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                      +........+..         ...+......+.+++..||+.+|++||+++++++.|+..
T Consensus       349 ~~~~~~~~~~~~---------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         349 EQFYNAIKRGYR---------MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             HHHHHHHHcCCC---------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            111111111110         111112235677888899999999999999999999753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-36  Score=303.36  Aligned_cols=243  Identities=27%  Similarity=0.395  Sum_probs=198.0

Q ss_pred             hcCCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      .++|...+.||+|+||.||++..+++..||||.+....   ....++.+|+..+.. ++|+||+++++++......++||
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~---~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~~v~   80 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT---MSPEAFLQEAQIMKK-LRHDKLVQLYAVCSEEEPIYIVT   80 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc---cCHHHHHHHHHHHhh-CCCCCEeeeeeeeecCCceEEEE
Confidence            35688889999999999999998778899999986432   234568889866654 89999999999999989999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcccC--
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA--  440 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~~--  440 (596)
                      ||+++++|.+++....  ...+++.++..++.+++.||.|||+   .+++|+||||+||++++++.+||+|||.+...  
T Consensus        81 e~~~~~~L~~~i~~~~--~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~  155 (261)
T cd05034          81 EYMSKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIED  155 (261)
T ss_pred             eccCCCCHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccc
Confidence            9999999999998753  2358999999999999999999999   89999999999999999999999999976432  


Q ss_pred             ----------CCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhccccccC
Q 047719          441 ----------GTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRG  509 (596)
Q Consensus       441 ----------gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  509 (596)
                                ++..|+|||.+.+..++.++|||||||++||+++ |+.||......  ..........          ..
T Consensus       156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~~~~~~~~~~----------~~  223 (261)
T cd05034         156 DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR--EVLEQVERGY----------RM  223 (261)
T ss_pred             hhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCC----------CC
Confidence                      2457999999998889999999999999999999 99999764321  1111111110          00


Q ss_pred             cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          510 KFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       510 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                      ..+......+.+++.+|++.+|++||+++++.+.|+.
T Consensus       224 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         224 PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            1111223567888999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.7e-36  Score=308.75  Aligned_cols=244  Identities=25%  Similarity=0.413  Sum_probs=193.1

Q ss_pred             cCCCccceeecCCceEEEEEEcC------CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCe
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP------SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNE  357 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~  357 (596)
                      .++...++||+|+||.||++...      ++..+|+|.+....  ......+.+|+..+. .++|+||+++++++.....
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~   81 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESARQDFQREAELLT-VLQHQHIVRFYGVCTEGRP   81 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC--HHHHHHHHHHHHHHh-cCCCCCCceEEEEEecCCc
Confidence            34666789999999999999632      35679999885432  334457888886555 4899999999999999999


Q ss_pred             EEEEEecCCCCCHHHHhhhCCCC-----------CcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCC
Q 047719          358 LVLVYEYLPNGSLDKILHNNSSS-----------SIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAE  426 (596)
Q Consensus       358 ~~lV~E~~~~gsL~~~l~~~~~~-----------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~  426 (596)
                      .+++|||+++|+|.+++......           ...+++..++.++.|++.||+|||+   .+++||||||+|||++++
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~  158 (280)
T cd05092          82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQG  158 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCC
Confidence            99999999999999999764321           1348899999999999999999999   899999999999999999


Q ss_pred             CceEEccCCCccc-------------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHH
Q 047719          427 FNAKLGDFEATIP-------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWN  492 (596)
Q Consensus       427 ~~~kl~Dfg~~~~-------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~  492 (596)
                      +.+||+|||++..             .++..|+|||.+.+..++.++|||||||++|||++ |..||......  +....
T Consensus       159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~  236 (280)
T cd05092         159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT--EAIEC  236 (280)
T ss_pred             CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH--HHHHH
Confidence            9999999997642             13567999999998899999999999999999998 99998653221  11111


Q ss_pred             HHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 047719          493 LRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK  545 (596)
Q Consensus       493 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~  545 (596)
                      . ..+..         ...+......+.+++.+||+.||.+||++++|.+.|+
T Consensus       237 ~-~~~~~---------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         237 I-TQGRE---------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             H-HcCcc---------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            1 11110         0111122345778889999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=3.8e-36  Score=303.90  Aligned_cols=248  Identities=24%  Similarity=0.386  Sum_probs=194.3

Q ss_pred             HHHHHhcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCC
Q 047719          278 DIKQATLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGN  356 (596)
Q Consensus       278 el~~at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~  356 (596)
                      |++.+++++.....||+|+||.||+|... ++..||+|.+....  ....+.+.+|+..+. .++|+||+++++++...+
T Consensus         2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~   78 (268)
T cd06624           2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHS-YLKHRNIVQYLGSDSENG   78 (268)
T ss_pred             CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHH-hcCCCCeeeeeeeeccCC
Confidence            45667888888899999999999999865 47789999986433  223456788886554 589999999999999999


Q ss_pred             eEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecC-CCceEEccCC
Q 047719          357 ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDA-EFNAKLGDFE  435 (596)
Q Consensus       357 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~-~~~~kl~Dfg  435 (596)
                      ..++|+||+++++|.+++..... ....++..+..++.||+.||+|||+   .+++||||||+||+++. ++.+||+|||
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg  154 (268)
T cd06624          79 FFKIFMEQVPGGSLSALLRSKWG-PLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFG  154 (268)
T ss_pred             EEEEEEecCCCCCHHHHHHHhcc-cCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecch
Confidence            99999999999999999986421 1112788889999999999999999   89999999999999986 6799999998


Q ss_pred             Ccc-----------cCCCcccCCccccccCC--CCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhh
Q 047719          436 ATI-----------PAGTMGYLAPEYVYSGV--PSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDA  502 (596)
Q Consensus       436 ~~~-----------~~gt~~y~aPE~~~~~~--~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~  502 (596)
                      .+.           ..|+..|+|||.+....  ++.++||||||+++|||++|+.||.......... +....       
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~-~~~~~-------  226 (268)
T cd06624         155 TSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM-FKVGM-------  226 (268)
T ss_pred             hheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH-hhhhh-------
Confidence            653           23688999999986643  7899999999999999999999997532211110 00000       


Q ss_pred             ccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          503 ADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       503 ~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                        ......++......+..++.+||+.+|.+|||+.|+++
T Consensus       227 --~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         227 --FKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             --hccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence              00111222334456778889999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.7e-36  Score=321.59  Aligned_cols=250  Identities=24%  Similarity=0.286  Sum_probs=190.9

Q ss_pred             HHHHHHHhcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchh-cccchHHHHHHHHHhccCCCceeeecceee
Q 047719          276 LTDIKQATLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVE-CARNPFTTEFATMAGCLRHKNLVQLQGWCC  353 (596)
Q Consensus       276 ~~el~~at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~-~~~~~~~~E~~~l~~~l~H~niv~l~g~~~  353 (596)
                      +.++....++|...+.||+|+||.||++... +++.||+|++.+..... .....+.+|+. +.+.++||||+++++++.
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~-i~~~~~hp~iv~~~~~~~  113 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD-IMAFANSPWVVQLFYAFQ  113 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHH-HHHhCCCCCCCeEEEEEE
Confidence            4455666788999999999999999999876 47899999986432211 22334556664 445589999999999999


Q ss_pred             eCCeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEcc
Q 047719          354 EGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGD  433 (596)
Q Consensus       354 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~D  433 (596)
                      +....|+||||+++|+|.+++....     ++...+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|
T Consensus       114 ~~~~~~lv~Ey~~gg~L~~~~~~~~-----~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~D  185 (371)
T cd05622         114 DDRYLYMVMEYMPGGDLVNLMSNYD-----VPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLAD  185 (371)
T ss_pred             cCCEEEEEEcCCCCCcHHHHHHhcC-----CCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEe
Confidence            9999999999999999999997542     7788888999999999999999   8999999999999999999999999


Q ss_pred             CCCcc------------cCCCcccCCccccccC----CCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcC
Q 047719          434 FEATI------------PAGTMGYLAPEYVYSG----VPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKG  497 (596)
Q Consensus       434 fg~~~------------~~gt~~y~aPE~~~~~----~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~  497 (596)
                      ||++.            ..||+.|+|||++...    .++.++|||||||++|||++|+.||......  ..........
T Consensus       186 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--~~~~~i~~~~  263 (371)
T cd05622         186 FGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--GTYSKIMNHK  263 (371)
T ss_pred             CCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH--HHHHHHHcCC
Confidence            99753            2489999999998753    3789999999999999999999999865321  1111111111


Q ss_pred             CchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCC--CCCHHHHHHH
Q 047719          498 KLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEK--RPSVKEAARI  543 (596)
Q Consensus       498 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~--RPs~~ev~~~  543 (596)
                      ......+       .......+.+++..|++.++.+  ||+++|+++.
T Consensus       264 ~~~~~~~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         264 NSLTFPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             CcccCCC-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence            1111111       1123345566777888744433  7789888773

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-36  Score=302.48  Aligned_cols=241  Identities=26%  Similarity=0.364  Sum_probs=193.9

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchh---cccchHHHHHHHHHhccCCCceeeecceeeeCCeEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVE---CARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELV  359 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~---~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~  359 (596)
                      ++|...+.||+|+||.||++... ++..||+|.+.......   .....+.+|+..+. .++||||+++++++.+....+
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~   80 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLK-NLQHERIVQYYGCLRDDETLS   80 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHH-hCCCCCeeeeEEEEccCCeEE
Confidence            46888999999999999999764 58899999986432221   12345778886554 489999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc-
Q 047719          360 LVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI-  438 (596)
Q Consensus       360 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~-  438 (596)
                      +|+||+++++|.+++....    .+++.....++.|++.||.|||+   .+++||||||+||++++++.++|+|||.+. 
T Consensus        81 ~v~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~  153 (263)
T cd06625          81 IFMEYMPGGSVKDQLKAYG----ALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKR  153 (263)
T ss_pred             EEEEECCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeccccee
Confidence            9999999999999997653    47889999999999999999999   899999999999999999999999999753 


Q ss_pred             -------------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccc
Q 047719          439 -------------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADF  505 (596)
Q Consensus       439 -------------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~  505 (596)
                                   ..|+..|+|||.+.+..++.++||||||+++|||++|+.||.......  -........        
T Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~~~~~--------  223 (263)
T cd06625         154 LQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA--AIFKIATQP--------  223 (263)
T ss_pred             ccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH--HHHHHhccC--------
Confidence                         235678999999999889999999999999999999999997542211  011111111        


Q ss_pred             cccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 047719          506 RLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARI  543 (596)
Q Consensus       506 ~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~  543 (596)
                       .....+......+.+++..||+.+|.+|||++++++.
T Consensus       224 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         224 -TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             -CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence             1112222334567788899999999999999999763

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.7e-36  Score=319.50  Aligned_cols=242  Identities=22%  Similarity=0.219  Sum_probs=186.7

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      .+|...+.||+|+||.||++... .++.||+|....        ..+.+|+..+.. ++|||||++++++......++|+
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~-l~HpnIv~~~~~~~~~~~~~lv~  162 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRA-INHPSIIQLKGTFTYNKFTCLIL  162 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHh-CCCCCCCCEeEEEEECCeeEEEE
Confidence            56999999999999999999765 588999997532        236788866654 99999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc----
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI----  438 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~----  438 (596)
                      |++. ++|..++....    .+++.+++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++.    
T Consensus       163 e~~~-~~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~  234 (391)
T PHA03212        163 PRYK-TDLYCYLAAKR----NIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVD  234 (391)
T ss_pred             ecCC-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCccccccc
Confidence            9995 68999987643    48899999999999999999999   899999999999999999999999999863    


Q ss_pred             --------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCCh--------hHHHHHHHHHhc-C----
Q 047719          439 --------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGC--------VIVDWVWNLRKK-G----  497 (596)
Q Consensus       439 --------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~--------~~~~~~~~~~~~-~----  497 (596)
                              ..||+.|+|||++.+..++.++|||||||++|||++|+.|+-....        .....+...... .    
T Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~  314 (391)
T PHA03212        235 INANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP  314 (391)
T ss_pred             ccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence                    2489999999999998999999999999999999999987643210        000001000000 0    


Q ss_pred             -----Cchhhc---------cccccCc--CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          498 -----KLLDAA---------DFRLRGK--FNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       498 -----~~~~~~---------d~~l~~~--~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                           .+....         .+..+..  ........+..|+.+|++.||++|||++|+++
T Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence                 000000         0000000  00122346778899999999999999999986

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=2.8e-36  Score=303.42  Aligned_cols=235  Identities=24%  Similarity=0.361  Sum_probs=186.8

Q ss_pred             eeecCCceEEEEEEcC---CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecCCC
Q 047719          291 IVGEGASATVYKGSLP---SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPN  367 (596)
Q Consensus       291 ~LG~G~fG~Vy~~~~~---~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  367 (596)
                      .||+|+||.||+|.+.   .+..||+|++.... .......+.+|+..+.. ++|+||++++++|. ....++||||+++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~-l~h~~ii~~~~~~~-~~~~~lv~e~~~~   78 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQ-LDNPYIVRMIGVCE-AEALMLVMEMASG   78 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHh-cCCCCeEEEEEEEc-CCCeEEEEEeCCC
Confidence            3899999999999754   35579999986432 23334568889866654 89999999999885 4578999999999


Q ss_pred             CCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcccC-------
Q 047719          368 GSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA-------  440 (596)
Q Consensus       368 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~~-------  440 (596)
                      |+|.+++....   ..+++..++.++.|++.||+|||+   .+++||||||+|||++.++.+||+|||.+...       
T Consensus        79 ~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~  152 (257)
T cd05115          79 GPLNKFLSGKK---DEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY  152 (257)
T ss_pred             CCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccce
Confidence            99999997543   258999999999999999999999   89999999999999999999999999976421       


Q ss_pred             -------CCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCC
Q 047719          441 -------GTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFN  512 (596)
Q Consensus       441 -------gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  512 (596)
                             ++..|+|||.+....++.++|||||||++||+++ |..||......  ++. .....+..         ...+
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~-~~~~~~~~---------~~~~  220 (257)
T cd05115         153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP--EVM-SFIEQGKR---------LDCP  220 (257)
T ss_pred             eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH--HHH-HHHHCCCC---------CCCC
Confidence                   2467999999988889999999999999999996 99999764321  111 11111111         1122


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          513 RKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       513 ~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                      ......+.+++..||+.+|++||++.+|.+.|+.
T Consensus       221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~  254 (257)
T cd05115         221 AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT  254 (257)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence            2334567788899999999999999999998874

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.7e-36  Score=309.86  Aligned_cols=247  Identities=27%  Similarity=0.446  Sum_probs=196.9

Q ss_pred             hcCCCccceeecCCceEEEEEEcC------CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCC
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLP------SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGN  356 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~  356 (596)
                      .++|...+.||+|+||.||++...      ++..||+|++..... .....++.+|+..+.+ ++||||++++++|....
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~ei~~l~~-l~h~~iv~~~~~~~~~~   81 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS-ADMQADFQREAALMAE-FDHPNIVKLLGVCAVGK   81 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC-HHHHHHHHHHHHHHHh-cCCCchheEEEEEcCCC
Confidence            456888899999999999999753      367899999864322 2334568889866654 89999999999999999


Q ss_pred             eEEEEEecCCCCCHHHHhhhCCC------------------CCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCC
Q 047719          357 ELVLVYEYLPNGSLDKILHNNSS------------------SSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKA  418 (596)
Q Consensus       357 ~~~lV~E~~~~gsL~~~l~~~~~------------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp  418 (596)
                      ..++||||+++|+|.+++.....                  ....+++..++.++.|++.||+|||+   .+++||||||
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p  158 (288)
T cd05050          82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLAT  158 (288)
T ss_pred             ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccH
Confidence            99999999999999999975321                  12347899999999999999999999   8999999999


Q ss_pred             CceeecCCCceEEccCCCccc-------------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCCh
Q 047719          419 CNILLDAEFNAKLGDFEATIP-------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGC  484 (596)
Q Consensus       419 ~NiLl~~~~~~kl~Dfg~~~~-------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~  484 (596)
                      +|||++.++.+||+|||.+..             ..+..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus       159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~  238 (288)
T cd05050         159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH  238 (288)
T ss_pred             hheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999997642             13456999999988899999999999999999998 8888865321


Q ss_pred             hHHHHHHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          485 VIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       485 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                        .+.... ...+....         .+......+.+++.+|++.+|++|||+.|+++.|++
T Consensus       239 --~~~~~~-~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         239 --EEVIYY-VRDGNVLS---------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             --HHHHHH-HhcCCCCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence              122211 12222111         111234567889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=4.2e-36  Score=305.65  Aligned_cols=235  Identities=22%  Similarity=0.281  Sum_probs=184.6

Q ss_pred             eecCCceEEEEEEcC-CCCEEEEEEeecCCchh-cccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecCCCCC
Q 047719          292 VGEGASATVYKGSLP-SGGAVAVKRFEKPNRVE-CARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGS  369 (596)
Q Consensus       292 LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~-~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  369 (596)
                      ||+|+||.||++... +|+.||+|++....... .....+..|++.+. .++||||+++++++..+...++||||+++|+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~-~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~   79 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILE-KVNSPFIVNLAYAFESKTHLCLVMSLMNGGD   79 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHH-hcCCCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence            699999999999865 48999999986432221 12334556775554 4899999999999999999999999999999


Q ss_pred             HHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc----------c
Q 047719          370 LDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI----------P  439 (596)
Q Consensus       370 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~----------~  439 (596)
                      |.+++....  ...+++..+..++.||+.||+|||+   .+++||||||+||+++.++.++|+|||++.          .
T Consensus        80 L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~  154 (277)
T cd05607          80 LKYHIYNVG--ERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQR  154 (277)
T ss_pred             HHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeecc
Confidence            999987543  2348899999999999999999999   899999999999999999999999999753          3


Q ss_pred             CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHH--HHHHHHHhcCCchhhccccccCcCCHHHHH
Q 047719          440 AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIV--DWVWNLRKKGKLLDAADFRLRGKFNRKEME  517 (596)
Q Consensus       440 ~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~--~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  517 (596)
                      .|+..|+|||.+.+..++.++|||||||++|||++|+.||........  +...... ...    .... .    .....
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~----~~~~-~----~~~~~  224 (277)
T cd05607         155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTL-EDE----VKFE-H----QNFTE  224 (277)
T ss_pred             CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhh-ccc----cccc-c----ccCCH
Confidence            478899999999988899999999999999999999999975422111  1111111 000    0000 0    11234


Q ss_pred             HHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          518 RMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       518 ~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      .+.+++..|++.||++||+++|+++
T Consensus       225 ~~~~li~~~L~~~P~~R~~~~~~~~  249 (277)
T cd05607         225 ESKDICRLFLAKKPEDRLGSREKND  249 (277)
T ss_pred             HHHHHHHHHhccCHhhCCCCccchh
Confidence            5678889999999999999977664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=6.6e-36  Score=315.83  Aligned_cols=248  Identities=23%  Similarity=0.317  Sum_probs=189.0

Q ss_pred             hcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCC-----
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGN-----  356 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~-----  356 (596)
                      .++|...+.||+|+||.||++... +|..||||++............+.+|+..+. .++||||+++++++....     
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLK-CVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHH-hCCCCCEeeeeeeeccCCCcccc
Confidence            467888999999999999999765 4889999999754433444556788886554 589999999999986543     


Q ss_pred             -eEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCC
Q 047719          357 -ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFE  435 (596)
Q Consensus       357 -~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg  435 (596)
                       ..|+||||+.+ +|.+.+..      .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg  168 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG  168 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCC
Confidence             57999999965 67776643      27888899999999999999999   899999999999999999999999999


Q ss_pred             Cccc----------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCC-------
Q 047719          436 ATIP----------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGK-------  498 (596)
Q Consensus       436 ~~~~----------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~-------  498 (596)
                      ++..          .||..|+|||.+.+..++.++|||||||++|||++|+.||...+. ...|.......+.       
T Consensus       169 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~  247 (359)
T cd07876         169 LARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDH-IDQWNKVIEQLGTPSAEFMN  247 (359)
T ss_pred             CccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCcHHHHH
Confidence            7642          478899999999998999999999999999999999999976432 1111100000000       


Q ss_pred             -----chhhc--ccccc----------------CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          499 -----LLDAA--DFRLR----------------GKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       499 -----~~~~~--d~~l~----------------~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                           .....  .+...                ..........+.+++.+|++.||++|||+.|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  314 (359)
T cd07876         248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR  314 (359)
T ss_pred             HHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence                 00000  00000                0001112345778889999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-37  Score=320.43  Aligned_cols=239  Identities=27%  Similarity=0.406  Sum_probs=200.2

Q ss_pred             CCccceeecCCceEEEEEEcCC---CC--EEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEE
Q 047719          286 FNKNRIVGEGASATVYKGSLPS---GG--AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVL  360 (596)
Q Consensus       286 f~~~~~LG~G~fG~Vy~~~~~~---g~--~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~l  360 (596)
                      ....++||.|-||.||+|.+.+   |.  .||||..+..+..+ ..+.|+.|...|.. ++|||||+|+|.|.+ ...+|
T Consensus       391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d-~tekflqEa~iMrn-fdHphIikLIGv~~e-~P~Wi  467 (974)
T KOG4257|consen  391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPD-DTEKFLQEASIMRN-FDHPHIIKLIGVCVE-QPMWI  467 (974)
T ss_pred             ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChh-hHHHHHHHHHHHHh-CCCcchhheeeeeec-cceeE
Confidence            3456899999999999997643   33  58999997655544 46779999866655 999999999999976 47999


Q ss_pred             EEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcccC
Q 047719          361 VYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA  440 (596)
Q Consensus       361 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~~  440 (596)
                      |||.++-|.|..||+.+..   .|+......++.||+.||+|||+   ..+|||||..+|||+.+...+||+|||+++..
T Consensus       468 vmEL~~~GELr~yLq~nk~---sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~  541 (974)
T KOG4257|consen  468 VMELAPLGELREYLQQNKD---SLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSRYL  541 (974)
T ss_pred             EEecccchhHHHHHHhccc---cchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhhhc
Confidence            9999999999999998753   48888999999999999999999   99999999999999999999999999998653


Q ss_pred             ------------CCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhccccc
Q 047719          441 ------------GTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRL  507 (596)
Q Consensus       441 ------------gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  507 (596)
                                  -...|||||.+.-.++|.+||||.|||.+||++. |..||.+-.            +.++...+...-
T Consensus       542 ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvk------------NsDVI~~iEnGe  609 (974)
T KOG4257|consen  542 EDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVK------------NSDVIGHIENGE  609 (974)
T ss_pred             cccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccc------------ccceEEEecCCC
Confidence                        2357999999999999999999999999999999 999998632            222333333333


Q ss_pred             cCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 047719          508 RGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK  545 (596)
Q Consensus       508 ~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~  545 (596)
                      +...++.+...+..|+-+||..+|.+||.+.|+...|+
T Consensus       610 RlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~ls  647 (974)
T KOG4257|consen  610 RLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILS  647 (974)
T ss_pred             CCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHH
Confidence            44566777788999999999999999999998877664

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=4.4e-36  Score=308.34  Aligned_cols=251  Identities=22%  Similarity=0.332  Sum_probs=194.0

Q ss_pred             cCCCccceeecCCceEEEEEEcC-----------------CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCcee
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-----------------SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLV  346 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-----------------~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv  346 (596)
                      ++|+..+.||+|+||.||++...                 ++..||+|++.... .......+.+|+..+.. ++|+||+
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~-l~~~~i~   82 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSR-LKDPNII   82 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHh-CCCCCcc
Confidence            46888899999999999998532                 23468999986432 23344578899866655 8999999


Q ss_pred             eecceeeeCCeEEEEEecCCCCCHHHHhhhCCCC-------CcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCC
Q 047719          347 QLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSS-------SIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKAC  419 (596)
Q Consensus       347 ~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~  419 (596)
                      ++++++...+..++||||+++|+|.+++......       ...+++.+.+.++.|++.||+|||+   .+++||||||+
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~  159 (296)
T cd05095          83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATR  159 (296)
T ss_pred             eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChh
Confidence            9999999999999999999999999999764321       1347889999999999999999999   89999999999


Q ss_pred             ceeecCCCceEEccCCCcccC-------------CCcccCCccccccCCCCCccceeehhHHHHHHHh--CCCCCCCCCh
Q 047719          420 NILLDAEFNAKLGDFEATIPA-------------GTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA--GKSPVDNDGC  484 (596)
Q Consensus       420 NiLl~~~~~~kl~Dfg~~~~~-------------gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t--G~~p~~~~~~  484 (596)
                      |||++.++.++|+|||.+...             ++..|++||....+.++.++|||||||++|||++  |..||.....
T Consensus       160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~  239 (296)
T cd05095         160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD  239 (296)
T ss_pred             eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence            999999999999999986431             2457999999888889999999999999999998  6788865321


Q ss_pred             -hHHHHHHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 047719          485 -VIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK  545 (596)
Q Consensus       485 -~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~  545 (596)
                       .................      ....+......+.+++.+||+.||++||++.+|.+.|+
T Consensus       240 ~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         240 EQVIENTGEFFRDQGRQV------YLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             HHHHHHHHHHHhhccccc------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence             11111111111110000      00111123367788999999999999999999999886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=3.6e-36  Score=317.95  Aligned_cols=191  Identities=26%  Similarity=0.351  Sum_probs=166.8

Q ss_pred             CCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          285 GFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      +|...+.||+|+||.||++... +++.||||++.+.... ......+.+|+..+. .++|+||+++++.+.+.+.+|+||
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~-~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILV-EADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHH-hCCCCCEeeEEEEEEcCCEEEEEE
Confidence            5778899999999999999865 4889999999643221 223345667775554 489999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc----
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI----  438 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~----  438 (596)
                      ||+++|+|.+++....    .+++.....++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++.    
T Consensus        81 E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~  153 (360)
T cd05627          81 EFLPGGDMMTLLMKKD----TLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK  153 (360)
T ss_pred             eCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence            9999999999997653    48899999999999999999999   999999999999999999999999999742    


Q ss_pred             ------------------------------------------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCC
Q 047719          439 ------------------------------------------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGK  476 (596)
Q Consensus       439 ------------------------------------------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~  476 (596)
                                                                ..||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~  233 (360)
T cd05627         154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY  233 (360)
T ss_pred             ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence                                                      25899999999999999999999999999999999999


Q ss_pred             CCCCCCC
Q 047719          477 SPVDNDG  483 (596)
Q Consensus       477 ~p~~~~~  483 (596)
                      .||....
T Consensus       234 ~Pf~~~~  240 (360)
T cd05627         234 PPFCSET  240 (360)
T ss_pred             CCCCCCC
Confidence            9997653

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2e-36  Score=306.29  Aligned_cols=243  Identities=26%  Similarity=0.383  Sum_probs=190.8

Q ss_pred             HHhcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeC----
Q 047719          281 QATLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG----  355 (596)
Q Consensus       281 ~at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~----  355 (596)
                      .++..|+..+.||+|+||.||+|... +++.||+|++....   .....+..|+..+....+|+||+++++++...    
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   79 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG   79 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence            45667888899999999999999865 48899999986432   23346778886666644799999999998763    


Q ss_pred             --CeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEcc
Q 047719          356 --NELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGD  433 (596)
Q Consensus       356 --~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~D  433 (596)
                        ...++||||+++|+|.+++....  ...++|..+..++.|++.||+|||+   .+++||||||+||++++++.+||+|
T Consensus        80 ~~~~~~iv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~D  154 (272)
T cd06637          80 MDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVD  154 (272)
T ss_pred             CCcEEEEEEEcCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEcc
Confidence              46899999999999999998643  2358899999999999999999999   8999999999999999999999999


Q ss_pred             CCCcc-----------cCCCcccCCccccc-----cCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcC
Q 047719          434 FEATI-----------PAGTMGYLAPEYVY-----SGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKG  497 (596)
Q Consensus       434 fg~~~-----------~~gt~~y~aPE~~~-----~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~  497 (596)
                      ||++.           ..|+..|+|||++.     ...++.++|||||||++|||++|+.||........ .. ..... 
T Consensus       155 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~-~~-~~~~~-  231 (272)
T cd06637         155 FGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-LF-LIPRN-  231 (272)
T ss_pred             CCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH-HH-HHhcC-
Confidence            99864           24678899999986     34578899999999999999999999975432111 11 11110 


Q ss_pred             CchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          498 KLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       498 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      .     ....   ........+.+++.+||+.+|.+|||+.++++
T Consensus       232 ~-----~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         232 P-----APRL---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             C-----CCCC---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            0     0001   11122345778889999999999999999865

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=4.8e-36  Score=308.26  Aligned_cols=238  Identities=28%  Similarity=0.386  Sum_probs=192.9

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      ..|...+.||+|+||.||+|... +++.||+|.+.....  .....+.+|+..+. .++|+||+++++.+......++||
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~e~~~l~-~~~h~~v~~~~~~~~~~~~~~lv~   96 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMR-ENKNPNIVNYLDSYLVGDELWVVM   96 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc--chHHHHHHHHHHHH-hCCCCCEeeEEEEEEeCCEEEEee
Confidence            46777889999999999999754 588999999864332  22345778886554 489999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc----
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI----  438 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~----  438 (596)
                      ||+++++|.+++.+.     .+++.++..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||.+.    
T Consensus        97 e~~~~~~L~~~~~~~-----~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~  168 (296)
T cd06654          97 EYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (296)
T ss_pred             cccCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence            999999999999754     37899999999999999999999   899999999999999999999999999653    


Q ss_pred             -------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcC
Q 047719          439 -------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKF  511 (596)
Q Consensus       439 -------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  511 (596)
                             ..|+..|+|||.+.+..++.++|||||||++|||++|+.||......  .+.......+. .       ....
T Consensus       169 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~--~~~~~~~~~~~-~-------~~~~  238 (296)
T cd06654         169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--RALYLIATNGT-P-------ELQN  238 (296)
T ss_pred             cccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH--HhHHHHhcCCC-C-------CCCC
Confidence                   25778899999998888999999999999999999999999765321  11111111110 0       0011


Q ss_pred             CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          512 NRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       512 ~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      +......+.+++.+||+.+|++||+++++++
T Consensus       239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             ccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence            2233456778889999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1e-35  Score=300.98  Aligned_cols=243  Identities=26%  Similarity=0.336  Sum_probs=183.8

Q ss_pred             ceeecCCceEEEEEEcCC---CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecCC
Q 047719          290 RIVGEGASATVYKGSLPS---GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLP  366 (596)
Q Consensus       290 ~~LG~G~fG~Vy~~~~~~---g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~~  366 (596)
                      +.||+|+||.||+|...+   +..+|+|.++.... ......+.+|+..+. .++||||+++++++.+....++||||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e~~~   78 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYR-SLQHSNLLQCLGQCTEVTPYLLVMEFCP   78 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHH-hCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence            368999999999997543   45799999864332 223346788885554 5899999999999999999999999999


Q ss_pred             CCCHHHHhhhCCC-CCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc------
Q 047719          367 NGSLDKILHNNSS-SSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP------  439 (596)
Q Consensus       367 ~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~------  439 (596)
                      +|+|.+++..... ....+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||.+..      
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~  155 (269)
T cd05087          79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY  155 (269)
T ss_pred             CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcce
Confidence            9999999976432 12346788888999999999999999   8999999999999999999999999997632      


Q ss_pred             -------CCCcccCCccccccC-------CCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhcc
Q 047719          440 -------AGTMGYLAPEYVYSG-------VPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAAD  504 (596)
Q Consensus       440 -------~gt~~y~aPE~~~~~-------~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d  504 (596)
                             .++..|+|||++...       .++.++|||||||++|||++ |+.||......-   ..............+
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~  232 (269)
T cd05087         156 YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---VLTYTVREQQLKLPK  232 (269)
T ss_pred             eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH---HHHHHhhcccCCCCC
Confidence                   256779999988642       35889999999999999997 999997543211   111111111112222


Q ss_pred             ccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 047719          505 FRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK  545 (596)
Q Consensus       505 ~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~  545 (596)
                      +.+...    ....+.+++..|| .+|++|||++||++.|+
T Consensus       233 ~~~~~~----~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         233 PRLKLP----LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CccCCC----CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            222211    2234566777898 58999999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=2.2e-36  Score=311.73  Aligned_cols=250  Identities=24%  Similarity=0.368  Sum_probs=196.8

Q ss_pred             hcCCCccceeecCCceEEEEEEcC--------CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeee
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLP--------SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE  354 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~--------~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~  354 (596)
                      ..+|...+.||+|+||.||++...        ++..||+|.+.... ......++.+|+..+...-+|+||+++++++..
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   92 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   92 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence            445777899999999999999631        24579999986432 223445688888666553389999999999999


Q ss_pred             CCeEEEEEecCCCCCHHHHhhhCCCC------------CcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCcee
Q 047719          355 GNELVLVYEYLPNGSLDKILHNNSSS------------SIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNIL  422 (596)
Q Consensus       355 ~~~~~lV~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiL  422 (596)
                      ....++||||+++|+|.+++......            ...++|.+++.++.||+.||.|||+   .+++||||||+|||
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nil  169 (304)
T cd05101          93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVL  169 (304)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceEE
Confidence            99999999999999999999864321            2358899999999999999999999   89999999999999


Q ss_pred             ecCCCceEEccCCCccc-------------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHH
Q 047719          423 LDAEFNAKLGDFEATIP-------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVD  488 (596)
Q Consensus       423 l~~~~~~kl~Dfg~~~~-------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~  488 (596)
                      ++.++.+||+|||.+..             .++..|+|||.+.+..++.++|||||||++|||++ |..||....  ..+
T Consensus       170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--~~~  247 (304)
T cd05101         170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP--VEE  247 (304)
T ss_pred             EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC--HHH
Confidence            99999999999987642             23467999999988889999999999999999998 788886542  222


Q ss_pred             HHHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Q 047719          489 WVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEA  548 (596)
Q Consensus       489 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~~  548 (596)
                      +.... ..+...         ..+......+.+++..||+.+|.+||++.|+++.|+...
T Consensus       248 ~~~~~-~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~  297 (304)
T cd05101         248 LFKLL-KEGHRM---------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL  297 (304)
T ss_pred             HHHHH-HcCCcC---------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence            22222 111111         111223456778889999999999999999999997654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=2.3e-36  Score=307.41  Aligned_cols=246  Identities=27%  Similarity=0.382  Sum_probs=193.7

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCC----EEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGG----AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNEL  358 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~----~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~  358 (596)
                      ..|...+.||+|+||.||+|.+. ++.    .||+|++..... .....++.+|+..+. .++|+||++++++|.. ...
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~-~~~~~~i~~~~~~~~~-~~~   83 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS-PKANKEILDEAYVMA-GVGSPYVCRLLGICLT-STV   83 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCC-HHHHHHHHHHHHHHH-hcCCCCCceEEEEEcC-CCc
Confidence            45777899999999999999753 344    489999864322 233456778886655 4899999999999975 457


Q ss_pred             EEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc
Q 047719          359 VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI  438 (596)
Q Consensus       359 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~  438 (596)
                      ++++||+++|+|.+++....   ..+++..++.++.||+.||+|||+   ++++||||||+|||++.++.+||+|||++.
T Consensus        84 ~l~~~~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~  157 (279)
T cd05109          84 QLVTQLMPYGCLLDYVRENK---DRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLAR  157 (279)
T ss_pred             EEEEEcCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCcee
Confidence            89999999999999998643   248999999999999999999999   899999999999999999999999999764


Q ss_pred             cC-------------CCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCCh-hHHHHHHHHHhcCCchhhc
Q 047719          439 PA-------------GTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGC-VIVDWVWNLRKKGKLLDAA  503 (596)
Q Consensus       439 ~~-------------gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~-~~~~~~~~~~~~~~~~~~~  503 (596)
                      ..             ++..|+|||.+.+..++.++|||||||++|||++ |..||..... .+..+.    ..+...   
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~----~~~~~~---  230 (279)
T cd05109         158 LLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL----EKGERL---  230 (279)
T ss_pred             ecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH----HCCCcC---
Confidence            21             3467999999998899999999999999999998 9999976432 121111    111110   


Q ss_pred             cccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCC
Q 047719          504 DFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEAPLP  551 (596)
Q Consensus       504 d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~~~~p  551 (596)
                            ..+......+.+++..||+.||++||++.++++.|+.....|
T Consensus       231 ------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         231 ------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             ------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence                  111123346778889999999999999999999987655433

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.8e-36  Score=307.51  Aligned_cols=251  Identities=25%  Similarity=0.352  Sum_probs=191.3

Q ss_pred             cCCCccceeecCCceEEEEEEcC-----CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeee--CC
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-----SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE--GN  356 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-----~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~--~~  356 (596)
                      +.|...+.||+|+||.||++...     ++..||+|++....  ......+.+|+..+.. ++||||+++++++..  ..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~   80 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHLRDFEREIEILKS-LQHDNIVKYKGVCYSAGRR   80 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC--HHHHHHHHHHHHHHHh-CCCCCeeEEEEEEccCCCC
Confidence            45677899999999999999742     47899999985432  3344568889866655 899999999998754  34


Q ss_pred             eEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCC
Q 047719          357 ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEA  436 (596)
Q Consensus       357 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~  436 (596)
                      .+++||||+++|+|.+++....   ..++|..++.++.|++.||+|||+   .+++||||||+||++++++.+||+|||+
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~  154 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKHR---ERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGL  154 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCcc
Confidence            6899999999999999997643   248999999999999999999999   8999999999999999999999999997


Q ss_pred             cccC--------------CCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCC----
Q 047719          437 TIPA--------------GTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGK----  498 (596)
Q Consensus       437 ~~~~--------------gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~----  498 (596)
                      +...              ++..|+|||.+.+..++.++|||||||++|||++|..|+.........   .......    
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~---~~~~~~~~~~~  231 (284)
T cd05081         155 TKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMR---MMGNDKQGQMI  231 (284)
T ss_pred             cccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhh---hcccccccccc
Confidence            6531              123599999998888999999999999999999988775432211100   0000000    


Q ss_pred             ---chhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          499 ---LLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       499 ---~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                         +.+.................+.+++.+||+.+|++|||++||++.|+.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~  282 (284)
T cd05081         232 VYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA  282 (284)
T ss_pred             hHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence               000011011111112234568889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.1e-36  Score=317.64  Aligned_cols=249  Identities=26%  Similarity=0.363  Sum_probs=193.6

Q ss_pred             cCCCccceeecCCceEEEEEEc------CCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeC-C
Q 047719          284 LGFNKNRIVGEGASATVYKGSL------PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG-N  356 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~-~  356 (596)
                      ++|...+.||+|+||.||+|..      .+++.||||+++.... ......+.+|+..+.+.-+|+||++++++|... .
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC-hHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            4678889999999999999963      2467899999964322 223456788997777744799999999988754 4


Q ss_pred             eEEEEEecCCCCCHHHHhhhCCCC--------------------------------------------------------
Q 047719          357 ELVLVYEYLPNGSLDKILHNNSSS--------------------------------------------------------  380 (596)
Q Consensus       357 ~~~lV~E~~~~gsL~~~l~~~~~~--------------------------------------------------------  380 (596)
                      ..++||||+++|+|.+++......                                                        
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            689999999999999999753210                                                        


Q ss_pred             -------CcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc-------------C
Q 047719          381 -------SIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP-------------A  440 (596)
Q Consensus       381 -------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~-------------~  440 (596)
                             ...++|.++..++.||++||+|||+   .+++||||||+|||++.++.+||+|||++..             .
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                   1247888999999999999999999   8999999999999999999999999997642             1


Q ss_pred             CCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHHHHHHH
Q 047719          441 GTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERM  519 (596)
Q Consensus       441 gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l  519 (596)
                      ++..|+|||.+.+..++.++|||||||++|||++ |..||.......  ........+.....     ..    .....+
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~~~~~~~-----~~----~~~~~~  311 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRRLKEGTRMRA-----PD----YTTPEM  311 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--HHHHHHhccCCCCC-----CC----CCCHHH
Confidence            3457999999988899999999999999999997 999987542210  11111111111110     11    112457


Q ss_pred             HHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          520 LMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       520 ~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                      .+++..||+.+|++||++.|+++.|+..
T Consensus       312 ~~~~~~cl~~~p~~Rps~~eil~~l~~~  339 (343)
T cd05103         312 YQTMLDCWHGEPSQRPTFSELVEHLGNL  339 (343)
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            8888999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=3.6e-36  Score=301.94  Aligned_cols=239  Identities=31%  Similarity=0.396  Sum_probs=192.0

Q ss_pred             CCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceee-eCCeEEEEEe
Q 047719          285 GFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCC-EGNELVLVYE  363 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~-~~~~~~lV~E  363 (596)
                      +|...+.||+|+||.||++.. .|..||+|.++...    ..+.+.+|+..+. .++|+|++++++++. +....++|||
T Consensus         7 ~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~----~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (256)
T cd05082           7 ELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA----TAQAFLAEASVMT-QLRHSNLVQLLGVIVEEKGGLYIVTE   80 (256)
T ss_pred             hCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc----hHHHHHHHHHHHH-hCCCCCeeeEEEEEEcCCCceEEEEE
Confidence            577789999999999999976 47889999985322    2346788886555 489999999999765 4567899999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc----
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP----  439 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~----  439 (596)
                      |+++++|.+++.....  ..+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||.+..    
T Consensus        81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  155 (256)
T cd05082          81 YMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  155 (256)
T ss_pred             CCCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence            9999999999986542  348899999999999999999999   8999999999999999999999999997653    


Q ss_pred             ----CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHH
Q 047719          440 ----AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRK  514 (596)
Q Consensus       440 ----~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  514 (596)
                          .++..|+|||.+....++.++|||||||++|||++ |+.||.....  .+....... +.         .......
T Consensus       156 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~--~~~~~~~~~-~~---------~~~~~~~  223 (256)
T cd05082         156 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRVEK-GY---------KMDAPDG  223 (256)
T ss_pred             CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHhc-CC---------CCCCCCC
Confidence                23557999999988889999999999999999998 9999875422  122211111 10         0111122


Q ss_pred             HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          515 EMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       515 ~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                      ....+.+++.+|++.+|++|||+.++++.|+.
T Consensus       224 ~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         224 CPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             CCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence            34567788899999999999999999999874

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=4.3e-36  Score=300.76  Aligned_cols=239  Identities=31%  Similarity=0.475  Sum_probs=193.8

Q ss_pred             ceeecCCceEEEEEEcCC----CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecC
Q 047719          290 RIVGEGASATVYKGSLPS----GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYL  365 (596)
Q Consensus       290 ~~LG~G~fG~Vy~~~~~~----g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~  365 (596)
                      +.||+|+||.||++....    +..||+|.+....... ....+.+|+..+.. ++|+|++++++++......++||||+
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~-~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKK-LGHPNVVRLLGVCTEEEPLYLVLEYM   78 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhh-cCCCChheeeeeecCCCceEEEEEec
Confidence            469999999999998754    7889999997544332 45678888866554 88999999999999999999999999


Q ss_pred             CCCCHHHHhhhCCCC-----CcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc-
Q 047719          366 PNGSLDKILHNNSSS-----SIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP-  439 (596)
Q Consensus       366 ~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~-  439 (596)
                      ++++|.+++......     ...+++..++.++.|++.||+|||+   .+++||||||+||++++++.+||+|||.+.. 
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~  155 (262)
T cd00192          79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDV  155 (262)
T ss_pred             cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccc
Confidence            999999999875211     2458999999999999999999999   8999999999999999999999999987643 


Q ss_pred             ------------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhcccc
Q 047719          440 ------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADFR  506 (596)
Q Consensus       440 ------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~  506 (596)
                                  .++..|+|||.+....++.++|||||||++|||++ |+.||......  + .......+..       
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~-~~~~~~~~~~-------  225 (262)
T cd00192         156 YDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE--E-VLEYLRKGYR-------  225 (262)
T ss_pred             ccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH--H-HHHHHHcCCC-------
Confidence                        25678999999988889999999999999999999 69999765321  1 1111111111       


Q ss_pred             ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 047719          507 LRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK  545 (596)
Q Consensus       507 l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~  545 (596)
                        ...+......+.+++.+|++.+|++|||+.|+++.|+
T Consensus       226 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         226 --LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             --CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence              1112223457788889999999999999999998874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=4.9e-36  Score=306.14  Aligned_cols=252  Identities=24%  Similarity=0.254  Sum_probs=186.2

Q ss_pred             CCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHh--ccCCCceeeecceeee-----CC
Q 047719          285 GFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAG--CLRHKNLVQLQGWCCE-----GN  356 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~--~l~H~niv~l~g~~~~-----~~  356 (596)
                      +|...+.||+|+||.||+|... +++.||+|.++...........+.+|+..+..  .++||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            3677889999999999999865 58899999986543322223345566644433  2479999999998864     34


Q ss_pred             eEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCC
Q 047719          357 ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEA  436 (596)
Q Consensus       357 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~  436 (596)
                      ..++||||++ ++|.+++.....  ..+++..+..++.|++.||.|||+   .+++||||||+|||++.++.+||+|||.
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~  154 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKVPP--PGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGL  154 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCc
Confidence            5899999997 489999876432  348999999999999999999999   8999999999999999999999999997


Q ss_pred             ccc----------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChh-HHHHHHHHHhcCCc------
Q 047719          437 TIP----------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV-IVDWVWNLRKKGKL------  499 (596)
Q Consensus       437 ~~~----------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~-~~~~~~~~~~~~~~------  499 (596)
                      +..          .||..|+|||.+.+..++.++|||||||++|||++|++||...... ...-..........      
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd07863         155 ARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD  234 (288)
T ss_pred             cccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence            642          4688899999999888999999999999999999999999764321 11111111000000      


Q ss_pred             hhh----ccccc---cCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          500 LDA----ADFRL---RGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       500 ~~~----~d~~l---~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ...    .....   ......+....+.+++.+|++.||++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            000    00000   00011122345678889999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=3e-36  Score=319.96  Aligned_cols=249  Identities=21%  Similarity=0.261  Sum_probs=189.3

Q ss_pred             CCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCC-----eE
Q 047719          285 GFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGN-----EL  358 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~-----~~  358 (596)
                      +|+..+.||+|+||.||++... +++.||||++............+.+|+..+.. ++|+||+++++++....     ..
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~~~~~   79 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCF-FKHDNVLSALDILQPPHIDPFEEI   79 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHh-CCCCCcCCHhheecCCCccccceE
Confidence            4778899999999999999864 68999999986433333344567889866654 89999999999998776     79


Q ss_pred             EEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc
Q 047719          359 VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI  438 (596)
Q Consensus       359 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~  438 (596)
                      |+|+||+. ++|.+++....    .+++..+..++.||+.||+|||+   .+++||||||+|||++.++.+||+|||++.
T Consensus        80 ~lv~e~~~-~~l~~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~  151 (372)
T cd07853          80 YVVTELMQ-SDLHKIIVSPQ----PLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLAR  151 (372)
T ss_pred             EEEeeccc-cCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEecccccee
Confidence            99999996 58888886543    48999999999999999999999   899999999999999999999999999754


Q ss_pred             ------------cCCCcccCCccccccC-CCCCccceeehhHHHHHHHhCCCCCCCCChh-HHHHHHHHHhcCCchh---
Q 047719          439 ------------PAGTMGYLAPEYVYSG-VPSEKTDVYSFGVVALEVAAGKSPVDNDGCV-IVDWVWNLRKKGKLLD---  501 (596)
Q Consensus       439 ------------~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~El~tG~~p~~~~~~~-~~~~~~~~~~~~~~~~---  501 (596)
                                  ..+|..|+|||.+.+. .++.++|||||||++|||++|+.||...... ..+.+..........+   
T Consensus       152 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~  231 (372)
T cd07853         152 VEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRS  231 (372)
T ss_pred             ecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence                        2367889999998764 5799999999999999999999999765321 1111111000000000   


Q ss_pred             -------hc-c----c-cc--cCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          502 -------AA-D----F-RL--RGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       502 -------~~-d----~-~l--~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                             .. .    + ..  ...........+.+++.+|++.||++|||+.|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  287 (372)
T cd07853         232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA  287 (372)
T ss_pred             hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence                   00 0    0 00  00011122356778899999999999999999986

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.4e-37  Score=305.66  Aligned_cols=247  Identities=23%  Similarity=0.328  Sum_probs=187.2

Q ss_pred             cCCCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCC-----e
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGN-----E  357 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~-----~  357 (596)
                      ..|...+++|+|+||.||+|.+.+ ++.||||+...+..-      --+|++.|. .++|||||+|+-++....     .
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~------knrEl~im~-~l~HpNIV~L~~~f~~~~~~d~~~   96 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY------KNRELQIMR-KLDHPNIVRLLYFFSSSTESDEVY   96 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc------CcHHHHHHH-hcCCcCeeeEEEEEEecCCCchhH
Confidence            345667999999999999998765 789999998543321      235665665 599999999998887533     3


Q ss_pred             EEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCC-CceEEccCCC
Q 047719          358 LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAE-FNAKLGDFEA  436 (596)
Q Consensus       358 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~-~~~kl~Dfg~  436 (596)
                      +.|||||||. +|.++++........++...+.-+..||.+||+|||+   .+|+||||||+|+|+|.+ +.+||||||.
T Consensus        97 lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGS  172 (364)
T KOG0658|consen   97 LNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGS  172 (364)
T ss_pred             HHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCc
Confidence            5789999987 9999998643334457777888899999999999999   999999999999999987 9999999998


Q ss_pred             cccC----------CCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCCh--hHHHHHHHHHhcCCc----
Q 047719          437 TIPA----------GTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGC--VIVDWVWNLRKKGKL----  499 (596)
Q Consensus       437 ~~~~----------gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~--~~~~~~~~~~~~~~~----  499 (596)
                      +...          .|..|.|||++.+ ..|+.+.||||.||++.||+-|++-|.++..  .+... ......+..    
T Consensus       173 AK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eI-ik~lG~Pt~e~I~  251 (364)
T KOG0658|consen  173 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEI-IKVLGTPTREDIK  251 (364)
T ss_pred             ceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHH-HHHhCCCCHHHHh
Confidence            7542          4667999999987 4799999999999999999999999988543  12111 111111111    


Q ss_pred             ------hhhccccccC-----cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          500 ------LDAADFRLRG-----KFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       500 ------~~~~d~~l~~-----~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                            .+...+.+..     .+........++++.++++.+|.+|.++.|++.
T Consensus       252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence                  1111111111     122344567788889999999999999999876

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=4.4e-36  Score=311.13  Aligned_cols=249  Identities=24%  Similarity=0.391  Sum_probs=196.1

Q ss_pred             cCCCccceeecCCceEEEEEEcC--------CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeC
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP--------SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG  355 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~--------~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~  355 (596)
                      .+|...+.||+|+||.||++...        ....+|+|+++... ......++..|+..+.+..+||||++++++|...
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            45777899999999999999642        24579999986432 2233456788887776644799999999999999


Q ss_pred             CeEEEEEecCCCCCHHHHhhhCCC------------CCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceee
Q 047719          356 NELVLVYEYLPNGSLDKILHNNSS------------SSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILL  423 (596)
Q Consensus       356 ~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl  423 (596)
                      +..++||||+++|+|.+++.....            ....++|.+++.++.|++.||.|||+   .+++||||||+|||+
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill  167 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLV  167 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEE
Confidence            999999999999999999976431            12358999999999999999999998   899999999999999


Q ss_pred             cCCCceEEccCCCcccC-------------CCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHH
Q 047719          424 DAEFNAKLGDFEATIPA-------------GTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDW  489 (596)
Q Consensus       424 ~~~~~~kl~Dfg~~~~~-------------gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~  489 (596)
                      +.++.+||+|||.+...             ++..|+|||.+..+.++.++|||||||++|||++ |..||......  + 
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--~-  244 (314)
T cd05099         168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE--E-  244 (314)
T ss_pred             cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH--H-
Confidence            99999999999976432             2346999999988889999999999999999999 89998764321  1 


Q ss_pred             HHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Q 047719          490 VWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEA  548 (596)
Q Consensus       490 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~~  548 (596)
                      .......+...         ..+......+.+++.+|++.+|++||++.++++.|+...
T Consensus       245 ~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~  294 (314)
T cd05099         245 LFKLLREGHRM---------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL  294 (314)
T ss_pred             HHHHHHcCCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence            11111111111         111222346678889999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=3.6e-36  Score=301.69  Aligned_cols=243  Identities=33%  Similarity=0.444  Sum_probs=193.0

Q ss_pred             CCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEec
Q 047719          286 FNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEY  364 (596)
Q Consensus       286 f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~  364 (596)
                      |...+.||+|+||+||++.... ++.+|+|++..............+|+..+.+ ++|+||+++++++......++||||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~-l~~~~i~~~~~~~~~~~~~~~v~~~   79 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRR-LRHPNIVQILDVFQDDNYLYIVMEY   79 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHH-HTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccc-ccccccccccccccccccccccccc
Confidence            3456899999999999998765 6689999998765544444445568866655 7999999999999999999999999


Q ss_pred             CCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc------
Q 047719          365 LPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI------  438 (596)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~------  438 (596)
                      +++++|.+++....    .+++..++.++.|+++||++||+   .+++|+||||+||+++.++.++|+|||.+.      
T Consensus        80 ~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~  152 (260)
T PF00069_consen   80 CPGGSLQDYLQKNK----PLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENN  152 (260)
T ss_dssp             ETTEBHHHHHHHHS----SBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTT
T ss_pred             cccccccccccccc----ccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence            99999999998332    48999999999999999999999   899999999999999999999999999864      


Q ss_pred             -----cCCCcccCCccccc-cCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCC
Q 047719          439 -----PAGTMGYLAPEYVY-SGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFN  512 (596)
Q Consensus       439 -----~~gt~~y~aPE~~~-~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  512 (596)
                           ..++..|+|||.+. ...++.++||||+|+++|||++|..|+......-................    .  ...
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~----~--~~~  226 (260)
T PF00069_consen  153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSS----S--QQS  226 (260)
T ss_dssp             SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHH----T--TSH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccc----c--ccc
Confidence                 24788999999998 78899999999999999999999999987521111111111111000000    0  000


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          513 RKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       513 ~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ......+.+++..|++.||++||++.++++
T Consensus       227 ~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  227 REKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             TTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             chhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            011267888889999999999999999875

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=4.7e-36  Score=303.21  Aligned_cols=248  Identities=23%  Similarity=0.350  Sum_probs=196.1

Q ss_pred             CCCccceeecCCceEEEEEEcCC--CCEEEEEEeecCCc--------hhcccchHHHHHHHHHhccCCCceeeecceeee
Q 047719          285 GFNKNRIVGEGASATVYKGSLPS--GGAVAVKRFEKPNR--------VECARNPFTTEFATMAGCLRHKNLVQLQGWCCE  354 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~~--g~~vAvK~l~~~~~--------~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~  354 (596)
                      +|...+.||+|+||.||+|....  ++.+|+|.+.....        ......++..|+..+.+.++|+||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            46777899999999999998765  67899998853221        122334567788767667899999999999999


Q ss_pred             CCeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccC
Q 047719          355 GNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF  434 (596)
Q Consensus       355 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Df  434 (596)
                      ++..++||||+++++|.+++.........+++..++.++.|++.||.|||+.  .+++|+||||+||+++.++.+||+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEecc
Confidence            9999999999999999999865332234589999999999999999999952  68999999999999999999999999


Q ss_pred             CCcc----------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhcc
Q 047719          435 EATI----------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAAD  504 (596)
Q Consensus       435 g~~~----------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d  504 (596)
                      |.+.          ..|+..|+|||.+.+..++.++||||||+++|||++|+.||.....  ........ .+.....  
T Consensus       159 g~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~--~~~~~~~~-~~~~~~~--  233 (269)
T cd08528         159 GLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM--LSLATKIV-EAVYEPL--  233 (269)
T ss_pred             cceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH--HHHHHHHh-hccCCcC--
Confidence            9753          3478889999999988899999999999999999999999975432  11111111 1111000  


Q ss_pred             ccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 047719          505 FRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK  545 (596)
Q Consensus       505 ~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~  545 (596)
                        .    .......+.+++.+||+.||++||++.|+..+++
T Consensus       234 --~----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         234 --P----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             --C----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence              0    1112345778888999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=3.4e-36  Score=307.71  Aligned_cols=241  Identities=22%  Similarity=0.286  Sum_probs=190.8

Q ss_pred             CCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchh-cccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          286 FNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVE-CARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       286 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~-~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      |...+.||+|+||.||++... +++.||||.+....... .....+..|+..+ +.++|+|++++++.+.+.+..++|||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il-~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQIL-EKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHH-HhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            666789999999999999765 58899999986433221 2234467788555 45899999999999999999999999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc-----
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI-----  438 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~-----  438 (596)
                      |+++++|.+++....  ...+++.++..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++.     
T Consensus        81 ~~~g~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05630          81 LMNGGDLKFHIYHMG--EAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  155 (285)
T ss_pred             ecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence            999999999997543  2348899999999999999999999   899999999999999999999999999753     


Q ss_pred             -----cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHH-HHHHHHHhcCCchhhccccccCcCC
Q 047719          439 -----PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIV-DWVWNLRKKGKLLDAADFRLRGKFN  512 (596)
Q Consensus       439 -----~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~-~~~~~~~~~~~~~~~~d~~l~~~~~  512 (596)
                           ..|+..|+|||.+.+..++.++|||||||++|||++|+.||........ +-.......      ..    ..+.
T Consensus       156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~------~~----~~~~  225 (285)
T cd05630         156 QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE------VQ----EEYS  225 (285)
T ss_pred             ccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh------hh----hhcC
Confidence                 2478899999999998999999999999999999999999986432111 001111000      00    0111


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHH
Q 047719          513 RKEMERMLMVGLSCVHPNHEKRPS-----VKEAAR  542 (596)
Q Consensus       513 ~~~~~~l~~l~~~C~~~dp~~RPs-----~~ev~~  542 (596)
                      ......+.+++..|++.||++|||     ++|+++
T Consensus       226 ~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         226 EKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             ccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            122345678888999999999999     778776

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=4e-36  Score=303.70  Aligned_cols=242  Identities=25%  Similarity=0.399  Sum_probs=193.7

Q ss_pred             cCCCccceeecCCceEEEEEEcC-C---CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-S---GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELV  359 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~---g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~  359 (596)
                      .+|...+.||+|+||.||+|... +   +..+|+|.++.... ......+..|+..+.+ ++||||+++++++..++..+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~   81 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT-EKQRRDFLSEASIMGQ-FDHPNIIHLEGVVTKSKPVM   81 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC-HHHHHHHHHHHHHHHh-CCCCCcceEEEEEecCCccE
Confidence            35777899999999999999763 2   33799999864332 2344578888866654 89999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc
Q 047719          360 LVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP  439 (596)
Q Consensus       360 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~  439 (596)
                      +||||+++++|.+++....   ..+++.+++.++.|++.||+|||+   .+++||||||+|||++.++.++|+|||.+..
T Consensus        82 lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~  155 (267)
T cd05066          82 IVTEYMENGSLDAFLRKHD---GQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRV  155 (267)
T ss_pred             EEEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCcccc
Confidence            9999999999999997653   248999999999999999999999   8999999999999999999999999987643


Q ss_pred             C--------------CCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCCh-hHHHHHHHHHhcCCchhhc
Q 047719          440 A--------------GTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGC-VIVDWVWNLRKKGKLLDAA  503 (596)
Q Consensus       440 ~--------------gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~-~~~~~~~~~~~~~~~~~~~  503 (596)
                      .              ++..|+|||.+.+..++.++|||||||++||+++ |+.||..... ......    ..+..    
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~----~~~~~----  227 (267)
T cd05066         156 LEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI----EEGYR----  227 (267)
T ss_pred             cccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHH----hCCCc----
Confidence            1              2346999999998889999999999999999887 9999975432 111111    11100    


Q ss_pred             cccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          504 DFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       504 d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                           ..........+.+++.+|++.+|.+||+|.++++.|+.
T Consensus       228 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  265 (267)
T cd05066         228 -----LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK  265 (267)
T ss_pred             -----CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence                 01111223466788899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-36  Score=315.73  Aligned_cols=242  Identities=25%  Similarity=0.365  Sum_probs=203.9

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCe-EEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNE-LVLV  361 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~-~~lV  361 (596)
                      ++|...+++|+|+||.++..+.+ ++..+++|.+......+..++...+|+..+.+ ++|||||.+.+.|.+++. ++||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~-~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSK-LLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHh-ccCCCeeeeccchhcCCceEEEE
Confidence            35677799999999999988765 47899999998777776667778889855555 999999999999999998 9999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc---
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI---  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---  438 (596)
                      |+|++||+|.+.|....  ...+++.....+..|++.|+.|||+   ..|+|||||+.|||++.+..+||+|||++.   
T Consensus        83 m~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~  157 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILN  157 (426)
T ss_pred             EeecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcC
Confidence            99999999999998765  3458999999999999999999998   899999999999999999999999999763   


Q ss_pred             --------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCc
Q 047719          439 --------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGK  510 (596)
Q Consensus       439 --------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  510 (596)
                              ..||+.||+||.+.+..|..|+|+|||||++|||++-+++|...+..  ..+.+...          .....
T Consensus       158 ~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~--~Li~ki~~----------~~~~P  225 (426)
T KOG0589|consen  158 PEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS--ELILKINR----------GLYSP  225 (426)
T ss_pred             CchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH--HHHHHHhh----------ccCCC
Confidence                    46999999999999999999999999999999999999999876431  11111111          11223


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 047719          511 FNRKEMERMLMVGLSCVHPNHEKRPSVKEAARI  543 (596)
Q Consensus       511 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~  543 (596)
                      .+......+..++..|++.+|+.||++.+++..
T Consensus       226 lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  226 LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            344455667778889999999999999999873

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.2e-35  Score=299.93  Aligned_cols=232  Identities=26%  Similarity=0.375  Sum_probs=180.3

Q ss_pred             ceeecCCceEEEEEEcCC-------------CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCC
Q 047719          290 RIVGEGASATVYKGSLPS-------------GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGN  356 (596)
Q Consensus       290 ~~LG~G~fG~Vy~~~~~~-------------g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~  356 (596)
                      +.||+|+||.||+|.+..             ...||+|.+....  ......+..|+. +.+.++||||+++++++..+.
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~-~l~~l~hp~iv~~~~~~~~~~   77 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETAS-MMRQVSHKHIVLLYGVCVRDV   77 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHH-HHHhCCCCCEeeEEEEEecCC
Confidence            468999999999997532             2258999875422  223345667764 445589999999999999999


Q ss_pred             eEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCc-------e
Q 047719          357 ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFN-------A  429 (596)
Q Consensus       357 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~-------~  429 (596)
                      ..++||||+++|+|..++....   ..+++..++.++.||++||+|||+   .+|+||||||+|||++.++.       +
T Consensus        78 ~~~lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~  151 (262)
T cd05077          78 ENIMVEEFVEFGPLDLFMHRKS---DVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFI  151 (262)
T ss_pred             CCEEEEecccCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCcee
Confidence            9999999999999999987543   248999999999999999999999   89999999999999987664       8


Q ss_pred             EEccCCCccc-------CCCcccCCccccc-cCCCCCccceeehhHHHHHHH-hCCCCCCCCChhHHHHHHHHHhcCCch
Q 047719          430 KLGDFEATIP-------AGTMGYLAPEYVY-SGVPSEKTDVYSFGVVALEVA-AGKSPVDNDGCVIVDWVWNLRKKGKLL  500 (596)
Q Consensus       430 kl~Dfg~~~~-------~gt~~y~aPE~~~-~~~~t~~sDV~SfGvll~El~-tG~~p~~~~~~~~~~~~~~~~~~~~~~  500 (596)
                      |++|||.+..       .++..|+|||.+. ...++.++|||||||++|||+ +|+.|+.........   ..... .. 
T Consensus       152 ~l~d~g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~---~~~~~-~~-  226 (262)
T cd05077         152 KLSDPGIPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE---RFYEG-QC-  226 (262)
T ss_pred             EeCCCCCCccccCcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH---HHHhc-Cc-
Confidence            9999997643       3678899999887 467899999999999999998 488888654211111   11111 00 


Q ss_pred             hhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 047719          501 DAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARIL  544 (596)
Q Consensus       501 ~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L  544 (596)
                           ....    .....+.+|+.+||+.||++||++.++++.+
T Consensus       227 -----~~~~----~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         227 -----MLVT----PSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             -----cCCC----CChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence                 0111    1234577889999999999999999998876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=6.9e-36  Score=300.74  Aligned_cols=240  Identities=23%  Similarity=0.399  Sum_probs=194.1

Q ss_pred             cCCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      .+|...+.||+|+||.||++...++..+|+|.+....   .....+.+|+..+.+ ++|+|++++++.+.+ ...+++||
T Consensus         6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~-~~~~~v~e   80 (260)
T cd05073           6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMKT-LQHDKLVKLHAVVTK-EPIYIITE   80 (260)
T ss_pred             cceeEEeEecCccceEEEEEEecCCccEEEEecCCCh---hHHHHHHHHHHHHHh-cCCCCcceEEEEEcC-CCeEEEEE
Confidence            4577789999999999999998778889999885432   234568888866554 899999999999887 77899999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc----
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP----  439 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~----  439 (596)
                      |+++++|.+++....  ...+++..++.++.|++.||.|||+   .+++||||||+||+++.++.+||+|||.+..    
T Consensus        81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  155 (260)
T cd05073          81 FMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDN  155 (260)
T ss_pred             eCCCCcHHHHHHhCC--ccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence            999999999997643  2358899999999999999999998   8999999999999999999999999986532    


Q ss_pred             --------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChh-HHHHHHHHHhcCCchhhccccccC
Q 047719          440 --------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCV-IVDWVWNLRKKGKLLDAADFRLRG  509 (596)
Q Consensus       440 --------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~-~~~~~~~~~~~~~~~~~~d~~l~~  509 (596)
                              .++..|+|||.+....++.++|+|||||++||+++ |+.||...... +..    ....+...         
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~----~~~~~~~~---------  222 (260)
T cd05073         156 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR----ALERGYRM---------  222 (260)
T ss_pred             CcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHH----HHhCCCCC---------
Confidence                    13456999999988889999999999999999999 99999764321 111    11111110         


Q ss_pred             cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          510 KFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       510 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                      .........+.+++.+|++.+|++||++.++.+.|+.
T Consensus       223 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         223 PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            1112233567788899999999999999999999974

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5.8e-36  Score=304.23  Aligned_cols=232  Identities=25%  Similarity=0.384  Sum_probs=180.0

Q ss_pred             eeecCCceEEEEEEcCC-------------------------CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCce
Q 047719          291 IVGEGASATVYKGSLPS-------------------------GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL  345 (596)
Q Consensus       291 ~LG~G~fG~Vy~~~~~~-------------------------g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~ni  345 (596)
                      .||+|+||.||+|.+..                         ...||+|++....  .....++.+|+. +.+.++||||
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~-~~~~l~h~ni   78 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETAS-LMSQVSHIHL   78 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHH-HHhcCCCCCe
Confidence            59999999999997421                         1358999885322  223345777764 4456999999


Q ss_pred             eeecceeeeCCeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecC
Q 047719          346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDA  425 (596)
Q Consensus       346 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~  425 (596)
                      ++++++|.+....++||||+++|+|..++....   ..+++..++.++.||++||+|||+   ++|+||||||+|||++.
T Consensus        79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~  152 (274)
T cd05076          79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK---GRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLAR  152 (274)
T ss_pred             eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEec
Confidence            999999999999999999999999999997543   247899999999999999999998   89999999999999976


Q ss_pred             CC-------ceEEccCCCccc-------CCCcccCCcccccc-CCCCCccceeehhHHHHHHH-hCCCCCCCCChhHHHH
Q 047719          426 EF-------NAKLGDFEATIP-------AGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVA-AGKSPVDNDGCVIVDW  489 (596)
Q Consensus       426 ~~-------~~kl~Dfg~~~~-------~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~-tG~~p~~~~~~~~~~~  489 (596)
                      .+       .+|++|||.+..       .++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||..........
T Consensus       153 ~~~~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~  232 (274)
T cd05076         153 LGLAEGTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER  232 (274)
T ss_pred             cCcccCccceeeecCCccccccccccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence            43       389999997532       36788999998875 56899999999999999995 6999997643221111


Q ss_pred             HHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 047719          490 VWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK  545 (596)
Q Consensus       490 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~  545 (596)
                      .   .....       ....    .....+.+++..||+.+|++||+++++++.|+
T Consensus       233 ~---~~~~~-------~~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         233 F---YEKKH-------RLPE----PSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             H---HHhcc-------CCCC----CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            1   11100       0111    11235778889999999999999999998773

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=5e-36  Score=303.16  Aligned_cols=241  Identities=24%  Similarity=0.396  Sum_probs=192.7

Q ss_pred             CCCccceeecCCceEEEEEEcCC-C---CEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEE
Q 047719          285 GFNKNRIVGEGASATVYKGSLPS-G---GAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVL  360 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~~-g---~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~l  360 (596)
                      .|...+.||+|+||.||+|.... +   ..||||++.... ......+|..|+..+.. ++||||+++++++.+....++
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~-l~h~ni~~~~~~~~~~~~~~l   82 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQ-FDHPNIIHLEGVVTKSRPVMI   82 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHh-CCCcCcceEEEEECCCCceEE
Confidence            35677899999999999998653 3   369999986432 23345678889866554 899999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcccC
Q 047719          361 VYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA  440 (596)
Q Consensus       361 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~~  440 (596)
                      ||||+++|+|.+++....   ..+++.+++.++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||.+...
T Consensus        83 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~  156 (269)
T cd05065          83 ITEFMENGALDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFL  156 (269)
T ss_pred             EEecCCCCcHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCcccccc
Confidence            999999999999997653   248999999999999999999999   89999999999999999999999999875321


Q ss_pred             ----------------CCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCCh-hHHHHHHHHHhcCCchhh
Q 047719          441 ----------------GTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGC-VIVDWVWNLRKKGKLLDA  502 (596)
Q Consensus       441 ----------------gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~-~~~~~~~~~~~~~~~~~~  502 (596)
                                      .+..|+|||.+....++.++|||||||++||+++ |..||..... ....++    ....    
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i----~~~~----  228 (269)
T cd05065         157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI----EQDY----  228 (269)
T ss_pred             ccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHH----HcCC----
Confidence                            1246999999998899999999999999999887 9999975432 111111    1110    


Q ss_pred             ccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          503 ADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       503 ~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                           ....+.+....+.+++..||+.+|.+||++++++..|+.
T Consensus       229 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  267 (269)
T cd05065         229 -----RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK  267 (269)
T ss_pred             -----cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence                 001111223456788899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=5.4e-36  Score=300.33  Aligned_cols=239  Identities=28%  Similarity=0.386  Sum_probs=194.0

Q ss_pred             CCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEec
Q 047719          285 GFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEY  364 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~  364 (596)
                      +|...+.||+|+||.||++...++..+|+|.+.....   ...++.+|+..+.+ ++|||++++++++......++||||
T Consensus         5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd05112           5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM---SEEDFIEEAQVMMK-LSHPKLVQLYGVCTERSPICLVFEF   80 (256)
T ss_pred             HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC---CHHHHHHHHHHHHh-CCCCCeeeEEEEEccCCceEEEEEc
Confidence            5667789999999999999887788999999854322   23468889865554 8999999999999999999999999


Q ss_pred             CCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcccC----
Q 047719          365 LPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA----  440 (596)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~~----  440 (596)
                      +++++|.+++....   ..+++..+..++.+++.||+|||+   .+++||||||+||+++.++.+||+|||.+...    
T Consensus        81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  154 (256)
T cd05112          81 MEHGCLSDYLRAQR---GKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ  154 (256)
T ss_pred             CCCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCc
Confidence            99999999997653   247899999999999999999999   89999999999999999999999999975421    


Q ss_pred             --------CCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcC
Q 047719          441 --------GTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKF  511 (596)
Q Consensus       441 --------gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  511 (596)
                              ++..|+|||.+.++.++.++|||||||++|||++ |+.||.....  .............   ..+      
T Consensus       155 ~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~~~---~~~------  223 (256)
T cd05112         155 YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN--SEVVETINAGFRL---YKP------  223 (256)
T ss_pred             ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH--HHHHHHHhCCCCC---CCC------
Confidence                    3457999999988889999999999999999998 9999976432  1122222111110   011      


Q ss_pred             CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 047719          512 NRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK  545 (596)
Q Consensus       512 ~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~  545 (596)
                       ......+.+++.+||+.+|++||++.++++.|+
T Consensus       224 -~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         224 -RLASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             -CCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence             112356888999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=9.1e-36  Score=310.62  Aligned_cols=245  Identities=23%  Similarity=0.313  Sum_probs=185.3

Q ss_pred             cceeecC--CceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecC
Q 047719          289 NRIVGEG--ASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYL  365 (596)
Q Consensus       289 ~~~LG~G--~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~  365 (596)
                      .++||+|  +|++||++... +|+.||||++............+.+|+ .+.+.++||||++++++|..++..++||||+
T Consensus         3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~-~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGEL-HVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHH-HHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            4789999  78999999765 589999999965433233333455666 4555589999999999999999999999999


Q ss_pred             CCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc-------
Q 047719          366 PNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI-------  438 (596)
Q Consensus       366 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~-------  438 (596)
                      ++|+|.+++.....  ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.++++||+...       
T Consensus        82 ~~~~l~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~  156 (327)
T cd08227          82 AYGSAKDLICTHFM--DGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ  156 (327)
T ss_pred             CCCcHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence            99999999976432  248899999999999999999999   899999999999999999999999996321       


Q ss_pred             -----------cCCCcccCCcccccc--CCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhcc-
Q 047719          439 -----------PAGTMGYLAPEYVYS--GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAAD-  504 (596)
Q Consensus       439 -----------~~gt~~y~aPE~~~~--~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d-  504 (596)
                                 ..++..|+|||.+.+  ..++.++|||||||++|||++|+.||.......  ...... .+......+ 
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~-~~~~~~~~~~  233 (327)
T cd08227         157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKL-NGTVPCLLDT  233 (327)
T ss_pred             cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH--HHHHHh-cCCccccccc
Confidence                       134567999999876  468999999999999999999999997532211  000000 000000000 


Q ss_pred             ------------------c-----------------cccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          505 ------------------F-----------------RLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       505 ------------------~-----------------~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                                        .                 .............+.+++..|++.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         234 TTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             cchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence                              0                 0000111223456788999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=4.5e-36  Score=303.16  Aligned_cols=239  Identities=26%  Similarity=0.418  Sum_probs=189.6

Q ss_pred             ceeecCCceEEEEEEcCC-------CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          290 RIVGEGASATVYKGSLPS-------GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       290 ~~LG~G~fG~Vy~~~~~~-------g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      +.||+|+||.||+|...+       +..+|||.+.+.. ......++.+|+..+. .++||||++++++|...+..++||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~~v~   78 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMS-NFNHPNIVKLLGVCLLNEPQYIIM   78 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHH-hcCCCCeeeEeeeecCCCCeEEEE
Confidence            368999999999997643       2579999885432 2233456888886654 489999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCC---CCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCC-----ceEEccC
Q 047719          363 EYLPNGSLDKILHNNSS---SSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEF-----NAKLGDF  434 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~-----~~kl~Df  434 (596)
                      ||+++++|.+++.....   ....++|.+++.++.|++.||+|||+   .+++|+||||+||+++.+.     .++|+||
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~df  155 (269)
T cd05044          79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDF  155 (269)
T ss_pred             eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCc
Confidence            99999999999976432   12348899999999999999999998   8999999999999999887     8999999


Q ss_pred             CCccc-------------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCch
Q 047719          435 EATIP-------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLL  500 (596)
Q Consensus       435 g~~~~-------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~  500 (596)
                      |++..             .++..|+|||.+.++.++.++|||||||++|||++ |+.||......  +...... .+.  
T Consensus       156 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~--~~~~~~~-~~~--  230 (269)
T cd05044         156 GLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ--EVLQHVT-AGG--  230 (269)
T ss_pred             ccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH--HHHHHHh-cCC--
Confidence            97642             23578999999999999999999999999999998 99999754321  1111111 111  


Q ss_pred             hhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 047719          501 DAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK  545 (596)
Q Consensus       501 ~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~  545 (596)
                             ....+......+.+++.+||+.+|.+||++.++.+.|+
T Consensus       231 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         231 -------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             -------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence                   01112223456788999999999999999999999886

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=5.1e-36  Score=324.76  Aligned_cols=249  Identities=21%  Similarity=0.274  Sum_probs=184.3

Q ss_pred             hcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeC------
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG------  355 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~------  355 (596)
                      ..+|...+.||+|+||.||+|... .++.||||++....      ....+|+..+. .++|+|||++++++...      
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~-~l~h~niv~l~~~~~~~~~~~~~  137 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMK-NLNHINIIFLKDYYYTECFKKNE  137 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHH-hcCCCCCcceeeeEeecccccCC
Confidence            457888999999999999999875 58899999985322      12346775554 48999999998876432      


Q ss_pred             --CeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCC-ceEEc
Q 047719          356 --NELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEF-NAKLG  432 (596)
Q Consensus       356 --~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~-~~kl~  432 (596)
                        ..+++||||+++ +|.+++.........+++.....++.||+.||+|||+   .+|+||||||+||||+.++ .+||+
T Consensus       138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~  213 (440)
T PTZ00036        138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLC  213 (440)
T ss_pred             CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeee
Confidence              247799999975 7888776433333468999999999999999999999   8999999999999999764 79999


Q ss_pred             cCCCcc----------cCCCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCChh-HHHHHHHHHhcCC--
Q 047719          433 DFEATI----------PAGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV-IVDWVWNLRKKGK--  498 (596)
Q Consensus       433 Dfg~~~----------~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~-~~~~~~~~~~~~~--  498 (596)
                      |||++.          ..||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.... .............  
T Consensus       214 DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~  293 (440)
T PTZ00036        214 DFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED  293 (440)
T ss_pred             ccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            999764          247889999998876 46899999999999999999999999765321 1111111110000  


Q ss_pred             --------chh-----hccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          499 --------LLD-----AADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       499 --------~~~-----~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                              ..+     .....+...++......+.+|+.+||+.||++|||+.|+++
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence                    000     00000111112223356788999999999999999999986

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-37  Score=321.49  Aligned_cols=234  Identities=26%  Similarity=0.381  Sum_probs=197.4

Q ss_pred             cceeecCCceEEEEEEcCC--CC--EEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEec
Q 047719          289 NRIVGEGASATVYKGSLPS--GG--AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEY  364 (596)
Q Consensus       289 ~~~LG~G~fG~Vy~~~~~~--g~--~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~  364 (596)
                      .++||+|.||.|++|.|..  |+  .||||.++..... ....+|++|+..|.+ ++|+|+++|||...+ ..+.+|+|+
T Consensus       115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~-~~mddflrEas~M~~-L~H~hliRLyGvVl~-qp~mMV~EL  191 (1039)
T KOG0199|consen  115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN-AIMDDFLREASHMLK-LQHPHLIRLYGVVLD-QPAMMVFEL  191 (1039)
T ss_pred             HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc-hhHHHHHHHHHHHHh-ccCcceeEEeeeecc-chhhHHhhh
Confidence            4789999999999998854  44  5899999754333 367889999988877 999999999999988 789999999


Q ss_pred             CCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcccCC---
Q 047719          365 LPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG---  441 (596)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~~g---  441 (596)
                      ++.|||.+.|+...  ...|--.....++.|||.||.||.+   +++|||||..+|+||-..-.+||+|||+.+..|   
T Consensus       192 aplGSLldrLrka~--~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne  266 (1039)
T KOG0199|consen  192 APLGSLLDRLRKAK--KAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGENE  266 (1039)
T ss_pred             cccchHHHHHhhcc--ccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence            99999999999833  3347778888999999999999999   999999999999999999999999999987543   


Q ss_pred             -----------CcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhccccccC
Q 047719          442 -----------TMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRG  509 (596)
Q Consensus       442 -----------t~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  509 (596)
                                 ...|.|||.+..++++.+||||+|||++|||+| |+.||.+.....            +++.+|..-+.
T Consensus       267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q------------IL~~iD~~erL  334 (1039)
T KOG0199|consen  267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ------------ILKNIDAGERL  334 (1039)
T ss_pred             cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH------------HHHhccccccC
Confidence                       346899999999999999999999999999999 899998753321            22233333333


Q ss_pred             cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          510 KFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       510 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      .-+..+.+.+.++++.||..+|++|||+..+.+
T Consensus       335 pRPk~csedIY~imk~cWah~paDRptFsair~  367 (1039)
T KOG0199|consen  335 PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE  367 (1039)
T ss_pred             CCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence            445567889999999999999999999999973

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=8e-36  Score=298.19  Aligned_cols=236  Identities=28%  Similarity=0.391  Sum_probs=191.2

Q ss_pred             ceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecCCCCC
Q 047719          290 RIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGS  369 (596)
Q Consensus       290 ~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  369 (596)
                      ++||+|+||.||++...+++.||+|++...... .....+.+|+..+ +.++|+||+++++++......++||||+++++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l-~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~   78 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEIL-KQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS   78 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHH-HhCCCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence            469999999999998877999999998654332 3445688888555 45899999999999999999999999999999


Q ss_pred             HHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcccC---------
Q 047719          370 LDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA---------  440 (596)
Q Consensus       370 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~~---------  440 (596)
                      |.+++....   ..+++..++.++.+++.||+|||+   ++++||||||+|||++.++.+||+|||.+...         
T Consensus        79 l~~~l~~~~---~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~  152 (251)
T cd05041          79 LLTFLRKKK---NRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD  152 (251)
T ss_pred             HHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc
Confidence            999997643   247899999999999999999999   89999999999999999999999999876432         


Q ss_pred             ----CCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHHH
Q 047719          441 ----GTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKE  515 (596)
Q Consensus       441 ----gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  515 (596)
                          ++..|+|||.+.++.++.++|+|||||++|||++ |..||......  ...... ...         .....+...
T Consensus       153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--~~~~~~-~~~---------~~~~~~~~~  220 (251)
T cd05041         153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--QTRERI-ESG---------YRMPAPQLC  220 (251)
T ss_pred             ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--HHHHHH-hcC---------CCCCCCccC
Confidence                2446999999988899999999999999999999 88888764321  111111 111         011112233


Q ss_pred             HHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 047719          516 MERMLMVGLSCVHPNHEKRPSVKEAARILK  545 (596)
Q Consensus       516 ~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~  545 (596)
                      ...+.+++.+|++.+|.+||++.|+++.|+
T Consensus       221 ~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         221 PEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            456888999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.1e-35  Score=297.94  Aligned_cols=240  Identities=25%  Similarity=0.345  Sum_probs=193.1

Q ss_pred             CCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeee-CCeEEEEE
Q 047719          285 GFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE-GNELVLVY  362 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~-~~~~~lV~  362 (596)
                      +|...+.||+|++|.||++... +++.||+|++............+.+|+..+ +.++|+|++++++.+.. ...++++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l-~~l~~~~i~~~~~~~~~~~~~~~lv~   79 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLL-SQLKHPNIVAYRESWEGEDGLLYIVM   79 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHH-HhCCCCCeeeeeeeecCCCCEEEEEe
Confidence            4777899999999999999865 478899999965443334445677887555 45899999999988764 44689999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc----
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI----  438 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~----  438 (596)
                      ||+++++|.+++....  ...+++.++..++.+++.||+|||+   .+++||||||+||+++.++.++|+|||++.    
T Consensus        80 e~~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~  154 (257)
T cd08223          80 GFCEGGDLYHKLKEQK--GKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN  154 (257)
T ss_pred             cccCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecc
Confidence            9999999999998643  2348999999999999999999999   899999999999999999999999998653    


Q ss_pred             -------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcC
Q 047719          439 -------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKF  511 (596)
Q Consensus       439 -------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  511 (596)
                             ..++..|+|||.+.+..++.++|||||||++|||++|+.||...+.  ........ .+.+         ...
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~--~~~~~~~~-~~~~---------~~~  222 (257)
T cd08223         155 QCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM--NSLVYRII-EGKL---------PPM  222 (257)
T ss_pred             cCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH--HHHHHHHH-hcCC---------CCC
Confidence                   2478899999999998999999999999999999999999976432  12222211 1111         112


Q ss_pred             CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          512 NRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       512 ~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      +......+.+++.+|++.+|++||++.++++
T Consensus       223 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         223 PKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             ccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            2234456788999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=8.9e-36  Score=300.84  Aligned_cols=243  Identities=25%  Similarity=0.298  Sum_probs=189.4

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      .+|...+.||+|+||.||+|... +++.||+|++.....  .....+.+|+..+ +.++|+||+++++++......++||
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l-~~~~h~~ii~~~~~~~~~~~~~iv~   85 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMV-KECKHCNIVAYFGSYLSREKLWICM   85 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--chHHHHHHHHHHH-HhcCCCCeeeeeEEEEeCCEEEEEE
Confidence            46788899999999999999864 588999999864322  2233567788555 4589999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc----
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI----  438 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~----  438 (596)
                      ||+++++|.+++....    .+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++.    
T Consensus        86 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06646          86 EYCGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITA  158 (267)
T ss_pred             eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence            9999999999997543    48899999999999999999999   899999999999999999999999998653    


Q ss_pred             -------cCCCcccCCccccc---cCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhcccccc
Q 047719          439 -------PAGTMGYLAPEYVY---SGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLR  508 (596)
Q Consensus       439 -------~~gt~~y~aPE~~~---~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  508 (596)
                             ..|+..|+|||.+.   ...++.++|||||||++|||++|+.|+........  ... .....   ...+...
T Consensus       159 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~--~~~-~~~~~---~~~~~~~  232 (267)
T cd06646         159 TIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--LFL-MSKSN---FQPPKLK  232 (267)
T ss_pred             cccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh--hee-eecCC---CCCCCCc
Confidence                   23677899999874   34578899999999999999999999864321000  000 00000   0001111


Q ss_pred             CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 047719          509 GKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARIL  544 (596)
Q Consensus       509 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L  544 (596)
                      .  .......+.+++..||+.+|++||+++++++.|
T Consensus       233 ~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         233 D--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             c--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            0  112335677889999999999999999998743

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=9.7e-36  Score=298.46  Aligned_cols=240  Identities=24%  Similarity=0.350  Sum_probs=195.7

Q ss_pred             CCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          285 GFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      +|...+.||+|+||.+|++... +|+.||+|++...........++.+|+..+. .++|+||+++++++.+.+..++|||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLS-NMKHPNIVQYQESFEENGNLYIVMD   79 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHH-hCCCCCeeeeEeeecCCCeEEEEEe
Confidence            3677899999999999999764 5889999998654333334457888886554 5999999999999999999999999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc----
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP----  439 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~----  439 (596)
                      |+++++|.+++....  ...+++.+++.++.|++.||.|||+   .+++|+||+|+|||++.++.++|+|||.+..    
T Consensus        80 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~  154 (256)
T cd08218          80 YCEGGDLYKKINAQR--GVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST  154 (256)
T ss_pred             cCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcc
Confidence            999999999997643  2247899999999999999999999   8999999999999999999999999987632    


Q ss_pred             -------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCC
Q 047719          440 -------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFN  512 (596)
Q Consensus       440 -------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  512 (596)
                             .|+..|+|||.+.+..++.++|+|||||+++||++|+.||...+.  .+.+..... +..         ...+
T Consensus       155 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~--~~~~~~~~~-~~~---------~~~~  222 (256)
T cd08218         155 VELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM--KNLVLKIIR-GSY---------PPVS  222 (256)
T ss_pred             hhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH--HHHHHHHhc-CCC---------CCCc
Confidence                   367889999999988899999999999999999999999975432  222222211 111         1112


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          513 RKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       513 ~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ......+.+++.+||+.+|.+||+|.+|++
T Consensus       223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         223 SHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             ccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            233456788899999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.3e-35  Score=300.50  Aligned_cols=250  Identities=23%  Similarity=0.254  Sum_probs=191.0

Q ss_pred             CCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          285 GFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      +|+..+.||+|+||.||+|... +++.||+|++..........+.+.+|+..+. .++|+|++++++++......++|||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~-~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLK-QLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHH-hCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            5777899999999999999876 4889999998654333333445778886554 4899999999999999999999999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc----
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP----  439 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~----  439 (596)
                      |+++++|..++....    .+++..++.++.|++.||+|||+   ++++||||||+||+++.++.+||+|||.+..    
T Consensus        81 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07847          81 YCDHTVLNELEKNPR----GVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGP  153 (286)
T ss_pred             ccCccHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence            999998888876432    48999999999999999999999   8999999999999999999999999987642    


Q ss_pred             -------CCCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCch-----------
Q 047719          440 -------AGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLL-----------  500 (596)
Q Consensus       440 -------~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~-----------  500 (596)
                             .++..|+|||.+.+ ..++.++|||||||++|||++|+.||.+....-..+...........           
T Consensus       154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07847         154 GDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQF  233 (286)
T ss_pred             cccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccc
Confidence                   35678999999876 56789999999999999999999999764321111110000000000           


Q ss_pred             --hhccccccCcCC-----HHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          501 --DAADFRLRGKFN-----RKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       501 --~~~d~~l~~~~~-----~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                        ....+......+     ......+.+++.+|++.+|++||++.|++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence              000000000000     112356778999999999999999998875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=7.1e-36  Score=299.62  Aligned_cols=237  Identities=27%  Similarity=0.372  Sum_probs=191.0

Q ss_pred             ceeecCCceEEEEEEcCC--C--CEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecC
Q 047719          290 RIVGEGASATVYKGSLPS--G--GAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYL  365 (596)
Q Consensus       290 ~~LG~G~fG~Vy~~~~~~--g--~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~  365 (596)
                      ++||+|++|.||+|.+.+  +  ..||||.+...... ...+.+..|+..+.+ ++|+||+++++.+.. ...++||||+
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~-~~~~~v~e~~   77 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHS-LDHENLIRLYGVVLT-HPLMMVTELA   77 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhh-cCCCCccceeEEEcC-CeEEEEEEec
Confidence            468999999999998643  3  36999999654432 455678889866655 899999999999988 8899999999


Q ss_pred             CCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc------
Q 047719          366 PNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP------  439 (596)
Q Consensus       366 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~------  439 (596)
                      ++|+|.+++.+...  ..++|...+.++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||.+..      
T Consensus        78 ~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~  152 (257)
T cd05040          78 PLGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED  152 (257)
T ss_pred             CCCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEecccccccccccccc
Confidence            99999999987542  358999999999999999999999   8999999999999999999999999987542      


Q ss_pred             --------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhccccccCc
Q 047719          440 --------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGK  510 (596)
Q Consensus       440 --------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  510 (596)
                              .++..|+|||.+....++.++|||||||++|||++ |+.||......  +...........         ..
T Consensus       153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~~~---------~~  221 (257)
T cd05040         153 HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS--QILKKIDKEGER---------LE  221 (257)
T ss_pred             ceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHhcCCc---------CC
Confidence                    25568999999998899999999999999999999 99999653221  111111111111         01


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 047719          511 FNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK  545 (596)
Q Consensus       511 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~  545 (596)
                      .+......+.+++..|++.+|++||++.++++.|.
T Consensus       222 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         222 RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            11223456788899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=5.9e-36  Score=338.61  Aligned_cols=249  Identities=23%  Similarity=0.336  Sum_probs=193.8

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      ++|...++||+|+||.||+|... .++.||||++...... +...+++.+|+..+.+ ++||||+++++++.+.+..++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~-L~HPNIVkl~~v~~d~~~lyLV   80 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAAD-LIHPGIVPVYSICSDGDPVYYT   80 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHh-CCCcCcCeEEEEEeeCCEEEEE
Confidence            46788899999999999999865 4889999999643222 2234568889866654 9999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCC-------CCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccC
Q 047719          362 YEYLPNGSLDKILHNNSS-------SSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF  434 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Df  434 (596)
                      |||+++|+|.+++.....       ....+++..++.++.||++||+|||+   .+|+||||||+|||++.++.+||+||
T Consensus        81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDF  157 (932)
T PRK13184         81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDW  157 (932)
T ss_pred             EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEec
Confidence            999999999999975211       12346778889999999999999999   89999999999999999999999999


Q ss_pred             CCccc-----------------------------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChh
Q 047719          435 EATIP-----------------------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV  485 (596)
Q Consensus       435 g~~~~-----------------------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~  485 (596)
                      |++..                             .||+.|||||.+.+..++.++|||||||++|||+||+.||......
T Consensus       158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~  237 (932)
T PRK13184        158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR  237 (932)
T ss_pred             CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence            97532                             4899999999999999999999999999999999999999764221


Q ss_pred             HHHHHHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHhc
Q 047719          486 IVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRP-SVKEAARILKG  546 (596)
Q Consensus       486 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RP-s~~ev~~~L~~  546 (596)
                      ...  ..    ...........    ..+....+.+++.+|++.||++|| +++++.+.|+.
T Consensus       238 ki~--~~----~~i~~P~~~~p----~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~  289 (932)
T PRK13184        238 KIS--YR----DVILSPIEVAP----YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP  289 (932)
T ss_pred             hhh--hh----hhccChhhccc----cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            110  00    00000000000    012234567788899999999996 56666666653

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=6.8e-36  Score=302.19  Aligned_cols=242  Identities=25%  Similarity=0.349  Sum_probs=182.5

Q ss_pred             eeecCCceEEEEEEcCC---CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecCCC
Q 047719          291 IVGEGASATVYKGSLPS---GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPN  367 (596)
Q Consensus       291 ~LG~G~fG~Vy~~~~~~---g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  367 (596)
                      .||+|+||.||+|...+   ...+|+|.+.... .......+.+|+..+. .++|+||+++++.|.+....++||||+++
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~-~l~h~nii~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYR-ELNHPNVLQCLGQCIESIPYLLVLEFCPL   79 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHH-hCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence            58999999999997543   3568888875332 2333456788886655 48999999999999999999999999999


Q ss_pred             CCHHHHhhhCCCC-CcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc-------
Q 047719          368 GSLDKILHNNSSS-SIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP-------  439 (596)
Q Consensus       368 gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~-------  439 (596)
                      |+|.+++...... ....++...+.++.||+.||+|||+   .+|+||||||+|||+++++.+||+|||++..       
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~  156 (269)
T cd05042          80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY  156 (269)
T ss_pred             CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence            9999999875421 2235688889999999999999999   8999999999999999999999999997642       


Q ss_pred             ------CCCcccCCcccccc-------CCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhccc
Q 047719          440 ------AGTMGYLAPEYVYS-------GVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADF  505 (596)
Q Consensus       440 ------~gt~~y~aPE~~~~-------~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~  505 (596)
                            .++..|+|||++..       ..++.++|||||||++|||++ |..||......  +........ .......+
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--~~~~~~~~~-~~~~~~~~  233 (269)
T cd05042         157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE--QVLKQVVRE-QDIKLPKP  233 (269)
T ss_pred             eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH--HHHHHHhhc-cCccCCCC
Confidence                  23567999998743       356889999999999999999 78888754321  111111111 11112222


Q ss_pred             cccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 047719          506 RLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK  545 (596)
Q Consensus       506 ~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~  545 (596)
                      .+..    .....+..++..|| .||++|||+++|++.|.
T Consensus       234 ~~~~----~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         234 QLDL----KYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             cccc----cCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            2222    22344555667788 59999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.9e-35  Score=300.93  Aligned_cols=244  Identities=24%  Similarity=0.317  Sum_probs=191.6

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      ++|...+.||+|+||.||++... +|..||||+++.....+ ...++..|+..+.+..+|+||+++++++..++..|++|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~   79 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ-EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM   79 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH-HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence            36778899999999999999875 58999999986543222 23456677766667789999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCC-CeEEccCCCCceeecCCCceEEccCCCcc---
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECER-QIIHRDVKACNILLDAEFNAKLGDFEATI---  438 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~-~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---  438 (596)
                      ||++ |+|.+++.........+++..++.++.||+.||+|||+   + +++||||||+|||++.++.+||+|||.+.   
T Consensus        80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (283)
T cd06617          80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV  155 (283)
T ss_pred             hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence            9996 68999887643334568999999999999999999998   5 89999999999999999999999998754   


Q ss_pred             -------cCCCcccCCcccccc----CCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccc
Q 047719          439 -------PAGTMGYLAPEYVYS----GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRL  507 (596)
Q Consensus       439 -------~~gt~~y~aPE~~~~----~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  507 (596)
                             ..|+..|+|||.+..    ..++.++|+|||||++|||++|+.||......... ...... +.     .+.+
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~-~~-----~~~~  228 (283)
T cd06617         156 DSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQ-LKQVVE-EP-----SPQL  228 (283)
T ss_pred             cccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHH-HHHHHh-cC-----CCCC
Confidence                   346788999998864    45689999999999999999999999753222111 111111 10     0111


Q ss_pred             cCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          508 RGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       508 ~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      .   .......+.+++..||+.+|.+||++.++++
T Consensus       229 ~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         229 P---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             C---ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0   0112345778889999999999999999976

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=8.6e-36  Score=303.71  Aligned_cols=250  Identities=25%  Similarity=0.319  Sum_probs=189.6

Q ss_pred             CCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          285 GFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      +|...+.||+|+||.||+|... ++..||||++......+.....+.+|+..+.. ++||||+++++++.++...++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~~v~e   79 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKE-LQHPNIVCLQDVLMQESRLYLIFE   79 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHh-cCCCCEeeeEEEEeeCCeEEEEEe
Confidence            3677789999999999999875 58899999986543333334567788865554 899999999999999999999999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc----
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP----  439 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~----  439 (596)
                      |++ ++|.+++..... ...+++..+..++.||++||+|||+   .+++||||||+||+++.++.+||+|||++..    
T Consensus        80 ~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  154 (285)
T cd07861          80 FLS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP  154 (285)
T ss_pred             cCC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCC
Confidence            997 689999875432 2358999999999999999999999   8999999999999999999999999997642    


Q ss_pred             -------CCCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHh-cCCc--------hhh
Q 047719          440 -------AGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRK-KGKL--------LDA  502 (596)
Q Consensus       440 -------~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~-~~~~--------~~~  502 (596)
                             .++..|+|||.+.+ ..++.++|||||||++|||+||+.||.......  ....... .+..        ...
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  232 (285)
T cd07861         155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID--QLFRIFRILGTPTEDVWPGVTSL  232 (285)
T ss_pred             cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhcchhh
Confidence                   35778999998865 457899999999999999999999997643211  1110000 0000        000


Q ss_pred             cc--cccc-------CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          503 AD--FRLR-------GKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       503 ~d--~~l~-------~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      .+  ....       ..........+.+++.+|++.||++|||+++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         233 PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            00  0000       0000112345568889999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.6e-35  Score=307.93  Aligned_cols=245  Identities=20%  Similarity=0.239  Sum_probs=183.9

Q ss_pred             cCCCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCchh-cccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRVE-CARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~-~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      ++|...+.||+|+||.||++.... ++.+|+|++.+..... .....+..|+..+ ..++|+||+++++++.+...+|+|
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l-~~~~~~~i~~~~~~~~~~~~~~lv   79 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVL-VNGDNQWITTLHYAFQDENNLYLV   79 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHH-hhCCCCCEeeEEEEEecCCEEEEE
Confidence            367888999999999999998764 7789999986432222 2223356666444 458999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc---
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI---  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---  438 (596)
                      |||+++|+|.+++....   ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++.   
T Consensus        80 ~ey~~~g~L~~~l~~~~---~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~  153 (332)
T cd05623          80 MDYYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLM  153 (332)
T ss_pred             EeccCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecc
Confidence            99999999999998642   248899999999999999999999   999999999999999999999999999652   


Q ss_pred             ---------cCCCcccCCccccc-----cCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhcc
Q 047719          439 ---------PAGTMGYLAPEYVY-----SGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAAD  504 (596)
Q Consensus       439 ---------~~gt~~y~aPE~~~-----~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d  504 (596)
                               ..||+.|+|||++.     ...++.++|||||||++|||++|+.||.....  .+..............  
T Consensus       154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~--~~~~~~i~~~~~~~~~--  229 (332)
T cd05623         154 EDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL--VETYGKIMNHKERFQF--  229 (332)
T ss_pred             cCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH--HHHHHHHhCCCccccC--
Confidence                     25899999999986     34688999999999999999999999976432  2222222211111100  


Q ss_pred             ccccCcCCHHHHHHHHHHHHHcC--CCCCCCCCCHHHHHHH
Q 047719          505 FRLRGKFNRKEMERMLMVGLSCV--HPNHEKRPSVKEAARI  543 (596)
Q Consensus       505 ~~l~~~~~~~~~~~l~~l~~~C~--~~dp~~RPs~~ev~~~  543 (596)
                      +......    ...+.+++.+|+  .+++..||+++|+++.
T Consensus       230 p~~~~~~----s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         230 PAQVTDV----SEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             CCccccC----CHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            0000112    233444445544  4555568899988763

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.6e-36  Score=300.25  Aligned_cols=240  Identities=25%  Similarity=0.255  Sum_probs=192.7

Q ss_pred             CCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCchh-cccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          286 FNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRVE-CARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       286 f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~-~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      |...+.||+|.-|+||++.+++ +..+|+|++.+..... ....+...|- .+++.++||.++.||..+..+...|||||
T Consensus        79 f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~-eIL~~lDHPFlPTLYa~fet~~~~cl~me  157 (459)
T KOG0610|consen   79 FRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTER-EILSLLDHPFLPTLYASFETDKYSCLVME  157 (459)
T ss_pred             HHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHH-HHHHhcCCCccchhhheeeccceeEEEEe
Confidence            4556889999999999999876 6899999997654332 2223344444 33455999999999999999999999999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc-----
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI-----  438 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~-----  438 (596)
                      ||+||+|...++.+.  ...++...+.-++.+|..||+|||.   .|||.|||||+||||.++|++.|+||.++.     
T Consensus       158 yCpGGdL~~LrqkQp--~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  158 YCPGGDLHSLRQKQP--GKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             cCCCccHHHHHhhCC--CCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence            999999999998876  3468999999999999999999999   999999999999999999999999993210     


Q ss_pred             --------------------------------------------------------------cCCCcccCCccccccCCC
Q 047719          439 --------------------------------------------------------------PAGTMGYLAPEYVYSGVP  456 (596)
Q Consensus       439 --------------------------------------------------------------~~gt~~y~aPE~~~~~~~  456 (596)
                                                                                    .+||..|+|||++.+...
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence                                                                          127889999999999999


Q ss_pred             CCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCC
Q 047719          457 SEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPS  536 (596)
Q Consensus       457 t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs  536 (596)
                      +.++|+|+|||+||||+.|..||.+.+..           ..+.+++...+.-.-.......+.+|+...+.+||++|..
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~-----------~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg  381 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNK-----------ETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLG  381 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCCCch-----------hhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhc
Confidence            99999999999999999999999876431           1122222222222222245567788889999999999997


Q ss_pred             ----HHHHHH
Q 047719          537 ----VKEAAR  542 (596)
Q Consensus       537 ----~~ev~~  542 (596)
                          +.||-+
T Consensus       382 ~~rGA~eIK~  391 (459)
T KOG0610|consen  382 SKRGAAEIKR  391 (459)
T ss_pred             cccchHHhhc
Confidence                777654

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.1e-35  Score=298.01  Aligned_cols=240  Identities=22%  Similarity=0.309  Sum_probs=192.9

Q ss_pred             CCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          285 GFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      +|...+.||+|+||.||++... +++.+|+|.++.... ....+.+..|+..+ +.++|+||+++++.+..++.+++|||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~~~~~~lv~e   78 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLL-AKMKHPNIVAFKESFEADGHLYIVME   78 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHH-HhCCCCCcceEEEEEEECCEEEEEEe
Confidence            3667799999999999999765 588999999864332 22345677787555 45899999999999999999999999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc-----
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI-----  438 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~-----  438 (596)
                      |+++|+|.+++....  ...+++...+.++.|++.||.|||+   .+++|+||||+||++++++.++|+|||.+.     
T Consensus        79 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  153 (255)
T cd08219          79 YCDGGDLMQKIKLQR--GKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP  153 (255)
T ss_pred             eCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeeccc
Confidence            999999999987543  2347889999999999999999999   899999999999999999999999999753     


Q ss_pred             ------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCC
Q 047719          439 ------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFN  512 (596)
Q Consensus       439 ------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  512 (596)
                            ..|+..|+|||.+.+..++.++|+||||+++|||++|+.||.....  ........ .+...         ..+
T Consensus       154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~--~~~~~~~~-~~~~~---------~~~  221 (255)
T cd08219         154 GAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW--KNLILKVC-QGSYK---------PLP  221 (255)
T ss_pred             ccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH--HHHHHHHh-cCCCC---------CCC
Confidence                  2367789999999888899999999999999999999999976432  11111111 11111         111


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 047719          513 RKEMERMLMVGLSCVHPNHEKRPSVKEAARI  543 (596)
Q Consensus       513 ~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~  543 (596)
                      ......+.+++.+||+.||++||++.+++..
T Consensus       222 ~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         222 SHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             cccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            2233456788899999999999999999763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1e-36  Score=303.66  Aligned_cols=238  Identities=24%  Similarity=0.331  Sum_probs=199.3

Q ss_pred             CCCccceeecCCceEEEEEEc-CCCCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          285 GFNKNRIVGEGASATVYKGSL-PSGGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      .|+..+.||+|.||+|-++.. ..|+.||||.++++... ++......+|+++|.. ++||||+.++.+|..++.+.|||
T Consensus        54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSs-LNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSS-LNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhh-cCCCceeehhhhhcCCceEEEEE
Confidence            355568899999999999976 46999999999876543 4555678899988866 99999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc----
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI----  438 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~----  438 (596)
                      ||..+|.|++|+.+++    .|++.+...+..||.+|+.|+|.   ++++|||||.+|||||.|+++||+|||++.    
T Consensus       133 EYaS~GeLYDYiSer~----~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~~  205 (668)
T KOG0611|consen  133 EYASGGELYDYISERG----SLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD  205 (668)
T ss_pred             EecCCccHHHHHHHhc----cccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhcc
Confidence            9999999999999875    49999999999999999999999   999999999999999999999999999864    


Q ss_pred             ------cCCCcccCCccccccCCC-CCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcC
Q 047719          439 ------PAGTMGYLAPEYVYSGVP-SEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKF  511 (596)
Q Consensus       439 ------~~gt~~y~aPE~~~~~~~-t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  511 (596)
                            .+|++-|.+||.+.+..| .+..|-|||||+||-|+.|.-||++.+-  ...+.+ ...+...+.         
T Consensus       206 ~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh--k~lvrQ-Is~GaYrEP---------  273 (668)
T KOG0611|consen  206 KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH--KRLVRQ-ISRGAYREP---------  273 (668)
T ss_pred             ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH--HHHHHH-hhcccccCC---------
Confidence                  479999999999998877 6899999999999999999999998642  111211 222222211         


Q ss_pred             CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 047719          512 NRKEMERMLMVGLSCVHPNHEKRPSVKEAARIL  544 (596)
Q Consensus       512 ~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L  544 (596)
                        +.......|+.|++-.||++|-|+++|....
T Consensus       274 --~~PSdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  274 --ETPSDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             --CCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence              2223455678899999999999999998743

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=9.4e-36  Score=299.05  Aligned_cols=246  Identities=26%  Similarity=0.354  Sum_probs=196.5

Q ss_pred             CCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeee--CCeEEEE
Q 047719          285 GFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE--GNELVLV  361 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~--~~~~~lV  361 (596)
                      +|+..+.||+|+||.||++... +++.+|+|++............+..|+..+. .++|+||+++++++..  ....+++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~~~~~   79 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILR-ELKHPNIVRYYDRIIDRSNQTLYIV   79 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHH-hcCCCccceeeeeeecCCCCEEEEE
Confidence            3667789999999999999764 5789999998755444445566788886554 4999999999998764  4568999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhcc--CCCeEEccCCCCceeecCCCceEEccCCCcc-
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC--ERQIIHRDVKACNILLDAEFNAKLGDFEATI-  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~--~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~-  438 (596)
                      |||+++++|.+++.........+++..++.++.||+.||+|||..+  ..+++|+||||+||+++.++.+||+|||.+. 
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~  159 (265)
T cd08217          80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI  159 (265)
T ss_pred             ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence            9999999999999875433456899999999999999999999321  2899999999999999999999999998643 


Q ss_pred             ----------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhcccccc
Q 047719          439 ----------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLR  508 (596)
Q Consensus       439 ----------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  508 (596)
                                ..++..|+|||.+....++.++||||||+++|+|++|+.||.....  .... .....+.         .
T Consensus       160 ~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~-~~~~~~~---------~  227 (265)
T cd08217         160 LGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ--LQLA-SKIKEGK---------F  227 (265)
T ss_pred             ccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH--HHHH-HHHhcCC---------C
Confidence                      2478889999999988899999999999999999999999986532  1111 1111111         1


Q ss_pred             CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 047719          509 GKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARI  543 (596)
Q Consensus       509 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~  543 (596)
                      ...+......+.+++.+|++.+|++||++++|++.
T Consensus       228 ~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         228 RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence            12233445677889999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-36  Score=315.40  Aligned_cols=240  Identities=26%  Similarity=0.429  Sum_probs=197.4

Q ss_pred             cceeecCCceEEEEEEcCC-CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecCCC
Q 047719          289 NRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPN  367 (596)
Q Consensus       289 ~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  367 (596)
                      .-+||+|.||+||-|+..+ ...+|||.+...  .....+.+..|+ .+-+.++|+|||+++|.|.+++.+-+.||-+||
T Consensus       580 rvVLGKGTYG~VYA~RD~~tqvrIaIKEIpek--dsr~~QPLhEEI-aLH~~LrHkNIVrYLGs~senGf~kIFMEqVPG  656 (1226)
T KOG4279|consen  580 RVVLGKGTYGTVYAARDMDTQVRIAIKEIPEK--DSREVQPLHEEI-ALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPG  656 (1226)
T ss_pred             eEEeecCceeEEEeeccccceeEEEeeecccc--cchhhccHHHHH-HHHHHHhhHhHHHHhhccCCCCeEEEEeecCCC
Confidence            3579999999999998766 557999999532  233444566676 666779999999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCccc--CHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecC-CCceEEccCCCcc------
Q 047719          368 GSLDKILHNNSSSSIVL--SWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDA-EFNAKLGDFEATI------  438 (596)
Q Consensus       368 gsL~~~l~~~~~~~~~l--~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~-~~~~kl~Dfg~~~------  438 (596)
                      |||.+.|+..-+   ++  .+.+.-...+||++||.|||+   +.|||||||-.||||+- .|.+||+|||.+.      
T Consensus       657 GSLSsLLrskWG---PlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin  730 (1226)
T KOG4279|consen  657 GSLSSLLRSKWG---PLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN  730 (1226)
T ss_pred             CcHHHHHHhccC---CCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhccCC
Confidence            999999987543   34  677888889999999999999   99999999999999964 6999999999764      


Q ss_pred             -----cCCCcccCCccccccC--CCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcC
Q 047719          439 -----PAGTMGYLAPEYVYSG--VPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKF  511 (596)
Q Consensus       439 -----~~gt~~y~aPE~~~~~--~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  511 (596)
                           ..||..|||||.+..+  .|+.++|||||||.+.||.||++||-.-+.....    +      ..+--....+++
T Consensus       731 P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA----M------FkVGmyKvHP~i  800 (1226)
T KOG4279|consen  731 PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA----M------FKVGMYKVHPPI  800 (1226)
T ss_pred             ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh----h------hhhcceecCCCC
Confidence                 3499999999999865  5899999999999999999999999754332111    1      111112345677


Q ss_pred             CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhcC
Q 047719          512 NRKEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKGE  547 (596)
Q Consensus       512 ~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~~~  547 (596)
                      +.+.......++++|+.+||.+||++.++++  +|+..
T Consensus       801 Peelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  801 PEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             cHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence            8888899999999999999999999999987  56543

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=7.8e-36  Score=312.08  Aligned_cols=249  Identities=24%  Similarity=0.374  Sum_probs=196.5

Q ss_pred             cCCCccceeecCCceEEEEEEcC--------CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeC
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP--------SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG  355 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~--------~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~  355 (596)
                      ..|...+.||+|+||.||++...        .+..||+|.+... .......++.+|+..+.+..+|+||++++++|...
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   90 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence            35777899999999999999642        1236899988632 22334457888987666633899999999999999


Q ss_pred             CeEEEEEecCCCCCHHHHhhhCCC------------CCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceee
Q 047719          356 NELVLVYEYLPNGSLDKILHNNSS------------SSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILL  423 (596)
Q Consensus       356 ~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl  423 (596)
                      +..+++|||+++|+|.+++.....            ....++|.+++.++.|++.||+|||+   .+++||||||+|||+
T Consensus        91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nill  167 (334)
T cd05100          91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVLV  167 (334)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEE
Confidence            999999999999999999976431            12358899999999999999999999   899999999999999


Q ss_pred             cCCCceEEccCCCcccC-------------CCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHH
Q 047719          424 DAEFNAKLGDFEATIPA-------------GTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDW  489 (596)
Q Consensus       424 ~~~~~~kl~Dfg~~~~~-------------gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~  489 (596)
                      +.++.+||+|||.+...             ++..|+|||.+.+..++.++|||||||++|||++ |..||....  ..++
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--~~~~  245 (334)
T cd05100         168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP--VEEL  245 (334)
T ss_pred             cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC--HHHH
Confidence            99999999999976421             2356999999999899999999999999999998 889987643  1222


Q ss_pred             HHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Q 047719          490 VWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEA  548 (596)
Q Consensus       490 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~~  548 (596)
                      ..... .....         ..+......+.+++..||+.+|++||++.|+++.|+...
T Consensus       246 ~~~~~-~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~  294 (334)
T cd05100         246 FKLLK-EGHRM---------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL  294 (334)
T ss_pred             HHHHH-cCCCC---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence            22211 11111         111223356778899999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.2e-35  Score=299.59  Aligned_cols=240  Identities=27%  Similarity=0.408  Sum_probs=191.5

Q ss_pred             CCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCch----hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEE
Q 047719          285 GFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRV----ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVL  360 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~----~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~l  360 (596)
                      +|...+.||+|+||.||+|...+++.+|||.+......    ......+.+|+..+.. ++|+||++++++|.+.+..++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKS-LKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHh-cCCCCEeeEeeEeecCCeEEE
Confidence            36677899999999999998878999999998643211    1223457778865554 899999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc-
Q 047719          361 VYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP-  439 (596)
Q Consensus       361 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~-  439 (596)
                      |+||+++++|.+++....    .+++..+..++.|++.||+|||+   .+++|+||||+||++++++.+||+|||.+.. 
T Consensus        80 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  152 (265)
T cd06631          80 FMEFVPGGSISSILNRFG----PLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRL  152 (265)
T ss_pred             EEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence            999999999999997643    47889999999999999999999   8999999999999999999999999986532 


Q ss_pred             ----------------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhc
Q 047719          440 ----------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAA  503 (596)
Q Consensus       440 ----------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  503 (596)
                                      .|+..|+|||.+.+..++.++|||||||++|||++|+.||...+.. .... .......    .
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-~~~~-~~~~~~~----~  226 (265)
T cd06631         153 AWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL-AAMF-YIGAHRG----L  226 (265)
T ss_pred             hhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH-HHHH-HhhhccC----C
Confidence                            3678899999999888999999999999999999999999764321 1111 0100000    0


Q ss_pred             cccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          504 DFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       504 d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      .+.+    +......+.+++.+||+.+|++||++.++++
T Consensus       227 ~~~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         227 MPRL----PDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             CCCC----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            1111    2223455678889999999999999998865

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.8e-35  Score=313.11  Aligned_cols=248  Identities=21%  Similarity=0.281  Sum_probs=189.1

Q ss_pred             hcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeC------
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG------  355 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~------  355 (596)
                      .++|...+.||+|+||.||++... .++.||||++............+.+|+..+ +.++||||+++++++...      
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l-~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLM-KCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHH-HhcCCCCccccceeeccccccccc
Confidence            467888999999999999999765 488999999975443334455677888555 458999999999987543      


Q ss_pred             CeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCC
Q 047719          356 NELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFE  435 (596)
Q Consensus       356 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg  435 (596)
                      ...|+||||+++ +|.+++..      .+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG  171 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG  171 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCC
Confidence            357999999965 78877753      27888999999999999999999   899999999999999999999999999


Q ss_pred             Cccc----------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHh----------
Q 047719          436 ATIP----------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRK----------  495 (596)
Q Consensus       436 ~~~~----------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~----------  495 (596)
                      ++..          .||..|+|||.+.+..++.++|||||||++|||++|+.||...+.. ..+......          
T Consensus       172 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~  250 (364)
T cd07875         172 LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI-DQWNKVIEQLGTPCPEFMK  250 (364)
T ss_pred             CccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCHHHHH
Confidence            7642          4788999999999999999999999999999999999999764321 111100000          


Q ss_pred             ------------cCCchhh----cccc----ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          496 ------------KGKLLDA----ADFR----LRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       496 ------------~~~~~~~----~d~~----l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                                  .......    ....    ............+.+++.+|++.||++|||+.|+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~  317 (364)
T cd07875         251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  317 (364)
T ss_pred             hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                        0000000    0000    000111112346778899999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.5e-35  Score=297.18  Aligned_cols=241  Identities=24%  Similarity=0.317  Sum_probs=196.8

Q ss_pred             CCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          285 GFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      +|+..+.||.|+||.||.+... +++.+++|++...........++.+|+..+.+ ++|+||+++++++.+.+.++++||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~-~~h~~i~~~~~~~~~~~~~~~~~e   79 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSL-LQHPNIIAYYNHFMDDNTLLIEME   79 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHh-CCCCCeeEEEeEEecCCeEEEEEE
Confidence            3677899999999999988754 58899999987554444556678899866655 899999999999999999999999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc-----
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI-----  438 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~-----  438 (596)
                      |+++|+|.+++....  ...+++.++..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||.+.     
T Consensus        80 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~  154 (256)
T cd08221          80 YANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE  154 (256)
T ss_pred             ecCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence            999999999998653  2358999999999999999999999   899999999999999999999999998643     


Q ss_pred             ------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCC
Q 047719          439 ------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFN  512 (596)
Q Consensus       439 ------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  512 (596)
                            ..|+..|+|||.+.+..++.++||||||+++|||++|+.||.....  .+...... .+...         ...
T Consensus       155 ~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~--~~~~~~~~-~~~~~---------~~~  222 (256)
T cd08221         155 YSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP--LNLVVKIV-QGNYT---------PVV  222 (256)
T ss_pred             cccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHH-cCCCC---------CCc
Confidence                  3478899999999888889999999999999999999999976432  22222221 11111         111


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 047719          513 RKEMERMLMVGLSCVHPNHEKRPSVKEAARI  543 (596)
Q Consensus       513 ~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~  543 (596)
                      ......+.+++..||+.+|.+||+++++++.
T Consensus       223 ~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         223 SVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             cccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence            2233557788889999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=7.2e-36  Score=300.49  Aligned_cols=238  Identities=26%  Similarity=0.386  Sum_probs=183.8

Q ss_pred             ceeecCCceEEEEEEcCC----CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeee-CCeEEEEEec
Q 047719          290 RIVGEGASATVYKGSLPS----GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE-GNELVLVYEY  364 (596)
Q Consensus       290 ~~LG~G~fG~Vy~~~~~~----g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~-~~~~~lV~E~  364 (596)
                      +.||+|+||.||+|...+    ...||+|++.... .......+.+|+..+ +.++||||++++++|.. ++..++|+||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l-~~l~h~~iv~~~~~~~~~~~~~~lv~e~   78 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-DLEEVEQFLKEGIIM-KDFSHPNVLSLLGICLPSEGSPLVVLPY   78 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccC-CHHHHHHHHHHHHHH-ccCCCCCcceEEEEeecCCCCcEEEEec
Confidence            468999999999997532    3579999985322 122345677888555 55899999999998764 5568999999


Q ss_pred             CCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc-----
Q 047719          365 LPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP-----  439 (596)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~-----  439 (596)
                      +++|+|.+++.....   .+.+..++.++.|+++||+|||+   .+++||||||+|||++.++.+||+|||++..     
T Consensus        79 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~  152 (262)
T cd05058          79 MKHGDLRNFIRSETH---NPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE  152 (262)
T ss_pred             CCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCc
Confidence            999999999976432   36788889999999999999999   8999999999999999999999999997642     


Q ss_pred             ----------CCCcccCCccccccCCCCCccceeehhHHHHHHHhC-CCCCCCCChhHHHHHHHHHhcCCchhhcccccc
Q 047719          440 ----------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAG-KSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLR  508 (596)
Q Consensus       440 ----------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  508 (596)
                                .++..|+|||.+....++.++|||||||++|||++| .+||.....  .+...........         
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--~~~~~~~~~~~~~---------  221 (262)
T cd05058         153 YYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS--FDITVYLLQGRRL---------  221 (262)
T ss_pred             ceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHhcCCCC---------
Confidence                      235679999999888899999999999999999994 566654322  1111111111100         


Q ss_pred             CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          509 GKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       509 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                       ..+......+.+++..||+.+|++||++.++++.|+..
T Consensus       222 -~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~  259 (262)
T cd05058         222 -LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI  259 (262)
T ss_pred             -CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence             01111234677899999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1e-35  Score=313.86  Aligned_cols=249  Identities=22%  Similarity=0.293  Sum_probs=189.9

Q ss_pred             HhcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeC-----
Q 047719          282 ATLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG-----  355 (596)
Q Consensus       282 at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~-----  355 (596)
                      ..++|...+.||+|+||.||++... .++.||||++............+.+|+..+ +.++||||+++++++...     
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLM-KCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHH-HHhCCCchhceeeeeeccccccc
Confidence            4567888999999999999999765 488999999975444344455677888555 458999999999988643     


Q ss_pred             -CeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccC
Q 047719          356 -NELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF  434 (596)
Q Consensus       356 -~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Df  434 (596)
                       ...|+||||+++ +|.+.+..      .+++..+..++.|+++||+|||+   .+|+||||||+|||++.++.+||+||
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Df  163 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDF  163 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeC
Confidence             357999999965 77777753      37888999999999999999999   89999999999999999999999999


Q ss_pred             CCccc----------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHH----------
Q 047719          435 EATIP----------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLR----------  494 (596)
Q Consensus       435 g~~~~----------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~----------  494 (596)
                      |++..          .||..|+|||.+.+..++.++|||||||++|||++|+.||..... ...+.....          
T Consensus       164 g~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~  242 (355)
T cd07874         164 GLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY-IDQWNKVIEQLGTPCPEFM  242 (355)
T ss_pred             cccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHHH
Confidence            97643          478899999999988999999999999999999999999976532 111110000          


Q ss_pred             -----------hc-CCchhhcccc-----c---cCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          495 -----------KK-GKLLDAADFR-----L---RGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       495 -----------~~-~~~~~~~d~~-----l---~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                                 .. ........+.     .   ...........+.+++.+|++.||++|||+.|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~  310 (355)
T cd07874         243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ  310 (355)
T ss_pred             HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence                       00 0000000000     0   00111122356788999999999999999999988

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.2e-35  Score=303.19  Aligned_cols=246  Identities=26%  Similarity=0.370  Sum_probs=192.0

Q ss_pred             cCCCccceeecCCceEEEEEEc-----CCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeC--C
Q 047719          284 LGFNKNRIVGEGASATVYKGSL-----PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG--N  356 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~-----~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~--~  356 (596)
                      +.|...+.||+|+||.||++.+     .++..||+|.++.... ......+.+|+..+. .++|+|++++++++...  .
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~   81 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKKEIEILR-NLYHENIVKYKGICTEDGGN   81 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc-HHHHHHHHHHHHHHH-hCCCCCeeeeeeEEecCCCC
Confidence            3467778999999999999974     2477899999864322 233456888986655 48999999999999875  5


Q ss_pred             eEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCC
Q 047719          357 ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEA  436 (596)
Q Consensus       357 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~  436 (596)
                      ..++||||+++++|.+++....   ..++|.+++.++.|++.||+|||+   ++++||||||+||+++.++.+||+|||+
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~  155 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPRNK---NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGL  155 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCcc
Confidence            6899999999999999997643   248999999999999999999999   8999999999999999999999999997


Q ss_pred             ccc--------------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhH------------HHHH
Q 047719          437 TIP--------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVI------------VDWV  490 (596)
Q Consensus       437 ~~~--------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~------------~~~~  490 (596)
                      +..              .++..|+|||.+.+..++.++|||||||++|||++++.|........            ....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd05079         156 TKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL  235 (284)
T ss_pred             ccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH
Confidence            642              24557999999988889999999999999999999877643211100            0001


Q ss_pred             HHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          491 WNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       491 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                      ......+.         ...........+.+++.+|++.+|++||++.++++.|+.
T Consensus       236 ~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  282 (284)
T cd05079         236 VRVLEEGK---------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA  282 (284)
T ss_pred             HHHHHcCc---------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence            11111111         011112234678889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=7.7e-36  Score=299.19  Aligned_cols=238  Identities=29%  Similarity=0.396  Sum_probs=191.4

Q ss_pred             CCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEec
Q 047719          285 GFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEY  364 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~  364 (596)
                      +|...+.||+|+||.||++.. .++.||+|.+....    ....+.+|+..+. .++|+|++++++++... ..++||||
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~----~~~~~~~e~~~l~-~~~~~~i~~~~~~~~~~-~~~~v~e~   79 (254)
T cd05083           7 KLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV----TAQAFLEETAVMT-KLHHKNLVRLLGVILHN-GLYIVMEL   79 (254)
T ss_pred             HceeeeeeccCCCCceEeccc-CCCceEEEeecCcc----hHHHHHHHHHHHH-hCCCCCcCeEEEEEcCC-CcEEEEEC
Confidence            467789999999999999975 67889999985422    2346788886554 48999999999998765 47999999


Q ss_pred             CCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc-----
Q 047719          365 LPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP-----  439 (596)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~-----  439 (596)
                      +++++|.+++....  ...+++..++.++.|++.||.|||+   .+++||||||+||+++.++.+||+|||.+..     
T Consensus        80 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~  154 (254)
T cd05083          80 MSKGNLVNFLRTRG--RALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV  154 (254)
T ss_pred             CCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccC
Confidence            99999999998654  2358899999999999999999998   8999999999999999999999999997643     


Q ss_pred             ---CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHHH
Q 047719          440 ---AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKE  515 (596)
Q Consensus       440 ---~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  515 (596)
                         ..+..|+|||.+.++.++.++|+|||||++|||++ |+.||.....  .+..... ..+..         .......
T Consensus       155 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--~~~~~~~-~~~~~---------~~~~~~~  222 (254)
T cd05083         155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL--KEVKECV-EKGYR---------MEPPEGC  222 (254)
T ss_pred             CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH--HHHHHHH-hCCCC---------CCCCCcC
Confidence               23457999999988899999999999999999998 9999976432  1111111 11111         1111223


Q ss_pred             HHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          516 MERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       516 ~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                      ...+.+++.+||+.+|++||+++++++.|+.
T Consensus       223 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         223 PADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            3567788899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.2e-35  Score=303.66  Aligned_cols=241  Identities=22%  Similarity=0.267  Sum_probs=190.2

Q ss_pred             CCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchh-cccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          286 FNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVE-CARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       286 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~-~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      |...+.||+|+||+||++... +++.||+|.+....... .....+.+|+..+.. ++|+|++++.+.+..++..++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~-l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEK-VNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHH-cCCcCceeEEEEEecCCEEEEEEE
Confidence            566789999999999999765 58899999986533222 223446778866654 899999999999999999999999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc-----
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI-----  438 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~-----  438 (596)
                      |+++++|.+++....  ...+++..+..++.|++.||.|||+   .+|+||||||+||++++++.+||+|||++.     
T Consensus        81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  155 (285)
T cd05632          81 IMNGGDLKFHIYNMG--NPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG  155 (285)
T ss_pred             eccCccHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence            999999999997643  2358999999999999999999999   899999999999999999999999999763     


Q ss_pred             -----cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHH-HHHHHHHhcCCchhhccccccCcCC
Q 047719          439 -----PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIV-DWVWNLRKKGKLLDAADFRLRGKFN  512 (596)
Q Consensus       439 -----~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~-~~~~~~~~~~~~~~~~d~~l~~~~~  512 (596)
                           ..|+..|+|||.+.+..++.++|+|||||++|||++|+.||........ ..+........          ..+.
T Consensus       156 ~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~----------~~~~  225 (285)
T cd05632         156 ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE----------EVYS  225 (285)
T ss_pred             CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccc----------cccC
Confidence                 2478899999999988999999999999999999999999976432111 11111111110          0112


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHH
Q 047719          513 RKEMERMLMVGLSCVHPNHEKRPS-----VKEAAR  542 (596)
Q Consensus       513 ~~~~~~l~~l~~~C~~~dp~~RPs-----~~ev~~  542 (596)
                      ......+.+++..|++.||++||+     +.++++
T Consensus       226 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         226 AKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             ccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence            223345677888999999999999     555554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.3e-35  Score=297.94  Aligned_cols=239  Identities=26%  Similarity=0.404  Sum_probs=186.3

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCch---hcccchHHHHHHHHHhccCCCceeeecceeee--CCe
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRV---ECARNPFTTEFATMAGCLRHKNLVQLQGWCCE--GNE  357 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~---~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~--~~~  357 (596)
                      .+|...+.||+|+||.||++... .+..||+|++......   ......+.+|+..+. .++|+||+++++++.+  ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~   80 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLK-NLQHERIVQYYGCLRDRAEKT   80 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHH-HcCCCCeeeEEEEEEcCCCCE
Confidence            46888899999999999999765 4889999998643221   122345778886554 4899999999998875  357


Q ss_pred             EEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCc
Q 047719          358 LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT  437 (596)
Q Consensus       358 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~  437 (596)
                      +++++||+++++|.+++....    .+++...+.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++
T Consensus        81 ~~l~~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~  153 (266)
T cd06651          81 LTIFMEYMPGGSVKDQLKAYG----ALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGAS  153 (266)
T ss_pred             EEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCc
Confidence            899999999999999997643    37899999999999999999998   89999999999999999999999999975


Q ss_pred             c--------------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhc
Q 047719          438 I--------------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAA  503 (596)
Q Consensus       438 ~--------------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  503 (596)
                      .              ..++..|+|||.+.+..++.++|||||||++|||++|+.||......  ..........      
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~--~~~~~~~~~~------  225 (266)
T cd06651         154 KRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM--AAIFKIATQP------  225 (266)
T ss_pred             cccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH--HHHHHHhcCC------
Confidence            3              23677899999998888999999999999999999999999754221  1111111111      


Q ss_pred             cccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          504 DFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       504 d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                         ....++......+..++ .||..+|++||+++||++
T Consensus       226 ---~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         226 ---TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             ---CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence               01112222223333443 688899999999999965

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=6.8e-36  Score=303.90  Aligned_cols=255  Identities=25%  Similarity=0.350  Sum_probs=194.7

Q ss_pred             CCCccceeecCCceEEEEEEcC-----CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeee--CCe
Q 047719          285 GFNKNRIVGEGASATVYKGSLP-----SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE--GNE  357 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~-----~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~--~~~  357 (596)
                      .|...+.||+|+||.||++.+.     .+..||||++...... .....+.+|+..+.. ++|+||+++++++..  ...
T Consensus         5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~-l~~~~i~~~~~~~~~~~~~~   82 (284)
T cd05038           5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRT-LDHENIVKYKGVCEKPGGRS   82 (284)
T ss_pred             hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHh-CCCCChheEEeeeecCCCCc
Confidence            4556689999999999999853     3678999999654332 245678899866654 899999999999987  557


Q ss_pred             EEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCc
Q 047719          358 LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT  437 (596)
Q Consensus       358 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~  437 (596)
                      .++||||+++++|.+++.....   .+++..++.++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||.+
T Consensus        83 ~~lv~e~~~~~~l~~~l~~~~~---~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~  156 (284)
T cd05038          83 LRLIMEYLPSGSLRDYLQRHRD---QINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLA  156 (284)
T ss_pred             eEEEEecCCCCCHHHHHHhCcc---ccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccccc
Confidence            9999999999999999986542   48999999999999999999999   89999999999999999999999999876


Q ss_pred             ccC--------------CCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHh---cCCch
Q 047719          438 IPA--------------GTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRK---KGKLL  500 (596)
Q Consensus       438 ~~~--------------gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~---~~~~~  500 (596)
                      ...              ++..|+|||.+....++.++||||||+++|||++|+.|+.........+......   ...+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05038         157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL  236 (284)
T ss_pred             cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence            542              2345999999988899999999999999999999999986532111100000000   00000


Q ss_pred             hhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          501 DAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       501 ~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                      +..........+......+.+++.+||+.+|++||+|.||+++|+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         237 ELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            00000011111122335688899999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=6.6e-36  Score=303.74  Aligned_cols=235  Identities=26%  Similarity=0.376  Sum_probs=190.2

Q ss_pred             CCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEec
Q 047719          286 FNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEY  364 (596)
Q Consensus       286 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~  364 (596)
                      |...+.||+|+||.||+|... ++..||+|.+..... ......+.+|+..+. .++|+||+++++++......++||||
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLS-QCDSPYITRYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHH-cCCCCccHhhhcccccCCceEEEEEc
Confidence            445578999999999999765 478899999864322 233456888886665 48999999999999999999999999


Q ss_pred             CCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc-----
Q 047719          365 LPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP-----  439 (596)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~-----  439 (596)
                      +++++|.+++...     .+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||++..     
T Consensus        84 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06642          84 LGGGSALDLLKPG-----PLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             cCCCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence            9999999998643     38899999999999999999998   8999999999999999999999999987632     


Q ss_pred             ------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCH
Q 047719          440 ------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNR  513 (596)
Q Consensus       440 ------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  513 (596)
                            .|+..|+|||.+.+..++.++|||||||++|||++|+.|+.......  ..... ...         .......
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~-~~~---------~~~~~~~  223 (277)
T cd06642         156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR--VLFLI-PKN---------SPPTLEG  223 (277)
T ss_pred             hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh--HHhhh-hcC---------CCCCCCc
Confidence                  36778999999998889999999999999999999999986532211  11111 111         0111122


Q ss_pred             HHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          514 KEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       514 ~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      .....+.+++.+||+.+|++||+|.++++
T Consensus       224 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06642         224 QYSKPFKEFVEACLNKDPRFRPTAKELLK  252 (277)
T ss_pred             ccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            33456778889999999999999999987

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=2.2e-35  Score=300.45  Aligned_cols=236  Identities=23%  Similarity=0.302  Sum_probs=187.3

Q ss_pred             CCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          285 GFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      +|...++||+|+||.||+|... +++.||+|++..... .....++.+|+..+. .++||||+++++++...+..++|||
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e   79 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT-VELQKQIMSELEILY-KCDSPYIIGFYGAFFVENRISICTE   79 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC-hHHHHHHHHHHHHHH-hCCCCCeeeEEEEEEECCEEEEEEe
Confidence            4667789999999999999754 588999999865322 233456888886664 4899999999999999999999999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc-----
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI-----  438 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~-----  438 (596)
                      |+++++|..+.        .+++.....++.|++.||.|||+   .+++|+||||+|||++.++.+||+|||++.     
T Consensus        80 ~~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~  148 (279)
T cd06619          80 FMDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS  148 (279)
T ss_pred             cCCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc
Confidence            99999997653        26788889999999999999999   899999999999999999999999999764     


Q ss_pred             ----cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChh-----HHHHHHHHHhcCCchhhccccccC
Q 047719          439 ----PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV-----IVDWVWNLRKKGKLLDAADFRLRG  509 (596)
Q Consensus       439 ----~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~d~~l~~  509 (596)
                          ..||..|+|||.+.+..++.++|||||||++|||++|+.||......     ...+. .......     ...+. 
T Consensus       149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~-----~~~~~-  221 (279)
T cd06619         149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLL-QCIVDED-----PPVLP-  221 (279)
T ss_pred             cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHH-HHHhccC-----CCCCC-
Confidence                25788999999999888999999999999999999999999642110     00111 0000000     01110 


Q ss_pred             cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          510 KFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       510 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                        .......+.+++.+|++.+|++||+++|+++
T Consensus       222 --~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~  252 (279)
T cd06619         222 --VGQFSEKFVHFITQCMRKQPKERPAPENLMD  252 (279)
T ss_pred             --CCcCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence              1112345778889999999999999999876

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=4.2e-35  Score=306.23  Aligned_cols=192  Identities=24%  Similarity=0.314  Sum_probs=163.5

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchh-cccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVE-CARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~-~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      ++|...+.||+|+||.||++... +++.||+|++.+..... .....+..|. .+...++|+||+++++++.+.+..|+|
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~-~~l~~~~~~~i~~l~~~~~~~~~~~lv   79 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREER-NVLVNGDCQWITTLHYAFQDENYLYLV   79 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHH-HHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence            36788899999999999999875 47889999986432222 2223455666 444558999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc---
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI---  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---  438 (596)
                      |||+++|+|.+++....   ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++.   
T Consensus        80 ~Ey~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~  153 (331)
T cd05624          80 MDYYVGGDLLTLLSKFE---DRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMN  153 (331)
T ss_pred             EeCCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeecc
Confidence            99999999999998642   248889999999999999999999   999999999999999999999999999752   


Q ss_pred             ---------cCCCcccCCcccccc-----CCCCCccceeehhHHHHHHHhCCCCCCCC
Q 047719          439 ---------PAGTMGYLAPEYVYS-----GVPSEKTDVYSFGVVALEVAAGKSPVDND  482 (596)
Q Consensus       439 ---------~~gt~~y~aPE~~~~-----~~~t~~sDV~SfGvll~El~tG~~p~~~~  482 (596)
                               ..||+.|+|||.+..     +.++.++|||||||+||||++|+.||...
T Consensus       154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~  211 (331)
T cd05624         154 QDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE  211 (331)
T ss_pred             CCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC
Confidence                     248999999998875     56789999999999999999999999764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.7e-35  Score=309.09  Aligned_cols=249  Identities=21%  Similarity=0.268  Sum_probs=188.4

Q ss_pred             HhcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeC-----
Q 047719          282 ATLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG-----  355 (596)
Q Consensus       282 at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~-----  355 (596)
                      ..++|...+.||+|+||.||++... +++.||||++............+.+|+..+.. ++|+||+++++++...     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKH-MKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHh-cCCCchhhhhhhhcccccccc
Confidence            3467888899999999999999764 57899999996543333344567788866655 8999999999987643     


Q ss_pred             -CeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccC
Q 047719          356 -NELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF  434 (596)
Q Consensus       356 -~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Df  434 (596)
                       ...|+++|++ +++|.+++...     .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+||
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Df  162 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVKCQ-----KLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDF  162 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCC
Confidence             3579999998 78999888643     38899999999999999999999   89999999999999999999999999


Q ss_pred             CCcc--------cCCCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCChh-HHHHHHHHHhcCCchhhcc
Q 047719          435 EATI--------PAGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV-IVDWVWNLRKKGKLLDAAD  504 (596)
Q Consensus       435 g~~~--------~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~-~~~~~~~~~~~~~~~~~~d  504 (596)
                      |++.        ..||..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ............ ..+...
T Consensus       163 g~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~  241 (343)
T cd07878         163 GLARQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTP-SPEVLK  241 (343)
T ss_pred             ccceecCCCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCC-CHHHHH
Confidence            9764        357899999999876 56899999999999999999999999764321 000000000000 000000


Q ss_pred             -----------ccccCcCCH--------HHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          505 -----------FRLRGKFNR--------KEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       505 -----------~~l~~~~~~--------~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                                 ..+ ...+.        .....+.+++.+|++.||++|||+.|+++
T Consensus       242 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         242 KISSEHARKYIQSL-PHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             hcchhhHHHHhhcc-ccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                       000 00000        11234678889999999999999999986

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=3.5e-35  Score=297.21  Aligned_cols=243  Identities=22%  Similarity=0.316  Sum_probs=182.4

Q ss_pred             ceeecCCceEEEEEEcCCC---CEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecCC
Q 047719          290 RIVGEGASATVYKGSLPSG---GAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLP  366 (596)
Q Consensus       290 ~~LG~G~fG~Vy~~~~~~g---~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~~  366 (596)
                      +.||+|+||.||+|...++   ..+++|.+.... .......+.+|+..+. .++||||+++++.|......|+||||++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~-~l~h~~iv~~~~~~~~~~~~~lv~e~~~   78 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYR-ILQHPNILQCLGQCVEAIPYLLVFEYCE   78 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHh-ccCCcchhheEEEecCCCccEEEEecCC
Confidence            3599999999999975443   346677765322 2233457888885554 5899999999999999999999999999


Q ss_pred             CCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc-------
Q 047719          367 NGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP-------  439 (596)
Q Consensus       367 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~-------  439 (596)
                      +|+|.+++.........+++.....++.||++||+|||+   .+++||||||+|||++.++.+||+|||++..       
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~  155 (268)
T cd05086          79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI  155 (268)
T ss_pred             CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhh
Confidence            999999998654323346777888999999999999999   8999999999999999999999999997532       


Q ss_pred             ------CCCcccCCcccccc-------CCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhccc
Q 047719          440 ------AGTMGYLAPEYVYS-------GVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADF  505 (596)
Q Consensus       440 ------~gt~~y~aPE~~~~-------~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~  505 (596)
                            .++..|+|||++..       ..++.++|||||||++|||++ |..||.....  .+....... +......++
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--~~~~~~~~~-~~~~~~~~~  232 (268)
T cd05086         156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD--REVLNHVIK-DQQVKLFKP  232 (268)
T ss_pred             hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHh-hcccccCCC
Confidence                  35678999998753       245789999999999999997 5778865432  111212111 111222233


Q ss_pred             cccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 047719          506 RLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK  545 (596)
Q Consensus       506 ~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~  545 (596)
                      .+...++    ..+.+++..|| .+|++||++++|++.|.
T Consensus       233 ~~~~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         233 QLELPYS----ERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             ccCCCCc----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            3332333    34556777899 57999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.7e-35  Score=296.79  Aligned_cols=231  Identities=28%  Similarity=0.422  Sum_probs=183.2

Q ss_pred             ceeecCCceEEEEEEcCCCC-----------EEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeE
Q 047719          290 RIVGEGASATVYKGSLPSGG-----------AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNEL  358 (596)
Q Consensus       290 ~~LG~G~fG~Vy~~~~~~g~-----------~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~  358 (596)
                      +.||+|+||.||+|...+..           .|++|.+.....   ....+.+|+..+ +.++|+||++++++|.. ...
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~-~~~   75 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR---DSLAFFETASLM-SQLSHKHLVKLYGVCVR-DEN   75 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh---hHHHHHHHHHHH-HcCCCcchhheeeEEec-CCc
Confidence            46899999999999876432           578887753321   145678888555 45899999999999988 788


Q ss_pred             EEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCC-------ceEE
Q 047719          359 VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEF-------NAKL  431 (596)
Q Consensus       359 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~-------~~kl  431 (596)
                      ++||||+++|+|.+++.....   .+++..++.++.||+.||+|||+   ++++||||||+|||++.++       .+||
T Consensus        76 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl  149 (259)
T cd05037          76 IMVEEYVKFGPLDVFLHREKN---NVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKL  149 (259)
T ss_pred             EEEEEcCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEe
Confidence            999999999999999987542   58899999999999999999998   8999999999999999887       7999


Q ss_pred             ccCCCccc-------CCCcccCCccccccC--CCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchh
Q 047719          432 GDFEATIP-------AGTMGYLAPEYVYSG--VPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLD  501 (596)
Q Consensus       432 ~Dfg~~~~-------~gt~~y~aPE~~~~~--~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~  501 (596)
                      +|||.+..       .++..|+|||++...  .++.++|||||||++|||++ |..|+.....  ..+.... .....  
T Consensus       150 ~Dfg~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~--~~~~~~~-~~~~~--  224 (259)
T cd05037         150 SDPGIPITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS--SEKERFY-QDQHR--  224 (259)
T ss_pred             CCCCcccccccccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc--hhHHHHH-hcCCC--
Confidence            99998654       467789999998876  78999999999999999999 5777765421  1111111 11100  


Q ss_pred             hccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 047719          502 AADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK  545 (596)
Q Consensus       502 ~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~  545 (596)
                           .    +......+.+++..||+.+|.+|||+.++++.|+
T Consensus       225 -----~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         225 -----L----PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             -----C----CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                 0    0011167788999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.5e-35  Score=302.41  Aligned_cols=243  Identities=26%  Similarity=0.361  Sum_probs=194.8

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      .+|...+.||+|+||+||++... ++..||+|++.... .......+.+|++.+.. ++||||+++++++.....+++||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~   82 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHE-CRSPYIVSFYGAFLNENNICMCM   82 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHH-cCCCCcceEeeeEecCCEEEEEE
Confidence            35666789999999999999865 48899999886432 23345678889866655 89999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc----
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI----  438 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~----  438 (596)
                      ||+++++|.+++....    .+++.....++.+++.||.|||+.  .+++||||||+||+++.++.++|+|||++.    
T Consensus        83 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~  156 (284)
T cd06620          83 EFMDCGSLDRIYKKGG----PIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN  156 (284)
T ss_pred             ecCCCCCHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence            9999999999987643    488999999999999999999973  589999999999999999999999999753    


Q ss_pred             -----cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChh---------HHHHHHHHHhcCCchhhcc
Q 047719          439 -----PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV---------IVDWVWNLRKKGKLLDAAD  504 (596)
Q Consensus       439 -----~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~---------~~~~~~~~~~~~~~~~~~d  504 (596)
                           ..|+..|+|||.+.+..++.++|||||||++|||++|+.||......         +.++........      .
T Consensus       157 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~  230 (284)
T cd06620         157 SIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP------P  230 (284)
T ss_pred             hccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc------C
Confidence                 25788999999998888999999999999999999999999754221         112221111110      0


Q ss_pred             ccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 047719          505 FRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARI  543 (596)
Q Consensus       505 ~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~  543 (596)
                      +.+.   .......+.+++.+|++.||++|||+.|+++.
T Consensus       231 ~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~  266 (284)
T cd06620         231 PRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAM  266 (284)
T ss_pred             CCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            0110   11133467788899999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.3e-35  Score=303.85  Aligned_cols=253  Identities=26%  Similarity=0.357  Sum_probs=196.7

Q ss_pred             cCHHHHHHHhcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeeccee
Q 047719          274 LALTDIKQATLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWC  352 (596)
Q Consensus       274 ~~~~el~~at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~  352 (596)
                      +++.++..++++|...+.||+|+||.||++... +++.+|+|++.....   ....+.+|+..+.+..+|||++++++++
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~~h~ni~~~~~~~   88 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD---VDEEIEAEYNILQSLPNHPNVVKFYGMF   88 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc---HHHHHHHHHHHHHHhcCCCCeEEEEEEE
Confidence            455677778899999999999999999999864 588999999854321   2234667776666544899999999998


Q ss_pred             eeC-----CeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCC
Q 047719          353 CEG-----NELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEF  427 (596)
Q Consensus       353 ~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~  427 (596)
                      ...     +..++||||+++|+|.++++........+++..++.++.|++.||+|||+   .+++||||||+||+++.++
T Consensus        89 ~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~  165 (291)
T cd06639          89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEG  165 (291)
T ss_pred             EeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCC
Confidence            754     35899999999999999987533223458999999999999999999999   8999999999999999999


Q ss_pred             ceEEccCCCccc-----------CCCcccCCccccccC-----CCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHH
Q 047719          428 NAKLGDFEATIP-----------AGTMGYLAPEYVYSG-----VPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVW  491 (596)
Q Consensus       428 ~~kl~Dfg~~~~-----------~gt~~y~aPE~~~~~-----~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~  491 (596)
                      .+||+|||.+..           .|+..|+|||.+...     .++.++|||||||++|||++|+.||......  .-+.
T Consensus       166 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~--~~~~  243 (291)
T cd06639         166 GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV--KTLF  243 (291)
T ss_pred             CEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH--HHHH
Confidence            999999986532           367889999987643     3689999999999999999999999764321  1111


Q ss_pred             HHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          492 NLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       492 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      .... ....     .+  ....+....+.+++.+||+.+|++||++.|+++
T Consensus       244 ~~~~-~~~~-----~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         244 KIPR-NPPP-----TL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             HHhc-CCCC-----CC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            1111 1110     00  011223346788999999999999999999876

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-36  Score=314.00  Aligned_cols=232  Identities=25%  Similarity=0.277  Sum_probs=179.4

Q ss_pred             eecCCceEEEEEEcC-CCCEEEEEEeecCCch-hcccchHHHHHHHHHhcc--CCCceeeecceeeeCCeEEEEEecCCC
Q 047719          292 VGEGASATVYKGSLP-SGGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCL--RHKNLVQLQGWCCEGNELVLVYEYLPN  367 (596)
Q Consensus       292 LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l--~H~niv~l~g~~~~~~~~~lV~E~~~~  367 (596)
                      ||+|+||+||+|... +++.||||++.+.... ......+..|...+....  +||||+++++++.+....|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999865 4899999998643211 112223445554554434  799999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc--------
Q 047719          368 GSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP--------  439 (596)
Q Consensus       368 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~--------  439 (596)
                      |+|.+++....    .+++..+..++.||++||+|||+   .+|+||||||+|||++.++.+||+|||++..        
T Consensus        81 g~L~~~l~~~~----~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~  153 (330)
T cd05586          81 GELFWHLQKEG----RFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTT  153 (330)
T ss_pred             ChHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCc
Confidence            99999997653    48899999999999999999999   8999999999999999999999999997542        


Q ss_pred             ---CCCcccCCccccccC-CCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHHH
Q 047719          440 ---AGTMGYLAPEYVYSG-VPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKE  515 (596)
Q Consensus       440 ---~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  515 (596)
                         .||..|+|||.+.+. .++.++|||||||++|||++|+.||.....  .+.. .....+..      .+...   ..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~--~~~~-~~i~~~~~------~~~~~---~~  221 (330)
T cd05586         154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT--QQMY-RNIAFGKV------RFPKN---VL  221 (330)
T ss_pred             cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH--HHHH-HHHHcCCC------CCCCc---cC
Confidence               488999999998764 479999999999999999999999976432  1111 11111111      11111   12


Q ss_pred             HHHHHHHHHHcCCCCCCCCCC----HHHHHH
Q 047719          516 MERMLMVGLSCVHPNHEKRPS----VKEAAR  542 (596)
Q Consensus       516 ~~~l~~l~~~C~~~dp~~RPs----~~ev~~  542 (596)
                      ...+.+++.+|++.||++||+    +.++++
T Consensus       222 ~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         222 SDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             CHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            344567788999999999994    555554

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=2.4e-35  Score=303.23  Aligned_cols=244  Identities=27%  Similarity=0.380  Sum_probs=194.5

Q ss_pred             cCCCccceeecCCceEEEEEEc-CCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSL-PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      .+|...+.||+|+||.||++.. .+++.||+|.+.....  ...+.+.+|+..+ +.++|+||+++++++......++||
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l-~~~~h~~i~~~~~~~~~~~~~~lv~   95 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ--PKKELIINEILVM-RENKNPNIVNYLDSYLVGDELWVVM   95 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc--chHHHHHHHHHHH-HhCCCCCEeeEEEEEecCCEEEEee
Confidence            5688889999999999999985 4689999999864332  2334577787555 4589999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc----
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI----  438 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~----  438 (596)
                      ||+++++|.+++.+.     .+++.++..++.|++.||.|||+   .+++||||||+|||++.++.++|+|||.+.    
T Consensus        96 e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~  167 (297)
T cd06656          96 EYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  167 (297)
T ss_pred             cccCCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence            999999999999754     37889999999999999999999   899999999999999999999999998653    


Q ss_pred             -------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcC
Q 047719          439 -------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKF  511 (596)
Q Consensus       439 -------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  511 (596)
                             ..++..|+|||.+.+..++.++|||||||++|||++|+.||......-  ........+        ......
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~--~~~~~~~~~--------~~~~~~  237 (297)
T cd06656         168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR--ALYLIATNG--------TPELQN  237 (297)
T ss_pred             CccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcch--heeeeccCC--------CCCCCC
Confidence                   246788999999998889999999999999999999999997643210  000000000        000011


Q ss_pred             CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhcCC
Q 047719          512 NRKEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKGEA  548 (596)
Q Consensus       512 ~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~~~~  548 (596)
                      +......+.+++.+||+.+|++||+++++++  +++...
T Consensus       238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (297)
T cd06656         238 PERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAK  276 (297)
T ss_pred             ccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccc
Confidence            2223345677889999999999999999988  554433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=5.9e-36  Score=301.04  Aligned_cols=233  Identities=25%  Similarity=0.355  Sum_probs=181.6

Q ss_pred             ceeecCCceEEEEEEcCC--------CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          290 RIVGEGASATVYKGSLPS--------GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       290 ~~LG~G~fG~Vy~~~~~~--------g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      +.||+|+||.||+|....        ...||+|.+....  ....+.+..|+.. .+.++|||++++++++..+...++|
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~-l~~~~h~~iv~~~~~~~~~~~~~lv   77 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASM-MSQLSHKHLVLNYGVCVCGDESIMV   77 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHH-HHhCCCCChhheeeEEEeCCCcEEE
Confidence            469999999999997643        2348888875322  2233456777744 4558999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCc--------eEEcc
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFN--------AKLGD  433 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~--------~kl~D  433 (596)
                      |||+++|+|.+++.....   .+++..++.++.||+.||+|||+   .+++||||||+|||++.++.        ++++|
T Consensus        78 ~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d  151 (258)
T cd05078          78 QEYVKFGSLDTYLKKNKN---LINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD  151 (258)
T ss_pred             EecCCCCcHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEecc
Confidence            999999999999986542   58899999999999999999999   89999999999999987765        69999


Q ss_pred             CCCcc-------cCCCcccCCcccccc-CCCCCccceeehhHHHHHHHhCC-CCCCCCChhHHHHHHHHHhcCCchhhcc
Q 047719          434 FEATI-------PAGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGK-SPVDNDGCVIVDWVWNLRKKGKLLDAAD  504 (596)
Q Consensus       434 fg~~~-------~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~-~p~~~~~~~~~~~~~~~~~~~~~~~~~d  504 (596)
                      ||.+.       ..++..|+|||.+.+ ..++.++|||||||++|||++|. .|+.......  ... .....       
T Consensus       152 ~g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~--~~~-~~~~~-------  221 (258)
T cd05078         152 PGISITVLPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK--KLQ-FYEDR-------  221 (258)
T ss_pred             cccccccCCchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH--HHH-HHHcc-------
Confidence            98764       347788999999976 45799999999999999999984 6665432211  110 11110       


Q ss_pred             ccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 047719          505 FRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK  545 (596)
Q Consensus       505 ~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~  545 (596)
                          ..++......+.+++..||+.+|++|||++++++.|+
T Consensus       222 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         222 ----HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             ----ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                0111122345788889999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-36  Score=304.49  Aligned_cols=244  Identities=23%  Similarity=0.267  Sum_probs=191.6

Q ss_pred             HhcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhc------------ccchHHHHHHHHHhccCCCceeee
Q 047719          282 ATLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVEC------------ARNPFTTEFATMAGCLRHKNLVQL  348 (596)
Q Consensus       282 at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~------------~~~~~~~E~~~l~~~l~H~niv~l  348 (596)
                      ..+.|...+.||+|.||.|-+|... +++.||||++.+.....+            ..+...+||.+|.+ ++|||||+|
T Consensus        95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKk-l~H~nVV~L  173 (576)
T KOG0585|consen   95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKK-LHHPNVVKL  173 (576)
T ss_pred             ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHh-cCCcCeeEE
Confidence            3467888899999999999999765 589999999975422111            12367889977765 999999999


Q ss_pred             cceeeeC--CeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCC
Q 047719          349 QGWCCEG--NELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAE  426 (596)
Q Consensus       349 ~g~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~  426 (596)
                      +.+..+.  +.+|||+|||..|.+...=...    ..|+..+.++++.++..||+|||.   ++||||||||+|+||+++
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d~----~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~  246 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPDK----PELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSD  246 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccCCCCc----ccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCC
Confidence            9998764  5799999999988765433221    228999999999999999999999   999999999999999999


Q ss_pred             CceEEccCCCcc----------------cCCCcccCCccccccCC----CCCccceeehhHHHHHHHhCCCCCCCCChhH
Q 047719          427 FNAKLGDFEATI----------------PAGTMGYLAPEYVYSGV----PSEKTDVYSFGVVALEVAAGKSPVDNDGCVI  486 (596)
Q Consensus       427 ~~~kl~Dfg~~~----------------~~gt~~y~aPE~~~~~~----~t~~sDV~SfGvll~El~tG~~p~~~~~~~~  486 (596)
                      |++||+|||.+.                .+||+.|+|||+..++.    .+.+.||||+||+||.|+.|+.||-++..  
T Consensus       247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~--  324 (576)
T KOG0585|consen  247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE--  324 (576)
T ss_pred             CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH--
Confidence            999999998654                35999999999987743    36789999999999999999999976421  


Q ss_pred             HHHHHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 047719          487 VDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARIL  544 (596)
Q Consensus       487 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L  544 (596)
                      .    .++.     .++...+......++.+.+.+|+++++++||++|.+..+|....
T Consensus       325 ~----~l~~-----KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp  373 (576)
T KOG0585|consen  325 L----ELFD-----KIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP  373 (576)
T ss_pred             H----HHHH-----HHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence            1    1111     11122222222335667788889999999999999999987643

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=3e-35  Score=304.07  Aligned_cols=250  Identities=23%  Similarity=0.339  Sum_probs=188.9

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      ++|...+.||+|+||.||+|... +++.||+|+++.... ......+.+|+..+.. ++|+||+++++++..++..++||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~lv~   83 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKD-LKHANIVTLHDIVHTDKSLTLVF   83 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHh-CCCCCcceEEEEEeeCCeEEEEE
Confidence            35778899999999999999865 478899999864332 2233457788866554 89999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc---
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP---  439 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~---  439 (596)
                      ||+++ +|.+++....   ..+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||.+..   
T Consensus        84 e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  156 (309)
T cd07872          84 EYLDK-DLKQYMDDCG---NIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSV  156 (309)
T ss_pred             eCCCC-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCC
Confidence            99975 8988887643   247889999999999999999999   8999999999999999999999999997532   


Q ss_pred             --------CCCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCChh-HHHHHHHHHhcCC---------ch
Q 047719          440 --------AGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV-IVDWVWNLRKKGK---------LL  500 (596)
Q Consensus       440 --------~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~-~~~~~~~~~~~~~---------~~  500 (596)
                              .+|..|+|||.+.+ ..++.++|||||||++|||++|+.||...... .............         ..
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
T cd07872         157 PTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND  236 (309)
T ss_pred             CccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh
Confidence                    36788999998865 56899999999999999999999999764321 1110111100000         00


Q ss_pred             hhccccccCc-------CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          501 DAADFRLRGK-------FNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       501 ~~~d~~l~~~-------~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      +..+......       ........+.+++.+|++.||++|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            0000000000       00112345678889999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-35  Score=305.41  Aligned_cols=245  Identities=20%  Similarity=0.255  Sum_probs=183.9

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      ++|...+.||+|+||.||++... +++.||||++.+.... ......+.+|+..+ ..++|+||+++++++.+.+.+|+|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l-~~~~~~~i~~~~~~~~~~~~~~lv   79 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVL-VNGDRRWITNLHYAFQDENNLYLV   79 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHH-HhCCCCCCCceEEEEecCCeEEEE
Confidence            36788899999999999999865 4889999999642221 12233466676444 458999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc---
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI---  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---  438 (596)
                      |||+++|+|.+++....   ..+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||++.   
T Consensus        80 ~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  153 (331)
T cd05597          80 MDYYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLL  153 (331)
T ss_pred             EecCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecC
Confidence            99999999999997632   248889999999999999999999   899999999999999999999999999753   


Q ss_pred             ---------cCCCcccCCcccccc-----CCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhcc
Q 047719          439 ---------PAGTMGYLAPEYVYS-----GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAAD  504 (596)
Q Consensus       439 ---------~~gt~~y~aPE~~~~-----~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d  504 (596)
                               ..||+.|+|||++..     ..++.++|||||||++|||++|+.||.....  .+................
T Consensus       154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~--~~~~~~i~~~~~~~~~~~  231 (331)
T cd05597         154 ADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL--VETYGKIMNHKEHFQFPP  231 (331)
T ss_pred             CCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH--HHHHHHHHcCCCcccCCC
Confidence                     248899999999863     4578899999999999999999999976432  121112211111111100


Q ss_pred             ccccCcCCHHHHHHHHHHHHH--cCCCCCCCCCCHHHHHHH
Q 047719          505 FRLRGKFNRKEMERMLMVGLS--CVHPNHEKRPSVKEAARI  543 (596)
Q Consensus       505 ~~l~~~~~~~~~~~l~~l~~~--C~~~dp~~RPs~~ev~~~  543 (596)
                        ....++.    .+.+++.+  |...++..||+++++++.
T Consensus       232 --~~~~~~~----~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         232 --DVTDVSE----EAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             --ccCCCCH----HHHHHHHHHccCcccccCCCCHHHHhcC
Confidence              0111222    23333334  555556668999988773

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.1e-35  Score=295.70  Aligned_cols=238  Identities=27%  Similarity=0.341  Sum_probs=193.0

Q ss_pred             cCCCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      ++|+..+.||+|+||.||+|...+ +..+++|.+.....    ..++.+|+..+.. ++|+||+++++++......|+++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~e~~~~~~-l~~~~i~~~~~~~~~~~~~~l~~   77 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED----LQEIIKEISILKQ-CDSPYIVKYYGSYFKNTDLWIVM   77 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH----HHHHHHHHHHHHh-CCCCcEeeeeeeeecCCcEEEEE
Confidence            568888999999999999998765 78999999854321    5578888865554 79999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc---
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP---  439 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~---  439 (596)
                      ||+++++|.+++....   ..+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.+||+|||++..   
T Consensus        78 e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~  151 (256)
T cd06612          78 EYCGAGSVSDIMKITN---KTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD  151 (256)
T ss_pred             ecCCCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhccc
Confidence            9999999999997543   358999999999999999999999   8999999999999999999999999986532   


Q ss_pred             --------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcC
Q 047719          440 --------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKF  511 (596)
Q Consensus       440 --------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  511 (596)
                              .++..|+|||.+.+..++.++|||||||++|||++|+.||....... ... .. ..     .....  ...
T Consensus       152 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~-~~~-~~-~~-----~~~~~--~~~  221 (256)
T cd06612         152 TMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR-AIF-MI-PN-----KPPPT--LSD  221 (256)
T ss_pred             CccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh-hhh-hh-cc-----CCCCC--CCc
Confidence                    36778999999988889999999999999999999999997542210 000 00 00     00000  111


Q ss_pred             CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          512 NRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       512 ~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      +......+.+++.+||+.+|++|||+.|+++
T Consensus       222 ~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         222 PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             hhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            2223356788889999999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.5e-35  Score=295.10  Aligned_cols=240  Identities=25%  Similarity=0.368  Sum_probs=193.4

Q ss_pred             CCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          285 GFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      +|...+.||+|+||.||++... +++.+|||++............+.+|+..+. .++|+|++++++.+...+..++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~-~~~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLK-LLSHPNIIEYYENFLEDKALMIVME   79 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHh-hCCCCchhheeeeEecCCEEEEEEe
Confidence            4677899999999999999764 5889999999765444445567888886554 4899999999999999999999999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCC-CceEEccCCCcc----
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAE-FNAKLGDFEATI----  438 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~-~~~kl~Dfg~~~----  438 (596)
                      |+++++|.+++....  ...+++..+..++.+++.+|+|||+   ++++|+||||+||+++.+ ..+||+|||.+.    
T Consensus        80 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~  154 (256)
T cd08220          80 YAPGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS  154 (256)
T ss_pred             cCCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence            999999999998653  2348899999999999999999999   899999999999999865 468999998754    


Q ss_pred             ------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCC
Q 047719          439 ------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFN  512 (596)
Q Consensus       439 ------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  512 (596)
                            ..|+..|+|||.+....++.++||||||+++|||++|+.||.....  .......... ..         ...+
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~--~~~~~~~~~~-~~---------~~~~  222 (256)
T cd08220         155 KSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL--PALVLKIMSG-TF---------APIS  222 (256)
T ss_pred             CccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch--HHHHHHHHhc-CC---------CCCC
Confidence                  2467889999999888899999999999999999999999976432  1111111111 10         0111


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          513 RKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       513 ~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ......+.+++..||+.+|++|||++|+++
T Consensus       223 ~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         223 DRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             CCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            123445778889999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.6e-35  Score=311.06  Aligned_cols=182  Identities=27%  Similarity=0.364  Sum_probs=157.2

Q ss_pred             HhcCCCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEE
Q 047719          282 ATLGFNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVL  360 (596)
Q Consensus       282 at~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~l  360 (596)
                      ...+|...+.||+|+||.||+|.... +..||+|...+.        ....|+..+ +.++|+||+++++++......++
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l-~~l~h~~iv~~~~~~~~~~~~~l  134 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLL-QNVNHPSVIRMKDTLVSGAITCM  134 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHH-HhCCCCCCcChhheEEeCCeeEE
Confidence            34579999999999999999998764 778999975321        234577555 45999999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc--
Q 047719          361 VYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI--  438 (596)
Q Consensus       361 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~--  438 (596)
                      |+||+. ++|.+++....   ..++|..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++.  
T Consensus       135 v~e~~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  207 (357)
T PHA03209        135 VLPHYS-SDLYTYLTKRS---RPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFP  207 (357)
T ss_pred             EEEccC-CcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCcccccc
Confidence            999995 68999987643   358999999999999999999999   899999999999999999999999999764  


Q ss_pred             --------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCC
Q 047719          439 --------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPV  479 (596)
Q Consensus       439 --------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~  479 (596)
                              ..||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        208 VVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             ccCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence                    24889999999999999999999999999999999955443

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=4.7e-35  Score=300.98  Aligned_cols=242  Identities=29%  Similarity=0.414  Sum_probs=194.0

Q ss_pred             cCCCccceeecCCceEEEEEEc-CCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSL-PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      .+|...+.||.|+||.||+|.. .+++.||+|.+....  ......+.+|+..+. .++|+|++++++++......++|+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~   95 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK--QPKKELIINEILVMK-ELKNPNIVNFLDSFLVGDELFVVM   95 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc--CchHHHHHHHHHHHH-hcCCCceeeeeeeEecCceEEEEE
Confidence            3577889999999999999975 468999999986432  223456778886554 489999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc----
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI----  438 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~----  438 (596)
                      ||+++++|.+++...     .+++.++..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++.    
T Consensus        96 e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~  167 (296)
T cd06655          96 EYLAGGSLTDVVTET-----CMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP  167 (296)
T ss_pred             EecCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence            999999999999754     38999999999999999999999   899999999999999999999999998643    


Q ss_pred             -------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcC
Q 047719          439 -------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKF  511 (596)
Q Consensus       439 -------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  511 (596)
                             ..++..|+|||.+.+..++.++|||||||++|||++|+.||......  ........... .     .+  ..
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~--~~~~~~~~~~~-~-----~~--~~  237 (296)
T cd06655         168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL--RALYLIATNGT-P-----EL--QN  237 (296)
T ss_pred             ccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhcCC-c-----cc--CC
Confidence                   24678899999999888999999999999999999999999765321  11111111110 0     00  01


Q ss_pred             CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhc
Q 047719          512 NRKEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKG  546 (596)
Q Consensus       512 ~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~~  546 (596)
                      +......+.+++.+||+.+|++||++.++++  +++.
T Consensus       238 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~  274 (296)
T cd06655         238 PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKL  274 (296)
T ss_pred             cccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhh
Confidence            1122345677889999999999999999986  4443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-35  Score=305.11  Aligned_cols=241  Identities=25%  Similarity=0.292  Sum_probs=192.7

Q ss_pred             CCCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCchh-cccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          285 GFNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRVE-CARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~-~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      +|...+.||+|+||.||++...+ ++.||+|.+....... .....+..|++.+. .++|+||+++++.+......|+||
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILA-TLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHH-hCCCCCchhheeeeecCCEEEEEE
Confidence            57788999999999999998764 8999999997543322 23456778886554 489999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc---
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP---  439 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~---  439 (596)
                      ||+.+++|.+++....  ...+++..+..++.|+++||+|||+   .+++|+||||+||+++.++.++|+|||++..   
T Consensus        81 e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  155 (316)
T cd05574          81 DYCPGGELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDV  155 (316)
T ss_pred             EecCCCCHHHHHHhCC--CCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence            9999999999997543  2358999999999999999999999   8999999999999999999999999986432   


Q ss_pred             -------------------------------------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCC
Q 047719          440 -------------------------------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDND  482 (596)
Q Consensus       440 -------------------------------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~  482 (596)
                                                           .||..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~  235 (316)
T cd05574         156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS  235 (316)
T ss_pred             cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence                                                 3677899999999888999999999999999999999999764


Q ss_pred             ChhHHHHHHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCC----HHHHHH
Q 047719          483 GCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPS----VKEAAR  542 (596)
Q Consensus       483 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs----~~ev~~  542 (596)
                      +.. ..+ .....         ..............+.+++.+|++.+|++||+    ++|+++
T Consensus       236 ~~~-~~~-~~~~~---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         236 NRD-ETF-SNILK---------KEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             chH-HHH-HHHhc---------CCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            321 001 11111         01111111114567888889999999999999    666655

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.4e-35  Score=293.73  Aligned_cols=253  Identities=24%  Similarity=0.288  Sum_probs=193.3

Q ss_pred             CCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCc-eeeecceeeeCC------e
Q 047719          286 FNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN-LVQLQGWCCEGN------E  357 (596)
Q Consensus       286 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~n-iv~l~g~~~~~~------~  357 (596)
                      |...++||+|.||+||+|+.. +|+.||+|++......+.......+|+ .+.+.++|+| ||+|++++....      .
T Consensus        13 ~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREi-sllk~L~~~~~iv~L~dv~~~~~~~~~~~~   91 (323)
T KOG0594|consen   13 YEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREI-SLLKRLSHANHIVRLHDVIHTSNNHRGIGK   91 (323)
T ss_pred             HHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHH-HHHHHhCCCcceEEEEeeeeecccccccce
Confidence            445577999999999999765 588999999976544333445568898 5556699999 999999999887      8


Q ss_pred             EEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCc
Q 047719          358 LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT  437 (596)
Q Consensus       358 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~  437 (596)
                      ++||+||+.. +|.+++.........++...+..+..||+.||+|||+   ++|+||||||+||||+++|.+||+|||++
T Consensus        92 l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFGlA  167 (323)
T KOG0594|consen   92 LYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFGLA  167 (323)
T ss_pred             EEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccchH
Confidence            9999999965 9999998765322346668899999999999999999   99999999999999999999999999976


Q ss_pred             cc-----------CCCcccCCccccccC-CCCCccceeehhHHHHHHHhCCCCCCCCCh-hHHHHHHHHHhcCCc-----
Q 047719          438 IP-----------AGTMGYLAPEYVYSG-VPSEKTDVYSFGVVALEVAAGKSPVDNDGC-VIVDWVWNLRKKGKL-----  499 (596)
Q Consensus       438 ~~-----------~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~El~tG~~p~~~~~~-~~~~~~~~~~~~~~~-----  499 (596)
                      +.           ++|..|.|||.+.+. .|+...||||+|||+.||++++.-|.+... ....-+.+....+..     
T Consensus       168 ra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~  247 (323)
T KOG0594|consen  168 RAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPG  247 (323)
T ss_pred             HHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCC
Confidence            43           478899999999876 799999999999999999999998987543 111112222211110     


Q ss_pred             -hhhcccc--ccCc-----CCH---HHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 047719          500 -LDAADFR--LRGK-----FNR---KEMERMLMVGLSCVHPNHEKRPSVKEAARI  543 (596)
Q Consensus       500 -~~~~d~~--l~~~-----~~~---~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~  543 (596)
                       ....+..  ....     ...   .......++..+|++.+|++|.|++.+++.
T Consensus       248 v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  248 VSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             ccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence             0011110  0000     000   111367788899999999999999999873

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=3.9e-35  Score=298.26  Aligned_cols=236  Identities=24%  Similarity=0.350  Sum_probs=192.8

Q ss_pred             CCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          285 GFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      .|...+.||+|+||.||+|... .+..||||.+..... ......+.+|+..+. .++|+||+++++++.+....++|||
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLS-QCDSPYVTKYYGSYLKGTKLWIIME   82 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHH-hCCCCCEeeEEEEEEECCEEEEEEe
Confidence            3556688999999999999865 488999999864322 233456788886555 4899999999999999999999999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc----
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP----  439 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~----  439 (596)
                      |+++|+|.+++...     .+++.+...++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||++..    
T Consensus        83 ~~~~~~L~~~i~~~-----~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06640          83 YLGGGSALDLLRAG-----PFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT  154 (277)
T ss_pred             cCCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCC
Confidence            99999999999753     37889999999999999999999   8999999999999999999999999987632    


Q ss_pred             -------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCC
Q 047719          440 -------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFN  512 (596)
Q Consensus       440 -------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  512 (596)
                             .++..|+|||.+.+..++.++|||||||++|||++|..|+.......  .....          .........
T Consensus       155 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~----------~~~~~~~~~  222 (277)
T cd06640         155 QIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR--VLFLI----------PKNNPPTLT  222 (277)
T ss_pred             ccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh--Hhhhh----------hcCCCCCCc
Confidence                   36778999999988889999999999999999999999997543211  01000          001112233


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          513 RKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       513 ~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ......+.+++..||+.+|++||++.++++
T Consensus       223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06640         223 GEFSKPFKEFIDACLNKDPSFRPTAKELLK  252 (277)
T ss_pred             hhhhHHHHHHHHHHcccCcccCcCHHHHHh
Confidence            445667889999999999999999999976

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2.3e-35  Score=300.43  Aligned_cols=251  Identities=24%  Similarity=0.375  Sum_probs=195.7

Q ss_pred             ccCHHHHHHHhcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecce
Q 047719          273 RLALTDIKQATLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW  351 (596)
Q Consensus       273 ~~~~~el~~at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~  351 (596)
                      +.++.++..+...|...+.||+|+||.||+|... +++.+|+|.+....   ....++..|+..+.+..+|+||++++++
T Consensus         5 ~~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~   81 (282)
T cd06636           5 DIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGA   81 (282)
T ss_pred             hhhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeee
Confidence            3456677777888999999999999999999875 48899999985432   2234577787666664589999999999


Q ss_pred             eee------CCeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecC
Q 047719          352 CCE------GNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDA  425 (596)
Q Consensus       352 ~~~------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~  425 (596)
                      +..      ....|++|||+++|+|.+++.....  ..+++..+..++.||+.||+|||+   .+++|+||||+||+++.
T Consensus        82 ~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~  156 (282)
T cd06636          82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG--NALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTE  156 (282)
T ss_pred             hhcccccCCCCEEEEEEEeCCCCcHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECC
Confidence            863      4578999999999999999976542  347888899999999999999999   89999999999999999


Q ss_pred             CCceEEccCCCcc-----------cCCCcccCCccccc-----cCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHH
Q 047719          426 EFNAKLGDFEATI-----------PAGTMGYLAPEYVY-----SGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDW  489 (596)
Q Consensus       426 ~~~~kl~Dfg~~~-----------~~gt~~y~aPE~~~-----~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~  489 (596)
                      ++.++|+|||++.           ..|+..|+|||.+.     ...++.++|||||||++|||++|+.||......-.  
T Consensus       157 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~--  234 (282)
T cd06636         157 NAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA--  234 (282)
T ss_pred             CCCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh--
Confidence            9999999998753           23778899999875     34678899999999999999999999965421100  


Q ss_pred             HHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          490 VWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       490 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ......      ......   ........+.+++..||+.||.+||++.|+++
T Consensus       235 ~~~~~~------~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         235 LFLIPR------NPPPKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             hhhHhh------CCCCCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            000000      000111   11123356788889999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.2e-35  Score=335.16  Aligned_cols=253  Identities=20%  Similarity=0.316  Sum_probs=195.0

Q ss_pred             HHHhcCCCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeee--CC
Q 047719          280 KQATLGFNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE--GN  356 (596)
Q Consensus       280 ~~at~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~--~~  356 (596)
                      ......|...+.||+|+||+||++.... +..||+|.+............+..|+..+.. ++|||||++++++..  ..
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~-L~HPNIVrl~d~f~de~~~   87 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRE-LKHKNIVRYIDRFLNKANQ   87 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHH-cCCCCcCeEEEEEEecCCC
Confidence            3445678889999999999999998654 7789999987544444455678889966654 999999999998865  35


Q ss_pred             eEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhcc----CCCeEEccCCCCceeecC-------
Q 047719          357 ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC----ERQIIHRDVKACNILLDA-------  425 (596)
Q Consensus       357 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~----~~~ivHrDlkp~NiLl~~-------  425 (596)
                      .+||||||+++|+|.++|.........+++..++.|+.||+.||+|||+..    ..+|+||||||+||||+.       
T Consensus        88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~  167 (1021)
T PTZ00266         88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK  167 (1021)
T ss_pred             EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence            689999999999999999764332345899999999999999999999832    145999999999999964       


Q ss_pred             ----------CCceEEccCCCccc----------CCCcccCCcccccc--CCCCCccceeehhHHHHHHHhCCCCCCCCC
Q 047719          426 ----------EFNAKLGDFEATIP----------AGTMGYLAPEYVYS--GVPSEKTDVYSFGVVALEVAAGKSPVDNDG  483 (596)
Q Consensus       426 ----------~~~~kl~Dfg~~~~----------~gt~~y~aPE~~~~--~~~t~~sDV~SfGvll~El~tG~~p~~~~~  483 (596)
                                ...+||+|||++..          .||+.|+|||++..  ..++.++|||||||+||||++|+.||....
T Consensus       168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~  247 (1021)
T PTZ00266        168 ITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN  247 (1021)
T ss_pred             ccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence                      23589999997642          48999999999864  458999999999999999999999997543


Q ss_pred             hhHHHHHHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHh
Q 047719          484 CVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILK  545 (596)
Q Consensus       484 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~  545 (596)
                      . ....+..+.....      ..+ .    .....+.+|+..||+.+|.+||++.|+++  ++.
T Consensus       248 ~-~~qli~~lk~~p~------lpi-~----~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik  299 (1021)
T PTZ00266        248 N-FSQLISELKRGPD------LPI-K----GKSKELNILIKNLLNLSAKERPSALQCLGYQIIK  299 (1021)
T ss_pred             c-HHHHHHHHhcCCC------CCc-C----CCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHh
Confidence            2 2222211111110      000 1    12345778889999999999999999984  554

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-35  Score=299.06  Aligned_cols=237  Identities=29%  Similarity=0.378  Sum_probs=191.3

Q ss_pred             CCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          285 GFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      +|...+.||.|+||.||+|... +++.||+|.+.... .......+.+|+..+. .++|+|++++++++.+....++|+|
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~~v~e   79 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLS-QCRSPYITKYYGSFLKGSKLWIIME   79 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHH-HcCCCCeeeeeEEEEECCeEEEEEE
Confidence            5677789999999999999865 58899999986433 2233446778885554 4899999999999999999999999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc-----
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI-----  438 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~-----  438 (596)
                      |+++++|.+++...     .+++..+..++.|++.||.|||+   .+++||||+|+||++++++.++|+|||++.     
T Consensus        80 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~  151 (274)
T cd06609          80 YCGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTST  151 (274)
T ss_pred             eeCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence            99999999999764     48999999999999999999999   899999999999999999999999998653     


Q ss_pred             ------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCC
Q 047719          439 ------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFN  512 (596)
Q Consensus       439 ------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  512 (596)
                            ..++..|+|||.+.+..++.++|||||||++|||++|+.||......  ....... ...     .+.+...  
T Consensus       152 ~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~-~~~-----~~~~~~~--  221 (274)
T cd06609         152 MSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM--RVLFLIP-KNN-----PPSLEGN--  221 (274)
T ss_pred             ccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH--HHHHHhh-hcC-----CCCCccc--
Confidence                  24677899999999888999999999999999999999999764321  1111111 110     0111111  


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          513 RKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       513 ~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                       .....+.+++..|++.+|++||+++++++
T Consensus       222 -~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         222 -KFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             -ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence             02345677888999999999999999976

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-35  Score=300.67  Aligned_cols=244  Identities=27%  Similarity=0.402  Sum_probs=194.0

Q ss_pred             cCCCccceeecCCceEEEEEEcCC-CC----EEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPS-GG----AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNEL  358 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~----~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~  358 (596)
                      ..|...+.||+|+||.||+|.... |.    .+|+|.+..... .....++.+|+..+.+ ++|+||++++++|.. ...
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~-~~~   83 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMAS-VDHPHVVRLLGICLS-SQV   83 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHh-CCCCCcceEEEEEec-Cce
Confidence            346677899999999999998643 33    589998864432 3344568888866655 899999999999987 789


Q ss_pred             EEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc
Q 047719          359 VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI  438 (596)
Q Consensus       359 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~  438 (596)
                      ++||||+++|+|.+++.....   .+++..++.++.||+.||+|||+   .+++||||||+|||+++++.+||+|||.+.
T Consensus        84 ~~v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~  157 (279)
T cd05057          84 QLITQLMPLGCLLDYVRNHKD---NIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAK  157 (279)
T ss_pred             EEEEecCCCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccc
Confidence            999999999999999987532   48999999999999999999999   899999999999999999999999999764


Q ss_pred             cC-------------CCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhcc
Q 047719          439 PA-------------GTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAAD  504 (596)
Q Consensus       439 ~~-------------gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d  504 (596)
                      ..             ++..|+|||.+....++.++|+|||||++||+++ |+.||.....  .++..... .+..     
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~-~~~~-----  229 (279)
T cd05057         158 LLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA--VEIPDLLE-KGER-----  229 (279)
T ss_pred             cccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH--HHHHHHHh-CCCC-----
Confidence            21             2457999999988889999999999999999999 9999976432  11111111 1111     


Q ss_pred             ccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Q 047719          505 FRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEA  548 (596)
Q Consensus       505 ~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~~  548 (596)
                          ...+......+.+++..||..+|++||++.++++.|+...
T Consensus       230 ----~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~  269 (279)
T cd05057         230 ----LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA  269 (279)
T ss_pred             ----CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence                0111112245678888999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=6e-35  Score=297.52  Aligned_cols=238  Identities=25%  Similarity=0.318  Sum_probs=187.8

Q ss_pred             CCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEec
Q 047719          286 FNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEY  364 (596)
Q Consensus       286 f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~  364 (596)
                      |...+.||+|+||.||+|.... +..+++|.+....  ......+.+|+..+.. ++|+|++++++++......++|+||
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~-l~h~~ii~~~~~~~~~~~~~~v~e~   83 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS--EEELEDYMVEIDILAS-CDHPNIVKLLDAFYYENNLWILIEF   83 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC--HHHHHHHHHHHHHHHH-CCCCCeeeEEEEEeeCCEEEEEEEe
Confidence            3456789999999999998764 7788999985332  3345568888866654 8999999999999999999999999


Q ss_pred             CCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc-----
Q 047719          365 LPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP-----  439 (596)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~-----  439 (596)
                      +++++|..++....   ..+++..+..++.|+++||.|||+   .+++||||||+|||++.++.+||+|||++..     
T Consensus        84 ~~~~~l~~~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~  157 (282)
T cd06643          84 CAGGAVDAVMLELE---RPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI  157 (282)
T ss_pred             cCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEccccccccccccc
Confidence            99999999887532   258999999999999999999999   8999999999999999999999999997532     


Q ss_pred             ------CCCcccCCccccc-----cCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhcccccc
Q 047719          440 ------AGTMGYLAPEYVY-----SGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLR  508 (596)
Q Consensus       440 ------~gt~~y~aPE~~~-----~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  508 (596)
                            .++..|+|||.+.     ...++.++|||||||++|||++|+.||......  +.+....... ....      
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~~~~~~-~~~~------  228 (282)
T cd06643         158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM--RVLLKIAKSE-PPTL------  228 (282)
T ss_pred             cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH--HHHHHHhhcC-CCCC------
Confidence                  3788999999884     345788999999999999999999999764321  1111111110 0000      


Q ss_pred             CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          509 GKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       509 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                       ..+......+.+++..||+.+|.+||++.++++
T Consensus       229 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         229 -AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             -CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             111122346778889999999999999998865

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.8e-35  Score=296.08  Aligned_cols=237  Identities=28%  Similarity=0.458  Sum_probs=189.7

Q ss_pred             CCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchh-------cccchHHHHHHHHHhccCCCceeeecceeeeCCe
Q 047719          286 FNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVE-------CARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNE  357 (596)
Q Consensus       286 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~-------~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~  357 (596)
                      |.....||+|+||.||+|... ++..||+|.+.......       ...+.+.+|+..+. .++||||+++++++.+...
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLK-ELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHH-hcCCCCeeeEEEEEEeCCc
Confidence            566789999999999999764 47899999886433221       12245677775554 4899999999999999999


Q ss_pred             EEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCc
Q 047719          358 LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT  437 (596)
Q Consensus       358 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~  437 (596)
                      .++||||+++++|.+++....    .+++..+..++.|++.||+|||+   .+++||||+|+||++++++.+||+|||.+
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~  153 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYG----AFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGIS  153 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCC
Confidence            999999999999999997653    47889999999999999999999   89999999999999999999999999864


Q ss_pred             cc-----------------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCch
Q 047719          438 IP-----------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLL  500 (596)
Q Consensus       438 ~~-----------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~  500 (596)
                      ..                 .|+..|+|||.+.+..++.++|||||||++|||++|+.||......  .-......     
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~-----  226 (267)
T cd06628         154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL--QAIFKIGE-----  226 (267)
T ss_pred             cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH--HHHHHHhc-----
Confidence            32                 3577899999998888999999999999999999999999764221  10111100     


Q ss_pred             hhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          501 DAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       501 ~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                       .    .....+......+.+++.+||++||.+||++.|+++
T Consensus       227 -~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         227 -N----ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             -c----CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence             0    111222233456778889999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.9e-35  Score=301.55  Aligned_cols=254  Identities=23%  Similarity=0.329  Sum_probs=194.5

Q ss_pred             cCHHHHHHHhcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeeccee
Q 047719          274 LALTDIKQATLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWC  352 (596)
Q Consensus       274 ~~~~el~~at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~  352 (596)
                      +.+..+..+.++|...+.||+|+||.||++... +++.+|+|++.....   ...++.+|+..+....+|+||+++++++
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~   84 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD---IDEEIEAEYNILKALSDHPNVVKFYGMY   84 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc---hHHHHHHHHHHHHHHhcCCCeeeeeeee
Confidence            344566678889999999999999999999765 478999998853221   2245677876665533799999999988


Q ss_pred             e-----eCCeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCC
Q 047719          353 C-----EGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEF  427 (596)
Q Consensus       353 ~-----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~  427 (596)
                      .     .....++||||+++++|.+++.........+++..+..++.|++.||.|||+   .+++||||||+||+++.++
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~  161 (286)
T cd06638          85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEG  161 (286)
T ss_pred             eecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCC
Confidence            4     3456899999999999999987543223458899999999999999999999   8999999999999999999


Q ss_pred             ceEEccCCCcc-----------cCCCcccCCcccccc-----CCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHH
Q 047719          428 NAKLGDFEATI-----------PAGTMGYLAPEYVYS-----GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVW  491 (596)
Q Consensus       428 ~~kl~Dfg~~~-----------~~gt~~y~aPE~~~~-----~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~  491 (596)
                      .+||+|||++.           ..|+..|+|||.+..     ..++.++|||||||++|||++|+.|+...... .. ..
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~-~~-~~  239 (286)
T cd06638         162 GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM-RA-LF  239 (286)
T ss_pred             CEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh-HH-Hh
Confidence            99999998753           247889999998753     45789999999999999999999998754211 10 00


Q ss_pred             HHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 047719          492 NLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARI  543 (596)
Q Consensus       492 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~  543 (596)
                      ..... .     .+...  .+......+..++.+||+.||++|||+.|+++.
T Consensus       240 ~~~~~-~-----~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         240 KIPRN-P-----PPTLH--QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             hcccc-C-----CCccc--CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            00000 0     00000  011122457788899999999999999999864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=6.3e-35  Score=301.69  Aligned_cols=252  Identities=24%  Similarity=0.330  Sum_probs=192.6

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      ++|...+.||+|+||.||++... ++..+|+|.+.... ......++.+|++.+.+ ++||||++++++|..++..++||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~lv~   78 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHE-CNSPYIVGFYGAFYSDGEISICM   78 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHh-CCCCCCCeEEEEEeeCCEEEEEe
Confidence            36888899999999999999865 47889999886432 22334567889866655 89999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc---
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP---  439 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~---  439 (596)
                      ||+++++|.+++....    .+++..+..++.|+++||.|||+.  .+++||||||+|||++.++.+||+|||++..   
T Consensus        79 ey~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  152 (308)
T cd06615          79 EHMDGGSLDQVLKKAG----RIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  152 (308)
T ss_pred             eccCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCcccccc
Confidence            9999999999997653    488999999999999999999972  5899999999999999999999999997542   


Q ss_pred             ------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChh-HHHHHHHHHhcCCch------------
Q 047719          440 ------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV-IVDWVWNLRKKGKLL------------  500 (596)
Q Consensus       440 ------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~-~~~~~~~~~~~~~~~------------  500 (596)
                            .|+..|+|||.+.+..++.++|||||||++|||++|+.||...... ...+...........            
T Consensus       153 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (308)
T cd06615         153 SMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPD  232 (308)
T ss_pred             cccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCC
Confidence                  4788999999998888999999999999999999999998653221 111000000000000            


Q ss_pred             --------hhccccc---cCcCC-HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 047719          501 --------DAADFRL---RGKFN-RKEMERMLMVGLSCVHPNHEKRPSVKEAARI  543 (596)
Q Consensus       501 --------~~~d~~l---~~~~~-~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~  543 (596)
                              +..+...   ....+ ......+.+++.+|++.+|++||+++++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         233 SPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             ccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                    0000000   00000 0123457789999999999999999999873

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=7e-35  Score=294.13  Aligned_cols=239  Identities=25%  Similarity=0.350  Sum_probs=188.2

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCch---hcccchHHHHHHHHHhccCCCceeeecceeeeC--Ce
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRV---ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG--NE  357 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~---~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~--~~  357 (596)
                      .+|...+.||+|+||.||+|... ++..||||.+......   ......+.+|+..+.+ ++|+||+++++++.+.  ..
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~~i~~~~~~~~~~~~~~   80 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKN-LLHERIVQYYGCLRDPMERT   80 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHh-cCCCCeeeEEeEeccCCCce
Confidence            46788899999999999999865 4889999998533221   1233467788866554 8999999999988764  46


Q ss_pred             EEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCc
Q 047719          358 LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT  437 (596)
Q Consensus       358 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~  437 (596)
                      +++||||+++++|.+++....    .+++...+.++.|++.||+|||+   .+++|+||||+|||++.++.++|+|||.+
T Consensus        81 ~~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~  153 (265)
T cd06652          81 LSIFMEHMPGGSIKDQLKSYG----ALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGAS  153 (265)
T ss_pred             EEEEEEecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCccc
Confidence            889999999999999997643    37888899999999999999999   89999999999999999999999999865


Q ss_pred             c--------------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhc
Q 047719          438 I--------------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAA  503 (596)
Q Consensus       438 ~--------------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  503 (596)
                      .              ..|+..|+|||.+.+..++.++|||||||++|||++|+.||...... .. .......       
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~~-~~~~~~~-------  224 (265)
T cd06652         154 KRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-AA-IFKIATQ-------  224 (265)
T ss_pred             cccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH-HH-HHHHhcC-------
Confidence            3              23677899999998888999999999999999999999999754211 11 1111100       


Q ss_pred             cccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          504 DFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       504 d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                        ......+......+.+++..|+. +|++||+++|+++
T Consensus       225 --~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         225 --PTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             --CCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence              01122333444566677778884 8999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.9e-35  Score=299.33  Aligned_cols=244  Identities=24%  Similarity=0.325  Sum_probs=192.0

Q ss_pred             CCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          285 GFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      +|+..+.||+|+||.||++... ++..||+|.+.... .+.....+.+|+..+.+ ++|+||+++++.+...+..++|||
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~-~~~~~i~~~~~~~~~~~~~~lv~e   79 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHK-AVSPYIVDFYGAFFIEGAVYMCME   79 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHh-cCCCcHHhhhhheecCCeEEEEEe
Confidence            4667789999999999999876 58999999986432 22234568888866655 899999999999999999999999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc----
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP----  439 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~----  439 (596)
                      |+++++|..++..... ...+++..+..++.+++.||.|||+.  .+++||||||+||+++.++.+||+|||.+..    
T Consensus        80 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  156 (286)
T cd06622          80 YMDAGSLDKLYAGGVA-TEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS  156 (286)
T ss_pred             ecCCCCHHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence            9999999999976421 23589999999999999999999962  5899999999999999999999999997642    


Q ss_pred             -----CCCcccCCccccccC------CCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhcccccc
Q 047719          440 -----AGTMGYLAPEYVYSG------VPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLR  508 (596)
Q Consensus       440 -----~gt~~y~aPE~~~~~------~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  508 (596)
                           .++..|+|||.+.+.      .++.++|+|||||++|||++|+.||.................+.         .
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------~  227 (286)
T cd06622         157 LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGD---------P  227 (286)
T ss_pred             ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcC---------C
Confidence                 367889999988543      35889999999999999999999997542211100000001111         1


Q ss_pred             CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          509 GKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       509 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ...+......+.+++.+|++.+|++||+++++++
T Consensus       228 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         228 PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence            1222334556778889999999999999999876

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.1e-35  Score=298.45  Aligned_cols=249  Identities=26%  Similarity=0.300  Sum_probs=194.3

Q ss_pred             CCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeC--CeEEEE
Q 047719          285 GFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG--NELVLV  361 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~--~~~~lV  361 (596)
                      +|...+.||.|++|.||++... +++.+|+|.+..... ......+.+|++.+. .++|+||++++++|...  ..+++|
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~~~lv   79 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINK-SCKSPYIVKYYGAFLDESSSSIGIA   79 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHH-hCCCCCeeeeeeEEEccCCCeEEEE
Confidence            5778899999999999999875 488999999864332 234456888986664 48999999999998654  468999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc--
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP--  439 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~--  439 (596)
                      |||+++++|.+++.........+++.....++.||+.||+|||+   .+++|+||+|+||+++.++.++|+|||++..  
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~  156 (287)
T cd06621          80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV  156 (287)
T ss_pred             EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence            99999999999886533333458899999999999999999999   8999999999999999999999999987542  


Q ss_pred             -------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCCh---hHHHHHHHHHhcCCchhhccccccC
Q 047719          440 -------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGC---VIVDWVWNLRKKGKLLDAADFRLRG  509 (596)
Q Consensus       440 -------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~---~~~~~~~~~~~~~~~~~~~d~~l~~  509 (596)
                             .++..|+|||.+.+..++.++|||||||++|||++|+.||.....   ...+....... .......+.   .
T Consensus       157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~  232 (287)
T cd06621         157 NSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN-MPNPELKDE---P  232 (287)
T ss_pred             ccccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc-CCchhhccC---C
Confidence                   367889999999988999999999999999999999999976421   11221111111 111111000   0


Q ss_pred             cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          510 KFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       510 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      .........+.+++.+||+.+|++|||+.|+++
T Consensus       233 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         233 GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            101123456788999999999999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=3.2e-35  Score=299.65  Aligned_cols=249  Identities=24%  Similarity=0.330  Sum_probs=191.0

Q ss_pred             CCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          285 GFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      +|+..+.||+|+||.||+|... +++.||+|++.+........+.+.+|+..+.. ++|+||+++++++...+..++|||
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQ-LRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHh-cCCcchhhHHHhcccCCeEEEEEe
Confidence            5777899999999999999876 48899999986543333344567788866554 899999999999999999999999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc----
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP----  439 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~----  439 (596)
                      |+++++|.++.....    .++|.+++.++.||++||+|||+   .+++|+||+|+||++++++.++|+|||++..    
T Consensus        81 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07846          81 FVDHTVLDDLEKYPN----GLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  153 (286)
T ss_pred             cCCccHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence            999999988876432    38999999999999999999999   8999999999999999999999999986532    


Q ss_pred             -------CCCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchh----------
Q 047719          440 -------AGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLD----------  501 (596)
Q Consensus       440 -------~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~----------  501 (596)
                             .++..|+|||.+.+ ..++.++|||||||++|||++|++||..... ...+.......+.+..          
T Consensus       154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07846         154 GEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD-IDQLYHIIKCLGNLIPRHQEIFQKNP  232 (286)
T ss_pred             ccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch-HHHHHHHHHHhCCCchhhHHHhccch
Confidence                   36778999998875 4578899999999999999999999975432 1111000000000000          


Q ss_pred             ----hccccccC-----cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          502 ----AADFRLRG-----KFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       502 ----~~d~~l~~-----~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                          ...+....     .........+.+++.+||+.+|++||++.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence                00000000     001123456888999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=5.4e-35  Score=319.62  Aligned_cols=254  Identities=19%  Similarity=0.196  Sum_probs=184.4

Q ss_pred             HHHHhcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHh-----ccCCCceeeeccee
Q 047719          279 IKQATLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAG-----CLRHKNLVQLQGWC  352 (596)
Q Consensus       279 l~~at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~-----~l~H~niv~l~g~~  352 (596)
                      +...+.+|...++||+|+||+||+|... .++.||||+++....   ...++..|+..+..     ...|.+++++++++
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~  200 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK---YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF  200 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh---hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence            4445678999999999999999999865 478899999954211   12223444433322     23456799999988


Q ss_pred             eeC-CeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCC----
Q 047719          353 CEG-NELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEF----  427 (596)
Q Consensus       353 ~~~-~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~----  427 (596)
                      ... .+.|+|||++ +++|.+++....    .+++..+..++.||+.||+|||+.  .+|+||||||+|||++.++    
T Consensus       201 ~~~~~~~~iv~~~~-g~~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~  273 (467)
T PTZ00284        201 QNETGHMCIVMPKY-GPCLLDWIMKHG----PFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVD  273 (467)
T ss_pred             EcCCceEEEEEecc-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccc
Confidence            764 5789999988 778999987653    489999999999999999999972  4999999999999998765    


Q ss_pred             ------------ceEEccCCCcc--------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChh-H
Q 047719          428 ------------NAKLGDFEATI--------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV-I  486 (596)
Q Consensus       428 ------------~~kl~Dfg~~~--------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~-~  486 (596)
                                  .+||+|||.+.        ..||..|+|||++.+..++.++|||||||++|||++|+.||...... .
T Consensus       274 ~~~~~~~~~~~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~  353 (467)
T PTZ00284        274 PVTNRALPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEH  353 (467)
T ss_pred             cccccccCCCCceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence                        49999999643        36899999999999999999999999999999999999999865421 1


Q ss_pred             HHHHHHHHh-----------cCCchhhccc--cccCcCC---------------HHHHHHHHHHHHHcCCCCCCCCCCHH
Q 047719          487 VDWVWNLRK-----------KGKLLDAADF--RLRGKFN---------------RKEMERMLMVGLSCVHPNHEKRPSVK  538 (596)
Q Consensus       487 ~~~~~~~~~-----------~~~~~~~~d~--~l~~~~~---------------~~~~~~l~~l~~~C~~~dp~~RPs~~  538 (596)
                      ...+.....           .....+..+.  .+.....               ......+.+|+..|++.||++|||++
T Consensus       354 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~  433 (467)
T PTZ00284        354 LHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNAR  433 (467)
T ss_pred             HHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHH
Confidence            110000000           0000000000  0000000               01124567899999999999999999


Q ss_pred             HHHH
Q 047719          539 EAAR  542 (596)
Q Consensus       539 ev~~  542 (596)
                      |+++
T Consensus       434 e~L~  437 (467)
T PTZ00284        434 QMTT  437 (467)
T ss_pred             HHhc
Confidence            9987

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=9.8e-35  Score=295.96  Aligned_cols=249  Identities=23%  Similarity=0.292  Sum_probs=188.1

Q ss_pred             CCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          285 GFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      +|...+.||+|+||.||+|... +|+.||+|++............+.+|+..+.+ ++|+||+++++++.+....++|+|
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~-l~h~~i~~~~~~~~~~~~~~lv~e   79 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKE-LKHKNIVRLYDVLHSDKKLTLVFE   79 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHh-cCCCCeeeHHHHhccCCceEEEEe
Confidence            3667789999999999999875 58899999997544333344567788866654 899999999999999999999999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc----
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP----  439 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~----  439 (596)
                      |++ ++|.+++....   ..+++..+..++.||++||.|||+   .+++||||||+||+++.++.+||+|||++..    
T Consensus        80 ~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  152 (284)
T cd07839          80 YCD-QDLKKYFDSCN---GDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP  152 (284)
T ss_pred             cCC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCC
Confidence            997 58888887543   248999999999999999999999   8999999999999999999999999986542    


Q ss_pred             -------CCCcccCCccccccC-CCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHh---cCC------chhh
Q 047719          440 -------AGTMGYLAPEYVYSG-VPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRK---KGK------LLDA  502 (596)
Q Consensus       440 -------~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~---~~~------~~~~  502 (596)
                             .++..|+|||.+.+. .++.++|||||||++|||++|+.|+...... .+.......   ...      ....
T Consensus       153 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd07839         153 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-DDQLKRIFRLLGTPTEESWPGVSKL  231 (284)
T ss_pred             CCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH-HHHHHHHHHHhCCCChHHhHHhhhc
Confidence                   357789999998764 4789999999999999999998886432211 111111000   000      0000


Q ss_pred             ccccccC---------cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          503 ADFRLRG---------KFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       503 ~d~~l~~---------~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      .+.....         .........+.+++..|++.||.+|||++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            0000000         001122356678899999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.3e-35  Score=314.77  Aligned_cols=180  Identities=28%  Similarity=0.342  Sum_probs=157.9

Q ss_pred             cCCCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      .+|...+.||+|+||.||++.... ++.||||...        ...+.+|+..+. .++|+|||++++++...+..++||
T Consensus       169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~--------~~~~~~E~~iL~-~L~HpnIv~l~~~~~~~~~~~lv~  239 (461)
T PHA03211        169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW--------YASSVHEARLLR-RLSHPAVLALLDVRVVGGLTCLVL  239 (461)
T ss_pred             CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc--------ccCHHHHHHHHH-HCCCCCCCcEEEEEEECCEEEEEE
Confidence            468888999999999999998765 7889999642        123567885555 499999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc----
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI----  438 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~----  438 (596)
                      |++. ++|.+++....   ..++|.+++.++.||+.||.|||+   .+|+||||||+||||+.++.+||+|||++.    
T Consensus       240 e~~~-~~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~  312 (461)
T PHA03211        240 PKYR-SDLYTYLGARL---RPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARG  312 (461)
T ss_pred             EccC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceeccc
Confidence            9994 79999987543   258999999999999999999999   899999999999999999999999999753    


Q ss_pred             ---------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCC
Q 047719          439 ---------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPV  479 (596)
Q Consensus       439 ---------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~  479 (596)
                               ..||..|+|||++.+..++.++|||||||+||||++|..|+
T Consensus       313 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l  362 (461)
T PHA03211        313 SWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL  362 (461)
T ss_pred             ccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence                     24899999999999999999999999999999999987654

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=5.8e-35  Score=292.57  Aligned_cols=238  Identities=28%  Similarity=0.395  Sum_probs=191.9

Q ss_pred             CCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCch---hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          286 FNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRV---ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       286 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~---~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      |...+.||+|+||.||+|... ++..|++|.+......   ....+.+.+|+..+. .++|+||+++++++......++|
T Consensus         2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~-~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLS-KLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHH-hcCCCCchheeeeEecCCeEEEE
Confidence            667789999999999999876 6899999998653321   223456888886554 48999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc---
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI---  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---  438 (596)
                      +||+++++|.+++....    .+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.+||+|||.+.   
T Consensus        81 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~  153 (258)
T cd06632          81 LELVPGGSLAKLLKKYG----SFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVV  153 (258)
T ss_pred             EEecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence            99999999999997653    48899999999999999999999   899999999999999999999999998653   


Q ss_pred             -------cCCCcccCCccccccCC-CCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCc
Q 047719          439 -------PAGTMGYLAPEYVYSGV-PSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGK  510 (596)
Q Consensus       439 -------~~gt~~y~aPE~~~~~~-~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  510 (596)
                             ..|+..|++||.+.... ++.++|+|||||++|||++|+.||.....  .+...........         ..
T Consensus       154 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~---------~~  222 (258)
T cd06632         154 EFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG--VAAVFKIGRSKEL---------PP  222 (258)
T ss_pred             ccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH--HHHHHHHHhcccC---------CC
Confidence                   23678899999987766 89999999999999999999999976432  1222222111111         11


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          511 FNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       511 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      .+......+.+++.+||+.+|.+||++.++++
T Consensus       223 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         223 IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence            12223355677888999999999999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2.4e-35  Score=304.04  Aligned_cols=242  Identities=29%  Similarity=0.411  Sum_probs=189.7

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCC----EEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGG----AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNEL  358 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~----~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~  358 (596)
                      .+|...+.||+|+||.||+|... ++.    .||+|.+..... .....++.+|+..+. .++||||++++++|... ..
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~-~l~h~niv~~~~~~~~~-~~   83 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG-PKANVEFMDEALIMA-SMDHPHLVRLLGVCLSP-TI   83 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC-HHHHHHHHHHHHHHH-hCCCCCcccEEEEEcCC-Cc
Confidence            45667789999999999999764 343    578998854322 222345778885554 48999999999999764 57


Q ss_pred             EEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc
Q 047719          359 VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI  438 (596)
Q Consensus       359 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~  438 (596)
                      ++++||+++|+|.+++....   ..+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++.
T Consensus        84 ~~v~e~~~~g~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~  157 (303)
T cd05110          84 QLVTQLMPHGCLLDYVHEHK---DNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLAR  157 (303)
T ss_pred             eeeehhcCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccc
Confidence            89999999999999997653   248899999999999999999999   899999999999999999999999999764


Q ss_pred             cC-------------CCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCCh-hHHHHHHHHHhcCCchhhc
Q 047719          439 PA-------------GTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGC-VIVDWVWNLRKKGKLLDAA  503 (596)
Q Consensus       439 ~~-------------gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~-~~~~~~~~~~~~~~~~~~~  503 (596)
                      ..             ++..|+|||.+.+..++.++|||||||++|||++ |+.||..... ...++    ...+....  
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~----~~~~~~~~--  231 (303)
T cd05110         158 LLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDL----LEKGERLP--  231 (303)
T ss_pred             cccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HHCCCCCC--
Confidence            21             3567999999988889999999999999999998 9999976432 11111    11111100  


Q ss_pred             cccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          504 DFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       504 d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                             .+......+..++..||..+|++||+++++++.|+..
T Consensus       232 -------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~  268 (303)
T cd05110         232 -------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM  268 (303)
T ss_pred             -------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                   0111234577888999999999999999999998764

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.4e-34  Score=296.41  Aligned_cols=240  Identities=27%  Similarity=0.323  Sum_probs=189.9

Q ss_pred             cCCCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      +.|...+.||+|+||.||+|.... +..||+|.+...  .......+.+|+..+. .++|+|++++++.+..++..++||
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~   88 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILA-TCNHPYIVKLLGAFYWDGKLWIMI   88 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHH-hCCCCcEeeeEEEEEeCCeEEEEE
Confidence            456778899999999999998754 889999998543  2334556788886554 489999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc---
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP---  439 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~---  439 (596)
                      ||+++++|..++.+..   ..+++..+..++.|++.+|.|||+   .+++||||||+||+++.++.+||+|||.+..   
T Consensus        89 e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  162 (292)
T cd06644          89 EFCPGGAVDAIMLELD---RGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK  162 (292)
T ss_pred             ecCCCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence            9999999999886543   248999999999999999999998   8999999999999999999999999997532   


Q ss_pred             --------CCCcccCCccccc-----cCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhcccc
Q 047719          440 --------AGTMGYLAPEYVY-----SGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFR  506 (596)
Q Consensus       440 --------~gt~~y~aPE~~~-----~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~  506 (596)
                              .++..|+|||.+.     ...++.++|||||||++|||++|+.||.....  ........ ....     +.
T Consensus       163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--~~~~~~~~-~~~~-----~~  234 (292)
T cd06644         163 TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP--MRVLLKIA-KSEP-----PT  234 (292)
T ss_pred             cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH--HHHHHHHh-cCCC-----cc
Confidence                    3678899999885     34568899999999999999999999875432  11111111 1100     00


Q ss_pred             ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          507 LRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       507 l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      .  ..+......+.+++.+||+.+|++||+++++++
T Consensus       235 ~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         235 L--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             C--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            0  111223345778889999999999999999876

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-35  Score=293.86  Aligned_cols=261  Identities=22%  Similarity=0.271  Sum_probs=197.7

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeee-----CCe
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE-----GNE  357 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~-----~~~  357 (596)
                      ..|...+.||+|+||.|..+... +|+.||||++..........++.++|+..+ +.++|+||+.++..+..     -..
T Consensus        22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklL-r~~~HeNIi~l~di~~p~~~~~f~D  100 (359)
T KOG0660|consen   22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLL-RHLRHENIIGLLDIFRPPSRDKFND  100 (359)
T ss_pred             ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHH-HHhcCCCcceEEeecccccccccce
Confidence            34445688999999999999765 589999999976566666677789999555 55999999999998875     346


Q ss_pred             EEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCc
Q 047719          358 LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT  437 (596)
Q Consensus       358 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~  437 (596)
                      +|+|+|+|+ -+|...++.+.    .|+......+++|+++||.|+|+   .+|+||||||+|+|++.+..+||+|||++
T Consensus       101 vYiV~elMe-tDL~~iik~~~----~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGLA  172 (359)
T KOG0660|consen  101 VYLVFELME-TDLHQIIKSQQ----DLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGLA  172 (359)
T ss_pred             eEEehhHHh-hHHHHHHHcCc----cccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccccce
Confidence            899999994 59999998764    48889999999999999999999   89999999999999999999999999987


Q ss_pred             ccC-------------CCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCCh-hHHHHHHHHHhcC-----
Q 047719          438 IPA-------------GTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGC-VIVDWVWNLRKKG-----  497 (596)
Q Consensus       438 ~~~-------------gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~-~~~~~~~~~~~~~-----  497 (596)
                      +..             -|.+|.|||.+.. ..||...||||.|||+.||++|++-|.+.+. ............+     
T Consensus       173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l  252 (359)
T KOG0660|consen  173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDL  252 (359)
T ss_pred             eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHH
Confidence            654             4678999998764 6899999999999999999999999987542 0111111111100     


Q ss_pred             ------Cchhhc-------cccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhcCCCCCCCC
Q 047719          498 ------KLLDAA-------DFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKGEAPLPLLP  554 (596)
Q Consensus       498 ------~~~~~~-------d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~~~~~~p~~p  554 (596)
                            .....+       .......++ ......++|..+++..||.+|+|++|+++  +|+....+..-|
T Consensus       253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP  323 (359)
T KOG0660|consen  253 QKIRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP  323 (359)
T ss_pred             HHhccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence                  000000       000001111 22345667777899999999999999987  666655544444

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.4e-34  Score=300.01  Aligned_cols=184  Identities=22%  Similarity=0.339  Sum_probs=151.9

Q ss_pred             cceeecCCceEEEEEEcC---CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeee--CCeEEEEEe
Q 047719          289 NRIVGEGASATVYKGSLP---SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE--GNELVLVYE  363 (596)
Q Consensus       289 ~~~LG~G~fG~Vy~~~~~---~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~--~~~~~lV~E  363 (596)
                      .++||+|+||.||+|...   ++..||+|.+....    ....+.+|+..+.+ ++||||+++++++..  ....++|||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~~~lv~e   80 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG----ISMSACREIALLRE-LKHPNVISLQKVFLSHADRKVWLLFD   80 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC----CcHHHHHHHHHHHh-cCCCCCcceeeeEecCCCcEEEEEEe
Confidence            468999999999999854   46789999985432    22346788866654 999999999998854  456899999


Q ss_pred             cCCCCCHHHHhhhCCC-----CCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceee----cCCCceEEccC
Q 047719          364 YLPNGSLDKILHNNSS-----SSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILL----DAEFNAKLGDF  434 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~-----~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl----~~~~~~kl~Df  434 (596)
                      |+. ++|.+++.....     ....+++..+..++.||+.||.|||+   .+|+||||||+|||+    +.++.+||+||
T Consensus        81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07868          81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence            996 488888764321     12358899999999999999999999   899999999999999    45678999999


Q ss_pred             CCcc--------------cCCCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCC
Q 047719          435 EATI--------------PAGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDN  481 (596)
Q Consensus       435 g~~~--------------~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~  481 (596)
                      |++.              ..||..|+|||.+.+ ..++.++||||+||++|||++|++||..
T Consensus       157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~  218 (317)
T cd07868         157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence            9763              246888999999876 4589999999999999999999999964

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=3.8e-35  Score=294.00  Aligned_cols=240  Identities=24%  Similarity=0.364  Sum_probs=193.2

Q ss_pred             CCCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          285 GFNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      +|...+.||+|+||.||+|.... |..+|+|.+..........+.+.+|+..+. .++|+||+++++.+......++|+|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~-~~~h~~i~~~~~~~~~~~~~~lv~e   79 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLA-KMKHPNIVTFFASFQENGRLFIVME   79 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHH-hCCCCChhhhhheeccCCeEEEEEe
Confidence            46778999999999999998764 889999998654333334456778886554 4899999999999999999999999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCC-ceEEccCCCccc---
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEF-NAKLGDFEATIP---  439 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~-~~kl~Dfg~~~~---  439 (596)
                      |+++++|.+++.....  ..+++..+..++.|+++||.|||+   .+++|+||||+||++++++ .+||+|||.+..   
T Consensus        80 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~  154 (257)
T cd08225          80 YCDGGDLMKRINRQRG--VLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND  154 (257)
T ss_pred             cCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence            9999999999976542  357999999999999999999999   8999999999999999885 469999986532   


Q ss_pred             --------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcC
Q 047719          440 --------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKF  511 (596)
Q Consensus       440 --------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  511 (596)
                              .|+..|+|||.+....++.++|||||||++|||++|+.||....  ..+++...... ...         ..
T Consensus       155 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~-~~~---------~~  222 (257)
T cd08225         155 SMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN--LHQLVLKICQG-YFA---------PI  222 (257)
T ss_pred             CcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc--HHHHHHHHhcc-cCC---------CC
Confidence                    47788999999988889999999999999999999999997542  22222222111 110         11


Q ss_pred             CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          512 NRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       512 ~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      .......+.+++.+|++.+|++|||+.++++
T Consensus       223 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         223 SPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             CCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            1122346778889999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=5.8e-35  Score=295.52  Aligned_cols=243  Identities=27%  Similarity=0.362  Sum_probs=191.6

Q ss_pred             cCCCccceeecCCceEEEEEEcCC----CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPS----GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELV  359 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~  359 (596)
                      .+|...+.||+|+||.||+|...+    ...||||....... ....+.+.+|+..+. .++|+||++++++|.+ ...+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~-~~~h~~i~~~~~~~~~-~~~~   82 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS-PSVREKFLQEAYIMR-QFDHPHIVKLIGVITE-NPVW   82 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC-HHHHHHHHHHHHHHH-hCCCCchhceeEEEcC-CCcE
Confidence            346778999999999999997643    24699998854322 234457888986554 4899999999998875 5678


Q ss_pred             EEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc
Q 047719          360 LVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP  439 (596)
Q Consensus       360 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~  439 (596)
                      +||||+++|+|.+++....   ..+++..++.++.+++.||+|||+   .+++||||||+|||++.++.+||+|||++..
T Consensus        83 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~  156 (270)
T cd05056          83 IVMELAPLGELRSYLQVNK---YSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRY  156 (270)
T ss_pred             EEEEcCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeee
Confidence            9999999999999997643   248999999999999999999998   8999999999999999999999999987642


Q ss_pred             C------------CCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhcccc
Q 047719          440 A------------GTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADFR  506 (596)
Q Consensus       440 ~------------gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~  506 (596)
                      .            ++..|+|||.+....++.++|||||||++||+++ |..||......  +..... ..+...      
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--~~~~~~-~~~~~~------  227 (270)
T cd05056         157 LEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN--DVIGRI-ENGERL------  227 (270)
T ss_pred             cccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHH-HcCCcC------
Confidence            1            2357999999988889999999999999999996 99999764321  111111 111110      


Q ss_pred             ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          507 LRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       507 l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                         ..+......+.+++.+|+..+|.+|||+.++++.|+..
T Consensus       228 ---~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~  265 (270)
T cd05056         228 ---PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI  265 (270)
T ss_pred             ---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence               11122335677888999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.8e-34  Score=297.79  Aligned_cols=245  Identities=20%  Similarity=0.215  Sum_probs=195.1

Q ss_pred             cCCCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      ++|...+.||+|+||.||++.... ++.||+|.+...... ......+.+|+..+ +.++|+||+++++.+..++..++|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l-~~~~~~~i~~~~~~~~~~~~~~lv   79 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDIL-TFAENPFVVSMFCSFETKRHLCMV   79 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHH-HhCCCCCeeeeEEEEecCCEEEEE
Confidence            367788999999999999998754 789999998654321 22334677787555 458999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc--
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP--  439 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~--  439 (596)
                      |||+++++|.+++....    .+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||.+..  
T Consensus        80 ~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~  152 (305)
T cd05609          80 MEYVEGGDCATLLKNIG----ALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGL  152 (305)
T ss_pred             EecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccC
Confidence            99999999999997653    48899999999999999999999   8999999999999999999999999997541  


Q ss_pred             ------------------------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHh
Q 047719          440 ------------------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRK  495 (596)
Q Consensus       440 ------------------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~  495 (596)
                                              .++..|+|||.+....++.++|+|||||++|||++|+.||.+...  .++......
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~--~~~~~~~~~  230 (305)
T cd05609         153 MSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP--EELFGQVIS  230 (305)
T ss_pred             cCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHh
Confidence                                    357789999999888899999999999999999999999975432  111111111


Q ss_pred             cCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          496 KGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       496 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                       +..   ..+....    .....+.+++.+||+.+|++||++.++.+.|+.
T Consensus       231 -~~~---~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         231 -DDI---EWPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             -ccc---CCCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence             110   0111111    223456788899999999999998878777765

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=5.2e-35  Score=296.07  Aligned_cols=244  Identities=24%  Similarity=0.377  Sum_probs=191.3

Q ss_pred             CCccceeecCCceEEEEEEcC----CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCC-----
Q 047719          286 FNKNRIVGEGASATVYKGSLP----SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGN-----  356 (596)
Q Consensus       286 f~~~~~LG~G~fG~Vy~~~~~----~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~-----  356 (596)
                      |...+.||+|+||.||+|.+.    .+..||||++..........+++.+|+..+ +.++||||+++++++....     
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l-~~l~h~~i~~~~~~~~~~~~~~~~   79 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACM-KEFDHPNVIKLIGVSLRSRAKGRL   79 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHH-hcCCCCCcceEEEEEccCCCCCcc
Confidence            456688999999999999753    367899999965444444556788898655 4589999999999886542     


Q ss_pred             -eEEEEEecCCCCCHHHHhhhCC--CCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEcc
Q 047719          357 -ELVLVYEYLPNGSLDKILHNNS--SSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGD  433 (596)
Q Consensus       357 -~~~lV~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~D  433 (596)
                       ..++++||+++|+|.+++....  .....+++...+.++.|++.||+|||+   .+++||||||+||+++.++.+||+|
T Consensus        80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~d  156 (273)
T cd05074          80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVAD  156 (273)
T ss_pred             cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECc
Confidence             2478999999999999886432  112357899999999999999999999   8999999999999999999999999


Q ss_pred             CCCcccC-------------CCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCCh-hHHHHHHHHHhcCC
Q 047719          434 FEATIPA-------------GTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGC-VIVDWVWNLRKKGK  498 (596)
Q Consensus       434 fg~~~~~-------------gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~-~~~~~~~~~~~~~~  498 (596)
                      ||.+...             ++..|++||.+....++.++|||||||++|||++ |+.||..... .+..+.    ....
T Consensus       157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~----~~~~  232 (273)
T cd05074         157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYL----IKGN  232 (273)
T ss_pred             ccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHH----HcCC
Confidence            9976432             3467999999988889999999999999999999 8899875432 111111    1111


Q ss_pred             chhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          499 LLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       499 ~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                      ..     .    .+......+.+++.+|++.+|++||++.++++.|+.
T Consensus       233 ~~-----~----~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~  271 (273)
T cd05074         233 RL-----K----QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL  271 (273)
T ss_pred             cC-----C----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence            00     0    111233578889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.3e-34  Score=296.73  Aligned_cols=253  Identities=21%  Similarity=0.223  Sum_probs=190.5

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCe-----
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNE-----  357 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~-----  357 (596)
                      ++|+..+.||+|+||.||+|... +++.||||++............+.+|+..+...-+|+||+++++++.....     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            35788899999999999999865 588999999865443333445678898777664467999999999887665     


Q ss_pred             EEEEEecCCCCCHHHHhhhCCCC-CcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecC-CCceEEccCC
Q 047719          358 LVLVYEYLPNGSLDKILHNNSSS-SIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDA-EFNAKLGDFE  435 (596)
Q Consensus       358 ~~lV~E~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~-~~~~kl~Dfg  435 (596)
                      .|+||||+++ +|.+++...... ...+++..++.++.||++||.|||+   .+++||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999985 899988764322 3458999999999999999999999   89999999999999999 8999999999


Q ss_pred             Cccc-----------CCCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHh---cCCc-
Q 047719          436 ATIP-----------AGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRK---KGKL-  499 (596)
Q Consensus       436 ~~~~-----------~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~---~~~~-  499 (596)
                      .+..           .+++.|+|||.+.+ ..++.++|||||||++|||++|..||......  ........   .... 
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~  234 (295)
T cd07837         157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL--QQLLHIFKLLGTPTEQ  234 (295)
T ss_pred             cceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHHHhCCCChh
Confidence            7642           34677999998865 45799999999999999999999999764321  11111111   0000 


Q ss_pred             -----hhhcc----cccc----CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          500 -----LDAAD----FRLR----GKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       500 -----~~~~d----~~l~----~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                           ....+    +...    ..........+.+++..|+++||++||++.|++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence                 00000    0000    0001123456778899999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-34  Score=289.67  Aligned_cols=242  Identities=26%  Similarity=0.316  Sum_probs=193.4

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      ++|...+.||+|+||.||++... +++.+|+|.+.....  .....+..|+..+. .++||||+++++.+.....++++|
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~-~~~h~~i~~~~~~~~~~~~~~l~~   79 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG--DDFEIIQQEISMLK-ECRHPNIVAYFGSYLRRDKLWIVM   79 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch--hhHHHHHHHHHHHH-hCCCCChhceEEEEEeCCEEEEEE
Confidence            56788899999999999999875 478899999864432  24556788886555 489999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc---
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP---  439 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~---  439 (596)
                      ||+++++|.+++....   ..+++.++..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||.+..   
T Consensus        80 e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  153 (262)
T cd06613          80 EYCGGGSLQDIYQVTR---GPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTA  153 (262)
T ss_pred             eCCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhh
Confidence            9999999999997652   248899999999999999999999   8999999999999999999999999986532   


Q ss_pred             --------CCCcccCCccccccC---CCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhcccccc
Q 047719          440 --------AGTMGYLAPEYVYSG---VPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLR  508 (596)
Q Consensus       440 --------~gt~~y~aPE~~~~~---~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  508 (596)
                              .++..|+|||.+...   .++.++|||||||++|||++|+.|+......-.  ...... ...   ....  
T Consensus       154 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~--~~~~~~-~~~---~~~~--  225 (262)
T cd06613         154 TIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA--LFLISK-SNF---PPPK--  225 (262)
T ss_pred             hhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHh-ccC---CCcc--
Confidence                    467789999998776   789999999999999999999999976432111  001111 100   0000  


Q ss_pred             CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          509 GKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       509 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ..........+.+++.+||+.+|.+|||+.+++.
T Consensus       226 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         226 LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            1112233456788999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=8.6e-35  Score=291.14  Aligned_cols=240  Identities=32%  Similarity=0.476  Sum_probs=192.3

Q ss_pred             CCccceeecCCceEEEEEEcCC-----CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEE
Q 047719          286 FNKNRIVGEGASATVYKGSLPS-----GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVL  360 (596)
Q Consensus       286 f~~~~~LG~G~fG~Vy~~~~~~-----g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~l  360 (596)
                      |...+.||.|+||.||++...+     +..||+|++..... ......+..|+..+.. ++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~~~~~~   78 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-EQQIEEFLREARIMRK-LDHPNIVKLLGVCTEEEPLMI   78 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-hHHHHHHHHHHHHHHh-cCCCchheEEEEEcCCCeeEE
Confidence            3456889999999999998754     37899999964322 2245678888866655 799999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc-
Q 047719          361 VYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP-  439 (596)
Q Consensus       361 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~-  439 (596)
                      +|||+++++|.+++.....  ..+++.++..++.|++.||+|||+   .+++|+||||+||++++++.++|+|||.+.. 
T Consensus        79 i~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~  153 (258)
T smart00219       79 VMEYMEGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDL  153 (258)
T ss_pred             EEeccCCCCHHHHHHhhhh--ccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceec
Confidence            9999999999999986542  128999999999999999999999   8999999999999999999999999987632 


Q ss_pred             -----------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhccccc
Q 047719          440 -----------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRL  507 (596)
Q Consensus       440 -----------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  507 (596)
                                 .++..|+|||.+....++.++||||||++++||++ |+.||.....  .+.. .........       
T Consensus       154 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~--~~~~-~~~~~~~~~-------  223 (258)
T smart00219      154 YDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN--EEVL-EYLKKGYRL-------  223 (258)
T ss_pred             ccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH--HHHH-HHHhcCCCC-------
Confidence                       25678999999988889999999999999999999 8888875422  1111 111111111       


Q ss_pred             cCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 047719          508 RGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARIL  544 (596)
Q Consensus       508 ~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L  544 (596)
                        .........+.+++.+|++.+|++|||+.|+++.|
T Consensus       224 --~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      224 --PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             --CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence              11112345677788999999999999999998864

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.2e-34  Score=295.35  Aligned_cols=251  Identities=24%  Similarity=0.322  Sum_probs=189.7

Q ss_pred             CCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          285 GFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      +|+..+.||+|+||.||+|... +++.||||++............+.+|+..+.+ ++||||+++++++.+.+..++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~-l~h~~i~~~~~~~~~~~~~~~v~e   79 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE-LNHPNIVKLLDVIHTENKLYLVFE   79 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHh-cCCCCCcchhhhcccCCcEEEEee
Confidence            4778899999999999999765 58899999986544333344568889866655 899999999999999999999999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc----
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP----  439 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~----  439 (596)
                      |+. ++|.+++.....  ..+++..+..++.|++.||+|||+   .+++||||+|+||+++.++.+||+|||.+..    
T Consensus        80 ~~~-~~l~~~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~  153 (284)
T cd07860          80 FLH-QDLKKFMDASPL--SGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP  153 (284)
T ss_pred             ccc-cCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccC
Confidence            996 689999876442  358999999999999999999999   8999999999999999999999999987532    


Q ss_pred             -------CCCcccCCccccccCC-CCCccceeehhHHHHHHHhCCCCCCCCChh--HHHHHHHHHhcCC-----chhhcc
Q 047719          440 -------AGTMGYLAPEYVYSGV-PSEKTDVYSFGVVALEVAAGKSPVDNDGCV--IVDWVWNLRKKGK-----LLDAAD  504 (596)
Q Consensus       440 -------~gt~~y~aPE~~~~~~-~t~~sDV~SfGvll~El~tG~~p~~~~~~~--~~~~~~~~~~~~~-----~~~~~d  504 (596)
                             .++..|+|||.+.+.. ++.++|||||||++|||+||+.||......  .............     ......
T Consensus       154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07860         154 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD  233 (284)
T ss_pred             ccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHH
Confidence                   2567899999887644 688999999999999999999999764321  1111100000000     000000


Q ss_pred             -----ccccC----cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          505 -----FRLRG----KFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       505 -----~~l~~----~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                           +....    .........+.+++.+|++.||++|||++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence                 00000    000112244667889999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.6e-34  Score=289.32  Aligned_cols=245  Identities=27%  Similarity=0.357  Sum_probs=194.3

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      ++|+..+.||+|+||+||+|... ++..+|+|++....... ....+.+|+..+. .++|+|++++++.+......++|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~iv~   78 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMS-QCNHPNVVKYYTSFVVGDELWLVM   78 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHH-hcCCCCEEEEEEEEeeCCEEEEEE
Confidence            36788899999999999999864 57899999986543333 4556888886554 589999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc----
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI----  438 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~----  438 (596)
                      ||+++++|.+++..... ...+++.....++.|++.||+|||+   .+++||||||+||++++++.+||+|||++.    
T Consensus        79 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~  154 (267)
T cd06610          79 PYLSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLAD  154 (267)
T ss_pred             eccCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence            99999999999986432 1358999999999999999999998   899999999999999999999999998642    


Q ss_pred             -----------cCCCcccCCccccccC-CCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhcccc
Q 047719          439 -----------PAGTMGYLAPEYVYSG-VPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFR  506 (596)
Q Consensus       439 -----------~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~  506 (596)
                                 ..|+..|+|||.+... .++.++|+|||||++|||++|+.||......  .-........      ...
T Consensus       155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--~~~~~~~~~~------~~~  226 (267)
T cd06610         155 GGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM--KVLMLTLQND------PPS  226 (267)
T ss_pred             CccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh--hhHHHHhcCC------CCC
Confidence                       1377889999998876 7899999999999999999999999754321  0011111110      011


Q ss_pred             ccCcC-CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          507 LRGKF-NRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       507 l~~~~-~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      +.... .......+.+++..|++.||++||+++++++
T Consensus       227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         227 LETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             cCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            11111 1133456778889999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=7.2e-35  Score=295.50  Aligned_cols=246  Identities=26%  Similarity=0.340  Sum_probs=194.0

Q ss_pred             cCCCccceeecCCceEEEEEEcC------CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCe
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP------SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNE  357 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~  357 (596)
                      .+|...+.||+|+||.||+|+..      +...|++|.+.... ......++.+|+..+.+ ++|+||+++++++.+...
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~   82 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRK-LSHKNVVRLLGLCREAEP   82 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHh-cCCcceeeeEEEECCCCc
Confidence            46778899999999999999853      24579999885322 22234568889866655 899999999999999999


Q ss_pred             EEEEEecCCCCCHHHHhhhCCCC-----CcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEc
Q 047719          358 LVLVYEYLPNGSLDKILHNNSSS-----SIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLG  432 (596)
Q Consensus       358 ~~lV~E~~~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~  432 (596)
                      .++||||+++|+|.+++......     ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.++++
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~  159 (275)
T cd05046          83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVS  159 (275)
T ss_pred             ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEc
Confidence            99999999999999999865421     1258999999999999999999999   899999999999999999999999


Q ss_pred             cCCCccc------------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCc
Q 047719          433 DFEATIP------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKL  499 (596)
Q Consensus       433 Dfg~~~~------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~  499 (596)
                      |||.+..            .++..|+|||.+.+..++.++||||||+++|||++ |..||......  ..+. ....+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~--~~~~-~~~~~~~  236 (275)
T cd05046         160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE--EVLN-RLQAGKL  236 (275)
T ss_pred             ccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH--HHHH-HHHcCCc
Confidence            9987542            24566999999988889999999999999999999 88888653211  1111 1111111


Q ss_pred             hhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 047719          500 LDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK  545 (596)
Q Consensus       500 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~  545 (596)
                      .        ..........+.+++.+|++.+|++||++.|+++.|.
T Consensus       237 ~--------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         237 E--------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             C--------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            1        0011122346778899999999999999999999885

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.2e-34  Score=292.51  Aligned_cols=241  Identities=27%  Similarity=0.440  Sum_probs=192.6

Q ss_pred             CCCccceeecCCceEEEEEEc-CCCCEEEEEEeecCCch----hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEE
Q 047719          285 GFNKNRIVGEGASATVYKGSL-PSGGAVAVKRFEKPNRV----ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELV  359 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~----~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~  359 (596)
                      +|...+.||+|+||.||++.. .+++.||+|++......    ......+.+|+..+.+ ++|+||+++++++.+.+..+
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~   79 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMAR-LNHPHIIRMLGATCEDSHFN   79 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHH-cCCCceehhhceeccCCeEE
Confidence            477789999999999999975 45889999998643211    1234568888866654 99999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCC-ceEEccCCCcc
Q 047719          360 LVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEF-NAKLGDFEATI  438 (596)
Q Consensus       360 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~-~~kl~Dfg~~~  438 (596)
                      +|+||+++++|.+++.+..    .+++..+..++.|++.||.|||+   .+++|+||||+||+++.++ .+||+|||.+.
T Consensus        80 ~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~  152 (268)
T cd06630          80 LFVEWMAGGSVSHLLSKYG----AFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAA  152 (268)
T ss_pred             EEEeccCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccccccc
Confidence            9999999999999997643    48899999999999999999999   8999999999999998875 59999998653


Q ss_pred             c---------------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCCh-hHHHHHHHHHhcCCchhh
Q 047719          439 P---------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGC-VIVDWVWNLRKKGKLLDA  502 (596)
Q Consensus       439 ~---------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~-~~~~~~~~~~~~~~~~~~  502 (596)
                      .               .|+..|+|||.+.+..++.++||||+||++|||++|+.||..... ............      
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~------  226 (268)
T cd06630         153 RLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASA------  226 (268)
T ss_pred             ccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhcc------
Confidence            2               367789999999888899999999999999999999999965321 111111111100      


Q ss_pred             ccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          503 ADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       503 ~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                         ......+......+.+++.+|++.+|.+||++.++++
T Consensus       227 ---~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         227 ---TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             ---CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence               1112333445567788899999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=3.5e-34  Score=294.13  Aligned_cols=254  Identities=24%  Similarity=0.323  Sum_probs=191.5

Q ss_pred             CCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCch---hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEE
Q 047719          285 GFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRV---ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVL  360 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~---~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~l  360 (596)
                      +|...+.||+|+||.||+|... +++.||||++......   ......+..|+..+. .++|+||+++++++.+....++
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~-~~~h~~i~~~~~~~~~~~~~~l   79 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQ-ELKHPNIIGLLDVFGHKSNINL   79 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHh-hcCCCCChhhhheeecCCEEEE
Confidence            3667789999999999999865 5899999999754332   222334667875554 4899999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc-
Q 047719          361 VYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP-  439 (596)
Q Consensus       361 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~-  439 (596)
                      ||||+ +|+|.+++....   ..+++..++.++.||++||+|||+   .+++|+||||+|||++.++.+||+|||++.. 
T Consensus        80 v~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~  152 (298)
T cd07841          80 VFEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSF  152 (298)
T ss_pred             EEccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeec
Confidence            99999 899999997643   258999999999999999999999   8999999999999999999999999987643 


Q ss_pred             ----------CCCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCChh-HHHHHHHHHhc---------CC
Q 047719          440 ----------AGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV-IVDWVWNLRKK---------GK  498 (596)
Q Consensus       440 ----------~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~-~~~~~~~~~~~---------~~  498 (596)
                                .++..|+|||.+.+ ..++.++|||||||++|||++|.+||...... ...-.......         ..
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (298)
T cd07841         153 GSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTS  232 (298)
T ss_pred             cCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccc
Confidence                      24567999998865 46789999999999999999998887654321 11000000000         00


Q ss_pred             chhhccccccCcC-----CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH--Hhc
Q 047719          499 LLDAADFRLRGKF-----NRKEMERMLMVGLSCVHPNHEKRPSVKEAARI--LKG  546 (596)
Q Consensus       499 ~~~~~d~~l~~~~-----~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~--L~~  546 (596)
                      +............     .......+.+++.+||+.+|++|||+.|+++.  +++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~  287 (298)
T cd07841         233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSN  287 (298)
T ss_pred             ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccC
Confidence            0011000000111     11234667889999999999999999999883  544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=9.7e-35  Score=300.94  Aligned_cols=185  Identities=22%  Similarity=0.338  Sum_probs=151.7

Q ss_pred             cceeecCCceEEEEEEcCC---CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeee--CCeEEEEEe
Q 047719          289 NRIVGEGASATVYKGSLPS---GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE--GNELVLVYE  363 (596)
Q Consensus       289 ~~~LG~G~fG~Vy~~~~~~---g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~--~~~~~lV~E  363 (596)
                      ..+||+|+||.||+|...+   +..||+|.+....    ....+.+|+..+.. ++||||+++++++..  ....++|||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~----~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~~~lv~e   80 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG----ISMSACREIALLRE-LKHPNVIALQKVFLSHSDRKVWLLFD   80 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC----CcHHHHHHHHHHHh-CCCCCeeeEEEEEeccCCCeEEEEEe
Confidence            4689999999999998643   5689999985432    22356788866654 999999999999854  567899999


Q ss_pred             cCCCCCHHHHhhhCC-----CCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceee----cCCCceEEccC
Q 047719          364 YLPNGSLDKILHNNS-----SSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILL----DAEFNAKLGDF  434 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl----~~~~~~kl~Df  434 (596)
                      |+++ +|.+++....     .....+++..+..++.||+.||.|||+   .+++||||||+|||+    +.++.+||+||
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07867          81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence            9875 8888875321     112358899999999999999999999   899999999999999    56689999999


Q ss_pred             CCccc--------------CCCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCC
Q 047719          435 EATIP--------------AGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDND  482 (596)
Q Consensus       435 g~~~~--------------~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~  482 (596)
                      |++..              .||..|+|||.+.+ ..++.++|||||||++|||+||++||...
T Consensus       157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             cceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            97642              36788999999876 45899999999999999999999999653

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.6e-34  Score=297.35  Aligned_cols=250  Identities=22%  Similarity=0.314  Sum_probs=188.6

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      +.|...+.||+|+||.||+|... +++.||+|.+...... .....+.+|+..+.. ++|+||+++++++...+..++||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~-l~h~nI~~~~~~~~~~~~~~lv~   83 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKD-LKHANIVTLHDIIHTEKSLTLVF   83 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHh-cCCCCcceEEEEEecCCeEEEEE
Confidence            35778899999999999999875 4789999998643322 223356778866554 89999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc---
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP---  439 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~---  439 (596)
                      ||++ ++|.+++....   ..+++..+..++.||++||+|||+   .+++|+||||+|||+++++.+||+|||.+..   
T Consensus        84 e~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  156 (301)
T cd07873          84 EYLD-KDLKQYLDDCG---NSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSI  156 (301)
T ss_pred             eccc-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCC
Confidence            9997 59999987643   247899999999999999999999   8999999999999999999999999997532   


Q ss_pred             --------CCCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCChh-HHHHHHHHHhcC------------
Q 047719          440 --------AGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV-IVDWVWNLRKKG------------  497 (596)
Q Consensus       440 --------~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~-~~~~~~~~~~~~------------  497 (596)
                              .++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ............            
T Consensus       157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (301)
T cd07873         157 PTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE  236 (301)
T ss_pred             CCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccc
Confidence                    35778999998865 45789999999999999999999999764321 111111100000            


Q ss_pred             CchhhccccccCc----CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          498 KLLDAADFRLRGK----FNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       498 ~~~~~~d~~l~~~----~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      .......+.....    ........+.+++.+|++.||++|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            0000000000000    00112335678889999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.6e-34  Score=292.40  Aligned_cols=242  Identities=28%  Similarity=0.418  Sum_probs=188.6

Q ss_pred             CCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhc--------ccchHHHHHHHHHhccCCCceeeecceeeeCC
Q 047719          286 FNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVEC--------ARNPFTTEFATMAGCLRHKNLVQLQGWCCEGN  356 (596)
Q Consensus       286 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~--------~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~  356 (596)
                      |...+.||+|+||.||+|... +++.||+|.++.......        ..+.+..|+..+ +.++|+|++++++++....
T Consensus         3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETL-KDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHH-HhcCCCCcceEEEEeccCC
Confidence            566789999999999999754 588999998854221111        123567787555 4589999999999999999


Q ss_pred             eEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCC
Q 047719          357 ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEA  436 (596)
Q Consensus       357 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~  436 (596)
                      ..++||||+++++|.+++....    .+++..+..++.||+.||.|||+   .+++||||+|+||+++.++.++|+|||.
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~  154 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYG----RFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGI  154 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeeccc
Confidence            9999999999999999998653    48899999999999999999999   8999999999999999999999999986


Q ss_pred             ccc-------------CCCcccCCccccccCC--CCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchh
Q 047719          437 TIP-------------AGTMGYLAPEYVYSGV--PSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLD  501 (596)
Q Consensus       437 ~~~-------------~gt~~y~aPE~~~~~~--~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~  501 (596)
                      +..             .|+..|+|||.+....  ++.++||||||+++||+++|..||......  ............ .
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~-~  231 (272)
T cd06629         155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI--AAMFKLGNKRSA-P  231 (272)
T ss_pred             cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH--HHHHHhhccccC-C
Confidence            532             3677899999987654  789999999999999999999999654321  111111111100 1


Q ss_pred             hccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          502 AADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       502 ~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ....    .........+.+++..||+++|.+||++++|++
T Consensus       232 ~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         232 PIPP----DVSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             cCCc----cccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            1111    111123456777888999999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.6e-34  Score=293.68  Aligned_cols=235  Identities=25%  Similarity=0.371  Sum_probs=190.5

Q ss_pred             CCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEec
Q 047719          286 FNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEY  364 (596)
Q Consensus       286 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~  364 (596)
                      |...+.||+|+||.||+|... ++..||||.+..... ......+.+|+..+.. ++|+||+++++++.++...++||||
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~lv~e~   83 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQ-CDSPYVTKYYGSYLKDTKLWIIMEY   83 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHh-cCCCCEeEEEEEEEeCCeEEEEEEe
Confidence            556788999999999999764 588999999854322 2234567788865554 8999999999999999999999999


Q ss_pred             CCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc------
Q 047719          365 LPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI------  438 (596)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~------  438 (596)
                      +++++|.+++...     .+++.....++.|++.+|.|||+   .+++|+||||+||+++.++.++|+|||++.      
T Consensus        84 ~~~~~l~~~i~~~-----~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06641          84 LGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             CCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence            9999999999753     38899999999999999999999   899999999999999999999999998653      


Q ss_pred             -----cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCH
Q 047719          439 -----PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNR  513 (596)
Q Consensus       439 -----~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  513 (596)
                           ..++..|+|||.+.+..++.++|||||||++|||++|..|+......  .+..... ...         ......
T Consensus       156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~-~~~---------~~~~~~  223 (277)
T cd06641         156 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM--KVLFLIP-KNN---------PPTLEG  223 (277)
T ss_pred             hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH--HHHHHHh-cCC---------CCCCCc
Confidence                 24678899999998888899999999999999999999999754321  1111111 111         011122


Q ss_pred             HHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          514 KEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       514 ~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      .....+.+++.+|++.+|.+||++.++++
T Consensus       224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  252 (277)
T cd06641         224 NYSKPLKEFVEACLNKEPSFRPTAKELLK  252 (277)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            23355678889999999999999999988

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.6e-34  Score=291.76  Aligned_cols=241  Identities=25%  Similarity=0.321  Sum_probs=188.3

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      ++|...+.||+|+||.||+|... ++..||+|.++....  .....+.+|+..+ +.++||||+++++.+...+..++||
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~~-~~l~h~~ii~~~~~~~~~~~~~lv~   85 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG--EDFAVVQQEIIMM-KDCKHSNIVAYFGSYLRRDKLWICM   85 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch--hHHHHHHHHHHHH-HhCCCCCeeeEEEEEEeCCEEEEEE
Confidence            35667789999999999999765 588999999864322  2233467787555 4589999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc----
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI----  438 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~----  438 (596)
                      ||+++++|.+++....    .+++.+.+.++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||.+.    
T Consensus        86 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06645          86 EFCGGGSLQDIYHVTG----PLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITA  158 (267)
T ss_pred             eccCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence            9999999999997653    48899999999999999999999   899999999999999999999999999753    


Q ss_pred             -------cCCCcccCCccccc---cCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhcccccc
Q 047719          439 -------PAGTMGYLAPEYVY---SGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLR  508 (596)
Q Consensus       439 -------~~gt~~y~aPE~~~---~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  508 (596)
                             ..|+..|+|||.+.   ...++.++|||||||++|||++|+.||........  +..... ....   .+...
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~--~~~~~~-~~~~---~~~~~  232 (267)
T cd06645         159 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--LFLMTK-SNFQ---PPKLK  232 (267)
T ss_pred             cccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh--HHhhhc-cCCC---CCccc
Confidence                   24788999999874   45688999999999999999999999865322111  111111 1100   00111


Q ss_pred             CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          509 GKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       509 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ..  ......+.+++.+|++.+|++||+++++++
T Consensus       233 ~~--~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         233 DK--MKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             cc--CCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            00  012235678889999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.5e-35  Score=293.99  Aligned_cols=246  Identities=27%  Similarity=0.363  Sum_probs=192.7

Q ss_pred             HHhcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCC---
Q 047719          281 QATLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGN---  356 (596)
Q Consensus       281 ~at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~---  356 (596)
                      .++++|...+.||+|+||.||+|... +++.+++|++.....   ....+.+|+..+.+..+|+||+++++++....   
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   79 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG   79 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence            45788999999999999999999875 478999999864332   23467888866666447999999999997654   


Q ss_pred             ---eEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEcc
Q 047719          357 ---ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGD  433 (596)
Q Consensus       357 ---~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~D  433 (596)
                         ..++||||+++++|.+++.........+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.+||+|
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d  156 (275)
T cd06608          80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVD  156 (275)
T ss_pred             cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECC
Confidence               4899999999999999987643223458999999999999999999999   8999999999999999999999999


Q ss_pred             CCCcc-----------cCCCcccCCcccccc-----CCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcC
Q 047719          434 FEATI-----------PAGTMGYLAPEYVYS-----GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKG  497 (596)
Q Consensus       434 fg~~~-----------~~gt~~y~aPE~~~~-----~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~  497 (596)
                      ||.+.           ..|+..|+|||.+..     ..++.++|||||||++|||++|+.||......  .-..... ..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~-~~  233 (275)
T cd06608         157 FGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM--RALFKIP-RN  233 (275)
T ss_pred             CccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH--HHHHHhh-cc
Confidence            98653           236788999998753     34678999999999999999999999753211  0011111 00


Q ss_pred             CchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          498 KLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       498 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      .     .+.  ...+......+.+++.+|++.||++|||+.++++
T Consensus       234 ~-----~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         234 P-----PPT--LKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             C-----CCC--CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            0     001  1112224456778899999999999999999875

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.3e-35  Score=282.81  Aligned_cols=244  Identities=27%  Similarity=0.374  Sum_probs=198.8

Q ss_pred             hcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchh------cccchHHHHHHHHHhccCCCceeeecceeeeC
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVE------CARNPFTTEFATMAGCLRHKNLVQLQGWCCEG  355 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~------~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~  355 (596)
                      -+.|...+.||.|..+.|-++..+ .|+..|+|++.......      .-+++-..|+.++.+...||+|+++.+++..+
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~   95 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD   95 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence            345677889999999999998765 58899999986432221      12334567888888888999999999999999


Q ss_pred             CeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCC
Q 047719          356 NELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFE  435 (596)
Q Consensus       356 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg  435 (596)
                      .-+++|+|.|+.|.|.++|.+.    ..+++....+|+.|+.+|++|||.   ..|+||||||+|||+|++.++||+|||
T Consensus        96 sF~FlVFdl~prGELFDyLts~----VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFG  168 (411)
T KOG0599|consen   96 AFVFLVFDLMPRGELFDYLTSK----VTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFG  168 (411)
T ss_pred             chhhhhhhhcccchHHHHhhhh----eeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEeccc
Confidence            9999999999999999999875    369999999999999999999999   999999999999999999999999999


Q ss_pred             Ccc----------cCCCcccCCcccccc------CCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCc
Q 047719          436 ATI----------PAGTMGYLAPEYVYS------GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKL  499 (596)
Q Consensus       436 ~~~----------~~gt~~y~aPE~~~~------~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~  499 (596)
                      .+.          .+||++|+|||.+..      ..|+...|+||.||+||.|+.|.+||-.....+   +..+..+|+.
T Consensus       169 Fa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQml---MLR~ImeGky  245 (411)
T KOG0599|consen  169 FACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQML---MLRMIMEGKY  245 (411)
T ss_pred             eeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHH---HHHHHHhccc
Confidence            764          479999999998853      357889999999999999999999995432110   1122222221


Q ss_pred             hhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          500 LDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       500 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                            ....+-..+......+|+.+|++.||.+|.|.+|+++
T Consensus       246 ------qF~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  246 ------QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             ------ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence                  2233334566677889999999999999999999876

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.7e-34  Score=290.40  Aligned_cols=241  Identities=27%  Similarity=0.425  Sum_probs=192.0

Q ss_pred             CCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          285 GFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      +|...+.||+|+||.||+|... +++.||+|.++...........+..|+..+.. ++|+||+++++.+......++|+|
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~-l~~~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLEL-LKHPNLVKYYGVEVHREKVYIFME   79 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHh-CCCCChhheeeeEecCCEEEEEEe
Confidence            3667789999999999999865 58899999997654433456678888866654 899999999999999999999999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc----
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP----  439 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~----  439 (596)
                      |+++++|.+++....    .+++..+..++.+++.||.|||+   .+++|+||+|+||++++++.+||+|||.+..    
T Consensus        80 ~~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~  152 (264)
T cd06626          80 YCSGGTLEELLEHGR----ILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN  152 (264)
T ss_pred             cCCCCcHHHHHhhcC----CCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence            999999999998643    37889999999999999999999   8999999999999999999999999986532    


Q ss_pred             -----------CCCcccCCccccccCC---CCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccc
Q 047719          440 -----------AGTMGYLAPEYVYSGV---PSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADF  505 (596)
Q Consensus       440 -----------~gt~~y~aPE~~~~~~---~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~  505 (596)
                                 .++..|+|||.+....   ++.++||||||+++||+++|+.||....... ........ ..     .+
T Consensus       153 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-~~~~~~~~-~~-----~~  225 (264)
T cd06626         153 TTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-QIMFHVGA-GH-----KP  225 (264)
T ss_pred             CCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-HHHHHHhc-CC-----CC
Confidence                       3577899999998766   8999999999999999999999997542211 11111111 10     01


Q ss_pred             cccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          506 RLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       506 ~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      .+..  .......+.+++.+||+.+|.+||++++++.
T Consensus       226 ~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         226 PIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             CCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            1111  0112445667888999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.1e-34  Score=295.60  Aligned_cols=235  Identities=19%  Similarity=0.241  Sum_probs=181.8

Q ss_pred             eeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcc-cchHHHHHH--HHHhccCCCceeeecceeeeCCeEEEEEecCC
Q 047719          291 IVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECA-RNPFTTEFA--TMAGCLRHKNLVQLQGWCCEGNELVLVYEYLP  366 (596)
Q Consensus       291 ~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~-~~~~~~E~~--~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~~  366 (596)
                      +||+|+||.||++... +++.+|+|.+.+....... ...+.+|..  .+....+|+|++.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999865 4889999998654322111 222333331  23333579999999999999999999999999


Q ss_pred             CCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc--------
Q 047719          367 NGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI--------  438 (596)
Q Consensus       367 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~--------  438 (596)
                      +|+|.+++....    .+++..+..++.|++.||+|||+   .+++||||||+|||+++++.++|+|||++.        
T Consensus        81 ~~~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~~  153 (279)
T cd05633          81 GGDLHYHLSQHG----VFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH  153 (279)
T ss_pred             CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCcc
Confidence            999999997653    48999999999999999999999   899999999999999999999999999763        


Q ss_pred             -cCCCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHHHH
Q 047719          439 -PAGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEM  516 (596)
Q Consensus       439 -~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  516 (596)
                       ..|+..|+|||.+.. ..++.++|||||||++|||++|+.||................          ......+....
T Consensus       154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~----------~~~~~~~~~~~  223 (279)
T cd05633         154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL----------TVNVELPDSFS  223 (279)
T ss_pred             CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh----------cCCcCCccccC
Confidence             248899999998864 557999999999999999999999997542211111111110          01112222334


Q ss_pred             HHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 047719          517 ERMLMVGLSCVHPNHEKRP-----SVKEAAR  542 (596)
Q Consensus       517 ~~l~~l~~~C~~~dp~~RP-----s~~ev~~  542 (596)
                      ..+.+++..|++.||++||     +++|+++
T Consensus       224 ~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~  254 (279)
T cd05633         224 PELKSLLEGLLQRDVSKRLGCLGRGAQEVKE  254 (279)
T ss_pred             HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence            5677888899999999999     5988877

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-34  Score=293.60  Aligned_cols=248  Identities=25%  Similarity=0.357  Sum_probs=192.1

Q ss_pred             CCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          285 GFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      +|+..+.||+|+||.||+|... +++.||||+++...........+.+|+..+.. ++|+||+++++++...+..++|||
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQ-LRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHh-cCCCCeeehhheEEECCEEEEEEe
Confidence            5778899999999999999876 47899999986544334445678889866654 899999999999999999999999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc----
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP----  439 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~----  439 (596)
                      |++++.|..++....    .+++.++..++.||+.||+|||+   .+++|+||+|+||++++++.+||+|||.+..    
T Consensus        81 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~  153 (288)
T cd07833          81 YVERTLLELLEASPG----GLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRAR  153 (288)
T ss_pred             cCCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence            999877776665432    38899999999999999999999   8999999999999999999999999986432    


Q ss_pred             --------CCCcccCCccccccC-CCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHh---------------
Q 047719          440 --------AGTMGYLAPEYVYSG-VPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRK---------------  495 (596)
Q Consensus       440 --------~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~---------------  495 (596)
                              .++..|+|||.+... .++.++||||||+++|||++|+.||......  +-.+....               
T Consensus       154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  231 (288)
T cd07833         154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI--DQLYLIQKCLGPLPPSHQELFSS  231 (288)
T ss_pred             ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHhhhccc
Confidence                    356779999999887 8899999999999999999999999764321  11111110               


Q ss_pred             cCCc-----hhhccc-cccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          496 KGKL-----LDAADF-RLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       496 ~~~~-----~~~~d~-~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ....     .+..+. .....++......+.+++..||+.+|++||+++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             CccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            0000     000000 0000111222567889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=3.3e-34  Score=294.23  Aligned_cols=246  Identities=29%  Similarity=0.402  Sum_probs=195.0

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      .+|...+.||+|+||.||++... ++..||+|.+....  ......+.+|+..+. .++|||++++++.|......++|+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~-~l~hp~i~~~~~~~~~~~~~~lv~   95 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ--QPKKELIINEILVMR-ENKHPNIVNYLDSYLVGDELWVVM   95 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc--chHHHHHHHHHHHHh-hcCCCCeeehhheeeeCCcEEEEE
Confidence            56788899999999999999754 57899999985332  223356788886554 489999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc----
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI----  438 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~----  438 (596)
                      ||+++++|.+++...     .+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||.+.    
T Consensus        96 e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~  167 (293)
T cd06647          96 EYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  167 (293)
T ss_pred             ecCCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence            999999999999754     37899999999999999999999   899999999999999999999999998643    


Q ss_pred             -------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcC
Q 047719          439 -------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKF  511 (596)
Q Consensus       439 -------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  511 (596)
                             ..|+..|+|||.+....++.++|||||||++||+++|+.||......  +.+......+.        .....
T Consensus       168 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~--~~~~~~~~~~~--------~~~~~  237 (293)
T cd06647         168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL--RALYLIATNGT--------PELQN  237 (293)
T ss_pred             cccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh--hheeehhcCCC--------CCCCC
Confidence                   24677899999998888999999999999999999999999764321  11111111110        00111


Q ss_pred             CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhcCCCC
Q 047719          512 NRKEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKGEAPL  550 (596)
Q Consensus       512 ~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~~~~~~  550 (596)
                      .......+.+++..||+.+|++||++++++.  +++...++
T Consensus       238 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~~  278 (293)
T cd06647         238 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPL  278 (293)
T ss_pred             ccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCccc
Confidence            2223456778889999999999999999987  44444433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-34  Score=294.63  Aligned_cols=241  Identities=26%  Similarity=0.321  Sum_probs=191.0

Q ss_pred             hcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      .++|...+.||+|+||.||++... ++..+|+|.+....  ....+.+..|+..+. .++|+||+++++.+......++|
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv   80 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES--EEELEDFMVEIDILS-ECKHPNIVGLYEAYFYENKLWIL   80 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC--HHHHHHHHHHHHHHH-hCCCCceeEEEEEEecCCeEEEE
Confidence            345777889999999999999875 58899999986432  233456888886555 48999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc--
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP--  439 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~--  439 (596)
                      |||+++++|.+++....   ..+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||.+..  
T Consensus        81 ~e~~~~~~L~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~  154 (280)
T cd06611          81 IEFCDGGALDSIMLELE---RGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNK  154 (280)
T ss_pred             eeccCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhc
Confidence            99999999999997643   248999999999999999999999   8999999999999999999999999986532  


Q ss_pred             ---------CCCcccCCccccc-----cCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccc
Q 047719          440 ---------AGTMGYLAPEYVY-----SGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADF  505 (596)
Q Consensus       440 ---------~gt~~y~aPE~~~-----~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~  505 (596)
                               .++..|+|||.+.     ...++.++|||||||++|||++|+.||......  ....... ....     +
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~--~~~~~~~-~~~~-----~  226 (280)
T cd06611         155 STLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM--RVLLKIL-KSEP-----P  226 (280)
T ss_pred             ccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH--HHHHHHh-cCCC-----C
Confidence                     3788899999875     344678999999999999999999999764321  1111111 1100     0


Q ss_pred             cccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          506 RLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       506 ~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      .+  ..+......+.+++..||+.+|.+||+++++++
T Consensus       227 ~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (280)
T cd06611         227 TL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK  261 (280)
T ss_pred             Cc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence            00  011122345677888999999999999999976

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-35  Score=325.40  Aligned_cols=249  Identities=24%  Similarity=0.398  Sum_probs=205.7

Q ss_pred             hcCCCccceeecCCceEEEEEEcCC--------CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeee
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLPS--------GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE  354 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~~--------g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~  354 (596)
                      .++....+.||+|.||.|++|....        ...||||.++..... ...+.+..|+..|....+|+|||.++|+|.+
T Consensus       295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~  373 (609)
T KOG0200|consen  295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQ  373 (609)
T ss_pred             hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence            3344455699999999999997431        346999999755444 5677899999999998999999999999999


Q ss_pred             CCeEEEEEecCCCCCHHHHhhhCC---CC-------C--cccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCcee
Q 047719          355 GNELVLVYEYLPNGSLDKILHNNS---SS-------S--IVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNIL  422 (596)
Q Consensus       355 ~~~~~lV~E~~~~gsL~~~l~~~~---~~-------~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiL  422 (596)
                      ++.+++|+||+..|+|.++|+..+   ..       .  ..+...+.+.++.|||.||+||++   .++|||||.++|||
T Consensus       374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRNVL  450 (609)
T KOG0200|consen  374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARNVL  450 (609)
T ss_pred             CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhhEE
Confidence            999999999999999999998876   10       1  238899999999999999999999   89999999999999


Q ss_pred             ecCCCceEEccCCCcccC------------C--CcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHH
Q 047719          423 LDAEFNAKLGDFEATIPA------------G--TMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIV  487 (596)
Q Consensus       423 l~~~~~~kl~Dfg~~~~~------------g--t~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~  487 (596)
                      +..+..+||+|||+++..            |  ...|||||.+....++.+||||||||+||||+| |..||.+... ..
T Consensus       451 i~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~-~~  529 (609)
T KOG0200|consen  451 ITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP-TE  529 (609)
T ss_pred             ecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc-HH
Confidence            999999999999998631            1  235999999999999999999999999999999 9999986211 11


Q ss_pred             HHHHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          488 DWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       488 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                      + +++..+.|..++         .+......+..+|+.||+.+|++||++.++.++++.
T Consensus       530 ~-l~~~l~~G~r~~---------~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~  578 (609)
T KOG0200|consen  530 E-LLEFLKEGNRME---------QPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK  578 (609)
T ss_pred             H-HHHHHhcCCCCC---------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence            1 233445554332         233445678899999999999999999999999986

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.1e-34  Score=297.66  Aligned_cols=233  Identities=27%  Similarity=0.378  Sum_probs=186.9

Q ss_pred             cceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecCCC
Q 047719          289 NRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPN  367 (596)
Q Consensus       289 ~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  367 (596)
                      ...||+|+||.||++... ++..||||++....  ....+.+.+|+..+.. ++|+||+++++.+...+..++||||+++
T Consensus        27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~-l~h~~ii~~~~~~~~~~~~~lv~e~~~~  103 (292)
T cd06658          27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRD-YHHENVVDMYNSYLVGDELWVVMEFLEG  103 (292)
T ss_pred             hhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHh-CCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence            367999999999999764 58899999985432  2334567888866554 8999999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc---------
Q 047719          368 GSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI---------  438 (596)
Q Consensus       368 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---------  438 (596)
                      ++|.+++...     .+++.+...++.||+.||+|||+   .+++||||||+||+++.++.+||+|||++.         
T Consensus       104 ~~L~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~  175 (292)
T cd06658         104 GALTDIVTHT-----RMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR  175 (292)
T ss_pred             CcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccC
Confidence            9999998643     38899999999999999999999   899999999999999999999999999753         


Q ss_pred             --cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHHHH
Q 047719          439 --PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEM  516 (596)
Q Consensus       439 --~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  516 (596)
                        ..|+..|+|||.+.+..++.++|||||||++|||++|+.||......-  -..... .     .....+..  .....
T Consensus       176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~~~~~~-~-----~~~~~~~~--~~~~~  245 (292)
T cd06658         176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ--AMRRIR-D-----NLPPRVKD--SHKVS  245 (292)
T ss_pred             ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHH-h-----cCCCcccc--ccccC
Confidence              247888999999988889999999999999999999999997643211  011110 0     01111111  11123


Q ss_pred             HHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          517 ERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       517 ~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ..+..++..|++.||++|||++|+++
T Consensus       246 ~~~~~li~~~l~~~P~~Rpt~~~il~  271 (292)
T cd06658         246 SVLRGFLDLMLVREPSQRATAQELLQ  271 (292)
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhh
Confidence            35667788899999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.5e-34  Score=309.20  Aligned_cols=243  Identities=23%  Similarity=0.255  Sum_probs=185.5

Q ss_pred             cCCCccceeecCCceEEEEEEcC---CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP---SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVL  360 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~---~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~l  360 (596)
                      ..|...+.||+|+||.||++...   .+..||+|.+...       ....+|+..+.. ++|||||++++++......|+
T Consensus        92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~-l~h~~iv~~~~~~~~~~~~~l  163 (392)
T PHA03207         92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKT-ISHRAIINLIHAYRWKSTVCM  163 (392)
T ss_pred             CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHh-cCCCCccceeeeEeeCCEEEE
Confidence            45888899999999999999653   3578999988532       234578866654 899999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc--
Q 047719          361 VYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI--  438 (596)
Q Consensus       361 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~--  438 (596)
                      |||++. ++|.+++...    ..+++.+++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++.  
T Consensus       164 v~e~~~-~~l~~~l~~~----~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~  235 (392)
T PHA03207        164 VMPKYK-CDLFTYVDRS----GPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKL  235 (392)
T ss_pred             EehhcC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence            999995 6899998543    258999999999999999999999   899999999999999999999999999753  


Q ss_pred             -----------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChh-----HHHHHHHHHhcCC-ch-
Q 047719          439 -----------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV-----IVDWVWNLRKKGK-LL-  500 (596)
Q Consensus       439 -----------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~-----~~~~~~~~~~~~~-~~-  500 (596)
                                 ..||..|+|||++....++.++|||||||++|||++|+.||.+....     +............ .. 
T Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~  315 (392)
T PHA03207        236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ  315 (392)
T ss_pred             CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence                       24899999999999999999999999999999999999999654211     1111110000000 00 


Q ss_pred             ----------hhccccccCcCC-------HHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          501 ----------DAADFRLRGKFN-------RKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       501 ----------~~~d~~l~~~~~-------~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                                .......+..+.       ......+..++.+|++.||++|||+.|++.
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~  374 (392)
T PHA03207        316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS  374 (392)
T ss_pred             ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence                      000000000000       011234567788999999999999999987

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.3e-34  Score=289.62  Aligned_cols=242  Identities=25%  Similarity=0.356  Sum_probs=197.5

Q ss_pred             CCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          285 GFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      +|...+.||+|+||.||++... +++.+|+|++...........++..|+..+.. ++|+||+++++++......++|||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~~~~~~v~e   79 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILAS-VNHPNIISYKEAFLDGNKLCIVME   79 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHh-CCCCCchhhhhhhccCCEEEEEeh
Confidence            4677889999999999999754 57899999987544444445567788866654 899999999999999999999999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc----
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP----  439 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~----  439 (596)
                      |+++++|.+++.........+++..++.++.|++.||+|||+   .+++|+||+|+||++++++.+||+|||.+..    
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~  156 (256)
T cd08530          80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN  156 (256)
T ss_pred             hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence            999999999997743333468999999999999999999999   8999999999999999999999999986532    


Q ss_pred             -----CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHH
Q 047719          440 -----AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRK  514 (596)
Q Consensus       440 -----~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  514 (596)
                           .++..|++||.+.+..++.++|+||||+++|||++|+.||...+..  ..... ...+.         ....+..
T Consensus       157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--~~~~~-~~~~~---------~~~~~~~  224 (256)
T cd08530         157 MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ--DLRYK-VQRGK---------YPPIPPI  224 (256)
T ss_pred             CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH-HhcCC---------CCCCchh
Confidence                 3778999999999888999999999999999999999999765421  11111 11111         1122234


Q ss_pred             HHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          515 EMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       515 ~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ....+.+++..|++.+|++||++.++++
T Consensus       225 ~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         225 YSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             hCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            4566888999999999999999999876

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.7e-34  Score=289.88  Aligned_cols=239  Identities=27%  Similarity=0.308  Sum_probs=194.3

Q ss_pred             CCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchh-cccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          285 GFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVE-CARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~-~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      +|...+.||.|+||.||++... ++..||+|.+.+..... ...+.+.+|+..+.+ ++||||+++++.+.+....++|+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~   79 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQE-LNHPFLVNLWYSFQDEENMYLVV   79 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHh-CCCCChHHHHHhhcCCCeEEEEE
Confidence            4777899999999999999876 48899999997543222 345578888866655 89999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc----
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI----  438 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~----  438 (596)
                      ||+++++|.+++....    .+++.....++.|+++||.|||+   .+++|+||+|+||++++++.++|+|||...    
T Consensus        80 e~~~~~~L~~~l~~~~----~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~  152 (258)
T cd05578          80 DLLLGGDLRYHLSQKV----KFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP  152 (258)
T ss_pred             eCCCCCCHHHHHHhcC----CcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCC
Confidence            9999999999997652    48899999999999999999999   899999999999999999999999998653    


Q ss_pred             ------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCC
Q 047719          439 ------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFN  512 (596)
Q Consensus       439 ------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  512 (596)
                            ..|+..|+|||.+....++.++|+||||+++|+|++|+.||........++........          ....+
T Consensus       153 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------~~~~~  222 (258)
T cd05578         153 DTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETA----------DVLYP  222 (258)
T ss_pred             CccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccc----------cccCc
Confidence                  34677899999998888999999999999999999999999865432222222221110          11122


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCH--HHHH
Q 047719          513 RKEMERMLMVGLSCVHPNHEKRPSV--KEAA  541 (596)
Q Consensus       513 ~~~~~~l~~l~~~C~~~dp~~RPs~--~ev~  541 (596)
                      ......+.+++.+||+.||.+||++  +|++
T Consensus       223 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         223 ATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             ccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            2233677788899999999999999  5543

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-34  Score=291.50  Aligned_cols=250  Identities=25%  Similarity=0.327  Sum_probs=188.6

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      ++|...+.||+|+||.||+|... +++.||||.+..... ......+.+|+..+. .++|+||+++++++.+....++||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~   82 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE-EGAPFTAIREASLLK-DLKHANIVTLHDIIHTKKTLTLVF   82 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc-cCCchhHHHHHHHHh-hCCCcceeeEEEEEecCCeEEEEE
Confidence            46778899999999999999876 588999999864332 222345677886555 489999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc---
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP---  439 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~---  439 (596)
                      ||+++ +|.+++.....   .+++.....++.|+++||.|||+   .+++||||||+||+++.++.+||+|||.+..   
T Consensus        83 e~~~~-~L~~~~~~~~~---~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  155 (291)
T cd07844          83 EYLDT-DLKQYMDDCGG---GLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSV  155 (291)
T ss_pred             ecCCC-CHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCC
Confidence            99985 99999876532   58899999999999999999999   8999999999999999999999999997542   


Q ss_pred             --------CCCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCChhH--HHHHHHHHhcCCc---------
Q 047719          440 --------AGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVI--VDWVWNLRKKGKL---------  499 (596)
Q Consensus       440 --------~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~--~~~~~~~~~~~~~---------  499 (596)
                              .++..|+|||.+.+ ..++.++|||||||++|||++|+.||.......  ....+........         
T Consensus       156 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (291)
T cd07844         156 PSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSN  235 (291)
T ss_pred             CCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhc
Confidence                    25678999998875 458899999999999999999999997543211  1111111100000         


Q ss_pred             hhhcc--------ccccCcC-CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          500 LDAAD--------FRLRGKF-NRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       500 ~~~~d--------~~l~~~~-~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      .....        ..+.... .......+.+++.+|++.+|++|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence            00000        0000000 0011256678889999999999999999865

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-34  Score=290.55  Aligned_cols=240  Identities=23%  Similarity=0.229  Sum_probs=188.7

Q ss_pred             ceeecCCceEEEEEEcC-CCCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecCCC
Q 047719          290 RIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPN  367 (596)
Q Consensus       290 ~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  367 (596)
                      +.||+|+||.||+|... +++.||||++.+.... ......+..|...+....+|+|++++++++...+..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            46899999999999875 4889999998653321 122234455655555667999999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc-------cC
Q 047719          368 GSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI-------PA  440 (596)
Q Consensus       368 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~-------~~  440 (596)
                      ++|.+++....    .+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.+||+|||.+.       ..
T Consensus        82 ~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  154 (260)
T cd05611          82 GDCASLIKTLG----GLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV  154 (260)
T ss_pred             CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccccccCC
Confidence            99999997653    47889999999999999999999   899999999999999999999999999754       35


Q ss_pred             CCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHHHHHHHH
Q 047719          441 GTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERML  520 (596)
Q Consensus       441 gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~  520 (596)
                      ++..|+|||.+.+..++.++||||||+++|||++|..||......  ... .........      ............+.
T Consensus       155 ~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~-~~~~~~~~~------~~~~~~~~~~~~~~  225 (260)
T cd05611         155 GTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD--AVF-DNILSRRIN------WPEEVKEFCSPEAV  225 (260)
T ss_pred             CCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH--HHH-HHHHhcccC------CCCcccccCCHHHH
Confidence            788999999998888999999999999999999999999764321  111 111111110      00111112345678


Q ss_pred             HHHHHcCCCCCCCCCCHHHHHHHHh
Q 047719          521 MVGLSCVHPNHEKRPSVKEAARILK  545 (596)
Q Consensus       521 ~l~~~C~~~dp~~RPs~~ev~~~L~  545 (596)
                      +++.+|++.+|++||++.++.+.|+
T Consensus       226 ~~i~~~l~~~p~~R~~~~~~~~~l~  250 (260)
T cd05611         226 DLINRLLCMDPAKRLGANGYQEIKS  250 (260)
T ss_pred             HHHHHHccCCHHHccCCCcHHHHHc
Confidence            8889999999999998877766654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=4.4e-34  Score=295.13  Aligned_cols=241  Identities=27%  Similarity=0.355  Sum_probs=190.3

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      ..|...+.||+|+||.||+|... +++.||+|++...... .....++.+|+..+. .++||||+++.++|......++|
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~-~l~h~niv~~~~~~~~~~~~~lv   93 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ-QLRHPNTIEYKGCYLREHTAWLV   93 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHH-hCCCCCEEEEEEEEEeCCeEEEE
Confidence            45777899999999999999865 5889999998643322 233456788886554 48999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc--
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP--  439 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~--  439 (596)
                      |||++ |+|.+++....   ..+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.+||+|||++..  
T Consensus        94 ~e~~~-g~l~~~~~~~~---~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~  166 (307)
T cd06607          94 MEYCL-GSASDILEVHK---KPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVS  166 (307)
T ss_pred             HHhhC-CCHHHHHHHcc---cCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecC
Confidence            99997 68888776433   248999999999999999999999   8999999999999999999999999997642  


Q ss_pred             -----CCCcccCCccccc---cCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcC
Q 047719          440 -----AGTMGYLAPEYVY---SGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKF  511 (596)
Q Consensus       440 -----~gt~~y~aPE~~~---~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  511 (596)
                           .++..|+|||.+.   .+.++.++||||||+++|||++|+.||.......  ......... .     +.   ..
T Consensus       167 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~--~~~~~~~~~-~-----~~---~~  235 (307)
T cd06607         167 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALYHIAQND-S-----PT---LS  235 (307)
T ss_pred             CCCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH--HHHHHhcCC-C-----CC---CC
Confidence                 4778899999874   3568899999999999999999999997643211  111111110 0     00   01


Q ss_pred             CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 047719          512 NRKEMERMLMVGLSCVHPNHEKRPSVKEAARI  543 (596)
Q Consensus       512 ~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~  543 (596)
                      .......+.+++..||+.+|++||++.+++..
T Consensus       236 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         236 SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            12234567888999999999999999999763

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=6.6e-34  Score=291.18  Aligned_cols=251  Identities=22%  Similarity=0.269  Sum_probs=187.9

Q ss_pred             HhcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEE
Q 047719          282 ATLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVL  360 (596)
Q Consensus       282 at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~l  360 (596)
                      ++.+|...+.||+|+||.||+|... +++.||+|++..... ......+.+|+..+.. ++|+||+++++++......++
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~-l~h~ni~~~~~~~~~~~~~~l   80 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKG-LKHANIVLLHDIIHTKETLTF   80 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHh-cCCCCEeEEEEEEecCCeEEE
Confidence            4567888999999999999999764 588999999864322 2223356788865554 899999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc-
Q 047719          361 VYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP-  439 (596)
Q Consensus       361 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~-  439 (596)
                      ||||+. ++|.+++....   ..+.+..+..++.|++.||+|||+   .+++|+||||+|||++.++.+||+|||++.. 
T Consensus        81 v~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~  153 (291)
T cd07870          81 VFEYMH-TDLAQYMIQHP---GGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAK  153 (291)
T ss_pred             EEeccc-CCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEecccccccc
Confidence            999995 68888776542   247788889999999999999999   8999999999999999999999999997542 


Q ss_pred             ----------CCCcccCCccccccC-CCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHh---cC--------
Q 047719          440 ----------AGTMGYLAPEYVYSG-VPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRK---KG--------  497 (596)
Q Consensus       440 ----------~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~---~~--------  497 (596)
                                .++..|+|||.+.+. .++.++|||||||++|||++|+.||....... +.....+.   ..        
T Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  232 (291)
T cd07870         154 SIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF-EQLEKIWTVLGVPTEDTWPGV  232 (291)
T ss_pred             CCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH-HHHHHHHHHcCCCChhhhhhh
Confidence                      357889999998754 57889999999999999999999997643211 11111110   00        


Q ss_pred             -CchhhccccccC----cC-----CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          498 -KLLDAADFRLRG----KF-----NRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       498 -~~~~~~d~~l~~----~~-----~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                       .+..........    ..     .......+.+++.+|++.||++|||+.|++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence             000000000000    00     0011345667889999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-34  Score=291.51  Aligned_cols=250  Identities=25%  Similarity=0.300  Sum_probs=189.9

Q ss_pred             CCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEec
Q 047719          286 FNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEY  364 (596)
Q Consensus       286 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~  364 (596)
                      |+..+.||.|++|.||+|... +|..||+|++............+.+|+..+.. ++|+|++++++++.+.+..+++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~-l~~~~iv~~~~~~~~~~~~~iv~e~   79 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKE-LNHPNIVRLLDVVHSENKLYLVFEF   79 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHh-cCCCCccCHhheeccCCeEEEEEec
Confidence            456789999999999999865 68999999987544333334567889866554 8999999999999999999999999


Q ss_pred             CCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc-----
Q 047719          365 LPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP-----  439 (596)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~-----  439 (596)
                      ++ ++|.+++.....  ..+++..++.++.|+++||+|||+   .+++||||+|+||+++.++.++|+|||.+..     
T Consensus        80 ~~-~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~  153 (283)
T cd07835          80 LD-LDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV  153 (283)
T ss_pred             cC-cCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc
Confidence            95 699999976542  358999999999999999999999   8999999999999999999999999987642     


Q ss_pred             ------CCCcccCCccccccC-CCCCccceeehhHHHHHHHhCCCCCCCCChh--HHHHHHHHHhcC--------Cchhh
Q 047719          440 ------AGTMGYLAPEYVYSG-VPSEKTDVYSFGVVALEVAAGKSPVDNDGCV--IVDWVWNLRKKG--------KLLDA  502 (596)
Q Consensus       440 ------~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~El~tG~~p~~~~~~~--~~~~~~~~~~~~--------~~~~~  502 (596)
                            .++..|+|||.+.+. .++.++|||||||++|||++|+.||...+..  +...........        .+.+.
T Consensus       154 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07835         154 RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY  233 (283)
T ss_pred             cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhh
Confidence                  246789999988664 5789999999999999999999999765321  111110000000        00000


Q ss_pred             cc--c----cccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          503 AD--F----RLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       503 ~d--~----~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ..  +    .............+.+++.+|++++|++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            00  0    0000011122356778999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-34  Score=291.29  Aligned_cols=237  Identities=27%  Similarity=0.404  Sum_probs=188.0

Q ss_pred             CCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccC---CCceeeecceeeeCCeEEE
Q 047719          285 GFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLR---HKNLVQLQGWCCEGNELVL  360 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~---H~niv~l~g~~~~~~~~~l  360 (596)
                      .|+..+.||+|+||.||+|... ++..||+|.+.... ......++.+|+..+.. ++   |+|++++++++......++
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~-l~~~~~~~vi~~~~~~~~~~~~~l   79 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQ-LRQSQPPNITKYYGSYLKGPRLWI   79 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHH-hccCCCCCeeeEeeeeeeCCEEEE
Confidence            3666788999999999999864 58899999986432 22234457778755544 54   9999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc-
Q 047719          361 VYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP-  439 (596)
Q Consensus       361 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~-  439 (596)
                      ||||+++++|.+++...     .+++...+.++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||.+.. 
T Consensus        80 v~e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  151 (277)
T cd06917          80 IMEYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALL  151 (277)
T ss_pred             EEecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeec
Confidence            99999999999998753     48899999999999999999999   8999999999999999999999999986532 


Q ss_pred             ----------CCCcccCCccccccC-CCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhcccccc
Q 047719          440 ----------AGTMGYLAPEYVYSG-VPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLR  508 (596)
Q Consensus       440 ----------~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  508 (596)
                                .|+..|+|||.+.++ .++.++|||||||++|||++|+.||.....  ..+.... ..     ...+.+.
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~--~~~~~~~-~~-----~~~~~~~  223 (277)
T cd06917         152 NQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA--FRAMMLI-PK-----SKPPRLE  223 (277)
T ss_pred             CCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh--hhhhhcc-cc-----CCCCCCC
Confidence                      477789999988764 468999999999999999999999976432  1111100 00     0011111


Q ss_pred             CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          509 GKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       509 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ..   .....+.+++..||+.||++||++.+++.
T Consensus       224 ~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         224 DN---GYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             cc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            11   13356778889999999999999999976

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=3.7e-34  Score=288.31  Aligned_cols=241  Identities=27%  Similarity=0.353  Sum_probs=194.8

Q ss_pred             CCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          285 GFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      +|+..+.||+|+||.||++... +++.+|+|++..... .....++.+|+..+.+ ++||||+++++.+......++++|
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~-~~~~~i~~~~~~~~~~~~~~lv~e   79 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHK-CNSPYIVGFYGAFYNNGDISICME   79 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHH-CCCCchhhhheeeecCCEEEEEEE
Confidence            5667789999999999999876 488999999875432 2445678889866655 889999999999999999999999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc-----
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI-----  438 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~-----  438 (596)
                      |+++++|.+++....   ..+++.....++.|++.||+|||+.  .+++|+||||+||+++.++.++|+|||.+.     
T Consensus        80 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~--~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~  154 (265)
T cd06605          80 YMDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEK--HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS  154 (265)
T ss_pred             ecCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCC--CCeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence            999999999998653   3588899999999999999999973  689999999999999999999999998754     


Q ss_pred             ----cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCC---hhHHHHHHHHHhcCCchhhccccccCcC
Q 047719          439 ----PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDG---CVIVDWVWNLRKKGKLLDAADFRLRGKF  511 (596)
Q Consensus       439 ----~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~---~~~~~~~~~~~~~~~~~~~~d~~l~~~~  511 (596)
                          ..++..|+|||.+.+..++.++||||||+++|||++|+.||....   ....+.+.......          ....
T Consensus       155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------~~~~  224 (265)
T cd06605         155 LAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP----------PPRL  224 (265)
T ss_pred             HhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCC----------CCCC
Confidence                347889999999998899999999999999999999999997542   11222221111111          0111


Q ss_pred             CHH-HHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          512 NRK-EMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       512 ~~~-~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      +.. ....+.+++..||+.+|++|||+.+++.
T Consensus       225 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         225 PSGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            111 3455778889999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=5.4e-34  Score=290.42  Aligned_cols=250  Identities=23%  Similarity=0.298  Sum_probs=191.7

Q ss_pred             CCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          285 GFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      +|...+.||+|+||.||+|... +|..||+|++............+.+|+..+. .++|+||+++++++......++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~-~~~~~~i~~~~~~~~~~~~~~~v~e   79 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQ-ACQHPYVVKLLDVFPHGSGFVLVME   79 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHH-hCCCCCCcceeeEEecCCeeEEEec
Confidence            3667789999999999999865 5889999999765443444567888885554 4899999999999999999999999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc-----
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI-----  438 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~-----  438 (596)
                      |+ +++|.+++....   ..+++.+++.++.||++||+|||+   .+++|+||||+||+++.++.++|+|||.+.     
T Consensus        80 ~~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~  152 (286)
T cd07832          80 YM-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEE  152 (286)
T ss_pred             cc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence            99 999999997643   358999999999999999999999   899999999999999999999999998543     


Q ss_pred             -------cCCCcccCCccccccC-CCCCccceeehhHHHHHHHhCCCCCCCCCh-hHHHHHHHHHhcCC---------ch
Q 047719          439 -------PAGTMGYLAPEYVYSG-VPSEKTDVYSFGVVALEVAAGKSPVDNDGC-VIVDWVWNLRKKGK---------LL  500 (596)
Q Consensus       439 -------~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~El~tG~~p~~~~~~-~~~~~~~~~~~~~~---------~~  500 (596)
                             ..|+..|+|||.+.+. .++.++||||+||++|||++|++||..... ....++........         +.
T Consensus       153 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07832         153 EPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLP  232 (286)
T ss_pred             CCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcc
Confidence                   2367789999988654 468999999999999999999888865432 11111111110000         00


Q ss_pred             h--hccccccC-----cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          501 D--AADFRLRG-----KFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       501 ~--~~d~~l~~-----~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      +  ........     ....+....+.+++.+|++.+|++||+++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            0  00000000     000122367788899999999999999999875

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2e-34  Score=296.43  Aligned_cols=233  Identities=27%  Similarity=0.361  Sum_probs=186.9

Q ss_pred             cceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecCCC
Q 047719          289 NRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPN  367 (596)
Q Consensus       289 ~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  367 (596)
                      ...||+|+||.||++... +++.||+|++....  ......+.+|+..+.. ++||||+++++.+...+..++|+||+++
T Consensus        26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~-l~hp~i~~~~~~~~~~~~~~iv~e~~~~  102 (297)
T cd06659          26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRD-YQHQNVVEMYKSYLVGEELWVLMEFLQG  102 (297)
T ss_pred             hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc--cchHHHHHHHHHHHHh-CCCCchhhhhhheeeCCeEEEEEecCCC
Confidence            457999999999999765 58899999986432  2234567788865554 8999999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc---------
Q 047719          368 GSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI---------  438 (596)
Q Consensus       368 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---------  438 (596)
                      ++|..++...     .+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++.         
T Consensus       103 ~~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~  174 (297)
T cd06659         103 GALTDIVSQT-----RLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR  174 (297)
T ss_pred             CCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccc
Confidence            9999988653     38899999999999999999999   899999999999999999999999998653         


Q ss_pred             --cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHHHH
Q 047719          439 --PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEM  516 (596)
Q Consensus       439 --~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  516 (596)
                        ..|+..|+|||.+.+..++.++|||||||++|||++|+.||.......  -........ .     ....  ......
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--~~~~~~~~~-~-----~~~~--~~~~~~  244 (297)
T cd06659         175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ--AMKRLRDSP-P-----PKLK--NAHKIS  244 (297)
T ss_pred             cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHhccC-C-----CCcc--ccCCCC
Confidence              247889999999988889999999999999999999999997543211  111111110 0     0000  011122


Q ss_pred             HHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          517 ERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       517 ~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ..+.+++..|++.+|++||+++++++
T Consensus       245 ~~l~~~i~~~l~~~P~~Rps~~~ll~  270 (297)
T cd06659         245 PVLRDFLERMLTREPQERATAQELLD  270 (297)
T ss_pred             HHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            44677888999999999999999988

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=5.5e-34  Score=292.03  Aligned_cols=251  Identities=22%  Similarity=0.279  Sum_probs=190.1

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeC--CeEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG--NELVL  360 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~--~~~~l  360 (596)
                      ++|...+.||+|+||.||+|... +++.+|+|.++.....+.....+.+|+..+.+ ++||||+++++++...  ...|+
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~-l~h~ni~~~~~~~~~~~~~~~~l   83 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLK-LQHPNIVTVKEVVVGSNLDKIYM   83 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHh-cCCCCEEEEEEEEEecCCCcEEE
Confidence            36777899999999999999876 48899999997544333333356778866655 8999999999999887  88999


Q ss_pred             EEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc-
Q 047719          361 VYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP-  439 (596)
Q Consensus       361 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~-  439 (596)
                      ||||++ ++|.+++.....   .+++..++.++.||+.||+|||+   .+++|+||||+|||++.++.+||+|||.+.. 
T Consensus        84 v~e~~~-~~L~~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~  156 (293)
T cd07843          84 VMEYVE-HDLKSLMETMKQ---PFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREY  156 (293)
T ss_pred             EehhcC-cCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeec
Confidence            999997 599999876532   58999999999999999999999   8999999999999999999999999986542 


Q ss_pred             ----------CCCcccCCccccccC-CCCCccceeehhHHHHHHHhCCCCCCCCChh-HHHH-----------HHHHHhc
Q 047719          440 ----------AGTMGYLAPEYVYSG-VPSEKTDVYSFGVVALEVAAGKSPVDNDGCV-IVDW-----------VWNLRKK  496 (596)
Q Consensus       440 ----------~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~El~tG~~p~~~~~~~-~~~~-----------~~~~~~~  496 (596)
                                .++..|+|||.+.+. .++.++|+||||+++|||++|+.||...... ...-           .|.....
T Consensus       157 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (293)
T cd07843         157 GSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE  236 (293)
T ss_pred             cCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence                      356779999988754 4689999999999999999999999764321 0000           0000000


Q ss_pred             ------CCchhhccccccCcCCHH-HHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          497 ------GKLLDAADFRLRGKFNRK-EMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       497 ------~~~~~~~d~~l~~~~~~~-~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                            ..........+...++.. ....+.+++..|++.+|++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence                  000000011111112211 2456778889999999999999999875

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=3.7e-34  Score=287.73  Aligned_cols=240  Identities=26%  Similarity=0.403  Sum_probs=196.1

Q ss_pred             CCCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          285 GFNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      +|...+.||+|++|.||++.... ++.||||++...... .....+.+|+..+.+ ++|+|++++++++......++|||
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRS-CESPYVVKCYGAFYKEGEISIVLE   79 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHh-cCCCCeeeEEEEEccCCeEEEEEE
Confidence            57788999999999999998765 899999998654332 345678888866655 889999999999999999999999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc----
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP----  439 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~----  439 (596)
                      |+++++|.+++....    .+++..++.++.|+++||+|||+.  .+++||||+|+||+++.++.++|+|||.+..    
T Consensus        80 ~~~~~~L~~~l~~~~----~l~~~~~~~~~~~l~~~l~~lh~~--~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~  153 (264)
T cd06623          80 YMDGGSLADLLKKVG----KIPEPVLAYIARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENT  153 (264)
T ss_pred             ecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHhcc--CCCccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence            999999999998653    489999999999999999999973  6999999999999999999999999986542    


Q ss_pred             -------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCCh-hHHHHHHHHHhcCCchhhccccccCcC
Q 047719          440 -------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGC-VIVDWVWNLRKKGKLLDAADFRLRGKF  511 (596)
Q Consensus       440 -------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~~~~  511 (596)
                             .++..|+|||.+....++.++|+||||+++|||++|+.||..... ...+....... ...         ...
T Consensus       154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~---------~~~  223 (264)
T cd06623         154 LDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD-GPP---------PSL  223 (264)
T ss_pred             CCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc-CCC---------CCC
Confidence                   367789999999988999999999999999999999999976531 11111111111 110         111


Q ss_pred             CHH-HHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          512 NRK-EMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       512 ~~~-~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      +.. ....+.+++..|++++|++||++.++++
T Consensus       224 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~  255 (264)
T cd06623         224 PAEEFSPEFRDFISACLQKDPKKRPSAAELLQ  255 (264)
T ss_pred             CcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            122 3467788888999999999999999987

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.8e-34  Score=294.70  Aligned_cols=244  Identities=30%  Similarity=0.338  Sum_probs=186.9

Q ss_pred             CCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEec
Q 047719          286 FNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEY  364 (596)
Q Consensus       286 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~  364 (596)
                      |...+.||+|+||.||++... +++.||+|++...... .....+.+|+..+.+...|+||+++++++......+++|||
T Consensus         6 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           6 LKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             hHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            445578999999999999865 4889999998643322 34456788987777644599999999999999999999999


Q ss_pred             CCCCCHHHHhh---hCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc---
Q 047719          365 LPNGSLDKILH---NNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI---  438 (596)
Q Consensus       365 ~~~gsL~~~l~---~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---  438 (596)
                      +.. +|.++..   ...  ...+++.....++.+++.||+|||+.  .+++||||||+||+++.++.+||+|||++.   
T Consensus        85 ~~~-~l~~l~~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  159 (288)
T cd06616          85 MDI-SLDKFYKYVYEVL--KSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV  159 (288)
T ss_pred             ccC-CHHHHHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence            864 6555432   221  23589999999999999999999973  589999999999999999999999999753   


Q ss_pred             -------cCCCcccCCccccccC---CCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhcccccc
Q 047719          439 -------PAGTMGYLAPEYVYSG---VPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLR  508 (596)
Q Consensus       439 -------~~gt~~y~aPE~~~~~---~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  508 (596)
                             ..|+..|+|||.+...   .++.++|||||||++|||++|+.||..... ..+....... +.     .+.+.
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-~~~~~~~~~~-~~-----~~~~~  232 (288)
T cd06616         160 DSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-VFDQLTQVVK-GD-----PPILS  232 (288)
T ss_pred             cCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-HHHHHhhhcC-CC-----CCcCC
Confidence                   2478889999998765   689999999999999999999999975431 1111111111 00     11111


Q ss_pred             CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          509 GKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       509 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ..........+.+++.+|++.+|++|||+++|++
T Consensus       233 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         233 NSEEREFSPSFVNFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1121234456788899999999999999999876

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=8.9e-34  Score=294.35  Aligned_cols=244  Identities=25%  Similarity=0.357  Sum_probs=190.5

Q ss_pred             CCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCc-hhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          286 FNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNR-VECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       286 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      |...+.||+|+||.||++... ++..||+|++..... .......+..|+..+.. ++|+|++++++++.++...++|||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQR-IKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHh-CCCCCEEEEEEEEeeCCeEEEEEe
Confidence            566788999999999999865 588999999864322 22233467888866654 899999999999999999999999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc-----
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI-----  438 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~-----  438 (596)
                      |++ |+|.+++....   ..++|.++..++.|++.||.|||+   .+++||||+|+||+++.++.+||+|||++.     
T Consensus       106 ~~~-g~l~~~~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (317)
T cd06635         106 YCL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA  178 (317)
T ss_pred             CCC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence            997 58888876542   248999999999999999999999   899999999999999999999999998753     


Q ss_pred             --cCCCcccCCccccc---cCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCH
Q 047719          439 --PAGTMGYLAPEYVY---SGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNR  513 (596)
Q Consensus       439 --~~gt~~y~aPE~~~---~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  513 (596)
                        ..|+..|+|||.+.   .+.++.++|||||||++|||++|+.||......  ...........         ......
T Consensus       179 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~~~~~~~---------~~~~~~  247 (317)
T cd06635         179 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYHIAQNES---------PTLQSN  247 (317)
T ss_pred             ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH--HHHHHHHhccC---------CCCCCc
Confidence              24788899999874   457899999999999999999999998654221  11111111110         001111


Q ss_pred             HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Q 047719          514 KEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEA  548 (596)
Q Consensus       514 ~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~~  548 (596)
                      .....+.+++.+|++.+|.+||++.++++.+-...
T Consensus       248 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  282 (317)
T cd06635         248 EWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR  282 (317)
T ss_pred             cccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence            23345778889999999999999999998554333

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.5e-33  Score=281.51  Aligned_cols=240  Identities=26%  Similarity=0.405  Sum_probs=196.6

Q ss_pred             CCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeC--CeEEEE
Q 047719          285 GFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG--NELVLV  361 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~--~~~~lV  361 (596)
                      +|...+.||+|++|.||+|... ++..|++|++............+.+|+..+.+ ++|+||+++++++...  ...++|
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~~~~~~~lv   79 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSS-LQHPNIVRYYGSERDEEKNTLNIF   79 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHH-cCCCCEeeEEEEEecCCCCeEEEE
Confidence            3667789999999999999876 58899999987654433455678888866654 8999999999999988  899999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc---
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI---  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---  438 (596)
                      +||+++++|.+++....    .+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||.+.   
T Consensus        80 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~  152 (260)
T cd06606          80 LEYVSGGSLSSLLKKFG----KLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLG  152 (260)
T ss_pred             EEecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEecc
Confidence            99999999999998654    58999999999999999999999   899999999999999999999999997542   


Q ss_pred             ----------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhcccccc
Q 047719          439 ----------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLR  508 (596)
Q Consensus       439 ----------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  508 (596)
                                ..++..|+|||.+.....+.++||||||+++|||++|+.||..... .....+......         ..
T Consensus       153 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~---------~~  222 (260)
T cd06606         153 DIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-PMAALYKIGSSG---------EP  222 (260)
T ss_pred             cccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-hHHHHHhccccC---------CC
Confidence                      2467789999999888899999999999999999999999987541 111111111101         11


Q ss_pred             CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          509 GKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       509 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ...+......+.+++.+|++.+|++||++.++++
T Consensus       223 ~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         223 PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            1222333567888889999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=6.6e-34  Score=297.48  Aligned_cols=251  Identities=20%  Similarity=0.294  Sum_probs=190.0

Q ss_pred             hcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeee----CCe
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE----GNE  357 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~----~~~  357 (596)
                      ..+|...+.||+|+||.||+|... +|..||+|++............+.+|+..+. .++|+||+++++++..    ...
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~~~   82 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILR-HFKHDNIIAIRDILRPPGADFKD   82 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHH-hcCCCCccCHHHhccccCCCCce
Confidence            367888899999999999999765 5899999999754333334456778886554 4899999999998763    346


Q ss_pred             EEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCc
Q 047719          358 LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT  437 (596)
Q Consensus       358 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~  437 (596)
                      +++||||+. |+|.+++....    .+++.....++.||+.||+|||+   .+++||||||+||++++++.+||+|||.+
T Consensus        83 ~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~  154 (334)
T cd07855          83 VYVVMDLME-SDLHHIIHSDQ----PLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMA  154 (334)
T ss_pred             EEEEEehhh-hhHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccc
Confidence            899999995 69999987543    38999999999999999999999   89999999999999999999999999865


Q ss_pred             c---------------cCCCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCChhH-HHHHHHHHhc----
Q 047719          438 I---------------PAGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVI-VDWVWNLRKK----  496 (596)
Q Consensus       438 ~---------------~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~-~~~~~~~~~~----  496 (596)
                      .               ..|+..|+|||.+.. ..++.++|||||||++|||++|+.||...+... ..........    
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~  234 (334)
T cd07855         155 RGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEE  234 (334)
T ss_pred             eeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhH
Confidence            3               246788999998865 568999999999999999999999997653211 1111010000    


Q ss_pred             -------CCchhhcc-ccccCcC-----CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          497 -------GKLLDAAD-FRLRGKF-----NRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       497 -------~~~~~~~d-~~l~~~~-----~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                             ....+..+ .......     .......+.+++..|++.+|++||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         235 VLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             hhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence                   00000000 0000011     1123466888999999999999999999887

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-34  Score=294.34  Aligned_cols=253  Identities=20%  Similarity=0.257  Sum_probs=186.7

Q ss_pred             CCCccceeecCCceEEEEEEcCC---CCEEEEEEeecCCc-hhcccchHHHHHHHHHhccCCCceeeecceeeeC--CeE
Q 047719          285 GFNKNRIVGEGASATVYKGSLPS---GGAVAVKRFEKPNR-VECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG--NEL  358 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~~---g~~vAvK~l~~~~~-~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~--~~~  358 (596)
                      +|...+.||+|+||.||+|....   +..||+|.+..... .......+.+|+..+. .++||||+++++++...  ..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~~   79 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLR-ELKHENVVSLVEVFLEHADKSV   79 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHH-hcCCCCccceEEEEeCCCCceE
Confidence            36777899999999999998654   78999999975331 1222345677885554 48999999999999988  789


Q ss_pred             EEEEecCCCCCHHHHhhhCCCC-CcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecC----CCceEEcc
Q 047719          359 VLVYEYLPNGSLDKILHNNSSS-SIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDA----EFNAKLGD  433 (596)
Q Consensus       359 ~lV~E~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~----~~~~kl~D  433 (596)
                      ++||||+++ +|.+++...... ...+++.....++.||+.||.|||+   .+++||||||+|||++.    ++.+||+|
T Consensus        80 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~D  155 (316)
T cd07842          80 YLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGD  155 (316)
T ss_pred             EEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECC
Confidence            999999975 777777543322 2368899999999999999999999   89999999999999999    89999999


Q ss_pred             CCCccc--------------CCCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCChhH-----------H
Q 047719          434 FEATIP--------------AGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVI-----------V  487 (596)
Q Consensus       434 fg~~~~--------------~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~-----------~  487 (596)
                      ||++..              .++..|+|||.+.+ ..++.++|||||||++|||++|+.||.......           .
T Consensus       156 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
T cd07842         156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE  235 (316)
T ss_pred             CccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence            997542              35678999998876 457899999999999999999999997543211           0


Q ss_pred             HHHHHHH-----------hcCCchhhccccccCcCC---------H--HHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          488 DWVWNLR-----------KKGKLLDAADFRLRGKFN---------R--KEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       488 ~~~~~~~-----------~~~~~~~~~d~~l~~~~~---------~--~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ..+..+.           .........+......++         .  .....+.+++.+|++.||++|||+.|+++
T Consensus       236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            0000000           000000000000000111         0  22346788999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.4e-33  Score=288.08  Aligned_cols=242  Identities=29%  Similarity=0.416  Sum_probs=195.9

Q ss_pred             HHhcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEE
Q 047719          281 QATLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELV  359 (596)
Q Consensus       281 ~at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~  359 (596)
                      ..++.|...+.||+|+||.||+|... ++..||+|++.....   ....+.+|++.+. .++|+|++++++.+......+
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~   91 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMK-DCKHPNIVDYYDSYLVGDELW   91 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHH-HCCCCCeeEEEEEEEECCEEE
Confidence            35667888899999999999999876 588999999964332   3456788886554 489999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc-
Q 047719          360 LVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI-  438 (596)
Q Consensus       360 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~-  438 (596)
                      +|+||+++++|.+++....   ..+++..++.++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||.+. 
T Consensus        92 lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~  165 (286)
T cd06614          92 VVMEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQ  165 (286)
T ss_pred             EEEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhh
Confidence            9999999999999998753   258999999999999999999999   999999999999999999999999998643 


Q ss_pred             ----------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhcccccc
Q 047719          439 ----------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLR  508 (596)
Q Consensus       439 ----------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  508 (596)
                                ..++..|+|||.+.+..++.++|||||||++|||++|+.||......  ......... ....     . 
T Consensus       166 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~--~~~~~~~~~-~~~~-----~-  236 (286)
T cd06614         166 LTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL--RALFLITTK-GIPP-----L-  236 (286)
T ss_pred             hccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhc-CCCC-----C-
Confidence                      23677899999998888999999999999999999999999764321  111111111 1100     0 


Q ss_pred             CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          509 GKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       509 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                       .........+..++.+|++.+|.+||++.++++
T Consensus       237 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         237 -KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             -cchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence             011113356778899999999999999999976

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=7.7e-34  Score=296.24  Aligned_cols=246  Identities=23%  Similarity=0.319  Sum_probs=186.4

Q ss_pred             ceeecC--CceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecCC
Q 047719          290 RIVGEG--ASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLP  366 (596)
Q Consensus       290 ~~LG~G--~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~~  366 (596)
                      ..||+|  +||+||++... +|+.||||++..........+.+.+|+ .+.+.++||||++++++|...+..++|+||+.
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~-~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~   82 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEV-VLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA   82 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHH-HHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence            356666  99999999865 589999999865443333445677777 45556899999999999999999999999999


Q ss_pred             CCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc--------
Q 047719          367 NGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI--------  438 (596)
Q Consensus       367 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~--------  438 (596)
                      +++|.+++.....  ..+++..+..++.|++.||+|||+   .+++||||||+|||++.++.++++||+...        
T Consensus        83 ~~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~  157 (328)
T cd08226          83 YGSANSLLKTYFP--EGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK  157 (328)
T ss_pred             CCCHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence            9999999987542  248899999999999999999998   899999999999999999999999995321        


Q ss_pred             ----------cCCCcccCCccccccC--CCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcC---------
Q 047719          439 ----------PAGTMGYLAPEYVYSG--VPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKG---------  497 (596)
Q Consensus       439 ----------~~gt~~y~aPE~~~~~--~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~---------  497 (596)
                                ..++..|+|||.+.+.  .++.++|||||||++|||++|+.||........ .........         
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~  236 (328)
T cd08226         158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM-LLQKLKGPPYSPLDITTF  236 (328)
T ss_pred             ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH-HHHHhcCCCCCCcccccc
Confidence                      1234569999998763  478999999999999999999999976432110 000000000         


Q ss_pred             --------------------------CchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          498 --------------------------KLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       498 --------------------------~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                                                ......+..+...........+.+++.+||+.||++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                                      000011111122223345567889999999999999999999976

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1e-33  Score=297.25  Aligned_cols=242  Identities=25%  Similarity=0.279  Sum_probs=201.2

Q ss_pred             hcCCCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCchh-cccchHHHHHHHHHhccC-CCceeeecceeeeCCeEE
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRVE-CARNPFTTEFATMAGCLR-HKNLVQLQGWCCEGNELV  359 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~-~~~~~~~~E~~~l~~~l~-H~niv~l~g~~~~~~~~~  359 (596)
                      ...|...+.||+|.||.||++..+. |+.+|+|.+.+..... .......+|+..|.+ +. |||||.+.+.+.....++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~-l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQ-LSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHh-ccCCCCEEEEEEEEEcCCeEE
Confidence            3457777999999999999998775 9999999997654432 234578899977766 66 999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCC----CceEEccCC
Q 047719          360 LVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAE----FNAKLGDFE  435 (596)
Q Consensus       360 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~----~~~kl~Dfg  435 (596)
                      +|||++.+|.|.+.+...     .+++.....++.||+.+++|||+   .+|+||||||+|+|+...    +.+|++|||
T Consensus       113 lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG  184 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFG  184 (382)
T ss_pred             EEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence            999999999999999876     28899999999999999999999   999999999999999643    479999999


Q ss_pred             Ccc----------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccc
Q 047719          436 ATI----------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADF  505 (596)
Q Consensus       436 ~~~----------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~  505 (596)
                      ++.          .+||+.|+|||.+....|+..+||||+||++|.|++|.+||..........   ....++      .
T Consensus       185 la~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~---~i~~~~------~  255 (382)
T KOG0032|consen  185 LAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL---AILRGD------F  255 (382)
T ss_pred             CceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH---HHHcCC------C
Confidence            864          469999999999999999999999999999999999999998764321110   111111      1


Q ss_pred             cccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          506 RLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       506 ~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ....+........+.+++..|+..||.+|+|+.++++
T Consensus       256 ~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  256 DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence            2233344455677788889999999999999999988

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=7.1e-34  Score=290.47  Aligned_cols=236  Identities=26%  Similarity=0.377  Sum_probs=189.7

Q ss_pred             CCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEec
Q 047719          286 FNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEY  364 (596)
Q Consensus       286 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~  364 (596)
                      |...+.||+|++|.||++... +++.+++|++....  ....+.+.+|+..+. .++|+||+++++++...+..++|+||
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~-~~~h~~vv~~~~~~~~~~~~~~v~e~   97 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMR-DYQHPNIVEMYSSYLVGDELWVVMEF   97 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHH-HcCCCChheEEEEEEcCCeEEEEEec
Confidence            444579999999999999864 58899999985332  223445778885554 48999999999999999999999999


Q ss_pred             CCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc------
Q 047719          365 LPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI------  438 (596)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~------  438 (596)
                      +++++|.+++...     .+++..+..++.|++.||+|||+   .+++||||+|+||+++.++.++|+|||.+.      
T Consensus        98 ~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~  169 (285)
T cd06648          98 LEGGALTDIVTHT-----RMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV  169 (285)
T ss_pred             cCCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCC
Confidence            9999999999863     38899999999999999999999   899999999999999999999999998643      


Q ss_pred             -----cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCH
Q 047719          439 -----PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNR  513 (596)
Q Consensus       439 -----~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  513 (596)
                           ..|+..|+|||.+.+..++.++|||||||++|||++|+.||.....  .......... .     .+...  ...
T Consensus       170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~--~~~~~~~~~~-~-----~~~~~--~~~  239 (285)
T cd06648         170 PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP--LQAMKRIRDN-L-----PPKLK--NLH  239 (285)
T ss_pred             cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH--HHHHHHHHhc-C-----CCCCc--ccc
Confidence                 2478889999999888899999999999999999999999875432  1112111111 0     00110  111


Q ss_pred             HHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          514 KEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       514 ~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      .....+.+++.+||+.+|++||++.++++
T Consensus       240 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         240 KVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             cCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            13356788999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.3e-33  Score=286.92  Aligned_cols=248  Identities=21%  Similarity=0.237  Sum_probs=186.4

Q ss_pred             CCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeC--CeEEEEE
Q 047719          286 FNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG--NELVLVY  362 (596)
Q Consensus       286 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~--~~~~lV~  362 (596)
                      |...+.||+|+||.||+|... ++..||+|+++...... .......|+..+.+...|+|++++++++.+.  +.+++|+
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~   79 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL-EQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF   79 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc-hhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence            455688999999999999865 58899999986533222 2233457876776655699999999999987  8899999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc---
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP---  439 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~---  439 (596)
                      ||++ |+|.+++....   ..++|.+++.++.|++.||+|||+   .+++||||||+||+++. +.+||+|||.+..   
T Consensus        80 e~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~  151 (282)
T cd07831          80 ELMD-MNLYELIKGRK---RPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYS  151 (282)
T ss_pred             ecCC-ccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence            9997 58888887643   258999999999999999999999   89999999999999999 9999999987642   


Q ss_pred             -------CCCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCCh-hHHHHHHHHHhc-----------CCc
Q 047719          440 -------AGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGC-VIVDWVWNLRKK-----------GKL  499 (596)
Q Consensus       440 -------~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~-~~~~~~~~~~~~-----------~~~  499 (596)
                             .++..|+|||.+.. +.++.++|||||||++|||++|..||...+. ....+.......           ...
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
T cd07831         152 KPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH  231 (282)
T ss_pred             CCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccc
Confidence                   36778999997654 5678999999999999999999999976432 111221111100           000


Q ss_pred             hhhccccccC----cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          500 LDAADFRLRG----KFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       500 ~~~~d~~l~~----~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      .....+....    .........+.+++.+|++++|++||+++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            0000000000    001123567888999999999999999999875

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=2.5e-33  Score=295.50  Aligned_cols=249  Identities=22%  Similarity=0.285  Sum_probs=189.7

Q ss_pred             HhcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeC-----
Q 047719          282 ATLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG-----  355 (596)
Q Consensus       282 at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~-----  355 (596)
                      ..+.|...+.||+|+||.||++... +++.||||++.+..........+.+|+..+. .++|+||+++++++...     
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMK-LVNHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHH-hcCCCCCcceeeeeccCCCccc
Confidence            3467888899999999999999865 5899999998654333334456778885554 58999999999988644     


Q ss_pred             -CeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccC
Q 047719          356 -NELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF  434 (596)
Q Consensus       356 -~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Df  434 (596)
                       ...|+||||+. ++|.+.+...      +++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+||
T Consensus        93 ~~~~~lv~e~~~-~~l~~~~~~~------l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Df  162 (353)
T cd07850          93 FQDVYLVMELMD-ANLCQVIQMD------LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDF  162 (353)
T ss_pred             cCcEEEEEeccC-CCHHHHHhhc------CCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccC
Confidence             35799999996 5888888642      7888999999999999999999   89999999999999999999999999


Q ss_pred             CCccc----------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcC-------
Q 047719          435 EATIP----------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKG-------  497 (596)
Q Consensus       435 g~~~~----------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~-------  497 (596)
                      |.+..          .++..|+|||.+.+..++.++|||||||++|||++|+.||...+. ...|.......+       
T Consensus       163 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~  241 (353)
T cd07850         163 GLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDH-IDQWNKIIEQLGTPSDEFM  241 (353)
T ss_pred             ccceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHHhcCCCCHHHH
Confidence            97642          367789999999998999999999999999999999999976432 111111000000       


Q ss_pred             --------------C------chhhcccc----ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          498 --------------K------LLDAADFR----LRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       498 --------------~------~~~~~d~~----l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                                    .      ..+.....    ............+.+++.+|++.||++|||+.|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                          0      00000000    000001123456788999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=9.9e-34  Score=295.54  Aligned_cols=268  Identities=22%  Similarity=0.248  Sum_probs=198.4

Q ss_pred             HHHHHhcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeee-C
Q 047719          278 DIKQATLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE-G  355 (596)
Q Consensus       278 el~~at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~-~  355 (596)
                      ++...+++|...+.||.|+||.||++... ++..||||++.+..........+..|+..+.. ++||||+++++++.. .
T Consensus         4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~-l~hpniv~~~~~~~~~~   82 (328)
T cd07856           4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKH-LRHENIISLSDIFISPL   82 (328)
T ss_pred             ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHh-cCCCCeeeEeeeEecCC
Confidence            34456788999999999999999999755 68999999986544333445567788866554 899999999999876 5


Q ss_pred             CeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCC
Q 047719          356 NELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFE  435 (596)
Q Consensus       356 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg  435 (596)
                      ...++|+||+ +++|.+++...     .+++.....++.|+++||+|||+   .+++||||||+|||+++++.+||+|||
T Consensus        83 ~~~~lv~e~~-~~~L~~~~~~~-----~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg  153 (328)
T cd07856          83 EDIYFVTELL-GTDLHRLLTSR-----PLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFG  153 (328)
T ss_pred             CcEEEEeehh-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccc
Confidence            5789999998 56899988753     37888888999999999999999   899999999999999999999999999


Q ss_pred             Cccc--------CCCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCChhHH-HHHHHHH-----------
Q 047719          436 ATIP--------AGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIV-DWVWNLR-----------  494 (596)
Q Consensus       436 ~~~~--------~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~-~~~~~~~-----------  494 (596)
                      .+..        .++..|+|||.+.+ ..++.++|||||||++|||++|+.||........ ....+..           
T Consensus       154 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (328)
T cd07856         154 LARIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI  233 (328)
T ss_pred             cccccCCCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            7643        36778999998766 5689999999999999999999999976532110 0000000           


Q ss_pred             hcCCchhhc-cccccCcCCH-----HHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhcCCCCCCCCC
Q 047719          495 KKGKLLDAA-DFRLRGKFNR-----KEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKGEAPLPLLPV  555 (596)
Q Consensus       495 ~~~~~~~~~-d~~l~~~~~~-----~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~~~~~~p~~p~  555 (596)
                      ..+...+.. ........+.     .....+.+++.+|++.+|++||++++++.  +++....++.-|.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~~~  302 (328)
T cd07856         234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDEPV  302 (328)
T ss_pred             cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCccccC
Confidence            000000000 0000111111     12356788899999999999999999976  3544444333343

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=2.1e-33  Score=284.28  Aligned_cols=241  Identities=21%  Similarity=0.206  Sum_probs=186.8

Q ss_pred             HHHHHHHhcCCCcccee--ecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeeccee
Q 047719          276 LTDIKQATLGFNKNRIV--GEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWC  352 (596)
Q Consensus       276 ~~el~~at~~f~~~~~L--G~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~  352 (596)
                      ..++....++|...+.+  |+|+||.||++... ++..+|+|.+.......     ...++..+  ..+|+|++++++++
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~--~~~h~~iv~~~~~~   78 (267)
T PHA03390          6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQL--MKDNPNFIKLYYSV   78 (267)
T ss_pred             HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHH--hhcCCCEEEEEEEE
Confidence            34445555666666665  99999999999764 57889999986432111     11111122  23799999999999


Q ss_pred             eeCCeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCC-ceEE
Q 047719          353 CEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEF-NAKL  431 (596)
Q Consensus       353 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~-~~kl  431 (596)
                      ...+..++||||+++++|.+++....    .++|.++..++.|+++||.|||+   .+++||||||+||+++.++ .++|
T Consensus        79 ~~~~~~~iv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l  151 (267)
T PHA03390         79 TTLKGHVLIMDYIKDGDLFDLLKKEG----KLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYL  151 (267)
T ss_pred             ecCCeeEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEE
Confidence            99999999999999999999998653    58999999999999999999999   8999999999999999998 9999


Q ss_pred             ccCCCcc-------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhH---HHHHHHHHhcCCchh
Q 047719          432 GDFEATI-------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVI---VDWVWNLRKKGKLLD  501 (596)
Q Consensus       432 ~Dfg~~~-------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~---~~~~~~~~~~~~~~~  501 (596)
                      +|||.+.       ..++..|+|||.+.+..++.++|||||||++|||++|+.||.......   ..+....   ...  
T Consensus       152 ~dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~--  226 (267)
T PHA03390        152 CDYGLCKIIGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ---QKK--  226 (267)
T ss_pred             ecCccceecCCCccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh---ccc--
Confidence            9999754       347889999999998889999999999999999999999997543221   1111111   000  


Q ss_pred             hccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCC-HHHHHH
Q 047719          502 AADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPS-VKEAAR  542 (596)
Q Consensus       502 ~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs-~~ev~~  542 (596)
                             ..........+.+++..|++.+|.+||+ ++|+++
T Consensus       227 -------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        227 -------LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             -------CCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence                   0111134456778888999999999995 688864

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.7e-33  Score=286.71  Aligned_cols=235  Identities=19%  Similarity=0.252  Sum_probs=181.7

Q ss_pred             eeecCCceEEEEEEcC-CCCEEEEEEeecCCchh-cccchHHHHHH--HHHhccCCCceeeecceeeeCCeEEEEEecCC
Q 047719          291 IVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVE-CARNPFTTEFA--TMAGCLRHKNLVQLQGWCCEGNELVLVYEYLP  366 (596)
Q Consensus       291 ~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~-~~~~~~~~E~~--~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~~  366 (596)
                      +||+|+||.||++... +++.||+|.+.+..... .....+..|..  .+.+...||||+++++++...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999764 48899999986543221 11122333332  23333679999999999999999999999999


Q ss_pred             CCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc--------
Q 047719          367 NGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI--------  438 (596)
Q Consensus       367 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~--------  438 (596)
                      +|+|.+++....    .+++..+..++.|+++||+|||+   .+++||||||+||+++.++.+||+|||.+.        
T Consensus        81 g~~L~~~l~~~~----~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~~  153 (278)
T cd05606          81 GGDLHYHLSQHG----VFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH  153 (278)
T ss_pred             CCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCCc
Confidence            999999997543    48999999999999999999999   899999999999999999999999999754        


Q ss_pred             -cCCCcccCCccccccC-CCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHHHH
Q 047719          439 -PAGTMGYLAPEYVYSG-VPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEM  516 (596)
Q Consensus       439 -~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  516 (596)
                       ..|+..|+|||.+.++ .++.++|||||||++|||++|+.||.................      ...    ..+....
T Consensus       154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~------~~~----~~~~~~s  223 (278)
T cd05606         154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT------MAV----ELPDSFS  223 (278)
T ss_pred             CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc------cCC----CCCCcCC
Confidence             2478999999998754 689999999999999999999999976422111111111110      011    1122224


Q ss_pred             HHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 047719          517 ERMLMVGLSCVHPNHEKRP-----SVKEAAR  542 (596)
Q Consensus       517 ~~l~~l~~~C~~~dp~~RP-----s~~ev~~  542 (596)
                      ..+.+++..|++.+|++||     ++.++++
T Consensus       224 ~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         224 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             HHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            5677888899999999999     8988875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.6e-33  Score=288.41  Aligned_cols=238  Identities=27%  Similarity=0.315  Sum_probs=191.7

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      ++|...+.||+|+||.||++... +++.||+|++.+.... ......+.+|++.+. .++||||+++++++......++|
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~~v   79 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQ-SIRHPFLVNLYGSFQDDSNLYLV   79 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHH-hCCCCCccceeeEEEcCCeEEEE
Confidence            35778899999999999999865 4889999998643322 123455778886554 48999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc--
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP--  439 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~--  439 (596)
                      |||+++++|.+++....    .+++..+..++.|++.||.|||+   .+++|+||+|+|||++.++.+||+|||++..  
T Consensus        80 ~e~~~~~~L~~~~~~~~----~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~  152 (290)
T cd05580          80 MEYVPGGELFSHLRKSG----RFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVK  152 (290)
T ss_pred             EecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccC
Confidence            99999999999997653    48899999999999999999999   8999999999999999999999999997643  


Q ss_pred             ------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCH
Q 047719          440 ------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNR  513 (596)
Q Consensus       440 ------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  513 (596)
                            .|+..|+|||.+.+...+.++||||||+++|||++|+.||......   ........+..          .++.
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~----------~~~~  219 (290)
T cd05580         153 GRTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI---QIYEKILEGKV----------RFPS  219 (290)
T ss_pred             CCCCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHhcCCc----------cCCc
Confidence                  4788999999998888899999999999999999999999765321   11111111110          1112


Q ss_pred             HHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 047719          514 KEMERMLMVGLSCVHPNHEKRP-----SVKEAAR  542 (596)
Q Consensus       514 ~~~~~l~~l~~~C~~~dp~~RP-----s~~ev~~  542 (596)
                      .....+.+++.+||+.||.+||     +++|+++
T Consensus       220 ~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         220 FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             cCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence            2245667788899999999999     6666653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1e-33  Score=288.23  Aligned_cols=251  Identities=24%  Similarity=0.323  Sum_probs=189.5

Q ss_pred             CCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          285 GFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      +|+..+.||.|++|.||+|+.. +|..||||+++.... ......+.+|+..+.+ ++|+||+++++++...+..++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~e   78 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKE-LKHENIVRLHDVIHTENKLMLVFE   78 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHh-hcCCCEeeeeeeEeeCCcEEEEEe
Confidence            4777899999999999999876 488999999865432 2233456778865554 899999999999999999999999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc-----
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI-----  438 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~-----  438 (596)
                      |+++ +|.+++..... ...+++..+..++.|+++||.|||+   .+++||||||+||++++++.++|+|||.+.     
T Consensus        79 ~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~  153 (284)
T cd07836          79 YMDK-DLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP  153 (284)
T ss_pred             cCCc-cHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC
Confidence            9985 89999876542 2358999999999999999999999   899999999999999999999999998764     


Q ss_pred             ------cCCCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCCh-hHHHHHHHHHhcCC--------chhh
Q 047719          439 ------PAGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGC-VIVDWVWNLRKKGK--------LLDA  502 (596)
Q Consensus       439 ------~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~-~~~~~~~~~~~~~~--------~~~~  502 (596)
                            ..++..|++||.+.+ ..++.++|||||||++|||++|+.||..... ....-.........        ....
T Consensus       154 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07836         154 VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE  233 (284)
T ss_pred             ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence                  235778999998865 4578999999999999999999999976432 11110000000000        0000


Q ss_pred             cccccc-------CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          503 ADFRLR-------GKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       503 ~d~~l~-------~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ......       ..........+.+++..|++.||.+||++.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            000000       0011122355678889999999999999999875

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.9e-33  Score=289.07  Aligned_cols=253  Identities=25%  Similarity=0.298  Sum_probs=190.2

Q ss_pred             HHhcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCC---
Q 047719          281 QATLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGN---  356 (596)
Q Consensus       281 ~at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~---  356 (596)
                      .+.++|...+.||+|+||.||+|... +++.||||+++...........+.+|+..+. .++||||+++++++.+..   
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~-~l~h~~i~~~~~~~~~~~~~~   82 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILR-QLNHRNIVNLKEIVTDKQDAL   82 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHH-hCCCCCeeeeeheecCcchhh
Confidence            45677888999999999999999876 4889999999754433333445677885554 489999999999987655   


Q ss_pred             -------eEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCce
Q 047719          357 -------ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNA  429 (596)
Q Consensus       357 -------~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~  429 (596)
                             .+++|+||+++ +|.+.+....   ..+++..+..++.||+.||+|||+   .+++||||||+||++++++.+
T Consensus        83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~  155 (302)
T cd07864          83 DFKKDKGAFYLVFEYMDH-DLMGLLESGL---VHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQI  155 (302)
T ss_pred             hccccCCcEEEEEcccCc-cHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcE
Confidence                   79999999976 7878776542   258999999999999999999999   899999999999999999999


Q ss_pred             EEccCCCccc------------CCCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCCh-hHHHHHHHHHh
Q 047719          430 KLGDFEATIP------------AGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGC-VIVDWVWNLRK  495 (596)
Q Consensus       430 kl~Dfg~~~~------------~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~-~~~~~~~~~~~  495 (596)
                      ||+|||.+..            .++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... .....+.....
T Consensus       156 kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~  235 (302)
T cd07864         156 KLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCG  235 (302)
T ss_pred             EeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            9999987642            23567999998865 4578999999999999999999999976432 11111111111


Q ss_pred             cCCch---hh--------ccc------cccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          496 KGKLL---DA--------ADF------RLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       496 ~~~~~---~~--------~d~------~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      .....   +.        .+.      ...... ......+.+++..||+.+|.+||+++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             CCChhhcccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            11000   00        000      000000 012356788889999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.6e-33  Score=288.76  Aligned_cols=250  Identities=22%  Similarity=0.281  Sum_probs=187.9

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      ++|...+.||+|++|.||+|... +++.||+|++............+.+|+..+.+ ++|+||+++++++......++||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~   80 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKE-MQHGNIVRLQDVVHSEKRLYLVF   80 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHh-ccCCCEeeEEEEEecCCeEEEEE
Confidence            46788899999999999999875 58899999986543333334567888866655 89999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecC-CCceEEccCCCccc--
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDA-EFNAKLGDFEATIP--  439 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~-~~~~kl~Dfg~~~~--  439 (596)
                      ||++ ++|.+++....  ...+++.....++.||+.||+|||+   .+++||||||+||+++. ++.+||+|||++..  
T Consensus        81 e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~  154 (294)
T PLN00009         81 EYLD-LDLKKHMDSSP--DFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG  154 (294)
T ss_pred             eccc-ccHHHHHHhCC--CCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence            9996 58888886543  2236788888999999999999999   89999999999999985 56799999997642  


Q ss_pred             ---------CCCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHH---HhcCC--------
Q 047719          440 ---------AGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNL---RKKGK--------  498 (596)
Q Consensus       440 ---------~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~---~~~~~--------  498 (596)
                               .++..|+|||.+.+ ..++.++|||||||++|||++|+.||......  +-..+.   .....        
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  232 (294)
T PLN00009        155 IPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI--DELFKIFRILGTPNEETWPGVT  232 (294)
T ss_pred             CCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCChhhccccc
Confidence                     34678999998866 45789999999999999999999999764321  111111   00000        


Q ss_pred             -chhhc--cccccC----cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          499 -LLDAA--DFRLRG----KFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       499 -~~~~~--d~~l~~----~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                       +.+..  .+....    .........+.+++.+|++.+|++||++.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             cchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence             00000  000000    001122345678889999999999999999986

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-33  Score=296.32  Aligned_cols=254  Identities=23%  Similarity=0.310  Sum_probs=189.8

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeC------C
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG------N  356 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~------~  356 (596)
                      .+|...+.||+|+||.||+|... +|+.||||++.+....+.....+.+|+..+. .++|+||+++++++...      .
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLK-HMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHH-hcCCCCccchhheecccccCCCCc
Confidence            67888899999999999999864 5899999998654333333445778886555 48999999999998754      3


Q ss_pred             eEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCC
Q 047719          357 ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEA  436 (596)
Q Consensus       357 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~  436 (596)
                      ..++|+||+.. +|..++..      .+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+
T Consensus        94 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~  163 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIMGH------PLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGL  163 (342)
T ss_pred             eEEEEeccccc-CHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCC
Confidence            56999999964 77776531      37899999999999999999999   8999999999999999999999999997


Q ss_pred             ccc--------CCCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhc-----------
Q 047719          437 TIP--------AGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKK-----------  496 (596)
Q Consensus       437 ~~~--------~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~-----------  496 (596)
                      +..        .++..|+|||.+.+ ..++.++|||||||++|||++|+.||......  .-.......           
T Consensus       164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~  241 (342)
T cd07879         164 ARHADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL--DQLTQILKVTGVPGPEFVQK  241 (342)
T ss_pred             CcCCCCCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCCCHHHHHH
Confidence            643        35778999999876 46899999999999999999999999864321  111111100           


Q ss_pred             ---CCchhhcc--cc-ccCcCC---HHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhcCCCC
Q 047719          497 ---GKLLDAAD--FR-LRGKFN---RKEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKGEAPL  550 (596)
Q Consensus       497 ---~~~~~~~d--~~-l~~~~~---~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~~~~~~  550 (596)
                         ........  +. ......   ......+.+++..|++.||++||+++++++  +++...+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~  306 (342)
T cd07879         242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA  306 (342)
T ss_pred             hcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence               00000000  00 000000   012345678899999999999999999985  56655443

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.2e-33  Score=282.43  Aligned_cols=242  Identities=26%  Similarity=0.385  Sum_probs=196.6

Q ss_pred             CCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          285 GFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      +|...+.||+|+||.||++... ++..+|+|++...........++..|++.+.. ++|+|++++++.+......++|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~-l~~~~~~~~~~~~~~~~~~~lv~e   79 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKK-LNHPNIIKYYESFEEKGKLCIVME   79 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHh-cCCCChhheEEEEecCCEEEEEEE
Confidence            4667789999999999999875 48899999997544433455567888866554 899999999999999999999999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc----
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP----  439 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~----  439 (596)
                      |+++++|.+++.........+++.++..++.+++.||.|||+   .+++|+||+|+||+++.++.++|+|||.+..    
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  156 (258)
T cd08215          80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST  156 (258)
T ss_pred             ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence            999999999998754323469999999999999999999999   8999999999999999999999999986543    


Q ss_pred             -------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCC
Q 047719          440 -------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFN  512 (596)
Q Consensus       440 -------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  512 (596)
                             .|+..|+|||.+....++.++||||||+++|+|++|+.||...+.  .+...... ....         ...+
T Consensus       157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~--~~~~~~~~-~~~~---------~~~~  224 (258)
T cd08215         157 VDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL--LELALKIL-KGQY---------PPIP  224 (258)
T ss_pred             cceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH--HHHHHHHh-cCCC---------CCCC
Confidence                   367789999999888899999999999999999999999976532  11111111 1111         1111


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          513 RKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       513 ~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ......+.+++.+|++.+|++||++.|+++
T Consensus       225 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         225 SQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            123356778889999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2.6e-33  Score=288.85  Aligned_cols=251  Identities=21%  Similarity=0.255  Sum_probs=185.5

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCC------
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGN------  356 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~------  356 (596)
                      ++|...+.||+|+||.||++... +++.||||++......+.....+.+|+..+. .++||||++++++|....      
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQ-LLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHH-hCCCCCccceEEEEecccccccCC
Confidence            35888899999999999999875 5889999998654333333334567885554 489999999999987654      


Q ss_pred             --eEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccC
Q 047719          357 --ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF  434 (596)
Q Consensus       357 --~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Df  434 (596)
                        ..++||||+.+ +|.+++....   ..+++.+.+.++.||++||+|||+   .+++|+||||+||+++.++.+||+||
T Consensus        91 ~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~df  163 (310)
T cd07865          91 KGSFYLVFEFCEH-DLAGLLSNKN---VKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADF  163 (310)
T ss_pred             CceEEEEEcCCCc-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcC
Confidence              45999999964 8888886542   248999999999999999999999   89999999999999999999999999


Q ss_pred             CCccc---------------CCCcccCCccccccC-CCCCccceeehhHHHHHHHhCCCCCCCCChh-HHHHHHHHHhc-
Q 047719          435 EATIP---------------AGTMGYLAPEYVYSG-VPSEKTDVYSFGVVALEVAAGKSPVDNDGCV-IVDWVWNLRKK-  496 (596)
Q Consensus       435 g~~~~---------------~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~El~tG~~p~~~~~~~-~~~~~~~~~~~-  496 (596)
                      |.+..               .++..|+|||.+.+. .++.++||||||+++|||++|+.||...... ....+...... 
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~  243 (310)
T cd07865         164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI  243 (310)
T ss_pred             CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            86532               246679999988664 4788999999999999999999999765321 11111111100 


Q ss_pred             -------CCchhhccc-cccCcCC---------HHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          497 -------GKLLDAADF-RLRGKFN---------RKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       497 -------~~~~~~~d~-~l~~~~~---------~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                             ....+..+. .......         ......+.+++.+|++.||++|||++|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence                   000000000 0000000         001235568999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-33  Score=286.66  Aligned_cols=249  Identities=25%  Similarity=0.268  Sum_probs=188.4

Q ss_pred             CCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCchhcccchHHHHHHHHHh--ccCCCceeeecceeeeCCe-----
Q 047719          286 FNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRVECARNPFTTEFATMAG--CLRHKNLVQLQGWCCEGNE-----  357 (596)
Q Consensus       286 f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~--~l~H~niv~l~g~~~~~~~-----  357 (596)
                      |...+.||+|+||.||+|.... ++.||+|+++.....+.....+.+|+..+..  .++|+|++++++++.....     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            4567899999999999998865 8999999997543322223345567644432  2469999999999998776     


Q ss_pred             EEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCc
Q 047719          358 LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT  437 (596)
Q Consensus       358 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~  437 (596)
                      .+++|||++ ++|.+++.....  ..+++..++.++.|++.||.|||+   .+++|+||+|+||+++.++.+||+|||.+
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~~--~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~  154 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCPK--PGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLA  154 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCcc
Confidence            999999997 489999876542  248999999999999999999999   89999999999999999999999999875


Q ss_pred             cc----------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCc--------
Q 047719          438 IP----------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKL--------  499 (596)
Q Consensus       438 ~~----------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~--------  499 (596)
                      ..          .++..|+|||.+.+..++.++|+|||||++|||++|++||.....  .+...........        
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07838         155 RIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE--ADQLDKIFDVIGLPSEEEWPR  232 (287)
T ss_pred             eeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh--HHHHHHHHHHcCCCChHhcCC
Confidence            33          367789999999988899999999999999999999999876432  1111111110000        


Q ss_pred             -----hhhcccccc---CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          500 -----LDAADFRLR---GKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       500 -----~~~~d~~l~---~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                           .........   .....+....+.+++..||+.||++||+++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence                 000000000   1111233466778999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=3.6e-33  Score=288.50  Aligned_cols=252  Identities=26%  Similarity=0.324  Sum_probs=187.9

Q ss_pred             hcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeC--CeEE
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG--NELV  359 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~--~~~~  359 (596)
                      ..+|...+.||+|+||.||+|... +|+.||+|+++...........+.+|+..+.+ ++|+||+++++++...  +..+
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~-l~h~~i~~~~~~~~~~~~~~~~   84 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLN-LRHPNIVELKEVVVGKHLDSIF   84 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHh-CCCCCCcceEEEEecCCCCeEE
Confidence            356888899999999999999875 48999999986543333333346678866654 9999999999998765  5689


Q ss_pred             EEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc
Q 047719          360 LVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP  439 (596)
Q Consensus       360 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~  439 (596)
                      +||||+. ++|.+++....   ..+++.++..++.||+.||+|||+   .+++||||||+||+++.++.+||+|||.+..
T Consensus        85 lv~e~~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~  157 (309)
T cd07845          85 LVMEYCE-QDLASLLDNMP---TPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLART  157 (309)
T ss_pred             EEEecCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeee
Confidence            9999996 48998887643   358999999999999999999999   8999999999999999999999999987643


Q ss_pred             C-----------CCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCChh-HHHHHHHHHhcC--Cc-----
Q 047719          440 A-----------GTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV-IVDWVWNLRKKG--KL-----  499 (596)
Q Consensus       440 ~-----------gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~-~~~~~~~~~~~~--~~-----  499 (596)
                      .           ++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ...-+.......  ..     
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07845         158 YGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS  237 (309)
T ss_pred             cCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence            2           3567999998865 45799999999999999999999999764321 111111110000  00     


Q ss_pred             --hhhccccccCc-C------CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          500 --LDAADFRLRGK-F------NRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       500 --~~~~d~~l~~~-~------~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                        .......+... .      .......+.+++..|++.||++|||++++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence              00000000000 0      0012345678889999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-33  Score=287.05  Aligned_cols=249  Identities=25%  Similarity=0.333  Sum_probs=189.0

Q ss_pred             CCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeC--CeEEEEE
Q 047719          286 FNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG--NELVLVY  362 (596)
Q Consensus       286 f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~--~~~~lV~  362 (596)
                      |...+.||+|+||.||+|...+ ++.+|+|++............+.+|+..+.. ++|+|++++++++...  +..++|+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~~~~~~~lv~   79 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQK-LRHPNIVRLKEIVTSKGKGSIYMVF   79 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHh-ccCCCeeeheeeEecCCCCcEEEEe
Confidence            4566889999999999998764 8899999997654233334567888866554 8999999999999988  8999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc---
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP---  439 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~---  439 (596)
                      ||+++ +|.+++....   ..+++..++.++.||++||+|||+   .+++|+||||+||++++++.+||+|||.+..   
T Consensus        80 e~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~  152 (287)
T cd07840          80 EYMDH-DLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTK  152 (287)
T ss_pred             ccccc-cHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccC
Confidence            99975 8999987642   258999999999999999999999   8999999999999999999999999986532   


Q ss_pred             ---------CCCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCChh-HHHHHHHHHhcCCch------h-
Q 047719          440 ---------AGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV-IVDWVWNLRKKGKLL------D-  501 (596)
Q Consensus       440 ---------~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~-~~~~~~~~~~~~~~~------~-  501 (596)
                               .++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ...............      . 
T Consensus       153 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07840         153 RNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL  232 (287)
T ss_pred             CCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccc
Confidence                     34677999998765 46799999999999999999999999765321 111111110000000      0 


Q ss_pred             ----------hccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          502 ----------AADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       502 ----------~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                                .....+...+...+...+.+++..|++.+|++||+++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                      00000001111112567788999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=3.1e-33  Score=281.42  Aligned_cols=234  Identities=24%  Similarity=0.267  Sum_probs=188.0

Q ss_pred             eecCCceEEEEEEcCC-CCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecCCCCC
Q 047719          292 VGEGASATVYKGSLPS-GGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGS  369 (596)
Q Consensus       292 LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  369 (596)
                      ||.|+||.||++.... ++.+|+|++.+.... ....+.+.+|+..+ +.++|+||+++++.+.++...++|+||+++++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEIL-EECNHPFIVKLYRTFKDKKYIYMLMEYCLGGE   79 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHH-HhCCCCCEeeeeeeEEcCCccEEEEecCCCCc
Confidence            6999999999998764 889999999754332 23345678888555 45899999999999999999999999999999


Q ss_pred             HHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc----------
Q 047719          370 LDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP----------  439 (596)
Q Consensus       370 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~----------  439 (596)
                      |.+++....    .+++..+..++.||+.||+|||+   .+++|+||||+||+++.++.+||+|||.+..          
T Consensus        80 L~~~l~~~~----~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~  152 (262)
T cd05572          80 LWTILRDRG----LFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTF  152 (262)
T ss_pred             HHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccc
Confidence            999998653    38899999999999999999999   8999999999999999999999999987542          


Q ss_pred             CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHHHHHHH
Q 047719          440 AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERM  519 (596)
Q Consensus       440 ~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l  519 (596)
                      .|+..|++||.+....++.++|+||||+++|||++|..||........+.........         ....++......+
T Consensus       153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~  223 (262)
T cd05572         153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGN---------GKLEFPNYIDKAA  223 (262)
T ss_pred             cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccC---------CCCCCCcccCHHH
Confidence            3677899999998888999999999999999999999999765422222221111101         1112222234577


Q ss_pred             HHHHHHcCCCCCCCCCC-----HHHHHH
Q 047719          520 LMVGLSCVHPNHEKRPS-----VKEAAR  542 (596)
Q Consensus       520 ~~l~~~C~~~dp~~RPs-----~~ev~~  542 (596)
                      ..++..||+.+|++||+     ++|+++
T Consensus       224 ~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         224 KDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             HHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            88889999999999999     666655

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.6e-33  Score=289.21  Aligned_cols=243  Identities=25%  Similarity=0.358  Sum_probs=188.0

Q ss_pred             cCCCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      ++|...+.||+|+||.||+|.... ++.||||++++.... ....++..|+..+.+...|+||++++++|.+....|++|
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            456778999999999999998865 889999999754322 233456677766666556999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc---
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP---  439 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~---  439 (596)
                      ||++ ++|.+++....   ..+++..+..++.|++.||+|||+.  .+++||||+|+||++++++.+||+|||.+..   
T Consensus        94 e~~~-~~l~~l~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~  167 (296)
T cd06618          94 ELMS-TCLDKLLKRIQ---GPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD  167 (296)
T ss_pred             eccC-cCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence            9985 47877776532   2589999999999999999999972  5899999999999999999999999997642   


Q ss_pred             -------CCCcccCCccccccCC----CCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhcccccc
Q 047719          440 -------AGTMGYLAPEYVYSGV----PSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLR  508 (596)
Q Consensus       440 -------~gt~~y~aPE~~~~~~----~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  508 (596)
                             .++..|+|||.+....    ++.++||||||+++|||++|+.||...... .+........ ....     ..
T Consensus       168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~-~~~~-----~~  240 (296)
T cd06618         168 SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-FEVLTKILQE-EPPS-----LP  240 (296)
T ss_pred             CCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-HHHHHHHhcC-CCCC-----CC
Confidence                   2567899999987543    789999999999999999999999753221 1111111111 1000     00


Q ss_pred             CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          509 GKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       509 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                        ........+.+++.+||+.||++||+++++++
T Consensus       241 --~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  272 (296)
T cd06618         241 --PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ  272 (296)
T ss_pred             --CCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence              00112346788889999999999999999976

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-36  Score=280.16  Aligned_cols=242  Identities=24%  Similarity=0.281  Sum_probs=193.6

Q ss_pred             hcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      ++.|+..++||+|.|+.||+.... +|+.+|+|.+..........+++.+|+ .+.+.++|||||+|...+.+....|||
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEa-rIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREA-RICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHH-HHHHhcCCCcEeehhhhhcccceeEEE
Confidence            345666789999999999998654 589999998875555555666777887 555679999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCC---CceEEccCCCcc
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAE---FNAKLGDFEATI  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~---~~~kl~Dfg~~~  438 (596)
                      +|+|.+++|..-|-.+    ...++...-..+.||+++|.|+|.   ++|||||+||+|+||.+.   --+||+|||++.
T Consensus        89 Fe~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi  161 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAI  161 (355)
T ss_pred             EecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEE
Confidence            9999999998766543    257788889999999999999999   999999999999999654   459999999764


Q ss_pred             ----------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCCh-hHHHHHHHHHhcCCchhhccccc
Q 047719          439 ----------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGC-VIVDWVWNLRKKGKLLDAADFRL  507 (596)
Q Consensus       439 ----------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l  507 (596)
                                .+||++|||||.+...+|+..+|||+-||+||-|+.|++||.+.+. .+.    +....+..      ..
T Consensus       162 ~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rly----e~I~~g~y------d~  231 (355)
T KOG0033|consen  162 EVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY----EQIKAGAY------DY  231 (355)
T ss_pred             EeCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHH----HHHhcccc------CC
Confidence                      3599999999999999999999999999999999999999987432 121    11112211      11


Q ss_pred             cCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          508 RGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       508 ~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      .+.+-....+...+|+.+++..||++|.|+.|++.
T Consensus       232 ~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  232 PSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             CCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence            22222334455667788899999999999988765

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-33  Score=294.77  Aligned_cols=254  Identities=20%  Similarity=0.277  Sum_probs=188.8

Q ss_pred             hcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeC-----C
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG-----N  356 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~-----~  356 (596)
                      +++|...+.||+|+||.||+|... +|+.||||++.... .......+..|+..+. .++|+||+++++++...     .
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~~~   81 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILR-RFKHENIIGILDIIRPPSFESFN   81 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHH-hCCCCCcCchhheeecccccccc
Confidence            467888999999999999999754 58999999985322 1223445778886555 48999999999987654     3


Q ss_pred             eEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCC
Q 047719          357 ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEA  436 (596)
Q Consensus       357 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~  436 (596)
                      ..++|+||+++ +|.+++...     .+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+
T Consensus        82 ~~~lv~e~~~~-~l~~~~~~~-----~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~  152 (336)
T cd07849          82 DVYIVQELMET-DLYKLIKTQ-----HLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGL  152 (336)
T ss_pred             eEEEEehhccc-CHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccc
Confidence            58999999974 888888653     38999999999999999999999   8999999999999999999999999997


Q ss_pred             ccc--------------CCCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCChh-HHHHHHHHHhcCCc-
Q 047719          437 TIP--------------AGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV-IVDWVWNLRKKGKL-  499 (596)
Q Consensus       437 ~~~--------------~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~-~~~~~~~~~~~~~~-  499 (596)
                      +..              .||..|+|||.+.+ ..++.++|||||||++|||++|+.||...+.. .............. 
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~  232 (336)
T cd07849         153 ARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQE  232 (336)
T ss_pred             eeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence            532              36788999998755 56899999999999999999999999764321 11111111110000 


Q ss_pred             --hhhcccc---------ccCcCC-----HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH--HhcC
Q 047719          500 --LDAADFR---------LRGKFN-----RKEMERMLMVGLSCVHPNHEKRPSVKEAARI--LKGE  547 (596)
Q Consensus       500 --~~~~d~~---------l~~~~~-----~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~--L~~~  547 (596)
                        ....+..         .....+     ......+.+++.+||+.+|++|||+.|+++.  ++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~  298 (336)
T cd07849         233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY  298 (336)
T ss_pred             HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence              0000000         000000     1123567889999999999999999999883  5443

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-33  Score=283.06  Aligned_cols=239  Identities=25%  Similarity=0.362  Sum_probs=189.2

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCc---hhcccchHHHHHHHHHhccCCCceeeecceeeeC--Ce
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNR---VECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG--NE  357 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~--~~  357 (596)
                      .+|...+.||+|+||.||+|... ++..||+|.+.....   .......+.+|+..+.+ ++|+||+++++++.+.  ..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~-l~h~~i~~~~~~~~~~~~~~   80 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKN-LRHDRIVQYYGCLRDPEEKK   80 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHH-cCCCCcceEEEEEEcCCCCE
Confidence            46888899999999999999865 488999999853221   12234567888866655 8999999999998764  46


Q ss_pred             EEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCc
Q 047719          358 LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT  437 (596)
Q Consensus       358 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~  437 (596)
                      +++++||+++++|.+++....    .+++.....++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||.+
T Consensus        81 ~~~v~e~~~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~  153 (264)
T cd06653          81 LSIFVEYMPGGSIKDQLKAYG----ALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGAS  153 (264)
T ss_pred             EEEEEEeCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECccccc
Confidence            899999999999999997643    37889999999999999999998   89999999999999999999999999876


Q ss_pred             c--------------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhc
Q 047719          438 I--------------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAA  503 (596)
Q Consensus       438 ~--------------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  503 (596)
                      .              ..++..|+|||.+.+..++.++|+|||||++|||++|+.||......  .-+.+....       
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~-------  224 (264)
T cd06653         154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM--AAIFKIATQ-------  224 (264)
T ss_pred             cccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH--HHHHHHHcC-------
Confidence            3              23678899999998888999999999999999999999999754211  111111111       


Q ss_pred             cccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          504 DFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       504 d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                        ......+......+.+++..|++ +|.+||+..+++.
T Consensus       225 --~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         225 --PTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             --CCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence              11122333444667788889999 5799999997754

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=6e-34  Score=302.25  Aligned_cols=189  Identities=28%  Similarity=0.347  Sum_probs=160.8

Q ss_pred             CCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccC-C-----CceeeecceeeeCCe
Q 047719          285 GFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLR-H-----KNLVQLQGWCCEGNE  357 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~-H-----~niv~l~g~~~~~~~  357 (596)
                      .|...++||+|.||.|-|+... +++.||||+++....   -..+-..|+..|.. ++ |     -|+|++++++...++
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~---f~~Q~~~Ei~iL~~-ln~~d~~~~~n~Vrm~d~F~fr~H  262 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR---FLRQAQIEIRILEL-LNKHDPDDKYNIVRMLDYFYFRNH  262 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH---HHHHHHHHHHHHHH-HhccCCCCCeeEEEeeeccccccc
Confidence            5778899999999999999765 589999999964322   22334566655544 44 3     589999999999999


Q ss_pred             EEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCC--CceEEccCC
Q 047719          358 LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAE--FNAKLGDFE  435 (596)
Q Consensus       358 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~--~~~kl~Dfg  435 (596)
                      +|||+|.+.. +|+++|+.+.-  ..++......++.||+.||.+||+   .+|||+||||+||||.+-  ..+||+|||
T Consensus       263 lciVfELL~~-NLYellK~n~f--~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFG  336 (586)
T KOG0667|consen  263 LCIVFELLST-NLYELLKNNKF--RGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFG  336 (586)
T ss_pred             eeeeehhhhh-hHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEecc
Confidence            9999999954 99999998763  348899999999999999999998   999999999999999653  479999999


Q ss_pred             CcccC--------CCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCC
Q 047719          436 ATIPA--------GTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDG  483 (596)
Q Consensus       436 ~~~~~--------gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~  483 (596)
                      .+...        -+..|.|||++.+.+|+.+.||||||||+.||++|.+.|.++.
T Consensus       337 SSc~~~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n  392 (586)
T KOG0667|consen  337 SSCFESQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN  392 (586)
T ss_pred             cccccCCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence            87654        4567999999999999999999999999999999998888764

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-33  Score=278.57  Aligned_cols=238  Identities=26%  Similarity=0.401  Sum_probs=193.9

Q ss_pred             CCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          285 GFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      +|...+.||+|++|.||++... +++.||+|.+......+.....+.+|++.+.+ ++|+|++++++++......++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~~~~~~v~e   79 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKN-LKHPNIVKYIGSIETSDSLYIILE   79 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHh-CCCCCccEEEEEEEeCCEEEEEEe
Confidence            3667789999999999999765 47899999997654433455678888866654 899999999999999999999999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc-----
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI-----  438 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~-----  438 (596)
                      |+++++|.+++....    .+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||.+.     
T Consensus        80 ~~~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  152 (254)
T cd06627          80 YAENGSLRQIIKKFG----PFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDV  152 (254)
T ss_pred             cCCCCcHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence            999999999997653    48999999999999999999998   899999999999999999999999998654     


Q ss_pred             ------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCC
Q 047719          439 ------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFN  512 (596)
Q Consensus       439 ------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  512 (596)
                            ..++..|+|||......++.++||||||+++|||++|+.|+.........  +.... ..         ....+
T Consensus       153 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~--~~~~~-~~---------~~~~~  220 (254)
T cd06627         153 SKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAAL--FRIVQ-DD---------HPPLP  220 (254)
T ss_pred             cccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHH--HHHhc-cC---------CCCCC
Confidence                  24677899999998877899999999999999999999999764321111  11111 10         11112


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          513 RKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       513 ~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ......+..++.+|++.+|++||++.+++.
T Consensus       221 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         221 EGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            223456678889999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.3e-33  Score=293.89  Aligned_cols=255  Identities=21%  Similarity=0.267  Sum_probs=191.4

Q ss_pred             hcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeC-----C
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG-----N  356 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~-----~  356 (596)
                      .+.|...+.||+|+||.||++... +++.||||.+............+.+|+..+.. ++|+||+++++++...     .
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~-l~h~ni~~~~~~~~~~~~~~~~   82 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRH-LDHENVIAIKDIMPPPHREAFN   82 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHh-cCCCCccchHHheecccccccC
Confidence            346888899999999999999764 58999999986543333334567788865554 8999999999988654     3


Q ss_pred             eEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCC
Q 047719          357 ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEA  436 (596)
Q Consensus       357 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~  436 (596)
                      ..|+||||+. ++|.+++....    .+++.....++.|++.||.|||+   .+++||||||+||+++.++.+||+|||+
T Consensus        83 ~~~lv~e~~~-~~L~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~  154 (337)
T cd07858          83 DVYIVYELMD-TDLHQIIRSSQ----TLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGL  154 (337)
T ss_pred             cEEEEEeCCC-CCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCcc
Confidence            5899999996 68999987543    48899999999999999999999   8999999999999999999999999997


Q ss_pred             ccc-----------CCCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCChh-HHHHHHHHHh--------
Q 047719          437 TIP-----------AGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV-IVDWVWNLRK--------  495 (596)
Q Consensus       437 ~~~-----------~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~-~~~~~~~~~~--------  495 (596)
                      +..           .++..|+|||.+.. ..++.++|||||||++|||++|+.||...+.. ..........        
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  234 (337)
T cd07858         155 ARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG  234 (337)
T ss_pred             ccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence            643           36778999998865 46899999999999999999999999764321 0000111000        


Q ss_pred             ---cCCchhh-------ccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH--HhcC
Q 047719          496 ---KGKLLDA-------ADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARI--LKGE  547 (596)
Q Consensus       496 ---~~~~~~~-------~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~--L~~~  547 (596)
                         .......       .+.... .........+.+++.+|++.+|++|||++++++.  ++..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         235 FIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             hcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence               0000000       000000 0011234567889999999999999999999874  5543

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=3.4e-33  Score=289.07  Aligned_cols=246  Identities=22%  Similarity=0.282  Sum_probs=185.7

Q ss_pred             cceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecCCCC
Q 047719          289 NRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNG  368 (596)
Q Consensus       289 ~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  368 (596)
                      .+.+|.|+++.||++.. +++.||||++............+..|+..+.. ++|+||+++++++.+....+++|||+++|
T Consensus         7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~-l~h~~i~~~~~~~~~~~~~~~~~e~~~~~   84 (314)
T cd08216           7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQ-LQHPNILPYVTSFIVDSELYVVSPLMAYG   84 (314)
T ss_pred             hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHh-cCCcchhhhhheeecCCeEEEEEeccCCC
Confidence            34556666777777665 68999999997543334455678889866655 89999999999999999999999999999


Q ss_pred             CHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc----------
Q 047719          369 SLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI----------  438 (596)
Q Consensus       369 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~----------  438 (596)
                      +|.+++.....  ..+++.....++.|+++||+|||+   .+|+||||||+||+++.++.+||+||+.+.          
T Consensus        85 ~l~~~l~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~  159 (314)
T cd08216          85 SCEDLLKTHFP--EGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR  159 (314)
T ss_pred             CHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence            99999986532  247889999999999999999999   899999999999999999999999998542          


Q ss_pred             --------cCCCcccCCcccccc--CCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhc------------
Q 047719          439 --------PAGTMGYLAPEYVYS--GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKK------------  496 (596)
Q Consensus       439 --------~~gt~~y~aPE~~~~--~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~------------  496 (596)
                              ..++..|+|||.+..  ..++.++|||||||++|||++|+.||....... .........            
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  238 (314)
T cd08216         160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ-MLLEKVRGTVPCLLDKSTYPL  238 (314)
T ss_pred             ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhccCccccccCchhh
Confidence                    125668999999876  358899999999999999999999997643211 000000000            


Q ss_pred             --CCchh----hccc----cccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          497 --GKLLD----AADF----RLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       497 --~~~~~----~~d~----~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                        .....    ..+.    .............+.+++..||+.||++|||++++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence              00000    0000    0111122233456788999999999999999999977

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-35  Score=295.61  Aligned_cols=239  Identities=23%  Similarity=0.261  Sum_probs=192.1

Q ss_pred             hcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEE
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVL  360 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~l  360 (596)
                      .+.|..-++||+||||.||-++.+ +|+.+|.|++.+.... ...+...++|- .++.+++.+.||.|-..+..++.+||
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk-~iL~kV~s~FiVslaYAfeTkd~LCl  262 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEK-QILEKVSSPFIVSLAYAFETKDALCL  262 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHH-HHHHHhccCcEEEEeeeecCCCceEE
Confidence            345888899999999999999776 4899999998654332 23444556676 44455899999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc--
Q 047719          361 VYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI--  438 (596)
Q Consensus       361 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~--  438 (596)
                      |+..|.||+|.-||.+.+.  ..+++...+-.+.+|+.||++||.   .+||.||+||+|||||+.|+++|+|.|++.  
T Consensus       263 VLtlMNGGDLkfHiyn~g~--~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei  337 (591)
T KOG0986|consen  263 VLTLMNGGDLKFHIYNHGN--PGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEI  337 (591)
T ss_pred             EEEeecCCceeEEeeccCC--CCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEec
Confidence            9999999999999988763  459999999999999999999999   899999999999999999999999999863  


Q ss_pred             --------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHH-HHHHHHhcCCchhhccccccC
Q 047719          439 --------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVD-WVWNLRKKGKLLDAADFRLRG  509 (596)
Q Consensus       439 --------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~d~~l~~  509 (596)
                              .+||.+|||||++..+.|+...|+||+||+||||+.|+.||.....-... -+.+....          -..
T Consensus       338 ~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~----------~~~  407 (591)
T KOG0986|consen  338 PEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE----------DPE  407 (591)
T ss_pred             CCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc----------chh
Confidence                    36999999999999999999999999999999999999999764321110 11111111          112


Q ss_pred             cCCHHHHHHHHHHHHHcCCCCCCCCCCH
Q 047719          510 KFNRKEMERMLMVGLSCVHPNHEKRPSV  537 (596)
Q Consensus       510 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~  537 (596)
                      ++++...+....|....++.||++|...
T Consensus       408 ey~~kFS~eakslc~~LL~Kdp~~RLGc  435 (591)
T KOG0986|consen  408 EYSDKFSEEAKSLCEGLLTKDPEKRLGC  435 (591)
T ss_pred             hcccccCHHHHHHHHHHHccCHHHhccC
Confidence            3444445556666667779999998743

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.8e-33  Score=285.96  Aligned_cols=232  Identities=22%  Similarity=0.271  Sum_probs=182.4

Q ss_pred             eecCCceEEEEEEcC-CCCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecCCCCC
Q 047719          292 VGEGASATVYKGSLP-SGGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGS  369 (596)
Q Consensus       292 LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  369 (596)
                      ||+|+||+||++... +|+.||+|.+.+.... ......+..|+..+ +.++||||+++++.+...+..|+||||+++++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l-~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKIL-EKVSSRFIVSLAYAFETKDDLCLVMTLMNGGD   79 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHH-HhCCCCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence            689999999999765 5889999998653322 22344567788555 45899999999999999999999999999999


Q ss_pred             HHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc----------
Q 047719          370 LDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP----------  439 (596)
Q Consensus       370 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~----------  439 (596)
                      |.+++.....  ..+++.+++.++.|++.||.|||+   .+++||||+|+||+++.++.+||+|||.+..          
T Consensus        80 L~~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  154 (277)
T cd05577          80 LKYHIYNVGE--PGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR  154 (277)
T ss_pred             HHHHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccc
Confidence            9999986542  358999999999999999999999   8999999999999999999999999986532          


Q ss_pred             CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChh-HHHHHHHHHhcCCchhhccccccCcCCHHHHHH
Q 047719          440 AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV-IVDWVWNLRKKGKLLDAADFRLRGKFNRKEMER  518 (596)
Q Consensus       440 ~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~-~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~  518 (596)
                      .++..|+|||.+.+..++.++|||||||++|||++|+.||...... .......    ....      .....+......
T Consensus       155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----~~~~------~~~~~~~~~~~~  224 (277)
T cd05577         155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR----RTLE------MAVEYPDKFSPE  224 (277)
T ss_pred             cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh----cccc------ccccCCccCCHH
Confidence            3677899999998888999999999999999999999999764321 0010000    0000      011122223456


Q ss_pred             HHHHHHHcCCCCCCCCCCHHH
Q 047719          519 MLMVGLSCVHPNHEKRPSVKE  539 (596)
Q Consensus       519 l~~l~~~C~~~dp~~RPs~~e  539 (596)
                      +.+++..||+.+|++||+.++
T Consensus       225 ~~~li~~~l~~~p~~R~~~~~  245 (277)
T cd05577         225 AKDLCEALLQKDPEKRLGCRG  245 (277)
T ss_pred             HHHHHHHHccCChhHccCCCc
Confidence            678889999999999994444

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=2e-33  Score=294.24  Aligned_cols=250  Identities=25%  Similarity=0.331  Sum_probs=187.6

Q ss_pred             hcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhcc-CCCceeeecceeeeC--CeE
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCL-RHKNLVQLQGWCCEG--NEL  358 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l-~H~niv~l~g~~~~~--~~~  358 (596)
                      .++|...+.||+|+||.||+|... +++.+|||++............+..|+..+.+ + +|+||++++++|...  ...
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~-l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQE-LGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHH-hcCCCCccceeeeeccCCCceE
Confidence            456778899999999999999875 48899999986433333344567788866655 7 999999999998654  368


Q ss_pred             EEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc
Q 047719          359 VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI  438 (596)
Q Consensus       359 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~  438 (596)
                      ++||||++ ++|..++...     .++|..+..++.||+.||+|||+   .+++||||||+||+++.++.+||+|||.+.
T Consensus        85 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~  155 (337)
T cd07852          85 YLVFEYME-TDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLAR  155 (337)
T ss_pred             EEEecccc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence            99999997 5999998754     48899999999999999999999   899999999999999999999999998653


Q ss_pred             c----------------CCCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCChh-HHHHHHHHHh-----
Q 047719          439 P----------------AGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV-IVDWVWNLRK-----  495 (596)
Q Consensus       439 ~----------------~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~-~~~~~~~~~~-----  495 (596)
                      .                .|+..|+|||.+.. ..++.++|||||||++|||++|+.||...... ..........     
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  235 (337)
T cd07852         156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE  235 (337)
T ss_pred             ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            1                36778999998765 56789999999999999999999999754321 1000000000     


Q ss_pred             ---------cCCchhhcccccc---CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          496 ---------KGKLLDAADFRLR---GKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       496 ---------~~~~~~~~d~~l~---~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                               .....+.....-.   ..........+.+++.+||+.+|++|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~  294 (337)
T cd07852         236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE  294 (337)
T ss_pred             HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh
Confidence                     0000000000000   0000112456788899999999999999999987

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=3.9e-33  Score=277.27  Aligned_cols=238  Identities=28%  Similarity=0.429  Sum_probs=191.6

Q ss_pred             CCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEec
Q 047719          286 FNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEY  364 (596)
Q Consensus       286 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~  364 (596)
                      |...+.||+|++|.||++... ++..+++|++.....  .....+.+|+..+. .++|+|++++++++......++++||
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~l~~e~   78 (253)
T cd05122           2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILK-KCKHPNIVKYYGSYLKKDELWIVMEF   78 (253)
T ss_pred             ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHH-hCCCCCEeEEEEEEecCCeEEEEEec
Confidence            667789999999999999876 588999999965332  34456888886554 48999999999999999999999999


Q ss_pred             CCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc-----
Q 047719          365 LPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP-----  439 (596)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~-----  439 (596)
                      +++++|.+++....   ..+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||.+..     
T Consensus        79 ~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  152 (253)
T cd05122          79 CSGGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK  152 (253)
T ss_pred             CCCCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeeccccccccccc
Confidence            99999999997653   358999999999999999999999   8999999999999999999999999986533     


Q ss_pred             -----CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHH
Q 047719          440 -----AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRK  514 (596)
Q Consensus       440 -----~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  514 (596)
                           .++..|+|||.+....++.++||||||+++|||++|+.|+...+..  ........ .....     +..  ...
T Consensus       153 ~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~-~~~~~-----~~~--~~~  222 (253)
T cd05122         153 ARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM--KALFKIAT-NGPPG-----LRN--PEK  222 (253)
T ss_pred             cccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH--HHHHHHHh-cCCCC-----cCc--ccc
Confidence                 3567899999998888999999999999999999999999764211  11111111 10000     000  011


Q ss_pred             HHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          515 EMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       515 ~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ....+.+++..|++.||++|||+.++++
T Consensus       223 ~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         223 WSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             cCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1356778889999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.2e-34  Score=296.32  Aligned_cols=241  Identities=25%  Similarity=0.300  Sum_probs=194.1

Q ss_pred             cCCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      ..|+..++||+||.++||++...+.+.+|+|++.......+...-|.+|+..|.++-.|.+||+|++|-..++.+|+|||
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE  440 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME  440 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence            45777899999999999999987888899998865555566777899999888887779999999999999999999999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc-----
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI-----  438 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~-----  438 (596)
                      |= .-+|..+|+....  ....| .+..+..|++.++.++|.   .+|||.||||.|.|+- .|.+||+|||++.     
T Consensus       441 ~G-d~DL~kiL~k~~~--~~~~~-~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~D  512 (677)
T KOG0596|consen  441 CG-DIDLNKILKKKKS--IDPDW-FLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPD  512 (677)
T ss_pred             cc-cccHHHHHHhccC--CCchH-HHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEE-eeeEEeeeechhcccCcc
Confidence            75 4599999988753  23445 677889999999999999   8999999999999985 4789999999864     


Q ss_pred             --------cCCCcccCCccccccC-----------CCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCc
Q 047719          439 --------PAGTMGYLAPEYVYSG-----------VPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKL  499 (596)
Q Consensus       439 --------~~gt~~y~aPE~~~~~-----------~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~  499 (596)
                              .+||..||+||.+...           +.+.+|||||+|||||+|+.|++||......   |       .++
T Consensus       513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~---~-------aKl  582 (677)
T KOG0596|consen  513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ---I-------AKL  582 (677)
T ss_pred             ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH---H-------HHH
Confidence                    3599999999988531           2578999999999999999999999753211   1       122


Q ss_pred             hhhccccccCcCCHH-HHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          500 LDAADFRLRGKFNRK-EMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       500 ~~~~d~~l~~~~~~~-~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ..+.++....+|+.- .-..+++++..|++.||++||++.|+++
T Consensus       583 ~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  583 HAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             HhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            334444333333321 1122889999999999999999999987

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-33  Score=284.57  Aligned_cols=249  Identities=21%  Similarity=0.290  Sum_probs=187.4

Q ss_pred             CCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCchhcccchHHHHHHHHHhccC-CCceeeecceeeeCCeEEEEEe
Q 047719          286 FNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLR-HKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       286 f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~-H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      |...+.||+|+||.||+|...+ ++.||||++...... .......+|+..+.+ ++ |+|++++++++..++..++|||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~-~~~h~~i~~~~~~~~~~~~~~lv~e   78 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRK-LNEHPNIVKLKEVFRENDELYFVFE   78 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHh-ccCCCCchhHHHHhhcCCcEEEEEe
Confidence            4567889999999999998764 788999998643321 222334567766655 67 9999999999999999999999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc----
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP----  439 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~----  439 (596)
                      |+ +|+|.+++....  ...+++..+..++.|++++|.|||+   .+++|+||+|+||+++.++.++|+|||.+..    
T Consensus        79 ~~-~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~  152 (283)
T cd07830          79 YM-EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR  152 (283)
T ss_pred             cC-CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCC
Confidence            99 889999997654  2358999999999999999999999   8999999999999999999999999986532    


Q ss_pred             ------CCCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCChh-HHH-------------HHHHHHhcCC
Q 047719          440 ------AGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV-IVD-------------WVWNLRKKGK  498 (596)
Q Consensus       440 ------~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~-~~~-------------~~~~~~~~~~  498 (596)
                            .++..|+|||.+.. ..++.++|+||||+++|||++|+.||...... ...             |.........
T Consensus       153 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07830         153 PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK  232 (283)
T ss_pred             CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence                  36778999998754 56799999999999999999999999654321 000             1100000000


Q ss_pred             chhhcccccc---CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          499 LLDAADFRLR---GKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       499 ~~~~~d~~l~---~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ..........   ..........+.+++..||+.+|++|||++|++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            0000000000   0000111356889999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-35  Score=284.13  Aligned_cols=235  Identities=26%  Similarity=0.324  Sum_probs=195.8

Q ss_pred             CCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEec
Q 047719          286 FNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEY  364 (596)
Q Consensus       286 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~  364 (596)
                      |...++||+|+||.|||+.++ .|..+|||.+..    +...++...|+.+|.+ .+.|++|++||.+.....+++||||
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV----~sDLQEIIKEISIMQQ-C~S~yVVKYYGSYFK~sDLWIVMEY  109 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV----DTDLQEIIKEISIMQQ-CKSKYVVKYYGSYFKHSDLWIVMEY  109 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc----cchHHHHHHHHHHHHH-cCCchhhhhhhhhccCCceEeehhh
Confidence            566789999999999999776 499999999853    3456678899966655 8999999999999999999999999


Q ss_pred             CCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc------
Q 047719          365 LPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI------  438 (596)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~------  438 (596)
                      |-.|+..+.++.++   .+|.+.++..++...++||+|||.   ..-||||||+.||||+-+|.+||+|||.+.      
T Consensus       110 CGAGSiSDI~R~R~---K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM  183 (502)
T KOG0574|consen  110 CGAGSISDIMRARR---KPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM  183 (502)
T ss_pred             cCCCcHHHHHHHhc---CCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhhH
Confidence            99999999998764   469999999999999999999999   788999999999999999999999998653      


Q ss_pred             -----cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhc-cccccCcCC
Q 047719          439 -----PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAA-DFRLRGKFN  512 (596)
Q Consensus       439 -----~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~-d~~l~~~~~  512 (596)
                           ..||+.|||||++..-.|..++||||+|+...||..|++||.+-..           ...+.-+. .+..--.-+
T Consensus       184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHP-----------MRAIFMIPT~PPPTF~KP  252 (502)
T KOG0574|consen  184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHP-----------MRAIFMIPTKPPPTFKKP  252 (502)
T ss_pred             HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccc-----------cceeEeccCCCCCCCCCh
Confidence                 4699999999999998999999999999999999999999986321           11111110 011111123


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          513 RKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       513 ~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ..-...+.+++..|+-.+|++|-|+.++++
T Consensus       253 E~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  253 EEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             HhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence            445677888999999999999999888776

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1e-32  Score=290.00  Aligned_cols=260  Identities=20%  Similarity=0.264  Sum_probs=194.1

Q ss_pred             ccCHHHHHHHhcCCCccceeecCCceEEEEEEc-CCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecce
Q 047719          273 RLALTDIKQATLGFNKNRIVGEGASATVYKGSL-PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW  351 (596)
Q Consensus       273 ~~~~~el~~at~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~  351 (596)
                      +....++...+++|...+.||+|+||.||++.. .+++.||+|++.+..........+.+|+..+.+ ++|+||++++++
T Consensus         6 ~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~-l~h~~iv~~~~~   84 (345)
T cd07877           6 QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKH-MKHENVIGLLDV   84 (345)
T ss_pred             hhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHH-cCCCcccceeee
Confidence            344566777889999999999999999999975 458899999996543333334567788865554 899999999998


Q ss_pred             eeeC------CeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecC
Q 047719          352 CCEG------NELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDA  425 (596)
Q Consensus       352 ~~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~  425 (596)
                      +...      ...|+++|++ +++|.+++...     .+++..+..++.|+++||+|||+   .+++||||||+||++++
T Consensus        85 ~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~  155 (345)
T cd07877          85 FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNE  155 (345)
T ss_pred             eeecccccccccEEEEehhc-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcC
Confidence            8643      3478888887 78999888653     38899999999999999999999   89999999999999999


Q ss_pred             CCceEEccCCCccc--------CCCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCChh--HHHHHHHHH
Q 047719          426 EFNAKLGDFEATIP--------AGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV--IVDWVWNLR  494 (596)
Q Consensus       426 ~~~~kl~Dfg~~~~--------~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~--~~~~~~~~~  494 (596)
                      ++.+||+|||++..        .++..|+|||.+.+ ..++.++|||||||++|||++|+.||......  +...+....
T Consensus       156 ~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  235 (345)
T cd07877         156 DCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG  235 (345)
T ss_pred             CCCEEEecccccccccccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            99999999997643        46788999998866 56889999999999999999999999754321  110000000


Q ss_pred             hcC-Cc------------hhhccccccCcCC---HHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          495 KKG-KL------------LDAADFRLRGKFN---RKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       495 ~~~-~~------------~~~~d~~l~~~~~---~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ... ..            ...........+.   ......+.+++..|++.||.+||++.+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  299 (345)
T cd07877         236 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  299 (345)
T ss_pred             CCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence            000 00            0000000000000   012345678899999999999999999876

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9e-34  Score=289.69  Aligned_cols=243  Identities=22%  Similarity=0.288  Sum_probs=202.0

Q ss_pred             CCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEec
Q 047719          286 FNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEY  364 (596)
Q Consensus       286 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~  364 (596)
                      |..++.||+|.|..|-++++- .|+.||||++.+....+.....+++|++.|. +++|||||+||.+......+|||+|+
T Consensus        20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMK-LVQHpNiVRLYEViDTQTKlyLiLEL   98 (864)
T KOG4717|consen   20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMK-LVQHPNIVRLYEVIDTQTKLYLILEL   98 (864)
T ss_pred             ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHH-HhcCcCeeeeeehhcccceEEEEEEe
Confidence            566688999999999999653 6999999999887776666677899997775 59999999999999999999999999


Q ss_pred             CCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecC-CCceEEccCCCcc-----
Q 047719          365 LPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDA-EFNAKLGDFEATI-----  438 (596)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~-~~~~kl~Dfg~~~-----  438 (596)
                      =.+|+|++||-.+.   ..+.+....++..||+.|+.|+|+   ..+|||||||+||..-+ -|-+||.|||.+.     
T Consensus        99 GD~GDl~DyImKHe---~Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG  172 (864)
T KOG4717|consen   99 GDGGDLFDYIMKHE---EGLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG  172 (864)
T ss_pred             cCCchHHHHHHhhh---ccccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence            99999999997653   248899999999999999999999   89999999999997755 5889999999753     


Q ss_pred             -----cCCCcccCCccccccCCC-CCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCC
Q 047719          439 -----PAGTMGYLAPEYVYSGVP-SEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFN  512 (596)
Q Consensus       439 -----~~gt~~y~aPE~~~~~~~-t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  512 (596)
                           .+|++.|-|||.+.+..| -++.||||||||||.|+||++||+....           ...+..++|...  ..+
T Consensus       173 ~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND-----------SETLTmImDCKY--tvP  239 (864)
T KOG4717|consen  173 KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND-----------SETLTMIMDCKY--TVP  239 (864)
T ss_pred             chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc-----------hhhhhhhhcccc--cCc
Confidence                 468999999999999877 5789999999999999999999986321           111222233221  234


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhcCC
Q 047719          513 RKEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKGEA  548 (596)
Q Consensus       513 ~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~~~~  548 (596)
                      ......+.+|+..++..||++|-+.+||+.  +|+...
T Consensus       240 shvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D  277 (864)
T KOG4717|consen  240 SHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGD  277 (864)
T ss_pred             hhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCC
Confidence            556677788888999999999999999976  565443

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-34  Score=272.69  Aligned_cols=238  Identities=24%  Similarity=0.341  Sum_probs=188.5

Q ss_pred             cceeecCCceEEEEEEcCC-CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecCCC
Q 047719          289 NRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPN  367 (596)
Q Consensus       289 ~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  367 (596)
                      ...||.|..|.|++.+.+. |..+|||.+.+.... ...+..+..+..+.....+|.||+.+|+|..+...++-||.|..
T Consensus        97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nk-ee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~  175 (391)
T KOG0983|consen   97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST  175 (391)
T ss_pred             HHhhcCCCccceEEEEEcccceEEEEEeecccCCH-HHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH
Confidence            3679999999999998875 888999999865543 34566788887777766789999999999999999999999843


Q ss_pred             CCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCc----------
Q 047719          368 GSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT----------  437 (596)
Q Consensus       368 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~----------  437 (596)
                       -+++.|..-.   .++++.-.-++...+.+||.||.+.  ++|+|||+||+|||+|+.|++||||||++          
T Consensus       176 -C~ekLlkrik---~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAht  249 (391)
T KOG0983|consen  176 -CAEKLLKRIK---GPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHT  249 (391)
T ss_pred             -HHHHHHHHhc---CCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeecccccc
Confidence             5666665543   2477777788999999999999984  89999999999999999999999999975          


Q ss_pred             ccCCCcccCCcccccc---CCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHH
Q 047719          438 IPAGTMGYLAPEYVYS---GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRK  514 (596)
Q Consensus       438 ~~~gt~~y~aPE~~~~---~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  514 (596)
                      +.+|.+.|||||.+.-   .+|..++||||||+.|+||+||+.||.+....+.....-+..+       .+.+....  .
T Consensus       250 rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~e-------PP~L~~~~--g  320 (391)
T KOG0983|consen  250 RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEE-------PPLLPGHM--G  320 (391)
T ss_pred             cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcC-------CCCCCccc--C
Confidence            3468899999999863   5789999999999999999999999998655432211111111       12332211  1


Q ss_pred             HHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          515 EMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       515 ~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ....+.++...|++.|+.+||...++++
T Consensus       321 FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  321 FSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             cCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence            3345667778899999999999998876

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=4.4e-34  Score=318.00  Aligned_cols=243  Identities=26%  Similarity=0.366  Sum_probs=189.4

Q ss_pred             HHhcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeee-----
Q 047719          281 QATLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE-----  354 (596)
Q Consensus       281 ~at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~-----  354 (596)
                      +...+|++.++||+||||.|||++.+ ||+.||||++.... +........+|+..+.+ ++|||||+++..|.+     
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LAr-LnHpNVVRYysAWVEs~~~~  553 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLAR-LNHPNVVRYYSAWVESTAEL  553 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhh-cCCcceeeeehhhhccCCcc
Confidence            45567888999999999999999876 79999999997544 45555678899977765 999999999887643     


Q ss_pred             --------------------------------------------------------------------------------
Q 047719          355 --------------------------------------------------------------------------------  354 (596)
Q Consensus       355 --------------------------------------------------------------------------------  354 (596)
                                                                                                      
T Consensus       554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t  633 (1351)
T KOG1035|consen  554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT  633 (1351)
T ss_pred             ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence                                                                                            


Q ss_pred             --------------------------C--------CeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHH
Q 047719          355 --------------------------G--------NELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASAL  400 (596)
Q Consensus       355 --------------------------~--------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL  400 (596)
                                                .        ..+||-||||+.-+|++++.++.-..   .-...+++..+|++||
T Consensus       634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEGL  710 (1351)
T KOG1035|consen  634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEGL  710 (1351)
T ss_pred             cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHHH
Confidence                                      0        12689999999988888888764211   3567889999999999


Q ss_pred             HHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc-----------------------------CCCcccCCcccc
Q 047719          401 SYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP-----------------------------AGTMGYLAPEYV  451 (596)
Q Consensus       401 ~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~-----------------------------~gt~~y~aPE~~  451 (596)
                      +|+|+   +++|||||||.||+||++..+||+|||++..                             +||.-|+|||++
T Consensus       711 aYIH~---~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll  787 (1351)
T KOG1035|consen  711 AYIHD---QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELL  787 (1351)
T ss_pred             HHHHh---CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHh
Confidence            99999   8999999999999999999999999986532                             489999999999


Q ss_pred             ccC---CCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCC
Q 047719          452 YSG---VPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVH  528 (596)
Q Consensus       452 ~~~---~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~  528 (596)
                      .+.   +|+.|+|+||+|||++||+.   ||... ..-+.-+.++. .+.+...      ..+..+.+..-.+++.++++
T Consensus       788 ~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts-MERa~iL~~LR-~g~iP~~------~~f~~~~~~~e~slI~~Ll~  856 (1351)
T KOG1035|consen  788 SDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTS-MERASILTNLR-KGSIPEP------ADFFDPEHPEEASLIRWLLS  856 (1351)
T ss_pred             cccccccccchhhhHHHHHHHHHHhc---cCCch-HHHHHHHHhcc-cCCCCCC------cccccccchHHHHHHHHHhc
Confidence            753   59999999999999999995   56542 11111122222 3333222      22344555566778889999


Q ss_pred             CCCCCCCCHHHHHH
Q 047719          529 PNHEKRPSVKEAAR  542 (596)
Q Consensus       529 ~dp~~RPs~~ev~~  542 (596)
                      .||.+|||+.|++.
T Consensus       857 hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  857 HDPSKRPTATELLN  870 (1351)
T ss_pred             CCCccCCCHHHHhh
Confidence            99999999998865

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.8e-33  Score=282.44  Aligned_cols=235  Identities=28%  Similarity=0.369  Sum_probs=188.1

Q ss_pred             eecCCceEEEEEEcCC-CCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecCCCCC
Q 047719          292 VGEGASATVYKGSLPS-GGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGS  369 (596)
Q Consensus       292 LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  369 (596)
                      ||+|+||.||++.... |+.+|+|.+...... ......+.+|+..+.+ ++|+||+++++.+......|++|||+++++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~-~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQ-AQSPYVVKLYYSFQGKKNLYLVMEYLPGGD   79 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHh-CCCcchhHHHHheecCcEEEEEEecCCCCc
Confidence            6899999999998865 899999998643321 2344567778755554 899999999999999999999999999999


Q ss_pred             HHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc----------
Q 047719          370 LDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP----------  439 (596)
Q Consensus       370 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~----------  439 (596)
                      |.+++....    .+++..+..++.||++||+|||+   .+++|+||+|+||+++.++.++|+|||++..          
T Consensus        80 L~~~l~~~~----~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  152 (265)
T cd05579          80 LASLLENVG----SLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLN  152 (265)
T ss_pred             HHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccc
Confidence            999998653    48999999999999999999999   8999999999999999999999999986432          


Q ss_pred             ---------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCc
Q 047719          440 ---------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGK  510 (596)
Q Consensus       440 ---------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  510 (596)
                               .++..|+|||.......+.++||||||+++|||++|+.||.....  ......... +...      ... 
T Consensus       153 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~--~~~~~~~~~-~~~~------~~~-  222 (265)
T cd05579         153 DDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP--EEIFQNILN-GKIE------WPE-  222 (265)
T ss_pred             cccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHhc-CCcC------CCc-
Confidence                     356689999999888899999999999999999999999976432  111111111 1110      000 


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 047719          511 FNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK  545 (596)
Q Consensus       511 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~  545 (596)
                       .......+..++..|++.+|++|||+.++.+.|+
T Consensus       223 -~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         223 -DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             -cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence             0012456778889999999999999977777665

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.9e-33  Score=290.53  Aligned_cols=257  Identities=22%  Similarity=0.295  Sum_probs=192.6

Q ss_pred             HHhcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCC---
Q 047719          281 QATLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGN---  356 (596)
Q Consensus       281 ~at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~---  356 (596)
                      ...++|...+.||+|+||.||++... ++..||||++.+..........+.+|+..+. .++|+||+++++++....   
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07880          12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLK-HMKHENVIGLLDVFTPDLSLD   90 (343)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHH-hcCCCCccceeeeecCCcccc
Confidence            34567888899999999999999754 5889999998654333333456778886665 489999999999987654   


Q ss_pred             ---eEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEcc
Q 047719          357 ---ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGD  433 (596)
Q Consensus       357 ---~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~D  433 (596)
                         ..++||||+ +++|.+++...     .+++..+..++.||++||+|||+   .+++||||||+||+++.++.+||+|
T Consensus        91 ~~~~~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~d  161 (343)
T cd07880          91 RFHDFYLVMPFM-GTDLGKLMKHE-----KLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILD  161 (343)
T ss_pred             ccceEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEee
Confidence               469999999 77999988643     38899999999999999999999   8999999999999999999999999


Q ss_pred             CCCccc--------CCCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHh-cCCc----
Q 047719          434 FEATIP--------AGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRK-KGKL----  499 (596)
Q Consensus       434 fg~~~~--------~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~-~~~~----  499 (596)
                      ||.+..        .++..|+|||.+.+ ..++.++|+|||||++|||++|+.||......  ........ ....    
T Consensus       162 fg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~  239 (343)
T cd07880         162 FGLARQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL--DQLMEIMKVTGTPSKEF  239 (343)
T ss_pred             cccccccccCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCCCHHH
Confidence            997643        46788999998876 46889999999999999999999999764321  11111000 0000    


Q ss_pred             ---------hhhcc--ccccC----cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhcCCC
Q 047719          500 ---------LDAAD--FRLRG----KFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKGEAP  549 (596)
Q Consensus       500 ---------~~~~d--~~l~~----~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~~~~~  549 (596)
                               .....  +....    .........+.+++.+|++.||++|||+.++++  +++....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~  306 (343)
T cd07880         240 VQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD  306 (343)
T ss_pred             HHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence                     00000  00000    000112335778899999999999999999984  5554433

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=5.7e-33  Score=286.37  Aligned_cols=252  Identities=23%  Similarity=0.299  Sum_probs=186.5

Q ss_pred             hcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCC-----
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGN-----  356 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~-----  356 (596)
                      .++|...+.||+|+||.||+|... +++.+|||++......+.....+.+|++.+. .++|+||+++++++.+..     
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~~~   85 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILK-KLKHPNVVPLIDMAVERPDKSKR   85 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHH-hcCCCCccchhhheecccccccc
Confidence            467888999999999999999865 5889999998654433333345678886555 489999999999875433     


Q ss_pred             ---eEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEcc
Q 047719          357 ---ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGD  433 (596)
Q Consensus       357 ---~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~D  433 (596)
                         .+++|+||+.. +|...+....   ..+++..+..++.|+++||+|||+   .+++|+||||+||++++++.+||+|
T Consensus        86 ~~~~~~lv~~~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~d  158 (311)
T cd07866          86 KRGSVYMVTPYMDH-DLSGLLENPS---VKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIAD  158 (311)
T ss_pred             cCceEEEEEecCCc-CHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECc
Confidence               47999999975 7877776532   358999999999999999999999   8999999999999999999999999


Q ss_pred             CCCccc----------------------CCCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCChh-HHHH
Q 047719          434 FEATIP----------------------AGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV-IVDW  489 (596)
Q Consensus       434 fg~~~~----------------------~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~-~~~~  489 (596)
                      ||++..                      .++..|+|||.+.+ ..++.++|||||||++|||++|++||...... ....
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~  238 (311)
T cd07866         159 FGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHL  238 (311)
T ss_pred             CccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            986542                      23567999998765 45799999999999999999999999764321 1111


Q ss_pred             HHHHHhcC---------CchhhccccccCcCC-------HHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          490 VWNLRKKG---------KLLDAADFRLRGKFN-------RKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       490 ~~~~~~~~---------~~~~~~d~~l~~~~~-------~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ........         .+....+.......+       ......+.+++.+|++.||++|||+.|++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            11111100         000000000000000       112256778999999999999999998864

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=4.7e-33  Score=284.43  Aligned_cols=244  Identities=26%  Similarity=0.308  Sum_probs=191.5

Q ss_pred             CCCccceeecCCceEEEEEEc----CCCCEEEEEEeecCCch--hcccchHHHHHHHHHhccCCCceeeecceeeeCCeE
Q 047719          285 GFNKNRIVGEGASATVYKGSL----PSGGAVAVKRFEKPNRV--ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNEL  358 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~----~~g~~vAvK~l~~~~~~--~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~  358 (596)
                      +|...+.||+|+||.||++..    .++..||||++++....  ......+.+|+..+.+.-+|+||+++++.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            366778999999999999874    24688999998643221  123345778886666634799999999999999999


Q ss_pred             EEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc
Q 047719          359 VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI  438 (596)
Q Consensus       359 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~  438 (596)
                      ++||||+++|+|.+++....    .+++.....++.|+++||.|||+   .+++||||||+||+++.++.++|+|||++.
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~  153 (288)
T cd05583          81 HLILDYVNGGELFTHLYQRE----HFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSK  153 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcC----CcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECcccc
Confidence            99999999999999997543    48899999999999999999999   899999999999999999999999998753


Q ss_pred             c------------CCCcccCCccccccCC--CCCccceeehhHHHHHHHhCCCCCCCCChh--HHHHHHHHHhcCCchhh
Q 047719          439 P------------AGTMGYLAPEYVYSGV--PSEKTDVYSFGVVALEVAAGKSPVDNDGCV--IVDWVWNLRKKGKLLDA  502 (596)
Q Consensus       439 ~------------~gt~~y~aPE~~~~~~--~t~~sDV~SfGvll~El~tG~~p~~~~~~~--~~~~~~~~~~~~~~~~~  502 (596)
                      .            .|+..|+|||.+.+..  .+.++||||||+++|||++|..||...+..  ..+........      
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~------  227 (288)
T cd05583         154 EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS------  227 (288)
T ss_pred             ccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc------
Confidence            2            3688899999987655  788999999999999999999999643211  11111111110      


Q ss_pred             ccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          503 ADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       503 ~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                       ..    ..+......+.+++.+|++.+|++|||+.++.+.|+.
T Consensus       228 -~~----~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         228 -KP----PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             -CC----CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence             01    1112223456778889999999999999999888764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=5e-33  Score=285.41  Aligned_cols=232  Identities=27%  Similarity=0.376  Sum_probs=185.6

Q ss_pred             ceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecCCCC
Q 047719          290 RIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNG  368 (596)
Q Consensus       290 ~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  368 (596)
                      .+||+|+||.||++... +++.||||++...  .......+.+|+..+. .++|+|++++++.+...+..++||||++++
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  102 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLR--KQQRRELLFNEVVIMR-DYQHENVVEMYNSYLVGDELWVVMEFLEGG  102 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEeccc--chhHHHHHHHHHHHHH-hcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence            67999999999999775 5889999998532  2234456888886554 589999999999999999999999999999


Q ss_pred             CHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc----------
Q 047719          369 SLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI----------  438 (596)
Q Consensus       369 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~----------  438 (596)
                      +|.+++...     .+++.....++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||.+.          
T Consensus       103 ~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~  174 (292)
T cd06657         103 ALTDIVTHT-----RMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK  174 (292)
T ss_pred             cHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceeccccccccc
Confidence            999988643     37899999999999999999999   899999999999999999999999998642          


Q ss_pred             -cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHHHHH
Q 047719          439 -PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEME  517 (596)
Q Consensus       439 -~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  517 (596)
                       ..|+..|+|||.+.+..++.++|+|||||++|||++|..||......  ..+..... . .    ...+..  ......
T Consensus       175 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~--~~~~~~~~-~-~----~~~~~~--~~~~~~  244 (292)
T cd06657         175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKMIRD-N-L----PPKLKN--LHKVSP  244 (292)
T ss_pred             ccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHh-h-C----CcccCC--cccCCH
Confidence             24678899999998888999999999999999999999999764321  11111100 0 0    000000  011233


Q ss_pred             HHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          518 RMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       518 ~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      .+.+++.+|++.+|.+||++.++++
T Consensus       245 ~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         245 SLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             HHHHHHHHHHhCCcccCcCHHHHhc
Confidence            4667788999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-34  Score=284.18  Aligned_cols=253  Identities=22%  Similarity=0.258  Sum_probs=203.6

Q ss_pred             HHHHHHHhcCCCccceeecCCceEEEEEEcC------CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeec
Q 047719          276 LTDIKQATLGFNKNRIVGEGASATVYKGSLP------SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQ  349 (596)
Q Consensus       276 ~~el~~at~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~  349 (596)
                      ..||.....++....++-+|.||.||+|.++      +.+.|-+|.++ ...++.+...++.|-..+.. +.|||+.++.
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk-~~AS~iQv~~~L~es~lly~-~sH~nll~V~  353 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVK-QHASQIQVNLLLQESMLLYG-ASHPNLLSVL  353 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHH-hcccHHHHHHHHHHHHHHhc-CcCCCcccee
Confidence            4456666667888889999999999999554      34567888875 34555566678888766655 7899999999


Q ss_pred             ceeeeCC-eEEEEEecCCCCCHHHHhhhCC----CCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeec
Q 047719          350 GWCCEGN-ELVLVYEYLPNGSLDKILHNNS----SSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLD  424 (596)
Q Consensus       350 g~~~~~~-~~~lV~E~~~~gsL~~~l~~~~----~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~  424 (596)
                      +.+.+.. ..+++|.++.-|+|..||...+    ...+.+.-.+...++.|++.||+|||.   .+|||.||.++|++||
T Consensus       354 ~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvId  430 (563)
T KOG1024|consen  354 GVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVID  430 (563)
T ss_pred             EEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceeh
Confidence            9998765 4688899999999999998432    224567888999999999999999999   9999999999999999


Q ss_pred             CCCceEEccCCCcccC-------------CCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHH
Q 047719          425 AEFNAKLGDFEATIPA-------------GTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWV  490 (596)
Q Consensus       425 ~~~~~kl~Dfg~~~~~-------------gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~  490 (596)
                      +..++||+|-.+++..             ....||+||.+....|+.++|||||||+||||+| |+.|+.+-+..   -+
T Consensus       431 d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf---Em  507 (563)
T KOG1024|consen  431 DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF---EM  507 (563)
T ss_pred             hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH---HH
Confidence            9999999998766432             3467999999999999999999999999999999 99999875432   12


Q ss_pred             HHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 047719          491 WNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK  545 (596)
Q Consensus       491 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~  545 (596)
                      ..+..+|..         ...+-++..++..++.-||...|++||+++|++.-|.
T Consensus       508 ~~ylkdGyR---------laQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLs  553 (563)
T KOG1024|consen  508 EHYLKDGYR---------LAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLS  553 (563)
T ss_pred             HHHHhccce---------ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHH
Confidence            233333322         2233356678889999999999999999999998775

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-34  Score=297.10  Aligned_cols=239  Identities=27%  Similarity=0.377  Sum_probs=191.6

Q ss_pred             CCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCC-chhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          285 GFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPN-RVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      -|...+.||.|+||-||-++.. +.+.||||++..+. .+.....+++.|+..+.+ ++|||++.+-|||....-.||||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~-l~HPntieYkgCyLre~TaWLVM  105 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQ-LRHPNTIEYKGCYLREHTAWLVM  105 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHh-ccCCCcccccceeeccchHHHHH
Confidence            3666788999999999999764 57889999996432 233456788999966655 99999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc----
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI----  438 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~----  438 (596)
                      |||- ||-.+.|.-..   .++.+.++..|+.+.+.||+|||+   .+.||||||+.||||++.|.+||+|||.+.    
T Consensus       106 EYCl-GSAsDlleVhk---KplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P  178 (948)
T KOG0577|consen  106 EYCL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP  178 (948)
T ss_pred             HHHh-ccHHHHHHHHh---ccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCc
Confidence            9995 58778776543   358899999999999999999999   899999999999999999999999999753    


Q ss_pred             ---cCCCcccCCccccc---cCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCC
Q 047719          439 ---PAGTMGYLAPEYVY---SGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFN  512 (596)
Q Consensus       439 ---~~gt~~y~aPE~~~---~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  512 (596)
                         .+||+.|||||++.   .+.|+-|+||||||++..||.-.++|+-....-..  ++....+.      .+.+.   .
T Consensus       179 AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA--LYHIAQNe------sPtLq---s  247 (948)
T KOG0577|consen  179 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHIAQNE------SPTLQ---S  247 (948)
T ss_pred             hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH--HHHHHhcC------CCCCC---C
Confidence               46999999999875   58999999999999999999999999765422100  11111110      11122   2


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          513 RKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       513 ~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      .+-...+..++-.|++.-|.+|||.++++.
T Consensus       248 ~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  248 NEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             chhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence            344566777788999999999999988776

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=9e-33  Score=280.78  Aligned_cols=249  Identities=22%  Similarity=0.267  Sum_probs=190.2

Q ss_pred             CCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEec
Q 047719          286 FNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEY  364 (596)
Q Consensus       286 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~  364 (596)
                      |...+.||+|++|.||++... +++.+++|++............+..|+..+.+ ++|+||+++++++......++|+||
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~~~~~~v~e~   79 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKE-LNHPNIIKLLDVFRHKGDLYLVFEF   79 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHH-hcCCCcchHHHhhccCCCEEEEEec
Confidence            455688999999999999875 58899999987544333344567788866554 8999999999999999999999999


Q ss_pred             CCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc------
Q 047719          365 LPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI------  438 (596)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~------  438 (596)
                      +++ +|.+++....   ..+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||.+.      
T Consensus        80 ~~~-~l~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~  152 (283)
T cd05118          80 MDT-DLYKLIKDRQ---RGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV  152 (283)
T ss_pred             cCC-CHHHHHHhhc---ccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc
Confidence            975 8988887643   258999999999999999999999   899999999999999999999999998653      


Q ss_pred             -----cCCCcccCCccccccC-CCCCccceeehhHHHHHHHhCCCCCCCCChh-HHHHHHHHHhcC------Cchh----
Q 047719          439 -----PAGTMGYLAPEYVYSG-VPSEKTDVYSFGVVALEVAAGKSPVDNDGCV-IVDWVWNLRKKG------KLLD----  501 (596)
Q Consensus       439 -----~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~El~tG~~p~~~~~~~-~~~~~~~~~~~~------~~~~----  501 (596)
                           ..++..|+|||.+.+. .++.++|+||||+++|||++|+.||...+.. ...-........      ...+    
T Consensus       153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd05118         153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARN  232 (283)
T ss_pred             ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhh
Confidence                 2356779999998876 7899999999999999999999999764321 000000000000      0000    


Q ss_pred             ----hccc--cccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          502 ----AADF--RLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       502 ----~~d~--~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                          ....  .............+.+++..||++||.+||++++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                0000  0000111234567889999999999999999999875

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.4e-33  Score=289.20  Aligned_cols=257  Identities=20%  Similarity=0.244  Sum_probs=195.1

Q ss_pred             CCCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCC-----eE
Q 047719          285 GFNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGN-----EL  358 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~-----~~  358 (596)
                      +|...+.||+|+||.||+|.... ++.||||++..........+.+..|+..+.. ++|+||+++++++....     ..
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~~~~~~~~~   79 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRH-LRHENIIGLLDILRPPSPEDFNDV   79 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHh-cCCcchhhhhhhhcccCcccccce
Confidence            36778999999999999998754 8899999997543323445568888866655 89999999999998875     78


Q ss_pred             EEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc
Q 047719          359 VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI  438 (596)
Q Consensus       359 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~  438 (596)
                      |+||||++ ++|.+++....    .+++..+..++.|++.||+|||+   .+++||||||+|||++.++.++|+|||.+.
T Consensus        80 ~lv~e~~~-~~l~~~l~~~~----~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~  151 (330)
T cd07834          80 YIVTELME-TDLHKVIKSPQ----PLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLAR  151 (330)
T ss_pred             EEEecchh-hhHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceE
Confidence            99999998 48999987643    58999999999999999999999   899999999999999999999999998653


Q ss_pred             c--------------CCCcccCCccccccC-CCCCccceeehhHHHHHHHhCCCCCCCCChh-HHHHHHHHHhc------
Q 047719          439 P--------------AGTMGYLAPEYVYSG-VPSEKTDVYSFGVVALEVAAGKSPVDNDGCV-IVDWVWNLRKK------  496 (596)
Q Consensus       439 ~--------------~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~El~tG~~p~~~~~~~-~~~~~~~~~~~------  496 (596)
                      .              .++..|+|||.+.+. .++.++|+||||+++|||++|+.||...... ....+......      
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  231 (330)
T cd07834         152 GVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDL  231 (330)
T ss_pred             eecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHh
Confidence            2              256679999999887 8899999999999999999999999765321 11111000000      


Q ss_pred             -----CCchhhccc-cccCc-----CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhcCCCC
Q 047719          497 -----GKLLDAADF-RLRGK-----FNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKGEAPL  550 (596)
Q Consensus       497 -----~~~~~~~d~-~l~~~-----~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~~~~~~  550 (596)
                           ....+.+.. .....     ........+.+++..||+.+|++||+++++++  ++++....
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~  298 (330)
T cd07834         232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP  298 (330)
T ss_pred             hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence                 000000000 00000     01112356778899999999999999999988  56654443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.7e-33  Score=295.86  Aligned_cols=238  Identities=27%  Similarity=0.324  Sum_probs=196.7

Q ss_pred             HhcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEE
Q 047719          282 ATLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVL  360 (596)
Q Consensus       282 at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~l  360 (596)
                      ....|.....||+|.|++|.++... ++..||||.+++.......+..+.+|+..|+. ++|||||+|+.+......+|+
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~-l~HPnIvkl~~v~~t~~~lyl  132 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKS-LNHPNIVKLFSVIETEATLYL  132 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHh-cCCcceeeeeeeeeecceeEE
Confidence            3556888899999999999999765 58999999998876666666678999988866 999999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc--
Q 047719          361 VYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI--  438 (596)
Q Consensus       361 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~--  438 (596)
                      ||||+.+|.+.+||..+..    +.......+..|+.++++|||+   +.|+|||||++||||+.+.++||+|||++.  
T Consensus       133 V~eya~~ge~~~yl~~~gr----~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~  205 (596)
T KOG0586|consen  133 VMEYASGGELFDYLVKHGR----MKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFF  205 (596)
T ss_pred             EEEeccCchhHHHHHhccc----chhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceee
Confidence            9999999999999998763    4457888899999999999999   999999999999999999999999999764  


Q ss_pred             --------cCCCcccCCccccccCCC-CCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccC
Q 047719          439 --------PAGTMGYLAPEYVYSGVP-SEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRG  509 (596)
Q Consensus       439 --------~~gt~~y~aPE~~~~~~~-t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  509 (596)
                              .+|++.|.|||++.+..| ++++|+||+|++||-|++|..||++..-               .+.-...+.+
T Consensus       206 ~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l---------------k~Lr~rvl~g  270 (596)
T KOG0586|consen  206 DYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL---------------KELRPRVLRG  270 (596)
T ss_pred             cccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc---------------ccccchheee
Confidence                    469999999999998765 7999999999999999999999987421               1111111111


Q ss_pred             c--CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          510 K--FNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       510 ~--~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      .  ++.-....+-+++++.+-.+|.+|++++++.+
T Consensus       271 k~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  271 KYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             eecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence            1  11112233445666777899999999999977

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=8.6e-33  Score=283.89  Aligned_cols=241  Identities=18%  Similarity=0.234  Sum_probs=175.6

Q ss_pred             cCCCccceeecCCceEEEEEEcCCC----CEEEEEEeecCCchhccc---------chHHHHHHHHHhccCCCceeeecc
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPSG----GAVAVKRFEKPNRVECAR---------NPFTTEFATMAGCLRHKNLVQLQG  350 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~g----~~vAvK~l~~~~~~~~~~---------~~~~~E~~~l~~~l~H~niv~l~g  350 (596)
                      +.|...++||+|+||.||+|...++    ..+|+|+...........         .....+...+ ..++|+|++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~-~~~~h~~i~~~~~   90 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNI-HNIDHLGIPKYYG   90 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHh-ccCCCCCCCcEEE
Confidence            5688889999999999999986543    456666543221110000         0111222222 3478999999999


Q ss_pred             eeeeCC----eEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCC
Q 047719          351 WCCEGN----ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAE  426 (596)
Q Consensus       351 ~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~  426 (596)
                      ++....    ..++++|++.. ++.+.+....    ..++..+..++.|+++||+|||+   .+++||||||+|||++.+
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~  162 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRIK----CKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGN  162 (294)
T ss_pred             eeeEecCCceEEEEEEehhcc-CHHHHHHhhc----cCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCC
Confidence            876544    34788887743 6777665432    25678889999999999999999   899999999999999999


Q ss_pred             CceEEccCCCcc------------------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCCh--hH
Q 047719          427 FNAKLGDFEATI------------------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGC--VI  486 (596)
Q Consensus       427 ~~~kl~Dfg~~~------------------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~--~~  486 (596)
                      +.++|+|||++.                  ..||+.|+|||.+.+..++.++|||||||++|||++|+.||.....  ..
T Consensus       163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~  242 (294)
T PHA02882        163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL  242 (294)
T ss_pred             CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence            999999999863                  2489999999999999999999999999999999999999976522  11


Q ss_pred             H-----HHHHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 047719          487 V-----DWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK  545 (596)
Q Consensus       487 ~-----~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~  545 (596)
                      .     ++..... .+..        ..   ......+.+++..|++.+|++||+++++.+.|+
T Consensus       243 ~~~~~~~~~~~~~-~~~~--------~~---~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        243 IHAAKCDFIKRLH-EGKI--------KI---KNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HHHhHHHHHHHhh-hhhh--------cc---CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            1     1111111 1100        00   112355778888999999999999999998763

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.4e-32  Score=285.00  Aligned_cols=238  Identities=27%  Similarity=0.379  Sum_probs=185.9

Q ss_pred             CCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          286 FNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       286 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      |...+.||+|+||.||+|... ++..||+|++...... ......+..|+..+. .++|+|++++++++.+....|+|||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e  101 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQ-QLKHPNTIEYKGCYLKEHTAWLVME  101 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHH-hCCCCCCccEEEEEEeCCEEEEEEe
Confidence            445578999999999999865 5889999998654322 223345778886555 4899999999999999999999999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc-----
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI-----  438 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~-----  438 (596)
                      |+. |+|.+++....   ..+++.+++.++.||+.+|.|||+   .+++|+||||+||+++.++.+||+|||.+.     
T Consensus       102 ~~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~  174 (313)
T cd06633         102 YCL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA  174 (313)
T ss_pred             cCC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCCC
Confidence            996 58888876543   258999999999999999999999   899999999999999999999999998754     


Q ss_pred             --cCCCcccCCccccc---cCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCH
Q 047719          439 --PAGTMGYLAPEYVY---SGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNR  513 (596)
Q Consensus       439 --~~gt~~y~aPE~~~---~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  513 (596)
                        ..|+..|+|||.+.   .+.++.++|||||||++|||++|..|+.....  ...+....... ...     .   ...
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~--~~~~~~~~~~~-~~~-----~---~~~  243 (313)
T cd06633         175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSALYHIAQND-SPT-----L---QSN  243 (313)
T ss_pred             CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHhcC-CCC-----C---Ccc
Confidence              24778899999984   45688999999999999999999999876432  11111111111 100     0   011


Q ss_pred             HHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          514 KEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       514 ~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      .....+.+++.+|++.+|.+||++.+++.
T Consensus       244 ~~~~~l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         244 EWTDSFRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            12234677888999999999999999976

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=4.3e-33  Score=280.13  Aligned_cols=240  Identities=22%  Similarity=0.288  Sum_probs=186.4

Q ss_pred             CCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCc---hhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          286 FNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNR---VECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       286 f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~---~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      |...+.||+|+||.||++.... +..+++|.++....   .......+..|+..+ +.++||||+++++++.+....++|
T Consensus         2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLL-SKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHH-HhCCCCcHHHHHHHHhcCCceEEE
Confidence            6677899999999999997654 45566666543221   112233456677544 458999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc---
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI---  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---  438 (596)
                      |||+++++|.+++.........+++..++.++.|+++||.|||+   .+++|+||||+||+++. +.+||+|||.+.   
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecC
Confidence            99999999999997643334468999999999999999999999   89999999999999975 569999998653   


Q ss_pred             --------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCc
Q 047719          439 --------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGK  510 (596)
Q Consensus       439 --------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  510 (596)
                              ..|+..|+|||.+....++.++|+||||+++|||++|+.||.....  ........ .+.         ...
T Consensus       157 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~~~~~~~-~~~---------~~~  224 (260)
T cd08222         157 GSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF--LSVVLRIV-EGP---------TPS  224 (260)
T ss_pred             CCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH--HHHHHHHH-cCC---------CCC
Confidence                    2367889999999888889999999999999999999999975421  11111111 111         111


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          511 FNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       511 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      .+......+.+++.+||+.+|++||++.|+++
T Consensus       225 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         225 LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            22334456788899999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-34  Score=322.95  Aligned_cols=246  Identities=24%  Similarity=0.350  Sum_probs=194.7

Q ss_pred             HHHhcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeE
Q 047719          280 KQATLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNEL  358 (596)
Q Consensus       280 ~~at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~  358 (596)
                      ...+-++.....||.|.||.||-+... +|...|+|-++.............+|+..+ ..++|||+|+++|+-...+..
T Consensus      1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vl-E~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVL-EGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred             ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHH-HhccCccccccCceeecHHHH
Confidence            344555667789999999999999755 588899998865444444455566676444 559999999999999999999


Q ss_pred             EEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc
Q 047719          359 VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI  438 (596)
Q Consensus       359 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~  438 (596)
                      +|.||||.+|+|.+.+...+    .+++.....+..|++.|++|||+   .+||||||||.||+|+.+|.+|++|||.+.
T Consensus      1310 ~IFMEyC~~GsLa~ll~~gr----i~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ 1382 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGR----IEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAV 1382 (1509)
T ss_pred             HHHHHHhccCcHHHHHHhcc----hhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeeccccee
Confidence            99999999999999998764    35566666778999999999999   999999999999999999999999999864


Q ss_pred             c---------------CCCcccCCccccccC---CCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCch
Q 047719          439 P---------------AGTMGYLAPEYVYSG---VPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLL  500 (596)
Q Consensus       439 ~---------------~gt~~y~aPE~~~~~---~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~  500 (596)
                      .               .||+.|||||.+.+.   ...-+.||||+||+++||+||++||...+.   +|.--+       
T Consensus      1383 ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn---e~aIMy------- 1452 (1509)
T KOG4645|consen 1383 KIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN---EWAIMY------- 1452 (1509)
T ss_pred             EecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc---hhHHHh-------
Confidence            3               499999999999753   356789999999999999999999986443   232111       


Q ss_pred             hhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 047719          501 DAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARIL  544 (596)
Q Consensus       501 ~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L  544 (596)
                       .+.....+.++......-.+++-.|++.||++|.++.|+++.=
T Consensus      1453 -~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1453 -HVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred             -HHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence             1111222334445556667788899999999999988777643

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=9.4e-33  Score=285.46  Aligned_cols=239  Identities=28%  Similarity=0.377  Sum_probs=186.9

Q ss_pred             CCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCc-hhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          286 FNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNR-VECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       286 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      |...+.||+|+||.||+|... ++..+|+|.+..... ......++.+|+..+. .++|+|++++++++......++|||
T Consensus        17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e   95 (308)
T cd06634          17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ-KLRHPNTIQYRGCYLREHTAWLVME   95 (308)
T ss_pred             HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHH-hCCCCCcccEEEEEEcCCeeEEEEE
Confidence            555688999999999999865 478899999864322 2223446778886554 4899999999999999999999999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc-----
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI-----  438 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~-----  438 (596)
                      |+. |+|.+++....   ..+++.++..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++.     
T Consensus        96 ~~~-~~l~~~~~~~~---~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  168 (308)
T cd06634          96 YCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (308)
T ss_pred             ccC-CCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence            996 68888876543   248899999999999999999999   899999999999999999999999999754     


Q ss_pred             --cCCCcccCCccccc---cCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCH
Q 047719          439 --PAGTMGYLAPEYVY---SGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNR  513 (596)
Q Consensus       439 --~~gt~~y~aPE~~~---~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  513 (596)
                        ..++..|+|||.+.   .+.++.++|||||||++|||++|+.|+......  ........ ...     +..   ...
T Consensus       169 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~-~~~-----~~~---~~~  237 (308)
T cd06634         169 NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYHIAQ-NES-----PAL---QSG  237 (308)
T ss_pred             ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH--HHHHHHhh-cCC-----CCc---Ccc
Confidence              24788999999875   356789999999999999999999998654221  11111111 111     000   111


Q ss_pred             HHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 047719          514 KEMERMLMVGLSCVHPNHEKRPSVKEAARI  543 (596)
Q Consensus       514 ~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~  543 (596)
                      .....+.+++.+||+.+|++||+++++++.
T Consensus       238 ~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         238 HWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             cccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence            234557788899999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.5e-32  Score=281.10  Aligned_cols=240  Identities=25%  Similarity=0.289  Sum_probs=186.7

Q ss_pred             CCCccceeecCCceEEEEEEc----CCCCEEEEEEeecCCchh--cccchHHHHHHHHHhccCCCceeeecceeeeCCeE
Q 047719          285 GFNKNRIVGEGASATVYKGSL----PSGGAVAVKRFEKPNRVE--CARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNEL  358 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~----~~g~~vAvK~l~~~~~~~--~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~  358 (596)
                      +|...+.||+|+||.||++..    .+|..||+|++.......  ...+.+.+|+..+.+.-+|+||+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            366778999999999999975    368899999986532211  22345677886666533799999999999999999


Q ss_pred             EEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc
Q 047719          359 VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI  438 (596)
Q Consensus       359 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~  438 (596)
                      ++||||+++++|.+++....    .+++.....++.|+++||.|||+   .+++||||||+|||++.++.+||+|||++.
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~  153 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE----RFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSK  153 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccce
Confidence            99999999999999997653    47889999999999999999999   899999999999999999999999998653


Q ss_pred             c------------CCCcccCCccccccC--CCCCccceeehhHHHHHHHhCCCCCCCCCh--hHHHHHHHHHhcCCchhh
Q 047719          439 P------------AGTMGYLAPEYVYSG--VPSEKTDVYSFGVVALEVAAGKSPVDNDGC--VIVDWVWNLRKKGKLLDA  502 (596)
Q Consensus       439 ~------------~gt~~y~aPE~~~~~--~~t~~sDV~SfGvll~El~tG~~p~~~~~~--~~~~~~~~~~~~~~~~~~  502 (596)
                      .            .|+..|+|||.+...  .++.++||||||+++|||++|+.||.....  ...++........     
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-----  228 (290)
T cd05613         154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE-----  228 (290)
T ss_pred             ecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccC-----
Confidence            2            367889999998753  468899999999999999999999964321  1112221111111     


Q ss_pred             ccccccCcCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 047719          503 ADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRP-----SVKEAAR  542 (596)
Q Consensus       503 ~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RP-----s~~ev~~  542 (596)
                            ..++......+.+++..|++.+|++||     +.++++.
T Consensus       229 ------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         229 ------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             ------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence                  112223345677888999999999997     5666544

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1e-33  Score=297.85  Aligned_cols=242  Identities=22%  Similarity=0.313  Sum_probs=189.8

Q ss_pred             ccceeecCCceEEEEEEcCC-CCEEEEEEeecC--CchhcccchHHHHHHHHHhccCCCceeeecceeeeCCe--EEEEE
Q 047719          288 KNRIVGEGASATVYKGSLPS-GGAVAVKRFEKP--NRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNE--LVLVY  362 (596)
Q Consensus       288 ~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~--~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~--~~lV~  362 (596)
                      ...+||+|.|-+||||.... |-.||--.++..  .......+.|..|+ .|++.|+|+|||+++.+|.+...  +-+|+
T Consensus        44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev-~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEV-HLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHH-HHHccCCCCceeeeeeheecCCCceeeeee
Confidence            34789999999999997753 777775443322  22333446789998 55566999999999999987665  88999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCC-CceEEccCCCcc---
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAE-FNAKLGDFEATI---  438 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~-~~~kl~Dfg~~~---  438 (596)
                      |.|..|+|..|+.+.+    .++......|+.||++||.|||+ ..++|||||||..||+|+.+ |.+||+|+|++.   
T Consensus       123 EL~TSGtLr~Y~kk~~----~vn~kaik~W~RQILkGL~yLHs-~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r  197 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKHR----RVNIKAIKSWCRQILKGLVYLHS-QDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR  197 (632)
T ss_pred             ecccCCcHHHHHHHhc----cCCHHHHHHHHHHHHHHhhhhhc-CCCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence            9999999999999876    37778899999999999999999 46899999999999999876 899999999864   


Q ss_pred             ------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCC
Q 047719          439 ------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFN  512 (596)
Q Consensus       439 ------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  512 (596)
                            ..||+.|||||+.. ..|....||||||+.|+||+|+..||.....  ...+++....|........     ..
T Consensus       198 ~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n--~AQIYKKV~SGiKP~sl~k-----V~  269 (632)
T KOG0584|consen  198 KSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN--PAQIYKKVTSGIKPAALSK-----VK  269 (632)
T ss_pred             ccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC--HHHHHHHHHcCCCHHHhhc-----cC
Confidence                  36999999999886 7899999999999999999999999986432  1222333333332222111     11


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhcC
Q 047719          513 RKEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKGE  547 (596)
Q Consensus       513 ~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~~~  547 (596)
                         ...+..++.+|+.. .+.|||+.|+++  +|..+
T Consensus       270 ---dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  270 ---DPEVREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             ---CHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence               23456777899999 999999999987  56543

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=8.7e-33  Score=280.25  Aligned_cols=238  Identities=25%  Similarity=0.336  Sum_probs=192.2

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCc-hhcccchHHHHHHHHHhccC-CCceeeecceeeeCCeEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNR-VECARNPFTTEFATMAGCLR-HKNLVQLQGWCCEGNELVL  360 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~~E~~~l~~~l~-H~niv~l~g~~~~~~~~~l  360 (596)
                      ++|...+.||+|+||.||++... +++.||+|++.+... .......+..|...+.+ ++ |+||+++++++...+..++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~-l~~~~~i~~~~~~~~~~~~~~l   79 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTR-LNGHPGIIKLYYTFQDEENLYF   79 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHh-cccCCCchhHHHHhcCCceEEE
Confidence            35778899999999999999875 589999999865322 22334567777766655 77 9999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc-
Q 047719          361 VYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP-  439 (596)
Q Consensus       361 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~-  439 (596)
                      ||||+++++|.+++....    .+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||+... 
T Consensus        80 v~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~  152 (280)
T cd05581          80 VLEYAPNGELLQYIRKYG----SLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVL  152 (280)
T ss_pred             EEcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCcccccc
Confidence            999999999999998754    48999999999999999999999   8999999999999999999999999986432 


Q ss_pred             ------------------------------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHH
Q 047719          440 ------------------------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDW  489 (596)
Q Consensus       440 ------------------------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~  489 (596)
                                                    .++..|+|||.+....++.++||||||++++|+++|+.||........  
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--  230 (280)
T cd05581         153 DPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT--  230 (280)
T ss_pred             CCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH--
Confidence                                          246789999999888899999999999999999999999986532110  


Q ss_pred             HHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHH
Q 047719          490 VWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSV----KEAAR  542 (596)
Q Consensus       490 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~----~ev~~  542 (596)
                      ..... .          .....+......+.+++..|++.+|.+||++    +++++
T Consensus       231 ~~~~~-~----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         231 FQKIL-K----------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             HHHHH-h----------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            01111 0          0111222334567888999999999999999    66653

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.6e-32  Score=285.17  Aligned_cols=249  Identities=21%  Similarity=0.236  Sum_probs=184.2

Q ss_pred             CCCccceeecCCceEEEEEEcC-C--CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeC----Ce
Q 047719          285 GFNKNRIVGEGASATVYKGSLP-S--GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG----NE  357 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~-~--g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~----~~  357 (596)
                      +|...+.||+|+||.||++... .  +..||||++..........+.+.+|+..+.+...|+||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4677789999999999999864 3  678999998643222223456778887776644699999999876433    45


Q ss_pred             EEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCc
Q 047719          358 LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT  437 (596)
Q Consensus       358 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~  437 (596)
                      .++++||+. ++|.+++....    .+++..+..++.||+.||.|||+   .+++||||||+|||++.++.+||+|||.+
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a  152 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQ----PLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLA  152 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence            789999986 69999987543    48899999999999999999999   89999999999999999999999999975


Q ss_pred             c---------------cCCCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCCh-hHHHHHHHHHh-----
Q 047719          438 I---------------PAGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGC-VIVDWVWNLRK-----  495 (596)
Q Consensus       438 ~---------------~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~-~~~~~~~~~~~-----  495 (596)
                      .               ..||..|+|||.+.+ ..++.++|+|||||++|||++|+.||...+. ...........     
T Consensus       153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  232 (332)
T cd07857         153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE  232 (332)
T ss_pred             eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            3               247888999998765 4689999999999999999999999976432 11110000000     


Q ss_pred             ------cCCchhh-------ccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          496 ------KGKLLDA-------ADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       496 ------~~~~~~~-------~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                            .......       ....+. .........+..++.+|++.||++|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         233 TLSRIGSPKAQNYIRSLPNIPKKPFE-SIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HHHhhhhhhHHHHHHhccccCCcchH-hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                  0000000       000000 000112356778899999999999999999875

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.5e-32  Score=287.32  Aligned_cols=245  Identities=23%  Similarity=0.275  Sum_probs=185.6

Q ss_pred             ccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhc------------ccchHHHHHHHHHhccCCCceeeecceeee
Q 047719          288 KNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVEC------------ARNPFTTEFATMAGCLRHKNLVQLQGWCCE  354 (596)
Q Consensus       288 ~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~------------~~~~~~~E~~~l~~~l~H~niv~l~g~~~~  354 (596)
                      ..+.||+|+||.||+|... +++.||||++........            ....+.+|+..+.. ++|+||+++++++..
T Consensus        13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~   91 (335)
T PTZ00024         13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE-IKHENIMGLVDVYVE   91 (335)
T ss_pred             hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHh-CCCcceeeeeEEEec
Confidence            3577999999999999865 589999999864332210            01246788865554 899999999999999


Q ss_pred             CCeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccC
Q 047719          355 GNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF  434 (596)
Q Consensus       355 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Df  434 (596)
                      .+..++||||+. |+|.+++....    .+++.....++.|++.||+|||+   .+++|+||||+||+++.++.+||+||
T Consensus        92 ~~~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~df  163 (335)
T PTZ00024         92 GDFINLVMDIMA-SDLKKVVDRKI----RLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADF  163 (335)
T ss_pred             CCcEEEEEeccc-cCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEECCc
Confidence            999999999996 69999997543    48899999999999999999999   89999999999999999999999999


Q ss_pred             CCcccC-------------------------CCcccCCccccccC-CCCCccceeehhHHHHHHHhCCCCCCCCCh-hHH
Q 047719          435 EATIPA-------------------------GTMGYLAPEYVYSG-VPSEKTDVYSFGVVALEVAAGKSPVDNDGC-VIV  487 (596)
Q Consensus       435 g~~~~~-------------------------gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~El~tG~~p~~~~~~-~~~  487 (596)
                      |.+...                         ++..|+|||.+.+. .++.++|||||||++|||++|+.||...+. ...
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~  243 (335)
T PTZ00024        164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL  243 (335)
T ss_pred             cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            876432                         36679999998764 468999999999999999999999976543 111


Q ss_pred             HHHHHHHhcCCch---hhc------------cccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          488 DWVWNLRKKGKLL---DAA------------DFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       488 ~~~~~~~~~~~~~---~~~------------d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ..+..........   ...            ..... .........+.+++..|++.+|++||+++|++.
T Consensus       244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             HHHHHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            1121111111000   000            00000 000112356778899999999999999999986

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.2e-33  Score=306.64  Aligned_cols=255  Identities=19%  Similarity=0.237  Sum_probs=177.0

Q ss_pred             hcCCCccceeecCCceEEEEEEcCC--CCEEEEEEe--------------ec-CCchhcccchHHHHHHHHHhccCCCce
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLPS--GGAVAVKRF--------------EK-PNRVECARNPFTTEFATMAGCLRHKNL  345 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~~--g~~vAvK~l--------------~~-~~~~~~~~~~~~~E~~~l~~~l~H~ni  345 (596)
                      ..+|...+.||+|+||+||++..+.  +...++|.+              .+ ..........+.+|+..+.+ ++|+||
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~-l~HpnI  225 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGR-LNHENI  225 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHh-CCCCCc
Confidence            4578999999999999999986532  222222211              00 01111223457788866655 899999


Q ss_pred             eeecceeeeCCeEEEEEecCCCCCHHHHhhhCCCC-CcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeec
Q 047719          346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSS-SIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLD  424 (596)
Q Consensus       346 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~  424 (596)
                      |++++++...+..|+|+|++. ++|.+++...... ...........++.||+.||+|||+   ++|+||||||+|||++
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl~  301 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLN  301 (501)
T ss_pred             CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEC
Confidence            999999999999999999985 5888887654211 1123355677899999999999999   8999999999999999


Q ss_pred             CCCceEEccCCCcc------------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCC-CCCCCChhHHHHHH
Q 047719          425 AEFNAKLGDFEATI------------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKS-PVDNDGCVIVDWVW  491 (596)
Q Consensus       425 ~~~~~kl~Dfg~~~------------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~-p~~~~~~~~~~~~~  491 (596)
                      .++.+||+|||++.            ..||..|+|||++.+..++.++|||||||++|||++|.. |+..........+.
T Consensus       302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~  381 (501)
T PHA03210        302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL  381 (501)
T ss_pred             CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence            99999999999863            248999999999999999999999999999999999875 44432211111111


Q ss_pred             HHHhc-C----C-------chhhcccc-c--cCcCCHH------HHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          492 NLRKK-G----K-------LLDAADFR-L--RGKFNRK------EMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       492 ~~~~~-~----~-------~~~~~d~~-l--~~~~~~~------~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ..... .    .       +.+.++.. .  .......      ....+.+++.+|++.||++|||+.|+++
T Consensus       382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            11100 0    0       00000000 0  0000000      1123556678999999999999999986

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-33  Score=274.26  Aligned_cols=237  Identities=26%  Similarity=0.309  Sum_probs=186.5

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccc-hHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARN-PFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~-~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      ++|...++||+|.||+|-+++-+ .++.+|||++++.-.....+. --+.|-+.+ +..+||.+..|-..++..+++|+|
T Consensus       168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL-~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVL-QNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHH-HhccCcHHHHhhhhhccCceEEEE
Confidence            56888899999999999999765 589999999987544332222 223444344 448999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCc----
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT----  437 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~----  437 (596)
                      |||..+|.|.-+|....    .+++....-....|..||.|||+   ++||.||||.+|.|||.+|++||+|||++    
T Consensus       247 MeyanGGeLf~HLsrer----~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I  319 (516)
T KOG0690|consen  247 MEYANGGELFFHLSRER----VFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI  319 (516)
T ss_pred             EEEccCceEeeehhhhh----cccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhcc
Confidence            99999999999998754    57888888889999999999999   99999999999999999999999999975    


Q ss_pred             -------ccCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCCh-hHHHHHHHHHhcCCchhhccccccC
Q 047719          438 -------IPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGC-VIVDWVWNLRKKGKLLDAADFRLRG  509 (596)
Q Consensus       438 -------~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~~  509 (596)
                             ..+||+.|+|||++....|....|+|.+||++|||+||+.||...+. .+.+.          .-+-+.+...
T Consensus       320 ~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeL----------Il~ed~kFPr  389 (516)
T KOG0690|consen  320 KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFEL----------ILMEDLKFPR  389 (516)
T ss_pred             cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHH----------HHhhhccCCc
Confidence                   35799999999999999999999999999999999999999976432 11111          1111222222


Q ss_pred             cCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 047719          510 KFNRKEMERMLMVGLSCVHPNHEKRP-----SVKEAAR  542 (596)
Q Consensus       510 ~~~~~~~~~l~~l~~~C~~~dp~~RP-----s~~ev~~  542 (596)
                      ...    .....|....+..||++|.     .+.||.+
T Consensus       390 ~ls----~eAktLLsGLL~kdP~kRLGgGpdDakEi~~  423 (516)
T KOG0690|consen  390 TLS----PEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR  423 (516)
T ss_pred             cCC----HHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence            222    2333344456789999997     3566654

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-33  Score=294.71  Aligned_cols=238  Identities=25%  Similarity=0.316  Sum_probs=191.4

Q ss_pred             CCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEec
Q 047719          286 FNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEY  364 (596)
Q Consensus       286 f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~  364 (596)
                      +.+...||.|+||+|||+..++ +-..|-|++  ...++...++|+-||.++.. ..||+||+|++.|.-.+.++++.||
T Consensus        34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvI--etkseEELEDylVEIeILa~-CdHP~ivkLl~ayy~enkLwiliEF  110 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVI--ETKSEEELEDYLVEIEILAE-CDHPVIVKLLSAYYFENKLWILIEF  110 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcccchhhhhhhhh--cccchhHHhhhhhhhhhhhc-CCChHHHHHHHHHhccCceEEEEee
Confidence            3455779999999999998776 445677887  34456677789999977766 7899999999999999999999999


Q ss_pred             CCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc------
Q 047719          365 LPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI------  438 (596)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~------  438 (596)
                      |.||-.+..+-.-.   .+|...++.-+++|++.||.|||+   +.|||||||+.|||++-+|.++|+|||.+.      
T Consensus       111 C~GGAVDaimlEL~---r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~  184 (1187)
T KOG0579|consen  111 CGGGAVDAIMLELG---RVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR  184 (1187)
T ss_pred             cCCchHhHHHHHhc---cccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchhHH
Confidence            99999999887643   369999999999999999999999   999999999999999999999999999764      


Q ss_pred             -----cCCCcccCCccccc-----cCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhcccccc
Q 047719          439 -----PAGTMGYLAPEYVY-----SGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLR  508 (596)
Q Consensus       439 -----~~gt~~y~aPE~~~-----~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  508 (596)
                           ..||+.|||||+++     ..+|..++||||||+.|.||..+.+|...-..  ...+...... .     .+.+ 
T Consensus       185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp--MRVllKiaKS-e-----PPTL-  255 (1187)
T KOG0579|consen  185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP--MRVLLKIAKS-E-----PPTL-  255 (1187)
T ss_pred             hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch--HHHHHHHhhc-C-----CCcc-
Confidence                 35999999999875     36799999999999999999999999765321  1111111111 0     0111 


Q ss_pred             CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          509 GKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       509 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                       ..+..-...+-++...|+..||..||++.++++
T Consensus       256 -lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  256 -LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             -cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence             112234456677778999999999999998876

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-32  Score=276.95  Aligned_cols=249  Identities=27%  Similarity=0.319  Sum_probs=189.6

Q ss_pred             CCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEec
Q 047719          286 FNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEY  364 (596)
Q Consensus       286 f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~  364 (596)
                      |...+.||+|+||.||+|.... ++.||+|++......+.....+..|+..+.. ++|+|++++++++...+..++||||
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~-~~~~~i~~~~~~~~~~~~~~~v~e~   79 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKE-LKHPNIVKLLDVIHTERKLYLVFEY   79 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHh-cCCCCHHHHHhhhhcCCceEEEecC
Confidence            4456789999999999998764 8999999997544233334567788866554 8999999999999999999999999


Q ss_pred             CCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc-----
Q 047719          365 LPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP-----  439 (596)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~-----  439 (596)
                      ++ ++|.+++....   ..+++..++.++.|++.||+|||+   .+++||||+|+||++++++.+||+|||.+..     
T Consensus        80 ~~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~  152 (282)
T cd07829          80 CD-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL  152 (282)
T ss_pred             cC-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCc
Confidence            98 59999998753   248999999999999999999999   8999999999999999999999999987542     


Q ss_pred             ------CCCcccCCccccccC-CCCCccceeehhHHHHHHHhCCCCCCCCChh-HHHHHHHHHhcC---------Cch--
Q 047719          440 ------AGTMGYLAPEYVYSG-VPSEKTDVYSFGVVALEVAAGKSPVDNDGCV-IVDWVWNLRKKG---------KLL--  500 (596)
Q Consensus       440 ------~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~El~tG~~p~~~~~~~-~~~~~~~~~~~~---------~~~--  500 (596)
                            .++..|+|||.+... .++.++|||||||++|||++|+.||...... ............         .+.  
T Consensus       153 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
T cd07829         153 RTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY  232 (282)
T ss_pred             cccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence                  245679999998776 8899999999999999999999999764321 111111100000         000  


Q ss_pred             hhccccccC----cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          501 DAADFRLRG----KFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       501 ~~~d~~l~~----~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      +..-+....    .........+.+++..|++.+|++||++++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            000000000    000112456888999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.9e-32  Score=287.43  Aligned_cols=251  Identities=20%  Similarity=0.233  Sum_probs=184.6

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeC-------
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG-------  355 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~-------  355 (596)
                      .+|...+.||.|+||.||+|... +++.||+|++.....  ...+.+.+|+..+.. ++||||+++++.+...       
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~-l~h~~i~~~~~~~~~~~~~~~~~   81 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRR-LDHDNIVKVYEVLGPSGSDLTED   81 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHh-cCCCcchhhHhhhcccccccccc
Confidence            56888899999999999999765 488999999864432  334567788866655 8999999999876554       


Q ss_pred             -------CeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecC-CC
Q 047719          356 -------NELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDA-EF  427 (596)
Q Consensus       356 -------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~-~~  427 (596)
                             ...++||||++ ++|.+++...     .+++.....++.||++||.|||+   .+++||||||+||+++. ++
T Consensus        82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~  152 (342)
T cd07854          82 VGSLTELNSVYIVQEYME-TDLANVLEQG-----PLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDL  152 (342)
T ss_pred             cccccccceEEEEeeccc-ccHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCc
Confidence                   35899999997 5999988653     38899999999999999999999   89999999999999974 56


Q ss_pred             ceEEccCCCccc--------------CCCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCChhH--HHHH
Q 047719          428 NAKLGDFEATIP--------------AGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVI--VDWV  490 (596)
Q Consensus       428 ~~kl~Dfg~~~~--------------~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~--~~~~  490 (596)
                      .+||+|||.+..              .++..|+|||.+.. ..++.++|||||||++|||++|+.||.......  ....
T Consensus       153 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~  232 (342)
T cd07854         153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL  232 (342)
T ss_pred             eEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            789999997632              35778999998754 567889999999999999999999997543210  0000


Q ss_pred             HHHHh-----cCCch----hhcc-ccccCc-----CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhc
Q 047719          491 WNLRK-----KGKLL----DAAD-FRLRGK-----FNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKG  546 (596)
Q Consensus       491 ~~~~~-----~~~~~----~~~d-~~l~~~-----~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~~  546 (596)
                      .....     .....    .... ......     ........+.+++.+|++.||++|||+.|+++  +++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~  305 (342)
T cd07854         233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC  305 (342)
T ss_pred             HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence            00000     00000    0000 000000     00112345778899999999999999999985  5543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.1e-32  Score=287.36  Aligned_cols=249  Identities=21%  Similarity=0.269  Sum_probs=189.8

Q ss_pred             HhcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCe---
Q 047719          282 ATLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNE---  357 (596)
Q Consensus       282 at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~---  357 (596)
                      ..++|...+.||+|+||.||+|... +++.||||++............+.+|+..+.. ++|+|++++++++.....   
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKH-MDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHh-ccCCCHHHHHHHhhccccccc
Confidence            3567888899999999999999875 47899999986543333334557788866554 899999999998876654   


Q ss_pred             ---EEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccC
Q 047719          358 ---LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF  434 (596)
Q Consensus       358 ---~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Df  434 (596)
                         .++|+||+ +++|.+++...     .+++..+..++.|+++||+|||+   .+++||||||+||+++.++.+||+||
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~df  162 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKCQ-----KLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDF  162 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEccc
Confidence               89999999 66999998753     48999999999999999999999   89999999999999999999999999


Q ss_pred             CCccc--------CCCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhc-CCchh---
Q 047719          435 EATIP--------AGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKK-GKLLD---  501 (596)
Q Consensus       435 g~~~~--------~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~-~~~~~---  501 (596)
                      |.+..        .++..|+|||.+.. ..++.++|||||||++|||++|+.||......  +.+...... +...+   
T Consensus       163 g~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~--~~~~~i~~~~~~~~~~~~  240 (343)
T cd07851         163 GLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI--DQLKRIMNLVGTPDEELL  240 (343)
T ss_pred             cccccccccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHhcCCCCHHHH
Confidence            97643        46788999998865 46789999999999999999999999764321  111111000 00000   


Q ss_pred             ----------h---ccccccCcC---CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          502 ----------A---ADFRLRGKF---NRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       502 ----------~---~d~~l~~~~---~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                                .   ........+   .......+.+++.+|++++|++|||+.||++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             hhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence                      0   000000000   0112456788999999999999999999976

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-32  Score=267.15  Aligned_cols=247  Identities=26%  Similarity=0.366  Sum_probs=193.2

Q ss_pred             CHHHHHHHhcCCCccceeecCCceEEEEEE-cCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceee
Q 047719          275 ALTDIKQATLGFNKNRIVGEGASATVYKGS-LPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCC  353 (596)
Q Consensus       275 ~~~el~~at~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~  353 (596)
                      .+.|+-+.|.     +.||+|+|+.|--+. +.+|.++|||++.+.  ....+...++|++.+...-.|+||++|+.||.
T Consensus        74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefFE  146 (463)
T KOG0607|consen   74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFFE  146 (463)
T ss_pred             hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHhc
Confidence            3566666664     789999999998875 557999999999654  44566778999999998889999999999999


Q ss_pred             eCCeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCC---CceE
Q 047719          354 EGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAE---FNAK  430 (596)
Q Consensus       354 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~---~~~k  430 (596)
                      ++..+|||||-|.+|+|..+|+++.    .+++.++.+++.+|+.||.|||.   ++|.||||||+|||-..-   .-+|
T Consensus       147 dd~~FYLVfEKm~GGplLshI~~~~----~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvK  219 (463)
T KOG0607|consen  147 DDTRFYLVFEKMRGGPLLSHIQKRK----HFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVK  219 (463)
T ss_pred             ccceEEEEEecccCchHHHHHHHhh----hccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCcee
Confidence            9999999999999999999999865    48899999999999999999999   999999999999999654   3489


Q ss_pred             EccCCC------------------cccCCCcccCCccccc-----cCCCCCccceeehhHHHHHHHhCCCCCCCCCh---
Q 047719          431 LGDFEA------------------TIPAGTMGYLAPEYVY-----SGVPSEKTDVYSFGVVALEVAAGKSPVDNDGC---  484 (596)
Q Consensus       431 l~Dfg~------------------~~~~gt~~y~aPE~~~-----~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~---  484 (596)
                      ||||.+                  ..++|+..|||||+..     ...|..++|.||||||||-|++|.+||.+.-.   
T Consensus       220 iCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC  299 (463)
T KOG0607|consen  220 ICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC  299 (463)
T ss_pred             eeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC
Confidence            999942                  3457889999999764     24688999999999999999999999976311   


Q ss_pred             ------hHHHHHHHHHhcCCchhhccccccCcCCHHH----HHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          485 ------VIVDWVWNLRKKGKLLDAADFRLRGKFNRKE----MERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       485 ------~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~----~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                            ....+...+      .+.+... .-++++++    .....+++...+..++.+|-++.++++
T Consensus       300 GWdrGe~Cr~CQ~~L------FesIQEG-kYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  300 GWDRGEVCRVCQNKL------FESIQEG-KYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             CccCCCccHHHHHHH------HHHHhcc-CCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence                  111111111      1111111 11233332    334455666677799999999988876

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.98  E-value=4e-34  Score=271.95  Aligned_cols=241  Identities=28%  Similarity=0.316  Sum_probs=188.4

Q ss_pred             cceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecCCC
Q 047719          289 NRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPN  367 (596)
Q Consensus       289 ~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  367 (596)
                      ...||.|.||+|+|-.++ .|+..|||+++.... +...++++.|.....+.-+.||||+++|.+...+..++-||.|. 
T Consensus        69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-  146 (361)
T KOG1006|consen   69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-  146 (361)
T ss_pred             HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-
Confidence            367999999999998765 599999999975443 55667899999888887899999999999999999999999995 


Q ss_pred             CCHHHHhh---hCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCc-------
Q 047719          368 GSLDKILH---NNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT-------  437 (596)
Q Consensus       368 gsL~~~l~---~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~-------  437 (596)
                      -||+.+-.   .-.  ...+++.-.-+|..-...||.||..+  ..|||||+||+|||||..|.+||||||++       
T Consensus       147 ~SlDklYk~vy~vq--~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si  222 (361)
T KOG1006|consen  147 ISLDKLYKRVYSVQ--KSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI  222 (361)
T ss_pred             hhHHHHHHHHHHHH--hccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHHH
Confidence            47665543   222  23477777778888899999999986  88999999999999999999999999975       


Q ss_pred             ---ccCCCcccCCcccccc--CCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccC-cC
Q 047719          438 ---IPAGTMGYLAPEYVYS--GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRG-KF  511 (596)
Q Consensus       438 ---~~~gt~~y~aPE~~~~--~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~-~~  511 (596)
                         ..+|...|||||.+..  ..|..+|||||||++|+|++||+.||..... +.+.+.+.... ...     .+.. .-
T Consensus       223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-vfeql~~Vv~g-dpp-----~l~~~~~  295 (361)
T KOG1006|consen  223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-VFEQLCQVVIG-DPP-----ILLFDKE  295 (361)
T ss_pred             HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-HHHHHHHHHcC-CCC-----eecCccc
Confidence               3468899999999864  3489999999999999999999999987543 22322222221 111     1111 11


Q ss_pred             CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          512 NRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       512 ~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ..+....+...+-.|+-.|-+.||...++.+
T Consensus       296 ~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  296 CVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             ccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence            1224456777788899999999999988765

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=6.3e-33  Score=306.54  Aligned_cols=200  Identities=27%  Similarity=0.334  Sum_probs=173.2

Q ss_pred             HHHHHHHhcCCCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeee
Q 047719          276 LTDIKQATLGFNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE  354 (596)
Q Consensus       276 ~~el~~at~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~  354 (596)
                      ..+++-...+|.+.++||+|+||.|..++.+. ++.||+|++.+..........++.|.+.+....+.+-||.|+..|.+
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD  146 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD  146 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence            45666667789999999999999999998865 78899999976444444445566666565555778999999999999


Q ss_pred             CCeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccC
Q 047719          355 GNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF  434 (596)
Q Consensus       355 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Df  434 (596)
                      ..++|+|||||+||+|...|....    .+++..+.-++..|..||.-||+   .|+|||||||.|||||..|++||+||
T Consensus       147 ~~~LYlVMdY~pGGDlltLlSk~~----~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLADF  219 (1317)
T KOG0612|consen  147 ERYLYLVMDYMPGGDLLTLLSKFD----RLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLADF  219 (1317)
T ss_pred             ccceEEEEecccCchHHHHHhhcC----CChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeeccc
Confidence            999999999999999999998654    47888888899999999999999   99999999999999999999999999


Q ss_pred             CCc------------ccCCCcccCCccccc----c-CCCCCccceeehhHHHHHHHhCCCCCCCC
Q 047719          435 EAT------------IPAGTMGYLAPEYVY----S-GVPSEKTDVYSFGVVALEVAAGKSPVDND  482 (596)
Q Consensus       435 g~~------------~~~gt~~y~aPE~~~----~-~~~t~~sDV~SfGvll~El~tG~~p~~~~  482 (596)
                      |.+            ..+|||.|++||++.    + +.|++.+|+||+||++|||+.|..||-.+
T Consensus       220 GsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad  284 (1317)
T KOG0612|consen  220 GSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD  284 (1317)
T ss_pred             hhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH
Confidence            864            357999999999985    2 67999999999999999999999999754

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.98  E-value=5.8e-32  Score=269.75  Aligned_cols=227  Identities=27%  Similarity=0.292  Sum_probs=184.1

Q ss_pred             eecCCceEEEEEEcC-CCCEEEEEEeecCCchh-cccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecCCCCC
Q 047719          292 VGEGASATVYKGSLP-SGGAVAVKRFEKPNRVE-CARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGS  369 (596)
Q Consensus       292 LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~-~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  369 (596)
                      ||+|+||.||++... +++.+|+|.+.+..... .....+..|+..+ +.++|+||+++++.+..+...++||||+++++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~   79 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNIL-SRINHPFIVKLHYAFQTEEKLYLVLEYAPGGE   79 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHH-HHcCCCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence            699999999999875 48899999986543221 2344677888555 45899999999999999999999999999999


Q ss_pred             HHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc----------
Q 047719          370 LDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP----------  439 (596)
Q Consensus       370 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~----------  439 (596)
                      |.+++....    .+++.....++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||.+..          
T Consensus        80 L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~  152 (250)
T cd05123          80 LFSHLSKEG----RFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT  152 (250)
T ss_pred             HHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccC
Confidence            999998653    48999999999999999999999   8999999999999999999999999987532          


Q ss_pred             -CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHHHHHH
Q 047719          440 -AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMER  518 (596)
Q Consensus       440 -~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~  518 (596)
                       .++..|++||...+...+.++|+||||+++|||++|+.||...+.  ......... .          ...++......
T Consensus       153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--~~~~~~~~~-~----------~~~~~~~~~~~  219 (250)
T cd05123         153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--KEIYEKILK-D----------PLRFPEFLSPE  219 (250)
T ss_pred             CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHhc-C----------CCCCCCCCCHH
Confidence             367889999999888899999999999999999999999976542  111111111 0          01122222456


Q ss_pred             HHHHHHHcCCCCCCCCCCHHH
Q 047719          519 MLMVGLSCVHPNHEKRPSVKE  539 (596)
Q Consensus       519 l~~l~~~C~~~dp~~RPs~~e  539 (596)
                      +.+++.+|+..||++||++.+
T Consensus       220 l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         220 ARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             HHHHHHHHhcCCHhhCCCccc
Confidence            678889999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd01951 lectin_L-type legume lectins

Probab=99.98  E-value=1.4e-31  Score=263.42  Aligned_cols=160  Identities=25%  Similarity=0.331  Sum_probs=133.7

Q ss_pred             cceEEEEEEEEecCCCCCCCCeEEEEEecCCC-CCCCCC--CccCCCCCCCCCCCceEEEEeeCccCCCCCCCCCCeeEE
Q 047719           10 ASFSCRFSFSIIPSPLCAFGDGFAFLITSNAD-SFGNDN--GYMGLPGPVLSPQDSFFAVEFDTSFDPSLGDINGNHIGI   86 (596)
Q Consensus        10 asF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~-~~~~~~--~~lG~~~~~~~~~~~~~AVEfDt~~~~~~~d~~~~Hvgi   86 (596)
                      ++|+|+|+|.|.... ..+||||||+|+|.+. +.+.+|  ++||+.     ..++.+||||||++|.+++||+.|||||
T Consensus        54 ~~F~~~F~f~i~~~~-~~~gdG~aF~l~~~~~~~~~~~g~~~~lG~~-----~~~~~~aVefDT~~N~~~~dp~~~higi  127 (223)
T cd01951          54 KDFTTTFKFYLGTKG-TNGADGIAFVLQNDPAGALGGGGGGGGLGYG-----GIGNSVAVEFDTYKNDDNNDPNGNHISI  127 (223)
T ss_pred             CCEEEEEEEEEeCCC-CCCCCcEEEEEecCCCCccccCCCCCccCcc-----ccCCeEEEEEeccccCCCCCCCCCEEEE
Confidence            799999999998764 5679999999999876 444444  788863     3567899999999999888999999999


Q ss_pred             ecCCcccc-------ccccCCCCCcccCCCceEEEEEEEcCCccEEEEEEeeCCCCCCCCeEEEeecCcccCCCceEEEE
Q 047719           87 DISSVISF-------VSVDALSRGIDLKSGRHITTWIEYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGF  159 (596)
Q Consensus        87 d~ns~~s~-------~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~l~~~vdl~~~l~~~~~vGF  159 (596)
                      |+|+..+.       .+..+   +....+|+.++|||+||+.+++|+|++..... +..|.++.++||+..++++|||||
T Consensus       128 ~~n~~~~~~~~~~~~~~~~~---~~~~~~g~~~~v~I~Y~~~~~~L~v~l~~~~~-~~~~~l~~~~~l~~~~~~~~yvGF  203 (223)
T cd01951         128 DVNGNGNNTALATSLGSASL---PNGTGLGNEHTVRITYDPTTNTLTVYLDNGST-LTSLDITIPVDLIQLGPTKAYFGF  203 (223)
T ss_pred             EcCCCCCCcccccccceeeC---CCccCCCCEEEEEEEEeCCCCEEEEEECCCCc-cccccEEEeeeecccCCCcEEEEE
Confidence            99999753       22221   22222389999999999999999999987443 667899999999999999999999


Q ss_pred             EeecCCccceeeeeeeeeec
Q 047719          160 SAANGQGSAIYTVDRWRFKT  179 (596)
Q Consensus       160 sastg~~~~~~~i~~Wsf~~  179 (596)
                      |||||...+.|.|++|+|+.
T Consensus       204 TAsTG~~~~~h~V~~wsf~~  223 (223)
T cd01951         204 TASTGGLTNLHDILNWSFTS  223 (223)
T ss_pred             EcccCCCcceeEEEEEEecC
Confidence            99999999999999999973

The L-type (legume-type) lectins are a highly diverse family of carbohydrate binding proteins that generally display no enzymatic activity toward the sugars they bind. This family includes arcelin, concanavalinA, the lectin-like receptor kinases, the ERGIC-53/VIP36/EMP46 type1 transmembrane proteins, and an alpha-amylase inhibitor. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded sheet and homotetramers occur by a back-to-back association of these homodimers. Though L-type lectins exhibit both sequence and structural similarity to one another, their carbohydrate binding specificities differ widely.

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.98  E-value=7.2e-32  Score=268.10  Aligned_cols=212  Identities=21%  Similarity=0.175  Sum_probs=169.9

Q ss_pred             CCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecCCCCCHHHH
Q 047719          295 GASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKI  373 (596)
Q Consensus       295 G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~  373 (596)
                      |.||.||++... +++.||+|++.+..       .+..|...+.. ..|||++++++++.+....++||||+++|+|.++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~-~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   75 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIP-HCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH   75 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHh-cCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence            889999999865 58899999996532       12334333333 5799999999999999999999999999999999


Q ss_pred             hhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc--------cCCCccc
Q 047719          374 LHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI--------PAGTMGY  445 (596)
Q Consensus       374 l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~--------~~gt~~y  445 (596)
                      +....    .+++.....++.|+++||.|||+   .+++||||||+||+++.++.++++|||...        ..++..|
T Consensus        76 l~~~~----~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~y  148 (237)
T cd05576          76 ISKFL----NIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMY  148 (237)
T ss_pred             HHHhc----CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhccccccccCCcCccc
Confidence            97653    38999999999999999999999   899999999999999999999999998643        2356679


Q ss_pred             CCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHH
Q 047719          446 LAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLS  525 (596)
Q Consensus       446 ~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~  525 (596)
                      +|||.+....++.++||||+||++|||++|+.|+.......             ......    ..+......+.+++.+
T Consensus       149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-------------~~~~~~----~~~~~~~~~~~~li~~  211 (237)
T cd05576         149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-------------NTHTTL----NIPEWVSEEARSLLQQ  211 (237)
T ss_pred             cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-------------cccccc----CCcccCCHHHHHHHHH
Confidence            99999988889999999999999999999998875421100             000000    1122233556778899


Q ss_pred             cCCCCCCCCCCHH
Q 047719          526 CVHPNHEKRPSVK  538 (596)
Q Consensus       526 C~~~dp~~RPs~~  538 (596)
                      |++.||++||++.
T Consensus       212 ~l~~dp~~R~~~~  224 (237)
T cd05576         212 LLQFNPTERLGAG  224 (237)
T ss_pred             HccCCHHHhcCCC
Confidence            9999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.98  E-value=1.6e-32  Score=266.08  Aligned_cols=193  Identities=21%  Similarity=0.312  Sum_probs=161.9

Q ss_pred             CCCccceeecCCceEEEEEEcCC-----CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeee-CCeE
Q 047719          285 GFNKNRIVGEGASATVYKGSLPS-----GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE-GNEL  358 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~~-----g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~-~~~~  358 (596)
                      .|+....||+|.||.|||+.-.+     ...+|||+++.+.....-.....+|+ .+.+.++||||+.|..++.+ +..+
T Consensus        25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREi-aL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREI-ALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHH-HHHHHhcCCcchhHHHHHhccCceE
Confidence            57777899999999999995322     33799999976654444445678898 55566999999999999888 7889


Q ss_pred             EEEEecCCCCCHHHHhhhCCC-CCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCC----CceEEcc
Q 047719          359 VLVYEYLPNGSLDKILHNNSS-SSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAE----FNAKLGD  433 (596)
Q Consensus       359 ~lV~E~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~----~~~kl~D  433 (596)
                      +|++||.+. +|...|+-.+. ....++......|+.||+.|+.|||+   +=|+||||||.|||+..+    |.+||+|
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEeec
Confidence            999999987 89998865432 23468889999999999999999999   779999999999999877    9999999


Q ss_pred             CCCccc--------------CCCcccCCccccccC-CCCCccceeehhHHHHHHHhCCCCCCCC
Q 047719          434 FEATIP--------------AGTMGYLAPEYVYSG-VPSEKTDVYSFGVVALEVAAGKSPVDND  482 (596)
Q Consensus       434 fg~~~~--------------~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~El~tG~~p~~~~  482 (596)
                      +|+++.              +-|..|.|||++.+. .||.+.||||.|||..||+|-++.|.+.
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~  243 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR  243 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence            998653              357899999999874 6899999999999999999999888654

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.98  E-value=2.5e-32  Score=290.65  Aligned_cols=192  Identities=34%  Similarity=0.455  Sum_probs=163.8

Q ss_pred             CCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCC------eE
Q 047719          286 FNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGN------EL  358 (596)
Q Consensus       286 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~------~~  358 (596)
                      +...+.||+|+||.||+|+.+ .|+.||||.+++.. .....+...+|++.|.+ ++|+|||++++.-.+..      ..
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkK-Lnh~NIVk~f~iee~~~~~~~~~~~   92 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKK-LNHPNIVKLFDIEETKFLGLVTRLP   92 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHH-cCchhhhhhcccCCccccCcccccc
Confidence            345678999999999999965 59999999997543 33445667899977766 88999999999866543      57


Q ss_pred             EEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeec----CCCceEEccC
Q 047719          359 VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLD----AEFNAKLGDF  434 (596)
Q Consensus       359 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~----~~~~~kl~Df  434 (596)
                      .+|||||.+|||+..|.+..+ ...|++.+.+.++.+++.||.|||+   ++|+||||||.||++-    ....-||+||
T Consensus        93 vlvmEyC~gGsL~~~L~~PEN-~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDf  168 (732)
T KOG4250|consen   93 VLVMEYCSGGSLRKVLNSPEN-AYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDF  168 (732)
T ss_pred             eEEEeecCCCcHHHHhcCccc-ccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeecc
Confidence            899999999999999987543 3459999999999999999999998   9999999999999993    2345899999


Q ss_pred             CCcc----------cCCCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCC
Q 047719          435 EATI----------PAGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDG  483 (596)
Q Consensus       435 g~~~----------~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~  483 (596)
                      |.++          .+||..|++||++.. +.|+..+|.|||||++||++||..||....
T Consensus       169 G~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~  228 (732)
T KOG4250|consen  169 GAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG  228 (732)
T ss_pred             cccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence            9875          369999999999985 889999999999999999999999997654

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=1.5e-32  Score=274.43  Aligned_cols=231  Identities=23%  Similarity=0.270  Sum_probs=186.2

Q ss_pred             CCCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCchhc-ccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          285 GFNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRVEC-ARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~-~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      +|+...+||+|+||+|.++.-+. .+.+|||++++.-..+. ..+--+.|-+.+.-.-+-|.+++|..+++..+.+|+||
T Consensus       350 DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVM  429 (683)
T KOG0696|consen  350 DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVM  429 (683)
T ss_pred             ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEE
Confidence            58888999999999999997654 67899999987543322 22223345445544457899999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc----
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI----  438 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~----  438 (596)
                      ||+.+|+|..++++-+.    +.+..+.-.+.+||-||-|||+   ++||.||||..|||||.+|++||+|||++.    
T Consensus       430 EyvnGGDLMyhiQQ~Gk----FKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~  502 (683)
T KOG0696|consen  430 EYVNGGDLMYHIQQVGK----FKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF  502 (683)
T ss_pred             EEecCchhhhHHHHhcc----cCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeeccccccccc
Confidence            99999999999998663    6677888899999999999999   999999999999999999999999999753    


Q ss_pred             -------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcC
Q 047719          439 -------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKF  511 (596)
Q Consensus       439 -------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  511 (596)
                             .+||+.|+|||.+..+.|+..+|+|||||+||||+.|++||+++++.-.  .......           .-.|
T Consensus       503 ~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el--F~aI~eh-----------nvsy  569 (683)
T KOG0696|consen  503 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL--FQAIMEH-----------NVSY  569 (683)
T ss_pred             CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH--HHHHHHc-----------cCcC
Confidence                   4699999999999999999999999999999999999999998654211  1111111           1234


Q ss_pred             CHHHHHHHHHHHHHcCCCCCCCCC
Q 047719          512 NRKEMERMLMVGLSCVHPNHEKRP  535 (596)
Q Consensus       512 ~~~~~~~l~~l~~~C~~~dp~~RP  535 (596)
                      +.....+...++..-+...|.+|.
T Consensus       570 PKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  570 PKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             cccccHHHHHHHHHHhhcCCcccc
Confidence            555556666666777788888886

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.97  E-value=4.5e-31  Score=299.52  Aligned_cols=145  Identities=30%  Similarity=0.363  Sum_probs=124.5

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      ++|...+.||+|+||.||+|... +++.||||+++..... ......+..|+..+ ..++|+||+++++++......|||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l-~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDAL-ALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHH-HhcCCCCcCeEEEEEEECCEEEEE
Confidence            46788899999999999999876 5889999999653322 22234567777555 458999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCC
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEA  436 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~  436 (596)
                      |||+++++|.+++....    .+++...+.++.||+.||.|||.   .+|+||||||+||||+.++.+||+|||+
T Consensus        83 mEy~~g~~L~~li~~~~----~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGl  150 (669)
T cd05610          83 MEYLIGGDVKSLLHIYG----YFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGL  150 (669)
T ss_pred             EeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCC
Confidence            99999999999997643    47889999999999999999999   8999999999999999999999999974

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.5e-31  Score=281.03  Aligned_cols=232  Identities=24%  Similarity=0.246  Sum_probs=187.5

Q ss_pred             hcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      +..|.....+|.|+|+.|-++... +++..++|++.+....      -.+|+..+....+|+||+++.+.+.+..+.|+|
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~------~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v  394 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD------NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV  394 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccccc------cccccchhhhhcCCCcceeecceecCCceeeee
Confidence            566777888999999999998754 5889999999654211      223444555557899999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceee-cCCCceEEccCCCc---
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILL-DAEFNAKLGDFEAT---  437 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl-~~~~~~kl~Dfg~~---  437 (596)
                      ||++.++-|.+.+....     ....++..|+.+|+.++.|||+   ++|+||||||+|||+ ++.++++|+|||..   
T Consensus       395 ~e~l~g~ell~ri~~~~-----~~~~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~  466 (612)
T KOG0603|consen  395 MELLDGGELLRRIRSKP-----EFCSEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSEL  466 (612)
T ss_pred             ehhccccHHHHHHHhcc-----hhHHHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhC
Confidence            99999998888887654     2227778899999999999999   999999999999999 68899999999864   


Q ss_pred             -----ccCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCC
Q 047719          438 -----IPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFN  512 (596)
Q Consensus       438 -----~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  512 (596)
                           .++-|..|.|||++....|++++|+||||++||||++|+.||......  .......            ..+.++
T Consensus       467 ~~~~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~~~i------------~~~~~s  532 (612)
T KOG0603|consen  467 ERSCDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIHTRI------------QMPKFS  532 (612)
T ss_pred             chhhcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHHHhh------------cCCccc
Confidence                 345688999999999999999999999999999999999999865332  0011111            122333


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          513 RKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       513 ~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ........+|+.+|++.||.+||+|.++..
T Consensus       533 ~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  533 ECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             cccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence            445566777888999999999999999876

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=8e-31  Score=236.05  Aligned_cols=191  Identities=26%  Similarity=0.398  Sum_probs=165.6

Q ss_pred             CCCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          285 GFNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      +|...++||+|.||+||||+..+ ++.||+|+++.....+.-....++|+..+ +.++|+|||++++....+..+-||+|
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicll-kelkhknivrl~dvlhsdkkltlvfe   81 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLL-KELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHH-HHhhhcceeehhhhhccCceeEEeHH
Confidence            35556889999999999998765 78899999987666555566789999555 55999999999999999999999999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcccC---
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA---  440 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~~---  440 (596)
                      ||.. +|.+|.....+   .++......++.|+.+||.|+|+   +.++|||+||+|.||+.+|..|++|||+++..   
T Consensus        82 ~cdq-dlkkyfdslng---~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgip  154 (292)
T KOG0662|consen   82 FCDQ-DLKKYFDSLNG---DLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP  154 (292)
T ss_pred             HhhH-HHHHHHHhcCC---cCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCc
Confidence            9954 89999876543   48889999999999999999999   89999999999999999999999999987654   


Q ss_pred             --------CCcccCCccccccC-CCCCccceeehhHHHHHHHh-CCCCCCCCC
Q 047719          441 --------GTMGYLAPEYVYSG-VPSEKTDVYSFGVVALEVAA-GKSPVDNDG  483 (596)
Q Consensus       441 --------gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~El~t-G~~p~~~~~  483 (596)
                              -|..|.+|.++.+. -|+...|+||-||++.|+.. |++.|.+.+
T Consensus       155 vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~d  207 (292)
T KOG0662|consen  155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND  207 (292)
T ss_pred             eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCc
Confidence                    47789999999875 58999999999999999998 777777653

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.97  E-value=7.7e-31  Score=253.34  Aligned_cols=248  Identities=19%  Similarity=0.235  Sum_probs=191.7

Q ss_pred             ceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeee----CCeEEEEEec
Q 047719          290 RIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE----GNELVLVYEY  364 (596)
Q Consensus       290 ~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~----~~~~~lV~E~  364 (596)
                      ++||-|-.|+|-.+..+ +++.+|+|++...       ...++|++.--..-.|||||.+++++..    ...+++|||.
T Consensus        68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~  140 (400)
T KOG0604|consen   68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMEC  140 (400)
T ss_pred             hhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeec
Confidence            68999999999998765 5889999998432       2345666544344689999999998764    4578999999


Q ss_pred             CCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecC---CCceEEccCCCcc---
Q 047719          365 LPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDA---EFNAKLGDFEATI---  438 (596)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~---~~~~kl~Dfg~~~---  438 (596)
                      |+||.|...+++++  ...+.+.++-.|+.||+.|+.|||+   ..|.||||||+|+|...   |-.+||+|||.+.   
T Consensus       141 meGGeLfsriq~~g--~~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~  215 (400)
T KOG0604|consen  141 MEGGELFSRIQDRG--DQAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQ  215 (400)
T ss_pred             ccchHHHHHHHHcc--cccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEecccccccccC
Confidence            99999999999876  4569999999999999999999999   99999999999999964   5679999998753   


Q ss_pred             -------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCCh-hHHHHHHHHHhcCCchhhccccccCc
Q 047719          439 -------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGC-VIVDWVWNLRKKGKLLDAADFRLRGK  510 (596)
Q Consensus       439 -------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~~~  510 (596)
                             ++-|+.|.|||++...+|...+|+||+||++|-|+||.+||-.... .+..=.......+.      ..+..+
T Consensus       216 ~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gq------y~FP~p  289 (400)
T KOG0604|consen  216 EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQ------YEFPEP  289 (400)
T ss_pred             CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccC------ccCCCh
Confidence                   4578999999999999999999999999999999999999965321 11110111111111      011111


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhcCCCCCCCCC
Q 047719          511 FNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKGEAPLPLLPV  555 (596)
Q Consensus       511 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~~~~~~p~~p~  555 (596)
                      -.....+...+++...+..+|++|.|+++++.  ++.+...+|..|.
T Consensus       290 EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tpl  336 (400)
T KOG0604|consen  290 EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTPL  336 (400)
T ss_pred             hHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCCc
Confidence            12344566677888889999999999999987  6666666665553

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=2.8e-30  Score=286.51  Aligned_cols=248  Identities=21%  Similarity=0.217  Sum_probs=163.0

Q ss_pred             HhcCCCccceeecCCceEEEEEEcCC-----CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecce-----
Q 047719          282 ATLGFNKNRIVGEGASATVYKGSLPS-----GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW-----  351 (596)
Q Consensus       282 at~~f~~~~~LG~G~fG~Vy~~~~~~-----g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~-----  351 (596)
                      ..++|...+.||+|+||.||+|.+.+     +..||||++.....    .+.+..|  .+.. ..+.+++.++..     
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----~e~~~~e--~l~~-~~~~~~~~~~~~~~~~~  202 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----VEIWMNE--RVRR-ACPNSCADFVYGFLEPV  202 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----hHHHHHH--HHHh-hchhhHHHHHHhhhccc
Confidence            56789999999999999999998754     68999999853221    1111222  1111 222333222221     


Q ss_pred             -eeeCCeEEEEEecCCCCCHHHHhhhCCCC----------------CcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEc
Q 047719          352 -CCEGNELVLVYEYLPNGSLDKILHNNSSS----------------SIVLSWEKRLNIVLGVASALSYLHEECERQIIHR  414 (596)
Q Consensus       352 -~~~~~~~~lV~E~~~~gsL~~~l~~~~~~----------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHr  414 (596)
                       +....+.+|||||+++++|.+++......                ........+..++.||+.||+|||+   ++|+||
T Consensus       203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHR  279 (566)
T PLN03225        203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHR  279 (566)
T ss_pred             ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeC
Confidence             34567899999999999999999754310                0011233456799999999999999   899999


Q ss_pred             cCCCCceeecC-CCceEEccCCCcc------------cCCCcccCCccccccC----------------------CCCCc
Q 047719          415 DVKACNILLDA-EFNAKLGDFEATI------------PAGTMGYLAPEYVYSG----------------------VPSEK  459 (596)
Q Consensus       415 Dlkp~NiLl~~-~~~~kl~Dfg~~~------------~~gt~~y~aPE~~~~~----------------------~~t~~  459 (596)
                      ||||+|||++. ++.+||+|||++.            ..+++.|||||.+...                      .++.+
T Consensus       280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k  359 (566)
T PLN03225        280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR  359 (566)
T ss_pred             cCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence            99999999986 5899999999874            2467899999965422                      23456


Q ss_pred             cceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCch----hhccccccCc------CCHHHHHHHHHHHHHcCCC
Q 047719          460 TDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLL----DAADFRLRGK------FNRKEMERMLMVGLSCVHP  529 (596)
Q Consensus       460 sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~----~~~d~~l~~~------~~~~~~~~l~~l~~~C~~~  529 (596)
                      +|||||||+||||+++..+.+..   +..+...+...+.-.    .........+      ..........+|+.+|++.
T Consensus       360 ~DVwSlGviL~el~~~~~~~~~~---~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~  436 (566)
T PLN03225        360 FDIYSAGLIFLQMAFPNLRSDSN---LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRF  436 (566)
T ss_pred             cccHHHHHHHHHHHhCcCCCchH---HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccC
Confidence            79999999999999987765432   111111111111000    0000000000      0001122344788999999


Q ss_pred             CCCCCCCHHHHHH
Q 047719          530 NHEKRPSVKEAAR  542 (596)
Q Consensus       530 dp~~RPs~~ev~~  542 (596)
                      ||++|||++|+++
T Consensus       437 dP~kR~ta~e~L~  449 (566)
T PLN03225        437 KGRQRISAKAALA  449 (566)
T ss_pred             CcccCCCHHHHhC
Confidence            9999999999987

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=4.1e-30  Score=253.57  Aligned_cols=229  Identities=30%  Similarity=0.353  Sum_probs=182.9

Q ss_pred             CceEEEEEEcCC-CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecCCCCCHHHHh
Q 047719          296 ASATVYKGSLPS-GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKIL  374 (596)
Q Consensus       296 ~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  374 (596)
                      +||.||+|...+ ++.+|+|++........ ...+.+|++.+.+ ++|+|++++++++......++++||+++++|.+++
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~-l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~   78 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKK-LKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL   78 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHh-CCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence            589999998864 89999999964332221 5678889866655 79999999999999999999999999999999999


Q ss_pred             hhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc----------cCCCcc
Q 047719          375 HNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI----------PAGTMG  444 (596)
Q Consensus       375 ~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~----------~~gt~~  444 (596)
                      ....    .+++..++.++.+++.+|.|||+   .+++|+||+|+||+++.++.++|+|||.+.          ..++..
T Consensus        79 ~~~~----~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~  151 (244)
T smart00220       79 KKRG----RLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPE  151 (244)
T ss_pred             Hhcc----CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcC
Confidence            8654    28899999999999999999999   899999999999999999999999998754          346778


Q ss_pred             cCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHHHHHHHHHHHH
Q 047719          445 YLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGL  524 (596)
Q Consensus       445 y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~  524 (596)
                      |++||.+....++.++||||||+++|||++|..||...... .... ..........       ..........+.+++.
T Consensus       152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~-~~~~-~~~~~~~~~~-------~~~~~~~~~~~~~~i~  222 (244)
T smart00220      152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL-LELF-KKIGKPKPPF-------PPPEWKISPEAKDLIR  222 (244)
T ss_pred             CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHH-HHHhccCCCC-------ccccccCCHHHHHHHH
Confidence            99999998888999999999999999999999999762111 1111 1111111100       0000003356788899


Q ss_pred             HcCCCCCCCCCCHHHHHH
Q 047719          525 SCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       525 ~C~~~dp~~RPs~~ev~~  542 (596)
                      +|+..+|++||++.++++
T Consensus       223 ~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      223 KLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHccCCchhccCHHHHhh
Confidence            999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=5.6e-31  Score=269.92  Aligned_cols=236  Identities=26%  Similarity=0.324  Sum_probs=187.3

Q ss_pred             cceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecCCC
Q 047719          289 NRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPN  367 (596)
Q Consensus       289 ~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  367 (596)
                      .++||+|-||+||-|..+ +|+.||||++.+.......+..+++|+.++.+ ++||.||.|-..|...+..++|||-+ +
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~-l~HPGiV~le~M~ET~ervFVVMEKl-~  646 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQN-LHHPGIVNLECMFETPERVFVVMEKL-H  646 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHh-cCCCCeeEEEEeecCCceEEEEehhh-c
Confidence            479999999999999876 59999999999877777777889999966655 99999999999999999999999999 5


Q ss_pred             CCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCC---CceEEccCCCccc-----
Q 047719          368 GSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAE---FNAKLGDFEATIP-----  439 (596)
Q Consensus       368 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~---~~~kl~Dfg~~~~-----  439 (596)
                      |++.++|-...  ...|++..-.-++.||+.||.|||.   ++|+|+||||+||||.+.   -.+||||||.++.     
T Consensus       647 GDMLEMILSsE--kgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks  721 (888)
T KOG4236|consen  647 GDMLEMILSSE--KGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS  721 (888)
T ss_pred             chHHHHHHHhh--cccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhh
Confidence            56666664432  2247777777889999999999999   999999999999999764   4699999998753     


Q ss_pred             -----CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHH
Q 047719          440 -----AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRK  514 (596)
Q Consensus       440 -----~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  514 (596)
                           +||+.|+|||++....|...-|+||.|||+|--++|..||..++. +-+.+    ....      ......-..+
T Consensus       722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd-IndQI----QNAa------FMyPp~PW~e  790 (888)
T KOG4236|consen  722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED-INDQI----QNAA------FMYPPNPWSE  790 (888)
T ss_pred             hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc-hhHHh----hccc------cccCCCchhh
Confidence                 599999999999999999999999999999999999999976532 21111    1111      1111222233


Q ss_pred             HHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          515 EMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       515 ~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      .....++|+-..+|..-++|-|..+.+.
T Consensus       791 is~~AidlIn~LLqVkm~kRysvdk~ls  818 (888)
T KOG4236|consen  791 ISPEAIDLINNLLQVKMRKRYSVDKSLS  818 (888)
T ss_pred             cCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence            4455666777777777788887765543

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=6.7e-30  Score=277.12  Aligned_cols=249  Identities=20%  Similarity=0.254  Sum_probs=170.3

Q ss_pred             HhcCCCccceeecCCceEEEEEEc-----------------CCCCEEEEEEeecCCchh------------cccchHHHH
Q 047719          282 ATLGFNKNRIVGEGASATVYKGSL-----------------PSGGAVAVKRFEKPNRVE------------CARNPFTTE  332 (596)
Q Consensus       282 at~~f~~~~~LG~G~fG~Vy~~~~-----------------~~g~~vAvK~l~~~~~~~------------~~~~~~~~E  332 (596)
                      ..++|...++||+|+||.||+|.+                 ..++.||||++.......            ...+.+..|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            466899999999999999999963                 235679999985432110            011223345


Q ss_pred             HHHHHhccCCCc-----eeeecceeee--------CCeEEEEEecCCCCCHHHHhhhCCC--------------------
Q 047719          333 FATMAGCLRHKN-----LVQLQGWCCE--------GNELVLVYEYLPNGSLDKILHNNSS--------------------  379 (596)
Q Consensus       333 ~~~l~~~l~H~n-----iv~l~g~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~~--------------------  379 (596)
                      +..+. .++|.+     +++++++|..        ++..+|||||+++|+|.++|+....                    
T Consensus       223 ~~~l~-~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        223 AYMCA-KIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHH-HhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            53333 355554     4778888764        3568999999999999999975321                    


Q ss_pred             CCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc------------CCCcccCC
Q 047719          380 SSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP------------AGTMGYLA  447 (596)
Q Consensus       380 ~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~------------~gt~~y~a  447 (596)
                      ....++|..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||++..            .+|+.|+|
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a  378 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP  378 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence            01235788899999999999999999   8999999999999999999999999997632            23678999


Q ss_pred             ccccccCCC----------------------CCccceeehhHHHHHHHhCCC-CCCCCC---hhHHHH-----HHHHHhc
Q 047719          448 PEYVYSGVP----------------------SEKTDVYSFGVVALEVAAGKS-PVDNDG---CVIVDW-----VWNLRKK  496 (596)
Q Consensus       448 PE~~~~~~~----------------------t~~sDV~SfGvll~El~tG~~-p~~~~~---~~~~~~-----~~~~~~~  496 (596)
                      ||.+.....                      ..+.||||+||+++||++|.. |+....   .....+     .|.....
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~  458 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG  458 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence            998754321                      235799999999999999875 665311   011100     0111111


Q ss_pred             CCchhhccccccCcCCHHHHHHHHHHHHHcCCCCC---CCCCCHHHHHH
Q 047719          497 GKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNH---EKRPSVKEAAR  542 (596)
Q Consensus       497 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp---~~RPs~~ev~~  542 (596)
                      ..    .+...    .........+++.+++..+|   .+|+|++|+++
T Consensus       459 ~~----~~~~~----~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        459 QK----YDFSL----LDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             cC----CCccc----ccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            11    11111    11223445566666777654   78999999875

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=7.5e-31  Score=241.39  Aligned_cols=195  Identities=27%  Similarity=0.338  Sum_probs=165.9

Q ss_pred             CCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEec
Q 047719          286 FNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEY  364 (596)
Q Consensus       286 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~  364 (596)
                      ......||+|++|.|-+-++. +|...|+|++...-. .+.....++|+....+...+|.+|.++|...+.+..++.||.
T Consensus        48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~  126 (282)
T KOG0984|consen   48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMEL  126 (282)
T ss_pred             hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHH
Confidence            344577999999999887664 689999999964333 345567888988887888999999999999999999999999


Q ss_pred             CCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc------
Q 047719          365 LPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI------  438 (596)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~------  438 (596)
                      |.. ||+.+-.+--.....+++.-.-+|+..|..||.|||+.  ..+||||+||+||||+.+|++|+||||.+.      
T Consensus       127 M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi  203 (282)
T KOG0984|consen  127 MDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI  203 (282)
T ss_pred             hhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhhh
Confidence            954 88888765433345688889999999999999999995  789999999999999999999999999763      


Q ss_pred             ----cCCCcccCCcccccc----CCCCCccceeehhHHHHHHHhCCCCCCCCCh
Q 047719          439 ----PAGTMGYLAPEYVYS----GVPSEKTDVYSFGVVALEVAAGKSPVDNDGC  484 (596)
Q Consensus       439 ----~~gt~~y~aPE~~~~----~~~t~~sDV~SfGvll~El~tG~~p~~~~~~  484 (596)
                          ..|...|||||.+..    ..|+.||||||||+.+.||++++.||+....
T Consensus       204 Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t  257 (282)
T KOG0984|consen  204 AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT  257 (282)
T ss_pred             HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence                358889999998853    3689999999999999999999999987543

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=5.3e-30  Score=277.71  Aligned_cols=249  Identities=25%  Similarity=0.365  Sum_probs=199.1

Q ss_pred             HHHHHHHhcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeee
Q 047719          276 LTDIKQATLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE  354 (596)
Q Consensus       276 ~~el~~at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~  354 (596)
                      ++.+..-+.-|.+.++||+|.+|+||+++.. +++.+|+|++....   ...++...|..++...-.|||++.++|++..
T Consensus        11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~---d~deEiE~eynil~~~~~hpnv~~fyg~~~k   87 (953)
T KOG0587|consen   11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE---DEEEEIELEYNMLKKYSHHPNVATFYGAFIK   87 (953)
T ss_pred             hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc---cccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence            3444455677889999999999999999754 58889999885432   2334456666666666789999999999875


Q ss_pred             -----CCeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCce
Q 047719          355 -----GNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNA  429 (596)
Q Consensus       355 -----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~  429 (596)
                           +++++||||||.+||..++++.-.  ...+.|..+..|+..++.||.+||.   ..++|||||-.||||+.++.+
T Consensus        88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~V  162 (953)
T KOG0587|consen   88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEV  162 (953)
T ss_pred             ecCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcE
Confidence                 468999999999999999998765  4469999999999999999999999   899999999999999999999


Q ss_pred             EEccCCCcc-----------cCCCcccCCcccccc-----CCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHH
Q 047719          430 KLGDFEATI-----------PAGTMGYLAPEYVYS-----GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNL  493 (596)
Q Consensus       430 kl~Dfg~~~-----------~~gt~~y~aPE~~~~-----~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~  493 (596)
                      ||+|||.+.           ..||+.|||||++..     ..|+.++|+||||++..||.-|.+|+.+.-..     ..+
T Consensus       163 KLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm-----raL  237 (953)
T KOG0587|consen  163 KLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM-----RAL  237 (953)
T ss_pred             EEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh-----hhh
Confidence            999999763           359999999999864     34678999999999999999999998764210     001


Q ss_pred             HhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          494 RKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       494 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      .   .+...  +.....-+..-.+.+.+++..|+..|-++||++.++++
T Consensus       238 F---~IpRN--PPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  238 F---LIPRN--PPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             c---cCCCC--CCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            0   11111  11222334566788999999999999999999988776

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=3.1e-30  Score=269.37  Aligned_cols=234  Identities=22%  Similarity=0.342  Sum_probs=181.3

Q ss_pred             HHHHHHHhc---CCCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCchhc-ccchHHHHHHHHHhccCCCceeeecc
Q 047719          276 LTDIKQATL---GFNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRVEC-ARNPFTTEFATMAGCLRHKNLVQLQG  350 (596)
Q Consensus       276 ~~el~~at~---~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~-~~~~~~~E~~~l~~~l~H~niv~l~g  350 (596)
                      |..|+.|.-   -|...+.||-|+||+|.+++..+ ...+|+|.+++.+.... ...-...|-.+| ..-..+-||+|+.
T Consensus       618 YiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDIL-AEADn~WVVrLyy  696 (1034)
T KOG0608|consen  618 YIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDIL-AEADNEWVVRLYY  696 (1034)
T ss_pred             HHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhH-hhcCCcceEEEEE
Confidence            444555543   37778899999999999997544 66799999976443221 112233444334 4478999999999


Q ss_pred             eeeeCCeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceE
Q 047719          351 WCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAK  430 (596)
Q Consensus       351 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~k  430 (596)
                      .|.+++.+|+||||++||++..+|-..+    .+.+..+.-++.++..|+++.|.   .|+|||||||.|||||.+|++|
T Consensus       697 SFQDkdnLYFVMdYIPGGDmMSLLIrmg----IFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIK  769 (1034)
T KOG0608|consen  697 SFQDKDNLYFVMDYIPGGDMMSLLIRMG----IFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIK  769 (1034)
T ss_pred             EeccCCceEEEEeccCCccHHHHHHHhc----cCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCcee
Confidence            9999999999999999999999998754    47888888899999999999999   9999999999999999999999


Q ss_pred             EccCCCccc-----------------------------------------------------CCCcccCCccccccCCCC
Q 047719          431 LGDFEATIP-----------------------------------------------------AGTMGYLAPEYVYSGVPS  457 (596)
Q Consensus       431 l~Dfg~~~~-----------------------------------------------------~gt~~y~aPE~~~~~~~t  457 (596)
                      |.|||++.-                                                     +||..|+|||++....++
T Consensus       770 LTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~  849 (1034)
T KOG0608|consen  770 LTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYT  849 (1034)
T ss_pred             eeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcc
Confidence            999986421                                                     389999999999999999


Q ss_pred             CccceeehhHHHHHHHhCCCCCCCCCh-----hHHHHHHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCC
Q 047719          458 EKTDVYSFGVVALEVAAGKSPVDNDGC-----VIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPN  530 (596)
Q Consensus       458 ~~sDV~SfGvll~El~tG~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~d  530 (596)
                      ..+|+||.|||||||+.|+.||-....     .+..|.          ..++....+..+.+....+.+   .|+..|
T Consensus       850 q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~----------~~l~~~~~~~ls~e~~~li~k---Lc~sad  914 (1034)
T KOG0608|consen  850 QLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWR----------NFLHIPYQGNLSKEALDLIQK---LCCSAD  914 (1034)
T ss_pred             ccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehh----------hccccccccccCHHHHHHHHH---HhcChh
Confidence            999999999999999999999976432     122332          233444455666655555444   465443

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.96  E-value=1.5e-30  Score=280.72  Aligned_cols=234  Identities=24%  Similarity=0.362  Sum_probs=179.9

Q ss_pred             CCCccceeecCCceE-EEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          285 GFNKNRIVGEGASAT-VYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~-Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      -|...+++|.|+-|+ ||+|.+ +|+.||||++....     ..-..+|+..+...=+|||||++++.-.+...+||..|
T Consensus       510 ~~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~-----~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalE  583 (903)
T KOG1027|consen  510 FFSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF-----FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALE  583 (903)
T ss_pred             eeccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh-----HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEeh
Confidence            467778999999986 799998 78899999985322     22356888777777789999999999889999999999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecC---C--CceEEccCCCcc
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDA---E--FNAKLGDFEATI  438 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~---~--~~~kl~Dfg~~~  438 (596)
                      .|. .+|.+++...........-...+.++.|+++||++||+   .+||||||||+||||+.   +  ..++|+|||++.
T Consensus       584 LC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK  659 (903)
T KOG1027|consen  584 LCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSK  659 (903)
T ss_pred             Hhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEeccccccc
Confidence            995 59999998741111111114457789999999999999   89999999999999976   2  579999999764


Q ss_pred             --------------cCCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhh-
Q 047719          439 --------------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDA-  502 (596)
Q Consensus       439 --------------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~-  502 (596)
                                    ..||.+|+|||++....-+..+||||+||++|.+++ |..||.+.-          .++.++..- 
T Consensus       660 kl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~----------~R~~NIl~~~  729 (903)
T KOG1027|consen  660 KLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSL----------ERQANILTGN  729 (903)
T ss_pred             ccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchH----------HhhhhhhcCc
Confidence                          358999999999999888999999999999999999 599998631          111111100 


Q ss_pred             cc-ccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          503 AD-FRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       503 ~d-~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      .+ ..+.. .. +.  ...+|+-.+++++|..||++.+|+.
T Consensus       730 ~~L~~L~~-~~-d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  730 YTLVHLEP-LP-DC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             cceeeecc-Cc-hH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            00 01111 11 11  5667888999999999999999865

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.96  E-value=6.7e-30  Score=254.83  Aligned_cols=250  Identities=20%  Similarity=0.235  Sum_probs=193.1

Q ss_pred             hcCCCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCC-----ceeeecceeeeCC
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHK-----NLVQLQGWCCEGN  356 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~-----niv~l~g~~~~~~  356 (596)
                      +..|....++|+|.||.|-.+.... +..||||+++.   ....++..+.|++.+.+...+.     -+|.+.+|+.-.+
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~---V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg  164 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN---VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG  164 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHH---HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence            5678888999999999999996554 78999999853   3345566777887766643332     3788999999999


Q ss_pred             eEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecC-----------
Q 047719          357 ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDA-----------  425 (596)
Q Consensus       357 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~-----------  425 (596)
                      +.|||+|.| +-|+.++|..+.  -.+++..++..|+.|++++++|||+   .+++|-||||+|||+-+           
T Consensus       165 hiCivfell-G~S~~dFlk~N~--y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~~~k~  238 (415)
T KOG0671|consen  165 HICIVFELL-GLSTFDFLKENN--YIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTYNPKK  238 (415)
T ss_pred             ceEEEEecc-ChhHHHHhccCC--ccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEeccCC
Confidence            999999998 559999999876  4468889999999999999999999   99999999999999921           


Q ss_pred             ---------CCceEEccCCCccc--------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCCh--hH
Q 047719          426 ---------EFNAKLGDFEATIP--------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGC--VI  486 (596)
Q Consensus       426 ---------~~~~kl~Dfg~~~~--------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~--~~  486 (596)
                               +..+||.|||.++.        +.|..|.|||++.+-.++..+||||+||||.|+.||...|+..+.  .+
T Consensus       239 ~~~~~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHL  318 (415)
T KOG0671|consen  239 KVCFIRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHL  318 (415)
T ss_pred             ccceeccCCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHH
Confidence                     34589999998653        579999999999999999999999999999999999999987542  11


Q ss_pred             HHHHHHH-----------------HhcCCch-----------hhcccc----ccCcCCHHHHHHHHHHHHHcCCCCCCCC
Q 047719          487 VDWVWNL-----------------RKKGKLL-----------DAADFR----LRGKFNRKEMERMLMVGLSCVHPNHEKR  534 (596)
Q Consensus       487 ~~~~~~~-----------------~~~~~~~-----------~~~d~~----l~~~~~~~~~~~l~~l~~~C~~~dp~~R  534 (596)
                      . .+...                 ...+.+.           ...+..    ........+..++++|+..++..||.+|
T Consensus       319 a-MMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~R  397 (415)
T KOG0671|consen  319 A-MMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARR  397 (415)
T ss_pred             H-HHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccc
Confidence            1 11000                 0001000           000000    0012334567789999999999999999


Q ss_pred             CCHHHHHH
Q 047719          535 PSVKEAAR  542 (596)
Q Consensus       535 Ps~~ev~~  542 (596)
                      +|++|+++
T Consensus       398 iTl~EAL~  405 (415)
T KOG0671|consen  398 ITLREALS  405 (415)
T ss_pred             ccHHHHhc
Confidence            99999976

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=6.7e-30  Score=249.58  Aligned_cols=236  Identities=26%  Similarity=0.304  Sum_probs=188.8

Q ss_pred             hcCCCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCchhc-ccchHHHHHHHHHhccCCCceeeecceeeeCCeEEE
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRVEC-ARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVL  360 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~-~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~l  360 (596)
                      -++|...++||+|+|.+|..+++.. .+.+|+|++++.-..+. ...-...|-....+.-+||.+|-|..++.....+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            3568889999999999999998865 77899999986543322 233334444445555789999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCc---
Q 047719          361 VYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT---  437 (596)
Q Consensus       361 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~---  437 (596)
                      |.||+++|+|.-++++.+    .|++..+.-....|..||.|||+   ++||.||||..|||||..|.+||.|+|++   
T Consensus       329 vieyv~ggdlmfhmqrqr----klpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~  401 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG  401 (593)
T ss_pred             EEEEecCcceeeehhhhh----cCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcC
Confidence            999999999999998765    48999999999999999999999   99999999999999999999999999853   


Q ss_pred             --------ccCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCC-----ChhHHHHHHHHHhcCCchhhcc
Q 047719          438 --------IPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDND-----GCVIVDWVWNLRKKGKLLDAAD  504 (596)
Q Consensus       438 --------~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~-----~~~~~~~~~~~~~~~~~~~~~d  504 (596)
                              ..+||+.|+|||.+.+..|....|+|++||+++||+.|+.||+--     +....+++.+...+..+     
T Consensus       402 l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi-----  476 (593)
T KOG0695|consen  402 LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI-----  476 (593)
T ss_pred             CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc-----
Confidence                    467999999999999999999999999999999999999999732     22344454444333221     


Q ss_pred             ccccCcCCHHHHHHHHHHHHHcCCCCCCCCC
Q 047719          505 FRLRGKFNRKEMERMLMVGLSCVHPNHEKRP  535 (596)
Q Consensus       505 ~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RP  535 (596)
                           .++.....+...+...-++.||++|.
T Consensus       477 -----riprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  477 -----RIPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             -----cccceeehhhHHHHHHhhcCCcHHhc
Confidence                 12223333444555566789998876

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.5e-29  Score=254.87  Aligned_cols=242  Identities=26%  Similarity=0.358  Sum_probs=179.1

Q ss_pred             CCccceeecCCceEEEEEEc-CCCCEEEEEEeecCCc--hh---cccchHHHHHHHHHhccCCCceeeecceeee-CCeE
Q 047719          286 FNKNRIVGEGASATVYKGSL-PSGGAVAVKRFEKPNR--VE---CARNPFTTEFATMAGCLRHKNLVQLQGWCCE-GNEL  358 (596)
Q Consensus       286 f~~~~~LG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~--~~---~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~-~~~~  358 (596)
                      |-..++||+|||+.|||+.. ...+.||||+-.....  .+   ...+-..+|. .+-+.+.||.||++++++.- .+.+
T Consensus       465 YLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREy-rIHKeLDHpRIVKlYDyfslDtdsF  543 (775)
T KOG1151|consen  465 YLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREY-RIHKELDHPRIVKLYDYFSLDTDSF  543 (775)
T ss_pred             HHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHH-hhhhccCcceeeeeeeeeeeccccc
Confidence            44568999999999999964 4578899998432211  11   1112345565 44456999999999999875 4578


Q ss_pred             EEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeec---CCCceEEccCC
Q 047719          359 VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLD---AEFNAKLGDFE  435 (596)
Q Consensus       359 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~---~~~~~kl~Dfg  435 (596)
                      |-|+|||++.+|+-||+.+.    .+++.++..|+.||..||.||.+ .+.+|||-||||.||||-   ..|.+||.|||
T Consensus       544 CTVLEYceGNDLDFYLKQhk----lmSEKEARSIiMQiVnAL~YLNE-ikpPIIHYDLKPgNILLv~GtacGeIKITDFG  618 (775)
T KOG1151|consen  544 CTVLEYCEGNDLDFYLKQHK----LMSEKEARSIIMQIVNALKYLNE-IKPPIIHYDLKPGNILLVNGTACGEIKITDFG  618 (775)
T ss_pred             eeeeeecCCCchhHHHHhhh----hhhHHHHHHHHHHHHHHHHHHhc-cCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence            99999999999999999875    48899999999999999999987 678999999999999994   45889999999


Q ss_pred             Ccc------------------cCCCcccCCccccccC----CCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHH
Q 047719          436 ATI------------------PAGTMGYLAPEYVYSG----VPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNL  493 (596)
Q Consensus       436 ~~~------------------~~gt~~y~aPE~~~~~----~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~  493 (596)
                      ++.                  .+||.+|++||.+.-+    +.+.|+||||.|||+|..+.|+.||..+... -    ..
T Consensus       619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ-Q----dI  693 (775)
T KOG1151|consen  619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ-Q----DI  693 (775)
T ss_pred             hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH-H----HH
Confidence            763                  2589999999988643    5689999999999999999999999865221 0    11


Q ss_pred             HhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Q 047719          494 RKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEA  540 (596)
Q Consensus       494 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev  540 (596)
                      .....+..+..-.+..  .+........++.+|++..-++|....++
T Consensus       694 LqeNTIlkAtEVqFP~--KPvVsseAkaFIRRCLaYRKeDR~DV~qL  738 (775)
T KOG1151|consen  694 LQENTILKATEVQFPP--KPVVSSEAKAFIRRCLAYRKEDRIDVQQL  738 (775)
T ss_pred             HhhhchhcceeccCCC--CCccCHHHHHHHHHHHHhhhhhhhhHHHH
Confidence            1112222221111111  11223345667789999998888765544

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=7.6e-31  Score=247.72  Aligned_cols=249  Identities=22%  Similarity=0.336  Sum_probs=183.7

Q ss_pred             CCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeC--------C
Q 047719          286 FNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG--------N  356 (596)
Q Consensus       286 f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~--------~  356 (596)
                      |....+||+|.||.||+++..+ |+.||+|++.-++..+.--...++|+..+ ..++|+|++.++..|...        .
T Consensus        19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL-~~lkHenv~nliEic~tk~Tp~~r~r~   97 (376)
T KOG0669|consen   19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKIL-QLLKHENVVNLIEICRTKATPTNRDRA   97 (376)
T ss_pred             HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHH-HHhcchhHHHHHHHHhhccCCcccccc
Confidence            3445789999999999998765 77899988654333333334567888555 559999999999998753        3


Q ss_pred             eEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCC
Q 047719          357 ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEA  436 (596)
Q Consensus       357 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~  436 (596)
                      .+|||+++|+. +|...|.+..   ..++..++.++..++..||.|+|.   ..|+|||+||.|+||+.++.+||+|||+
T Consensus        98 t~ylVf~~ceh-DLaGlLsn~~---vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGl  170 (376)
T KOG0669|consen   98 TFYLVFDFCEH-DLAGLLSNRK---VRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGL  170 (376)
T ss_pred             eeeeeHHHhhh-hHHHHhcCcc---ccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeecccc
Confidence            48999999987 8999887652   458889999999999999999999   8999999999999999999999999998


Q ss_pred             cccC---------------CCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCChh-HHHHHHHHH-----
Q 047719          437 TIPA---------------GTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV-IVDWVWNLR-----  494 (596)
Q Consensus       437 ~~~~---------------gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~-~~~~~~~~~-----  494 (596)
                      ++..               -|..|.+||.+.+ ..|+++.|||.-||+|.||+||.+.++++... ....+..+.     
T Consensus       171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk  250 (376)
T KOG0669|consen  171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK  250 (376)
T ss_pred             ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence            7432               3789999999887 57999999999999999999999998876431 111111111     


Q ss_pred             ------hcCCchhhcccc-cc-CcCC--HHHH------HHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          495 ------KKGKLLDAADFR-LR-GKFN--RKEM------ERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       495 ------~~~~~~~~~d~~-l~-~~~~--~~~~------~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                            .+-.+...+... +. +.+.  .+..      ...++|+-..+..||.+|+...+++.
T Consensus       251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN  314 (376)
T ss_pred             ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence                  111111111000 00 0000  0111      24556666777999999999999876

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=5.7e-30  Score=261.94  Aligned_cols=238  Identities=24%  Similarity=0.284  Sum_probs=189.8

Q ss_pred             CCccceeecCCceEEEEEEcCCCC-EEEEEEeecCCchhcc-cchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          286 FNKNRIVGEGASATVYKGSLPSGG-AVAVKRFEKPNRVECA-RNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       286 f~~~~~LG~G~fG~Vy~~~~~~g~-~vAvK~l~~~~~~~~~-~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      +.....||-||||.|=++...... .+|+|.+++....+.. .+-...|-.+|.. .+.|.||+||..|.+....|++||
T Consensus       422 l~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~-~~s~fIvrLYrTfrd~kyvYmLmE  500 (732)
T KOG0614|consen  422 LKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMME-CRSDFIVRLYRTFRDSKYVYMLME  500 (732)
T ss_pred             hhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHh-cCchHHHHHHHHhccchhhhhhHH
Confidence            344567999999999999876533 4899999876554433 3335566666666 789999999999999999999999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc-----
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI-----  438 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~-----  438 (596)
                      -|-+|.|...|++++    .++..+..-++..+.+|++|||+   ++||.|||||+|+|||.+|-+||.|||.+.     
T Consensus       501 aClGGElWTiLrdRg----~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g  573 (732)
T KOG0614|consen  501 ACLGGELWTILRDRG----SFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG  573 (732)
T ss_pred             hhcCchhhhhhhhcC----CcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence            999999999999876    37778888899999999999999   999999999999999999999999999764     


Q ss_pred             -----cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCH
Q 047719          439 -----PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNR  513 (596)
Q Consensus       439 -----~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  513 (596)
                           .+||+.|.|||.+.......++|.||||+++|||++|.+||++.+.-.   .+++...+  .+.      .+++.
T Consensus       574 ~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmk---tYn~ILkG--id~------i~~Pr  642 (732)
T KOG0614|consen  574 RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMK---TYNLILKG--IDK------IEFPR  642 (732)
T ss_pred             CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHH---HHHHHHhh--hhh------hhccc
Confidence                 479999999999999999999999999999999999999998764310   11111111  011      13344


Q ss_pred             HHHHHHHHHHHHcCCCCCCCCCC-----HHHHHH
Q 047719          514 KEMERMLMVGLSCVHPNHEKRPS-----VKEAAR  542 (596)
Q Consensus       514 ~~~~~l~~l~~~C~~~dp~~RPs-----~~ev~~  542 (596)
                      .......+|++..+..+|.+|..     +.+|-+
T Consensus       643 ~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkk  676 (732)
T KOG0614|consen  643 RITKTATDLIKKLCRDNPTERLGYQKGGINDIKK  676 (732)
T ss_pred             ccchhHHHHHHHHHhcCcHhhhccccCChHHHHh
Confidence            45566677777878899999985     555543

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.95  E-value=6.5e-27  Score=224.68  Aligned_cols=200  Identities=37%  Similarity=0.513  Sum_probs=173.6

Q ss_pred             eecCCceEEEEEEcCC-CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecCCCCCH
Q 047719          292 VGEGASATVYKGSLPS-GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSL  370 (596)
Q Consensus       292 LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  370 (596)
                      ||+|.+|.||++...+ ++.+++|++....... ....+.+|+..+.. ++|++++++++++......++++||+++++|
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~-l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l   78 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKK-LNHPNIVKLYGVFEDENHLYLVMEYCEGGSL   78 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHh-cCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence            6899999999998865 8999999986433221 24568888866654 8999999999999999999999999999999


Q ss_pred             HHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecC-CCceEEccCCCcc-----------
Q 047719          371 DKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDA-EFNAKLGDFEATI-----------  438 (596)
Q Consensus       371 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~-~~~~kl~Dfg~~~-----------  438 (596)
                      .+++....   ..+++..+..++.+++++|.+||+   .+++|+||+|.||+++. ++.++|+||+.+.           
T Consensus        79 ~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~  152 (215)
T cd00180          79 KDLLKENE---GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT  152 (215)
T ss_pred             HHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhc
Confidence            99998652   248899999999999999999999   89999999999999999 8999999998654           


Q ss_pred             cCCCcccCCccccccC-CCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHHHHH
Q 047719          439 PAGTMGYLAPEYVYSG-VPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEME  517 (596)
Q Consensus       439 ~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  517 (596)
                      ..+...|++||..... .++.++|+|++|+++++|                                            .
T Consensus       153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------~  188 (215)
T cd00180         153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------P  188 (215)
T ss_pred             ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------------H
Confidence            2366789999999877 889999999999999999                                            5


Q ss_pred             HHHHHHHHcCCCCCCCCCCHHHHHHH
Q 047719          518 RMLMVGLSCVHPNHEKRPSVKEAARI  543 (596)
Q Consensus       518 ~l~~l~~~C~~~dp~~RPs~~ev~~~  543 (596)
                      .+.+++..|++.+|++||+++++++.
T Consensus       189 ~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         189 ELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             HHHHHHHHHhhCCcccCcCHHHHhhC
Confidence            66778889999999999999998764

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=9.7e-29  Score=235.72  Aligned_cols=248  Identities=24%  Similarity=0.277  Sum_probs=184.1

Q ss_pred             ccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCC-----eEEEE
Q 047719          288 KNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGN-----ELVLV  361 (596)
Q Consensus       288 ~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~-----~~~lV  361 (596)
                      ..+.||-|+||.||..+.+ +|+.||+|++..-...-...+.+.+|+ .|+...+|.|++..++...-..     ++|++
T Consensus        57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~-kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREI-KMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHH-HHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            4588999999999999875 699999999865444444566788998 5555699999999988765443     57899


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcccC-
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA-  440 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~~-  440 (596)
                      +|.|.. +|++.|-..    ..|+-....-+++||++||.|||+   .+|+||||||.|.|+++|..+||||||+++.- 
T Consensus       136 TELmQS-DLHKIIVSP----Q~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee  207 (449)
T KOG0664|consen  136 TELMQS-DLHKIIVSP----QALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTWD  207 (449)
T ss_pred             HHHHHh-hhhheeccC----CCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccccc
Confidence            999965 888888653    358888888899999999999999   89999999999999999999999999998642 


Q ss_pred             -----------CCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCCh-hHHHHHHHHHhcCCc--------
Q 047719          441 -----------GTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGC-VIVDWVWNLRKKGKL--------  499 (596)
Q Consensus       441 -----------gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~-~~~~~~~~~~~~~~~--------  499 (596)
                                 -|..|.|||.+++ ..|+.+.||||.|||..|++..+..|+..+. ...+.+..+.....+        
T Consensus       208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE  287 (449)
T KOG0664|consen  208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE  287 (449)
T ss_pred             hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence                       4778999999987 5789999999999999999998888875432 111222222111111        


Q ss_pred             ---hhhcccc--------ccC-cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 047719          500 ---LDAADFR--------LRG-KFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARIL  544 (596)
Q Consensus       500 ---~~~~d~~--------l~~-~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L  544 (596)
                         ..+....        +.. ..+...-...+.+.+..+++||.+|.+.++.+..+
T Consensus       288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence               1111000        000 01111223344555667899999999999888755

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.94  E-value=6.2e-26  Score=221.70  Aligned_cols=188  Identities=35%  Similarity=0.447  Sum_probs=162.3

Q ss_pred             CCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEec
Q 047719          286 FNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEY  364 (596)
Q Consensus       286 f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~  364 (596)
                      |...+.||+|++|.||++...+ ++.+|+|.+...... .....+.+|+..+.. ++|+|++++++++......++++||
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~-~~~~~i~~~~~~~~~~~~~~~v~e~   78 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKK-LKHPNIVKLYGVFEDPEPLYLVMEY   78 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHh-CCCCChhhheeeeecCCceEEEEec
Confidence            4566889999999999998875 889999999654322 135567888866655 7999999999999999999999999


Q ss_pred             CCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc-----
Q 047719          365 LPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP-----  439 (596)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~-----  439 (596)
                      +++++|.+++.....   .+++.....++.+++.+|.+||+   .+++|+||+|+||+++.++.++|+|||.+..     
T Consensus        79 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~  152 (225)
T smart00221       79 CEGGDLFDYLRKKGG---KLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL  152 (225)
T ss_pred             cCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc
Confidence            999999999987542   17899999999999999999999   8999999999999999999999999986432     


Q ss_pred             -------CCCcccCCcccc-ccCCCCCccceeehhHHHHHHHhCCCCCCC
Q 047719          440 -------AGTMGYLAPEYV-YSGVPSEKTDVYSFGVVALEVAAGKSPVDN  481 (596)
Q Consensus       440 -------~gt~~y~aPE~~-~~~~~t~~sDV~SfGvll~El~tG~~p~~~  481 (596)
                             .++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus       153 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      153 AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence                   355679999998 667788899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.93  E-value=1.1e-26  Score=226.84  Aligned_cols=245  Identities=24%  Similarity=0.288  Sum_probs=183.1

Q ss_pred             CCCccceeecCCceEEEEEEc-CCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCC------e
Q 047719          285 GFNKNRIVGEGASATVYKGSL-PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGN------E  357 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~------~  357 (596)
                      .|...+.+|.|.- .|-.+.. -.++.||+|++..+.......+...+|...+ ..+.|+|+++++.++.-..      +
T Consensus        18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~-~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLM-KCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhh-hhhcccceeeeeeccCccccHHHHHh
Confidence            3455567788877 4444432 2488999999876655556667788898555 4599999999999987543      5


Q ss_pred             EEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCc
Q 047719          358 LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT  437 (596)
Q Consensus       358 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~  437 (596)
                      .|+|||||. .+|...+...      ++-.+...|..|++.|+.|||+   .+|+||||||+||++..+..+||.|||++
T Consensus        96 ~y~v~e~m~-~nl~~vi~~e------lDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~a  165 (369)
T KOG0665|consen   96 VYLVMELMD-ANLCQVILME------LDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLA  165 (369)
T ss_pred             HHHHHHhhh-hHHHHHHHHh------cchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhh
Confidence            799999995 5999998732      7778899999999999999999   99999999999999999999999999987


Q ss_pred             ccC----------CCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCc--------
Q 047719          438 IPA----------GTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKL--------  499 (596)
Q Consensus       438 ~~~----------gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~--------  499 (596)
                      ...          .|..|.|||.+.+..+.+.+||||.||++.||++|+--|.+.+ .+.+|-.-...-+..        
T Consensus       166 r~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d-~idQ~~ki~~~lgtpd~~F~~qL  244 (369)
T KOG0665|consen  166 RTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD-HIDQWNKIIEQLGTPDPSFMKQL  244 (369)
T ss_pred             cccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch-HHHHHHHHHHHhcCCCHHHHHHh
Confidence            654          4667999999998889999999999999999999998887532 222221111110000        


Q ss_pred             -------------------h-hhccccc--cCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          500 -------------------L-DAADFRL--RGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       500 -------------------~-~~~d~~l--~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                                         . ...|.-.  ..+.+.-....+-+++.+++-.||++|.+++++++
T Consensus       245 ~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  245 QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence                               0 0011101  11122233455667778899999999999999987

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.7e-26  Score=220.53  Aligned_cols=244  Identities=24%  Similarity=0.368  Sum_probs=185.9

Q ss_pred             cCCCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecce-eeeCCeEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW-CCEGNELVLV  361 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~-~~~~~~~~lV  361 (596)
                      +.|.+.+.||+|.||.+-++.++. .+.+++|-+.++.   ....+|.+|..--..+-.|.||+.-+.. |+..+..+++
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~---tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~  100 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ---TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV  100 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch---hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence            457888999999999999998875 7789999986543   3456799998544444679999998765 6777888999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceee-cC-CCceEEccCCCccc
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILL-DA-EFNAKLGDFEATIP  439 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl-~~-~~~~kl~Dfg~~~~  439 (596)
                      +||+|.|+|..-+...+     +.+....+++.|+++||.|+|+   ..+||||||.+|||| +. ..++||||||.+..
T Consensus       101 qE~aP~gdL~snv~~~G-----igE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k  172 (378)
T KOG1345|consen  101 QEFAPRGDLRSNVEAAG-----IGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRK  172 (378)
T ss_pred             eccCccchhhhhcCccc-----ccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccc
Confidence            99999999999887654     7778889999999999999999   899999999999999 33 35899999999998


Q ss_pred             CCCc--------ccCCcccccc---C--CCCCccceeehhHHHHHHHhCCCCCCCCC-hhHHHHHHHHHhcCCchhhccc
Q 047719          440 AGTM--------GYLAPEYVYS---G--VPSEKTDVYSFGVVALEVAAGKSPVDNDG-CVIVDWVWNLRKKGKLLDAADF  505 (596)
Q Consensus       440 ~gt~--------~y~aPE~~~~---~--~~t~~sDV~SfGvll~El~tG~~p~~~~~-~~~~~~~~~~~~~~~~~~~~d~  505 (596)
                      .|+.        .|.+||....   +  ...+.+|+|.||++++.++||..|++... ....-|-|..|..+......  
T Consensus       173 ~g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P--  250 (378)
T KOG1345|consen  173 VGTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALP--  250 (378)
T ss_pred             cCceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCc--
Confidence            8763        5889997653   2  34788999999999999999999998421 12223445555555443221  


Q ss_pred             cccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 047719          506 RLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARIL  544 (596)
Q Consensus       506 ~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L  544 (596)
                      +.-..+    .++++.+..+-+.+++++|--..++.++.
T Consensus       251 ~~F~~f----s~~a~r~Fkk~lt~~~~drcki~~~kk~r  285 (378)
T KOG1345|consen  251 KKFNPF----SEKALRLFKKSLTPRFKDRCKIWTAKKMR  285 (378)
T ss_pred             hhhccc----CHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence            111222    24455556677899999996555555433

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.93  E-value=1.1e-26  Score=241.26  Aligned_cols=188  Identities=22%  Similarity=0.286  Sum_probs=161.0

Q ss_pred             CCCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCchhc------ccchHHHHHHHHHhccC---CCceeeecceeee
Q 047719          285 GFNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRVEC------ARNPFTTEFATMAGCLR---HKNLVQLQGWCCE  354 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~------~~~~~~~E~~~l~~~l~---H~niv~l~g~~~~  354 (596)
                      .|...+.||.|+||.|+++.++. ...|+||.+.++..-..      ..-..-.|+++|.. ++   |+||++++.+|.+
T Consensus       562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~-l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILAT-LNKHSHENILKLLDFFED  640 (772)
T ss_pred             cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHH-hhhcCccchhhhhheeec
Confidence            47778999999999999998765 66899999876543221      11234578866655 66   9999999999999


Q ss_pred             CCeEEEEEecC-CCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEcc
Q 047719          355 GNELVLVYEYL-PNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGD  433 (596)
Q Consensus       355 ~~~~~lV~E~~-~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~D  433 (596)
                      ++.+||+||-. ++-+|.++|....    .+++.+...|..||+.|+++||+   ++|||||||-+||.++.+|-+||.|
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~kp----~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klid  713 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFKP----RMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLID  713 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhccC----ccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEee
Confidence            99999999976 5668999998754    48899999999999999999999   9999999999999999999999999


Q ss_pred             CCCcc---------cCCCcccCCccccccCCC-CCccceeehhHHHHHHHhCCCCCC
Q 047719          434 FEATI---------PAGTMGYLAPEYVYSGVP-SEKTDVYSFGVVALEVAAGKSPVD  480 (596)
Q Consensus       434 fg~~~---------~~gt~~y~aPE~~~~~~~-t~~sDV~SfGvll~El~tG~~p~~  480 (596)
                      ||.+.         .+||..|.|||++.+.+| ...-|||++|++||.++....||-
T Consensus       714 fgsaa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  714 FGSAAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             ccchhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            99764         359999999999998877 677899999999999999988874

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.93  E-value=1.3e-26  Score=268.87  Aligned_cols=182  Identities=17%  Similarity=0.223  Sum_probs=138.0

Q ss_pred             cCC-Cceeeeccee-------eeCCeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCe
Q 047719          340 LRH-KNLVQLQGWC-------CEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI  411 (596)
Q Consensus       340 l~H-~niv~l~g~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~i  411 (596)
                      ++| +||++++++|       .+...+++++||+ .++|.++|....   ..+++.+++.++.||++||+|||+   ++|
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~---~gI  101 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD---RSVDAFECFHVFRQIVEIVNAAHS---QGI  101 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc---ccccHHHHHHHHHHHHHHHHHHHh---CCe
Confidence            445 5788888877       3334678889988 569999997532   358999999999999999999999   999


Q ss_pred             EEccCCCCceeecC-------------------CCceEEccCCCcc---------------------------cCCCccc
Q 047719          412 IHRDVKACNILLDA-------------------EFNAKLGDFEATI---------------------------PAGTMGY  445 (596)
Q Consensus       412 vHrDlkp~NiLl~~-------------------~~~~kl~Dfg~~~---------------------------~~gt~~y  445 (596)
                      +||||||+||||+.                   ++.+|++|||++.                           ..||+.|
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  181 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY  181 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence            99999999999953                   5567788887653                           1367789


Q ss_pred             CCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHH
Q 047719          446 LAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLS  525 (596)
Q Consensus       446 ~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~  525 (596)
                      ||||++.+..++.++|||||||+||||++|..|+...........    ..     ...+..     .........++.+
T Consensus       182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~----~~-----~~~~~~-----~~~~~~~~~~~~~  247 (793)
T PLN00181        182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLR----HR-----VLPPQI-----LLNWPKEASFCLW  247 (793)
T ss_pred             EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHH----Hh-----hcChhh-----hhcCHHHHHHHHH
Confidence            999999999999999999999999999999988754221111111    00     000100     1122345677889


Q ss_pred             cCCCCCCCCCCHHHHHH
Q 047719          526 CVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       526 C~~~dp~~RPs~~ev~~  542 (596)
                      ||+++|.+||+|.|+++
T Consensus       248 ~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        248 LLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             hCCCChhhCcChHHHhh
Confidence            99999999999999976

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.92  E-value=4.9e-26  Score=240.14  Aligned_cols=242  Identities=27%  Similarity=0.304  Sum_probs=186.7

Q ss_pred             hcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      ...|...+.+|+|.||.|||++.. .++..|||+++....  ....-...|+ .+.+--+|+|||.++|.+.....+++.
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~--dd~~~iqqei-~~~~dc~h~nivay~gsylr~dklwic   90 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG--DDFSGIQQEI-GMLRDCRHPNIVAYFGSYLRRDKLWIC   90 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCC--ccccccccce-eeeecCCCcChHHHHhhhhhhcCcEEE
Confidence            456777899999999999999865 589999999975432  2233345666 444558999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc---
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI---  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---  438 (596)
                      ||||.+|+|.+.-+-..    ++++.++-.+++...+||+|||+   .+-+|||||-.|||+++.+.+|++|||.+.   
T Consensus        91 MEycgggslQdiy~~Tg----plselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqit  163 (829)
T KOG0576|consen   91 MEYCGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQIT  163 (829)
T ss_pred             EEecCCCcccceeeecc----cchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhh
Confidence            99999999999887654    58889999999999999999999   899999999999999999999999998653   


Q ss_pred             --------cCCCcccCCccccc---cCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccc
Q 047719          439 --------PAGTMGYLAPEYVY---SGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRL  507 (596)
Q Consensus       439 --------~~gt~~y~aPE~~~---~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  507 (596)
                              ..||+.|||||+..   .+.|..++|||+.|+...|+.--++|.-+--.   ..+..++.+..   .-.+.+
T Consensus       164 ati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp---mr~l~LmTkS~---~qpp~l  237 (829)
T KOG0576|consen  164 ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP---MRALFLMTKSG---FQPPTL  237 (829)
T ss_pred             hhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch---HHHHHHhhccC---CCCCcc
Confidence                    35999999999764   46789999999999999999988877543111   00111111111   011112


Q ss_pred             cCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          508 RGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       508 ~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      .+  ...-.+.+-+++..|+-.+|++||+++.+++
T Consensus       238 kD--k~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  238 KD--KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             cC--CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            11  1233455667778899999999999876544

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.92  E-value=4.2e-25  Score=226.98  Aligned_cols=252  Identities=21%  Similarity=0.233  Sum_probs=190.4

Q ss_pred             HhcCCCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCchhcccchHHHHHHHHHhccC------CCceeeecceeee
Q 047719          282 ATLGFNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLR------HKNLVQLQGWCCE  354 (596)
Q Consensus       282 at~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~------H~niv~l~g~~~~  354 (596)
                      ....|......|+|-|++|.+|.... |..||||++.....   -.+.=+.|+++|.+ |+      --|+++|+..|..
T Consensus       430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~---M~KtGl~EleiLkK-L~~AD~Edk~Hclrl~r~F~h  505 (752)
T KOG0670|consen  430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV---MHKTGLKELEILKK-LNDADPEDKFHCLRLFRHFKH  505 (752)
T ss_pred             hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH---HhhhhhHHHHHHHH-hhccCchhhhHHHHHHHHhhh
Confidence            34567777889999999999997654 88999999964322   22334667766655 43      3589999999999


Q ss_pred             CCeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCC-CceEEcc
Q 047719          355 GNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAE-FNAKLGD  433 (596)
Q Consensus       355 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~-~~~kl~D  433 (596)
                      .+++|||+|-+ ..+|.+.|+.-+. ...|....+..++.|+..||..|-.   .+|+|.||||.|||+++. ..+||||
T Consensus       506 knHLClVFE~L-slNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVNE~k~iLKLCD  580 (752)
T KOG0670|consen  506 KNHLCLVFEPL-SLNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVNESKNILKLCD  580 (752)
T ss_pred             cceeEEEehhh-hchHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEeccCcceeeecc
Confidence            99999999987 4599999987543 3457888899999999999999998   899999999999999986 6789999


Q ss_pred             CCCcccCC---------CcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCCh-hHHHHH--------HHHHh
Q 047719          434 FEATIPAG---------TMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGC-VIVDWV--------WNLRK  495 (596)
Q Consensus       434 fg~~~~~g---------t~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~-~~~~~~--------~~~~~  495 (596)
                      ||.+..++         +..|.|||.+.+-.|....|+||.||.||||.||+..|.+... ....+.        ..+..
T Consensus       581 fGSA~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlR  660 (752)
T KOG0670|consen  581 FGSASFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLR  660 (752)
T ss_pred             CccccccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhh
Confidence            99887654         3469999999999999999999999999999999999987532 111111        11111


Q ss_pred             cCCchh---------------------------hccc------cccC--cCC---HHHHHHHHHHHHHcCCCCCCCCCCH
Q 047719          496 KGKLLD---------------------------AADF------RLRG--KFN---RKEMERMLMVGLSCVHPNHEKRPSV  537 (596)
Q Consensus       496 ~~~~~~---------------------------~~d~------~l~~--~~~---~~~~~~l~~l~~~C~~~dp~~RPs~  537 (596)
                      .+...+                           .+.|      .+..  .++   ......+.+|.-.|+..||++|.|.
T Consensus       661 KgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~  740 (752)
T KOG0670|consen  661 KGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITV  740 (752)
T ss_pred             hcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCH
Confidence            111110                           0111      0111  122   2345677788889999999999999


Q ss_pred             HHHHH
Q 047719          538 KEAAR  542 (596)
Q Consensus       538 ~ev~~  542 (596)
                      .++++
T Consensus       741 nqAL~  745 (752)
T KOG0670|consen  741 NQALK  745 (752)
T ss_pred             HHHhc
Confidence            98865

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=5.1e-24  Score=218.18  Aligned_cols=133  Identities=26%  Similarity=0.285  Sum_probs=106.7

Q ss_pred             hcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccC-------CCceeeecceeee
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLR-------HKNLVQLQGWCCE  354 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~-------H~niv~l~g~~~~  354 (596)
                      ...|...++||-|.|++||++... ..+.||+|+.+..   +...+..+.||+.+.+.-.       ..+||+|+++|..
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh  153 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH  153 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence            356778899999999999999654 4678999998532   2334456778866654322       3579999999976


Q ss_pred             C----CeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceee
Q 047719          355 G----NELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILL  423 (596)
Q Consensus       355 ~----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl  423 (596)
                      .    .++|+|+|++ +-+|..+|......  -++...+.+|+.||+.||.|||.+  .+|||-||||+||||
T Consensus       154 sGpNG~HVCMVfEvL-GdnLLklI~~s~Yr--Glpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  154 SGPNGQHVCMVFEVL-GDNLLKLIKYSNYR--GLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPENVLL  221 (590)
T ss_pred             cCCCCcEEEEEehhh-hhHHHHHHHHhCCC--CCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcceeee
Confidence            4    4899999999 66899999875533  378889999999999999999997  689999999999999

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.91  E-value=1.5e-25  Score=213.99  Aligned_cols=242  Identities=21%  Similarity=0.346  Sum_probs=190.9

Q ss_pred             cceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecCCCC
Q 047719          289 NRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNG  368 (596)
Q Consensus       289 ~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  368 (596)
                      ..+|.+...|..|+|++ .|..+++|++....-.....++|..|.-.+ +...||||+.++|.|....++.++..|||.|
T Consensus       195 ~tkl~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~l-rifshpnilpvlgacnsppnlv~isq~mp~g  272 (448)
T KOG0195|consen  195 ITKLAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPAL-RIFSHPNILPVLGACNSPPNLVIISQYMPFG  272 (448)
T ss_pred             hhhhccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcce-eeecCCchhhhhhhccCCCCceEeeeeccch
Confidence            35688889999999999 455677788764444444455677777444 5689999999999999999999999999999


Q ss_pred             CHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEc--cC----CCcccCCC
Q 047719          369 SLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLG--DF----EATIPAGT  442 (596)
Q Consensus       369 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~--Df----g~~~~~gt  442 (596)
                      ||+..|++..  ....+-.+..+++.+||+|++|||+. ++-|.---|.+..|+||++.+++|+  |-    ........
T Consensus       273 slynvlhe~t--~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfqe~gr~y~  349 (448)
T KOG0195|consen  273 SLYNVLHEQT--SVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQEVGRAYS  349 (448)
T ss_pred             HHHHHHhcCc--cEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeeeccccccC
Confidence            9999999865  45688899999999999999999994 3334445689999999999998886  32    22233457


Q ss_pred             cccCCccccccCCC---CCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHHHHHHH
Q 047719          443 MGYLAPEYVYSGVP---SEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERM  519 (596)
Q Consensus       443 ~~y~aPE~~~~~~~---t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l  519 (596)
                      +.||+||.+...+.   -.++|+|||.++|||+.|...||.+-..--           --+.++-..++..+++.....+
T Consensus       350 pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspme-----------cgmkialeglrv~ippgis~hm  418 (448)
T KOG0195|consen  350 PAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPME-----------CGMKIALEGLRVHIPPGISRHM  418 (448)
T ss_pred             cccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchh-----------hhhhhhhccccccCCCCccHHH
Confidence            88999999986543   457999999999999999999997632110           0122333455666777778889


Q ss_pred             HHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          520 LMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       520 ~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                      .+|+.-|++.||.+||.+..|+-.|++
T Consensus       419 ~klm~icmnedpgkrpkfdmivpilek  445 (448)
T KOG0195|consen  419 NKLMNICMNEDPGKRPKFDMIVPILEK  445 (448)
T ss_pred             HHHHHHHhcCCCCcCCCcceehhhHHH
Confidence            999999999999999999999988875

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.91  E-value=2.6e-24  Score=217.73  Aligned_cols=189  Identities=24%  Similarity=0.373  Sum_probs=161.7

Q ss_pred             HHHHhcCCCccceeecCCceEEEEEEcCC----CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeee
Q 047719          279 IKQATLGFNKNRIVGEGASATVYKGSLPS----GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE  354 (596)
Q Consensus       279 l~~at~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~  354 (596)
                      +....+.|...++||.|.|++||++.+..    ...||+|.+...    .......+|++.+.....+.||+++.+++..
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t----s~p~ri~~El~~L~~~gG~~ni~~~~~~~rn  106 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT----SSPSRILNELEMLYRLGGSDNIIKLNGCFRN  106 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc----cCchHHHHHHHHHHHhccchhhhcchhhhcc
Confidence            33445568888999999999999997643    568999998543    2344578899888887889999999999999


Q ss_pred             CCeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCC-CceEEcc
Q 047719          355 GNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAE-FNAKLGD  433 (596)
Q Consensus       355 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~-~~~kl~D  433 (596)
                      .+...+|+||++.-...+++..       ++...+...+..+..||+++|.   +|||||||||+|+|.+.. +.-.|.|
T Consensus       107 nd~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvD  176 (418)
T KOG1167|consen  107 NDQVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVD  176 (418)
T ss_pred             CCeeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEe
Confidence            9999999999999999999874       5678888899999999999999   999999999999999865 6788999


Q ss_pred             CCCcc-------------------------------------------------------cCCCcccCCcccccc-CCCC
Q 047719          434 FEATI-------------------------------------------------------PAGTMGYLAPEYVYS-GVPS  457 (596)
Q Consensus       434 fg~~~-------------------------------------------------------~~gt~~y~aPE~~~~-~~~t  457 (596)
                      ||++.                                                       .+||+||.|||++.. ...+
T Consensus       177 FgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qt  256 (418)
T KOG1167|consen  177 FGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQT  256 (418)
T ss_pred             chhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcC
Confidence            97532                                                       128999999999875 6789


Q ss_pred             CccceeehhHHHHHHHhCCCCCCC
Q 047719          458 EKTDVYSFGVVALEVAAGKSPVDN  481 (596)
Q Consensus       458 ~~sDV~SfGvll~El~tG~~p~~~  481 (596)
                      ++.||||-|||++-+++++.||-.
T Consensus       257 taiDiws~GVI~Lslls~~~PFf~  280 (418)
T KOG1167|consen  257 TAIDIWSAGVILLSLLSRRYPFFK  280 (418)
T ss_pred             Cccceeeccceeehhhcccccccc
Confidence            999999999999999999999854

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.91  E-value=6.1e-24  Score=200.83  Aligned_cols=160  Identities=21%  Similarity=0.155  Sum_probs=121.0

Q ss_pred             CCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc------cCC
Q 047719          368 GSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI------PAG  441 (596)
Q Consensus       368 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~------~~g  441 (596)
                      |+|.+++....   ..++|.+++.++.||++||.|||+   .+      ||+|||++.++.+|+  ||.+.      ..|
T Consensus         1 GsL~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~~~g   66 (176)
T smart00750        1 VSLADILEVRG---RPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQSRV   66 (176)
T ss_pred             CcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeeccccCCC
Confidence            78999998643   259999999999999999999998   44      999999999999999  98754      358


Q ss_pred             CcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHHHHH--HH
Q 047719          442 TMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEME--RM  519 (596)
Q Consensus       442 t~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~--~l  519 (596)
                      |..|||||.+.+..++.++|||||||++|||++|+.||..... ...............   ++. ..........  .+
T Consensus        67 ~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~-~~~~~~~~~~~~~~~---~~~-~~~~~~~~~~~~~~  141 (176)
T smart00750       67 DPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE-LSAILEILLNGMPAD---DPR-DRSNLESVSAARSF  141 (176)
T ss_pred             cccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch-hcHHHHHHHHHhccC---Ccc-ccccHHHHHhhhhH
Confidence            9999999999999999999999999999999999999965422 111111111110000   000 0011112222  58


Q ss_pred             HHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          520 LMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       520 ~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                      .+++..||+.+|++||++.|+++.+..
T Consensus       142 ~~~i~~cl~~~p~~Rp~~~~ll~~~~~  168 (176)
T smart00750      142 ADFMRVCASRLPQRREAANHYLAHCRA  168 (176)
T ss_pred             HHHHHHHHhcccccccCHHHHHHHHHH
Confidence            899999999999999999999987653

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.90  E-value=7.8e-24  Score=197.87  Aligned_cols=184  Identities=20%  Similarity=0.304  Sum_probs=153.0

Q ss_pred             hcCCCccceeecCCceEEEEEEc-CCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCC--eEE
Q 047719          283 TLGFNKNRIVGEGASATVYKGSL-PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGN--ELV  359 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~--~~~  359 (596)
                      .++|...+++|+|.++.||.|.. .+++.++||+++.-     ..+...+|+.++..+-.||||++|++...+..  -..
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa  111 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV-----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS  111 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH-----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence            34567778999999999999964 46889999999642     23457889988877556999999999987754  468


Q ss_pred             EEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCC-CceEEccCCCcc
Q 047719          360 LVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAE-FNAKLGDFEATI  438 (596)
Q Consensus       360 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~-~~~kl~Dfg~~~  438 (596)
                      ||+||+.+.+......       .|+-..+...+.++++||.|+|+   .||.|||+||.|+|||.. -.++|+|+|++.
T Consensus       112 LiFE~v~n~Dfk~ly~-------tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAE  181 (338)
T KOG0668|consen  112 LIFEYVNNTDFKQLYP-------TLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAE  181 (338)
T ss_pred             hHhhhhccccHHHHhh-------hhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHh
Confidence            9999999987776654       36677888899999999999999   999999999999999975 679999999874


Q ss_pred             c----------CCCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCC
Q 047719          439 P----------AGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDN  481 (596)
Q Consensus       439 ~----------~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~  481 (596)
                      .          +.+..|.-||++.. ..|...-|+|||||+|.+|+..+.||-.
T Consensus       182 FYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFh  235 (338)
T KOG0668|consen  182 FYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH  235 (338)
T ss_pred             hcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccC
Confidence            3          24556788998865 6789999999999999999999999854

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.87  E-value=1.1e-21  Score=204.73  Aligned_cols=156  Identities=21%  Similarity=0.164  Sum_probs=119.5

Q ss_pred             HHHhcCCCccceeecCCceEEEEEEcC--CCCEEEEEEeecCCc---hhcccchHHHHHHHHHhccCCCceeeecceeee
Q 047719          280 KQATLGFNKNRIVGEGASATVYKGSLP--SGGAVAVKRFEKPNR---VECARNPFTTEFATMAGCLRHKNLVQLQGWCCE  354 (596)
Q Consensus       280 ~~at~~f~~~~~LG~G~fG~Vy~~~~~--~g~~vAvK~l~~~~~---~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~  354 (596)
                      ...-.+|...+.||+|+||+||+|...  +++.||||++.....   .......+.+|+..+.+ ++|+|+++.+..   
T Consensus        14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~-L~h~~iv~~l~~---   89 (365)
T PRK09188         14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKT-VRGIGVVPQLLA---   89 (365)
T ss_pred             ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHh-ccCCCCCcEEEE---
Confidence            344567999999999999999999764  467789998753211   12234568899966655 899999853322   


Q ss_pred             CCeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccC-CCCceeecCCCceEEcc
Q 047719          355 GNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDV-KACNILLDAEFNAKLGD  433 (596)
Q Consensus       355 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDl-kp~NiLl~~~~~~kl~D  433 (596)
                      .+..||||||+++++|... ...       .   ...++.+++++|.|||+   .+|+|||| ||+|||++.++.+||+|
T Consensus        90 ~~~~~LVmE~~~G~~L~~~-~~~-------~---~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiD  155 (365)
T PRK09188         90 TGKDGLVRGWTEGVPLHLA-RPH-------G---DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVID  155 (365)
T ss_pred             cCCcEEEEEccCCCCHHHh-Ccc-------c---hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEE
Confidence            2468999999999999732 110       0   14578899999999999   89999999 99999999999999999


Q ss_pred             CCCccc-------------------CCCcccCCcccccc
Q 047719          434 FEATIP-------------------AGTMGYLAPEYVYS  453 (596)
Q Consensus       434 fg~~~~-------------------~gt~~y~aPE~~~~  453 (596)
                      ||++..                   .++..|+|||.+..
T Consensus       156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             CccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            998652                   25667999998863

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.85  E-value=8.7e-20  Score=186.20  Aligned_cols=249  Identities=28%  Similarity=0.349  Sum_probs=186.4

Q ss_pred             CCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhc-ccchHHHHHHHHHhccCCC-ceeeecceeeeCCeEEEEEe
Q 047719          286 FNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVEC-ARNPFTTEFATMAGCLRHK-NLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       286 f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~-~~~~~~~E~~~l~~~l~H~-niv~l~g~~~~~~~~~lV~E  363 (596)
                      |...+.||.|+||.||++...  ..+++|.+........ ....+.+|+..+.. +.|+ ++++++..+......++++|
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILAS-LNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHH-ccCCcceeeEEEEEecCCEEEEEEe
Confidence            556688999999999999876  8899999975444332 46678888865655 7776 79999999977778899999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCC-ceEEccCCCcc----
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEF-NAKLGDFEATI----  438 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~-~~kl~Dfg~~~----  438 (596)
                      |+.+++|.+++...... ..+.......++.|++.++.|+|+   .+++|||+||+||+++... .++++|||.+.    
T Consensus        79 ~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~  154 (384)
T COG0515          79 YVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD  154 (384)
T ss_pred             cCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCC
Confidence            99999999777654311 248888999999999999999999   8899999999999999998 79999998542    


Q ss_pred             -------------cCCCcccCCcccccc---CCCCCccceeehhHHHHHHHhCCCCCCCCChh-HHHHHHHHHhcCCchh
Q 047719          439 -------------PAGTMGYLAPEYVYS---GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV-IVDWVWNLRKKGKLLD  501 (596)
Q Consensus       439 -------------~~gt~~y~aPE~~~~---~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~-~~~~~~~~~~~~~~~~  501 (596)
                                   ..||..|++||.+..   ..++...|+||+|++++++++|..|+...... ............... 
T Consensus       155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-  233 (384)
T COG0515         155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-  233 (384)
T ss_pred             CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-
Confidence                         247889999999987   67899999999999999999999997664321 011111111111100 


Q ss_pred             hccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          502 AADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       502 ~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      .................+.++...|+..+|..|.++.+...
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~  274 (384)
T COG0515         234 SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS  274 (384)
T ss_pred             ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence            00000000000122346667778888999999999887765

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.84  E-value=1.3e-19  Score=188.60  Aligned_cols=246  Identities=20%  Similarity=0.179  Sum_probs=179.4

Q ss_pred             CCCccceeecCCceEEEEEEcCCC--CEEEEEEeecCCchhcccchHHHHHHHHHhcc---CCCceeeeccee-eeCCeE
Q 047719          285 GFNKNRIVGEGASATVYKGSLPSG--GAVAVKRFEKPNRVECARNPFTTEFATMAGCL---RHKNLVQLQGWC-CEGNEL  358 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~~g--~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l---~H~niv~l~g~~-~~~~~~  358 (596)
                      .|...++||+|+||.||++.....  ..+|+|.........  ...+..|...+....   .-+++..++... ......
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~--~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~   96 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK--PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN   96 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC--CccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence            788899999999999999986553  478998875432221  114566665555422   135788888887 477789


Q ss_pred             EEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCC-----CceEEcc
Q 047719          359 VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAE-----FNAKLGD  433 (596)
Q Consensus       359 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~-----~~~kl~D  433 (596)
                      ++||+.+ +.+|.++.....  ...++..+.+.|+.|++.+|++||+   .+++||||||.|+++...     ..+.|.|
T Consensus        97 ~iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llD  170 (322)
T KOG1164|consen   97 FIVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLD  170 (322)
T ss_pred             EEEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEe
Confidence            9999988 779999886654  3468999999999999999999999   999999999999999765     4699999


Q ss_pred             CCCcc--c-------------------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChh-HHHHHH
Q 047719          434 FEATI--P-------------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV-IVDWVW  491 (596)
Q Consensus       434 fg~~~--~-------------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~-~~~~~~  491 (596)
                      ||+++  .                   .||..|.++....+...+.+.|+||++.++.|+..|..|+...... ...-+.
T Consensus       171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~  250 (322)
T KOG1164|consen  171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE  250 (322)
T ss_pred             cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence            99876  1                   1889999999999999999999999999999999999999654321 111011


Q ss_pred             HHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          492 NLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       492 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                      ..........      .......+..   ++...+-..+...+|....+...|+..
T Consensus       251 ~~~~~~~~~~------~~~~~~~~~~---~~~~~~~~~~~~~~Pdy~~~~~~l~~~  297 (322)
T KOG1164|consen  251 KDPRKLLTDR------FGDLKPEEFA---KILEYIDSLDYEDKPDYEKLAELLKDV  297 (322)
T ss_pred             HHhhhhcccc------ccCCChHHHH---HHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence            1111100000      1112223333   333344457899999999988877544

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.82  E-value=5.3e-20  Score=176.44  Aligned_cols=144  Identities=19%  Similarity=0.235  Sum_probs=105.5

Q ss_pred             cceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcc-------cchH-----------------HHHHHHHHhccCCCc
Q 047719          289 NRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECA-------RNPF-----------------TTEFATMAGCLRHKN  344 (596)
Q Consensus       289 ~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~-------~~~~-----------------~~E~~~l~~~l~H~n  344 (596)
                      ...||+|+||.||+|...+|+.||||+++........       ...|                 ..|+..+.+ +.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKR-LVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHH-HHHCC
Confidence            3679999999999999888999999999754321111       1122                 237655554 66666


Q ss_pred             eeeecceeeeCCeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHH-HhccCCCeEEccCCCCceee
Q 047719          345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL-HEECERQIIHRDVKACNILL  423 (596)
Q Consensus       345 iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~L-H~~~~~~ivHrDlkp~NiLl  423 (596)
                      +........  ...+|||||+++++|...+...    ..+++.+...++.|++.+|.|| |+   .+|+||||||+|||+
T Consensus        81 v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~----~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli  151 (190)
T cd05147          81 IPCPEPILL--KSHVLVMEFIGDDGWAAPRLKD----APLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLY  151 (190)
T ss_pred             CCCCcEEEe--cCCEEEEEEeCCCCCcchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEE
Confidence            533222211  2238999999988776553322    2488899999999999999999 57   799999999999999


Q ss_pred             cCCCceEEccCCCcccCCCc
Q 047719          424 DAEFNAKLGDFEATIPAGTM  443 (596)
Q Consensus       424 ~~~~~~kl~Dfg~~~~~gt~  443 (596)
                      + ++.++|+|||++...+.+
T Consensus       152 ~-~~~v~LiDFG~a~~~~~~  170 (190)
T cd05147         152 H-DGKLYIIDVSQSVEHDHP  170 (190)
T ss_pred             E-CCcEEEEEccccccCCCc
Confidence            8 478999999998755443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.80  E-value=1.2e-19  Score=192.72  Aligned_cols=198  Identities=27%  Similarity=0.419  Sum_probs=154.8

Q ss_pred             ccCCCceeeecceeeeCCeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCC
Q 047719          339 CLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKA  418 (596)
Q Consensus       339 ~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp  418 (596)
                      .+.|.|+.+++|.|.+....+.|.+||..|+|.+.+...   ...++|.-...++++|++||+|||..  +-..|+.+++
T Consensus         3 ~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~---~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l~s   77 (484)
T KOG1023|consen    3 QLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE---DIKLDYFFILSFIRDISKGLAYLHNS--PIGYHGALKS   77 (484)
T ss_pred             ccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc---ccCccHHHHHHHHHHHHHHHHHHhcC--cceeeeeecc
Confidence            478999999999999999999999999999999999874   35699999999999999999999993  3339999999


Q ss_pred             CceeecCCCceEEccCCCcccCC-------------CcccCCccccccC-------CCCCccceeehhHHHHHHHhCCCC
Q 047719          419 CNILLDAEFNAKLGDFEATIPAG-------------TMGYLAPEYVYSG-------VPSEKTDVYSFGVVALEVAAGKSP  478 (596)
Q Consensus       419 ~NiLl~~~~~~kl~Dfg~~~~~g-------------t~~y~aPE~~~~~-------~~t~~sDV~SfGvll~El~tG~~p  478 (596)
                      +|+++|....+||+|||+.....             ..-|.|||.+...       ..+.+.||||||++++|+++.+.|
T Consensus        78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP  157 (484)
T ss_pred             ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence            99999999999999999865542             2358999998753       147789999999999999999999


Q ss_pred             CCCCCh--hHHHHHHHHHhcCCchhhccccccCcCC-H-HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          479 VDNDGC--VIVDWVWNLRKKGKLLDAADFRLRGKFN-R-KEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       479 ~~~~~~--~~~~~~~~~~~~~~~~~~~d~~l~~~~~-~-~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                      |+....  ...+.+......+.      ..+++... . +....++.++..||..+|++||++++|-..++..
T Consensus       158 ~~~~~~~~~~~eii~~~~~~~~------~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~  224 (484)
T KOG1023|consen  158 FDLRNLVEDPDEIILRVKKGGS------NPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI  224 (484)
T ss_pred             cccccccCChHHHHHHHHhcCC------CCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence            986322  11122222211111      11111111 1 3333688899999999999999999998877644

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.80  E-value=3e-20  Score=206.09  Aligned_cols=242  Identities=20%  Similarity=0.241  Sum_probs=172.2

Q ss_pred             ccceeecCCceEEEEEEcC-CCCEEEEEEeec---CCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          288 KNRIVGEGASATVYKGSLP-SGGAVAVKRFEK---PNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       288 ~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~---~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      ..+++|.|.+|.|+..... .....+.|....   .... ......+..|+ .+...+.|+|++..+..+.+....+-.|
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~-~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEF-CIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhhe-eecccccCCchhhhHHHHhhcccchhhh
Confidence            4688999999977777533 344444443321   1111 11111134444 4445689999999988888877777779


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc----
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI----  438 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~----  438 (596)
                      ||+++ +|..++....    .+...++..+..|+..|+.|||+   .++.|||+|++|+++..++.+||+|||.+.    
T Consensus       401 E~~~~-Dlf~~~~~~~----~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~  472 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNG----KLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRY  472 (601)
T ss_pred             hcccH-HHHHHHhccc----ccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeecc
Confidence            99999 9999998752    37778888999999999999999   999999999999999999999999998643    


Q ss_pred             -----------cCCCcccCCccccccCCCCC-ccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhcccc
Q 047719          439 -----------PAGTMGYLAPEYVYSGVPSE-KTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFR  506 (596)
Q Consensus       439 -----------~~gt~~y~aPE~~~~~~~t~-~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~  506 (596)
                                 ..|+..|+|||.+....|.+ ..||||.|+++..|++|+.||......-...    .........-...
T Consensus       473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~----~~~~~~~~~~~~~  548 (601)
T KOG0590|consen  473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF----KTNNYSDQRNIFE  548 (601)
T ss_pred             CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch----hhhcccccccccc
Confidence                       34888999999999888865 5899999999999999999986431110000    0000000000000


Q ss_pred             ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          507 LRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       507 l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      -..........+...++.++++.||.+|-||++|++
T Consensus       549 ~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  549 GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            001122334456667788899999999999999986

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.80  E-value=3.2e-20  Score=205.81  Aligned_cols=239  Identities=22%  Similarity=0.250  Sum_probs=176.6

Q ss_pred             CCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHH-HhccCCCceeeecceeeeCCeEEEEEe
Q 047719          285 GFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATM-AGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l-~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      ++...+.||++.|=+|.+++.++|. |+||++-+... ......|.++++.+ ...++|||.+++.-+-...+.-|||-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p-~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDP-TISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCC-CCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            5666789999999999999997776 99999865432 23344454444322 234799999999998888888899999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcccC---
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA---  440 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~~---  440 (596)
                      |..+ +|+|.|..+.    -|...+..-|+.|++.||.-+|.   .+|.|||||.+||||++-.-+.|+||..-.+.   
T Consensus       102 yvkh-nLyDRlSTRP----FL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP  173 (1431)
T KOG1240|consen  102 YVKH-NLYDRLSTRP----FLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLP  173 (1431)
T ss_pred             HHhh-hhhhhhccch----HHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCC
Confidence            9976 9999997654    46777888899999999999999   99999999999999999999999999532211   


Q ss_pred             ---------------CCcccCCccccccC-----------CCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHH
Q 047719          441 ---------------GTMGYLAPEYVYSG-----------VPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNL  493 (596)
Q Consensus       441 ---------------gt~~y~aPE~~~~~-----------~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~  493 (596)
                                     ...+|+|||.+...           ..+++-||||.||++.||++ |++||.-.     +.. .+
T Consensus       174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-----QL~-aY  247 (1431)
T KOG1240|consen  174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-----QLL-AY  247 (1431)
T ss_pred             CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-----HHH-hH
Confidence                           23469999987531           15788999999999999999 89998632     111 11


Q ss_pred             Hhc-CCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          494 RKK-GKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       494 ~~~-~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                      ... ....+..-    ..+..   ..+..+++.+++.||++|-++++.++.-.+
T Consensus       248 r~~~~~~~e~~L----e~Ied---~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG  294 (1431)
T KOG1240|consen  248 RSGNADDPEQLL----EKIED---VSLRNLILSMIQRDPSKRLSAEDYLQKYRG  294 (1431)
T ss_pred             hccCccCHHHHH----HhCcC---ccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence            111 11111111    11111   145567778889999999999999886444

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.79  E-value=3e-19  Score=173.87  Aligned_cols=173  Identities=11%  Similarity=0.141  Sum_probs=128.9

Q ss_pred             HhcCCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcc-cch------HHHHHHHHHhccCCCceeeecceeee
Q 047719          282 ATLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECA-RNP------FTTEFATMAGCLRHKNLVQLQGWCCE  354 (596)
Q Consensus       282 at~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~-~~~------~~~E~~~l~~~l~H~niv~l~g~~~~  354 (596)
                      ...+|...++||.|+||.||+... ++..+|||.+.......+. ...      +.+|+..+.+ ++|++|..+..++..
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~r-L~~~GI~~~~d~~~~  106 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDR-VRSEGLASLNDFYLL  106 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHH-HHHCCCCcceEeeee
Confidence            467789999999999999999765 5778999999644322211 112      4677756655 799999999888654


Q ss_pred             C--------CeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCC
Q 047719          355 G--------NELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAE  426 (596)
Q Consensus       355 ~--------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~  426 (596)
                      .        +..+|||||++|.+|.++..        ++.    ....+++.+|..||+   .+++|||+||+|++++.+
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~~  171 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSKN  171 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeCC
Confidence            3        35899999999999988742        222    245689999999999   999999999999999998


Q ss_pred             CceEEccCCCcccCCCcccCCccccccCCCCCccceeehhHHHHHHH
Q 047719          427 FNAKLGDFEATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVA  473 (596)
Q Consensus       427 ~~~kl~Dfg~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~  473 (596)
                      + ++|+|||.....- .......++....+..++|+|+||+.+.-..
T Consensus       172 g-i~liDfg~~~~~~-e~~a~d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        172 G-LRIIDLSGKRCTA-QRKAKDRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             C-EEEEECCCccccc-chhhHHHHHHHhHhcccccccceeEeehHHH
Confidence            8 9999998764321 1111111334455678999999999986554

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.78  E-value=2.2e-18  Score=165.50  Aligned_cols=141  Identities=20%  Similarity=0.217  Sum_probs=105.4

Q ss_pred             cceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcc------------------------cchHHHHHHHHHhccCCCc
Q 047719          289 NRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECA------------------------RNPFTTEFATMAGCLRHKN  344 (596)
Q Consensus       289 ~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~------------------------~~~~~~E~~~l~~~l~H~n  344 (596)
                      ...||+|+||.||+|...+|+.||||+++........                        ...+..|...+.+ +.|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKR-LYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHH-HHhCC
Confidence            4689999999999999878999999999754211000                        0112456655554 77887


Q ss_pred             eeeecceeeeCCeEEEEEecCCCCCHHHH-hhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceee
Q 047719          345 LVQLQGWCCEGNELVLVYEYLPNGSLDKI-LHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILL  423 (596)
Q Consensus       345 iv~l~g~~~~~~~~~lV~E~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl  423 (596)
                      +.....+...  ..+|||||++++++... +...     .++..+...++.+++.+|.+||+.  .+|+||||||+|||+
T Consensus        81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~-----~~~~~~~~~i~~~l~~~l~~lH~~--~givHrDlkP~NIll  151 (190)
T cd05145          81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLKDV-----PLEEEEAEELYEQVVEQMRRLYQE--AGLVHGDLSEYNILY  151 (190)
T ss_pred             CCCceEEEec--CCEEEEEEecCCCchhhhhhhc-----cCCHHHHHHHHHHHHHHHHHHHHh--CCEecCCCChhhEEE
Confidence            7443333322  24899999998865443 4332     367788999999999999999984  699999999999999


Q ss_pred             cCCCceEEccCCCcccC
Q 047719          424 DAEFNAKLGDFEATIPA  440 (596)
Q Consensus       424 ~~~~~~kl~Dfg~~~~~  440 (596)
                      + ++.++|+|||++...
T Consensus       152 ~-~~~~~liDFG~a~~~  167 (190)
T cd05145         152 H-DGKPYIIDVSQAVEL  167 (190)
T ss_pred             E-CCCEEEEEcccceec
Confidence            9 889999999987643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.78  E-value=1.6e-18  Score=173.65  Aligned_cols=227  Identities=20%  Similarity=0.280  Sum_probs=144.0

Q ss_pred             CCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCc-hhcccchHHHHHHHHHhccC----------CCceeeecceee
Q 047719          286 FNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNR-VECARNPFTTEFATMAGCLR----------HKNLVQLQGWCC  353 (596)
Q Consensus       286 f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~-~~~~~~~~~~E~~~l~~~l~----------H~niv~l~g~~~  353 (596)
                      +...+.||.|+++.||.++..+ |+.+|||++..... .....+++.+|...+ ..+.          |-.++-.++...
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~-~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAI-TLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGG-GGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHh-hhhccCCCHHHHHHhceEEeeeEEEE
Confidence            3456899999999999998765 89999999764432 233444555554222 2122          212222222211


Q ss_pred             ---------eCC--------eEEEEEecCCCCCHHHHhh---hCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEE
Q 047719          354 ---------EGN--------ELVLVYEYLPNGSLDKILH---NNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIH  413 (596)
Q Consensus       354 ---------~~~--------~~~lV~E~~~~gsL~~~l~---~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH  413 (596)
                               ...        +.+++|+-+ .++|.+++.   ........+....++.+..|+.+.+++||+   .+++|
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVH  168 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVH  168 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEe
Confidence                     111        247788877 558888864   332223345566778888999999999999   99999


Q ss_pred             ccCCCCceeecCCCceEEccCCCccc--------CCCcccCCccccccC--------CCCCccceeehhHHHHHHHhCCC
Q 047719          414 RDVKACNILLDAEFNAKLGDFEATIP--------AGTMGYLAPEYVYSG--------VPSEKTDVYSFGVVALEVAAGKS  477 (596)
Q Consensus       414 rDlkp~NiLl~~~~~~kl~Dfg~~~~--------~gt~~y~aPE~~~~~--------~~t~~sDV~SfGvll~El~tG~~  477 (596)
                      +||||+|++++.+|.+.|+||+....        ..+..|.+||.....        .+|.+.|.|++|+++|.|+||+.
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l  248 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL  248 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence            99999999999999999999965433        345678999976442        47899999999999999999999


Q ss_pred             CCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCC
Q 047719          478 PVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKR  534 (596)
Q Consensus       478 p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~R  534 (596)
                      ||......                ..+...-..+. +..+.+..|+...++.+|++|
T Consensus       249 Pf~~~~~~----------------~~~~~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  249 PFGLSSPE----------------ADPEWDFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             STCCCGGG----------------STSGGGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCcc----------------ccccccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            99864211                00000112333 566777888889999999987

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.77  E-value=3.1e-18  Score=163.45  Aligned_cols=176  Identities=13%  Similarity=0.051  Sum_probs=132.1

Q ss_pred             CccceeecCCceEEEEEEcCCCCEEEEEEeecCCchh--cccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEec
Q 047719          287 NKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVE--CARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEY  364 (596)
Q Consensus       287 ~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~--~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~  364 (596)
                      .....|++|+||+||.+.- .+..++.+.+.....-.  .....+.+|++.|.++-.|+++.+++++    ...+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            3467899999999997765 67788888775332211  1122478899888774356889999886    347999999


Q ss_pred             CCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccC-CCCceeecCCCceEEccCCCcccC---
Q 047719          365 LPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDV-KACNILLDAEFNAKLGDFEATIPA---  440 (596)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDl-kp~NiLl~~~~~~kl~Dfg~~~~~---  440 (596)
                      +.+.+|.+.+...           ...+..|++.+|.++|+   .+|+|||| ||+|||++.++.++|+|||++...   
T Consensus        80 I~G~~L~~~~~~~-----------~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~  145 (218)
T PRK12274         80 LAGAAMYQRPPRG-----------DLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR  145 (218)
T ss_pred             ecCccHHhhhhhh-----------hHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence            9999987654211           13467899999999999   89999999 799999999999999999987532   


Q ss_pred             ---------------------CCcccCCcccccc-CCCC-CccceeehhHHHHHHHhCCCCCCC
Q 047719          441 ---------------------GTMGYLAPEYVYS-GVPS-EKTDVYSFGVVALEVAAGKSPVDN  481 (596)
Q Consensus       441 ---------------------gt~~y~aPE~~~~-~~~t-~~sDV~SfGvll~El~tG~~p~~~  481 (596)
                                           .++.|++|+...- ...+ .+.+.++-|+-+|.++|++.+.-.
T Consensus       146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence                                 3555666664332 1233 678999999999999999887643

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.76  E-value=2e-19  Score=191.12  Aligned_cols=182  Identities=28%  Similarity=0.310  Sum_probs=149.9

Q ss_pred             eeecCCceEEEEEE----cCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecCC
Q 047719          291 IVGEGASATVYKGS----LPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLP  366 (596)
Q Consensus       291 ~LG~G~fG~Vy~~~----~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~~  366 (596)
                      ++|+|.||.|+++.    .+.|..+|+|++++.............|-..+...-+||.+|++...+..+..++++++|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            47999999999864    23477899999876543332222233343344443449999999999999999999999999


Q ss_pred             CCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc-------c
Q 047719          367 NGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI-------P  439 (596)
Q Consensus       367 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~-------~  439 (596)
                      +|.|...+....    .+...........++.+++++|+   .+++|||+|++||+++.+|++++.|||++.       .
T Consensus        81 gg~lft~l~~~~----~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~  153 (612)
T KOG0603|consen   81 GGDLFTRLSKEV----MFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA  153 (612)
T ss_pred             cchhhhccccCC----chHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence            999999987654    35666677778889999999999   899999999999999999999999999764       3


Q ss_pred             CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCC
Q 047719          440 AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDN  481 (596)
Q Consensus       440 ~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~  481 (596)
                      +||..|||||.+.  .....+|.||||++++||+||..||..
T Consensus       154 cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  154 CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence            6899999999998  567889999999999999999999986

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.76  E-value=1.2e-18  Score=174.91  Aligned_cols=186  Identities=25%  Similarity=0.334  Sum_probs=134.8

Q ss_pred             cCCCceeeecceeee---------------------------CCeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHH
Q 047719          340 LRHKNLVQLQGWCCE---------------------------GNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNI  392 (596)
Q Consensus       340 l~H~niv~l~g~~~~---------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i  392 (596)
                      -+|||||+++++|.+                           ...+||||.-++. +|+.++-.+.     .+...+.-|
T Consensus       273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~-----~s~r~~~~~  346 (598)
T KOG4158|consen  273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH-----RSYRTGRVI  346 (598)
T ss_pred             CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC-----CchHHHHHH
Confidence            469999999998865                           2348999998865 9999998664     556677789


Q ss_pred             HHHHHHHHHHHHhccCCCeEEccCCCCceee--cCC--CceEEccCCCccc-----------------CCCcccCCcccc
Q 047719          393 VLGVASALSYLHEECERQIIHRDVKACNILL--DAE--FNAKLGDFEATIP-----------------AGTMGYLAPEYV  451 (596)
Q Consensus       393 ~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl--~~~--~~~kl~Dfg~~~~-----------------~gt~~y~aPE~~  451 (596)
                      +.|+++|+.|||.   ++|.|||+|+.||||  |+|  -...|+|||++..                 -|...-||||..
T Consensus       347 laQlLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~  423 (598)
T KOG4158|consen  347 LAQLLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIA  423 (598)
T ss_pred             HHHHHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhh
Confidence            9999999999999   999999999999999  333  3578899987542                 256677999987


Q ss_pred             ccCC------CCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHH
Q 047719          452 YSGV------PSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLS  525 (596)
Q Consensus       452 ~~~~------~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~  525 (596)
                      ....      --.|+|.|+.|.+.||+++...||-..+....+-..  +.+.++     +.+...++    ..+.+++..
T Consensus       424 ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~--Yqe~qL-----Palp~~vp----p~~rqlV~~  492 (598)
T KOG4158|consen  424 TAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT--YQESQL-----PALPSRVP----PVARQLVFD  492 (598)
T ss_pred             hcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh--hhhhhC-----CCCcccCC----hHHHHHHHH
Confidence            5421      135899999999999999999999764432221110  111111     22222222    344556666


Q ss_pred             cCCCCCCCCCCHHHHHHHHh
Q 047719          526 CVHPNHEKRPSVKEAARILK  545 (596)
Q Consensus       526 C~~~dp~~RPs~~ev~~~L~  545 (596)
                      .+++||++||+..-....|+
T Consensus       493 lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  493 LLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             HhcCCccccCCccHHHhHHH
Confidence            78999999999766555554

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.76  E-value=6.8e-18  Score=159.47  Aligned_cols=243  Identities=21%  Similarity=0.236  Sum_probs=174.7

Q ss_pred             cCCCccceeecCCceEEEEEEc-CCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCC-CceeeecceeeeCCeEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSL-PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRH-KNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H-~niv~l~g~~~~~~~~~lV  361 (596)
                      ..|...++||+|+||.+|.|.. .+|..||||+-.....    ...+..|. .+.+.++| ..|..+..+..+...-.||
T Consensus        15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~----hpqL~yEs-kvY~iL~~g~GiP~i~~y~~e~~ynvlV   89 (341)
T KOG1163|consen   15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK----HPQLLYES-KVYRILQGGVGIPHIRHYGTEKDYNVLV   89 (341)
T ss_pred             cceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC----CcchhHHH-HHHHHhccCCCCchhhhhccccccceee
Confidence            4678889999999999999964 5699999998643222    22345555 33333554 5666667777888889999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCC---CceEEccCCCcc
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAE---FNAKLGDFEATI  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~---~~~kl~Dfg~~~  438 (596)
                      ||.+ +.||.+.+.-..   ..++..+.+-++-|+..-++|+|.   +++|||||||.|.|..-+   ..+.++|||++.
T Consensus        90 MdLL-GPsLEdLfnfC~---R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK  162 (341)
T KOG1163|consen   90 MDLL-GPSLEDLFNFCS---RRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK  162 (341)
T ss_pred             eecc-CccHHHHHHHHh---hhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchh
Confidence            9988 779999887653   248888999999999999999999   999999999999999654   568899999864


Q ss_pred             c------------------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCch
Q 047719          439 P------------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLL  500 (596)
Q Consensus       439 ~------------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~  500 (596)
                      .                  .||.+|.+--...+...+.+.|+-|+|.+|...--|..||++-.......-.+...+.+ .
T Consensus       163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK-~  241 (341)
T KOG1163|consen  163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKK-M  241 (341)
T ss_pred             hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhh-c
Confidence            2                  48999988877777778899999999999999999999998753322111111111111 1


Q ss_pred             hhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 047719          501 DAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARI  543 (596)
Q Consensus       501 ~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~  543 (596)
                      ...-..+...++.+    +...+.-|-..--++-|...-+.+.
T Consensus       242 s~~ie~LC~G~P~E----F~myl~Y~R~L~F~E~Pdy~ylrql  280 (341)
T KOG1163|consen  242 STPIEVLCKGFPAE----FAMYLNYCRGLGFEEKPDYMYLRQL  280 (341)
T ss_pred             CCCHHHHhCCCcHH----HHHHHHHHhhcCCCCCCcHHHHHHH
Confidence            11222233444433    3344456777777888876555553

>PRK10345 hypothetical protein; Provisional

Probab=99.74  E-value=2.1e-17  Score=160.27  Aligned_cols=136  Identities=15%  Similarity=0.204  Sum_probs=103.9

Q ss_pred             CCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhcc-----CCCceeeecceeeeCC---e
Q 047719          286 FNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCL-----RHKNLVQLQGWCCEGN---E  357 (596)
Q Consensus       286 f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l-----~H~niv~l~g~~~~~~---~  357 (596)
                      .+..++||+|+||.||.  .++....+||++.....  ...+.+.+|+..+.. +     .||||++++|++.++.   .
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~--~~~~~~~rEi~~l~~-L~~~~~~h~nIvr~yg~~et~~g~g~   78 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGD--GGDKEIRRELKYYAH-LSRRLIDWSGIPRYYGTVETDCGTGY   78 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCeEEEEEecccc--chHHHHHHHHHHHHH-hhccCCCCcccceeeEEEEeCCCCeE
Confidence            34568999999999996  44433347999864322  234568999977766 5     5899999999998874   4


Q ss_pred             -EEEEEec--CCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHH-HHHHhccCCCeEEccCCCCceeecC----CCce
Q 047719          358 -LVLVYEY--LPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASAL-SYLHEECERQIIHRDVKACNILLDA----EFNA  429 (596)
Q Consensus       358 -~~lV~E~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL-~~LH~~~~~~ivHrDlkp~NiLl~~----~~~~  429 (596)
                       ..+|+||  +++|+|.+++.+..     +++.  ..++.+++.++ +|||+   ++|+||||||+|||++.    +..+
T Consensus        79 v~~~I~e~~G~~~~tL~~~l~~~~-----~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~  148 (210)
T PRK10345         79 VYDVIADFDGKPSITLTEFAEQCR-----YEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIP  148 (210)
T ss_pred             EEEEEecCCCCcchhHHHHHHccc-----ccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcE
Confidence             3478999  66899999997632     4444  35677888777 99999   99999999999999974    3479


Q ss_pred             EEccCCC
Q 047719          430 KLGDFEA  436 (596)
Q Consensus       430 kl~Dfg~  436 (596)
                      +|+||+.
T Consensus       149 ~LiDg~G  155 (210)
T PRK10345        149 VVCDNIG  155 (210)
T ss_pred             EEEECCC
Confidence            9999543

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.74  E-value=5.6e-17  Score=159.76  Aligned_cols=188  Identities=21%  Similarity=0.279  Sum_probs=158.4

Q ss_pred             cCCCccceeecCCceEEEEEE-cCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGS-LPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      -.|..+++||+|+||.++.|+ +-++++||||.-.....    .-++..|.+....+...+.|...+.+-.++.+-.||+
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~----APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi  103 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE----APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI  103 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccCC----cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence            358889999999999999996 45799999998643322    2235566655555567899999998888888899999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCC-----CceEEccCCCc
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAE-----FNAKLGDFEAT  437 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~-----~~~kl~Dfg~~  437 (596)
                      |.+ +-||.++..-+.   ..++..+...+|.|+..-++|+|+   +.+|.|||||+|.||..-     ..+.+.|||++
T Consensus       104 dLL-GPSLEDLFD~Cg---R~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA  176 (449)
T KOG1165|consen  104 DLL-GPSLEDLFDLCG---RRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA  176 (449)
T ss_pred             hhh-CcCHHHHHHHhc---CcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccch
Confidence            998 779999887654   358899999999999999999999   999999999999999643     45899999986


Q ss_pred             cc------------------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCC
Q 047719          438 IP------------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDND  482 (596)
Q Consensus       438 ~~------------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~  482 (596)
                      ..                  .||.+||+--...+...+.+.|+-|+|=+....+-|..||++-
T Consensus       177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGL  239 (449)
T KOG1165|consen  177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL  239 (449)
T ss_pred             hhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccc
Confidence            42                  4999999998888899999999999999999999999999874

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.72  E-value=2.4e-17  Score=186.73  Aligned_cols=241  Identities=22%  Similarity=0.229  Sum_probs=174.5

Q ss_pred             CHHHHHHHhcCCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccC---CCceeeecce
Q 047719          275 ALTDIKQATLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLR---HKNLVQLQGW  351 (596)
Q Consensus       275 ~~~el~~at~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~---H~niv~l~g~  351 (596)
                      ...+++.....|.+.+.||+|+||+||+|...+|+.||+|+-+..+.-+...   ..++  + .+|+   -+-|..+...
T Consensus       689 ~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI---~~q~--~-~RLk~~~~~~~~~~~~a  762 (974)
T KOG1166|consen  689 PNTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYI---CLQV--M-ERLKPQMLPSIMHISSA  762 (974)
T ss_pred             ccceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeee---hHHH--H-HhhchhhhcchHHHHHH
Confidence            3456666777899999999999999999998889999999875443322111   1111  1 1122   2344555555


Q ss_pred             eeeCCeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeec-------
Q 047719          352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLD-------  424 (596)
Q Consensus       352 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~-------  424 (596)
                      +.-.+..+||+||.+.|+|.+++...    ..++|.....++.|++..+++||.   .+|||+||||.|.||.       
T Consensus       763 ~~~~~~S~lv~ey~~~Gtlld~~N~~----~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~  835 (974)
T KOG1166|consen  763 HVFQNASVLVSEYSPYGTLLDLINTN----KVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADS  835 (974)
T ss_pred             HccCCcceeeeeccccccHHHhhccC----CCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCC
Confidence            56667789999999999999999843    358999999999999999999999   8999999999999993       


Q ss_pred             CCCceEEccCCCcc-------------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHH
Q 047719          425 AEFNAKLGDFEATI-------------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVW  491 (596)
Q Consensus       425 ~~~~~kl~Dfg~~~-------------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~  491 (596)
                      .+..++|+|||.+.             ..+|-.+-.+|+..+..++...|.|.|+.+++-|+.|+.--            
T Consensus       836 ~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q------------  903 (974)
T KOG1166|consen  836 DSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME------------  903 (974)
T ss_pred             cccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH------------
Confidence            24569999999653             23677788999999999999999999999999999987421            


Q ss_pred             HHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          492 NLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       492 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                        ...+.. ..++..++.-...+....+..+++.   +|-..=|...++...|++
T Consensus       904 --~~~g~~-~~~~~~~~Ry~~~~~W~~~F~~lLN---~~~~~~p~l~~lr~~~~~  952 (974)
T KOG1166|consen  904 --VKNGSS-WMVKTNFPRYWKRDMWNKFFDLLLN---PDCDTLPNLQELRTELEE  952 (974)
T ss_pred             --hcCCcc-eeccccchhhhhHHHHHHHHHHHhC---cCcccchhHHHHHHHHHH
Confidence              111111 1111112223334556666666654   666666666666665553

>smart00090 RIO RIO-like kinase

Probab=99.68  E-value=2.3e-16  Score=156.38  Aligned_cols=145  Identities=19%  Similarity=0.198  Sum_probs=107.6

Q ss_pred             CCCccceeecCCceEEEEEE--cCCCCEEEEEEeecCCchhc----------------------ccchHHHHHHHHHhcc
Q 047719          285 GFNKNRIVGEGASATVYKGS--LPSGGAVAVKRFEKPNRVEC----------------------ARNPFTTEFATMAGCL  340 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~--~~~g~~vAvK~l~~~~~~~~----------------------~~~~~~~E~~~l~~~l  340 (596)
                      .|...+.||+|+||.||+|.  ..+|+.||||+++.......                      ....+..|+..+.+ +
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~-L  107 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR-L  107 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH-H
Confidence            37788999999999999998  56799999999874321100                      01124567766655 5


Q ss_pred             CCC--ceeeecceeeeCCeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCC-eEEccCC
Q 047719          341 RHK--NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQ-IIHRDVK  417 (596)
Q Consensus       341 ~H~--niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~-ivHrDlk  417 (596)
                      .+.  .+.+++++    ...+|||||+++++|...+....    .+...+...++.||+.+|.+||+   .+ ++|||||
T Consensus       108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dik  176 (237)
T smart00090      108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV----EPEEEEEFELYDDILEEMRKLYK---EGELVHGDLS  176 (237)
T ss_pred             HhcCCCCCeeeEe----cCceEEEEEecCCcccccccccC----CcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCC
Confidence            442  23344432    23589999999988877653322    24556678899999999999999   88 9999999


Q ss_pred             CCceeecCCCceEEccCCCcccCCC
Q 047719          418 ACNILLDAEFNAKLGDFEATIPAGT  442 (596)
Q Consensus       418 p~NiLl~~~~~~kl~Dfg~~~~~gt  442 (596)
                      |+||+++ ++.++|+|||.+...+.
T Consensus       177 p~NIli~-~~~i~LiDFg~a~~~~~  200 (237)
T smart00090      177 EYNILVH-DGKVVIIDVSQSVELDH  200 (237)
T ss_pred             hhhEEEE-CCCEEEEEChhhhccCC
Confidence            9999999 88999999998765543

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.68  E-value=2.8e-16  Score=151.83  Aligned_cols=145  Identities=21%  Similarity=0.273  Sum_probs=106.8

Q ss_pred             HHHHHhcCCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhc--------------------ccchHHHHHHHHH
Q 047719          278 DIKQATLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVEC--------------------ARNPFTTEFATMA  337 (596)
Q Consensus       278 el~~at~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~--------------------~~~~~~~E~~~l~  337 (596)
                      ++......|...+.||+|+||.||++...+|+.||||++........                    ....+..|...+.
T Consensus         9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   88 (198)
T cd05144           9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK   88 (198)
T ss_pred             HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence            33333334777899999999999999988899999998764321100                    0112455665454


Q ss_pred             hccCCC--ceeeecceeeeCCeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEcc
Q 047719          338 GCLRHK--NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRD  415 (596)
Q Consensus       338 ~~l~H~--niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrD  415 (596)
                      . +.|+  .+.+.++.    ...++||||+++++|......          .....++.+++.++.++|+   .+++|||
T Consensus        89 ~-l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~---~gi~H~D  150 (198)
T cd05144          89 A-LYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYK---HGIIHGD  150 (198)
T ss_pred             H-HHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHH---CCCCcCC
Confidence            4 5666  34444432    346899999999999776431          2345788999999999999   8999999


Q ss_pred             CCCCceeecCCCceEEccCCCcccC
Q 047719          416 VKACNILLDAEFNAKLGDFEATIPA  440 (596)
Q Consensus       416 lkp~NiLl~~~~~~kl~Dfg~~~~~  440 (596)
                      |||+||++++++.++|+|||.+...
T Consensus       151 l~p~Nill~~~~~~~liDfg~~~~~  175 (198)
T cd05144         151 LSEFNILVDDDEKIYIIDWPQMVST  175 (198)
T ss_pred             CCcccEEEcCCCcEEEEECCccccC
Confidence            9999999999999999999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.67  E-value=3.7e-16  Score=152.28  Aligned_cols=136  Identities=21%  Similarity=0.308  Sum_probs=110.7

Q ss_pred             ceeecCCceEEEEEEcCCCCEEEEEEeecCCchh------cccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          290 RIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVE------CARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       290 ~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~------~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      +.||+|++|.||+|.. .|..++||+........      .....+.+|+..+.. ++|+++.....++......++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~~~~i~~p~~~~~~~~~~~lv~e   79 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSR-ARKAGVNVPAVYFVDPENFIIVME   79 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHH-HHHCCCCCCeEEEEeCCCCEEEEE
Confidence            5799999999999987 67789999864322111      112346778755544 889998887777777888999999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP  439 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~  439 (596)
                      |+++++|.+++....       + .+..++.+++.+|.+||+   .+++|+|++|.|||++ ++.++|+|||.+..
T Consensus        80 ~~~G~~L~~~~~~~~-------~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         80 YIEGEPLKDLINSNG-------M-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EeCCcCHHHHHHhcc-------H-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            999999999986532       2 788999999999999999   8999999999999999 78999999998754

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.67  E-value=4e-16  Score=173.37  Aligned_cols=140  Identities=20%  Similarity=0.247  Sum_probs=109.8

Q ss_pred             HhcCCCccceeecCCceEEEEEEcCCCCEEEEEEe-ecCCch-----hcccchHHHHHHHHHhccCCCceeeecceeeeC
Q 047719          282 ATLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRF-EKPNRV-----ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG  355 (596)
Q Consensus       282 at~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l-~~~~~~-----~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~  355 (596)
                      ....|...++||+|+||.||+|.+... .+++|+. .+....     ......+.+|+..+.. ++|++++....++...
T Consensus       331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~~~~i~~p~~~~~~~  408 (535)
T PRK09605        331 VKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSE-ARRAGVPTPVIYDVDP  408 (535)
T ss_pred             cccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHh-hcccCCCeeEEEEEeC
Confidence            344556779999999999999987544 3444443 221111     1123457788866654 8999999888888887


Q ss_pred             CeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCC
Q 047719          356 NELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFE  435 (596)
Q Consensus       356 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg  435 (596)
                      ...++||||+++++|.+++.            ....++.+++++|.|||+   .+++||||||+|||+ .++.++|+|||
T Consensus       409 ~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFG  472 (535)
T PRK09605        409 EEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFG  472 (535)
T ss_pred             CCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCc
Confidence            78899999999999999885            346789999999999999   899999999999999 67899999999


Q ss_pred             Cccc
Q 047719          436 ATIP  439 (596)
Q Consensus       436 ~~~~  439 (596)
                      ++..
T Consensus       473 la~~  476 (535)
T PRK09605        473 LGKY  476 (535)
T ss_pred             cccc
Confidence            8754

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.65  E-value=7e-16  Score=148.92  Aligned_cols=132  Identities=18%  Similarity=0.281  Sum_probs=103.8

Q ss_pred             eeecCCceEEEEEEcCCCCEEEEEEeecCCch------hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEec
Q 047719          291 IVGEGASATVYKGSLPSGGAVAVKRFEKPNRV------ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEY  364 (596)
Q Consensus       291 ~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~------~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~  364 (596)
                      .||+|+||.||+|.+ ++..|++|+.......      ......+.+|+..+.. ++|+++.....++......++||||
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSR-ARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHH-HHHCCCCCCEEEEEECCCCEEEEEE
Confidence            489999999999986 6788999986432211      1112456678766654 7787766555556667778999999


Q ss_pred             CCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc
Q 047719          365 LPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP  439 (596)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~  439 (596)
                      +++++|.+++....     .      .++.+++.+|.+||+   .+++|+|++|.||+++ ++.+++.|||++..
T Consensus        79 ~~g~~l~~~~~~~~-----~------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        79 IEGKPLKDVIEEGN-----D------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             ECCccHHHHHhhcH-----H------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            99999999886532     1      789999999999999   8999999999999999 88999999998654

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.61  E-value=1.2e-16  Score=167.05  Aligned_cols=111  Identities=29%  Similarity=0.469  Sum_probs=100.2

Q ss_pred             eEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCC
Q 047719          357 ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEA  436 (596)
Q Consensus       357 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~  436 (596)
                      .+|+.|++|...+|.+||..+.. ....+|...+.++.|++.|+.|      ++.+|||+||.||+...+..+||+|||+
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~-~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRT-GEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCc-ccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhh
Confidence            58999999999999999986543 2347889999999999999999      5899999999999999999999999986


Q ss_pred             cc-----------------cCCCcccCCccccccCCCCCccceeehhHHHHHHHh
Q 047719          437 TI-----------------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA  474 (596)
Q Consensus       437 ~~-----------------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t  474 (596)
                      ..                 ..||..||+||.+.+..|+.|+||||||++|+|++.
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            42                 248999999999999999999999999999999998

>cd07308 lectin_leg-like legume-like lectins: ERGIC-53, ERGL, VIP36, VIPL, EMP46, and EMP47

Probab=99.58  E-value=7.7e-14  Score=136.78  Aligned_cols=154  Identities=22%  Similarity=0.192  Sum_probs=100.7

Q ss_pred             cccceEEEEEEEEecCCCCCCCCeEEEEEecCCCCCCCCCCccCCCCCCCCCCCceEEEEeeCccCCCCCCCCCCeeEEe
Q 047719            8 TTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQDSFFAVEFDTSFDPSLGDINGNHIGID   87 (596)
Q Consensus         8 ~~asF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~~~~~~~~~lG~~~~~~~~~~~~~AVEfDt~~~~~~~d~~~~Hvgid   87 (596)
                      ..++|+|+|+|.|.... ..+||||||++++...+   .|..+|..+     ..+-+||||||+.|.   +-..++|.+-
T Consensus        55 ~~~~F~~~f~F~i~~~~-~~~gdG~af~~~~~~~~---~g~~~G~~~-----~~~Glai~fdt~~n~---~~~~p~i~~~  122 (218)
T cd07308          55 PAKDFEIEVEFSIHGGS-GLGGDGFAFWYTEEPGS---DGPLFGGPD-----KFKGLAIFFDTYDND---GKGFPSISVF  122 (218)
T ss_pred             cCCCEEEEEEEEEeCCC-CCCCCEEEEEEECCCCC---CCcccccCC-----CCCEEEEEEEcCCCC---CCCCCeEEEE
Confidence            45799999999998653 56799999999985443   344555422     345689999999985   2233444432


Q ss_pred             cC-Cccccc------cccCCCCCcccCC-CceEEEEEEEcCCccEEEEEEeeCCCCCCCCeEEEeecCcccCCCceEEEE
Q 047719           88 IS-SVISFV------SVDALSRGIDLKS-GRHITTWIEYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGF  159 (596)
Q Consensus        88 ~n-s~~s~~------~~~~~~~~~~l~~-g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~l~~~vdl~~~l~~~~~vGF  159 (596)
                      +| +..+..      ....+.-.+...+ +.+++++|.|+  .+.|.|.+....  +....+...++. ..+|+..|+||
T Consensus       123 ~Ndg~~~~~~~~d~~~~~~~~c~~~~~~~~~~~~~~I~y~--~~~l~v~i~~~~--~~~~~~c~~~~~-~~l~~~~y~G~  197 (218)
T cd07308         123 LNDGTKSYDYETDGEKLELASCSLKFRNSNAPTTLRISYL--NNTLKVDITYSE--GNNWKECFTVED-VILPSQGYFGF  197 (218)
T ss_pred             EeCCCceecccCCCccccccceeEecccCCCCeEEEEEEE--CCEEEEEEeCCC--CCCccEEEEcCC-cccCCCCEEEE
Confidence            22 111111      1111111122222 67899999999  678999886532  222234444443 25788999999


Q ss_pred             EeecCCccceeeeeeeeee
Q 047719          160 SAANGQGSAIYTVDRWRFK  178 (596)
Q Consensus       160 sastg~~~~~~~i~~Wsf~  178 (596)
                      ||+||...+.|.|++|.+.
T Consensus       198 sA~tg~~~d~~dIls~~~~  216 (218)
T cd07308         198 SAQTGDLSDNHDILSVHTY  216 (218)
T ss_pred             EeccCCCcCcEEEEEEEee
Confidence            9999999999999999874

The legume-like (leg-like) lectins are eukaryotic intracellular sugar transport proteins with a carbohydrate recognition domain similar to that of the legume lectins. This domain binds high-mannose-type oligosaccharides for transport from the endoplasmic reticulum to the Golgi complex. These leg-like lectins include ERGIC-53, ERGL, VIP36, VIPL, EMP46, EMP47, and the UIP5 (ULP1-interacting protein 5) precursor protein. Leg-like lectins have different intracellular distributions and dynamics in the endoplasmic reticulum-Golgi system of the secretory pathway and interact with N-glycans of glycoproteins in a calcium-dependent manner, suggesting a role in glycoprotein sorting and trafficking. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "ba

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.57  E-value=1.4e-14  Score=138.35  Aligned_cols=137  Identities=23%  Similarity=0.292  Sum_probs=93.6

Q ss_pred             cceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchH----------------------HHHHHHHHhccCCC--c
Q 047719          289 NRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPF----------------------TTEFATMAGCLRHK--N  344 (596)
Q Consensus       289 ~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~----------------------~~E~~~l~~~l~H~--n  344 (596)
                      .+.||+|+||.||+|...+++.||||++............+                      ..|...+.. +.+.  .
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~-l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKR-LYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHH-HHHcCCC
Confidence            46799999999999998889999999986533221111111                      123322322 2222  2


Q ss_pred             eeeecceeeeCCeEEEEEecCCCCCHHHH-hhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceee
Q 047719          345 LVQLQGWCCEGNELVLVYEYLPNGSLDKI-LHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILL  423 (596)
Q Consensus       345 iv~l~g~~~~~~~~~lV~E~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl  423 (596)
                      +.+.+++    ...++||||++++++... +....     .. .....++.+++.++.++|..  .+++||||||+||++
T Consensus        81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~--~~ivH~Dl~p~Nili  148 (187)
T cd05119          81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYRE--AGLVHGDLSEYNILV  148 (187)
T ss_pred             CCceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhc--cCcCcCCCChhhEEE
Confidence            3333332    246899999999554321 21111     11 55678999999999999974  789999999999999


Q ss_pred             cCCCceEEccCCCccc
Q 047719          424 DAEFNAKLGDFEATIP  439 (596)
Q Consensus       424 ~~~~~~kl~Dfg~~~~  439 (596)
                      + ++.++|+|||.+..
T Consensus       149 ~-~~~~~liDfg~a~~  163 (187)
T cd05119         149 D-DGKVYIIDVPQAVE  163 (187)
T ss_pred             E-CCcEEEEECccccc
Confidence            9 89999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.54  E-value=5.3e-14  Score=128.11  Aligned_cols=133  Identities=20%  Similarity=0.162  Sum_probs=108.6

Q ss_pred             cceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCC--CceeeecceeeeCCeEEEEEecCC
Q 047719          289 NRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRH--KNLVQLQGWCCEGNELVLVYEYLP  366 (596)
Q Consensus       289 ~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H--~niv~l~g~~~~~~~~~lV~E~~~  366 (596)
                      .+.||+|.++.||++...+ ..+++|.......    ...+..|+..+.. ++|  .++.+++++....+..+++|||++
T Consensus         3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~----~~~~~~e~~~~~~-l~~~~~~~p~~~~~~~~~~~~~~v~e~~~   76 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK----GADREREVAILQL-LARKGLPVPKVLASGESDGWSYLLMEWIE   76 (155)
T ss_pred             ceecccccccceEEEEecC-CeEEEEecCCCCc----hhHHHHHHHHHHH-HHHcCCCCCeEEEEcCCCCccEEEEEecC
Confidence            4779999999999999744 7899999854322    3457788766655 555  588899888888888999999998


Q ss_pred             CCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc
Q 047719          367 NGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI  438 (596)
Q Consensus       367 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~  438 (596)
                      ++.+..+           +......++.+++++|++||.....+++|+|++|+||+++..+.+++.||+.+.
T Consensus        77 g~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~  137 (155)
T cd05120          77 GETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG  137 (155)
T ss_pred             CeecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence            8776654           445677889999999999998544579999999999999999999999998764

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.51  E-value=1.2e-14  Score=162.06  Aligned_cols=153  Identities=27%  Similarity=0.389  Sum_probs=115.0

Q ss_pred             hcCCCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      ..+|+..++|-.|+||.||..+++. .+.+|+ ++.+.+.       .++.   +......|.+|               
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~l-------ilRn---ilt~a~npfvv---------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNL-------ILRN---ILTFAGNPFVV---------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhh-cccccch-------hhhc---cccccCCccee---------------
Confidence            3578888999999999999998865 667888 4432211       1111   11112233333               


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc---
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI---  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---  438 (596)
                            |+=.+.++..+    +++-        +++.+++|||+   .+|+|||+||.|.+|+.-|.+|+.|||++.   
T Consensus       136 ------gDc~tllk~~g----~lPv--------dmvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GL  194 (1205)
T KOG0606|consen  136 ------GDCATLLKNIG----PLPV--------DMVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGL  194 (1205)
T ss_pred             ------chhhhhcccCC----CCcc--------hhhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhh
Confidence                  44444444332    1221        12788999999   999999999999999999999999997532   


Q ss_pred             -----------------------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCC
Q 047719          439 -----------------------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDND  482 (596)
Q Consensus       439 -----------------------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~  482 (596)
                                             .+||+.|+|||++....|...+|+|++|+|+||.+-|+.||.++
T Consensus       195 ms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGd  261 (1205)
T KOG0606|consen  195 MSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD  261 (1205)
T ss_pred             hhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCC
Confidence                                   25999999999999999999999999999999999999999876

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.51  E-value=1.5e-13  Score=136.60  Aligned_cols=137  Identities=21%  Similarity=0.238  Sum_probs=103.1

Q ss_pred             cceee-cCCceEEEEEEcCCCCEEEEEEeecCCc-----------hhcccchHHHHHHHHHhccCCCce--eeecceeee
Q 047719          289 NRIVG-EGASATVYKGSLPSGGAVAVKRFEKPNR-----------VECARNPFTTEFATMAGCLRHKNL--VQLQGWCCE  354 (596)
Q Consensus       289 ~~~LG-~G~fG~Vy~~~~~~g~~vAvK~l~~~~~-----------~~~~~~~~~~E~~~l~~~l~H~ni--v~l~g~~~~  354 (596)
                      ...|| .||.|+||+... .+..++||++.....           .......+.+|+..+.. ++|+++  ++.++++..
T Consensus        36 ~~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~-L~~~gi~vP~pl~~~~~  113 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQ-LYEAGLPVPRPIAARVV  113 (239)
T ss_pred             CceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHH-HHhCCCCCceeEeeeee
Confidence            46788 899999999987 477899998854221           01223456778865554 888775  667776544


Q ss_pred             CC----eEEEEEecCCC-CCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCce
Q 047719          355 GN----ELVLVYEYLPN-GSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNA  429 (596)
Q Consensus       355 ~~----~~~lV~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~  429 (596)
                      ..    ..++||||+++ .+|.+++....     ++..    .+.+|+.+|.+||+   .+|+||||||.|||++.++.+
T Consensus       114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~~-----l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v  181 (239)
T PRK01723        114 RHGLFYRADILIERIEGARDLVALLQEAP-----LSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKF  181 (239)
T ss_pred             ecCcceeeeEEEEecCCCCCHHHHHhcCC-----CCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCE
Confidence            32    23599999997 69999986532     4433    35689999999999   999999999999999999999


Q ss_pred             EEccCCCccc
Q 047719          430 KLGDFEATIP  439 (596)
Q Consensus       430 kl~Dfg~~~~  439 (596)
                      +|+|||.+..
T Consensus       182 ~LIDfg~~~~  191 (239)
T PRK01723        182 WLIDFDRGEL  191 (239)
T ss_pred             EEEECCCccc
Confidence            9999998754

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.45  E-value=1.6e-13  Score=135.53  Aligned_cols=186  Identities=24%  Similarity=0.384  Sum_probs=138.1

Q ss_pred             cCCCceeeecceeeeCC-----eEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEc
Q 047719          340 LRHKNLVQLQGWCCEGN-----ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHR  414 (596)
Q Consensus       340 l~H~niv~l~g~~~~~~-----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHr  414 (596)
                      +-|.|||+++.|+.+..     +..++.|||..|+|..+|++.......+......+++.||..||.|||+ |.++++|+
T Consensus       124 lvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~Ppiihg  202 (458)
T KOG1266|consen  124 LVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDPPIIHG  202 (458)
T ss_pred             HHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCCccccC
Confidence            67999999999987643     5789999999999999998866555667778888999999999999999 78999999


Q ss_pred             cCCCCceeecCCCceEEccCC---------------CcccCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCC
Q 047719          415 DVKACNILLDAEFNAKLGDFE---------------ATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPV  479 (596)
Q Consensus       415 Dlkp~NiLl~~~~~~kl~Dfg---------------~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~  479 (596)
                      ++..+-|++..++-+|++--.               .+...+-++|.+||+-..-..+..+|||+||+..+||..+..-.
T Consensus       203 nlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~  282 (458)
T KOG1266|consen  203 NLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQS  282 (458)
T ss_pred             CcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheecc
Confidence            999999999999999987321               12234678899999877777888999999999999999876432


Q ss_pred             -CCCChhHHHHHHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          480 -DNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       480 -~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                       .......++        ...... ...+....       -..++..|++..|..||+|++++.
T Consensus       283 tnseS~~~~e--------e~ia~~-i~~len~l-------qr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  283 TNSESKVEVE--------ENIANV-IIGLENGL-------QRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             CCCcceeehh--------hhhhhh-eeeccCcc-------ccCcCcccccCCCCCCcchhhhhc
Confidence             221111110        000000 00011111       113445799999999999998765

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.40  E-value=3.3e-14  Score=158.08  Aligned_cols=242  Identities=24%  Similarity=0.248  Sum_probs=171.7

Q ss_pred             cCCCccceeecCCceEEEEEEcCC--CCEEEEEEeecCCchhcccchHHHHHHHHHhccC-CCceeeecceeeeCCeEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPS--GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLR-HKNLVQLQGWCCEGNELVL  360 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~-H~niv~l~g~~~~~~~~~l  360 (596)
                      ..|...+.||+|.|+.|-......  ...+|+|.+...............|. .+...+. |+|++++++.....+..++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~-~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTET-DIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccc-cccccccccccccccCCccCCCccccc
Confidence            446666789999999998876533  45677777654331221111222233 3333344 9999999999999999999


Q ss_pred             EEecCCCCCHHHHhh-hCCCCCcccCHHHHHHHHHHHHHHHHHHH-hccCCCeEEccCCCCceeecCCC-ceEEccCCCc
Q 047719          361 VYEYLPNGSLDKILH-NNSSSSIVLSWEKRLNIVLGVASALSYLH-EECERQIIHRDVKACNILLDAEF-NAKLGDFEAT  437 (596)
Q Consensus       361 V~E~~~~gsL~~~l~-~~~~~~~~l~~~~~~~i~~~ia~gL~~LH-~~~~~~ivHrDlkp~NiLl~~~~-~~kl~Dfg~~  437 (596)
                      .+||..++++.+.+. ...   ...+....-....|+..++.|+| .   .++.|||+||+|.+++..+ ..+++|||++
T Consensus        99 ~~~~s~g~~~f~~i~~~~~---~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~A  172 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDS---TGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLA  172 (601)
T ss_pred             ccCcccccccccccccCCc---cCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhh
Confidence            999999999999883 322   12444556678899999999999 6   8999999999999999999 9999999865


Q ss_pred             c--------------cCC-CcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchh
Q 047719          438 I--------------PAG-TMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLD  501 (596)
Q Consensus       438 ~--------------~~g-t~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~  501 (596)
                      .              .+| ++.|+|||...+ ....+..|+||.|+++.-+++|..|++......          .....
T Consensus       173 t~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~----------~~~~~  242 (601)
T KOG0590|consen  173 TAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD----------GRYSS  242 (601)
T ss_pred             ccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc----------cccee
Confidence            3              247 899999999887 456789999999999999999999987532110          00001


Q ss_pred             hccccc--cCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          502 AADFRL--RGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       502 ~~d~~l--~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ......  .............++...++..+|..|.+.+++..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  243 WKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             ecccccccccCccccCChhhhhcccccccCCchhccccccccc
Confidence            111100  01111223345556666788889999999887643

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.37  E-value=2.5e-12  Score=138.80  Aligned_cols=143  Identities=19%  Similarity=0.151  Sum_probs=98.2

Q ss_pred             cceeecCCceEEEEEEcCCCCEEEEEEeecCCchhc--------------------------------------ccchHH
Q 047719          289 NRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVEC--------------------------------------ARNPFT  330 (596)
Q Consensus       289 ~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~--------------------------------------~~~~~~  330 (596)
                      .+.||.|++|+||+|++.+|+.||||+.+.......                                      .+-+|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            478999999999999999999999999854311100                                      011244


Q ss_pred             HHHHHHHh---ccCCCceeeeccee-eeCCeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHH-HHHHHHh
Q 047719          331 TEFATMAG---CLRHKNLVQLQGWC-CEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVAS-ALSYLHE  405 (596)
Q Consensus       331 ~E~~~l~~---~l~H~niv~l~g~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~-gL~~LH~  405 (596)
                      +|...+.+   .++|.+-+.+-..+ ......+|||||+++++|.+++.....   ..   .+..++..++. .+..+|.
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~---~~---~~~~ia~~~~~~~l~ql~~  275 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA---GL---DRKALAENLARSFLNQVLR  275 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc---CC---CHHHHHHHHHHHHHHHHHh
Confidence            45433332   22333333433333 223457999999999999988754321   12   23456666665 4677887


Q ss_pred             ccCCCeEEccCCCCceeecCCCceEEccCCCcccC
Q 047719          406 ECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA  440 (596)
Q Consensus       406 ~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~~  440 (596)
                         .+++|+|+||.||+++.++.+++.|||++...
T Consensus       276 ---~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l  307 (437)
T TIGR01982       276 ---DGFFHADLHPGNIFVLKDGKIIALDFGIVGRL  307 (437)
T ss_pred             ---CCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence               89999999999999999999999999987543

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.26  E-value=6.9e-12  Score=134.00  Aligned_cols=238  Identities=23%  Similarity=0.254  Sum_probs=168.6

Q ss_pred             CCCccceeec--CCceEEEEEEc--C-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEE
Q 047719          285 GFNKNRIVGE--GASATVYKGSL--P-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELV  359 (596)
Q Consensus       285 ~f~~~~~LG~--G~fG~Vy~~~~--~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~  359 (596)
                      .|...+.+|.  |.+|.||.+..  . ++..+|+|+-+...........-.+|...-...-.|+|.|+.+..+...+.++
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            3556688999  99999999976  3 47889999854433333333334556545445457999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHH----HHHHHHhccCCCeEEccCCCCceeecCC-CceEEccC
Q 047719          360 LVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVAS----ALSYLHEECERQIIHRDVKACNILLDAE-FNAKLGDF  434 (596)
Q Consensus       360 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~----gL~~LH~~~~~~ivHrDlkp~NiLl~~~-~~~kl~Df  434 (596)
                      +-+|++. .+|.++.+....   .++....+....+..+    ||.++|.   ..++|-|+||.||++..+ ...+++||
T Consensus       195 iqtE~~~-~sl~~~~~~~~~---~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~~df  267 (524)
T KOG0601|consen  195 IQTELCG-ESLQSYCHTPCN---FLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKLTDF  267 (524)
T ss_pred             eeecccc-chhHHhhhcccc---cCCchhhhhHHhhhhhcccccccccCC---CcccccccchhheecccccceeecCCc
Confidence            9999985 689988876543   2455566666666666    9999999   899999999999999999 89999999


Q ss_pred             CCccc----------------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCC
Q 047719          435 EATIP----------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGK  498 (596)
Q Consensus       435 g~~~~----------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~  498 (596)
                      |....                .|...|++||.. .+.++...|+|++|.+..|..++..+....-.  ..  |...+.+.
T Consensus       268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~--~~--W~~~r~~~  342 (524)
T KOG0601|consen  268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKN--SS--WSQLRQGY  342 (524)
T ss_pred             ceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCC--CC--cccccccc
Confidence            75322                356679999976 45688999999999999999998766543200  01  11111111


Q ss_pred             chhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          499 LLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       499 ~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      +        ..++-......+......+++.+|..|++.+.+..
T Consensus       343 i--------p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  343 I--------PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             C--------chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            1        11111111122222556778999999998876644

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.22  E-value=1.6e-11  Score=134.17  Aligned_cols=145  Identities=15%  Similarity=0.102  Sum_probs=89.3

Q ss_pred             hcCCCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCchh--------------------------------c-----
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRVE--------------------------------C-----  324 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~--------------------------------~-----  324 (596)
                      -..|+. +.||+|++|+||+|++++ |+.||||+++..-...                                +     
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            345665 789999999999999987 9999999996431100                                0     


Q ss_pred             -ccchHHHHHHHHHh---ccCCCceeeecceeee-CCeEEEEEecCCCCCHHHHh--hhCCCCCcccCHHHHHHHHHHHH
Q 047719          325 -ARNPFTTEFATMAG---CLRHKNLVQLQGWCCE-GNELVLVYEYLPNGSLDKIL--HNNSSSSIVLSWEKRLNIVLGVA  397 (596)
Q Consensus       325 -~~~~~~~E~~~l~~---~l~H~niv~l~g~~~~-~~~~~lV~E~~~~gsL~~~l--~~~~~~~~~l~~~~~~~i~~~ia  397 (596)
                       .+-++.+|...+.+   ...+.+.+.+-..+.+ ....+|||||++|+.|.++-  ...+.....+.......+..|+ 
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-  276 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-  276 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence             01124444433322   1223333333222222 34578999999999998753  2221100112211222222222 


Q ss_pred             HHHHHHHhccCCCeEEccCCCCceeecCCC----ceEEccCCCcc
Q 047719          398 SALSYLHEECERQIIHRDVKACNILLDAEF----NAKLGDFEATI  438 (596)
Q Consensus       398 ~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~----~~kl~Dfg~~~  438 (596)
                            ..   .+++|+|+||.||+++.++    .+++.|||+..
T Consensus       277 ------f~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg  312 (537)
T PRK04750        277 ------FR---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVG  312 (537)
T ss_pred             ------Hh---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEE
Confidence                  23   7999999999999999988    99999999764

>cd06902 lectin_ERGIC-53_ERGL ERGIC-53 and ERGL type 1 transmembrane proteins, N-terminal lectin domain

Probab=99.17  E-value=1.5e-09  Score=106.13  Aligned_cols=158  Identities=15%  Similarity=0.080  Sum_probs=97.0

Q ss_pred             cccceEEEEEEEEecCCCCCCCCeEEEEEecCCCCCCCCCCccCCCCCCCCCCCceEEEEeeCccCCCCCCCCCCeeEEe
Q 047719            8 TTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQDSFFAVEFDTSFDPSLGDINGNHIGID   87 (596)
Q Consensus         8 ~~asF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~~~~~~~~~lG~~~~~~~~~~~~~AVEfDt~~~~~~~d~~~~Hvgid   87 (596)
                      ..-+|+.+|+|.|.... ..+||||||.++....   ..|..+|..+.-+|     +||.|||+.|.+  ..+.+.|-+-
T Consensus        57 ~~~~w~ie~~Fri~g~~-~~~gdG~a~W~t~~~~---~~G~~~G~~~~f~G-----l~I~~Dt~~n~~--~~~~p~i~~~  125 (225)
T cd06902          57 SFENWEVEVTFRVTGRG-RIGADGLAIWYTKERG---EEGPVFGSSDKWNG-----VGIFFDSFDNDG--KKNNPAILVV  125 (225)
T ss_pred             CCCCEEEEEEEEEecCC-CCCCCEEEEEEECCCC---CCCCccCCCCcccE-----EEEEEECCCCCC--CCCCcEEEEE
Confidence            35689999999998653 3468999999997543   23455554332222     799999998753  2333455332


Q ss_pred             c-CCccccccc-cC-----CCCCcccC-CCceEEEEEEEcCCccEEEEEEeeCCCCCCCCeEEEeecCcc-cCCCceEEE
Q 047719           88 I-SSVISFVSV-DA-----LSRGIDLK-SGRHITTWIEYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSK-QFKDYMHVG  158 (596)
Q Consensus        88 ~-ns~~s~~~~-~~-----~~~~~~l~-~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~l~~~vdl~~-~l~~~~~vG  158 (596)
                      + ++.+..... +.     +.-....+ ...+.+++|.|...  .|.|.+..+. .+...-...-+++.. .||...|+|
T Consensus       126 ~NDGt~~yd~~~D~~~~~~~~C~~~~rn~~~p~~~rI~Y~~~--~l~V~~d~~~-~~~~~~~~~Cf~~~~v~LP~~~yfG  202 (225)
T cd06902         126 GNDGTKSYDHQNDGLTQALGSCLRDFRNKPYPVRAKITYYQN--VLTVSINNGF-TPNKDDYELCTRVENMVLPPNGYFG  202 (225)
T ss_pred             ECCCCeeccccCCCcccccceEEEeccCCCCCeEEEEEEECC--eEEEEEeCCc-CCCCCcccEEEecCCeeCCCCCEEE
Confidence            2 232221111 10     00011222 24678999999884  5888886432 112111112233333 578889999


Q ss_pred             EEeecCCccceeeeeeeeeec
Q 047719          159 FSAANGQGSAIYTVDRWRFKT  179 (596)
Q Consensus       159 Fsastg~~~~~~~i~~Wsf~~  179 (596)
                      |||+||...+.|.|++|++.+
T Consensus       203 iSA~Tg~l~d~hDIls~~~~s  223 (225)
T cd06902         203 VSAATGGLADDHDVLSFLTFS  223 (225)
T ss_pred             EEecCCCCCCcEeEEEEEEec
Confidence            999999999999999999863

ERGIC-53 and ERGL, N-terminal carbohydrate recognition domain. ERGIC-53 and ERGL are eukaryotic mannose-binding type 1 transmembrane proteins of the early secretory pathway that transport newly synthesized glycoproteins from the endoplasmic reticulum (ER) to the ER-Golgi intermediate compartment (ERGIC). ERGIC-53 and ERGL have an N-terminal lectin-like carbohydrate recognition domain (represented by this alignment model) as well as a C-terminal transmembrane domain. ERGIC-53 functions as a 'cargo receptor' to facilitate the export of glycoproteins with different characteristics from the ER, while the ERGIC-53-like protein (ERGL) which may act as a regulator of ERGIC-53. In mammals, ERGIC-53 forms a complex with MCFD2 (multi-coagulation factor deficiency 2) which then recruits blood coagulation factors V and VIII. Mutations in either MCFD2 or ERGIC-53 cause a mild form of inherite

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.15  E-value=3e-11  Score=129.15  Aligned_cols=243  Identities=20%  Similarity=0.182  Sum_probs=172.2

Q ss_pred             HHHhcCCCccceeecCCceEEEEEEcC--CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCe
Q 047719          280 KQATLGFNKNRIVGEGASATVYKGSLP--SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNE  357 (596)
Q Consensus       280 ~~at~~f~~~~~LG~G~fG~Vy~~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~  357 (596)
                      ...+..|.....||.|.|+.|++...+  ++..|++|.+.+.........--+.|+........|.+++.....|...++
T Consensus       261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~  340 (524)
T KOG0601|consen  261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ  340 (524)
T ss_pred             eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence            344567888999999999999998654  478899998865433332222234455444455679999999888888888


Q ss_pred             EEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCC-CceEEccCCC
Q 047719          358 LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAE-FNAKLGDFEA  436 (596)
Q Consensus       358 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~-~~~kl~Dfg~  436 (596)
                      .|+--||+.++++...+..    ...++...++++..|++.++.++|+   ..++|+|+||+||++..+ +..+++||++
T Consensus       341 ~~ip~e~~~~~s~~l~~~~----~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~  413 (524)
T KOG0601|consen  341 GYIPLEFCEGGSSSLRSVT----SQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGC  413 (524)
T ss_pred             ccCchhhhcCcchhhhhHH----HHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhcccccc
Confidence            9999999999998877732    2357888899999999999999998   999999999999999886 8889999986


Q ss_pred             ccc--------CCCcccC--CccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhcccc
Q 047719          437 TIP--------AGTMGYL--APEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFR  506 (596)
Q Consensus       437 ~~~--------~gt~~y~--aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~  506 (596)
                      ...        ...-+++  +++......+..+.|+||||.-+.|.+++..--....    .|.  ....+..     +.
T Consensus       414 ~t~~~~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~----~~~--~i~~~~~-----p~  482 (524)
T KOG0601|consen  414 WTRLAFSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV----QSL--TIRSGDT-----PN  482 (524)
T ss_pred             ccccceecccccccccccccchhhccccccccccccccccccccccccCcccCcccc----cce--eeecccc-----cC
Confidence            532        1233444  5555556778899999999999999999874433211    111  1111111     11


Q ss_pred             ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 047719          507 LRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK  545 (596)
Q Consensus       507 l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~  545 (596)
                      ...     ....+..+......+++..||.+.+......
T Consensus       483 ~~~-----~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~  516 (524)
T KOG0601|consen  483 LPG-----LKLQLQVLLKVMINPDRKRRPSAVELSLHSE  516 (524)
T ss_pred             CCc-----hHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence            111     1133334444566899999999887765443

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.12  E-value=2.6e-10  Score=106.82  Aligned_cols=129  Identities=17%  Similarity=0.082  Sum_probs=89.5

Q ss_pred             ceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCcee-eecceeeeCCeEEEEEecCCCC
Q 047719          290 RIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLV-QLQGWCCEGNELVLVYEYLPNG  368 (596)
Q Consensus       290 ~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv-~l~g~~~~~~~~~lV~E~~~~g  368 (596)
                      +.|+.|.++.||+++.. ++.|++|.......   ....+..|...+.. +.+.+++ +++.+.  ....++||||+++.
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~---~~~~~~~E~~~l~~-l~~~~~~P~~~~~~--~~~~~lv~e~i~G~   76 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE---LLINRENEAENSKL-AAEAGIGPKLYYFD--PETGVLITEFIEGS   76 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCcc---cccCHHHHHHHHHH-HHHhCCCCceEEEe--CCCCeEEEEecCCC
Confidence            56889999999999864 77899998743321   12245667655544 4444444 344433  23458999999998


Q ss_pred             CHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhcc--CCCeEEccCCCCceeecCCCceEEccCCCcc
Q 047719          369 SLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC--ERQIIHRDVKACNILLDAEFNAKLGDFEATI  438 (596)
Q Consensus       369 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~--~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~  438 (596)
                      ++....         .   ....++.+++++|+.||+..  ...++|+|++|.||+++ ++.+++.||+.+.
T Consensus        77 ~l~~~~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          77 ELLTED---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             cccccc---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            876430         0   11245678999999999831  12369999999999999 6689999998764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd06901 lectin_VIP36_VIPL VIP36 and VIPL type 1 transmembrane proteins, lectin domain

Probab=99.10  E-value=5.5e-09  Score=103.49  Aligned_cols=158  Identities=16%  Similarity=0.127  Sum_probs=92.3

Q ss_pred             cccceEEEEEEEEecCCCCCCCCeEEEEEecCCCCCCCCCCccCCCCCCCCCCCceEEEEeeCccCCCC-CCCCCCee-E
Q 047719            8 TTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQDSFFAVEFDTSFDPSL-GDINGNHI-G   85 (596)
Q Consensus         8 ~~asF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~~~~~~~~~lG~~~~~~~~~~~~~AVEfDt~~~~~~-~d~~~~Hv-g   85 (596)
                      ...+|+|+|+|.|.......+||||||+++.....   .|..+|-.+.-+|     +||-|||+.|..- .....+-| +
T Consensus        55 ~~~~F~~~f~F~I~~~~~~~~GdGlAfw~t~~~~~---~G~~fG~~~~f~G-----l~I~~Dt~~n~~~~~~~~~P~i~~  126 (248)
T cd06901          55 YLRDWEMHVHFKVHGSGKNLFGDGFAIWYTKERMQ---PGPVFGSKDNFHG-----LAIFFDTYSNQNGEHEHVHPYISA  126 (248)
T ss_pred             cCCCEEEEEEEEEeCCCCCCCCCEEEEEEEcCCCc---cCcccccCCCCce-----EEEEEECCCCCCCcccCCCceEEE
Confidence            56899999999999876667899999999976432   2333443222122     7999999988631 00111122 2


Q ss_pred             EecCCcccccc------ccCCCCCccc-CCCceEEEEEEEcCCccEEEEEEeeCCCCCCCCeEEEeecCcccCCCceEEE
Q 047719           86 IDISSVISFVS------VDALSRGIDL-KSGRHITTWIEYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVG  158 (596)
Q Consensus        86 id~ns~~s~~~------~~~~~~~~~l-~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~l~~~vdl~~~l~~~~~vG  158 (596)
                      +-.++...-..      ...+.-.... ..+.+.+++|.|...  .+.|.+.......-..+  ..++ .-.||...|+|
T Consensus       127 ~~NDGt~~yd~~~Dg~~~~~~~C~~~~rn~~~~t~~rI~Y~~~--~l~v~vd~~~~~~w~~C--f~~~-~v~LP~~~yfG  201 (248)
T cd06901         127 MVNNGSLSYDHDRDGTHTELAGCSAPFRNKDHDTFVAIRYSKG--RLTVMTDIDGKNEWKEC--FDVT-GVRLPTGYYFG  201 (248)
T ss_pred             EEcCCCeeecccCCCchhhcCceeeeccCCCCCeEEEEEEECC--eEEEEEecCCCCceeee--EEeC-CeecCCCCEEE
Confidence            22223222110      0111001112 234457899999864  47777765221111111  1111 12468889999


Q ss_pred             EEeecCCccceeeeeeeeee
Q 047719          159 FSAANGQGSAIYTVDRWRFK  178 (596)
Q Consensus       159 Fsastg~~~~~~~i~~Wsf~  178 (596)
                      |||+||...+.|.|++-.+.
T Consensus       202 iSA~Tg~~sd~hdIlsv~~~  221 (248)
T cd06901         202 ASAATGDLSDNHDIISMKLY  221 (248)
T ss_pred             EEecCCCCCCcEEEEEEEEe
Confidence            99999999999999985554

The vesicular integral protein of 36 kDa (VIP36) is a type 1 transmembrane protein of the mammalian early secretory pathway that acts as a cargo receptor transporting high mannose type glycoproteins between the Golgi and the endoplasmic reticulum (ER). Lectins of the early secretory pathway are involved in the selective transport of newly synthesized glycoproteins from the ER to the ER-Golgi intermediate compartment (ERGIC). The most prominent cycling lectin is the mannose-binding type1 membrane protein ERGIC-53, which functions as a cargo receptor to facilitate export of glycoproteins from the ER. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded she

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.03  E-value=1.3e-09  Score=117.78  Aligned_cols=155  Identities=23%  Similarity=0.308  Sum_probs=114.8

Q ss_pred             cCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecCCCCCHHHHhhhCCCCCccc
Q 047719          305 LPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVL  384 (596)
Q Consensus       305 ~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l  384 (596)
                      ..++.+|.|+..+....  .......+-+..+ +.++||||++++..+..++.+|||+|-+.  -|..++.+..      
T Consensus        34 k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~l-KtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~------  102 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNG--EVTELAKRAVKRL-KTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG------  102 (690)
T ss_pred             eccCCceEEEEEeCCCc--hhhHHHHHHHHHh-hhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH------
Confidence            34688999998865443  1222234444444 45999999999999999999999999874  5777776533      


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcccC-CCc----------ccCCcccccc
Q 047719          385 SWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA-GTM----------GYLAPEYVYS  453 (596)
Q Consensus       385 ~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~~-gt~----------~y~aPE~~~~  453 (596)
                       -....-.+.||+.||.|||+.  .+++|++|.-.-|++++.|..||++|.+.... |+.          .|..|+.+..
T Consensus       103 -~~~v~~Gl~qIl~AL~FL~~d--~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~  179 (690)
T KOG1243|consen  103 -KEEVCLGLFQILAALSFLNDD--CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDP  179 (690)
T ss_pred             -HHHHHHHHHHHHHHHHHHhcc--CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCc
Confidence             344455688999999999974  78999999999999999999999999654322 222          2444543322


Q ss_pred             CCCCCccceeehhHHHHHHHhC
Q 047719          454 GVPSEKTDVYSFGVVALEVAAG  475 (596)
Q Consensus       454 ~~~t~~sDV~SfGvll~El~tG  475 (596)
                      ..  ...|.|-|||+++|++.|
T Consensus       180 s~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  180 SE--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             cc--cchhhhhHHHHHHHHhCc
Confidence            11  346999999999999999

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.02  E-value=3e-09  Score=101.64  Aligned_cols=139  Identities=17%  Similarity=0.202  Sum_probs=92.8

Q ss_pred             ceeecCCceEEEEEEcCC-------CCEEEEEEeecCCch-----h---------------cccchHH----HHHHHHHh
Q 047719          290 RIVGEGASATVYKGSLPS-------GGAVAVKRFEKPNRV-----E---------------CARNPFT----TEFATMAG  338 (596)
Q Consensus       290 ~~LG~G~fG~Vy~~~~~~-------g~~vAvK~l~~~~~~-----~---------------~~~~~~~----~E~~~l~~  338 (596)
                      ..||.|--+.||.|.-.+       +..+|||+.+.....     .               ..+..+.    +|...|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            578999999999997543       479999987532100     0               0011222    56655554


Q ss_pred             ccCC-CceeeecceeeeCCeEEEEEecCCCCCHHH-HhhhCCCCCcccCHHHHHHHHHHHHHHHHHH-HhccCCCeEEcc
Q 047719          339 CLRH-KNLVQLQGWCCEGNELVLVYEYLPNGSLDK-ILHNNSSSSIVLSWEKRLNIVLGVASALSYL-HEECERQIIHRD  415 (596)
Q Consensus       339 ~l~H-~niv~l~g~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~L-H~~~~~~ivHrD  415 (596)
                      +-.. -++.+++++    ..-+|||||+.+..+.. .|.+.     .++..+...+..+++.+|..| |.   .+++|+|
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~-----~~~~~~~~~i~~~i~~~l~~l~H~---~glVHGD  150 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA-----KLNDEEMKNAYYQVLSMMKQLYKE---CNLVHAD  150 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc-----ccCHHHHHHHHHHHHHHHHHHHHh---CCeecCC
Confidence            3222 234444433    45789999997654422 23221     244455667889999999999 77   8999999


Q ss_pred             CCCCceeecCCCceEEccCCCcccCC
Q 047719          416 VKACNILLDAEFNAKLGDFEATIPAG  441 (596)
Q Consensus       416 lkp~NiLl~~~~~~kl~Dfg~~~~~g  441 (596)
                      |++.|||++ ++.+.|+||+.+....
T Consensus       151 Ls~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         151 LSEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             CCHHHEEEE-CCcEEEEECCCceeCC
Confidence            999999997 4689999999876554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.99  E-value=3.1e-09  Score=103.83  Aligned_cols=142  Identities=19%  Similarity=0.233  Sum_probs=104.8

Q ss_pred             ceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCC--CceeeecceeeeCC---eEEEEEec
Q 047719          290 RIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRH--KNLVQLQGWCCEGN---ELVLVYEY  364 (596)
Q Consensus       290 ~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H--~niv~l~g~~~~~~---~~~lV~E~  364 (596)
                      +.|+.|..+.||++...+|+.+++|........ .....+..|...+.. +++  .++.+++.++....   ..++||||
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~-l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~   81 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRA-LAGTGVPVPKVLALCEDPSVLGTPFYVMER   81 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHH-hhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence            568999999999998877789999997543221 234467778766554 554  34566777766543   56899999


Q ss_pred             CCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhc--------------------------------------
Q 047719          365 LPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEE--------------------------------------  406 (596)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~--------------------------------------  406 (596)
                      +++.+|.+.+...     .++..++..++.++++.|..||+.                                      
T Consensus        82 i~G~~l~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (223)
T cd05154          82 VDGRVLRDRLLRP-----ELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA  156 (223)
T ss_pred             eCCEecCCCCCCC-----CCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence            9998888765321     366777788888888888888852                                      


Q ss_pred             ---------------cCCCeEEccCCCCceeecC--CCceEEccCCCcc
Q 047719          407 ---------------CERQIIHRDVKACNILLDA--EFNAKLGDFEATI  438 (596)
Q Consensus       407 ---------------~~~~ivHrDlkp~NiLl~~--~~~~kl~Dfg~~~  438 (596)
                                     ....++|+|+++.||+++.  ++.+.|.||+.+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence                           0256899999999999998  6678999997653

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.86  E-value=1.1e-09  Score=123.09  Aligned_cols=194  Identities=25%  Similarity=0.306  Sum_probs=140.9

Q ss_pred             HHhcCCCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCchh-cccchHHHHHHHHHhccCCCceeeecceeeeCCeE
Q 047719          281 QATLGFNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRVE-CARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNEL  358 (596)
Q Consensus       281 ~at~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~-~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~  358 (596)
                      ....+|...+-+-+|.++.++.+.-.. |...++|......... ...+....+-...+ ..+||-++....-+.-...+
T Consensus       801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i-~p~~P~v~~~~~s~~~rsP~  879 (1205)
T KOG0606|consen  801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILI-TPRSPAVVRSFPSFPCRSPL  879 (1205)
T ss_pred             CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccc-cCCCCceecccCCCCCCCCc
Confidence            345567777788899999999876443 4344444433221111 11112222211111 14567777766665566789


Q ss_pred             EEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc
Q 047719          359 VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI  438 (596)
Q Consensus       359 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~  438 (596)
                      +||++|+.+++|...|+...    .++..-....+..+..+++|||.   ..+.|+|++|.|.|+..++..+++||++..
T Consensus       880 ~L~~~~~~~~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~  952 (1205)
T KOG0606|consen  880 PLVGHYLNGGDLPSKLHNSG----CLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLS  952 (1205)
T ss_pred             chhhHHhccCCchhhhhcCC----CcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCcccccc
Confidence            99999999999999998754    23434444566678889999998   568999999999999999999999995210


Q ss_pred             ------------------------------------------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCC
Q 047719          439 ------------------------------------------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGK  476 (596)
Q Consensus       439 ------------------------------------------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~  476 (596)
                                                                ..||..|.+||...+......+|+|++|++++|.++|.
T Consensus       953 ~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~ 1032 (1205)
T KOG0606|consen  953 KVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGI 1032 (1205)
T ss_pred             ccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCC
Confidence                                                      12788999999999999999999999999999999999


Q ss_pred             CCCCCC
Q 047719          477 SPVDND  482 (596)
Q Consensus       477 ~p~~~~  482 (596)
                      +||...
T Consensus      1033 pp~na~ 1038 (1205)
T KOG0606|consen 1033 PPFNAE 1038 (1205)
T ss_pred             CCCCCc
Confidence            999865

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.79  E-value=7.6e-08  Score=88.96  Aligned_cols=159  Identities=23%  Similarity=0.311  Sum_probs=105.1

Q ss_pred             ccceeecCCceEEEEEEcCCCCEEEEEE-eecCCch-----hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          288 KNRIVGEGASATVYKGSLPSGGAVAVKR-FEKPNRV-----ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       288 ~~~~LG~G~fG~Vy~~~~~~g~~vAvK~-l~~~~~~-----~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      ...+|-+|+-+.|+++.+ .|+...||. +.+.-+.     .-......+|.+.+.+ .+--.|.-..-++.+...-.|+
T Consensus        11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k-~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAK-CRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHH-HHHhCCCCceEEEEecCCCeEE
Confidence            457899999999999988 667666664 3322111     1123345666655544 2222222222245566667899


Q ss_pred             EecCCC-CCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCc---eEEccCCCc
Q 047719          362 YEYLPN-GSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFN---AKLGDFEAT  437 (596)
Q Consensus       362 ~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~---~kl~Dfg~~  437 (596)
                      |||+++ -++.+++.......  ..-.....++..|-+.+.-||.   ..++|+||..+||+|..++.   +-+.|||++
T Consensus        89 ME~~~g~~~vk~~i~~~~~~~--~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls  163 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMEDE--SEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLS  163 (229)
T ss_pred             EEeccchhHHHHHHHHHccCc--ccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecch
Confidence            999976 47888887653211  2222336788899999999999   89999999999999976543   579999997


Q ss_pred             ccCCCcccCCccccccCCCCCccceeeh
Q 047719          438 IPAGTMGYLAPEYVYSGVPSEKTDVYSF  465 (596)
Q Consensus       438 ~~~gt~~y~aPE~~~~~~~t~~sDV~Sf  465 (596)
                      ...     ..||       ...+|+|-|
T Consensus       164 ~~s-----~~~E-------DKgVDLYVl  179 (229)
T KOG3087|consen  164 SVS-----RLPE-------DKGVDLYVL  179 (229)
T ss_pred             hcc-----cCcc-------cccceeeee
Confidence            654     2344       456777744

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.66  E-value=1.8e-07  Score=86.95  Aligned_cols=134  Identities=22%  Similarity=0.281  Sum_probs=93.5

Q ss_pred             ceeecCCceEEEEEEcCCCCEEEEEE-eecCCchhc-----ccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          290 RIVGEGASATVYKGSLPSGGAVAVKR-FEKPNRVEC-----ARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       290 ~~LG~G~fG~Vy~~~~~~g~~vAvK~-l~~~~~~~~-----~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      ..+++|+-..+|.+.+ -|.++.+|. +.+.-....     ....-.+|...+.+ ++--.|--..=+..+.....|+||
T Consensus         2 ~~i~~GAEa~i~~~~~-~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~-a~~~GV~~P~v~dvD~~~~~I~me   79 (204)
T COG3642           2 DLIKQGAEAIIYLTDF-LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAK-AREAGVPVPIVYDVDPDNGLIVME   79 (204)
T ss_pred             chhhCCcceeEEeeec-cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHH-HHHcCCCCCeEEEEcCCCCEEEEE
Confidence            3578999999999977 344455554 322221111     12234566644443 333333333335566778899999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcccC
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA  440 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~~  440 (596)
                      |+++-.|.+.+...           +..++..+-.-+.-||.   .+|+|+||.++||++..+. +.+.|||+....
T Consensus        80 ~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642          80 YIEGELLKDALEEA-----------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             EeCChhHHHHHHhc-----------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence            99999999998754           24667778888889999   9999999999999998765 999999997643

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.66  E-value=4.6e-07  Score=95.57  Aligned_cols=168  Identities=21%  Similarity=0.292  Sum_probs=121.5

Q ss_pred             eEEEEEEc-CCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeee----CCeEEEEEecCCC-CCHH
Q 047719          298 ATVYKGSL-PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE----GNELVLVYEYLPN-GSLD  371 (596)
Q Consensus       298 G~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~----~~~~~lV~E~~~~-gsL~  371 (596)
                      .+.||+.. .+|..|++|+++.........  ...-++.. +.+.|.|+|++..++..    +..++|||+|.|+ ++|.
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk--~t~lve~w-kkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~  366 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNK--DTSLVEAW-KKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY  366 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccCccc--chHHHHHH-HHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence            56899964 479999999995432221111  11222233 44899999999988773    4578999999986 6788


Q ss_pred             HHhhhCCCC-----------CcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcccC
Q 047719          372 KILHNNSSS-----------SIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA  440 (596)
Q Consensus       372 ~~l~~~~~~-----------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~~  440 (596)
                      +.-......           ....++...|.++.|+..||.++|+   .|+.-+-|.+++||++.+.+++|+..|.....
T Consensus       367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl  443 (655)
T KOG3741|consen  367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVL  443 (655)
T ss_pred             HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeee
Confidence            876554321           2346788999999999999999999   89999999999999999999999877654322


Q ss_pred             CCcccCCc-cccccCCCCCccceeehhHHHHHHHhCCCC
Q 047719          441 GTMGYLAP-EYVYSGVPSEKTDVYSFGVVALEVAAGKSP  478 (596)
Q Consensus       441 gt~~y~aP-E~~~~~~~t~~sDV~SfGvll~El~tG~~p  478 (596)
                      -.    .| |.+..   -.+-|.=.||.+++-|.||..-
T Consensus       444 ~~----d~~~~le~---~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  444 QE----DPTEPLES---QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             cC----CCCcchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence            11    11 11221   2356888999999999999643

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.66  E-value=3.5e-07  Score=92.17  Aligned_cols=143  Identities=15%  Similarity=0.133  Sum_probs=96.0

Q ss_pred             ceeecCCceEEEEEEcCCCCEEEEEEeecCCchh---------cccchHHHHHHHHHhccCCCc--eeeecceeee----
Q 047719          290 RIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVE---------CARNPFTTEFATMAGCLRHKN--LVQLQGWCCE----  354 (596)
Q Consensus       290 ~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~---------~~~~~~~~E~~~l~~~l~H~n--iv~l~g~~~~----  354 (596)
                      +.+-.-.-..|++..+ +|+.|.||+.......+         .....+.+|...+.. +...+  ..+++++...    
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~-L~~~GIptP~pVa~~e~~~~~  105 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHR-LHEVGVDTMTGVAFGERGSNP  105 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHH-HHHcCCCCCCeeEEEEecCCC
Confidence            4444444455777766 67789999774322111         011136677755544 32222  2233344332    


Q ss_pred             -CCeEEEEEecCCCC-CHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecC-------
Q 047719          355 -GNELVLVYEYLPNG-SLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDA-------  425 (596)
Q Consensus       355 -~~~~~lV~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~-------  425 (596)
                       ...-+||+|++++- +|.+++.....  ...+...+..++.+++..+.-||.   .+|+|+|++++|||++.       
T Consensus       106 ~~~~s~LVte~l~~~~sL~~~~~~~~~--~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~  180 (268)
T PRK15123        106 ATRTSFIITEDLAPTISLEDYCADWAT--NPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREE  180 (268)
T ss_pred             ccceeEEEEeeCCCCccHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCC
Confidence             23578999999886 89999864321  124556777899999999999999   99999999999999975       


Q ss_pred             CCceEEccCCCccc
Q 047719          426 EFNAKLGDFEATIP  439 (596)
Q Consensus       426 ~~~~kl~Dfg~~~~  439 (596)
                      +..+.++||+.+..
T Consensus       181 ~~~~~LIDl~r~~~  194 (268)
T PRK15123        181 DLKLSVIDLHRAQI  194 (268)
T ss_pred             CceEEEEECCcccc
Confidence            46899999987743

>PF03388 Lectin_leg-like: Legume-like lectin family; InterPro: IPR005052 Lectins are structurally diverse proteins that bind to specific carbohydrates

Probab=98.59  E-value=1.2e-06  Score=86.33  Aligned_cols=163  Identities=20%  Similarity=0.149  Sum_probs=90.5

Q ss_pred             CCCCCCcccceEEEEEEEEecCCCCCCCCeEEEEEecCCCCCCCCCCccCCCCCCCCCCCceEEEEeeCccCCCCC-CCC
Q 047719            2 LDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQDSFFAVEFDTSFDPSLG-DIN   80 (596)
Q Consensus         2 ~~~~~~~~asF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~~~~~~~~~lG~~~~~~~~~~~~~AVEfDt~~~~~~~-d~~   80 (596)
                      |.+..-...+|+.+|+|.|........||||||.++.....   .|..+|..+.-+|     +||=|||+.|.+-. ...
T Consensus        51 ws~~~~~~~~w~i~~~Fri~g~~~~~~g~G~a~W~t~~~~~---~G~~fG~~~~f~G-----l~i~idt~~N~~~~~~~~  122 (229)
T PF03388_consen   51 WSRKPIPFDNWEIEFTFRISGQEKGLGGDGMAFWYTKDPGS---DGPVFGGPDKFDG-----LGIFIDTYDNDEGGHKRG  122 (229)
T ss_dssp             EESS-BEESEEEEEEEEEEESS-SSS-S-EEEEEEESSSSS---SCSBTTB-SS-EE-----EEEEEEES-TTCTTCTST
T ss_pred             EEcCCCCccCEEEEEEEEEeccccCcCCCeEEEEEEcCccc---cccccCCCcccce-----EEEEEEcccCCCcccccc
Confidence            44444456789999999998775566899999999965443   4444553222122     68999999986311 112


Q ss_pred             CCeeEEecC-Ccccccccc------CCCCCcccC-CCceEEEEEEEcCCccEEEEEEeeCCCCC-CCCeEEEeecCcccC
Q 047719           81 GNHIGIDIS-SVISFVSVD------ALSRGIDLK-SGRHITTWIEYRDSLKLIRVWAGYSQIRP-PSPLIIAQIDLSKQF  151 (596)
Q Consensus        81 ~~Hvgid~n-s~~s~~~~~------~~~~~~~l~-~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~-~~p~l~~~vdl~~~l  151 (596)
                      ...|.+-+| +..+.....      ++.-....+ .+.+.+++|.|...  .+.|.+..+-.+. ..-.....++ .-.|
T Consensus       123 ~p~i~~~~NDGt~~~~~~~dg~~~~~~~C~~~~rn~~~p~~~ri~Y~~~--~l~v~id~~~~~~~~~~~~Cf~~~-~v~L  199 (229)
T PF03388_consen  123 FPYISAMLNDGTKSYDHDNDGKDQSLGSCSADYRNSDVPTRIRISYSKN--TLTVSIDSNYLKNQDDWELCFTTD-GVDL  199 (229)
T ss_dssp             SSEEEEEEEESSS---GGGTTTTT-SEEEE---BTESSEEEEEEEEETT--EEEEEEETSCCSECCTTEEEEEES-TEEG
T ss_pred             cceEEEEecCCCccccccccCcccccccceeccCcCCCCEEEEEEEECC--eEEEEEecccccCCcCCcEEEEcC-Ceec
Confidence            233433222 211111110      000011222 34567999999776  4777776321111 1112333332 1246


Q ss_pred             CCceEEEEEeecCCccceeeeeee
Q 047719          152 KDYMHVGFSAANGQGSAIYTVDRW  175 (596)
Q Consensus       152 ~~~~~vGFsastg~~~~~~~i~~W  175 (596)
                      |+..|+||||+||.....|.|++-
T Consensus       200 P~~~yfGvSA~Tg~~~d~hdi~s~  223 (229)
T PF03388_consen  200 PEGYYFGVSAATGELSDNHDILSV  223 (229)
T ss_dssp             GSSBEEEEEEEESSSGGEEEEEEE
T ss_pred             CCCCEEEEEecCCCCCCcEEEEEE
Confidence            888899999999999999999983

This family includes the VIP36 and ERGIC-53 lectins. These two proteins were the first members of the family of animal lectins similar to the leguminous plant lectins []. The alignment for this family is towards the N terminus, where the similarity of VIP36 and ERGIC-53 is greatest. Although they have been identified as a family of animal lectins, this alignment also includes yeast sequences[]. ERGIC-53 is a 53kDa protein, localised to the intermediate region between the endoplasmic reticulum and the Golgi apparatus (ER-Golgi-Intermediate Compartment, ERGIC). It was identified as a calcium-dependent, mannose-specific lectin []. Its dysfunction has been associated with combined factors V and VIII deficiency, suggesting an important and substrate-specific role for ERGIC-53 in the glycoprotein-secreting pathway [,]. The L-type lectin-like domain has an overall globular shape composed of a beta-sandwich of two major twisted antiparallel beta-sheets. The beta-sandwich comprises a major concave beta-sheet and a minor convex beta-sheet, in a variation of the jelly roll fold [, , , ]. ; GO: 0016020 membrane; PDB: 3A4U_A 3LCP_B 2A6Z_A 2A71_C 2A70_B 2A6Y_A 2A6X_A 2A6W_B 2A6V_B 2E6V_B ....

>cd06903 lectin_EMP46_EMP47 EMP46 and EMP47 type 1 transmembrane proteins, N-terminal lectin domain

Probab=98.57  E-value=2.7e-06  Score=82.57  Aligned_cols=146  Identities=15%  Similarity=0.153  Sum_probs=85.9

Q ss_pred             ceEEEEEEEEecCCCCCCCCeEEEEEecCCCCCCCCCCccCCCCCCCCCCCceEEEEeeCccCCCCCCCCCCeeEEecCC
Q 047719           11 SFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQDSFFAVEFDTSFDPSLGDINGNHIGIDISS   90 (596)
Q Consensus        11 sF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~~~~~~~~~lG~~~~~~~~~~~~~AVEfDt~~~~~~~d~~~~Hvgid~ns   90 (596)
                      +|+.+|+|.|.... ..+||||||.++..+...+. ...+|-.+.=+|     +||.|||+.|..   |  ..-++--++
T Consensus        59 ~w~ie~~Fri~G~~-~~~gdGla~W~t~~~~~~~g-~~~fG~~~~f~G-----l~I~~Dt~~n~~---p--~i~~~~NDG  126 (215)
T cd06903          59 EWTIEWTFRSTGPE-GRSGGGLNFWLVKDGNADVG-TSSIYGPSKFDG-----LQLLIDNNGGSG---G--SLRGFLNDG  126 (215)
T ss_pred             CEEEEEEEEecccC-CcCCCEEEEEEECCCcccCC-ccccCCCCCCcE-----EEEEEECCCCCC---c--eEEEEECCC
Confidence            89999999998553 26799999999975432110 022332111122     799999998731   1  122222233


Q ss_pred             cccccccc-----CCCCCcc-cCCCceEEEEEEEcCCccEEEEEEeeCCCCCCCCeEEEeecCcccCC-CceEEEEEeec
Q 047719           91 VISFVSVD-----ALSRGID-LKSGRHITTWIEYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFK-DYMHVGFSAAN  163 (596)
Q Consensus        91 ~~s~~~~~-----~~~~~~~-l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~l~~~vdl~~~l~-~~~~vGFsast  163 (596)
                      ........     ++.=... ...+.+.+++|.|......|+|.+..      +  +...++ .-.|| .-.|+||||+|
T Consensus       127 t~~yd~~~d~~~~~g~C~~~~rn~~~p~~iri~Y~~~~~~l~v~vd~------~--~Cf~~~-~v~lP~~~y~fGiSAaT  197 (215)
T cd06903         127 SKDYKNEDVDSLAFGSCLFAYQDSGVPSTIRLSYDALNSLFKVQVDN------R--LCFQTD-KVQLPQGGYRFGITAAN  197 (215)
T ss_pred             CeeccccCCcccccceeeEeccCCCCCEEEEEEEECCCCEEEEEECC------C--EEEecC-CeecCCCCCEEEEEEcC
Confidence            22211111     1100011 23455789999998877788888742      1  222221 11356 45679999999


Q ss_pred             CCccceeeeeeeee
Q 047719          164 GQGSAIYTVDRWRF  177 (596)
Q Consensus       164 g~~~~~~~i~~Wsf  177 (596)
                      |...+.|.|++-..
T Consensus       198 g~~~d~hdIl~~~~  211 (215)
T cd06903         198 ADNPESFEILKLKV  211 (215)
T ss_pred             CCCCCcEEEEEEEE
Confidence            99999999998544

EMP46 and EMP47, N-terminal carbohydrate recognition domain. EMP46 and EMP47 are fungal type-I transmembrane proteins that cycle between the endoplasmic reticulum and the golgi apparatus and are thought to function as cargo receptors that transport newly synthesized glycoproteins. EMP47 is a receptor for EMP46 responsible for the selective transport of EMP46 by forming hetero-oligomerization between the two proteins. EMP46 and EMP47 have an N-terminal lectin-like carbohydrate recognition domain (represented by this alignment model) as well as a C-terminal transmembrane domain. EMP46 and EMP47 are 45% sequence-identical to one another and have sequence homology to a class of intracellular lectins defined by ERGIC-53 and VIP36. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat s

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.54  E-value=8.6e-07  Score=91.33  Aligned_cols=184  Identities=20%  Similarity=0.277  Sum_probs=125.9

Q ss_pred             ccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceee-------eCCeEEE
Q 047719          288 KNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCC-------EGNELVL  360 (596)
Q Consensus       288 ~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~-------~~~~~~l  360 (596)
                      .++.||+|+-+.+|---- -+..|| |+.....-..+  .+.   +..|...-.||-+-.-+.|=.       +....-+
T Consensus        15 ~gr~LgqGgea~ly~l~e-~~d~VA-KIYh~Pppa~~--aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf   87 (637)
T COG4248          15 PGRPLGQGGEADLYTLGE-VRDQVA-KIYHAPPPAAQ--AQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF   87 (637)
T ss_pred             CCccccCCccceeeecch-hhchhh-eeecCCCchHH--HHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence            457899999999995421 122344 77654332211  111   223444456665544233311       1223677


Q ss_pred             EEecCCCCC-HHHHhhh--CCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccC---
Q 047719          361 VYEYLPNGS-LDKILHN--NSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF---  434 (596)
Q Consensus       361 V~E~~~~gs-L~~~l~~--~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Df---  434 (596)
                      +|..+++.- ...++.-  ++.......|...++.+..+|.+.+-||+   .|.+-+|+.++|+|+.+++.+.|.|-   
T Consensus        88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf  164 (637)
T COG4248          88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSF  164 (637)
T ss_pred             ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcccce
Confidence            888776542 3333321  12223457899999999999999999999   89999999999999999999998763   


Q ss_pred             C-------CcccCCCcccCCccccc-----cCCCCCccceeehhHHHHHHHhC-CCCCCC
Q 047719          435 E-------ATIPAGTMGYLAPEYVY-----SGVPSEKTDVYSFGVVALEVAAG-KSPVDN  481 (596)
Q Consensus       435 g-------~~~~~gt~~y~aPE~~~-----~~~~t~~sDV~SfGvll~El~tG-~~p~~~  481 (596)
                      .       ...++|...|.+||.-.     +...+...|-|.+||++++++.| +.||.+
T Consensus       165 qi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG  224 (637)
T COG4248         165 QINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG  224 (637)
T ss_pred             eeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence            2       23467889999999764     34557889999999999999985 999986

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.47  E-value=8.6e-08  Score=104.40  Aligned_cols=139  Identities=24%  Similarity=0.430  Sum_probs=95.4

Q ss_pred             HHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcccC--------------------CCcccCCccccc
Q 047719          393 VLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA--------------------GTMGYLAPEYVY  452 (596)
Q Consensus       393 ~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~~--------------------gt~~y~aPE~~~  452 (596)
                      +.+++.||.|+|..  .++||++|.|++|.++.++..||+.|+.....                    -...|.|||++.
T Consensus       105 l~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            34456999999985  89999999999999999999999999653221                    234689999999


Q ss_pred             cCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCC
Q 047719          453 SGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNH  531 (596)
Q Consensus       453 ~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp  531 (596)
                      ....+.++|+||+||++|-+.. |+.-+...+..+.     ........+..........+.+..+.+    .+.+..++
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~-----~~~~~~~~~~~~~~~s~~~p~el~~~l----~k~l~~~~  253 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS-----YSFSRNLLNAGAFGYSNNLPSELRESL----KKLLNGDS  253 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCCcch-----hhhhhcccccccccccccCcHHHHHHH----HHHhcCCc
Confidence            9888999999999999999995 5544443322111     111112222222222233444433333    45678999


Q ss_pred             CCCCCHHHHHH
Q 047719          532 EKRPSVKEAAR  542 (596)
Q Consensus       532 ~~RPs~~ev~~  542 (596)
                      ..||++.++..
T Consensus       254 ~~rp~~~~l~~  264 (700)
T KOG2137|consen  254 AVRPTLDLLLS  264 (700)
T ss_pred             ccCcchhhhhc
Confidence            99998777654

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.46  E-value=7.3e-07  Score=84.92  Aligned_cols=128  Identities=25%  Similarity=0.343  Sum_probs=77.3

Q ss_pred             EEEEEEcCCCCEEEEEEeecCCch------------------------hcccchHHHHHHHHHhccCCC--ceeeeccee
Q 047719          299 TVYKGSLPSGGAVAVKRFEKPNRV------------------------ECARNPFTTEFATMAGCLRHK--NLVQLQGWC  352 (596)
Q Consensus       299 ~Vy~~~~~~g~~vAvK~l~~~~~~------------------------~~~~~~~~~E~~~l~~~l~H~--niv~l~g~~  352 (596)
                      .||.|...+|..+|||..+....+                        ........+|...|.+ +...  ++.+++.+-
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~-l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKR-LYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHH-CCCTT-SS--EEEEE
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHH-HHHCCccCCcEEEEe
Confidence            489999889999999987531000                        0011235567766665 4433  344554332


Q ss_pred             eeCCeEEEEEecCC--CCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHH-HHhccCCCeEEccCCCCceeecCCCce
Q 047719          353 CEGNELVLVYEYLP--NGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY-LHEECERQIIHRDVKACNILLDAEFNA  429 (596)
Q Consensus       353 ~~~~~~~lV~E~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~-LH~~~~~~ivHrDlkp~NiLl~~~~~~  429 (596)
                          .-+|||||++  +..+.. |....     ++......++.+++..+.. +|.   .+++|+||.+.|||++++ .+
T Consensus        80 ----~~~ivME~I~~~G~~~~~-l~~~~-----~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~  145 (188)
T PF01163_consen   80 ----RNVIVMEYIGEDGVPLPR-LKDVD-----LSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KV  145 (188)
T ss_dssp             ----TTEEEEE--EETTEEGGC-HHHCG-----GGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CE
T ss_pred             ----CCEEEEEecCCCccchhh-HHhcc-----ccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eE
Confidence                3479999998  544444 33221     1123445667777775555 466   899999999999999988 99


Q ss_pred             EEccCCCcccCC
Q 047719          430 KLGDFEATIPAG  441 (596)
Q Consensus       430 kl~Dfg~~~~~g  441 (596)
                      .|+|||.+....
T Consensus       146 ~iIDf~qav~~~  157 (188)
T PF01163_consen  146 YIIDFGQAVDSS  157 (188)
T ss_dssp             EE--GTTEEETT
T ss_pred             EEEecCcceecC
Confidence            999999876554

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK09902 hypothetical protein; Provisional

Probab=98.21  E-value=2e-05  Score=75.77  Aligned_cols=140  Identities=19%  Similarity=0.114  Sum_probs=100.3

Q ss_pred             eecCCceEEEEEEcCCCCEEEEEEeecC-Cch---hcccchHHHHHHHHHhccCCC--ceeeecceee-eC----CeEEE
Q 047719          292 VGEGASATVYKGSLPSGGAVAVKRFEKP-NRV---ECARNPFTTEFATMAGCLRHK--NLVQLQGWCC-EG----NELVL  360 (596)
Q Consensus       292 LG~G~fG~Vy~~~~~~g~~vAvK~l~~~-~~~---~~~~~~~~~E~~~l~~~l~H~--niv~l~g~~~-~~----~~~~l  360 (596)
                      -|+||-+.|++-.+ +|..+-+|+-... ..+   ...+..|.+|+..+.. +...  .+.+.. ++. .+    ..-+|
T Consensus        26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~-L~~~GvPVP~pv-f~~~~k~~~~~rA~L  102 (216)
T PRK09902         26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKE-LERAGVIVPKIV-FGEAVKIEGEWRALL  102 (216)
T ss_pred             cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHH-HHHcCCCCCccc-eeeeeccCCceEEEE
Confidence            46789999999877 4557888886411 111   2356679999866655 3322  234444 332 21    24689


Q ss_pred             EEecCCC-CCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCc--eEEccCCCc
Q 047719          361 VYEYLPN-GSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFN--AKLGDFEAT  437 (596)
Q Consensus       361 V~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~--~kl~Dfg~~  437 (596)
                      |+|-+++ -+|.+++.+...  .+.+...+..++.+++..++-||+   .++.|+|+-+.|||++.++.  +++.||..+
T Consensus       103 VTe~L~g~~~L~~~l~~~~~--~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~  177 (216)
T PRK09902        103 VTEDMAGFISIADWYAQHAV--SPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKS  177 (216)
T ss_pred             EEEeCCCCccHHHHHhcCCc--CCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence            9997763 589999876532  235677788999999999999999   99999999999999986666  999999766


Q ss_pred             cc
Q 047719          438 IP  439 (596)
Q Consensus       438 ~~  439 (596)
                      ..
T Consensus       178 r~  179 (216)
T PRK09902        178 RR  179 (216)
T ss_pred             ch
Confidence            54

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.21  E-value=2.8e-06  Score=92.76  Aligned_cols=146  Identities=19%  Similarity=0.174  Sum_probs=88.5

Q ss_pred             CCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhc--------------------------------------cc
Q 047719          285 GFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVEC--------------------------------------AR  326 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~--------------------------------------~~  326 (596)
                      .|+ .+-|+.++-|+||+|++.+|+.||||+.+..-...-                                      .+
T Consensus       127 eF~-~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~E  205 (517)
T COG0661         127 EFE-PEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREE  205 (517)
T ss_pred             HcC-CCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHH
Confidence            344 378999999999999999999999999853211000                                      00


Q ss_pred             chHHHHHHHHHh---ccC-CCceeeecceeeeCCeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHH
Q 047719          327 NPFTTEFATMAG---CLR-HKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY  402 (596)
Q Consensus       327 ~~~~~E~~~l~~---~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~  402 (596)
                      -++.+|...+.+   .++ .+++.=..=++.-.+...|+|||++|-.+.+.......   .++-   ..++..++++  |
T Consensus       206 lDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~---g~d~---k~ia~~~~~~--f  277 (517)
T COG0661         206 LDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA---GIDR---KELAELLVRA--F  277 (517)
T ss_pred             hCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc---CCCH---HHHHHHHHHH--H
Confidence            112233222211   111 22222222222334567899999999999888532221   1332   2233333332  1


Q ss_pred             HHhccCCCeEEccCCCCceeecCCCceEEccCCCccc
Q 047719          403 LHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP  439 (596)
Q Consensus       403 LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~  439 (596)
                      +-+-...+++|.|..|.||+++.++.+.+-|||+...
T Consensus       278 ~~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~  314 (517)
T COG0661         278 LRQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGR  314 (517)
T ss_pred             HHHHHhcCccccCCCccceEEecCCcEEEEcCcceec
Confidence            1111226899999999999999999999999998643

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.19  E-value=1.3e-05  Score=77.80  Aligned_cols=104  Identities=22%  Similarity=0.279  Sum_probs=77.2

Q ss_pred             chHHHHHHHHHhccC--CCceeeecceeeeC----CeEEEEEecCCCC-CHHHHhhhCCCCCcccCHHHHHHHHHHHHHH
Q 047719          327 NPFTTEFATMAGCLR--HKNLVQLQGWCCEG----NELVLVYEYLPNG-SLDKILHNNSSSSIVLSWEKRLNIVLGVASA  399 (596)
Q Consensus       327 ~~~~~E~~~l~~~l~--H~niv~l~g~~~~~----~~~~lV~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~g  399 (596)
                      ....+|...+.. +.  .=...+.+++....    ...+||+|++++- +|.+++.....    ++......++.+++..
T Consensus        56 ~ra~~E~~~~~~-L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~----~~~~~~~~ll~~l~~~  130 (206)
T PF06293_consen   56 SRAKREWRNLQR-LREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ----LDPSQRRELLRALARL  130 (206)
T ss_pred             hHHHHHHHHHHH-HHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc----cchhhHHHHHHHHHHH
Confidence            346666654433 22  22234445555442    2468999999874 89999986432    4556778899999999


Q ss_pred             HHHHHhccCCCeEEccCCCCceeecCCC---ceEEccCCCcc
Q 047719          400 LSYLHEECERQIIHRDVKACNILLDAEF---NAKLGDFEATI  438 (596)
Q Consensus       400 L~~LH~~~~~~ivHrDlkp~NiLl~~~~---~~kl~Dfg~~~  438 (596)
                      ++-||+   .+|+|+|+++.|||++.+.   .+.+.||+.+.
T Consensus       131 i~~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~  169 (206)
T PF06293_consen  131 IAKLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMR  169 (206)
T ss_pred             HHHHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhce
Confidence            999999   9999999999999999887   89999997654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.13  E-value=1.4e-05  Score=78.88  Aligned_cols=141  Identities=21%  Similarity=0.276  Sum_probs=88.9

Q ss_pred             CccceeecCCceEEEEEEcCCCCEEEEEEeecCC------------------ch--hcccchHHHHHHHHHhccCC-Cce
Q 047719          287 NKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPN------------------RV--ECARNPFTTEFATMAGCLRH-KNL  345 (596)
Q Consensus       287 ~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~------------------~~--~~~~~~~~~E~~~l~~~l~H-~ni  345 (596)
                      ..+..||-|--+.||.|..++|.++|||.=+...                  .+  ...+....+|.+.|..+-.+ -.+
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V  173 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV  173 (304)
T ss_pred             hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence            4568899999999999999999999999532100                  00  01122345666666542222 144


Q ss_pred             eeecceeeeCCeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecC
Q 047719          346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDA  425 (596)
Q Consensus       346 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~  425 (596)
                      .+.++|    +.-.+||||+++--|...--.      .-....++   ..|++-+.-+-.   .++||+|+.+-||++++
T Consensus       174 P~P~~~----nRHaVvMe~ieG~eL~~~r~~------~en~~~il---~~il~~~~~~~~---~GiVHGDlSefNIlV~~  237 (304)
T COG0478         174 PKPIAW----NRHAVVMEYIEGVELYRLRLD------VENPDEIL---DKILEEVRKAYR---RGIVHGDLSEFNILVTE  237 (304)
T ss_pred             CCcccc----ccceeeeehcccceeecccCc------ccCHHHHH---HHHHHHHHHHHH---cCccccCCchheEEEec
Confidence            444443    346899999988655543210      11222333   333333332223   79999999999999999


Q ss_pred             CCceEEccCCCcccCCCc
Q 047719          426 EFNAKLGDFEATIPAGTM  443 (596)
Q Consensus       426 ~~~~kl~Dfg~~~~~gt~  443 (596)
                      +|.+.+.||--+...+.+
T Consensus       238 dg~~~vIDwPQ~v~~~hp  255 (304)
T COG0478         238 DGDIVVIDWPQAVPISHP  255 (304)
T ss_pred             CCCEEEEeCcccccCCCC
Confidence            999999999766555443

>KOG3838 consensus Mannose lectin ERGIC-53, involved in glycoprotein traffic [Intracellular trafficking, secretion, and vesicular transport]

Probab=98.10  E-value=9.2e-05  Score=75.02  Aligned_cols=160  Identities=15%  Similarity=0.114  Sum_probs=99.2

Q ss_pred             CCCCCCcccceEEEEEEEEecCCCCCCCCeEEEEEecCCCCCCCCCCccCCCCCCCCCCCceEEEEeeCccCCCCCCCCC
Q 047719            2 LDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQDSFFAVEFDTSFDPSLGDING   81 (596)
Q Consensus         2 ~~~~~~~~asF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~~~~~~~~~lG~~~~~~~~~~~~~AVEfDt~~~~~~~d~~~   81 (596)
                      |.++.-..-.|...-+|.|+.. +.-++|||||--+...   |--|.-+|-.+.=+|     +++=||.+.|.  +..|+
T Consensus        83 Wtka~~~fe~weVev~~rVtGr-GRiGAdGlaiWYt~~~---G~~GpVfGg~d~WnG-----igiffDSfdnD--~qknn  151 (497)
T KOG3838|consen   83 WTKASVPFENWEVEVQFRVTGR-GRIGADGLAIWYTRGR---GHVGPVFGGLDSWNG-----IGIFFDSFDND--GQKNN  151 (497)
T ss_pred             eecccCCcccceEEEEEEeccc-ccccCCceEEEEecCC---Ccccccccccccccc-----eEEEeeccccc--CCcCC
Confidence            6665556667888999999866 3456899999987521   122222221111012     58889998885  34455


Q ss_pred             CeeEEecCC-ccccccc------cCCCCCcccCCC-ceEEEEEEEcCCccEEEEEEeeCCCCCCCCeEEEeecCcccCCC
Q 047719           82 NHIGIDISS-VISFVSV------DALSRGIDLKSG-RHITTWIEYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKD  153 (596)
Q Consensus        82 ~Hvgid~ns-~~s~~~~------~~~~~~~~l~~g-~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~l~~~vdl~~~l~~  153 (596)
                      +-|.+-.|. .++-...      -++.--.+++|. -++.|+|+|  ..++|+|.+..+.......-+...++= -.||.
T Consensus       152 P~Is~~lndGt~~ydh~~DGasQ~LssCqrDFRNkPyPvRarItY--~~nvLtv~innGmtp~d~yE~C~rve~-~~lp~  228 (497)
T KOG3838|consen  152 PAISVLLNDGTIPYDHPGDGASQGLSSCQRDFRNKPYPVRARITY--YGNVLTVMINNGMTPSDDYEFCVRVEN-LLLPP  228 (497)
T ss_pred             ccEEEEecCCcccccCCCccHHHHHHHhhHHhccCCCCceEEEEE--eccEEEEEEcCCCCCCCCcceeEeccc-eeccC
Confidence            556554432 2221110      011111234433 368999999  566899999877643333335555441 25788


Q ss_pred             ceEEEEEeecCCccceeeeeee
Q 047719          154 YMHVGFSAANGQGSAIYTVDRW  175 (596)
Q Consensus       154 ~~~vGFsastg~~~~~~~i~~W  175 (596)
                      --|+|.||+||....-|.|+++
T Consensus       229 nGyFGvSAATGgLADDHDVl~F  250 (497)
T KOG3838|consen  229 NGYFGVSAATGGLADDHDVLSF  250 (497)
T ss_pred             CCeeeeeecccccccccceeee
Confidence            9999999999999999999985

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=97.91  E-value=0.00014  Score=71.66  Aligned_cols=140  Identities=16%  Similarity=0.222  Sum_probs=78.1

Q ss_pred             ceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCc--eeeecceeeeCCeEEEEEecCCC
Q 047719          290 RIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN--LVQLQGWCCEGNELVLVYEYLPN  367 (596)
Q Consensus       290 ~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~n--iv~l~g~~~~~~~~~lV~E~~~~  367 (596)
                      ..||+|..+.||+.   .+..+++|......    ......+|.+.+.. +..-.  +.+.++++...+...+|||+++|
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~----~~~~i~~E~~~l~~-l~~~glpvP~~~~~~~~~~~~glv~e~i~G   78 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF----DKETIKREFDASRK-VFSLGIPTPHPFDLVEDGGRLGLIYELIVG   78 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC----CHHHHHHHHHHHHH-HHHcCCCCCceEEEEecCCeeeeeeeecCC
Confidence            67899999999984   35567788874322    12234667655544 33222  35556667677778899999988


Q ss_pred             CC-HHHHh---------------------hhCCCCCcccC--HHHHHHHHH-------HHHH-HHHHHHhc-cCCCeEEc
Q 047719          368 GS-LDKIL---------------------HNNSSSSIVLS--WEKRLNIVL-------GVAS-ALSYLHEE-CERQIIHR  414 (596)
Q Consensus       368 gs-L~~~l---------------------~~~~~~~~~l~--~~~~~~i~~-------~ia~-gL~~LH~~-~~~~ivHr  414 (596)
                      .+ +...+                     +........+.  +......+.       .+.+ ...+|... ....++|+
T Consensus        79 ~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~Hg  158 (226)
T TIGR02172        79 KRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHG  158 (226)
T ss_pred             ccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEec
Confidence            63 22111                     11100010110  000000000       0011 12222211 13457899


Q ss_pred             cCCCCceeecCCCceEEccCCCcc
Q 047719          415 DVKACNILLDAEFNAKLGDFEATI  438 (596)
Q Consensus       415 Dlkp~NiLl~~~~~~kl~Dfg~~~  438 (596)
                      |+.|.||++++++ +.+.||+.+.
T Consensus       159 D~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       159 DFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCCCCcEEEcCCC-cEEEechhcC
Confidence            9999999999888 9999997653

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG3839 consensus Lectin VIP36, involved in the transport of glycoproteins carrying high mannose-type glycans [Intracellular trafficking, secretion, and vesicular transport]

Probab=97.79  E-value=0.0011  Score=66.44  Aligned_cols=151  Identities=18%  Similarity=0.175  Sum_probs=90.1

Q ss_pred             cceEEEEEEEEecCCCCCCCCeEEEEEecCCCCCCCCCCccCCCCCCCCCCCceEEEEeeCccCCCCCCCCCCe--e--E
Q 047719           10 ASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQDSFFAVEFDTSFDPSLGDINGNH--I--G   85 (596)
Q Consensus        10 asF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~~~~~~~~~lG~~~~~~~~~~~~~AVEfDt~~~~~~~d~~~~H--v--g   85 (596)
                      -+|.-.+.|+|..+....-|||||+..+-....   .|.-+|-++     .-+..||=.||+-|.. +-+.--|  +  -
T Consensus       109 ~~wev~v~fkv~~~s~~lfgdG~Aiw~t~Er~q---~GPvFG~~d-----kF~GL~vfidtY~n~~-g~~~~v~P~isvm  179 (351)
T KOG3839|consen  109 RDWEVLVHFKVHGQSKNLFGDGMAIWYTKERAQ---PGPVFGSKD-----KFTGLAVFIDTYGNHN-GPHEHVFPYISVM  179 (351)
T ss_pred             cceeEEEEEEEecCCCcccccceEEEeeccccc---CCCCCCCcc-----cceeEEEEEeccCCcC-CCcccceeeEEEE
Confidence            468899999999887788899999999864432   444455332     2345799999998852 1111111  1  1


Q ss_pred             EecCCcc-----ccccccCCCCCcccCCCc-eEEEEEEEcCCccEEEEEEeeCCCCCCCCeEEEeecCcc-cCCCceEEE
Q 047719           86 IDISSVI-----SFVSVDALSRGIDLKSGR-HITTWIEYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSK-QFKDYMHVG  158 (596)
Q Consensus        86 id~ns~~-----s~~~~~~~~~~~~l~~g~-~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~l~~~vdl~~-~l~~~~~vG  158 (596)
                      +.+++..     +...+.++.-...+++.. .-.+-|.|+.  +.|++......  |..  ..--.+|.. .||.--|+|
T Consensus       180 v~~gs~sYD~~~Dg~~tel~gc~a~~rn~~~dt~~~iry~~--~~l~~~~dl~~--~~~--~~~c~~~n~v~lp~g~~fg  253 (351)
T KOG3839|consen  180 VNIGSLSYDHSKDGTHTELAGCTANFRNLPHDTLVVIRYEK--KTLSISIDLEG--PNE--WIDCFSLNNVELPLGYFFG  253 (351)
T ss_pred             eccCCcccccCCCCCccccccceeeeccCCCcceeEEEecC--CceEEEEecCC--Cce--eeeeeeecceecccceEEe
Confidence            1222221     001111110011222221 1356688887  56777665532  122  344466766 478888999


Q ss_pred             EEeecCCccceeeeeee
Q 047719          159 FSAANGQGSAIYTVDRW  175 (596)
Q Consensus       159 Fsastg~~~~~~~i~~W  175 (596)
                      +||+||.....|.|.+-
T Consensus       254 ~SasTGdlSd~HdivS~  270 (351)
T KOG3839|consen  254 VSASTGDLSDSHDIVSL  270 (351)
T ss_pred             eeeccCccchhhHHHHh
Confidence            99999999999999985

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.79  E-value=0.00011  Score=80.33  Aligned_cols=139  Identities=19%  Similarity=0.169  Sum_probs=86.9

Q ss_pred             cceeecCCceEEEEEEcCCCCEEEEEEeecCCchh-----------------------------------cccchHHHHH
Q 047719          289 NRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVE-----------------------------------CARNPFTTEF  333 (596)
Q Consensus       289 ~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~-----------------------------------~~~~~~~~E~  333 (596)
                      .+.||.-+.|.||+|++++|+.||||+-+..-...                                   ..+-+|.+|.
T Consensus       166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            47899999999999999999999999865321100                                   0122344444


Q ss_pred             HHHH---hccCCCc------eeeecceeeeCCeEEEEEecCCCCCHHHHh--hhCCCCCcccCHHHHHHHHHHHHHHHHH
Q 047719          334 ATMA---GCLRHKN------LVQLQGWCCEGNELVLVYEYLPNGSLDKIL--HNNSSSSIVLSWEKRLNIVLGVASALSY  402 (596)
Q Consensus       334 ~~l~---~~l~H~n------iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l--~~~~~~~~~l~~~~~~~i~~~ia~gL~~  402 (596)
                      +...   +.+.|-+      |.+++-  .-.....|+||||+|..+.+.-  .+.+     ++......-+.+.     |
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~g-----i~~~~i~~~l~~~-----~  313 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKRG-----ISPHDILNKLVEA-----Y  313 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHcC-----CCHHHHHHHHHHH-----H
Confidence            3322   2234444      222221  1234679999999998766553  3332     4444433333332     2


Q ss_pred             HHhccCCCeEEccCCCCceeecC----CCceEEccCCCccc
Q 047719          403 LHEECERQIIHRDVKACNILLDA----EFNAKLGDFEATIP  439 (596)
Q Consensus       403 LH~~~~~~ivHrDlkp~NiLl~~----~~~~kl~Dfg~~~~  439 (596)
                      ++.-...|++|+|-.|.||+++.    ++.+.+-|||+...
T Consensus       314 ~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~  354 (538)
T KOG1235|consen  314 LEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAV  354 (538)
T ss_pred             HHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEccccccc
Confidence            22222368999999999999984    67899999998654

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.76  E-value=7.7e-05  Score=71.25  Aligned_cols=101  Identities=26%  Similarity=0.276  Sum_probs=76.6

Q ss_pred             HHHHHHhccCC-CceeeecceeeeCCeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCC
Q 047719          332 EFATMAGCLRH-KNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQ  410 (596)
Q Consensus       332 E~~~l~~~l~H-~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~  410 (596)
                      |. .+.+.+++ +++.+++|+|-+    ++|.||...+++...-..- ..-..-+|..|.+|+.++++.+.+|++.....
T Consensus         9 E~-lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l-~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    9 EP-LLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPL-SQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             HH-HHHHHcCCCCCCCCeeeECCC----EEEEEeecCcccccccccc-ccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            44 34444665 699999999943    6799999877665320000 00113689999999999999999999866556


Q ss_pred             eEEccCCCCceeecCCCceEEccCCCcc
Q 047719          411 IIHRDVKACNILLDAEFNAKLGDFEATI  438 (596)
Q Consensus       411 ivHrDlkp~NiLl~~~~~~kl~Dfg~~~  438 (596)
                      +.-.|++++|+-+++++++|+.|.....
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~  110 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVF  110 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcc
Confidence            8889999999999999999999986543

Proteins in this uncharacterised family are described as transmembrane proteins.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=97.73  E-value=0.00022  Score=69.01  Aligned_cols=141  Identities=13%  Similarity=0.128  Sum_probs=87.1

Q ss_pred             HhcCCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcc-cch------HHHHHHHHHhc--cCCCceeeeccee
Q 047719          282 ATLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECA-RNP------FTTEFATMAGC--LRHKNLVQLQGWC  352 (596)
Q Consensus       282 at~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~-~~~------~~~E~~~l~~~--l~H~niv~l~g~~  352 (596)
                      ...+|...+++-......|.+-.. +|+.+.+|..+....-.+. ...      ..+++..+...  ......+.++...
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            345677677777777777777766 6788999987543221111 011      12222222221  1122222322222


Q ss_pred             ee-----CCeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCC
Q 047719          353 CE-----GNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEF  427 (596)
Q Consensus       353 ~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~  427 (596)
                      ..     ....+|+|||++|..|.++..        ++.    .++..+.+++.-||.   .|++|+|..|+|++++.+ 
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~-  171 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNN-  171 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECC-
Confidence            22     234679999999988776542        221    244567788999999   899999999999999865 


Q ss_pred             ceEEccCCCccc
Q 047719          428 NAKLGDFEATIP  439 (596)
Q Consensus       428 ~~kl~Dfg~~~~  439 (596)
                      .+++.||+....
T Consensus       172 ~i~iID~~~k~~  183 (229)
T PF06176_consen  172 GIRIIDTQGKRM  183 (229)
T ss_pred             cEEEEECccccc
Confidence            499999976543

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=97.70  E-value=0.00044  Score=67.64  Aligned_cols=142  Identities=23%  Similarity=0.259  Sum_probs=77.7

Q ss_pred             ceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCC--ceeeecceee---eCCeEEEEEec
Q 047719          290 RIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHK--NLVQLQGWCC---EGNELVLVYEY  364 (596)
Q Consensus       290 ~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~--niv~l~g~~~---~~~~~~lV~E~  364 (596)
                      +.|+.|..+.||+....+ +.+++|.....    ........|...+.. +...  .+.+++.++.   .....+++|++
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~----~~~~~~~~e~~~~~~-l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~   76 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP----DAAERLRREAAVLRQ-LAEHGIPVPRVLAFDTSDEFNGFPYLLMEY   76 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSH----HHHHHHHHHHHHHHH-HHHTTSBS--EEEEEEETEETSEEEEEEEE
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCC----CCHHHHHHHHHHHHH-HHhcCCCCceEEeecccccccccceEEEEE
Confidence            578999999999998866 69999997432    222344555544332 3222  2445555433   33457999999


Q ss_pred             CCCCCHHH----------------Hh---hhCCCCCcccCHHH---------HHHH------------HHHHHH-HHHHH
Q 047719          365 LPNGSLDK----------------IL---HNNSSSSIVLSWEK---------RLNI------------VLGVAS-ALSYL  403 (596)
Q Consensus       365 ~~~gsL~~----------------~l---~~~~~~~~~l~~~~---------~~~i------------~~~ia~-gL~~L  403 (596)
                      +++..+..                .+   +........+.+..         ....            ...+.+ .+..+
T Consensus        77 i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (239)
T PF01636_consen   77 IPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQEL  156 (239)
T ss_dssp             ESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHH
T ss_pred             eccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHH
Confidence            99988777                11   11110111111111         0000            112222 33344


Q ss_pred             Hhc----cCCCeEEccCCCCceeec-CCCceEEccCCCc
Q 047719          404 HEE----CERQIIHRDVKACNILLD-AEFNAKLGDFEAT  437 (596)
Q Consensus       404 H~~----~~~~ivHrDlkp~NiLl~-~~~~~kl~Dfg~~  437 (596)
                      ++.    ....++|+|+.+.|||++ +++.+.|.||+.+
T Consensus       157 ~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a  195 (239)
T PF01636_consen  157 EALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDA  195 (239)
T ss_dssp             HHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-
T ss_pred             HhhhccCCCcEEEEeccccccceeeeccceeEEEecccc
Confidence            432    346799999999999999 6666789999765

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.67  E-value=0.00089  Score=64.37  Aligned_cols=133  Identities=17%  Similarity=0.261  Sum_probs=91.3

Q ss_pred             CccceeecCCceEEEEEEcCCCCEEEEEEeecCC--------------chhcccchHHHHHHHHHh-----ccCCCceee
Q 047719          287 NKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPN--------------RVECARNPFTTEFATMAG-----CLRHKNLVQ  347 (596)
Q Consensus       287 ~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~--------------~~~~~~~~~~~E~~~l~~-----~l~H~niv~  347 (596)
                      +....||+|+.-.||.  +++.....||+.....              .......+..+|+.....     ...+.+|.+
T Consensus         4 ~~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r   81 (199)
T PF10707_consen    4 SESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR   81 (199)
T ss_pred             CCCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence            3457899999999996  4566778889886544              011123455666544332     234889999


Q ss_pred             ecceeeeCCeEEEEEecCCC------CCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCce
Q 047719          348 LQGWCCEGNELVLVYEYLPN------GSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNI  421 (596)
Q Consensus       348 l~g~~~~~~~~~lV~E~~~~------gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~Ni  421 (596)
                      ++|+..++.-+-+|+|.+.+      -+|.+++.+..     ++. ...+.+.   +-..||-+   ..|+.+|++|.||
T Consensus        82 ~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~-----~~~-~~~~~L~---~f~~~l~~---~~Iv~~dl~~~NI  149 (199)
T PF10707_consen   82 FYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG-----LTE-ELRQALD---EFKRYLLD---HHIVIRDLNPHNI  149 (199)
T ss_pred             EeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC-----ccH-HHHHHHH---HHHHHHHH---cCCeecCCCcccE
Confidence            99999999999999998743      36888886543     444 3333333   33456655   7899999999999


Q ss_pred             eecCCC----ceEEcc
Q 047719          422 LLDAEF----NAKLGD  433 (596)
Q Consensus       422 Ll~~~~----~~kl~D  433 (596)
                      ++..+.    .+.|.|
T Consensus       150 v~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  150 VVQRRDSGEFRLVLID  165 (199)
T ss_pred             EEEecCCCceEEEEEe
Confidence            995432    466776

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.65  E-value=0.00011  Score=71.76  Aligned_cols=154  Identities=21%  Similarity=0.220  Sum_probs=93.0

Q ss_pred             ccccCHHHHHHHhcCCCccceee---cCCceEEEEEEcCCCCEEEEEEeecCCchhcccch-------------------
Q 047719          271 PMRLALTDIKQATLGFNKNRIVG---EGASATVYKGSLPSGGAVAVKRFEKPNRVECARNP-------------------  328 (596)
Q Consensus       271 ~~~~~~~el~~at~~f~~~~~LG---~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~-------------------  328 (596)
                      ....+++.|...........+.|   +|.-..||+|.-.++..+|||+.+.....-..+..                   
T Consensus        32 ~D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv  111 (268)
T COG1718          32 FDKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLV  111 (268)
T ss_pred             hhhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHH
Confidence            34456666666666665555544   56667899998878999999998643211111000                   


Q ss_pred             ---HHHHHHHHHhccCCCceeeecceeeeC------CeEEEEEecCCCC-CHHHHhhhCCCCCcccCHHHHHHHHHHHHH
Q 047719          329 ---FTTEFATMAGCLRHKNLVQLQGWCCEG------NELVLVYEYLPNG-SLDKILHNNSSSSIVLSWEKRLNIVLGVAS  398 (596)
Q Consensus       329 ---~~~E~~~l~~~l~H~niv~l~g~~~~~------~~~~lV~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~  398 (596)
                         ...|.         .|+-+++.....-      .+-.|||||+... .-.-.|.+     ..+...+...+..++.+
T Consensus       112 ~~W~~kEf---------~NL~R~~eAGVrvP~Pi~~~~nVLvMEfIg~~g~pAP~LkD-----v~~e~~e~~~~~~~~v~  177 (268)
T COG1718         112 FAWARKEF---------RNLKRAYEAGVRVPEPIAFRNNVLVMEFIGDDGLPAPRLKD-----VPLELEEAEGLYEDVVE  177 (268)
T ss_pred             HHHHHHHH---------HHHHHHHHcCCCCCCceeecCCeEEEEeccCCCCCCCCccc-----CCcCchhHHHHHHHHHH
Confidence               11222         2333333332211      1347999999653 11111211     11222245566677777


Q ss_pred             HHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcccCC
Q 047719          399 ALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG  441 (596)
Q Consensus       399 gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~~g  441 (596)
                      .+.-|-..  .++||+||..=|||+. ++.+.|+|++-+....
T Consensus       178 ~~~~l~~~--a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         178 YMRRLYKE--AGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             HHHHHHHh--cCcccccchhhheEEE-CCeEEEEECccccccC
Confidence            77776653  7899999999999999 8899999998776543

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.64  E-value=1e-05  Score=87.56  Aligned_cols=175  Identities=21%  Similarity=0.140  Sum_probs=124.4

Q ss_pred             CccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCc-eeeecceeeeCCeEEEEEecC
Q 047719          287 NKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN-LVQLQGWCCEGNELVLVYEYL  365 (596)
Q Consensus       287 ~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~n-iv~l~g~~~~~~~~~lV~E~~  365 (596)
                      ..-+-+++|+++++||.+-...+...+|.+...       .....++ .|+...+||| .++.++-+..+...+++++++
T Consensus       245 ~~fh~fvK~altknpKkRptaeklL~h~fvs~~-------l~~rl~~-eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~  316 (829)
T KOG0576|consen  245 EFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-------LSRRLAI-ELLDKVNNPNPVVRYLEDYDGEDYLWIPMRIC  316 (829)
T ss_pred             HHHHHHHHHHhcCCCccCCChhhheeceeeccc-------hhhHHHH-HHHHHccCCCCcccccccCCcccccchhhhhh
Confidence            334667899999999987544444556655321       2234455 4556699999 788888888888899999999


Q ss_pred             CCC-CHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCc-------
Q 047719          366 PNG-SLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT-------  437 (596)
Q Consensus       366 ~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~-------  437 (596)
                      ..+ +-..-.   ......+...+...+...-++++++||+   ..-+|+|    ||+..+ +..|..||+..       
T Consensus       317 s~~rs~~~~~---~~se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~  385 (829)
T KOG0576|consen  317 STGRSSALEM---TVSEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM  385 (829)
T ss_pred             cCCccccccC---ChhhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc
Confidence            876 211111   0112234444555666777889999998   4458888    777665 67889999643       


Q ss_pred             ---ccCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCC
Q 047719          438 ---IPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVD  480 (596)
Q Consensus       438 ---~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~  480 (596)
                         ...+|+.++|||......+....|+|+.|+-..++.-|-+|-.
T Consensus       386 ~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  386 KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence               2358899999999999999999999999998788888877754

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.53  E-value=0.00099  Score=66.28  Aligned_cols=140  Identities=16%  Similarity=0.137  Sum_probs=79.2

Q ss_pred             eecCCc-eEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecCCCCCH
Q 047719          292 VGEGAS-ATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSL  370 (596)
Q Consensus       292 LG~G~f-G~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  370 (596)
                      |-.|.. ..||+...+ +..+.||+.....     .....+|+..+...-.+--+.+++++....+..++|||+++|.+|
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l   79 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA   79 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence            445555 789999764 4778888874321     234556665544322333355667777666678999999998777


Q ss_pred             HHHh-------------------hhCCCCCcccC--HHHHHHHHH--------------------HHHHHHHHHHh----
Q 047719          371 DKIL-------------------HNNSSSSIVLS--WEKRLNIVL--------------------GVASALSYLHE----  405 (596)
Q Consensus       371 ~~~l-------------------~~~~~~~~~l~--~~~~~~i~~--------------------~ia~gL~~LH~----  405 (596)
                      ....                   +.......++.  +...+....                    .+...+..|-.    
T Consensus        80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  159 (244)
T cd05150          80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA  159 (244)
T ss_pred             hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence            6432                   11110000111  001110000                    01111222211    


Q ss_pred             ccCCCeEEccCCCCceeecCCCceEEccCCCc
Q 047719          406 ECERQIIHRDVKACNILLDAEFNAKLGDFEAT  437 (596)
Q Consensus       406 ~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~  437 (596)
                      .....++|+|+.|.|||++++....|.||+.+
T Consensus       160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a  191 (244)
T cd05150         160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRL  191 (244)
T ss_pred             cCceEEECCCCCCccEEEeCCcEEEEEEcccc
Confidence            11356899999999999999877899999765

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PLN02876 acyl-CoA dehydrogenase

Probab=97.48  E-value=0.00085  Score=78.78  Aligned_cols=80  Identities=13%  Similarity=0.223  Sum_probs=53.3

Q ss_pred             cceeecCCceEEEEEEcCCC---CEEEEEEeecCCchhcccchHHHHHHHHHhccCCCce--eeecceeeeC---CeEEE
Q 047719          289 NRIVGEGASATVYKGSLPSG---GAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL--VQLQGWCCEG---NELVL  360 (596)
Q Consensus       289 ~~~LG~G~fG~Vy~~~~~~g---~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~ni--v~l~g~~~~~---~~~~l  360 (596)
                      .+.|+.|.+..+|+....++   ..+++|+...... ......+.+|...+...-.|.++  .+++.+|.+.   +..|+
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~-~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl  121 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKL-LQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY  121 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCcc-CccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence            36788999999999876554   3677777532211 12234577888666553236654  7778888764   46789


Q ss_pred             EEecCCCCC
Q 047719          361 VYEYLPNGS  369 (596)
Q Consensus       361 V~E~~~~gs  369 (596)
                      ||||+++..
T Consensus       122 VME~v~G~~  130 (822)
T PLN02876        122 IMEYLEGRI  130 (822)
T ss_pred             EEEecCCcc
Confidence            999998764

>PRK10593 hypothetical protein; Provisional

Probab=97.24  E-value=0.005  Score=63.32  Aligned_cols=78  Identities=14%  Similarity=0.024  Sum_probs=51.8

Q ss_pred             ccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCC--Cceeeecceeee---CCeEEEEE
Q 047719          288 KNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRH--KNLVQLQGWCCE---GNELVLVY  362 (596)
Q Consensus       288 ~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H--~niv~l~g~~~~---~~~~~lV~  362 (596)
                      ..+.||.|..+.||+-...++ .+.+|..+ ..   .....+..|...+...-.+  -.+.+++++|..   .+..+|||
T Consensus        18 ~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~-~~---~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm   92 (297)
T PRK10593         18 RVECISEQPYAALWALYDSQG-NPMPLMAR-SF---STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL   92 (297)
T ss_pred             eeeecCCccceeEEEEEcCCC-CEEEEEec-cc---ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence            346799999999999876555 46667642 21   1123567777666543232  356677777654   36689999


Q ss_pred             ecCCCCCH
Q 047719          363 EYLPNGSL  370 (596)
Q Consensus       363 E~~~~gsL  370 (596)
                      |+++++++
T Consensus        93 E~i~G~~~  100 (297)
T PRK10593         93 ERLRGVSV  100 (297)
T ss_pred             eccCCEec
Confidence            99998765

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.18  E-value=0.0046  Score=65.85  Aligned_cols=78  Identities=19%  Similarity=0.160  Sum_probs=48.9

Q ss_pred             ceeecCCceEEEEEEcCCC-CEEEEEEeecCCc---h--hcccchHHHHHHHHHhccC--CCceeeecceeeeCCeEEEE
Q 047719          290 RIVGEGASATVYKGSLPSG-GAVAVKRFEKPNR---V--ECARNPFTTEFATMAGCLR--HKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       290 ~~LG~G~fG~Vy~~~~~~g-~~vAvK~l~~~~~---~--~~~~~~~~~E~~~l~~~l~--H~niv~l~g~~~~~~~~~lV  361 (596)
                      +.||.|.+..||+....+| +.|.||.-.....   .  ......+..|.+.|...-.  ..++.+++.+  +....++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence            5789999999999998776 4899998431111   0  1122344555544443222  2455666665  33557899


Q ss_pred             EecCCCCC
Q 047719          362 YEYLPNGS  369 (596)
Q Consensus       362 ~E~~~~gs  369 (596)
                      |||+++..
T Consensus       110 ME~L~~~~  117 (401)
T PRK09550        110 MEDLSDHK  117 (401)
T ss_pred             EecCCCcc
Confidence            99998643

>cd06900 lectin_VcfQ VcfQ bacterial pilus biogenesis protein, lectin domain

Probab=97.17  E-value=0.025  Score=54.79  Aligned_cols=161  Identities=15%  Similarity=0.168  Sum_probs=84.7

Q ss_pred             eEEEEEEEEecCCCCCCCCeEEEEEecCCC--CCCCCCCccCCCCCC---CCCCCceEEEEeeCccCCCC-CCCCC----
Q 047719           12 FSCRFSFSIIPSPLCAFGDGFAFLITSNAD--SFGNDNGYMGLPGPV---LSPQDSFFAVEFDTSFDPSL-GDING----   81 (596)
Q Consensus        12 F~t~F~f~i~~~~~~~~g~G~aF~l~~~~~--~~~~~~~~lG~~~~~---~~~~~~~~AVEfDt~~~~~~-~d~~~----   81 (596)
                      ...+|.+-.-.. ...++||+||||+-...  .+|..||-||+--..   .|-..-.+.|-||-|-|... .+-..    
T Consensus        60 v~veFd~yayg~-~g~GADGia~vLsDasv~p~~G~fGGsLGYa~~~~~~~GfaGGwLGiGlDEyGNFsn~~eg~~~~~g  138 (255)
T cd06900          60 VEVEFDYYAYGS-GGNGADGVALVLSDASVTPQAGAFGGSLGYAQRNDGVPGFAGGWLGIGLDEYGNFSNPNEGRNGFSG  138 (255)
T ss_pred             EEEEEEEEEecC-CCCCCceEEEEEeCCCcCCcCCCcCcccccccccCCCCccccceEEEEEeccccccCCCCCccCCcc
Confidence            345555555433 56779999999994322  578889999996553   12256688999998776431 11111    


Q ss_pred             ---CeeEEecCCcccc-------ccccCCCCCcccCC------CceEEEEEEEcCCc-cEEEEEEeeCCCCCCCCeEEEe
Q 047719           82 ---NHIGIDISSVISF-------VSVDALSRGIDLKS------GRHITTWIEYRDSL-KLIRVWAGYSQIRPPSPLIIAQ  144 (596)
Q Consensus        82 ---~Hvgid~ns~~s~-------~~~~~~~~~~~l~~------g~~~~~~I~Y~~~~-~~l~v~~~~~~~~~~~p~l~~~  144 (596)
                         +-|+|=  +.-+.       ..+......++..+      +-.+++.|+=.... ..|+|.-..+......+ +-..
T Consensus       139 ~r~~sV~vR--Gsg~g~~gY~yl~gt~~~~~~id~~~~~~~~~~hrY~i~Ids~~~~~~~vsV~R~~~~gg~~~~-~I~~  215 (255)
T cd06900         139 RRPQSVTVR--GSGSGYTGYKYITGTGVLPPGIDNNSTSTPAPGHRYRITIDSTNGDNAWLSVERDIGNGGAYFV-VILT  215 (255)
T ss_pred             cccceEEEE--CCCCCCcCceEecccCCCCcccccCCCCCCCCceEEEEEEecCCCCceEEEEEEEccCCceeEE-eecc
Confidence               223331  11110       00000011111111      12344555444222 33455443322111122 2222


Q ss_pred             ec---Cc--ccCCCceEEEEEeecCCccceeeeeeee
Q 047719          145 ID---LS--KQFKDYMHVGFSAANGQGSAIYTVDRWR  176 (596)
Q Consensus       145 vd---l~--~~l~~~~~vGFsastg~~~~~~~i~~Ws  176 (596)
                      +|   ..  .-+|+..+++|++|||..+-.|.|-...
T Consensus       216 ~d~~~~~~q~avP~~f~lS~TgSTGgstN~HEIdnf~  252 (255)
T cd06900         216 FDALAEQNQDAIPENFYLSFTGSTGGSTNTHEIDNFQ  252 (255)
T ss_pred             eeeccccCCCCCCccEEEEEEecCCCcccceeecceE
Confidence            22   23  4679999999999999999999887643

This family includes bacterial proteins homologous to the VcfQ (also known as MshQ) bacterial pilus biogenesis protein. VcfQ is encoded by the vcfQ gene of the type IV pilus gene cluster of Vibrio cholerae and is essential for type IV pilus assembly. VcfQ has a Laminin G-like domain as well as an L-type lectin domain.

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.15  E-value=0.0046  Score=59.22  Aligned_cols=128  Identities=24%  Similarity=0.348  Sum_probs=87.8

Q ss_pred             cCCCccceeecCCc-eEEEEEEcCCCCEEEEEEeec---CC-------ch--h-------cccchHHHHHHHHHh--ccC
Q 047719          284 LGFNKNRIVGEGAS-ATVYKGSLPSGGAVAVKRFEK---PN-------RV--E-------CARNPFTTEFATMAG--CLR  341 (596)
Q Consensus       284 ~~f~~~~~LG~G~f-G~Vy~~~~~~g~~vAvK~l~~---~~-------~~--~-------~~~~~~~~E~~~l~~--~l~  341 (596)
                      ..++..+.||.|.- |.|||+.. +|..+|+|.+..   ..       ..  +       .....|..|.+...+  ...
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            67788899999999 99999998 677999999321   00       00  0       123357777755432  234


Q ss_pred             CCce--eeecceeeeC------------------CeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHH
Q 047719          342 HKNL--VQLQGWCCEG------------------NELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALS  401 (596)
Q Consensus       342 H~ni--v~l~g~~~~~------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~  401 (596)
                      +.++  |+.+||..-.                  ....||.||++...             .+    ...-+.+|.+-|.
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~----~~~~~~~~~~dl~  178 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PL----QIRDIPQMLRDLK  178 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------cc----chhHHHHHHHHHH
Confidence            5566  9999997322                  12467888776532             11    1233456777788


Q ss_pred             HHHhccCCCeEEccCCCCceeecCCCceEEccCCCc
Q 047719          402 YLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT  437 (596)
Q Consensus       402 ~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~  437 (596)
                      .+|.   .+|+-+|+++.|..     .-||+|||.+
T Consensus       179 ~~~k---~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  179 ILHK---LGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHH---CCeeeccCcccccc-----CCEEEecccC
Confidence            8998   89999999999976     5689999864

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.11  E-value=0.0064  Score=60.00  Aligned_cols=74  Identities=19%  Similarity=0.171  Sum_probs=43.2

Q ss_pred             ceeecCCceEEEEEEcCC--CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecCCC
Q 047719          290 RIVGEGASATVYKGSLPS--GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPN  367 (596)
Q Consensus       290 ~~LG~G~fG~Vy~~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  367 (596)
                      +.|..|-...+|+....+  ++.|++|+......   ......+|+..+...-.+.-..++++.+. .   .+||||+++
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~---~~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e~i~G   76 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE---LIIDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYEFIPG   76 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc---ceecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEEeeCC
Confidence            457777788999998764  67899997643211   11223456644443222333344444332 2   479999988


Q ss_pred             CCH
Q 047719          368 GSL  370 (596)
Q Consensus       368 gsL  370 (596)
                      .++
T Consensus        77 ~~l   79 (235)
T cd05157          77 RTL   79 (235)
T ss_pred             CcC
Confidence            665

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02721 ycfN_thiK thiamine kinase

Probab=96.81  E-value=0.0073  Score=60.56  Aligned_cols=138  Identities=16%  Similarity=0.110  Sum_probs=70.9

Q ss_pred             eecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCce-eeecceeeeCCeEEEEEecCCCCCH
Q 047719          292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL-VQLQGWCCEGNELVLVYEYLPNGSL  370 (596)
Q Consensus       292 LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~ni-v~l~g~~~~~~~~~lV~E~~~~gsL  370 (596)
                      +..|-...+|+... ++..+++|.......  .-.....+|...+.. +....+ .++++.+.    -++||||+++..+
T Consensus         4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~--~~~~~r~~E~~~l~~-l~~~g~~P~~i~~~~----~~~v~e~i~G~~~   75 (256)
T TIGR02721         4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCK--ALGVDRQREYQILQA-LSALGLAPKPILVNE----HWLLVEWLEGEVI   75 (256)
T ss_pred             CCCcCcCCeEEEEe-CCccEEEeeCCcccc--cccCcHHHHHHHHHH-HHhcCCCCceEEEeC----CEEEEEeccCccc
Confidence            45577788998874 567888887532211  110124556544443 322222 22333321    3689999998665


Q ss_pred             HHH-----------------hhhCCCCCcccCHHHHH-HHH---------HHHHHHHHHHHhc-----cCCCeEEccCCC
Q 047719          371 DKI-----------------LHNNSSSSIVLSWEKRL-NIV---------LGVASALSYLHEE-----CERQIIHRDVKA  418 (596)
Q Consensus       371 ~~~-----------------l~~~~~~~~~l~~~~~~-~i~---------~~ia~gL~~LH~~-----~~~~ivHrDlkp  418 (596)
                      ...                 |+.......+++...++ ...         ..+..-+..+-..     ....++|+|+.|
T Consensus        76 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~  155 (256)
T TIGR02721        76 TLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHA  155 (256)
T ss_pred             ccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCc
Confidence            321                 12211111122222111 111         0111112222111     124689999999


Q ss_pred             CceeecCCCceEEccCCCcc
Q 047719          419 CNILLDAEFNAKLGDFEATI  438 (596)
Q Consensus       419 ~NiLl~~~~~~kl~Dfg~~~  438 (596)
                      .||++++++ ++|.||..+.
T Consensus       156 ~Nil~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       156 YNLVVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             CcEEEeCCC-CEEEeccccC
Confidence            999999877 7899997653

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=96.80  E-value=0.0089  Score=55.69  Aligned_cols=127  Identities=20%  Similarity=0.304  Sum_probs=77.5

Q ss_pred             ccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceee-ecceeeeCCeEEEEEecCC
Q 047719          288 KNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQ-LQGWCCEGNELVLVYEYLP  366 (596)
Q Consensus       288 ~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~-l~g~~~~~~~~~lV~E~~~  366 (596)
                      ..+.|++|.+|.||+|.+ .|..+|+|+-+.    +..+..+..|.+.+.. +.-.++.+ ++.+    +.-++.|||+.
T Consensus        26 v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~----ds~r~~l~kEakiLei-l~g~~~~p~vy~y----g~~~i~me~i~   95 (201)
T COG2112          26 VEKELAKGTTSVVYLGEW-RGGEVALKVRRR----DSPRRNLEKEAKILEI-LAGEGVTPEVYFY----GEDFIRMEYID   95 (201)
T ss_pred             hhhhhhcccccEEEEeec-cCceEEEEEecC----CcchhhHHHHHHHHHH-hhhcCCCceEEEe----chhhhhhhhhc
Confidence            347899999999999998 455899997643    2334556667644432 44333322 2222    23345699998


Q ss_pred             CCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCC-C-CceeecCCCceEEccCCCccc
Q 047719          367 NGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVK-A-CNILLDAEFNAKLGDFEATIP  439 (596)
Q Consensus       367 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlk-p-~NiLl~~~~~~kl~Dfg~~~~  439 (596)
                      +-.|.+.-...       +-.    -+..+++.---|..   .+|-|+.|. | .||++. +..+.|+||..+..
T Consensus        96 G~~L~~~~~~~-------~rk----~l~~vlE~a~~LD~---~GI~H~El~~~~k~vlv~-~~~~~iIDFd~At~  155 (201)
T COG2112          96 GRPLGKLEIGG-------DRK----HLLRVLEKAYKLDR---LGIEHGELSRPWKNVLVN-DRDVYIIDFDSATF  155 (201)
T ss_pred             Ccchhhhhhcc-------cHH----HHHHHHHHHHHHHH---hccchhhhcCCceeEEec-CCcEEEEEccchhh
Confidence            87877765431       112    23334444333444   678888775 3 455554 44999999977653

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=96.75  E-value=0.0078  Score=59.54  Aligned_cols=30  Identities=20%  Similarity=0.178  Sum_probs=25.3

Q ss_pred             CCeEEccCCCCceeecCCCceEEccCCCcc
Q 047719          409 RQIIHRDVKACNILLDAEFNAKLGDFEATI  438 (596)
Q Consensus       409 ~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~  438 (596)
                      ..++|+|+.+.|||++.+...-|.||+.+.
T Consensus       164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~  193 (235)
T cd05155         164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLG  193 (235)
T ss_pred             ceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence            458999999999999877666799998753

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=96.74  E-value=0.0033  Score=73.06  Aligned_cols=184  Identities=20%  Similarity=0.235  Sum_probs=123.1

Q ss_pred             HHHHHHHhccCCCceeeecceeeeCCe----EEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhc
Q 047719          331 TEFATMAGCLRHKNLVQLQGWCCEGNE----LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEE  406 (596)
Q Consensus       331 ~E~~~l~~~l~H~niv~l~g~~~~~~~----~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~  406 (596)
                      -|+..+. .+.|+|++.++.|..++..    ..+..|++..-++...++.-.    .++..+.+.+..+..+||+|+|+ 
T Consensus       231 ~e~~~l~-k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~----~i~~~~~r~~~~~~~~GL~~~h~-  304 (1351)
T KOG1035|consen  231 IELESLS-KIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG----SIPLETLRILHQKLLEGLAYLHS-  304 (1351)
T ss_pred             HHHHHHH-hhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc----ccCHHHHHHHHHHHhhhHHHHHH-
Confidence            3443444 4899999999999776543    345567888888888887654    46778888899999999999999 


Q ss_pred             cCCCeEEccCCCC---ceeecCCCceEEc--cCCCcccCC----------CcccCCccccccCCC--CCccceeehhHHH
Q 047719          407 CERQIIHRDVKAC---NILLDAEFNAKLG--DFEATIPAG----------TMGYLAPEYVYSGVP--SEKTDVYSFGVVA  469 (596)
Q Consensus       407 ~~~~ivHrDlkp~---NiLl~~~~~~kl~--Dfg~~~~~g----------t~~y~aPE~~~~~~~--t~~sDV~SfGvll  469 (596)
                        ....|.-+..+   +.-.+..+...++  ||+.....+          +..|.++|......+  ....|+|.+|.++
T Consensus       305 --~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~  382 (1351)
T KOG1035|consen  305 --LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL  382 (1351)
T ss_pred             --hccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence              55555555444   4444566667776  886654432          344667776665444  4457999999999


Q ss_pred             HHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 047719          470 LEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARIL  544 (596)
Q Consensus       470 ~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L  544 (596)
                      ..+..|..+-.... .             ..     .+......   ..+.+....|...++++|++..+++...
T Consensus       383 ~~~~~~~~i~~~~~-~-------------~~-----~~l~~~~~---~~~~d~~~~~~~~~~~~Rl~~~~ll~~~  435 (1351)
T KOG1035|consen  383 LQLSQGEDISEKSA-V-------------PV-----SLLDVLST---SELLDALPKCLDEDSEERLSALELLTHP  435 (1351)
T ss_pred             hhhhhcCccccccc-c-------------hh-----hhhccccc---hhhhhhhhhhcchhhhhccchhhhhhch
Confidence            99999876532210 0             00     00010111   1345556789999999999999988743

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=96.49  E-value=0.022  Score=58.32  Aligned_cols=143  Identities=20%  Similarity=0.196  Sum_probs=77.9

Q ss_pred             cceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCC--ceeeecce------eeeCCeEEE
Q 047719          289 NRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHK--NLVQLQGW------CCEGNELVL  360 (596)
Q Consensus       289 ~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~--niv~l~g~------~~~~~~~~l  360 (596)
                      .+.|..|....+|+.... +..+++|+...  ..   ......|+..+.. +.+.  .+.+++..      ....+..++
T Consensus        19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~--~~---~~~~~~e~~~l~~-L~~~g~~vp~~i~~~~g~~~~~~~~~~~~   91 (296)
T cd05153          19 FEGISAGIENTNYFVTTD-SGRYVLTLFEK--VS---AEELPFFLALLDH-LAERGLPVPRPIADRDGEYLSELAGKPAA   91 (296)
T ss_pred             eecccCccccceEEEEeC-CCcEEEEEcCC--CC---hHhccHHHHHHHH-HHHCCCCCCccccCCCCcEeeeeCCceEE
Confidence            356677777899998764 44788898743  11   1223334433222 2221  23344332      123456789


Q ss_pred             EEecCCCCCHHH-----------H---hhhCCC-------CCcccCHHHHHH----------HHHHHHHHHHHHHh----
Q 047719          361 VYEYLPNGSLDK-----------I---LHNNSS-------SSIVLSWEKRLN----------IVLGVASALSYLHE----  405 (596)
Q Consensus       361 V~E~~~~gsL~~-----------~---l~~~~~-------~~~~l~~~~~~~----------i~~~ia~gL~~LH~----  405 (596)
                      |++|++|..+..           .   |+....       ......|.....          ....+...+.++..    
T Consensus        92 l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~  171 (296)
T cd05153          92 LVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPS  171 (296)
T ss_pred             EEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhh
Confidence            999998866432           0   111100       001123332211          11123334445443    


Q ss_pred             ccCCCeEEccCCCCceeecCCCceEEccCCCcc
Q 047719          406 ECERQIIHRDVKACNILLDAEFNAKLGDFEATI  438 (596)
Q Consensus       406 ~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~  438 (596)
                      ....+++|+|+.|.|||++++....|.||+.+.
T Consensus       172 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         172 DLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             cCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            223579999999999999998778899997653

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=96.38  E-value=0.027  Score=57.91  Aligned_cols=32  Identities=31%  Similarity=0.265  Sum_probs=27.3

Q ss_pred             cCCCeEEccCCCCceeecCC----CceEEccCCCcc
Q 047719          407 CERQIIHRDVKACNILLDAE----FNAKLGDFEATI  438 (596)
Q Consensus       407 ~~~~ivHrDlkp~NiLl~~~----~~~kl~Dfg~~~  438 (596)
                      ....++|+|+.+.|||++.+    +.+++.||..+.
T Consensus       177 ~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         177 SPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             CCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            34678999999999999985    889999997653

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.26  E-value=0.035  Score=56.66  Aligned_cols=141  Identities=26%  Similarity=0.335  Sum_probs=71.6

Q ss_pred             ccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhc--cCCCceeeecceeeeCCeEEEEEecC
Q 047719          288 KNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGC--LRHKNLVQLQGWCCEGNELVLVYEYL  365 (596)
Q Consensus       288 ~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~--l~H~niv~l~g~~~~~~~~~lV~E~~  365 (596)
                      ..+.++.|....+|+.. .+++.+-||.-.     ......|..|...|..+  ..--.+.+.+++....+.-+||+||+
T Consensus        21 ~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~-----~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l   94 (288)
T PF03881_consen   21 SIEPVSGGDINEAYRLD-TDGGSYFVKVNS-----ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL   94 (288)
T ss_dssp             EEEEE--SSSSEEEEEE-TTS-EEEEEEEE-----GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred             eeEecCCCChhheEEEE-CCCccEEEEecC-----hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence            34678889999999988 578889999864     22344577777665542  23455778888887777779999999


Q ss_pred             CCCC--------HH---HHhhh-CCCCC-----------------cccCHHH-----HHHHHHH--------------HH
Q 047719          366 PNGS--------LD---KILHN-NSSSS-----------------IVLSWEK-----RLNIVLG--------------VA  397 (596)
Q Consensus       366 ~~gs--------L~---~~l~~-~~~~~-----------------~~l~~~~-----~~~i~~~--------------ia  397 (596)
                      +.+.        |-   ..|+. .....                 -.-+|..     |+.-..+              +.
T Consensus        95 ~~~~~~~~~~~~lg~~LA~LH~~~~~~~FGf~~~~~~G~~~q~N~w~~~W~~Ff~~~RL~~~l~~~~~~~~~~~~~~~l~  174 (288)
T PF03881_consen   95 EMGSPSPPDWEELGRQLAALHQWSPAGKFGFPVDTYIGSLPQPNTWTDSWEEFFAEQRLRPQLELAREKGGLDAELERLV  174 (288)
T ss_dssp             ------CCHHHHHHHHHHHHHH-T--SSBB-SS-EEETTEEE----BS-HHHHHHHHCCHHHHHHHHHCTSS-CHHHHHH
T ss_pred             cCCCCCchhHHHHHHHHHHHhhhcCCCCcCCCcCCcccCcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCchhHHHHHH
Confidence            8761        11   11233 21110                 0123332     1111111              11


Q ss_pred             HHHH-HHHh-ccCCCeEEccCCCCceeecCCCceEEccC
Q 047719          398 SALS-YLHE-ECERQIIHRDVKACNILLDAEFNAKLGDF  434 (596)
Q Consensus       398 ~gL~-~LH~-~~~~~ivHrDlkp~NiLl~~~~~~kl~Df  434 (596)
                      +.+. .|+. ...+.++|+||-+.|++.+.++.+.|.|=
T Consensus       175 ~~~~~~l~~~~~~PsLlHGDLW~GN~~~~~~g~p~l~DP  213 (288)
T PF03881_consen  175 ERLPSLLPGREPKPSLLHGDLWSGNVGFDADGEPVLFDP  213 (288)
T ss_dssp             HHHHHCCTTS----EEE-SS-SGGGEEEETTE-EEE-S-
T ss_pred             HHHHHHhcCCCCCceeeEcCccccceeecCCCCceeecc
Confidence            1111 1221 12467999999999999999988999884

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=96.25  E-value=0.1  Score=53.77  Aligned_cols=41  Identities=29%  Similarity=0.438  Sum_probs=31.6

Q ss_pred             HHHHHHHHh----ccCCCeEEccCCCCceeecCCCceEEccCCCc
Q 047719          397 ASALSYLHE----ECERQIIHRDVKACNILLDAEFNAKLGDFEAT  437 (596)
Q Consensus       397 a~gL~~LH~----~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~  437 (596)
                      .+.++++..    ....+++|+|+.+.||+++.++...|.||+.+
T Consensus       171 ~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~  215 (307)
T TIGR00938       171 DKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFA  215 (307)
T ss_pred             HHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccc
Confidence            344555543    23478999999999999999887789999765

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK05231 homoserine kinase; Provisional

Probab=96.07  E-value=0.12  Score=53.46  Aligned_cols=31  Identities=26%  Similarity=0.339  Sum_probs=26.3

Q ss_pred             CCCeEEccCCCCceeecCCCceEEccCCCcc
Q 047719          408 ERQIIHRDVKACNILLDAEFNAKLGDFEATI  438 (596)
Q Consensus       408 ~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~  438 (596)
                      ..+++|+|+.+.|||++.+...-|.||+.+.
T Consensus       186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             CcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            4689999999999999977666899997653

>PLN02756 S-methyl-5-thioribose kinase

Probab=95.98  E-value=0.091  Score=56.00  Aligned_cols=83  Identities=20%  Similarity=0.139  Sum_probs=49.6

Q ss_pred             cceeecCCceEEEEEEcCCCCEEEEEEeecCCc--hh---cccchHHHHHHHHHh--ccCCCceeeecceeeeCCeEEEE
Q 047719          289 NRIVGEGASATVYKGSLPSGGAVAVKRFEKPNR--VE---CARNPFTTEFATMAG--CLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       289 ~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~--~~---~~~~~~~~E~~~l~~--~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      .+.||.|....||+... .++.++||+-.....  +.   .....-..|...|..  .....++.+++.+|.  +.-+++
T Consensus        37 ~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence            36789999999999886 456799998541111  00   122222333433432  122346777888887  346788


Q ss_pred             EecCCC--CCHHHHh
Q 047719          362 YEYLPN--GSLDKIL  374 (596)
Q Consensus       362 ~E~~~~--gsL~~~l  374 (596)
                      |||+++  ..+.+-+
T Consensus       114 ME~L~~~~~ilr~~L  128 (418)
T PLN02756        114 MRYLEPPHIILRKGL  128 (418)
T ss_pred             EeecCCcceehhhhh
Confidence            999976  3455444

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=95.25  E-value=0.17  Score=53.00  Aligned_cols=85  Identities=21%  Similarity=0.053  Sum_probs=46.2

Q ss_pred             eeecCCceEEEEEEcCCC-CEEEEEEeecCCc-----hhcccchHHHHHHHHHhccC-CCceeeecceeeeCCeEEEEEe
Q 047719          291 IVGEGASATVYKGSLPSG-GAVAVKRFEKPNR-----VECARNPFTTEFATMAGCLR-HKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       291 ~LG~G~fG~Vy~~~~~~g-~~vAvK~l~~~~~-----~~~~~~~~~~E~~~l~~~l~-H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      .||.|....||++..++| +.|+||.-.....     -.....+...|...|...-. -|..|+=+- +.+.....+|||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy-~~D~e~~~~vME   80 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIF-HFDTEMAVTVME   80 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEE-EEccccceehHh
Confidence            479999999999998654 5899997431111     11222233344444432111 233333222 234445679999


Q ss_pred             cCCCC-CHHHHhhh
Q 047719          364 YLPNG-SLDKILHN  376 (596)
Q Consensus       364 ~~~~g-sL~~~l~~  376 (596)
                      +++.. .|++.|-.
T Consensus        81 dL~~~~ilR~~Li~   94 (370)
T TIGR01767        81 DLSHHKIARKGLIE   94 (370)
T ss_pred             hCccchHHHHHHHc
Confidence            99653 35455533

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PLN02236 choline kinase

Probab=95.21  E-value=0.17  Score=53.24  Aligned_cols=30  Identities=23%  Similarity=0.320  Sum_probs=25.6

Q ss_pred             CCeEEccCCCCceeecC-CCceEEccCCCcc
Q 047719          409 RQIIHRDVKACNILLDA-EFNAKLGDFEATI  438 (596)
Q Consensus       409 ~~ivHrDlkp~NiLl~~-~~~~kl~Dfg~~~  438 (596)
                      ..++|+|+++.|||+++ ++.+++.||..+.
T Consensus       200 ~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        200 IGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             ceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            57899999999999986 4789999997653

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=94.92  E-value=0.25  Score=51.07  Aligned_cols=32  Identities=19%  Similarity=0.316  Sum_probs=28.0

Q ss_pred             CCCeEEccCCCCceeecCCCceEEccCCCccc
Q 047719          408 ERQIIHRDVKACNILLDAEFNAKLGDFEATIP  439 (596)
Q Consensus       408 ~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~  439 (596)
                      ...++|+|+.+.|++++.+.-+-+.||+++..
T Consensus       197 ~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         197 PPVLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             CceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence            35699999999999999988899999987753

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=94.88  E-value=0.084  Score=55.46  Aligned_cols=62  Identities=21%  Similarity=0.147  Sum_probs=43.3

Q ss_pred             EEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCC
Q 047719          358 LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAE  426 (596)
Q Consensus       358 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~  426 (596)
                      ..|+-+|+++-++..++....     .++.-+.+++.-.+.||--+--.  .+++|.|+.|.||++.-+
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~~~-----~pe~l~kkva~lg~~AllkMl~v--DNFvHaDlHPGNVlirf~  381 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKWKS-----QPEALVKKVAKLGVNALLKMLIV--DNFVHADLHPGNVLIRFN  381 (565)
T ss_pred             ceeeeeccccccHHhhhhccc-----ChHHHHHHHHHHHHHHHHHHHHh--hcceecccCCCcEEEEec
Confidence            467778999999999998654     33344555555555555433322  689999999999999543

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=94.81  E-value=0.0031  Score=74.94  Aligned_cols=140  Identities=12%  Similarity=-0.034  Sum_probs=103.0

Q ss_pred             cCCCceeeecceee--eCCeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhc--cCCCeEEcc
Q 047719          340 LRHKNLVQLQGWCC--EGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEE--CERQIIHRD  415 (596)
Q Consensus       340 l~H~niv~l~g~~~--~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~--~~~~ivHrD  415 (596)
                      ..|++++....-..  +..+.+.+++|+..|.+.+.|-........++..-....-.+...+..-.|+.  ...-.+|++
T Consensus      1286 ~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~ 1365 (2724)
T KOG1826|consen 1286 AKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKS 1365 (2724)
T ss_pred             hhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhh
Confidence            57888766554433  23467899999999999999977654444444433333333324444444442  234578999


Q ss_pred             CCCCceeecCCCceEEccCCCccc-----------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCC
Q 047719          416 VKACNILLDAEFNAKLGDFEATIP-----------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPV  479 (596)
Q Consensus       416 lkp~NiLl~~~~~~kl~Dfg~~~~-----------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~  479 (596)
                      +|+-|.+|..+.++|++++|+...           .+++-|+.|+....-.++.++|+|..|+.+|+..-|..+|
T Consensus      1366 Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1366 LKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred             hhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence            999999999999999999998761           3677788999888888999999999999999998887765

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=94.38  E-value=0.039  Score=56.23  Aligned_cols=133  Identities=20%  Similarity=0.236  Sum_probs=83.1

Q ss_pred             CCccceeecCCceEEEEEEcCCCCEEEEEEeecCC---------c------hh-----cccchHHHHHHHHHhccCCCce
Q 047719          286 FNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPN---------R------VE-----CARNPFTTEFATMAGCLRHKNL  345 (596)
Q Consensus       286 f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~---------~------~~-----~~~~~~~~E~~~l~~~l~H~ni  345 (596)
                      ++.++.||-|.-+.||.+...+|++.++|.=+...         +      ..     -.+-....|..-|..+-.|..=
T Consensus        94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp  173 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP  173 (465)
T ss_pred             hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence            56779999999999999999889999988521100         0      00     0111234455444442233222


Q ss_pred             e-eecceeeeCCeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeec
Q 047719          346 V-QLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLD  424 (596)
Q Consensus       346 v-~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~  424 (596)
                      | +.+    +....++|||++.+-.|...-+-       .+..+++.-+.++   +.-|-.   .|+||+|..-=||+++
T Consensus       174 VPkpi----D~~RH~Vvmelv~g~Pl~~v~~v-------~d~~~ly~~lm~~---Iv~la~---~GlIHgDFNEFNimv~  236 (465)
T KOG2268|consen  174 VPKPI----DHNRHCVVMELVDGYPLRQVRHV-------EDPPTLYDDLMGL---IVRLAN---HGLIHGDFNEFNIMVK  236 (465)
T ss_pred             CCCcc----cccceeeHHHhhcccceeeeeec-------CChHHHHHHHHHH---HHHHHH---cCceecccchheeEEe
Confidence            2 222    23456899999988777655432       1223333322222   223333   8999999999999999


Q ss_pred             CCCceEEccCC
Q 047719          425 AEFNAKLGDFE  435 (596)
Q Consensus       425 ~~~~~kl~Dfg  435 (596)
                      ++..++++||-
T Consensus       237 dd~~i~vIDFP  247 (465)
T KOG2268|consen  237 DDDKIVVIDFP  247 (465)
T ss_pred             cCCCEEEeech
Confidence            99999999994

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=94.20  E-value=0.058  Score=58.12  Aligned_cols=150  Identities=23%  Similarity=0.268  Sum_probs=79.9

Q ss_pred             HHhccCCCceeeecceeeeCC-eEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEc
Q 047719          336 MAGCLRHKNLVQLQGWCCEGN-ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHR  414 (596)
Q Consensus       336 l~~~l~H~niv~l~g~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHr  414 (596)
                      +.+.+.|+|+-..+.+..... ...+|+|++ +.||++.+..+...     -.          +++    .   +++.|-
T Consensus        35 ~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~l~-----~~----------s~~----~---~~~~~~   91 (725)
T KOG1093|consen   35 YLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGNLK-----DE----------SLL----A---HGVLHL   91 (725)
T ss_pred             HHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcccc-----hh----------hhc----c---ccccee
Confidence            344589999998887765443 478889998 56999999765410     00          111    1   334443


Q ss_pred             cCCCCceeecCCCceEEccCCCcccCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCCh-hHHHHHHHH
Q 047719          415 DVKACNILLDAEFNAKLGDFEATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGC-VIVDWVWNL  493 (596)
Q Consensus       415 Dlkp~NiLl~~~~~~kl~Dfg~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~-~~~~~~~~~  493 (596)
                      .+     +       +.+|- +    -|. |  |-     ...+|+|||++|.++.|+.-|..-+..-.. ....-...+
T Consensus        92 ~~-----~-------~~td~-~----~t~-~--~~-----~~~pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~  146 (725)
T KOG1093|consen   92 NI-----I-------YITDH-F----LTK-Y--PS-----PIGPKSDVWSLGFIILELYLGISLEAELTESEYLEILLKY  146 (725)
T ss_pred             hh-----h-------hcccc-c----ccc-C--CC-----CCCcchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHh
Confidence            22     1       22220 0    000 0  11     112599999999999999998865543211 011111111


Q ss_pred             HhcC-CchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCC
Q 047719          494 RKKG-KLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPS  536 (596)
Q Consensus       494 ~~~~-~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs  536 (596)
                      .... .....+-.   ..+..+.....+++-..|.-..|..||.
T Consensus       147 ~~~d~~~~~~a~e---~~~~~~~d~~~~~~~~~c~~~~~~ir~l  187 (725)
T KOG1093|consen  147 YTDDQELLSTAME---HLIQLLADKKRLPLLKKCLWLEPIIRPL  187 (725)
T ss_pred             ccCchhHHHHHHH---HHHHHhhhHhHHHHhccCCccccccccc
Confidence            1111 11000000   0222344566777888999999988874

>PRK12396 5-methylribose kinase; Reviewed

Probab=93.88  E-value=0.27  Score=52.24  Aligned_cols=83  Identities=17%  Similarity=0.103  Sum_probs=45.6

Q ss_pred             ceeecCCceEEEEEEcCC-CCEEEEEEeecCCch----hcccchHHHHHHHHHhccC-CC-ceeeecceeeeCCeEEEEE
Q 047719          290 RIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRV----ECARNPFTTEFATMAGCLR-HK-NLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       290 ~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~----~~~~~~~~~E~~~l~~~l~-H~-niv~l~g~~~~~~~~~lV~  362 (596)
                      +.||.|.-..||++...+ ++.|+||.-...-+.    ....++..-|...|...-. .| .+.+++.  .+.....+||
T Consensus        35 ~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~vM  112 (409)
T PRK12396         35 KEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCCVM  112 (409)
T ss_pred             eEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhHHH
Confidence            578999999999998753 568999974311111    1122233344433332111 23 3334443  3444567899


Q ss_pred             ecCCCC-CHHHHh
Q 047719          363 EYLPNG-SLDKIL  374 (596)
Q Consensus       363 E~~~~g-sL~~~l  374 (596)
                      |+++.. .|++.|
T Consensus       113 EdL~~~~ilR~~L  125 (409)
T PRK12396        113 EDLSDHTILRTAL  125 (409)
T ss_pred             HhCcccHHHHHHH
Confidence            998642 344444

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=93.43  E-value=0.57  Score=47.58  Aligned_cols=30  Identities=23%  Similarity=0.420  Sum_probs=24.7

Q ss_pred             CCeEEccCCCCceeecCCCc-eEEccCCCcc
Q 047719          409 RQIIHRDVKACNILLDAEFN-AKLGDFEATI  438 (596)
Q Consensus       409 ~~ivHrDlkp~NiLl~~~~~-~kl~Dfg~~~  438 (596)
                      ..++|+|+++.|||++.++. .-|.||+.+.
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~  215 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAK  215 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence            45899999999999997555 5699998764

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=93.42  E-value=1.3  Score=45.42  Aligned_cols=29  Identities=31%  Similarity=0.334  Sum_probs=25.0

Q ss_pred             CCCeEEccCCCCceeecCCCceEEccCCCc
Q 047719          408 ERQIIHRDVKACNILLDAEFNAKLGDFEAT  437 (596)
Q Consensus       408 ~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~  437 (596)
                      ..+++|+|+.+.||+++. +.+.|.||+.+
T Consensus       186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~  214 (313)
T TIGR02906       186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYC  214 (313)
T ss_pred             cCceEcCCCCcccEEEeC-CcEEEEECccc
Confidence            367899999999999988 67899999754

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	596
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		5e-52
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		3e-51
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		7e-40
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		7e-40
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		9e-31
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-30
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-30
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		8e-28
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-21
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-20
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-16
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-16
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-15
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-15
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-15
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-15
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-15
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-15
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		6e-15
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		6e-15
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		7e-15
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		7e-15
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		7e-15
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		7e-15
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		7e-15
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		7e-15
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		8e-15
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		8e-15
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		8e-15
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		8e-15
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		8e-15
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		8e-15
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		8e-15
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		8e-15
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		8e-15
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		8e-15
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		8e-15
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		8e-15
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		8e-15
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		8e-15
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		8e-15
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		9e-15
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		9e-15
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-14
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-14
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-14
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-14
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-14
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-14
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-14
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-14
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-14
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-14
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		5e-14
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		5e-14
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		5e-14
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-14
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		7e-14
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-14
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		7e-14
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		8e-14
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		8e-14
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-13
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-13
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-13
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-13
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-13
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-13
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-13
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-13
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-13
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-13
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-13
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-13
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-13
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-13
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		3e-13
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-13
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-13
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		3e-13
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-13
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		3e-13
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-13
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-13
4h58_A	275	Braf In Complex With Compound 3 Length = 275		3e-13
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-13
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-13
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		4e-13
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		4e-13
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		4e-13
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		4e-13
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		5e-13
1fvr_A	327	Tie2 Kinase Domain Length = 327		5e-13
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		6e-13
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		6e-13
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		6e-13
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		6e-13
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-13
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		7e-13
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		7e-13
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		8e-13
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		8e-13
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		8e-13
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		9e-13
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		9e-13
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		9e-13
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-12
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-12
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-12
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-12
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-12
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-12
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-12
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-12
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-12
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-12
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-12
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-12
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-12
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-12
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-12
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-12
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-12
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-12
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-12
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-12
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-12
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-12
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-12
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-12
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-12
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		4e-12
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		4e-12
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		4e-12
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		4e-12
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		4e-12
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-12
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-12
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		5e-12
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-12
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		5e-12
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		6e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		6e-12
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		6e-12
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		7e-12
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		9e-12
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		9e-12
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-11
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-11
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-11
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-11
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-11
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-11
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-11
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-11
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-11
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-11
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-11
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-11
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-11
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-11
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-11
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-11
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-11
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		4e-11
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		4e-11
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		4e-11
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		5e-11
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		5e-11
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		5e-11
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		5e-11
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		5e-11
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		5e-11
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		5e-11
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		6e-11
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		6e-11
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		6e-11
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		6e-11
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		7e-11
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		7e-11
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		7e-11
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		7e-11
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		8e-11
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		8e-11
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		8e-11
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		8e-11
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		8e-11
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		8e-11
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		8e-11
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		8e-11
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		8e-11
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		9e-11
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		9e-11
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		9e-11
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		9e-11
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		9e-11
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-10
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-10
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-10
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-10
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-10
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-10
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-10
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-10
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-10
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-10
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-10
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-10
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-10
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-10
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-10
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-10
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-10
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-10
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-10
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-10
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-10
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-10
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-10
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-10
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-10
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-10
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-10
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-10
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-10
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-10
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-10
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-10
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-10
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-10
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-10
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-10
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-10
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-10
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-10
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-10
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-10
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-10
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-10
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-10
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-10
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-10
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-10
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-10
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-10
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-10
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-10
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-10
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-10
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-10
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		3e-10
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		3e-10
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-10
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-10
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		3e-10
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-10
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		3e-10
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-10
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-10
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		4e-10
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		4e-10
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-10
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		4e-10
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-10
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		4e-10
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-10
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		5e-10
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-10
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		5e-10
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		6e-10
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-10
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-10
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		6e-10
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-10
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		6e-10
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		6e-10
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		6e-10
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-10
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		6e-10
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		6e-10
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		6e-10
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		6e-10
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		6e-10
3a7f_A	303	Human Mst3 Kinase Length = 303		7e-10
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		7e-10
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-10
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		7e-10
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		7e-10
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		8e-10
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		8e-10
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		8e-10
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		8e-10
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		8e-10
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		8e-10
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		8e-10
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		8e-10
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		8e-10
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-10
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		8e-10
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		8e-10
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		9e-10
3b2t_A	311	Structure Of Phosphotransferase Length = 311		9e-10
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		9e-10
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		9e-10
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		9e-10
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		9e-10
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		9e-10
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-10
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		9e-10
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-10
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-09
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-09
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-09
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-09
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		1e-09
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-09
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-09
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-09
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-09
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-09
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-09
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-09
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-09
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-09
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-09
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-09
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-09
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-09
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-09
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-09
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-09
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-09
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-09
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-09
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-09
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-09
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-09
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-09
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-09
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-09
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-09
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-09
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-09
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-09
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-09
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-09
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-09
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-09
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-09
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-09
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-09
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-09
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-09
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		3e-09
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		3e-09
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-09
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-09
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-09
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		3e-09
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		3e-09
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-09
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-09
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-09
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		3e-09
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-09
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-09
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-09
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		3e-09
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-09
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-09
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-09
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-09
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		3e-09
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-09
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		3e-09
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-09
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-09
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		3e-09
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		3e-09
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-09
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-09
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-09
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-09
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-09
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-09
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-09
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		3e-09
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-09
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-09
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		3e-09
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		3e-09
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-09
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-09
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-09
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-09
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-09
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-09
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-09
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		3e-09
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-09
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-09
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-09
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-09
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-09
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-09
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-09
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-09
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		3e-09
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-09
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-09
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		4e-09
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-09
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		4e-09
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		4e-09
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-09
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		4e-09
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		4e-09
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		4e-09
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		4e-09
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		4e-09
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		4e-09
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		4e-09
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		4e-09
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		4e-09
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		4e-09
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-09
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		4e-09
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		4e-09
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-09
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		5e-09
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-09
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		5e-09
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-09
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		5e-09
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		5e-09
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		5e-09
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-09
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-09
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-09
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-09
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		7e-09
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-09
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		7e-09
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		7e-09
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		8e-09
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		8e-09
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		8e-09
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		9e-09
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		9e-09
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		9e-09
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		9e-09
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		9e-09
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		9e-09
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-08
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-08
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		1e-08
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-08
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-08
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-08
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-08
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-08
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-08
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-08
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-08
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-08
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-08
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-08
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-08
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-08
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-08
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-08
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-08
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-08
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-08
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-08
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-08
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-08
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-08
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-08
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-08
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-08
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-08
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-08
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-08
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-08
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-08
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-08
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-08
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-08
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-08
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-08
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-08
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-08
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-08
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-08
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-08
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-08
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-08
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		4e-08
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		4e-08
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-08
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		5e-08
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		5e-08
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		5e-08
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		5e-08
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		5e-08
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		5e-08
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		5e-08
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		6e-08
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		6e-08
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		6e-08
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		6e-08
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-08
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		9e-08
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		9e-08
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		9e-08
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		1e-07
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-07
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-07
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-07
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-07
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-07
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-07
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-07
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-07
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-07
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-07
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-07
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-07
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-07
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-07
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-07
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-07
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-07
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-07
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-07
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-07
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-07
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-07
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-07
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-07
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-07
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-07
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-07
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-07
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-07
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		3e-07
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		3e-07
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-07
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-07
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-07
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-07
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-07
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-07
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-07
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-07
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-07
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		3e-07
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-07
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		3e-07
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		3e-07
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-07
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-07
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		4e-07
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		4e-07
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		4e-07
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		4e-07
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		4e-07
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		5e-07
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		5e-07
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		5e-07
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		5e-07
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		5e-07
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-07
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		6e-07
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		6e-07
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		6e-07
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		6e-07
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		6e-07
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		6e-07
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		6e-07
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-07
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-07
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		7e-07
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		7e-07
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		7e-07
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		7e-07
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		7e-07
4ae6_A	343	Structure And Function Of The Human Sperm-specific		7e-07
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		7e-07
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		7e-07
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		7e-07
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		7e-07
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		7e-07
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		7e-07
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		7e-07
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		8e-07
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-07
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		8e-07
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		8e-07
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		8e-07
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		8e-07
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		8e-07
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		8e-07
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		9e-07
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		9e-07
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		9e-07
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		9e-07
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		9e-07
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-06
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-06
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-06
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-06
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-06
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-06
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-06
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-06
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-06
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-06
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-06
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-06
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-06
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		1e-06
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-06
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-06
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-06
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-06
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-06
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-06
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-06
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-06
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-06
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-06
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-06
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-06
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-06
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-06
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-06
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-06
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-06
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-06
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-06
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-06
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-06
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-06
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-06
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-06
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-06
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-06
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-06
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-06
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-06
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-06
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-06
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-06
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-06
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-06
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-06
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-06
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-06
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-06
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-06
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-06
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-06
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		3e-06
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-06
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-06
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		3e-06
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-06
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-06
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-06
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		3e-06
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-06
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		3e-06
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		3e-06
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-06
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		3e-06
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		3e-06
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		3e-06
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-06
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		3e-06
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		3e-06
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		4e-06
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		4e-06
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-06
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		4e-06
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		4e-06
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-06
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		4e-06
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		4e-06
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-06
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		4e-06
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		4e-06
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		4e-06
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		4e-06
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		5e-06
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		5e-06
1wbf_A	242	Winged Bean Lectin, Saccharide Free Form Length = 2		5e-06
1wbl_A	241	Winged Bean Lectin Complexed With Methyl-Alpha-D-Ga		5e-06
2e7q_A	237	Crystal Structure Of Basic Winged Bean Lectin In Co		6e-06
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		6e-06
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		6e-06
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		7e-06
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		7e-06
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		7e-06
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		7e-06
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		8e-06
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		8e-06
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		8e-06
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		8e-06
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		8e-06
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		8e-06
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		8e-06
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		8e-06
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		9e-06
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		9e-06
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		9e-06
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		9e-06
4exu_A	371	Mapk13, Inactive Form Length = 371		9e-06
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		9e-06
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		9e-06
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		9e-06
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		9e-06
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		9e-06
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-05
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-05
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-05
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-05
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-05
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-05
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-05
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-05
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-05
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		1e-05
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		1e-05
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-05
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-05
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-05
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-05
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-05
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-05
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-05
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-05
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-05
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-05
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-05
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-05
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-05
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-05
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-05
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-05
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-05
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-05
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-05
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-05
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-05
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-05
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-05
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-05
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-05
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-05
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-05
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-05
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-05
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-05
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		3e-05
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		3e-05
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-05
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		3e-05
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-05
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-05
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		3e-05
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-05
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-05
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		3e-05
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-05
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		3e-05
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		3e-05
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		3e-05
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-05
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		3e-05
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		4e-05
3gni_B	389	Structure Of Strad And Mo25 Length = 389		4e-05
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		4e-05
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		4e-05
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		4e-05
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		4e-05
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		4e-05
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		4e-05
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		4e-05
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		4e-05
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		5e-05
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		5e-05
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		5e-05
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		6e-05
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		6e-05
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		7e-05
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		7e-05
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		7e-05
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		7e-05
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		7e-05
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		7e-05
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		8e-05
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		8e-05
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		8e-05
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		8e-05
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		8e-05
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		8e-05
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		8e-05
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		8e-05
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		9e-05
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		9e-05
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		9e-05
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		9e-05
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		9e-05
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-04
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-04
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-04
3zvx_A	261	Structure Of The Lectin From Platypodium Elegans In		1e-04
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-04
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-04
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-04
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-04
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-04
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-04
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-04
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-04
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-04
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-04
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-04
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-04
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-04
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-04
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-04
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-04
3kk8_A	284	Camkii Substrate Complex A Length = 284		3e-04
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-04
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		3e-04
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		3e-04
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		3e-04
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-04
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		3e-04
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		3e-04
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-04
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		3e-04
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		3e-04
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-04
3ipv_A	251	Crystal Structure Of Spatholobus Parviflorus Seed L		4e-04
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-04
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		4e-04
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-04
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		4e-04
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		4e-04
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		4e-04
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		4e-04
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		4e-04
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		4e-04
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		4e-04
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		4e-04
1fay_A	238	Winged Bean Acidic Lectin Complexed With Methyl-Alp		4e-04
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		4e-04
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		4e-04
2oza_B	366	Structure Of P38alpha Complex Length = 366		4e-04
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		5e-04
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		5e-04
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		5e-04
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		5e-04
3hec_A	348	P38 In Complex With Imatinib Length = 348		5e-04
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		5e-04
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		5e-04
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		5e-04
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		6e-04
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		6e-04
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		6e-04
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		6e-04
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		6e-04
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		6e-04
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		6e-04
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		6e-04
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		6e-04
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		6e-04
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		6e-04
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		6e-04
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		6e-04
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		6e-04
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		6e-04
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		6e-04
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		6e-04
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		6e-04
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		7e-04
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		7e-04
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		7e-04
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		7e-04
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		7e-04
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		7e-04
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		7e-04
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		7e-04
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		7e-04
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		7e-04
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		7e-04
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		7e-04
3soa_A	444	Full-Length Human Camkii Length = 444		7e-04
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		7e-04
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		8e-04
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		8e-04
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		8e-04
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		9e-04
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		9e-04
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		9e-04
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  202 bits (514), Expect = 5e-52,   Method: Compositional matrix adjust.
 Identities = 113/294 (38%), Positives = 165/294 (56%), Gaps = 20/294 (6%)
Query: 273 RLALTDIKQATLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTE 332
           R +L +++ A+  F+   I+G G    VYKG L  G  VAVKR  K  R +     F TE
Sbjct: 27  RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRL-KEERXQGGELQFQTE 85
Query: 333 FATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNI 392
              ++  + H+NL++L+G+C    E +LVY Y+ NGS+   L     S   L W KR  I
Sbjct: 86  VEMISMAV-HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 144
Query: 393 VLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFE------------ATIPA 440
            LG A  L+YLH+ C+ +IIHRDVKA NILLD EF A +GDF                  
Sbjct: 145 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVR 204
Query: 441 GTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVD------NDGCVIVDWVWNLR 494
           GT+G++APEY+ +G  SEKTDV+ +GV+ LE+  G+   D      +D  +++DWV  L 
Sbjct: 205 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 264
Query: 495 KKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEA 548
           K+ KL    D  L+G +  +E+E+++ V L C   +  +RP + E  R+L+G+ 
Sbjct: 265 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 318

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  199 bits (507), Expect = 3e-51,   Method: Compositional matrix adjust.
 Identities = 112/294 (38%), Positives = 163/294 (55%), Gaps = 20/294 (6%)
Query: 273 RLALTDIKQATLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTE 332
           R +L +++ A+  F    I+G G    VYKG L  G  VAVKR  K  R +     F TE
Sbjct: 19  RFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRL-KEERTQGGELQFQTE 77
Query: 333 FATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNI 392
              ++  + H+NL++L+G+C    E +LVY Y+ NGS+   L     S   L W KR  I
Sbjct: 78  VEMISMAV-HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 393 VLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFE------------ATIPA 440
            LG A  L+YLH+ C+ +IIHRDVKA NILLD EF A +GDF                  
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVR 196
Query: 441 GTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVD------NDGCVIVDWVWNLR 494
           G +G++APEY+ +G  SEKTDV+ +GV+ LE+  G+   D      +D  +++DWV  L 
Sbjct: 197 GXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256
Query: 495 KKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEA 548
           K+ KL    D  L+G +  +E+E+++ V L C   +  +RP + E  R+L+G+ 
Sbjct: 257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  162 bits (409), Expect = 7e-40,   Method: Compositional matrix adjust.
 Identities = 100/290 (34%), Positives = 150/290 (51%), Gaps = 39/290 (13%)
Query: 273 RLALTDIKQATLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTE 332
           R+ L D+++AT  F+   ++G G    VYKG L  G  VA+KR          R P +++
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR----------RTPESSQ 77
Query: 333 --------FATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVL 384
                     T++ C RH +LV L G+C E NE++L+Y+Y+ NG+L + L+ +   ++ +
Sbjct: 78  GIEEFETEIETLSFC-RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSM 136
Query: 385 SWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT------- 437
           SWE+RL I +G A  L YLH    R IIHRDVK+ NILLD  F  K+ DF  +       
Sbjct: 137 SWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELD 193
Query: 438 ------IPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPV----DNDGCVIV 487
                 +  GT+GY+ PEY   G  +EK+DVYSFGVV  EV   +S +      +   + 
Sbjct: 194 QTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLA 253
Query: 488 DWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSV 537
           +W       G+L    D  L  K   + + +     + C+  + E RPS+
Sbjct: 254 EWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSM 303

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  161 bits (408), Expect = 7e-40,   Method: Compositional matrix adjust.
 Identities = 100/290 (34%), Positives = 150/290 (51%), Gaps = 39/290 (13%)
Query: 273 RLALTDIKQATLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTE 332
           R+ L D+++AT  F+   ++G G    VYKG L  G  VA+KR          R P +++
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR----------RTPESSQ 77
Query: 333 --------FATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVL 384
                     T++ C RH +LV L G+C E NE++L+Y+Y+ NG+L + L+ +   ++ +
Sbjct: 78  GIEEFETEIETLSFC-RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSM 136
Query: 385 SWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT------- 437
           SWE+RL I +G A  L YLH    R IIHRDVK+ NILLD  F  K+ DF  +       
Sbjct: 137 SWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELG 193
Query: 438 ------IPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPV----DNDGCVIV 487
                 +  GT+GY+ PEY   G  +EK+DVYSFGVV  EV   +S +      +   + 
Sbjct: 194 QTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLA 253
Query: 488 DWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSV 537
           +W       G+L    D  L  K   + + +     + C+  + E RPS+
Sbjct: 254 EWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSM 303

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  131 bits (330), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 96/287 (33%), Positives = 146/287 (50%), Gaps = 31/287 (10%)
Query: 278 DIKQATLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRV--ECARNPFTTEFAT 335
           D +  ++G NK   +GEG    VYKG + +   VAVK+      +  E  +  F  E   
Sbjct: 22  DERPISVGGNK---MGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKV 77
Query: 336 MAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGS-LDKILHNNSSSSIVLSWEKRLNIVL 394
           MA C +H+NLV+L G+  +G++L LVY Y+PNGS LD++   + +    LSW  R  I  
Sbjct: 78  MAKC-QHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP--LSWHMRCKIAQ 134
Query: 395 GVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA-------------G 441
           G A+ +++LH   E   IHRD+K+ NILLD  F AK+ DF     +             G
Sbjct: 135 GAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVG 191
Query: 442 TMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDND---GCVIVDWVWNLRKKGK 498
           T  Y+APE +  G  + K+D+YSFGVV LE+  G   VD       ++        ++  
Sbjct: 192 TTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKT 250
Query: 499 LLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK 545
           + D  D ++    +   +E M  V   C+H    KRP +K+  ++L+
Sbjct: 251 IEDYIDKKMNDA-DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 296

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  131 bits (330), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 97/287 (33%), Positives = 147/287 (51%), Gaps = 31/287 (10%)
Query: 278 DIKQATLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRV--ECARNPFTTEFAT 335
           D +  ++G NK   +GEG    VYKG + +   VAVK+      +  E  +  F  E   
Sbjct: 28  DERPISVGGNK---MGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKV 83
Query: 336 MAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGS-LDKILHNNSSSSIVLSWEKRLNIVL 394
           MA C +H+NLV+L G+  +G++L LVY Y+PNGS LD++   + +    LSW  R  I  
Sbjct: 84  MAKC-QHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP--LSWHMRCKIAQ 140
Query: 395 GVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGD---------FEATIP----AG 441
           G A+ +++LH   E   IHRD+K+ NILLD  F AK+ D         F  T+      G
Sbjct: 141 GAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVG 197
Query: 442 TMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDND---GCVIVDWVWNLRKKGK 498
           T  Y+APE +  G  + K+D+YSFGVV LE+  G   VD       ++        ++  
Sbjct: 198 TTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKT 256
Query: 499 LLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK 545
           + D  D ++    +   +E M  V   C+H    KRP +K+  ++L+
Sbjct: 257 IEDYIDKKMNDA-DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  131 bits (330), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 97/287 (33%), Positives = 147/287 (51%), Gaps = 31/287 (10%)
Query: 278 DIKQATLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRV--ECARNPFTTEFAT 335
           D +  ++G NK   +GEG    VYKG + +   VAVK+      +  E  +  F  E   
Sbjct: 28  DERPISVGGNK---MGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKV 83
Query: 336 MAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGS-LDKILHNNSSSSIVLSWEKRLNIVL 394
           MA C +H+NLV+L G+  +G++L LVY Y+PNGS LD++   + +    LSW  R  I  
Sbjct: 84  MAKC-QHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP--LSWHMRCKIAQ 140
Query: 395 GVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGD---------FEATIP----AG 441
           G A+ +++LH   E   IHRD+K+ NILLD  F AK+ D         F  T+      G
Sbjct: 141 GAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVG 197
Query: 442 TMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDND---GCVIVDWVWNLRKKGK 498
           T  Y+APE +  G  + K+D+YSFGVV LE+  G   VD       ++        ++  
Sbjct: 198 TTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKT 256
Query: 499 LLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK 545
           + D  D ++    +   +E M  V   C+H    KRP +K+  ++L+
Sbjct: 257 IEDYIDKKMNDA-DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  122 bits (305), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 94/287 (32%), Positives = 140/287 (48%), Gaps = 31/287 (10%)
Query: 278 DIKQATLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRV--ECARNPFTTEFAT 335
           D +  ++G NK    GEG    VYKG + +   VAVK+      +  E  +  F  E   
Sbjct: 19  DERPISVGGNK---XGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKV 74
Query: 336 MAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGS-LDKILHNNSSSSIVLSWEKRLNIVL 394
            A C +H+NLV+L G+  +G++L LVY Y PNGS LD++   + +    LSW  R  I  
Sbjct: 75  XAKC-QHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPP--LSWHXRCKIAQ 131
Query: 395 GVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-------------EATIPAG 441
           G A+ +++LH   E   IHRD+K+ NILLD  F AK+ DF               +   G
Sbjct: 132 GAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVG 188
Query: 442 TMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDND---GCVIVDWVWNLRKKGK 498
           T  Y APE +  G  + K+D+YSFGVV LE+  G   VD       ++        ++  
Sbjct: 189 TTAYXAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKT 247
Query: 499 LLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK 545
           + D  D +     +   +E    V   C+H    KRP +K+  ++L+
Sbjct: 248 IEDYID-KKXNDADSTSVEAXYSVASQCLHEKKNKRPDIKKVQQLLQ 293

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 70/207 (33%), Positives = 104/207 (50%), Gaps = 15/207 (7%)
Query: 286 FNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
            N    +G G+  TV++     G  VAVK   + +      N F  E A M   LRH N+
Sbjct: 39  LNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKR-LRHPNI 96
Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
           V   G   +   L +V EYL  GSL ++LH  S +   L   +RL++   VA  ++YLH 
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-SGAREQLDERRRLSMAYDVAKGMNYLHN 155
Query: 406 ECERQIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTMGYLAPEYVYSG 454
                I+HRD+K+ N+L+D ++  K+ DF            +   AGT  ++APE +   
Sbjct: 156 R-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEVLRDE 214
Query: 455 VPSEKTDVYSFGVVALEVAAGKSPVDN 481
             +EK+DVYSFGV+  E+A  + P  N
Sbjct: 215 PSNEKSDVYSFGVILWELATLQQPWGN 241

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 104/207 (50%), Gaps = 15/207 (7%)
Query: 286 FNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
            N    +G G+  TV++     G  VAVK   + +      N F  E A M   LRH N+
Sbjct: 39  LNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKR-LRHPNI 96
Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
           V   G   +   L +V EYL  GSL ++LH  S +   L   +RL++   VA  ++YLH 
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-SGAREQLDERRRLSMAYDVAKGMNYLHN 155
Query: 406 ECERQIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTMGYLAPEYVYSG 454
                I+HR++K+ N+L+D ++  K+ DF            +   AGT  ++APE +   
Sbjct: 156 R-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDE 214
Query: 455 VPSEKTDVYSFGVVALEVAAGKSPVDN 481
             +EK+DVYSFGV+  E+A  + P  N
Sbjct: 215 PSNEKSDVYSFGVILWELATLQQPWGN 241

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 120/276 (43%), Gaps = 41/276 (14%)
Query: 289 NRIVGEGASATVYKGSLPSGGA----VAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
            +I+G G S  V  G L   G     VA+K   K    E  R  F +E A++ G   H N
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL-KAGYTERQRRDFLSE-ASIMGQFDHPN 111
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           +++L+G    G   ++V EY+ NGSLD  L  +     ++   + + ++ GV + + YL 
Sbjct: 112 IIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIM---QLVGMLRGVGAGMRYL- 167
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF------------EATIPAGT--MGYLAPEY 450
              +   +HRD+ A N+L+D+    K+ DF              T   G   + + APE 
Sbjct: 168 --SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEA 225
Query: 451 VYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAAD-FRLR 508
           +     S  +DV+SFGVV  EV A G+ P            WN+  +  +    + +RL 
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLAYGERP-----------YWNMTNRDVISSVEEGYRLP 274
Query: 509 GKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARIL 544
                      LM  L C H +  +RP   +   +L
Sbjct: 275 APMGCPHALHQLM--LDCWHKDRAQRPRFSQIVSVL 308

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 120/276 (43%), Gaps = 41/276 (14%)
Query: 289 NRIVGEGASATVYKGSLPSGGA----VAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
            +I+G G S  V  G L   G     VA+K   K    E  R  F +E A++ G   H N
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL-KAGYTERQRRDFLSE-ASIMGQFDHPN 111
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           +++L+G    G   ++V EY+ NGSLD  L  +     ++   + + ++ GV + + YL 
Sbjct: 112 IIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIM---QLVGMLRGVGAGMRYL- 167
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF------------EATIPAGT--MGYLAPEY 450
              +   +HRD+ A N+L+D+    K+ DF              T   G   + + APE 
Sbjct: 168 --SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEA 225
Query: 451 VYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAAD-FRLR 508
           +     S  +DV+SFGVV  EV A G+ P            WN+  +  +    + +RL 
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLAYGERP-----------YWNMTNRDVISSVEEGYRLP 274
Query: 509 GKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARIL 544
                      LM  L C H +  +RP   +   +L
Sbjct: 275 APMGCPHALHQLM--LDCWHKDRAQRPRFSQIVSVL 308

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 86/327 (26%), Positives = 135/327 (41%), Gaps = 59/327 (18%)
Query: 274 LALTDIKQATLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEF 333
           L + D K+  +      +VG GA   V K        VA+K+ E     E  R  F  E 
Sbjct: 3   LHMIDYKEIEV----EEVVGRGAFGVVCKAKW-RAKDVAIKQIES----ESERKAFIVEL 53
Query: 334 ATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNS-----SSSIVLSWEK 388
             ++  + H N+V+L G C   N + LV EY   GSL  +LH        +++  +SW  
Sbjct: 54  RQLSR-VNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW-- 108
Query: 389 RLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNA-KLGDF--------EATIP 439
                L  +  ++YLH    + +IHRD+K  N+LL A     K+ DF          T  
Sbjct: 109 ----CLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNN 164
Query: 440 AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKL 499
            G+  ++APE       SEK DV+S+G++  EV   + P D  G      +W +    + 
Sbjct: 165 KGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP 224
Query: 500 LDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEAXXXXXXVKKPT 559
               +         K +E ++     C   +  +RPS++E  +I+               
Sbjct: 225 PLIKNL-------PKPIESLMT---RCWSKDPSQRPSMEEIVKIM--------------- 259
Query: 560 VNIRSVFPEASELIDSGGDHS--PGFD 584
            ++   FP A E +     HS  PG D
Sbjct: 260 THLMRYFPGADEPLQYPCQHSLPPGED 286

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 86/327 (26%), Positives = 135/327 (41%), Gaps = 59/327 (18%)
Query: 274 LALTDIKQATLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEF 333
           L + D K+  +      +VG GA   V K        VA+K+ E     E  R  F  E 
Sbjct: 2   LHMIDYKEIEV----EEVVGRGAFGVVCKAKW-RAKDVAIKQIES----ESERKAFIVEL 52
Query: 334 ATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNS-----SSSIVLSWEK 388
             ++  + H N+V+L G C   N + LV EY   GSL  +LH        +++  +SW  
Sbjct: 53  RQLSR-VNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW-- 107
Query: 389 RLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNA-KLGDF--------EATIP 439
                L  +  ++YLH    + +IHRD+K  N+LL A     K+ DF          T  
Sbjct: 108 ----CLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNN 163
Query: 440 AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKL 499
            G+  ++APE       SEK DV+S+G++  EV   + P D  G      +W +    + 
Sbjct: 164 KGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP 223
Query: 500 LDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEAXXXXXXVKKPT 559
               +         K +E ++     C   +  +RPS++E  +I+               
Sbjct: 224 PLIKNL-------PKPIESLMT---RCWSKDPSQRPSMEEIVKIM--------------- 258
Query: 560 VNIRSVFPEASELIDSGGDHS--PGFD 584
            ++   FP A E +     HS  PG D
Sbjct: 259 THLMRYFPGADEPLQYPCQHSLPPGED 285

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/284 (25%), Positives = 130/284 (45%), Gaps = 27/284 (9%)
Query: 268 QRVPMRLALTDIKQATLG-FNKNRIVGEGASATVYKGS-LPSGGAVAVKRFEKPNRVECA 325
           Q  P +    D+   TL  F   + +G G  + VY+ + L  G  VA+K+ +  + ++  
Sbjct: 15  QFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAK 74
Query: 326 RNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLS 385
                 +   +   L H N+++      E NEL +V E    G L +++ +      ++ 
Sbjct: 75  ARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIP 134
Query: 386 WEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGD------FEATIP 439
                   + + SAL ++H    R+++HRD+K  N+ + A    KLGD      F +   
Sbjct: 135 ERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 191
Query: 440 A-----GTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLR 494
           A     GT  Y++PE ++    + K+D++S G +  E+AA +SP   D         NL 
Sbjct: 192 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-------MNLY 244
Query: 495 KKGKLLDAADF-RLRGKFNRKEMERMLMVGLSCVHPNHEKRPSV 537
              K ++  D+  L      +E+ +++ +   C++P+ EKRP V
Sbjct: 245 SLCKKIEQCDYPPLPSDHYSEELRQLVNM---CINPDPEKRPDV 285

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/298 (26%), Positives = 123/298 (41%), Gaps = 51/298 (17%)
Query: 277 TDIKQATLGFN---------KNRIVGEGASATVYKGSLPSGGA-----VAVKRFEKPNRV 322
           +D  QA L F          + +++G G    VYKG L +        VA+K   K    
Sbjct: 28  SDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-KAGYT 86
Query: 323 ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSI 382
           E  R  F  E   M G   H N+++L+G   +   ++++ EY+ NG+LDK L        
Sbjct: 87  EKQRVDFLGEAGIM-GQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFS 145
Query: 383 VLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-------- 434
           VL   + + ++ G+A+ + YL        +HRD+ A NIL+++    K+ DF        
Sbjct: 146 VL---QLVGMLRGIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199
Query: 435 --EATIPAG----TMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIV 487
             EAT         + + APE +     +  +DV+SFG+V  EV   G+ P         
Sbjct: 200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP--------- 250
Query: 488 DWVWNLRKKGKLLDAAD-FRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARIL 544
              W L     +    D FRL    +       LM  + C      +RP   +   IL
Sbjct: 251 --YWELSNHEVMKAINDGFRLPTPMDCPSAIYQLM--MQCWQQERARRPKFADIVSIL 304

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 78/152 (51%), Gaps = 16/152 (10%)
Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASA 399
           LRH N+++L G+  +   + L+ EY P G + K L   S        ++    +  +A+A
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK----FDEQRTATYITELANA 125
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA---------GTMGYLAPEY 450
           LSY H    +++IHRD+K  N+LL +    K+ DF  ++ A         GT+ YL PE 
Sbjct: 126 LSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEM 182
Query: 451 VYSGVPSEKTDVYSFGVVALEVAAGKSPVDND 482
           +   +  EK D++S GV+  E   GK P + +
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 214

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 78/152 (51%), Gaps = 16/152 (10%)
Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASA 399
           LRH N+++L G+  +   + L+ EY P G + K L   S        ++    +  +A+A
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK----FDEQRTATYITELANA 125
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA---------GTMGYLAPEY 450
           LSY H    +++IHRD+K  N+LL +    K+ DF  ++ A         GT+ YL PE 
Sbjct: 126 LSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLXGTLDYLPPEM 182
Query: 451 VYSGVPSEKTDVYSFGVVALEVAAGKSPVDND 482
           +   +  EK D++S GV+  E   GK P + +
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 214

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 79/152 (51%), Gaps = 16/152 (10%)
Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASA 399
           LRH N+++L G+  +   + L+ EY P G++ + L   S        ++    +  +A+A
Sbjct: 69  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANA 124
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA---------GTMGYLAPEY 450
           LSY H    +++IHRD+K  N+LL +    K+ DF  ++ A         GT+ YL PE 
Sbjct: 125 LSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEM 181
Query: 451 VYSGVPSEKTDVYSFGVVALEVAAGKSPVDND 482
           +   +  EK D++S GV+  E   GK P + +
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 213

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 17/207 (8%)
Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F   R +G+G    VY      S   +A+K   K    +            +   LRH N
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           +++L G+  +   + L+ EY P G++ + L   S        ++    +  +A+ALSY H
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCH 128
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA---------GTMGYLAPEYVYSGV 455
               +++IHRD+K  N+LL +    K+ DF  ++ A         GT+ YL PE +   +
Sbjct: 129 S---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLCGTLDYLPPEMIEGRM 185
Query: 456 PSEKTDVYSFGVVALEVAAGKSPVDND 482
             EK D++S GV+  E   GK P + +
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPPFEAN 212

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 78/152 (51%), Gaps = 16/152 (10%)
Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASA 399
           LRH N+++L G+  +   + L+ EY P G++ + L   S        ++    +  +A+A
Sbjct: 66  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANA 121
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGTMGYLAPEY 450
           LSY H    +++IHRD+K  N+LL +    K+ DF           T  +GT+ YL PE 
Sbjct: 122 LSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLSGTLDYLPPEM 178
Query: 451 VYSGVPSEKTDVYSFGVVALEVAAGKSPVDND 482
           +   +  EK D++S GV+  E   GK P + +
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 210

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 79/152 (51%), Gaps = 16/152 (10%)
Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASA 399
           LRH N+++L G+  +   + L+ EY P G++ + L   S        ++    +  +A+A
Sbjct: 64  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANA 119
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA---------GTMGYLAPEY 450
           LSY H    +++IHRD+K  N+LL +    K+ DF  ++ A         GT+ YL PE 
Sbjct: 120 LSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEM 176
Query: 451 VYSGVPSEKTDVYSFGVVALEVAAGKSPVDND 482
           +   +  EK D++S GV+  E   GK P + +
Sbjct: 177 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 208

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 79/152 (51%), Gaps = 16/152 (10%)
Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASA 399
           LRH N+++L G+  +   + L+ EY P G++ + L   S        ++    +  +A+A
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANA 120
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA---------GTMGYLAPEY 450
           LSY H    +++IHRD+K  N+LL +    K+ DF  ++ A         GT+ YL PE 
Sbjct: 121 LSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEM 177
Query: 451 VYSGVPSEKTDVYSFGVVALEVAAGKSPVDND 482
           +   +  EK D++S GV+  E   GK P + +
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 209

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 79/152 (51%), Gaps = 16/152 (10%)
Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASA 399
           LRH N+++L G+  +   + L+ EY P G++ + L   S        ++    +  +A+A
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANA 123
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA---------GTMGYLAPEY 450
           LSY H    +++IHRD+K  N+LL +    K+ DF  ++ A         GT+ YL PE 
Sbjct: 124 LSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEM 180
Query: 451 VYSGVPSEKTDVYSFGVVALEVAAGKSPVDND 482
           +   +  EK D++S GV+  E   GK P + +
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 212

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 124/278 (44%), Gaps = 40/278 (14%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G+  TVYKG     G VAVK              F  E   +    RH N++   G+
Sbjct: 20  IGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGY 76
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
             +  +L +V ++    SL   LH   +S      +K ++I    A  + YLH    + I
Sbjct: 77  STKP-QLAIVTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYLHA---KSI 129
Query: 412 IHRDVKACNILLDAEFNAKLGDFE-ATIP------------AGTMGYLAPEYVY---SGV 455
           IHRD+K+ NI L  +   K+GDF  AT+             +G++ ++APE +    S  
Sbjct: 130 IHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 189
Query: 456 PSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKE 515
            S ++DVY+FG+V  E+  G+ P  N      D +  +  +G L  + D         K 
Sbjct: 190 YSFQSDVYAFGIVLYELMTGQLPYSNINN--RDQIIEMVGRGSL--SPDLSKVRSNCPKR 245
Query: 516 MERMLMVGLSCVHPNHEKRPS-------VKEAARILKG 546
           M+R++     C+    ++RPS       ++E AR L G
Sbjct: 246 MKRLMA---ECLKKKRDERPSFPRILAEIEELARELSG 280

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 79/152 (51%), Gaps = 16/152 (10%)
Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASA 399
           LRH N+++L G+  +   + L+ EY P G++ + L   S        ++    +  +A+A
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANA 123
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA---------GTMGYLAPEY 450
           LSY H    +++IHRD+K  N+LL +    K+ DF  ++ A         GT+ YL PE 
Sbjct: 124 LSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEM 180
Query: 451 VYSGVPSEKTDVYSFGVVALEVAAGKSPVDND 482
           +   +  EK D++S GV+  E   GK P + +
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 212

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 79/152 (51%), Gaps = 16/152 (10%)
Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASA 399
           LRH N+++L G+  +   + L+ EY P G++ + L   S        ++    +  +A+A
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANA 125
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA---------GTMGYLAPEY 450
           LSY H    +++IHRD+K  N+LL +    K+ DF  ++ A         GT+ YL PE 
Sbjct: 126 LSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEM 182
Query: 451 VYSGVPSEKTDVYSFGVVALEVAAGKSPVDND 482
           +   +  EK D++S GV+  E   GK P + +
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 214

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 17/207 (8%)
Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F   R +G+G    VY      S   +A+K   K    +            +   LRH N
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           +++L G+  +   + L+ EY P G++ + L   S        ++    +  +A+ALSY H
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCH 128
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA---------GTMGYLAPEYVYSGV 455
               +++IHRD+K  N+LL +    K+ DF  ++ A         GT+ YL PE +   +
Sbjct: 129 S---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTLDYLPPEMIEGRM 185
Query: 456 PSEKTDVYSFGVVALEVAAGKSPVDND 482
             EK D++S GV+  E   GK P + +
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPPFEAN 212

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 79/152 (51%), Gaps = 16/152 (10%)
Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASA 399
           LRH N+++L G+  +   + L+ EY P G++ + L   S        ++    +  +A+A
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANA 120
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA---------GTMGYLAPEY 450
           LSY H    +++IHRD+K  N+LL +    K+ DF  ++ A         GT+ YL PE 
Sbjct: 121 LSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTXLCGTLDYLPPEM 177
Query: 451 VYSGVPSEKTDVYSFGVVALEVAAGKSPVDND 482
           +   +  EK D++S GV+  E   GK P + +
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 209

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 78/150 (52%), Gaps = 16/150 (10%)
Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASA 399
           LRH N+++L G+  +   + L+ EY P G++ + L   S        ++    +  +A+A
Sbjct: 66  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANA 121
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA---------GTMGYLAPEY 450
           LSY H    +++IHRD+K  N+LL +    K+ DF  ++ A         GT+ YL PE 
Sbjct: 122 LSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLCGTLDYLPPEM 178
Query: 451 VYSGVPSEKTDVYSFGVVALEVAAGKSPVD 480
           +   +  EK D++S GV+  E   GK P +
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 78/150 (52%), Gaps = 16/150 (10%)
Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASA 399
           LRH N+++L G+  +   + L+ EY P G++ + L   S        ++    +  +A+A
Sbjct: 66  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANA 121
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA---------GTMGYLAPEY 450
           LSY H    +++IHRD+K  N+LL +    K+ DF  ++ A         GT+ YL PE 
Sbjct: 122 LSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEM 178
Query: 451 VYSGVPSEKTDVYSFGVVALEVAAGKSPVD 480
           +   +  EK D++S GV+  E   GK P +
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 79/152 (51%), Gaps = 16/152 (10%)
Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASA 399
           LRH N+++L G+  +   + L+ EY P G++ + L   S        ++    +  +A+A
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANA 120
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA---------GTMGYLAPEY 450
           LSY H    +++IHRD+K  N+LL +    K+ DF  ++ A         GT+ YL PE 
Sbjct: 121 LSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTLDYLPPEM 177
Query: 451 VYSGVPSEKTDVYSFGVVALEVAAGKSPVDND 482
           +   +  EK D++S GV+  E   GK P + +
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 209

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 78/150 (52%), Gaps = 16/150 (10%)
Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASA 399
           LRH N+++L G+  +   + L+ EY P G++ + L   S        ++    +  +A+A
Sbjct: 91  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANA 146
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA---------GTMGYLAPEY 450
           LSY H    +++IHRD+K  N+LL +    K+ DF  ++ A         GT+ YL PE 
Sbjct: 147 LSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEM 203
Query: 451 VYSGVPSEKTDVYSFGVVALEVAAGKSPVD 480
           +   +  EK D++S GV+  E   GK P +
Sbjct: 204 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 233

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 78/150 (52%), Gaps = 16/150 (10%)
Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASA 399
           LRH N+++L G+  +   + L+ EY P G++ + L   S        ++    +  +A+A
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANA 120
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA---------GTMGYLAPEY 450
           LSY H    +++IHRD+K  N+LL +    K+ DF  ++ A         GT+ YL PE 
Sbjct: 121 LSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEM 177
Query: 451 VYSGVPSEKTDVYSFGVVALEVAAGKSPVD 480
           +   +  EK D++S GV+  E   GK P +
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 100/222 (45%), Gaps = 24/222 (10%)
Query: 271 PMRLALTDIKQATLGFNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPF 329
           P + AL D       F   R +G+G    VY      S   +A+K   K    +      
Sbjct: 2   PRQWALED-------FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ 54
Query: 330 TTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKR 389
                 +   LRH N+++L G+  +   + L+ EY P G++ + L   S        ++ 
Sbjct: 55  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRT 110
Query: 390 LNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA--------- 440
              +  +A+ALSY H    +++IHRD+K  N+LL +    K+ DF  ++ A         
Sbjct: 111 ATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTELC 167
Query: 441 GTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDND 482
           GT+ YL PE +   +  EK D++S GV+  E   GK P + +
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 209

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 79/152 (51%), Gaps = 16/152 (10%)
Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASA 399
           LRH N+++L G+  +   + L+ EY P G++ + L   S        ++    +  +A+A
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANA 120
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA---------GTMGYLAPEY 450
           LSY H    +++IHRD+K  N+LL +    K+ DF  ++ A         GT+ YL PE 
Sbjct: 121 LSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTLDYLPPEM 177
Query: 451 VYSGVPSEKTDVYSFGVVALEVAAGKSPVDND 482
           +   +  EK D++S GV+  E   GK P + +
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 209

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 79/152 (51%), Gaps = 16/152 (10%)
Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASA 399
           LRH N+++L G+  +   + L+ EY P G++ + L   S        ++    +  +A+A
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANA 123
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA---------GTMGYLAPEY 450
           LSY H    +++IHRD+K  N+LL +    K+ DF  ++ A         GT+ YL PE 
Sbjct: 124 LSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTLDYLPPEM 180
Query: 451 VYSGVPSEKTDVYSFGVVALEVAAGKSPVDND 482
           +   +  EK D++S GV+  E   GK P + +
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 212

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 78/150 (52%), Gaps = 16/150 (10%)
Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASA 399
           LRH N+++L G+  +   + L+ EY P G++ + L   S        ++    +  +A+A
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANA 125
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA---------GTMGYLAPEY 450
           LSY H    +++IHRD+K  N+LL +    K+ DF  ++ A         GT+ YL PE 
Sbjct: 126 LSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEM 182
Query: 451 VYSGVPSEKTDVYSFGVVALEVAAGKSPVD 480
           +   +  EK D++S GV+  E   GK P +
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 79/152 (51%), Gaps = 16/152 (10%)
Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASA 399
           LRH N+++L G+  +   + L+ EY P G++ + L   S        ++    +  +A+A
Sbjct: 62  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANA 117
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA---------GTMGYLAPEY 450
           LSY H    +++IHRD+K  N+LL +    K+ DF  ++ A         GT+ YL PE 
Sbjct: 118 LSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEM 174
Query: 451 VYSGVPSEKTDVYSFGVVALEVAAGKSPVDND 482
           +   +  EK D++S GV+  E   GK P + +
Sbjct: 175 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 206

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 78/150 (52%), Gaps = 16/150 (10%)
Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASA 399
           LRH N+++L G+  +   + L+ EY P G++ + L   S        ++    +  +A+A
Sbjct: 91  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANA 146
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA---------GTMGYLAPEY 450
           LSY H    +++IHRD+K  N+LL +    K+ DF  ++ A         GT+ YL PE 
Sbjct: 147 LSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLCGTLDYLPPEM 203
Query: 451 VYSGVPSEKTDVYSFGVVALEVAAGKSPVD 480
           +   +  EK D++S GV+  E   GK P +
Sbjct: 204 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 233

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 79/152 (51%), Gaps = 16/152 (10%)
Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASA 399
           LRH N+++L G+  +   + L+ EY P G++ + L   S        ++    +  +A+A
Sbjct: 67  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANA 122
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA---------GTMGYLAPEY 450
           LSY H    +++IHRD+K  N+LL +    K+ DF  ++ A         GT+ YL PE 
Sbjct: 123 LSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTLDYLPPEM 179
Query: 451 VYSGVPSEKTDVYSFGVVALEVAAGKSPVDND 482
           +   +  EK D++S GV+  E   GK P + +
Sbjct: 180 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 211

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 79/152 (51%), Gaps = 16/152 (10%)
Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASA 399
           LRH N+++L G+  +   + L+ EY P G++ + L   S        ++    +  +A+A
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANA 120
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA---------GTMGYLAPEY 450
           LSY H    +++IHRD+K  N+LL +    K+ DF  ++ A         GT+ YL PE 
Sbjct: 121 LSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEM 177
Query: 451 VYSGVPSEKTDVYSFGVVALEVAAGKSPVDND 482
           +   +  EK D++S GV+  E   GK P + +
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 209

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 79/152 (51%), Gaps = 16/152 (10%)
Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASA 399
           LRH N+++L G+  +   + L+ EY P G++ + L   S        ++    +  +A+A
Sbjct: 65  LRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANA 120
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA---------GTMGYLAPEY 450
           LSY H    +++IHRD+K  N+LL +    K+ DF  ++ A         GT+ YL PE 
Sbjct: 121 LSYCHS---KKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTLDYLPPEM 177
Query: 451 VYSGVPSEKTDVYSFGVVALEVAAGKSPVDND 482
           +   +  EK D++S GV+  E   GK P + +
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 209

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 78/150 (52%), Gaps = 16/150 (10%)
Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASA 399
           LRH N+++L G+  +   + L+ EY P G++ + L   S        ++    +  +A+A
Sbjct: 82  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANA 137
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA---------GTMGYLAPEY 450
           LSY H    +++IHRD+K  N+LL +    K+ DF  ++ A         GT+ YL PE 
Sbjct: 138 LSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEM 194
Query: 451 VYSGVPSEKTDVYSFGVVALEVAAGKSPVD 480
           +   +  EK D++S GV+  E   GK P +
Sbjct: 195 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 224

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 18/212 (8%)
Query: 280 KQATL-GFNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMA 337
           +Q TL  F+  R +G+G    VY      S   +A+K   K    +            + 
Sbjct: 7   RQWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQ 66
Query: 338 GCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVA 397
             LRH N+++L G+  +   + L+ EY P G++ + L   S        ++    +  +A
Sbjct: 67  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSR----FDEQRTATYITELA 122
Query: 398 SALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA---------GTMGYLAP 448
           +ALSY H    +++IHRD+K  N+LL +    K+ DF  ++ A         GT+ YL P
Sbjct: 123 NALSYCHS---KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDTLCGTLDYLPP 179
Query: 449 EYVYSGVPSEKTDVYSFGVVALEVAAGKSPVD 480
           E +   +  EK D++S GV+  E   G  P +
Sbjct: 180 EMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFE 211

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 18/212 (8%)
Query: 280 KQATL-GFNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMA 337
           +Q TL  F+  R +G+G    VY      S   +A+K   K    +            + 
Sbjct: 7   RQWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQ 66
Query: 338 GCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVA 397
             LRH N+++L G+  +   + L+ EY P G++ + L   S        ++    +  +A
Sbjct: 67  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSR----FDEQRTATYITELA 122
Query: 398 SALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA---------GTMGYLAP 448
           +ALSY H    +++IHRD+K  N+LL +    K+ DF  ++ A         GT+ YL P
Sbjct: 123 NALSYCHS---KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLCGTLDYLPP 179
Query: 449 EYVYSGVPSEKTDVYSFGVVALEVAAGKSPVD 480
           E +   +  EK D++S GV+  E   G  P +
Sbjct: 180 EMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFE 211

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 78/152 (51%), Gaps = 16/152 (10%)
Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASA 399
           LRH N+++L G+  +   + L+ EY P G++ + L   S        ++    +  +A+A
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANA 125
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA---------GTMGYLAPEY 450
           LSY H    +++IHRD+K  N+LL +    K+ DF  ++ A         GT+ YL PE 
Sbjct: 126 LSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEX 182
Query: 451 VYSGVPSEKTDVYSFGVVALEVAAGKSPVDND 482
           +      EK D++S GV+  E   GK P + +
Sbjct: 183 IEGRXHDEKVDLWSLGVLCYEFLVGKPPFEAN 214

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/278 (27%), Positives = 121/278 (43%), Gaps = 40/278 (14%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G+  TVYKG     G VAVK              F  E   +    RH N++   G+
Sbjct: 32  IGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGY 88
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
             +  +L +V ++    SL   LH   +S      +K ++I    A  + YLH    + I
Sbjct: 89  STK-PQLAIVTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYLHA---KSI 141
Query: 412 IHRDVKACNILLDAEFNAKLGDFEATIP-------------AGTMGYLAPEYVY---SGV 455
           IHRD+K+ NI L  +   K+GDF                  +G++ ++APE +    S  
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 456 PSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKE 515
            S ++DVY+FG+V  E+  G+ P  N      D +  +  +G L  + D         K 
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLPYSNINN--RDQIIEMVGRGSL--SPDLSKVRSNCPKR 257
Query: 516 MERMLMVGLSCVHPNHEKRPS-------VKEAARILKG 546
           M+R++     C+    ++RPS       ++E AR L G
Sbjct: 258 MKRLMA---ECLKKKRDERPSFPRILAEIEELARELSG 292

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 117/263 (44%), Gaps = 39/263 (14%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G+  TVYKG     G VAVK  +  +        F  E A +    RH N++   G+
Sbjct: 44  IGSGSFGTVYKGKW--HGDVAVKILKVVDPTPEQFQAFRNEVAVLRKT-RHVNILLFMGY 100
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
             + N L +V ++    SL K LH   +   +    + ++I    A  + YLH    + I
Sbjct: 101 MTKDN-LAIVTQWCEGSSLYKHLHVQETKFQMF---QLIDIARQTAQGMDYLHA---KNI 153
Query: 412 IHRDVKACNILLDAEFNAKLGDF-------------EATIPAGTMGYLAPEYVY---SGV 455
           IHRD+K+ NI L      K+GDF             +   P G++ ++APE +    +  
Sbjct: 154 IHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNP 213
Query: 456 PSEKTDVYSFGVVALEVAAGKSP---VDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFN 512
            S ++DVYS+G+V  E+  G+ P   ++N   +I          G+   + D     K  
Sbjct: 214 FSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIF-------MVGRGYASPDLSKLYKNC 266
Query: 513 RKEMERMLMVGLSCVHPNHEKRP 535
            K M+R++     CV    E+RP
Sbjct: 267 PKAMKRLVA---DCVKKVKEERP 286

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 79/152 (51%), Gaps = 16/152 (10%)
Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASA 399
           LRH N+++L G+  +   + L+ EY P G++ + L   S        ++    +  +A+A
Sbjct: 67  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANA 122
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA---------GTMGYLAPEY 450
           LSY H    +++IHRD+K  N+LL +    K+ +F  ++ A         GT+ YL PE 
Sbjct: 123 LSYCHS---KRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLCGTLDYLPPEM 179
Query: 451 VYSGVPSEKTDVYSFGVVALEVAAGKSPVDND 482
           +   +  EK D++S GV+  E   GK P + +
Sbjct: 180 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 211

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 26/221 (11%)
Query: 276 LTDIKQATLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEK-PNRVECARNPFTTEFA 334
           L +I  A L   +  I+G G    VY+ +   G  VAVK     P+           + A
Sbjct: 1   LLEIDFAELTLEE--IIGIGGFGKVYR-AFWIGDEVAVKAARHDPDEDISQTIENVRQEA 57
Query: 335 TMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVL 394
            +   L+H N++ L+G C +   L LV E+   G L+++L        +L     +N  +
Sbjct: 58  KLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDIL-----VNWAV 112
Query: 395 GVASALSYLHEECERQIIHRDVKACNILLDAEFN--------AKLGDF---------EAT 437
            +A  ++YLH+E    IIHRD+K+ NIL+  +           K+ DF            
Sbjct: 113 QIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM 172
Query: 438 IPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSP 478
             AG   ++APE + + + S+ +DV+S+GV+  E+  G+ P
Sbjct: 173 SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 79/152 (51%), Gaps = 16/152 (10%)
Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASA 399
           LRH N+++L G+  +   + L+ EY P G++ + L   S        ++    +  +A+A
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANA 123
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA---------GTMGYLAPEY 450
           LSY H    +++IHRD+K  N+LL +    K+ +F  ++ A         GT+ YL PE 
Sbjct: 124 LSYCHS---KRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLCGTLDYLPPEM 180
Query: 451 VYSGVPSEKTDVYSFGVVALEVAAGKSPVDND 482
           +   +  EK D++S GV+  E   GK P + +
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 212

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 81/309 (26%), Positives = 137/309 (44%), Gaps = 48/309 (15%)
Query: 256 DGRSKEDHVCTVQRVPMRLALTDIKQATLGFNKNRIVGEGASATVYKG--SLPSGGAVAV 313
           D  + ED   TV      L  T+I       + +++VG G    V  G   LPS   ++V
Sbjct: 24  DPHTFEDPTQTVHEFAKELDATNI-------SIDKVVGAGEFGEVCSGRLKLPSKKEISV 76
Query: 314 K-RFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDK 372
             +  K    E  R  F  E A++ G   H N+++L+G   +   +++V EY+ NGSLD 
Sbjct: 77  AIKTLKVGYTEKQRRDFLGE-ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 135
Query: 373 ILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLG 432
            L  + +   V+   + + ++ G+AS + YL    +   +HRD+ A NIL+++    K+ 
Sbjct: 136 FLRKHDAQFTVI---QLVGMLRGIASGMKYL---SDMGFVHRDLAARNILINSNLVCKVS 189
Query: 433 DF----------EA--TIPAGT--MGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKS 477
           DF          EA  T   G   + + +PE +     +  +DV+S+G+V  EV + G+ 
Sbjct: 190 DFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
Query: 478 PVDNDGCVIVDWVWNLRKKGKLLDAAD--FRLRGKFNRKEMERMLMVGLSCVHPNHEKRP 535
           P            W +  +  ++ A D  +RL    +       LM  L C   +   RP
Sbjct: 250 P-----------YWEMSNQ-DVIKAVDEGYRLPPPMDCPAALYQLM--LDCWQKDRNNRP 295
Query: 536 SVKEAARIL 544
             ++   IL
Sbjct: 296 KFEQIVSIL 304

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 81/309 (26%), Positives = 137/309 (44%), Gaps = 48/309 (15%)
Query: 256 DGRSKEDHVCTVQRVPMRLALTDIKQATLGFNKNRIVGEGASATVYKG--SLPSGGAVAV 313
           D  + ED   TV      L  T+I       + +++VG G    V  G   LPS   ++V
Sbjct: 24  DPHTYEDPTQTVHEFAKELDATNI-------SIDKVVGAGEFGEVCSGRLKLPSKKEISV 76
Query: 314 K-RFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDK 372
             +  K    E  R  F  E A++ G   H N+++L+G   +   +++V EY+ NGSLD 
Sbjct: 77  AIKTLKVGYTEKQRRDFLGE-ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 135
Query: 373 ILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLG 432
            L  + +   V+   + + ++ G+AS + YL    +   +HRD+ A NIL+++    K+ 
Sbjct: 136 FLRKHDAQFTVI---QLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVS 189
Query: 433 DF----------EA--TIPAGT--MGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKS 477
           DF          EA  T   G   + + +PE +     +  +DV+S+G+V  EV + G+ 
Sbjct: 190 DFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
Query: 478 PVDNDGCVIVDWVWNLRKKGKLLDAAD--FRLRGKFNRKEMERMLMVGLSCVHPNHEKRP 535
           P            W +  +  ++ A D  +RL    +       LM  L C   +   RP
Sbjct: 250 P-----------YWEMSNQ-DVIKAVDEGYRLPPPMDCPAALYQLM--LDCWQKDRNNRP 295
Query: 536 SVKEAARIL 544
             ++   IL
Sbjct: 296 KFEQIVSIL 304

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 81/309 (26%), Positives = 137/309 (44%), Gaps = 48/309 (15%)
Query: 256 DGRSKEDHVCTVQRVPMRLALTDIKQATLGFNKNRIVGEGASATVYKG--SLPSGGAVAV 313
           D  + ED   TV      L  T+I       + +++VG G    V  G   LPS   ++V
Sbjct: 24  DPHTYEDPTQTVHEFAKELDATNI-------SIDKVVGAGEFGEVCSGRLKLPSKKEISV 76
Query: 314 K-RFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDK 372
             +  K    E  R  F  E A++ G   H N+++L+G   +   +++V EY+ NGSLD 
Sbjct: 77  AIKTLKVGYTEKQRRDFLGE-ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 135
Query: 373 ILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLG 432
            L  + +   V+   + + ++ G+AS + YL    +   +HRD+ A NIL+++    K+ 
Sbjct: 136 FLRKHDAQFTVI---QLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVS 189
Query: 433 DF----------EA--TIPAGT--MGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKS 477
           DF          EA  T   G   + + +PE +     +  +DV+S+G+V  EV + G+ 
Sbjct: 190 DFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
Query: 478 PVDNDGCVIVDWVWNLRKKGKLLDAAD--FRLRGKFNRKEMERMLMVGLSCVHPNHEKRP 535
           P            W +  +  ++ A D  +RL    +       LM  L C   +   RP
Sbjct: 250 P-----------YWEMSNQ-DVIKAVDEGYRLPPPMDCPAALYQLM--LDCWQKDRNNRP 295
Query: 536 SVKEAARIL 544
             ++   IL
Sbjct: 296 KFEQIVSIL 304

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 81/309 (26%), Positives = 137/309 (44%), Gaps = 48/309 (15%)
Query: 256 DGRSKEDHVCTVQRVPMRLALTDIKQATLGFNKNRIVGEGASATVYKG--SLPSGGAVAV 313
           D  + ED   TV      L  T+I       + +++VG G    V  G   LPS   ++V
Sbjct: 22  DPHTYEDPTQTVHEFAKELDATNI-------SIDKVVGAGEFGEVCSGRLKLPSKKEISV 74
Query: 314 K-RFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDK 372
             +  K    E  R  F  E A++ G   H N+++L+G   +   +++V EY+ NGSLD 
Sbjct: 75  AIKTLKVGYTEKQRRDFLGE-ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 133
Query: 373 ILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLG 432
            L  + +   V+   + + ++ G+AS + YL    +   +HRD+ A NIL+++    K+ 
Sbjct: 134 FLRKHDAQFTVI---QLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVS 187
Query: 433 DF----------EA--TIPAGT--MGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKS 477
           DF          EA  T   G   + + +PE +     +  +DV+S+G+V  EV + G+ 
Sbjct: 188 DFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 247
Query: 478 PVDNDGCVIVDWVWNLRKKGKLLDAAD--FRLRGKFNRKEMERMLMVGLSCVHPNHEKRP 535
           P            W +  +  ++ A D  +RL    +       LM  L C   +   RP
Sbjct: 248 P-----------YWEMSNQ-DVIKAVDEGYRLPPPMDCPAALYQLM--LDCWQKDRNNRP 293
Query: 536 SVKEAARIL 544
             ++   IL
Sbjct: 294 KFEQIVSIL 302

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 81/309 (26%), Positives = 137/309 (44%), Gaps = 48/309 (15%)
Query: 256 DGRSKEDHVCTVQRVPMRLALTDIKQATLGFNKNRIVGEGASATVYKG--SLPSGGAVAV 313
           D  + ED   TV      L  T+I       + +++VG G    V  G   LPS   ++V
Sbjct: 24  DPHTFEDPTQTVHEFAKELDATNI-------SIDKVVGAGEFGEVCSGRLKLPSKKEISV 76
Query: 314 K-RFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDK 372
             +  K    E  R  F  E A++ G   H N+++L+G   +   +++V EY+ NGSLD 
Sbjct: 77  AIKTLKVGYTEKQRRDFLGE-ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 135
Query: 373 ILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLG 432
            L  + +   V+   + + ++ G+AS + YL    +   +HRD+ A NIL+++    K+ 
Sbjct: 136 FLRKHDAQFTVI---QLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVS 189
Query: 433 DF----------EA--TIPAGT--MGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKS 477
           DF          EA  T   G   + + +PE +     +  +DV+S+G+V  EV + G+ 
Sbjct: 190 DFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
Query: 478 PVDNDGCVIVDWVWNLRKKGKLLDAAD--FRLRGKFNRKEMERMLMVGLSCVHPNHEKRP 535
           P            W +  +  ++ A D  +RL    +       LM  L C   +   RP
Sbjct: 250 P-----------YWEMSNQ-DVIKAVDEGYRLPPPMDCPAALYQLM--LDCWQKDRNNRP 295
Query: 536 SVKEAARIL 544
             ++   IL
Sbjct: 296 KFEQIVSIL 304

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 81/309 (26%), Positives = 137/309 (44%), Gaps = 48/309 (15%)
Query: 256 DGRSKEDHVCTVQRVPMRLALTDIKQATLGFNKNRIVGEGASATVYKG--SLPSGGAVAV 313
           D  + ED   TV      L  T+I       + +++VG G    V  G   LPS   ++V
Sbjct: 24  DPHTFEDPTQTVHEFAKELDATNI-------SIDKVVGAGEFGEVCSGRLKLPSKKEISV 76
Query: 314 K-RFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDK 372
             +  K    E  R  F  E A++ G   H N+++L+G   +   +++V EY+ NGSLD 
Sbjct: 77  AIKTLKVGYTEKQRRDFLGE-ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 135
Query: 373 ILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLG 432
            L  + +   V+   + + ++ G+AS + YL    +   +HRD+ A NIL+++    K+ 
Sbjct: 136 FLRKHDAQFTVI---QLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVS 189
Query: 433 DF----------EA--TIPAGT--MGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKS 477
           DF          EA  T   G   + + +PE +     +  +DV+S+G+V  EV + G+ 
Sbjct: 190 DFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
Query: 478 PVDNDGCVIVDWVWNLRKKGKLLDAAD--FRLRGKFNRKEMERMLMVGLSCVHPNHEKRP 535
           P            W +  +  ++ A D  +RL    +       LM  L C   +   RP
Sbjct: 250 P-----------YWEMSNQ-DVIKAVDEGYRLPPPMDCPAALYQLM--LDCWQKDRNNRP 295
Query: 536 SVKEAARIL 544
             ++   IL
Sbjct: 296 KFEQIVSIL 304

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 81/309 (26%), Positives = 137/309 (44%), Gaps = 48/309 (15%)
Query: 256 DGRSKEDHVCTVQRVPMRLALTDIKQATLGFNKNRIVGEGASATVYKG--SLPSGGAVAV 313
           D  + ED   TV      L  T+I       + +++VG G    V  G   LPS   ++V
Sbjct: 24  DPHTFEDPTQTVHEFAKELDATNI-------SIDKVVGAGEFGEVCSGRLKLPSKKEISV 76
Query: 314 K-RFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDK 372
             +  K    E  R  F  E A++ G   H N+++L+G   +   +++V EY+ NGSLD 
Sbjct: 77  AIKTLKVGYTEKQRRDFLGE-ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 135
Query: 373 ILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLG 432
            L  + +   V+   + + ++ G+AS + YL    +   +HRD+ A NIL+++    K+ 
Sbjct: 136 FLRKHDAQFTVI---QLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVS 189
Query: 433 DF----------EA--TIPAGT--MGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKS 477
           DF          EA  T   G   + + +PE +     +  +DV+S+G+V  EV + G+ 
Sbjct: 190 DFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
Query: 478 PVDNDGCVIVDWVWNLRKKGKLLDAAD--FRLRGKFNRKEMERMLMVGLSCVHPNHEKRP 535
           P            W +  +  ++ A D  +RL    +       LM  L C   +   RP
Sbjct: 250 P-----------YWEMSNQ-DVIKAVDEGYRLPPPMDCPAALYQLM--LDCWQKDRNNRP 295
Query: 536 SVKEAARIL 544
             ++   IL
Sbjct: 296 KFEQIVSIL 304

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 81/309 (26%), Positives = 137/309 (44%), Gaps = 48/309 (15%)
Query: 256 DGRSKEDHVCTVQRVPMRLALTDIKQATLGFNKNRIVGEGASATVYKG--SLPSGGAVAV 313
           D  + ED   TV      L  T+I       + +++VG G    V  G   LPS   ++V
Sbjct: 24  DPHTFEDPTQTVHEFAKELDATNI-------SIDKVVGAGEFGEVCSGRLKLPSKKEISV 76
Query: 314 K-RFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDK 372
             +  K    E  R  F  E A++ G   H N+++L+G   +   +++V EY+ NGSLD 
Sbjct: 77  AIKTLKVGYTEKQRRDFLGE-ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 135
Query: 373 ILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLG 432
            L  + +   V+   + + ++ G+AS + YL    +   +HRD+ A NIL+++    K+ 
Sbjct: 136 FLRKHDAQFTVI---QLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVS 189
Query: 433 DF----------EA--TIPAGT--MGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKS 477
           DF          EA  T   G   + + +PE +     +  +DV+S+G+V  EV + G+ 
Sbjct: 190 DFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
Query: 478 PVDNDGCVIVDWVWNLRKKGKLLDAAD--FRLRGKFNRKEMERMLMVGLSCVHPNHEKRP 535
           P            W +  +  ++ A D  +RL    +       LM  L C   +   RP
Sbjct: 250 P-----------YWEMSNQ-DVIKAVDEGYRLPPPMDCPAALYQLM--LDCWQKDRNNRP 295
Query: 536 SVKEAARIL 544
             ++   IL
Sbjct: 296 KFEQIVSIL 304

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 94/203 (46%), Gaps = 23/203 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G    V+ G   +   VA+K  ++ +  E   + F  E   M   L H  LVQL G 
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSE---DDFIEEAEVMMK-LSHPKLVQLYGV 90
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
           C E   + LV+E++ +G L   L        + + E  L + L V   ++YL E C   +
Sbjct: 91  CLEQAPICLVFEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEAC---V 144
Query: 412 IHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVPSEK 459
           IHRD+ A N L+      K+ DF         + T   GT   + + +PE       S K
Sbjct: 145 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 204
Query: 460 TDVYSFGVVALEV-AAGKSPVDN 481
           +DV+SFGV+  EV + GK P +N
Sbjct: 205 SDVWSFGVLMWEVFSEGKIPYEN 227

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 104/222 (46%), Gaps = 38/222 (17%)
Query: 289 NRIVGEGASATVYKGSL----PSGGA--VAVKRFEKPNRVECARNPFTTEFATMAGCLRH 342
            R +GEGA   V+        P+     VAVK  + P     AR  F  E A +   L+H
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL--AARKDFQRE-AELLTNLQH 76
Query: 343 KNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIV------------LSWEKRL 390
           +++V+  G C +G+ L++V+EY+ +G L+K L  +   +++            L   + L
Sbjct: 77  EHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQML 136
Query: 391 NIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT----------IPA 440
           +I   +AS + YL     +  +HRD+   N L+ A    K+GDF  +          +  
Sbjct: 137 HIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG 193
Query: 441 GTM---GYLAPEYVYSGVPSEKTDVYSFGVVALEV-AAGKSP 478
            TM    ++ PE +     + ++DV+SFGV+  E+   GK P
Sbjct: 194 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 92/206 (44%), Gaps = 26/206 (12%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G+  TVYKG     G VAVK              F  E   +    RH N++   G+
Sbjct: 32  IGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGY 88
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
                +L +V ++    SL   LH   +S      +K ++I    A  + YLH    + I
Sbjct: 89  ST-APQLAIVTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYLHA---KSI 141
Query: 412 IHRDVKACNILLDAEFNAKLGDFEATIP-------------AGTMGYLAPEYVY---SGV 455
           IHRD+K+ NI L  +   K+GDF                  +G++ ++APE +    S  
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 456 PSEKTDVYSFGVVALEVAAGKSPVDN 481
            S ++DVY+FG+V  E+  G+ P  N
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLPYSN 227

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/278 (24%), Positives = 123/278 (44%), Gaps = 45/278 (16%)
Query: 290 RIVGEGASATVYKGSLPSGGA----VAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           +++G G    V  G L   G     VA+K   K    E  R  F +E A++ G   H N+
Sbjct: 39  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTL-KSGYTEKQRRDFLSE-ASIMGQFDHPNV 96
Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
           + L+G   +   ++++ E++ NGSLD  L  N     V+   + + ++ G+A+ + YL  
Sbjct: 97  IHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVI---QLVGMLRGIAAGMKYL-- 151
Query: 406 ECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGT--------MGYLAPE 449
             +   +HRD+ A NIL+++    K+ DF        + + P  T        + + APE
Sbjct: 152 -ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPE 210
Query: 450 YVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDA--ADFR 506
            +     +  +DV+S+G+V  EV + G+ P            W++  +  +++A   D+R
Sbjct: 211 AIQYRKFTSASDVWSYGIVMWEVMSYGERP-----------YWDMTNQ-DVINAIEQDYR 258
Query: 507 LRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARIL 544
           L    +       LM  L C   +   RP   +    L
Sbjct: 259 LPPPMDCPSALHQLM--LDCWQKDRNHRPKFGQIVNTL 294

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 23/203 (11%)
Query: 292 VGEGASATVYKGSLPSGGA-VAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQG 350
           +GEG++  V   ++ S G  VAVK+ +   R +  R     E   M    +H+N+V++  
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDL--RKQQRRELLFNEVVIMRD-YQHENVVEMYN 93
Query: 351 WCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQ 410
               G+EL +V E+L  G+L  I+ +       ++ E+   + L V  ALS LH +    
Sbjct: 94  SYLVGDELWVVMEFLEGGALTDIVTHTR-----MNEEQIAAVCLAVLQALSVLHAQG--- 145
Query: 411 IIHRDVKACNILLDAEFNAKLGDF------EATIP-----AGTMGYLAPEYVYSGVPSEK 459
           +IHRD+K+ +ILL  +   KL DF         +P      GT  ++APE +       +
Sbjct: 146 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPE 205
Query: 460 TDVYSFGVVALEVAAGKSPVDND 482
            D++S G++ +E+  G+ P  N+
Sbjct: 206 VDIWSLGIMVIEMVDGEPPYFNE 228

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 23/203 (11%)
Query: 292 VGEGASATVYKGSLPSGGA-VAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQG 350
           +GEG++  V   ++ S G  VAVK+ +   R +  R     E   M    +H+N+V++  
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDL--RKQQRRELLFNEVVIMRDY-QHENVVEMYN 95
Query: 351 WCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQ 410
               G+EL +V E+L  G+L  I+ +       ++ E+   + L V  ALS LH +    
Sbjct: 96  SYLVGDELWVVMEFLEGGALTDIVTHTR-----MNEEQIAAVCLAVLQALSVLHAQG--- 147
Query: 411 IIHRDVKACNILLDAEFNAKLGDF------EATIP-----AGTMGYLAPEYVYSGVPSEK 459
           +IHRD+K+ +ILL  +   KL DF         +P      GT  ++APE +       +
Sbjct: 148 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPE 207
Query: 460 TDVYSFGVVALEVAAGKSPVDND 482
            D++S G++ +E+  G+ P  N+
Sbjct: 208 VDIWSLGIMVIEMVDGEPPYFNE 230

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 23/203 (11%)
Query: 292 VGEGASATVYKGSLPSGGA-VAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQG 350
           +GEG++  V   ++ S G  VAVK+ +   R +  R     E   M    +H+N+V++  
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDL--RKQQRRELLFNEVVIMRDY-QHENVVEMYN 88
Query: 351 WCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQ 410
               G+EL +V E+L  G+L  I+ +       ++ E+   + L V  ALS LH +    
Sbjct: 89  SYLVGDELWVVMEFLEGGALTDIVTHTR-----MNEEQIAAVCLAVLQALSVLHAQG--- 140
Query: 411 IIHRDVKACNILLDAEFNAKLGDF------EATIP-----AGTMGYLAPEYVYSGVPSEK 459
           +IHRD+K+ +ILL  +   KL DF         +P      GT  ++APE +       +
Sbjct: 141 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPE 200
Query: 460 TDVYSFGVVALEVAAGKSPVDND 482
            D++S G++ +E+  G+ P  N+
Sbjct: 201 VDIWSLGIMVIEMVDGEPPYFNE 223

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 101/209 (48%), Gaps = 27/209 (12%)
Query: 289 NRIVGEGASATVYKGSLPSGG----AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
            R++G G    V  G L   G    AVA+K   K    E  R  F  E A++ G   H N
Sbjct: 48  ERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTL-KVGYTEKQRRDFLCE-ASIMGQFDHPN 105
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           +V L+G    G  +++V E++ NG+LD  L  +     V+   + + ++ G+A+ + YL 
Sbjct: 106 VVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVI---QLVGMLRGIAAGMRYL- 161
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF----------EA--TIPAGTM--GYLAPEY 450
              +   +HRD+ A NIL+++    K+ DF          EA  T   G +   + APE 
Sbjct: 162 --ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEA 219
Query: 451 VYSGVPSEKTDVYSFGVVALEVAA-GKSP 478
           +     +  +DV+S+G+V  EV + G+ P
Sbjct: 220 IQYRKFTSASDVWSYGIVMWEVMSYGERP 248

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 23/203 (11%)
Query: 292 VGEGASATVYKGSLPSGGA-VAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQG 350
           +GEG++  V   ++ S G  VAVK+ +   R +  R     E   M    +H+N+V++  
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDL--RKQQRRELLFNEVVIMRDY-QHENVVEMYN 84
Query: 351 WCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQ 410
               G+EL +V E+L  G+L  I+ +       ++ E+   + L V  ALS LH +    
Sbjct: 85  SYLVGDELWVVMEFLEGGALTDIVTHTR-----MNEEQIAAVCLAVLQALSVLHAQG--- 136
Query: 411 IIHRDVKACNILLDAEFNAKLGDF------EATIP-----AGTMGYLAPEYVYSGVPSEK 459
           +IHRD+K+ +ILL  +   KL DF         +P      GT  ++APE +       +
Sbjct: 137 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPE 196
Query: 460 TDVYSFGVVALEVAAGKSPVDND 482
            D++S G++ +E+  G+ P  N+
Sbjct: 197 VDIWSLGIMVIEMVDGEPPYFNE 219

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 23/203 (11%)
Query: 292 VGEGASATVYKGSLPSGGA-VAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQG 350
           +GEG++  V   ++ S G  VAVK+ +   R +  R     E   M    +H+N+V++  
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDL--RKQQRRELLFNEVVIMRD-YQHENVVEMYN 215
Query: 351 WCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQ 410
               G+EL +V E+L  G+L  I+ +       ++ E+   + L V  ALS LH +    
Sbjct: 216 SYLVGDELWVVMEFLEGGALTDIVTHTR-----MNEEQIAAVCLAVLQALSVLHAQG--- 267
Query: 411 IIHRDVKACNILLDAEFNAKLGDF------EATIP-----AGTMGYLAPEYVYSGVPSEK 459
           +IHRD+K+ +ILL  +   KL DF         +P      GT  ++APE +       +
Sbjct: 268 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPE 327
Query: 460 TDVYSFGVVALEVAAGKSPVDND 482
            D++S G++ +E+  G+ P  N+
Sbjct: 328 VDIWSLGIMVIEMVDGEPPYFNE 350

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 23/203 (11%)
Query: 292 VGEGASATVYKGSLPSGGA-VAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQG 350
           +GEG++  V   ++ S G  VAVK+ +   R +  R     E   M    +H+N+V++  
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDL--RKQQRRELLFNEVVIMRDY-QHENVVEMYN 138
Query: 351 WCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQ 410
               G+EL +V E+L  G+L  I+ +       ++ E+   + L V  ALS LH +    
Sbjct: 139 SYLVGDELWVVMEFLEGGALTDIVTHTR-----MNEEQIAAVCLAVLQALSVLHAQG--- 190
Query: 411 IIHRDVKACNILLDAEFNAKLGDF------EATIP-----AGTMGYLAPEYVYSGVPSEK 459
           +IHRD+K+ +ILL  +   KL DF         +P      GT  ++APE +       +
Sbjct: 191 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPE 250
Query: 460 TDVYSFGVVALEVAAGKSPVDND 482
            D++S G++ +E+  G+ P  N+
Sbjct: 251 VDIWSLGIMVIEMVDGEPPYFNE 273

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 91/203 (44%), Gaps = 23/203 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G    V+ G   +   VA+K   +    E     F  E   M   L H  LVQL G 
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMK-LSHPKLVQLYGV 68
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
           C E   + LV+E++ +G L   L        + + E  L + L V   ++YL E C   +
Sbjct: 69  CLEQAPICLVFEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEAC---V 122
Query: 412 IHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVPSEK 459
           IHRD+ A N L+      K+ DF         + T   GT   + + +PE       S K
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 182
Query: 460 TDVYSFGVVALEV-AAGKSPVDN 481
           +DV+SFGV+  EV + GK P +N
Sbjct: 183 SDVWSFGVLMWEVFSEGKIPYEN 205

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 91/203 (44%), Gaps = 23/203 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G    V+ G   +   VA+K   +    E     F  E   M   L H  LVQL G 
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMK-LSHPKLVQLYGV 73
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
           C E   + LV+E++ +G L   L        + + E  L + L V   ++YL E C   +
Sbjct: 74  CLEQAPICLVFEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEAC---V 127
Query: 412 IHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVPSEK 459
           IHRD+ A N L+      K+ DF         + T   GT   + + +PE       S K
Sbjct: 128 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 187
Query: 460 TDVYSFGVVALEV-AAGKSPVDN 481
           +DV+SFGV+  EV + GK P +N
Sbjct: 188 SDVWSFGVLMWEVFSEGKIPYEN 210

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 99/203 (48%), Gaps = 23/203 (11%)
Query: 292 VGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQG 350
           +GEG++  V   +   +G  VAVK+ +   R +  R     E   M     H N+V +  
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDL--RKQQRRELLFNEVVIMRD-YHHDNVVDMYS 109
Query: 351 WCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQ 410
               G+EL +V E+L  G+L  I+ +       ++ E+   + L V  ALSYLH +    
Sbjct: 110 SYLVGDELWVVMEFLEGGALTDIVTHTR-----MNEEQIATVCLSVLRALSYLHNQG--- 161
Query: 411 IIHRDVKACNILLDAEFNAKLGDF------EATIP-----AGTMGYLAPEYVYSGVPSEK 459
           +IHRD+K+ +ILL ++   KL DF         +P      GT  ++APE +       +
Sbjct: 162 VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLPYGTE 221
Query: 460 TDVYSFGVVALEVAAGKSPVDND 482
            D++S G++ +E+  G+ P  N+
Sbjct: 222 VDIWSLGIMVIEMIDGEPPYFNE 244

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 26/206 (12%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G+  TVYKG     G VAVK              F  E   +    RH N++   G+
Sbjct: 43  IGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGY 99
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
             +  +L +V ++    SL   LH   +   ++   K ++I    A  + YLH    + I
Sbjct: 100 STKP-QLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHA---KSI 152
Query: 412 IHRDVKACNILLDAEFNAKLGDFE-ATIP------------AGTMGYLAPEYVY---SGV 455
           IHRD+K+ NI L  +   K+GDF  AT+             +G++ ++APE +       
Sbjct: 153 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 212
Query: 456 PSEKTDVYSFGVVALEVAAGKSPVDN 481
            S ++DVY+FG+V  E+  G+ P  N
Sbjct: 213 YSFQSDVYAFGIVLYELMTGQLPYSN 238

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 91/203 (44%), Gaps = 23/203 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G    V+ G   +   VA+K   +    E     F  E   M   L H  LVQL G 
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMK-LSHPKLVQLYGV 70
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
           C E   + LV+E++ +G L   L        + + E  L + L V   ++YL E C   +
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEAC---V 124
Query: 412 IHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVPSEK 459
           IHRD+ A N L+      K+ DF         + T   GT   + + +PE       S K
Sbjct: 125 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 184
Query: 460 TDVYSFGVVALEV-AAGKSPVDN 481
           +DV+SFGV+  EV + GK P +N
Sbjct: 185 SDVWSFGVLMWEVFSEGKIPYEN 207

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 126/276 (45%), Gaps = 41/276 (14%)
Query: 289 NRIVGEGASATVYKG--SLPSGGAVAVK-RFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           +++VG G    V  G   LPS   ++V  +  K    E  R  F  E A++ G   H N+
Sbjct: 21  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE-ASIMGQFDHPNI 79
Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
           ++L+G   +   +++V EY+ NGSLD  L  + +   V+   + + ++ G+AS + YL  
Sbjct: 80  IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI---QLVGMLRGIASGMKYL-- 134
Query: 406 ECERQIIHRDVKACNILLDAEFNAKLGDF----------EA--TIPAGT--MGYLAPEYV 451
             +   +HRD+ A NIL+++    K+ DF          EA  T   G   + + +PE +
Sbjct: 135 -SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 193
Query: 452 YSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAAD--FRLR 508
                +  +DV+S+G+V  EV + G+ P            W +  +  ++ A D  +RL 
Sbjct: 194 AYRKFTSASDVWSYGIVLWEVMSYGERP-----------YWEMSNQ-DVIKAVDEGYRLP 241
Query: 509 GKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARIL 544
              +       LM  L C   +   RP  ++   IL
Sbjct: 242 PPMDCPAALYQLM--LDCWQKDRNNRPKFEQIVSIL 275

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 26/206 (12%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G+  TVYKG     G VAVK              F  E   +    RH N++   G+
Sbjct: 44  IGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGY 100
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
             +  +L +V ++    SL   LH   +   ++   K ++I    A  + YLH    + I
Sbjct: 101 STK-PQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHA---KSI 153
Query: 412 IHRDVKACNILLDAEFNAKLGDFE-ATIP------------AGTMGYLAPEYVY---SGV 455
           IHRD+K+ NI L  +   K+GDF  AT+             +G++ ++APE +       
Sbjct: 154 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 213
Query: 456 PSEKTDVYSFGVVALEVAAGKSPVDN 481
            S ++DVY+FG+V  E+  G+ P  N
Sbjct: 214 YSFQSDVYAFGIVLYELMTGQLPYSN 239

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 26/206 (12%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G+  TVYKG     G VAVK              F  E   +    RH N++   G+
Sbjct: 21  IGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGY 77
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
             +  +L +V ++    SL   LH   +   ++   K ++I    A  + YLH    + I
Sbjct: 78  STK-PQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHA---KSI 130
Query: 412 IHRDVKACNILLDAEFNAKLGDFE-ATIP------------AGTMGYLAPEYVY---SGV 455
           IHRD+K+ NI L  +   K+GDF  AT+             +G++ ++APE +       
Sbjct: 131 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 190
Query: 456 PSEKTDVYSFGVVALEVAAGKSPVDN 481
            S ++DVY+FG+V  E+  G+ P  N
Sbjct: 191 YSFQSDVYAFGIVLYELMTGQLPYSN 216

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 26/206 (12%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G+  TVYKG     G VAVK              F  E   +    RH N++   G+
Sbjct: 18  IGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGY 74
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
             +  +L +V ++    SL   LH   +   ++   K ++I    A  + YLH    + I
Sbjct: 75  STKP-QLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHA---KSI 127
Query: 412 IHRDVKACNILLDAEFNAKLGDFE-ATIP------------AGTMGYLAPEYVY---SGV 455
           IHRD+K+ NI L  +   K+GDF  AT+             +G++ ++APE +       
Sbjct: 128 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 187
Query: 456 PSEKTDVYSFGVVALEVAAGKSPVDN 481
            S ++DVY+FG+V  E+  G+ P  N
Sbjct: 188 YSFQSDVYAFGIVLYELMTGQLPYSN 213

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 26/206 (12%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G+  TVYKG     G VAVK              F  E   +    RH N++   G+
Sbjct: 21  IGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGY 77
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
             +  +L +V ++    SL   LH   +   ++   K ++I    A  + YLH    + I
Sbjct: 78  STK-PQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHA---KSI 130
Query: 412 IHRDVKACNILLDAEFNAKLGDFE-ATIP------------AGTMGYLAPEYVY---SGV 455
           IHRD+K+ NI L  +   K+GDF  AT+             +G++ ++APE +       
Sbjct: 131 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 190
Query: 456 PSEKTDVYSFGVVALEVAAGKSPVDN 481
            S ++DVY+FG+V  E+  G+ P  N
Sbjct: 191 YSFQSDVYAFGIVLYELMTGQLPYSN 216

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 126/276 (45%), Gaps = 41/276 (14%)
Query: 289 NRIVGEGASATVYKG--SLPSGGAVAVK-RFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           +++VG G    V  G   LPS   ++V  +  K    E  R  F  E A++ G   H N+
Sbjct: 38  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE-ASIMGQFDHPNI 96
Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
           ++L+G   +   +++V EY+ NGSLD  L  + +   V+   + + ++ G+AS + YL  
Sbjct: 97  IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI---QLVGMLRGIASGMKYL-- 151
Query: 406 ECERQIIHRDVKACNILLDAEFNAKLGDF----------EA--TIPAGT--MGYLAPEYV 451
             +   +HRD+ A NIL+++    K+ DF          EA  T   G   + + +PE +
Sbjct: 152 -SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 210
Query: 452 YSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAAD--FRLR 508
                +  +DV+S+G+V  EV + G+ P            W +  +  ++ A D  +RL 
Sbjct: 211 AYRKFTSASDVWSYGIVLWEVMSYGERP-----------YWEMSNQ-DVIKAVDEGYRLP 258
Query: 509 GKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARIL 544
              +       LM  L C   +   RP  ++   IL
Sbjct: 259 PPMDCPAALYQLM--LDCWQKDRNNRPKFEQIVSIL 292

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/232 (29%), Positives = 108/232 (46%), Gaps = 30/232 (12%)
Query: 266 TVQ-RVPMRLALTDIKQATLG------FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFE 317
           TVQ R P R  L  + + +L       F+    +GEG+  +VYK     +G  VA+K+  
Sbjct: 4   TVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP 63
Query: 318 KPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNN 377
               VE        E + M  C    ++V+  G   +  +L +V EY   GS+  I+   
Sbjct: 64  ----VESDLQEIIKEISIMQQC-DSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLR 118
Query: 378 SSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--- 434
           + +   L+ ++   I+      L YLH     + IHRD+KA NILL+ E +AKL DF   
Sbjct: 119 NKT---LTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVA 172
Query: 435 --------EATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSP 478
                   +     GT  ++APE +     +   D++S G+ A+E+A GK P
Sbjct: 173 GQLTDXMAKRNXVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 23/206 (11%)
Query: 292 VGEGASATV-YKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQG 350
           +GEG++  V       SG  VAVK  +   R +  R     E   M    +H N+V++  
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDL--RKQQRRELLFNEVVIMRD-YQHFNVVEMYK 109
Query: 351 WCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQ 410
               G EL ++ E+L  G+L  I+     S + L+ E+   +   V  AL+YLH +    
Sbjct: 110 SYLVGEELWVLMEFLQGGALTDIV-----SQVRLNEEQIATVCEAVLQALAYLHAQG--- 161
Query: 411 IIHRDVKACNILLDAEFNAKLGDF------EATIP-----AGTMGYLAPEYVYSGVPSEK 459
           +IHRD+K+ +ILL  +   KL DF         +P      GT  ++APE +   + + +
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRSLYATE 221
Query: 460 TDVYSFGVVALEVAAGKSPVDNDGCV 485
            D++S G++ +E+  G+ P  +D  V
Sbjct: 222 VDIWSLGIMVIEMVDGEPPYFSDSPV 247

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 26/206 (12%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G+  TVYKG     G VAVK              F  E   +    RH N++   G+
Sbjct: 16  IGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGY 72
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
             +  +L +V ++    SL   LH   +   ++   K ++I    A  + YLH    + I
Sbjct: 73  STK-PQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHA---KSI 125
Query: 412 IHRDVKACNILLDAEFNAKLGDFE-ATIP------------AGTMGYLAPEYVY---SGV 455
           IHRD+K+ NI L  +   K+GDF  AT+             +G++ ++APE +       
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 456 PSEKTDVYSFGVVALEVAAGKSPVDN 481
            S ++DVY+FG+V  E+  G+ P  N
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQLPYSN 211

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 121/281 (43%), Gaps = 34/281 (12%)
Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           +    ++G GA+A V      P    VA+KR     + + + +    E   M+ C  H N
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRI-NLEKCQTSMDELLKEIQAMSQC-HHPN 74
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGS-LDKILH---NNSSSSIVLSWEKRLNIVLGVASAL 400
           +V         +EL LV + L  GS LD I H        S VL       I+  V   L
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 401 SYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGTMG---------------- 444
            YLH+  +   IHRDVKA NILL  + + ++ DF  +    T G                
Sbjct: 135 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 445 YLAPEYVYSGVPSE-KTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAA 503
           ++APE +      + K D++SFG+ A+E+A G +P      + V  +  L+     L+  
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV-LMLTLQNDPPSLETG 250
Query: 504 --DFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR 542
             D  +  K+  K   +M+ +   C+  + EKRP+  E  R
Sbjct: 251 VQDKEMLKKYG-KSFRKMISL---CLQKDPEKRPTAAELLR 287

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 26/206 (12%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G+  TVYKG     G VAVK              F  E   +    RH N++   G+
Sbjct: 16  IGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGY 72
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
                +L +V ++    SL   LH   +   ++   K ++I    A  + YLH    + I
Sbjct: 73  ST-APQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHA---KSI 125
Query: 412 IHRDVKACNILLDAEFNAKLGDFE-ATIP------------AGTMGYLAPEYVY---SGV 455
           IHRD+K+ NI L  +   K+GDF  AT+             +G++ ++APE +       
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 456 PSEKTDVYSFGVVALEVAAGKSPVDN 481
            S ++DVY+FG+V  E+  G+ P  N
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQLPYSN 211

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 121/281 (43%), Gaps = 34/281 (12%)
Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           +    ++G GA+A V      P    VA+KR     + + + +    E   M+ C  H N
Sbjct: 12  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRIN-LEKCQTSMDELLKEIQAMSQC-HHPN 69
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGS-LDKILH---NNSSSSIVLSWEKRLNIVLGVASAL 400
           +V         +EL LV + L  GS LD I H        S VL       I+  V   L
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 401 SYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGTMG---------------- 444
            YLH+  +   IHRDVKA NILL  + + ++ DF  +    T G                
Sbjct: 130 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 186
Query: 445 YLAPEYVYSGVPSE-KTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAA 503
           ++APE +      + K D++SFG+ A+E+A G +P      + V  +  L+     L+  
Sbjct: 187 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV-LMLTLQNDPPSLETG 245
Query: 504 --DFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR 542
             D  +  K+  K   +M+ +   C+  + EKRP+  E  R
Sbjct: 246 VQDKEMLKKYG-KSFRKMISL---CLQKDPEKRPTAAELLR 282

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 98/200 (49%), Gaps = 23/200 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G +  V+ G       VAVK  ++ +    + + F  E A +   L+H+ LV+L   
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAE-ANLMKQLQHQRLVRLYA- 75
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
                 + ++ EY+ NGSL   L   + S I L+  K L++   +A  ++++ E   R  
Sbjct: 76  VVTQEPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNY 130
Query: 412 IHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVPSEK 459
           IHRD++A NIL+    + K+ DF         E T   G    + + APE +  G  + K
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 460 TDVYSFGVVALEVAA-GKSP 478
           +DV+SFG++  E+   G+ P
Sbjct: 191 SDVWSFGILLTEIVTHGRIP 210

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 80/309 (25%), Positives = 136/309 (44%), Gaps = 48/309 (15%)
Query: 256 DGRSKEDHVCTVQRVPMRLALTDIKQATLGFNKNRIVGEGASATVYKG--SLPSGGAVAV 313
           D  + ED   TV      L  T+I       + +++VG G    V  G   LPS   ++V
Sbjct: 24  DPHTYEDPTQTVHEFAKELDATNI-------SIDKVVGAGEFGEVCSGRLKLPSKKEISV 76
Query: 314 K-RFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDK 372
             +  K    E  R  F  E A++ G   H N+++L+G   +   +++V E + NGSLD 
Sbjct: 77  AIKTLKVGYTEKQRRDFLGE-ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDS 135
Query: 373 ILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLG 432
            L  + +   V+   + + ++ G+AS + YL    +   +HRD+ A NIL+++    K+ 
Sbjct: 136 FLRKHDAQFTVI---QLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVS 189
Query: 433 DF----------EA--TIPAGT--MGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKS 477
           DF          EA  T   G   + + +PE +     +  +DV+S+G+V  EV + G+ 
Sbjct: 190 DFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
Query: 478 PVDNDGCVIVDWVWNLRKKGKLLDAAD--FRLRGKFNRKEMERMLMVGLSCVHPNHEKRP 535
           P            W +  +  ++ A D  +RL    +       LM  L C   +   RP
Sbjct: 250 P-----------YWEMSNQ-DVIKAVDEGYRLPPPMDCPAALYQLM--LDCWQKDRNNRP 295
Query: 536 SVKEAARIL 544
             ++   IL
Sbjct: 296 KFEQIVSIL 304

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 90/207 (43%), Gaps = 19/207 (9%)
Query: 286 FNKNRIVGEGASATVYKGSLPSGGAVAVKR--FEKPNRVECARNPFTTEFATMAGCLRHK 343
           F+  R +G+G    VY         +   +  F+     E   +    E    +  LRH 
Sbjct: 17  FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSH-LRHP 75
Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
           N++++  +  +   + L+ E+ P G L K L  +         ++    +  +A AL Y 
Sbjct: 76  NILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR----FDEQRSATFMEELADALHYC 131
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA---------GTMGYLAPEYVYSG 454
           HE   R++IHRD+K  N+L+  +   K+ DF  ++ A         GT+ YL PE +   
Sbjct: 132 HE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMCGTLDYLPPEMIEGK 188
Query: 455 VPSEKTDVYSFGVVALEVAAGKSPVDN 481
              EK D++  GV+  E   G  P D+
Sbjct: 189 THDEKVDLWCAGVLCYEFLVGMPPFDS 215

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 30/214 (14%)
Query: 291 IVGEGASATVYKGSLPSGGA---VAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQ 347
           ++GEG    V K  +   G     A+KR ++    +  R+ F  E   +     H N++ 
Sbjct: 32  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD-FAGELEVLCKLGHHPNIIN 90
Query: 348 LQGWCCEGNELVLVYEYLPNGSLDKILHNN------------SSSSIVLSWEKRLNIVLG 395
           L G C     L L  EY P+G+L   L  +            +S++  LS ++ L+    
Sbjct: 91  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 396 VASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-----EATIPAGTMG-----Y 445
           VA  + YL    ++Q IHRD+ A NIL+   + AK+ DF     +      TMG     +
Sbjct: 151 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW 207
Query: 446 LAPEYVYSGVPSEKTDVYSFGVVALE-VAAGKSP 478
           +A E +   V +  +DV+S+GV+  E V+ G +P
Sbjct: 208 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 92/206 (44%), Gaps = 26/206 (12%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G+  TVYKG     G VAVK              F  E   +    RH N++   G+
Sbjct: 44  IGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGY 100
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
             +  +L +V ++    SL   LH   +   ++   K ++I    A  + YLH    + I
Sbjct: 101 STK-PQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHA---KSI 153
Query: 412 IHRDVKACNILLDAEFNAKLGDFEATIP-------------AGTMGYLAPEYVY---SGV 455
           IHRD+K+ NI L  +   K+GDF                  +G++ ++APE +       
Sbjct: 154 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 213
Query: 456 PSEKTDVYSFGVVALEVAAGKSPVDN 481
            S ++DVY+FG+V  E+  G+ P  N
Sbjct: 214 YSFQSDVYAFGIVLYELMTGQLPYSN 239

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 30/214 (14%)
Query: 291 IVGEGASATVYKGSLPSGGA---VAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQ 347
           ++GEG    V K  +   G     A+KR ++    +  R+ F  E   +     H N++ 
Sbjct: 22  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD-FAGELEVLCKLGHHPNIIN 80
Query: 348 LQGWCCEGNELVLVYEYLPNGSLDKILHNN------------SSSSIVLSWEKRLNIVLG 395
           L G C     L L  EY P+G+L   L  +            +S++  LS ++ L+    
Sbjct: 81  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 140
Query: 396 VASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-----EATIPAGTMG-----Y 445
           VA  + YL    ++Q IHRD+ A NIL+   + AK+ DF     +      TMG     +
Sbjct: 141 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW 197
Query: 446 LAPEYVYSGVPSEKTDVYSFGVVALE-VAAGKSP 478
           +A E +   V +  +DV+S+GV+  E V+ G +P
Sbjct: 198 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 231

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 92/206 (44%), Gaps = 26/206 (12%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G+  TVYKG     G VAVK              F  E   +    RH N++   G+
Sbjct: 36  IGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGY 92
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
             +  +L +V ++    SL   LH   +   ++   K ++I    A  + YLH    + I
Sbjct: 93  STKP-QLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHA---KSI 145
Query: 412 IHRDVKACNILLDAEFNAKLGDFEATIP-------------AGTMGYLAPEYVY---SGV 455
           IHRD+K+ NI L  +   K+GDF                  +G++ ++APE +       
Sbjct: 146 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 205
Query: 456 PSEKTDVYSFGVVALEVAAGKSPVDN 481
            S ++DVY+FG+V  E+  G+ P  N
Sbjct: 206 YSFQSDVYAFGIVLYELMTGQLPYSN 231

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 27/208 (12%)
Query: 290 RIVGEGASATVYKGSLPSGGA----VAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           R++G G    V  G L   G     VA+K   K    E  R  F  E A++ G   H N+
Sbjct: 28  RVIGAGEFGEVCSGRLKLPGKRELPVAIKTL-KVGYTEKQRRDFLGE-ASIMGQFDHPNI 85
Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
           + L+G   +   +++V EY+ NGSLD  L  N     V+   + + ++ G+++ + YL  
Sbjct: 86  IHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVI---QLVGMLRGISAGMKYL-- 140
Query: 406 ECERQIIHRDVKACNILLDAEFNAKLGDF----------EA--TIPAGT--MGYLAPEYV 451
             +   +HRD+ A NIL+++    K+ DF          EA  T   G   + + APE +
Sbjct: 141 -SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 199
Query: 452 YSGVPSEKTDVYSFGVVALEVAA-GKSP 478
                +  +DV+S+G+V  EV + G+ P
Sbjct: 200 AFRKFTSASDVWSYGIVMWEVVSYGERP 227

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 80/309 (25%), Positives = 136/309 (44%), Gaps = 48/309 (15%)
Query: 256 DGRSKEDHVCTVQRVPMRLALTDIKQATLGFNKNRIVGEGASATVYKG--SLPSGGAVAV 313
           D  + ED   TV      L  T+I       + +++VG G    V  G   LPS   ++V
Sbjct: 24  DPHTFEDPTQTVHEFAKELDATNI-------SIDKVVGAGEFGEVCSGRLKLPSKKEISV 76
Query: 314 K-RFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDK 372
             +  K    E  R  F  E A++ G   H N+++L+G   +   +++V E + NGSLD 
Sbjct: 77  AIKTLKVGYTEKQRRDFLGE-ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDS 135
Query: 373 ILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLG 432
            L  + +   V+   + + ++ G+AS + YL    +   +HRD+ A NIL+++    K+ 
Sbjct: 136 FLRKHDAQFTVI---QLVGMLRGIASGMKYL---SDMGAVHRDLAARNILINSNLVCKVS 189
Query: 433 DF----------EA--TIPAGT--MGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKS 477
           DF          EA  T   G   + + +PE +     +  +DV+S+G+V  EV + G+ 
Sbjct: 190 DFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
Query: 478 PVDNDGCVIVDWVWNLRKKGKLLDAAD--FRLRGKFNRKEMERMLMVGLSCVHPNHEKRP 535
           P            W +  +  ++ A D  +RL    +       LM  L C   +   RP
Sbjct: 250 P-----------YWEMSNQ-DVIKAVDEGYRLPPPMDCPAALYQLM--LDCWQKDRNNRP 295
Query: 536 SVKEAARIL 544
             ++   IL
Sbjct: 296 KFEQIVSIL 304

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 73/151 (48%), Gaps = 16/151 (10%)
Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASA 399
           LRH N++++  +  +   + L+ E+ P G L K L  +         ++    +  +A A
Sbjct: 71  LRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR----FDEQRSATFMEELADA 126
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA---------GTMGYLAPEY 450
           L Y HE   R++IHRD+K  N+L+  +   K+ DF  ++ A         GT+ YL PE 
Sbjct: 127 LHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMCGTLDYLPPEM 183
Query: 451 VYSGVPSEKTDVYSFGVVALEVAAGKSPVDN 481
           +      EK D++  GV+  E   G  P D+
Sbjct: 184 IEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS 214

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 92/206 (44%), Gaps = 26/206 (12%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G+  TVYKG     G VAVK              F  E   +    RH N++   G+
Sbjct: 16  IGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGY 72
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
             +  +L +V ++    SL   LH   +   ++   K ++I    A  + YLH    + I
Sbjct: 73  STK-PQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHA---KSI 125
Query: 412 IHRDVKACNILLDAEFNAKLGDFEATIP-------------AGTMGYLAPEYVY---SGV 455
           IHRD+K+ NI L  +   K+GDF                  +G++ ++APE +       
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 456 PSEKTDVYSFGVVALEVAAGKSPVDN 481
            S ++DVY+FG+V  E+  G+ P  N
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQLPYSN 211

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 90/203 (44%), Gaps = 23/203 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G    V+ G   +   VA+K   +    E     F  E   M   L H  LVQL G 
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMK-LSHPKLVQLYGV 71
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
           C E   + LV E++ +G L   L        + + E  L + L V   ++YL E C   +
Sbjct: 72  CLEQAPICLVTEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEAC---V 125
Query: 412 IHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVPSEK 459
           IHRD+ A N L+      K+ DF         + T   GT   + + +PE       S K
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 185
Query: 460 TDVYSFGVVALEV-AAGKSPVDN 481
           +DV+SFGV+  EV + GK P +N
Sbjct: 186 SDVWSFGVLMWEVFSEGKIPYEN 208

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 97/200 (48%), Gaps = 23/200 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G    V+ G       VAVK  ++ +    + + F  E A +   L+H+ LV+L   
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAE-ANLMKQLQHQRLVRLYA- 75
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
                 + ++ EY+ NGSL   L   + S I L+  K L++   +A  ++++ E   R  
Sbjct: 76  VVTQEPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNY 130
Query: 412 IHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVPSEK 459
           IHRD++A NIL+    + K+ DF         E T   G    + + APE +  G  + K
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 460 TDVYSFGVVALEVAA-GKSP 478
           +DV+SFG++  E+   G+ P
Sbjct: 191 SDVWSFGILLTEIVTHGRIP 210

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 23/203 (11%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQG 350
           +G+GAS TVY    + +G  VA+++     + +  +     E   M    ++ N+V    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMREN-KNPNIVNYLD 84
Query: 351 WCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQ 410
               G+EL +V EYL  GSL  ++     +   +   +   +      AL +LH     Q
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHS---NQ 136
Query: 411 IIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTMGYLAPEYVYSGVPSEK 459
           +IHRD+K+ NILL  + + KL DF           + +   GT  ++APE V       K
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196
Query: 460 TDVYSFGVVALEVAAGKSPVDND 482
            D++S G++A+E+  G+ P  N+
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNE 219

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 97/200 (48%), Gaps = 23/200 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G    V+ G       VAVK  ++ +    + + F  E A +   L+H+ LV+L   
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAE-ANLMKQLQHQRLVRLYA- 76
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
                 + ++ EY+ NGSL   L   + S I L+  K L++   +A  ++++ E   R  
Sbjct: 77  VVTQEPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNY 131
Query: 412 IHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVPSEK 459
           IHRD++A NIL+    + K+ DF         E T   G    + + APE +  G  + K
Sbjct: 132 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 191
Query: 460 TDVYSFGVVALEVAA-GKSP 478
           +DV+SFG++  E+   G+ P
Sbjct: 192 SDVWSFGILLTEIVTHGRIP 211

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 101/209 (48%), Gaps = 29/209 (13%)
Query: 291 IVGEGASATVYKGSLPSGG----AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLV 346
           ++G G    V +G L + G     VA+K   K    E  R  F +E A++ G   H N++
Sbjct: 23  VIGAGEFGEVCRGRLKAPGKKESCVAIKTL-KGGYTERQRREFLSE-ASIMGQFEHPNII 80
Query: 347 QLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEE 406
           +L+G       ++++ E++ NG+LD  L  N     V+   + + ++ G+AS + YL   
Sbjct: 81  RLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVI---QLVGMLRGIASGMRYL--- 134
Query: 407 CERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGT--------MGYLAPEY 450
            E   +HRD+ A NIL+++    K+ DF         ++ P  T        + + APE 
Sbjct: 135 AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEA 194
Query: 451 VYSGVPSEKTDVYSFGVVALEVAA-GKSP 478
           +     +  +D +S+G+V  EV + G+ P
Sbjct: 195 IAFRKFTSASDAWSYGIVMWEVMSFGERP 223

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 97/200 (48%), Gaps = 23/200 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G    V+ G       VAVK  ++ +    + + F  E A +   L+H+ LV+L   
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAE-ANLMKQLQHQRLVRLYA- 77
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
                 + ++ EY+ NGSL   L   + S I L+  K L++   +A  ++++ E   R  
Sbjct: 78  VVTQEPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNY 132
Query: 412 IHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVPSEK 459
           IHRD++A NIL+    + K+ DF         E T   G    + + APE +  G  + K
Sbjct: 133 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 192
Query: 460 TDVYSFGVVALEVAA-GKSP 478
           +DV+SFG++  E+   G+ P
Sbjct: 193 SDVWSFGILLTEIVTHGRIP 212

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 101/209 (48%), Gaps = 29/209 (13%)
Query: 291 IVGEGASATVYKGSLPSGG----AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLV 346
           ++G G    V +G L + G     VA+K   K    E  R  F +E A++ G   H N++
Sbjct: 21  VIGAGEFGEVCRGRLKAPGKKESCVAIKTL-KGGYTERQRREFLSE-ASIMGQFEHPNII 78
Query: 347 QLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEE 406
           +L+G       ++++ E++ NG+LD  L  N     V+   + + ++ G+AS + YL   
Sbjct: 79  RLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVI---QLVGMLRGIASGMRYL--- 132
Query: 407 CERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGT--------MGYLAPEY 450
            E   +HRD+ A NIL+++    K+ DF         ++ P  T        + + APE 
Sbjct: 133 AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEA 192
Query: 451 VYSGVPSEKTDVYSFGVVALEVAA-GKSP 478
           +     +  +D +S+G+V  EV + G+ P
Sbjct: 193 IAFRKFTSASDAWSYGIVMWEVMSFGERP 221

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 98/200 (49%), Gaps = 23/200 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G    V+ G       VAVK  ++ +    + + F  E A +   L+H+ LV+L   
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAE-ANLMKQLQHQRLVRLYAV 84
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
             +   + ++ EY+ NGSL   L   + S I L+  K L++   +A  ++++ E   R  
Sbjct: 85  VTQ-EPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNY 138
Query: 412 IHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVPSEK 459
           IHRD++A NIL+    + K+ DF         E T   G    + + APE +  G  + K
Sbjct: 139 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 198
Query: 460 TDVYSFGVVALEVAA-GKSP 478
           +DV+SFG++  E+   G+ P
Sbjct: 199 SDVWSFGILLTEIVTHGRIP 218

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 100/216 (46%), Gaps = 31/216 (14%)
Query: 290 RIVGEGASATVYKGSL----PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           R +GEGA   V+        P    + V      +  + AR  F  E A +   L+H+++
Sbjct: 19  RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHRE-AELLTNLQHEHI 77
Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIV---------LSWEKRLNIVLGV 396
           V+  G C EG+ L++V+EY+ +G L+K L  +   +++         L+  + L+I   +
Sbjct: 78  VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQI 137
Query: 397 ASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT----------IPAGTM--- 443
           A+ + YL     +  +HRD+   N L+      K+GDF  +          +   TM   
Sbjct: 138 AAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 194
Query: 444 GYLAPEYVYSGVPSEKTDVYSFGVVALEV-AAGKSP 478
            ++ PE +     + ++DV+S GVV  E+   GK P
Sbjct: 195 RWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 230

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 97/200 (48%), Gaps = 23/200 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G    V+ G       VAVK  ++ +    + + F  E A +   L+H+ LV+L   
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAE-ANLMKQLQHQRLVRLYA- 75
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
                 + ++ EY+ NGSL   L   + S I L+  K L++   +A  ++++ E   R  
Sbjct: 76  VVTQEPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNY 130
Query: 412 IHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVPSEK 459
           IHRD++A NIL+    + K+ DF         E T   G    + + APE +  G  + K
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 460 TDVYSFGVVALEVAA-GKSP 478
           +DV+SFG++  E+   G+ P
Sbjct: 191 SDVWSFGILLTEIVTHGRIP 210

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 97/200 (48%), Gaps = 23/200 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G    V+ G       VAVK  ++ +    + + F  E A +   L+H+ LV+L   
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAE-ANLMKQLQHQRLVRLYA- 84
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
                 + ++ EY+ NGSL   L   + S I L+  K L++   +A  ++++ E   R  
Sbjct: 85  VVTQEPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNY 139
Query: 412 IHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVPSEK 459
           IHRD++A NIL+    + K+ DF         E T   G    + + APE +  G  + K
Sbjct: 140 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 199
Query: 460 TDVYSFGVVALEVAA-GKSP 478
           +DV+SFG++  E+   G+ P
Sbjct: 200 SDVWSFGILLTEIVTHGRIP 219

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 97/200 (48%), Gaps = 23/200 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G    V+ G       VAVK  ++ +    + + F  E A +   L+H+ LV+L   
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAE-ANLMKQLQHQRLVRLYA- 81
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
                 + ++ EY+ NGSL   L   + S I L+  K L++   +A  ++++ E   R  
Sbjct: 82  VVTQEPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNY 136
Query: 412 IHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVPSEK 459
           IHRD++A NIL+    + K+ DF         E T   G    + + APE +  G  + K
Sbjct: 137 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 196
Query: 460 TDVYSFGVVALEVAA-GKSP 478
           +DV+SFG++  E+   G+ P
Sbjct: 197 SDVWSFGILLTEIVTHGRIP 216

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 23/203 (11%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQG 350
           +G+GAS TVY    + +G  VA+++     + +  +     E   M    ++ N+V    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMREN-KNPNIVNYLD 84
Query: 351 WCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQ 410
               G+EL +V EYL  GSL  ++     +   +   +   +      AL +LH     Q
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHS---NQ 136
Query: 411 IIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTMGYLAPEYVYSGVPSEK 459
           +IHRD+K+ NILL  + + KL DF           + +   GT  ++APE V       K
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPK 196
Query: 460 TDVYSFGVVALEVAAGKSPVDND 482
            D++S G++A+E+  G+ P  N+
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNE 219

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 97/200 (48%), Gaps = 23/200 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G    V+ G       VAVK  ++ +    + + F  E A +   L+H+ LV+L   
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAE-ANLMKQLQHQRLVRLYA- 80
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
                 + ++ EY+ NGSL   L   + S I L+  K L++   +A  ++++ E   R  
Sbjct: 81  VVTQEPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNY 135
Query: 412 IHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVPSEK 459
           IHRD++A NIL+    + K+ DF         E T   G    + + APE +  G  + K
Sbjct: 136 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 195
Query: 460 TDVYSFGVVALEVAA-GKSP 478
           +DV+SFG++  E+   G+ P
Sbjct: 196 SDVWSFGILLTEIVTHGRIP 215

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 23/203 (11%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQG 350
           +G+GAS TVY    + +G  VA+++     + +  +     E   M    ++ N+V    
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMREN-KNPNIVNYLD 85
Query: 351 WCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQ 410
               G+EL +V EYL  GSL  ++     +   +   +   +      AL +LH     Q
Sbjct: 86  SYLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHS---NQ 137
Query: 411 IIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTMGYLAPEYVYSGVPSEK 459
           +IHRD+K+ NILL  + + KL DF           + +   GT  ++APE V       K
Sbjct: 138 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPK 197
Query: 460 TDVYSFGVVALEVAAGKSPVDND 482
            D++S G++A+E+  G+ P  N+
Sbjct: 198 VDIWSLGIMAIEMIEGEPPYLNE 220

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 97/200 (48%), Gaps = 23/200 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G    V+ G       VAVK  ++ +    + + F  E A +   L+H+ LV+L   
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAE-ANLMKQLQHQRLVRLYA- 81
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
                 + ++ EY+ NGSL   L   + S I L+  K L++   +A  ++++ E   R  
Sbjct: 82  VVTQEPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNY 136
Query: 412 IHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVPSEK 459
           IHRD++A NIL+    + K+ DF         E T   G    + + APE +  G  + K
Sbjct: 137 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 196
Query: 460 TDVYSFGVVALEVAA-GKSP 478
           +DV+SFG++  E+   G+ P
Sbjct: 197 SDVWSFGILLTEIVTHGRIP 216

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 97/200 (48%), Gaps = 23/200 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G    V+ G       VAVK  ++ +    + + F  E A +   L+H+ LV+L   
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAE-ANLMKQLQHQRLVRLYA- 75
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
                 + ++ EY+ NGSL   L   + S I L+  K L++   +A  ++++ E   R  
Sbjct: 76  VVTQEPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNY 130
Query: 412 IHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVPSEK 459
           IHRD++A NIL+    + K+ DF         E T   G    + + APE +  G  + K
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 460 TDVYSFGVVALEVAA-GKSP 478
           +DV+SFG++  E+   G+ P
Sbjct: 191 SDVWSFGILLTEIVTHGRIP 210

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 27/208 (12%)
Query: 290 RIVGEGASATVYKGSLPSGG----AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           +++G G    V  G L   G     VA+K   K    +  R  F +E A++ G   H N+
Sbjct: 35  KVIGVGEFGEVCSGRLKVPGKREICVAIKTL-KAGYTDKQRRDFLSE-ASIMGQFDHPNI 92
Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
           + L+G   +   ++++ EY+ NGSLD  L  N     V+   + + ++ G+ S + YL  
Sbjct: 93  IHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVI---QLVGMLRGIGSGMKYLS- 148
Query: 406 ECERQIIHRDVKACNILLDAEFNAKLGDF----------EA--TIPAGT--MGYLAPEYV 451
             +   +HRD+ A NIL+++    K+ DF          EA  T   G   + + APE +
Sbjct: 149 --DMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 206
Query: 452 YSGVPSEKTDVYSFGVVALEVAA-GKSP 478
                +  +DV+S+G+V  EV + G+ P
Sbjct: 207 AYRKFTSASDVWSYGIVMWEVMSYGERP 234

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 98/200 (49%), Gaps = 23/200 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G    V+ G       VAVK  ++ +    + + F  E A +   L+H+ LV+L   
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAE-ANLMKQLQHQRLVRLYAV 71
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
             +   + ++ EY+ NGSL   L   + S I L+  K L++   +A  ++++ E   R  
Sbjct: 72  VTQ-EPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNY 125
Query: 412 IHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVPSEK 459
           IHRD++A NIL+    + K+ DF         E T   G    + + APE +  G  + K
Sbjct: 126 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 185
Query: 460 TDVYSFGVVALEVAA-GKSP 478
           +DV+SFG++  E+   G+ P
Sbjct: 186 SDVWSFGILLTEIVTHGRIP 205

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 97/213 (45%), Gaps = 33/213 (15%)
Query: 287 NKNRIV-GEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           N +R+V G+G    VY G  L +   +A+K  E P R      P   E A +   L+HKN
Sbjct: 24  NGDRVVLGKGTYGIVYAGRDLSNQVRIAIK--EIPERDSRYSQPLHEEIA-LHKHLKHKN 80
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHN-----NSSSSIVLSWEKRLNIVLGVASA 399
           +VQ  G   E   + +  E +P GSL  +L +       +   +  + K+      +   
Sbjct: 81  IVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQ------ILEG 134
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNA-KLGDFEAT-----------IPAGTMGYLA 447
           L YLH   + QI+HRD+K  N+L++      K+ DF  +              GT+ Y+A
Sbjct: 135 LKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMA 191
Query: 448 PEYVYSGVP--SEKTDVYSFGVVALEVAAGKSP 478
           PE +  G     +  D++S G   +E+A GK P
Sbjct: 192 PEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 98/200 (49%), Gaps = 23/200 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G    V+ G       VAVK  ++ +    + + F  E A +   L+H+ LV+L   
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAE-ANLMKQLQHQRLVRLYAV 86
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
             +   + ++ EY+ NGSL   L   + S I L+  K L++   +A  ++++ E   R  
Sbjct: 87  VTQ-EPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNY 140
Query: 412 IHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVPSEK 459
           IHRD++A NIL+    + K+ DF         E T   G    + + APE +  G  + K
Sbjct: 141 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 200
Query: 460 TDVYSFGVVALEVAA-GKSP 478
           +DV+SFG++  E+   G+ P
Sbjct: 201 SDVWSFGILLTEIVTHGRIP 220

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 27/208 (12%)
Query: 290 RIVGEGASATVYKGSLPSGG----AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           +++G G    V  G L   G     VA+K   K    +  R  F +E A++ G   H N+
Sbjct: 20  KVIGVGEFGEVCSGRLKVPGKREICVAIKTL-KAGYTDKQRRDFLSE-ASIMGQFDHPNI 77
Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
           + L+G   +   ++++ EY+ NGSLD  L  N     V+   + + ++ G+ S + YL  
Sbjct: 78  IHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVI---QLVGMLRGIGSGMKYLS- 133
Query: 406 ECERQIIHRDVKACNILLDAEFNAKLGDF----------EA--TIPAGT--MGYLAPEYV 451
             +   +HRD+ A NIL+++    K+ DF          EA  T   G   + + APE +
Sbjct: 134 --DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 191
Query: 452 YSGVPSEKTDVYSFGVVALEVAA-GKSP 478
                +  +DV+S+G+V  EV + G+ P
Sbjct: 192 AYRKFTSASDVWSYGIVMWEVMSYGERP 219

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 97/213 (45%), Gaps = 33/213 (15%)
Query: 287 NKNRIV-GEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           N +R+V G+G    VY G  L +   +A+K  E P R      P   E A +   L+HKN
Sbjct: 10  NGDRVVLGKGTYGIVYAGRDLSNQVRIAIK--EIPERDSRYSQPLHEEIA-LHKHLKHKN 66
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHN-----NSSSSIVLSWEKRLNIVLGVASA 399
           +VQ  G   E   + +  E +P GSL  +L +       +   +  + K+      +   
Sbjct: 67  IVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQ------ILEG 120
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNA-KLGDFEAT-----------IPAGTMGYLA 447
           L YLH   + QI+HRD+K  N+L++      K+ DF  +              GT+ Y+A
Sbjct: 121 LKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMA 177
Query: 448 PEYVYSGVP--SEKTDVYSFGVVALEVAAGKSP 478
           PE +  G     +  D++S G   +E+A GK P
Sbjct: 178 PEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 210

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 27/208 (12%)
Query: 290 RIVGEGASATVYKGSLPSGG----AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           +++G G    V  G L   G     VA+K   K    +  R  F +E A++ G   H N+
Sbjct: 14  KVIGVGEFGEVCSGRLKVPGKREICVAIKTL-KAGYTDKQRRDFLSE-ASIMGQFDHPNI 71
Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
           + L+G   +   ++++ EY+ NGSLD  L  N     V+   + + ++ G+ S + YL  
Sbjct: 72  IHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVI---QLVGMLRGIGSGMKYLS- 127
Query: 406 ECERQIIHRDVKACNILLDAEFNAKLGDF----------EA--TIPAGT--MGYLAPEYV 451
             +   +HRD+ A NIL+++    K+ DF          EA  T   G   + + APE +
Sbjct: 128 --DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 185
Query: 452 YSGVPSEKTDVYSFGVVALEVAA-GKSP 478
                +  +DV+S+G+V  EV + G+ P
Sbjct: 186 AYRKFTSASDVWSYGIVMWEVMSYGERP 213

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 122/278 (43%), Gaps = 45/278 (16%)
Query: 290 RIVGEGASATVYKGSLPSGGA----VAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           +++G G    V  G L   G     VA+K   K    E  R  F +E A++ G   H N+
Sbjct: 13  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTL-KSGYTEKQRRDFLSE-ASIMGQFDHPNV 70
Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
           + L+G   +   ++++ E++ NGSLD  L  N     V+   + + ++ G+A+ + YL  
Sbjct: 71  IHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVI---QLVGMLRGIAAGMKYL-- 125
Query: 406 ECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGT--------MGYLAPE 449
             +   +HR + A NIL+++    K+ DF        + + P  T        + + APE
Sbjct: 126 -ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPE 184
Query: 450 YVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDA--ADFR 506
            +     +  +DV+S+G+V  EV + G+ P            W++  +  +++A   D+R
Sbjct: 185 AIQYRKFTSASDVWSYGIVMWEVMSYGERP-----------YWDMTNQ-DVINAIEQDYR 232
Query: 507 LRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARIL 544
           L    +       LM  L C   +   RP   +    L
Sbjct: 233 LPPPMDCPSALHQLM--LDCWQKDRNHRPKFGQIVNTL 268

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 23/203 (11%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQG 350
           +G+GAS TVY    + +G  VA+++     + +  +     E   M    ++ N+V    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMREN-KNPNIVNYLD 84
Query: 351 WCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQ 410
               G+EL +V EYL  GSL  ++     +   +   +   +      AL +LH     Q
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHS---NQ 136
Query: 411 IIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTMGYLAPEYVYSGVPSEK 459
           +IHRD+K+ NILL  + + KL DF           + +   GT  ++APE V       K
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKAYGPK 196
Query: 460 TDVYSFGVVALEVAAGKSPVDND 482
            D++S G++A+E+  G+ P  N+
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNE 219

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 30/214 (14%)
Query: 291 IVGEGASATVYKGSLPSGGA---VAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQ 347
           ++GEG    V K  +   G     A+KR ++    +  R+ F  E   +     H N++ 
Sbjct: 29  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD-FAGELEVLCKLGHHPNIIN 87
Query: 348 LQGWCCEGNELVLVYEYLPNGSLDKILHNN------------SSSSIVLSWEKRLNIVLG 395
           L G C     L L  EY P+G+L   L  +            +S++  LS ++ L+    
Sbjct: 88  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 147
Query: 396 VASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-----EATIPAGTMG-----Y 445
           VA  + YL    ++Q IHR++ A NIL+   + AK+ DF     +      TMG     +
Sbjct: 148 VARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW 204
Query: 446 LAPEYVYSGVPSEKTDVYSFGVVALE-VAAGKSP 478
           +A E +   V +  +DV+S+GV+  E V+ G +P
Sbjct: 205 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 238

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 125/276 (45%), Gaps = 41/276 (14%)
Query: 289 NRIVGEGASATVYKG--SLPSGGAVAVK-RFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           +++VG G    V  G   LPS   ++V  +  K    E  R  F  E A++ G   H N+
Sbjct: 21  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE-ASIMGQFDHPNI 79
Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
           ++L+G   +   +++V E + NGSLD  L  + +   V+   + + ++ G+AS + YL  
Sbjct: 80  IRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVI---QLVGMLRGIASGMKYL-- 134
Query: 406 ECERQIIHRDVKACNILLDAEFNAKLGDF----------EA--TIPAGT--MGYLAPEYV 451
             +   +HRD+ A NIL+++    K+ DF          EA  T   G   + + +PE +
Sbjct: 135 -SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 193
Query: 452 YSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAAD--FRLR 508
                +  +DV+S+G+V  EV + G+ P            W +  +  ++ A D  +RL 
Sbjct: 194 AYRKFTSASDVWSYGIVLWEVMSYGERP-----------YWEMSNQ-DVIKAVDEGYRLP 241
Query: 509 GKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARIL 544
              +       LM  L C   +   RP  ++   IL
Sbjct: 242 PPMDCPAALYQLM--LDCWQKDRNNRPKFEQIVSIL 275

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 109/228 (47%), Gaps = 26/228 (11%)
Query: 267 VQRVPMRLALTDIKQATLGFNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECA 325
           ++++ + +++ D K+    F K   +G+GAS TVY    + +G  VA+++     + +  
Sbjct: 7   LEKLRIIVSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-- 61
Query: 326 RNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLS 385
           +     E   M    ++ N+V        G+EL +V EYL  GSL  ++     +   + 
Sbjct: 62  KELIINEILVMREN-KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-----TETCMD 115
Query: 386 WEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF----------- 434
             +   +      AL +LH     Q+IHR++K+ NILL  + + KL DF           
Sbjct: 116 EGQIAAVCRECLQALEFLHS---NQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQS 172
Query: 435 EATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDND 482
           + +   GT  ++APE V       K D++S G++A+E+  G+ P  N+
Sbjct: 173 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE 220

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 94/209 (44%), Gaps = 18/209 (8%)
Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F    ++G+G+ A VY+  S+ +G  VA+K  +K    +            +   L+H +
Sbjct: 13  FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPS 72
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           +++L  +  + N + LV E   NG +++ L N        S  +  + +  + + + YLH
Sbjct: 73  ILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKP---FSENEARHFMHQIITGMLYLH 129
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF----EATIP-------AGTMGYLAPEYVYS 453
                 I+HRD+   N+LL    N K+ DF    +  +P        GT  Y++PE    
Sbjct: 130 SH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATR 186
Query: 454 GVPSEKTDVYSFGVVALEVAAGKSPVDND 482
                ++DV+S G +   +  G+ P D D
Sbjct: 187 SAHGLESDVWSLGCMFYTLLIGRPPFDTD 215

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 90/203 (44%), Gaps = 23/203 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G    V+ G   +   VA+K   +    E     F  E   M   L H  LVQL G 
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMK-LSHPKLVQLYGV 70
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
           C E   + LV+E++ +G L   L        + + E  L + L V   ++YL E     +
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEA---SV 124
Query: 412 IHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVPSEK 459
           IHRD+ A N L+      K+ DF         + T   GT   + + +PE       S K
Sbjct: 125 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 184
Query: 460 TDVYSFGVVALEV-AAGKSPVDN 481
           +DV+SFGV+  EV + GK P +N
Sbjct: 185 SDVWSFGVLMWEVFSEGKIPYEN 207

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 16/203 (7%)
Query: 286 FNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           F K   +G G    V+K S    G V  ++          RN    E   +  C     +
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYI 66
Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
           V   G      E+ +  E++  GSLD++L         +  +    + + V   L+YL E
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR----IPEQILGKVSIAVIKGLTYLRE 122
Query: 406 ECERQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGTMGYLAPEYVYSGVP 456
           +   +I+HRDVK  NIL+++    KL DF          A    GT  Y++PE +     
Sbjct: 123 K--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHY 180
Query: 457 SEKTDVYSFGVVALEVAAGKSPV 479
           S ++D++S G+  +E+A G+ P+
Sbjct: 181 SVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 16/203 (7%)
Query: 286 FNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           F K   +G G    V+K S    G V  ++          RN    E   +  C     +
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYI 66
Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
           V   G      E+ +  E++  GSLD++L         +  +    + + V   L+YL E
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR----IPEQILGKVSIAVIKGLTYLRE 122
Query: 406 ECERQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGTMGYLAPEYVYSGVP 456
           +   +I+HRDVK  NIL+++    KL DF          A    GT  Y++PE +     
Sbjct: 123 K--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHY 180
Query: 457 SEKTDVYSFGVVALEVAAGKSPV 479
           S ++D++S G+  +E+A G+ P+
Sbjct: 181 SVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 16/203 (7%)
Query: 286 FNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           F K   +G G    V+K S    G V  ++          RN    E   +  C     +
Sbjct: 27  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYI 85
Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
           V   G      E+ +  E++  GSLD++L         +  +    + + V   L+YL E
Sbjct: 86  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR----IPEQILGKVSIAVIKGLTYLRE 141
Query: 406 ECERQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGTMGYLAPEYVYSGVP 456
           +   +I+HRDVK  NIL+++    KL DF          A    GT  Y++PE +     
Sbjct: 142 K--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHY 199
Query: 457 SEKTDVYSFGVVALEVAAGKSPV 479
           S ++D++S G+  +E+A G+ P+
Sbjct: 200 SVQSDIWSMGLSLVEMAVGRYPI 222

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 16/203 (7%)
Query: 286 FNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           F K   +G G    V+K S    G V  ++          RN    E   +  C     +
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYI 66
Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
           V   G      E+ +  E++  GSLD++L         +  +    + + V   L+YL E
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR----IPEQILGKVSIAVIKGLTYLRE 122
Query: 406 ECERQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGTMGYLAPEYVYSGVP 456
           +   +I+HRDVK  NIL+++    KL DF          A    GT  Y++PE +     
Sbjct: 123 K--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHY 180
Query: 457 SEKTDVYSFGVVALEVAAGKSPV 479
           S ++D++S G+  +E+A G+ P+
Sbjct: 181 SVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 99/207 (47%), Gaps = 31/207 (14%)
Query: 286 FNKNRIVGEGASATVYKGS-LPSGGAVAVKRFEKPNRVECARNPF--TTEFATMAGCLRH 342
             K +++G G   TV+KG  +P G ++ +    K    +  R  F   T+     G L H
Sbjct: 15  LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDH 74
Query: 343 KNLVQLQGWCCEGNELVLVYEYLPNGS-LDKILHNNSSSSIVLSWEKRLNIVLGVASALS 401
            ++V+L G  C G+ L LV +YLP GS LD +  +  +    L  +  LN  + +A  + 
Sbjct: 75  AHIVRLLG-LCPGSSLQLVTQYLPLGSLLDHVRQHRGA----LGPQLLLNWGVQIAKGMY 129
Query: 402 YLHEECERQIIHRDVKACNILLDAEFNAKLGDF----------------EATIPAGTMGY 445
           YL E     ++HR++ A N+LL +    ++ DF                EA  P   + +
Sbjct: 130 YLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP---IKW 183
Query: 446 LAPEYVYSGVPSEKTDVYSFGVVALEV 472
           +A E ++ G  + ++DV+S+GV   E+
Sbjct: 184 MALESIHFGKYTHQSDVWSYGVTVWEL 210

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 16/203 (7%)
Query: 286 FNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           F K   +G G    V+K S    G V  ++          RN    E   +  C     +
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYI 66
Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
           V   G      E+ +  E++  GSLD++L         +  +    + + V   L+YL E
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR----IPEQILGKVSIAVIKGLTYLRE 122
Query: 406 ECERQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGTMGYLAPEYVYSGVP 456
           +   +I+HRDVK  NIL+++    KL DF          A    GT  Y++PE +     
Sbjct: 123 K--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHY 180
Query: 457 SEKTDVYSFGVVALEVAAGKSPV 479
           S ++D++S G+  +E+A G+ P+
Sbjct: 181 SVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 16/203 (7%)
Query: 286 FNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           F K   +G G    V+K S    G V  ++          RN    E   +  C     +
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYI 66
Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
           V   G      E+ +  E++  GSLD++L         +  +    + + V   L+YL E
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR----IPEQILGKVSIAVIKGLTYLRE 122
Query: 406 ECERQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGTMGYLAPEYVYSGVP 456
           +   +I+HRDVK  NIL+++    KL DF          A    GT  Y++PE +     
Sbjct: 123 K--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHY 180
Query: 457 SEKTDVYSFGVVALEVAAGKSPV 479
           S ++D++S G+  +E+A G+ P+
Sbjct: 181 SVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 29/206 (14%)
Query: 286 FNKNRIVGEGASATVYKGS-LPSGGAVAVKRFEKPNRVECARNPF--TTEFATMAGCLRH 342
             K +++G G   TV+KG  +P G ++ +    K    +  R  F   T+     G L H
Sbjct: 33  LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDH 92
Query: 343 KNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
            ++V+L G  C G+ L LV +YLP GSL   L +       L  +  LN  + +A  + Y
Sbjct: 93  AHIVRLLG-LCPGSSLQLVTQYLPLGSL---LDHVRQHRGALGPQLLLNWGVQIAKGMYY 148
Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDF----------------EATIPAGTMGYL 446
           L E     ++HR++ A N+LL +    ++ DF                EA  P   + ++
Sbjct: 149 LEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP---IKWM 202
Query: 447 APEYVYSGVPSEKTDVYSFGVVALEV 472
           A E ++ G  + ++DV+S+GV   E+
Sbjct: 203 ALESIHFGKYTHQSDVWSYGVTVWEL 228

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 16/203 (7%)
Query: 286 FNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           F K   +G G    V+K S    G V  ++          RN    E   +  C     +
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYI 93
Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
           V   G      E+ +  E++  GSLD++L         +  +    + + V   L+YL E
Sbjct: 94  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR----IPEQILGKVSIAVIKGLTYLRE 149
Query: 406 ECERQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGTMGYLAPEYVYSGVP 456
           +   +I+HRDVK  NIL+++    KL DF          A    GT  Y++PE +     
Sbjct: 150 K--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHY 207
Query: 457 SEKTDVYSFGVVALEVAAGKSPV 479
           S ++D++S G+  +E+A G+ P+
Sbjct: 208 SVQSDIWSMGLSLVEMAVGRYPI 230

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 98/200 (49%), Gaps = 23/200 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G    V+ G       VAVK  ++ +    + + F  E A +   L+H+ LV+L   
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAE-ANLMKQLQHQRLVRLYAV 72
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
             +   + ++ EY+ NGSL   L   + S I L+  K L++   +A  ++++ E   R  
Sbjct: 73  VTQ-EPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNY 126
Query: 412 IHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVPSEK 459
           IHR+++A NIL+    + K+ DF         E T   G    + + APE +  G  + K
Sbjct: 127 IHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 186
Query: 460 TDVYSFGVVALEVAA-GKSP 478
           +DV+SFG++  E+   G+ P
Sbjct: 187 SDVWSFGILLTEIVTHGRIP 206

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 77/149 (51%), Gaps = 22/149 (14%)
Query: 340 LRHKNLVQLQGWCCE--GNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVA 397
           L H+N+V+ +G C E  GN + L+ E+LP+GSL + L  N +    ++ +++L   + + 
Sbjct: 80  LYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAVQIC 136
Query: 398 SALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGT--------------M 443
             + YL     RQ +HRD+ A N+L+++E   K+GDF  T    T              +
Sbjct: 137 KGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPV 193
Query: 444 GYLAPEYVYSGVPSEKTDVYSFGVVALEV 472
            + APE +        +DV+SFGV   E+
Sbjct: 194 FWYAPECLMQSKFYIASDVWSFGVTLHEL 222

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 16/203 (7%)
Query: 286 FNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           F K   +G G    V+K S    G V  ++          RN    E   +  C     +
Sbjct: 70  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYI 128
Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
           V   G      E+ +  E++  GSLD++L         +  +    + + V   L+YL E
Sbjct: 129 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR----IPEQILGKVSIAVIKGLTYLRE 184
Query: 406 ECERQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGTMGYLAPEYVYSGVP 456
           +   +I+HRDVK  NIL+++    KL DF          A    GT  Y++PE +     
Sbjct: 185 K--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHY 242
Query: 457 SEKTDVYSFGVVALEVAAGKSPV 479
           S ++D++S G+  +E+A G+ P+
Sbjct: 243 SVQSDIWSMGLSLVEMAVGRYPI 265

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 77/149 (51%), Gaps = 22/149 (14%)
Query: 340 LRHKNLVQLQGWCCE--GNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVA 397
           L H+N+V+ +G C E  GN + L+ E+LP+GSL + L  N +    ++ +++L   + + 
Sbjct: 68  LYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAVQIC 124
Query: 398 SALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGT--------------M 443
             + YL     RQ +HRD+ A N+L+++E   K+GDF  T    T              +
Sbjct: 125 KGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPV 181
Query: 444 GYLAPEYVYSGVPSEKTDVYSFGVVALEV 472
            + APE +        +DV+SFGV   E+
Sbjct: 182 FWYAPECLMQSKFYIASDVWSFGVTLHEL 210

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 91/217 (41%), Gaps = 34/217 (15%)
Query: 291 IVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQG 350
           ++G+G      K +    G V V + E     E  +  F  E   M  CL H N+++  G
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMK-ELIRFDEETQRTFLKEVKVMR-CLEHPNVLKFIG 74
Query: 351 WCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQ 410
              +   L  + EY+  G+L  I+ +  S      W +R++    +AS ++YLH      
Sbjct: 75  VLYKDKRLNFITEYIKGGTLRGIIKSMDSQ---YPWSQRVSFAKDIASGMAYLHS---MN 128
Query: 411 IIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMG-----------------Y 445
           IIHRD+ + N L+    N  + DF        E T P G                    +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 446 LAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDND 482
           +APE +      EK DV+SFG+V  E+  G+   D D
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEI-IGRVNADPD 224

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 94/203 (46%), Gaps = 29/203 (14%)
Query: 290 RIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEF----ATMAGCLRHKNL 345
           + +G+G    V  G    G  VAVK         C +N  T +     A++   LRH NL
Sbjct: 18  QTIGKGEFGDVMLGDY-RGNKVAVK---------CIKNDATAQAFLAEASVMTQLRHSNL 67
Query: 346 VQLQGWCCE-GNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           VQL G   E    L +V EY+  GSL   L +   S  VL  +  L   L V  A+ YL 
Sbjct: 68  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS--VLGGDCLLKFSLDVCEAMEYLE 125
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGT--------MGYLAPEYVYSGVP 456
                  +HRD+ A N+L+  +  AK+ DF  T  A +        + + APE +     
Sbjct: 126 G---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREAAF 182
Query: 457 SEKTDVYSFGVVALEVAA-GKSP 478
           S K+DV+SFG++  E+ + G+ P
Sbjct: 183 STKSDVWSFGILLWEIYSFGRVP 205

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 18/214 (8%)
Query: 274 LALTDIKQATLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEF 333
           +AL ++K     F K   +G G    V+K S    G V  ++          RN    E 
Sbjct: 1   MALGELKDDD--FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIREL 58
Query: 334 ATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIV 393
             +  C     +V   G      E+ +  E++  GSLD++L         +  +    + 
Sbjct: 59  QVLHEC-NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR----IPEQILGKVS 113
Query: 394 LGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGTMG 444
           + V   L+YL E+   +I+HRDVK  NIL+++    KL DF          A    GT  
Sbjct: 114 IAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFVGTRS 171
Query: 445 YLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSP 478
           Y++PE +     S ++D++S G+  +E+A G+ P
Sbjct: 172 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 205

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 112/232 (48%), Gaps = 36/232 (15%)
Query: 271 PMRLALTDIKQATLGFNKNRIVGEGASATVYKGS-LPSGGAV----AVKRFEKPNRVECA 325
           P +  L  +K+  L   + +++G GA  TVYKG  +P G  V    A+K   +    + A
Sbjct: 4   PNQAQLRILKETEL--KRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPK-A 60
Query: 326 RNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILH---NNSSSSI 382
              F  E   MA  + H +LV+L G C     + LV + +P+G L + +H   +N  S +
Sbjct: 61  NVEFMDEALIMAS-MDHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLEYVHEHKDNIGSQL 118
Query: 383 VLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-------- 434
           +L+W       + +A  + YL E   R+++HRD+ A N+L+ +  + K+ DF        
Sbjct: 119 LLNW------CVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 169
Query: 435 ---EATIPAGTM--GYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVD 480
              E     G M   ++A E ++    + ++DV+S+GV   E+   G  P D
Sbjct: 170 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 221

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 91/200 (45%), Gaps = 22/200 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G    V+ G   +   VAVK   KP  +      F  E A +   L+H  LV+L   
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSV--QAFLEE-ANLMKTLQHDKLVRLYAV 76
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
                 + ++ EY+  GSL   L ++    ++L   K ++    +A  ++Y+     +  
Sbjct: 77  VTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLP--KLIDFSAQIAEGMAYIER---KNY 131
Query: 412 IHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVPSEK 459
           IHRD++A N+L+      K+ DF         E T   G    + + APE +  G  + K
Sbjct: 132 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIK 191
Query: 460 TDVYSFGVVALEVAA-GKSP 478
           +DV+SFG++  E+   GK P
Sbjct: 192 SDVWSFGILLYEIVTYGKIP 211

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 112/232 (48%), Gaps = 36/232 (15%)
Query: 271 PMRLALTDIKQATLGFNKNRIVGEGASATVYKGS-LPSGGAV----AVKRFEKPNRVECA 325
           P +  L  +K+  L   + +++G GA  TVYKG  +P G  V    A+K   +    + A
Sbjct: 27  PNQAQLRILKETEL--KRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPK-A 83
Query: 326 RNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILH---NNSSSSI 382
              F  E   MA  + H +LV+L G C     + LV + +P+G L + +H   +N  S +
Sbjct: 84  NVEFMDEALIMAS-MDHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLEYVHEHKDNIGSQL 141
Query: 383 VLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-------- 434
           +L+W       + +A  + YL E   R+++HRD+ A N+L+ +  + K+ DF        
Sbjct: 142 LLNW------CVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 192
Query: 435 ---EATIPAGTM--GYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVD 480
              E     G M   ++A E ++    + ++DV+S+GV   E+   G  P D
Sbjct: 193 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 244

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 20/208 (9%)
Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F+  R +G G+   VY    + +   VA+K+     +    +     +       LRH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKI-LHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
            +Q +G     +   LV EY    + D + +H      + ++      +  G    L+YL
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA-----AVTHGALQGLAYL 131
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF-EATIPA------GTMGYLAPEYVYS--- 453
           H      +IHRDVKA NILL      KLGDF  A+I A      GT  ++APE + +   
Sbjct: 132 HS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEVILAMDE 188
Query: 454 GVPSEKTDVYSFGVVALEVAAGKSPVDN 481
           G    K DV+S G+  +E+A  K P+ N
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPPLFN 216

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 87/203 (42%), Gaps = 16/203 (7%)
Query: 286 FNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           F +   +G G    V K      G +  ++          RN    E   +  C     +
Sbjct: 18  FERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYI 76
Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
           V   G      E+ +  E++  GSLD++L         +  E    + + V   L+YL E
Sbjct: 77  VGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR----IPEEILGKVSIAVLRGLAYLRE 132
Query: 406 ECERQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGTMGYLAPEYVYSGVP 456
           +   QI+HRDVK  NIL+++    KL DF          A    GT  Y+APE +     
Sbjct: 133 K--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMAPERLQGTHY 190
Query: 457 SEKTDVYSFGVVALEVAAGKSPV 479
           S ++D++S G+  +E+A G+ P+
Sbjct: 191 SVQSDIWSMGLSLVELAVGRYPI 213

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 20/208 (9%)
Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F+  R +G G+   VY    + +   VA+K+     +    +     +       LRH N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKI-LHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
            +Q +G     +   LV EY    + D + +H      + ++      +  G    L+YL
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA-----AVTHGALQGLAYL 170
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF-EATIPA------GTMGYLAPEYVYS--- 453
           H      +IHRDVKA NILL      KLGDF  A+I A      GT  ++APE + +   
Sbjct: 171 HSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEVILAMDE 227
Query: 454 GVPSEKTDVYSFGVVALEVAAGKSPVDN 481
           G    K DV+S G+  +E+A  K P+ N
Sbjct: 228 GQYDGKVDVWSLGITCIELAERKPPLFN 255

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 94/203 (46%), Gaps = 29/203 (14%)
Query: 290 RIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEF----ATMAGCLRHKNL 345
           + +G+G    V  G    G  VAVK         C +N  T +     A++   LRH NL
Sbjct: 27  QTIGKGEFGDVMLGDY-RGNKVAVK---------CIKNDATAQAFLAEASVMTQLRHSNL 76
Query: 346 VQLQGWCCE-GNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           VQL G   E    L +V EY+  GSL   L +   S  VL  +  L   L V  A+ YL 
Sbjct: 77  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS--VLGGDCLLKFSLDVCEAMEYLE 134
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGT--------MGYLAPEYVYSGVP 456
                  +HRD+ A N+L+  +  AK+ DF  T  A +        + + APE +     
Sbjct: 135 GN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKF 191
Query: 457 SEKTDVYSFGVVALEVAA-GKSP 478
           S K+DV+SFG++  E+ + G+ P
Sbjct: 192 STKSDVWSFGILLWEIYSFGRVP 214

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 94/203 (46%), Gaps = 29/203 (14%)
Query: 290 RIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEF----ATMAGCLRHKNL 345
           + +G+G    V  G    G  VAVK         C +N  T +     A++   LRH NL
Sbjct: 12  QTIGKGEFGDVMLGDY-RGNKVAVK---------CIKNDATAQAFLAEASVMTQLRHSNL 61
Query: 346 VQLQGWCCE-GNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           VQL G   E    L +V EY+  GSL   L +   S  VL  +  L   L V  A+ YL 
Sbjct: 62  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS--VLGGDCLLKFSLDVCEAMEYLE 119
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGT--------MGYLAPEYVYSGVP 456
                  +HRD+ A N+L+  +  AK+ DF  T  A +        + + APE +     
Sbjct: 120 GN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKF 176
Query: 457 SEKTDVYSFGVVALEVAA-GKSP 478
           S K+DV+SFG++  E+ + G+ P
Sbjct: 177 STKSDVWSFGILLWEIYSFGRVP 199

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 102/218 (46%), Gaps = 37/218 (16%)
Query: 292 VGEGASATVYKGS----LPSGGA--VAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           +GEGA   V+       LP      VAVK  ++ +  E AR  F  E A +   L+H+++
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESARQDFQRE-AELLTMLQHQHI 82
Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLS-----------WEKRLNIVL 394
           V+  G C EG  L++V+EY+ +G L++ L ++   + +L+             + L +  
Sbjct: 83  VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 142
Query: 395 GVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT----------IPAGTM- 443
            VA+ + YL        +HRD+   N L+      K+GDF  +          +   TM 
Sbjct: 143 QVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 199
Query: 444 --GYLAPEYVYSGVPSEKTDVYSFGVVALEV-AAGKSP 478
              ++ PE +     + ++DV+SFGVV  E+   GK P
Sbjct: 200 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 237

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 102/218 (46%), Gaps = 37/218 (16%)
Query: 292 VGEGASATVYKGS----LPSGGA--VAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           +GEGA   V+       LP      VAVK  ++ +  E AR  F  E A +   L+H+++
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESARQDFQRE-AELLTMLQHQHI 76
Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLS-----------WEKRLNIVL 394
           V+  G C EG  L++V+EY+ +G L++ L ++   + +L+             + L +  
Sbjct: 77  VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 136
Query: 395 GVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT----------IPAGTM- 443
            VA+ + YL        +HRD+   N L+      K+GDF  +          +   TM 
Sbjct: 137 QVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 193
Query: 444 --GYLAPEYVYSGVPSEKTDVYSFGVVALEV-AAGKSP 478
              ++ PE +     + ++DV+SFGVV  E+   GK P
Sbjct: 194 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 231

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 20/204 (9%)
Query: 286 FNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           F K   +G+G+   V+KG       V   +       E        E   ++ C     +
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSSYV 83
Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
            +  G   +G++L ++ EYL  GS   +L         ++      ++  +   L YLH 
Sbjct: 84  TKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIA-----TMLKEILKGLDYLHS 138
Query: 406 ECERQIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTMGYLAPEYVYSG 454
           E +   IHRD+KA N+LL  + + KL DF           +     GT  ++APE +   
Sbjct: 139 EKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQS 195
Query: 455 VPSEKTDVYSFGVVALEVAAGKSP 478
               K D++S G+ A+E+A G+ P
Sbjct: 196 AYDSKADIWSLGITAIELAKGEPP 219

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 94/203 (46%), Gaps = 29/203 (14%)
Query: 290 RIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEF----ATMAGCLRHKNL 345
           + +G+G    V  G    G  VAVK         C +N  T +     A++   LRH NL
Sbjct: 199 QTIGKGEFGDVMLGDY-RGNKVAVK---------CIKNDATAQAFLAEASVMTQLRHSNL 248
Query: 346 VQLQGWCCE-GNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           VQL G   E    L +V EY+  GSL   L +   S  VL  +  L   L V  A+ YL 
Sbjct: 249 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS--VLGGDCLLKFSLDVCEAMEYLE 306
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGT--------MGYLAPEYVYSGVP 456
                  +HRD+ A N+L+  +  AK+ DF  T  A +        + + APE +     
Sbjct: 307 G---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKF 363
Query: 457 SEKTDVYSFGVVALEVAA-GKSP 478
           S K+DV+SFG++  E+ + G+ P
Sbjct: 364 STKSDVWSFGILLWEIYSFGRVP 386

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 102/218 (46%), Gaps = 37/218 (16%)
Query: 292 VGEGASATVYKGS----LPSGGA--VAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           +GEGA   V+       LP      VAVK  ++ +  E AR  F  E A +   L+H+++
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESARQDFQRE-AELLTMLQHQHI 105
Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLS-----------WEKRLNIVL 394
           V+  G C EG  L++V+EY+ +G L++ L ++   + +L+             + L +  
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 395 GVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT----------IPAGTM- 443
            VA+ + YL        +HRD+   N L+      K+GDF  +          +   TM 
Sbjct: 166 QVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222
Query: 444 --GYLAPEYVYSGVPSEKTDVYSFGVVALEV-AAGKSP 478
              ++ PE +     + ++DV+SFGVV  E+   GK P
Sbjct: 223 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 26/204 (12%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G+GA   VYK      GA+A  +  +  + E     +  E   +A C  H  +V+L G 
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIE-TKSEEELEDYIVEIEILATC-DHPYIVKLLGA 76
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVL-GVASALSYLHEECERQ 410
                +L ++ E+ P G++D I+            E ++ +V   +  AL++LH    ++
Sbjct: 77  YYHDGKLWIMIEFCPGGAVDAIMLELDRGLT----EPQIQVVCRQMLEALNFLHS---KR 129
Query: 411 IIHRDVKACNILLDAEFNAKLGDFEATIP-----------AGTMGYLAPEYVYSGVPSE- 458
           IIHRD+KA N+L+  E + +L DF  +              GT  ++APE V      + 
Sbjct: 130 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDT 189
Query: 459 ----KTDVYSFGVVALEVAAGKSP 478
               K D++S G+  +E+A  + P
Sbjct: 190 PYDYKADIWSLGITLIEMAQIEPP 213

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 91/207 (43%), Gaps = 21/207 (10%)
Query: 286 FNKNRIVGEGA-SATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F   +I+GEG+ S TV    L +    A+K  EK + ++  + P+ T    +   L H  
Sbjct: 32  FKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
            V+L     +  +L     Y  NG L K +    S     +      IV    SAL YLH
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLH 147
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF-------------EATIPAGTMGYLAPEYV 451
               + IIHRD+K  NILL+ + + ++ DF              A    GT  Y++PE +
Sbjct: 148 G---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 204
Query: 452 YSGVPSEKTDVYSFGVVALEVAAGKSP 478
                 + +D+++ G +  ++ AG  P
Sbjct: 205 TEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 26/204 (12%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G+GA   VYK      GA+A  +  +  + E     +  E   +A C  H  +V+L G 
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIE-TKSEEELEDYIVEIEILATC-DHPYIVKLLGA 84
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVL-GVASALSYLHEECERQ 410
                +L ++ E+ P G++D I+            E ++ +V   +  AL++LH    ++
Sbjct: 85  YYHDGKLWIMIEFCPGGAVDAIMLELDRGLT----EPQIQVVCRQMLEALNFLHS---KR 137
Query: 411 IIHRDVKACNILLDAEFNAKLGDFEATIP-----------AGTMGYLAPEYVYSGVPSE- 458
           IIHRD+KA N+L+  E + +L DF  +              GT  ++APE V      + 
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDT 197
Query: 459 ----KTDVYSFGVVALEVAAGKSP 478
               K D++S G+  +E+A  + P
Sbjct: 198 PYDYKADIWSLGITLIEMAQIEPP 221

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 96/221 (43%), Gaps = 23/221 (10%)
Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F   +I+GEG+ +TV     L +    A+K  EK + ++  + P+ T    +   L H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
            V+L     +  +L     Y  NG L K +    S     +      IV    SAL YLH
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLH 149
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF-------------EATIPAGTMGYLAPEYV 451
               + IIHRD+K  NILL+ + + ++ DF              A    GT  Y++PE +
Sbjct: 150 G---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 206
Query: 452 YSGVPSEKTDVYSFGVVALEVAAGKSP--VDNDGCVIVDWV 490
                 + +D+++ G +  ++ AG  P    N+G +    +
Sbjct: 207 TEKSAXKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKII 247

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 19/207 (9%)
Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVK-RFEKPNRVECARNPFTTEFATMAGCLRHK 343
           F   R +G+G    VY      S   VA+K  F+     E   +    E    A  L H 
Sbjct: 25  FEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAH-LHHP 83
Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
           N+++L  +  +   + L+ EY P G L K L      S     ++   I+  +A AL Y 
Sbjct: 84  NILRLYNYFYDRRRIYLILEYAPRGELYKEL----QKSCTFDEQRTATIMEELADALMYC 139
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA---------GTMGYLAPEYVYSG 454
           H    +++IHRD+K  N+LL  +   K+ DF  ++ A         GT+ YL PE +   
Sbjct: 140 HG---KKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKTMCGTLDYLPPEMIEGR 196
Query: 455 VPSEKTDVYSFGVVALEVAAGKSPVDN 481
           + +EK D++  GV+  E+  G  P ++
Sbjct: 197 MHNEKVDLWCIGVLCYELLVGNPPFES 223

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/265 (24%), Positives = 118/265 (44%), Gaps = 45/265 (16%)
Query: 311 VAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSL 370
           VAVK  +     +  +    +E   M+   +H+N+V L G C  G  ++++ EY   G L
Sbjct: 79  VAVKMLKSTAHAD-EKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 137
Query: 371 -------DKILHNNSSSSI---VLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACN 420
                   ++L  + + +I    LS    L+    VA  +++L     +  IHRDV A N
Sbjct: 138 LNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARN 194
Query: 421 ILLDAEFNAKLGDF----------------EATIPAGTMGYLAPEYVYSGVPSEKTDVYS 464
           +LL     AK+GDF                 A +P   + ++APE ++  V + ++DV+S
Sbjct: 195 VLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP---VKWMAPESIFDCVYTVQSDVWS 251
Query: 465 FGVVALEV-AAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVG 523
           +G++  E+ + G +P    G ++    + L K G  +    F  +  ++       +M  
Sbjct: 252 YGILLWEIFSLGLNPY--PGILVNSKFYKLVKDGYQMAQPAFAPKNIYS-------IMQA 302
Query: 524 LSCVHPNHEKRPSVKEAARILKGEA 548
              + P H  RP+ ++    L+ +A
Sbjct: 303 CWALEPTH--RPTFQQICSFLQEQA 325

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 96/221 (43%), Gaps = 23/221 (10%)
Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F   +I+GEG+ +TV     L +    A+K  EK + ++  + P+ T    +   L H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
            V+L     +  +L     Y  NG L K +    S     +      IV    SAL YLH
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLH 149
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF-------------EATIPAGTMGYLAPEYV 451
               + IIHRD+K  NILL+ + + ++ DF              A    GT  Y++PE +
Sbjct: 150 G---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 206
Query: 452 YSGVPSEKTDVYSFGVVALEVAAGKSP--VDNDGCVIVDWV 490
                 + +D+++ G +  ++ AG  P    N+G +    +
Sbjct: 207 TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKII 247

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/261 (23%), Positives = 114/261 (43%), Gaps = 41/261 (15%)
Query: 311 VAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSL 370
           VAVK  +     +  +    +E   M+   +H+N+V L G C  G  ++++ EY   G L
Sbjct: 71  VAVKMLKSTAHAD-EKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 129
Query: 371 DKILHNNSSSSI------VLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLD 424
              L   + + +       L     L+    VA  +++L     +  IHRDV A N+LL 
Sbjct: 130 LNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLT 186
Query: 425 AEFNAKLGDF----------------EATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVV 468
               AK+GDF                 A +P   + ++APE ++  V + ++DV+S+G++
Sbjct: 187 NGHVAKIGDFGLARDIMNDSNYIVKGNARLP---VKWMAPESIFDCVYTVQSDVWSYGIL 243
Query: 469 ALEV-AAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCV 527
             E+ + G +P    G ++    + L K G  +    F  +  ++       +M     +
Sbjct: 244 LWEIFSLGLNPY--PGILVNSKFYKLVKDGYQMAQPAFAPKNIYS-------IMQACWAL 294
Query: 528 HPNHEKRPSVKEAARILKGEA 548
            P H  RP+ ++    L+ +A
Sbjct: 295 EPTH--RPTFQQICSFLQEQA 313

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 21/207 (10%)
Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F   +I+GEG+ +TV     L +    A+K  EK + ++  + P+ T    +   L H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
            V+L     +  +L     Y  NG L K +    S     +      IV    SAL YLH
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIV----SALEYLH 149
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF-------------EATIPAGTMGYLAPEYV 451
               + IIHRD+K  NILL+ + + ++ DF              A    GT  Y++PE +
Sbjct: 150 G---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 206
Query: 452 YSGVPSEKTDVYSFGVVALEVAAGKSP 478
                S+ +D+++ G +  ++ AG  P
Sbjct: 207 TEKSASKSSDLWALGCIIYQLVAGLPP 233

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/261 (23%), Positives = 114/261 (43%), Gaps = 41/261 (15%)
Query: 311 VAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSL 370
           VAVK  +     +  +    +E   M+   +H+N+V L G C  G  ++++ EY   G L
Sbjct: 79  VAVKMLKSTAHAD-EKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 137
Query: 371 DKILHNNSSSSI------VLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLD 424
              L   + + +       L     L+    VA  +++L     +  IHRDV A N+LL 
Sbjct: 138 LNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLT 194
Query: 425 AEFNAKLGDF----------------EATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVV 468
               AK+GDF                 A +P   + ++APE ++  V + ++DV+S+G++
Sbjct: 195 NGHVAKIGDFGLARDIMNDSNYIVKGNARLP---VKWMAPESIFDCVYTVQSDVWSYGIL 251
Query: 469 ALEV-AAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCV 527
             E+ + G +P    G ++    + L K G  +    F  +  ++       +M     +
Sbjct: 252 LWEIFSLGLNPY--PGILVNSKFYKLVKDGYQMAQPAFAPKNIYS-------IMQACWAL 302
Query: 528 HPNHEKRPSVKEAARILKGEA 548
            P H  RP+ ++    L+ +A
Sbjct: 303 EPTH--RPTFQQICSFLQEQA 321

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 120/286 (41%), Gaps = 49/286 (17%)
Query: 279 IKQATLGFNKNRIVGEGASATVYKGSLPSGGA----VAVKRFEKPNRV-ECARNPFTTEF 333
           I  ++L  + N ++G G    VY G+L          AVK   +   + E ++  F TE 
Sbjct: 44  IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ--FLTEG 101
Query: 334 ATMAGCLRHKNLVQLQGWCC--EGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLN 391
             M     H N++ L G C   EG+ LV V  Y+ +G L   + N + +  V   +  + 
Sbjct: 102 IIMKD-FSHPNVLSLLGICLRSEGSPLV-VLPYMKHGDLRNFIRNETHNPTV---KDLIG 156
Query: 392 IVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF---------------EA 436
             L VA  + YL     ++ +HRD+ A N +LD +F  K+ DF                 
Sbjct: 157 FGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK 213
Query: 437 TIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKK 496
           T     + ++A E + +   + K+DV+SFGV+  E+    +P   D              
Sbjct: 214 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-------------- 259
Query: 497 GKLLDAADFRLRG-KFNRKEM--ERMLMVGLSCVHPNHEKRPSVKE 539
               D   + L+G +  + E   + +  V L C HP  E RPS  E
Sbjct: 260 VNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSE 305

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 120/286 (41%), Gaps = 49/286 (17%)
Query: 279 IKQATLGFNKNRIVGEGASATVYKGSLPSGGA----VAVKRFEKPNRV-ECARNPFTTEF 333
           I  ++L  + N ++G G    VY G+L          AVK   +   + E ++  F TE 
Sbjct: 22  IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ--FLTEG 79
Query: 334 ATMAGCLRHKNLVQLQGWCC--EGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLN 391
             M     H N++ L G C   EG+ LV V  Y+ +G L   + N + +  V   +  + 
Sbjct: 80  IIMKD-FSHPNVLSLLGICLRSEGSPLV-VLPYMKHGDLRNFIRNETHNPTV---KDLIG 134
Query: 392 IVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF---------------EA 436
             L VA  + YL     ++ +HRD+ A N +LD +F  K+ DF                 
Sbjct: 135 FGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK 191
Query: 437 TIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKK 496
           T     + ++A E + +   + K+DV+SFGV+  E+    +P   D              
Sbjct: 192 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-------------- 237
Query: 497 GKLLDAADFRLRG-KFNRKEM--ERMLMVGLSCVHPNHEKRPSVKE 539
               D   + L+G +  + E   + +  V L C HP  E RPS  E
Sbjct: 238 VNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSE 283

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 120/286 (41%), Gaps = 49/286 (17%)
Query: 279 IKQATLGFNKNRIVGEGASATVYKGSLPSGGA----VAVKRFEKPNRV-ECARNPFTTEF 333
           I  ++L  + N ++G G    VY G+L          AVK   +   + E ++  F TE 
Sbjct: 43  IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ--FLTEG 100
Query: 334 ATMAGCLRHKNLVQLQGWCC--EGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLN 391
             M     H N++ L G C   EG+ LV V  Y+ +G L   + N + +  V   +  + 
Sbjct: 101 IIMKD-FSHPNVLSLLGICLRSEGSPLV-VLPYMKHGDLRNFIRNETHNPTV---KDLIG 155
Query: 392 IVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF---------------EA 436
             L VA  + YL     ++ +HRD+ A N +LD +F  K+ DF                 
Sbjct: 156 FGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK 212
Query: 437 TIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKK 496
           T     + ++A E + +   + K+DV+SFGV+  E+    +P   D              
Sbjct: 213 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-------------- 258
Query: 497 GKLLDAADFRLRG-KFNRKEM--ERMLMVGLSCVHPNHEKRPSVKE 539
               D   + L+G +  + E   + +  V L C HP  E RPS  E
Sbjct: 259 VNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSE 304

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 120/286 (41%), Gaps = 49/286 (17%)
Query: 279 IKQATLGFNKNRIVGEGASATVYKGSLPSGGA----VAVKRFEKPNRV-ECARNPFTTEF 333
           I  ++L  + N ++G G    VY G+L          AVK   +   + E ++  F TE 
Sbjct: 17  IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ--FLTEG 74
Query: 334 ATMAGCLRHKNLVQLQGWCC--EGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLN 391
             M     H N++ L G C   EG+ LV V  Y+ +G L   + N + +  V   +  + 
Sbjct: 75  IIMKD-FSHPNVLSLLGICLRSEGSPLV-VLPYMKHGDLRNFIRNETHNPTV---KDLIG 129
Query: 392 IVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF---------------EA 436
             L VA  + YL     ++ +HRD+ A N +LD +F  K+ DF                 
Sbjct: 130 FGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK 186
Query: 437 TIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKK 496
           T     + ++A E + +   + K+DV+SFGV+  E+    +P   D              
Sbjct: 187 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-------------- 232
Query: 497 GKLLDAADFRLRG-KFNRKEM--ERMLMVGLSCVHPNHEKRPSVKE 539
               D   + L+G +  + E   + +  V L C HP  E RPS  E
Sbjct: 233 VNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSE 278

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 120/286 (41%), Gaps = 49/286 (17%)
Query: 279 IKQATLGFNKNRIVGEGASATVYKGSLPSGGA----VAVKRFEKPNRV-ECARNPFTTEF 333
           I  ++L  + N ++G G    VY G+L          AVK   +   + E ++  F TE 
Sbjct: 24  IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ--FLTEG 81
Query: 334 ATMAGCLRHKNLVQLQGWCC--EGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLN 391
             M     H N++ L G C   EG+ LV V  Y+ +G L   + N + +  V   +  + 
Sbjct: 82  IIMKD-FSHPNVLSLLGICLRSEGSPLV-VLPYMKHGDLRNFIRNETHNPTV---KDLIG 136
Query: 392 IVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF---------------EA 436
             L VA  + YL     ++ +HRD+ A N +LD +F  K+ DF                 
Sbjct: 137 FGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNK 193
Query: 437 TIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKK 496
           T     + ++A E + +   + K+DV+SFGV+  E+    +P   D              
Sbjct: 194 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-------------- 239
Query: 497 GKLLDAADFRLRG-KFNRKEM--ERMLMVGLSCVHPNHEKRPSVKE 539
               D   + L+G +  + E   + +  V L C HP  E RPS  E
Sbjct: 240 VNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSE 285

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 120/286 (41%), Gaps = 49/286 (17%)
Query: 279 IKQATLGFNKNRIVGEGASATVYKGSLPSGGA----VAVKRFEKPNRV-ECARNPFTTEF 333
           I  ++L  + N ++G G    VY G+L          AVK   +   + E ++  F TE 
Sbjct: 20  IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ--FLTEG 77
Query: 334 ATMAGCLRHKNLVQLQGWCC--EGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLN 391
             M     H N++ L G C   EG+ LV V  Y+ +G L   + N + +  V   +  + 
Sbjct: 78  IIMKD-FSHPNVLSLLGICLRSEGSPLV-VLPYMKHGDLRNFIRNETHNPTV---KDLIG 132
Query: 392 IVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF---------------EA 436
             L VA  + YL     ++ +HRD+ A N +LD +F  K+ DF                 
Sbjct: 133 FGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK 189
Query: 437 TIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKK 496
           T     + ++A E + +   + K+DV+SFGV+  E+    +P   D              
Sbjct: 190 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-------------- 235
Query: 497 GKLLDAADFRLRG-KFNRKEM--ERMLMVGLSCVHPNHEKRPSVKE 539
               D   + L+G +  + E   + +  V L C HP  E RPS  E
Sbjct: 236 VNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSE 281

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 120/286 (41%), Gaps = 49/286 (17%)
Query: 279 IKQATLGFNKNRIVGEGASATVYKGSLPSGGA----VAVKRFEKPNRV-ECARNPFTTEF 333
           I  ++L  + N ++G G    VY G+L          AVK   +   + E ++  F TE 
Sbjct: 23  IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ--FLTEG 80
Query: 334 ATMAGCLRHKNLVQLQGWCC--EGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLN 391
             M     H N++ L G C   EG+ LV V  Y+ +G L   + N + +  V   +  + 
Sbjct: 81  IIMKD-FSHPNVLSLLGICLRSEGSPLV-VLPYMKHGDLRNFIRNETHNPTV---KDLIG 135
Query: 392 IVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF---------------EA 436
             L VA  + YL     ++ +HRD+ A N +LD +F  K+ DF                 
Sbjct: 136 FGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK 192
Query: 437 TIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKK 496
           T     + ++A E + +   + K+DV+SFGV+  E+    +P   D              
Sbjct: 193 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-------------- 238
Query: 497 GKLLDAADFRLRG-KFNRKEM--ERMLMVGLSCVHPNHEKRPSVKE 539
               D   + L+G +  + E   + +  V L C HP  E RPS  E
Sbjct: 239 VNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSE 284

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 120/286 (41%), Gaps = 49/286 (17%)
Query: 279 IKQATLGFNKNRIVGEGASATVYKGSLPSGGA----VAVKRFEKPNRV-ECARNPFTTEF 333
           I  ++L  + N ++G G    VY G+L          AVK   +   + E ++  F TE 
Sbjct: 25  IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ--FLTEG 82
Query: 334 ATMAGCLRHKNLVQLQGWCC--EGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLN 391
             M     H N++ L G C   EG+ LV V  Y+ +G L   + N + +  V   +  + 
Sbjct: 83  IIMKD-FSHPNVLSLLGICLRSEGSPLV-VLPYMKHGDLRNFIRNETHNPTV---KDLIG 137
Query: 392 IVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF---------------EA 436
             L VA  + YL     ++ +HRD+ A N +LD +F  K+ DF                 
Sbjct: 138 FGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK 194
Query: 437 TIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKK 496
           T     + ++A E + +   + K+DV+SFGV+  E+    +P   D              
Sbjct: 195 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-------------- 240
Query: 497 GKLLDAADFRLRG-KFNRKEM--ERMLMVGLSCVHPNHEKRPSVKE 539
               D   + L+G +  + E   + +  V L C HP  E RPS  E
Sbjct: 241 VNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSE 286

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 23/208 (11%)
Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F   +I+GEG+ +TV     L +    A+K  EK + ++  + P+ T    +   L H  
Sbjct: 39  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 98
Query: 345 LVQLQGWCCEGNE-LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
            V+L  +C + +E L     Y  NG L K +    S     +      IV    SAL YL
Sbjct: 99  FVKLY-FCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYL 153
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF-------------EATIPAGTMGYLAPEY 450
           H    + IIHRD+K  NILL+ + + ++ DF              A    GT  Y++PE 
Sbjct: 154 HG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 210
Query: 451 VYSGVPSEKTDVYSFGVVALEVAAGKSP 478
           +      + +D+++ G +  ++ AG  P
Sbjct: 211 LTEKSACKSSDLWALGCIIYQLVAGLPP 238

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 65/265 (24%), Positives = 112/265 (42%), Gaps = 45/265 (16%)
Query: 311 VAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSL 370
           VAVK  +     +  +    +E   M+   +H+N+V L G C  G  ++++ EY   G L
Sbjct: 79  VAVKMLKSTAHAD-EKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 137
Query: 371 DKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE----------RQIIHRDVKACN 420
              L   S    VL  +    I    AS    LH   +          +  IHRDV A N
Sbjct: 138 LNFLRRKSR---VLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARN 194
Query: 421 ILLDAEFNAKLGDF----------------EATIPAGTMGYLAPEYVYSGVPSEKTDVYS 464
           +LL     AK+GDF                 A +P   + ++APE ++  V + ++DV+S
Sbjct: 195 VLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP---VKWMAPESIFDCVYTVQSDVWS 251
Query: 465 FGVVALEV-AAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVG 523
           +G++  E+ + G +P    G ++    + L K G  +    F  +  ++       +M  
Sbjct: 252 YGILLWEIFSLGLNPY--PGILVNSKFYKLVKDGYQMAQPAFAPKNIYS-------IMQA 302
Query: 524 LSCVHPNHEKRPSVKEAARILKGEA 548
              + P H  RP+ ++    L+ +A
Sbjct: 303 CWALEPTH--RPTFQQICSFLQEQA 325

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 21/207 (10%)
Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F   +I+GEG+ +TV     L +    A+K  EK + ++  + P+ T    +   L H  
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
            V+L     +  +L     Y  NG L K +    S     +      IV    SAL YLH
Sbjct: 70  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLH 125
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF-------------EATIPAGTMGYLAPEYV 451
               + IIHRD+K  NILL+ + + ++ DF              A    GT  Y++PE +
Sbjct: 126 G---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 182
Query: 452 YSGVPSEKTDVYSFGVVALEVAAGKSP 478
                 + +D+++ G +  ++ AG  P
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVAGLPP 209

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 21/207 (10%)
Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F   +I+GEG+ +TV     L +    A+K  EK + ++  + P+ T    +   L H  
Sbjct: 9   FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 68
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
            V+L     +  +L     Y  NG L K +    S     +      IV    SAL YLH
Sbjct: 69  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLH 124
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF-------------EATIPAGTMGYLAPEYV 451
               + IIHRD+K  NILL+ + + ++ DF              A    GT  Y++PE +
Sbjct: 125 G---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 181
Query: 452 YSGVPSEKTDVYSFGVVALEVAAGKSP 478
                 + +D+++ G +  ++ AG  P
Sbjct: 182 TEKSACKSSDLWALGCIIYQLVAGLPP 208

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 120/286 (41%), Gaps = 49/286 (17%)
Query: 279 IKQATLGFNKNRIVGEGASATVYKGSLPSGGA----VAVKRFEKPNRV-ECARNPFTTEF 333
           I  ++L  + N ++G G    VY G+L          AVK   +   + E ++  F TE 
Sbjct: 25  IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ--FLTEG 82
Query: 334 ATMAGCLRHKNLVQLQGWCC--EGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLN 391
             M     H N++ L G C   EG+ LV V  Y+ +G L   + N + +  V   +  + 
Sbjct: 83  IIMKD-FSHPNVLSLLGICLRSEGSPLV-VLPYMKHGDLRNFIRNETHNPTV---KDLIG 137
Query: 392 IVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF---------------EA 436
             L VA  + YL     ++ +HRD+ A N +LD +F  K+ DF                 
Sbjct: 138 FGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK 194
Query: 437 TIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKK 496
           T     + ++A E + +   + K+DV+SFGV+  E+    +P   D              
Sbjct: 195 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-------------- 240
Query: 497 GKLLDAADFRLRG-KFNRKEM--ERMLMVGLSCVHPNHEKRPSVKE 539
               D   + L+G +  + E   + +  V L C HP  E RPS  E
Sbjct: 241 VNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSE 286

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 120/286 (41%), Gaps = 49/286 (17%)
Query: 279 IKQATLGFNKNRIVGEGASATVYKGSLPSGGA----VAVKRFEKPNRV-ECARNPFTTEF 333
           I  ++L  + N ++G G    VY G+L          AVK   +   + E ++  F TE 
Sbjct: 24  IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ--FLTEG 81
Query: 334 ATMAGCLRHKNLVQLQGWCC--EGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLN 391
             M     H N++ L G C   EG+ LV V  Y+ +G L   + N + +  V   +  + 
Sbjct: 82  IIMKD-FSHPNVLSLLGICLRSEGSPLV-VLPYMKHGDLRNFIRNETHNPTV---KDLIG 136
Query: 392 IVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF---------------EA 436
             L VA  + YL     ++ +HRD+ A N +LD +F  K+ DF                 
Sbjct: 137 FGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK 193
Query: 437 TIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKK 496
           T     + ++A E + +   + K+DV+SFGV+  E+    +P   D              
Sbjct: 194 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-------------- 239
Query: 497 GKLLDAADFRLRG-KFNRKEM--ERMLMVGLSCVHPNHEKRPSVKE 539
               D   + L+G +  + E   + +  V L C HP  E RPS  E
Sbjct: 240 VNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSE 285

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 21/207 (10%)
Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F   +I+GEG+ +TV     L +    A+K  EK + ++  + P+ T    +   L H  
Sbjct: 11  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 70
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
            V+L     +  +L     Y  NG L K +    S     +      IV    SAL YLH
Sbjct: 71  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLH 126
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF-------------EATIPAGTMGYLAPEYV 451
               + IIHRD+K  NILL+ + + ++ DF              A    GT  Y++PE +
Sbjct: 127 G---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 183
Query: 452 YSGVPSEKTDVYSFGVVALEVAAGKSP 478
                 + +D+++ G +  ++ AG  P
Sbjct: 184 TEKSACKSSDLWALGCIIYQLVAGLPP 210

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 109/233 (46%), Gaps = 18/233 (7%)
Query: 252 KKRHDGRSKEDHVCTVQRVPMRLALTD---IKQATLGFNKNRIVGEGASATVYKGSLPSG 308
           KK +DG  ++  V  +   P +    D   I + +L   K   +G G    V+  +    
Sbjct: 149 KKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKK--LGAGQFGEVWMATYNKH 206
Query: 309 GAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNG 368
             VAVK   KP  +      F  E A +   L+H  LV+L         + ++ E++  G
Sbjct: 207 TKVAVKTM-KPGSMSV--EAFLAE-ANVMKTLQHDKLVKLHA-VVTKEPIYIITEFMAKG 261
Query: 369 SLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFN 428
           SL   L ++  S   L   K ++    +A  ++++ +   R  IHRD++A NIL+ A   
Sbjct: 262 SLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLV 316
Query: 429 AKLGDFE-ATIPAG-TMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSP 478
            K+ DF  A + A   + + APE +  G  + K+DV+SFG++ +E+   G+ P
Sbjct: 317 CKIADFGLARVGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 369

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 21/207 (10%)
Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F   +I+GEG+ +TV     L +    A+K  EK + ++  + P+ T    +   L H  
Sbjct: 16  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 75
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
            V+L     +  +L     Y  NG L K +    S     +      IV    SAL YLH
Sbjct: 76  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLH 131
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF-------------EATIPAGTMGYLAPEYV 451
               + IIHRD+K  NILL+ + + ++ DF              A    GT  Y++PE +
Sbjct: 132 G---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 188
Query: 452 YSGVPSEKTDVYSFGVVALEVAAGKSP 478
                 + +D+++ G +  ++ AG  P
Sbjct: 189 TEKSACKSSDLWALGCIIYQLVAGLPP 215

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 21/207 (10%)
Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F   +I+GEG+ +TV     L +    A+K  EK + ++  + P+ T    +   L H  
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
            V+L     +  +L     Y  NG L K +    S     +      IV    SAL YLH
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLH 147
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF-------------EATIPAGTMGYLAPEYV 451
               + IIHRD+K  NILL+ + + ++ DF              A    GT  Y++PE +
Sbjct: 148 G---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 204
Query: 452 YSGVPSEKTDVYSFGVVALEVAAGKSP 478
                 + +D+++ G +  ++ AG  P
Sbjct: 205 TEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 21/207 (10%)
Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F   +I+GEG+ +TV     L +    A+K  EK + ++  + P+ T    +   L H  
Sbjct: 12  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 71
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
            V+L     +  +L     Y  NG L K +    S     +      IV    SAL YLH
Sbjct: 72  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLH 127
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF-------------EATIPAGTMGYLAPEYV 451
               + IIHRD+K  NILL+ + + ++ DF              A    GT  Y++PE +
Sbjct: 128 G---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 184
Query: 452 YSGVPSEKTDVYSFGVVALEVAAGKSP 478
                 + +D+++ G +  ++ AG  P
Sbjct: 185 TEKSACKSSDLWALGCIIYQLVAGLPP 211

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 21/207 (10%)
Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F   +I+GEG+ +TV     L +    A+K  EK + ++  + P+ T    +   L H  
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
            V+L     +  +L     Y  NG L K +    S     +      IV    SAL YLH
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLH 147
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF-------------EATIPAGTMGYLAPEYV 451
               + IIHRD+K  NILL+ + + ++ DF              A    GT  Y++PE +
Sbjct: 148 G---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 204
Query: 452 YSGVPSEKTDVYSFGVVALEVAAGKSP 478
                 + +D+++ G +  ++ AG  P
Sbjct: 205 TEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 21/207 (10%)
Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F   +I+GEG+ +TV     L +    A+K  EK + ++  + P+ T    +   L H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
            V+L     +  +L     Y  NG L K +    S     +      IV    SAL YLH
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLH 149
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF-------------EATIPAGTMGYLAPEYV 451
               + IIHRD+K  NILL+ + + ++ DF              A    GT  Y++PE +
Sbjct: 150 G---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 206
Query: 452 YSGVPSEKTDVYSFGVVALEVAAGKSP 478
                 + +D+++ G +  ++ AG  P
Sbjct: 207 TEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 21/207 (10%)
Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F   +I+GEG+ +TV     L +    A+K  EK + ++  + P+ T    +   L H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
            V+L     +  +L     Y  NG L K +    S     +      IV    SAL YLH
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLH 149
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF-------------EATIPAGTMGYLAPEYV 451
               + IIHRD+K  NILL+ + + ++ DF              A    GT  Y++PE +
Sbjct: 150 G---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 206
Query: 452 YSGVPSEKTDVYSFGVVALEVAAGKSP 478
                 + +D+++ G +  ++ AG  P
Sbjct: 207 TEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 21/207 (10%)
Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F   +I+GEG+ +TV     L +    A+K  EK + ++  + P+ T    +   L H  
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 90
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
            V+L     +  +L     Y  NG L K +    S     +      IV    SAL YLH
Sbjct: 91  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLH 146
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF-------------EATIPAGTMGYLAPEYV 451
               + IIHRD+K  NILL+ + + ++ DF              A    GT  Y++PE +
Sbjct: 147 G---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 203
Query: 452 YSGVPSEKTDVYSFGVVALEVAAGKSP 478
                 + +D+++ G +  ++ AG  P
Sbjct: 204 TEKSACKSSDLWALGCIIYQLVAGLPP 230

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 89/207 (42%), Gaps = 25/207 (12%)
Query: 292 VGEGASATVYKGSLPSGGAVAV-KRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQG 350
           +G G+     K    S G + V K  +  +  E  +    +E   +   L+H N+V+   
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE-LKHPNIVRYYD 72
Query: 351 WCCE--GNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE 408
              +     L +V EY   G L  ++   +     L  E     VL V + L+   +EC 
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE----FVLRVMTQLTLALKECH 128
Query: 409 RQ------IIHRDVKACNILLDAEFNAKLGDFE-----------ATIPAGTMGYLAPEYV 451
           R+      ++HRD+K  N+ LD + N KLGDF            A    GT  Y++PE +
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQM 188
Query: 452 YSGVPSEKTDVYSFGVVALEVAAGKSP 478
                +EK+D++S G +  E+ A   P
Sbjct: 189 NRMSYNEKSDIWSLGCLLYELCALMPP 215

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 96/208 (46%), Gaps = 16/208 (7%)
Query: 280 KQATLGFNKNRIVGEGASATVYK-GSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAG 338
           K +   F   R +G G+   V+   S  +G   A+K  +K   V   +   T +   M  
Sbjct: 2   KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS 61
Query: 339 CLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVAS 398
            + H  ++++ G   +  ++ ++ +Y+  G L  +L  +      ++      + L    
Sbjct: 62  IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCL---- 117
Query: 399 ALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--EATIP------AGTMGYLAPEY 450
           AL YLH    + II+RD+K  NILLD   + K+ DF     +P       GT  Y+APE 
Sbjct: 118 ALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYXLCGTPDYIAPEV 174
Query: 451 VYSGVPSEKTDVYSFGVVALEVAAGKSP 478
           V +   ++  D +SFG++  E+ AG +P
Sbjct: 175 VSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 21/207 (10%)
Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F   +I+GEG+ +TV     L +    A+K  EK + ++  + P+ T    +   L H  
Sbjct: 37  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 96
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
            V+L     +  +L     Y  NG L K +    S     +      IV    SAL YLH
Sbjct: 97  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLH 152
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF-------------EATIPAGTMGYLAPEYV 451
               + IIHRD+K  NILL+ + + ++ DF              A    GT  Y++PE +
Sbjct: 153 G---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 209
Query: 452 YSGVPSEKTDVYSFGVVALEVAAGKSP 478
                 + +D+++ G +  ++ AG  P
Sbjct: 210 TEKSACKSSDLWALGCIIYQLVAGLPP 236

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 21/207 (10%)
Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F   +I+GEG+ +TV     L +    A+K  EK + ++  + P+ T    +   L H  
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 94
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
            V+L     +  +L     Y  NG L K +    S     +      IV    SAL YLH
Sbjct: 95  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLH 150
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF-------------EATIPAGTMGYLAPEYV 451
               + IIHRD+K  NILL+ + + ++ DF              A    GT  Y++PE +
Sbjct: 151 G---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 207
Query: 452 YSGVPSEKTDVYSFGVVALEVAAGKSP 478
                 + +D+++ G +  ++ AG  P
Sbjct: 208 TEKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 21/207 (10%)
Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F   +I+GEG+ +TV     L +    A+K  EK + ++  + P+ T    +   L H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
            V+L     +  +L     Y  NG L K +    S     +      IV    SAL YLH
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLH 149
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF-------------EATIPAGTMGYLAPEYV 451
               + IIHRD+K  NILL+ + + ++ DF              A    GT  Y++PE +
Sbjct: 150 G---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 206
Query: 452 YSGVPSEKTDVYSFGVVALEVAAGKSP 478
                 + +D+++ G +  ++ AG  P
Sbjct: 207 TEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/280 (23%), Positives = 117/280 (41%), Gaps = 42/280 (15%)
Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F    +VG G    VYKG  + +G   A+K  +     E        E   +     H+N
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE---EEIKQEINMLKKYSHHRN 82
Query: 345 LVQLQGWCCEGN------ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVAS 398
           +    G   + N      +L LV E+   GS+  ++ N   +++   W     I   +  
Sbjct: 83  IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW--IAYICREILR 140
Query: 399 ALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP-----------AGTMGYLA 447
            LS+LH+    ++IHRD+K  N+LL      KL DF  +              GT  ++A
Sbjct: 141 GLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMA 197
Query: 448 PEYVYSGVPSE-----KTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDA 502
           PE +      +     K+D++S G+ A+E+A G  P+ +        +  +R    +   
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD--------MHPMRALFLIPRN 249
Query: 503 ADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR 542
              RL+ K   K+ +  +    SC+  NH +RP+ ++  +
Sbjct: 250 PAPRLKSKKWSKKFQSFIE---SCLVKNHSQRPATEQLMK 286

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 21/207 (10%)
Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F   +I+GEG+ +TV     L +    A+K  EK + ++  + P+ T    +   L H  
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
            V+L     +  +L     Y  NG L K +    S     +      IV    SAL YLH
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLH 147
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF-------------EATIPAGTMGYLAPEYV 451
               + IIHRD+K  NILL+ + + ++ DF              A    GT  Y++PE +
Sbjct: 148 G---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELL 204
Query: 452 YSGVPSEKTDVYSFGVVALEVAAGKSP 478
                 + +D+++ G +  ++ AG  P
Sbjct: 205 TEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 92/200 (46%), Gaps = 22/200 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G    V+ G   +   VAVK   KP  +      F  E A +   L+H  LV+L   
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSV--QAFLEE-ANLMKTLQHDKLVRLYAV 75
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
             +   + ++ E++  GSL   L ++    ++L   K ++    +A  ++Y+     +  
Sbjct: 76  VTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLP--KLIDFSAQIAEGMAYIER---KNY 130
Query: 412 IHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVPSEK 459
           IHRD++A N+L+      K+ DF         E T   G    + + APE +  G  + K
Sbjct: 131 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIK 190
Query: 460 TDVYSFGVVALEVAA-GKSP 478
           ++V+SFG++  E+   GK P
Sbjct: 191 SNVWSFGILLYEIVTYGKIP 210

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 101/227 (44%), Gaps = 28/227 (12%)
Query: 292 VGEGASATVYKGSL-PSGGAVAVKRF-----EKPNRVECARNPFTTEFATMAGCLRHKNL 345
           +G+G    V+KG L      VA+K       E    +      F  E   M+  L H N+
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSN-LNHPNI 85
Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
           V+L G     N   +V E++P G L    H     +  + W  +L ++L +A  + Y+  
Sbjct: 86  VKLYGLM--HNPPRMVMEFVPCGDL---YHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN 140
Query: 406 ECERQIIHRDVKACNILL-----DAEFNAKLGDFEATIPA--------GTMGYLAPEYVY 452
           +    I+HRD+++ NI L     +A   AK+ DF  +  +        G   ++APE + 
Sbjct: 141 Q-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVHSVSGLLGNFQWMAPETIG 199
Query: 453 SGVPS--EKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKG 497
           +   S  EK D YSF ++   +  G+ P D      + ++  +R++G
Sbjct: 200 AEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG 246

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 87/208 (41%), Gaps = 20/208 (9%)
Query: 286 FNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNP--FTTEFATMAGCLRHK 343
           F+  R++G G+ A V    L     +   R  K   V    +     TE         H 
Sbjct: 54  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHP 113
Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
            LV L       + L  V EY+  G L  + H        L  E        ++ AL+YL
Sbjct: 114 FLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRK--LPEEHARFYSAEISLALNYL 169
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF----EATIPA-------GTMGYLAPEYVY 452
           HE   R II+RD+K  N+LLD+E + KL D+    E   P        GT  Y+APE + 
Sbjct: 170 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR 226
Query: 453 SGVPSEKTDVYSFGVVALEVAAGKSPVD 480
                   D ++ GV+  E+ AG+SP D
Sbjct: 227 GEDYGFSVDWWALGVLMFEMMAGRSPFD 254

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 89/207 (42%), Gaps = 25/207 (12%)
Query: 292 VGEGASATVYKGSLPSGGAVAV-KRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQG 350
           +G G+     K    S G + V K  +  +  E  +    +E   +   L+H N+V+   
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE-LKHPNIVRYYD 72
Query: 351 WCCE--GNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE 408
              +     L +V EY   G L  ++   +     L  E     VL V + L+   +EC 
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE----FVLRVMTQLTLALKECH 128
Query: 409 RQ------IIHRDVKACNILLDAEFNAKLGDFE-----------ATIPAGTMGYLAPEYV 451
           R+      ++HRD+K  N+ LD + N KLGDF            A    GT  Y++PE +
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQM 188
Query: 452 YSGVPSEKTDVYSFGVVALEVAAGKSP 478
                +EK+D++S G +  E+ A   P
Sbjct: 189 NRMSYNEKSDIWSLGCLLYELCALMPP 215

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 90/202 (44%), Gaps = 23/202 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G    V  G       VAVK  ++ +  E   + F  E  TM   L H  LV+  G 
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE---DEFFQEAQTMMK-LSHPKLVKFYGV 71
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
           C +   + +V EY+ NG L   L ++      L   + L +   V   +++L      Q 
Sbjct: 72  CSKEYPIYIVTEYISNGCLLNYLRSHGKG---LEPSQLLEMCYDVCEGMAFLES---HQF 125
Query: 412 IHRDVKACNILLDAEFNAKLGDFEAT---------IPAGT---MGYLAPEYVYSGVPSEK 459
           IHRD+ A N L+D +   K+ DF  T            GT   + + APE  +    S K
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSK 185
Query: 460 TDVYSFGVVALEV-AAGKSPVD 480
           +DV++FG++  EV + GK P D
Sbjct: 186 SDVWAFGILMWEVFSLGKMPYD 207

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 85/204 (41%), Gaps = 20/204 (9%)
Query: 286 FNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           F K   +G+G+   VYKG       V   +       E        E   ++ C     +
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYI 79
Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
            +  G   +  +L ++ EYL  GS   +L         ++      I+  +   L YLH 
Sbjct: 80  TRYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIA-----TILREILKGLDYLHS 134
Query: 406 ECERQIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTMGYLAPEYVYSG 454
           E +   IHRD+KA N+LL  + + KL DF           +     GT  ++APE +   
Sbjct: 135 ERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQS 191
Query: 455 VPSEKTDVYSFGVVALEVAAGKSP 478
               K D++S G+ A+E+A G+ P
Sbjct: 192 AYDFKADIWSLGITAIELAKGEPP 215

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 21/207 (10%)
Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F   +I+GEG+ +TV     L +    A+K  EK + ++  + P+ T    +   L H  
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 94
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
            V+L     +  +L     Y  NG L K +    S     +      IV    SAL YLH
Sbjct: 95  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLH 150
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF-------------EATIPAGTMGYLAPEYV 451
               + IIHRD+K  NILL+ + + ++ DF              A    GT  Y++PE +
Sbjct: 151 G---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 207
Query: 452 YSGVPSEKTDVYSFGVVALEVAAGKSP 478
                 + +D+++ G +  ++ AG  P
Sbjct: 208 TEKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 101/227 (44%), Gaps = 28/227 (12%)
Query: 292 VGEGASATVYKGSL-PSGGAVAVKRF-----EKPNRVECARNPFTTEFATMAGCLRHKNL 345
           +G+G    V+KG L      VA+K       E    +      F  E   M+  L H N+
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSN-LNHPNI 85
Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
           V+L G     N   +V E++P G L    H     +  + W  +L ++L +A  + Y+  
Sbjct: 86  VKLYGLM--HNPPRMVMEFVPCGDL---YHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN 140
Query: 406 ECERQIIHRDVKACNILL-----DAEFNAKLGDFEATIPA--------GTMGYLAPEYVY 452
           +    I+HRD+++ NI L     +A   AK+ DF  +  +        G   ++APE + 
Sbjct: 141 Q-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVHSVSGLLGNFQWMAPETIG 199
Query: 453 SGVPS--EKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKG 497
           +   S  EK D YSF ++   +  G+ P D      + ++  +R++G
Sbjct: 200 AEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG 246

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 21/207 (10%)
Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F   +I+GEG+ +TV     L +    A+K  EK + ++  + P+ T    +   L H  
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 90
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
            V+L     +  +L     Y  NG L K +    S     +      IV    SAL YLH
Sbjct: 91  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLH 146
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF-------------EATIPAGTMGYLAPEYV 451
               + IIHRD+K  NILL+ + + ++ DF              A    GT  Y++PE +
Sbjct: 147 G---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 203
Query: 452 YSGVPSEKTDVYSFGVVALEVAAGKSP 478
                 + +D+++ G +  ++ AG  P
Sbjct: 204 TEKSACKSSDLWALGCIIYQLVAGLPP 230

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 110/266 (41%), Gaps = 51/266 (19%)
Query: 307 SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG--NELVLVYEY 364
           +G  VAVK+ +  +  E     F  E   +   L+H N+V+ +G C       L L+ EY
Sbjct: 69  TGEVVAVKKLQ--HSTEEHLRDFEREIEILKS-LQHDNIVKYKGVCYSAGRRNLKLIMEY 125
Query: 365 LPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLD 424
           LP GSL   L  +      +   K L     +   + YL     ++ IHRD+   NIL++
Sbjct: 126 LPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVE 179
Query: 425 AEFNAKLGDFEAT--IPA------------GTMGYLAPEYVYSGVPSEKTDVYSFGVVAL 470
            E   K+GDF  T  +P               + + APE +     S  +DV+SFGVV  
Sbjct: 180 NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 239
Query: 471 E----VAAGKSPV---------DNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKE-- 515
           E    +   KSP          D  G +IV  +  L K             G+  R +  
Sbjct: 240 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN-----------GRLPRPDGC 288
Query: 516 MERMLMVGLSCVHPNHEKRPSVKEAA 541
            + + M+   C + N  +RPS ++ A
Sbjct: 289 PDEIYMIMTECWNNNVNQRPSFRDLA 314

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 87/208 (41%), Gaps = 20/208 (9%)
Query: 286 FNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNP--FTTEFATMAGCLRHK 343
           F+  R++G G+ A V    L     +   +  K   V    +     TE         H 
Sbjct: 11  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 70
Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
            LV L       + L  V EY+  G L  + H        L  E        ++ AL+YL
Sbjct: 71  FLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRK--LPEEHARFYSAEISLALNYL 126
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF----EATIPA-------GTMGYLAPEYVY 452
           HE   R II+RD+K  N+LLD+E + KL D+    E   P        GT  Y+APE + 
Sbjct: 127 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILR 183
Query: 453 SGVPSEKTDVYSFGVVALEVAAGKSPVD 480
                   D ++ GV+  E+ AG+SP D
Sbjct: 184 GEDYGFSVDWWALGVLMFEMMAGRSPFD 211

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 103/229 (44%), Gaps = 30/229 (13%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G    VY G           +  K + +E     F  E A M   ++H NLVQL G 
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKE-IKHPNLVQLLGV 96
Query: 352 CCEGNELVLVYEYLPNGSLDKIL---HNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE 408
           C       +V EY+P G+L   L   +    +++VL     L +   ++SA+ YL    +
Sbjct: 97  CTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVL-----LYMATQISSAMEYLE---K 148
Query: 409 RQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVP 456
           +  IHRD+ A N L+      K+ DF           T  AG    + + APE +     
Sbjct: 149 KNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTF 208
Query: 457 SEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAAD 504
           S K+DV++FGV+  E+A  G SP      + +  V++L +KG  ++  +
Sbjct: 209 SIKSDVWAFGVLLWEIATYGMSPYPG---IDLSQVYDLLEKGYRMEQPE 254

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 110/266 (41%), Gaps = 51/266 (19%)
Query: 307 SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG--NELVLVYEY 364
           +G  VAVK+ +  +  E     F  E   +   L+H N+V+ +G C       L L+ EY
Sbjct: 43  TGEVVAVKKLQ--HSTEEHLRDFEREIEILKS-LQHDNIVKYKGVCYSAGRRNLKLIMEY 99
Query: 365 LPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLD 424
           LP GSL   L  +      +   K L     +   + YL     ++ IHRD+   NIL++
Sbjct: 100 LPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVE 153
Query: 425 AEFNAKLGDFEAT--IPAGT------------MGYLAPEYVYSGVPSEKTDVYSFGVVAL 470
            E   K+GDF  T  +P               + + APE +     S  +DV+SFGVV  
Sbjct: 154 NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 213
Query: 471 E----VAAGKSPV---------DNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKE-- 515
           E    +   KSP          D  G +IV  +  L K             G+  R +  
Sbjct: 214 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN-----------GRLPRPDGC 262
Query: 516 MERMLMVGLSCVHPNHEKRPSVKEAA 541
            + + M+   C + N  +RPS ++ A
Sbjct: 263 PDEIYMIMTECWNNNVNQRPSFRDLA 288

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 89/207 (42%), Gaps = 25/207 (12%)
Query: 292 VGEGASATVYKGSLPSGGAVAV-KRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQG 350
           +G G+     K    S G + V K  +  +  E  +    +E   +   L+H N+V+   
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE-LKHPNIVRYYD 72
Query: 351 WCCE--GNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE 408
              +     L +V EY   G L  ++   +     L  E     VL V + L+   +EC 
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE----FVLRVMTQLTLALKECH 128
Query: 409 RQ------IIHRDVKACNILLDAEFNAKLGDFE-----------ATIPAGTMGYLAPEYV 451
           R+      ++HRD+K  N+ LD + N KLGDF            A    GT  Y++PE +
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYMSPEQM 188
Query: 452 YSGVPSEKTDVYSFGVVALEVAAGKSP 478
                +EK+D++S G +  E+ A   P
Sbjct: 189 NRMSYNEKSDIWSLGCLLYELCALMPP 215

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 91/197 (46%), Gaps = 18/197 (9%)
Query: 292 VGEGA-SATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQG 350
           +GEG+    +   S   G    +K           R     E A +A  ++H N+VQ + 
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLAN-MKHPNIVQYRE 90
Query: 351 WCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQ 410
              E   L +V +Y   G L K +  N+   ++   ++ L+  + +  AL ++H+   R+
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRI--NAQKGVLFQEDQILDWFVQICLALKHVHD---RK 145
Query: 411 IIHRDVKACNILLDAEFNAKLGDF------EATIP-----AGTMGYLAPEYVYSGVPSEK 459
           I+HRD+K+ NI L  +   +LGDF       +T+       GT  YL+PE   +   + K
Sbjct: 146 ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNK 205
Query: 460 TDVYSFGVVALEVAAGK 476
           +D+++ G V  E+   K
Sbjct: 206 SDIWALGCVLYELCTLK 222

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 109/243 (44%), Gaps = 28/243 (11%)
Query: 252 KKRHDGRSKEDHVCTVQRVPMRLALTD---IKQATLGFNKNRIVGEGASATVYKGSLPSG 308
           KK +DG  ++  V  +   P +    D   I + +L   K   +G G    V+  +    
Sbjct: 155 KKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKK--LGAGQFGEVWMATYNKH 212
Query: 309 GAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNG 368
             VAVK   KP  +      F  E A +   L+H  LV+L         + ++ E++  G
Sbjct: 213 TKVAVKTM-KPGSMSV--EAFLAE-ANVMKTLQHDKLVKLHA-VVTKEPIYIITEFMAKG 267
Query: 369 SLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFN 428
           SL   L ++  S   L   K ++    +A  ++++ +   R  IHRD++A NIL+ A   
Sbjct: 268 SLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLV 322
Query: 429 AKLGDF---------EATIPAGT---MGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-G 475
            K+ DF         E T   G    + + APE +  G  + K+DV+SFG++ +E+   G
Sbjct: 323 CKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYG 382
Query: 476 KSP 478
           + P
Sbjct: 383 RIP 385

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 99/215 (46%), Gaps = 25/215 (11%)
Query: 286 FNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           F +   +G G  ATVYKG   + G     +  K +  E   +    E + M   L+H+N+
Sbjct: 7   FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKE-LKHENI 65
Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIV----LGVASALS 401
           V+L       N+L LV+E++ N  L K + + +  +     E  LN+V      +   L+
Sbjct: 66  VRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLE--LNLVKYFQWQLLQGLA 122
Query: 402 YLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT----IPAG-------TMGYLAPEY 450
           + HE    +I+HRD+K  N+L++     KLGDF       IP         T+ Y AP+ 
Sbjct: 123 FCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDV 179
Query: 451 VY-SGVPSEKTDVYSFGVVALEVAAGKS--PVDND 482
           +  S   S   D++S G +  E+  GK   P  ND
Sbjct: 180 LMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND 214

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 110/266 (41%), Gaps = 51/266 (19%)
Query: 307 SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG--NELVLVYEY 364
           +G  VAVK+ +  +  E     F  E   +   L+H N+V+ +G C       L L+ EY
Sbjct: 41  TGEVVAVKKLQ--HSTEEHLRDFEREIEILKS-LQHDNIVKYKGVCYSAGRRNLKLIMEY 97
Query: 365 LPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLD 424
           LP GSL   L  +      +   K L     +   + YL     ++ IHRD+   NIL++
Sbjct: 98  LPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVE 151
Query: 425 AEFNAKLGDFEAT--IPAGT------------MGYLAPEYVYSGVPSEKTDVYSFGVVAL 470
            E   K+GDF  T  +P               + + APE +     S  +DV+SFGVV  
Sbjct: 152 NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 211
Query: 471 E----VAAGKSPV---------DNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKE-- 515
           E    +   KSP          D  G +IV  +  L K             G+  R +  
Sbjct: 212 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN-----------GRLPRPDGC 260
Query: 516 MERMLMVGLSCVHPNHEKRPSVKEAA 541
            + + M+   C + N  +RPS ++ A
Sbjct: 261 PDEIYMIMTECWNNNVNQRPSFRDLA 286

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 110/266 (41%), Gaps = 51/266 (19%)
Query: 307 SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG--NELVLVYEY 364
           +G  VAVK+ +  +  E     F  E   +   L+H N+V+ +G C       L L+ EY
Sbjct: 44  TGEVVAVKKLQ--HSTEEHLRDFEREIEILKS-LQHDNIVKYKGVCYSAGRRNLKLIMEY 100
Query: 365 LPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLD 424
           LP GSL   L  +      +   K L     +   + YL     ++ IHRD+   NIL++
Sbjct: 101 LPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVE 154
Query: 425 AEFNAKLGDFEAT--IPAGT------------MGYLAPEYVYSGVPSEKTDVYSFGVVAL 470
            E   K+GDF  T  +P               + + APE +     S  +DV+SFGVV  
Sbjct: 155 NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 214
Query: 471 E----VAAGKSPV---------DNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKE-- 515
           E    +   KSP          D  G +IV  +  L K             G+  R +  
Sbjct: 215 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN-----------GRLPRPDGC 263
Query: 516 MERMLMVGLSCVHPNHEKRPSVKEAA 541
            + + M+   C + N  +RPS ++ A
Sbjct: 264 PDEIYMIMTECWNNNVNQRPSFRDLA 289

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/286 (25%), Positives = 120/286 (41%), Gaps = 49/286 (17%)
Query: 279 IKQATLGFNKNRIVGEGASATVYKGSLPSGGA----VAVKRFEKPNRV-ECARNPFTTEF 333
           I  ++L  + N ++G G    VY G+L          AVK   +   + E ++  F TE 
Sbjct: 25  IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ--FLTEG 82
Query: 334 ATMAGCLRHKNLVQLQGWCC--EGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLN 391
             M     H N++ L G C   EG+ LV V  Y+ +G L   + N + +  V   +  + 
Sbjct: 83  IIMKD-FSHPNVLSLLGICLRSEGSPLV-VLPYMKHGDLRNFIRNETHNPTV---KDLIG 137
Query: 392 IVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF---------------EA 436
             L VA  + +L     ++ +HRD+ A N +LD +F  K+ DF                 
Sbjct: 138 FGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 194
Query: 437 TIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKK 496
           T     + ++A E + +   + K+DV+SFGV+  E+    +P   D              
Sbjct: 195 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-------------- 240
Query: 497 GKLLDAADFRLRG-KFNRKEM--ERMLMVGLSCVHPNHEKRPSVKE 539
               D   + L+G +  + E   + +  V L C HP  E RPS  E
Sbjct: 241 VNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSE 286

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/255 (24%), Positives = 110/255 (43%), Gaps = 42/255 (16%)
Query: 311 VAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSL 370
           VAVK   K +  E   +   +E   M    +HKN++ L G C +   L ++ EY   G+L
Sbjct: 104 VAVKML-KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 162
Query: 371 DKILHNNSSSSIVLSW------EKRL------NIVLGVASALSYLHEECERQIIHRDVKA 418
            + L       +  S+      E++L      +    VA  + YL     ++ IHRD+ A
Sbjct: 163 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAA 219
Query: 419 CNILLDAEFNAKLGDF-------------EATIPAGTMGYLAPEYVYSGVPSEKTDVYSF 465
            N+L+  +   K+ DF             + T     + ++APE ++  + + ++DV+SF
Sbjct: 220 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 279
Query: 466 GVVALEV-AAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGL 524
           GV+  E+   G SP      V V+ ++ L K+G  +D                 + M+  
Sbjct: 280 GVLLWEIFTLGGSPYPG---VPVEELFKLLKEGHRMDKPS---------NCTNELYMMMR 327
Query: 525 SCVHPNHEKRPSVKE 539
            C H    +RP+ K+
Sbjct: 328 DCWHAVPSQRPTFKQ 342

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 110/266 (41%), Gaps = 51/266 (19%)
Query: 307 SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG--NELVLVYEY 364
           +G  VAVK+ +  +  E     F  E   +   L+H N+V+ +G C       L L+ EY
Sbjct: 42  TGEVVAVKKLQ--HSTEEHLRDFEREIEILKS-LQHDNIVKYKGVCYSAGRRNLKLIMEY 98
Query: 365 LPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLD 424
           LP GSL   L  +      +   K L     +   + YL     ++ IHRD+   NIL++
Sbjct: 99  LPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVE 152
Query: 425 AEFNAKLGDFEAT--IPAGT------------MGYLAPEYVYSGVPSEKTDVYSFGVVAL 470
            E   K+GDF  T  +P               + + APE +     S  +DV+SFGVV  
Sbjct: 153 NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 212
Query: 471 E----VAAGKSPV---------DNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKE-- 515
           E    +   KSP          D  G +IV  +  L K             G+  R +  
Sbjct: 213 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN-----------GRLPRPDGC 261
Query: 516 MERMLMVGLSCVHPNHEKRPSVKEAA 541
            + + M+   C + N  +RPS ++ A
Sbjct: 262 PDEIYMIMTECWNNNVNQRPSFRDLA 287

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/291 (24%), Positives = 115/291 (39%), Gaps = 50/291 (17%)
Query: 286 FNKNRIVGEGASATVYKG------SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGC 339
            N  + +G GA   V +          +   VAVK   K            +E   +   
Sbjct: 29  LNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKML-KEGATHSEHRALMSELKILIHI 87
Query: 340 LRHKNLVQLQGWCCE-GNELVLVYEYLPNGSLDKILHNNSSSSI--------VLSWEKRL 390
             H N+V L G C + G  L+++ E+   G+L   L +  +  +         L+ E  +
Sbjct: 88  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLI 147
Query: 391 NIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF---------------- 434
                VA  + +L     R+ IHRD+ A NILL  +   K+ DF                
Sbjct: 148 XYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKG 204
Query: 435 EATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEV-AAGKSPVDNDGCVIVDWVWNL 493
           +A +P   + ++APE ++  V + ++DV+SFGV+  E+ + G SP    G  I +     
Sbjct: 205 DARLP---LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY--PGVKIDEEFXRR 259
Query: 494 RKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARIL 544
            K+G  + A D+             M    L C H    +RP+  E    L
Sbjct: 260 LKEGTRMRAPDY---------TTPEMYQTMLDCWHGEPSQRPTFSELVEHL 301

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 110/266 (41%), Gaps = 51/266 (19%)
Query: 307 SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG--NELVLVYEY 364
           +G  VAVK+ +  +  E     F  E   +   L+H N+V+ +G C       L L+ EY
Sbjct: 38  TGEVVAVKKLQ--HSTEEHLRDFEREIEILKS-LQHDNIVKYKGVCYSAGRRNLKLIMEY 94
Query: 365 LPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLD 424
           LP GSL   L  +      +   K L     +   + YL     ++ IHRD+   NIL++
Sbjct: 95  LPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVE 148
Query: 425 AEFNAKLGDFEAT--IPAGT------------MGYLAPEYVYSGVPSEKTDVYSFGVVAL 470
            E   K+GDF  T  +P               + + APE +     S  +DV+SFGVV  
Sbjct: 149 NENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 208
Query: 471 E----VAAGKSPV---------DNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKE-- 515
           E    +   KSP          D  G +IV  +  L K             G+  R +  
Sbjct: 209 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN-----------GRLPRPDGC 257
Query: 516 MERMLMVGLSCVHPNHEKRPSVKEAA 541
            + + M+   C + N  +RPS ++ A
Sbjct: 258 PDEIYMIMTECWNNNVNQRPSFRDLA 283

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 110/266 (41%), Gaps = 51/266 (19%)
Query: 307 SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG--NELVLVYEY 364
           +G  VAVK+ +  +  E     F  E   +   L+H N+V+ +G C       L L+ EY
Sbjct: 36  TGEVVAVKKLQ--HSTEEHLRDFEREIEILKS-LQHDNIVKYKGVCYSAGRRNLKLIMEY 92
Query: 365 LPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLD 424
           LP GSL   L  +      +   K L     +   + YL     ++ IHRD+   NIL++
Sbjct: 93  LPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVE 146
Query: 425 AEFNAKLGDFEAT--IPAGT------------MGYLAPEYVYSGVPSEKTDVYSFGVVAL 470
            E   K+GDF  T  +P               + + APE +     S  +DV+SFGVV  
Sbjct: 147 NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 206
Query: 471 E----VAAGKSPV---------DNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKE-- 515
           E    +   KSP          D  G +IV  +  L K             G+  R +  
Sbjct: 207 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN-----------GRLPRPDGC 255
Query: 516 MERMLMVGLSCVHPNHEKRPSVKEAA 541
            + + M+   C + N  +RPS ++ A
Sbjct: 256 PDEIYMIMTECWNNNVNQRPSFRDLA 281

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/286 (25%), Positives = 120/286 (41%), Gaps = 49/286 (17%)
Query: 279 IKQATLGFNKNRIVGEGASATVYKGSLPSGGA----VAVKRFEKPNRV-ECARNPFTTEF 333
           I  ++L  + N ++G G    VY G+L          AVK   +   + E ++  F TE 
Sbjct: 23  IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ--FLTEG 80
Query: 334 ATMAGCLRHKNLVQLQGWCC--EGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLN 391
             M     H N++ L G C   EG+ LV V  Y+ +G L   + N + +  V   +  + 
Sbjct: 81  IIMKD-FSHPNVLSLLGICLRSEGSPLV-VLPYMKHGDLRNFIRNETHNPTV---KDLIG 135
Query: 392 IVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF---------------EA 436
             L VA  + +L     ++ +HRD+ A N +LD +F  K+ DF                 
Sbjct: 136 FGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 192
Query: 437 TIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKK 496
           T     + ++A E + +   + K+DV+SFGV+  E+    +P   D              
Sbjct: 193 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-------------- 238
Query: 497 GKLLDAADFRLRG-KFNRKEM--ERMLMVGLSCVHPNHEKRPSVKE 539
               D   + L+G +  + E   + +  V L C HP  E RPS  E
Sbjct: 239 VNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSE 284

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 110/266 (41%), Gaps = 51/266 (19%)
Query: 307 SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG--NELVLVYEY 364
           +G  VAVK+ +  +  E     F  E   +   L+H N+V+ +G C       L L+ EY
Sbjct: 38  TGEVVAVKKLQ--HSTEEHLRDFEREIEILKS-LQHDNIVKYKGVCYSAGRRNLKLIMEY 94
Query: 365 LPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLD 424
           LP GSL   L  +      +   K L     +   + YL     ++ IHRD+   NIL++
Sbjct: 95  LPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVE 148
Query: 425 AEFNAKLGDFEAT--IPAGT------------MGYLAPEYVYSGVPSEKTDVYSFGVVAL 470
            E   K+GDF  T  +P               + + APE +     S  +DV+SFGVV  
Sbjct: 149 NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 208
Query: 471 E----VAAGKSPV---------DNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKE-- 515
           E    +   KSP          D  G +IV  +  L K             G+  R +  
Sbjct: 209 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN-----------GRLPRPDGC 257
Query: 516 MERMLMVGLSCVHPNHEKRPSVKEAA 541
            + + M+   C + N  +RPS ++ A
Sbjct: 258 PDEIYMIMTECWNNNVNQRPSFRDLA 283

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 110/266 (41%), Gaps = 51/266 (19%)
Query: 307 SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG--NELVLVYEY 364
           +G  VAVK+ +  +  E     F  E   +   L+H N+V+ +G C       L L+ EY
Sbjct: 45  TGEVVAVKKLQ--HSTEEHLRDFEREIEILKS-LQHDNIVKYKGVCYSAGRRNLKLIMEY 101
Query: 365 LPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLD 424
           LP GSL   L  +      +   K L     +   + YL     ++ IHRD+   NIL++
Sbjct: 102 LPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVE 155
Query: 425 AEFNAKLGDFEAT--IPAGT------------MGYLAPEYVYSGVPSEKTDVYSFGVVAL 470
            E   K+GDF  T  +P               + + APE +     S  +DV+SFGVV  
Sbjct: 156 NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 215
Query: 471 E----VAAGKSPV---------DNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKE-- 515
           E    +   KSP          D  G +IV  +  L K             G+  R +  
Sbjct: 216 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN-----------GRLPRPDGC 264
Query: 516 MERMLMVGLSCVHPNHEKRPSVKEAA 541
            + + M+   C + N  +RPS ++ A
Sbjct: 265 PDEIYMIMTECWNNNVNQRPSFRDLA 290

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 85/201 (42%), Gaps = 33/201 (16%)
Query: 311 VAVKRFEKPNRVECARNP-FTTEF---ATMAGCLRHKNLVQL----QGWCCEGNELVLVY 362
           VAVK      R + AR+P F   F   A  A  L H  +V +    +     G    +V 
Sbjct: 40  VAVKVL----RADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVM 95
Query: 363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNIL 422
           EY+   +L  I+H        ++ ++ + ++     AL++ H+     IIHRDVK  NIL
Sbjct: 96  EYVDGVTLRDIVHTEGP----MTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIL 148
Query: 423 LDAEFNAKLGDF--------------EATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVV 468
           + A    K+ DF              +     GT  YL+PE         ++DVYS G V
Sbjct: 149 ISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCV 208
Query: 469 ALEVAAGKSPVDNDGCVIVDW 489
             EV  G+ P   D  V V +
Sbjct: 209 LYEVLTGEPPFTGDSPVSVAY 229

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 87/208 (41%), Gaps = 20/208 (9%)
Query: 286 FNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNP--FTTEFATMAGCLRHK 343
           F+  R++G G+ A V    L     +   +  K   V    +     TE         H 
Sbjct: 7   FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 66
Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
            LV L       + L  V EY+  G L  + H        L  E        ++ AL+YL
Sbjct: 67  FLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRK--LPEEHARFYSAEISLALNYL 122
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF----EATIPA-------GTMGYLAPEYVY 452
           HE   R II+RD+K  N+LLD+E + KL D+    E   P        GT  Y+APE + 
Sbjct: 123 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILR 179
Query: 453 SGVPSEKTDVYSFGVVALEVAAGKSPVD 480
                   D ++ GV+  E+ AG+SP D
Sbjct: 180 GEDYGFSVDWWALGVLMFEMMAGRSPFD 207

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 98/214 (45%), Gaps = 25/214 (11%)
Query: 278 DIKQATLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMA 337
           +I + +L   K   +G G    V+  +      VAVK   KP  +      F  E A + 
Sbjct: 11  EIPRESLKLEKK--LGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSV--EAFLAE-ANVM 64
Query: 338 GCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVA 397
             L+H  LV+L         + ++ E++  GSL   L ++  S   L   K ++    +A
Sbjct: 65  KTLQHDKLVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIA 121
Query: 398 SALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGY 445
             ++++ +   R  IHRD++A NIL+ A    K+ DF         E T   G    + +
Sbjct: 122 EGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKW 178
Query: 446 LAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSP 478
            APE +  G  + K+DV+SFG++ +E+   G+ P
Sbjct: 179 TAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 212

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/255 (24%), Positives = 110/255 (43%), Gaps = 42/255 (16%)
Query: 311 VAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSL 370
           VAVK   K +  E   +   +E   M    +HKN++ L G C +   L ++ EY   G+L
Sbjct: 52  VAVKML-KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 110
Query: 371 DKILHNNSSSSIVLSW------EKRL------NIVLGVASALSYLHEECERQIIHRDVKA 418
            + L       +  S+      E++L      +    VA  + YL     ++ IHRD+ A
Sbjct: 111 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAA 167
Query: 419 CNILLDAEFNAKLGDF-------------EATIPAGTMGYLAPEYVYSGVPSEKTDVYSF 465
            N+L+  +   K+ DF             + T     + ++APE ++  + + ++DV+SF
Sbjct: 168 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 227
Query: 466 GVVALEV-AAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGL 524
           GV+  E+   G SP      V V+ ++ L K+G  +D                 + M+  
Sbjct: 228 GVLLWEIFTLGGSPYPG---VPVEELFKLLKEGHRMDKPS---------NCTNELYMMMR 275
Query: 525 SCVHPNHEKRPSVKE 539
            C H    +RP+ K+
Sbjct: 276 DCWHAVPSQRPTFKQ 290

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 110/266 (41%), Gaps = 51/266 (19%)
Query: 307 SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG--NELVLVYEY 364
           +G  VAVK+ +  +  E     F  E   +   L+H N+V+ +G C       L L+ EY
Sbjct: 37  TGEVVAVKKLQ--HSTEEHLRDFEREIEILKS-LQHDNIVKYKGVCYSAGRRNLKLIMEY 93
Query: 365 LPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLD 424
           LP GSL   L  +      +   K L     +   + YL     ++ IHRD+   NIL++
Sbjct: 94  LPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVE 147
Query: 425 AEFNAKLGDFEAT--IPAGT------------MGYLAPEYVYSGVPSEKTDVYSFGVVAL 470
            E   K+GDF  T  +P               + + APE +     S  +DV+SFGVV  
Sbjct: 148 NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 207
Query: 471 E----VAAGKSPV---------DNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKE-- 515
           E    +   KSP          D  G +IV  +  L K             G+  R +  
Sbjct: 208 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN-----------GRLPRPDGC 256
Query: 516 MERMLMVGLSCVHPNHEKRPSVKEAA 541
            + + M+   C + N  +RPS ++ A
Sbjct: 257 PDEIYMIMTECWNNNVNQRPSFRDLA 282

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/255 (24%), Positives = 110/255 (43%), Gaps = 42/255 (16%)
Query: 311 VAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSL 370
           VAVK   K +  E   +   +E   M    +HKN++ L G C +   L ++ EY   G+L
Sbjct: 63  VAVKML-KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 121
Query: 371 DKILHNNSSSSIVLSW------EKRL------NIVLGVASALSYLHEECERQIIHRDVKA 418
            + L       +  S+      E++L      +    VA  + YL     ++ IHRD+ A
Sbjct: 122 REYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAA 178
Query: 419 CNILLDAEFNAKLGDF-------------EATIPAGTMGYLAPEYVYSGVPSEKTDVYSF 465
            N+L+  +   K+ DF             + T     + ++APE ++  + + ++DV+SF
Sbjct: 179 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 238
Query: 466 GVVALEV-AAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGL 524
           GV+  E+   G SP      V V+ ++ L K+G  +D                 + M+  
Sbjct: 239 GVLLWEIFTLGGSPYPG---VPVEELFKLLKEGHRMDKPS---------NCTNELYMMMR 286
Query: 525 SCVHPNHEKRPSVKE 539
            C H    +RP+ K+
Sbjct: 287 DCWHAVPSQRPTFKQ 301

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 121/283 (42%), Gaps = 43/283 (15%)
Query: 279 IKQATLGFNKNRIVGEGASATVYKGSLPSGGA----VAVKRFEKPNRV-ECARNPFTTEF 333
           I  ++L  + N ++G G    VY G+L          AVK   +   + E ++  F TE 
Sbjct: 84  IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ--FLTEG 141
Query: 334 ATMAGCLRHKNLVQLQGWCC--EGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLN 391
             M     H N++ L G C   EG+ LV V  Y+ +G L   + N + +  V   +  + 
Sbjct: 142 IIMKD-FSHPNVLSLLGICLRSEGSPLV-VLPYMKHGDLRNFIRNETHNPTV---KDLIG 196
Query: 392 IVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF---------------EA 436
             L VA  + +L     ++ +HRD+ A N +LD +F  K+ DF                 
Sbjct: 197 FGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 253
Query: 437 TIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKK 496
           T     + ++A E + +   + K+DV+SFGV+  E+    +P   D       V+ L  +
Sbjct: 254 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL--Q 311
Query: 497 GKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKE 539
           G+ L   ++           + +  V L C HP  E RPS  E
Sbjct: 312 GRRLLQPEYC---------PDPLYEVMLKCWHPKAEMRPSFSE 345

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 101/227 (44%), Gaps = 28/227 (12%)
Query: 292 VGEGASATVYKGSL-PSGGAVAVKRF-----EKPNRVECARNPFTTEFATMAGCLRHKNL 345
           +G+G    V+KG L      VA+K       E    +      F  E   M+  L H N+
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSN-LNHPNI 85
Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
           V+L G     N   +V E++P G L    H     +  + W  +L ++L +A  + Y+  
Sbjct: 86  VKLYGLM--HNPPRMVMEFVPCGDL---YHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN 140
Query: 406 ECERQIIHRDVKACNILL-----DAEFNAKLGDFEATIPA--------GTMGYLAPEYVY 452
           +    I+HRD+++ NI L     +A   AK+ DF  +  +        G   ++APE + 
Sbjct: 141 Q-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLGNFQWMAPETIG 199
Query: 453 SGVPS--EKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKG 497
           +   S  EK D YSF ++   +  G+ P D      + ++  +R++G
Sbjct: 200 AEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG 246

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 111/266 (41%), Gaps = 51/266 (19%)
Query: 307 SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG--NELVLVYEY 364
           +G  VAVK+ +  +  E     F  E   +   L+H N+V+ +G C       L L+ EY
Sbjct: 41  TGEVVAVKKLQ--HSTEEHLRDFEREIEILKS-LQHDNIVKYKGVCYSAGRRNLKLIMEY 97
Query: 365 LPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLD 424
           LP GSL   L  ++     +   K L     +   + YL     ++ IHRD+   NIL++
Sbjct: 98  LPYGSLRDYLQAHAER---IDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVE 151
Query: 425 AEFNAKLGDFEAT--IPAGT------------MGYLAPEYVYSGVPSEKTDVYSFGVVAL 470
            E   K+GDF  T  +P               + + APE +     S  +DV+SFGVV  
Sbjct: 152 NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 211
Query: 471 E----VAAGKSPV---------DNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKE-- 515
           E    +   KSP          D  G +IV  +  L K             G+  R +  
Sbjct: 212 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN-----------GRLPRPDGC 260
Query: 516 MERMLMVGLSCVHPNHEKRPSVKEAA 541
            + + M+   C + N  +RPS ++ A
Sbjct: 261 PDEIYMIMTECWNNNVNQRPSFRDLA 286

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/286 (25%), Positives = 120/286 (41%), Gaps = 49/286 (17%)
Query: 279 IKQATLGFNKNRIVGEGASATVYKGSLPSGGA----VAVKRFEKPNRV-ECARNPFTTEF 333
           I  ++L  + N ++G G    VY G+L          AVK   +   + E ++  F TE 
Sbjct: 30  IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ--FLTEG 87
Query: 334 ATMAGCLRHKNLVQLQGWCC--EGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLN 391
             M     H N++ L G C   EG+ LV V  Y+ +G L   + N + +  V   +  + 
Sbjct: 88  IIMKD-FSHPNVLSLLGICLRSEGSPLV-VLPYMKHGDLRNFIRNETHNPTV---KDLIG 142
Query: 392 IVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF---------------EA 436
             L VA  + +L     ++ +HRD+ A N +LD +F  K+ DF                 
Sbjct: 143 FGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 199
Query: 437 TIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKK 496
           T     + ++A E + +   + K+DV+SFGV+  E+    +P   D              
Sbjct: 200 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-------------- 245
Query: 497 GKLLDAADFRLRG-KFNRKEM--ERMLMVGLSCVHPNHEKRPSVKE 539
               D   + L+G +  + E   + +  V L C HP  E RPS  E
Sbjct: 246 VNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSE 291

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/255 (24%), Positives = 110/255 (43%), Gaps = 42/255 (16%)
Query: 311 VAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSL 370
           VAVK   K +  E   +   +E   M    +HKN++ L G C +   L ++ EY   G+L
Sbjct: 63  VAVKML-KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 121
Query: 371 DKILHNNSSSSIVLSW------EKRL------NIVLGVASALSYLHEECERQIIHRDVKA 418
            + L       +  S+      E++L      +    VA  + YL     ++ IHRD+ A
Sbjct: 122 REYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAA 178
Query: 419 CNILLDAEFNAKLGDF-------------EATIPAGTMGYLAPEYVYSGVPSEKTDVYSF 465
            N+L+  +   K+ DF             + T     + ++APE ++  + + ++DV+SF
Sbjct: 179 RNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 238
Query: 466 GVVALEV-AAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGL 524
           GV+  E+   G SP      V V+ ++ L K+G  +D                 + M+  
Sbjct: 239 GVLLWEIFTLGGSPYPG---VPVEELFKLLKEGHRMDKPS---------NCTNELYMMMR 286
Query: 525 SCVHPNHEKRPSVKE 539
            C H    +RP+ K+
Sbjct: 287 DCWHAVPSQRPTFKQ 301

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/255 (24%), Positives = 110/255 (43%), Gaps = 42/255 (16%)
Query: 311 VAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSL 370
           VAVK   K +  E   +   +E   M    +HKN++ L G C +   L ++ EY   G+L
Sbjct: 63  VAVKML-KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 121
Query: 371 DKILHNNSSSSIVLSW------EKRL------NIVLGVASALSYLHEECERQIIHRDVKA 418
            + L       +  S+      E++L      +    VA  + YL     ++ IHRD+ A
Sbjct: 122 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAA 178
Query: 419 CNILLDAEFNAKLGDF-------------EATIPAGTMGYLAPEYVYSGVPSEKTDVYSF 465
            N+L+  +   K+ DF             + T     + ++APE ++  + + ++DV+SF
Sbjct: 179 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 238
Query: 466 GVVALEV-AAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGL 524
           GV+  E+   G SP      V V+ ++ L K+G  +D                 + M+  
Sbjct: 239 GVLLWEIFTLGGSPYPG---VPVEELFKLLKEGHRMDKPS---------NCTNELYMMMR 286
Query: 525 SCVHPNHEKRPSVKE 539
            C H    +RP+ K+
Sbjct: 287 DCWHAVPSQRPTFKQ 301

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 110/266 (41%), Gaps = 51/266 (19%)
Query: 307 SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG--NELVLVYEY 364
           +G  VAVK+ +  +  E     F  E   +   L+H N+V+ +G C       L L+ EY
Sbjct: 38  TGEVVAVKKLQ--HSTEEHLRDFEREIEILKS-LQHDNIVKYKGVCYSAGRRNLKLIMEY 94
Query: 365 LPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLD 424
           LP GSL   L  +      +   K L     +   + YL     ++ IHRD+   NIL++
Sbjct: 95  LPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVE 148
Query: 425 AEFNAKLGDFEAT--IPAGT------------MGYLAPEYVYSGVPSEKTDVYSFGVVAL 470
            E   K+GDF  T  +P               + + APE +     S  +DV+SFGVV  
Sbjct: 149 NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 208
Query: 471 E----VAAGKSPV---------DNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKE-- 515
           E    +   KSP          D  G +IV  +  L K             G+  R +  
Sbjct: 209 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN-----------GRLPRPDGC 257
Query: 516 MERMLMVGLSCVHPNHEKRPSVKEAA 541
            + + M+   C + N  +RPS ++ A
Sbjct: 258 PDEIYMIMTECWNNNVNQRPSFRDLA 283

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/255 (24%), Positives = 110/255 (43%), Gaps = 42/255 (16%)
Query: 311 VAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSL 370
           VAVK   K +  E   +   +E   M    +HKN++ L G C +   L ++ EY   G+L
Sbjct: 55  VAVKML-KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 113
Query: 371 DKILHNNSSSSIVLSW------EKRL------NIVLGVASALSYLHEECERQIIHRDVKA 418
            + L       +  S+      E++L      +    VA  + YL     ++ IHRD+ A
Sbjct: 114 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAA 170
Query: 419 CNILLDAEFNAKLGDF-------------EATIPAGTMGYLAPEYVYSGVPSEKTDVYSF 465
            N+L+  +   K+ DF             + T     + ++APE ++  + + ++DV+SF
Sbjct: 171 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 230
Query: 466 GVVALEV-AAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGL 524
           GV+  E+   G SP      V V+ ++ L K+G  +D                 + M+  
Sbjct: 231 GVLLWEIFTLGGSPYPG---VPVEELFKLLKEGHRMDKPS---------NCTNELYMMMR 278
Query: 525 SCVHPNHEKRPSVKE 539
            C H    +RP+ K+
Sbjct: 279 DCWHAVPSQRPTFKQ 293

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/286 (25%), Positives = 120/286 (41%), Gaps = 49/286 (17%)
Query: 279 IKQATLGFNKNRIVGEGASATVYKGSLPSGGA----VAVKRFEKPNRV-ECARNPFTTEF 333
           I  ++L  + N ++G G    VY G+L          AVK   +   + E ++  F TE 
Sbjct: 26  IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ--FLTEG 83
Query: 334 ATMAGCLRHKNLVQLQGWCC--EGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLN 391
             M     H N++ L G C   EG+ LV V  Y+ +G L   + N + +  V   +  + 
Sbjct: 84  IIMKD-FSHPNVLSLLGICLRSEGSPLV-VLPYMKHGDLRNFIRNETHNPTV---KDLIG 138
Query: 392 IVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF---------------EA 436
             L VA  + +L     ++ +HRD+ A N +LD +F  K+ DF                 
Sbjct: 139 FGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 195
Query: 437 TIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKK 496
           T     + ++A E + +   + K+DV+SFGV+  E+    +P   D              
Sbjct: 196 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-------------- 241
Query: 497 GKLLDAADFRLRG-KFNRKEM--ERMLMVGLSCVHPNHEKRPSVKE 539
               D   + L+G +  + E   + +  V L C HP  E RPS  E
Sbjct: 242 VNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSE 287

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/286 (25%), Positives = 120/286 (41%), Gaps = 49/286 (17%)
Query: 279 IKQATLGFNKNRIVGEGASATVYKGSLPSGGA----VAVKRFEKPNRV-ECARNPFTTEF 333
           I  ++L  + N ++G G    VY G+L          AVK   +   + E ++  F TE 
Sbjct: 25  IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ--FLTEG 82
Query: 334 ATMAGCLRHKNLVQLQGWCC--EGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLN 391
             M     H N++ L G C   EG+ LV V  Y+ +G L   + N + +  V   +  + 
Sbjct: 83  IIMKD-FSHPNVLSLLGICLRSEGSPLV-VLPYMKHGDLRNFIRNETHNPTV---KDLIG 137
Query: 392 IVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF---------------EA 436
             L VA  + +L     ++ +HRD+ A N +LD +F  K+ DF                 
Sbjct: 138 FGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 194
Query: 437 TIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKK 496
           T     + ++A E + +   + K+DV+SFGV+  E+    +P   D              
Sbjct: 195 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-------------- 240
Query: 497 GKLLDAADFRLRG-KFNRKEM--ERMLMVGLSCVHPNHEKRPSVKE 539
               D   + L+G +  + E   + +  V L C HP  E RPS  E
Sbjct: 241 VNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSE 286

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 110/266 (41%), Gaps = 51/266 (19%)
Query: 307 SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG--NELVLVYEY 364
           +G  VAVK+ +  +  E     F  E   +   L+H N+V+ +G C       L L+ EY
Sbjct: 56  TGEVVAVKKLQ--HSTEEHLRDFEREIEILKS-LQHDNIVKYKGVCYSAGRRNLKLIMEY 112
Query: 365 LPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLD 424
           LP GSL   L  +      +   K L     +   + YL     ++ IHRD+   NIL++
Sbjct: 113 LPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVE 166
Query: 425 AEFNAKLGDFEAT--IPAGT------------MGYLAPEYVYSGVPSEKTDVYSFGVVAL 470
            E   K+GDF  T  +P               + + APE +     S  +DV+SFGVV  
Sbjct: 167 NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 226
Query: 471 E----VAAGKSPV---------DNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKE-- 515
           E    +   KSP          D  G +IV  +  L K             G+  R +  
Sbjct: 227 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN-----------GRLPRPDGC 275
Query: 516 MERMLMVGLSCVHPNHEKRPSVKEAA 541
            + + M+   C + N  +RPS ++ A
Sbjct: 276 PDEIYMIMTECWNNNVNQRPSFRDLA 301

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 87/208 (41%), Gaps = 20/208 (9%)
Query: 286 FNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNP--FTTEFATMAGCLRHK 343
           F+  R++G G+ A V    L     +   +  K   V    +     TE         H 
Sbjct: 22  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 81
Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
            LV L       + L  V EY+  G L  + H        L  E        ++ AL+YL
Sbjct: 82  FLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRK--LPEEHARFYSAEISLALNYL 137
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF----EATIPA-------GTMGYLAPEYVY 452
           HE   R II+RD+K  N+LLD+E + KL D+    E   P        GT  Y+APE + 
Sbjct: 138 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILR 194
Query: 453 SGVPSEKTDVYSFGVVALEVAAGKSPVD 480
                   D ++ GV+  E+ AG+SP D
Sbjct: 195 GEDYGFSVDWWALGVLMFEMMAGRSPFD 222

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/286 (25%), Positives = 120/286 (41%), Gaps = 49/286 (17%)
Query: 279 IKQATLGFNKNRIVGEGASATVYKGSLPSGGA----VAVKRFEKPNRV-ECARNPFTTEF 333
           I  ++L  + N ++G G    VY G+L          AVK   +   + E ++  F TE 
Sbjct: 26  IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ--FLTEG 83
Query: 334 ATMAGCLRHKNLVQLQGWCC--EGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLN 391
             M     H N++ L G C   EG+ LV V  Y+ +G L   + N + +  V   +  + 
Sbjct: 84  IIMKD-FSHPNVLSLLGICLRSEGSPLV-VLPYMKHGDLRNFIRNETHNPTV---KDLIG 138
Query: 392 IVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF---------------EA 436
             L VA  + +L     ++ +HRD+ A N +LD +F  K+ DF                 
Sbjct: 139 FGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNK 195
Query: 437 TIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKK 496
           T     + ++A E + +   + K+DV+SFGV+  E+    +P   D              
Sbjct: 196 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-------------- 241
Query: 497 GKLLDAADFRLRG-KFNRKEM--ERMLMVGLSCVHPNHEKRPSVKE 539
               D   + L+G +  + E   + +  V L C HP  E RPS  E
Sbjct: 242 VNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSE 287

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/255 (24%), Positives = 110/255 (43%), Gaps = 42/255 (16%)
Query: 311 VAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSL 370
           VAVK   K +  E   +   +E   M    +HKN++ L G C +   L ++ EY   G+L
Sbjct: 56  VAVKML-KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 114
Query: 371 DKILHNNSSSSIVLSW------EKRL------NIVLGVASALSYLHEECERQIIHRDVKA 418
            + L       +  S+      E++L      +    VA  + YL     ++ IHRD+ A
Sbjct: 115 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAA 171
Query: 419 CNILLDAEFNAKLGDF-------------EATIPAGTMGYLAPEYVYSGVPSEKTDVYSF 465
            N+L+  +   K+ DF             + T     + ++APE ++  + + ++DV+SF
Sbjct: 172 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 231
Query: 466 GVVALEV-AAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGL 524
           GV+  E+   G SP      V V+ ++ L K+G  +D                 + M+  
Sbjct: 232 GVLLWEIFTLGGSPYPG---VPVEELFKLLKEGHRMDKPS---------NCTNELYMMMR 279
Query: 525 SCVHPNHEKRPSVKE 539
            C H    +RP+ K+
Sbjct: 280 DCWHAVPSQRPTFKQ 294

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 92/203 (45%), Gaps = 27/203 (13%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G    VY+G           +  K + +E     F  E A M   ++H NLVQL G 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKE-IKHPNLVQLLGV 79
Query: 352 CCEGNELVLVYEYLPNGSLDKIL---HNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE 408
           C       ++ E++  G+L   L   +    +++VL     L +   ++SA+ YL    +
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAMEYLE---K 131
Query: 409 RQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVP 456
           +  IHRD+ A N L+      K+ DF           T PAG    + + APE +     
Sbjct: 132 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKF 191
Query: 457 SEKTDVYSFGVVALEVAA-GKSP 478
           S K+DV++FGV+  E+A  G SP
Sbjct: 192 SIKSDVWAFGVLLWEIATYGMSP 214

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 110/266 (41%), Gaps = 51/266 (19%)
Query: 307 SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG--NELVLVYEY 364
           +G  VAVK+ +  +  E     F  E   +   L+H N+V+ +G C       L L+ EY
Sbjct: 56  TGEVVAVKKLQ--HSTEEHLRDFEREIEILKS-LQHDNIVKYKGVCYSAGRRNLKLIMEY 112
Query: 365 LPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLD 424
           LP GSL   L  +      +   K L     +   + YL     ++ IHRD+   NIL++
Sbjct: 113 LPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVE 166
Query: 425 AEFNAKLGDFEAT--IPAGT------------MGYLAPEYVYSGVPSEKTDVYSFGVVAL 470
            E   K+GDF  T  +P               + + APE +     S  +DV+SFGVV  
Sbjct: 167 NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 226
Query: 471 E----VAAGKSPV---------DNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKE-- 515
           E    +   KSP          D  G +IV  +  L K             G+  R +  
Sbjct: 227 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN-----------GRLPRPDGC 275
Query: 516 MERMLMVGLSCVHPNHEKRPSVKEAA 541
            + + M+   C + N  +RPS ++ A
Sbjct: 276 PDEIYMIMTECWNNNVNQRPSFRDLA 301

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 92/200 (46%), Gaps = 23/200 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G+G    V+ G+      VA+K   KP  +  +   F  E   M   LRH+ LVQL   
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTM--SPEAFLQEAQVMKK-LRHEKLVQLYAV 71
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
             E   + +V EY+  GSL   L   +   + L   + +++   +AS ++Y+        
Sbjct: 72  VSE-EPIXIVTEYMSKGSLLDFLKGETGKYLRLP--QLVDMAAQIASGMAYVER---MNY 125
Query: 412 IHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVPSEK 459
           +HRD++A NIL+      K+ DF         E T   G    + + APE    G  + K
Sbjct: 126 VHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIK 185
Query: 460 TDVYSFGVVALEVAA-GKSP 478
           +DV+SFG++  E+   G+ P
Sbjct: 186 SDVWSFGILLTELTTKGRVP 205

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 85/201 (42%), Gaps = 33/201 (16%)
Query: 311 VAVKRFEKPNRVECARNP-FTTEF---ATMAGCLRHKNLVQL----QGWCCEGNELVLVY 362
           VAVK      R + AR+P F   F   A  A  L H  +V +    +     G    +V 
Sbjct: 40  VAVKVL----RADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVM 95
Query: 363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNIL 422
           EY+   +L  I+H        ++ ++ + ++     AL++ H+     IIHRDVK  NI+
Sbjct: 96  EYVDGVTLRDIVHTEGP----MTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIM 148
Query: 423 LDAEFNAKLGDF--------------EATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVV 468
           + A    K+ DF              +     GT  YL+PE         ++DVYS G V
Sbjct: 149 ISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCV 208
Query: 469 ALEVAAGKSPVDNDGCVIVDW 489
             EV  G+ P   D  V V +
Sbjct: 209 LYEVLTGEPPFTGDSPVSVAY 229

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 92/203 (45%), Gaps = 27/203 (13%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G    VY+G           +  K + +E     F  E A M   ++H NLVQL G 
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKE-IKHPNLVQLLGV 78
Query: 352 CCEGNELVLVYEYLPNGSLDKIL---HNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE 408
           C       ++ E++  G+L   L   +    +++VL     L +   ++SA+ YL    +
Sbjct: 79  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAMEYLE---K 130
Query: 409 RQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVP 456
           +  IHRD+ A N L+      K+ DF           T PAG    + + APE +     
Sbjct: 131 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKF 190
Query: 457 SEKTDVYSFGVVALEVAA-GKSP 478
           S K+DV++FGV+  E+A  G SP
Sbjct: 191 SIKSDVWAFGVLLWEIATYGMSP 213

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 85/201 (42%), Gaps = 33/201 (16%)
Query: 311 VAVKRFEKPNRVECARNP-FTTEF---ATMAGCLRHKNLVQL----QGWCCEGNELVLVY 362
           VAVK      R + AR+P F   F   A  A  L H  +V +    +     G    +V 
Sbjct: 40  VAVKVL----RADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVM 95
Query: 363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNIL 422
           EY+   +L  I+H        ++ ++ + ++     AL++ H+     IIHRDVK  NI+
Sbjct: 96  EYVDGVTLRDIVHTEGP----MTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIM 148
Query: 423 LDAEFNAKLGDF--------------EATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVV 468
           + A    K+ DF              +     GT  YL+PE         ++DVYS G V
Sbjct: 149 ISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCV 208
Query: 469 ALEVAAGKSPVDNDGCVIVDW 489
             EV  G+ P   D  V V +
Sbjct: 209 LYEVLTGEPPFTGDSPVSVAY 229

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 85/201 (42%), Gaps = 33/201 (16%)
Query: 311 VAVKRFEKPNRVECARNP-FTTEF---ATMAGCLRHKNLVQL----QGWCCEGNELVLVY 362
           VAVK      R + AR+P F   F   A  A  L H  +V +    +     G    +V 
Sbjct: 40  VAVKVL----RADLARDPSFYLRFRREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVM 95
Query: 363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNIL 422
           EY+   +L  I+H        ++ ++ + ++     AL++ H+     IIHRDVK  NI+
Sbjct: 96  EYVDGVTLRDIVHTEGP----MTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIM 148
Query: 423 LDAEFNAKLGDF--------------EATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVV 468
           + A    K+ DF              +     GT  YL+PE         ++DVYS G V
Sbjct: 149 ISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCV 208
Query: 469 ALEVAAGKSPVDNDGCVIVDW 489
             EV  G+ P   D  V V +
Sbjct: 209 LYEVLTGEPPFTGDSPVSVAY 229

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 71/266 (26%), Positives = 111/266 (41%), Gaps = 51/266 (19%)
Query: 307 SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG--NELVLVYEY 364
           +G  VAVK+ +  +  E     F  E   +   L+H N+V+ +G C       L L+ E+
Sbjct: 41  TGEVVAVKKLQ--HSTEEHLRDFEREIEILKS-LQHDNIVKYKGVCYSAGRRNLKLIMEF 97
Query: 365 LPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLD 424
           LP GSL + L  +      +   K L     +   + YL     ++ IHRD+   NIL++
Sbjct: 98  LPYGSLREYLQKHKER---IDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVE 151
Query: 425 AEFNAKLGDFEAT--IPAGT------------MGYLAPEYVYSGVPSEKTDVYSFGVVAL 470
            E   K+GDF  T  +P               + + APE +     S  +DV+SFGVV  
Sbjct: 152 NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 211
Query: 471 E----VAAGKSPV---------DNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKE-- 515
           E    +   KSP          D  G +IV  +  L K             G+  R +  
Sbjct: 212 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN-----------GRLPRPDGC 260
Query: 516 MERMLMVGLSCVHPNHEKRPSVKEAA 541
            + + M+   C + N  +RPS ++ A
Sbjct: 261 PDEIYMIMTECWNNNVNQRPSFRDLA 286

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/267 (23%), Positives = 113/267 (42%), Gaps = 47/267 (17%)
Query: 311 VAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSL 370
           VAVK  +     +  +    +E   M+   +H+N+V L G C  G  ++++ EY   G L
Sbjct: 79  VAVKMLKSTAHAD-EKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 137
Query: 371 DKILHNNSSSSIVLSWEKR------------LNIVLGVASALSYLHEECERQIIHRDVKA 418
              L       +  S+               L+    VA  +++L     +  IHRDV A
Sbjct: 138 LNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFL---ASKNCIHRDVAA 194
Query: 419 CNILLDAEFNAKLGDF----------------EATIPAGTMGYLAPEYVYSGVPSEKTDV 462
            N+LL     AK+GDF                 A +P   + ++APE ++  V + ++DV
Sbjct: 195 RNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP---VKWMAPESIFDCVYTVQSDV 251
Query: 463 YSFGVVALEV-AAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLM 521
           +S+G++  E+ + G +P    G ++    + L K G  +    F  +  ++       +M
Sbjct: 252 WSYGILLWEIFSLGLNPY--PGILVNSKFYKLVKDGYQMAQPAFAPKNIYS-------IM 302
Query: 522 VGLSCVHPNHEKRPSVKEAARILKGEA 548
                + P H  RP+ ++    L+ +A
Sbjct: 303 QACWALEPTH--RPTFQQICSFLQEQA 327

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 85/201 (42%), Gaps = 33/201 (16%)
Query: 311 VAVKRFEKPNRVECARNP-FTTEF---ATMAGCLRHKNLVQL----QGWCCEGNELVLVY 362
           VAVK      R + AR+P F   F   A  A  L H  +V +    +     G    +V 
Sbjct: 57  VAVKVL----RADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVM 112
Query: 363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNIL 422
           EY+   +L  I+H        ++ ++ + ++     AL++ H+     IIHRDVK  NI+
Sbjct: 113 EYVDGVTLRDIVHTEGP----MTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIM 165
Query: 423 LDAEFNAKLGDF--------------EATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVV 468
           + A    K+ DF              +     GT  YL+PE         ++DVYS G V
Sbjct: 166 ISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCV 225
Query: 469 ALEVAAGKSPVDNDGCVIVDW 489
             EV  G+ P   D  V V +
Sbjct: 226 LYEVLTGEPPFTGDSPVSVAY 246

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/255 (24%), Positives = 108/255 (42%), Gaps = 42/255 (16%)
Query: 311 VAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSL 370
           VAVK   K +  E   +   +E   M    +HKN++ L G C +   L ++ EY   G+L
Sbjct: 63  VAVKML-KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 121
Query: 371 DKILHNNSSSSI------------VLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKA 418
            + L       +             LS +  ++    VA  + YL     ++ IHRD+ A
Sbjct: 122 REYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAA 178
Query: 419 CNILLDAEFNAKLGDF-------------EATIPAGTMGYLAPEYVYSGVPSEKTDVYSF 465
            N+L+  +   K+ DF             + T     + ++APE ++  + + ++DV+SF
Sbjct: 179 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 238
Query: 466 GVVALEV-AAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGL 524
           GV+  E+   G SP      V V+ ++ L K+G  +D                 + M+  
Sbjct: 239 GVLLWEIFTLGGSPYPG---VPVEELFKLLKEGHRMDKPS---------NCTNELYMMMR 286
Query: 525 SCVHPNHEKRPSVKE 539
            C H    +RP+ K+
Sbjct: 287 DCWHAVPSQRPTFKQ 301

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 109/266 (40%), Gaps = 51/266 (19%)
Query: 307 SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG--NELVLVYEY 364
           +G  VAVK+ +  +  E     F  E   +   L+H N+V+ +G C       L L+ EY
Sbjct: 39  TGEVVAVKKLQ--HSTEEHLRDFEREIEILKS-LQHDNIVKYKGVCYSAGRRNLKLIMEY 95
Query: 365 LPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLD 424
           LP GSL   L  +      +   K L     +   + YL     ++ IHR++   NIL++
Sbjct: 96  LPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL---GTKRYIHRNLATRNILVE 149
Query: 425 AEFNAKLGDFEAT--IPAGTMGY------------LAPEYVYSGVPSEKTDVYSFGVVAL 470
            E   K+GDF  T  +P     Y             APE +     S  +DV+SFGVV  
Sbjct: 150 NENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 209
Query: 471 E----VAAGKSPV---------DNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKE-- 515
           E    +   KSP          D  G +IV  +  L K             G+  R +  
Sbjct: 210 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN-----------GRLPRPDGC 258
Query: 516 MERMLMVGLSCVHPNHEKRPSVKEAA 541
            + + M+   C + N  +RPS ++ A
Sbjct: 259 PDEIYMIMTECWNNNVNQRPSFRDLA 284

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/255 (24%), Positives = 108/255 (42%), Gaps = 42/255 (16%)
Query: 311 VAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSL 370
           VAVK   K +  E   +   +E   M    +HKN++ L G C +   L ++ EY   G+L
Sbjct: 48  VAVKML-KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 106
Query: 371 DKILHNNSSSSI------------VLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKA 418
            + L       +             LS +  ++    VA  + YL     ++ IHRD+ A
Sbjct: 107 REYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAA 163
Query: 419 CNILLDAEFNAKLGDF-------------EATIPAGTMGYLAPEYVYSGVPSEKTDVYSF 465
            N+L+  +   K+ DF             + T     + ++APE ++  + + ++DV+SF
Sbjct: 164 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 223
Query: 466 GVVALEV-AAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGL 524
           GV+  E+   G SP      V V+ ++ L K+G  +D                 + M+  
Sbjct: 224 GVLLWEIFTLGGSPYPG---VPVEELFKLLKEGHRMDKPS---------NCTNELYMMMR 271
Query: 525 SCVHPNHEKRPSVKE 539
            C H    +RP+ K+
Sbjct: 272 DCWHAVPSQRPTFKQ 286

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 92/200 (46%), Gaps = 23/200 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G+G    V+ G+      VA+K   KP  +  +   F  E   M   LRH+ LVQL   
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTM--SPEAFLQEAQVMKK-LRHEKLVQLYAV 247
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
             E   + +V EY+  GSL   L   +   + L   + +++   +AS ++Y+        
Sbjct: 248 VSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLP--QLVDMAAQIASGMAYVER---MNY 301
Query: 412 IHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVPSEK 459
           +HRD++A NIL+      K+ DF         E T   G    + + APE    G  + K
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 460 TDVYSFGVVALEVAA-GKSP 478
           +DV+SFG++  E+   G+ P
Sbjct: 362 SDVWSFGILLTELTTKGRVP 381

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 22/208 (10%)
Query: 292 VGEGASATVYKGS-LPSGGAVAVKR-FEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQ 349
           +G G  +TVY          VA+K  F  P   E     F  E    +  L H+N+V + 
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHN-SSQLSHQNIVSMI 77
Query: 350 GWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECER 409
               E +   LV EY+   +L + + ++      LS +  +N    +   + + H+    
Sbjct: 78  DVDEEDDCYYLVMEYIEGPTLSEYIESHGP----LSVDTAINFTNQILDGIKHAHD---M 130
Query: 410 QIIHRDVKACNILLDAEFNAKLGDF-------EATIPA-----GTMGYLAPEYVYSGVPS 457
           +I+HRD+K  NIL+D+    K+ DF       E ++       GT+ Y +PE        
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATD 190
Query: 458 EKTDVYSFGVVALEVAAGKSPVDNDGCV 485
           E TD+YS G+V  E+  G+ P + +  V
Sbjct: 191 ECTDIYSIGIVLYEMLVGEPPFNGETAV 218

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 101/210 (48%), Gaps = 30/210 (14%)
Query: 290 RIVGEGASATVYKGS---LPSGGA---VAVKRFEKPNRVECARNPFTTEFATMAGCLRHK 343
           R +G+G+   VY+G+   +  G A   VAVK   +   +   R  F  E + M G   H 
Sbjct: 20  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR-ERIEFLNEASVMKGFTCH- 77
Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHN------NSSSSIVLSWEKRLNIVLGVA 397
           ++V+L G   +G   ++V E + +G L   L +      N+      + ++ + +   +A
Sbjct: 78  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 137
Query: 398 SALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT--------IPAGTMG----- 444
             ++YL+    ++ +HRD+ A N ++  +F  K+GDF  T           G  G     
Sbjct: 138 DGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 194
Query: 445 YLAPEYVYSGVPSEKTDVYSFGVVALEVAA 474
           ++APE +  GV +  +D++SFGVV  E+ +
Sbjct: 195 WMAPESLKDGVFTTSSDMWSFGVVLWEITS 224

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 92/200 (46%), Gaps = 23/200 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G+G    V+ G+      VA+K   KP  +  +   F  E   M   LRH+ LVQL   
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTM--SPEAFLQEAQVMKK-LRHEKLVQLYAV 74
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
             E   + +V EY+  GSL   L   +   + L   + +++   +AS ++Y+        
Sbjct: 75  VSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLP--QLVDMAAQIASGMAYVER---MNY 128
Query: 412 IHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVPSEK 459
           +HRD++A NIL+      K+ DF         E T   G    + + APE    G  + K
Sbjct: 129 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 188
Query: 460 TDVYSFGVVALEVAA-GKSP 478
           +DV+SFG++  E+   G+ P
Sbjct: 189 SDVWSFGILLTELTTKGRVP 208

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 92/200 (46%), Gaps = 23/200 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G+G    V+ G+      VA+K   KP  +  +   F  E   M   LRH+ LVQL   
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTM--SPEAFLQEAQVMKK-LRHEKLVQLYAV 247
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
             E   + +V EY+  GSL   L   +   + L   + +++   +AS ++Y+        
Sbjct: 248 VSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLP--QLVDMAAQIASGMAYVER---MNY 301
Query: 412 IHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVPSEK 459
           +HRD++A NIL+      K+ DF         E T   G    + + APE    G  + K
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 460 TDVYSFGVVALEVAA-GKSP 478
           +DV+SFG++  E+   G+ P
Sbjct: 362 SDVWSFGILLTELTTKGRVP 381

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 99/210 (47%), Gaps = 30/210 (14%)
Query: 290 RIVGEGASATVYKGS---LPSGGA---VAVKRFEKPNRVECARNPFTTEFATMAGCLRHK 343
           R +G+G+   VY+G+   +  G A   VAVK   +   +   R  F  E + M G   H 
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR-ERIEFLNEASVMKGFTCH- 80
Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHN------NSSSSIVLSWEKRLNIVLGVA 397
           ++V+L G   +G   ++V E + +G L   L +      N+      + ++ + +   +A
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 398 SALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGTMGY------------ 445
             ++YL+    ++ +HRD+ A N ++  +F  K+GDF  T       Y            
Sbjct: 141 DGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVR 197
Query: 446 -LAPEYVYSGVPSEKTDVYSFGVVALEVAA 474
            +APE +  GV +  +D++SFGVV  E+ +
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 101/210 (48%), Gaps = 30/210 (14%)
Query: 290 RIVGEGASATVYKGS---LPSGGA---VAVKRFEKPNRVECARNPFTTEFATMAGCLRHK 343
           R +G+G+   VY+G+   +  G A   VAVK   +   +   R  F  E + M G   H 
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR-ERIEFLNEASVMKGFTCH- 80
Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHN------NSSSSIVLSWEKRLNIVLGVA 397
           ++V+L G   +G   ++V E + +G L   L +      N+      + ++ + +   +A
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 398 SALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT--------IPAGTMG----- 444
             ++YL+    ++ +HRD+ A N ++  +F  K+GDF  T           G  G     
Sbjct: 141 DGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 197
Query: 445 YLAPEYVYSGVPSEKTDVYSFGVVALEVAA 474
           ++APE +  GV +  +D++SFGVV  E+ +
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 101/210 (48%), Gaps = 30/210 (14%)
Query: 290 RIVGEGASATVYKGS---LPSGGA---VAVKRFEKPNRVECARNPFTTEFATMAGCLRHK 343
           R +G+G+   VY+G+   +  G A   VAVK   +   +   R  F  E + M G   H 
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR-ERIEFLNEASVMKGFTCH- 80
Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHN------NSSSSIVLSWEKRLNIVLGVA 397
           ++V+L G   +G   ++V E + +G L   L +      N+      + ++ + +   +A
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 398 SALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT--------IPAGTMG----- 444
             ++YL+    ++ +HRD+ A N ++  +F  K+GDF  T           G  G     
Sbjct: 141 DGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 197
Query: 445 YLAPEYVYSGVPSEKTDVYSFGVVALEVAA 474
           ++APE +  GV +  +D++SFGVV  E+ +
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 91/200 (45%), Gaps = 23/200 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G+G    V+ G+      VA+K   KP  +  +   F  E   M   LRH+ LVQL   
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTM--SPEAFLQEAQVMKK-LRHEKLVQLYAV 81
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
             E   + +V EY+  GSL   L       + L   + +++   +AS ++Y+        
Sbjct: 82  VSE-EPIYIVIEYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQIASGMAYVER---MNY 135
Query: 412 IHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVPSEK 459
           +HRD++A NIL+      K+ DF         E T   G    + + APE    G  + K
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 460 TDVYSFGVVALEVAA-GKSP 478
           +DV+SFG++  E+   G+ P
Sbjct: 196 SDVWSFGILLTELTTKGRVP 215

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 71/291 (24%), Positives = 115/291 (39%), Gaps = 50/291 (17%)
Query: 286 FNKNRIVGEGASATVYKG------SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGC 339
            N  + +G GA   V +          +   VAVK   K            +E   +   
Sbjct: 29  LNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKML-KEGATHSEHRALMSELKILIHI 87
Query: 340 LRHKNLVQLQGWCCE-GNELVLVYEYLPNGSLDKILHNNSSSSI--------VLSWEKRL 390
             H N+V L G C + G  L+++ E+   G+L   L +  +  +         L+ E  +
Sbjct: 88  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLI 147
Query: 391 NIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF---------------- 434
                VA  + +L     R+ IHRD+ A NILL  +   K+ DF                
Sbjct: 148 CYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 204
Query: 435 EATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEV-AAGKSPVDNDGCVIVDWVWNL 493
           +A +P   + ++APE ++  V + ++DV+SFGV+  E+ + G SP    G  I +     
Sbjct: 205 DARLP---LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY--PGVKIDEEFCRR 259
Query: 494 RKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARIL 544
            K+G  + A D+             M    L C H    +RP+  E    L
Sbjct: 260 LKEGTRMRAPDY---------TTPEMYQTMLDCWHGEPSQRPTFSELVEHL 301

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 83/204 (40%), Gaps = 20/204 (9%)
Query: 286 FNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           F K   +G+G+   V+KG       V   +       E        E   ++ C     +
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYV 67
Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
            +  G   +  +L ++ EYL  GS   +L         ++      I+  +   L YLH 
Sbjct: 68  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA-----TILREILKGLDYLHS 122
Query: 406 ECERQIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTMGYLAPEYVYSG 454
           E +   IHRD+KA N+LL      KL DF           +     GT  ++APE +   
Sbjct: 123 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS 179
Query: 455 VPSEKTDVYSFGVVALEVAAGKSP 478
               K D++S G+ A+E+A G+ P
Sbjct: 180 AYDSKADIWSLGITAIELARGEPP 203

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 101/210 (48%), Gaps = 30/210 (14%)
Query: 290 RIVGEGASATVYKGS---LPSGGA---VAVKRFEKPNRVECARNPFTTEFATMAGCLRHK 343
           R +G+G+   VY+G+   +  G A   VAVK   +   +   R  F  E + M G   H 
Sbjct: 22  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR-ERIEFLNEASVMKGFTCH- 79
Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHN------NSSSSIVLSWEKRLNIVLGVA 397
           ++V+L G   +G   ++V E + +G L   L +      N+      + ++ + +   +A
Sbjct: 80  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 139
Query: 398 SALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT--------IPAGTMG----- 444
             ++YL+    ++ +HRD+ A N ++  +F  K+GDF  T           G  G     
Sbjct: 140 DGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 196
Query: 445 YLAPEYVYSGVPSEKTDVYSFGVVALEVAA 474
           ++APE +  GV +  +D++SFGVV  E+ +
Sbjct: 197 WMAPESLKDGVFTTSSDMWSFGVVLWEITS 226

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 101/210 (48%), Gaps = 30/210 (14%)
Query: 290 RIVGEGASATVYKGS---LPSGGA---VAVKRFEKPNRVECARNPFTTEFATMAGCLRHK 343
           R +G+G+   VY+G+   +  G A   VAVK   +   +   R  F  E + M G   H 
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR-ERIEFLNEASVMKGFTCH- 80
Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHN------NSSSSIVLSWEKRLNIVLGVA 397
           ++V+L G   +G   ++V E + +G L   L +      N+      + ++ + +   +A
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 398 SALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT--------IPAGTMG----- 444
             ++YL+    ++ +HRD+ A N ++  +F  K+GDF  T           G  G     
Sbjct: 141 DGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 197
Query: 445 YLAPEYVYSGVPSEKTDVYSFGVVALEVAA 474
           ++APE +  GV +  +D++SFGVV  E+ +
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 90/202 (44%), Gaps = 23/202 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G    V  G       VA+K  ++ +  E   + F  E   M   L H+ LVQL G 
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMN-LSHEKLVQLYGV 71
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
           C +   + ++ EY+ NG L   L            ++ L +   V  A+ YL     +Q 
Sbjct: 72  CTKQRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLE---SKQF 125
Query: 412 IHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVPSEK 459
           +HRD+ A N L++ +   K+ DF         E T   G+   + +  PE +     S K
Sbjct: 126 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 185
Query: 460 TDVYSFGVVALEV-AAGKSPVD 480
           +D+++FGV+  E+ + GK P +
Sbjct: 186 SDIWAFGVLMWEIYSLGKMPYE 207

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 97/222 (43%), Gaps = 44/222 (19%)
Query: 290 RIVGEGASATVYKGSLPS------GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHK 343
           R +GEGA   V++   P          VAVK  ++    +   + F  E A MA    + 
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD-FQREAALMAE-FDNP 110
Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIV-------------------- 383
           N+V+L G C  G  + L++EY+  G L++ L + S  ++                     
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 384 LSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGTM 443
           LS  ++L I   VA+ ++YL    ER+ +HRD+   N L+      K+ DF  +    + 
Sbjct: 171 LSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227
Query: 444 GY-------------LAPEYVYSGVPSEKTDVYSFGVVALEV 472
            Y             + PE ++    + ++DV+++GVV  E+
Sbjct: 228 DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 269

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 66/263 (25%), Positives = 106/263 (40%), Gaps = 46/263 (17%)
Query: 310 AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE-GNELVLVYEYLPNG 368
            VAVK   K            +E   +     H N+V L G C + G  L+++ E+   G
Sbjct: 61  TVAVKML-KEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 119
Query: 369 SLDKILHNNSSSSI----------VLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKA 418
           +L   L +  +  +           L+ E  +     VA  + +L     R+ IHRD+ A
Sbjct: 120 NLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAA 176
Query: 419 CNILLDAEFNAKLGDF----------------EATIPAGTMGYLAPEYVYSGVPSEKTDV 462
            NILL  +   K+ DF                +A +P   + ++APE ++  V + ++DV
Sbjct: 177 RNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP---LKWMAPETIFDRVYTIQSDV 233
Query: 463 YSFGVVALEV-AAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLM 521
           +SFGV+  E+ + G SP    G  I +      K+G  + A D+             M  
Sbjct: 234 WSFGVLLWEIFSLGASPY--PGVKIDEEFCRRLKEGTRMRAPDY---------TTPEMYQ 282
Query: 522 VGLSCVHPNHEKRPSVKEAARIL 544
             L C H    +RP+  E    L
Sbjct: 283 TMLDCWHGEPSQRPTFSELVEHL 305

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 83/204 (40%), Gaps = 20/204 (9%)
Query: 286 FNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           F K   +G+G+   V+KG       V   +       E        E   ++ C     +
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYV 67
Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
            +  G   +  +L ++ EYL  GS   +L         ++      I+  +   L YLH 
Sbjct: 68  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA-----TILREILKGLDYLHS 122
Query: 406 ECERQIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTMGYLAPEYVYSG 454
           E +   IHRD+KA N+LL      KL DF           +     GT  ++APE +   
Sbjct: 123 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQS 179
Query: 455 VPSEKTDVYSFGVVALEVAAGKSP 478
               K D++S G+ A+E+A G+ P
Sbjct: 180 AYDSKADIWSLGITAIELARGEPP 203

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 92/200 (46%), Gaps = 23/200 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G+G    V+ G+      VA+K   KP  +  +   F  E   M   LRH+ LVQL   
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTM--SPEAFLQEAQVMKK-LRHEKLVQLYAV 247
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
             E   + +V EY+  GSL   L   +   + L   + +++   +AS ++Y+        
Sbjct: 248 VSE-EPIYIVGEYMSKGSLLDFLKGETGKYLRLP--QLVDMAAQIASGMAYVER---MNY 301
Query: 412 IHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVPSEK 459
           +HRD++A NIL+      K+ DF         E T   G    + + APE    G  + K
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 460 TDVYSFGVVALEVAA-GKSP 478
           +DV+SFG++  E+   G+ P
Sbjct: 362 SDVWSFGILLTELTTKGRVP 381

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 23/200 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G+G    V+ G+      VA+K  +  N    +   F  E   M   LRH+ LVQL   
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPGN---MSPEAFLQEAQVMKK-LRHEKLVQLYAV 248
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
             E   + +V EY+  GSL   L       + L   + +++   +AS ++Y+        
Sbjct: 249 VSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQIASGMAYVER---MNY 302
Query: 412 IHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVPSEK 459
           +HRD++A NIL+      K+ DF         E T   G    + + APE    G  + K
Sbjct: 303 VHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 362
Query: 460 TDVYSFGVVALEVAA-GKSP 478
           +DV+SFG++  E+   G+ P
Sbjct: 363 SDVWSFGILLTELTTKGRVP 382

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 90/202 (44%), Gaps = 23/202 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G    V  G       VA+K  ++ +  E   + F  E   M   L H+ LVQL G 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMN-LSHEKLVQLYGV 72
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
           C +   + ++ EY+ NG L   L            ++ L +   V  A+ YL     +Q 
Sbjct: 73  CTKQRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLE---SKQF 126
Query: 412 IHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVPSEK 459
           +HRD+ A N L++ +   K+ DF         E T   G+   + +  PE +     S K
Sbjct: 127 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 186
Query: 460 TDVYSFGVVALEV-AAGKSPVD 480
           +D+++FGV+  E+ + GK P +
Sbjct: 187 SDIWAFGVLMWEIYSLGKMPYE 208

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 90/202 (44%), Gaps = 23/202 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G    V  G       VA+K  ++ +  E   + F  E   M   L H+ LVQL G 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMN-LSHEKLVQLYGV 67
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
           C +   + ++ EY+ NG L   L            ++ L +   V  A+ YL     +Q 
Sbjct: 68  CTKQRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLE---SKQF 121
Query: 412 IHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVPSEK 459
           +HRD+ A N L++ +   K+ DF         E T   G+   + +  PE +     S K
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 181
Query: 460 TDVYSFGVVALEV-AAGKSPVD 480
           +D+++FGV+  E+ + GK P +
Sbjct: 182 SDIWAFGVLMWEIYSLGKMPYE 203

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 90/219 (41%), Gaps = 47/219 (21%)
Query: 291 IVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL-- 348
           ++G G    VYKGSL     VAVK F   NR    +N    +       + H N+ +   
Sbjct: 20  LIGRGRYGAVYKGSLDER-PVAVKVFSFANR----QNFINEKNIYRVPLMEHDNIARFIV 74
Query: 349 --QGWCCEGN-ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
             +    +G  E +LV EY PNGSL K L  ++S      W     +   V   L+YLH 
Sbjct: 75  GDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS-----DWVSSCRLAHSVTRGLAYLHT 129
Query: 406 ECER------QIIHRDVKACNILLDAEFNAKLGDF-------------------EATIPA 440
           E  R       I HRD+ + N+L+  +    + DF                    A    
Sbjct: 130 ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEV 189
Query: 441 GTMGYLAPEYVYSGV-------PSEKTDVYSFGVVALEV 472
           GT+ Y+APE +   V         ++ D+Y+ G++  E+
Sbjct: 190 GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 83/204 (40%), Gaps = 20/204 (9%)
Query: 286 FNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           F K   +G+G+   V+KG       V   +       E        E   ++ C     +
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYV 82
Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
            +  G   +  +L ++ EYL  GS   +L         ++      I+  +   L YLH 
Sbjct: 83  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA-----TILREILKGLDYLHS 137
Query: 406 ECERQIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTMGYLAPEYVYSG 454
           E +   IHRD+KA N+LL      KL DF           +     GT  ++APE +   
Sbjct: 138 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQS 194
Query: 455 VPSEKTDVYSFGVVALEVAAGKSP 478
               K D++S G+ A+E+A G+ P
Sbjct: 195 AYDSKADIWSLGITAIELARGEPP 218

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 93/204 (45%), Gaps = 22/204 (10%)
Query: 290 RIVGEGASATV-YKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           + +G+G  A V     + +G  VA+K  +K      +      E   M   L H N+V+L
Sbjct: 18  KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMK-ILNHPNIVKL 76
Query: 349 QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE 408
                    L L+ EY   G +   L  +       +  K   IV    SA+ Y H+   
Sbjct: 77  FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIV----SAVQYCHQ--- 129
Query: 409 RQIIHRDVKACNILLDAEFNAKLGDF----EATIPA------GTMGYLAPEYVYSGVPSE 458
           ++I+HRD+KA N+LLDA+ N K+ DF    E T+        G+  Y APE ++ G   +
Sbjct: 130 KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPE-LFQGKKYD 188
Query: 459 --KTDVYSFGVVALEVAAGKSPVD 480
             + DV+S GV+   + +G  P D
Sbjct: 189 GPEVDVWSLGVILYTLVSGSLPFD 212

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/286 (22%), Positives = 111/286 (38%), Gaps = 48/286 (16%)
Query: 292 VGEGASATVYKGSL-------PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           +GEGA   V            P        +  K +  E   +   +E   M    +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHN------------NSSSSIVLSWEKRLNI 392
           ++ L G C +   L ++ EY   G+L + L              N      ++++  ++ 
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 393 VLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGTMGY------- 445
              +A  + YL     ++ IHRD+ A N+L+      K+ DF        + Y       
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 446 ------LAPEYVYSGVPSEKTDVYSFGVVALEV-AAGKSPVDNDGCVIVDWVWNLRKKGK 498
                 +APE ++  V + ++DV+SFGV+  E+   G SP      + V+ ++ L K+G 
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG---IPVEELFKLLKEGH 276
Query: 499 LLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARIL 544
            +D                 + M+   C H    +RP+ K+    L
Sbjct: 277 RMDKP---------ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 91/200 (45%), Gaps = 23/200 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G+G    V+ G+      VA+K   KP  +  +   F  E   M   LRH+ LVQL   
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTM--SPEAFLQEAQVMKK-LRHEKLVQLYAV 81
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
             E   + +V EY+  GSL   L       + L   + +++   +AS ++Y+        
Sbjct: 82  VSE-EPIYIVIEYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQIASGMAYVER---MNY 135
Query: 412 IHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVPSEK 459
           +HRD++A NIL+      K+ DF         E T   G    + + APE    G  + K
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 460 TDVYSFGVVALEVAA-GKSP 478
           +DV+SFG++  E+   G+ P
Sbjct: 196 SDVWSFGILLTELTTKGRVP 215

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 92/200 (46%), Gaps = 23/200 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G+G    V+ G+      VA+K   KP  +  +   F  E   M   LRH+ LVQL   
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTM--SPEAFLQEAQVMKK-LRHEKLVQLYAV 330
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
             E   + +V EY+  GSL   L   +   + L   + +++   +AS ++Y+        
Sbjct: 331 VSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLP--QLVDMAAQIASGMAYVER---MNY 384
Query: 412 IHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVPSEK 459
           +HRD++A NIL+      K+ DF         E T   G    + + APE    G  + K
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 444
Query: 460 TDVYSFGVVALEVAA-GKSP 478
           +DV+SFG++  E+   G+ P
Sbjct: 445 SDVWSFGILLTELTTKGRVP 464

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 90/202 (44%), Gaps = 23/202 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G    V  G       VA+K  ++ +  E   + F  E   M   L H+ LVQL G 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMN-LSHEKLVQLYGV 87
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
           C +   + ++ EY+ NG L   L            ++ L +   V  A+ YL     +Q 
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLE---SKQF 141
Query: 412 IHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVPSEK 459
           +HRD+ A N L++ +   K+ DF         E T   G+   + +  PE +     S K
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSKFSSK 201
Query: 460 TDVYSFGVVALEV-AAGKSPVD 480
           +D+++FGV+  E+ + GK P +
Sbjct: 202 SDIWAFGVLMWEIYSLGKMPYE 223

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 90/202 (44%), Gaps = 23/202 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G    V  G       VA+K  ++ +  E   + F  E   M   L H+ LVQL G 
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMN-LSHEKLVQLYGV 78
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
           C +   + ++ EY+ NG L   L            ++ L +   V  A+ YL     +Q 
Sbjct: 79  CTKQRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLE---SKQF 132
Query: 412 IHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVPSEK 459
           +HRD+ A N L++ +   K+ DF         E T   G+   + +  PE +     S K
Sbjct: 133 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 192
Query: 460 TDVYSFGVVALEV-AAGKSPVD 480
           +D+++FGV+  E+ + GK P +
Sbjct: 193 SDIWAFGVLMWEIYSLGKMPYE 214

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 89/204 (43%), Gaps = 26/204 (12%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G+GA   VYK        +A  +     + E     +  E   +A C  H N+V+L   
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKV-IDTKSEEELEDYMVEIDILASC-DHPNIVKLLDA 102
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVL-GVASALSYLHEECERQ 410
               N L ++ E+   G++D ++            E ++ +V      AL+YLH+    +
Sbjct: 103 FYYENNLWILIEFCAGGAVDAVMLELERPLT----ESQIQVVCKQTLDALNYLHD---NK 155
Query: 411 IIHRDVKACNILLDAEFNAKLGDFEATIP-----------AGTMGYLAPEYVYSGVPSE- 458
           IIHRD+KA NIL   + + KL DF  +              GT  ++APE V      + 
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSKDR 215
Query: 459 ----KTDVYSFGVVALEVAAGKSP 478
               K DV+S G+  +E+A  + P
Sbjct: 216 PYDYKADVWSLGITLIEMAEIEPP 239

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 89/204 (43%), Gaps = 26/204 (12%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G+GA   VYK        +A  +     + E     +  E   +A C  H N+V+L   
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKV-IDTKSEEELEDYMVEIDILASC-DHPNIVKLLDA 102
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVL-GVASALSYLHEECERQ 410
               N L ++ E+   G++D ++            E ++ +V      AL+YLH+    +
Sbjct: 103 FYYENNLWILIEFCAGGAVDAVMLELERPLT----ESQIQVVCKQTLDALNYLHD---NK 155
Query: 411 IIHRDVKACNILLDAEFNAKLGDFEATIP-----------AGTMGYLAPEYVYSGVPSE- 458
           IIHRD+KA NIL   + + KL DF  +              GT  ++APE V      + 
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETSKDR 215
Query: 459 ----KTDVYSFGVVALEVAAGKSP 478
               K DV+S G+  +E+A  + P
Sbjct: 216 PYDYKADVWSLGITLIEMAEIEPP 239

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 89/204 (43%), Gaps = 26/204 (12%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G+GA   VYK        +A  +     + E     +  E   +A C  H N+V+L   
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKV-IDTKSEEELEDYMVEIDILASC-DHPNIVKLLDA 102
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVL-GVASALSYLHEECERQ 410
               N L ++ E+   G++D ++            E ++ +V      AL+YLH+    +
Sbjct: 103 FYYENNLWILIEFCAGGAVDAVMLELERPLT----ESQIQVVCKQTLDALNYLHD---NK 155
Query: 411 IIHRDVKACNILLDAEFNAKLGDFEATIP-----------AGTMGYLAPEYVYSGVPSE- 458
           IIHRD+KA NIL   + + KL DF  +              GT  ++APE V      + 
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 215
Query: 459 ----KTDVYSFGVVALEVAAGKSP 478
               K DV+S G+  +E+A  + P
Sbjct: 216 PYDYKADVWSLGITLIEMAEIEPP 239

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 67/250 (26%), Positives = 103/250 (41%), Gaps = 49/250 (19%)
Query: 249 LIKKKRHDGRSKEDHVCTVQRVPMRLALTDIKQATLGFNKNRIVGEGASATVYKGSLPSG 308
           + +K++HDGR K  H               I   TLG      VG      V K  L +G
Sbjct: 3   MAEKQKHDGRVKIGHY--------------ILGDTLG------VGTFGKVKVGKHEL-TG 41
Query: 309 GAVAVKRFEKPN-RVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPN 367
             VAVK   +   R          E   +    RH ++++L       +++ +V EY+  
Sbjct: 42  HKVAVKILNRQKIRSLDVVGKIRREIQNLK-LFRHPHIIKLYQVISTPSDIFMVMEYVSG 100
Query: 368 GSL-DKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAE 426
           G L D I  N       L  ++   +   + S + Y H      ++HRD+K  N+LLDA 
Sbjct: 101 GELFDYICKNGR-----LDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAH 152
Query: 427 FNAKLGDFEAT----------IPAGTMGYLAPEYV----YSGVPSEKTDVYSFGVVALEV 472
            NAK+ DF  +             G+  Y APE +    Y+G    + D++S GV+   +
Sbjct: 153 MNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLYAG---PEVDIWSSGVILYAL 209
Query: 473 AAGKSPVDND 482
             G  P D+D
Sbjct: 210 LCGTLPFDDD 219

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 90/202 (44%), Gaps = 23/202 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G    V  G       VA+K  ++ +  E   + F  E   M   L H+ LVQL G 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMN-LSHEKLVQLYGV 72
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
           C +   + ++ EY+ NG L   L            ++ L +   V  A+ YL     +Q 
Sbjct: 73  CTKQRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLE---SKQF 126
Query: 412 IHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVPSEK 459
           +HRD+ A N L++ +   K+ DF         E T   G+   + +  PE +     S K
Sbjct: 127 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSSK 186
Query: 460 TDVYSFGVVALEV-AAGKSPVD 480
           +D+++FGV+  E+ + GK P +
Sbjct: 187 SDIWAFGVLMWEIYSLGKMPYE 208

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 92/200 (46%), Gaps = 23/200 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G+G    V+ G+      VA+K   KP  +  +   F  E   M   LRH+ LVQL   
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTM--SPEAFLQEAQVMKK-LRHEKLVQLYAV 78
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
             E   + +V EY+  GSL   L   +   + L   + +++   +AS ++Y+        
Sbjct: 79  VSE-EPIYIVTEYMNKGSLLDFLKGETGKYLRLP--QLVDMSAQIASGMAYVER---MNY 132
Query: 412 IHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVPSEK 459
           +HRD++A NIL+      K+ DF         E T   G    + + APE    G  + K
Sbjct: 133 VHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFTIK 192
Query: 460 TDVYSFGVVALEVAA-GKSP 478
           +DV+SFG++  E+   G+ P
Sbjct: 193 SDVWSFGILLTELTTKGRVP 212

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 91/200 (45%), Gaps = 23/200 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G+G    V+ G+      VA+K   KP  +  +   F  E   M   LRH+ LVQL   
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTM--SPEAFLQEAQVMKK-LRHEKLVQLYAV 81
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
             E   + +V EY+  GSL   L       + L   + +++   +AS ++Y+        
Sbjct: 82  VSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQIASGMAYVER---MNY 135
Query: 412 IHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVPSEK 459
           +HRD++A NIL+      K+ DF         E T   G    + + APE    G  + K
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 460 TDVYSFGVVALEVAA-GKSP 478
           +DV+SFG++  E+   G+ P
Sbjct: 196 SDVWSFGILLTELTTKGRVP 215

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 63/286 (22%), Positives = 111/286 (38%), Gaps = 48/286 (16%)
Query: 292 VGEGASATVYKGSL-------PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           +GEGA   V            P        +  K +  E   +   +E   M    +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHN------------NSSSSIVLSWEKRLNI 392
           ++ L G C +   L ++ EY   G+L + L              N      ++++  ++ 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 393 VLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGTMGY------- 445
              +A  + YL     ++ IHRD+ A N+L+      K+ DF        + Y       
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNG 219
Query: 446 ------LAPEYVYSGVPSEKTDVYSFGVVALEV-AAGKSPVDNDGCVIVDWVWNLRKKGK 498
                 +APE ++  V + ++DV+SFGV+  E+   G SP      + V+ ++ L K+G 
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG---IPVEELFKLLKEGH 276
Query: 499 LLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARIL 544
            +D                 + M+   C H    +RP+ K+    L
Sbjct: 277 RMDKP---------ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 91/200 (45%), Gaps = 23/200 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G+G    V+ G+      VA+K   KP  +  +   F  E   M   LRH+ LVQL   
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTM--SPEAFLQEAQVMKK-LRHEKLVQLYAV 72
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
             E   + +V EY+  GSL   L       + L   + +++   +AS ++Y+        
Sbjct: 73  VSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQIASGMAYVER---MNY 126
Query: 412 IHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVPSEK 459
           +HRD++A NIL+      K+ DF         E T   G    + + APE    G  + K
Sbjct: 127 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 186
Query: 460 TDVYSFGVVALEVAA-GKSP 478
           +DV+SFG++  E+   G+ P
Sbjct: 187 SDVWSFGILLTELTTKGRVP 206

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 83/204 (40%), Gaps = 20/204 (9%)
Query: 286 FNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           F K   +G+G+   V+KG       V   +       E        E   ++ C     +
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYV 87
Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
            +  G   +  +L ++ EYL  GS   +L         ++      I+  +   L YLH 
Sbjct: 88  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA-----TILREILKGLDYLHS 142
Query: 406 ECERQIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTMGYLAPEYVYSG 454
           E +   IHRD+KA N+LL      KL DF           +     GT  ++APE +   
Sbjct: 143 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS 199
Query: 455 VPSEKTDVYSFGVVALEVAAGKSP 478
               K D++S G+ A+E+A G+ P
Sbjct: 200 AYDSKADIWSLGITAIELARGEPP 223

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/261 (23%), Positives = 107/261 (40%), Gaps = 42/261 (16%)
Query: 310 AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGS 369
            VAVK   K +  E   +   +E   M    +HKN++ L G C +   L ++ EY   G+
Sbjct: 56  TVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 114
Query: 370 LDKILHN------------NSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVK 417
           L + L              N      ++++  ++    +A  + YL     ++ IHRD+ 
Sbjct: 115 LREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLT 171
Query: 418 ACNILLDAEFNAKLGDFEATIPAGTMGY-------------LAPEYVYSGVPSEKTDVYS 464
           A N+L+      K+ DF        + Y             +APE ++  V + ++DV+S
Sbjct: 172 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 231
Query: 465 FGVVALEV-AAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVG 523
           FGV+  E+   G SP      + V+ ++ L K+G  +D                 + M+ 
Sbjct: 232 FGVLMWEIFTLGGSPYPG---IPVEELFKLLKEGHRMDKP---------ANCTNELYMMM 279
Query: 524 LSCVHPNHEKRPSVKEAARIL 544
             C H    +RP+ K+    L
Sbjct: 280 RDCWHAVPSQRPTFKQLVEDL 300

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/261 (23%), Positives = 107/261 (40%), Gaps = 42/261 (16%)
Query: 310 AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGS 369
            VAVK   K +  E   +   +E   M    +HKN++ L G C +   L ++ EY   G+
Sbjct: 58  TVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 116
Query: 370 LDKILHN------------NSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVK 417
           L + L              N      ++++  ++    +A  + YL     ++ IHRD+ 
Sbjct: 117 LREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLA 173
Query: 418 ACNILLDAEFNAKLGDFEATIPAGTMGY-------------LAPEYVYSGVPSEKTDVYS 464
           A N+L+      K+ DF        + Y             +APE ++  V + ++DV+S
Sbjct: 174 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 233
Query: 465 FGVVALEV-AAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVG 523
           FGV+  E+   G SP      + V+ ++ L K+G  +D                 + M+ 
Sbjct: 234 FGVLMWEIFTLGGSPYPG---IPVEELFKLLKEGHRMDKP---------ANCTNELYMMM 281
Query: 524 LSCVHPNHEKRPSVKEAARIL 544
             C H    +RP+ K+    L
Sbjct: 282 RDCWHAVPSQRPTFKQLVEDL 302

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 91/200 (45%), Gaps = 23/200 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G+G    V+ G+      VA+K   KP  +  +   F  E   M   LRH+ LVQL   
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTM--SPEAFLQEAQVMKK-LRHEKLVQLYAV 70
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
             E   + +V EY+  GSL   L       + L   + +++   +AS ++Y+        
Sbjct: 71  VSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQIASGMAYVER---MNY 124
Query: 412 IHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVPSEK 459
           +HRD++A NIL+      K+ DF         E T   G    + + APE    G  + K
Sbjct: 125 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 184
Query: 460 TDVYSFGVVALEVAA-GKSP 478
           +DV+SFG++  E+   G+ P
Sbjct: 185 SDVWSFGILLTELTTKGRVP 204

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 90/202 (44%), Gaps = 23/202 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G    V  G       VA+K  ++ +  E   + F  E   M   L H+ LVQL G 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMN-LSHEKLVQLYGV 87
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
           C +   + ++ EY+ NG L   L            ++ L +   V  A+ YL     +Q 
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLE---SKQF 141
Query: 412 IHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVPSEK 459
           +HRD+ A N L++ +   K+ DF         E T   G+   + +  PE +     S K
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 201
Query: 460 TDVYSFGVVALEV-AAGKSPVD 480
           +D+++FGV+  E+ + GK P +
Sbjct: 202 SDIWAFGVLMWEIYSLGKMPYE 223

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 92/200 (46%), Gaps = 23/200 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G+G    V+ G+      VA+K   KP  +  +   F  E   M   LRH+ LVQL   
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTM--SPEAFLQEAQVMKK-LRHEKLVQLYAV 78
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
             E   + +V EY+  GSL   L   +   + L   + +++   +AS ++Y+        
Sbjct: 79  VSE-EPIYIVTEYMNKGSLLDFLKGETGKYLRLP--QLVDMSAQIASGMAYVER---MNY 132
Query: 412 IHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVPSEK 459
           +HRD++A NIL+      K+ DF         E T   G    + + APE    G  + K
Sbjct: 133 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 192
Query: 460 TDVYSFGVVALEVAA-GKSP 478
           +DV+SFG++  E+   G+ P
Sbjct: 193 SDVWSFGILLTELTTKGRVP 212

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/261 (23%), Positives = 107/261 (40%), Gaps = 42/261 (16%)
Query: 310 AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGS 369
            VAVK   K +  E   +   +E   M    +HKN++ L G C +   L ++ EY   G+
Sbjct: 61  TVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 119
Query: 370 LDKILHN------------NSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVK 417
           L + L              N      ++++  ++    +A  + YL     ++ IHRD+ 
Sbjct: 120 LREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLA 176
Query: 418 ACNILLDAEFNAKLGDFEATIPAGTMGY-------------LAPEYVYSGVPSEKTDVYS 464
           A N+L+      K+ DF        + Y             +APE ++  V + ++DV+S
Sbjct: 177 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 236
Query: 465 FGVVALEV-AAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVG 523
           FGV+  E+   G SP      + V+ ++ L K+G  +D                 + M+ 
Sbjct: 237 FGVLMWEIFTLGGSPYPG---IPVEELFKLLKEGHRMDKP---------ANCTNELYMMM 284
Query: 524 LSCVHPNHEKRPSVKEAARIL 544
             C H    +RP+ K+    L
Sbjct: 285 RDCWHAVPSQRPTFKQLVEDL 305

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 91/203 (44%), Gaps = 27/203 (13%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G    VY+G           +  K + +E     F  E A M   ++H NLVQL G 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKE-IKHPNLVQLLGV 75
Query: 352 CCEGNELVLVYEYLPNGSLDKIL---HNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE 408
           C       ++ E++  G+L   L   +    S++VL     L +   ++SA+ YL    +
Sbjct: 76  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVL-----LYMATQISSAMEYLE---K 127
Query: 409 RQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVP 456
           +  IHRD+ A N L+      K+ DF           T  AG    + + APE +     
Sbjct: 128 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKF 187
Query: 457 SEKTDVYSFGVVALEVAA-GKSP 478
           S K+DV++FGV+  E+A  G SP
Sbjct: 188 SIKSDVWAFGVLLWEIATYGMSP 210

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 60/256 (23%), Positives = 106/256 (41%), Gaps = 42/256 (16%)
Query: 310 AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGS 369
            VAVK   K +  E   +   +E   M    +HKN++ L G C +   L ++ EY   G+
Sbjct: 115 TVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 173
Query: 370 LDKILHN------------NSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVK 417
           L + L              N      ++++  ++    +A  + YL     ++ IHRD+ 
Sbjct: 174 LREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLA 230
Query: 418 ACNILLDAEFNAKLGDFEATIPAGTMGY-------------LAPEYVYSGVPSEKTDVYS 464
           A N+L+      K+ DF        + Y             +APE ++  V + ++DV+S
Sbjct: 231 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 290
Query: 465 FGVVALEV-AAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVG 523
           FGV+  E+   G SP      + V+ ++ L K+G  +D                 + M+ 
Sbjct: 291 FGVLMWEIFTLGGSPYPG---IPVEELFKLLKEGHRMDKP---------ANCTNELYMMM 338
Query: 524 LSCVHPNHEKRPSVKE 539
             C H    +RP+ K+
Sbjct: 339 RDCWHAVPSQRPTFKQ 354

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 67/287 (23%), Positives = 114/287 (39%), Gaps = 50/287 (17%)
Query: 292 VGEGASATVY--------KGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHK 343
           +GEGA   V         K        VAVK   K +  E   +   +E   M    +HK
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHN------------NSSSSIVLSWEKRLN 391
           N++ L G C +   L ++ EY   G+L + L              N      ++++  ++
Sbjct: 102 NIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 392 IVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGTMGY------ 445
               +A  + YL     ++ IHRD+ A N+L+      K+ DF        + Y      
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 446 -------LAPEYVYSGVPSEKTDVYSFGVVALEV-AAGKSPVDNDGCVIVDWVWNLRKKG 497
                  +APE ++  V + ++DV+SFGV+  E+   G SP      + V+ ++ L K+G
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG---IPVEELFKLLKEG 275
Query: 498 KLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARIL 544
             +D                 + M+   C H    +RP+ K+    L
Sbjct: 276 HRMDKP---------ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/286 (22%), Positives = 111/286 (38%), Gaps = 48/286 (16%)
Query: 292 VGEGASATVYKGSL-------PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           +GEGA   V            P        +  K +  E   +   +E   M    +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHN------------NSSSSIVLSWEKRLNI 392
           ++ L G C +   L ++ EY   G+L + L              N      ++++  ++ 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 393 VLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGTMGY------- 445
              +A  + YL     ++ IHRD+ A N+L+      K+ DF        + Y       
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 446 ------LAPEYVYSGVPSEKTDVYSFGVVALEV-AAGKSPVDNDGCVIVDWVWNLRKKGK 498
                 +APE ++  V + ++DV+SFGV+  E+   G SP      + V+ ++ L K+G 
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG---IPVEELFKLLKEGH 276
Query: 499 LLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARIL 544
            +D                 + M+   C H    +RP+ K+    L
Sbjct: 277 RMDKP---------ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 91/200 (45%), Gaps = 23/200 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G+G    V+ G+      VA+K   KP  +  +   F  E   M   LRH+ LVQL   
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTM--SPEAFLQEAQVMKK-LRHEKLVQLYAV 81
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
             E   + +V EY+  GSL   L       + L   + +++   +AS ++Y+        
Sbjct: 82  VSE-EPIYIVCEYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQIASGMAYVER---MNY 135
Query: 412 IHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVPSEK 459
           +HRD++A NIL+      K+ DF         E T   G    + + APE    G  + K
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 460 TDVYSFGVVALEVAA-GKSP 478
           +DV+SFG++  E+   G+ P
Sbjct: 196 SDVWSFGILLTELTTKGRVP 215

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 82/194 (42%), Gaps = 33/194 (17%)
Query: 311 VAVKRFEKPNRVECARNP-FTTEF---ATMAGCLRHKNLVQL----QGWCCEGNELVLVY 362
           VAVK      R + AR+P F   F   A  A  L H  +V +    +     G    +V 
Sbjct: 40  VAVKVL----RADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVM 95
Query: 363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNIL 422
           EY+   +L  I+H        ++ ++ + ++     AL++ H+     IIHRDVK  NI+
Sbjct: 96  EYVDGVTLRDIVHTEGP----MTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIM 148
Query: 423 LDAEFNAKLGDF--------------EATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVV 468
           + A    K+ DF              +     GT  YL+PE         ++DVYS G V
Sbjct: 149 ISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCV 208
Query: 469 ALEVAAGKSPVDND 482
             EV  G+ P   D
Sbjct: 209 LYEVLTGEPPFTGD 222

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/287 (23%), Positives = 116/287 (40%), Gaps = 50/287 (17%)
Query: 292 VGEGASATVY--------KGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHK 343
           +GEGA   V         K        VAVK   K +  E   +   +E   M    +HK
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHN------------NSSSSIVLSWEKRLN 391
           N++ L G C +   L ++ EY   G+L + L              N      ++++  ++
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 392 IVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-------------EATI 438
               +A  + YL     ++ IHRD+ A N+L+      K+ DF             + T 
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTN 218
Query: 439 PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEV-AAGKSPVDNDGCVIVDWVWNLRKKG 497
               + ++APE ++  V + ++DV+SFGV+  E+   G SP      + V+ ++ L K+G
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG---IPVEELFKLLKEG 275
Query: 498 KLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARIL 544
             +D                 + M+   C H    +RP+ K+    L
Sbjct: 276 HRMDKP---------ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 104/221 (47%), Gaps = 35/221 (15%)
Query: 279 IKQATLGFNKNRIVGEGASATVYKGSLPSGG--------AVAVKRFEKPNRVECARNPFT 330
           I+   L FN++  +G+G    ++KG     G         V +K  +K +R   + + F 
Sbjct: 5   IRNEDLIFNES--LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR-NYSESFF- 60
Query: 331 TEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRL 390
            E A+M   L HK+LV   G C  G+E +LV E++  GSLD  L  N +   +L W  +L
Sbjct: 61  -EAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINIL-W--KL 116
Query: 391 NIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGD---FEATIPAGTMGYLA 447
            +   +A+A+ +L    E  +IH +V A NILL  E + K G+    + + P  ++  L 
Sbjct: 117 EVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP 173
Query: 448 PEYVYSGVP-------------SEKTDVYSFGVVALEVAAG 475
            + +   +P             +  TD +SFG    E+ +G
Sbjct: 174 KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 92/204 (45%), Gaps = 22/204 (10%)
Query: 290 RIVGEGASATV-YKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           + +G+G  A V     + +G  VA+K  +K      +      E   M   L H N+V+L
Sbjct: 21  KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMK-ILNHPNIVKL 79
Query: 349 QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE 408
                    L L+ EY   G +   L  +       +  K   IV    SA+ Y H+   
Sbjct: 80  FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIV----SAVQYCHQ--- 132
Query: 409 RQIIHRDVKACNILLDAEFNAKLGDF----EATIPA------GTMGYLAPEYVYSGVPSE 458
           ++I+HRD+KA N+LLDA+ N K+ DF    E T+        G   Y APE ++ G   +
Sbjct: 133 KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPE-LFQGKKYD 191
Query: 459 --KTDVYSFGVVALEVAAGKSPVD 480
             + DV+S GV+   + +G  P D
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 91/203 (44%), Gaps = 27/203 (13%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G    VY+G           +  K + +E     F  E A M   ++H NLVQL G 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKE-IKHPNLVQLLGV 77
Query: 352 CCEGNELVLVYEYLPNGSLDKIL---HNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE 408
           C       ++ E++  G+L   L   +    S++VL     L +   ++SA+ YL    +
Sbjct: 78  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVL-----LYMATQISSAMEYLE---K 129
Query: 409 RQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVP 456
           +  IHRD+ A N L+      K+ DF           T  AG    + + APE +     
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 189
Query: 457 SEKTDVYSFGVVALEVAA-GKSP 478
           S K+DV++FGV+  E+A  G SP
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSP 212

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 91/203 (44%), Gaps = 27/203 (13%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G    VY+G           +  K + +E     F  E A M   ++H NLVQL G 
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKE-IKHPNLVQLLGV 75
Query: 352 CCEGNELVLVYEYLPNGSLDKIL---HNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE 408
           C       ++ E++  G+L   L   +    S++VL     L +   ++SA+ YL    +
Sbjct: 76  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL-----LYMATQISSAMEYLE---K 127
Query: 409 RQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVP 456
           +  IHRD+ A N L+      K+ DF           T  AG    + + APE +     
Sbjct: 128 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKF 187
Query: 457 SEKTDVYSFGVVALEVAA-GKSP 478
           S K+DV++FGV+  E+A  G SP
Sbjct: 188 SIKSDVWAFGVLLWEIATYGMSP 210

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 91/203 (44%), Gaps = 27/203 (13%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G    VY+G           +  K + +E     F  E A M   ++H NLVQL G 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKE-IKHPNLVQLLGV 77
Query: 352 CCEGNELVLVYEYLPNGSLDKIL---HNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE 408
           C       ++ E++  G+L   L   +    S++VL     L +   ++SA+ YL    +
Sbjct: 78  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVL-----LYMATQISSAMEYLE---K 129
Query: 409 RQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVP 456
           +  IHRD+ A N L+      K+ DF           T  AG    + + APE +     
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 189
Query: 457 SEKTDVYSFGVVALEVAA-GKSP 478
           S K+DV++FGV+  E+A  G SP
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSP 212

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/282 (23%), Positives = 115/282 (40%), Gaps = 50/282 (17%)
Query: 292 VGEGASATVY--------KGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHK 343
           +GEGA   V         K        VAVK   K +  E   +   +E   M    +HK
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHN------------NSSSSIVLSWEKRLN 391
           N++ L G C +   L ++ EY   G+L + L              N      ++++  ++
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVS 161
Query: 392 IVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-------------EATI 438
               +A  + YL     ++ IHRD+ A N+L+      K+ DF             + T 
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTN 218
Query: 439 PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEV-AAGKSPVDNDGCVIVDWVWNLRKKG 497
               + ++APE ++  V + ++DV+SFGV+  E+   G SP      + V+ ++ L K+G
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG---IPVEELFKLLKEG 275
Query: 498 KLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKE 539
             +D                 + M+   C H    +RP+ K+
Sbjct: 276 HRMDKP---------ANCTNELYMMMRDCWHAVPSQRPTFKQ 308

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 95/213 (44%), Gaps = 28/213 (13%)
Query: 290 RIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           + +GEGA+  V    +  +  AVAVK  +    V+C  N    +   +   L H+N+V+ 
Sbjct: 12  QTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--IKKEICINKMLNHENVVKF 69
Query: 349 QGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC 407
            G   EGN   L  EY   G L D+I        I +           + + + YLH   
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYLHG-- 122
Query: 408 ERQIIHRDVKACNILLDAEFNAKLGDFE-ATI------------PAGTMGYLAPEYV-YS 453
              I HRD+K  N+LLD   N K+ DF  AT+              GT+ Y+APE +   
Sbjct: 123 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 454 GVPSEKTDVYSFGVVALEVAAGKSPVD--NDGC 484
              +E  DV+S G+V   + AG+ P D  +D C
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 214

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 91/203 (44%), Gaps = 27/203 (13%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G    VY+G           +  K + +E     F  E A M   ++H NLVQL G 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKE-IKHPNLVQLLGV 82
Query: 352 CCEGNELVLVYEYLPNGSLDKIL---HNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE 408
           C       ++ E++  G+L   L   +    S++VL     L +   ++SA+ YL    +
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL-----LYMATQISSAMEYLE---K 134
Query: 409 RQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVP 456
           +  IHRD+ A N L+      K+ DF           T  AG    + + APE +     
Sbjct: 135 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 194
Query: 457 SEKTDVYSFGVVALEVAA-GKSP 478
           S K+DV++FGV+  E+A  G SP
Sbjct: 195 SIKSDVWAFGVLLWEIATYGMSP 217

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 94/214 (43%), Gaps = 20/214 (9%)
Query: 285 GFNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHK 343
            F K   +GEG    VYK  +  +G  VA+K+       E   +    E + +   L H 
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE-LNHP 62
Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
           N+V+L       N+L LV+E+L +  L K +  ++ + I L   K  + +  +   LS+ 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLSFC 119
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG-----------TMGYLAPEYVY 452
           H     +++HRD+K  N+L++ E   KL DF      G           T+ Y APE + 
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 176
Query: 453 S-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV 485
                S   D++S G +  E+   ++    D  +
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 210

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 91/203 (44%), Gaps = 27/203 (13%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G    VY+G           +  K + +E     F  E A M   ++H NLVQL G 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKE-IKHPNLVQLLGV 77
Query: 352 CCEGNELVLVYEYLPNGSLDKIL---HNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE 408
           C       ++ E++  G+L   L   +    S++VL     L +   ++SA+ YL    +
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL-----LYMATQISSAMEYLE---K 129
Query: 409 RQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVP 456
           +  IHRD+ A N L+      K+ DF           T  AG    + + APE +     
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 189
Query: 457 SEKTDVYSFGVVALEVAA-GKSP 478
           S K+DV++FGV+  E+A  G SP
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSP 212

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 91/203 (44%), Gaps = 27/203 (13%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G    VY+G           +  K + +E     F  E A M   ++H NLVQL G 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKE-IKHPNLVQLLGV 77
Query: 352 CCEGNELVLVYEYLPNGSLDKIL---HNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE 408
           C       ++ E++  G+L   L   +    S++VL     L +   ++SA+ YL    +
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL-----LYMATQISSAMEYLE---K 129
Query: 409 RQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVP 456
           +  IHRD+ A N L+      K+ DF           T  AG    + + APE +     
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 189
Query: 457 SEKTDVYSFGVVALEVAA-GKSP 478
           S K+DV++FGV+  E+A  G SP
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSP 212

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 91/200 (45%), Gaps = 23/200 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G+G    V+ G+      VA+K   KP  +  +   F  E   M   +RH+ LVQL   
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTM--SPEAFLQEAQVMKK-IRHEKLVQLYAV 81
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
             E   + +V EY+  GSL   L       + L   + +++   +AS ++Y+        
Sbjct: 82  VSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQIASGMAYVER---MNY 135
Query: 412 IHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVPSEK 459
           +HRD++A NIL+      K+ DF         E T   G    + + APE    G  + K
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 460 TDVYSFGVVALEVAA-GKSP 478
           +DV+SFG++  E+   G+ P
Sbjct: 196 SDVWSFGILLTELTTKGRVP 215

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/274 (22%), Positives = 114/274 (41%), Gaps = 54/274 (19%)
Query: 311 VAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSL 370
           VAVK  +     +  +    +E   M+   +H+N+V L G C  G  ++++ EY   G L
Sbjct: 64  VAVKMLKSTAHAD-EKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 122
Query: 371 DKILHNNSSSSI-------------------VLSWEKRLNIVLGVASALSYLHEECERQI 411
              L   + + +                    L     L+    VA  +++L     +  
Sbjct: 123 LNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNC 179
Query: 412 IHRDVKACNILLDAEFNAKLGDF----------------EATIPAGTMGYLAPEYVYSGV 455
           IHRDV A N+LL     AK+GDF                 A +P   + ++APE ++  V
Sbjct: 180 IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP---VKWMAPESIFDCV 236
Query: 456 PSEKTDVYSFGVVALEV-AAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRK 514
            + ++DV+S+G++  E+ + G +P    G ++    + L K G  +    F  +  ++  
Sbjct: 237 YTVQSDVWSYGILLWEIFSLGLNPY--PGILVNSKFYKLVKDGYQMAQPAFAPKNIYS-- 292
Query: 515 EMERMLMVGLSCVHPNHEKRPSVKEAARILKGEA 548
                +M     + P H  RP+ ++    L+ +A
Sbjct: 293 -----IMQACWALEPTH--RPTFQQICSFLQEQA 319

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 91/203 (44%), Gaps = 27/203 (13%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G    VY+G           +  K + +E     F  E A M   ++H NLVQL G 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKE-IKHPNLVQLLGV 75
Query: 352 CCEGNELVLVYEYLPNGSLDKIL---HNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE 408
           C       ++ E++  G+L   L   +    S++VL     L +   ++SA+ YL    +
Sbjct: 76  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL-----LYMATQISSAMEYLE---K 127
Query: 409 RQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVP 456
           +  IHRD+ A N L+      K+ DF           T  AG    + + APE +     
Sbjct: 128 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAYNKF 187
Query: 457 SEKTDVYSFGVVALEVAA-GKSP 478
           S K+DV++FGV+  E+A  G SP
Sbjct: 188 SIKSDVWAFGVLLWEIATYGMSP 210

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/281 (21%), Positives = 110/281 (39%), Gaps = 48/281 (17%)
Query: 292 VGEGASATVYKGSL-------PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           +GEGA   V            P        +  K +  E   +   +E   M    +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHN------------NSSSSIVLSWEKRLNI 392
           ++ L G C +   L ++ EY   G+L + L              N      ++++  ++ 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 393 VLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGTMGY------- 445
              +A  + YL     ++ IHRD+ A N+L+      ++ DF        + Y       
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNG 219
Query: 446 ------LAPEYVYSGVPSEKTDVYSFGVVALEV-AAGKSPVDNDGCVIVDWVWNLRKKGK 498
                 +APE ++  V + ++DV+SFGV+  E+   G SP      + V+ ++ L K+G 
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG---IPVEELFKLLKEGH 276
Query: 499 LLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKE 539
            +D                 + M+   C H    +RP+ K+
Sbjct: 277 RMDKP---------ANCTNELYMMMRDCWHAVPSQRPTFKQ 308

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 71/294 (24%), Positives = 115/294 (39%), Gaps = 53/294 (18%)
Query: 286 FNKNRIVGEGASATVYKG------SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGC 339
            N  + +G GA   V +          +   VAVK   K            +E   +   
Sbjct: 30  LNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRALMSELKILIHI 88
Query: 340 LRHKNLVQLQGWCCE-GNELVLVYEYLPNGSLDKILHNNSSSSI-----------VLSWE 387
             H N+V L G C + G  L+++ E+   G+L   L +  +  +            L+ E
Sbjct: 89  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLE 148
Query: 388 KRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF------------- 434
             +     VA  + +L     R+ IHRD+ A NILL  +   K+ DF             
Sbjct: 149 HLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXV 205
Query: 435 ---EATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEV-AAGKSPVDNDGCVIVDWV 490
              +A +P   + ++APE ++  V + ++DV+SFGV+  E+ + G SP    G  I +  
Sbjct: 206 RKGDARLP---LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY--PGVKIDEEF 260
Query: 491 WNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARIL 544
               K+G  + A D+             M    L C H    +RP+  E    L
Sbjct: 261 CRRLKEGTRMRAPDY---------TTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 98/221 (44%), Gaps = 44/221 (19%)
Query: 289 NRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQ 347
           + ++GEGA A V    SL +G   AVK  EK  +   +R+    E  T+  C  +KN+++
Sbjct: 18  SELLGEGAYAKVQGAVSLQNGKEYAVKIIEK--QAGHSRSRVFREVETLYQCQGNKNILE 75
Query: 348 LQGWCCEGNELVLVYEYLPNGS----LDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
           L  +  +     LV+E L  GS    + K  H N   +          +V  VA+AL +L
Sbjct: 76  LIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREAS--------RVVRDVAAALDFL 127
Query: 404 HEECERQIIHRDVKACNILLDAEFN---AKLGDF------------------EATIPAGT 442
           H    + I HRD+K  NIL ++       K+ DF                  E T P G+
Sbjct: 128 H---TKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGS 184
Query: 443 MGYLAPEYV-----YSGVPSEKTDVYSFGVVALEVAAGKSP 478
             Y+APE V      +    ++ D++S GVV   + +G  P
Sbjct: 185 AEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPP 225

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 94/216 (43%), Gaps = 30/216 (13%)
Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFE------KPNRVECARNPFTTEFATMAG 338
           ++   ++G G S+ V +     +G   AVK  E       P ++E  R     E   +  
Sbjct: 96  YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155
Query: 339 CLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVAS 398
              H +++ L       + + LV++ +  G L   L    +  + LS ++  +I+  +  
Sbjct: 156 VAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL----TEKVALSEKETRSIMRSLLE 211
Query: 399 ALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP----------AGTMGYLAP 448
           A+S+LH      I+HRD+K  NILLD     +L DF  +             GT GYLAP
Sbjct: 212 AVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAP 268
Query: 449 EYVYSGVPS------EKTDVYSFGVVALEVAAGKSP 478
           E +   +        ++ D+++ GV+   + AG  P
Sbjct: 269 EILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 91/204 (44%), Gaps = 22/204 (10%)
Query: 290 RIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           + +G+G  A V     + +G  VAVK  +K      +      E   M   L H N+V+L
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMK-VLNHPNIVKL 78
Query: 349 QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE 408
                    L LV EY   G +   L  +       +  K   IV    SA+ Y H++  
Sbjct: 79  FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIV----SAVQYCHQKF- 133
Query: 409 RQIIHRDVKACNILLDAEFNAKLGDF----EATIP------AGTMGYLAPEYVYSGVPSE 458
             I+HRD+KA N+LLDA+ N K+ DF    E T         G+  Y APE ++ G   +
Sbjct: 134 --IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPE-LFQGKKYD 190
Query: 459 --KTDVYSFGVVALEVAAGKSPVD 480
             + DV+S GV+   + +G  P D
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 27/203 (13%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G    VY+G           +  K + +E     F  E A M   ++H NLVQL G 
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKE-IKHPNLVQLLGV 78
Query: 352 CCEGNELVLVYEYLPNGSLDKIL---HNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE 408
           C       ++ E++  G+L   L   +    +++VL     L +   ++SA+ YL    +
Sbjct: 79  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAMEYLE---K 130
Query: 409 RQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVP 456
           +  IHRD+ A N L+      K+ DF           T  AG    + + APE +     
Sbjct: 131 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKF 190
Query: 457 SEKTDVYSFGVVALEVAA-GKSP 478
           S K+DV++FGV+  E+A  G SP
Sbjct: 191 SIKSDVWAFGVLLWEIATYGMSP 213

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 93/213 (43%), Gaps = 28/213 (13%)
Query: 290 RIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           + +GEGA   V    +  +  AVAVK  +    V+C  N    +   +   L H+N+V+ 
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--IKKEIXINKMLNHENVVKF 70
Query: 349 QGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC 407
            G   EGN   L  EY   G L D+I        I +           + + + YLH   
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYLHG-- 123
Query: 408 ERQIIHRDVKACNILLDAEFNAKLGDFE-ATI------------PAGTMGYLAPEYV-YS 453
              I HRD+K  N+LLD   N K+ DF  AT+              GT+ Y+APE +   
Sbjct: 124 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 182
Query: 454 GVPSEKTDVYSFGVVALEVAAGKSPVDN--DGC 484
              +E  DV+S G+V   + AG+ P D   D C
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 215

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 90/200 (45%), Gaps = 23/200 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G+G    V+ G+      VA+K   KP  +  +   F  E   M   LRH+ LVQL   
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTM--SPEAFLQEAQVMKK-LRHEKLVQLYAV 81
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
             E   + +V EY+  GSL   L       + L   + +++   +AS ++Y+        
Sbjct: 82  VSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQIASGMAYVER---MNY 135
Query: 412 IHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVPSEK 459
           +HRD+ A NIL+      K+ DF         E T   G    + + APE    G  + K
Sbjct: 136 VHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 460 TDVYSFGVVALEVAA-GKSP 478
           +DV+SFG++  E+   G+ P
Sbjct: 196 SDVWSFGILLTELTTKGRVP 215

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 94/213 (44%), Gaps = 28/213 (13%)
Query: 290 RIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           + +GEGA   V    +  +  AVAVK  +    V+C  N    +   +   L H+N+V+ 
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--IKKEICINAMLNHENVVKF 70
Query: 349 QGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC 407
            G   EGN   L  EY   G L D+I        I +           + + + YLH   
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYLHG-- 123
Query: 408 ERQIIHRDVKACNILLDAEFNAKLGDFE-ATI------------PAGTMGYLAPEYV-YS 453
              I HRD+K  N+LLD   N K+ DF  AT+              GT+ Y+APE +   
Sbjct: 124 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 454 GVPSEKTDVYSFGVVALEVAAGKSPVD--NDGC 484
              +E  DV+S G+V   + AG+ P D  +D C
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 215

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 91/204 (44%), Gaps = 22/204 (10%)
Query: 290 RIVGEGASATV-YKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           + +G+G  A V     + +G  VAVK  +K      +      E   M   L H N+V+L
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMK-VLNHPNIVKL 78
Query: 349 QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE 408
                    L LV EY   G +   L  +       +  K   IV    SA+ Y H++  
Sbjct: 79  FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIV----SAVQYCHQKF- 133
Query: 409 RQIIHRDVKACNILLDAEFNAKLGDF----EATIP------AGTMGYLAPEYVYSGVPSE 458
             I+HRD+KA N+LLDA+ N K+ DF    E T         G+  Y APE ++ G   +
Sbjct: 134 --IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPE-LFQGKKYD 190
Query: 459 --KTDVYSFGVVALEVAAGKSPVD 480
             + DV+S GV+   + +G  P D
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 23/200 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G+G    V+ G+      VA+K   KP  +  +   F  E   M   LRH+ LVQL   
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTM--SPEAFLQEAQVMKK-LRHEKLVQLYAV 81
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
             E   + +V EY+  G L   L       + L   + +++   +AS ++Y+        
Sbjct: 82  VSE-EPIYIVMEYMSKGCLLDFLKGEMGKYLRLP--QLVDMAAQIASGMAYVER---MNY 135
Query: 412 IHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVPSEK 459
           +HRD++A NIL+      K+ DF         E T   G    + + APE    G  + K
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 460 TDVYSFGVVALEVAA-GKSP 478
           +DV+SFG++  E+   G+ P
Sbjct: 196 SDVWSFGILLTELTTKGRVP 215

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 93/213 (43%), Gaps = 28/213 (13%)
Query: 290 RIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           + +GEGA   V    +  +  AVAVK  +    V+C  N    +   +   L H+N+V+ 
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--IKKEIXINKMLNHENVVKF 69
Query: 349 QGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC 407
            G   EGN   L  EY   G L D+I        I +           + + + YLH   
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYLHG-- 122
Query: 408 ERQIIHRDVKACNILLDAEFNAKLGDFE-ATI------------PAGTMGYLAPEYV-YS 453
              I HRD+K  N+LLD   N K+ DF  AT+              GT+ Y+APE +   
Sbjct: 123 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 181
Query: 454 GVPSEKTDVYSFGVVALEVAAGKSPVDN--DGC 484
              +E  DV+S G+V   + AG+ P D   D C
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 214

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/260 (25%), Positives = 105/260 (40%), Gaps = 48/260 (18%)
Query: 310 AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE-GNELVLVYEYLPNG 368
            VAVK   K            +E   +     H N+V L G C + G  L+++ E+   G
Sbjct: 50  TVAVKML-KEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 108
Query: 369 SLDKILHNNSSSSI------------VLSWEKRLNIVLGVASALSYLHEECERQIIHRDV 416
           +L   L +  +  +             L+ E  +     VA  + +L     R+ IHRD+
Sbjct: 109 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDL 165
Query: 417 KACNILLDAEFNAKLGDF----------------EATIPAGTMGYLAPEYVYSGVPSEKT 460
            A NILL  +   K+ DF                +A +P   + ++APE ++  V + ++
Sbjct: 166 AARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP---LKWMAPETIFDRVYTIQS 222
Query: 461 DVYSFGVVALEV-AAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERM 519
           DV+SFGV+  E+ + G SP    G  I +      K+G  + A D+             M
Sbjct: 223 DVWSFGVLLWEIFSLGASPY--PGVKIDEEFCRRLKEGTRMRAPDY---------TTPEM 271
Query: 520 LMVGLSCVHPNHEKRPSVKE 539
               L C H    +RP+  E
Sbjct: 272 YQTMLDCWHGEPSQRPTFSE 291

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/265 (24%), Positives = 106/265 (40%), Gaps = 48/265 (18%)
Query: 310 AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE-GNELVLVYEYLPNG 368
            VAVK   K            +E   +     H N+V L G C + G  L+++ E+   G
Sbjct: 61  TVAVKML-KEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 119
Query: 369 SLDKILHNNSSSSI------------VLSWEKRLNIVLGVASALSYLHEECERQIIHRDV 416
           +L   L +  +  +             L+ E  +     VA  + +L     R+ IHRD+
Sbjct: 120 NLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDL 176
Query: 417 KACNILLDAEFNAKLGDF----------------EATIPAGTMGYLAPEYVYSGVPSEKT 460
            A NILL  +   K+ DF                +A +P   + ++APE ++  V + ++
Sbjct: 177 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP---LKWMAPETIFDRVYTIQS 233
Query: 461 DVYSFGVVALEV-AAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERM 519
           DV+SFGV+  E+ + G SP    G  I +      K+G  + A D+             M
Sbjct: 234 DVWSFGVLLWEIFSLGASPY--PGVKIDEEFCRRLKEGTRMRAPDY---------TTPEM 282
Query: 520 LMVGLSCVHPNHEKRPSVKEAARIL 544
               L C H    +RP+  E    L
Sbjct: 283 YQTMLDCWHGEPSQRPTFSELVEHL 307

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 123/288 (42%), Gaps = 49/288 (17%)
Query: 289 NRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRV------ECARNPFTTEFATMAGCLRH 342
           +R +G+G+   VY+G      A  V + E   RV      E A      EF   A  ++ 
Sbjct: 24  SRELGQGSFGMVYEGV-----AKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 78
Query: 343 KN---LVQLQGWCCEGNELVLVYEYLPNGSLDKILHN---NSSSSIVL---SWEKRLNIV 393
            N   +V+L G   +G   +++ E +  G L   L +      ++ VL   S  K + + 
Sbjct: 79  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMA 138
Query: 394 LGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT--------IPAGTMG- 444
             +A  ++YL+     + +HRD+ A N ++  +F  K+GDF  T           G  G 
Sbjct: 139 GEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGL 195
Query: 445 ----YLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKL 499
               +++PE +  GV +  +DV+SFGVV  E+A   + P      +  + V     +G L
Sbjct: 196 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG---LSNEQVLRFVMEGGL 252
Query: 500 LDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE 547
           LD  D      F   E+ RM      C   N + RPS  E    +K E
Sbjct: 253 LDKPDNCPDMLF---ELMRM------CWQYNPKMRPSFLEIISSIKEE 291

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 101/210 (48%), Gaps = 30/210 (14%)
Query: 290 RIVGEGASATVYKGS---LPSGGA---VAVKRFEKPNRVECARNPFTTEFATMAGCLRHK 343
           R +G+G+   VY+G+   +  G A   VAVK   +   +   R  F  E + M G   H 
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR-ERIEFLNEASVMKGFTCH- 80
Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHN------NSSSSIVLSWEKRLNIVLGVA 397
           ++V+L G   +G   ++V E + +G L   L +      N+      + ++ + +   +A
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 398 SALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT--------IPAGTMG----- 444
             ++YL+    ++ +HR++ A N ++  +F  K+GDF  T           G  G     
Sbjct: 141 DGMAYLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 197
Query: 445 YLAPEYVYSGVPSEKTDVYSFGVVALEVAA 474
           ++APE +  GV +  +D++SFGVV  E+ +
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 27/203 (13%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G    VY+G           +  K + +E     F  E A M   ++H NLVQL G 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKE-IKHPNLVQLLGV 82
Query: 352 CCEGNELVLVYEYLPNGSLDKIL---HNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE 408
           C       ++ E++  G+L   L   +    +++VL     L +   ++SA+ YL    +
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAMEYLE---K 134
Query: 409 RQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVP 456
           +  IHRD+ A N L+      K+ DF           T  AG    + + APE +     
Sbjct: 135 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKF 194
Query: 457 SEKTDVYSFGVVALEVAA-GKSP 478
           S K+DV++FGV+  E+A  G SP
Sbjct: 195 SIKSDVWAFGVLLWEIATYGMSP 217

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 94/213 (44%), Gaps = 28/213 (13%)
Query: 290 RIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           + +GEGA   V    +  +  AVAVK  +    V+C  N    +   +   L H+N+V+ 
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--IKKEIXINKMLNHENVVKF 69
Query: 349 QGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC 407
            G   EGN   L  EY   G L D+I        I +           + + + YLH   
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYLHG-- 122
Query: 408 ERQIIHRDVKACNILLDAEFNAKLGDFE-ATI------------PAGTMGYLAPEYV-YS 453
              I HRD+K  N+LLD   N K+ DF  AT+              GT+ Y+APE +   
Sbjct: 123 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 454 GVPSEKTDVYSFGVVALEVAAGKSPVD--NDGC 484
              +E  DV+S G+V   + AG+ P D  +D C
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 214

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 94/213 (44%), Gaps = 28/213 (13%)
Query: 290 RIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           + +GEGA   V    +  +  AVAVK  +    V+C  N    +   +   L H+N+V+ 
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--IKKEICINKMLNHENVVKF 70
Query: 349 QGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC 407
            G   EGN   L  EY   G L D+I        I +           + + + YLH   
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYLHG-- 123
Query: 408 ERQIIHRDVKACNILLDAEFNAKLGDFE-ATI------------PAGTMGYLAPEYV-YS 453
              I HRD+K  N+LLD   N K+ DF  AT+              GT+ Y+APE +   
Sbjct: 124 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 454 GVPSEKTDVYSFGVVALEVAAGKSPVD--NDGC 484
              +E  DV+S G+V   + AG+ P D  +D C
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 215

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/265 (24%), Positives = 106/265 (40%), Gaps = 48/265 (18%)
Query: 310 AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE-GNELVLVYEYLPNG 368
            VAVK   K            +E   +     H N+V L G C + G  L+++ E+   G
Sbjct: 59  TVAVKML-KEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 117
Query: 369 SLDKILHNNSSSSI------------VLSWEKRLNIVLGVASALSYLHEECERQIIHRDV 416
           +L   L +  +  +             L+ E  +     VA  + +L     R+ IHRD+
Sbjct: 118 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDL 174
Query: 417 KACNILLDAEFNAKLGDF----------------EATIPAGTMGYLAPEYVYSGVPSEKT 460
            A NILL  +   K+ DF                +A +P   + ++APE ++  V + ++
Sbjct: 175 AARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARLP---LKWMAPETIFDRVYTIQS 231
Query: 461 DVYSFGVVALEV-AAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERM 519
           DV+SFGV+  E+ + G SP    G  I +      K+G  + A D+             M
Sbjct: 232 DVWSFGVLLWEIFSLGASPY--PGVKIDEEFCRRLKEGTRMRAPDY---------TTPEM 280
Query: 520 LMVGLSCVHPNHEKRPSVKEAARIL 544
               L C H    +RP+  E    L
Sbjct: 281 YQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 101/210 (48%), Gaps = 30/210 (14%)
Query: 290 RIVGEGASATVYKGS---LPSGGA---VAVKRFEKPNRVECARNPFTTEFATMAGCLRHK 343
           R +G+G+   VY+G+   +  G A   VAVK   +   +   R  F  E + M G   H 
Sbjct: 24  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR-ERIEFLNEASVMKGFTCH- 81
Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHN------NSSSSIVLSWEKRLNIVLGVA 397
           ++V+L G   +G   ++V E + +G L   L +      N+      + ++ + +   +A
Sbjct: 82  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 141
Query: 398 SALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT--------IPAGTMG----- 444
             ++YL+    ++ +HR++ A N ++  +F  K+GDF  T           G  G     
Sbjct: 142 DGMAYLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 198
Query: 445 YLAPEYVYSGVPSEKTDVYSFGVVALEVAA 474
           ++APE +  GV +  +D++SFGVV  E+ +
Sbjct: 199 WMAPESLKDGVFTTSSDMWSFGVVLWEITS 228

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 94/213 (44%), Gaps = 28/213 (13%)
Query: 290 RIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           + +GEGA   V    +  +  AVAVK  +    V+C  N    +   +   L H+N+V+ 
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--IKKEICINKMLNHENVVKF 69
Query: 349 QGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC 407
            G   EGN   L  EY   G L D+I        I +           + + + YLH   
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYLHG-- 122
Query: 408 ERQIIHRDVKACNILLDAEFNAKLGDFE-ATI------------PAGTMGYLAPEYV-YS 453
              I HRD+K  N+LLD   N K+ DF  AT+              GT+ Y+APE +   
Sbjct: 123 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 454 GVPSEKTDVYSFGVVALEVAAGKSPVD--NDGC 484
              +E  DV+S G+V   + AG+ P D  +D C
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 214

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 94/213 (44%), Gaps = 28/213 (13%)
Query: 290 RIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           + +GEGA   V    +  +  AVAVK  +    V+C  N    +   +   L H+N+V+ 
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--IKKEICINKMLNHENVVKF 69
Query: 349 QGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC 407
            G   EGN   L  EY   G L D+I        I +           + + + YLH   
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYLHG-- 122
Query: 408 ERQIIHRDVKACNILLDAEFNAKLGDFE-ATI------------PAGTMGYLAPEYV-YS 453
              I HRD+K  N+LLD   N K+ DF  AT+              GT+ Y+APE +   
Sbjct: 123 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 454 GVPSEKTDVYSFGVVALEVAAGKSPVD--NDGC 484
              +E  DV+S G+V   + AG+ P D  +D C
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 214

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 123/288 (42%), Gaps = 49/288 (17%)
Query: 289 NRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRV------ECARNPFTTEFATMAGCLRH 342
           +R +G+G+   VY+G      A  V + E   RV      E A      EF   A  ++ 
Sbjct: 24  SRELGQGSFGMVYEGV-----AKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 78
Query: 343 KN---LVQLQGWCCEGNELVLVYEYLPNGSLDKILHN---NSSSSIVL---SWEKRLNIV 393
            N   +V+L G   +G   +++ E +  G L   L +      ++ VL   S  K + + 
Sbjct: 79  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMA 138
Query: 394 LGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT--------IPAGTMG- 444
             +A  ++YL+     + +HRD+ A N ++  +F  K+GDF  T           G  G 
Sbjct: 139 GEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 195
Query: 445 ----YLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKL 499
               +++PE +  GV +  +DV+SFGVV  E+A   + P      +  + V     +G L
Sbjct: 196 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG---LSNEQVLRFVMEGGL 252
Query: 500 LDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE 547
           LD  D      F   E+ RM      C   N + RPS  E    +K E
Sbjct: 253 LDKPDNCPDMLF---ELMRM------CWQYNPKMRPSFLEIISSIKEE 291

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 94/213 (44%), Gaps = 28/213 (13%)
Query: 290 RIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           + +GEGA   V    +  +  AVAVK  +    V+C  N    +   +   L H+N+V+ 
Sbjct: 11  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--IKKEICINKMLNHENVVKF 68
Query: 349 QGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC 407
            G   EGN   L  EY   G L D+I        I +           + + + YLH   
Sbjct: 69  YGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYLHG-- 121
Query: 408 ERQIIHRDVKACNILLDAEFNAKLGDFE-ATI------------PAGTMGYLAPEYV-YS 453
              I HRD+K  N+LLD   N K+ DF  AT+              GT+ Y+APE +   
Sbjct: 122 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 454 GVPSEKTDVYSFGVVALEVAAGKSPVD--NDGC 484
              +E  DV+S G+V   + AG+ P D  +D C
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 213

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/265 (24%), Positives = 106/265 (40%), Gaps = 48/265 (18%)
Query: 310 AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE-GNELVLVYEYLPNG 368
            VAVK   K            +E   +     H N+V L G C + G  L+++ E+   G
Sbjct: 59  TVAVKML-KEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 117
Query: 369 SLDKILHNNSSSSI------------VLSWEKRLNIVLGVASALSYLHEECERQIIHRDV 416
           +L   L +  +  +             L+ E  +     VA  + +L     R+ IHRD+
Sbjct: 118 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDL 174
Query: 417 KACNILLDAEFNAKLGDF----------------EATIPAGTMGYLAPEYVYSGVPSEKT 460
            A NILL  +   K+ DF                +A +P   + ++APE ++  V + ++
Sbjct: 175 AARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP---LKWMAPETIFDRVYTIQS 231
Query: 461 DVYSFGVVALEV-AAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERM 519
           DV+SFGV+  E+ + G SP    G  I +      K+G  + A D+             M
Sbjct: 232 DVWSFGVLLWEIFSLGASPY--PGVKIDEEFCRRLKEGTRMRAPDY---------TTPEM 280
Query: 520 LMVGLSCVHPNHEKRPSVKEAARIL 544
               L C H    +RP+  E    L
Sbjct: 281 YQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/265 (24%), Positives = 106/265 (40%), Gaps = 48/265 (18%)
Query: 310 AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE-GNELVLVYEYLPNG 368
            VAVK   K            +E   +     H N+V L G C + G  L+++ E+   G
Sbjct: 96  TVAVKML-KEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 154
Query: 369 SLDKILHNNSSSSI------------VLSWEKRLNIVLGVASALSYLHEECERQIIHRDV 416
           +L   L +  +  +             L+ E  +     VA  + +L     R+ IHRD+
Sbjct: 155 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDL 211
Query: 417 KACNILLDAEFNAKLGDF----------------EATIPAGTMGYLAPEYVYSGVPSEKT 460
            A NILL  +   K+ DF                +A +P   + ++APE ++  V + ++
Sbjct: 212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP---LKWMAPETIFDRVYTIQS 268
Query: 461 DVYSFGVVALEV-AAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERM 519
           DV+SFGV+  E+ + G SP    G  I +      K+G  + A D+             M
Sbjct: 269 DVWSFGVLLWEIFSLGASPY--PGVKIDEEFCRRLKEGTRMRAPDY---------TTPEM 317
Query: 520 LMVGLSCVHPNHEKRPSVKEAARIL 544
               L C H    +RP+  E    L
Sbjct: 318 YQTMLDCWHGEPSQRPTFSELVEHL 342

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/265 (24%), Positives = 106/265 (40%), Gaps = 48/265 (18%)
Query: 310 AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE-GNELVLVYEYLPNG 368
            VAVK   K            +E   +     H N+V L G C + G  L+++ E+   G
Sbjct: 59  TVAVKML-KEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 117
Query: 369 SLDKILHNNSSSSI------------VLSWEKRLNIVLGVASALSYLHEECERQIIHRDV 416
           +L   L +  +  +             L+ E  +     VA  + +L     R+ IHRD+
Sbjct: 118 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDL 174
Query: 417 KACNILLDAEFNAKLGDF----------------EATIPAGTMGYLAPEYVYSGVPSEKT 460
            A NILL  +   K+ DF                +A +P   + ++APE ++  V + ++
Sbjct: 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP---LKWMAPETIFDRVYTIQS 231
Query: 461 DVYSFGVVALEV-AAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERM 519
           DV+SFGV+  E+ + G SP    G  I +      K+G  + A D+             M
Sbjct: 232 DVWSFGVLLWEIFSLGASPY--PGVKIDEEFCRRLKEGTRMRAPDY---------TTPEM 280
Query: 520 LMVGLSCVHPNHEKRPSVKEAARIL 544
               L C H    +RP+  E    L
Sbjct: 281 YQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 90/207 (43%), Gaps = 28/207 (13%)
Query: 290 RIVGEGASATV-YKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           + +G+G  A V     + +G  VAVK  +K      +      E   M   L H N+V+L
Sbjct: 13  KTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMK-VLNHPNIVKL 71
Query: 349 QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNI---VLGVASALSYLHE 405
                    L LV EY   G +   L       +   W K          + SA+ Y H+
Sbjct: 72  FEVIETEKTLYLVMEYASGGEVFDYL-------VAHGWMKEKEARAKFRQIVSAVQYCHQ 124
Query: 406 ECERQIIHRDVKACNILLDAEFNAKLGDF----EATIP------AGTMGYLAPEYVYSGV 455
           +    I+HRD+KA N+LLDA+ N K+ DF    E T         G+  Y APE ++ G 
Sbjct: 125 KF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPE-LFQGK 180
Query: 456 PSE--KTDVYSFGVVALEVAAGKSPVD 480
             +  + DV+S GV+   + +G  P D
Sbjct: 181 KYDGPEVDVWSLGVILYTLVSGSLPFD 207

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 95/217 (43%), Gaps = 22/217 (10%)
Query: 277 TDIKQATLGFNKNRIVGEGASATV-YKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFAT 335
           TD +     +   + +G+G  A V     + +G  VAVK  +K      +      E   
Sbjct: 8   TDEQPHIGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRI 67
Query: 336 MAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLG 395
           M   L H N+V+L         L LV EY   G +   L  +       +  K   IV  
Sbjct: 68  MK-ILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIV-- 124
Query: 396 VASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF----EATIP------AGTMGY 445
             SA+ Y H+   + I+HRD+KA N+LLD + N K+ DF    E T+        G+  Y
Sbjct: 125 --SAVQYCHQ---KYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCGSPPY 179
Query: 446 LAPEYVYSGVPSE--KTDVYSFGVVALEVAAGKSPVD 480
            APE ++ G   +  + DV+S GV+   + +G  P D
Sbjct: 180 AAPE-LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 123/288 (42%), Gaps = 49/288 (17%)
Query: 289 NRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRV------ECARNPFTTEFATMAGCLRH 342
           +R +G+G+   VY+G      A  V + E   RV      E A      EF   A  ++ 
Sbjct: 21  SRELGQGSFGMVYEGV-----AKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 75
Query: 343 KN---LVQLQGWCCEGNELVLVYEYLPNGSLDKILHN---NSSSSIVL---SWEKRLNIV 393
            N   +V+L G   +G   +++ E +  G L   L +      ++ VL   S  K + + 
Sbjct: 76  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMA 135
Query: 394 LGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT--------IPAGTMG- 444
             +A  ++YL+     + +HRD+ A N ++  +F  K+GDF  T           G  G 
Sbjct: 136 GEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 192
Query: 445 ----YLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKL 499
               +++PE +  GV +  +DV+SFGVV  E+A   + P      +  + V     +G L
Sbjct: 193 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG---LSNEQVLRFVMEGGL 249
Query: 500 LDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE 547
           LD  D      F   E+ RM      C   N + RPS  E    +K E
Sbjct: 250 LDKPDNCPDMLF---ELMRM------CWQYNPKMRPSFLEIISSIKEE 288

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 124/288 (43%), Gaps = 49/288 (17%)
Query: 289 NRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRV------ECARNPFTTEFATMAGCLRH 342
           +R +G+G+   VY+G      A  V + E   RV      E A      EF   A  ++ 
Sbjct: 15  SRELGQGSFGMVYEGV-----AKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 69
Query: 343 KN---LVQLQGWCCEGNELVLVYEYLPNGSLDKILHN---NSSSSIVL---SWEKRLNIV 393
            N   +V+L G   +G   +++ E +  G L   L +      ++ VL   S  K + + 
Sbjct: 70  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMA 129
Query: 394 LGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT--------IPAGTMG- 444
             +A  ++YL+     + +HRD+ A N ++  +F  K+GDF  T           G  G 
Sbjct: 130 GEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGL 186
Query: 445 ----YLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKL 499
               +++PE +  GV +  +DV+SFGVV  E+A   + P      +  + V     +G L
Sbjct: 187 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG---LSNEQVLRFVMEGGL 243
Query: 500 LDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE 547
           LD  D       N  +M  +L +   C   N + RPS  E    +K E
Sbjct: 244 LDKPD-------NCPDM--LLELMRMCWQYNPKMRPSFLEIISSIKEE 282

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/260 (25%), Positives = 105/260 (40%), Gaps = 48/260 (18%)
Query: 310 AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE-GNELVLVYEYLPNG 368
            VAVK   K            +E   +     H N+V L G C + G  L+++ E+   G
Sbjct: 50  TVAVKML-KEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFG 108
Query: 369 SLDKILHNNSSSSI------------VLSWEKRLNIVLGVASALSYLHEECERQIIHRDV 416
           +L   L +  +  +             L+ E  +     VA  + +L     R+ IHRD+
Sbjct: 109 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDL 165
Query: 417 KACNILLDAEFNAKLGDF----------------EATIPAGTMGYLAPEYVYSGVPSEKT 460
            A NILL  +   K+ DF                +A +P   + ++APE ++  V + ++
Sbjct: 166 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP---LKWMAPETIFDRVYTIQS 222
Query: 461 DVYSFGVVALEV-AAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERM 519
           DV+SFGV+  E+ + G SP    G  I +      K+G  + A D+             M
Sbjct: 223 DVWSFGVLLWEIFSLGASPY--PGVKIDEEFCRRLKEGTRMRAPDY---------TTPEM 271
Query: 520 LMVGLSCVHPNHEKRPSVKE 539
               L C H    +RP+  E
Sbjct: 272 YQTMLDCWHGEPSQRPTFSE 291

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 94/213 (44%), Gaps = 28/213 (13%)
Query: 290 RIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           + +GEGA   V    +  +  AVAVK  +    V+C  N    +   +   L H+N+V+ 
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--IKKEICINKMLNHENVVKF 69
Query: 349 QGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC 407
            G   EGN   L  EY   G L D+I        I +           + + + YLH   
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYLHG-- 122
Query: 408 ERQIIHRDVKACNILLDAEFNAKLGDFE-ATI------------PAGTMGYLAPEYV-YS 453
              I HRD+K  N+LLD   N K+ DF  AT+              GT+ Y+APE +   
Sbjct: 123 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 454 GVPSEKTDVYSFGVVALEVAAGKSPVD--NDGC 484
              +E  DV+S G+V   + AG+ P D  +D C
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 214

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 93/213 (43%), Gaps = 28/213 (13%)
Query: 290 RIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           + +GEGA   V    +  +  AVAVK  +    V+C  N    +   +   L H+N+V+ 
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--IKKEICINKMLNHENVVKF 70
Query: 349 QGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC 407
            G   EGN   L  EY   G L D+I        I +           + + + YLH   
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYLHG-- 123
Query: 408 ERQIIHRDVKACNILLDAEFNAKLGDFE-ATI------------PAGTMGYLAPEYV-YS 453
              I HRD+K  N+LLD   N K+ DF  AT+              GT+ Y+APE +   
Sbjct: 124 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 454 GVPSEKTDVYSFGVVALEVAAGKSPVDN--DGC 484
              +E  DV+S G+V   + AG+ P D   D C
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 215

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 93/213 (43%), Gaps = 28/213 (13%)
Query: 290 RIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           + +GEGA   V    +  +  AVAVK  +    V+C  N    +   +   L H+N+V+ 
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--IKKEICINKMLNHENVVKF 69
Query: 349 QGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC 407
            G   EGN   L  EY   G L D+I        I +           + + + YLH   
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYLHG-- 122
Query: 408 ERQIIHRDVKACNILLDAEFNAKLGDFE-ATI------------PAGTMGYLAPEYV-YS 453
              I HRD+K  N+LLD   N K+ DF  AT+              GT+ Y+APE +   
Sbjct: 123 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 181
Query: 454 GVPSEKTDVYSFGVVALEVAAGKSPVDN--DGC 484
              +E  DV+S G+V   + AG+ P D   D C
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 214

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 94/213 (44%), Gaps = 28/213 (13%)
Query: 290 RIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           + +GEGA   V    +  +  AVAVK  +    V+C  N    +   +   L H+N+V+ 
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--IKKEICINKMLNHENVVKF 69
Query: 349 QGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC 407
            G   EGN   L  EY   G L D+I        I +           + + + YLH   
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYLHG-- 122
Query: 408 ERQIIHRDVKACNILLDAEFNAKLGDFE-ATI------------PAGTMGYLAPEYV-YS 453
              I HRD+K  N+LLD   N K+ DF  AT+              GT+ Y+APE +   
Sbjct: 123 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 454 GVPSEKTDVYSFGVVALEVAAGKSPVD--NDGC 484
              +E  DV+S G+V   + AG+ P D  +D C
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 214

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 94/213 (44%), Gaps = 28/213 (13%)
Query: 290 RIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           + +GEGA   V    +  +  AVAVK  +    V+C  N    +   +   L H+N+V+ 
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--IKKEICINKMLNHENVVKF 70
Query: 349 QGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC 407
            G   EGN   L  EY   G L D+I        I +           + + + YLH   
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYLHG-- 123
Query: 408 ERQIIHRDVKACNILLDAEFNAKLGDFE-ATI------------PAGTMGYLAPEYV-YS 453
              I HRD+K  N+LLD   N K+ DF  AT+              GT+ Y+APE +   
Sbjct: 124 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 454 GVPSEKTDVYSFGVVALEVAAGKSPVD--NDGC 484
              +E  DV+S G+V   + AG+ P D  +D C
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 215

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/260 (25%), Positives = 105/260 (40%), Gaps = 48/260 (18%)
Query: 310 AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE-GNELVLVYEYLPNG 368
            VAVK   K            +E   +     H N+V L G C + G  L+++ E+   G
Sbjct: 50  TVAVKML-KEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFG 108
Query: 369 SLDKILHNNSSSSI------------VLSWEKRLNIVLGVASALSYLHEECERQIIHRDV 416
           +L   L +  +  +             L+ E  +     VA  + +L     R+ IHRD+
Sbjct: 109 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDL 165
Query: 417 KACNILLDAEFNAKLGDF----------------EATIPAGTMGYLAPEYVYSGVPSEKT 460
            A NILL  +   K+ DF                +A +P   + ++APE ++  V + ++
Sbjct: 166 AARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP---LKWMAPETIFDRVYTIQS 222
Query: 461 DVYSFGVVALEV-AAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERM 519
           DV+SFGV+  E+ + G SP    G  I +      K+G  + A D+             M
Sbjct: 223 DVWSFGVLLWEIFSLGASPY--PGVKIDEEFCRRLKEGTRMRAPDY---------TTPEM 271
Query: 520 LMVGLSCVHPNHEKRPSVKE 539
               L C H    +RP+  E
Sbjct: 272 YQTMLDCWHGEPSQRPTFSE 291

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 94/213 (44%), Gaps = 28/213 (13%)
Query: 290 RIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           + +GEGA   V    +  +  AVAVK  +    V+C  N    +   +   L H+N+V+ 
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--IKKEICINKMLNHENVVKF 69
Query: 349 QGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC 407
            G   EGN   L  EY   G L D+I        I +           + + + YLH   
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYLHG-- 122
Query: 408 ERQIIHRDVKACNILLDAEFNAKLGDFE-ATI------------PAGTMGYLAPEYV-YS 453
              I HRD+K  N+LLD   N K+ DF  AT+              GT+ Y+APE +   
Sbjct: 123 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 181
Query: 454 GVPSEKTDVYSFGVVALEVAAGKSPVD--NDGC 484
              +E  DV+S G+V   + AG+ P D  +D C
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 214

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 27/203 (13%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G    VY+G           +  K + +E     F  E A M   ++H NLVQL G 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKE-IKHPNLVQLLGV 82
Query: 352 CCEGNELVLVYEYLPNGSLDKIL---HNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE 408
           C       ++ E++  G+L   L   +    +++VL     L +   ++SA+ YL    +
Sbjct: 83  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAMEYLE---K 134
Query: 409 RQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVP 456
           +  IHRD+ A N L+      K+ DF           T  AG    + + APE +     
Sbjct: 135 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 194
Query: 457 SEKTDVYSFGVVALEVAA-GKSP 478
           S K+DV++FGV+  E+A  G SP
Sbjct: 195 SIKSDVWAFGVLLWEIATYGMSP 217

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 20/214 (9%)
Query: 285 GFNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHK 343
            F K   +GEG    VYK  +  +G  VA+K+       E   +    E + +   L H 
Sbjct: 8   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE-LNHP 66
Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
           N+V+L       N+L LV+E+L +  L K +  ++ + I L   K  + +  +   L++ 
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 123
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG-----------TMGYLAPEYVY 452
           H     +++HRD+K  N+L++ E   KL DF      G           T+ Y APE + 
Sbjct: 124 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 180
Query: 453 S-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV 485
                S   D++S G +  E+   ++    D  +
Sbjct: 181 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 214

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/265 (24%), Positives = 106/265 (40%), Gaps = 48/265 (18%)
Query: 310 AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE-GNELVLVYEYLPNG 368
            VAVK   K            +E   +     H N+V L G C + G  L+++ E+   G
Sbjct: 50  TVAVKML-KEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFG 108
Query: 369 SLDKILHNNSSSSI------------VLSWEKRLNIVLGVASALSYLHEECERQIIHRDV 416
           +L   L +  +  +             L+ E  +     VA  + +L     R+ IHRD+
Sbjct: 109 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDL 165
Query: 417 KACNILLDAEFNAKLGDF----------------EATIPAGTMGYLAPEYVYSGVPSEKT 460
            A NILL  +   K+ DF                +A +P   + ++APE ++  V + ++
Sbjct: 166 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP---LKWMAPETIFDRVYTIQS 222
Query: 461 DVYSFGVVALEV-AAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERM 519
           DV+SFGV+  E+ + G SP    G  I +      K+G  + A D+             M
Sbjct: 223 DVWSFGVLLWEIFSLGASPY--PGVKIDEEFCRRLKEGTRMRAPDY---------TTPEM 271
Query: 520 LMVGLSCVHPNHEKRPSVKEAARIL 544
               L C H    +RP+  E    L
Sbjct: 272 YQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 20/214 (9%)
Query: 285 GFNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHK 343
            F K   +GEG    VYK  +  +G  VA+K+       E   +    E + +   L H 
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE-LNHP 62
Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
           N+V+L       N+L LV+E+L +  L K +  ++ + I L   K  + +  +   L++ 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 119
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG-----------TMGYLAPEYVY 452
           H     +++HRD+K  N+L++ E   KL DF      G           T+ Y APE + 
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 176
Query: 453 -SGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV 485
                S   D++S G +  E+   ++    D  +
Sbjct: 177 GXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 210

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 23/200 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G+G    V+ G+      VA+K   KP  +  +   F  E   M   LRH+ LVQL   
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTM--SPEAFLQEAQVMKK-LRHEKLVQLYAV 81
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
             E   + +V EY+  G L   L       + L   + +++   +AS ++Y+        
Sbjct: 82  VSE-EPIYIVTEYMSKGCLLDFLKGEMGKYLRLP--QLVDMAAQIASGMAYVER---MNY 135
Query: 412 IHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVPSEK 459
           +HRD++A NIL+      K+ DF         E T   G    + + APE    G  + K
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 460 TDVYSFGVVALEVAA-GKSP 478
           +DV+SFG++  E+   G+ P
Sbjct: 196 SDVWSFGILLTELTTKGRVP 215

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 94/213 (44%), Gaps = 28/213 (13%)
Query: 290 RIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           + +GEGA   V    +  +  AVAVK  +    V+C  N    +   +   L H+N+V+ 
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--IKKEICINKMLNHENVVKF 69
Query: 349 QGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC 407
            G   EGN   L  EY   G L D+I        I +           + + + YLH   
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYLHG-- 122
Query: 408 ERQIIHRDVKACNILLDAEFNAKLGDFE-ATI------------PAGTMGYLAPEYV-YS 453
              I HRD+K  N+LLD   N K+ DF  AT+              GT+ Y+APE +   
Sbjct: 123 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 454 GVPSEKTDVYSFGVVALEVAAGKSPVD--NDGC 484
              +E  DV+S G+V   + AG+ P D  +D C
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 214

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 85/339 (25%), Positives = 141/339 (41%), Gaps = 56/339 (16%)
Query: 244 IISCFLIKKKRHDGRSKEDHVCTVQRVPMRLALTDI------KQATLGFNKNRIVGEGAS 297
           +I  ++  +KR++ R   + V      P   +  D+      + A      +R +G+G+ 
Sbjct: 2   VIMLYVFHRKRNNSRLG-NGVLYASVNPEYFSAADVYVPDEWEVAREKITMSRELGQGSF 60
Query: 298 ATVYKGSLPSGGAVAVKRFEKPNRV------ECARNPFTTEFATMAGCLRHKN---LVQL 348
             VY+G      A  V + E   RV      E A      EF   A  ++  N   +V+L
Sbjct: 61  GMVYEGV-----AKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRL 115
Query: 349 QGWCCEGNELVLVYEYLPNGSLDKILHN---NSSSSIVL---SWEKRLNIVLGVASALSY 402
            G   +G   +++ E +  G L   L +      ++ VL   S  K + +   +A  ++Y
Sbjct: 116 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAY 175
Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT--------IPAGTMG-----YLAPE 449
           L+     + +HRD+ A N ++  +F  K+GDF  T           G  G     +++PE
Sbjct: 176 LNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 232
Query: 450 YVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLR 508
            +  GV +  +DV+SFGVV  E+A   + P      +  + V     +G LLD  D    
Sbjct: 233 SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG---LSNEQVLRFVMEGGLLDKPDNCPD 289
Query: 509 GKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE 547
             F   E+ RM      C   N + RPS  E    +K E
Sbjct: 290 MLF---ELMRM------CWQYNPKMRPSFLEIISSIKEE 319

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 92/213 (43%), Gaps = 26/213 (12%)
Query: 290 RIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           + +GEG+   V       +G  VA+K   K    +           +    LRH ++++L
Sbjct: 10  KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 69
Query: 349 QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE 408
                  +E+++V EY  N   D I+  +      +S ++       + SA+ Y H    
Sbjct: 70  YDVIKSKDEIIMVIEYAGNELFDYIVQRDK-----MSEQEARRFFQQIISAVEYCHRH-- 122
Query: 409 RQIIHRDVKACNILLDAEFNAKLGDFEAT----------IPAGTMGYLAPEYV----YSG 454
            +I+HRD+K  N+LLD   N K+ DF  +             G+  Y APE +    Y+G
Sbjct: 123 -KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 181
Query: 455 VPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIV 487
               + DV+S GV+   +   + P D++   ++
Sbjct: 182 ---PEVDVWSCGVILYVMLCRRLPFDDESIPVL 211

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 27/203 (13%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G    VY+G           +  K + +E     F  E A M   ++H NLVQL G 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKE-IKHPNLVQLLGV 82
Query: 352 CCEGNELVLVYEYLPNGSLDKIL---HNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE 408
           C       ++ E++  G+L   L   +    +++VL     L +   ++SA+ YL    +
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAMEYLE---K 134
Query: 409 RQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVP 456
           +  IHRD+ A N L+      K+ DF           T  AG    + + APE +     
Sbjct: 135 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 194
Query: 457 SEKTDVYSFGVVALEVAA-GKSP 478
           S K+DV++FGV+  E+A  G SP
Sbjct: 195 SIKSDVWAFGVLLWEIATYGMSP 217

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 121/288 (42%), Gaps = 49/288 (17%)
Query: 289 NRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRV------ECARNPFTTEFATMAGCLRH 342
           +R +G+G+   VY+G      A  V + E   RV      E A      EF   A  ++ 
Sbjct: 30  SRELGQGSFGMVYEGV-----AKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84
Query: 343 KN---LVQLQGWCCEGNELVLVYEYLPNGSLDKILHN------NSSSSIVLSWEKRLNIV 393
            N   +V+L G   +G   +++ E +  G L   L +      N+      S  K + + 
Sbjct: 85  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 394 LGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT--------IPAGTMG- 444
             +A  ++YL+     + +HRD+ A N ++  +F  K+GDF  T           G  G 
Sbjct: 145 GEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 201
Query: 445 ----YLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKL 499
               +++PE +  GV +  +DV+SFGVV  E+A   + P      +  + V     +G L
Sbjct: 202 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG---LSNEQVLRFVMEGGL 258
Query: 500 LDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE 547
           LD  D      F   E+ RM      C   N + RPS  E    +K E
Sbjct: 259 LDKPDNCPDMLF---ELMRM------CWQYNPKMRPSFLEIISSIKEE 297

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 94/213 (44%), Gaps = 20/213 (9%)
Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F K   +GEG    VYK  +  +G  VA+K+       E   +    E + +   L H N
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE-LNHPN 70
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           +V+L       N+L LV+E+L +  L K +  ++ + I L   K  + +  +   L++ H
Sbjct: 71  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCH 127
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG-----------TMGYLAPEYVYS 453
                +++HRD+K  N+L++ E   KL DF      G           T+ Y APE +  
Sbjct: 128 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 184
Query: 454 -GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV 485
               S   D++S G +  E+   ++    D  +
Sbjct: 185 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 217

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 94/213 (44%), Gaps = 28/213 (13%)
Query: 290 RIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           + +GEGA   V    +  +  AVAVK  +    V+C  N    +   +   L H+N+V+ 
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--IKKEICINKMLNHENVVKF 70
Query: 349 QGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC 407
            G   EGN   L  EY   G L D+I        I +           + + + YLH   
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYLHG-- 123
Query: 408 ERQIIHRDVKACNILLDAEFNAKLGDFE-ATI------------PAGTMGYLAPEYV-YS 453
              I HRD+K  N+LLD   N K+ DF  AT+              GT+ Y+APE +   
Sbjct: 124 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 454 GVPSEKTDVYSFGVVALEVAAGKSPVD--NDGC 484
              +E  DV+S G+V   + AG+ P D  +D C
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 215

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 94/213 (44%), Gaps = 28/213 (13%)
Query: 290 RIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           + +GEGA   V    +  +  AVAVK  +    V+C  N    +   +   L H+N+V+ 
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--IKKEICINKMLNHENVVKF 70
Query: 349 QGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC 407
            G   EGN   L  EY   G L D+I        I +           + + + YLH   
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYLHG-- 123
Query: 408 ERQIIHRDVKACNILLDAEFNAKLGDFE-ATI------------PAGTMGYLAPEYV-YS 453
              I HRD+K  N+LLD   N K+ DF  AT+              GT+ Y+APE +   
Sbjct: 124 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 454 GVPSEKTDVYSFGVVALEVAAGKSPVD--NDGC 484
              +E  DV+S G+V   + AG+ P D  +D C
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 215

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 94/213 (44%), Gaps = 28/213 (13%)
Query: 290 RIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           + +GEGA   V    +  +  AVAVK  +    V+C  N    +   +   L H+N+V+ 
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--IKKEICINKMLNHENVVKF 70
Query: 349 QGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC 407
            G   EGN   L  EY   G L D+I        I +           + + + YLH   
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYLHG-- 123
Query: 408 ERQIIHRDVKACNILLDAEFNAKLGDFE-ATI------------PAGTMGYLAPEYV-YS 453
              I HRD+K  N+LLD   N K+ DF  AT+              GT+ Y+APE +   
Sbjct: 124 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 454 GVPSEKTDVYSFGVVALEVAAGKSPVD--NDGC 484
              +E  DV+S G+V   + AG+ P D  +D C
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 215

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 27/203 (13%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G    VY+G           +  K + +E     F  E A M   ++H NLVQL G 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKE-IKHPNLVQLLGV 77
Query: 352 CCEGNELVLVYEYLPNGSLDKIL---HNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE 408
           C       ++ E++  G+L   L   +    +++VL     L +   ++SA+ YL    +
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAMEYLE---K 129
Query: 409 RQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVP 456
           +  IHRD+ A N L+      K+ DF           T  AG    + + APE +     
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 189
Query: 457 SEKTDVYSFGVVALEVAA-GKSP 478
           S K+DV++FGV+  E+A  G SP
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSP 212

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 20/214 (9%)
Query: 285 GFNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHK 343
            F K   +GEG    VYK  +  +G  VA+K+       E   +    E + +   L H 
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE-LNHP 62
Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
           N+V+L       N+L LV+E+L +  L K +  ++ + I L   K  + +  +   L++ 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 119
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG-----------TMGYLAPEYVY 452
           H     +++HRD+K  N+L++ E   KL DF      G           T+ Y APE + 
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 176
Query: 453 S-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV 485
                S   D++S G +  E+   ++    D  +
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 210

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 27/203 (13%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G    VY+G           +  K + +E     F  E A M   ++H NLVQL G 
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKE-IKHPNLVQLLGV 90
Query: 352 CCEGNELVLVYEYLPNGSLDKIL---HNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE 408
           C       ++ E++  G+L   L   +    +++VL     L +   ++SA+ YL    +
Sbjct: 91  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAMEYLE---K 142
Query: 409 RQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVP 456
           +  IHRD+ A N L+      K+ DF           T  AG    + + APE +     
Sbjct: 143 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 202
Query: 457 SEKTDVYSFGVVALEVAA-GKSP 478
           S K+DV++FGV+  E+A  G SP
Sbjct: 203 SIKSDVWAFGVLLWEIATYGMSP 225

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 20/214 (9%)
Query: 285 GFNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHK 343
            F K   +GEG    VYK  +  +G  VA+K+       E   +    E + +   L H 
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE-LNHP 61
Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
           N+V+L       N+L LV+E+L +  L K +  ++ + I L   K  + +  +   L++ 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 118
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG-----------TMGYLAPEYVY 452
           H     +++HRD+K  N+L++ E   KL DF      G           T+ Y APE + 
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175
Query: 453 S-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV 485
                S   D++S G +  E+   ++    D  +
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 209

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 121/288 (42%), Gaps = 49/288 (17%)
Query: 289 NRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRV------ECARNPFTTEFATMAGCLRH 342
           +R +G+G+   VY+G      A  V + E   RV      E A      EF   A  ++ 
Sbjct: 30  SRELGQGSFGMVYEGV-----AKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84
Query: 343 KN---LVQLQGWCCEGNELVLVYEYLPNGSLDKILHN------NSSSSIVLSWEKRLNIV 393
            N   +V+L G   +G   +++ E +  G L   L +      N+      S  K + + 
Sbjct: 85  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMA 144
Query: 394 LGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT--------IPAGTMG- 444
             +A  ++YL+     + +HRD+ A N ++  +F  K+GDF  T           G  G 
Sbjct: 145 GEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 201
Query: 445 ----YLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKL 499
               +++PE +  GV +  +DV+SFGVV  E+A   + P      +  + V     +G L
Sbjct: 202 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG---LSNEQVLRFVMEGGL 258
Query: 500 LDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE 547
           LD  D      F   E+ RM      C   N + RPS  E    +K E
Sbjct: 259 LDKPDNCPDMLF---ELMRM------CWQYNPKMRPSFLEIISSIKEE 297

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 20/214 (9%)
Query: 285 GFNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHK 343
            F K   +GEG    VYK  +  +G  VA+K+       E   +    E + +   L H 
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE-LNHP 62
Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
           N+V+L       N+L LV+E+L +  L K +  ++ + I L   K  + +  +   L++ 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 119
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG-----------TMGYLAPEYVY 452
           H     +++HRD+K  N+L++ E   KL DF      G           T+ Y APE + 
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 176
Query: 453 S-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV 485
                S   D++S G +  E+   ++    D  +
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 210

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 93/213 (43%), Gaps = 28/213 (13%)
Query: 290 RIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           + +GEGA   V    +  +  AVAVK  +    V+C  N    +   +   L H+N+V+ 
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--IKKEICINKMLNHENVVKF 69
Query: 349 QGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC 407
            G   EGN   L  EY   G L D+I        I +           + + + YLH   
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYLHG-- 122
Query: 408 ERQIIHRDVKACNILLDAEFNAKLGDFE-ATI------------PAGTMGYLAPEYV-YS 453
              I HRD+K  N+LLD   N K+ DF  AT+              GT+ Y+APE +   
Sbjct: 123 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 454 GVPSEKTDVYSFGVVALEVAAGKSPVDN--DGC 484
              +E  DV+S G+V   + AG+ P D   D C
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 214

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 121/288 (42%), Gaps = 49/288 (17%)
Query: 289 NRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRV------ECARNPFTTEFATMAGCLRH 342
           +R +G+G+   VY+G      A  V + E   RV      E A      EF   A  ++ 
Sbjct: 20  SRELGQGSFGMVYEGV-----AKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 74
Query: 343 KN---LVQLQGWCCEGNELVLVYEYLPNGSLDKILHN------NSSSSIVLSWEKRLNIV 393
            N   +V+L G   +G   +++ E +  G L   L +      N+      S  K + + 
Sbjct: 75  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 134
Query: 394 LGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT--------IPAGTMG- 444
             +A  ++YL+     + +HRD+ A N ++  +F  K+GDF  T           G  G 
Sbjct: 135 GEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 191
Query: 445 ----YLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKL 499
               +++PE +  GV +  +DV+SFGVV  E+A   + P      +  + V     +G L
Sbjct: 192 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG---LSNEQVLRFVMEGGL 248
Query: 500 LDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE 547
           LD  D      F   E+ RM      C   N + RPS  E    +K E
Sbjct: 249 LDKPDNCPDMLF---ELMRM------CWQYNPKMRPSFLEIISSIKEE 287

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 94/213 (44%), Gaps = 20/213 (9%)
Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F K   +GEG    VYK  +  +G  VA+K+       E   +    E + +   L H N
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE-LNHPN 63
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           +V+L       N+L LV+E+L +  L K +  ++ + I L   K  + +  +   L++ H
Sbjct: 64  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCH 120
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG-----------TMGYLAPEYVYS 453
                +++HRD+K  N+L++ E   KL DF      G           T+ Y APE +  
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 177
Query: 454 -GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV 485
               S   D++S G +  E+   ++    D  +
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 210

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 123/288 (42%), Gaps = 49/288 (17%)
Query: 289 NRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRV------ECARNPFTTEFATMAGCLRH 342
           +R +G+G+   VY+G      A  V + E   RV      E A      EF   A  ++ 
Sbjct: 17  SRELGQGSFGMVYEGV-----AKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 71
Query: 343 KN---LVQLQGWCCEGNELVLVYEYLPNGSLDKILHN---NSSSSIVL---SWEKRLNIV 393
            N   +V+L G   +G   +++ E +  G L   L +      ++ VL   S  K + + 
Sbjct: 72  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMA 131
Query: 394 LGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT--------IPAGTMG- 444
             +A  ++YL+     + +HRD+ A N ++  +F  K+GDF  T           G  G 
Sbjct: 132 GEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 188
Query: 445 ----YLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKL 499
               +++PE +  GV +  +DV+SFGVV  E+A   + P      +  + V     +G L
Sbjct: 189 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG---LSNEQVLRFVMEGGL 245
Query: 500 LDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE 547
           LD  D      F   E+ RM      C   N + RPS  E    +K E
Sbjct: 246 LDKPDNCPDMLF---ELMRM------CWQYNPKMRPSFLEIISSIKEE 284

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 20/214 (9%)
Query: 285 GFNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHK 343
            F K   +GEG    VYK  +  +G  VA+K+       E   +    E + +   L H 
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE-LNHP 61
Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
           N+V+L       N+L LV+E+L +  L K +  ++ + I L   K  + +  +   L++ 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 118
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG-----------TMGYLAPEYVY 452
           H     +++HRD+K  N+L++ E   KL DF      G           T+ Y APE + 
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 175
Query: 453 S-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV 485
                S   D++S G +  E+   ++    D  +
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 209

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 92/213 (43%), Gaps = 26/213 (12%)
Query: 290 RIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           + +GEG+   V       +G  VA+K   K    +           +    LRH ++++L
Sbjct: 20  KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 79
Query: 349 QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE 408
                  +E+++V EY  N   D I+  +      +S ++       + SA+ Y H    
Sbjct: 80  YDVIKSKDEIIMVIEYAGNELFDYIVQRDK-----MSEQEARRFFQQIISAVEYCHRH-- 132
Query: 409 RQIIHRDVKACNILLDAEFNAKLGDFEAT----------IPAGTMGYLAPEYV----YSG 454
            +I+HRD+K  N+LLD   N K+ DF  +             G+  Y APE +    Y+G
Sbjct: 133 -KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 191
Query: 455 VPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIV 487
               + DV+S GV+   +   + P D++   ++
Sbjct: 192 ---PEVDVWSCGVILYVMLCRRLPFDDESIPVL 221

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 90/208 (43%), Gaps = 26/208 (12%)
Query: 290 RIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           + +GEG+   V       +G  VA+K   K    +           +    LRH ++++L
Sbjct: 19  KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 78
Query: 349 QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE 408
                  +E+++V EY  N   D I+  +      +S ++       + SA+ Y H    
Sbjct: 79  YDVIKSKDEIIMVIEYAGNELFDYIVQRDK-----MSEQEARRFFQQIISAVEYCHRH-- 131
Query: 409 RQIIHRDVKACNILLDAEFNAKLGDFEAT----------IPAGTMGYLAPEYV----YSG 454
            +I+HRD+K  N+LLD   N K+ DF  +             G+  Y APE +    Y+G
Sbjct: 132 -KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 190
Query: 455 VPSEKTDVYSFGVVALEVAAGKSPVDND 482
               + DV+S GV+   +   + P D++
Sbjct: 191 ---PEVDVWSCGVILYVMLCRRLPFDDE 215

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 94/213 (44%), Gaps = 20/213 (9%)
Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F K   +GEG    VYK  +  +G  VA+K+       E   +    E + +   L H N
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE-LNHPN 70
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           +V+L       N+L LV+E+L +  L K +  ++ + I L   K  + +  +   L++ H
Sbjct: 71  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCH 127
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG-----------TMGYLAPEYVY- 452
                +++HRD+K  N+L++ E   KL DF      G           T+ Y APE +  
Sbjct: 128 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 184
Query: 453 SGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV 485
               S   D++S G +  E+   ++    D  +
Sbjct: 185 XKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 217

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 20/214 (9%)
Query: 285 GFNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHK 343
            F K   +GEG    VYK  +  +G  VA+K+       E   +    E + +   L H 
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE-LNHP 62
Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
           N+V+L       N+L LV+E+L +  L K +  ++ + I L   K  + +  +   L++ 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 119
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG-----------TMGYLAPEYVY 452
           H     +++HRD+K  N+L++ E   KL DF      G           T+ Y APE + 
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 176
Query: 453 S-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV 485
                S   D++S G +  E+   ++    D  +
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 210

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 94/213 (44%), Gaps = 20/213 (9%)
Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F K   +GEG    VYK  +  +G  VA+K+       E   +    E + +   L H N
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE-LNHPN 64
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           +V+L       N+L LV+E+L +  L K +  ++ + I L   K  + +  +   L++ H
Sbjct: 65  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCH 121
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG-----------TMGYLAPEYVYS 453
                +++HRD+K  N+L++ E   KL DF      G           T+ Y APE +  
Sbjct: 122 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 178
Query: 454 -GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV 485
               S   D++S G +  E+   ++    D  +
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 211

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 123/288 (42%), Gaps = 49/288 (17%)
Query: 289 NRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRV------ECARNPFTTEFATMAGCLRH 342
           +R +G+G+   VY+G      A  V + E   RV      E A      EF   A  ++ 
Sbjct: 23  SRELGQGSFGMVYEGV-----AKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 77
Query: 343 KN---LVQLQGWCCEGNELVLVYEYLPNGSLDKILHN---NSSSSIVL---SWEKRLNIV 393
            N   +V+L G   +G   +++ E +  G L   L +      ++ VL   S  K + + 
Sbjct: 78  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMA 137
Query: 394 LGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT--------IPAGTMG- 444
             +A  ++YL+     + +HRD+ A N ++  +F  K+GDF  T           G  G 
Sbjct: 138 GEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 194
Query: 445 ----YLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKL 499
               +++PE +  GV +  +DV+SFGVV  E+A   + P      +  + V     +G L
Sbjct: 195 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG---LSNEQVLRFVMEGGL 251
Query: 500 LDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE 547
           LD  D      F   E+ RM      C   N + RPS  E    +K E
Sbjct: 252 LDKPDNCPDMLF---ELMRM------CWQYNPKMRPSFLEIISSIKEE 290

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 90/204 (44%), Gaps = 22/204 (10%)
Query: 290 RIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           + +G+G  A V     + +G  VAVK  +K      +      E   M   L H N+V+L
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMK-VLNHPNIVKL 78
Query: 349 QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE 408
                    L LV EY   G +   L  +       +  K   IV    SA+ Y H++  
Sbjct: 79  FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIV----SAVQYCHQKF- 133
Query: 409 RQIIHRDVKACNILLDAEFNAKLGDF----EATIP------AGTMGYLAPEYVYSGVPSE 458
             I+HRD+KA N+LLDA+ N K+ DF    E T         G   Y APE ++ G   +
Sbjct: 134 --IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPE-LFQGKKYD 190
Query: 459 --KTDVYSFGVVALEVAAGKSPVD 480
             + DV+S GV+   + +G  P D
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 20/210 (9%)
Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F K   +GEG    VYK  +  +G  VA+K+       E   +    E + +   L H N
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE-LNHPN 66
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           +V+L       N+L LV+E+L +  L K +  ++ + I L   K  + +  +   L++ H
Sbjct: 67  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCH 123
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG-----------TMGYLAPEYVYS 453
                +++HRD+K  N+L++ E   KL DF      G           T+ Y APE +  
Sbjct: 124 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 180
Query: 454 -GVPSEKTDVYSFGVVALEVAAGKSPVDND 482
               S   D++S G +  E+   ++    D
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGD 210

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 27/203 (13%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G    VY+G           +  K + +E     F  E A M   ++H NLVQL G 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKE-IKHPNLVQLLGV 79
Query: 352 CCEGNELVLVYEYLPNGSLDKIL---HNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE 408
           C       ++ E++  G+L   L   +    +++VL     L +   ++SA+ YL    +
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAMEYLE---K 131
Query: 409 RQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVP 456
           +  IHRD+ A N L+      K+ DF           T  AG    + + APE +     
Sbjct: 132 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 191
Query: 457 SEKTDVYSFGVVALEVAA-GKSP 478
           S K+DV++FGV+  E+A  G SP
Sbjct: 192 SIKSDVWAFGVLLWEIATYGMSP 214

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 94/213 (44%), Gaps = 20/213 (9%)
Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F K   +GEG    VYK  +  +G  VA+K+       E   +    E + +   L H N
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE-LNHPN 65
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           +V+L       N+L LV+E+L +  L K +  ++ + I L   K  + +  +   L++ H
Sbjct: 66  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCH 122
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG-----------TMGYLAPEYVYS 453
                +++HRD+K  N+L++ E   KL DF      G           T+ Y APE +  
Sbjct: 123 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 179
Query: 454 -GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV 485
               S   D++S G +  E+   ++    D  +
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 212

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 20/214 (9%)
Query: 285 GFNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHK 343
            F K   +GEG    VYK  +  +G  VA+K+       E   +    E + +   L H 
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE-LNHP 61
Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
           N+V+L       N+L LV+E+L +  L K +  ++ + I L   K  + +  +   L++ 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 118
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG-----------TMGYLAPEYVY 452
           H     +++HRD+K  N+L++ E   KL DF      G           T+ Y APE + 
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 175
Query: 453 S-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV 485
                S   D++S G +  E+   ++    D  +
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 209

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 20/210 (9%)
Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F K   +GEG    VYK  +  +G  VA+K+       E   +    E + +   L H N
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE-LNHPN 67
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           +V+L       N+L LV+E+L +  L K +  ++ + I L   K  + +  +   L++ H
Sbjct: 68  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCH 124
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG-----------TMGYLAPEYVYS 453
                +++HRD+K  N+L++ E   KL DF      G           T+ Y APE +  
Sbjct: 125 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 181
Query: 454 -GVPSEKTDVYSFGVVALEVAAGKSPVDND 482
               S   D++S G +  E+   ++    D
Sbjct: 182 CKYYSTAVDIWSLGCIFAEMVTRRALFPGD 211

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 20/214 (9%)
Query: 285 GFNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHK 343
            F K   +GEG    VYK  +  +G  VA+K+       E   +    E + +   L H 
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE-LNHP 61
Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
           N+V+L       N+L LV+E+L +  L K +  ++ + I L   K  + +  +   L++ 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 118
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG-----------TMGYLAPEYVY 452
           H     +++HRD+K  N+L++ E   KL DF      G           T+ Y APE + 
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175
Query: 453 S-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV 485
                S   D++S G +  E+   ++    D  +
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 209

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 94/213 (44%), Gaps = 20/213 (9%)
Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F K   +GEG    VYK  +  +G  VA+K+       E   +    E + +   L H N
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE-LNHPN 64
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           +V+L       N+L LV+E+L +  L K +  ++ + I L   K  + +  +   L++ H
Sbjct: 65  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCH 121
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG-----------TMGYLAPEYVYS 453
                +++HRD+K  N+L++ E   KL DF      G           T+ Y APE +  
Sbjct: 122 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 178
Query: 454 -GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV 485
               S   D++S G +  E+   ++    D  +
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 211

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 27/203 (13%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G    VY+G           +  K + +E     F  E A M   ++H NLVQL G 
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKE-IKHPNLVQLLGV 81
Query: 352 CCEGNELVLVYEYLPNGSLDKIL---HNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE 408
           C       ++ E++  G+L   L   +    +++VL     L +   ++SA+ YL    +
Sbjct: 82  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAMEYLE---K 133
Query: 409 RQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVP 456
           +  IHRD+ A N L+      K+ DF           T  AG    + + APE +     
Sbjct: 134 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 193
Query: 457 SEKTDVYSFGVVALEVAA-GKSP 478
           S K+DV++FGV+  E+A  G SP
Sbjct: 194 SIKSDVWAFGVLLWEIATYGMSP 216

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 92/213 (43%), Gaps = 26/213 (12%)
Query: 290 RIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           + +GEG+   V       +G  VA+K   K    +           +    LRH ++++L
Sbjct: 14  KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 73
Query: 349 QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE 408
                  +E+++V EY  N   D I+  +      +S ++       + SA+ Y H    
Sbjct: 74  YDVIKSKDEIIMVIEYAGNELFDYIVQRDK-----MSEQEARRFFQQIISAVEYCHRH-- 126
Query: 409 RQIIHRDVKACNILLDAEFNAKLGDFEAT----------IPAGTMGYLAPEYV----YSG 454
            +I+HRD+K  N+LLD   N K+ DF  +             G+  Y APE +    Y+G
Sbjct: 127 -KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 185
Query: 455 VPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIV 487
               + DV+S GV+   +   + P D++   ++
Sbjct: 186 ---PEVDVWSCGVILYVMLCRRLPFDDESIPVL 215

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 20/214 (9%)
Query: 285 GFNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHK 343
            F K   +GEG    VYK  +  +G  VA+K+       E   +    E + +   L H 
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE-LNHP 62
Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
           N+V+L       N+L LV+E+L +  L K +  ++ + I L   K  + +  +   L++ 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 119
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG-----------TMGYLAPEYVY 452
           H     +++HRD+K  N+L++ E   KL DF      G           T+ Y APE + 
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 176
Query: 453 S-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV 485
                S   D++S G +  E+   ++    D  +
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 210

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 94/213 (44%), Gaps = 20/213 (9%)
Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F K   +GEG    VYK  +  +G  VA+K+       E   +    E + +   L H N
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE-LNHPN 63
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           +V+L       N+L LV+E+L +  L K +  ++ + I L   K  + +  +   L++ H
Sbjct: 64  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCH 120
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG-----------TMGYLAPEYVYS 453
                +++HRD+K  N+L++ E   KL DF      G           T+ Y APE +  
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 177
Query: 454 -GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV 485
               S   D++S G +  E+   ++    D  +
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 210

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 27/203 (13%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G    VY+G           +  K + +E     F  E A M   ++H NLVQL G 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKE-IKHPNLVQLLGV 79
Query: 352 CCEGNELVLVYEYLPNGSLDKIL---HNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE 408
           C       ++ E++  G+L   L   +    +++VL     L +   ++SA+ YL    +
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAMEYLE---K 131
Query: 409 RQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVP 456
           +  IHRD+ A N L+      K+ DF           T  AG    + + APE +     
Sbjct: 132 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 191
Query: 457 SEKTDVYSFGVVALEVAA-GKSP 478
           S K+DV++FGV+  E+A  G SP
Sbjct: 192 SIKSDVWAFGVLLWEIATYGMSP 214

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 102/231 (44%), Gaps = 44/231 (19%)
Query: 276 LTDIKQATLGFNKNRIVGEGASATVYKGSL--PSGG----AVAVKRFEKPNRVECARNPF 329
           L +I  + + F +   +GE     VYKG L  P+ G    AVA+K  +     + A  P 
Sbjct: 3   LKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK-----DKAEGPL 55
Query: 330 TTEF---ATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSW 386
             EF   A +   L+H N+V L G   +   L +++ Y  +G L + L   S  S V S 
Sbjct: 56  REEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGST 115
Query: 387 EKR------------LNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGD- 433
           +              +++V  +A+ + YL       ++H+D+   N+L+  + N K+ D 
Sbjct: 116 DDDRTVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDL 172
Query: 434 --FEATIPAG----------TMGYLAPEYVYSGVPSEKTDVYSFGVVALEV 472
             F     A            + ++APE +  G  S  +D++S+GVV  EV
Sbjct: 173 GLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEV 223

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 102/231 (44%), Gaps = 44/231 (19%)
Query: 276 LTDIKQATLGFNKNRIVGEGASATVYKGSL--PSGG----AVAVKRFEKPNRVECARNPF 329
           L +I  + + F +   +GE     VYKG L  P+ G    AVA+K  +     + A  P 
Sbjct: 20  LKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK-----DKAEGPL 72
Query: 330 TTEF---ATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSW 386
             EF   A +   L+H N+V L G   +   L +++ Y  +G L + L   S  S V S 
Sbjct: 73  REEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGST 132
Query: 387 EKR------------LNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGD- 433
           +              +++V  +A+ + YL       ++H+D+   N+L+  + N K+ D 
Sbjct: 133 DDDRTVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDL 189
Query: 434 --FEATIPAG----------TMGYLAPEYVYSGVPSEKTDVYSFGVVALEV 472
             F     A            + ++APE +  G  S  +D++S+GVV  EV
Sbjct: 190 GLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEV 240

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 94/213 (44%), Gaps = 20/213 (9%)
Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F K   +GEG    VYK  +  +G  VA+K+       E   +    E + +   L H N
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE-LNHPN 66
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           +V+L       N+L LV+E+L +  L K +  ++ + I L   K  + +  +   L++ H
Sbjct: 67  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCH 123
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG-----------TMGYLAPEYVYS 453
                +++HRD+K  N+L++ E   KL DF      G           T+ Y APE +  
Sbjct: 124 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 180
Query: 454 -GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV 485
               S   D++S G +  E+   ++    D  +
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 213

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 94/213 (44%), Gaps = 20/213 (9%)
Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F K   +GEG    VYK  +  +G  VA+K+       E   +    E + +   L H N
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE-LNHPN 65
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           +V+L       N+L LV+E+L +  L K +  ++ + I L   K  + +  +   L++ H
Sbjct: 66  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCH 122
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG-----------TMGYLAPEYVYS 453
                +++HRD+K  N+L++ E   KL DF      G           T+ Y APE +  
Sbjct: 123 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 179
Query: 454 -GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV 485
               S   D++S G +  E+   ++    D  +
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 212

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 27/203 (13%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G    VY+G           +  K + +E     F  E A M   ++H NLVQL G 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKE-IKHPNLVQLLGV 77
Query: 352 CCEGNELVLVYEYLPNGSLDKIL---HNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE 408
           C       ++ E++  G+L   L   +    +++VL     L +   ++SA+ YL    +
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAMEYLE---K 129
Query: 409 RQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVP 456
           +  IHRD+ A N L+      K+ DF           T  AG    + + APE +     
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 189
Query: 457 SEKTDVYSFGVVALEVAA-GKSP 478
           S K+DV++FGV+  E+A  G SP
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSP 212

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 103/221 (46%), Gaps = 35/221 (15%)
Query: 279 IKQATLGFNKNRIVGEGASATVYKGSLPSGG--------AVAVKRFEKPNRVECARNPFT 330
           I+   L FN++  +G+G    ++KG     G         V +K  +K +R   + + F 
Sbjct: 5   IRNEDLIFNES--LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR-NYSESFF- 60
Query: 331 TEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRL 390
            E A+M   L HK+LV   G C  G+E +LV E++  GSLD  L  N +   +L W  +L
Sbjct: 61  -EAASMMSKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINIL-W--KL 116
Query: 391 NIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGD---FEATIPAGTMGYLA 447
            +   +A A+ +L    E  +IH +V A NILL  E + K G+    + + P  ++  L 
Sbjct: 117 EVAKQLAWAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP 173
Query: 448 PEYVYSGVP-------------SEKTDVYSFGVVALEVAAG 475
            + +   +P             +  TD +SFG    E+ +G
Sbjct: 174 KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 94/213 (44%), Gaps = 20/213 (9%)
Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F K   +GEG    VYK  +  +G  VA+K+       E   +    E + +   L H N
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE-LNHPN 64
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           +V+L       N+L LV+E+L +  L K +  ++ + I L   K  + +  +   L++ H
Sbjct: 65  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCH 121
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG-----------TMGYLAPEYVYS 453
                +++HRD+K  N+L++ E   KL DF      G           T+ Y APE +  
Sbjct: 122 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 178
Query: 454 -GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV 485
               S   D++S G +  E+   ++    D  +
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 211

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 123/288 (42%), Gaps = 49/288 (17%)
Query: 289 NRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRV------ECARNPFTTEFATMAGCLRH 342
           +R +G+G+   VY+G      A  V + E   RV      E A      EF   A  ++ 
Sbjct: 23  SRELGQGSFGMVYEGV-----AKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 77
Query: 343 KN---LVQLQGWCCEGNELVLVYEYLPNGSLDKILHN---NSSSSIVL---SWEKRLNIV 393
            N   +V+L G   +G   +++ E +  G L   L +      ++ VL   S  K + + 
Sbjct: 78  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMA 137
Query: 394 LGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT--------IPAGTMG- 444
             +A  ++YL+     + +HRD+ A N ++  +F  K+GDF  T           G  G 
Sbjct: 138 GEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 194
Query: 445 ----YLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKL 499
               +++PE +  GV +  +DV+SFGVV  E+A   + P      +  + V     +G L
Sbjct: 195 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG---LSNEQVLRFVMEGGL 251
Query: 500 LDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE 547
           LD  D      F   E+ RM      C   N + RPS  E    +K E
Sbjct: 252 LDKPDNCPDMLF---ELMRM------CWQYNPKMRPSFLEIISSIKEE 290

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 27/203 (13%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G    VY+G           +  K + +E     F  E A M   ++H NLVQL G 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKE-IKHPNLVQLLGV 82
Query: 352 CCEGNELVLVYEYLPNGSLDKIL---HNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE 408
           C       ++ E++  G+L   L   +    +++VL     L +   ++SA+ YL    +
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAMEYLE---K 134
Query: 409 RQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVP 456
           +  IHRD+ A N L+      K+ DF           T  AG    + + APE +     
Sbjct: 135 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 194
Query: 457 SEKTDVYSFGVVALEVAA-GKSP 478
           S K+DV++FGV+  E+A  G SP
Sbjct: 195 SIKSDVWAFGVLLWEIATYGMSP 217

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 94/226 (41%), Gaps = 35/226 (15%)
Query: 281 QATLGFNKN----RIVGEGASATVYKG-SLPSGGAVAVKRFE-------KPNRVECARNP 328
            +T GF +N     I+G G S+ V +    P+    AVK  +           V+  R  
Sbjct: 10  HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 329 FTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEK 388
              E   +     H N++QL+          LV++ +  G L   L    +  + LS ++
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKE 125
Query: 389 RLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP--------- 439
              I+  +   +  LH+     I+HRD+K  NILLD + N KL DF  +           
Sbjct: 126 TRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRS 182
Query: 440 -AGTMGYLAPEYVYSGVPS------EKTDVYSFGVVALEVAAGKSP 478
             GT  YLAPE +   +        ++ D++S GV+   + AG  P
Sbjct: 183 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 91/204 (44%), Gaps = 22/204 (10%)
Query: 290 RIVGEGASATV-YKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           + +G+G  A V     + +G  VAV+  +K      +      E   M   L H N+V+L
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMK-VLNHPNIVKL 78
Query: 349 QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE 408
                    L LV EY   G +   L  +       +  K   IV    SA+ Y H++  
Sbjct: 79  FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIV----SAVQYCHQKF- 133
Query: 409 RQIIHRDVKACNILLDAEFNAKLGDF----EATIP------AGTMGYLAPEYVYSGVPSE 458
             I+HRD+KA N+LLDA+ N K+ DF    E T         G+  Y APE ++ G   +
Sbjct: 134 --IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPE-LFQGKKYD 190
Query: 459 --KTDVYSFGVVALEVAAGKSPVD 480
             + DV+S GV+   + +G  P D
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 91/206 (44%), Gaps = 24/206 (11%)
Query: 289 NRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECA---RNPFTTEFATMAGCLRHKNL 345
           NRI+GEG    VY+G   +     +    K  + +C    +  F +E   M   L H ++
Sbjct: 13  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN-LDHPHI 71
Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
           V+L G   E     ++ E  P G L   L  N +S  VL+    +   L +  A++YL  
Sbjct: 72  VKLIG-IIEEEPTWIIMELYPYGELGHYLERNKNSLKVLT---LVLYSLQICKAMAYLES 127
Query: 406 ECERQIIHRDVKACNILLDAEFNAKLGDF------------EATIPAGTMGYLAPEYVYS 453
                 +HRD+   NIL+ +    KLGDF            +A++    + +++PE +  
Sbjct: 128 ---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF 184
Query: 454 GVPSEKTDVYSFGVVALEVAA-GKSP 478
              +  +DV+ F V   E+ + GK P
Sbjct: 185 RRFTTASDVWMFAVCMWEILSFGKQP 210

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 93/221 (42%), Gaps = 47/221 (21%)
Query: 292 VGEGASATVYK-GSLPSGGAVAVKRFEKP-NRVECAR-------------NPFTTEFATM 336
           +G GA   V K   +PSG  +AVKR     N  E  R              PFT  F   
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFY-- 116
Query: 337 AGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGV 396
            G L  +  V    W C   EL+       + SLDK           +  +    I + +
Sbjct: 117 -GALFREGDV----WIC--MELM-------DTSLDKFYKQVIDKGQTIPEDILGKIAVSI 162
Query: 397 ASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF----------EATIPAGTMGYL 446
             AL +LH +    +IHRDVK  N+L++A    K+ DF            TI AG   Y+
Sbjct: 163 VKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKPYM 220
Query: 447 APEYVYSGVP----SEKTDVYSFGVVALEVAAGKSPVDNDG 483
           APE +   +     S K+D++S G+  +E+A  + P D+ G
Sbjct: 221 APERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWG 261

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 91/204 (44%), Gaps = 22/204 (10%)
Query: 290 RIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           + +G+G  A V     + +G  VAV+  +K      +      E   M   L H N+V+L
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMK-VLNHPNIVKL 78
Query: 349 QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE 408
                    L LV EY   G +   L  +       +  K   IV    SA+ Y H++  
Sbjct: 79  FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIV----SAVQYCHQKF- 133
Query: 409 RQIIHRDVKACNILLDAEFNAKLGDF----EATIP------AGTMGYLAPEYVYSGVPSE 458
             I+HRD+KA N+LLDA+ N K+ DF    E T         G+  Y APE ++ G   +
Sbjct: 134 --IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPE-LFQGKKYD 190
Query: 459 --KTDVYSFGVVALEVAAGKSPVD 480
             + DV+S GV+   + +G  P D
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 91/200 (45%), Gaps = 23/200 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G    V+ G+      VA+K   KP  +  +   F  E A +   L+H  LVQL   
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTL-KPGTM--SPESFLEE-AQIMKKLKHDKLVQLYAV 72
Query: 352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQI 411
             E   + +V EY+  GSL   L +    ++ L     +++   VA+ ++Y+        
Sbjct: 73  VSE-EPIYIVTEYMNKGSLLDFLKDGEGRALKLP--NLVDMAAQVAAGMAYIER---MNY 126
Query: 412 IHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVPSEK 459
           IHRD+++ NIL+      K+ DF         E T   G    + + APE    G  + K
Sbjct: 127 IHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIK 186
Query: 460 TDVYSFGVVALE-VAAGKSP 478
           +DV+SFG++  E V  G+ P
Sbjct: 187 SDVWSFGILLTELVTKGRVP 206

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 91/206 (44%), Gaps = 24/206 (11%)
Query: 289 NRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECA---RNPFTTEFATMAGCLRHKNL 345
           NRI+GEG    VY+G   +     +    K  + +C    +  F +E   M   L H ++
Sbjct: 29  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN-LDHPHI 87
Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
           V+L G   E     ++ E  P G L   L  N +S  VL+    +   L +  A++YL  
Sbjct: 88  VKLIG-IIEEEPTWIIMELYPYGELGHYLERNKNSLKVLT---LVLYSLQICKAMAYLES 143
Query: 406 ECERQIIHRDVKACNILLDAEFNAKLGDF------------EATIPAGTMGYLAPEYVYS 453
                 +HRD+   NIL+ +    KLGDF            +A++    + +++PE +  
Sbjct: 144 ---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF 200
Query: 454 GVPSEKTDVYSFGVVALEVAA-GKSP 478
              +  +DV+ F V   E+ + GK P
Sbjct: 201 RRFTTASDVWMFAVCMWEILSFGKQP 226

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/282 (23%), Positives = 112/282 (39%), Gaps = 50/282 (17%)
Query: 292 VGEGASATVY--------KGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHK 343
           +GEGA   V         K        VAVK   K +  E   +   +E   M    +HK
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHN------------NSSSSIVLSWEKRLN 391
           N++ L G C +   L ++  Y   G+L + L              N      ++++  ++
Sbjct: 102 NIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 392 IVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGTMGY------ 445
               +A  + YL     ++ IHRD+ A N+L+      K+ DF        + Y      
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 446 -------LAPEYVYSGVPSEKTDVYSFGVVALEV-AAGKSPVDNDGCVIVDWVWNLRKKG 497
                  +APE ++  V + ++DV+SFGV+  E+   G SP      + V+ ++ L K+G
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG---IPVEELFKLLKEG 275
Query: 498 KLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKE 539
             +D                 + M+   C H    +RP+ K+
Sbjct: 276 HRMDKP---------ANCTNELYMMMRDCWHAVPSQRPTFKQ 308

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 94/226 (41%), Gaps = 35/226 (15%)
Query: 281 QATLGFNKN----RIVGEGASATVYKG-SLPSGGAVAVKRFE-------KPNRVECARNP 328
            +T GF +N     I+G G S+ V +    P+    AVK  +           V+  R  
Sbjct: 10  HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 329 FTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEK 388
              E   +     H N++QL+          LV++ +  G L   L    +  + LS ++
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKE 125
Query: 389 RLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP--------- 439
              I+  +   +  LH+     I+HRD+K  NILLD + N KL DF  +           
Sbjct: 126 TRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE 182
Query: 440 -AGTMGYLAPEYVYSGVPS------EKTDVYSFGVVALEVAAGKSP 478
             GT  YLAPE +   +        ++ D++S GV+   + AG  P
Sbjct: 183 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 94/213 (44%), Gaps = 20/213 (9%)
Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F K   +GEG    VYK  +  +G  VA+K+       E   +    E + +   L H N
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE-LNHPN 64
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           +V+L       N+L LV+E+L +  L K +  ++ + I L   K  + +  +   L++ H
Sbjct: 65  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCH 121
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG-----------TMGYLAPEYVYS 453
                +++HRD+K  N+L++ E   KL DF      G           T+ Y APE +  
Sbjct: 122 SH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 178
Query: 454 -GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV 485
               S   D++S G +  E+   ++    D  +
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 211

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 91/208 (43%), Gaps = 26/208 (12%)
Query: 290 RIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           + +GEGA   V    +  +  AVAVK  +    V+C  N    +   +   L H+N+V+ 
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--IKKEICINKMLNHENVVKF 69
Query: 349 QGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC 407
            G   EGN   L  EY   G L D+I        I +           + + + YLH   
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYLHG-- 122
Query: 408 ERQIIHRDVKACNILLDAEFNAKLGDFE-ATI------------PAGTMGYLAPEYV-YS 453
              I HRD+K  N+LLD   N K+ DF  AT+              GT+ Y+APE +   
Sbjct: 123 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 181
Query: 454 GVPSEKTDVYSFGVVALEVAAGKSPVDN 481
              +E  DV+S G+V   + AG+ P D 
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 94/213 (44%), Gaps = 20/213 (9%)
Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F K   +GEG    VYK  +  +G  VA+K+       E   +    E + +   L H N
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE-LNHPN 65
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           +V+L       N+L LV+E+L +  L K +  ++ + I L   K  + +  +   L++ H
Sbjct: 66  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCH 122
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG-----------TMGYLAPEYVYS 453
                +++HRD+K  N+L++ E   KL DF      G           T+ Y APE +  
Sbjct: 123 SH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 179
Query: 454 -GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV 485
               S   D++S G +  E+   ++    D  +
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 212

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 87/203 (42%), Gaps = 20/203 (9%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQG 350
           +G GA  +V K    PSG  +AVKR  +    E  +     +   +        +VQ  G
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRI-RSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 351 WCCEGNELVLVYEYLPNGSLDKIL-HNNSSSSIVLSWEKRLNIVLGVASALSYLHEECER 409
                 +  +  E L + S DK   +  S    V+  E    I L    AL++L E    
Sbjct: 89  ALFREGDCWICME-LMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL-- 145
Query: 410 QIIHRDVKACNILLDAEFNAKLGDF----------EATIPAGTMGYLAPEYVYSGVPSE- 458
           +IIHRD+K  NILLD   N KL DF            T  AG   Y+APE +      + 
Sbjct: 146 KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQG 205
Query: 459 ---KTDVYSFGVVALEVAAGKSP 478
              ++DV+S G+   E+A G+ P
Sbjct: 206 YDVRSDVWSLGITLYELATGRFP 228

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 91/206 (44%), Gaps = 24/206 (11%)
Query: 289 NRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECA---RNPFTTEFATMAGCLRHKNL 345
           NRI+GEG    VY+G   +     +    K  + +C    +  F +E   M   L H ++
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN-LDHPHI 75
Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
           V+L G   E     ++ E  P G L   L  N +S  VL+    +   L +  A++YL  
Sbjct: 76  VKLIG-IIEEEPTWIIMELYPYGELGHYLERNKNSLKVLT---LVLYSLQICKAMAYLES 131
Query: 406 ECERQIIHRDVKACNILLDAEFNAKLGDF------------EATIPAGTMGYLAPEYVYS 453
                 +HRD+   NIL+ +    KLGDF            +A++    + +++PE +  
Sbjct: 132 ---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF 188
Query: 454 GVPSEKTDVYSFGVVALEVAA-GKSP 478
              +  +DV+ F V   E+ + GK P
Sbjct: 189 RRFTTASDVWMFAVCMWEILSFGKQP 214

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 100/223 (44%), Gaps = 43/223 (19%)
Query: 291 IVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQG 350
           +   G    V+K  L +   VAVK F   ++ +  +N +  E  ++ G ++H+N++Q  G
Sbjct: 31  VKARGRFGCVWKAQLLNE-YVAVKIFPIQDK-QSWQNEY--EVYSLPG-MKHENILQFIG 85
Query: 351 WCCEGN----ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEE 406
               G     +L L+  +   GSL   L  N     V+SW +  +I   +A  L+YLHE+
Sbjct: 86  AEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-----VVSWNELCHIAETMARGLAYLHED 140
Query: 407 C-------ERQIIHRDVKACNILLDAEFNAKLGDFEATI-------------PAGTMGYL 446
                   +  I HRD+K+ N+LL     A + DF   +               GT  Y+
Sbjct: 141 IPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYM 200
Query: 447 APEYVYSGVPSE-----KTDVYSFGVVALEVA----AGKSPVD 480
           APE +   +  +     + D+Y+ G+V  E+A    A   PVD
Sbjct: 201 APEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/261 (22%), Positives = 106/261 (40%), Gaps = 42/261 (16%)
Query: 310 AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGS 369
            VAVK   K +  E   +   +E   M    +HKN++ L G C +   L ++  Y   G+
Sbjct: 69  TVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGN 127
Query: 370 LDKILHN------------NSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVK 417
           L + L              N      ++++  ++    +A  + YL     ++ IHRD+ 
Sbjct: 128 LREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLA 184
Query: 418 ACNILLDAEFNAKLGDFEATIPAGTMGY-------------LAPEYVYSGVPSEKTDVYS 464
           A N+L+      K+ DF        + Y             +APE ++  V + ++DV+S
Sbjct: 185 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 244
Query: 465 FGVVALEV-AAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVG 523
           FGV+  E+   G SP      + V+ ++ L K+G  +D                 + M+ 
Sbjct: 245 FGVLMWEIFTLGGSPYPG---IPVEELFKLLKEGHRMDKP---------ANCTNELYMMM 292
Query: 524 LSCVHPNHEKRPSVKEAARIL 544
             C H    +RP+ K+    L
Sbjct: 293 RDCWHAVPSQRPTFKQLVEDL 313

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 94/213 (44%), Gaps = 20/213 (9%)
Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F K   +GEG    VYK  +  +G  VA+K+       E   +    E + +   L H N
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE-LNHPN 66
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           +V+L       N+L LV+E+L +  L K +  ++ + I L   K  + +  +   L++ H
Sbjct: 67  IVKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCH 123
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG-----------TMGYLAPEYVYS 453
                +++HRD+K  N+L++ E   KL DF      G           T+ Y APE +  
Sbjct: 124 SH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 180
Query: 454 -GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV 485
               S   D++S G +  E+   ++    D  +
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 213

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 20/210 (9%)
Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F K   +GEG    VYK  +  +G  VA+K+       E   +    E + +   L H N
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE-LNHPN 64
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           +V+L       N+L LV+E+L +  L K +  ++ + I L   K  + +  +   L++ H
Sbjct: 65  IVKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCH 121
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG-----------TMGYLAPEYVYS 453
                +++HRD+K  N+L++ E   KL DF      G           T+ Y APE +  
Sbjct: 122 SH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 178
Query: 454 -GVPSEKTDVYSFGVVALEVAAGKSPVDND 482
               S   D++S G +  E+   ++    D
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGD 208

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 94/212 (44%), Gaps = 36/212 (16%)
Query: 290 RIVGEGASATVYKGSL-PSGGAVAVKRFEKP-----NRVECARNPFTTEFATMAGCLRHK 343
           R++G+G+   V    +  +G   AVK  +K      + VEC      TE   ++    H 
Sbjct: 29  RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECT----MTEKRILSLARNHP 84
Query: 344 NLVQLQGWCC--EGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLG-VASAL 400
            L QL  +CC    + L  V E++  G L  + H   S       E R       + SAL
Sbjct: 85  FLTQL--FCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFD---EARARFYAAEIISAL 137
Query: 401 SYLHEECERQIIHRDVKACNILLDAEFNAKLGDF------------EATIPAGTMGYLAP 448
            +LH+   + II+RD+K  N+LLD E + KL DF             AT   GT  Y+AP
Sbjct: 138 MFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATF-CGTPDYIAP 193
Query: 449 EYVYSGVPSEKTDVYSFGVVALEVAAGKSPVD 480
           E +   +     D ++ GV+  E+  G +P +
Sbjct: 194 EILQEMLYGPAVDWWAMGVLLYEMLCGHAPFE 225

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 98/215 (45%), Gaps = 30/215 (13%)
Query: 286 FNKNRIVGEGASATVYKGS-LPSGGAVAVKRFEKPNRVECA--RNPFTTEFATMAGCLRH 342
           F K +++G GA  TVYKG  +P G  V +    K  R   +   N    + A +   + +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 343 KNLVQLQGWCCEGNELVLVYEYLPNGSLDKILH---NNSSSSIVLSWEKRLNIVLGVASA 399
            ++ +L G C     + L+ + +P G L   +    +N  S  +L+W       + +A  
Sbjct: 78  PHVCRLLGICLTST-VQLIMQLMPFGXLLDYVREHKDNIGSQYLLNW------CVQIAKG 130
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGT-------------MGYL 446
           ++YL +   R+++HRD+ A N+L+    + K+ DF      G              + ++
Sbjct: 131 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 187
Query: 447 APEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVD 480
           A E +   + + ++DV+S+GV   E+   G  P D
Sbjct: 188 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 222

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 115/266 (43%), Gaps = 43/266 (16%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G    VY+G           +  K + +E     F  E A M   ++H NLVQL G 
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKE-IKHPNLVQLLGV 284
Query: 352 CCEGNELVLVYEYLPNGSLDKIL---HNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE 408
           C       ++ E++  G+L   L   +    S++VL     L +   ++SA+ YL    +
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL-----LYMATQISSAMEYLE---K 336
Query: 409 RQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVP 456
           +  IHR++ A N L+      K+ DF           T  AG    + + APE +     
Sbjct: 337 KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 396
Query: 457 SEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKE 515
           S K+DV++FGV+  E+A  G SP      + +  V+ L +K       D+R+     R E
Sbjct: 397 SIKSDVWAFGVLLWEIATYGMSPYPG---IDLSQVYELLEK-------DYRME----RPE 442
Query: 516 --MERMLMVGLSCVHPNHEKRPSVKE 539
              E++  +  +C   N   RPS  E
Sbjct: 443 GCPEKVYELMRACWQWNPSDRPSFAE 468

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 104/227 (45%), Gaps = 31/227 (13%)
Query: 274 LALTDIKQATLGFNKNRIVGEGASATVYKGS-LPSGGAVAVKRFEKPNRVECA--RNPFT 330
           +AL  I + T  F K +++G GA  TVYKG  +P G  V +    K  R   +   N   
Sbjct: 3   MALLRILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI 61
Query: 331 TEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILH---NNSSSSIVLSWE 387
            + A +   + + ++ +L G C     + L+ + +P G L   +    +N  S  +L+W 
Sbjct: 62  LDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW- 119
Query: 388 KRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGT----- 442
                 + +A  ++YL +   R+++HRD+ A N+L+    + K+ DF      G      
Sbjct: 120 -----CVQIAEGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 171
Query: 443 --------MGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVD 480
                   + ++A E +   + + ++DV+S+GV   E+   G  P D
Sbjct: 172 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 218

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 123/288 (42%), Gaps = 49/288 (17%)
Query: 289 NRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRV------ECARNPFTTEFATMAGCLRH 342
           +R +G+G+   VY+G      A  V + E   RV      E A      EF   A  ++ 
Sbjct: 17  SRELGQGSFGMVYEGV-----AKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 71
Query: 343 KN---LVQLQGWCCEGNELVLVYEYLPNGSLDKILHN---NSSSSIVL---SWEKRLNIV 393
            N   +V+L G   +G   +++ E +  G L   L +      ++ VL   S  K + + 
Sbjct: 72  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMA 131
Query: 394 LGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT--------IPAGTMG- 444
             +A  ++YL+     + +HRD+ A N  +  +F  K+GDF  T           G  G 
Sbjct: 132 GEIADGMAYLNA---NKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 188
Query: 445 ----YLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKL 499
               +++PE +  GV +  +DV+SFGVV  E+A   + P      +  + V     +G L
Sbjct: 189 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG---LSNEQVLRFVMEGGL 245
Query: 500 LDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE 547
           LD  D       N  +M  +L +   C   N + RPS  E    +K E
Sbjct: 246 LDKPD-------NCPDM--LLELMRMCWQYNPKMRPSFLEIISSIKEE 284

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 98/215 (45%), Gaps = 30/215 (13%)
Query: 286 FNKNRIVGEGASATVYKGS-LPSGGAVAVKRFEKPNRVECA--RNPFTTEFATMAGCLRH 342
           F K +++G GA  TVYKG  +P G  V +    K  R   +   N    + A +   + +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 343 KNLVQLQGWCCEGNELVLVYEYLPNGSLDKILH---NNSSSSIVLSWEKRLNIVLGVASA 399
            ++ +L G C     + L+ + +P G L   +    +N  S  +L+W       + +A  
Sbjct: 80  PHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 132
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGT-------------MGYL 446
           ++YL +   R+++HRD+ A N+L+    + K+ DF      G              + ++
Sbjct: 133 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 189
Query: 447 APEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVD 480
           A E +   + + ++DV+S+GV   E+   G  P D
Sbjct: 190 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 96/227 (42%), Gaps = 48/227 (21%)
Query: 291 IVGEGASATVYKGSLPSGGAVAVKRF--EKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           I   G    V+K  L     VAVK F  +     +  R  F+T        ++H+NL+Q 
Sbjct: 22  IKARGRFGCVWKAQL-MNDFVAVKIFPLQDKQSWQSEREIFSTP------GMKHENLLQF 74
Query: 349 QGWCCEGN----ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
                 G+    EL L+  +   GSL   L  N     +++W +  ++   ++  LSYLH
Sbjct: 75  IAAEKRGSNLEVELWLITAFHDKGSLTDYLKGN-----IITWNELCHVAETMSRGLSYLH 129
Query: 405 EE---CERQ-----IIHRDVKACNILLDAEFNAKLGDFEATI-------------PAGTM 443
           E+   C  +     I HRD K+ N+LL ++  A L DF   +               GT 
Sbjct: 130 EDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTR 189
Query: 444 GYLAPEYVYSGVPSE-----KTDVYSFGVVALEVA----AGKSPVDN 481
            Y+APE +   +  +     + D+Y+ G+V  E+     A   PVD 
Sbjct: 190 RYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADGPVDE 236

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 90/207 (43%), Gaps = 21/207 (10%)
Query: 286 FNKNRIVGEGASATVY---KGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRH 342
           F   +++G+G+   V+   K + P  G +   +  K   ++      T     +   + H
Sbjct: 30  FELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNH 89
Query: 343 KNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
             +V+L        +L L+ ++L  G L   L    S  ++ + E     +  +A  L +
Sbjct: 90  PFVVKLHYAFQTEGKLYLILDFLRGGDLFTRL----SKEVMFTEEDVKFYLAELALGLDH 145
Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA-----------GTMGYLAPEYV 451
           LH      II+RD+K  NILLD E + KL DF  +  A           GT+ Y+APE V
Sbjct: 146 LHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVV 202
Query: 452 YSGVPSEKTDVYSFGVVALEVAAGKSP 478
                S   D +S+GV+  E+  G  P
Sbjct: 203 NRQGHSHSADWWSYGVLMFEMLTGSLP 229

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 98/215 (45%), Gaps = 30/215 (13%)
Query: 286 FNKNRIVGEGASATVYKGS-LPSGGAVAVKRFEKPNRVECA--RNPFTTEFATMAGCLRH 342
           F K +++G GA  TVYKG  +P G  V +    K  R   +   N    + A +   + +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 343 KNLVQLQGWCCEGNELVLVYEYLPNGSLDKILH---NNSSSSIVLSWEKRLNIVLGVASA 399
            ++ +L G C     + L+ + +P G L   +    +N  S  +L+W       + +A  
Sbjct: 81  PHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 133
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGT-------------MGYL 446
           ++YL +   R+++HRD+ A N+L+    + K+ DF      G              + ++
Sbjct: 134 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 190
Query: 447 APEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVD 480
           A E +   + + ++DV+S+GV   E+   G  P D
Sbjct: 191 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 225

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 98/215 (45%), Gaps = 30/215 (13%)
Query: 286 FNKNRIVGEGASATVYKGS-LPSGGAVAVKRFEKPNRVECA--RNPFTTEFATMAGCLRH 342
           F K +++G GA  TVYKG  +P G  V +    K  R   +   N    + A +   + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 343 KNLVQLQGWCCEGNELVLVYEYLPNGSLDKILH---NNSSSSIVLSWEKRLNIVLGVASA 399
            ++ +L G C     + L+ + +P G L   +    +N  S  +L+W       + +A  
Sbjct: 77  PHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 129
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGT-------------MGYL 446
           ++YL +   R+++HRD+ A N+L+    + K+ DF      G              + ++
Sbjct: 130 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 447 APEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVD 480
           A E +   + + ++DV+S+GV   E+   G  P D
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 98/215 (45%), Gaps = 30/215 (13%)
Query: 286 FNKNRIVGEGASATVYKGS-LPSGGAVAVKRFEKPNRVECA--RNPFTTEFATMAGCLRH 342
           F K +++G GA  TVYKG  +P G  V +    K  R   +   N    + A +   + +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 343 KNLVQLQGWCCEGNELVLVYEYLPNGSLDKILH---NNSSSSIVLSWEKRLNIVLGVASA 399
            ++ +L G C     + L+ + +P G L   +    +N  S  +L+W       + +A  
Sbjct: 81  PHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 133
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGT-------------MGYL 446
           ++YL +   R+++HRD+ A N+L+    + K+ DF      G              + ++
Sbjct: 134 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 190
Query: 447 APEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVD 480
           A E +   + + ++DV+S+GV   E+   G  P D
Sbjct: 191 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 225

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 98/215 (45%), Gaps = 30/215 (13%)
Query: 286 FNKNRIVGEGASATVYKGS-LPSGGAVAVKRFEKPNRVECA--RNPFTTEFATMAGCLRH 342
           F K +++G GA  TVYKG  +P G  V +    K  R   +   N    + A +   + +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 343 KNLVQLQGWCCEGNELVLVYEYLPNGSLDKILH---NNSSSSIVLSWEKRLNIVLGVASA 399
            ++ +L G C     + L+ + +P G L   +    +N  S  +L+W       + +A  
Sbjct: 78  PHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 130
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGT-------------MGYL 446
           ++YL +   R+++HRD+ A N+L+    + K+ DF      G              + ++
Sbjct: 131 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 187
Query: 447 APEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVD 480
           A E +   + + ++DV+S+GV   E+   G  P D
Sbjct: 188 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 222

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 98/215 (45%), Gaps = 30/215 (13%)
Query: 286 FNKNRIVGEGASATVYKGS-LPSGGAVAVKRFEKPNRVECA--RNPFTTEFATMAGCLRH 342
           F K +++G GA  TVYKG  +P G  V +    K  R   +   N    + A +   + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 343 KNLVQLQGWCCEGNELVLVYEYLPNGSLDKILH---NNSSSSIVLSWEKRLNIVLGVASA 399
            ++ +L G C     + L+ + +P G L   +    +N  S  +L+W       + +A  
Sbjct: 77  PHVCRLLGICLTST-VQLITQLMPFGXLLDYVREHKDNIGSQYLLNW------CVQIAKG 129
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGT-------------MGYL 446
           ++YL +   R+++HRD+ A N+L+    + K+ DF      G              + ++
Sbjct: 130 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 447 APEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVD 480
           A E +   + + ++DV+S+GV   E+   G  P D
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 98/215 (45%), Gaps = 30/215 (13%)
Query: 286 FNKNRIVGEGASATVYKGS-LPSGGAVAVKRFEKPNRVECA--RNPFTTEFATMAGCLRH 342
           F K +++G GA  TVYKG  +P G  V +    K  R   +   N    + A +   + +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 343 KNLVQLQGWCCEGNELVLVYEYLPNGSLDKILH---NNSSSSIVLSWEKRLNIVLGVASA 399
            ++ +L G C     + L+ + +P G L   +    +N  S  +L+W       + +A  
Sbjct: 71  PHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 123
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGT-------------MGYL 446
           ++YL +   R+++HRD+ A N+L+    + K+ DF      G              + ++
Sbjct: 124 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 180
Query: 447 APEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVD 480
           A E +   + + ++DV+S+GV   E+   G  P D
Sbjct: 181 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 215

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 98/215 (45%), Gaps = 30/215 (13%)
Query: 286 FNKNRIVGEGASATVYKGS-LPSGGAVAVKRFEKPNRVECA--RNPFTTEFATMAGCLRH 342
           F K +++G GA  TVYKG  +P G  V +    K  R   +   N    + A +   + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 343 KNLVQLQGWCCEGNELVLVYEYLPNGSLDKILH---NNSSSSIVLSWEKRLNIVLGVASA 399
            ++ +L G C     + L+ + +P G L   +    +N  S  +L+W       + +A  
Sbjct: 79  PHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 131
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGT-------------MGYL 446
           ++YL +   R+++HRD+ A N+L+    + K+ DF      G              + ++
Sbjct: 132 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 447 APEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVD 480
           A E +   + + ++DV+S+GV   E+   G  P D
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 98/215 (45%), Gaps = 30/215 (13%)
Query: 286 FNKNRIVGEGASATVYKGS-LPSGGAVAVKRFEKPNRVECA--RNPFTTEFATMAGCLRH 342
           F K +++G GA  TVYKG  +P G  V +    K  R   +   N    + A +   + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 343 KNLVQLQGWCCEGNELVLVYEYLPNGSLDKILH---NNSSSSIVLSWEKRLNIVLGVASA 399
            ++ +L G C     + L+ + +P G L   +    +N  S  +L+W       + +A  
Sbjct: 79  PHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 131
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGT-------------MGYL 446
           ++YL +   R+++HRD+ A N+L+    + K+ DF      G              + ++
Sbjct: 132 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 447 APEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVD 480
           A E +   + + ++DV+S+GV   E+   G  P D
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 98/215 (45%), Gaps = 30/215 (13%)
Query: 286 FNKNRIVGEGASATVYKGS-LPSGGAVAVKRFEKPNRVECA--RNPFTTEFATMAGCLRH 342
           F K +++G GA  TVYKG  +P G  V +    K  R   +   N    + A +   + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 343 KNLVQLQGWCCEGNELVLVYEYLPNGSLDKILH---NNSSSSIVLSWEKRLNIVLGVASA 399
            ++ +L G C     + L+ + +P G L   +    +N  S  +L+W       + +A  
Sbjct: 79  PHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 131
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGT-------------MGYL 446
           ++YL +   R+++HRD+ A N+L+    + K+ DF      G              + ++
Sbjct: 132 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 447 APEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVD 480
           A E +   + + ++DV+S+GV   E+   G  P D
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 98/215 (45%), Gaps = 30/215 (13%)
Query: 286 FNKNRIVGEGASATVYKGS-LPSGGAVAVKRFEKPNRVECA--RNPFTTEFATMAGCLRH 342
           F K +++G GA  TVYKG  +P G  V +    K  R   +   N    + A +   + +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 343 KNLVQLQGWCCEGNELVLVYEYLPNGSLDKILH---NNSSSSIVLSWEKRLNIVLGVASA 399
            ++ +L G C     + L+ + +P G L   +    +N  S  +L+W       + +A  
Sbjct: 80  PHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 132
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGT-------------MGYL 446
           ++YL +   R+++HRD+ A N+L+    + K+ DF      G              + ++
Sbjct: 133 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 189
Query: 447 APEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVD 480
           A E +   + + ++DV+S+GV   E+   G  P D
Sbjct: 190 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 98/215 (45%), Gaps = 30/215 (13%)
Query: 286 FNKNRIVGEGASATVYKGS-LPSGGAVAVKRFEKPNRVECA--RNPFTTEFATMAGCLRH 342
           F K +++G GA  TVYKG  +P G  V +    K  R   +   N    + A +   + +
Sbjct: 27  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 86
Query: 343 KNLVQLQGWCCEGNELVLVYEYLPNGSLDKILH---NNSSSSIVLSWEKRLNIVLGVASA 399
            ++ +L G C     + L+ + +P G L   +    +N  S  +L+W       + +A  
Sbjct: 87  PHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 139
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGT-------------MGYL 446
           ++YL +   R+++HRD+ A N+L+    + K+ DF      G              + ++
Sbjct: 140 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 196
Query: 447 APEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVD 480
           A E +   + + ++DV+S+GV   E+   G  P D
Sbjct: 197 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 231

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 98/215 (45%), Gaps = 30/215 (13%)
Query: 286 FNKNRIVGEGASATVYKGS-LPSGGAVAVKRFEKPNRVECA--RNPFTTEFATMAGCLRH 342
           F K +++G GA  TVYKG  +P G  V +    K  R   +   N    + A +   + +
Sbjct: 42  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 101
Query: 343 KNLVQLQGWCCEGNELVLVYEYLPNGSLDKILH---NNSSSSIVLSWEKRLNIVLGVASA 399
            ++ +L G C     + L+ + +P G L   +    +N  S  +L+W       + +A  
Sbjct: 102 PHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 154
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGT-------------MGYL 446
           ++YL +   R+++HRD+ A N+L+    + K+ DF      G              + ++
Sbjct: 155 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 211
Query: 447 APEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVD 480
           A E +   + + ++DV+S+GV   E+   G  P D
Sbjct: 212 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 246

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 98/215 (45%), Gaps = 30/215 (13%)
Query: 286 FNKNRIVGEGASATVYKGS-LPSGGAVAVKRFEKPNRVECA--RNPFTTEFATMAGCLRH 342
           F K +++G GA  TVYKG  +P G  V +    K  R   +   N    + A +   + +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 343 KNLVQLQGWCCEGNELVLVYEYLPNGSLDKILH---NNSSSSIVLSWEKRLNIVLGVASA 399
            ++ +L G C     + L+ + +P G L   +    +N  S  +L+W       + +A  
Sbjct: 80  PHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 132
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGT-------------MGYL 446
           ++YL +   R+++HRD+ A N+L+    + K+ DF      G              + ++
Sbjct: 133 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 189
Query: 447 APEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVD 480
           A E +   + + ++DV+S+GV   E+   G  P D
Sbjct: 190 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 98/215 (45%), Gaps = 30/215 (13%)
Query: 286 FNKNRIVGEGASATVYKGS-LPSGGAVAVKRFEKPNRVECA--RNPFTTEFATMAGCLRH 342
           F K +++G GA  TVYKG  +P G  V +    K  R   +   N    + A +   + +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 343 KNLVQLQGWCCEGNELVLVYEYLPNGSLDKILH---NNSSSSIVLSWEKRLNIVLGVASA 399
            ++ +L G C     + L+ + +P G L   +    +N  S  +L+W       + +A  
Sbjct: 84  PHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 136
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGT-------------MGYL 446
           ++YL +   R+++HRD+ A N+L+    + K+ DF      G              + ++
Sbjct: 137 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 193
Query: 447 APEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVD 480
           A E +   + + ++DV+S+GV   E+   G  P D
Sbjct: 194 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 20/205 (9%)
Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F K   +GEG    VYK  +  +G  VA+K+       E   +    E + +   L H N
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE-LNHPN 66
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           +V+L       N+L LV+E++ +  L K +  ++ + I L   K  + +  +   L++ H
Sbjct: 67  IVKLLDVIHTENKLYLVFEHV-DQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCH 123
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG-----------TMGYLAPEYVYS 453
                +++HRD+K  N+L++ E   KL DF      G           T+ Y APE +  
Sbjct: 124 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 180
Query: 454 -GVPSEKTDVYSFGVVALEVAAGKS 477
               S   D++S G +  E+   ++
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRA 205

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 98/215 (45%), Gaps = 30/215 (13%)
Query: 286 FNKNRIVGEGASATVYKGS-LPSGGAVAVKRFEKPNRVECA--RNPFTTEFATMAGCLRH 342
           F K +++G GA  TVYKG  +P G  V +    K  R   +   N    + A +   + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 343 KNLVQLQGWCCEGNELVLVYEYLPNGSLDKILH---NNSSSSIVLSWEKRLNIVLGVASA 399
            ++ +L G C     + L+ + +P G L   +    +N  S  +L+W       + +A  
Sbjct: 77  PHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 129
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGT-------------MGYL 446
           ++YL +   R+++HRD+ A N+L+    + K+ DF      G              + ++
Sbjct: 130 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 447 APEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVD 480
           A E +   + + ++DV+S+GV   E+   G  P D
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 98/215 (45%), Gaps = 30/215 (13%)
Query: 286 FNKNRIVGEGASATVYKGS-LPSGGAVAVKRFEKPNRVECA--RNPFTTEFATMAGCLRH 342
           F K +++G GA  TVYKG  +P G  V +    K  R   +   N    + A +   + +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 343 KNLVQLQGWCCEGNELVLVYEYLPNGSLDKILH---NNSSSSIVLSWEKRLNIVLGVASA 399
            ++ +L G C     + L+ + +P G L   +    +N  S  +L+W       + +A  
Sbjct: 84  PHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 136
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGT-------------MGYL 446
           ++YL +   R+++HRD+ A N+L+    + K+ DF      G              + ++
Sbjct: 137 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 193
Query: 447 APEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVD 480
           A E +   + + ++DV+S+GV   E+   G  P D
Sbjct: 194 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 98/215 (45%), Gaps = 30/215 (13%)
Query: 286 FNKNRIVGEGASATVYKGS-LPSGGAVAVKRFEKPNRVECA--RNPFTTEFATMAGCLRH 342
           F K +++G GA  TVYKG  +P G  V +    K  R   +   N    + A +   + +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 343 KNLVQLQGWCCEGNELVLVYEYLPNGSLDKILH---NNSSSSIVLSWEKRLNIVLGVASA 399
            ++ +L G C     + L+ + +P G L   +    +N  S  +L+W       + +A  
Sbjct: 80  PHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 132
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGT-------------MGYL 446
           ++YL +   R+++HRD+ A N+L+    + K+ DF      G              + ++
Sbjct: 133 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 189
Query: 447 APEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVD 480
           A E +   + + ++DV+S+GV   E+   G  P D
Sbjct: 190 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 98/215 (45%), Gaps = 30/215 (13%)
Query: 286 FNKNRIVGEGASATVYKGS-LPSGGAVAVKRFEKPNRVECA--RNPFTTEFATMAGCLRH 342
           F K +++G GA  TVYKG  +P G  V +    K  R   +   N    + A +   + +
Sbjct: 23  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 82
Query: 343 KNLVQLQGWCCEGNELVLVYEYLPNGSLDKILH---NNSSSSIVLSWEKRLNIVLGVASA 399
            ++ +L G C     + L+ + +P G L   +    +N  S  +L+W       + +A  
Sbjct: 83  PHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 135
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGT-------------MGYL 446
           ++YL +   R+++HRD+ A N+L+    + K+ DF      G              + ++
Sbjct: 136 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 192
Query: 447 APEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVD 480
           A E +   + + ++DV+S+GV   E+   G  P D
Sbjct: 193 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 227

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 98/215 (45%), Gaps = 30/215 (13%)
Query: 286 FNKNRIVGEGASATVYKGS-LPSGGAVAVKRFEKPNRVECA--RNPFTTEFATMAGCLRH 342
           F K +++G GA  TVYKG  +P G  V +    K  R   +   N    + A +   + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 343 KNLVQLQGWCCEGNELVLVYEYLPNGSLDKILH---NNSSSSIVLSWEKRLNIVLGVASA 399
            ++ +L G C     + L+ + +P G L   +    +N  S  +L+W       + +A  
Sbjct: 79  PHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 131
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGT-------------MGYL 446
           ++YL +   R+++HRD+ A N+L+    + K+ DF      G              + ++
Sbjct: 132 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 447 APEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVD 480
           A E +   + + ++DV+S+GV   E+   G  P D
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 98/215 (45%), Gaps = 30/215 (13%)
Query: 286 FNKNRIVGEGASATVYKGS-LPSGGAVAVKRFEKPNRVECA--RNPFTTEFATMAGCLRH 342
           F K +++G GA  TVYKG  +P G  V +    K  R   +   N    + A +   + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 343 KNLVQLQGWCCEGNELVLVYEYLPNGSLDKILH---NNSSSSIVLSWEKRLNIVLGVASA 399
            ++ +L G C     + L+ + +P G L   +    +N  S  +L+W       + +A  
Sbjct: 77  PHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 129
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGT-------------MGYL 446
           ++YL +   R+++HRD+ A N+L+    + K+ DF      G              + ++
Sbjct: 130 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 447 APEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVD 480
           A E +   + + ++DV+S+GV   E+   G  P D
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 98/215 (45%), Gaps = 30/215 (13%)
Query: 286 FNKNRIVGEGASATVYKGS-LPSGGAVAVKRFEKPNRVECA--RNPFTTEFATMAGCLRH 342
           F K +++G GA  TVYKG  +P G  V +    K  R   +   N    + A +   + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 343 KNLVQLQGWCCEGNELVLVYEYLPNGSLDKILH---NNSSSSIVLSWEKRLNIVLGVASA 399
            ++ +L G C     + L+ + +P G L   +    +N  S  +L+W       + +A  
Sbjct: 77  PHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 129
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGT-------------MGYL 446
           ++YL +   R+++HRD+ A N+L+    + K+ DF      G              + ++
Sbjct: 130 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 447 APEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVD 480
           A E +   + + ++DV+S+GV   E+   G  P D
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 98/215 (45%), Gaps = 30/215 (13%)
Query: 286 FNKNRIVGEGASATVYKGS-LPSGGAVAVKRFEKPNRVECA--RNPFTTEFATMAGCLRH 342
           F K +++G GA  TVYKG  +P G  V +    K  R   +   N    + A +   + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 343 KNLVQLQGWCCEGNELVLVYEYLPNGSLDKILH---NNSSSSIVLSWEKRLNIVLGVASA 399
            ++ +L G C     + L+ + +P G L   +    +N  S  +L+W       + +A  
Sbjct: 79  PHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 131
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGT-------------MGYL 446
           ++YL +   R+++HRD+ A N+L+    + K+ DF      G              + ++
Sbjct: 132 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 447 APEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVD 480
           A E +   + + ++DV+S+GV   E+   G  P D
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 92/222 (41%), Gaps = 35/222 (15%)
Query: 285 GFNKN----RIVGEGASATVYKG-SLPSGGAVAVKRFE-------KPNRVECARNPFTTE 332
           GF +N     I+G G S+ V +    P+    AVK  +           V+  R     E
Sbjct: 1   GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKE 60
Query: 333 FATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNI 392
              +     H N++QL+          LV++ +  G L   L    +  + LS ++   I
Sbjct: 61  VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETRKI 116
Query: 393 VLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP----------AGT 442
           +  +   +  LH+     I+HRD+K  NILLD + N KL DF  +             GT
Sbjct: 117 MRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGT 173
Query: 443 MGYLAPEYVYSGVPS------EKTDVYSFGVVALEVAAGKSP 478
             YLAPE +   +        ++ D++S GV+   + AG  P
Sbjct: 174 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 215

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 20/214 (9%)
Query: 285 GFNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHK 343
            F K   +GEG    VYK  +  +G  VA+ +       E   +    E + +   L H 
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKE-LNHP 62
Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
           N+V+L       N+L LV+E+L +  L K +  ++ + I L   K  + +  +   L++ 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 119
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG-----------TMGYLAPEYVY 452
           H     +++HRD+K  N+L++ E   KL DF      G           T+ Y APE + 
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 176
Query: 453 S-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV 485
                S   D++S G +  E+   ++    D  +
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 210

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 20/214 (9%)
Query: 285 GFNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHK 343
            F K   +GEG    VYK  +  +G  VA+ +       E   +    E + +   L H 
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKE-LNHP 61
Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
           N+V+L       N+L LV+E+L +  L K +  ++ + I L   K  + +  +   L++ 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 118
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG-----------TMGYLAPEYVY 452
           H     +++HRD+K  N+L++ E   KL DF      G           T+ Y APE + 
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175
Query: 453 S-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV 485
                S   D++S G +  E+   ++    D  +
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 209

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 96/213 (45%), Gaps = 27/213 (12%)
Query: 290 RIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLR---HKNLV 346
           +I+GEG   +V +G+L      ++K   K  +++ +      EF + A C++   H N++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 347 QLQGWCCEGNEL-----VLVYEYLPNGSLDKILHNN--SSSSIVLSWEKRLNIVLGVASA 399
           +L G C E +       +++  ++  G L   L  +   +    +  +  L  ++ +A  
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-------------EATIPAGTMGYL 446
           + YL     R  +HRD+ A N +L  +    + DF             +  I    + ++
Sbjct: 160 MEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 216
Query: 447 APEYVYSGVPSEKTDVYSFGVVALEVAA-GKSP 478
           A E +   V + K+DV++FGV   E+A  G +P
Sbjct: 217 AIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 72/162 (44%), Gaps = 32/162 (19%)
Query: 337 AGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGV 396
           A  L  +N V+      + + L +  EY  NG+L  ++H   S ++    ++   +   +
Sbjct: 69  AAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH---SENLNQQRDEYWRLFRQI 125
Query: 397 ASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF---------------------- 434
             ALSY+H +    IIHRD+K  NI +D   N K+GDF                      
Sbjct: 126 LEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 435 ---EATIPAGTMGYLAPEYVY-SGVPSEKTDVYSFGVVALEV 472
                T   GT  Y+A E +  +G  +EK D+YS G++  E+
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM 224

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 20/210 (9%)
Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F K   +GEG    VYK  +  +G  VA+K+       E   +    E + +   L H N
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE-LNHPN 66
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           +V+L       N+L LV+E+L +  L   +  ++ + I L   K  + +  +   L++ H
Sbjct: 67  IVKLLDVIHTENKLYLVFEFL-HQDLKTFMDASALTGIPLPLIK--SYLFQLLQGLAFCH 123
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG-----------TMGYLAPEYVYS 453
                +++HRD+K  N+L++ E   KL DF      G           T+ Y APE +  
Sbjct: 124 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 180
Query: 454 -GVPSEKTDVYSFGVVALEVAAGKSPVDND 482
               S   D++S G +  E+   ++    D
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGD 210

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 96/215 (44%), Gaps = 30/215 (13%)
Query: 286 FNKNRIVGEGASATVYKGS-LPSGGAVA--VKRFEKPNRVECARNPFTTEFATMAGCLRH 342
           F K +++G GA  TVYKG  +P G  V   V   E         N    + A +   + +
Sbjct: 51  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDN 110
Query: 343 KNLVQLQGWCCEGNELVLVYEYLPNGSLDKILH---NNSSSSIVLSWEKRLNIVLGVASA 399
            ++ +L G C     + L+ + +P G L   +    +N  S  +L+W       + +A  
Sbjct: 111 PHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 163
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGT-------------MGYL 446
           ++YL +   R+++HRD+ A N+L+    + K+ DF      G              + ++
Sbjct: 164 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 220
Query: 447 APEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVD 480
           A E +   + + ++DV+S+GV   E+   G  P D
Sbjct: 221 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 255

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 91/219 (41%), Gaps = 32/219 (14%)
Query: 279 IKQATLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKP-----NRVECARNPFTTE 332
           IK     F  ++++G+G+   V+      +    A+K  +K      + VEC       E
Sbjct: 13  IKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECT----MVE 68
Query: 333 FATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRL-- 390
              ++    H  L  +         L  V EYL  G L  + H  S     LS       
Sbjct: 69  KRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL--MYHIQSCHKFDLSRATFYAA 126
Query: 391 NIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-----------EATIP 439
            I+LG    L +LH    + I++RD+K  NILLD + + K+ DF           +    
Sbjct: 127 EIILG----LQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEF 179
Query: 440 AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSP 478
            GT  Y+APE +     +   D +SFGV+  E+  G+SP
Sbjct: 180 CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 218

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 93/204 (45%), Gaps = 30/204 (14%)
Query: 292 VGEGASATVYK-GSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQG 350
           +G GA   V++     +G   A K    P+  E  +     E  TM+  LRH  LV L  
Sbjct: 59  LGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMS-VLRHPTLVNLHD 115
Query: 351 WCCEGNELVLVYEYLPNGSL-DKIL--HNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC 407
              + NE+V++YE++  G L +K+   HN  S    + + ++      V   L ++H   
Sbjct: 116 AFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQ------VCKGLCHMH--- 166
Query: 408 ERQIIHRDVKACNILLDAEFN--AKLGDFEAT----------IPAGTMGYLAPEYVYSGV 455
           E   +H D+K  NI+   + +   KL DF  T          +  GT  + APE V  G 
Sbjct: 167 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPE-VAEGK 225
Query: 456 P-SEKTDVYSFGVVALEVAAGKSP 478
           P    TD++S GV++  + +G SP
Sbjct: 226 PVGYYTDMWSVGVLSYILLSGLSP 249

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 27/209 (12%)
Query: 291 IVGEGASATVYK-GSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQ 349
           +VGEG+   V K  +  +G  VA+K+F + +  +  +     E   +   LRH+NLV L 
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQ-LRHENLVNLL 90
Query: 350 GWCCEGNELVLVYEYLPNGSLD--KILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC 407
             C +     LV+E++ +  LD  ++  N     +V  +      +  + + + + H   
Sbjct: 91  EVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKY------LFQIINGIGFCH--- 141
Query: 408 ERQIIHRDVKACNILLDAEFNAKLGD--FEATIPA---------GTMGYLAPEYVYSGVP 456
              IIHRD+K  NIL+      KL D  F  T+ A          T  Y APE +   V 
Sbjct: 142 SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVK 201
Query: 457 SEK-TDVYSFGVVALEVAAGKS--PVDND 482
             K  DV++ G +  E+  G+   P D+D
Sbjct: 202 YGKAVDVWAIGCLVTEMFMGEPLFPGDSD 230

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 91/221 (41%), Gaps = 47/221 (21%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKP-NRVECAR-------------NPFTTEFATM 336
           +G GA   V K   +PSG  +AVKR     N  E  R              PFT  F   
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFY-- 72
Query: 337 AGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGV 396
            G L  +  V    W C           L + SLDK           +  +    I + +
Sbjct: 73  -GALFREGDV----WICME---------LMDTSLDKFYKQVIDKGQTIPEDILGKIAVSI 118
Query: 397 ASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT----------IPAGTMGYL 446
             AL +LH +    +IHRDVK  N+L++A    K+ DF  +          I AG   Y+
Sbjct: 119 VKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYM 176
Query: 447 APEYVYSGVP----SEKTDVYSFGVVALEVAAGKSPVDNDG 483
           APE +   +     S K+D++S G+  +E+A  + P D+ G
Sbjct: 177 APERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWG 217

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 89/204 (43%), Gaps = 22/204 (10%)
Query: 286 FNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           + K   VGEG    VYK     G  VA+KR       E   +    E + +   L H N+
Sbjct: 23  YQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKE-LHHPNI 81
Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVL-GVASALSYLH 404
           V L         L LV+E++    L K+L  N +       + ++ I L  +   +++ H
Sbjct: 82  VSLIDVIHSERCLTLVFEFM-EKDLKKVLDENKTGL----QDSQIKIYLYQLLRGVAHCH 136
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTMGYLAPEYVY- 452
           +    +I+HRD+K  N+L++++   KL DF             T    T+ Y AP+ +  
Sbjct: 137 QH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMG 193
Query: 453 SGVPSEKTDVYSFGVVALEVAAGK 476
           S   S   D++S G +  E+  GK
Sbjct: 194 SKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 91/219 (41%), Gaps = 32/219 (14%)
Query: 279 IKQATLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKP-----NRVECARNPFTTE 332
           IK     F  ++++G+G+   V+      +    A+K  +K      + VEC       E
Sbjct: 12  IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECT----MVE 67
Query: 333 FATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRL-- 390
              ++    H  L  +         L  V EYL  G L  + H  S     LS       
Sbjct: 68  KRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL--MYHIQSCHKFDLSRATFYAA 125
Query: 391 NIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-----------EATIP 439
            I+LG    L +LH    + I++RD+K  NILLD + + K+ DF           +    
Sbjct: 126 EIILG----LQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXF 178
Query: 440 AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSP 478
            GT  Y+APE +     +   D +SFGV+  E+  G+SP
Sbjct: 179 CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 89/204 (43%), Gaps = 22/204 (10%)
Query: 286 FNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           + K   VGEG    VYK     G  VA+KR       E   +    E + +   L H N+
Sbjct: 23  YQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKE-LHHPNI 81
Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVL-GVASALSYLH 404
           V L         L LV+E++    L K+L  N +       + ++ I L  +   +++ H
Sbjct: 82  VSLIDVIHSERCLTLVFEFM-EKDLKKVLDENKTGL----QDSQIKIYLYQLLRGVAHCH 136
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTMGYLAPEYVY- 452
           +    +I+HRD+K  N+L++++   KL DF             T    T+ Y AP+ +  
Sbjct: 137 QH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMG 193
Query: 453 SGVPSEKTDVYSFGVVALEVAAGK 476
           S   S   D++S G +  E+  GK
Sbjct: 194 SKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 90/203 (44%), Gaps = 28/203 (13%)
Query: 292 VGEGASATVYK-GSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQG 350
           +G GA   V++     +G   A K    P+  E  +     E  TM+  LRH  LV L  
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMS-VLRHPTLVNLHD 221
Query: 351 WCCEGNELVLVYEYLPNGSL-DKIL--HNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC 407
              + NE+V++YE++  G L +K+   HN  S    + + ++      V   L ++H   
Sbjct: 222 AFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQ------VCKGLCHMH--- 272
Query: 408 ERQIIHRDVKACNILLDAEFN--AKLGDFEAT----------IPAGTMGYLAPEYVYSGV 455
           E   +H D+K  NI+   + +   KL DF  T          +  GT  + APE      
Sbjct: 273 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKP 332
Query: 456 PSEKTDVYSFGVVALEVAAGKSP 478
               TD++S GV++  + +G SP
Sbjct: 333 VGYYTDMWSVGVLSYILLSGLSP 355

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 90/204 (44%), Gaps = 22/204 (10%)
Query: 290 RIVGEGASATV-YKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           + +G+G  A V     + +G  VAVK  +K      +      E   +   L H N+V+L
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFRE-VRIXKVLNHPNIVKL 78
Query: 349 QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE 408
                    L LV EY   G +   L  +       +  K   IV    SA+ Y H++  
Sbjct: 79  FEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIV----SAVQYCHQKF- 133
Query: 409 RQIIHRDVKACNILLDAEFNAKLGDF----EATIP------AGTMGYLAPEYVYSGVPSE 458
             I+HRD+KA N+LLDA+ N K+ DF    E T         G   Y APE ++ G   +
Sbjct: 134 --IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPE-LFQGKKYD 190
Query: 459 --KTDVYSFGVVALEVAAGKSPVD 480
             + DV+S GV+   + +G  P D
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 93/213 (43%), Gaps = 20/213 (9%)
Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F K   +GEG    VYK  +  +G  VA+K+       E   +    E + +   L H N
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE-LNHPN 66
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           +V+L       N+L LV+E+L +  L   +  ++ + I L   K  + +  +   L++ H
Sbjct: 67  IVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIK--SYLFQLLQGLAFCH 123
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG-----------TMGYLAPEYVYS 453
                +++HRD+K  N+L++ E   KL DF      G           T+ Y APE +  
Sbjct: 124 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 180
Query: 454 -GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV 485
               S   D++S G +  E+   ++    D  +
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 213

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 20/214 (9%)
Query: 285 GFNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHK 343
            F K   +GEG    VYK  +  +G  VA+K+       E   +    E + +   L H 
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE-LNHP 62
Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
           N+V+L       N+L LV+E+L +  L   +  ++ + I L   K  + +  +   L++ 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKDFMDASALTGIPLPLIK--SYLFQLLQGLAFC 119
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG-----------TMGYLAPEYVY 452
           H     +++HRD+K  N+L++ E   KL DF      G           T+ Y APE + 
Sbjct: 120 HSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 176
Query: 453 S-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV 485
                S   D++S G +  E+   ++    D  +
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 210

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 20/210 (9%)
Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F K   +GEG    VYK  +  +G  VA+K+       E   +    E + +   L H N
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE-LNHPN 65
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           +V+L       N+L LV+E+L +  L   +  ++ + I L   K  + +  +   L++ H
Sbjct: 66  IVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIK--SYLFQLLQGLAFCH 122
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG-----------TMGYLAPEYVYS 453
                +++HRD+K  N+L++ E   KL DF      G           T+ Y APE +  
Sbjct: 123 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 179
Query: 454 -GVPSEKTDVYSFGVVALEVAAGKSPVDND 482
               S   D++S G +  E+   ++    D
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGD 209

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 71/266 (26%), Positives = 115/266 (43%), Gaps = 43/266 (16%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G G    VY+G           +  K + +E     F  E A M   ++H NLVQL G 
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKE-IKHPNLVQLLGV 323
Query: 352 CCEGNELVLVYEYLPNGSLDKIL---HNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE 408
           C       ++ E++  G+L   L   +    +++VL     L +   ++SA+ YL    +
Sbjct: 324 CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAMEYLE---K 375
Query: 409 RQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGT---MGYLAPEYVYSGVP 456
           +  IHR++ A N L+      K+ DF           T  AG    + + APE +     
Sbjct: 376 KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 435
Query: 457 SEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKE 515
           S K+DV++FGV+  E+A  G SP      + +  V+ L +K       D+R+     R E
Sbjct: 436 SIKSDVWAFGVLLWEIATYGMSPYPG---IDLSQVYELLEK-------DYRME----RPE 481
Query: 516 --MERMLMVGLSCVHPNHEKRPSVKE 539
              E++  +  +C   N   RPS  E
Sbjct: 482 GCPEKVYELMRACWQWNPSDRPSFAE 507

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 70/150 (46%), Gaps = 26/150 (17%)
Query: 340 LRHKNLVQLQGWCCE---GNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGV 396
           L H+++++ +G CCE      L LV EY+P GSL   L  +S     +   + L     +
Sbjct: 90  LYHEHIIKYKG-CCEDAGAASLQLVMEYVPLGSLRDYLPRHS-----IGLAQLLLFAQQI 143
Query: 397 ASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--EATIPAGTMGY--------- 445
              ++YLH +     IHRD+ A N+LLD +   K+GDF     +P G   Y         
Sbjct: 144 CEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSP 200
Query: 446 ---LAPEYVYSGVPSEKTDVYSFGVVALEV 472
               APE +        +DV+SFGV   E+
Sbjct: 201 VFWYAPECLKEYKFYYASDVWSFGVTLYEL 230

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/148 (31%), Positives = 69/148 (46%), Gaps = 18/148 (12%)
Query: 342 HKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALS 401
           H  +V+L        +L L+ ++L  G L        S  ++ + E     +  +A AL 
Sbjct: 85  HPFIVKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALD 140
Query: 402 YLHEECERQIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTMGYLAPEY 450
           +LH      II+RD+K  NILLD E + KL DF           +A    GT+ Y+APE 
Sbjct: 141 HLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 197
Query: 451 VYSGVPSEKTDVYSFGVVALEVAAGKSP 478
           V     ++  D +SFGV+  E+  G  P
Sbjct: 198 VNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 89/198 (44%), Gaps = 24/198 (12%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +GEG    VYK     G   A+K+       E   +    E + +   L+H N+V+L   
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKE-LKHSNIVKLYDV 68
Query: 352 CCEGNELVLVYEYLPNGSLDKILH--NNSSSSIVLSWEKRLNIVLGVASALSYLHEECER 409
                 LVLV+E+L +  L K+L        S+        + +L + + ++Y H+   R
Sbjct: 69  IHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAK-----SFLLQLLNGIAYCHD---R 119
Query: 410 QIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTMGYLAPEYVY-SGVPS 457
           +++HRD+K  N+L++ E   K+ DF           + T    T+ Y AP+ +  S   S
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYS 179
Query: 458 EKTDVYSFGVVALEVAAG 475
              D++S G +  E+  G
Sbjct: 180 TTIDIWSVGCIFAEMVNG 197

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 89/198 (44%), Gaps = 24/198 (12%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +GEG    VYK     G   A+K+       E   +    E + +   L+H N+V+L   
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKE-LKHSNIVKLYDV 68
Query: 352 CCEGNELVLVYEYLPNGSLDKILH--NNSSSSIVLSWEKRLNIVLGVASALSYLHEECER 409
                 LVLV+E+L +  L K+L        S+        + +L + + ++Y H+   R
Sbjct: 69  IHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAK-----SFLLQLLNGIAYCHD---R 119
Query: 410 QIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTMGYLAPEYVY-SGVPS 457
           +++HRD+K  N+L++ E   K+ DF           + T    T+ Y AP+ +  S   S
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYS 179
Query: 458 EKTDVYSFGVVALEVAAG 475
              D++S G +  E+  G
Sbjct: 180 TTIDIWSVGCIFAEMVNG 197

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 90/211 (42%), Gaps = 16/211 (7%)
Query: 286 FNKNRIVGEGASATVY-KGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F + + +G G+   V     + +G   A+K  +K   V+  +   T     +   +    
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           LV+L+    + + L +V EY+P G +   L      S   +      IVL       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVL----TFEYLH 158
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGVP 456
                 +I+RD+K  N+L+D +   K+ DF              GT  YLAPE + S   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 457 SEKTDVYSFGVVALEVAAGKSPVDNDGCVIV 487
           ++  D ++ GV+  E+AAG  P   D  + +
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 90/211 (42%), Gaps = 16/211 (7%)
Query: 286 FNKNRIVGEGASATVY-KGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F + + +G G+   V     + +G   A+K  +K   V+  +   T     +   +    
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           LV+L+    + + L +V EY+P G +   L      S   +      IVL       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVL----TFEYLH 158
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGVP 456
                 +I+RD+K  N+L+D +   K+ DF              GT  YLAPE + S   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 457 SEKTDVYSFGVVALEVAAGKSPVDNDGCVIV 487
           ++  D ++ GV+  E+AAG  P   D  + +
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 89/198 (44%), Gaps = 24/198 (12%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +GEG    VYK     G   A+K+       E   +    E + +   L+H N+V+L   
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKE-LKHSNIVKLYDV 68
Query: 352 CCEGNELVLVYEYLPNGSLDKILH--NNSSSSIVLSWEKRLNIVLGVASALSYLHEECER 409
                 LVLV+E+L +  L K+L        S+        + +L + + ++Y H+   R
Sbjct: 69  IHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAK-----SFLLQLLNGIAYCHD---R 119
Query: 410 QIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTMGYLAPEYVY-SGVPS 457
           +++HRD+K  N+L++ E   K+ DF           + T    T+ Y AP+ +  S   S
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYS 179
Query: 458 EKTDVYSFGVVALEVAAG 475
              D++S G +  E+  G
Sbjct: 180 TTIDIWSVGCIFAEMVNG 197

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/148 (31%), Positives = 69/148 (46%), Gaps = 18/148 (12%)
Query: 342 HKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALS 401
           H  +V+L        +L L+ ++L  G L        S  ++ + E     +  +A AL 
Sbjct: 86  HPFIVKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALD 141
Query: 402 YLHEECERQIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTMGYLAPEY 450
           +LH      II+RD+K  NILLD E + KL DF           +A    GT+ Y+APE 
Sbjct: 142 HLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 198
Query: 451 VYSGVPSEKTDVYSFGVVALEVAAGKSP 478
           V     ++  D +SFGV+  E+  G  P
Sbjct: 199 VNRRGHTQSADWWSFGVLMFEMLTGTLP 226

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/148 (31%), Positives = 69/148 (46%), Gaps = 18/148 (12%)
Query: 342 HKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALS 401
           H  +V+L        +L L+ ++L  G L        S  ++ + E     +  +A AL 
Sbjct: 85  HPFIVKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALD 140
Query: 402 YLHEECERQIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTMGYLAPEY 450
           +LH      II+RD+K  NILLD E + KL DF           +A    GT+ Y+APE 
Sbjct: 141 HLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 197
Query: 451 VYSGVPSEKTDVYSFGVVALEVAAGKSP 478
           V     ++  D +SFGV+  E+  G  P
Sbjct: 198 VNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 84/199 (42%), Gaps = 24/199 (12%)
Query: 292 VGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATM--AGCLRHKNLVQL 348
           +G GA  TVYK   P SG  VA+K    PN  E        E A +       H N+V+L
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 349 QGWCCEGN-----ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
              C         ++ LV+E++     D   + + +    L  E   +++      L +L
Sbjct: 72  MDVCATSRTDREIKVTLVFEHVDQ---DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFL 128
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF---------EATIP-AGTMGYLAPEYVYS 453
           H  C   I+HRD+K  NIL+ +    KL DF          A  P   T+ Y APE +  
Sbjct: 129 HANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVVTLWYRAPEVLLQ 185
Query: 454 GVPSEKTDVYSFGVVALEV 472
              +   D++S G +  E+
Sbjct: 186 STYATPVDMWSVGCIFAEM 204

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 97/215 (45%), Gaps = 30/215 (13%)
Query: 286 FNKNRIVGEGASATVYKGS-LPSGGAVAVKRFEKPNRVECA--RNPFTTEFATMAGCLRH 342
           F K +++  GA  TVYKG  +P G  V +    K  R   +   N    + A +   + +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 343 KNLVQLQGWCCEGNELVLVYEYLPNGSLDKILH---NNSSSSIVLSWEKRLNIVLGVASA 399
            ++ +L G C     + L+ + +P G L   +    +N  S  +L+W       + +A  
Sbjct: 84  PHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 136
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGT-------------MGYL 446
           ++YL +   R+++HRD+ A N+L+    + K+ DF      G              + ++
Sbjct: 137 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 193
Query: 447 APEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVD 480
           A E +   + + ++DV+S+GV   E+   G  P D
Sbjct: 194 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 90/211 (42%), Gaps = 16/211 (7%)
Query: 286 FNKNRIVGEGASATVY-KGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F + + +G G+   V     + +G   A+K  +K   V+  +   T     +   +    
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           LV+L+    + + L +V EY+P G +   L      S   +      IVL       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEYLH 158
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGVP 456
                 +I+RD+K  N+L+D +   K+ DF              GT  YLAPE + S   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 457 SEKTDVYSFGVVALEVAAGKSPVDNDGCVIV 487
           ++  D ++ GV+  E+AAG  P   D  + +
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 68/248 (27%), Positives = 104/248 (41%), Gaps = 53/248 (21%)
Query: 262 DHVCTV---QRVPMRLALTDIKQATLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEK 318
           DH CT      +P  +  T  +Q TL       VG+G    V++GS   G  VAVK F  
Sbjct: 16  DHSCTSGSGSGLPFLVQRTVARQITLL----ECVGKGRYGEVWRGSW-QGENVAVKIFSS 70
Query: 319 PNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE-------GNELVLVYEYLPNGSLD 371
            +     R   T  + T+   LRH+N++   G+            +L L+  Y   GSL 
Sbjct: 71  RDEKSWFRE--TELYNTVM--LRHENIL---GFIASDMTSRHSSTQLWLITHYHEMGSLY 123
Query: 372 KILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC-----ERQIIHRDVKACNILLDAE 426
             L   +  ++       L IVL +AS L++LH E      +  I HRD+K+ NIL+   
Sbjct: 124 DYLQLTTLDTVSC-----LRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKN 178
Query: 427 FNAKLGDFEATI---------------PAGTMGYLAPEYVYSGVPSE------KTDVYSF 465
               + D    +                 GT  Y+APE +   +  +      + D+++F
Sbjct: 179 GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAF 238
Query: 466 GVVALEVA 473
           G+V  EVA
Sbjct: 239 GLVLWEVA 246

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 123/291 (42%), Gaps = 64/291 (21%)
Query: 290 RIVGEGA-----SATVYKGSLPSGGA--VAVKRF-EKPNRVECARNPFTTEFATMAGCLR 341
           +++G GA     +AT Y G   +G +  VAVK   EK +  E  R    +E   M     
Sbjct: 51  KVLGSGAFGKVMNATAY-GISKTGVSIQVAVKMLKEKADSSE--REALMSELKMMTQLGS 107
Query: 342 HKNLVQLQGWCCEGNELVLVYEYLPNGSL-------------DKILHNNS------SSSI 382
           H+N+V L G C     + L++EY   G L             D+I + N           
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 383 VLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-------- 434
           VL++E  L     VA  + +L     +  +HRD+ A N+L+      K+ DF        
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224
Query: 435 --------EATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEV-AAGKSPVDNDGCV 485
                    A +P   + ++APE ++ G+ + K+DV+S+G++  E+ + G +P    G  
Sbjct: 225 DSNYVVRGNARLP---VKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY--PGIP 279
Query: 486 IVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPS 536
           +    + L + G  +D   +           E + ++  SC   +  KRPS
Sbjct: 280 VDANFYKLIQNGFKMDQPFY---------ATEEIYIIMQSCWAFDSRKRPS 321

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 72/158 (45%), Gaps = 26/158 (16%)
Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVAS 398
            RH ++++L        +  +V EY+  G L D I  +      V   E R  +   + S
Sbjct: 68  FRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGR----VEEMEAR-RLFQQILS 122
Query: 399 ALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT----------IPAGTMGYLAP 448
           A+ Y H      ++HRD+K  N+LLDA  NAK+ DF  +             G+  Y AP
Sbjct: 123 AVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAP 179
Query: 449 EYV----YSGVPSEKTDVYSFGVVALEVAAGKSPVDND 482
           E +    Y+G    + D++S GV+   +  G  P D++
Sbjct: 180 EVISGRLYAG---PEVDIWSCGVILYALLCGTLPFDDE 214

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 89/205 (43%), Gaps = 28/205 (13%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNR--VECARNPFTTEFATMAGCLRHKNLVQL- 348
           +G G+  TVYKG L +   V V   E  +R   +  R  F  E   + G L+H N+V+  
Sbjct: 34  IGRGSFKTVYKG-LDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKG-LQHPNIVRFY 91
Query: 349 QGW--CCEGNE-LVLVYEYLPNGSLDKILHNNSSSSI--VLSWEKRLNIVLGVASALSYL 403
             W    +G + +VLV E   +G+L   L       I  + SW ++      +   L +L
Sbjct: 92  DSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQ------ILKGLQFL 145
Query: 404 HEECERQIIHRDVKACNILLDAEF-NAKLGDFE---------ATIPAGTMGYLAPEYVYS 453
           H      IIHRD+K  NI +     + K+GD           A    GT  + APE  Y 
Sbjct: 146 HTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFXAPE-XYE 203
Query: 454 GVPSEKTDVYSFGVVALEVAAGKSP 478
               E  DVY+FG   LE A  + P
Sbjct: 204 EKYDESVDVYAFGXCXLEXATSEYP 228

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 93/214 (43%), Gaps = 20/214 (9%)
Query: 285 GFNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHK 343
            F K   +GEG    VYK  +  +G  VA+K+       E   +    E + +   L H 
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE-LNHP 61
Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
           N+V+L       N+L LV+E++ +  L   +  ++ + I L   K  + +  +   L++ 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHV-HQDLKTFMDASALTGIPLPLIK--SYLFQLLQGLAFC 118
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG-----------TMGYLAPEYVY 452
           H     +++HRD+K  N+L++ E   KL DF      G           T+ Y APE + 
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175
Query: 453 S-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV 485
                S   D++S G +  E+   ++    D  +
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 209

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 97/215 (45%), Gaps = 30/215 (13%)
Query: 286 FNKNRIVGEGASATVYKGS-LPSGGAVAVKRFEKPNRVECA--RNPFTTEFATMAGCLRH 342
           F K +++  GA  TVYKG  +P G  V +    K  R   +   N    + A +   + +
Sbjct: 17  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 343 KNLVQLQGWCCEGNELVLVYEYLPNGSLDKILH---NNSSSSIVLSWEKRLNIVLGVASA 399
            ++ +L G C     + L+ + +P G L   +    +N  S  +L+W       + +A  
Sbjct: 77  PHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 129
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGT-------------MGYL 446
           ++YL +   R+++HRD+ A N+L+    + K+ DF      G              + ++
Sbjct: 130 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 447 APEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVD 480
           A E +   + + ++DV+S+GV   E+   G  P D
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 90/200 (45%), Gaps = 26/200 (13%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVK--RFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           +GEG  ATVYKG S  +   VA+K  R E      C          ++   L+H N+V L
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCT----AIREVSLLKDLKHANIVTL 65
Query: 349 QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE 408
                    L LV+EYL +  L + L  +   +I+     +L  +  +   L+Y H +  
Sbjct: 66  HDIIHTEKSLTLVFEYL-DKDLKQYL--DDCGNIINMHNVKL-FLFQLLRGLAYCHRQ-- 119
Query: 409 RQIIHRDVKACNILLDAEFNAKLGDF----EATIPAG-------TMGYLAPEYVYSGVP- 456
            +++HRD+K  N+L++     KL DF      +IP         T+ Y  P+ +      
Sbjct: 120 -KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDY 178
Query: 457 SEKTDVYSFGVVALEVAAGK 476
           S + D++  G +  E+A G+
Sbjct: 179 STQIDMWGVGCIFYEMATGR 198

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 97/215 (45%), Gaps = 30/215 (13%)
Query: 286 FNKNRIVGEGASATVYKGS-LPSGGAVAVKRFEKPNRVECA--RNPFTTEFATMAGCLRH 342
           F K +++  GA  TVYKG  +P G  V +    K  R   +   N    + A +   + +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 343 KNLVQLQGWCCEGNELVLVYEYLPNGSLDKILH---NNSSSSIVLSWEKRLNIVLGVASA 399
            ++ +L G C     + L+ + +P G L   +    +N  S  +L+W       + +A  
Sbjct: 84  PHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 136
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGT-------------MGYL 446
           ++YL +   R+++HRD+ A N+L+    + K+ DF      G              + ++
Sbjct: 137 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 193
Query: 447 APEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVD 480
           A E +   + + ++DV+S+GV   E+   G  P D
Sbjct: 194 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 95/213 (44%), Gaps = 26/213 (12%)
Query: 287 NKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLV 346
           +K  I+G G    V+K    + G     +  K  R    +     E + M   L H NL+
Sbjct: 92  SKTEILGGGRFGQVHKCEETATGLKLAAKIIK-TRGMKDKEEVKNEISVM-NQLDHANLI 149
Query: 347 QLQGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
           QL       N++VLV EY+  G L D+I+      S  L+    +  +  +   + ++H+
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRII----DESYNLTELDTILFMKQICEGIRHMHQ 205
Query: 406 ECERQIIHRDVKACNILL---DAEFNAKLGDF----------EATIPAGTMGYLAPEYVY 452
                I+H D+K  NIL    DA+   K+ DF          +  +  GT  +LAPE V 
Sbjct: 206 ---MYILHLDLKPENILCVNRDAK-QIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVN 261
Query: 453 SGVPSEKTDVYSFGVVALEVAAGKSPV--DNDG 483
               S  TD++S GV+A  + +G SP   DND 
Sbjct: 262 YDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA 294

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 84/199 (42%), Gaps = 24/199 (12%)
Query: 292 VGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATM--AGCLRHKNLVQL 348
           +G GA  TVYK   P SG  VA+K    PN  E        E A +       H N+V+L
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 349 QGWCCEGN-----ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
              C         ++ LV+E++     D   + + +    L  E   +++      L +L
Sbjct: 72  MDVCATSRTDREIKVTLVFEHVDQ---DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFL 128
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF---------EATIP-AGTMGYLAPEYVYS 453
           H  C   I+HRD+K  NIL+ +    KL DF          A  P   T+ Y APE +  
Sbjct: 129 HANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVVTLWYRAPEVLLQ 185
Query: 454 GVPSEKTDVYSFGVVALEV 472
              +   D++S G +  E+
Sbjct: 186 STYATPVDMWSVGCIFAEM 204

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 70/150 (46%), Gaps = 26/150 (17%)
Query: 340 LRHKNLVQLQGWCCEGN---ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGV 396
           L H+++++ +G CCE      L LV EY+P GSL   L  +S     +   + L     +
Sbjct: 73  LYHEHIIKYKG-CCEDQGEKSLQLVMEYVPLGSLRDYLPRHS-----IGLAQLLLFAQQI 126
Query: 397 ASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--EATIPAGTMGY--------- 445
              ++YLH +     IHR++ A N+LLD +   K+GDF     +P G   Y         
Sbjct: 127 CEGMAYLHSQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 183
Query: 446 ---LAPEYVYSGVPSEKTDVYSFGVVALEV 472
               APE +        +DV+SFGV   E+
Sbjct: 184 VFWYAPECLKEYKFYYASDVWSFGVTLYEL 213

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 86/216 (39%), Gaps = 31/216 (14%)
Query: 290 RIVGEGASATV----YKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           +++G GA   V    +K S        + +FE   R + A   F  E   +        +
Sbjct: 81  KVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSA---FFWEERDIMAFANSPWV 137
Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
           VQL     +   L +V EY+P G L  ++ N     +   W K       V  AL  +H 
Sbjct: 138 VQLFCAFQDDKYLYMVMEYMPGGDLVNLMSN---YDVPEKWAKFYTA--EVVLALDAIHS 192
Query: 406 ECERQIIHRDVKACNILLDAEFNAKLGDFEATI------------PAGTMGYLAPEYVYS 453
                +IHRDVK  N+LLD   + KL DF   +              GT  Y++PE + S
Sbjct: 193 ---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKS 249
Query: 454 ----GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV 485
               G    + D +S GV   E+  G +P   D  V
Sbjct: 250 QGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV 285

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 36/106 (33%), Positives = 52/106 (49%), Gaps = 17/106 (16%)
Query: 391 NIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT----------IPA 440
            + + +  AL YL E+    +IHRDVK  NILLD     KL DF  +            A
Sbjct: 128 KMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA 185
Query: 441 GTMGYLAPEYVYSGVPSE-----KTDVYSFGVVALEVAAGKSPVDN 481
           G   Y+APE +    P++     + DV+S G+  +E+A G+ P  N
Sbjct: 186 GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN 231

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 70/262 (26%), Positives = 109/262 (41%), Gaps = 35/262 (13%)
Query: 288 KNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLV 346
           K++ +GEG+ +   K     S  A AVK   K  R+E        E   +  C  H N+V
Sbjct: 15  KDKPLGEGSFSICRKCVHKKSNQAFAVKIISK--RMEANTQ---KEITALKLCEGHPNIV 69
Query: 347 QLQGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
           +L     +     LV E L  G L ++I      S    S+     I+  + SA+S++H+
Sbjct: 70  KLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASY-----IMRKLVSAVSHMHD 124
Query: 406 ECERQIIHRDVKACNILLDAE---FNAKLGDF-----------EATIPAGTMGYLAPEYV 451
                ++HRD+K  N+L   E      K+ DF               P  T+ Y APE +
Sbjct: 125 ---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELL 181
Query: 452 YSGVPSEKTDVYSFGVVALEVAAGKSPVD-NDGCVIVDWVWNLRKKGKLLDAADFRLRGK 510
                 E  D++S GV+   + +G+ P   +D  +       + KK K     DF   G+
Sbjct: 182 NQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIK---KGDFSFEGE 238
Query: 511 F--NRKEMERMLMVGLSCVHPN 530
              N  +  + L+ GL  V PN
Sbjct: 239 AWKNVSQEAKDLIQGLLTVDPN 260

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 84/199 (42%), Gaps = 24/199 (12%)
Query: 292 VGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATM--AGCLRHKNLVQL 348
           +G GA  TVYK   P SG  VA+K    PN  E        E A +       H N+V+L
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 349 QGWCCEGN-----ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
              C         ++ LV+E++     D   + + +    L  E   +++      L +L
Sbjct: 72  MDVCATSRTDREIKVTLVFEHVDQ---DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFL 128
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF---------EATIP-AGTMGYLAPEYVYS 453
           H  C   I+HRD+K  NIL+ +    KL DF          A  P   T+ Y APE +  
Sbjct: 129 HANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVVTLWYRAPEVLLQ 185
Query: 454 GVPSEKTDVYSFGVVALEV 472
              +   D++S G +  E+
Sbjct: 186 STYATPVDMWSVGCIFAEM 204

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 85/205 (41%), Gaps = 25/205 (12%)
Query: 290 RIVGEGASATV-YKGSLPSGGAVAVKRFEKPNRVEC--ARNPFTTEFATMAGCLRHKNLV 346
           R +G+G+   V       +    A+K   K   VE    RN F  E   M G L H  LV
Sbjct: 21  RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFK-ELQIMQG-LEHPFLV 78
Query: 347 QLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEE 406
            L     +  ++ +V + L  G L   L  N    +    E     +  +  AL YL  +
Sbjct: 79  NLWYSFQDEEDMFMVVDLLLGGDLRYHLQQN----VHFKEETVKLFICELVMALDYLQNQ 134
Query: 407 CERQIIHRDVKACNILLDAEFNAKLGDF----------EATIPAGTMGYLAPEYVYS--- 453
              +IIHRD+K  NILLD   +  + DF          + T  AGT  Y+APE   S   
Sbjct: 135 ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKG 191
Query: 454 GVPSEKTDVYSFGVVALEVAAGKSP 478
              S   D +S GV A E+  G+ P
Sbjct: 192 AGYSFAVDWWSLGVTAYELLRGRRP 216

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 70/150 (46%), Gaps = 26/150 (17%)
Query: 340 LRHKNLVQLQGWCCEGN---ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGV 396
           L H+++++ +G CCE      L LV EY+P GSL   L  +S     +   + L     +
Sbjct: 73  LYHEHIIKYKG-CCEDQGEKSLQLVMEYVPLGSLRDYLPRHS-----IGLAQLLLFAQQI 126
Query: 397 ASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--EATIPAGTMGY--------- 445
              ++YLH +     IHR++ A N+LLD +   K+GDF     +P G   Y         
Sbjct: 127 CEGMAYLHAQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 183
Query: 446 ---LAPEYVYSGVPSEKTDVYSFGVVALEV 472
               APE +        +DV+SFGV   E+
Sbjct: 184 VFWYAPECLKEYKFYYASDVWSFGVTLYEL 213

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 71/162 (43%), Gaps = 32/162 (19%)
Query: 337 AGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGV 396
           A  L  +N V+      + + L +  EY  N +L  ++H   S ++    ++   +   +
Sbjct: 69  AAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIH---SENLNQQRDEYWRLFRQI 125
Query: 397 ASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF---------------------- 434
             ALSY+H +    IIHRD+K  NI +D   N K+GDF                      
Sbjct: 126 LEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 435 ---EATIPAGTMGYLAPEYVY-SGVPSEKTDVYSFGVVALEV 472
                T   GT  Y+A E +  +G  +EK D+YS G++  E+
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM 224

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 72/158 (45%), Gaps = 26/158 (16%)
Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVAS 398
            RH ++++L        +  +V EY+  G L D I  +      V   E R  +   + S
Sbjct: 68  FRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGR----VEEMEAR-RLFQQILS 122
Query: 399 ALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT----------IPAGTMGYLAP 448
           A+ Y H      ++HRD+K  N+LLDA  NAK+ DF  +             G+  Y AP
Sbjct: 123 AVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAP 179
Query: 449 EYV----YSGVPSEKTDVYSFGVVALEVAAGKSPVDND 482
           E +    Y+G    + D++S GV+   +  G  P D++
Sbjct: 180 EVISGRLYAG---PEVDIWSCGVILYALLCGTLPFDDE 214

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 63/130 (48%), Gaps = 20/130 (15%)
Query: 357 ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDV 416
           EL LV EYLP+G L   L  + +    L   + L     +   + YL     R+ +HRD+
Sbjct: 84  ELRLVMEYLPSGCLRDFLQRHRAR---LDASRLLLYSSQICKGMEYLGS---RRCVHRDL 137
Query: 417 KACNILLDAEFNAKLGDF--EATIP------------AGTMGYLAPEYVYSGVPSEKTDV 462
            A NIL+++E + K+ DF     +P               + + APE +   + S ++DV
Sbjct: 138 AARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNIFSRQSDV 197
Query: 463 YSFGVVALEV 472
           +SFGVV  E+
Sbjct: 198 WSFGVVLYEL 207

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 77/171 (45%), Gaps = 31/171 (18%)
Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASA 399
           LRH ++++L        ++V+V EY      D I+         ++ ++       +  A
Sbjct: 66  LRHPHIIKLYDVITTPTDIVMVIEYAGGELFDYIVEKKR-----MTEDEGRRFFQQIICA 120
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT----------IPAGTMGYLAPE 449
           + Y H     +I+HRD+K  N+LLD   N K+ DF  +             G+  Y APE
Sbjct: 121 IEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPE 177
Query: 450 YV----YSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKK 496
            +    Y+G    + DV+S G+V   +  G+ P D+      +++ NL KK
Sbjct: 178 VINGKLYAG---PEVDVWSCGIVLYVMLVGRLPFDD------EFIPNLFKK 219

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 89/208 (42%), Gaps = 29/208 (13%)
Query: 292 VGEGASATVYKGSLPSGGA-VAVKRFEKPNRVECARNPFTTEFATMAGCLR---HKNLVQ 347
           +G G    V+ G L +    VAVK        E        +F   A  L+   H N+V+
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCR-----ETLPPDLKAKFLQEARILKQYSHPNIVR 176
Query: 348 LQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC 407
           L G C +   + +V E +  G     L    +    L  +  L +V   A+ + YL  +C
Sbjct: 177 LIGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR---LRVKTLLQMVGDAAAGMEYLESKC 233
Query: 408 ERQIIHRDVKACNILLDAEFNAKLGDFEAT------IPAGTMG-------YLAPEYVYSG 454
               IHRD+ A N L+  +   K+ DF  +      + A + G       + APE +  G
Sbjct: 234 ---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYG 290
Query: 455 VPSEKTDVYSFGVVALEV-AAGKSPVDN 481
             S ++DV+SFG++  E  + G SP  N
Sbjct: 291 RYSSESDVWSFGILLWETFSLGASPYPN 318

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 22/210 (10%)
Query: 278 DIKQATLGFNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEF--A 334
           D+K     + K   +GEG  ATVYK     +   VA+K+ +  +R E       T     
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 335 TMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVL 394
            +   L H N++ L       + + LV++++    L+ I+ +NS   +VL+       +L
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNS---LVLTPSHIKAYML 119
Query: 395 GVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG-----------TM 443
                L YLH+     I+HRD+K  N+LLD     KL DF      G           T 
Sbjct: 120 MTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTR 176
Query: 444 GYLAPEYVYSG-VPSEKTDVYSFGVVALEV 472
            Y APE ++   +     D+++ G +  E+
Sbjct: 177 WYRAPELLFGARMYGVGVDMWAVGCILAEL 206

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 87/221 (39%), Gaps = 47/221 (21%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKP-NRVECAR-------------NPFTTEFATM 336
           +G GA   V K   +PSG   AVKR     N  E  R              PFT  F   
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFTVTF--Y 99
Query: 337 AGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGV 396
               R  ++     W C           L + SLDK           +  +    I + +
Sbjct: 100 GALFREGDV-----WICXE---------LXDTSLDKFYKQVIDKGQTIPEDILGKIAVSI 145
Query: 397 ASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT----------IPAGTMGYL 446
             AL +LH +    +IHRDVK  N+L++A    K  DF  +          I AG   Y 
Sbjct: 146 VKALEHLHSKL--SVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKPYX 203
Query: 447 APEYVYSGVP----SEKTDVYSFGVVALEVAAGKSPVDNDG 483
           APE +   +     S K+D++S G+  +E+A  + P D+ G
Sbjct: 204 APERINPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWG 244

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 90/211 (42%), Gaps = 16/211 (7%)
Query: 286 FNKNRIVGEGASATVYK-GSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F + + +G G+   V     + +G   A+K  +K   V+  +   T     +   +    
Sbjct: 29  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 88
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           LV+L+    + + L +V EY+P G +   L      S   +      IVL       YLH
Sbjct: 89  LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEYLH 144
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGVP 456
                 +I+RD+K  N+L+D +   ++ DF              GT  YLAPE + S   
Sbjct: 145 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEYLAPEIILSKGY 201
Query: 457 SEKTDVYSFGVVALEVAAGKSPVDNDGCVIV 487
           ++  D ++ GV+  E+AAG  P   D  + +
Sbjct: 202 NKAVDWWALGVLIYEMAAGYPPFFADQPIQI 232

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 88/211 (41%), Gaps = 16/211 (7%)
Query: 286 FNKNRIVGEGASATVYK-GSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F + R +G G+   V       +G   A+K  +K   V+  +   T     +   +    
Sbjct: 44  FERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNFPF 103
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           LV+L+    + + L +V EY P G +   L      S   +      IVL       YLH
Sbjct: 104 LVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEYLH 159
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGVP 456
                 +I+RD+K  N+L+D +   K+ DF              GT  YLAPE + S   
Sbjct: 160 S---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 457 SEKTDVYSFGVVALEVAAGKSPVDNDGCVIV 487
           ++  D ++ GV+  E+AAG  P   D  + +
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPFFADQPIQI 247

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 72/159 (45%), Gaps = 17/159 (10%)
Query: 334 ATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIV 393
           A++   L+H ++V+L         L +V+E++    L   +   + +  V S     + +
Sbjct: 77  ASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYM 136
Query: 394 LGVASALSYLHEECERQIIHRDVKACNILLDAEFNA---KLGDFEATIPAGTMG------ 444
             +  AL Y H   +  IIHRDVK  N+LL ++ N+   KLGDF   I  G  G      
Sbjct: 137 RQILEALRYCH---DNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGR 193
Query: 445 -----YLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSP 478
                ++APE V      +  DV+  GV+   + +G  P
Sbjct: 194 VGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 85/202 (42%), Gaps = 27/202 (13%)
Query: 292 VGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARN-PFTT--EFATM--AGCLRHKNL 345
           +G GA  TVYK   P SG  VA+K    PN        P +T  E A +       H N+
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 346 VQLQGWCCEGN-----ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASAL 400
           V+L   C         ++ LV+E++     D   + + +    L  E   +++      L
Sbjct: 77  VRLMDVCATSRTDREIKVTLVFEHVDQ---DLRTYLDKAPPPGLPAETIKDLMRQFLRGL 133
Query: 401 SYLHEECERQIIHRDVKACNILLDAEFNAKLGDF----------EATIPAGTMGYLAPEY 450
            +LH  C   I+HRD+K  NIL+ +    KL DF            T    T+ Y APE 
Sbjct: 134 DFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEV 190
Query: 451 VYSGVPSEKTDVYSFGVVALEV 472
           +     +   D++S G +  E+
Sbjct: 191 LLQSTYATPVDMWSVGCIFAEM 212

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/137 (32%), Positives = 66/137 (48%), Gaps = 26/137 (18%)
Query: 353 CEG-----NELVLVYEYLPNGSLDK------ILHNNSSSSIVLSWEKRLNIVLGVASALS 401
           CEG     +E+ ++YEY+ N S+ K      +L  N +  I +   K   I+  V ++ S
Sbjct: 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKC--IIKSVLNSFS 165
Query: 402 YLHEECERQIIHRDVKACNILLDAEFNAKLGDF---EATIPA------GTMGYLAPEYV- 451
           Y+H E  + I HRDVK  NIL+D     KL DF   E  +        GT  ++ PE+  
Sbjct: 166 YIHNE--KNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFS 223
Query: 452 -YSGVPSEKTDVYSFGV 467
             S     K D++S G+
Sbjct: 224 NESSYNGAKVDIWSLGI 240

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 66/152 (43%), Gaps = 18/152 (11%)
Query: 341 RHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASAL 400
           RH  L  L+      + L  V EY   G L    H   S   V + E+       + SAL
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFH--LSRERVFTEERARFYGAEIVSAL 118
Query: 401 SYLHEECERQIIHRDVKACNILLDAEFNAKLGDF---------EATIPA--GTMGYLAPE 449
            YLH    R +++RD+K  N++LD + + K+ DF          AT+    GT  YLAPE
Sbjct: 119 EYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 175
Query: 450 YVYSGVPSEKTDVYSFGVVALEVAAGKSPVDN 481
            +         D +  GVV  E+  G+ P  N
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 207

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 66/152 (43%), Gaps = 18/152 (11%)
Query: 341 RHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASAL 400
           RH  L  L+      + L  V EY   G L    H   S   V + E+       + SAL
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFH--LSRERVFTEERARFYGAEIVSAL 118
Query: 401 SYLHEECERQIIHRDVKACNILLDAEFNAKLGDF---------EATIPA--GTMGYLAPE 449
            YLH    R +++RD+K  N++LD + + K+ DF          AT+    GT  YLAPE
Sbjct: 119 EYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 175
Query: 450 YVYSGVPSEKTDVYSFGVVALEVAAGKSPVDN 481
            +         D +  GVV  E+  G+ P  N
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 207

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 89/208 (42%), Gaps = 29/208 (13%)
Query: 292 VGEGASATVYKGSLPSGGA-VAVKRFEKPNRVECARNPFTTEFATMAGCLR---HKNLVQ 347
           +G G    V+ G L +    VAVK        E        +F   A  L+   H N+V+
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCR-----ETLPPDLKAKFLQEARILKQYSHPNIVR 176
Query: 348 LQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC 407
           L G C +   + +V E +  G     L    +    L  +  L +V   A+ + YL  +C
Sbjct: 177 LIGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR---LRVKTLLQMVGDAAAGMEYLESKC 233
Query: 408 ERQIIHRDVKACNILLDAEFNAKLGDFEAT------IPAGTMG-------YLAPEYVYSG 454
               IHRD+ A N L+  +   K+ DF  +      + A + G       + APE +  G
Sbjct: 234 ---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYG 290
Query: 455 VPSEKTDVYSFGVVALEV-AAGKSPVDN 481
             S ++DV+SFG++  E  + G SP  N
Sbjct: 291 RYSSESDVWSFGILLWETFSLGASPYPN 318

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 66/152 (43%), Gaps = 18/152 (11%)
Query: 341 RHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASAL 400
           RH  L  L+      + L  V EY   G L    H   S   V + E+       + SAL
Sbjct: 66  RHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFH--LSRERVFTEERARFYGAEIVSAL 121
Query: 401 SYLHEECERQIIHRDVKACNILLDAEFNAKLGDF---------EATIPA--GTMGYLAPE 449
            YLH    R +++RD+K  N++LD + + K+ DF          AT+    GT  YLAPE
Sbjct: 122 EYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 178
Query: 450 YVYSGVPSEKTDVYSFGVVALEVAAGKSPVDN 481
            +         D +  GVV  E+  G+ P  N
Sbjct: 179 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 210

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 101/228 (44%), Gaps = 28/228 (12%)
Query: 271 PMRLALTDIKQATLGFNKNRIVGEGASATVYKGS-LPSGGAVAVK---RFEKPNRVECAR 326
           P +  L  +K+  L   K +++G GA  TVYKG  +P G  V +    +  + N    A 
Sbjct: 6   PNQALLRILKETEL--RKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN 63
Query: 327 NPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSW 386
                E   MAG +    + +L G C     + LV + +P G L   +  N      L  
Sbjct: 64  KEILDEAYVMAG-VGSPYVSRLLGICLTST-VQLVTQLMPYGCLLDHVRENRGR---LGS 118
Query: 387 EKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-----------E 435
           +  LN  + +A  +SYL +    +++HRD+ A N+L+ +  + K+ DF           E
Sbjct: 119 QDLLNWCMQIAKGMSYLEDV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE 175
Query: 436 ATIPAGT--MGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVD 480
                G   + ++A E +     + ++DV+S+GV   E+   G  P D
Sbjct: 176 YHADGGKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKPYD 223

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 93/209 (44%), Gaps = 23/209 (11%)
Query: 286 FNKNRIVGEGASATVYK----GSLPSGGAVAVKRFEKPNRVECARNPFTTEFA-TMAGCL 340
           F   R++G+G    V++        +G   A+K  +K   V  A++   T+    +   +
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 341 RHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASAL 400
           +H  +V L      G +L L+ EYL  G L   L        +   +     +  ++ AL
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREG----IFMEDTACFYLAEISMAL 134
Query: 401 SYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIP---AGTMGYLAPE 449
            +LH+   + II+RD+K  NI+L+ + + KL DF        + T+     GT+ Y+APE
Sbjct: 135 GHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPE 191
Query: 450 YVYSGVPSEKTDVYSFGVVALEVAAGKSP 478
            +     +   D +S G +  ++  G  P
Sbjct: 192 ILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 50/223 (22%)
Query: 287 NKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFT--TEFATMAGCLR--- 341
           + +R++G+G    VY G             +  NR++CA    +  TE   +   LR   
Sbjct: 24  HSDRVIGKGHFGVVYHGEYID---------QAQNRIQCAIKSLSRITEMQQVEAFLREGL 74
Query: 342 ------HKNLVQLQGWCC--EGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIV 393
                 H N++ L G     EG   VL+  Y+ +G L + + +   +  V   +  ++  
Sbjct: 75  LMRGLNHPNVLALIGIMLPPEGLPHVLL-PYMCHGDLLQFIRSPQRNPTV---KDLISFG 130
Query: 394 LGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF------------------E 435
           L VA  + YL    E++ +HRD+ A N +LD  F  K+ DF                   
Sbjct: 131 LQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRH 187
Query: 436 ATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSP 478
           A +P   + + A E + +   + K+DV+SFGV+  E+    +P
Sbjct: 188 ARLP---VKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAP 227

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 66/152 (43%), Gaps = 18/152 (11%)
Query: 341 RHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASAL 400
           RH  L  L+      + L  V EY   G L    H   S   V + E+       + SAL
Sbjct: 68  RHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFH--LSRERVFTEERARFYGAEIVSAL 123
Query: 401 SYLHEECERQIIHRDVKACNILLDAEFNAKLGDF---------EATIPA--GTMGYLAPE 449
            YLH    R +++RD+K  N++LD + + K+ DF          AT+    GT  YLAPE
Sbjct: 124 EYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPE 180
Query: 450 YVYSGVPSEKTDVYSFGVVALEVAAGKSPVDN 481
            +         D +  GVV  E+  G+ P  N
Sbjct: 181 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 212

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 93/209 (44%), Gaps = 23/209 (11%)
Query: 286 FNKNRIVGEGASATVYK----GSLPSGGAVAVKRFEKPNRVECARNPFTTEFA-TMAGCL 340
           F   R++G+G    V++        +G   A+K  +K   V  A++   T+    +   +
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 341 RHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASAL 400
           +H  +V L      G +L L+ EYL  G L   L        +   +     +  ++ AL
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREG----IFMEDTACFYLAEISMAL 134
Query: 401 SYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIP---AGTMGYLAPE 449
            +LH+   + II+RD+K  NI+L+ + + KL DF        + T+     GT+ Y+APE
Sbjct: 135 GHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPE 191
Query: 450 YVYSGVPSEKTDVYSFGVVALEVAAGKSP 478
            +     +   D +S G +  ++  G  P
Sbjct: 192 ILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 66/152 (43%), Gaps = 18/152 (11%)
Query: 341 RHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASAL 400
           RH  L  L+      + L  V EY   G L    H   S   V + E+       + SAL
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFH--LSRERVFTEERARFYGAEIVSAL 118
Query: 401 SYLHEECERQIIHRDVKACNILLDAEFNAKLGDF---------EATIPA--GTMGYLAPE 449
            YLH    R +++RD+K  N++LD + + K+ DF          AT+    GT  YLAPE
Sbjct: 119 EYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPE 175
Query: 450 YVYSGVPSEKTDVYSFGVVALEVAAGKSPVDN 481
            +         D +  GVV  E+  G+ P  N
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 207

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 92/215 (42%), Gaps = 46/215 (21%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           VG+G    V++GS   G  VAVK F   +     R   T  + T+   LRH+N++   G+
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRE--TELYNTVM--LRHENIL---GF 67
Query: 352 CCE-------GNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
                       +L L+  Y   GSL   L   +  ++       L IVL +AS L++LH
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSC-----LRIVLSIASGLAHLH 122
Query: 405 EEC-----ERQIIHRDVKACNILLDAEFNAKLGDFEATI---------------PAGTMG 444
            E      +  I HRD+K+ NIL+       + D    +                 GT  
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182
Query: 445 YLAPEYVYSGVPSE------KTDVYSFGVVALEVA 473
           Y+APE +   +  +      + D+++FG+V  EVA
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 90/211 (42%), Gaps = 16/211 (7%)
Query: 286 FNKNRIVGEGASATVYK-GSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F + + +G G+   V     + +G   A+K  +K   V+  +   T     +   +    
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           LV+L+    + + L +V EY+P G +   L      S   +      IVL       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEYLH 158
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGVP 456
                 +I+RD+K  N+L+D +   ++ DF              GT  YLAPE + S   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 457 SEKTDVYSFGVVALEVAAGKSPVDNDGCVIV 487
           ++  D ++ GV+  E+AAG  P   D  + +
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 90/211 (42%), Gaps = 16/211 (7%)
Query: 286 FNKNRIVGEGASATVY-KGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F + + +G G+   V     + +G   A+K  +K   V+  +   T     +   +    
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           LV+L+    + + L +V EY+P G +   L      S   +      IVL       YLH
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEYLH 159
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGVP 456
                 +I+RD+K  N+L+D +   ++ DF              GT  YLAPE + S   
Sbjct: 160 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEYLAPEIILSKGY 216
Query: 457 SEKTDVYSFGVVALEVAAGKSPVDNDGCVIV 487
           ++  D ++ GV+  E+AAG  P   D  + +
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPFFADQPIQI 247

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 90/227 (39%), Gaps = 25/227 (11%)
Query: 276 LTDIKQATLGFNKNRIVGEGASATVYKGSLPSGGAV-AVKRFEKPNRVECARNPFTTEFA 334
           + D++     +   +++G GA   V      S   V A+K   K   ++ + + F  E  
Sbjct: 61  IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 120
Query: 335 TMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVL 394
            +        +VQL     +   L +V EY+P G L  ++ N     +   W +      
Sbjct: 121 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFY--TA 175
Query: 395 GVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI------------PAGT 442
            V  AL  +H       IHRDVK  N+LLD   + KL DF   +              GT
Sbjct: 176 EVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGT 232
Query: 443 MGYLAPEYVYS----GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV 485
             Y++PE + S    G    + D +S GV   E+  G +P   D  V
Sbjct: 233 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 279

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 92/215 (42%), Gaps = 46/215 (21%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           VG+G    V++GS   G  VAVK F   +     R   T  + T+   LRH+N++   G+
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRE--TELYNTVM--LRHENIL---GF 67
Query: 352 CCE-------GNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
                       +L L+  Y   GSL   L   +  ++       L IVL +AS L++LH
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSC-----LRIVLSIASGLAHLH 122
Query: 405 EEC-----ERQIIHRDVKACNILLDAEFNAKLGDFEATI---------------PAGTMG 444
            E      +  I HRD+K+ NIL+       + D    +                 GT  
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182
Query: 445 YLAPEYVYSGVPSE------KTDVYSFGVVALEVA 473
           Y+APE +   +  +      + D+++FG+V  EVA
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 97/221 (43%), Gaps = 48/221 (21%)
Query: 291 IVGEGASATVYKG-SLPSGGAVAVKRFEK-PNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           ++GEGA A V    +L +    AVK  EK P  +   R+    E   +  C  H+N+++L
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHI---RSRVFREVEMLYQCQGHRNVLEL 76
Query: 349 QGWCCEGNELVLVYEYLPNGSLDKILH-----NNSSSSIVLSWEKRLNIVLGVASALSYL 403
             +  E +   LV+E +  GS+   +H     N   +S+V         V  VASAL +L
Sbjct: 77  IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVV---------VQDVASALDFL 127
Query: 404 HEECERQIIHRDVKACNILLDAEFN---AKLGDF------------------EATIPAGT 442
           H    + I HRD+K  NIL +        K+ DF                  E   P G+
Sbjct: 128 H---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGS 184
Query: 443 MGYLAPEYV-----YSGVPSEKTDVYSFGVVALEVAAGKSP 478
             Y+APE V      + +  ++ D++S GV+   + +G  P
Sbjct: 185 AEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 90/211 (42%), Gaps = 16/211 (7%)
Query: 286 FNKNRIVGEGASATVY-KGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F + + +G G+   V     + +G   A+K  +K   V+  +   T     +   +    
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           LV+L+    + + L +V EY+P G +   L      S   +      IVL       YLH
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEYLH 159
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGVP 456
                 +I+RD+K  N+L+D +   ++ DF              GT  YLAPE + S   
Sbjct: 160 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 457 SEKTDVYSFGVVALEVAAGKSPVDNDGCVIV 487
           ++  D ++ GV+  E+AAG  P   D  + +
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPFFADQPIQI 247

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 67/152 (44%), Gaps = 17/152 (11%)
Query: 341 RHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASAL 400
           RH  L  L+      + L  V EY   G L    H   S   V S ++       + SAL
Sbjct: 206 RHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFH--LSRERVFSEDRARFYGAEIVSAL 261
Query: 401 SYLHEECERQIIHRDVKACNILLDAEFNAKLGDF---------EATIPA--GTMGYLAPE 449
            YLH   E+ +++RD+K  N++LD + + K+ DF          AT+    GT  YLAPE
Sbjct: 262 DYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPE 319
Query: 450 YVYSGVPSEKTDVYSFGVVALEVAAGKSPVDN 481
            +         D +  GVV  E+  G+ P  N
Sbjct: 320 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 351

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 90/227 (39%), Gaps = 25/227 (11%)
Query: 276 LTDIKQATLGFNKNRIVGEGASATVYKGSLPSGGAV-AVKRFEKPNRVECARNPFTTEFA 334
           + D++     +   +++G GA   V      S   V A+K   K   ++ + + F  E  
Sbjct: 66  IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 125
Query: 335 TMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVL 394
            +        +VQL     +   L +V EY+P G L  ++ N     +   W +      
Sbjct: 126 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTA-- 180
Query: 395 GVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI------------PAGT 442
            V  AL  +H       IHRDVK  N+LLD   + KL DF   +              GT
Sbjct: 181 EVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGT 237
Query: 443 MGYLAPEYVYS----GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV 485
             Y++PE + S    G    + D +S GV   E+  G +P   D  V
Sbjct: 238 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 284

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/237 (24%), Positives = 95/237 (40%), Gaps = 60/237 (25%)
Query: 280 KQATLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGC 339
           K+  + F +  ++G G    V+K      G   V R  K N  +  R     E   +A  
Sbjct: 8   KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAER-----EVKALAK- 61
Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHN--------NSSSS---------- 381
           L H N+V   G C +G      ++Y P  S D +  +        NSS S          
Sbjct: 62  LDHVNIVHYNG-CWDG------FDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQME 114
Query: 382 -----IVLSW-EKR----------LNIVLGVASALSYLHEECERQIIHRDVKACNILLDA 425
                 +  W EKR          L +   +   + Y+H    +++IHRD+K  NI L  
Sbjct: 115 FCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS---KKLIHRDLKPSNIFLVD 171
Query: 426 EFNAKLGDF----------EATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEV 472
               K+GDF          + T   GT+ Y++PE + S    ++ D+Y+ G++  E+
Sbjct: 172 TKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAEL 228

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 66/152 (43%), Gaps = 18/152 (11%)
Query: 341 RHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASAL 400
           RH  L  L+      + L  V EY   G L    H   S   V + E+       + SAL
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFH--LSRERVFTEERARFYGAEIVSAL 118
Query: 401 SYLHEECERQIIHRDVKACNILLDAEFNAKLGDF---------EATIPA--GTMGYLAPE 449
            YLH    R +++RD+K  N++LD + + K+ DF          AT+    GT  YLAPE
Sbjct: 119 EYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPE 175
Query: 450 YVYSGVPSEKTDVYSFGVVALEVAAGKSPVDN 481
            +         D +  GVV  E+  G+ P  N
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 207

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 90/211 (42%), Gaps = 16/211 (7%)
Query: 286 FNKNRIVGEGASATVYK-GSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F + + +G G+   V     + +G   A+K  +K   V+  +   T     +   +    
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           LV+L+    + + L +V EY+P G +   L      S   +      IVL       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEYLH 158
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGVP 456
                 +I+RD+K  N+L+D +   ++ DF              GT  YLAPE + S   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 457 SEKTDVYSFGVVALEVAAGKSPVDNDGCVIV 487
           ++  D ++ GV+  E+AAG  P   D  + +
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 67/152 (44%), Gaps = 17/152 (11%)
Query: 341 RHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASAL 400
           RH  L  L+      + L  V EY   G L    H   S   V S ++       + SAL
Sbjct: 209 RHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFH--LSRERVFSEDRARFYGAEIVSAL 264
Query: 401 SYLHEECERQIIHRDVKACNILLDAEFNAKLGDF---------EATIPA--GTMGYLAPE 449
            YLH   E+ +++RD+K  N++LD + + K+ DF          AT+    GT  YLAPE
Sbjct: 265 DYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPE 322
Query: 450 YVYSGVPSEKTDVYSFGVVALEVAAGKSPVDN 481
            +         D +  GVV  E+  G+ P  N
Sbjct: 323 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 354

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 66/152 (43%), Gaps = 18/152 (11%)
Query: 341 RHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASAL 400
           RH  L  L+      + L  V EY   G L    H   S   V + E+       + SAL
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFH--LSRERVFTEERARFYGAEIVSAL 118
Query: 401 SYLHEECERQIIHRDVKACNILLDAEFNAKLGDF---------EATIPA--GTMGYLAPE 449
            YLH    R +++RD+K  N++LD + + K+ DF          AT+    GT  YLAPE
Sbjct: 119 EYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPE 175
Query: 450 YVYSGVPSEKTDVYSFGVVALEVAAGKSPVDN 481
            +         D +  GVV  E+  G+ P  N
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 207

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 90/227 (39%), Gaps = 25/227 (11%)
Query: 276 LTDIKQATLGFNKNRIVGEGASATVYKGSLPSGGAV-AVKRFEKPNRVECARNPFTTEFA 334
           + D++     +   +++G GA   V      S   V A+K   K   ++ + + F  E  
Sbjct: 66  IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 125
Query: 335 TMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVL 394
            +        +VQL     +   L +V EY+P G L  ++ N     +   W +      
Sbjct: 126 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFY--TA 180
Query: 395 GVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI------------PAGT 442
            V  AL  +H       IHRDVK  N+LLD   + KL DF   +              GT
Sbjct: 181 EVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGT 237
Query: 443 MGYLAPEYVYS----GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV 485
             Y++PE + S    G    + D +S GV   E+  G +P   D  V
Sbjct: 238 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 284

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 90/211 (42%), Gaps = 16/211 (7%)
Query: 286 FNKNRIVGEGASATVYK-GSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F + + +G G+   V     + +G   A+K  +K   V+  +   T     +   +    
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           LV+L+    + + L +V EY+P G +   L      S   +      IVL       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEYLH 158
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGVP 456
                 +I+RD+K  N+L+D +   ++ DF              GT  YLAPE + S   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 457 SEKTDVYSFGVVALEVAAGKSPVDNDGCVIV 487
           ++  D ++ GV+  E+AAG  P   D  + +
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 67/152 (44%), Gaps = 17/152 (11%)
Query: 341 RHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASAL 400
           RH  L  L+      + L  V EY   G L    H   S   V S ++       + SAL
Sbjct: 68  RHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFH--LSRERVFSEDRARFYGAEIVSAL 123
Query: 401 SYLHEECERQIIHRDVKACNILLDAEFNAKLGDF---------EATIPA--GTMGYLAPE 449
            YLH   E+ +++RD+K  N++LD + + K+ DF          AT+    GT  YLAPE
Sbjct: 124 DYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPE 181
Query: 450 YVYSGVPSEKTDVYSFGVVALEVAAGKSPVDN 481
            +         D +  GVV  E+  G+ P  N
Sbjct: 182 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 213

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 97/221 (43%), Gaps = 48/221 (21%)
Query: 291 IVGEGASATVYKG-SLPSGGAVAVKRFEK-PNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           ++GEGA A V    +L +    AVK  EK P  +   R+    E   +  C  H+N+++L
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHI---RSRVFREVEMLYQCQGHRNVLEL 76
Query: 349 QGWCCEGNELVLVYEYLPNGSLDKILH-----NNSSSSIVLSWEKRLNIVLGVASALSYL 403
             +  E +   LV+E +  GS+   +H     N   +S+V         V  VASAL +L
Sbjct: 77  IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVV---------VQDVASALDFL 127
Query: 404 HEECERQIIHRDVKACNILLDAEFN---AKLGDF------------------EATIPAGT 442
           H    + I HRD+K  NIL +        K+ DF                  E   P G+
Sbjct: 128 H---NKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGS 184
Query: 443 MGYLAPEYV-----YSGVPSEKTDVYSFGVVALEVAAGKSP 478
             Y+APE V      + +  ++ D++S GV+   + +G  P
Sbjct: 185 AEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 67/152 (44%), Gaps = 17/152 (11%)
Query: 341 RHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASAL 400
           RH  L  L+      + L  V EY   G L    H   S   V S ++       + SAL
Sbjct: 67  RHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFH--LSRERVFSEDRARFYGAEIVSAL 122
Query: 401 SYLHEECERQIIHRDVKACNILLDAEFNAKLGDF---------EATIPA--GTMGYLAPE 449
            YLH   E+ +++RD+K  N++LD + + K+ DF          AT+    GT  YLAPE
Sbjct: 123 DYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPE 180
Query: 450 YVYSGVPSEKTDVYSFGVVALEVAAGKSPVDN 481
            +         D +  GVV  E+  G+ P  N
Sbjct: 181 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 212

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 94/222 (42%), Gaps = 35/222 (15%)
Query: 286 FNKNRIVGEGASATVYK----GSLPSGGAVAVKRFEKPNRVECARNPFTTEFA-TMAGCL 340
           F   +++G GA   V+         +G   A+K  +K   V+ A+   TTE   T    L
Sbjct: 56  FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAK---TTEHTRTERQVL 112
Query: 341 RHKN----LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLG- 395
            H      LV L        +L L+ +Y+  G L   L      +     E  + I +G 
Sbjct: 113 EHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFT-----EHEVQIYVGE 167
Query: 396 VASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF------------EATIPAGTM 443
           +  AL +LH+     II+RD+K  NILLD+  +  L DF             A    GT+
Sbjct: 168 IVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTI 224
Query: 444 GYLAPEYVYSGVP--SEKTDVYSFGVVALEVAAGKSPVDNDG 483
            Y+AP+ V  G     +  D +S GV+  E+  G SP   DG
Sbjct: 225 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG 266

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 67/152 (44%), Gaps = 17/152 (11%)
Query: 341 RHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASAL 400
           RH  L  L+      + L  V EY   G L    H   S   V S ++       + SAL
Sbjct: 66  RHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFH--LSRERVFSEDRARFYGAEIVSAL 121
Query: 401 SYLHEECERQIIHRDVKACNILLDAEFNAKLGDF---------EATIPA--GTMGYLAPE 449
            YLH   E+ +++RD+K  N++LD + + K+ DF          AT+    GT  YLAPE
Sbjct: 122 DYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPE 179
Query: 450 YVYSGVPSEKTDVYSFGVVALEVAAGKSPVDN 481
            +         D +  GVV  E+  G+ P  N
Sbjct: 180 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 211

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 89/211 (42%), Gaps = 16/211 (7%)
Query: 286 FNKNRIVGEGASATVYK-GSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F + + +G G+   V     + +G   A+K  +K   V+  +   T     +   +    
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           LV+L+    + + L +V EY P G +   L      S   +      IVL       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEYLH 158
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGVP 456
                 +I+RD+K  N+++D +   K+ DF              GT  YLAPE + S   
Sbjct: 159 S---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 457 SEKTDVYSFGVVALEVAAGKSPVDNDGCVIV 487
           ++  D ++ GV+  E+AAG  P   D  + +
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 62/131 (47%), Gaps = 20/131 (15%)
Query: 356 NELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRD 415
             L LV EYLP+G L   L  + +    L   + L     +   + YL     R+ +HRD
Sbjct: 86  QSLRLVMEYLPSGCLRDFLQRHRAR---LDASRLLLYSSQICKGMEYLGS---RRCVHRD 139
Query: 416 VKACNILLDAEFNAKLGDF--EATIPAGTMGYL------------APEYVYSGVPSEKTD 461
           + A NIL+++E + K+ DF     +P     Y+            APE +   + S ++D
Sbjct: 140 LAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSD 199
Query: 462 VYSFGVVALEV 472
           V+SFGVV  E+
Sbjct: 200 VWSFGVVLYEL 210

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 69/287 (24%), Positives = 123/287 (42%), Gaps = 50/287 (17%)
Query: 293 GEGASATVYKGSLPSGGAVAVK-RFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           G+   AT Y G + S  A+ V  +  KP+     R    +E   ++    H N+V L G 
Sbjct: 37  GKVVEATAY-GLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGA 95
Query: 352 CCEGNELVLVYEYLPNGSL--------DKILHNNSSSSIV------LSWEKRLNIVLGVA 397
           C  G   +++ EY   G L        D  + + +S +I+      L  E  L+    VA
Sbjct: 96  CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVA 155
Query: 398 SALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF----------------EATIPAG 441
             +++L     +  IHRD+ A NILL      K+ DF                 A +P  
Sbjct: 156 KGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP-- 210
Query: 442 TMGYLAPEYVYSGVPSEKTDVYSFGVVALEV-AAGKSPVDNDGCVIVDWVWNLRKKGKLL 500
            + ++APE +++ V + ++DV+S+G+   E+ + G SP    G  +    + + K+G   
Sbjct: 211 -VKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY--PGMPVDSKFYKMIKEG--- 264
Query: 501 DAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE 547
               FR+           M  +  +C   +  KRP+ K+  ++++ +
Sbjct: 265 ----FRMLSP--EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 62/131 (47%), Gaps = 20/131 (15%)
Query: 356 NELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRD 415
             L LV EYLP+G L   L  + +    L   + L     +   + YL     R+ +HRD
Sbjct: 87  QSLRLVMEYLPSGCLRDFLQRHRAR---LDASRLLLYSSQICKGMEYLGS---RRCVHRD 140
Query: 416 VKACNILLDAEFNAKLGDF--EATIPAGTMGYL------------APEYVYSGVPSEKTD 461
           + A NIL+++E + K+ DF     +P     Y+            APE +   + S ++D
Sbjct: 141 LAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSD 200
Query: 462 VYSFGVVALEV 472
           V+SFGVV  E+
Sbjct: 201 VWSFGVVLYEL 211

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 62/131 (47%), Gaps = 20/131 (15%)
Query: 356 NELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRD 415
             L LV EYLP+G L   L  + +    L   + L     +   + YL     R+ +HRD
Sbjct: 99  QSLRLVMEYLPSGCLRDFLQRHRAR---LDASRLLLYSSQICKGMEYLGS---RRCVHRD 152
Query: 416 VKACNILLDAEFNAKLGDF--EATIPAGTMGYL------------APEYVYSGVPSEKTD 461
           + A NIL+++E + K+ DF     +P     Y+            APE +   + S ++D
Sbjct: 153 LAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSD 212
Query: 462 VYSFGVVALEV 472
           V+SFGVV  E+
Sbjct: 213 VWSFGVVLYEL 223

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 69/287 (24%), Positives = 123/287 (42%), Gaps = 50/287 (17%)
Query: 293 GEGASATVYKGSLPSGGAVAVK-RFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           G+   AT Y G + S  A+ V  +  KP+     R    +E   ++    H N+V L G 
Sbjct: 53  GKVVEATAY-GLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGA 111
Query: 352 CCEGNELVLVYEYLPNGSL--------DKILHNNSSSSIV------LSWEKRLNIVLGVA 397
           C  G   +++ EY   G L        D  + + +S +I+      L  E  L+    VA
Sbjct: 112 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVA 171
Query: 398 SALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF----------------EATIPAG 441
             +++L     +  IHRD+ A NILL      K+ DF                 A +P  
Sbjct: 172 KGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP-- 226
Query: 442 TMGYLAPEYVYSGVPSEKTDVYSFGVVALEV-AAGKSPVDNDGCVIVDWVWNLRKKGKLL 500
            + ++APE +++ V + ++DV+S+G+   E+ + G SP    G  +    + + K+G   
Sbjct: 227 -VKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY--PGMPVDSKFYKMIKEG--- 280
Query: 501 DAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE 547
               FR+           M  +  +C   +  KRP+ K+  ++++ +
Sbjct: 281 ----FRMLSP--EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 321

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 69/287 (24%), Positives = 123/287 (42%), Gaps = 50/287 (17%)
Query: 293 GEGASATVYKGSLPSGGAVAVK-RFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           G+   AT Y G + S  A+ V  +  KP+     R    +E   ++    H N+V L G 
Sbjct: 55  GKVVEATAY-GLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGA 113
Query: 352 CCEGNELVLVYEYLPNGSL--------DKILHNNSSSSIV------LSWEKRLNIVLGVA 397
           C  G   +++ EY   G L        D  + + +S +I+      L  E  L+    VA
Sbjct: 114 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVA 173
Query: 398 SALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF----------------EATIPAG 441
             +++L     +  IHRD+ A NILL      K+ DF                 A +P  
Sbjct: 174 KGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP-- 228
Query: 442 TMGYLAPEYVYSGVPSEKTDVYSFGVVALEV-AAGKSPVDNDGCVIVDWVWNLRKKGKLL 500
            + ++APE +++ V + ++DV+S+G+   E+ + G SP    G  +    + + K+G   
Sbjct: 229 -VKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY--PGMPVDSKFYKMIKEG--- 282
Query: 501 DAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE 547
               FR+           M  +  +C   +  KRP+ K+  ++++ +
Sbjct: 283 ----FRMLSP--EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 323

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 87/214 (40%), Gaps = 42/214 (19%)
Query: 290 RIVGEGASATVYKGSL------PSGGAVAVKRFEKPNRVECARNP---FTTEFATMAGCL 340
           R +G GA   VY+G +      PS   VAVK   +     C+      F  E A +   L
Sbjct: 37  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE----VCSEQDELDFLME-ALIISKL 91
Query: 341 RHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNN---SSSSIVLSWEKRLNIVLGVA 397
            H+N+V+  G   +     ++ E +  G L   L       S    L+    L++   +A
Sbjct: 92  NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 151
Query: 398 SALSYLHEECERQIIHRDVKACNILLDAEFN---AKLGDFE----------------ATI 438
               YL E      IHRD+ A N LL        AK+GDF                 A +
Sbjct: 152 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 208
Query: 439 PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEV 472
           P   + ++ PE    G+ + KTD +SFGV+  E+
Sbjct: 209 P---VKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 239

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 96/211 (45%), Gaps = 26/211 (12%)
Query: 286 FNKNRIVGEGASATVY--KGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHK 343
           +   R++G+G+   V   K  + +G   AVK   K    +            +   L H 
Sbjct: 34  YKGQRVLGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 92
Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
           N+++L  +  +     LV E    G L D+I+     S +  +      I+  V S ++Y
Sbjct: 93  NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA-----RIIRQVLSGITY 147
Query: 403 LHEECERQIIHRDVKACNILLDA---EFNAKLGD------FEATIPA----GTMGYLAPE 449
           +H+    +I+HRD+K  N+LL++   + N ++ D      FEA+       GT  Y+APE
Sbjct: 148 MHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE 204
Query: 450 YVYSGVPSEKTDVYSFGVVALEVAAGKSPVD 480
            V  G   EK DV+S GV+   + +G  P +
Sbjct: 205 -VLHGTYDEKCDVWSTGVILYILLSGCPPFN 234

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 69/287 (24%), Positives = 123/287 (42%), Gaps = 50/287 (17%)
Query: 293 GEGASATVYKGSLPSGGAVAVK-RFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           G+   AT Y G + S  A+ V  +  KP+     R    +E   ++    H N+V L G 
Sbjct: 60  GKVVEATAY-GLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGA 118
Query: 352 CCEGNELVLVYEYLPNGSL--------DKILHNNSSSSIV------LSWEKRLNIVLGVA 397
           C  G   +++ EY   G L        D  + + +S +I+      L  E  L+    VA
Sbjct: 119 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVA 178
Query: 398 SALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF----------------EATIPAG 441
             +++L     +  IHRD+ A NILL      K+ DF                 A +P  
Sbjct: 179 KGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP-- 233
Query: 442 TMGYLAPEYVYSGVPSEKTDVYSFGVVALEV-AAGKSPVDNDGCVIVDWVWNLRKKGKLL 500
            + ++APE +++ V + ++DV+S+G+   E+ + G SP    G  +    + + K+G   
Sbjct: 234 -VKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY--PGMPVDSKFYKMIKEG--- 287
Query: 501 DAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE 547
               FR+           M  +  +C   +  KRP+ K+  ++++ +
Sbjct: 288 ----FRMLSP--EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 328

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 26/209 (12%)
Query: 286 FNKNRIVGEGASATVY--KGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHK 343
           +   R++G+G+   V   K  + +G   AVK   K    +            +   L H 
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
           N+++L  +  +     LV E    G L D+I+     S +  +      I+  V S ++Y
Sbjct: 87  NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA-----RIIRQVLSGITY 141
Query: 403 LHEECERQIIHRDVKACNILLDA---EFNAKLGD------FEATIPA----GTMGYLAPE 449
           +H+    +I+HRD+K  N+LL++   + N ++ D      FEA+       GT  Y+APE
Sbjct: 142 MHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE 198
Query: 450 YVYSGVPSEKTDVYSFGVVALEVAAGKSP 478
            V  G   EK DV+S GV+   + +G  P
Sbjct: 199 -VLHGTYDEKCDVWSTGVILYILLSGCPP 226

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 68/153 (44%), Gaps = 18/153 (11%)
Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASA 399
           L H+++V   G+  + + + +V E     SL ++     + +   +      IVLG    
Sbjct: 72  LAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC--- 128
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTMGYLAP 448
             YLH     ++IHRD+K  N+ L+ +   K+GDF              +  GT  Y+AP
Sbjct: 129 -QYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAP 184
Query: 449 EYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDN 481
           E +     S + DV+S G +   +  GK P + 
Sbjct: 185 EVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 217

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 84/195 (43%), Gaps = 39/195 (20%)
Query: 312 AVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQ-LQGWCCEGNELVL------VYEY 364
           A+KR   PNR E AR     E   +A  L H  +V+    W  +     L      VY Y
Sbjct: 34  AIKRIRLPNR-ELAREKVMREVKALAK-LEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLY 91
Query: 365 LPNGSLDKI-LHNNSSSSIVLSWEKR---LNIVLGVASALSYLHEECERQIIHRDVKACN 420
           +      K  L +  +    +   +R   L+I L +A A+ +LH    + ++HRD+K  N
Sbjct: 92  IQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSN 148
Query: 421 ILLDAEFNAKLGDF-----------EATI----PA--------GTMGYLAPEYVYSGVPS 457
           I    +   K+GDF           E T+    PA        GT  Y++PE ++    S
Sbjct: 149 IFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYS 208
Query: 458 EKTDVYSFGVVALEV 472
            K D++S G++  E+
Sbjct: 209 HKVDIFSLGLILFEL 223

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 69/287 (24%), Positives = 123/287 (42%), Gaps = 50/287 (17%)
Query: 293 GEGASATVYKGSLPSGGAVAVK-RFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           G+   AT Y G + S  A+ V  +  KP+     R    +E   ++    H N+V L G 
Sbjct: 60  GKVVEATAY-GLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGA 118
Query: 352 CCEGNELVLVYEYLPNGSL--------DKILHNNSSSSIV------LSWEKRLNIVLGVA 397
           C  G   +++ EY   G L        D  + + +S +I+      L  E  L+    VA
Sbjct: 119 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVA 178
Query: 398 SALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF----------------EATIPAG 441
             +++L     +  IHRD+ A NILL      K+ DF                 A +P  
Sbjct: 179 KGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARLP-- 233
Query: 442 TMGYLAPEYVYSGVPSEKTDVYSFGVVALEV-AAGKSPVDNDGCVIVDWVWNLRKKGKLL 500
            + ++APE +++ V + ++DV+S+G+   E+ + G SP    G  +    + + K+G   
Sbjct: 234 -VKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY--PGMPVDSKFYKMIKEG--- 287
Query: 501 DAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE 547
               FR+           M  +  +C   +  KRP+ K+  ++++ +
Sbjct: 288 ----FRMLSP--EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 328

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 68/153 (44%), Gaps = 18/153 (11%)
Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASA 399
           L H+++V   G+  + + + +V E     SL ++     + +   +      IVLG    
Sbjct: 96  LAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC--- 152
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTMGYLAP 448
             YLH     ++IHRD+K  N+ L+ +   K+GDF              +  GT  Y+AP
Sbjct: 153 -QYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAP 208
Query: 449 EYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDN 481
           E +     S + DV+S G +   +  GK P + 
Sbjct: 209 EVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 241

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 69/159 (43%), Gaps = 18/159 (11%)
Query: 356 NELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRD 415
            +L LV   +  G +   ++N    +      + +     + S L +LH+   R II+RD
Sbjct: 258 TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRD 314
Query: 416 VKACNILLDAEFNAKLGDFEATIP-----------AGTMGYLAPEYVYSGVPSEKTDVYS 464
           +K  N+LLD + N ++ D    +            AGT G++APE +         D ++
Sbjct: 315 LKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFA 374
Query: 465 FGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAA 503
            GV   E+ A + P    G    + V N   K ++L+ A
Sbjct: 375 LGVTLYEMIAARGPFRARG----EKVENKELKQRVLEQA 409

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 68/153 (44%), Gaps = 18/153 (11%)
Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASA 399
           L H+++V   G+  + + + +V E     SL ++     + +   +      IVLG    
Sbjct: 98  LAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC--- 154
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTMGYLAP 448
             YLH     ++IHRD+K  N+ L+ +   K+GDF              +  GT  Y+AP
Sbjct: 155 -QYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAP 210
Query: 449 EYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDN 481
           E +     S + DV+S G +   +  GK P + 
Sbjct: 211 EVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 243

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 69/159 (43%), Gaps = 18/159 (11%)
Query: 356 NELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRD 415
            +L LV   +  G +   ++N    +      + +     + S L +LH+   R II+RD
Sbjct: 258 TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRD 314
Query: 416 VKACNILLDAEFNAKLGDFEATIP-----------AGTMGYLAPEYVYSGVPSEKTDVYS 464
           +K  N+LLD + N ++ D    +            AGT G++APE +         D ++
Sbjct: 315 LKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFA 374
Query: 465 FGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAA 503
            GV   E+ A + P    G    + V N   K ++L+ A
Sbjct: 375 LGVTLYEMIAARGPFRARG----EKVENKELKQRVLEQA 409

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 88/211 (41%), Gaps = 16/211 (7%)
Query: 286 FNKNRIVGEGASATVYK-GSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F + + +G G+   V     + +G   A+K  +K   V+      T     +   +    
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPF 102
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           LV+L+    + + L +V EY P G +   L      S   +      IVL       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEYLH 158
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGVP 456
                 +I+RD+K  N+++D +   K+ DF              GT  YLAPE + S   
Sbjct: 159 S---LDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 457 SEKTDVYSFGVVALEVAAGKSPVDNDGCVIV 487
           ++  D ++ GV+  E+AAG  P   D  + +
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 69/159 (43%), Gaps = 18/159 (11%)
Query: 356 NELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRD 415
            +L LV   +  G +   ++N    +      + +     + S L +LH+   R II+RD
Sbjct: 258 TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRD 314
Query: 416 VKACNILLDAEFNAKLGDFEATIP-----------AGTMGYLAPEYVYSGVPSEKTDVYS 464
           +K  N+LLD + N ++ D    +            AGT G++APE +         D ++
Sbjct: 315 LKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFA 374
Query: 465 FGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAA 503
            GV   E+ A + P    G    + V N   K ++L+ A
Sbjct: 375 LGVTLYEMIAARGPFRARG----EKVENKELKQRVLEQA 409

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 87/214 (40%), Gaps = 42/214 (19%)
Query: 290 RIVGEGASATVYKGSL------PSGGAVAVKRFEKPNRVECARNP---FTTEFATMAGCL 340
           R +G GA   VY+G +      PS   VAVK   +     C+      F  E A +   L
Sbjct: 51  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE----VCSEQDELDFLME-ALIISKL 105
Query: 341 RHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNN---SSSSIVLSWEKRLNIVLGVA 397
            H+N+V+  G   +     ++ E +  G L   L       S    L+    L++   +A
Sbjct: 106 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 165
Query: 398 SALSYLHEECERQIIHRDVKACNILLDAEFN---AKLGDFE----------------ATI 438
               YL E      IHRD+ A N LL        AK+GDF                 A +
Sbjct: 166 CGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 222
Query: 439 PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEV 472
           P   + ++ PE    G+ + KTD +SFGV+  E+
Sbjct: 223 P---VKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 253

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 88/208 (42%), Gaps = 25/208 (12%)
Query: 286 FNKNRIVGEGA-SATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           ++   ++G GA S  +      +   VA+K   K   +E        E A +   ++H N
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAK-EALEGKEGSMENEIAVLHK-IKHPN 77
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
           +V L      G  L L+ + +  G L D+I+     +    S      ++  V  A+ YL
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS-----RLIFQVLDAVKYL 132
Query: 404 HEECERQIIHRDVKACNIL---LDAEFNAKLGDF----------EATIPAGTMGYLAPEY 450
           H+     I+HRD+K  N+L   LD +    + DF            +   GT GY+APE 
Sbjct: 133 HD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEV 189
Query: 451 VYSGVPSEKTDVYSFGVVALEVAAGKSP 478
           +     S+  D +S GV+A  +  G  P
Sbjct: 190 LAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 79/199 (39%), Gaps = 19/199 (9%)
Query: 286 FNKNRIVGEGASATVYK-GSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F +   +G G+   V+K  S   G   AVKR   P R    R     E  +     +H  
Sbjct: 59  FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPC 118
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
            V+L+    EG  L L  E              +S      W    + +L    AL++LH
Sbjct: 119 CVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLL----ALAHLH 174
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGTMG----------YLAPEYVYSG 454
            +    ++H DVK  NI L      KLGDF   +  GT G          Y+APE +  G
Sbjct: 175 SQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPE-LLQG 230
Query: 455 VPSEKTDVYSFGVVALEVA 473
                 DV+S G+  LEVA
Sbjct: 231 SYGTAADVFSLGLTILEVA 249

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 69/159 (43%), Gaps = 18/159 (11%)
Query: 356 NELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRD 415
            +L LV   +  G +   ++N    +      + +     + S L +LH+   R II+RD
Sbjct: 258 TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRD 314
Query: 416 VKACNILLDAEFNAKLGDFEATIP-----------AGTMGYLAPEYVYSGVPSEKTDVYS 464
           +K  N+LLD + N ++ D    +            AGT G++APE +         D ++
Sbjct: 315 LKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFA 374
Query: 465 FGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAA 503
            GV   E+ A + P    G    + V N   K ++L+ A
Sbjct: 375 LGVTLYEMIAARGPFRARG----EKVENKELKQRVLEQA 409

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 86/203 (42%), Gaps = 25/203 (12%)
Query: 291 IVGEGA-SATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQ 349
           ++G GA S  +      +   VA+K   K   +E        E A +   ++H N+V L 
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAK-EALEGKEGSMENEIAVLHK-IKHPNIVALD 82
Query: 350 GWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE 408
                G  L L+ + +  G L D+I+     +    S      ++  V  A+ YLH+   
Sbjct: 83  DIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS-----RLIFQVLDAVKYLHD--- 134
Query: 409 RQIIHRDVKACNIL---LDAEFNAKLGDF----------EATIPAGTMGYLAPEYVYSGV 455
             I+HRD+K  N+L   LD +    + DF            +   GT GY+APE +    
Sbjct: 135 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKP 194
Query: 456 PSEKTDVYSFGVVALEVAAGKSP 478
            S+  D +S GV+A  +  G  P
Sbjct: 195 YSKAVDCWSIGVIAYILLCGYPP 217

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 81/189 (42%), Gaps = 15/189 (7%)
Query: 307 SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLP 366
           +G   A+K  +K   V+  +   T     +   +    LV+L+    + + L +V EY+P
Sbjct: 58  TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVP 117
Query: 367 NGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAE 426
            G +   L      S   +      IVL       YLH      +I+RD+K  N+L+D +
Sbjct: 118 GGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEYLHS---LDLIYRDLKPENLLIDQQ 170
Query: 427 FNAKLGDF--------EATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSP 478
              ++ DF              GT  YLAPE + S   ++  D ++ GV+  E+AAG  P
Sbjct: 171 GYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 230
Query: 479 VDNDGCVIV 487
              D  + +
Sbjct: 231 FFADQPIQI 239

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 93/221 (42%), Gaps = 36/221 (16%)
Query: 286 FNKNRIVGEGASATVY-KGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F + + +G G+   V     + +G   A+K  +K   V+  +   T     +   +    
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNS----------SSSIVLSWEKRLNIVL 394
           LV+L+    + + L +V EY+P G +   L              ++ IVL++E       
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE------- 156
Query: 395 GVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYL 446
                  YLH      +I+RD+K  N+L+D +   ++ DF              GT  YL
Sbjct: 157 -------YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYL 206
Query: 447 APEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIV 487
           APE + S   ++  D ++ GV+  E+AAG  P   D  + +
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 247

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 83/211 (39%), Gaps = 36/211 (17%)
Query: 290 RIVGEGASATVYKGSL------PSGGAVAVKRFEKPNRVECARNP---FTTEFATMAGCL 340
           R +G GA   VY+G +      PS   VAVK   +     C+      F  E A +    
Sbjct: 54  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE----VCSEQDELDFLME-ALIISKF 108
Query: 341 RHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNN---SSSSIVLSWEKRLNIVLGVA 397
            H+N+V+  G   +     ++ E +  G L   L       S    L+    L++   +A
Sbjct: 109 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 168
Query: 398 SALSYLHEECERQIIHRDVKACNILLDAEFN---AKLGDFEATIPAGTMGY--------- 445
               YL E      IHRD+ A N LL        AK+GDF         GY         
Sbjct: 169 CGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAML 225
Query: 446 ----LAPEYVYSGVPSEKTDVYSFGVVALEV 472
               + PE    G+ + KTD +SFGV+  E+
Sbjct: 226 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 256

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 81/189 (42%), Gaps = 15/189 (7%)
Query: 307 SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLP 366
           +G   A+K  +K   V+  +   T     +   +    LV+L+    + + L +V EY+P
Sbjct: 65  TGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVP 124
Query: 367 NGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAE 426
            G +   L      S   +      IVL       YLH      +I+RD+K  N+L+D +
Sbjct: 125 GGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEYLHS---LDLIYRDLKPENLLIDQQ 177
Query: 427 FNAKLGDF--------EATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSP 478
              ++ DF              GT  YLAPE + S   ++  D ++ GV+  E+AAG  P
Sbjct: 178 GYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
Query: 479 VDNDGCVIV 487
              D  + +
Sbjct: 238 FFADQPIQI 246

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 81/189 (42%), Gaps = 15/189 (7%)
Query: 307 SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLP 366
           +G   A+K  +K   V+  +   T     +   +    LV+L+    + + L +V EY+P
Sbjct: 65  TGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVP 124
Query: 367 NGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAE 426
            G +   L      S   +      IVL       YLH      +I+RD+K  N+L+D +
Sbjct: 125 GGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEYLHS---LDLIYRDLKPENLLIDQQ 177
Query: 427 FNAKLGDF--------EATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSP 478
              ++ DF              GT  YLAPE + S   ++  D ++ GV+  E+AAG  P
Sbjct: 178 GYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
Query: 479 VDNDGCVIV 487
              D  + +
Sbjct: 238 FFADQPIQI 246

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 81/189 (42%), Gaps = 15/189 (7%)
Query: 307 SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLP 366
           +G   A+K  +K   V+  +   T     +   +    LV+L+    + + L +V EY+P
Sbjct: 65  TGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVP 124
Query: 367 NGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAE 426
            G +   L      S   +      IVL       YLH      +I+RD+K  N+L+D +
Sbjct: 125 GGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEYLHS---LDLIYRDLKPENLLIDQQ 177
Query: 427 FNAKLGDF--------EATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSP 478
              ++ DF              GT  YLAPE + S   ++  D ++ GV+  E+AAG  P
Sbjct: 178 GYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
Query: 479 VDNDGCVIV 487
              D  + +
Sbjct: 238 FFADQPIQI 246

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 93/221 (42%), Gaps = 36/221 (16%)
Query: 286 FNKNRIVGEGASATVYK-GSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F + + +G G+   V     + +G   A+K  +K   V+  +   T     +   +    
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNS----------SSSIVLSWEKRLNIVL 394
           LV+L+    + + L +V EY+P G +   L              ++ IVL++E       
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE------- 155
Query: 395 GVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYL 446
                  YLH      +I+RD+K  N+L+D +   ++ DF              GT  YL
Sbjct: 156 -------YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYL 205
Query: 447 APEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIV 487
           APE + S   ++  D ++ GV+  E+AAG  P   D  + +
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 83/211 (39%), Gaps = 36/211 (17%)
Query: 290 RIVGEGASATVYKGSL------PSGGAVAVKRFEKPNRVECARNP---FTTEFATMAGCL 340
           R +G GA   VY+G +      PS   VAVK   +     C+      F  E A +    
Sbjct: 77  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE----VCSEQDELDFLME-ALIISKF 131
Query: 341 RHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNN---SSSSIVLSWEKRLNIVLGVA 397
            H+N+V+  G   +     ++ E +  G L   L       S    L+    L++   +A
Sbjct: 132 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 191
Query: 398 SALSYLHEECERQIIHRDVKACNILLDAEFN---AKLGDFEATIPAGTMGY--------- 445
               YL E      IHRD+ A N LL        AK+GDF         GY         
Sbjct: 192 CGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAML 248
Query: 446 ----LAPEYVYSGVPSEKTDVYSFGVVALEV 472
               + PE    G+ + KTD +SFGV+  E+
Sbjct: 249 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 279

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 86/203 (42%), Gaps = 25/203 (12%)
Query: 291 IVGEGA-SATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQ 349
           ++G GA S  +      +   VA+K   K   +E        E A +   ++H N+V L 
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAK-KALEGKEGSMENEIAVLHK-IKHPNIVALD 82
Query: 350 GWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE 408
                G  L L+ + +  G L D+I+     +    S      ++  V  A+ YLH+   
Sbjct: 83  DIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS-----RLIFQVLDAVKYLHD--- 134
Query: 409 RQIIHRDVKACNIL---LDAEFNAKLGDFEAT----------IPAGTMGYLAPEYVYSGV 455
             I+HRD+K  N+L   LD +    + DF  +             GT GY+APE +    
Sbjct: 135 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKP 194
Query: 456 PSEKTDVYSFGVVALEVAAGKSP 478
            S+  D +S GV+A  +  G  P
Sbjct: 195 YSKAVDCWSIGVIAYILLCGYPP 217

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 81/189 (42%), Gaps = 15/189 (7%)
Query: 307 SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLP 366
           +G   A+K  +K   V+  +   T     +   +    LV+L+    + + L +V EY+P
Sbjct: 66  TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVP 125
Query: 367 NGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAE 426
            G +   L      S   +      IVL       YLH      +I+RD+K  N+L+D +
Sbjct: 126 GGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEYLHS---LDLIYRDLKPENLLIDQQ 178
Query: 427 FNAKLGDF--------EATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSP 478
              ++ DF              GT  YLAPE + S   ++  D ++ GV+  E+AAG  P
Sbjct: 179 GYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238
Query: 479 VDNDGCVIV 487
              D  + +
Sbjct: 239 FFADQPIQI 247

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 97/248 (39%), Gaps = 30/248 (12%)
Query: 286 FNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           F K  +    A    Y   +    A+  K+ EK   +   RN        +   ++H  L
Sbjct: 51  FGKVLLARHKAEEVFYAVKVLQKKAILKKKEEK--HIMSERN-------VLLKNVKHPFL 101
Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
           V L       ++L  V +Y+  G L    ++       L    R      +ASAL YLH 
Sbjct: 102 VGLHFSFQTADKLYFVLDYINGGEL---FYHLQRERCFLEPRARF-YAAEIASALGYLHS 157
Query: 406 ECERQIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTMGYLAPEYVYSG 454
                I++RD+K  NILLD++ +  L DF             +   GT  YLAPE ++  
Sbjct: 158 ---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQ 214
Query: 455 VPSEKTDVYSFGVVALEVAAGKSPV-DNDGCVIVDWVWN--LRKKGKLLDAADFRLRGKF 511
                 D +  G V  E+  G  P    +   + D + N  L+ K  + ++A   L G  
Sbjct: 215 PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLL 274
Query: 512 NRKEMERM 519
            +   +R+
Sbjct: 275 QKDRTKRL 282

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 81/189 (42%), Gaps = 15/189 (7%)
Query: 307 SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLP 366
           +G   A+K  +K   V+  +   T     +   +    LV+L+    + + L +V EY+P
Sbjct: 66  TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVP 125
Query: 367 NGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAE 426
            G +   L      S   +      IVL       YLH      +I+RD+K  N+L+D +
Sbjct: 126 GGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEYLHS---LDLIYRDLKPENLLIDQQ 178
Query: 427 FNAKLGDF--------EATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSP 478
              ++ DF              GT  YLAPE + S   ++  D ++ GV+  E+AAG  P
Sbjct: 179 GYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238
Query: 479 VDNDGCVIV 487
              D  + +
Sbjct: 239 FFADQPIQI 247

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 93/221 (42%), Gaps = 36/221 (16%)
Query: 286 FNKNRIVGEGASATVYK-GSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F + + +G G+   V     + +G   A+K  +K   V+  +   T     +   +    
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNS----------SSSIVLSWEKRLNIVL 394
           LV+L+    + + L +V EY+P G +   L              ++ IVL++E       
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE------- 155
Query: 395 GVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYL 446
                  YLH      +I+RD+K  N+L+D +   ++ DF              GT  YL
Sbjct: 156 -------YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYL 205
Query: 447 APEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIV 487
           APE + S   ++  D ++ GV+  E+AAG  P   D  + +
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 86/203 (42%), Gaps = 25/203 (12%)
Query: 291 IVGEGA-SATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQ 349
           ++G GA S  +      +   VA+K   K   +E        E A +   ++H N+V L 
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAK-EALEGKEGSMENEIAVLHK-IKHPNIVALD 82
Query: 350 GWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE 408
                G  L L+ + +  G L D+I+     +    S      ++  V  A+ YLH+   
Sbjct: 83  DIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS-----RLIFQVLDAVKYLHD--- 134
Query: 409 RQIIHRDVKACNIL---LDAEFNAKLGDF----------EATIPAGTMGYLAPEYVYSGV 455
             I+HRD+K  N+L   LD +    + DF            +   GT GY+APE +    
Sbjct: 135 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKP 194
Query: 456 PSEKTDVYSFGVVALEVAAGKSP 478
            S+  D +S GV+A  +  G  P
Sbjct: 195 YSKAVDCWSIGVIAYILLCGYPP 217

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 81/189 (42%), Gaps = 15/189 (7%)
Query: 307 SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLP 366
           +G   A+K  +K   V+  +   T     +   +    LV+L+    + + L +V EY+P
Sbjct: 86  TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVP 145
Query: 367 NGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAE 426
            G +   L      S   +      IVL       YLH      +I+RD+K  N+L+D +
Sbjct: 146 GGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEYLHS---LDLIYRDLKPENLLIDQQ 198
Query: 427 FNAKLGDF--------EATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSP 478
              ++ DF              GT  YLAPE + S   ++  D ++ GV+  E+AAG  P
Sbjct: 199 GYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 258
Query: 479 VDNDGCVIV 487
              D  + +
Sbjct: 259 FFADQPIQI 267

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 26/209 (12%)
Query: 286 FNKNRIVGEGASATVY--KGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHK 343
           +   R++G+G+   V   K  + +G   AVK   K    +            +   L H 
Sbjct: 51  YKGQRVLGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 109
Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
           N+++L  +  +     LV E    G L D+I+     S +  +      I+  V S ++Y
Sbjct: 110 NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA-----RIIRQVLSGITY 164
Query: 403 LHEECERQIIHRDVKACNILLDA---EFNAKLGD------FEATIPA----GTMGYLAPE 449
           +H+    +I+HRD+K  N+LL++   + N ++ D      FEA+       GT  Y+APE
Sbjct: 165 MHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE 221
Query: 450 YVYSGVPSEKTDVYSFGVVALEVAAGKSP 478
            V  G   EK DV+S GV+   + +G  P
Sbjct: 222 -VLHGTYDEKCDVWSTGVILYILLSGCPP 249

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 81/189 (42%), Gaps = 15/189 (7%)
Query: 307 SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLP 366
           +G   A+K  +K   V+  +   T     +   +    LV+L+    + + L +V EY+P
Sbjct: 66  TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVP 125
Query: 367 NGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAE 426
            G +   L      S   +      IVL       YLH      +I+RD+K  N+L+D +
Sbjct: 126 GGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEYLHS---LDLIYRDLKPENLLIDQQ 178
Query: 427 FNAKLGDF--------EATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSP 478
              ++ DF              GT  YLAPE + S   ++  D ++ GV+  E+AAG  P
Sbjct: 179 GYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238
Query: 479 VDNDGCVIV 487
              D  + +
Sbjct: 239 FFADQPIQI 247

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 26/209 (12%)
Query: 286 FNKNRIVGEGASATVY--KGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHK 343
           +   R++G+G+   V   K  + +G   AVK   K    +            +   L H 
Sbjct: 52  YKGQRVLGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 110
Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
           N+++L  +  +     LV E    G L D+I+     S +  +      I+  V S ++Y
Sbjct: 111 NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA-----RIIRQVLSGITY 165
Query: 403 LHEECERQIIHRDVKACNILLDA---EFNAKLGD------FEATIPA----GTMGYLAPE 449
           +H+    +I+HRD+K  N+LL++   + N ++ D      FEA+       GT  Y+APE
Sbjct: 166 MHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE 222
Query: 450 YVYSGVPSEKTDVYSFGVVALEVAAGKSP 478
            V  G   EK DV+S GV+   + +G  P
Sbjct: 223 -VLHGTYDEKCDVWSTGVILYILLSGCPP 250

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 89/211 (42%), Gaps = 16/211 (7%)
Query: 286 FNKNRIVGEGASATVY-KGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F + + +G G+   V     + +G   A+K  +K   V+  +   T     +   +    
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           LV+L+    + + L +V EY P G +   L      S   +      IVL       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEYLH 158
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGVP 456
                 +I+RD+K  N+++D +   ++ DF              GT  YLAPE + S   
Sbjct: 159 S---LDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 457 SEKTDVYSFGVVALEVAAGKSPVDNDGCVIV 487
           ++  D ++ GV+  E+AAG  P   D  + +
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 90/211 (42%), Gaps = 16/211 (7%)
Query: 286 FNKNRIVGEGASATVYK-GSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F++ + +G G+   V       SG   A+K  +K   V+  +   T     +   +    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           LV+L+    + + L +V EY+  G +   L      S   +      IVL       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEYLH 158
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGVP 456
                 +I+RD+K  N+L+D +   ++ DF             AGT  YLAPE + S   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLAGTPEYLAPEIILSKGY 215
Query: 457 SEKTDVYSFGVVALEVAAGKSPVDNDGCVIV 487
           ++  D ++ GV+  E+AAG  P   D  + +
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 62/290 (21%), Positives = 116/290 (40%), Gaps = 56/290 (19%)
Query: 293 GEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWC 352
           G+   AT +     +G      +  K N          +EF  +   + H ++++L G C
Sbjct: 37  GKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ-VNHPHVIKLYGAC 95
Query: 353 CEGNELVLVYEYLPNGSLDKILHN--------------------NSSSSIVLSWEKRLNI 392
            +   L+L+ EY   GSL   L                      +      L+    ++ 
Sbjct: 96  SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISF 155
Query: 393 VLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF----------------EA 436
              ++  + YL    E +++HRD+ A NIL+      K+ DF                + 
Sbjct: 156 AWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQG 212
Query: 437 TIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALE-VAAGKSPVDNDGCVIVDWVWNLRK 495
            IP   + ++A E ++  + + ++DV+SFGV+  E V  G +P      +  + ++NL K
Sbjct: 213 RIP---VKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG---IPPERLFNLLK 266
Query: 496 KGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK 545
            G  ++  D         +EM R++   L C     +KRP   + ++ L+
Sbjct: 267 TGHRMERPD------NCSEEMYRLM---LQCWKQEPDKRPVFADISKDLE 307

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/290 (21%), Positives = 116/290 (40%), Gaps = 56/290 (19%)
Query: 293 GEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWC 352
           G+   AT +     +G      +  K N          +EF  +   + H ++++L G C
Sbjct: 37  GKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ-VNHPHVIKLYGAC 95
Query: 353 CEGNELVLVYEYLPNGSLDKILHN--------------------NSSSSIVLSWEKRLNI 392
            +   L+L+ EY   GSL   L                      +      L+    ++ 
Sbjct: 96  SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISF 155
Query: 393 VLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF----------------EA 436
              ++  + YL    E +++HRD+ A NIL+      K+ DF                + 
Sbjct: 156 AWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQG 212
Query: 437 TIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALE-VAAGKSPVDNDGCVIVDWVWNLRK 495
            IP   + ++A E ++  + + ++DV+SFGV+  E V  G +P      +  + ++NL K
Sbjct: 213 RIP---VKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG---IPPERLFNLLK 266
Query: 496 KGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK 545
            G  ++  D         +EM R++   L C     +KRP   + ++ L+
Sbjct: 267 TGHRMERPD------NCSEEMYRLM---LQCWKQEPDKRPVFADISKDLE 307

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/133 (33%), Positives = 60/133 (45%), Gaps = 17/133 (12%)
Query: 359 VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKA 418
           +L  EY   G L K L N   +   L       ++  ++SAL YLHE    +IIHRD+K 
Sbjct: 95  LLAMEYCEGGDLRKYL-NQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKP 150
Query: 419 CNILL------------DAEFNAKLGDFE-ATIPAGTMGYLAPEYVYSGVPSEKTDVYSF 465
            NI+L            D  +  +L   E  T   GT+ YLAPE +     +   D +SF
Sbjct: 151 ENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSF 210
Query: 466 GVVALEVAAGKSP 478
           G +A E   G  P
Sbjct: 211 GTLAFECITGFRP 223

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/133 (33%), Positives = 60/133 (45%), Gaps = 17/133 (12%)
Query: 359 VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKA 418
           +L  EY   G L K L N   +   L       ++  ++SAL YLHE    +IIHRD+K 
Sbjct: 94  LLAMEYCEGGDLRKYL-NQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKP 149
Query: 419 CNILL------------DAEFNAKLGDFE-ATIPAGTMGYLAPEYVYSGVPSEKTDVYSF 465
            NI+L            D  +  +L   E  T   GT+ YLAPE +     +   D +SF
Sbjct: 150 ENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSF 209
Query: 466 GVVALEVAAGKSP 478
           G +A E   G  P
Sbjct: 210 GTLAFECITGFRP 222

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 92/221 (41%), Gaps = 36/221 (16%)
Query: 286 FNKNRIVGEGASATVYK-GSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F + + +G G+   V     + +G   A+K  +K   V+  +   T     +   +    
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNS----------SSSIVLSWEKRLNIVL 394
           LV+L+    + + L +V EY P G +   L              ++ IVL++E       
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE------- 155
Query: 395 GVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYL 446
                  YLH      +I+RD+K  N+++D +   K+ DF              GT  YL
Sbjct: 156 -------YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYL 205
Query: 447 APEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIV 487
           APE + S   ++  D ++ GV+  E+AAG  P   D  + +
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 88/211 (41%), Gaps = 16/211 (7%)
Query: 286 FNKNRIVGEGASATVYK-GSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F + + +G G+   V     + +G   A+K  +K   V+  +   T     +   +    
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           L +L+    + + L +V EY P G +   L      S   +      IVL       YLH
Sbjct: 104 LTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEYLH 159
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGVP 456
                 +I+RD+K  N+++D +   K+ DF              GT  YLAPE + S   
Sbjct: 160 S---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 457 SEKTDVYSFGVVALEVAAGKSPVDNDGCVIV 487
           ++  D ++ GV+  E+AAG  P   D  + +
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPFFADQPIQI 247

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 88/211 (41%), Gaps = 16/211 (7%)
Query: 286 FNKNRIVGEGASATVY-KGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F + + +G G+   V     + +G   A+K  +K   V+  +   T     +   +    
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           L +L+    + + L +V EY P G +   L      S   +      IVL       YLH
Sbjct: 104 LTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEYLH 159
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGVP 456
                 +I+RD+K  N+++D +   K+ DF              GT  YLAPE + S   
Sbjct: 160 S---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 457 SEKTDVYSFGVVALEVAAGKSPVDNDGCVIV 487
           ++  D ++ GV+  E+AAG  P   D  + +
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPFFADQPIQI 247

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 88/199 (44%), Gaps = 25/199 (12%)
Query: 290 RIVGEGASATVYKGSLPS----GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           R +GEG    V++G   S      AVA+K   K    +  R  F  E  TM     H ++
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTC-KNCTSDSVREKFLQEALTMRQ-FDHPHI 73
Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
           V+L G   E N + ++ E    G L   L     S   L     +     +++AL+YL  
Sbjct: 74  VKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFS---LDLASLILYAYQLSTALAYLES 129
Query: 406 ECERQIIHRDVKACNILLDAEFNAKLGDF-------EATIPAGTMG-----YLAPEYVYS 453
              ++ +HRD+ A N+L+ A    KLGDF       ++T    + G     ++APE +  
Sbjct: 130 ---KRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 186
Query: 454 GVPSEKTDVYSFGVVALEV 472
              +  +DV+ FGV   E+
Sbjct: 187 RRFTSASDVWMFGVCMWEI 205

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 80/189 (42%), Gaps = 15/189 (7%)
Query: 307 SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLP 366
           +G   A+K  +K   V+  +   T     +   +    LV+L+    + + L +V EY P
Sbjct: 66  TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAP 125
Query: 367 NGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAE 426
            G +   L      S   +      IVL       YLH      +I+RD+K  N+++D +
Sbjct: 126 GGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEYLHS---LDLIYRDLKPENLMIDQQ 178
Query: 427 FNAKLGDF--------EATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSP 478
              K+ DF              GT  YLAPE + S   ++  D ++ GV+  E+AAG  P
Sbjct: 179 GYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238
Query: 479 VDNDGCVIV 487
              D  + +
Sbjct: 239 FFADQPIQI 247

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 69/161 (42%), Gaps = 32/161 (19%)
Query: 337 AGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGV 396
           A  L  +N V+      + + L +  EY  N +L  ++H   S ++    ++   +   +
Sbjct: 69  AAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIH---SENLNQQRDEYWRLFRQI 125
Query: 397 ASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF---------------------- 434
             ALSY+H +    IIHR++K  NI +D   N K+GDF                      
Sbjct: 126 LEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 435 ---EATIPAGTMGYLAPEYVY-SGVPSEKTDVYSFGVVALE 471
                T   GT  Y+A E +  +G  +EK D YS G++  E
Sbjct: 183 SSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFE 223

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 80/175 (45%), Gaps = 23/175 (13%)
Query: 318 KPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSL-DKILHN 376
           +   V  + N    E   +   L H N+++L  +  +     LV E    G L D+I+H 
Sbjct: 71  RKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHR 130
Query: 377 NSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDA-EFNA--KLGD 433
              + +  +      I+  V S ++YLH+     I+HRD+K  N+LL++ E +A  K+ D
Sbjct: 131 MKFNEVDAAV-----IIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVD 182
Query: 434 F----------EATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSP 478
           F          +     GT  Y+APE V      EK DV+S GV+   + AG  P
Sbjct: 183 FGLSAVFENQKKMKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPP 236

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 73/153 (47%), Gaps = 23/153 (15%)
Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLG-VA 397
           ++H+N+V L+          LV + +  G L D+IL     +      EK  ++V+  V 
Sbjct: 63  IKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYT------EKDASLVIQQVL 116
Query: 398 SALSYLHEECERQIIHRDVKACNIL-LDAEFNAKL--GDFE---------ATIPAGTMGY 445
           SA+ YLHE     I+HRD+K  N+L L  E N+K+   DF           +   GT GY
Sbjct: 117 SAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGY 173
Query: 446 LAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSP 478
           +APE +     S+  D +S GV+   +  G  P
Sbjct: 174 VAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 86/214 (40%), Gaps = 42/214 (19%)
Query: 290 RIVGEGASATVYKGSL------PSGGAVAVKRFEKPNRVECARNP---FTTEFATMAGCL 340
           R +G GA   VY+G +      PS   VAVK   +     C+      F  E A +    
Sbjct: 28  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE----VCSEQDELDFLME-ALIISKF 82
Query: 341 RHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNN---SSSSIVLSWEKRLNIVLGVA 397
            H+N+V+  G   +     ++ E +  G L   L       S    L+    L++   +A
Sbjct: 83  NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 142
Query: 398 SALSYLHEECERQIIHRDVKACNILLDAEFN---AKLGDFE----------------ATI 438
               YL E      IHRD+ A N LL        AK+GDF                 A +
Sbjct: 143 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 199
Query: 439 PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEV 472
           P   + ++ PE    G+ + KTD +SFGV+  E+
Sbjct: 200 P---VKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 230

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/298 (21%), Positives = 118/298 (39%), Gaps = 61/298 (20%)
Query: 290 RIVGEGASATVYKGSL-----PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           + +GEG    V K +       +G      +  K N          +EF  +   + H +
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ-VNHPH 87
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHN--------------------NSSSSIVL 384
           +++L G C +   L+L+ EY   GSL   L                      +      L
Sbjct: 88  VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 385 SWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF---------- 434
           +    ++    ++  + YL    E  ++HRD+ A NIL+      K+ DF          
Sbjct: 148 TMGDLISFAWQISQGMQYL---AEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 435 ------EATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALE-VAAGKSPVDNDGCVIV 487
                 +  IP   + ++A E ++  + + ++DV+SFGV+  E V  G +P      +  
Sbjct: 205 SXVKRSQGRIP---VKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG---IPP 258
Query: 488 DWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK 545
           + ++NL K G  ++  D         +EM R++   L C     +KRP   + ++ L+
Sbjct: 259 ERLFNLLKTGHRMERPD------NCSEEMYRLM---LQCWKQEPDKRPVFADISKDLE 307

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 86/214 (40%), Gaps = 42/214 (19%)
Query: 290 RIVGEGASATVYKGSL------PSGGAVAVKRFEKPNRVECARNP---FTTEFATMAGCL 340
           R +G GA   VY+G +      PS   VAVK   +     C+      F  E A +    
Sbjct: 37  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE----VCSEQDELDFLME-ALIISKF 91
Query: 341 RHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNN---SSSSIVLSWEKRLNIVLGVA 397
            H+N+V+  G   +     ++ E +  G L   L       S    L+    L++   +A
Sbjct: 92  NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 151
Query: 398 SALSYLHEECERQIIHRDVKACNILLDAEFN---AKLGDFE----------------ATI 438
               YL E      IHRD+ A N LL        AK+GDF                 A +
Sbjct: 152 CGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAML 208
Query: 439 PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEV 472
           P   + ++ PE    G+ + KTD +SFGV+  E+
Sbjct: 209 P---VKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 239

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 67/150 (44%), Gaps = 26/150 (17%)
Query: 340 LRHKNLVQLQGWCCEGN---ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGV 396
           L H+++V+ +G CCE      + LV EY+P GSL   L  +      L     L     +
Sbjct: 68  LYHEHIVKYKG-CCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQL-----LLFAQQI 121
Query: 397 ASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--EATIPAGTMGY--------- 445
              ++YLH +     IHR + A N+LLD +   K+GDF     +P G   Y         
Sbjct: 122 CEGMAYLHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 178
Query: 446 ---LAPEYVYSGVPSEKTDVYSFGVVALEV 472
               APE +        +DV+SFGV   E+
Sbjct: 179 VFWYAPECLKECKFYYASDVWSFGVTLYEL 208

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 88/211 (41%), Gaps = 16/211 (7%)
Query: 286 FNKNRIVGEGASATVYK-GSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F + + +G G+   V     + +G   A+K  +K   V+      T     +   +    
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPF 102
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           LV+L+    + + L +V EY P G +   L      S   +      IVL       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEYLH 158
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGVP 456
                 +I+RD+K  N+++D +   ++ DF              GT  YLAPE + S   
Sbjct: 159 S---LDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 457 SEKTDVYSFGVVALEVAAGKSPVDNDGCVIV 487
           ++  D ++ GV+  E+AAG  P   D  + +
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 89/213 (41%), Gaps = 29/213 (13%)
Query: 286 FNKNRIVGEGASATVYK------GSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGC 339
           + + R +G+G  A  Y+        + +G  V      KP++ E      +TE A +   
Sbjct: 28  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKE----KMSTEIA-IHKS 82
Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASA 399
           L + ++V   G+  + + + +V E     SL   L  +     V   E R   +      
Sbjct: 83  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSL---LELHKRRKAVTEPEARY-FMRQTIQG 138
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP-----------AGTMGYLAP 448
           + YLH     ++IHRD+K  N+ L+ + + K+GDF                 GT  Y+AP
Sbjct: 139 VQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAP 195
Query: 449 EYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDN 481
           E +     S + D++S G +   +  GK P + 
Sbjct: 196 EVLCKKGHSFEVDIWSLGCILYTLLVGKPPFET 228

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 67/150 (44%), Gaps = 26/150 (17%)
Query: 340 LRHKNLVQLQGWCCEGN---ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGV 396
           L H+++V+ +G CCE      + LV EY+P GSL   L  +      L     L     +
Sbjct: 67  LYHEHIVKYKG-CCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQL-----LLFAQQI 120
Query: 397 ASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--EATIPAGTMGY--------- 445
              ++YLH +     IHR + A N+LLD +   K+GDF     +P G   Y         
Sbjct: 121 CEGMAYLHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 177
Query: 446 ---LAPEYVYSGVPSEKTDVYSFGVVALEV 472
               APE +        +DV+SFGV   E+
Sbjct: 178 VFWYAPECLKECKFYYASDVWSFGVTLYEL 207

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 86/214 (40%), Gaps = 42/214 (19%)
Query: 290 RIVGEGASATVYKGSL------PSGGAVAVKRFEKPNRVECARNP---FTTEFATMAGCL 340
           R +G GA   VY+G +      PS   VAVK   +     C+      F  E A +    
Sbjct: 37  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE----VCSEQDELDFLME-ALIISKF 91
Query: 341 RHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNN---SSSSIVLSWEKRLNIVLGVA 397
            H+N+V+  G   +     ++ E +  G L   L       S    L+    L++   +A
Sbjct: 92  NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 151
Query: 398 SALSYLHEECERQIIHRDVKACNILLDAEFN---AKLGDFE----------------ATI 438
               YL E      IHRD+ A N LL        AK+GDF                 A +
Sbjct: 152 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 208
Query: 439 PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEV 472
           P   + ++ PE    G+ + KTD +SFGV+  E+
Sbjct: 209 P---VKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 239

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 86/214 (40%), Gaps = 42/214 (19%)
Query: 290 RIVGEGASATVYKGSL------PSGGAVAVKRFEKPNRVECARNP---FTTEFATMAGCL 340
           R +G GA   VY+G +      PS   VAVK   +     C+      F  E A +    
Sbjct: 43  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE----VCSEQDELDFLME-ALIISKF 97
Query: 341 RHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNN---SSSSIVLSWEKRLNIVLGVA 397
            H+N+V+  G   +     ++ E +  G L   L       S    L+    L++   +A
Sbjct: 98  NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 157
Query: 398 SALSYLHEECERQIIHRDVKACNILLDAEFN---AKLGDFE----------------ATI 438
               YL E      IHRD+ A N LL        AK+GDF                 A +
Sbjct: 158 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 214
Query: 439 PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEV 472
           P   + ++ PE    G+ + KTD +SFGV+  E+
Sbjct: 215 P---VKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 245

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 88/199 (44%), Gaps = 25/199 (12%)
Query: 290 RIVGEGASATVYKGSLPS----GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           R +GEG    V++G   S      AVA+K   K    +  R  F  E  TM     H ++
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTC-KNCTSDSVREKFLQEALTMRQ-FDHPHI 73
Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
           V+L G   E N + ++ E    G L   L     S   L     +     +++AL+YL  
Sbjct: 74  VKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFS---LDLASLILYAYQLSTALAYLES 129
Query: 406 ECERQIIHRDVKACNILLDAEFNAKLGDF-------EATIPAGTMG-----YLAPEYVYS 453
              ++ +HRD+ A N+L+ +    KLGDF       ++T    + G     ++APE +  
Sbjct: 130 ---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESINF 186
Query: 454 GVPSEKTDVYSFGVVALEV 472
              +  +DV+ FGV   E+
Sbjct: 187 RRFTSASDVWMFGVCMWEI 205

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 67/153 (43%), Gaps = 18/153 (11%)
Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASA 399
           L H+++V   G+  + + + +V E     SL ++     + +   +      IVLG    
Sbjct: 78  LAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC--- 134
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTMGYLAP 448
             YLH     ++IHRD+K  N+ L+ +   K+GDF                 GT  Y+AP
Sbjct: 135 -QYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAP 190
Query: 449 EYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDN 481
           E +     S + DV+S G +   +  GK P + 
Sbjct: 191 EVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 223

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 92/222 (41%), Gaps = 43/222 (19%)
Query: 280 KQATLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGC 339
           K+  + F +  ++G G    V+K      G   V +  K N  +  R     E   +A  
Sbjct: 7   KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER-----EVKALAK- 60
Query: 340 LRHKNLVQLQGWCCEGNE-----------------LVLVYEYLPNGSLDKILHNNSSSSI 382
           L H N+V   G C +G +                 L +  E+   G+L++ +       +
Sbjct: 61  LDHVNIVHYNG-CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKL 119
Query: 383 --VLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF------ 434
             VL+ E    I  GV     Y+H    +++I+RD+K  NI L      K+GDF      
Sbjct: 120 DKVLALELFEQITKGV----DYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL 172
Query: 435 ----EATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEV 472
               +     GT+ Y++PE + S    ++ D+Y+ G++  E+
Sbjct: 173 KNDGKRXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAEL 214

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 85/211 (40%), Gaps = 36/211 (17%)
Query: 290 RIVGEGASATVYKGSL------PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHK 343
           R +G GA   VY+G +      PS   VAVK   +    E     F  E A +     H+
Sbjct: 51  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE-VYSEQDELDFLME-ALIISKFNHQ 108
Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNN---SSSSIVLSWEKRLNIVLGVASAL 400
           N+V+  G   +     ++ E +  G L   L       S    L+    L++   +A   
Sbjct: 109 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 168
Query: 401 SYLHEECERQIIHRDVKACNILLDAEFN---AKLGDFE----------------ATIPAG 441
            YL E      IHRD+ A N LL        AK+GDF                 A +P  
Sbjct: 169 QYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP-- 223
Query: 442 TMGYLAPEYVYSGVPSEKTDVYSFGVVALEV 472
            + ++ PE    G+ + KTD +SFGV+  E+
Sbjct: 224 -VKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 253

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 67/153 (43%), Gaps = 18/153 (11%)
Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASA 399
           L H+++V   G+  + + + +V E     SL ++     + +   +      IVLG    
Sbjct: 74  LAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC--- 130
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTMGYLAP 448
             YLH     ++IHRD+K  N+ L+ +   K+GDF                 GT  Y+AP
Sbjct: 131 -QYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAP 186
Query: 449 EYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDN 481
           E +     S + DV+S G +   +  GK P + 
Sbjct: 187 EVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 219

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 86/214 (40%), Gaps = 42/214 (19%)
Query: 290 RIVGEGASATVYKGSL------PSGGAVAVKRFEKPNRVECARNP---FTTEFATMAGCL 340
           R +G GA   VY+G +      PS   VAVK   +     C+      F  E A +    
Sbjct: 51  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE----VCSEQDELDFLME-ALIISKF 105
Query: 341 RHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNN---SSSSIVLSWEKRLNIVLGVA 397
            H+N+V+  G   +     ++ E +  G L   L       S    L+    L++   +A
Sbjct: 106 NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 165
Query: 398 SALSYLHEECERQIIHRDVKACNILLDAEFN---AKLGDFE----------------ATI 438
               YL E      IHRD+ A N LL        AK+GDF                 A +
Sbjct: 166 CGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 222
Query: 439 PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEV 472
           P   + ++ PE    G+ + KTD +SFGV+  E+
Sbjct: 223 P---VKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 253

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 91/216 (42%), Gaps = 28/216 (12%)
Query: 278 DIKQATLGFNKNRIVGEGA-SATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATM 336
           DIK+    F     +G GA S  V      +G   AVK   K   ++   +    E A +
Sbjct: 19  DIKKI---FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPK-KALKGKESSIENEIAVL 74
Query: 337 AGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLG 395
              ++H+N+V L+      N L LV + +  G L D+I+     +    S      ++  
Sbjct: 75  RK-IKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDAS-----TLIRQ 128
Query: 396 VASALSYLHEECERQIIHRDVKACNILL---DAEFNAKLGDFE----------ATIPAGT 442
           V  A+ YLH      I+HRD+K  N+L    D E    + DF            +   GT
Sbjct: 129 VLDAVYYLHR---MGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGT 185
Query: 443 MGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSP 478
            GY+APE +     S+  D +S GV+A  +  G  P
Sbjct: 186 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 221

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 86/214 (40%), Gaps = 42/214 (19%)
Query: 290 RIVGEGASATVYKGSL------PSGGAVAVKRFEKPNRVECARNP---FTTEFATMAGCL 340
           R +G GA   VY+G +      PS   VAVK   +     C+      F  E A +    
Sbjct: 53  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE----VCSEQDELDFLME-ALIISKF 107
Query: 341 RHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNN---SSSSIVLSWEKRLNIVLGVA 397
            H+N+V+  G   +     ++ E +  G L   L       S    L+    L++   +A
Sbjct: 108 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 167
Query: 398 SALSYLHEECERQIIHRDVKACNILLDAEFN---AKLGDFE----------------ATI 438
               YL E      IHRD+ A N LL        AK+GDF                 A +
Sbjct: 168 CGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 224
Query: 439 PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEV 472
           P   + ++ PE    G+ + KTD +SFGV+  E+
Sbjct: 225 P---VKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 255

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 86/214 (40%), Gaps = 42/214 (19%)
Query: 290 RIVGEGASATVYKGSL------PSGGAVAVKRFEKPNRVECARNP---FTTEFATMAGCL 340
           R +G GA   VY+G +      PS   VAVK   +     C+      F  E A +    
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE----VCSEQDELDFLME-ALIISKF 90
Query: 341 RHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNN---SSSSIVLSWEKRLNIVLGVA 397
            H+N+V+  G   +     ++ E +  G L   L       S    L+    L++   +A
Sbjct: 91  NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 150
Query: 398 SALSYLHEECERQIIHRDVKACNILLDAEFN---AKLGDFE----------------ATI 438
               YL E      IHRD+ A N LL        AK+GDF                 A +
Sbjct: 151 CGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 207
Query: 439 PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEV 472
           P   + ++ PE    G+ + KTD +SFGV+  E+
Sbjct: 208 P---VKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 238

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 67/153 (43%), Gaps = 18/153 (11%)
Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASA 399
           L H+++V   G+  + + + +V E     SL ++     + +   +      IVLG    
Sbjct: 74  LAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC--- 130
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTMGYLAP 448
             YLH     ++IHRD+K  N+ L+ +   K+GDF                 GT  Y+AP
Sbjct: 131 -QYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAP 186
Query: 449 EYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDN 481
           E +     S + DV+S G +   +  GK P + 
Sbjct: 187 EVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 219

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 88/199 (44%), Gaps = 25/199 (12%)
Query: 290 RIVGEGASATVYKGSLPS----GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           R +GEG    V++G   S      AVA+K   K    +  R  F  E  TM     H ++
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTC-KNCTSDSVREKFLQEALTMRQ-FDHPHI 453
Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
           V+L G   E N + ++ E    G L   L     S   L     +     +++AL+YL  
Sbjct: 454 VKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFS---LDLASLILYAYQLSTALAYLES 509
Query: 406 ECERQIIHRDVKACNILLDAEFNAKLGDF-------EATIPAGTMG-----YLAPEYVYS 453
              ++ +HRD+ A N+L+ A    KLGDF       ++T    + G     ++APE +  
Sbjct: 510 ---KRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 566
Query: 454 GVPSEKTDVYSFGVVALEV 472
              +  +DV+ FGV   E+
Sbjct: 567 RRFTSASDVWMFGVCMWEI 585

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/141 (31%), Positives = 63/141 (44%), Gaps = 22/141 (15%)
Query: 353 CEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQII 412
           CE    +LV E    G L+K L  N         +  + +V  V+  + YL E      +
Sbjct: 81  CEAESWMLVMEMAELGPLNKYLQQNRHVKD----KNIIELVHQVSMGMKYLEES---NFV 133
Query: 413 HRDVKACNILLDAEFNAKLGDF---------EATIPAGTMG-----YLAPEYVYSGVPSE 458
           HRD+ A N+LL  +  AK+ DF         E    A T G     + APE +     S 
Sbjct: 134 HRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYYKFSS 193
Query: 459 KTDVYSFGVVALEV-AAGKSP 478
           K+DV+SFGV+  E  + G+ P
Sbjct: 194 KSDVWSFGVLMWEAFSYGQKP 214

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 86/214 (40%), Gaps = 42/214 (19%)
Query: 290 RIVGEGASATVYKGSL------PSGGAVAVKRFEKPNRVECARNP---FTTEFATMAGCL 340
           R +G GA   VY+G +      PS   VAVK   +     C+      F  E A +    
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE----VCSEQDELDFLME-ALIISKF 90
Query: 341 RHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNN---SSSSIVLSWEKRLNIVLGVA 397
            H+N+V+  G   +     ++ E +  G L   L       S    L+    L++   +A
Sbjct: 91  NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 150
Query: 398 SALSYLHEECERQIIHRDVKACNILLDAEFN---AKLGDFE----------------ATI 438
               YL E      IHRD+ A N LL        AK+GDF                 A +
Sbjct: 151 CGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 207
Query: 439 PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEV 472
           P   + ++ PE    G+ + KTD +SFGV+  E+
Sbjct: 208 P---VKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 238

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 96/227 (42%), Gaps = 35/227 (15%)
Query: 273 RLALTDIKQATLGFNKNRIVGEGASATVYKGSLPSGGAV-AVKRFEKP-----NRVECAR 326
           R+ LTD       FN   ++G+G+   V          + A+K  +K      + VEC  
Sbjct: 15  RVKLTD-------FNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECT- 66
Query: 327 NPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSW 386
                E   +A   +   L QL       + L  V EY+  G L  + H           
Sbjct: 67  ---MVEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDL--MYHIQQVGK--FKE 119
Query: 387 EKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF----EATIPA-- 440
            + +     ++  L +LH+   R II+RD+K  N++LD+E + K+ DF    E  +    
Sbjct: 120 PQAVFYAAEISIGLFFLHK---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVT 176
Query: 441 -----GTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDND 482
                GT  Y+APE +      +  D +++GV+  E+ AG+ P D +
Sbjct: 177 TREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE 223

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 86/214 (40%), Gaps = 42/214 (19%)
Query: 290 RIVGEGASATVYKGSL------PSGGAVAVKRFEKPNRVECARNP---FTTEFATMAGCL 340
           R +G GA   VY+G +      PS   VAVK   +     C+      F  E A +    
Sbjct: 63  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE----VCSEQDELDFLME-ALIISKF 117
Query: 341 RHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNN---SSSSIVLSWEKRLNIVLGVA 397
            H+N+V+  G   +     ++ E +  G L   L       S    L+    L++   +A
Sbjct: 118 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 177
Query: 398 SALSYLHEECERQIIHRDVKACNILLDAEFN---AKLGDFE----------------ATI 438
               YL E      IHRD+ A N LL        AK+GDF                 A +
Sbjct: 178 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 234
Query: 439 PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEV 472
           P   + ++ PE    G+ + KTD +SFGV+  E+
Sbjct: 235 P---VKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 265

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 84/199 (42%), Gaps = 35/199 (17%)
Query: 307 SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLP 366
           +G   A+K  +K   V+  +   T     +   +    LV+L+    + + L +V EY+P
Sbjct: 58  TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVP 117
Query: 367 NGSLDKILHNNS----------SSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDV 416
            G +   L              ++ IVL++E              YLH      +I+RD+
Sbjct: 118 GGEMFSHLRRIGRFXEPHARFYAAQIVLTFE--------------YLHS---LDLIYRDL 160
Query: 417 KACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVV 468
           K  N+L+D +   ++ DF              GT  YLAPE + S   ++  D ++ GV+
Sbjct: 161 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVL 220
Query: 469 ALEVAAGKSPVDNDGCVIV 487
             E+AAG  P   D  + +
Sbjct: 221 IYEMAAGYPPFFADQPIQI 239

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 89/213 (41%), Gaps = 29/213 (13%)
Query: 286 FNKNRIVGEGASATVYK------GSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGC 339
           + + R +G+G  A  Y+        + +G  V      KP++ E      +TE A +   
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKE----KMSTEIA-IHKS 98
Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASA 399
           L + ++V   G+  + + + +V E     SL   L  +     V   E R   +      
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSL---LELHKRRKAVTEPEARY-FMRQTIQG 154
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTMGYLAP 448
           + YLH     ++IHRD+K  N+ L+ + + K+GDF                 GT  Y+AP
Sbjct: 155 VQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAP 211
Query: 449 EYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDN 481
           E +     S + D++S G +   +  GK P + 
Sbjct: 212 EVLCKKGHSFEVDIWSLGCILYTLLVGKPPFET 244

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 89/213 (41%), Gaps = 29/213 (13%)
Query: 286 FNKNRIVGEGASATVYK------GSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGC 339
           + + R +G+G  A  Y+        + +G  V      KP++ E      +TE A +   
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKE----KMSTEIA-IHKS 98
Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASA 399
           L + ++V   G+  + + + +V E     SL   L  +     V   E R   +      
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSL---LELHKRRKAVTEPEARY-FMRQTIQG 154
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTMGYLAP 448
           + YLH     ++IHRD+K  N+ L+ + + K+GDF                 GT  Y+AP
Sbjct: 155 VQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAP 211
Query: 449 EYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDN 481
           E +     S + D++S G +   +  GK P + 
Sbjct: 212 EVLCKKGHSFEVDIWSLGCILYTLLVGKPPFET 244

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 90/207 (43%), Gaps = 21/207 (10%)
Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           + K   +GEG   TV+K  +  +   VA+KR    +  E   +    E   +   L+HKN
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKE-LKHKN 62
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           +V+L        +L LV+E+  +  L K      S +  L  E   + +  +   L + H
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFC-DQDLKKYF---DSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG-----------TMGYLAPEYVY- 452
               R ++HRD+K  N+L++     KL DF      G           T+ Y  P+ ++ 
Sbjct: 119 S---RNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175
Query: 453 SGVPSEKTDVYSFGVVALEVAAGKSPV 479
           + + S   D++S G +  E+A    P+
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAARPL 202

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/141 (31%), Positives = 64/141 (45%), Gaps = 22/141 (15%)
Query: 353 CEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQII 412
           CE    +LV E    G L+K L  N      +  +  + +V  V+  + YL E      +
Sbjct: 439 CEAESWMLVMEMAELGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYLEES---NFV 491
Query: 413 HRDVKACNILLDAEFNAKLGDF---------EATIPAGTMG-----YLAPEYVYSGVPSE 458
           HRD+ A N+LL  +  AK+ DF         E    A T G     + APE +     S 
Sbjct: 492 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 551
Query: 459 KTDVYSFGVVALEV-AAGKSP 478
           K+DV+SFGV+  E  + G+ P
Sbjct: 552 KSDVWSFGVLMWEAFSYGQKP 572

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 89/213 (41%), Gaps = 29/213 (13%)
Query: 286 FNKNRIVGEGASATVYK------GSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGC 339
           + + R +G+G  A  Y+        + +G  V      KP++ E      +TE A +   
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKE----KMSTEIA-IHKS 98
Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASA 399
           L + ++V   G+  + + + +V E     SL   L  +     V   E R   +      
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSL---LELHKRRKAVTEPEARY-FMRQTIQG 154
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP-----------AGTMGYLAP 448
           + YLH     ++IHRD+K  N+ L+ + + K+GDF                 GT  Y+AP
Sbjct: 155 VQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAP 211
Query: 449 EYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDN 481
           E +     S + D++S G +   +  GK P + 
Sbjct: 212 EVLCKKGHSFEVDIWSLGCILYTLLVGKPPFET 244

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/141 (31%), Positives = 64/141 (45%), Gaps = 22/141 (15%)
Query: 353 CEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQII 412
           CE    +LV E    G L+K L  N      +  +  + +V  V+  + YL E      +
Sbjct: 440 CEAESWMLVMEMAELGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYLEES---NFV 492
Query: 413 HRDVKACNILLDAEFNAKLGDF---------EATIPAGTMG-----YLAPEYVYSGVPSE 458
           HRD+ A N+LL  +  AK+ DF         E    A T G     + APE +     S 
Sbjct: 493 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 552
Query: 459 KTDVYSFGVVALEV-AAGKSP 478
           K+DV+SFGV+  E  + G+ P
Sbjct: 553 KSDVWSFGVLMWEAFSYGQKP 573

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 88/199 (44%), Gaps = 25/199 (12%)
Query: 290 RIVGEGASATVYKGSLPS----GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           R +GEG    V++G   S      AVA+K   K    +  R  F  E  TM     H ++
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTC-KNCTSDSVREKFLQEALTMRQ-FDHPHI 73
Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
           V+L G   E N + ++ E    G L   L     S   L     +     +++AL+YL  
Sbjct: 74  VKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYLES 129
Query: 406 ECERQIIHRDVKACNILLDAEFNAKLGDF-------EATIPAGTMG-----YLAPEYVYS 453
              ++ +HRD+ A N+L+ +    KLGDF       ++T    + G     ++APE +  
Sbjct: 130 ---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 186
Query: 454 GVPSEKTDVYSFGVVALEV 472
              +  +DV+ FGV   E+
Sbjct: 187 RRFTSASDVWMFGVCMWEI 205

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 72/160 (45%), Gaps = 23/160 (14%)
Query: 334 ATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIV 393
           A +   L +  +V++ G  CE    +LV E    G L+K L  N         +  + +V
Sbjct: 79  ANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKD----KNIIELV 133
Query: 394 LGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGTMG 444
             V+  + YL E      +HRD+ A N+LL  +  AK+ DF         E    A T G
Sbjct: 134 HQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 190
Query: 445 -----YLAPEYVYSGVPSEKTDVYSFGVVALEV-AAGKSP 478
                + APE +     S K+DV+SFGV+  E  + G+ P
Sbjct: 191 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 72/160 (45%), Gaps = 23/160 (14%)
Query: 334 ATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIV 393
           A +   L +  +V++ G  CE    +LV E    G L+K L  N         +  + +V
Sbjct: 79  ANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKD----KNIIELV 133
Query: 394 LGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGTMG 444
             V+  + YL E      +HRD+ A N+LL  +  AK+ DF         E    A T G
Sbjct: 134 HQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 190
Query: 445 -----YLAPEYVYSGVPSEKTDVYSFGVVALEV-AAGKSP 478
                + APE +     S K+DV+SFGV+  E  + G+ P
Sbjct: 191 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/141 (31%), Positives = 63/141 (44%), Gaps = 22/141 (15%)
Query: 353 CEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQII 412
           CE    +LV E    G L+K L  N         +  + +V  V+  + YL E      +
Sbjct: 75  CEAESWMLVMEMAELGPLNKYLQQNRHVKD----KNIIELVHQVSMGMKYLEES---NFV 127
Query: 413 HRDVKACNILLDAEFNAKLGDF---------EATIPAGTMG-----YLAPEYVYSGVPSE 458
           HRD+ A N+LL  +  AK+ DF         E    A T G     + APE +     S 
Sbjct: 128 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 187
Query: 459 KTDVYSFGVVALEV-AAGKSP 478
           K+DV+SFGV+  E  + G+ P
Sbjct: 188 KSDVWSFGVLMWEAFSYGQKP 208

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/141 (31%), Positives = 63/141 (44%), Gaps = 22/141 (15%)
Query: 353 CEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQII 412
           CE    +LV E    G L+K L  N         +  + +V  V+  + YL E      +
Sbjct: 87  CEAESWMLVMEMAELGPLNKYLQQNRHVKD----KNIIELVHQVSMGMKYLEES---NFV 139
Query: 413 HRDVKACNILLDAEFNAKLGDF---------EATIPAGTMG-----YLAPEYVYSGVPSE 458
           HRD+ A N+LL  +  AK+ DF         E    A T G     + APE +     S 
Sbjct: 140 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 199
Query: 459 KTDVYSFGVVALEV-AAGKSP 478
           K+DV+SFGV+  E  + G+ P
Sbjct: 200 KSDVWSFGVLMWEAFSYGQKP 220

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/141 (31%), Positives = 63/141 (44%), Gaps = 22/141 (15%)
Query: 353 CEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQII 412
           CE    +LV E    G L+K L  N         +  + +V  V+  + YL E      +
Sbjct: 81  CEAESWMLVMEMAELGPLNKYLQQNRHVKD----KNIIELVHQVSMGMKYLEES---NFV 133
Query: 413 HRDVKACNILLDAEFNAKLGDF---------EATIPAGTMG-----YLAPEYVYSGVPSE 458
           HRD+ A N+LL  +  AK+ DF         E    A T G     + APE +     S 
Sbjct: 134 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 193
Query: 459 KTDVYSFGVVALEV-AAGKSP 478
           K+DV+SFGV+  E  + G+ P
Sbjct: 194 KSDVWSFGVLMWEAFSYGQKP 214

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/141 (31%), Positives = 63/141 (44%), Gaps = 22/141 (15%)
Query: 353 CEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQII 412
           CE    +LV E    G L+K L  N         +  + +V  V+  + YL E      +
Sbjct: 77  CEAESWMLVMEMAELGPLNKYLQQNRHVKD----KNIIELVHQVSMGMKYLEES---NFV 129
Query: 413 HRDVKACNILLDAEFNAKLGDF---------EATIPAGTMG-----YLAPEYVYSGVPSE 458
           HRD+ A N+LL  +  AK+ DF         E    A T G     + APE +     S 
Sbjct: 130 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 189
Query: 459 KTDVYSFGVVALEV-AAGKSP 478
           K+DV+SFGV+  E  + G+ P
Sbjct: 190 KSDVWSFGVLMWEAFSYGQKP 210

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 88/198 (44%), Gaps = 23/198 (11%)
Query: 290 RIVGEGASATVYKGSL--PSGGAVAVK-RFEKPNRVECARNPFTTEFATMAGCLRHKNLV 346
           R +GEG    V++G    P   A+AV  +  K    +  R  F  E  TM     H ++V
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQ-FDHPHIV 74
Query: 347 QLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEE 406
           +L G   E N + ++ E    G L   L     S   L     +     +++AL+YL   
Sbjct: 75  KLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYLES- 129
Query: 407 CERQIIHRDVKACNILLDAEFNAKLGDF-------EATIPAGTMG-----YLAPEYVYSG 454
             ++ +HRD+ A N+L+ +    KLGDF       ++T    + G     ++APE +   
Sbjct: 130 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 187
Query: 455 VPSEKTDVYSFGVVALEV 472
             +  +DV+ FGV   E+
Sbjct: 188 RFTSASDVWMFGVCMWEI 205

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/141 (31%), Positives = 63/141 (44%), Gaps = 22/141 (15%)
Query: 353 CEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQII 412
           CE    +LV E    G L+K L  N         +  + +V  V+  + YL E      +
Sbjct: 95  CEAESWMLVMEMAELGPLNKYLQQNRHVKD----KNIIELVHQVSMGMKYLEES---NFV 147
Query: 413 HRDVKACNILLDAEFNAKLGDF---------EATIPAGTMG-----YLAPEYVYSGVPSE 458
           HRD+ A N+LL  +  AK+ DF         E    A T G     + APE +     S 
Sbjct: 148 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 207
Query: 459 KTDVYSFGVVALEV-AAGKSP 478
           K+DV+SFGV+  E  + G+ P
Sbjct: 208 KSDVWSFGVLMWEAFSYGQKP 228

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 91/207 (43%), Gaps = 28/207 (13%)
Query: 292 VGEGASATVYKGSL--PSGGAVAVK-RFEKPNRVEC--ARNPFTTEFATMAGCLRHKNLV 346
           +G+G+   V +G    PSG  V+V  +  KP+ +    A + F  E   M   L H+NL+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS-LDHRNLI 74
Query: 347 QLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEE 406
           +L G       + +V E  P GSL   L  +    ++ +  +     + VA  + YL   
Sbjct: 75  RLYG-VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSR---YAVQVAEGMGYLES- 129
Query: 407 CERQIIHRDVKACNILLDAEFNAKLGDF--EATIPAGTMGYL------------APEYVY 452
             ++ IHRD+ A N+LL      K+GDF     +P     Y+            APE + 
Sbjct: 130 --KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 453 SGVPSEKTDVYSFGVVALEV-AAGKSP 478
           +   S  +D + FGV   E+   G+ P
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 89/211 (42%), Gaps = 16/211 (7%)
Query: 286 FNKNRIVGEGASATVYK-GSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F + + +G G+   V     + +G   A+K  +K   V+  +   T     +   +    
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           LV+L+    + + L +V EY+  G +   L      S   +      IVL       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEYLH 158
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGVP 456
                 +I+RD+K  N+L+D +   ++ DF              GT  YLAPE + S   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 457 SEKTDVYSFGVVALEVAAGKSPVDNDGCVIV 487
           ++  D ++ GV+  E+AAG  P   D  + +
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 91/207 (43%), Gaps = 28/207 (13%)
Query: 292 VGEGASATVYKGSL--PSGGAVAVK-RFEKPNRVEC--ARNPFTTEFATMAGCLRHKNLV 346
           +G+G+   V +G    PSG  V+V  +  KP+ +    A + F  E   M   L H+NL+
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS-LDHRNLI 78
Query: 347 QLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEE 406
           +L G       + +V E  P GSL   L  +    ++ +  +     + VA  + YL   
Sbjct: 79  RLYG-VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSR---YAVQVAEGMGYLES- 133
Query: 407 CERQIIHRDVKACNILLDAEFNAKLGDF--EATIPAGTMGYL------------APEYVY 452
             ++ IHRD+ A N+LL      K+GDF     +P     Y+            APE + 
Sbjct: 134 --KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 191
Query: 453 SGVPSEKTDVYSFGVVALEV-AAGKSP 478
           +   S  +D + FGV   E+   G+ P
Sbjct: 192 TRTFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 88/198 (44%), Gaps = 23/198 (11%)
Query: 290 RIVGEGASATVYKGSL--PSGGAVAVK-RFEKPNRVECARNPFTTEFATMAGCLRHKNLV 346
           R +GEG    V++G    P   A+AV  +  K    +  R  F  E  TM     H ++V
Sbjct: 13  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQ-FDHPHIV 71
Query: 347 QLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEE 406
           +L G   E N + ++ E    G L   L     S   L     +     +++AL+YL   
Sbjct: 72  KLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYLES- 126
Query: 407 CERQIIHRDVKACNILLDAEFNAKLGDF-------EATIPAGTMG-----YLAPEYVYSG 454
             ++ +HRD+ A N+L+ +    KLGDF       ++T    + G     ++APE +   
Sbjct: 127 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 184
Query: 455 VPSEKTDVYSFGVVALEV 472
             +  +DV+ FGV   E+
Sbjct: 185 RFTSASDVWMFGVCMWEI 202

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 91/207 (43%), Gaps = 28/207 (13%)
Query: 292 VGEGASATVYKGSL--PSGGAVAVK-RFEKPNRVEC--ARNPFTTEFATMAGCLRHKNLV 346
           +G+G+   V +G    PSG  V+V  +  KP+ +    A + F  E   M   L H+NL+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS-LDHRNLI 74
Query: 347 QLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEE 406
           +L G       + +V E  P GSL   L  +    ++ +  +     + VA  + YL   
Sbjct: 75  RLYG-VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSR---YAVQVAEGMGYLES- 129
Query: 407 CERQIIHRDVKACNILLDAEFNAKLGDF--EATIPAGTMGYL------------APEYVY 452
             ++ IHRD+ A N+LL      K+GDF     +P     Y+            APE + 
Sbjct: 130 --KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 453 SGVPSEKTDVYSFGVVALEV-AAGKSP 478
           +   S  +D + FGV   E+   G+ P
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 88/198 (44%), Gaps = 23/198 (11%)
Query: 290 RIVGEGASATVYKGSL--PSGGAVAVK-RFEKPNRVECARNPFTTEFATMAGCLRHKNLV 346
           R +GEG    V++G    P   A+AV  +  K    +  R  F  E  TM     H ++V
Sbjct: 21  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQ-FDHPHIV 79
Query: 347 QLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEE 406
           +L G   E N + ++ E    G L   L     S   L     +     +++AL+YL   
Sbjct: 80  KLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYLES- 134
Query: 407 CERQIIHRDVKACNILLDAEFNAKLGDF-------EATIPAGTMG-----YLAPEYVYSG 454
             ++ +HRD+ A N+L+ +    KLGDF       ++T    + G     ++APE +   
Sbjct: 135 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 192
Query: 455 VPSEKTDVYSFGVVALEV 472
             +  +DV+ FGV   E+
Sbjct: 193 RFTSASDVWMFGVCMWEI 210

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 88/198 (44%), Gaps = 23/198 (11%)
Query: 290 RIVGEGASATVYKGSL--PSGGAVAVK-RFEKPNRVECARNPFTTEFATMAGCLRHKNLV 346
           R +GEG    V++G    P   A+AV  +  K    +  R  F  E  TM     H ++V
Sbjct: 18  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQ-FDHPHIV 76
Query: 347 QLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEE 406
           +L G   E N + ++ E    G L   L     S   L     +     +++AL+YL   
Sbjct: 77  KLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYLES- 131
Query: 407 CERQIIHRDVKACNILLDAEFNAKLGDF-------EATIPAGTMG-----YLAPEYVYSG 454
             ++ +HRD+ A N+L+ +    KLGDF       ++T    + G     ++APE +   
Sbjct: 132 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 189
Query: 455 VPSEKTDVYSFGVVALEV 472
             +  +DV+ FGV   E+
Sbjct: 190 RFTSASDVWMFGVCMWEI 207

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 91/207 (43%), Gaps = 28/207 (13%)
Query: 292 VGEGASATVYKGSL--PSGGAVAVK-RFEKPNRVEC--ARNPFTTEFATMAGCLRHKNLV 346
           +G+G+   V +G    PSG  V+V  +  KP+ +    A + F  E   M   L H+NL+
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS-LDHRNLI 78
Query: 347 QLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEE 406
           +L G       + +V E  P GSL   L  +    ++ +  +     + VA  + YL   
Sbjct: 79  RLYG-VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSR---YAVQVAEGMGYLES- 133
Query: 407 CERQIIHRDVKACNILLDAEFNAKLGDF--EATIPAGTMGYL------------APEYVY 452
             ++ IHRD+ A N+LL      K+GDF     +P     Y+            APE + 
Sbjct: 134 --KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 191
Query: 453 SGVPSEKTDVYSFGVVALEV-AAGKSP 478
           +   S  +D + FGV   E+   G+ P
Sbjct: 192 TRTFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 88/198 (44%), Gaps = 23/198 (11%)
Query: 290 RIVGEGASATVYKGSL--PSGGAVAVK-RFEKPNRVECARNPFTTEFATMAGCLRHKNLV 346
           R +GEG    V++G    P   A+AV  +  K    +  R  F  E  TM     H ++V
Sbjct: 19  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQ-FDHPHIV 77
Query: 347 QLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEE 406
           +L G   E N + ++ E    G L   L     S   L     +     +++AL+YL   
Sbjct: 78  KLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYLES- 132
Query: 407 CERQIIHRDVKACNILLDAEFNAKLGDF-------EATIPAGTMG-----YLAPEYVYSG 454
             ++ +HRD+ A N+L+ +    KLGDF       ++T    + G     ++APE +   
Sbjct: 133 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 190
Query: 455 VPSEKTDVYSFGVVALEV 472
             +  +DV+ FGV   E+
Sbjct: 191 RFTSASDVWMFGVCMWEI 208

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 86/204 (42%), Gaps = 32/204 (15%)
Query: 292 VGEGASATV---YKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           +G GA   V   Y   L     VA+K+  +P + +        E   M  C+ HKN++ L
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMK-CVNHKNIISL 88
Query: 349 ------QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
                 Q    E  ++ LV E L + +L +++       + L  E+   ++  +   + +
Sbjct: 89  LNVFTPQKTLEEFQDVYLVME-LMDANLXQVIQ------MELDHERMSYLLYQMLXGIKH 141
Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG----------TMGYLAPEYVY 452
           LH      IIHRD+K  NI++ ++   K+ DF     AG          T  Y APE + 
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 453 SGVPSEKTDVYSFGVVALEVAAGK 476
                E  D++S G +  E+   K
Sbjct: 199 GMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 88/198 (44%), Gaps = 23/198 (11%)
Query: 290 RIVGEGASATVYKGSL--PSGGAVAVK-RFEKPNRVECARNPFTTEFATMAGCLRHKNLV 346
           R +GEG    V++G    P   A+AV  +  K    +  R  F  E  TM     H ++V
Sbjct: 44  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQ-FDHPHIV 102
Query: 347 QLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEE 406
           +L G   E N + ++ E    G L   L     S   L     +     +++AL+YL   
Sbjct: 103 KLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYLES- 157
Query: 407 CERQIIHRDVKACNILLDAEFNAKLGDF-------EATIPAGTMG-----YLAPEYVYSG 454
             ++ +HRD+ A N+L+ +    KLGDF       ++T    + G     ++APE +   
Sbjct: 158 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 215
Query: 455 VPSEKTDVYSFGVVALEV 472
             +  +DV+ FGV   E+
Sbjct: 216 RFTSASDVWMFGVCMWEI 233

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 91/207 (43%), Gaps = 28/207 (13%)
Query: 292 VGEGASATVYKGSL--PSGGAVAVK-RFEKPNRVEC--ARNPFTTEFATMAGCLRHKNLV 346
           +G+G+   V +G    PSG  V+V  +  KP+ +    A + F  E   M   L H+NL+
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS-LDHRNLI 84
Query: 347 QLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEE 406
           +L G       + +V E  P GSL   L  +    ++ +  +     + VA  + YL   
Sbjct: 85  RLYG-VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSR---YAVQVAEGMGYLES- 139
Query: 407 CERQIIHRDVKACNILLDAEFNAKLGDF--EATIPAGTMGYL------------APEYVY 452
             ++ IHRD+ A N+LL      K+GDF     +P     Y+            APE + 
Sbjct: 140 --KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 197
Query: 453 SGVPSEKTDVYSFGVVALEV-AAGKSP 478
           +   S  +D + FGV   E+   G+ P
Sbjct: 198 TRTFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 91/221 (41%), Gaps = 36/221 (16%)
Query: 286 FNKNRIVGEGASATVYK-GSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F + + +G G+   V     + +G   A+K  +K   V+  +   T     +   +    
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNS----------SSSIVLSWEKRLNIVL 394
           L +L+    + + L +V EY P G +   L              ++ IVL++E       
Sbjct: 104 LTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE------- 156
Query: 395 GVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYL 446
                  YLH      +I+RD+K  N+++D +   K+ DF              GT  YL
Sbjct: 157 -------YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYL 206
Query: 447 APEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIV 487
           APE + S   ++  D ++ GV+  E+AAG  P   D  + +
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 247

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 89/211 (42%), Gaps = 16/211 (7%)
Query: 286 FNKNRIVGEGASATVY-KGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F++ + +G G+   V       SG   A+K  +K   V+  +   T     +   +    
Sbjct: 30  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 89
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           LV+L+    + + L +V EY+  G +   L      S   +      IVL       YLH
Sbjct: 90  LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEYLH 145
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGVP 456
                 +I+RD+K  N+L+D +   ++ DF              GT  YLAPE + S   
Sbjct: 146 S---LDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 202
Query: 457 SEKTDVYSFGVVALEVAAGKSPVDNDGCVIV 487
           ++  D ++ GV+  E+AAG  P   D  + +
Sbjct: 203 NKAVDWWALGVLIYEMAAGYPPFFADQPIQI 233

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 89/211 (42%), Gaps = 16/211 (7%)
Query: 286 FNKNRIVGEGASATVY-KGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F++ + +G G+   V       SG   A+K  +K   V+  +   T     +   +    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           LV+L+    + + L +V EY+  G +   L      S   +      IVL       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEYLH 158
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGVP 456
                 +I+RD+K  N+L+D +   ++ DF              GT  YLAPE + S   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLXGTPEYLAPEIILSKGY 215
Query: 457 SEKTDVYSFGVVALEVAAGKSPVDNDGCVIV 487
           ++  D ++ GV+  E+AAG  P   D  + +
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 26/209 (12%)
Query: 286 FNKNRIVGEGASATVY--KGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHK 343
           +   R++G+G+   V   K  + +G   AVK   K    +            +   L H 
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
           N+ +L  +  +     LV E    G L D+I+     S +  +      I+  V S ++Y
Sbjct: 87  NIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA-----RIIRQVLSGITY 141
Query: 403 LHEECERQIIHRDVKACNILLDA---EFNAKLGD------FEATIPA----GTMGYLAPE 449
            H+    +I+HRD+K  N+LL++   + N ++ D      FEA+       GT  Y+APE
Sbjct: 142 XHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPE 198
Query: 450 YVYSGVPSEKTDVYSFGVVALEVAAGKSP 478
            V  G   EK DV+S GV+   + +G  P
Sbjct: 199 -VLHGTYDEKCDVWSTGVILYILLSGCPP 226

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 89/211 (42%), Gaps = 16/211 (7%)
Query: 286 FNKNRIVGEGASATVYK-GSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F++ + +G G+   V       SG   A+K  +K   V+  +   T     +   +    
Sbjct: 44  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           LV+L+    + + L +V EY+  G +   L      S   +      IVL       YLH
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEYLH 159
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGVP 456
                 +I+RD+K  N+L+D +   ++ DF              GT  YLAPE + S   
Sbjct: 160 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 457 SEKTDVYSFGVVALEVAAGKSPVDNDGCVIV 487
           ++  D ++ GV+  E+AAG  P   D  + +
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPFFADQPIQI 247

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 86/204 (42%), Gaps = 32/204 (15%)
Query: 292 VGEGASATV---YKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           +G GA   V   Y   L     VA+K+  +P + +        E   M  C+ HKN++ L
Sbjct: 25  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMK-CVNHKNIISL 81
Query: 349 ------QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
                 Q    E  ++ LV E L + +L +++       + L  E+   ++  +   + +
Sbjct: 82  LNVFTPQKTLEEFQDVYLVME-LMDANLXQVIQ------MELDHERMSYLLYQMLXGIKH 134
Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG----------TMGYLAPEYVY 452
           LH      IIHRD+K  NI++ ++   K+ DF     AG          T  Y APE + 
Sbjct: 135 LHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 191
Query: 453 SGVPSEKTDVYSFGVVALEVAAGK 476
                E  D++S G +  E+   K
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 89/211 (42%), Gaps = 16/211 (7%)
Query: 286 FNKNRIVGEGASATVY-KGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F++ + +G G+   V       SG   A+K  +K   V+  +   T     +   +    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           LV+L+    + + L +V EY+  G +   L      S   +      IVL       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEYLH 158
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGVP 456
                 +I+RD+K  N+L+D +   ++ DF              GT  YLAPE + S   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 457 SEKTDVYSFGVVALEVAAGKSPVDNDGCVIV 487
           ++  D ++ GV+  E+AAG  P   D  + +
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 88/199 (44%), Gaps = 25/199 (12%)
Query: 290 RIVGEGASATVYKGSLPS----GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           R +GEG    V++G   S      AVA+K   K    +  R  F  E  TM     H ++
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTC-KNCTSDSVREKFLQEALTMRQ-FDHPHI 453
Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
           V+L G   E N + ++ E    G L   L     S   L     +     +++AL+YL  
Sbjct: 454 VKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFS---LDLASLILYAYQLSTALAYLES 509
Query: 406 ECERQIIHRDVKACNILLDAEFNAKLGDF-------EATIPAGTMG-----YLAPEYVYS 453
              ++ +HRD+ A N+L+ +    KLGDF       ++T    + G     ++APE +  
Sbjct: 510 ---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 566
Query: 454 GVPSEKTDVYSFGVVALEV 472
              +  +DV+ FGV   E+
Sbjct: 567 RRFTSASDVWMFGVCMWEI 585

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 89/211 (42%), Gaps = 16/211 (7%)
Query: 286 FNKNRIVGEGASATVY-KGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F++ + +G G+   V       SG   A+K  +K   V+  +   T     +   +    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           LV+L+    + + L +V EY+  G +   L      S   +      IVL       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEYLH 158
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGVP 456
                 +I+RD+K  N+L+D +   ++ DF              GT  YLAPE + S   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 457 SEKTDVYSFGVVALEVAAGKSPVDNDGCVIV 487
           ++  D ++ GV+  E+AAG  P   D  + +
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 89/211 (42%), Gaps = 16/211 (7%)
Query: 286 FNKNRIVGEGASATVY-KGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F++ + +G G+   V       SG   A+K  +K   V+  +   T     +   +    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           LV+L+    + + L +V EY+  G +   L      S   +      IVL       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEYLH 158
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGVP 456
                 +I+RD+K  N+L+D +   ++ DF              GT  YLAPE + S   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 457 SEKTDVYSFGVVALEVAAGKSPVDNDGCVIV 487
           ++  D ++ GV+  E+AAG  P   D  + +
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 89/211 (42%), Gaps = 16/211 (7%)
Query: 286 FNKNRIVGEGASATVYK-GSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F++ + +G G+   V       SG   A+K  +K   V+  +   T     +   +    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           LV+L+    + + L +V EY+  G +   L      S   +      IVL       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEYLH 158
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGVP 456
                 +I+RD+K  N+L+D +   ++ DF              GT  YLAPE + S   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 457 SEKTDVYSFGVVALEVAAGKSPVDNDGCVIV 487
           ++  D ++ GV+  E+AAG  P   D  + +
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 90/207 (43%), Gaps = 28/207 (13%)
Query: 292 VGEGASATVYKGSL--PSGGAVAVK-RFEKPNRVEC--ARNPFTTEFATMAGCLRHKNLV 346
           +G+G+   V +G    PSG  V+V  +  KP+ +    A + F  E   M   L H+NL+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS-LDHRNLI 74
Query: 347 QLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEE 406
           +L G       + +V E  P GSL   L  +    ++ +  +     + VA  + YL   
Sbjct: 75  RLYG-VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSR---YAVQVAEGMGYLES- 129
Query: 407 CERQIIHRDVKACNILLDAEFNAKLGDF--EATIPAG------------TMGYLAPEYVY 452
             ++ IHRD+ A N+LL      K+GDF     +P                 + APE + 
Sbjct: 130 --KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLK 187
Query: 453 SGVPSEKTDVYSFGVVALEV-AAGKSP 478
           +   S  +D + FGV   E+   G+ P
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 76/178 (42%), Gaps = 34/178 (19%)
Query: 384 LSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--------- 434
           L+ E  +     VA  + +L     R+ IHRD+ A NILL  +   K+ DF         
Sbjct: 190 LTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246
Query: 435 -------EATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEV-AAGKSPVDNDGCVI 486
                  +A +P   + ++APE ++  V + ++DV+SFGV+  E+ + G SP    G  I
Sbjct: 247 PDYVRKGDARLP---LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY--PGVKI 301
Query: 487 VDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARIL 544
            +      K+G  + A D+             M    L C H    +RP+  E    L
Sbjct: 302 DEEFCRRLKEGTRMRAPDY---------TTPEMYQTMLDCWHGEPSQRPTFSELVEHL 350

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 76/178 (42%), Gaps = 34/178 (19%)
Query: 384 LSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--------- 434
           L+ E  +     VA  + +L     R+ IHRD+ A NILL  +   K+ DF         
Sbjct: 195 LTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 251
Query: 435 -------EATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEV-AAGKSPVDNDGCVI 486
                  +A +P   + ++APE ++  V + ++DV+SFGV+  E+ + G SP    G  I
Sbjct: 252 PDYVRKGDARLP---LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY--PGVKI 306
Query: 487 VDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARIL 544
            +      K+G  + A D+             M    L C H    +RP+  E    L
Sbjct: 307 DEEFCRRLKEGTRMRAPDY---------TTPEMYQTMLDCWHGEPSQRPTFSELVEHL 355

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 87/206 (42%), Gaps = 16/206 (7%)
Query: 286 FNKNRIVGEGASATVY-KGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F++ + +G G+   V       SG   A+K  +K   V+  +   T     +   +    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           LV+L+    + + L +V EY+  G +   L      S   +      IVL       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEYLH 158
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGVP 456
                 +I+RD+K  N+L+D +   ++ DF              GT  YLAPE + S   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 457 SEKTDVYSFGVVALEVAAGKSPVDND 482
           ++  D ++ GV+  E+AAG  P   D
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFAD 241

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 76/178 (42%), Gaps = 34/178 (19%)
Query: 384 LSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--------- 434
           L+ E  +     VA  + +L     R+ IHRD+ A NILL  +   K+ DF         
Sbjct: 188 LTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 244
Query: 435 -------EATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEV-AAGKSPVDNDGCVI 486
                  +A +P   + ++APE ++  V + ++DV+SFGV+  E+ + G SP    G  I
Sbjct: 245 PDYVRKGDARLP---LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY--PGVKI 299
Query: 487 VDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARIL 544
            +      K+G  + A D+             M    L C H    +RP+  E    L
Sbjct: 300 DEEFCRRLKEGTRMRAPDY---------TTPEMYQTMLDCWHGEPSQRPTFSELVEHL 348

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 93/215 (43%), Gaps = 35/215 (16%)
Query: 291 IVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECAR--NPFTTEFATMAGCLRHKNLVQ 347
           I+G+GA+A V++G    +G   A+K F   N +   R  +    EF  +   L HKN+V+
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVF---NNISFLRPVDVQMREFEVLKK-LNHKNIVK 71
Query: 348 LQGWCCEGN--ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
           L     E      VL+ E+ P GSL  +L    S++  L   + L ++  V   +++L E
Sbjct: 72  LFAIEEETTTRHKVLIMEFCPCGSLYTVL-EEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 406 ECERQIIHRDVKACNILL----DAEFNAKLGDFEA----------TIPAGTMGYLAPEYV 451
                I+HR++K  NI+     D +   KL DF A              GT  YL P+  
Sbjct: 131 NG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEYLHPDMY 187
Query: 452 YSGVPSE--------KTDVYSFGVVALEVAAGKSP 478
              V  +          D++S GV     A G  P
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 90/207 (43%), Gaps = 28/207 (13%)
Query: 292 VGEGASATVYKGSL--PSGGAVAVK-RFEKPNRVEC--ARNPFTTEFATMAGCLRHKNLV 346
           +G+G+   V +G    PSG  V+V  +  KP+ +    A + F  E   M   L H+NL+
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS-LDHRNLI 84
Query: 347 QLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEE 406
           +L G       + +V E  P GSL   L  +    ++ +  +     + VA  + YL   
Sbjct: 85  RLYG-VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSR---YAVQVAEGMGYLES- 139
Query: 407 CERQIIHRDVKACNILLDAEFNAKLGDF--EATIPAG------------TMGYLAPEYVY 452
             ++ IHRD+ A N+LL      K+GDF     +P                 + APE + 
Sbjct: 140 --KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLK 197
Query: 453 SGVPSEKTDVYSFGVVALEV-AAGKSP 478
           +   S  +D + FGV   E+   G+ P
Sbjct: 198 TRTFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 76/178 (42%), Gaps = 34/178 (19%)
Query: 384 LSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--------- 434
           L+ E  +     VA  + +L     R+ IHRD+ A NILL  +   K+ DF         
Sbjct: 197 LTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 253
Query: 435 -------EATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEV-AAGKSPVDNDGCVI 486
                  +A +P   + ++APE ++  V + ++DV+SFGV+  E+ + G SP    G  I
Sbjct: 254 PDYVRKGDARLP---LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY--PGVKI 308
Query: 487 VDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARIL 544
            +      K+G  + A D+             M    L C H    +RP+  E    L
Sbjct: 309 DEEFCRRLKEGTRMRAPDY---------TTPEMYQTMLDCWHGEPSQRPTFSELVEHL 357

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 93/215 (43%), Gaps = 35/215 (16%)
Query: 291 IVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECAR--NPFTTEFATMAGCLRHKNLVQ 347
           I+G+GA+A V++G    +G   A+K F   N +   R  +    EF  +   L HKN+V+
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVF---NNISFLRPVDVQMREFEVLKK-LNHKNIVK 71
Query: 348 LQGWCCEGN--ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
           L     E      VL+ E+ P GSL  +L    S++  L   + L ++  V   +++L E
Sbjct: 72  LFAIEEETTTRHKVLIMEFCPCGSLYTVL-EEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 406 ECERQIIHRDVKACNILL----DAEFNAKLGDFEATIPA----------GTMGYLAPEYV 451
                I+HR++K  NI+     D +   KL DF A              GT  YL P+  
Sbjct: 131 NG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187
Query: 452 YSGVPSE--------KTDVYSFGVVALEVAAGKSP 478
              V  +          D++S GV     A G  P
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 96/227 (42%), Gaps = 45/227 (19%)
Query: 292 VGEGASATVYKG-SLPSGGA-VAVKRFEKPNRVECARN--PFTT--EFATMAG--CLRHK 343
           +GEGA   V+K   L +GG  VA+KR     RV+      P +T  E A +       H 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRV----RVQTGEEGMPLSTIREVAVLRHLETFEHP 74
Query: 344 NLVQLQGWCC-----EGNELVLVYEYLPNG---SLDKILHNNSSSSIVLSWEKRLNIVLG 395
           N+V+L   C         +L LV+E++       LDK+      +  +       +++  
Sbjct: 75  NVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK------DMMFQ 128
Query: 396 VASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF----------EATIPAGTMGY 445
           +   L +LH     +++HRD+K  NIL+ +    KL DF            T    T+ Y
Sbjct: 129 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWY 185
Query: 446 LAPEYVYSGVPSEKTDVYSFGVVALE------VAAGKSPVDNDGCVI 486
            APE +     +   D++S G +  E      +  G S VD  G ++
Sbjct: 186 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL 232

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 89/211 (42%), Gaps = 16/211 (7%)
Query: 286 FNKNRIVGEGASATVY-KGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F++ + +G G+   V       SG   A+K  +K   V+  +   T     +   +    
Sbjct: 64  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 123
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           LV+L+    + + L +V EY+  G +   L      S   +      IVL       YLH
Sbjct: 124 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEYLH 179
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGVP 456
                 +I+RD+K  N+L+D +   ++ DF              GT  YLAPE + S   
Sbjct: 180 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWTLCGTPEYLAPEIILSKGY 236
Query: 457 SEKTDVYSFGVVALEVAAGKSPVDNDGCVIV 487
           ++  D ++ GV+  E+AAG  P   D  + +
Sbjct: 237 NKAVDWWALGVLIYEMAAGYPPFFADQPIQI 267

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 96/227 (42%), Gaps = 45/227 (19%)
Query: 292 VGEGASATVYKG-SLPSGGA-VAVKRFEKPNRVECARN--PFTT--EFATMAG--CLRHK 343
           +GEGA   V+K   L +GG  VA+KR     RV+      P +T  E A +       H 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRV----RVQTGEEGMPLSTIREVAVLRHLETFEHP 74
Query: 344 NLVQLQGWCC-----EGNELVLVYEYLPNG---SLDKILHNNSSSSIVLSWEKRLNIVLG 395
           N+V+L   C         +L LV+E++       LDK+      +  +       +++  
Sbjct: 75  NVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK------DMMFQ 128
Query: 396 VASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF----------EATIPAGTMGY 445
           +   L +LH     +++HRD+K  NIL+ +    KL DF            T    T+ Y
Sbjct: 129 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWY 185
Query: 446 LAPEYVYSGVPSEKTDVYSFGVVALE------VAAGKSPVDNDGCVI 486
            APE +     +   D++S G +  E      +  G S VD  G ++
Sbjct: 186 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL 232

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 96/227 (42%), Gaps = 45/227 (19%)
Query: 292 VGEGASATVYKG-SLPSGGA-VAVKRFEKPNRVECARN--PFTT--EFATMAG--CLRHK 343
           +GEGA   V+K   L +GG  VA+KR     RV+      P +T  E A +       H 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRV----RVQTGEEGMPLSTIREVAVLRHLETFEHP 74
Query: 344 NLVQLQGWCC-----EGNELVLVYEYLPNG---SLDKILHNNSSSSIVLSWEKRLNIVLG 395
           N+V+L   C         +L LV+E++       LDK+      +  +       +++  
Sbjct: 75  NVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK------DMMFQ 128
Query: 396 VASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF----------EATIPAGTMGY 445
           +   L +LH     +++HRD+K  NIL+ +    KL DF            T    T+ Y
Sbjct: 129 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWY 185
Query: 446 LAPEYVYSGVPSEKTDVYSFGVVALE------VAAGKSPVDNDGCVI 486
            APE +     +   D++S G +  E      +  G S VD  G ++
Sbjct: 186 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL 232

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 95/242 (39%), Gaps = 60/242 (24%)
Query: 270 VPMRLALTDIKQATLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPF 329
           +P+ +  T  KQ  +     + +G+G    V+ G    G  VAVK F            F
Sbjct: 27  LPLLVQRTIAKQIQM----VKQIGKGRYGEVWMGKW-RGEKVAVKVF------------F 69
Query: 330 TTEFAT--------MAGCLRHKNLVQLQGWCCEGN----ELVLVYEYLPNGSLDKILHNN 377
           TTE A+            +RH+N++       +G     +L L+ +Y  NGSL   L   
Sbjct: 70  TTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL--- 126
Query: 378 SSSSIVLSWEKRLNIVLGVASALSYLHEEC-----ERQIIHRDVKACNILLDAEFNAKLG 432
              S  L  +  L +     S L +LH E      +  I HRD+K+ NIL+       + 
Sbjct: 127 --KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184
Query: 433 DF-----------EATIP----AGTMGYLAPEYVYSGVPSEK------TDVYSFGVVALE 471
           D            E  IP     GT  Y+ PE +   +           D+YSFG++  E
Sbjct: 185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWE 244
Query: 472 VA 473
           VA
Sbjct: 245 VA 246

>pdb|1WBF|A Chain A, Winged Bean Lectin, Saccharide Free Form Length = 242

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 70/171 (40%), Gaps = 19/171 (11%)
Query: 3   DPKTNTTASFSCRFSFSI-IPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQD 61
           D  T   ASF  RFSFSI  P P     DG  F I       G   GY G+  P LSP  
Sbjct: 60  DSTTGNVASFETRFSFSIRQPFPRPHPADGLVFFIAPPNTQTGEGGGYFGIYNP-LSPY- 117
Query: 62  SFFAVEFDT---SFDPSLXXXXXXXXXXXXXXXXXXXXXDALSRGIDLKSGRHITTWIEY 118
            F AVEFDT   ++DP +                        +    L +G      I+Y
Sbjct: 118 PFVAVEFDTFRNTWDPQIPHIGIDVNSVISTK----------TVPFTLDNGGIANVVIKY 167
Query: 119 RDSLKLIRVWAGYSQIRPPSPLIIAQI-DLSKQFKDYMHVGFSAANGQGSA 168
             S K++ V   +  +   +   IA I DL +   + ++VGFSAA G  S 
Sbjct: 168 DASTKILHVVLVFPSLG--TIYTIADIVDLKQVLPESVNVGFSAATGDPSG 216

>pdb|1WBL|A Chain A, Winged Bean Lectin Complexed With Methyl-Alpha-D-Galactose Length = 241

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 70/171 (40%), Gaps = 19/171 (11%)
Query: 3   DPKTNTTASFSCRFSFSI-IPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQD 61
           D  T   ASF  RFSFSI  P P     DG  F I       G   GY G+  P LSP  
Sbjct: 59  DSTTGNVASFETRFSFSIRQPFPRPHPADGLVFFIAPPNTQTGEGGGYFGIYNP-LSPY- 116
Query: 62  SFFAVEFDT---SFDPSLXXXXXXXXXXXXXXXXXXXXXDALSRGIDLKSGRHITTWIEY 118
            F AVEFDT   ++DP +                        +    L +G      I+Y
Sbjct: 117 PFVAVEFDTFRNTWDPQIPHIGIDVNSVISTK----------TVPFTLDNGGIANVVIKY 166
Query: 119 RDSLKLIRVWAGYSQIRPPSPLIIAQI-DLSKQFKDYMHVGFSAANGQGSA 168
             S K++ V   +  +   +   IA I DL +   + ++VGFSAA G  S 
Sbjct: 167 DASTKILHVVLVFPSLG--TIYTIADIVDLKQVLPESVNVGFSAATGDPSG 215

>pdb|2E7Q|A Chain A, Crystal Structure Of Basic Winged Bean Lectin In Complex With B Blood Group Trisaccharide Length = 237

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 69/171 (40%), Gaps = 19/171 (11%)
Query: 3   DPKTNTTASFSCRFSFSI-IPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQD 61
           D  T   ASF  RFSFSI  P P     DG  F I       G   GY G+  P LSP  
Sbjct: 59  DSTTGNVASFETRFSFSIRQPFPRPHPADGLVFFIAPPNTQTGEGGGYFGIYNP-LSPY- 116
Query: 62  SFFAVEFDT---SFDPSLXXXXXXXXXXXXXXXXXXXXXDALSRGIDLKSGRHITTWIEY 118
            F AVEFDT   ++DP +                             L +G      I+Y
Sbjct: 117 PFVAVEFDTFRNTWDPQIPHIGIDVNSVISTKTVP----------FTLDNGGIANVVIKY 166
Query: 119 RDSLKLIRVWAGYSQIRPPSPLIIAQI-DLSKQFKDYMHVGFSAANGQGSA 168
             S K++ V   +  +   +   IA I DL +   + ++VGFSAA G  S 
Sbjct: 167 DASTKILHVVLVFPSLG--TIYTIADIVDLKQVLPESVNVGFSAATGDPSG 215

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 88/207 (42%), Gaps = 28/207 (13%)
Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           + + + +G GA   V        G  VAVK+  +P + +        E   +  C+ HKN
Sbjct: 24  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLK-CVNHKN 82
Query: 345 LVQL------QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVAS 398
           ++ L      Q    E  ++ LV E L + +L +++H      + L  E+   ++  +  
Sbjct: 83  IISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVIH------MELDHERMSYLLYQMLC 135
Query: 399 ALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG----------TMGYLAP 448
            + +LH      IIHRD+K  NI++ ++   K+ DF     A           T  Y AP
Sbjct: 136 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVVTRYYRAP 192
Query: 449 EYVYSGVPSEKTDVYSFGVVALEVAAG 475
           E +      E  D++S G +  E+  G
Sbjct: 193 EVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 93/215 (43%), Gaps = 46/215 (21%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G+G    V++G    G  VAVK F   +R E  R+ F          LRH+N++   G+
Sbjct: 50  IGKGRFGEVWRGKW-RGEEVAVKIF--SSREE--RSWFREAEIYQTVMLRHENIL---GF 101
Query: 352 CCEGN-------ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
               N       +L LV +Y  +GSL   L+  +     ++ E  + + L  AS L++LH
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLH 156
Query: 405 EEC-----ERQIIHRDVKACNILLDAEFNAKLGDFEATI---------------PAGTMG 444
            E      +  I HRD+K+ NIL+       + D    +                 GT  
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 216
Query: 445 YLAPEYVYSGVPS------EKTDVYSFGVVALEVA 473
           Y+APE +   +        ++ D+Y+ G+V  E+A
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 88/201 (43%), Gaps = 25/201 (12%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQG 350
           VG GA  +V       SG  VA+K+  +P + E        E   +   ++H+N++ L  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKH-MQHENVIGLLD 90
Query: 351 WCCEGNELVLVYEY---LP--NGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
                + L   Y++   +P     L KI+       +  S EK   +V  +   L Y+H 
Sbjct: 91  VFTPASSLRNFYDFYLVMPFMQTDLQKIM------GLKFSEEKIQYLVYQMLKGLKYIHS 144
Query: 406 ECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGVPS 457
                ++HRD+K  N+ ++ +   K+ DF        E T    T  Y APE + S +  
Sbjct: 145 AG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHY 201
Query: 458 EKT-DVYSFGVVALEVAAGKS 477
            +T D++S G +  E+  GK+
Sbjct: 202 NQTVDIWSVGCIMAEMLTGKT 222

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 93/215 (43%), Gaps = 46/215 (21%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G+G    V++G    G  VAVK F   +R E  R+ F          LRH+N++   G+
Sbjct: 37  IGKGRFGEVWRGKW-RGEEVAVKIF--SSREE--RSWFREAEIYQTVMLRHENIL---GF 88
Query: 352 CCEGN-------ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
               N       +L LV +Y  +GSL   L+  +     ++ E  + + L  AS L++LH
Sbjct: 89  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLH 143
Query: 405 EEC-----ERQIIHRDVKACNILLDAEFNAKLGDFEATI---------------PAGTMG 444
            E      +  I HRD+K+ NIL+       + D    +                 GT  
Sbjct: 144 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 203
Query: 445 YLAPEYVYSGVPS------EKTDVYSFGVVALEVA 473
           Y+APE +   +        ++ D+Y+ G+V  E+A
Sbjct: 204 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 238

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 89/211 (42%), Gaps = 16/211 (7%)
Query: 286 FNKNRIVGEGASATVY-KGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F++ + +G G+   V       SG   A+K  +K   V+  +   T     +   +    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           LV+L+    + + L +V EY+  G +   L      +   +      IVL       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVL----TFEYLH 158
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGVP 456
                 +I+RD+K  N+L+D +   ++ DF              GT  YLAPE + S   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 457 SEKTDVYSFGVVALEVAAGKSPVDNDGCVIV 487
           ++  D ++ GV+  E+AAG  P   D  + +
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 46/215 (21%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G+G    V++G    G  VAVK F   +R E  R+ F          LRH+N++   G+
Sbjct: 14  IGKGRFGEVWRGKW-RGEEVAVKIF--SSREE--RSWFREAEIYQTVMLRHENIL---GF 65
Query: 352 CCEGN-------ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
               N       +L LV +Y  +GSL   L+  + +      E  + + L  AS L++LH
Sbjct: 66  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTV-----EGMIKLALSTASGLAHLH 120
Query: 405 EEC-----ERQIIHRDVKACNILLDAEFNAKLGDFEATI---------------PAGTMG 444
            E      +  I HRD+K+ NIL+       + D    +                 GT  
Sbjct: 121 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 180
Query: 445 YLAPEYVYSGVPS------EKTDVYSFGVVALEVA 473
           Y+APE +   +        ++ D+Y+ G+V  E+A
Sbjct: 181 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 215

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 89/211 (42%), Gaps = 16/211 (7%)
Query: 286 FNKNRIVGEGASATVY-KGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F++ + +G G+   V       SG   A+K  +K   V+  +   T     +   +    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           LV+L+    + + L +V EY+  G +   L      S   +      IVL       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEYLH 158
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGVP 456
                 +I+RD+K  N+L+D +   ++ DF              GT  YLAPE + S   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 457 SEKTDVYSFGVVALEVAAGKSPVDNDGCVIV 487
           ++  D ++ GV+  ++AAG  P   D  + +
Sbjct: 216 NKAVDWWALGVLIYQMAAGYPPFFADQPIQI 246

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 46/215 (21%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G+G    V++G    G  VAVK F   +R E  R+ F          LRH+N++   G+
Sbjct: 12  IGKGRFGEVWRGKW-RGEEVAVKIF--SSREE--RSWFREAEIYQTVMLRHENIL---GF 63
Query: 352 CCEGN-------ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
               N       +L LV +Y  +GSL   L+  + +      E  + + L  AS L++LH
Sbjct: 64  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTV-----EGMIKLALSTASGLAHLH 118
Query: 405 EEC-----ERQIIHRDVKACNILLDAEFNAKLGDFEATI---------------PAGTMG 444
            E      +  I HRD+K+ NIL+       + D    +                 GT  
Sbjct: 119 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 178
Query: 445 YLAPEYVYSGVPS------EKTDVYSFGVVALEVA 473
           Y+APE +   +        ++ D+Y+ G+V  E+A
Sbjct: 179 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 213

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 86/203 (42%), Gaps = 32/203 (15%)
Query: 292 VGEGASATV---YKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           +G GA   V   Y   L     VA+K+  +P + +        E   M  C+ HKN++ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMK-CVNHKNIIGL 88
Query: 349 ------QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
                 Q    E  ++ +V E L + +L +++       + L  E+   ++  +   + +
Sbjct: 89  LNVFTPQKSLEEFQDVYIVME-LMDANLSQVIQ------MELDHERMSYLLYQMLCGIKH 141
Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG----------TMGYLAPEYVY 452
           LH      IIHRD+K  NI++ ++   K+ DF     AG          T  Y APE + 
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 453 SGVPSEKTDVYSFGVVALEVAAG 475
                E  D++S G +  E+  G
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 86/203 (42%), Gaps = 32/203 (15%)
Query: 292 VGEGASATV---YKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           +G GA   V   Y   L     VA+K+  +P + +        E   M  C+ HKN++ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMK-CVNHKNIIGL 88
Query: 349 ------QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
                 Q    E  ++ +V E L + +L +++       + L  E+   ++  +   + +
Sbjct: 89  LNVFTPQKSLEEFQDVYIVME-LMDANLSQVIQ------MELDHERMSYLLYQMLCGIKH 141
Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG----------TMGYLAPEYVY 452
           LH      IIHRD+K  NI++ ++   K+ DF     AG          T  Y APE + 
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 453 SGVPSEKTDVYSFGVVALEVAAG 475
                E  D++S G +  E+  G
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 89/211 (42%), Gaps = 16/211 (7%)
Query: 286 FNKNRIVGEGASATVY-KGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F++ + +G G+   V       SG   A+K  +K   V+  +   T     +   +    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           LV+L+    + + L +V EY+  G +   L      S   +      IVL       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEYLH 158
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGVP 456
                 +I+RD+K  N+++D +   ++ DF              GT  YLAPE + S   
Sbjct: 159 S---LDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIIISKGY 215
Query: 457 SEKTDVYSFGVVALEVAAGKSPVDNDGCVIV 487
           ++  D ++ GV+  E+AAG  P   D  + +
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 93/215 (43%), Gaps = 46/215 (21%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G+G    V++G    G  VAVK F   +R E  R+ F          LRH+N++   G+
Sbjct: 17  IGKGRFGEVWRGKW-RGEEVAVKIF--SSREE--RSWFREAEIYQTVMLRHENIL---GF 68
Query: 352 CCEGN-------ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
               N       +L LV +Y  +GSL   L+  +     ++ E  + + L  AS L++LH
Sbjct: 69  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLH 123
Query: 405 EEC-----ERQIIHRDVKACNILLDAEFNAKLGDFEATI---------------PAGTMG 444
            E      +  I HRD+K+ NIL+       + D    +                 GT  
Sbjct: 124 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 183
Query: 445 YLAPEYVYSGVPS------EKTDVYSFGVVALEVA 473
           Y+APE +   +        ++ D+Y+ G+V  E+A
Sbjct: 184 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 218

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 92/221 (41%), Gaps = 36/221 (16%)
Query: 286 FNKNRIVGEGASATVY-KGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F++ + +G G+   V       SG   A+K  +K   V+  +   T     +   +    
Sbjct: 38  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 97
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNS----------SSSIVLSWEKRLNIVL 394
           LV+L+    + + L +V EY+  G +   L              ++ IVL++E       
Sbjct: 98  LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE------- 150
Query: 395 GVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYL 446
                  YLH      +I+RD+K  N+L+D +   ++ DF              GT  YL
Sbjct: 151 -------YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYL 200
Query: 447 APEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIV 487
           APE + S   ++  D ++ GV+  E+AAG  P   D  + +
Sbjct: 201 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 241

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 70/159 (44%), Gaps = 17/159 (10%)
Query: 334 ATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIV 393
           A++   L+H ++V+L         L +V+E++    L   +   + +  V S     + +
Sbjct: 77  ASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYM 136
Query: 394 LGVASALSYLHEECERQIIHRDVKACNILLDAEFNA---KLGDFEATIPAGTMG------ 444
             +  AL Y H   +  IIHRDVK   +LL ++ N+   KLG F   I  G  G      
Sbjct: 137 RQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR 193
Query: 445 -----YLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSP 478
                ++APE V      +  DV+  GV+   + +G  P
Sbjct: 194 VGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 46/215 (21%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           +G+G    V++G    G  VAVK F   +R E  R+ F          LRH+N++   G+
Sbjct: 11  IGKGRFGEVWRGKW-RGEEVAVKIF--SSREE--RSWFREAEIYQTVMLRHENIL---GF 62
Query: 352 CCEGN-------ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
               N       +L LV +Y  +GSL   L+  + +      E  + + L  AS L++LH
Sbjct: 63  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTV-----EGMIKLALSTASGLAHLH 117
Query: 405 EEC-----ERQIIHRDVKACNILLDAEFNAKLGDFEATI---------------PAGTMG 444
            E      +  I HRD+K+ NIL+       + D    +                 GT  
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177
Query: 445 YLAPEYVYSGVPS------EKTDVYSFGVVALEVA 473
           Y+APE +   +        ++ D+Y+ G+V  E+A
Sbjct: 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 212

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 87/210 (41%), Gaps = 27/210 (12%)
Query: 292 VGEGASATVYKGSLPSGG-----AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLV 346
           +G G  A V K    S G         KR  + +R   +R     E + +   L H N++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHH-NVI 78
Query: 347 QLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEE 406
            L        ++VL+ E +  G L   L    S    LS E+  + +  +   ++YLH  
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFLAQKES----LSEEEATSFIKQILDGVNYLHT- 133
Query: 407 CERQIIHRDVKACNI-LLDAEF---NAKLGDF----------EATIPAGTMGYLAPEYVY 452
             ++I H D+K  NI LLD      + KL DF          E     GT  ++APE V 
Sbjct: 134 --KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN 191
Query: 453 SGVPSEKTDVYSFGVVALEVAAGKSPVDND 482
                 + D++S GV+   + +G SP   D
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASPFLGD 221

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 92/221 (41%), Gaps = 36/221 (16%)
Query: 286 FNKNRIVGEGASATVY-KGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F++ + +G G+   V       SG   A+K  +K   V+  +   T     +   +    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNS----------SSSIVLSWEKRLNIVL 394
           LV+L+    + + L +V EY+  G +   L              ++ IVL++E       
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE------- 155
Query: 395 GVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYL 446
                  YLH      +I+RD+K  N+L+D +   ++ DF              GT  YL
Sbjct: 156 -------YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYL 205
Query: 447 APEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIV 487
           APE + S   ++  D ++ GV+  E+AAG  P   D  + +
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 92/221 (41%), Gaps = 36/221 (16%)
Query: 286 FNKNRIVGEGASATVY-KGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F++ + +G G+   V       SG   A+K  +K   V+  +   T     +   +    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNS----------SSSIVLSWEKRLNIVL 394
           LV+L+    + + L +V EY+  G +   L              ++ IVL++E       
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE------- 155
Query: 395 GVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYL 446
                  YLH      +I+RD+K  N+L+D +   ++ DF              GT  YL
Sbjct: 156 -------YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYL 205
Query: 447 APEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIV 487
           APE + S   ++  D ++ GV+  E+AAG  P   D  + +
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 88/201 (43%), Gaps = 25/201 (12%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQG 350
           VG GA  +V       SG  VA+K+  +P + E        E   +   ++H+N++ L  
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKH-MQHENVIGLLD 108
Query: 351 WCCEGNELVLVYEY---LP--NGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
                + L   Y++   +P     L KI+       +  S EK   +V  +   L Y+H 
Sbjct: 109 VFTPASSLRNFYDFYLVMPFMQTDLQKIM------GMEFSEEKIQYLVYQMLKGLKYIHS 162
Query: 406 ECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGVPS 457
                ++HRD+K  N+ ++ +   K+ DF        E T    T  Y APE + S +  
Sbjct: 163 AG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHY 219
Query: 458 EKT-DVYSFGVVALEVAAGKS 477
            +T D++S G +  E+  GK+
Sbjct: 220 NQTVDIWSVGCIMAEMLTGKT 240

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 71/153 (46%), Gaps = 23/153 (15%)
Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVAS 398
           L H N+++L     + +   +V E    G L D+I+          S      I+  V S
Sbjct: 78  LDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR-----FSEHDAARIIKQVFS 132
Query: 399 ALSYLHEECERQIIHRDVKACNILLDA---EFNAKLGDFEATI----------PAGTMGY 445
            ++Y+H+     I+HRD+K  NILL++   + + K+ DF  +             GT  Y
Sbjct: 133 GITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYY 189
Query: 446 LAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSP 478
           +APE V  G   EK DV+S GV+   + +G  P
Sbjct: 190 IAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 71/153 (46%), Gaps = 23/153 (15%)
Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVAS 398
           L H N+++L     + +   +V E    G L D+I+          S      I+  V S
Sbjct: 78  LDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR-----FSEHDAARIIKQVFS 132
Query: 399 ALSYLHEECERQIIHRDVKACNILLDA---EFNAKLGDFEATI----------PAGTMGY 445
            ++Y+H+     I+HRD+K  NILL++   + + K+ DF  +             GT  Y
Sbjct: 133 GITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYY 189
Query: 446 LAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSP 478
           +APE V  G   EK DV+S GV+   + +G  P
Sbjct: 190 IAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 87/210 (41%), Gaps = 27/210 (12%)
Query: 292 VGEGASATVYKGSLPSGG-----AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLV 346
           +G G  A V K    S G         KR  + +R   +R     E + +   L H N++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHH-NVI 78
Query: 347 QLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEE 406
            L        ++VL+ E +  G L   L    S    LS E+  + +  +   ++YLH  
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFLAQKES----LSEEEATSFIKQILDGVNYLHT- 133
Query: 407 CERQIIHRDVKACNI-LLDAEF---NAKLGDF----------EATIPAGTMGYLAPEYVY 452
             ++I H D+K  NI LLD      + KL DF          E     GT  ++APE V 
Sbjct: 134 --KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN 191
Query: 453 SGVPSEKTDVYSFGVVALEVAAGKSPVDND 482
                 + D++S GV+   + +G SP   D
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASPFLGD 221

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 71/153 (46%), Gaps = 23/153 (15%)
Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVAS 398
           L H N+++L     + +   +V E    G L D+I+          S      I+  V S
Sbjct: 78  LDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR-----FSEHDAARIIKQVFS 132
Query: 399 ALSYLHEECERQIIHRDVKACNILLDA---EFNAKLGDFEATI----------PAGTMGY 445
            ++Y+H+     I+HRD+K  NILL++   + + K+ DF  +             GT  Y
Sbjct: 133 GITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYY 189
Query: 446 LAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSP 478
           +APE V  G   EK DV+S GV+   + +G  P
Sbjct: 190 IAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 90/207 (43%), Gaps = 21/207 (10%)
Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           + K   +GEG   TV+K  +  +   VA+KR    +  E   +    E   +   L+HKN
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKE-LKHKN 62
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           +V+L        +L LV+E+  +  L K      S +  L  E   + +  +   L + H
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFC-DQDLKKYF---DSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG-----------TMGYLAPEYVY- 452
               R ++HRD+K  N+L++     KL +F      G           T+ Y  P+ ++ 
Sbjct: 119 S---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175
Query: 453 SGVPSEKTDVYSFGVVALEVAAGKSPV 479
           + + S   D++S G +  E+A    P+
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPL 202

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 92/221 (41%), Gaps = 36/221 (16%)
Query: 286 FNKNRIVGEGASATVY-KGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F++ + +G G+   V       SG   A+K  +K   V+  +   T     +   +    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNS----------SSSIVLSWEKRLNIVL 394
           LV+L+    + + L +V EY+  G +   L              ++ IVL++E       
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE------- 155
Query: 395 GVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYL 446
                  YLH      +I+RD+K  N+L+D +   ++ DF              GT  YL
Sbjct: 156 -------YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYL 205
Query: 447 APEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIV 487
           APE + S   ++  D ++ GV+  E+AAG  P   D  + +
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 87/210 (41%), Gaps = 27/210 (12%)
Query: 292 VGEGASATVYKGSLPSGG-----AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLV 346
           +G G  A V K    S G         KR  + +R   +R     E + +   L H N++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHH-NVI 78
Query: 347 QLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEE 406
            L        ++VL+ E +  G L   L    S    LS E+  + +  +   ++YLH  
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFLAQKES----LSEEEATSFIKQILDGVNYLHT- 133
Query: 407 CERQIIHRDVKACNI-LLDAEF---NAKLGDF----------EATIPAGTMGYLAPEYVY 452
             ++I H D+K  NI LLD      + KL DF          E     GT  ++APE V 
Sbjct: 134 --KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN 191
Query: 453 SGVPSEKTDVYSFGVVALEVAAGKSPVDND 482
                 + D++S GV+   + +G SP   D
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASPFLGD 221

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 70/159 (44%), Gaps = 17/159 (10%)
Query: 334 ATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIV 393
           A++   L+H ++V+L         L +V+E++    L   +   + +  V S     + +
Sbjct: 79  ASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYM 138
Query: 394 LGVASALSYLHEECERQIIHRDVKACNILLDAEFNA---KLGDFEATIPAGTMG------ 444
             +  AL Y H+     IIHRDVK   +LL ++ N+   KLG F   I  G  G      
Sbjct: 139 RQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR 195
Query: 445 -----YLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSP 478
                ++APE V      +  DV+  GV+   + +G  P
Sbjct: 196 VGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 234

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 87/210 (41%), Gaps = 27/210 (12%)
Query: 292 VGEGASATVYKGSLPSGG-----AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLV 346
           +G G  A V K    S G         KR  + +R   +R     E + +   L H N++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHH-NVI 78
Query: 347 QLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEE 406
            L        ++VL+ E +  G L   L    S    LS E+  + +  +   ++YLH  
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFLAQKES----LSEEEATSFIKQILDGVNYLHT- 133
Query: 407 CERQIIHRDVKACNI-LLDAEF---NAKLGDF----------EATIPAGTMGYLAPEYVY 452
             ++I H D+K  NI LLD      + KL DF          E     GT  ++APE V 
Sbjct: 134 --KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN 191
Query: 453 SGVPSEKTDVYSFGVVALEVAAGKSPVDND 482
                 + D++S GV+   + +G SP   D
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASPFLGD 221

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 87/210 (41%), Gaps = 27/210 (12%)
Query: 292 VGEGASATVYKGSLPSGG-----AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLV 346
           +G G  A V K    S G         KR  + +R   +R     E + +   L H N++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHH-NVI 78
Query: 347 QLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEE 406
            L        ++VL+ E +  G L   L    S    LS E+  + +  +   ++YLH  
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFLAQKES----LSEEEATSFIKQILDGVNYLHT- 133
Query: 407 CERQIIHRDVKACNI-LLDAEF---NAKLGDF----------EATIPAGTMGYLAPEYVY 452
             ++I H D+K  NI LLD      + KL DF          E     GT  ++APE V 
Sbjct: 134 --KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN 191
Query: 453 SGVPSEKTDVYSFGVVALEVAAGKSPVDND 482
                 + D++S GV+   + +G SP   D
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASPFLGD 221

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 77/168 (45%), Gaps = 25/168 (14%)
Query: 335 TMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIV 393
           ++   L H N+++L     +     LV E+   G L ++I++ +       +     NI+
Sbjct: 98  SLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAA-----NIM 152
Query: 394 LGVASALSYLHEECERQIIHRDVKACNILLDAE---FNAKLGDF----------EATIPA 440
             + S + YLH+     I+HRD+K  NILL+ +    N K+ DF          +     
Sbjct: 153 KQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL 209
Query: 441 GTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPV--DNDGCVI 486
           GT  Y+APE V     +EK DV+S GV+   +  G  P    ND  +I
Sbjct: 210 GTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDII 256

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 52/106 (49%), Gaps = 26/106 (24%)
Query: 390 LNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-----------EATI 438
           L+I + +A A+ +LH    + ++HRD+K  NI    +   K+GDF           E T+
Sbjct: 167 LHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 439 ----PA--------GTMGYLAPEYVYSGVPSEKTDVYSFGVVALEV 472
               PA        GT  Y++PE ++    S K D++S G++  E+
Sbjct: 224 LTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFEL 269

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 86/204 (42%), Gaps = 32/204 (15%)
Query: 292 VGEGASATV---YKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           +G GA   V   Y   L     VA+K+  +P + +        E   M  C+ HKN++ L
Sbjct: 70  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMK-CVNHKNIISL 126
Query: 349 ------QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
                 Q    E  ++ LV E L + +L +++       + L  E+   ++  +   + +
Sbjct: 127 LNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQ------MELDHERMSYLLYQMLCGIKH 179
Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG----------TMGYLAPEYVY 452
           LH      IIHRD+K  NI++ ++   K+ DF     AG          T  Y APE + 
Sbjct: 180 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 236
Query: 453 SGVPSEKTDVYSFGVVALEVAAGK 476
                E  D++S G +  E+   K
Sbjct: 237 GMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 32/203 (15%)
Query: 292 VGEGASATV---YKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           +G GA   V   Y   L     VA+K+  +P + +        E   M  C+ HKN++ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMK-CVNHKNIIGL 88
Query: 349 ------QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
                 Q    E  ++ +V E L + +L +++       + L  E+   ++  +   + +
Sbjct: 89  LNVFTPQKSLEEFQDVYIVME-LMDANLCQVIQ------MELDHERMSYLLYQMLCGIKH 141
Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGTMGYLAPEYV--YSGVPS--- 457
           LH      IIHRD+K  NI++ ++   K+ DF     AGT   + PE V  Y   P    
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVVTRYYRAPEVIL 198
Query: 458 -----EKTDVYSFGVVALEVAAG 475
                E  D++S G +  E+  G
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 90/215 (41%), Gaps = 46/215 (21%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           VG+G    V++G L  G +VAVK F   +     R   T  + T+   LRH N++   G+
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFSSRDEQSWFRE--TEIYNTV--LLRHDNIL---GF 67
Query: 352 CCE-------GNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
                       +L L+  Y  +GSL   L   +     L     L + +  A  L++LH
Sbjct: 68  IASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQT-----LEPHLALRLAVSAACGLAHLH 122
Query: 405 EEC-----ERQIIHRDVKACNILLDAEFNAKLGDFEATI---------------PAGTMG 444
            E      +  I HRD K+ N+L+ +     + D    +                 GT  
Sbjct: 123 VEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKR 182
Query: 445 YLAPEYVYSGVPSE------KTDVYSFGVVALEVA 473
           Y+APE +   + ++       TD+++FG+V  E+A
Sbjct: 183 YMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEIA 217

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 92/221 (41%), Gaps = 36/221 (16%)
Query: 286 FNKNRIVGEGASATVY-KGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F++ + +G G+   V       SG   A+K  +K   V+  +   T     +   +    
Sbjct: 64  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 123
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNS----------SSSIVLSWEKRLNIVL 394
           LV+L+    + + L +V EY+  G +   L              ++ IVL++E       
Sbjct: 124 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE------- 176
Query: 395 GVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYL 446
                  YLH      +I+RD+K  N+L+D +   ++ DF              GT  YL
Sbjct: 177 -------YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYL 226
Query: 447 APEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIV 487
           APE + S   ++  D ++ GV+  E+AAG  P   D  + +
Sbjct: 227 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 267

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 86/204 (42%), Gaps = 32/204 (15%)
Query: 292 VGEGASATV---YKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           +G GA   V   Y   L     VA+K+  +P + +        E   M  C+ HKN++ L
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMK-CVNHKNIISL 88
Query: 349 ------QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
                 Q    E  ++ LV E L + +L +++       + L  E+   ++  +   + +
Sbjct: 89  LNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQ------MELDHERMSYLLYQMLCGIKH 141
Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG----------TMGYLAPEYVY 452
           LH      IIHRD+K  NI++ ++   K+ DF     AG          T  Y APE + 
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 453 SGVPSEKTDVYSFGVVALEVAAGK 476
                E  D++S G +  E+   K
Sbjct: 199 GMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 86/204 (42%), Gaps = 32/204 (15%)
Query: 292 VGEGASATV---YKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           +G GA   V   Y   L     VA+K+  +P + +        E   M  C+ HKN++ L
Sbjct: 33  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMK-CVNHKNIISL 89
Query: 349 ------QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
                 Q    E  ++ LV E L + +L +++       + L  E+   ++  +   + +
Sbjct: 90  LNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQ------MELDHERMSYLLYQMLCGIKH 142
Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG----------TMGYLAPEYVY 452
           LH      IIHRD+K  NI++ ++   K+ DF     AG          T  Y APE + 
Sbjct: 143 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 199
Query: 453 SGVPSEKTDVYSFGVVALEVAAGK 476
                E  D++S G +  E+   K
Sbjct: 200 GMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 86/204 (42%), Gaps = 32/204 (15%)
Query: 292 VGEGASATV---YKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           +G GA   V   Y   L     VA+K+  +P + +        E   M  C+ HKN++ L
Sbjct: 26  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMK-CVNHKNIISL 82
Query: 349 ------QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
                 Q    E  ++ LV E L + +L +++       + L  E+   ++  +   + +
Sbjct: 83  LNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQ------MELDHERMSYLLYQMLCGIKH 135
Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG----------TMGYLAPEYVY 452
           LH      IIHRD+K  NI++ ++   K+ DF     AG          T  Y APE + 
Sbjct: 136 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 192
Query: 453 SGVPSEKTDVYSFGVVALEVAAGK 476
                E  D++S G +  E+   K
Sbjct: 193 GMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 86/220 (39%), Gaps = 40/220 (18%)
Query: 292 VGEGASATV-YKGSLPSGGAVAVKRF---EKPNRVECARNPFTTEFATMAGCLRHKNLVQ 347
           +GEG  + V     L  G   A+KR    E+ +R E  R       A M     H N+++
Sbjct: 37  LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQRE------ADMHRLFNHPNILR 90
Query: 348 LQGWCCE----GNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
           L  +C       +E  L+  +   G+L   +         L+ ++ L ++LG+   L  +
Sbjct: 91  LVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAI 150
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG--------------------TM 443
           H    +   HRD+K  NILL  E    L D  +   A                     T+
Sbjct: 151 HA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207
Query: 444 GYLAPEYVY---SGVPSEKTDVYSFGVVALEVAAGKSPVD 480
            Y APE        V  E+TDV+S G V   +  G+ P D
Sbjct: 208 SYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD 247

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 86/204 (42%), Gaps = 32/204 (15%)
Query: 292 VGEGASATV---YKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           +G GA   V   Y   L     VA+K+  +P + +        E   M  C+ HKN++ L
Sbjct: 31  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMK-CVNHKNIISL 87
Query: 349 ------QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
                 Q    E  ++ LV E L + +L +++       + L  E+   ++  +   + +
Sbjct: 88  LNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQ------MELDHERMSYLLYQMLCGIKH 140
Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG----------TMGYLAPEYVY 452
           LH      IIHRD+K  NI++ ++   K+ DF     AG          T  Y APE + 
Sbjct: 141 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 197
Query: 453 SGVPSEKTDVYSFGVVALEVAAGK 476
                E  D++S G +  E+   K
Sbjct: 198 GMGYKENVDIWSVGCIMGEMVRHK 221

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 86/204 (42%), Gaps = 32/204 (15%)
Query: 292 VGEGASATV---YKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           +G GA   V   Y   L     VA+K+  +P + +        E   M  C+ HKN++ L
Sbjct: 33  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMK-CVNHKNIISL 89
Query: 349 ------QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
                 Q    E  ++ LV E L + +L +++       + L  E+   ++  +   + +
Sbjct: 90  LNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQ------MELDHERMSYLLYQMLCGIKH 142
Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG----------TMGYLAPEYVY 452
           LH      IIHRD+K  NI++ ++   K+ DF     AG          T  Y APE + 
Sbjct: 143 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 199
Query: 453 SGVPSEKTDVYSFGVVALEVAAGK 476
                E  D++S G +  E+   K
Sbjct: 200 GMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 86/204 (42%), Gaps = 32/204 (15%)
Query: 292 VGEGASATV---YKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           +G GA   V   Y   L     VA+K+  +P + +        E   M  C+ HKN++ L
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMK-CVNHKNIISL 88
Query: 349 ------QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
                 Q    E  ++ LV E L + +L +++       + L  E+   ++  +   + +
Sbjct: 89  LNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQ------MELDHERMSYLLYQMLCGIKH 141
Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG----------TMGYLAPEYVY 452
           LH      IIHRD+K  NI++ ++   K+ DF     AG          T  Y APE + 
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 453 SGVPSEKTDVYSFGVVALEVAAGK 476
                E  D++S G +  E+   K
Sbjct: 199 GMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 86/204 (42%), Gaps = 32/204 (15%)
Query: 292 VGEGASATV---YKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           +G GA   V   Y   L     VA+K+  +P + +        E   M  C+ HKN++ L
Sbjct: 70  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMK-CVNHKNIISL 126
Query: 349 ------QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
                 Q    E  ++ LV E L + +L +++       + L  E+   ++  +   + +
Sbjct: 127 LNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQ------MELDHERMSYLLYQMLCGIKH 179
Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG----------TMGYLAPEYVY 452
           LH      IIHRD+K  NI++ ++   K+ DF     AG          T  Y APE + 
Sbjct: 180 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 236
Query: 453 SGVPSEKTDVYSFGVVALEVAAGK 476
                E  D++S G +  E+   K
Sbjct: 237 GMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 86/204 (42%), Gaps = 32/204 (15%)
Query: 292 VGEGASATV---YKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           +G GA   V   Y   L     VA+K+  +P + +        E   M  C+ HKN++ L
Sbjct: 25  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMK-CVNHKNIISL 81
Query: 349 ------QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
                 Q    E  ++ LV E L + +L +++       + L  E+   ++  +   + +
Sbjct: 82  LNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQ------MELDHERMSYLLYQMLCGIKH 134
Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG----------TMGYLAPEYVY 452
           LH      IIHRD+K  NI++ ++   K+ DF     AG          T  Y APE + 
Sbjct: 135 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 191
Query: 453 SGVPSEKTDVYSFGVVALEVAAGK 476
                E  D++S G +  E+   K
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 95/231 (41%), Gaps = 43/231 (18%)
Query: 273 RLALTDIKQATLGFNKNRIVGEGASATVYKGSLPSGGAV-AVKRFEKP-----NRVECAR 326
           R+ LTD       FN   ++G+G+   V          + AVK  +K      + VEC  
Sbjct: 16  RMKLTD-------FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECT- 67
Query: 327 NPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSL----DKILHNNSSSSI 382
                E   +A   +   L QL       + L  V EY+  G L     ++       ++
Sbjct: 68  ---MVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAV 124
Query: 383 VLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-------- 434
             + E        +A  L +L     + II+RD+K  N++LD+E + K+ DF        
Sbjct: 125 FYAAE--------IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173
Query: 435 ---EATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDND 482
                    GT  Y+APE +      +  D ++FGV+  E+ AG++P + +
Sbjct: 174 DGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 224

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 86/203 (42%), Gaps = 32/203 (15%)
Query: 292 VGEGASATV---YKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           +G GA   V   Y   L     VA+K+  +P + +        E   M   + HKN++ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMK-VVNHKNIIGL 88
Query: 349 ------QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
                 Q    E  ++ +V E L + +L +++       + L  E+   ++  +   + +
Sbjct: 89  LNVFTPQKSLEEFQDVYIVME-LMDANLSQVIQ------MELDHERMSYLLYQMLVGIKH 141
Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG----------TMGYLAPEYVY 452
           LH      IIHRD+K  NI++ ++   K+ DF     AG          T  Y APE + 
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 453 SGVPSEKTDVYSFGVVALEVAAG 475
                E  D++S GV+  E+  G
Sbjct: 199 GMGYKENVDIWSVGVIMGEMIKG 221

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 86/209 (41%), Gaps = 25/209 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTE----FATMAGCLRHKNLVQ 347
           +G G  A V K    S G     +F K  R + +R   + E      ++   ++H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 348 LQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC 407
           L        +++L+ E +  G L   L    S    L+ E+    +  + + + YLH   
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKES----LTEEEATEFLKQILNGVYYLHS-- 132
Query: 408 ERQIIHRDVKACNI-LLDAEF---NAKLGDF----------EATIPAGTMGYLAPEYVYS 453
             QI H D+K  NI LLD        K+ DF          E     GT  ++APE V  
Sbjct: 133 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAPEIVNY 191
Query: 454 GVPSEKTDVYSFGVVALEVAAGKSPVDND 482
                + D++S GV+   + +G SP   D
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASPFLGD 220

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 86/204 (42%), Gaps = 32/204 (15%)
Query: 292 VGEGASATV---YKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           +G GA   V   Y   L     VA+K+  +P + +        E   M  C+ HKN++ L
Sbjct: 26  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMK-CVNHKNIISL 82
Query: 349 ------QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
                 Q    E  ++ LV E L + +L +++       + L  E+   ++  +   + +
Sbjct: 83  LNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQ------MELDHERMSYLLYQMLCGIKH 135
Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG----------TMGYLAPEYVY 452
           LH      IIHRD+K  NI++ ++   K+ DF     AG          T  Y APE + 
Sbjct: 136 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 192
Query: 453 SGVPSEKTDVYSFGVVALEVAAGK 476
                E  D++S G +  E+   K
Sbjct: 193 GMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 86/203 (42%), Gaps = 32/203 (15%)
Query: 292 VGEGASATV---YKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           +G GA   V   Y   L     VA+K+  +P + +        E   M   + HKN++ L
Sbjct: 32  IGSGAQGIVVAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMK-VVNHKNIIGL 88
Query: 349 ------QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
                 Q    E  ++ +V E L + +L +++       + L  E+   ++  +   + +
Sbjct: 89  LNVFTPQKSLEEFQDVYIVME-LMDANLSQVIQ------MELDHERMSYLLYQMLVGIKH 141
Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG----------TMGYLAPEYVY 452
           LH      IIHRD+K  NI++ ++   K+ DF     AG          T  Y APE + 
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 453 SGVPSEKTDVYSFGVVALEVAAG 475
                E  D++S GV+  E+  G
Sbjct: 199 GMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 71/158 (44%), Gaps = 26/158 (16%)
Query: 341 RHKNLVQLQGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVL-GVAS 398
           +H N++ L+    +G  + LV E +  G L DKIL     S      E+  + VL  +  
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFS------EREASFVLHTIGK 132
Query: 399 ALSYLHEECERQIIHRDVKACNIL-LDAEFNA---KLGDFE-----------ATIPAGTM 443
            + YLH +    ++HRD+K  NIL +D   N    ++ DF               P  T 
Sbjct: 133 TVEYLHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTA 189
Query: 444 GYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDN 481
            ++APE +      E  D++S G++   + AG +P  N
Sbjct: 190 NFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFAN 227

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 71/158 (44%), Gaps = 26/158 (16%)
Query: 341 RHKNLVQLQGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVL-GVAS 398
           +H N++ L+    +G  + LV E +  G L DKIL     S      E+  + VL  +  
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFS------EREASFVLHTIGK 132
Query: 399 ALSYLHEECERQIIHRDVKACNIL-LDAEFNA---KLGDFE-----------ATIPAGTM 443
            + YLH +    ++HRD+K  NIL +D   N    ++ DF               P  T 
Sbjct: 133 TVEYLHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTA 189
Query: 444 GYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDN 481
            ++APE +      E  D++S G++   + AG +P  N
Sbjct: 190 NFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFAN 227

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 67/153 (43%), Gaps = 26/153 (16%)
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSL----DKILHNNSSSSIVLSWEKRLNIVLGVASAL 400
           L QL       + L  V EY+  G L     ++       ++  + E        +A  L
Sbjct: 404 LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAE--------IAIGL 455
Query: 401 SYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTMGYLAPE 449
            +L     + II+RD+K  N++LD+E + K+ DF                 GT  Y+APE
Sbjct: 456 FFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPE 512
Query: 450 YVYSGVPSEKTDVYSFGVVALEVAAGKSPVDND 482
            +      +  D ++FGV+  E+ AG++P + +
Sbjct: 513 IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 545

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 32/204 (15%)
Query: 292 VGEGASATV---YKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           +G GA   V   Y   L     VA+K+  +P + +        E   M  C+ HKN++ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMK-CVNHKNIIGL 88
Query: 349 ------QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
                 Q    E  ++ +V E L + +L +++       + L  E+   ++  +   + +
Sbjct: 89  LNVFTPQKSLEEFQDVYIVME-LMDANLCQVIQ------MELDHERMSYLLYQMLCGIKH 141
Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGTMGYLAPEYV--YSGVPS--- 457
           LH      IIHRD+K  NI++ ++   K+ DF     AGT   + PE V  Y   P    
Sbjct: 142 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVIL 198
Query: 458 -----EKTDVYSFGVVALEVAAGK 476
                E  D++S G +  E+   K
Sbjct: 199 GMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 86/210 (40%), Gaps = 27/210 (12%)
Query: 292 VGEGASATVYKGSLPSGG-----AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLV 346
           +G G  A V K    S G         KR  + +R    R     E + +   L H N++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL-HPNII 78
Query: 347 QLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEE 406
            L        ++VL+ E +  G L   L    S    LS E+  + +  +   ++YLH  
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFLAQKES----LSEEEATSFIKQILDGVNYLHT- 133
Query: 407 CERQIIHRDVKACNI-LLDAEF---NAKLGDF----------EATIPAGTMGYLAPEYVY 452
             ++I H D+K  NI LLD      + KL DF          E     GT  ++APE V 
Sbjct: 134 --KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN 191
Query: 453 SGVPSEKTDVYSFGVVALEVAAGKSPVDND 482
                 + D++S GV+   + +G SP   D
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASPFLGD 221

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 88/201 (43%), Gaps = 24/201 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRF-EKPNRVECARNPFTTEFATMAGCLRHKNLVQLQG 350
           +G GA   V++    + G V V +F   P  ++  +     E + M   L H  L+ L  
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD--KYTVKNEISIM-NQLHHPKLINLHD 115
Query: 351 WCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECER 409
              +  E+VL+ E+L  G L D+I    ++    +S  + +N +      L ++HE    
Sbjct: 116 AFEDKYEMVLILEFLSGGELFDRI----AAEDYKMSEAEVINYMRQACEGLKHMHEHS-- 169
Query: 410 QIIHRDVKACNILLDAE--FNAKLGDFE----------ATIPAGTMGYLAPEYVYSGVPS 457
            I+H D+K  NI+ + +   + K+ DF             +   T  + APE V      
Sbjct: 170 -IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVG 228
Query: 458 EKTDVYSFGVVALEVAAGKSP 478
             TD+++ GV+   + +G SP
Sbjct: 229 FYTDMWAIGVLGYVLLSGLSP 249

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 88/211 (41%), Gaps = 16/211 (7%)
Query: 286 FNKNRIVGEGASATVYK-GSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F++ + +G G+   V       SG   A+K  +K   V+  +   T     +   +    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           LV+L+    + + L +V EY+  G +   L      S   +      IVL       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEYLH 158
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGVP 456
                 +I+RD+K  N+L+D +   ++ DF              GT  YLAP  + S   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPAIILSKGY 215
Query: 457 SEKTDVYSFGVVALEVAAGKSPVDNDGCVIV 487
           ++  D ++ GV+  E+AAG  P   D  + +
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 86/209 (41%), Gaps = 25/209 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTE----FATMAGCLRHKNLVQ 347
           +G G  A V K    S G     +F K  R + +R   + E      ++   ++H N++ 
Sbjct: 19  LGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 348 LQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC 407
           L        +++L+ E +  G L   L    S    L+ E+    +  + + + YLH   
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKES----LTEEEATEFLKQILNGVYYLHS-- 132
Query: 408 ERQIIHRDVKACNI-LLDAEF---NAKLGDF----------EATIPAGTMGYLAPEYVYS 453
             QI H D+K  NI LLD        K+ DF          E     GT  ++APE V  
Sbjct: 133 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY 191
Query: 454 GVPSEKTDVYSFGVVALEVAAGKSPVDND 482
                + D++S GV+   + +G SP   D
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASPFLGD 220

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 50/98 (51%), Gaps = 17/98 (17%)
Query: 391 NIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLG------DFEATIP---AG 441
            I+LG    L ++H    R +++RD+K  NILLD   + ++       DF    P    G
Sbjct: 300 EIILG----LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG 352
Query: 442 TMGYLAPEYVYSGVPSEKT-DVYSFGVVALEVAAGKSP 478
           T GY+APE +  GV  + + D +S G +  ++  G SP
Sbjct: 353 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 50/98 (51%), Gaps = 17/98 (17%)
Query: 391 NIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLG------DFEATIP---AG 441
            I+LG    L ++H    R +++RD+K  NILLD   + ++       DF    P    G
Sbjct: 300 EIILG----LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG 352
Query: 442 TMGYLAPEYVYSGVPSEKT-DVYSFGVVALEVAAGKSP 478
           T GY+APE +  GV  + + D +S G +  ++  G SP
Sbjct: 353 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 86/203 (42%), Gaps = 32/203 (15%)
Query: 292 VGEGASATV---YKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           +G GA   V   Y   L     VA+K+  +P + +        E   M  C+ HKN++ L
Sbjct: 34  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMK-CVNHKNIIGL 90
Query: 349 ------QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
                 Q    E  ++ +V E L + +L +++       + L  E+   ++  +   + +
Sbjct: 91  LNVFTPQKSLEEFQDVYIVME-LMDANLCQVIQ------MELDHERMSYLLYQMLCGIKH 143
Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG----------TMGYLAPEYVY 452
           LH      IIHRD+K  NI++ ++   K+ DF     AG          T  Y APE + 
Sbjct: 144 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVVTRYYRAPEVIL 200
Query: 453 SGVPSEKTDVYSFGVVALEVAAG 475
                E  D++S G +  E+  G
Sbjct: 201 GMGYKENVDIWSVGCIMGEMIKG 223

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 50/98 (51%), Gaps = 17/98 (17%)
Query: 391 NIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLG------DFEATIP---AG 441
            I+LG    L ++H    R +++RD+K  NILLD   + ++       DF    P    G
Sbjct: 300 EIILG----LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG 352
Query: 442 TMGYLAPEYVYSGVPSEKT-DVYSFGVVALEVAAGKSP 478
           T GY+APE +  GV  + + D +S G +  ++  G SP
Sbjct: 353 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 86/203 (42%), Gaps = 32/203 (15%)
Query: 292 VGEGASATV---YKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           +G GA   V   Y   L     VA+K+  +P + +        E   M  C+ HKN++ L
Sbjct: 33  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMK-CVNHKNIIGL 89
Query: 349 ------QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
                 Q    E  ++ +V E L + +L +++       + L  E+   ++  +   + +
Sbjct: 90  LNVFTPQKSLEEFQDVYIVME-LMDANLCQVIQ------MELDHERMSYLLYQMLCGIKH 142
Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG----------TMGYLAPEYVY 452
           LH      IIHRD+K  NI++ ++   K+ DF     AG          T  Y APE + 
Sbjct: 143 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 199
Query: 453 SGVPSEKTDVYSFGVVALEVAAG 475
                E  D++S G +  E+  G
Sbjct: 200 GMGYKENVDIWSVGCIMGEMIKG 222

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 50/98 (51%), Gaps = 17/98 (17%)
Query: 391 NIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLG------DFEATIP---AG 441
            I+LG    L ++H    R +++RD+K  NILLD   + ++       DF    P    G
Sbjct: 299 EIILG----LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG 351
Query: 442 TMGYLAPEYVYSGVPSEKT-DVYSFGVVALEVAAGKSP 478
           T GY+APE +  GV  + + D +S G +  ++  G SP
Sbjct: 352 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 389

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 86/203 (42%), Gaps = 32/203 (15%)
Query: 292 VGEGASATV---YKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           +G GA   V   Y   L     VA+K+  +P + +        E   M  C+ HKN++ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMK-CVNHKNIIGL 88
Query: 349 ------QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
                 Q    E  ++ +V E L + +L +++       + L  E+   ++  +   + +
Sbjct: 89  LNVFTPQKSLEEFQDVYIVME-LMDANLCQVIQ------MELDHERMSYLLYQMLCGIKH 141
Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG----------TMGYLAPEYVY 452
           LH      IIHRD+K  NI++ ++   K+ DF     AG          T  Y APE + 
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 453 SGVPSEKTDVYSFGVVALEVAAG 475
                E  D++S G +  E+  G
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 83/205 (40%), Gaps = 25/205 (12%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEF----ATMAGCLRHKNLVQ 347
           +G G  A V K      G     +F K  R+  +R   + E       +   +RH N++ 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 348 LQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC 407
           L        ++VL+ E +  G L   L    S    L+ ++    +  +   + YLH   
Sbjct: 73  LHDIFENKTDVVLILELVSGGELFDFLAEKES----LTEDEATQFLKQILDGVHYLHS-- 126
Query: 408 ERQIIHRDVKACNI-LLDAEF---NAKLGDF----------EATIPAGTMGYLAPEYVYS 453
            ++I H D+K  NI LLD        KL DF          E     GT  ++APE V  
Sbjct: 127 -KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNY 185
Query: 454 GVPSEKTDVYSFGVVALEVAAGKSP 478
                + D++S GV+   + +G SP
Sbjct: 186 EPLGLEADMWSIGVITYILLSGASP 210

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 86/203 (42%), Gaps = 32/203 (15%)
Query: 292 VGEGASATV---YKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           +G GA   V   Y   L     VA+K+  +P + +        E   M  C+ HKN++ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMK-CVNHKNIIGL 88
Query: 349 ------QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
                 Q    E  ++ +V E L + +L +++       + L  E+   ++  +   + +
Sbjct: 89  LNVFTPQKSLEEFQDVYIVME-LMDANLCQVIQ------MELDHERMSYLLYQMLCGIKH 141
Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG----------TMGYLAPEYVY 452
           LH      IIHRD+K  NI++ ++   K+ DF     AG          T  Y APE + 
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 453 SGVPSEKTDVYSFGVVALEVAAG 475
                E  D++S G +  E+  G
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 89/215 (41%), Gaps = 29/215 (13%)
Query: 280 KQATLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGC 339
           +Q  + +   +++G G+   V++  L     VA+K+  +  R       F      +   
Sbjct: 36  EQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR-------FKNRELQIMRI 88
Query: 340 LRHKNLVQLQGWCCEGNE------LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIV 393
           ++H N+V L+ +     +      L LV EY+P        H       +     +L  +
Sbjct: 89  VKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKL-YM 147
Query: 394 LGVASALSYLHEECERQIIHRDVKACNILLDAEFNA-KLGDFEAT--IPAG--------T 442
             +  +L+Y+H      I HRD+K  N+LLD      KL DF +   + AG        +
Sbjct: 148 YQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICS 204
Query: 443 MGYLAPEYVYSGVP-SEKTDVYSFGVVALEVAAGK 476
             Y APE ++     +   D++S G V  E+  G+
Sbjct: 205 RYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 83/205 (40%), Gaps = 25/205 (12%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEF----ATMAGCLRHKNLVQ 347
           +G G  A V K      G     +F K  R+  +R   + E       +   +RH N++ 
Sbjct: 20  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 79
Query: 348 LQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC 407
           L        ++VL+ E +  G L   L    S    L+ ++    +  +   + YLH   
Sbjct: 80  LHDIFENKTDVVLILELVSGGELFDFLAEKES----LTEDEATQFLKQILDGVHYLHS-- 133
Query: 408 ERQIIHRDVKACNI-LLDAEF---NAKLGDF----------EATIPAGTMGYLAPEYVYS 453
            ++I H D+K  NI LLD        KL DF          E     GT  ++APE V  
Sbjct: 134 -KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNY 192
Query: 454 GVPSEKTDVYSFGVVALEVAAGKSP 478
                + D++S GV+   + +G SP
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASP 217

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 86/209 (41%), Gaps = 25/209 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTE----FATMAGCLRHKNLVQ 347
           +G G  A V K    S G     +F K  R + +R   + E      ++   ++H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 348 LQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC 407
           L        +++L+ E +  G L   L    S    L+ E+    +  + + + YLH   
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKES----LTEEEATEFLKQILNGVYYLHS-- 132
Query: 408 ERQIIHRDVKACNI-LLDAEF---NAKLGDF----------EATIPAGTMGYLAPEYVYS 453
             QI H D+K  NI LLD        K+ DF          E     GT  ++APE V  
Sbjct: 133 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY 191
Query: 454 GVPSEKTDVYSFGVVALEVAAGKSPVDND 482
                + D++S GV+   + +G SP   D
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASPFLGD 220

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 86/209 (41%), Gaps = 25/209 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTE----FATMAGCLRHKNLVQ 347
           +G G  A V K    S G     +F K  R + +R   + E      ++   ++H N++ 
Sbjct: 19  LGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 348 LQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC 407
           L        +++L+ E +  G L   L    S    L+ E+    +  + + + YLH   
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKES----LTEEEATEFLKQILNGVYYLHS-- 132
Query: 408 ERQIIHRDVKACNI-LLDAEF---NAKLGDF----------EATIPAGTMGYLAPEYVYS 453
             QI H D+K  NI LLD        K+ DF          E     GT  ++APE V  
Sbjct: 133 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY 191
Query: 454 GVPSEKTDVYSFGVVALEVAAGKSPVDND 482
                + D++S GV+   + +G SP   D
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASPFLGD 220

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 86/209 (41%), Gaps = 25/209 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTE----FATMAGCLRHKNLVQ 347
           +G G  A V K    S G     +F K  R + +R   + E      ++   ++H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 348 LQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC 407
           L        +++L+ E +  G L   L    S    L+ E+    +  + + + YLH   
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKES----LTEEEATEFLKQILNGVYYLHS-- 132
Query: 408 ERQIIHRDVKACNI-LLDAEF---NAKLGDF----------EATIPAGTMGYLAPEYVYS 453
             QI H D+K  NI LLD        K+ DF          E     GT  ++APE V  
Sbjct: 133 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY 191
Query: 454 GVPSEKTDVYSFGVVALEVAAGKSPVDND 482
                + D++S GV+   + +G SP   D
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASPFLGD 220

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 86/209 (41%), Gaps = 25/209 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTE----FATMAGCLRHKNLVQ 347
           +G G  A V K    S G     +F K  R + +R   + E      ++   ++H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 348 LQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC 407
           L        +++L+ E +  G L   L    S    L+ E+    +  + + + YLH   
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKES----LTEEEATEFLKQILNGVYYLHS-- 132
Query: 408 ERQIIHRDVKACNI-LLDAEF---NAKLGDF----------EATIPAGTMGYLAPEYVYS 453
             QI H D+K  NI LLD        K+ DF          E     GT  ++APE V  
Sbjct: 133 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY 191
Query: 454 GVPSEKTDVYSFGVVALEVAAGKSPVDND 482
                + D++S GV+   + +G SP   D
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASPFLGD 220

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 86/209 (41%), Gaps = 25/209 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTE----FATMAGCLRHKNLVQ 347
           +G G  A V K    S G     +F K  R + +R   + E      ++   ++H N++ 
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 348 LQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC 407
           L        +++L+ E +  G L   L    S    L+ E+    +  + + + YLH   
Sbjct: 78  LHEVYENKTDVILILELVAGGELFDFLAEKES----LTEEEATEFLKQILNGVYYLHS-- 131
Query: 408 ERQIIHRDVKACNI-LLDAEF---NAKLGDF----------EATIPAGTMGYLAPEYVYS 453
             QI H D+K  NI LLD        K+ DF          E     GT  ++APE V  
Sbjct: 132 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY 190
Query: 454 GVPSEKTDVYSFGVVALEVAAGKSPVDND 482
                + D++S GV+   + +G SP   D
Sbjct: 191 EPLGLEADMWSIGVITYILLSGASPFLGD 219

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 83/205 (40%), Gaps = 25/205 (12%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEF----ATMAGCLRHKNLVQ 347
           +G G  A V K      G     +F K  R+  +R   + E       +   +RH N++ 
Sbjct: 34  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNIIT 93
Query: 348 LQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC 407
           L        ++VL+ E +  G L   L    S    L+ ++    +  +   + YLH   
Sbjct: 94  LHDIFENKTDVVLILELVSGGELFDFLAEKES----LTEDEATQFLKQILDGVHYLHS-- 147
Query: 408 ERQIIHRDVKACNI-LLDAEF---NAKLGDF----------EATIPAGTMGYLAPEYVYS 453
            ++I H D+K  NI LLD        KL DF          E     GT  ++APE V  
Sbjct: 148 -KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNY 206
Query: 454 GVPSEKTDVYSFGVVALEVAAGKSP 478
                + D++S GV+   + +G SP
Sbjct: 207 EPLGLEADMWSIGVITYILLSGASP 231

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 86/209 (41%), Gaps = 25/209 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTE----FATMAGCLRHKNLVQ 347
           +G G  A V K    S G     +F K  R + +R   + E      ++   ++H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 348 LQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC 407
           L        +++L+ E +  G L   L    S    L+ E+    +  + + + YLH   
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKES----LTEEEATEFLKQILNGVYYLHS-- 132
Query: 408 ERQIIHRDVKACNI-LLDAEF---NAKLGDF----------EATIPAGTMGYLAPEYVYS 453
             QI H D+K  NI LLD        K+ DF          E     GT  ++APE V  
Sbjct: 133 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY 191
Query: 454 GVPSEKTDVYSFGVVALEVAAGKSPVDND 482
                + D++S GV+   + +G SP   D
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASPFLGD 220

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 86/209 (41%), Gaps = 25/209 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTE----FATMAGCLRHKNLVQ 347
           +G G  A V K    S G     +F K  R + +R   + E      ++   ++H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 348 LQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC 407
           L        +++L+ E +  G L   L    S    L+ E+    +  + + + YLH   
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKES----LTEEEATEFLKQILNGVYYLHS-- 132
Query: 408 ERQIIHRDVKACNI-LLDAEF---NAKLGDF----------EATIPAGTMGYLAPEYVYS 453
             QI H D+K  NI LLD        K+ DF          E     GT  ++APE V  
Sbjct: 133 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY 191
Query: 454 GVPSEKTDVYSFGVVALEVAAGKSPVDND 482
                + D++S GV+   + +G SP   D
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASPFLGD 220

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 86/209 (41%), Gaps = 25/209 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTE----FATMAGCLRHKNLVQ 347
           +G G  A V K    S G     +F K  R + +R   + E      ++   ++H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 348 LQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC 407
           L        +++L+ E +  G L   L    S    L+ E+    +  + + + YLH   
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKES----LTEEEATEFLKQILNGVYYLHS-- 132
Query: 408 ERQIIHRDVKACNI-LLDAEF---NAKLGDF----------EATIPAGTMGYLAPEYVYS 453
             QI H D+K  NI LLD        K+ DF          E     GT  ++APE V  
Sbjct: 133 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY 191
Query: 454 GVPSEKTDVYSFGVVALEVAAGKSPVDND 482
                + D++S GV+   + +G SP   D
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASPFLGD 220

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 86/209 (41%), Gaps = 25/209 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTE----FATMAGCLRHKNLVQ 347
           +G G  A V K    S G     +F K  R + +R   + E      ++   ++H N++ 
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 348 LQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC 407
           L        +++L+ E +  G L   L    S    L+ E+    +  + + + YLH   
Sbjct: 78  LHEVYENKTDVILILELVAGGELFDFLAEKES----LTEEEATEFLKQILNGVYYLHS-- 131
Query: 408 ERQIIHRDVKACNI-LLDAEF---NAKLGDF----------EATIPAGTMGYLAPEYVYS 453
             QI H D+K  NI LLD        K+ DF          E     GT  ++APE V  
Sbjct: 132 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY 190
Query: 454 GVPSEKTDVYSFGVVALEVAAGKSPVDND 482
                + D++S GV+   + +G SP   D
Sbjct: 191 EPLGLEADMWSIGVITYILLSGASPFLGD 219

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 32/204 (15%)
Query: 292 VGEGASATV---YKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           +G GA   V   Y   L     VA+K+  +P + +        E   M  C+ HKN++ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMK-CVNHKNIIGL 88
Query: 349 ------QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
                 Q    E  ++ +V E L + +L +++       + L  E+   ++  +   + +
Sbjct: 89  LNVFTPQKSLEEFQDVYIVME-LMDANLCQVIQ------MELDHERMSYLLYQMLCGIKH 141
Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGTMGYLAPEYV--YSGVPS--- 457
           LH      IIHRD+K  NI++ ++   K+ DF     AGT   + PE V  Y   P    
Sbjct: 142 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVIL 198
Query: 458 -----EKTDVYSFGVVALEVAAGK 476
                E  D++S G +  E+   K
Sbjct: 199 GMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 86/209 (41%), Gaps = 25/209 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTE----FATMAGCLRHKNLVQ 347
           +G G  A V K    S G     +F K  R + +R   + E      ++   ++H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 348 LQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC 407
           L        +++L+ E +  G L   L    S    L+ E+    +  + + + YLH   
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKES----LTEEEATEFLKQILNGVYYLHS-- 132
Query: 408 ERQIIHRDVKACNI-LLDAEF---NAKLGDF----------EATIPAGTMGYLAPEYVYS 453
             QI H D+K  NI LLD        K+ DF          E     GT  ++APE V  
Sbjct: 133 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY 191
Query: 454 GVPSEKTDVYSFGVVALEVAAGKSPVDND 482
                + D++S GV+   + +G SP   D
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASPFLGD 220

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 88/207 (42%), Gaps = 28/207 (13%)
Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           + + + +G GA   V        G  VAVK+  +P + +        E   +  C+ HKN
Sbjct: 26  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLK-CVNHKN 84
Query: 345 LVQL------QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVAS 398
           ++ L      Q    E  ++ LV E L + +L +++H      + L  E+   ++  +  
Sbjct: 85  IISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVIH------MELDHERMSYLLYQMLC 137
Query: 399 ALSYLHEECERQIIHRDVKACNILLDAEFNAKLGD----------FEATIPAGTMGYLAP 448
            + +LH      IIHRD+K  NI++ ++   K+ D          F  T    T  Y AP
Sbjct: 138 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAP 194
Query: 449 EYVYSGVPSEKTDVYSFGVVALEVAAG 475
           E +     +   D++S G +  E+  G
Sbjct: 195 EVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/199 (23%), Positives = 81/199 (40%), Gaps = 38/199 (19%)
Query: 306 PSGGAVAVKRFEKPNRVECARNPFTTEFA---TMAGCLRHKNLVQLQGWCCEGNELVLVY 362
           P+G  V V+R      +E   N   T       ++    H N+V  +      NEL +V 
Sbjct: 34  PTGEYVTVRRI----NLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT 89
Query: 363 EYLPNGSLDKIL---HNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKAC 419
            ++  GS   ++     +  + + +++     I+ GV  AL Y+H       +HR VKA 
Sbjct: 90  SFMAYGSAKDLICTHFMDGMNELAIAY-----ILQGVLKALDYIHH---MGYVHRSVKAS 141
Query: 420 NILLDAEFNAKLGDFEATIPAGTMG------------------YLAPEYVYSGVP--SEK 459
           +IL+  +    L    + +   + G                  +L+PE +   +     K
Sbjct: 142 HILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAK 201
Query: 460 TDVYSFGVVALEVAAGKSP 478
           +D+YS G+ A E+A G  P
Sbjct: 202 SDIYSVGITACELANGHVP 220

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/199 (23%), Positives = 81/199 (40%), Gaps = 38/199 (19%)
Query: 306 PSGGAVAVKRFEKPNRVECARNPFTTEFA---TMAGCLRHKNLVQLQGWCCEGNELVLVY 362
           P+G  V V+R      +E   N   T       ++    H N+V  +      NEL +V 
Sbjct: 50  PTGEYVTVRRI----NLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT 105
Query: 363 EYLPNGSLDKIL---HNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKAC 419
            ++  GS   ++     +  + + +++     I+ GV  AL Y+H       +HR VKA 
Sbjct: 106 SFMAYGSAKDLICTHFMDGMNELAIAY-----ILQGVLKALDYIHH---MGYVHRSVKAS 157
Query: 420 NILLDAEFNAKLGDFEATIPAGTMG------------------YLAPEYVYSGVPS--EK 459
           +IL+  +    L    + +   + G                  +L+PE +   +     K
Sbjct: 158 HILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAK 217
Query: 460 TDVYSFGVVALEVAAGKSP 478
           +D+YS G+ A E+A G  P
Sbjct: 218 SDIYSVGITACELANGHVP 236

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 47/96 (48%), Gaps = 13/96 (13%)
Query: 396 VASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA----------GTMGY 445
           +   L  LH E   +I++RD+K  NILLD   + ++ D    +            GT+GY
Sbjct: 295 ICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGY 351
Query: 446 LAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDN 481
           +APE V +   +   D ++ G +  E+ AG+SP   
Sbjct: 352 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ 387

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 47/96 (48%), Gaps = 13/96 (13%)
Query: 396 VASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA----------GTMGY 445
           +   L  LH E   +I++RD+K  NILLD   + ++ D    +            GT+GY
Sbjct: 295 ICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGY 351
Query: 446 LAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDN 481
           +APE V +   +   D ++ G +  E+ AG+SP   
Sbjct: 352 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ 387

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 87/204 (42%), Gaps = 32/204 (15%)
Query: 292 VGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQG 350
           +G GA++ VY+     +    A+K  +K    +  R    TE   +   L H N+++L+ 
Sbjct: 61  LGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVR----TEIGVLLR-LSHPNIIKLKE 115
Query: 351 WCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECER 409
                 E+ LV E +  G L D+I+     S          + V  +  A++YLHE    
Sbjct: 116 IFETPTEISLVLELVTGGELFDRIVEKGYYSE-----RDAADAVKQILEAVAYLHEN--- 167
Query: 410 QIIHRDVKACNILL-----DAEFNAKLGDFEAT----------IPAGTMGYLAPEYVYSG 454
            I+HRD+K  N+L      DA    K+ DF  +             GT GY APE +   
Sbjct: 168 GIVHRDLKPENLLYATPAPDAPL--KIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGC 225
Query: 455 VPSEKTDVYSFGVVALEVAAGKSP 478
               + D++S G++   +  G  P
Sbjct: 226 AYGPEVDMWSVGIITYILLCGFEP 249

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 85/204 (41%), Gaps = 32/204 (15%)
Query: 292 VGEGASATV---YKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           +G GA   V   Y   L     VA+K+  +P + +        E   M   + HKN++ L
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMK-XVNHKNIISL 88
Query: 349 ------QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
                 Q    E  ++ LV E L + +L +++       + L  E+   ++  +   + +
Sbjct: 89  LNVFTPQKTLEEFQDVYLVME-LMDANLXQVIQ------MELDHERMSYLLYQMLXGIKH 141
Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG----------TMGYLAPEYVY 452
           LH      IIHRD+K  NI++ ++   K+ DF     AG          T  Y APE + 
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 453 SGVPSEKTDVYSFGVVALEVAAGK 476
                E  D++S G +  E+   K
Sbjct: 199 GMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 86/209 (41%), Gaps = 25/209 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTE----FATMAGCLRHKNLVQ 347
           +G G  A V K    S G     +F K  R + +R   + E      ++   ++H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 348 LQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC 407
           L        +++L+ E +  G L   L    S    L+ E+    +  + + + YLH   
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKES----LTEEEATEFLKQILNGVYYLHS-- 132
Query: 408 ERQIIHRDVKACNI-LLDAEF---NAKLGDF----------EATIPAGTMGYLAPEYVYS 453
             QI H D+K  NI LLD        K+ DF          E     GT  ++APE V  
Sbjct: 133 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY 191
Query: 454 GVPSEKTDVYSFGVVALEVAAGKSPVDND 482
                + D++S GV+   + +G SP   D
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASPFLGD 220

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 88/211 (41%), Gaps = 16/211 (7%)
Query: 286 FNKNRIVGEGASATVY-KGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F++ + +G G+   V       SG   A+K  +K   V+  +   T     +   +    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           LV+L+    + + L +V EY+  G +   L      S   +      IVL       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEYLH 158
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGVP 456
                 +I+RD+K  N+L+D +   ++ DF              GT   LAPE + S   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEALAPEIILSKGY 215
Query: 457 SEKTDVYSFGVVALEVAAGKSPVDNDGCVIV 487
           ++  D ++ GV+  E+AAG  P   D  + +
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/183 (24%), Positives = 79/183 (43%), Gaps = 44/183 (24%)
Query: 384 LSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--------- 434
           ++ E  ++    VA  + +L     R+ IHRD+ A NILL      K+ DF         
Sbjct: 196 ITMEDLISYSFQVARGMEFL---SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKN 252
Query: 435 -------EATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEV-AAGKSP-----VDN 481
                  +  +P   + ++APE ++  + S K+DV+S+GV+  E+ + G SP     +D 
Sbjct: 253 PDYVRKGDTRLP---LKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDE 309
Query: 482 DGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAA 541
           D C  +       ++G  + A ++             +  + L C H + ++RP   E  
Sbjct: 310 DFCSRL-------REGMRMRAPEY---------STPEIYQIMLDCWHRDPKERPRFAELV 353
Query: 542 RIL 544
             L
Sbjct: 354 EKL 356

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/201 (23%), Positives = 85/201 (42%), Gaps = 19/201 (9%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQG 350
           +G G  A V +  S  +G   A K  +K  R +  R     E A +        ++ L  
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 351 WCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQ 410
                +E++L+ EY   G +  +     +   ++S    + ++  +   + YLH+     
Sbjct: 97  VYENTSEIILILEYAAGGEIFSLCLPELAE--MVSENDVIRLIKQILEGVYYLHQ---NN 151
Query: 411 IIHRDVKACNILLDAEF---NAKLGDF----------EATIPAGTMGYLAPEYVYSGVPS 457
           I+H D+K  NILL + +   + K+ DF          E     GT  YLAPE +     +
Sbjct: 152 IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPIT 211
Query: 458 EKTDVYSFGVVALEVAAGKSP 478
             TD+++ G++A  +    SP
Sbjct: 212 TATDMWNIGIIAYMLLTHTSP 232

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 83/201 (41%), Gaps = 29/201 (14%)
Query: 292 VGEGASATVYK-GSLPSGGAVAVKRFEKPNRVECARNPFTTEFAT----MAGCLRHKNLV 346
           +GEG+   V+K  +  +G  VA+K+F     +E   +P   + A     M   L+H NLV
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKF-----LESEDDPVIKKIALREIRMLKQLKHPNLV 65
Query: 347 QLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEE 406
            L         L LV+EY  +     +LH        +      +I      A+++ H+ 
Sbjct: 66  NLLEVFRRKRRLHLVFEYCDHT----VLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH 121
Query: 407 CERQIIHRDVKACNILLDAEFNAKLGDF----EATIPA-------GTMGYLAPEYVYSGV 455
                IHRDVK  NIL+      KL DF      T P+        T  Y +PE +    
Sbjct: 122 ---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDT 178
Query: 456 P-SEKTDVYSFGVVALEVAAG 475
                 DV++ G V  E+ +G
Sbjct: 179 QYGPPVDVWAIGCVFAELLSG 199

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 90/222 (40%), Gaps = 47/222 (21%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKR-FEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQ 349
           +G+GA   V+K     +G  VAVK+ F+       A+  F  E   +     H+N+V L 
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR-EIMILTELSGHENIVNLL 75
Query: 350 GWCCEGNE--LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC 407
                 N+  + LV++Y+        LH    ++I+    K+  +V  +   + YLH   
Sbjct: 76  NVLRADNDRDVYLVFDYMETD-----LHAVIRANILEPVHKQY-VVYQLIKVIKYLHSGG 129
Query: 408 ERQIIHRDVKACNILLDAEFNAKLGDF------------EATIP---------------- 439
              ++HRD+K  NILL+AE + K+ DF               IP                
Sbjct: 130 ---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186
Query: 440 ----AGTMGYLAPEYVYSGVPSEK-TDVYSFGVVALEVAAGK 476
                 T  Y APE +       K  D++S G +  E+  GK
Sbjct: 187 LTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 85/204 (41%), Gaps = 32/204 (15%)
Query: 292 VGEGASATV---YKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           +G GA   V   Y   L     VA+K+  +P + +        E   M   + HKN++ L
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKX-VNHKNIISL 88
Query: 349 ------QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
                 Q    E  ++ LV E L + +L +++       + L  E+   ++  +   + +
Sbjct: 89  LNVFTPQKTLEEFQDVYLVME-LMDANLXQVIQ------MELDHERMSYLLYQMLCGIKH 141
Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG----------TMGYLAPEYVY 452
           LH      IIHRD+K  NI++ ++   K+ DF     AG          T  Y APE + 
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 453 SGVPSEKTDVYSFGVVALEVAAGK 476
                E  D++S G +  E+   K
Sbjct: 199 GMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 86/204 (42%), Gaps = 32/204 (15%)
Query: 292 VGEGASATV---YKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           +G GA   V   Y   L     VA+K+  +P + +        E   M  C+ HKN++ L
Sbjct: 37  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMK-CVNHKNIIGL 93
Query: 349 ------QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
                 Q    E  ++ +V E L + +L +++       + L  E+   ++  +   + +
Sbjct: 94  LNVFTPQKSLEEFQDVYIVME-LMDANLCQVIQ------MELDHERMSYLLYQMLCGIKH 146
Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG----------TMGYLAPEYVY 452
           LH      IIHRD+K  NI++ ++   K+ DF     AG          T  Y APE + 
Sbjct: 147 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 203
Query: 453 SGVPSEKTDVYSFGVVALEVAAGK 476
                E  D++S G +  E+   K
Sbjct: 204 GMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 86/209 (41%), Gaps = 25/209 (11%)
Query: 292 VGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTE----FATMAGCLRHKNLVQ 347
           +G G  A V K    S G     +F K  R + +R   + E      ++   ++H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 348 LQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC 407
           L        +++L+ E +  G L   L    S    L+ E+    +  + + + YLH   
Sbjct: 79  LHEVYENKTDVILIGELVAGGELFDFLAEKES----LTEEEATEFLKQILNGVYYLHS-- 132
Query: 408 ERQIIHRDVKACNI-LLDAEF---NAKLGDF----------EATIPAGTMGYLAPEYVYS 453
             QI H D+K  NI LLD        K+ DF          E     GT  ++APE V  
Sbjct: 133 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY 191
Query: 454 GVPSEKTDVYSFGVVALEVAAGKSPVDND 482
                + D++S GV+   + +G SP   D
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASPFLGD 220

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 28/206 (13%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQG 350
           +GEG    VYK     +   VA+KR    +  E        E + +   L+H+N+++L+ 
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKE-LQHRNIIELKS 100
Query: 351 WCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQ 410
                + L L++EY  N  L K +  N   S+ +       ++ GV    ++ H    R+
Sbjct: 101 VIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGV----NFCH---SRR 152
Query: 411 IIHRDVKACNILLDAEFNA-----KLGDF-----------EATIPAGTMGYLAPEYVY-S 453
            +HRD+K  N+LL     +     K+GDF           + T    T+ Y  PE +  S
Sbjct: 153 CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGS 212
Query: 454 GVPSEKTDVYSFGVVALEVAAGKSPV 479
              S   D++S   +  E+   K+P+
Sbjct: 213 RHYSTSVDIWSIACIWAEMLM-KTPL 237

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 52/237 (21%), Positives = 93/237 (39%), Gaps = 46/237 (19%)
Query: 271 PMRLALTDIKQATLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECAR--NP 328
           P    + +++     F   +++G GA            G VAV + +   R+   +  N 
Sbjct: 77  PFTQLVKEMQLHREDFEIIKVIGRGAF-----------GEVAVVKMKNTERIYAMKILNK 125
Query: 329 FTTEFATMAGCLRHKNLVQLQGWCC----------EGNELVLVYEYLPNGSLDKILHNNS 378
           +         C R +  V + G C           + N L LV +Y   G L  +L   S
Sbjct: 126 WEMLKRAETACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLL---S 182
Query: 379 SSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF---- 434
                L  +     +  +  A+  +H+      +HRD+K  N+LLD   + +L DF    
Sbjct: 183 KFEDKLPEDMARFYIGEMVLAIDSIHQ---LHYVHRDIKPDNVLLDVNGHIRLADFGSCL 239
Query: 435 --------EATIPAGTMGYLAPEYVYS-----GVPSEKTDVYSFGVVALEVAAGKSP 478
                   ++++  GT  Y++PE + +     G    + D +S GV   E+  G++P
Sbjct: 240 KMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 296

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 67/149 (44%), Gaps = 22/149 (14%)
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           +V+L G  C+   L+LV E    G L K L        V +  + L+    V+  + YL 
Sbjct: 72  IVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLH---QVSMGMKYLE 127
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGT--------------MGYLAPEY 450
           E   +  +HRD+ A N+LL     AK+ DF  +   G               + + APE 
Sbjct: 128 E---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 184
Query: 451 VYSGVPSEKTDVYSFGVVALE-VAAGKSP 478
           +     S ++DV+S+GV   E ++ G+ P
Sbjct: 185 INFRKFSSRSDVWSYGVTMWEALSYGQKP 213

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 90/241 (37%), Gaps = 46/241 (19%)
Query: 279 IKQATLGFNKNRIVGEGASATVYKGS-LPSGGAVAVKRF----EKPNRVECARNPFTTEF 333
           ++   L     R++ EG  A VY+   + SG   A+KR     E+ NR          E 
Sbjct: 23  VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRA------IIQEV 76
Query: 334 ATMAGCLRHKNLVQLQGWCCEGNEL-------VLVYEYLPNGSLDKILHNNSSSSIVLSW 386
             M     H N+VQ       G E         L+   L  G L + L    S    LS 
Sbjct: 77  CFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRG-PLSC 135
Query: 387 EKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF------------ 434
           +  L I      A+ ++H + +  IIHRD+K  N+LL  +   KL DF            
Sbjct: 136 DTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDY 194
Query: 435 -----------EATIPAGTMGYLAPEYV--YSGVP-SEKTDVYSFGVVALEVAAGKSPVD 480
                      E      T  Y  PE +  YS  P  EK D+++ G +   +   + P +
Sbjct: 195 SWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE 254
Query: 481 N 481
           +
Sbjct: 255 D 255

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 85/203 (41%), Gaps = 32/203 (15%)
Query: 292 VGEGASATV---YKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           +G GA   V   Y   L     VA+K+  +P + +        E   M   + HKN++ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMK-VVNHKNIIGL 88
Query: 349 ------QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
                 Q    E  ++ +V E L + +L +++       + L  E+   ++  +   + +
Sbjct: 89  LNVFTPQKSLEEFQDVYIVME-LMDANLSQVIQ------MELDHERMSYLLYQMLVGIKH 141
Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG----------TMGYLAPEYVY 452
           LH      IIHRD+K  NI++ ++   K+ DF     AG          T  Y APE + 
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 453 SGVPSEKTDVYSFGVVALEVAAG 475
                E  D++S G +  E+  G
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 52/237 (21%), Positives = 93/237 (39%), Gaps = 46/237 (19%)
Query: 271 PMRLALTDIKQATLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECAR--NP 328
           P    + +++     F   +++G GA            G VAV + +   R+   +  N 
Sbjct: 61  PFTQLVKEMQLHREDFEIIKVIGRGAF-----------GEVAVVKMKNTERIYAMKILNK 109
Query: 329 FTTEFATMAGCLRHKNLVQLQGWCC----------EGNELVLVYEYLPNGSLDKILHNNS 378
           +         C R +  V + G C           + N L LV +Y   G L  +L   S
Sbjct: 110 WEMLKRAETACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLL---S 166
Query: 379 SSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF---- 434
                L  +     +  +  A+  +H+      +HRD+K  N+LLD   + +L DF    
Sbjct: 167 KFEDKLPEDMARFYIGEMVLAIDSIHQ---LHYVHRDIKPDNVLLDVNGHIRLADFGSCL 223
Query: 435 --------EATIPAGTMGYLAPEYVYS-----GVPSEKTDVYSFGVVALEVAAGKSP 478
                   ++++  GT  Y++PE + +     G    + D +S GV   E+  G++P
Sbjct: 224 KMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 280

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 86/204 (42%), Gaps = 32/204 (15%)
Query: 292 VGEGASATV---YKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           +G GA   V   Y   L     VA+K+  +P + +        E   M  C+ HKN++ L
Sbjct: 26  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMK-CVNHKNIIGL 82
Query: 349 ------QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
                 Q    E  ++ +V E L + +L +++       + L  E+   ++  +   + +
Sbjct: 83  LNVFTPQKSLEEFQDVYIVME-LMDANLCQVIQ------MELDHERMSYLLYQMLCGIKH 135
Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG----------TMGYLAPEYVY 452
           LH      IIHRD+K  NI++ ++   K+ DF     AG          T  Y APE + 
Sbjct: 136 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 192
Query: 453 SGVPSEKTDVYSFGVVALEVAAGK 476
                E  D++S G +  E+   K
Sbjct: 193 GMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 92/221 (41%), Gaps = 30/221 (13%)
Query: 284 LGFNKNRIVGEGASATVYKGSL-PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRH 342
           + +   +++G G+   VY+  L  SG  VA+K+  +  R       F      +   L H
Sbjct: 20  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDH 72
Query: 343 KNLVQLQGWCCEGNE------LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGV 396
            N+V+L+ +     E      L LV +Y+P        H + +   +     +L +   +
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQL 131
Query: 397 ASALSYLHEECERQIIHRDVKACNILLDAEFNA-KLGDF---------EATIPA-GTMGY 445
             +L+Y+H      I HRD+K  N+LLD +    KL DF         E  +    +  Y
Sbjct: 132 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYY 188
Query: 446 LAPEYVYSGVP-SEKTDVYSFGVVALEVAAGKSPVDNDGCV 485
            APE ++     +   DV+S G V  E+  G+     D  V
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV 229

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 92/221 (41%), Gaps = 30/221 (13%)
Query: 284 LGFNKNRIVGEGASATVYKGSL-PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRH 342
           + +   +++G G+   VY+  L  SG  VA+K+  +  R       F      +   L H
Sbjct: 20  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDH 72
Query: 343 KNLVQLQGWCCEGNE------LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGV 396
            N+V+L+ +     E      L LV +Y+P        H + +   +     +L +   +
Sbjct: 73  CNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQL 131
Query: 397 ASALSYLHEECERQIIHRDVKACNILLDAEFNA-KLGDF---------EATIPA-GTMGY 445
             +L+Y+H      I HRD+K  N+LLD +    KL DF         E  +    +  Y
Sbjct: 132 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYY 188
Query: 446 LAPEYVYSGVP-SEKTDVYSFGVVALEVAAGKSPVDNDGCV 485
            APE ++     +   DV+S G V  E+  G+     D  V
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV 229

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 92/221 (41%), Gaps = 30/221 (13%)
Query: 284 LGFNKNRIVGEGASATVYKGSL-PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRH 342
           + +   +++G G+   VY+  L  SG  VA+K+  +  R       F      +   L H
Sbjct: 21  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDH 73
Query: 343 KNLVQLQGWCCEGNE------LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGV 396
            N+V+L+ +     E      L LV +Y+P        H + +   +     +L +   +
Sbjct: 74  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQL 132
Query: 397 ASALSYLHEECERQIIHRDVKACNILLDAEFNA-KLGDF---------EATIPA-GTMGY 445
             +L+Y+H      I HRD+K  N+LLD +    KL DF         E  +    +  Y
Sbjct: 133 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYY 189
Query: 446 LAPEYVYSGVP-SEKTDVYSFGVVALEVAAGKSPVDNDGCV 485
            APE ++     +   DV+S G V  E+  G+     D  V
Sbjct: 190 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV 230

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 92/221 (41%), Gaps = 30/221 (13%)
Query: 284 LGFNKNRIVGEGASATVYKGSL-PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRH 342
           + +   +++G G+   VY+  L  SG  VA+K+  +  R       F      +   L H
Sbjct: 39  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDH 91
Query: 343 KNLVQLQGWCCEGNE------LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGV 396
            N+V+L+ +     E      L LV +Y+P        H + +   +     +L  +  +
Sbjct: 92  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQL 150
Query: 397 ASALSYLHEECERQIIHRDVKACNILLDAEFNA-KLGDF---------EATIPA-GTMGY 445
             +L+Y+H      I HRD+K  N+LLD +    KL DF         E  +    +  Y
Sbjct: 151 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYY 207
Query: 446 LAPEYVYSGVP-SEKTDVYSFGVVALEVAAGKSPVDNDGCV 485
            APE ++     +   DV+S G V  E+  G+     D  V
Sbjct: 208 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV 248

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 72/160 (45%), Gaps = 23/160 (14%)
Query: 334 ATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNI 392
           A +   L+H N+V+L     E     LV++ +  G L + I+     S    S     + 
Sbjct: 81  ARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS-----HC 135
Query: 393 VLGVASALSYLHEECERQIIHRDVKACNILLDAEFN---AKLGDFEATIP---------- 439
           +  +  +++++H+     I+HRD+K  N+LL ++      KL DF   I           
Sbjct: 136 IHQILESVNHIHQH---DIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFG 192
Query: 440 -AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSP 478
            AGT GYL+PE +      +  D+++ GV+   +  G  P
Sbjct: 193 FAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPP 232

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 92/221 (41%), Gaps = 30/221 (13%)
Query: 284 LGFNKNRIVGEGASATVYKGSL-PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRH 342
           + +   +++G G+   VY+  L  SG  VA+K+  +  R       F      +   L H
Sbjct: 28  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDH 80
Query: 343 KNLVQLQGWCCEGNE------LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGV 396
            N+V+L+ +     E      L LV +Y+P        H + +   +     +L  +  +
Sbjct: 81  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQL 139
Query: 397 ASALSYLHEECERQIIHRDVKACNILLDAEFNA-KLGDF---------EATIPA-GTMGY 445
             +L+Y+H      I HRD+K  N+LLD +    KL DF         E  +    +  Y
Sbjct: 140 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYY 196
Query: 446 LAPEYVYSGVP-SEKTDVYSFGVVALEVAAGKSPVDNDGCV 485
            APE ++     +   DV+S G V  E+  G+     D  V
Sbjct: 197 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV 237

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 92/221 (41%), Gaps = 30/221 (13%)
Query: 284 LGFNKNRIVGEGASATVYKGSL-PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRH 342
           + +   +++G G+   VY+  L  SG  VA+K+  +  R       F      +   L H
Sbjct: 20  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDH 72
Query: 343 KNLVQLQGWCCEGNE------LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGV 396
            N+V+L+ +     E      L LV +Y+P        H + +   +     +L +   +
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQL 131
Query: 397 ASALSYLHEECERQIIHRDVKACNILLDAEFNA-KLGDF---------EATIP-AGTMGY 445
             +L+Y+H      I HRD+K  N+LLD +    KL DF         E  +    +  Y
Sbjct: 132 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 188
Query: 446 LAPEYVYSGVP-SEKTDVYSFGVVALEVAAGKSPVDNDGCV 485
            APE ++     +   DV+S G V  E+  G+     D  V
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV 229

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 92/221 (41%), Gaps = 30/221 (13%)
Query: 284 LGFNKNRIVGEGASATVYKGSL-PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRH 342
           + +   +++G G+   VY+  L  SG  VA+K+  +  R       F      +   L H
Sbjct: 32  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDH 84
Query: 343 KNLVQLQGWCCEGNE------LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGV 396
            N+V+L+ +     E      L LV +Y+P        H + +   +     +L +   +
Sbjct: 85  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQL 143
Query: 397 ASALSYLHEECERQIIHRDVKACNILLDAEFNA-KLGDF---------EATIPA-GTMGY 445
             +L+Y+H      I HRD+K  N+LLD +    KL DF         E  +    +  Y
Sbjct: 144 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYY 200
Query: 446 LAPEYVYSGVP-SEKTDVYSFGVVALEVAAGKSPVDNDGCV 485
            APE ++     +   DV+S G V  E+  G+     D  V
Sbjct: 201 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV 241

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 92/221 (41%), Gaps = 30/221 (13%)
Query: 284 LGFNKNRIVGEGASATVYKGSL-PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRH 342
           + +   +++G G+   VY+  L  SG  VA+K+  +  R       F      +   L H
Sbjct: 20  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDH 72
Query: 343 KNLVQLQGWCCEGNE------LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGV 396
            N+V+L+ +     E      L LV +Y+P        H + +   +     +L +   +
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQL 131
Query: 397 ASALSYLHEECERQIIHRDVKACNILLDAEFNA-KLGDF---------EATIPA-GTMGY 445
             +L+Y+H      I HRD+K  N+LLD +    KL DF         E  +    +  Y
Sbjct: 132 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYY 188
Query: 446 LAPEYVYSGVP-SEKTDVYSFGVVALEVAAGKSPVDNDGCV 485
            APE ++     +   DV+S G V  E+  G+     D  V
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV 229

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 85/203 (41%), Gaps = 32/203 (15%)
Query: 292 VGEGASATV---YKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           +G GA   V   Y   L     VA+K+  +P + +        E   M   + HKN++ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMK-VVNHKNIIGL 88
Query: 349 ------QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
                 Q    E  ++ +V E L + +L +++       + L  E+   ++  +   + +
Sbjct: 89  LNVFTPQKSLEEFQDVYIVME-LMDANLSQVIQ------MELDHERMSYLLYQMLCGIKH 141
Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG----------TMGYLAPEYVY 452
           LH      IIHRD+K  NI++ ++   K+ DF     AG          T  Y APE + 
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 453 SGVPSEKTDVYSFGVVALEVAAG 475
                E  D++S G +  E+  G
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 92/221 (41%), Gaps = 30/221 (13%)
Query: 284 LGFNKNRIVGEGASATVYKGSL-PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRH 342
           + +   +++G G+   VY+  L  SG  VA+K+  +  R       F      +   L H
Sbjct: 24  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDH 76
Query: 343 KNLVQLQGWCCEGNE------LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGV 396
            N+V+L+ +     E      L LV +Y+P        H + +   +     +L +   +
Sbjct: 77  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQL 135
Query: 397 ASALSYLHEECERQIIHRDVKACNILLDAEFNA-KLGDF---------EATIPA-GTMGY 445
             +L+Y+H      I HRD+K  N+LLD +    KL DF         E  +    +  Y
Sbjct: 136 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYY 192
Query: 446 LAPEYVYSGVP-SEKTDVYSFGVVALEVAAGKSPVDNDGCV 485
            APE ++     +   DV+S G V  E+  G+     D  V
Sbjct: 193 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV 233

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 92/221 (41%), Gaps = 30/221 (13%)
Query: 284 LGFNKNRIVGEGASATVYKGSL-PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRH 342
           + +   +++G G+   VY+  L  SG  VA+K+  +  R       F      +   L H
Sbjct: 32  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDH 84
Query: 343 KNLVQLQGWCCEGNE------LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGV 396
            N+V+L+ +     E      L LV +Y+P        H + +   +     +L  +  +
Sbjct: 85  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQL 143
Query: 397 ASALSYLHEECERQIIHRDVKACNILLDAEFNA-KLGDF---------EATIPA-GTMGY 445
             +L+Y+H      I HRD+K  N+LLD +    KL DF         E  +    +  Y
Sbjct: 144 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYY 200
Query: 446 LAPEYVYSGVP-SEKTDVYSFGVVALEVAAGKSPVDNDGCV 485
            APE ++     +   DV+S G V  E+  G+     D  V
Sbjct: 201 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV 241

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 92/221 (41%), Gaps = 30/221 (13%)
Query: 284 LGFNKNRIVGEGASATVYKGSL-PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRH 342
           + +   +++G G+   VY+  L  SG  VA+K+  +  R       F      +   L H
Sbjct: 33  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDH 85
Query: 343 KNLVQLQGWCCEGNE------LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGV 396
            N+V+L+ +     E      L LV +Y+P        H + +   +     +L  +  +
Sbjct: 86  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQL 144
Query: 397 ASALSYLHEECERQIIHRDVKACNILLDAEFNA-KLGDF---------EATIP-AGTMGY 445
             +L+Y+H      I HRD+K  N+LLD +    KL DF         E  +    +  Y
Sbjct: 145 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 201
Query: 446 LAPEYVYSGVP-SEKTDVYSFGVVALEVAAGKSPVDNDGCV 485
            APE ++     +   DV+S G V  E+  G+     D  V
Sbjct: 202 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV 242

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 92/221 (41%), Gaps = 30/221 (13%)
Query: 284 LGFNKNRIVGEGASATVYKGSL-PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRH 342
           + +   +++G G+   VY+  L  SG  VA+K+  +  R       F      +   L H
Sbjct: 54  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDH 106
Query: 343 KNLVQLQGWCCEGNE------LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGV 396
            N+V+L+ +     E      L LV +Y+P        H + +   +     +L  +  +
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQL 165
Query: 397 ASALSYLHEECERQIIHRDVKACNILLDAEFNA-KLGDF---------EATIPA-GTMGY 445
             +L+Y+H      I HRD+K  N+LLD +    KL DF         E  +    +  Y
Sbjct: 166 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYY 222
Query: 446 LAPEYVYSGVP-SEKTDVYSFGVVALEVAAGKSPVDNDGCV 485
            APE ++     +   DV+S G V  E+  G+     D  V
Sbjct: 223 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV 263

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 91/225 (40%), Gaps = 32/225 (14%)
Query: 266 TVQRVPMRLALTDIKQATLGFNKNRIVGEGASATV---YKGSLPSGGAVAVKRFEKP-NR 321
           TV  VP RL               R VG GA  +V   Y   L     VAVK+  +P   
Sbjct: 22  TVWEVPQRL------------QGLRPVGSGAYGSVCSAYDARLRQ--KVAVKKLSRPFQS 67
Query: 322 VECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSS 381
           +  AR  +      +   L+H+N++ L         +    E     +L     NN   S
Sbjct: 68  LIHARRTYRE--LRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKS 125
Query: 382 IVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF------- 434
             LS E    +V  +   L Y+H      IIHRD+K  N+ ++ +   ++ DF       
Sbjct: 126 QALSDEHVQFLVYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLARQAD 182
Query: 435 -EATIPAGTMGYLAPEYVYSGVPSEKT-DVYSFGVVALEVAAGKS 477
            E T    T  Y APE + + +   +T D++S G +  E+  GK+
Sbjct: 183 EEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKA 227

>pdb|3ZVX|A Chain A, Structure Of The Lectin From Platypodium Elegans In Complex With A Trimannoside Length = 261

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 79/202 (39%), Gaps = 51/202 (25%)
Query: 3   DPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSF--GNDNGYMGLPGPVLSPQ 60
           +  TN  A+   +FSF  + SPL    DG AF I     +   G+  G +GL  P  +  
Sbjct: 69  EKSTNRVANLQTQFSF-FLSSPLSNPADGIAFFIAPPDTTIPSGSAGGLLGLFNPRTALN 127
Query: 61  DS---FFAVEFDTSF-------DPSLXXXXXXXXXXXXXXXXXXXXXDALSRGIDLKS-- 108
           +S     AVEFDT F       DP+                           GID+ S  
Sbjct: 128 ESANQVLAVEFDTFFAQNSNTWDPNYQHI-----------------------GIDVNSIR 164
Query: 109 -----------GRHITTWIEYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHV 157
                      G+ +   + Y  S + I V A Y   +     +   +DL+    +++ V
Sbjct: 165 SSKVVRWERREGKTLNVLVTYNPSTRTIDVVATYPDGQRYQ--LSHVVDLTTILPEWVRV 222
Query: 158 GFSAANGQGSAIYTVDRWRFKT 179
           GFSAA+G+    + ++ W F +
Sbjct: 223 GFSAASGEQFQTHNLESWSFTS 244

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 85/204 (41%), Gaps = 32/204 (15%)
Query: 292 VGEGASATV---YKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           +G GA   V   Y   L     VA+K+  +P + +        E   M   + HKN++ L
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKX-VNHKNIISL 88
Query: 349 ------QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
                 Q    E  ++ LV E L + +L +++       + L  E+   ++  +   + +
Sbjct: 89  LNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQ------MELDHERMSYLLYQMLCGIKH 141
Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG----------TMGYLAPEYVY 452
           LH      IIHRD+K  NI++ ++   K+ DF     AG          T  Y APE + 
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 453 SGVPSEKTDVYSFGVVALEVAAGK 476
                E  D++S G +  E+   K
Sbjct: 199 GMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 92/221 (41%), Gaps = 30/221 (13%)
Query: 284 LGFNKNRIVGEGASATVYKGSL-PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRH 342
           + +   +++G G+   VY+  L  SG  VA+K+  +  R       F      +   L H
Sbjct: 48  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDH 100
Query: 343 KNLVQLQGWCCEGNE------LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGV 396
            N+V+L+ +     E      L LV +Y+P        H + +   +     +L  +  +
Sbjct: 101 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQL 159
Query: 397 ASALSYLHEECERQIIHRDVKACNILLDAEFNA-KLGDF---------EATIP-AGTMGY 445
             +L+Y+H      I HRD+K  N+LLD +    KL DF         E  +    +  Y
Sbjct: 160 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 216
Query: 446 LAPEYVYSGVP-SEKTDVYSFGVVALEVAAGKSPVDNDGCV 485
            APE ++     +   DV+S G V  E+  G+     D  V
Sbjct: 217 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV 257

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/234 (23%), Positives = 94/234 (40%), Gaps = 49/234 (20%)
Query: 277 TDIKQATL---GFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECAR--NPFTT 331
           + +KQ  L    F   +++G GA            G VAV + +  ++V   +  N +  
Sbjct: 64  SKVKQMRLHREDFEILKVIGRGAF-----------GEVAVVKLKNADKVFAMKILNKWEM 112
Query: 332 EFATMAGCLRHKNLVQLQG---WCC-------EGNELVLVYEYLPNGSLDKILHNNSSSS 381
                  C R +  V + G   W         + N L LV +Y   G L  +L   S   
Sbjct: 113 LKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLL---SKFE 169
Query: 382 IVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF------- 434
             L  E     +  +  A+  +H+      +HRD+K  NIL+D   + +L DF       
Sbjct: 170 DRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLM 226
Query: 435 -----EATIPAGTMGYLAPEYVYS-----GVPSEKTDVYSFGVVALEVAAGKSP 478
                ++++  GT  Y++PE + +     G    + D +S GV   E+  G++P
Sbjct: 227 EDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 92/221 (41%), Gaps = 30/221 (13%)
Query: 284 LGFNKNRIVGEGASATVYKGSL-PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRH 342
           + +   +++G G+   VY+  L  SG  VA+K+  +  R       F      +   L H
Sbjct: 54  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDH 106
Query: 343 KNLVQLQGWCCEGNE------LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGV 396
            N+V+L+ +     E      L LV +Y+P        H + +   +     +L  +  +
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQL 165
Query: 397 ASALSYLHEECERQIIHRDVKACNILLDAEFNA-KLGDF---------EATIP-AGTMGY 445
             +L+Y+H      I HRD+K  N+LLD +    KL DF         E  +    +  Y
Sbjct: 166 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 222
Query: 446 LAPEYVYSGVP-SEKTDVYSFGVVALEVAAGKSPVDNDGCV 485
            APE ++     +   DV+S G V  E+  G+     D  V
Sbjct: 223 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV 263

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 92/221 (41%), Gaps = 30/221 (13%)
Query: 284 LGFNKNRIVGEGASATVYKGSL-PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRH 342
           + +   +++G G+   VY+  L  SG  VA+K+  +  R       F      +   L H
Sbjct: 56  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDH 108
Query: 343 KNLVQLQGWCCEGNE------LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGV 396
            N+V+L+ +     E      L LV +Y+P        H + +   +     +L  +  +
Sbjct: 109 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQL 167
Query: 397 ASALSYLHEECERQIIHRDVKACNILLDAEFNA-KLGDF---------EATIP-AGTMGY 445
             +L+Y+H      I HRD+K  N+LLD +    KL DF         E  +    +  Y
Sbjct: 168 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 224
Query: 446 LAPEYVYSGVP-SEKTDVYSFGVVALEVAAGKSPVDNDGCV 485
            APE ++     +   DV+S G V  E+  G+     D  V
Sbjct: 225 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV 265

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 92/221 (41%), Gaps = 30/221 (13%)
Query: 284 LGFNKNRIVGEGASATVYKGSL-PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRH 342
           + +   +++G G+   VY+  L  SG  VA+K+  +  R       F      +   L H
Sbjct: 58  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDH 110
Query: 343 KNLVQLQGWCCEGNE------LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGV 396
            N+V+L+ +     E      L LV +Y+P        H + +   +     +L  +  +
Sbjct: 111 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQL 169
Query: 397 ASALSYLHEECERQIIHRDVKACNILLDAEFNA-KLGDF---------EATIP-AGTMGY 445
             +L+Y+H      I HRD+K  N+LLD +    KL DF         E  +    +  Y
Sbjct: 170 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 226
Query: 446 LAPEYVYSGVP-SEKTDVYSFGVVALEVAAGKSPVDNDGCV 485
            APE ++     +   DV+S G V  E+  G+     D  V
Sbjct: 227 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV 267

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 92/221 (41%), Gaps = 30/221 (13%)
Query: 284 LGFNKNRIVGEGASATVYKGSL-PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRH 342
           + +   +++G G+   VY+  L  SG  VA+K+  +  R       F      +   L H
Sbjct: 25  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDH 77
Query: 343 KNLVQLQGWCCEGNE------LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGV 396
            N+V+L+ +     E      L LV +Y+P        H + +   +     +L  +  +
Sbjct: 78  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQL 136
Query: 397 ASALSYLHEECERQIIHRDVKACNILLDAEFNA-KLGDF---------EATIP-AGTMGY 445
             +L+Y+H      I HRD+K  N+LLD +    KL DF         E  +    +  Y
Sbjct: 137 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 193
Query: 446 LAPEYVYSGVP-SEKTDVYSFGVVALEVAAGKSPVDNDGCV 485
            APE ++     +   DV+S G V  E+  G+     D  V
Sbjct: 194 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV 234

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 92/221 (41%), Gaps = 30/221 (13%)
Query: 284 LGFNKNRIVGEGASATVYKGSL-PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRH 342
           + +   +++G G+   VY+  L  SG  VA+K+  +  R       F      +   L H
Sbjct: 99  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDH 151
Query: 343 KNLVQLQGWCCEGNE------LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGV 396
            N+V+L+ +     E      L LV +Y+P        H + +   +     +L  +  +
Sbjct: 152 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQL 210
Query: 397 ASALSYLHEECERQIIHRDVKACNILLDAEFNA-KLGDF---------EATIP-AGTMGY 445
             +L+Y+H      I HRD+K  N+LLD +    KL DF         E  +    +  Y
Sbjct: 211 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 267
Query: 446 LAPEYVYSGVP-SEKTDVYSFGVVALEVAAGKSPVDNDGCV 485
            APE ++     +   DV+S G V  E+  G+     D  V
Sbjct: 268 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV 308

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 26/209 (12%)
Query: 286 FNKNRIVGEGASATVY--KGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHK 343
           + + + +G GA   V   K  L +G   A+K  +K +    + +    +   +   L H 
Sbjct: 6   YQRVKKLGSGAYGEVLLCKDKL-TGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHP 64
Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
           N+++L  +  +     LV E    G L D+I+     S +  +      I+  V S  +Y
Sbjct: 65  NIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV-----IMKQVLSGTTY 119
Query: 403 LHEECERQIIHRDVKACNILLDAEFN---AKLGDF----------EATIPAGTMGYLAPE 449
           LH+     I+HRD+K  N+LL+++      K+ DF          +     GT  Y+APE
Sbjct: 120 LHK---HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPE 176
Query: 450 YVYSGVPSEKTDVYSFGVVALEVAAGKSP 478
            V      EK DV+S GV+   +  G  P
Sbjct: 177 -VLRKKYDEKCDVWSCGVILYILLCGYPP 204

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 26/209 (12%)
Query: 286 FNKNRIVGEGASATVY--KGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHK 343
           + + + +G GA   V   K  L +G   A+K  +K +    + +    +   +   L H 
Sbjct: 23  YQRVKKLGSGAYGEVLLCKDKL-TGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHP 81
Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
           N+++L  +  +     LV E    G L D+I+     S +  +      I+  V S  +Y
Sbjct: 82  NIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAA-----VIMKQVLSGTTY 136
Query: 403 LHEECERQIIHRDVKACNILLDAEFN---AKLGDF----------EATIPAGTMGYLAPE 449
           LH+     I+HRD+K  N+LL+++      K+ DF          +     GT  Y+APE
Sbjct: 137 LHK---HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPE 193
Query: 450 YVYSGVPSEKTDVYSFGVVALEVAAGKSP 478
            V      EK DV+S GV+   +  G  P
Sbjct: 194 -VLRKKYDEKCDVWSCGVILYILLCGYPP 221

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 86/203 (42%), Gaps = 28/203 (13%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNR--VECARNPFTTEFATMAGCLRHKNLVQL 348
           VG GA  +V       +G  VAVK+  +P +  +   R   T     +   ++H+N++ L
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVIGL 86
Query: 349 QGWCCEGNEL-----VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
                    L     V +  +L    L     NN   S  L+ +    ++  +   L Y+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADL-----NNIVKSQKLTDDHVQFLIYQILRGLKYI 141
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGV 455
           H      IIHRD+K  N+ ++ +   K+ DF        E T    T  Y APE + + +
Sbjct: 142 HSA---DIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 456 PSEKT-DVYSFGVVALEVAAGKS 477
              +T D++S G +  E+  G++
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 89/204 (43%), Gaps = 30/204 (14%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNR--VECARNPFTTEFATMAGCLRHKNLVQL 348
           VG GA  +V       +G  VAVK+  +P +  +   R   T     +   ++H+N++ L
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVIGL 86
Query: 349 QGWCC------EGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
                      E N++ LV  +L    L+ I+     +   + +     ++  +   L Y
Sbjct: 87  LDVFTPARSLEEFNDVYLV-THLMGADLNNIVKXQKLTDDHVQF-----LIYQILRGLKY 140
Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSG 454
           +H      IIHRD+K  N+ ++ +   K+ DF        E T    T  Y APE + + 
Sbjct: 141 IHSA---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNW 197
Query: 455 VPSEKT-DVYSFGVVALEVAAGKS 477
           +   +T D++S G +  E+  G++
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/172 (25%), Positives = 73/172 (42%), Gaps = 25/172 (14%)
Query: 326 RNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVL 384
           R+P T E   +    +H N++ L+    +G  + +V E +  G L DKIL          
Sbjct: 60  RDP-TEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK-----FF 113
Query: 385 SWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNIL-LDAEFN---AKLGDFE----- 435
           S  +   ++  +   + YLH +    ++HRD+K  NIL +D   N    ++ DF      
Sbjct: 114 SEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170
Query: 436 ------ATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDN 481
                    P  T  ++APE +         D++S GV+   +  G +P  N
Sbjct: 171 RAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFAN 222

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 70/153 (45%), Gaps = 22/153 (14%)
Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVAS 398
           L+H N+V+L     E +   LV++ +  G L + I+     S    S     + +  +  
Sbjct: 61  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS-----HCIQQILE 115
Query: 399 ALSYLHEECERQIIHRDVKACNILLDAEFN---AKLGDFEATIP----------AGTMGY 445
           +++Y H      I+HR++K  N+LL ++      KL DF   I           AGT GY
Sbjct: 116 SIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGY 172
Query: 446 LAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSP 478
           L+PE +     S+  D+++ GV+   +  G  P
Sbjct: 173 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 205

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 70/153 (45%), Gaps = 22/153 (14%)
Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVAS 398
           L+H N+V+L     E +   LV++ +  G L + I+     S    S     + +  +  
Sbjct: 62  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS-----HCIQQILE 116
Query: 399 ALSYLHEECERQIIHRDVKACNILLDAEFN---AKLGDFEATIP----------AGTMGY 445
           +++Y H      I+HR++K  N+LL ++      KL DF   I           AGT GY
Sbjct: 117 SIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGY 173
Query: 446 LAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSP 478
           L+PE +     S+  D+++ GV+   +  G  P
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 70/153 (45%), Gaps = 22/153 (14%)
Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVAS 398
           L+H N+V+L     E +   LV++ +  G L + I+     S    S     + +  +  
Sbjct: 85  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS-----HCIQQILE 139
Query: 399 ALSYLHEECERQIIHRDVKACNILLDAEFNA---KLGDFEATIP----------AGTMGY 445
           +++Y H      I+HR++K  N+LL ++      KL DF   I           AGT GY
Sbjct: 140 SIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGY 196
Query: 446 LAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSP 478
           L+PE +     S+  D+++ GV+   +  G  P
Sbjct: 197 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 70/153 (45%), Gaps = 22/153 (14%)
Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVAS 398
           L+H N+V+L     E +   LV++ +  G L + I+     S    S     + +  +  
Sbjct: 62  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS-----HCIQQILE 116
Query: 399 ALSYLHEECERQIIHRDVKACNILLDAEFN---AKLGDFEATIP----------AGTMGY 445
           +++Y H      I+HR++K  N+LL ++      KL DF   I           AGT GY
Sbjct: 117 SIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGY 173
Query: 446 LAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSP 478
           L+PE +     S+  D+++ GV+   +  G  P
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 70/160 (43%), Gaps = 23/160 (14%)
Query: 334 ATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNI 392
           A +   L+H N+V+L     E     L+++ +  G L + I+     S    S     + 
Sbjct: 72  ARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS-----HC 126
Query: 393 VLGVASALSYLHEECERQIIHRDVKACNILLDAEFNA---KLGDFEATIP---------- 439
           +  +  A+ + H+     ++HRD+K  N+LL ++      KL DF   I           
Sbjct: 127 IQQILEAVLHCHQ---MGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG 183
Query: 440 -AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSP 478
            AGT GYL+PE +      +  D+++ GV+   +  G  P
Sbjct: 184 FAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 223

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 98/226 (43%), Gaps = 48/226 (21%)
Query: 290 RIVGEGASATV-YKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           +I+G G+S TV ++GS   G  VAVKR    +  + A      E   +     H N+++ 
Sbjct: 39  KILGYGSSGTVVFQGSF-QGRPVAVKRM-LIDFCDIA----LMEIKLLTESDDHPNVIRY 92
Query: 349 QGWCCEGNELVL-VYEYLPNGSLDKILHNNSSSSIVLSWEKRLN---IVLGVASALSYLH 404
             +C E  +  L +   L N +L  ++ + + S   L  +K  N   ++  +AS +++LH
Sbjct: 93  --YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 150
Query: 405 EECERQIIHRDVKACNILL--DAEFNAK-----------LGDF---------------EA 436
                +IIHRD+K  NIL+   + F A            + DF                 
Sbjct: 151 S---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNL 207
Query: 437 TIPAGTMGYLAPEYVYSGVPSEKT---DVYSFGVVALEV-AAGKSP 478
             P+GT G+ APE +        T   D++S G V   + + GK P
Sbjct: 208 NNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHP 253

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 98/226 (43%), Gaps = 48/226 (21%)
Query: 290 RIVGEGASATV-YKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           +I+G G+S TV ++GS   G  VAVKR    +  + A      E   +     H N+++ 
Sbjct: 39  KILGYGSSGTVVFQGSF-QGRPVAVKRM-LIDFCDIA----LMEIKLLTESDDHPNVIRY 92
Query: 349 QGWCCEGNELVL-VYEYLPNGSLDKILHNNSSSSIVLSWEKRLN---IVLGVASALSYLH 404
             +C E  +  L +   L N +L  ++ + + S   L  +K  N   ++  +AS +++LH
Sbjct: 93  --YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 150
Query: 405 EECERQIIHRDVKACNILL--DAEFNAK-----------LGDF---------------EA 436
                +IIHRD+K  NIL+   + F A            + DF                 
Sbjct: 151 S---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNL 207
Query: 437 TIPAGTMGYLAPEYVYSGVPSEKT---DVYSFGVVALEV-AAGKSP 478
             P+GT G+ APE +        T   D++S G V   + + GK P
Sbjct: 208 NNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHP 253

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 85/203 (41%), Gaps = 28/203 (13%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNR--VECARNPFTTEFATMAGCLRHKNLVQL 348
           VG GA  +V       +G  VAVK+  +P +  +   R   T     +   ++H+N++ L
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVIGL 82
Query: 349 QGWCCEGNEL-----VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
                    L     V +  +L    L     NN      L+ +    ++  +   L Y+
Sbjct: 83  LDVFTPARSLEEFNDVYLVTHLMGADL-----NNIVKCAKLTDDHVQFLIYQILRGLKYI 137
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGV 455
           H      IIHRD+K  N+ ++ +   K+ DF        E T    T  Y APE + + +
Sbjct: 138 HSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 194
Query: 456 PSEKT-DVYSFGVVALEVAAGKS 477
              +T D++S G +  E+  G++
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGRT 217

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 57/190 (30%), Positives = 78/190 (41%), Gaps = 34/190 (17%)
Query: 307 SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLP 366
           +G   AVK+     R+E  R     E    AG L    +V L G   EG  + +  E L 
Sbjct: 98  TGFQCAVKKV----RLEVFR---AEELMACAG-LTSPRIVPLYGAVREGPWVNIFMELLE 149
Query: 367 NGSLDKILHNNSSSSIVLSWEKRLNIVLGVA-SALSYLHEECERQIIHRDVKACNILLDA 425
            GSL +++            E R    LG A   L YLH    R+I+H DVKA N+LL +
Sbjct: 150 GGSLGQLVKEQGCLP-----EDRALYYLGQALEGLEYLHS---RRILHGDVKADNVLLSS 201
Query: 426 E-FNAKLGDFEATIP----------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVV 468
           +  +A L DF   +                  GT  ++APE V       K DV+S   +
Sbjct: 202 DGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCM 261
Query: 469 ALEVAAGKSP 478
            L +  G  P
Sbjct: 262 MLHMLNGCHP 271

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 65/158 (41%), Gaps = 26/158 (16%)
Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASA 399
           LRH N+V+ +        L ++ EY   G L + + N        S ++       + S 
Sbjct: 73  LRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGR----FSEDEARFFFQQLLSG 128
Query: 400 LSYLHEECERQIIHRDVKACNILLDAE--FNAKLGDF----------EATIPAGTMGYLA 447
           +SY H     QI HRD+K  N LLD       K+ DF          +     GT  Y+A
Sbjct: 129 VSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIA 185
Query: 448 PEYV----YSGVPSEKTDVYSFGVVALEVAAGKSPVDN 481
           PE +    Y G   +  DV+S GV    +  G  P ++
Sbjct: 186 PEVLLRQEYDG---KIADVWSCGVTLYVMLVGAYPFED 220

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 57/190 (30%), Positives = 78/190 (41%), Gaps = 34/190 (17%)
Query: 307 SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLP 366
           +G   AVK+     R+E  R     E    AG L    +V L G   EG  + +  E L 
Sbjct: 117 TGFQCAVKKV----RLEVFR---AEELMACAG-LTSPRIVPLYGAVREGPWVNIFMELLE 168
Query: 367 NGSLDKILHNNSSSSIVLSWEKRLNIVLGVA-SALSYLHEECERQIIHRDVKACNILLDA 425
            GSL +++            E R    LG A   L YLH    R+I+H DVKA N+LL +
Sbjct: 169 GGSLGQLVKEQGCLP-----EDRALYYLGQALEGLEYLHS---RRILHGDVKADNVLLSS 220
Query: 426 E-FNAKLGDFEATIP----------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVV 468
           +  +A L DF   +                  GT  ++APE V       K DV+S   +
Sbjct: 221 DGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCM 280
Query: 469 ALEVAAGKSP 478
            L +  G  P
Sbjct: 281 MLHMLNGCHP 290

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 89/204 (43%), Gaps = 30/204 (14%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNR--VECARNPFTTEFATMAGCLRHKNLVQL 348
           VG GA  +V       +G  VAVK+  +P +  +   R   T     +   ++H+N++ L
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVIGL 86
Query: 349 QGWCC------EGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
                      E N++ LV  +L    L+ I+     +   + +     ++  +   L Y
Sbjct: 87  LDVFTPARSLEEFNDVYLV-THLMGADLNNIVKXQKLTDDHVQF-----LIYQILRGLKY 140
Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSG 454
           +H      IIHRD+K  N+ ++ +   K+ DF        E T    T  Y APE + + 
Sbjct: 141 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNW 197
Query: 455 VPSEKT-DVYSFGVVALEVAAGKS 477
           +   +T D++S G +  E+  G++
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 67/149 (44%), Gaps = 22/149 (14%)
Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           +V+L G  C+   L+LV E    G L K L        V +  + L+    V+  + YL 
Sbjct: 398 IVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLH---QVSMGMKYLE 453
Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGT--------------MGYLAPEY 450
           E   +  +HR++ A N+LL     AK+ DF  +   G               + + APE 
Sbjct: 454 E---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 510
Query: 451 VYSGVPSEKTDVYSFGVVALE-VAAGKSP 478
           +     S ++DV+S+GV   E ++ G+ P
Sbjct: 511 INFRKFSSRSDVWSYGVTMWEALSYGQKP 539

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 86/203 (42%), Gaps = 28/203 (13%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNR--VECARNPFTTEFATMAGCLRHKNLVQL 348
           VG GA  +V       +G  VAVK+  +P +  +   R   T     +   ++H+N++ L
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVIGL 86
Query: 349 QGWCCEGNEL-----VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
                    L     V +  +L    L+ I+     +   + +     ++  +   L Y+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-----LIYQILRGLKYI 141
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGV 455
           H      IIHRD+K  N+ ++ +   K+ DF        E T    T  Y APE + + +
Sbjct: 142 HSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNAM 198
Query: 456 PSEKT-DVYSFGVVALEVAAGKS 477
              +T D++S G +  E+  G++
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 86/203 (42%), Gaps = 28/203 (13%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNR--VECARNPFTTEFATMAGCLRHKNLVQL 348
           VG GA  +V       +G  VAVK+  KP +  +   R   T     +   ++H+N++ L
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKR---TYRELRLLKHMKHENVIGL 98
Query: 349 QGWCCEGNEL-----VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
                    L     V +  +L    L+ I+     +   + +     ++  +   L Y+
Sbjct: 99  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-----LIYQILRGLKYI 153
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGV 455
           H      IIHRD+K  N+ ++ +   K+ DF        E T    T  Y APE + + +
Sbjct: 154 HSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 210
Query: 456 PSEKT-DVYSFGVVALEVAAGKS 477
              +T D++S G +  E+  G++
Sbjct: 211 HYNQTVDIWSVGCIMAELLTGRT 233

>pdb|3IPV|A Chain A, Crystal Structure Of Spatholobus Parviflorus Seed Lectin Length = 251

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 75/184 (40%), Gaps = 16/184 (8%)
Query: 3   DPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQD- 61
           D  T   ASF+  F F+I    +    DG AF +   A +  +  G++GL    +S    
Sbjct: 61  DSATGLVASFATSFRFTIYAPNIATIADGLAFFLAPVASAPDSGGGFLGLFDSAVSGSTY 120
Query: 62  SFFAVEFDTSFDPSLXXXXXXXXXXXXXXXXXXXXXDALSRGIDLKSGRHITTWIEYRDS 121
              AVEFDT ++ ++                        S    L +G      I Y  +
Sbjct: 121 QTVAVEFDT-YENTVFTDPPYTHIGFDVNSISSIKTVKWS----LANGEAAKVLITYNSA 175
Query: 122 LKLIRVWAGYSQIRPPS--PLIIAQI-DLSKQFKDYMHVGFSAANG-QGSAIYTVD--RW 175
           +KL+      S + P S    I+A I DLS    +++ VGFSAA G  G  I T D   W
Sbjct: 176 VKLLVA----SLVYPSSKTSFILADIVDLSSVLPEWVRVGFSAATGASGGKIETHDVFSW 231
Query: 176 RFKT 179
            F +
Sbjct: 232 SFAS 235

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 86/203 (42%), Gaps = 28/203 (13%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNR--VECARNPFTTEFATMAGCLRHKNLVQL 348
           VG GA  +V       +G  VAVK+  +P +  +   R   T     +   ++H+N++ L
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVIGL 86
Query: 349 QGWCCEGNEL-----VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
                    L     V +  +L    L+ I+     +   + +     ++  +   L Y+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-----LIYQILRGLKYI 141
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGV 455
           H      IIHRD+K  N+ ++ +   K+ DF        E T    T  Y APE + + +
Sbjct: 142 HSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGXVATRWYRAPEIMLNWM 198
Query: 456 PSEKT-DVYSFGVVALEVAAGKS 477
              +T D++S G +  E+  G++
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRT 221

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 86/203 (42%), Gaps = 28/203 (13%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNR--VECARNPFTTEFATMAGCLRHKNLVQL 348
           VG GA  +V       +G  VAVK+  +P +  +   R   T     +   ++H+N++ L
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVIGL 82
Query: 349 QGWCCEGNEL-----VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
                    L     V +  +L    L+ I+     +   + +     ++  +   L Y+
Sbjct: 83  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-----LIYQILRGLKYI 137
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGV 455
           H      IIHRD+K  N+ ++ +   K+ DF        E T    T  Y APE + + +
Sbjct: 138 HSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 194
Query: 456 PSEKT-DVYSFGVVALEVAAGKS 477
              +T D++S G +  E+  G++
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGRT 217

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 86/207 (41%), Gaps = 37/207 (17%)
Query: 292 VGEGASATVYK-GSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQG 350
           VG G+   V++     +G   AVK+     R+E  R     E    AG L    +V L G
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKV----RLEVFR---VEELVACAG-LSSPRIVPLYG 117
Query: 351 WCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVA-SALSYLHEECER 409
              EG  + +  E L  GSL +++            E R    LG A   L YLH    R
Sbjct: 118 AVREGPWVNIFMELLEGGSLGQLIKQMGCLP-----EDRALYYLGQALEGLEYLHT---R 169
Query: 410 QIIHRDVKACNILLDAEFN-AKLGDFEAT-----------------IPAGTMGYLAPEYV 451
           +I+H DVKA N+LL ++ + A L DF                    IP GT  ++APE V
Sbjct: 170 RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP-GTETHMAPEVV 228
Query: 452 YSGVPSEKTDVYSFGVVALEVAAGKSP 478
                  K D++S   + L +  G  P
Sbjct: 229 MGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 89/204 (43%), Gaps = 30/204 (14%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNR--VECARNPFTTEFATMAGCLRHKNLVQL 348
           VG GA  +V       +G  VAVK+  +P +  +   R   T     +   ++H+N++ L
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVIGL 86
Query: 349 QGWCC------EGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
                      E N++ LV  +L    L+ I+     +   + +     ++  +   L Y
Sbjct: 87  LDVFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQF-----LIYQILRGLKY 140
Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSG 454
           +H      IIHRD+K  N+ ++ +   K+ DF        E T    T  Y APE + + 
Sbjct: 141 IHSA---DIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMTGYVATRWYRAPEIMLNW 197
Query: 455 VPSEKT-DVYSFGVVALEVAAGKS 477
           +   +T D++S G +  E+  G++
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 70/160 (43%), Gaps = 23/160 (14%)
Query: 334 ATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNI 392
           A +   L+H N+V+L     E     LV++ +  G L + I+     S    S     + 
Sbjct: 54  ARICRLLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS-----HC 108
Query: 393 VLGVASALSYLHEECERQIIHRDVKACNILLDAEFN---AKLGDFEATIP---------- 439
           +  +  A+ + H+     ++HRD+K  N+LL ++      KL DF   I           
Sbjct: 109 IQQILEAVLHCHQ---MGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFG 165
Query: 440 -AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSP 478
            AGT GYL+PE +      +  D+++ GV+   +  G  P
Sbjct: 166 FAGTPGYLSPEVLRKEAYGKPVDIWACGVILYILLVGYPP 205

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 86/207 (41%), Gaps = 37/207 (17%)
Query: 292 VGEGASATVYK-GSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQG 350
           VG G+   V++     +G   AVK+     R+E  R     E    AG L    +V L G
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKV----RLEVFR---VEELVACAG-LSSPRIVPLYG 133
Query: 351 WCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVA-SALSYLHEECER 409
              EG  + +  E L  GSL +++            E R    LG A   L YLH    R
Sbjct: 134 AVREGPWVNIFMELLEGGSLGQLIKQMGCLP-----EDRALYYLGQALEGLEYLHT---R 185
Query: 410 QIIHRDVKACNILLDAEFN-AKLGDFEAT-----------------IPAGTMGYLAPEYV 451
           +I+H DVKA N+LL ++ + A L DF                    IP GT  ++APE V
Sbjct: 186 RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP-GTETHMAPEVV 244
Query: 452 YSGVPSEKTDVYSFGVVALEVAAGKSP 478
                  K D++S   + L +  G  P
Sbjct: 245 MGKPCDAKVDIWSSCCMMLHMLNGCHP 271

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 86/203 (42%), Gaps = 28/203 (13%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNR--VECARNPFTTEFATMAGCLRHKNLVQL 348
           VG GA  +V       +G  VAVK+  +P +  +   R   T     +   ++H+N++ L
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVIGL 96
Query: 349 QGWCCEGNEL-----VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
                    L     V +  +L    L+ I+     +   + +     ++  +   L Y+
Sbjct: 97  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-----LIYQILRGLKYI 151
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGV 455
           H      IIHRD+K  N+ ++ +   K+ DF        E T    T  Y APE + + +
Sbjct: 152 HSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 208
Query: 456 PSEKT-DVYSFGVVALEVAAGKS 477
              +T D++S G +  E+  G++
Sbjct: 209 HYNQTVDIWSVGCIMAELLTGRT 231

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 96/233 (41%), Gaps = 28/233 (12%)
Query: 271 PMRLALTDIKQATLGFNKNRIVGEGASATVYKGSLPSGGAV-AVKRFEKPNRVECAR-NP 328
           P+ + L +++     F   +++G GA + V    +   G V A+K   K + ++    + 
Sbjct: 48  PIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSC 107
Query: 329 FTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEK 388
           F  E   +    R + + QL     + N L LV EY   G L  +L         +  E 
Sbjct: 108 FREERDVLVNGDR-RWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGER---IPAEM 163
Query: 389 RLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF------------EA 436
               +  +  A+  +H       +HRD+K  NILLD   + +L DF             +
Sbjct: 164 ARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRS 220
Query: 437 TIPAGTMGYLAPEYVYS-------GVPSEKTDVYSFGVVALEVAAGKSPVDND 482
            +  GT  YL+PE + +       G    + D ++ GV A E+  G++P   D
Sbjct: 221 LVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD 273

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 68/158 (43%), Gaps = 26/158 (16%)
Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASA 399
           LRH N+V+ +        L +V EY   G L + + N        S ++       + S 
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISG 127
Query: 400 LSYLHEECERQIIHRDVKACNILLDAE--FNAKLGDF---EATI-------PAGTMGYLA 447
           +SY H     Q+ HRD+K  N LLD       K+ DF   +A++         GT  Y+A
Sbjct: 128 VSYAH---AMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIA 184
Query: 448 PEYV----YSGVPSEKTDVYSFGVVALEVAAGKSPVDN 481
           PE +    Y G   +  DV+S GV    +  G  P ++
Sbjct: 185 PEVLLKKEYDG---KVADVWSCGVTLYVMLVGAYPFED 219

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 86/203 (42%), Gaps = 28/203 (13%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNR--VECARNPFTTEFATMAGCLRHKNLVQL 348
           VG GA  +V       +G  VAVK+  +P +  +   R   T     +   ++H+N++ L
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVIGL 97
Query: 349 QGWCCEGNEL-----VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
                    L     V +  +L    L+ I+     +   + +     ++  +   L Y+
Sbjct: 98  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-----LIYQILRGLKYI 152
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGV 455
           H      IIHRD+K  N+ ++ +   K+ DF        E T    T  Y APE + + +
Sbjct: 153 HSA---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 209
Query: 456 PSEKT-DVYSFGVVALEVAAGKS 477
              +T D++S G +  E+  G++
Sbjct: 210 HYNQTVDIWSVGCIMAELLTGRT 232

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 86/203 (42%), Gaps = 28/203 (13%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNR--VECARNPFTTEFATMAGCLRHKNLVQL 348
           VG GA  +V       +G  VAVK+  +P +  +   R   T     +   ++H+N++ L
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVIGL 86
Query: 349 QGWCCEGNEL-----VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
                    L     V +  +L    L+ I+     +   + +     ++  +   L Y+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-----LIYQILRGLKYI 141
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGV 455
           H      IIHRD+K  N+ ++ +   K+ DF        E T    T  Y APE + + +
Sbjct: 142 HSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 456 PSEKT-DVYSFGVVALEVAAGKS 477
              +T D++S G +  E+  G++
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRT 221

>pdb|1FAY|A Chain A, Winged Bean Acidic Lectin Complexed With Methyl-Alpha-D-Galactose (Monoclinic Form) Length = 238

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 79/187 (42%), Gaps = 24/187 (12%)
Query: 3   DPKTNTTASFSCRFSFSII-PSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQ- 60
           D  T   ASF  RFSF+I  P       DG  F +       G D G +G+  P   P+ 
Sbjct: 60  DSTTGNVASFETRFSFNITQPYAYPEPADGLTFFMVPPNSPQGEDGGNLGVFKP---PEG 116
Query: 61  DSFFAVEFDT---SFDPSLXXXXXXXXXXXXXXXXXXXXXDALSRGIDLKSGRHITTWIE 117
           D+ FAVEFDT   ++DP +                      + +    L++G      I+
Sbjct: 117 DNAFAVEFDTFQNTWDPQV----------PHIGIDVNSIVSSKTLHFQLENGGVANVVIK 166
Query: 118 YRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQF--KDYMHVGFSAANG-QGSAIYT--V 172
           Y    K++ V   +  +     L    +DL ++F   ++++VG SA  G Q +A+ T  +
Sbjct: 167 YDSPTKILNVVLAFHSVGTVYTLSNI-VDLKQEFPNSEWVNVGLSATTGYQKNAVETHEI 225
Query: 173 DRWRFKT 179
             W F +
Sbjct: 226 ISWSFTS 232

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 86/203 (42%), Gaps = 28/203 (13%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNR--VECARNPFTTEFATMAGCLRHKNLVQL 348
           VG GA  +V       +G  VAVK+  +P +  +   R   T     +   ++H+N++ L
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVIGL 106
Query: 349 QGWCCEGNEL-----VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
                    L     V +  +L    L+ I+     +   + +     ++  +   L Y+
Sbjct: 107 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-----LIYQILRGLKYI 161
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGV 455
           H      IIHRD+K  N+ ++ +   K+ DF        E T    T  Y APE + + +
Sbjct: 162 HSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 218
Query: 456 PSEKT-DVYSFGVVALEVAAGKS 477
              +T D++S G +  E+  G++
Sbjct: 219 HYNQTVDIWSVGCIMAELLTGRT 241

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 89/204 (43%), Gaps = 30/204 (14%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNR--VECARNPFTTEFATMAGCLRHKNLVQL 348
           VG GA  +V       +G  VAVK+  +P +  +   R   T     +   ++H+N++ L
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVIGL 91
Query: 349 QGWCC------EGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
                      E N++ LV  +L    L+ I+     +   + +     ++  +   L Y
Sbjct: 92  LDVFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQF-----LIYQILRGLKY 145
Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSG 454
           +H      IIHRD+K  N+ ++ +   K+ DF        E T    T  Y APE + + 
Sbjct: 146 IHSA---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNW 202
Query: 455 VPSEKT-DVYSFGVVALEVAAGKS 477
           +   +T D++S G +  E+  G++
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGRT 226

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 88/204 (43%), Gaps = 30/204 (14%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNR--VECARNPFTTEFATMAGCLRHKNLVQL 348
           VG GA  +V       +G  VAVK+  +P +  +   R   T     +   ++H+N++ L
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVIGL 92
Query: 349 QGWCC------EGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
                      E N++ LV  +L    L     NN      L+ +    ++  +   L Y
Sbjct: 93  LDVFTPARSLEEFNDVYLV-THLMGADL-----NNIVKCQKLTDDHVQFLIYQILRGLKY 146
Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSG 454
           +H      IIHRD+K  N+ ++ +   K+ DF        E T    T  Y APE + + 
Sbjct: 147 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNW 203
Query: 455 VPSEKT-DVYSFGVVALEVAAGKS 477
           +   +T D++S G +  E+  G++
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGRT 227

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 86/203 (42%), Gaps = 28/203 (13%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNR--VECARNPFTTEFATMAGCLRHKNLVQL 348
           VG GA  +V       +G  VAVK+  +P +  +   R   T     +   ++H+N++ L
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVIGL 105
Query: 349 QGWCCEGNEL-----VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
                    L     V +  +L    L+ I+     +   + +     ++  +   L Y+
Sbjct: 106 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-----LIYQILRGLKYI 160
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGV 455
           H      IIHRD+K  N+ ++ +   K+ DF        E T    T  Y APE + + +
Sbjct: 161 HSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 217
Query: 456 PSEKT-DVYSFGVVALEVAAGKS 477
              +T D++S G +  E+  G++
Sbjct: 218 HYNQTVDIWSVGCIMAELLTGRT 240

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 91/225 (40%), Gaps = 32/225 (14%)
Query: 266 TVQRVPMRLALTDIKQATLGFNKNRIVGEGASATV---YKGSLPSGGAVAVKRFEKP-NR 321
           TV  VP RL          G    R VG GA  +V   Y   L     VAVK+  +P   
Sbjct: 14  TVWEVPQRLQ---------GL---RPVGSGAYGSVCSAYDARLRQ--KVAVKKLSRPFQS 59
Query: 322 VECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSS 381
           +  AR  +      +   L+H+N++ L         +    E     +L     NN    
Sbjct: 60  LIHARRTYRE--LRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKC 117
Query: 382 IVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF------- 434
             LS E    +V  +   L Y+H      IIHRD+K  N+ ++ +   ++ DF       
Sbjct: 118 QALSDEHVQFLVYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQAD 174
Query: 435 -EATIPAGTMGYLAPEYVYSGVPSEKT-DVYSFGVVALEVAAGKS 477
            E T    T  Y APE + + +   +T D++S G +  E+  GK+
Sbjct: 175 EEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKA 219

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 90/225 (40%), Gaps = 32/225 (14%)
Query: 266 TVQRVPMRLALTDIKQATLGFNKNRIVGEGASATV---YKGSLPSGGAVAVKRFEKP-NR 321
           TV  VP RL               R VG GA  +V   Y   L     VAVK+  +P   
Sbjct: 22  TVWEVPQRL------------QGLRPVGSGAYGSVCSAYDARLRQ--KVAVKKLSRPFQS 67
Query: 322 VECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSS 381
           +  AR  +      +   L+H+N++ L         +    E     +L     NN    
Sbjct: 68  LIHARRTYRE--LRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKC 125
Query: 382 IVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF------- 434
             LS E    +V  +   L Y+H      IIHRD+K  N+ ++ +   ++ DF       
Sbjct: 126 QALSDEHVQFLVYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLARQAD 182
Query: 435 -EATIPAGTMGYLAPEYVYSGVPSEKT-DVYSFGVVALEVAAGKS 477
            E T    T  Y APE + + +   +T D++S G +  E+  GK+
Sbjct: 183 EEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKA 227

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 86/203 (42%), Gaps = 28/203 (13%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNR--VECARNPFTTEFATMAGCLRHKNLVQL 348
           VG GA  +V       +G  VAVK+  +P +  +   R   T     +   ++H+N++ L
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVIGL 83
Query: 349 QGWCCEGNEL-----VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
                    L     V +  +L    L+ I+     +   + +     ++  +   L Y+
Sbjct: 84  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-----LIYQILRGLKYI 138
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGV 455
           H      IIHRD+K  N+ ++ +   K+ DF        E T    T  Y APE + + +
Sbjct: 139 HSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 195
Query: 456 PSEKT-DVYSFGVVALEVAAGKS 477
              +T D++S G +  E+  G++
Sbjct: 196 HYNQTVDIWSVGCIMAELLTGRT 218

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 86/203 (42%), Gaps = 28/203 (13%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNR--VECARNPFTTEFATMAGCLRHKNLVQL 348
           VG GA  +V       +G  VAVK+  +P +  +   R   T     +   ++H+N++ L
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVIGL 82
Query: 349 QGWCCEGNEL-----VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
                    L     V +  +L    L+ I+     +   + +     ++  +   L Y+
Sbjct: 83  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-----LIYQILRGLKYI 137
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGV 455
           H      IIHRD+K  N+ ++ +   K+ DF        E T    T  Y APE + + +
Sbjct: 138 HSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 194
Query: 456 PSEKT-DVYSFGVVALEVAAGKS 477
              +T D++S G +  E+  G++
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGRT 217

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 85/203 (41%), Gaps = 25/203 (12%)
Query: 292 VGEGASATVYK-GSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQG 350
           +G+GA + V +   +P+G   A K                 E A +   L+H N+V+L  
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLERE-ARICRLLKHPNIVRLHD 70
Query: 351 WCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECER 409
              E     LV++ +  G L + I+     S    S     + +  +  ++++ H     
Sbjct: 71  SISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS-----HCIQQILESVNHCHLN--- 122
Query: 410 QIIHRDVKACNILLDAEFN---AKLGDFEATIP-----------AGTMGYLAPEYVYSGV 455
            I+HRD+K  N+LL ++      KL DF   I            AGT GYL+PE +    
Sbjct: 123 GIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDP 182
Query: 456 PSEKTDVYSFGVVALEVAAGKSP 478
             +  D+++ GV+   +  G  P
Sbjct: 183 YGKPVDMWACGVILYILLVGYPP 205

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 86/203 (42%), Gaps = 28/203 (13%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNR--VECARNPFTTEFATMAGCLRHKNLVQL 348
           VG GA  +V       +G  VAVK+  +P +  +   R   T     +   ++H+N++ L
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVIGL 83
Query: 349 QGWCCEGNEL-----VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
                    L     V +  +L    L+ I+     +   + +     ++  +   L Y+
Sbjct: 84  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-----LIYQILRGLKYI 138
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGV 455
           H      IIHRD+K  N+ ++ +   K+ DF        E T    T  Y APE + + +
Sbjct: 139 HSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 195
Query: 456 PSEKT-DVYSFGVVALEVAAGKS 477
              +T D++S G +  E+  G++
Sbjct: 196 HYNQTVDIWSVGCIMAELLTGRT 218

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 86/203 (42%), Gaps = 28/203 (13%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNR--VECARNPFTTEFATMAGCLRHKNLVQL 348
           VG GA  +V       +G  VAVK+  +P +  +   R   T     +   ++H+N++ L
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVIGL 84
Query: 349 QGWCCEGNEL-----VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
                    L     V +  +L    L+ I+     +   + +     ++  +   L Y+
Sbjct: 85  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-----LIYQILRGLKYI 139
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGV 455
           H      IIHRD+K  N+ ++ +   K+ DF        E T    T  Y APE + + +
Sbjct: 140 HSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 196
Query: 456 PSEKT-DVYSFGVVALEVAAGKS 477
              +T D++S G +  E+  G++
Sbjct: 197 HYNQTVDIWSVGCIMAELLTGRT 219

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 86/203 (42%), Gaps = 28/203 (13%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNR--VECARNPFTTEFATMAGCLRHKNLVQL 348
           VG GA  +V       +G  VAVK+  +P +  +   R   T     +   ++H+N++ L
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVIGL 86
Query: 349 QGWCCEGNEL-----VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
                    L     V +  +L    L+ I+     +   + +     ++  +   L Y+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-----LIYQILRGLKYI 141
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGV 455
           H      IIHRD+K  N+ ++ +   K+ DF        E T    T  Y APE + + +
Sbjct: 142 HSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 456 PSEKT-DVYSFGVVALEVAAGKS 477
              +T D++S G +  E+  G++
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 86/203 (42%), Gaps = 28/203 (13%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNR--VECARNPFTTEFATMAGCLRHKNLVQL 348
           VG GA  +V       +G  VAVK+  +P +  +   R   T     +   ++H+N++ L
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVIGL 86
Query: 349 QGWCCEGNEL-----VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
                    L     V +  +L    L+ I+     +   + +     ++  +   L Y+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-----LIYQILRGLKYI 141
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGV 455
           H      IIHRD+K  N+ ++ +   K+ DF        E T    T  Y APE + + +
Sbjct: 142 HSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 456 PSEKT-DVYSFGVVALEVAAGKS 477
              +T D++S G +  E+  G++
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRT 221

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 86/203 (42%), Gaps = 28/203 (13%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNR--VECARNPFTTEFATMAGCLRHKNLVQL 348
           VG GA  +V       +G  VAVK+  +P +  +   R   T     +   ++H+N++ L
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVIGL 91
Query: 349 QGWCCEGNEL-----VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
                    L     V +  +L    L+ I+     +   + +     ++  +   L Y+
Sbjct: 92  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-----LIYQILRGLKYI 146
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGV 455
           H      IIHRD+K  N+ ++ +   K+ DF        E T    T  Y APE + + +
Sbjct: 147 HSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 203
Query: 456 PSEKT-DVYSFGVVALEVAAGKS 477
              +T D++S G +  E+  G++
Sbjct: 204 HYNQTVDIWSVGCIMAELLTGRT 226

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 86/203 (42%), Gaps = 28/203 (13%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNR--VECARNPFTTEFATMAGCLRHKNLVQL 348
           VG GA  +V       +G  VAVK+  +P +  +   R   T     +   ++H+N++ L
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVIGL 86
Query: 349 QGWCCEGNEL-----VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
                    L     V +  +L    L+ I+     +   + +     ++  +   L Y+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-----LIYQILRGLKYI 141
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGV 455
           H      IIHRD+K  N+ ++ +   K+ DF        E T    T  Y APE + + +
Sbjct: 142 HSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 456 PSEKT-DVYSFGVVALEVAAGKS 477
              +T D++S G +  E+  G++
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRT 221

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 86/203 (42%), Gaps = 28/203 (13%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNR--VECARNPFTTEFATMAGCLRHKNLVQL 348
           VG GA  +V       +G  VAVK+  +P +  +   R   T     +   ++H+N++ L
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVIGL 91
Query: 349 QGWCCEGNEL-----VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
                    L     V +  +L    L+ I+     +   + +     ++  +   L Y+
Sbjct: 92  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-----LIYQILRGLKYI 146
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGV 455
           H      IIHRD+K  N+ ++ +   K+ DF        E T    T  Y APE + + +
Sbjct: 147 HSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 203
Query: 456 PSEKT-DVYSFGVVALEVAAGKS 477
              +T D++S G +  E+  G++
Sbjct: 204 HYNQTVDIWSVGCIMAELLTGRT 226

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 86/203 (42%), Gaps = 28/203 (13%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNR--VECARNPFTTEFATMAGCLRHKNLVQL 348
           VG GA  +V       +G  VAVK+  +P +  +   R   T     +   ++H+N++ L
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVIGL 85
Query: 349 QGWCCEGNEL-----VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
                    L     V +  +L    L+ I+     +   + +     ++  +   L Y+
Sbjct: 86  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-----LIYQILRGLKYI 140
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGV 455
           H      IIHRD+K  N+ ++ +   K+ DF        E T    T  Y APE + + +
Sbjct: 141 HSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 197
Query: 456 PSEKT-DVYSFGVVALEVAAGKS 477
              +T D++S G +  E+  G++
Sbjct: 198 HYNQTVDIWSVGCIMAELLTGRT 220

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 86/203 (42%), Gaps = 28/203 (13%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNR--VECARNPFTTEFATMAGCLRHKNLVQL 348
           VG GA  +V     + SG  +AVK+  +P +  +   R   T     +   ++H+N++ L
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVIGL 115
Query: 349 QGWCCEGNEL-----VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
                    L     V +  +L    L+ I+     +   + +     ++  +   L Y+
Sbjct: 116 LDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-----LIYQILRGLKYI 170
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGV 455
           H      IIHRD+K  N+ ++ +   K+ DF        E T    T  Y APE + + +
Sbjct: 171 HSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 227
Query: 456 PSEKT-DVYSFGVVALEVAAGKS 477
               T D++S G +  E+  G++
Sbjct: 228 HYNMTVDIWSVGCIMAELLTGRT 250

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 89/204 (43%), Gaps = 30/204 (14%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNR--VECARNPFTTEFATMAGCLRHKNLVQL 348
           +G GA  +V       +G  VAVK+  +P +  +   R   T     +   ++H+N++ L
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVIGL 91
Query: 349 QGWCC------EGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
                      E N++ LV  +L    L+ I+     +   + +     ++  +   L Y
Sbjct: 92  LDVFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQF-----LIYQILRGLKY 145
Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSG 454
           +H      IIHRD+K  N+ ++ +   K+ DF        E T    T  Y APE + + 
Sbjct: 146 IHSA---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNW 202
Query: 455 VPSEKT-DVYSFGVVALEVAAGKS 477
           +   +T D++S G +  E+  G++
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGRT 226

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 89/204 (43%), Gaps = 30/204 (14%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNR--VECARNPFTTEFATMAGCLRHKNLVQL 348
           VG GA  +V       +G  VAVK+  +P +  +   R   T     +   ++H+N++ L
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVIGL 88
Query: 349 QGWCC------EGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
                      E N++ LV  +L    L+ I+     +   + +     ++  +   L Y
Sbjct: 89  LDVFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQF-----LIYQILRGLKY 142
Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSG 454
           +H      IIHRD+K  N+ ++ +   K+ DF        E T    T  Y APE + + 
Sbjct: 143 IHSA---DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNW 199
Query: 455 VPSEKT-DVYSFGVVALEVAAGKS 477
           +   +T D++S G +  E+  G++
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGRT 223

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 86/203 (42%), Gaps = 28/203 (13%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNR--VECARNPFTTEFATMAGCLRHKNLVQL 348
           VG GA  +V       +G  VAVK+  +P +  +   R   T     +   ++H+N++ L
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVIGL 86
Query: 349 QGWCCEGNEL-----VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
                    L     V +  +L    L+ I+     +   + +     ++  +   L Y+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-----LIYQILRGLKYI 141
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGV 455
           H      IIHRD+K  N+ ++ +   K+ DF        E T    T  Y APE + + +
Sbjct: 142 HSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 456 PSEKT-DVYSFGVVALEVAAGKS 477
              +T D++S G +  E+  G++
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRT 221

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 79/191 (41%), Gaps = 36/191 (18%)
Query: 307 SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLP 366
           +G   AVK+     R+E  R     E    AG L    +V L G   EG  + +  E L 
Sbjct: 96  TGFQCAVKKV----RLEVFR---VEELVACAG-LSSPRIVPLYGAVREGPWVNIFMELLE 147
Query: 367 NGSLDKILHNNSSSSIVLSWEKRLNIVLGVA-SALSYLHEECERQIIHRDVKACNILLDA 425
            GSL +++            E R    LG A   L YLH    R+I+H DVKA N+LL +
Sbjct: 148 GGSLGQLIKQMGCLP-----EDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSS 199
Query: 426 EFN-AKLGDFEAT-----------------IPAGTMGYLAPEYVYSGVPSEKTDVYSFGV 467
           + + A L DF                    IP GT  ++APE V       K D++S   
Sbjct: 200 DGSRAALCDFGHALCLQPDGLGKSLLTGDYIP-GTETHMAPEVVMGKPCDAKVDIWSSCC 258
Query: 468 VALEVAAGKSP 478
           + L +  G  P
Sbjct: 259 MMLHMLNGCHP 269

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 85/203 (41%), Gaps = 25/203 (12%)
Query: 292 VGEGASATVYK-GSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQG 350
           +G+GA + V +   +P+G   A K                 E A +   L+H N+V+L  
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLERE-ARICRLLKHPNIVRLHD 70
Query: 351 WCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECER 409
              E     LV++ +  G L + I+     S    S     + +  +  ++++ H     
Sbjct: 71  SISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS-----HCIQQILESVNHCHLN--- 122
Query: 410 QIIHRDVKACNILLDAEFN---AKLGDFEATIP-----------AGTMGYLAPEYVYSGV 455
            I+HRD+K  N+LL ++      KL DF   I            AGT GYL+PE +    
Sbjct: 123 GIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDP 182
Query: 456 PSEKTDVYSFGVVALEVAAGKSP 478
             +  D+++ GV+   +  G  P
Sbjct: 183 YGKPVDMWACGVILYILLVGYPP 205

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 86/203 (42%), Gaps = 28/203 (13%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNR--VECARNPFTTEFATMAGCLRHKNLVQL 348
           VG GA  +V       +G  VAVK+  +P +  +   R   T     +   ++H+N++ L
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVIGL 86
Query: 349 QGWCCEGNEL-----VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
                    L     V +  +L    L+ I+     +   + +     ++  +   L Y+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-----LIYQILRGLKYI 141
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGV 455
           H      IIHRD+K  N+ ++ +   K+ DF        E T    T  Y APE + + +
Sbjct: 142 HSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 456 PSEKT-DVYSFGVVALEVAAGKS 477
              +T D++S G +  E+  G++
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 70/156 (44%), Gaps = 25/156 (16%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQG 350
           +G+G    V+K     +G  VA+K+    N  E        E   +   L+H+N+V L  
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQ-LLKHENVVNLIE 83
Query: 351 WC---------CEGNELVLVYEYLPN---GSLDKILHNNSSSSIVLSWEKRLNIVLGVAS 398
            C         C+G+ + LV+++  +   G L  +L   + S I    +  LN       
Sbjct: 84  ICRTKASPYNRCKGS-IYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN------- 135
Query: 399 ALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF 434
            L Y+H     +I+HRD+KA N+L+  +   KL DF
Sbjct: 136 GLYYIHRN---KILHRDMKAANVLITRDGVLKLADF 168

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 86/203 (42%), Gaps = 28/203 (13%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNR--VECARNPFTTEFATMAGCLRHKNLVQL 348
           VG GA  +V       +G  VAVK+  +P +  +   R   T     +   ++H+N++ L
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVIGL 86
Query: 349 QGWCCEGNEL-----VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
                    L     V +  +L    L+ I+     +   + +     ++  +   L Y+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-----LIYQILRGLKYI 141
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGV 455
           H      IIHRD+K  N+ ++ +   K+ DF        E T    T  Y APE + + +
Sbjct: 142 HSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 456 PSEKT-DVYSFGVVALEVAAGKS 477
              +T D++S G +  E+  G++
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 86/203 (42%), Gaps = 28/203 (13%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNR--VECARNPFTTEFATMAGCLRHKNLVQL 348
           VG GA  +V       +G  VAVK+  +P +  +   R   T     +   ++H+N++ L
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVIGL 97
Query: 349 QGWCCEGNEL-----VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
                    L     V +  +L    L+ I+     +   + +     ++  +   L Y+
Sbjct: 98  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-----LIYQILRGLKYI 152
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGV 455
           H      IIHRD+K  N+ ++ +   K+ DF        E T    T  Y APE + + +
Sbjct: 153 HSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 209
Query: 456 PSEKT-DVYSFGVVALEVAAGKS 477
              +T D++S G +  E+  G++
Sbjct: 210 HYNQTVDIWSVGCIMAELLTGRT 232

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 86/203 (42%), Gaps = 28/203 (13%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNR--VECARNPFTTEFATMAGCLRHKNLVQL 348
           VG GA  +V       +G  VAVK+  +P +  +   R   T     +   ++H+N++ L
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVIGL 106
Query: 349 QGWCCEGNEL-----VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
                    L     V +  +L    L+ I+     +   + +     ++  +   L Y+
Sbjct: 107 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-----LIYQILRGLKYI 161
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGV 455
           H      IIHRD+K  N+ ++ +   K+ DF        E T    T  Y APE + + +
Sbjct: 162 HSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 218
Query: 456 PSEKT-DVYSFGVVALEVAAGKS 477
              +T D++S G +  E+  G++
Sbjct: 219 HYNQTVDIWSVGCIMAELLTGRT 241

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 86/203 (42%), Gaps = 28/203 (13%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNR--VECARNPFTTEFATMAGCLRHKNLVQL 348
           VG GA  +V       +G  VAVK+  +P +  +   R   T     +   ++H+N++ L
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVIGL 86
Query: 349 QGWCCEGNEL-----VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
                    L     V +  +L    L+ I+     +   + +     ++  +   L Y+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-----LIYQILRGLKYI 141
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGV 455
           H      IIHRD+K  N+ ++ +   K+ DF        E T    T  Y APE + + +
Sbjct: 142 HSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 456 PSEKT-DVYSFGVVALEVAAGKS 477
              +T D++S G +  E+  G++
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 86/203 (42%), Gaps = 28/203 (13%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNR--VECARNPFTTEFATMAGCLRHKNLVQL 348
           VG GA  +V       +G  VAVK+  +P +  +   R   T     +   ++H+N++ L
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVIGL 88
Query: 349 QGWCCEGNEL-----VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
                    L     V +  +L    L+ I+     +   + +     ++  +   L Y+
Sbjct: 89  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-----LIYQILRGLKYI 143
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGV 455
           H      IIHRD+K  N+ ++ +   K+ DF        E T    T  Y APE + + +
Sbjct: 144 HSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 200
Query: 456 PSEKT-DVYSFGVVALEVAAGKS 477
              +T D++S G +  E+  G++
Sbjct: 201 HYNQTVDIWSVGCIMAELLTGRT 223

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 86/203 (42%), Gaps = 28/203 (13%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNR--VECARNPFTTEFATMAGCLRHKNLVQL 348
           VG GA  +V       +G  VAVK+  +P +  +   R   T     +   ++H+N++ L
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVIGL 98
Query: 349 QGWCCEGNEL-----VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
                    L     V +  +L    L+ I+     +   + +     ++  +   L Y+
Sbjct: 99  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-----LIYQILRGLKYI 153
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGV 455
           H      IIHRD+K  N+ ++ +   K+ DF        E T    T  Y APE + + +
Sbjct: 154 HSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 210
Query: 456 PSEKT-DVYSFGVVALEVAAGKS 477
              +T D++S G +  E+  G++
Sbjct: 211 HYNQTVDIWSVGCIMAELLTGRT 233

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 86/203 (42%), Gaps = 28/203 (13%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNR--VECARNPFTTEFATMAGCLRHKNLVQL 348
           VG GA  +V       +G  VAVK+  +P +  +   R   T     +   ++H+N++ L
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVIGL 98
Query: 349 QGWCCEGNEL-----VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
                    L     V +  +L    L+ I+     +   + +     ++  +   L Y+
Sbjct: 99  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-----LIYQILRGLKYI 153
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGV 455
           H      IIHRD+K  N+ ++ +   K+ DF        E T    T  Y APE + + +
Sbjct: 154 HSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 210
Query: 456 PSEKT-DVYSFGVVALEVAAGKS 477
              +T D++S G +  E+  G++
Sbjct: 211 HYNQTVDIWSVGCIMAELLTGRT 233

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 89/204 (43%), Gaps = 30/204 (14%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNR--VECARNPFTTEFATMAGCLRHKNLVQL 348
           VG GA  +V       +G  VAVK+  +P +  +   R   T     +   ++H+N++ L
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVIGL 92
Query: 349 QGWCC------EGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
                      E N++ LV  +L    L+ I+     +   + +     ++  +   L Y
Sbjct: 93  LDVFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQF-----LIYQILRGLKY 146
Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSG 454
           +H      IIHRD+K  N+ ++ +   K+ DF        E T    T  Y APE + + 
Sbjct: 147 IHSA---DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNW 203
Query: 455 VPSEKT-DVYSFGVVALEVAAGKS 477
           +   +T D++S G +  E+  G++
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGRT 227

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 86/203 (42%), Gaps = 28/203 (13%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNR--VECARNPFTTEFATMAGCLRHKNLVQL 348
           VG GA  +V       +G  VAVK+  +P +  +   R   T     +   ++H+N++ L
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVIGL 88
Query: 349 QGWCCEGNEL-----VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
                    L     V +  +L    L+ I+     +   + +     ++  +   L Y+
Sbjct: 89  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-----LIYQILRGLKYI 143
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGV 455
           H      IIHRD+K  N+ ++ +   K+ DF        E T    T  Y APE + + +
Sbjct: 144 HSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 200
Query: 456 PSEKT-DVYSFGVVALEVAAGKS 477
              +T D++S G +  E+  G++
Sbjct: 201 HYNQTVDIWSVGCIMAELLTGRT 223

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 86/203 (42%), Gaps = 28/203 (13%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNR--VECARNPFTTEFATMAGCLRHKNLVQL 348
           VG GA  +V       +G  VAVK+  +P +  +   R   T     +   ++H+N++ L
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVIGL 105
Query: 349 QGWCCEGNEL-----VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
                    L     V +  +L    L+ I+     +   + +     ++  +   L Y+
Sbjct: 106 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-----LIYQILRGLKYI 160
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGV 455
           H      IIHRD+K  N+ ++ +   K+ DF        E T    T  Y APE + + +
Sbjct: 161 HSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 217
Query: 456 PSEKT-DVYSFGVVALEVAAGKS 477
              +T D++S G +  E+  G++
Sbjct: 218 HYNQTVDIWSVGCIMAELLTGRT 240

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 88/204 (43%), Gaps = 30/204 (14%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNR--VECARNPFTTEFATMAGCLRHKNLVQL 348
           VG GA  +V       +G  VAVK+  +P +  +   R   T     +   ++H+N++ L
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVIGL 92
Query: 349 QGWCC------EGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
                      E N++ LV  +L    L     NN      L+ +    ++  +   L Y
Sbjct: 93  LDVFTPARSLEEFNDVYLV-THLMGADL-----NNIVKCQKLTDDHVQFLIYQILRGLKY 146
Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSG 454
           +H      IIHRD+K  N+ ++ +   K+ DF        E T    T  Y APE + + 
Sbjct: 147 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNW 203
Query: 455 VPSEKT-DVYSFGVVALEVAAGKS 477
           +   +T D++S G +  E+  G++
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGRT 227

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 86/203 (42%), Gaps = 28/203 (13%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNR--VECARNPFTTEFATMAGCLRHKNLVQL 348
           VG GA  +V       +G  VAVK+  +P +  +   R   T     +   ++H+N++ L
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVIGL 93
Query: 349 QGWCCEGNEL-----VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
                    L     V +  +L    L+ I+     +   + +     ++  +   L Y+
Sbjct: 94  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-----LIYQILRGLKYI 148
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGV 455
           H      IIHRD+K  N+ ++ +   K+ DF        E T    T  Y APE + + +
Sbjct: 149 HSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 205
Query: 456 PSEKT-DVYSFGVVALEVAAGKS 477
              +T D++S G +  E+  G++
Sbjct: 206 HYNQTVDIWSVGCIMAELLTGRT 228

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 86/203 (42%), Gaps = 28/203 (13%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNR--VECARNPFTTEFATMAGCLRHKNLVQL 348
           VG GA  +V       +G  VAVK+  +P +  +   R   T     +   ++H+N++ L
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVIGL 109
Query: 349 QGWCCEGNEL-----VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
                    L     V +  +L    L+ I+     +   + +     ++  +   L Y+
Sbjct: 110 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-----LIYQILRGLKYI 164
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGV 455
           H      IIHRD+K  N+ ++ +   K+ DF        E T    T  Y APE + + +
Sbjct: 165 HSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 221
Query: 456 PSEKT-DVYSFGVVALEVAAGKS 477
              +T D++S G +  E+  G++
Sbjct: 222 HYNQTVDIWSVGCIMAELLTGRT 244

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 70/156 (44%), Gaps = 25/156 (16%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQG 350
           +G+G    V+K     +G  VA+K+    N  E        E   +   L+H+N+V L  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQ-LLKHENVVNLIE 84
Query: 351 WC---------CEGNELVLVYEYLPN---GSLDKILHNNSSSSIVLSWEKRLNIVLGVAS 398
            C         C+G+ + LV+++  +   G L  +L   + S I    +  LN       
Sbjct: 85  ICRTKASPYNRCKGS-IYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN------- 136
Query: 399 ALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF 434
            L Y+H     +I+HRD+KA N+L+  +   KL DF
Sbjct: 137 GLYYIHRN---KILHRDMKAANVLITRDGVLKLADF 169

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 86/203 (42%), Gaps = 28/203 (13%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNR--VECARNPFTTEFATMAGCLRHKNLVQL 348
           VG GA  +V       +G  VAVK+  +P +  +   R   T     +   ++H+N++ L
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVIGL 92
Query: 349 QGWCCEGNEL-----VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
                    L     V +  +L    L+ I+     +   + +     ++  +   L Y+
Sbjct: 93  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-----LIYQILRGLKYI 147
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGV 455
           H      IIHRD+K  N+ ++ +   K+ DF        E T    T  Y APE + + +
Sbjct: 148 HSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 204
Query: 456 PSEKT-DVYSFGVVALEVAAGKS 477
              +T D++S G +  E+  G++
Sbjct: 205 HYNQTVDIWSVGCIMAELLTGRT 227

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 86/203 (42%), Gaps = 28/203 (13%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNR--VECARNPFTTEFATMAGCLRHKNLVQL 348
           VG GA  +V       +G  VAVK+  +P +  +   R   T     +   ++H+N++ L
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVIGL 88
Query: 349 QGWCCEGNEL-----VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
                    L     V +  +L    L+ I+     +   + +     ++  +   L Y+
Sbjct: 89  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-----LIYQILRGLKYI 143
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGV 455
           H      IIHRD+K  N+ ++ +   K+ DF        E T    T  Y APE + + +
Sbjct: 144 HSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 200
Query: 456 PSEKT-DVYSFGVVALEVAAGKS 477
              +T D++S G +  E+  G++
Sbjct: 201 HYNQTVDIWSVGCIMAELLTGRT 223

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 39/160 (24%), Positives = 70/160 (43%), Gaps = 23/160 (14%)
Query: 334 ATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNI 392
           A +   L+H N+V+L     E     L+++ +  G L + I+     S    S     + 
Sbjct: 61  ARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS-----HC 115
Query: 393 VLGVASALSYLHEECERQIIHRDVKACNILLDAEFN---AKLGDFEATIP---------- 439
           +  +  A+ + H+     ++HR++K  N+LL ++      KL DF   I           
Sbjct: 116 IQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG 172
Query: 440 -AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSP 478
            AGT GYL+PE +      +  D+++ GV+   +  G  P
Sbjct: 173 FAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 70/156 (44%), Gaps = 25/156 (16%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQG 350
           +G+G    V+K     +G  VA+K+    N  E        E   +   L+H+N+V L  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQ-LLKHENVVNLIE 84
Query: 351 WC---------CEGNELVLVYEYLPN---GSLDKILHNNSSSSIVLSWEKRLNIVLGVAS 398
            C         C+G+ + LV+++  +   G L  +L   + S I    +  LN       
Sbjct: 85  ICRTKASPYNRCKGS-IYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN------- 136
Query: 399 ALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF 434
            L Y+H     +I+HRD+KA N+L+  +   KL DF
Sbjct: 137 GLYYIHRN---KILHRDMKAANVLITRDGVLKLADF 169

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 86/203 (42%), Gaps = 28/203 (13%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNR--VECARNPFTTEFATMAGCLRHKNLVQL 348
           VG GA  +V       +G  VAVK+  +P +  +   R   T     +   ++H+N++ L
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVIGL 93
Query: 349 QGWCCEGNEL-----VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
                    L     V +  +L    L+ I+     +   + +     ++  +   L Y+
Sbjct: 94  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-----LIYQILRGLKYI 148
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGV 455
           H      IIHRD+K  N+ ++ +   K+ DF        E T    T  Y APE + + +
Sbjct: 149 HSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRWYRAPEIMLNWM 205
Query: 456 PSEKT-DVYSFGVVALEVAAGKS 477
              +T D++S G +  E+  G++
Sbjct: 206 HYNQTVDIWSVGCIMAELLTGRT 228

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 86/203 (42%), Gaps = 28/203 (13%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNR--VECARNPFTTEFATMAGCLRHKNLVQL 348
           VG GA  +V       +G  VAVK+  +P +  +   R   T     +   ++H+N++ L
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVIGL 93
Query: 349 QGWCCEGNEL-----VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
                    L     V +  +L    L+ I+     +   + +     ++  +   L Y+
Sbjct: 94  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-----LIYQILRGLKYI 148
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGV 455
           H      IIHRD+K  N+ ++ +   K+ DF        E T    T  Y APE + + +
Sbjct: 149 HSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRWYRAPEIMLNWM 205
Query: 456 PSEKT-DVYSFGVVALEVAAGKS 477
              +T D++S G +  E+  G++
Sbjct: 206 HYNQTVDIWSVGCIMAELLTGRT 228

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 86/203 (42%), Gaps = 28/203 (13%)
Query: 292 VGEGASATVYKG-SLPSGGAVAVKRFEKPNR--VECARNPFTTEFATMAGCLRHKNLVQL 348
           VG GA  +V       +G  VAVK+  +P +  +   R   T     +   ++H+N++ L
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVIGL 93
Query: 349 QGWCCEGNEL-----VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
                    L     V +  +L    L+ I+     +   + +     ++  +   L Y+
Sbjct: 94  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-----LIYQILRGLKYI 148
Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGV 455
           H      IIHRD+K  N+ ++ +   K+ DF        E T    T  Y APE + + +
Sbjct: 149 HSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRWYRAPEIMLNWM 205
Query: 456 PSEKT-DVYSFGVVALEVAAGKS 477
              +T D++S G +  E+  G++
Sbjct: 206 HYNQTVDIWSVGCIMAELLTGRT 228

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 93/221 (42%), Gaps = 30/221 (13%)
Query: 284 LGFNKNRIVGEGASATVYKGSL-PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRH 342
           + +   +++G G+   VY+  L  SG  VA+K+  +          F      +   L H
Sbjct: 20  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-------GKAFKNRELQIMRKLDH 72
Query: 343 KNLVQLQGWCCEGNE------LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGV 396
            N+V+L+ +     E      L LV +Y+P  ++ ++  + S +   L        +  +
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVP-ATVYRVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 397 ASALSYLHEECERQIIHRDVKACNILLDAEFNA-KLGDF---------EATIPA-GTMGY 445
             +L+Y+H      I HRD+K  N+LLD +    KL DF         E  +    +  Y
Sbjct: 132 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYY 188
Query: 446 LAPEYVYSGVP-SEKTDVYSFGVVALEVAAGKSPVDNDGCV 485
            APE ++     +   DV+S G V  E+  G+     D  V
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV 229

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 43/172 (25%), Positives = 71/172 (41%), Gaps = 25/172 (14%)
Query: 326 RNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVL 384
           R+P T E   +    +H N++ L+    +G  + +V E    G L DKIL          
Sbjct: 60  RDP-TEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQK-----FF 113
Query: 385 SWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNIL-LDAEFN---AKLGDFE----- 435
           S  +   ++  +   + YLH +    ++HRD+K  NIL +D   N    ++ DF      
Sbjct: 114 SEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170
Query: 436 ------ATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDN 481
                    P  T  ++APE +         D++S GV+      G +P  N
Sbjct: 171 RAENGLLXTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTPFAN 222

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 65/158 (41%), Gaps = 26/158 (16%)
Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASA 399
           LRH N+V+ +        L +V EY   G L + + N        S ++       + S 
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISG 127
Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLG--DF----------EATIPAGTMGYLA 447
           +SY H     Q+ HRD+K  N LLD     +L   DF          +     GT  Y+A
Sbjct: 128 VSYCH---AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIA 184
Query: 448 PEYV----YSGVPSEKTDVYSFGVVALEVAAGKSPVDN 481
           PE +    Y G   +  DV+S GV    +  G  P ++
Sbjct: 185 PEVLLKKEYDG---KVADVWSCGVTLYVMLVGAYPFED 219

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 91/221 (41%), Gaps = 30/221 (13%)
Query: 284 LGFNKNRIVGEGASATVYKGSL-PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRH 342
           + +   +++G G+   VY+  L  SG  VA+K+  +          F      +   L H
Sbjct: 20  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-------GKAFKNRELQIMRKLDH 72
Query: 343 KNLVQLQGWCCEGNE------LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGV 396
            N+V+L+ +     E      L LV +Y+P        H + +   +     +L +   +
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQL 131
Query: 397 ASALSYLHEECERQIIHRDVKACNILLDAEFNA-KLGDF---------EATIP-AGTMGY 445
             +L+Y+H      I HRD+K  N+LLD +    KL DF         E  +    +  Y
Sbjct: 132 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 188
Query: 446 LAPEYVYSGVP-SEKTDVYSFGVVALEVAAGKSPVDNDGCV 485
            APE ++     +   DV+S G V  E+  G+     D  V
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV 229

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	596
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-113
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-100
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	5e-92
3soc_A	322	Activin receptor type-2A; structural genomics cons	4e-61
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	9e-53
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-50
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	6e-50
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	4e-49
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-48
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-47
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-46
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-46
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	5e-46
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-44
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-42
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-42
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	3e-41
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	6e-40
3ipv_A	251	Lectin alpha chain; galactose binding, SEED lectin	3e-34
1v6i_A	232	Agglutinin, PNA, galactose-binding lectin; open qu	2e-33
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	6e-33
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-32
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-32
2bqp_A	234	Protein (PEA lectin); D-glucopyranose complex, sug	5e-32
1hql_A	257	Lectin; xenograft antigen, sugar BI protein; HET:	5e-32
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	8e-32
1g7y_A	253	Stem/LEAF lectin DB58; jelly roll fold, sugar bind	9e-32
1fny_A	237	BARK lectin, BARK agglutinin I,polypeptide A; legu	2e-31
3zyr_A	261	Lectin; sugar binding protein, N-glycan; HET: NAG	3e-31
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-31
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	5e-31
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	5e-31
1fx5_A	242	UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HO	6e-31
1fat_A	252	Phytohemagglutinin-L; glycoprotein, plant defense	7e-31
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-30
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-30
1gsl_A	243	Griffonia simplicifolia lectin 4; glycoprotein, ma	2e-30
1dbn_A	239	MAL, protein (leukoagglutinin); plant lectin, carb	6e-30
1sbf_A	253	Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {G	9e-30
2fmd_A	240	Lectin, agglutinin, BMA; legume lectin, beta sandw	1e-29
2eig_A	234	Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG bin	3e-29
1wbf_A	242	Protein (agglutinin); lectin (agglutinin), legume	3e-29
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	4e-29
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	4e-29
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	5e-29
2a19_B	284	Interferon-induced, double-stranded RNA-activated	5e-29
1gzc_A	239	Erythrina crista-galli lectin; carbohydrate, sugar	6e-29
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	8e-29
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-28
1n47_A	233	Isolectin B4; cancer antigen, vicia villosa lectin	1e-28
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-28
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-28
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	8e-28
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	9e-28
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-27
1avb_A	226	Arcelin-1; lectin-like glycoprotein, plant defense	1e-27
1f9k_A	238	Acidic lectin; legume lectin, glycosylated protein	3e-27
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-27
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	3e-27
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-27
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-27
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-27
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-27
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	4e-27
3aln_A	327	Dual specificity mitogen-activated protein kinase;	4e-27
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	5e-27
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	6e-27
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	9e-27
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	9e-27
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-26
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-26
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-26
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-26
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-26
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-26
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-26
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-26
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-26
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-26
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-26
3pls_A	298	Macrophage-stimulating protein receptor; protein k	4e-26
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	4e-26
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	4e-26
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	5e-26
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	5e-26
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	5e-26
3fme_A	290	Dual specificity mitogen-activated protein kinase;	5e-26
1qnw_A	242	Chitin binding lectin, UEA-II; carbohydrate bindin	6e-26
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	6e-26
1ioa_A	240	Arcelin-5A, ARC5A; lectin-like proteins, plant def	6e-26
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	6e-26
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-25
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-25
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-25
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-25
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-25
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-25
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-25
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-25
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-25
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-25
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	4e-25
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	4e-25
3ork_A	311	Serine/threonine protein kinase; structural genomi	4e-25
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	5e-25
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	5e-25
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	6e-25
2dyl_A	318	Dual specificity mitogen-activated protein kinase	7e-25
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	8e-25
1nls_A	237	Concanavalin A; lectin, agglutinin; 0.94A {Canaval	8e-25
1nls_A	237	Concanavalin A; lectin, agglutinin; 0.94A {Canaval	5e-04
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	9e-25
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-24
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-24
2ltn_A	181	PEA lectin, alpha chain; 1.70A {Pisum sativum} SCO	2e-24
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-24
1qmo_E	133	Mannose binding lectin, FRIL; crosslink, hematopoi	3e-24
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	4e-24
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	4e-24
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	6e-24
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	8e-24
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	8e-24
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	9e-24
4aoj_A	329	High affinity nerve growth factor receptor; transf	9e-24
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-23
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-23
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-23
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-23
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-23
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	4e-23
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	4e-23
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	4e-23
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	4e-23
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-22
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-22
1dhk_B	223	Bean lectin-like inhibitor, porcine pancreatic alp	2e-22
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-22
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	3e-22
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	3e-22
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-22
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-22
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	4e-22
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	4e-22
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-21
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	4e-21
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-20
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-18
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-18
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-18
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-18
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	5e-18
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	6e-18
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	6e-18
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-17
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-17
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-17
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-17
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	4e-17
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	4e-17
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	4e-17
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	6e-17
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	7e-17
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-16
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-16
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-16
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-16
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-16
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-16
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	3e-16
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-16
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-16
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	4e-16
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	4e-16
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	4e-16
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	5e-16
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	5e-16
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	6e-16
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	6e-16
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	6e-16
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	6e-16
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	6e-16
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	9e-16
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-15
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-15
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-15
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-15
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-15
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-15
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-15
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-15
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-15
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	4e-15
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	7e-15
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	7e-15
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	9e-15
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	9e-15
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-14
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-14
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-14
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	5e-14
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-13
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-13
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-13
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-13
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-13
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	4e-13
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	6e-13
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	8e-13
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-12
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	6e-12
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-11
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-11
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-11
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-11
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	5e-11
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	6e-11
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	7e-11
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	6e-08
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	7e-11
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	9e-11
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	9e-11
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-10
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-10
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-10
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-10
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-10
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-10
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-10
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-10
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-10
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-10
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-10
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-10
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	6e-10
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	8e-10
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	8e-10
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-09
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-09
1gv9_A	260	P58/ergic-53; lectin, carbohydrate binding; 1.46A	3e-09
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	4e-09
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	8e-09
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-08
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	7e-08
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	7e-08
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-07
2dur_A	253	VIP36;, vesicular integral-membrane protein VIP36;	1e-07
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-07
1qmo_A	113	Mannose binding lectin, FRIL; crosslink, hematopoi	3e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	7e-07
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-06
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-06
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	9e-06
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-05
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-05
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-05
2ltn_B	52	PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP	3e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  340 bits (875), Expect = e-113
 Identities = 115/294 (39%), Positives = 163/294 (55%), Gaps = 20/294 (6%)

Query: 273 RLALTDIKQATLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTE 332
           R +L +++ A+  F+   I+G G    VYKG L  G  VAVKR  K  R +     F TE
Sbjct: 19  RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRL-KEERTQGGELQFQTE 77

Query: 333 FATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNI 392
              M     H+NL++L+G+C    E +LVY Y+ NGS+   L     S   L W KR  I
Sbjct: 78  -VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136

Query: 393 VLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF------------EATIPA 440
            LG A  L+YLH+ C+ +IIHRDVKA NILLD EF A +GDF              T   
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 196

Query: 441 GTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDN------DGCVIVDWVWNLR 494
           GT+G++APEY+ +G  SEKTDV+ +GV+ LE+  G+   D       D  +++DWV  L 
Sbjct: 197 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256

Query: 495 KKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEA 548
           K+ KL    D  L+G +  +E+E+++ V L C   +  +RP + E  R+L+G+ 
Sbjct: 257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  306 bits (786), Expect = e-100
 Identities = 104/295 (35%), Positives = 150/295 (50%), Gaps = 23/295 (7%)

Query: 273 RLALTDIKQATLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTE 332
           R+ L D+++AT  F+   ++G G    VYKG L  G  VA+KR   P   +     F TE
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRR-TPESSQGIEE-FETE 85

Query: 333 FATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNI 392
                   RH +LV L G+C E NE++L+Y+Y+ NG+L + L+ +   ++ +SWE+RL I
Sbjct: 86  -IETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEI 144

Query: 393 VLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-------EA------TIP 439
            +G A  L YLH      IIHRDVK+ NILLD  F  K+ DF       E       T+ 
Sbjct: 145 CIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVV 201

Query: 440 AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDN---DGCV-IVDWVWNLRK 495
            GT+GY+ PEY   G  +EK+DVYSFGVV  EV   +S +        V + +W      
Sbjct: 202 KGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN 261

Query: 496 KGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEAPL 550
            G+L    D  L  K   + + +     + C+  + E RPS+ +    L+    L
Sbjct: 262 NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  284 bits (730), Expect = 5e-92
 Identities = 92/297 (30%), Positives = 142/297 (47%), Gaps = 32/297 (10%)

Query: 276 LTDIKQATLGFNK------NRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECA--RN 327
             ++K  T  F++         +GEG    VYKG +     VAVK+      +     + 
Sbjct: 17  FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTEELKQ 75

Query: 328 PFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWE 387
            F  E   +    +H+NLV+L G+  +G++L LVY Y+PNGSL   L     +   LSW 
Sbjct: 76  QFDQE-IKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTP-PLSWH 133

Query: 388 KRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF------------- 434
            R  I  G A+ +++LHE      IHRD+K+ NILLD  F AK+ DF             
Sbjct: 134 MRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190

Query: 435 EATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDN--DGCVIVDWVWN 492
             +   GT  Y+APE +  G  + K+D+YSFGVV LE+  G   VD   +  +++D    
Sbjct: 191 MTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEE 249

Query: 493 -LRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEA 548
              ++  + D  D ++    +   +E M  V   C+H    KRP +K+  ++L+   
Sbjct: 250 IEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  204 bits (521), Expect = 4e-61
 Identities = 65/309 (21%), Positives = 113/309 (36%), Gaps = 49/309 (15%)

Query: 276 LTDIKQATLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFAT 335
             ++   ++      +   G    V+K  L     VAVK F   ++          E  +
Sbjct: 16  TENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQ---NEYEVYS 71

Query: 336 MAGCLRHKNLVQLQGWCCEGN----ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLN 391
           + G ++H+N++Q  G    G     +L L+  +   GSL   L  N     V+SW +  +
Sbjct: 72  LPG-MKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-----VVSWNELCH 125

Query: 392 IVLGVASALSYLHEECERQ-------IIHRDVKACNILLDAEFNAKLGDF---------- 434
           I   +A  L+YLHE+           I HRD+K+ N+LL     A + DF          
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185

Query: 435 ---EATIPAGTMGYLAPEYVYSGVP-----SEKTDVYSFGVVALEVAAGKSPVDNDG--- 483
              +     GT  Y+APE +   +        + D+Y+ G+V  E+A+  +  D      
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245

Query: 484 -CVIVDWVWNLRKKGKLLDAADFR-----LRGKFNRKEMERMLM-VGLSCVHPNHEKRPS 536
                + +        + +    +     LR  + +     ML      C   + E R S
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305

Query: 537 VKEAARILK 545
                  + 
Sbjct: 306 AGCVGERIT 314

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  182 bits (463), Expect = 9e-53
 Identities = 75/245 (30%), Positives = 118/245 (48%), Gaps = 23/245 (9%)

Query: 250 IKKKRHDGRSKEDHVCTVQRVPMRLALT----DIKQATLGFNKNRIVGEGASATVYKGSL 305
           +K   H     +  + T + +  + A+     DI    L   +   +G G+  TV++   
Sbjct: 1   MKHHHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKE--KIGAGSFGTVHRAEW 58

Query: 306 PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYL 365
             G  VAVK   + +      N F  E A M   LRH N+V   G   +   L +V EYL
Sbjct: 59  -HGSDVAVKILMEQDFHAERVNEFLREVAIMK-RLRHPNIVLFMGAVTQPPNLSIVTEYL 116

Query: 366 PNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDA 425
             GSL ++LH +  +   L   +RL++   VA  ++YLH      I+HR++K+ N+L+D 
Sbjct: 117 SRGSLYRLLHKS-GAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVHRNLKSPNLLVDK 174

Query: 426 EFNAKLGDF-----------EATIPAGTMGYLAPEYVYSGVP-SEKTDVYSFGVVALEVA 473
           ++  K+ DF            +   AGT  ++APE V    P +EK+DVYSFGV+  E+A
Sbjct: 175 KYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPE-VLRDEPSNEKSDVYSFGVILWELA 233

Query: 474 AGKSP 478
             + P
Sbjct: 234 TLQQP 238

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  175 bits (445), Expect = 3e-50
 Identities = 75/266 (28%), Positives = 114/266 (42%), Gaps = 30/266 (11%)

Query: 290 RIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQ 349
            +VG GA   V K        VA+K+       E  R  F  E   ++  + H N+V+L 
Sbjct: 14  EVVGRGAFGVVCKAKW-RAKDVAIKQI----ESESERKAFIVELRQLSR-VNHPNIVKLY 67

Query: 350 GWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECER 409
           G C   N + LV EY   GSL  +LH         +    ++  L  +  ++YLH    +
Sbjct: 68  GACL--NPVCLVMEYAEGGSLYNVLHGAEPLP-YYTAAHAMSWCLQCSQGVAYLHSMQPK 124

Query: 410 QIIHRDVKACNILLDAEFN-AKLGDF--------EATIPAGTMGYLAPEYVYSGVP-SEK 459
            +IHRD+K  N+LL A     K+ DF          T   G+  ++APE V+ G   SEK
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPE-VFEGSNYSEK 183

Query: 460 TDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERM 519
            DV+S+G++  EV   + P D  G      +W +            R     N  +    
Sbjct: 184 CDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN--------GTRPPLIKNLPKPIES 235

Query: 520 LMVGLSCVHPNHEKRPSVKEAARILK 545
           LM    C   +  +RPS++E  +I+ 
Sbjct: 236 LMT--RCWSKDPSQRPSMEEIVKIMT 259

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  173 bits (441), Expect = 6e-50
 Identities = 66/277 (23%), Positives = 112/277 (40%), Gaps = 37/277 (13%)

Query: 290 RIVGEGASATVYKGSLPSGGA-VAVKRFEKPN-----RVECARNPFTTEFATMAGCLRHK 343
           + +G+G    V+KG L    + VA+K     +      +      F  E   M+  L H 
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSN-LNHP 83

Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
           N+V+L G     N   +V E++P G L   L + +     + W  +L ++L +A  + Y+
Sbjct: 84  NIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKA---HPIKWSVKLRLMLDIALGIEYM 138

Query: 404 HEECERQIIHRDVKACNILLD-----AEFNAKLGDF--------EATIPAGTMGYLAPE- 449
                  I+HRD+++ NI L      A   AK+ DF          +   G   ++APE 
Sbjct: 139 QN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLGNFQWMAPET 197

Query: 450 YVYSGVP-SEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLR 508
                   +EK D YSF ++   +  G+ P D      + ++  +R++G         LR
Sbjct: 198 IGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG---------LR 248

Query: 509 GKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK 545
                    R+  V   C   + +KRP      + L 
Sbjct: 249 PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELS 285

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  170 bits (434), Expect = 4e-49
 Identities = 39/201 (19%), Positives = 80/201 (39%), Gaps = 18/201 (8%)

Query: 290 RIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQ 349
             + E  S  ++KG    G  + VK  +  +        F  E   +     H N++ + 
Sbjct: 16  TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLR-IFSHPNVLPVL 73

Query: 350 GWCCE--GNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC 407
           G C         L+  ++P GSL  +LH  ++   V+   + +   L +A  +++LH   
Sbjct: 74  GACQSPPAPHPTLITHWMPYGSLYNVLHEGTN--FVVDQSQAVKFALDMARGMAFLHT-L 130

Query: 408 ERQIIHRDVKACNILLDAEFNAKLGDF------EATIPAGTMGYLAPEYVYSGVP----S 457
           E  I    + + ++++D +  A++         ++        ++APE      P     
Sbjct: 131 EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAPAWVAPE-ALQKKPEDTNR 189

Query: 458 EKTDVYSFGVVALEVAAGKSP 478
              D++SF V+  E+   + P
Sbjct: 190 RSADMWSFAVLLWELVTREVP 210

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  168 bits (428), Expect = 3e-48
 Identities = 69/277 (24%), Positives = 110/277 (39%), Gaps = 41/277 (14%)

Query: 290 RIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNP--FTTEFATMAGCLRHKNLVQ 347
            I+G G    VY+     G  VAVK        + ++       E    A  L+H N++ 
Sbjct: 13  EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAM-LKHPNIIA 70

Query: 348 LQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC 407
           L+G C +   L LV E+   G L+++L         +  +  +N  + +A  ++YLH+E 
Sbjct: 71  LRGVCLKEPNLCLVMEFARGGPLNRVLSGKR-----IPPDILVNWAVQIARGMNYLHDEA 125

Query: 408 ERQIIHRDVKACNILLDAEF--------NAKLGDF---------EATIPAGTMGYLAPEY 450
              IIHRD+K+ NIL+  +           K+ DF              AG   ++APE 
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPE- 184

Query: 451 VYSGVP-SEKTDVYSFGVVALEVAAGKSPVDN-DGCVIVDWVWNLRKKGKLLDAADFRLR 508
           V      S+ +DV+S+GV+  E+  G+ P    DG  +   V   +    +         
Sbjct: 185 VIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPF- 243

Query: 509 GKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK 545
                      LM    C +P+   RPS       L 
Sbjct: 244 ---------AKLM--EDCWNPDPHSRPSFTNILDQLT 269

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  164 bits (417), Expect = 2e-46
 Identities = 69/275 (25%), Positives = 116/275 (42%), Gaps = 39/275 (14%)

Query: 290 RIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQ 349
           + +G G+  TVYKG     G VAVK              F  E   +    RH N++   
Sbjct: 30  QRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRK-TRHVNILLFM 86

Query: 350 GWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECER 409
           G+      L +V ++    SL   LH + +       +K ++I    A  + YLH    +
Sbjct: 87  GYSTAPQ-LAIVTQWCEGSSLYHHLHASETK---FEMKKLIDIARQTARGMDYLHA---K 139

Query: 410 QIIHRDVKACNILLDAEFNAKLGDF-------------EATIPAGTMGYLAPE---YVYS 453
            IIHRD+K+ NI L  +   K+GDF             +    +G++ ++APE      S
Sbjct: 140 SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDS 199

Query: 454 GVPSEKTDVYSFGVVALEVAAGKSP---VDNDGCVIVDWVWNLRKKGKLLDAADFRLRGK 510
              S ++DVY+FG+V  E+  G+ P   ++N   +I      + +     D +  R    
Sbjct: 200 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII----EMVGRGSLSPDLSKVR---S 252

Query: 511 FNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK 545
              K M+R++     C+    ++RPS       ++
Sbjct: 253 NCPKRMKRLMA---ECLKKKRDERPSFPRILAEIE 284

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  165 bits (419), Expect = 3e-46
 Identities = 65/306 (21%), Positives = 102/306 (33%), Gaps = 62/306 (20%)

Query: 291 IVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGC-LRHKNLVQLQ 349
           ++G G    VYKGSL     VAVK F   NR       F  E        + H N+ +  
Sbjct: 20  LIGRGRYGAVYKGSL-DERPVAVKVFSFANRQN-----FINEKNIYRVPLMEHDNIARFI 73

Query: 350 GWCCEGN-----ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
                       E +LV EY PNGSL K L  ++       W     +   V   L+YLH
Sbjct: 74  VGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-----SDWVSSCRLAHSVTRGLAYLH 128

Query: 405 EE------CERQIIHRDVKACNILLDAEFNAKLGDF-------------------EATIP 439
            E       +  I HRD+ + N+L+  +    + DF                    A   
Sbjct: 129 TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISE 188

Query: 440 AGTMGYLAPEYVYSGV-------PSEKTDVYSFGVVALEVAAGKSPVDNDGCV------I 486
            GT+ Y+APE +   V         ++ D+Y+ G++  E+    + +     V       
Sbjct: 189 VGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAF 248

Query: 487 VDWVWNLRKKGKLLDAADFR-----LRGKFNRKEMERMLMVGL--SCVHPNHEKRPSVKE 539
              V N      +                +    +    +      C   + E R + + 
Sbjct: 249 QTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQX 308

Query: 540 AARILK 545
           A   + 
Sbjct: 309 AEERMA 314

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  164 bits (416), Expect = 5e-46
 Identities = 59/281 (20%), Positives = 105/281 (37%), Gaps = 46/281 (16%)

Query: 290 RIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQ 349
            ++G+G    VY G     G VA++  +     E     F  E        RH+N+V   
Sbjct: 39  ELIGKGRFGQVYHGRW--HGEVAIRLIDIERDNEDQLKAFKREVMAYRQ-TRHENVVLFM 95

Query: 350 GWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECER 409
           G C     L ++       +L  ++ +     IVL   K   I   +   + YLH    +
Sbjct: 96  GACMSPPHLAIITSLCKGRTLYSVVRDA---KIVLDVNKTRQIAQEIVKGMGYLH---AK 149

Query: 410 QIIHRDVKACNILLDAEFNAKLGDF----------------EATIPAGTMGYLAPEYVYS 453
            I+H+D+K+ N+  D      + DF                +  I  G + +LAPE +  
Sbjct: 150 GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQ 208

Query: 454 GVP---------SEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAAD 504
             P         S+ +DV++ G +  E+ A + P        + W       G   + + 
Sbjct: 209 LSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMG---TGMKPNLSQ 265

Query: 505 FRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK 545
             +      KE+  +L+    C     E+RP+  +   +L+
Sbjct: 266 IGM-----GKEISDILL---FCWAFEQEERPTFTKLMDMLE 298

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  160 bits (406), Expect = 1e-44
 Identities = 62/288 (21%), Positives = 109/288 (37%), Gaps = 57/288 (19%)

Query: 290 RIVGEGASATVYKGSL-PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
            ++G+G      K +   +G  + +K   + +  E  +  F  E   M  CL H N+++ 
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFD--EETQRTFLKEVKVM-RCLEHPNVLKF 72

Query: 349 QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE 408
            G   +   L  + EY+  G+L  I+ +  S      W +R++    +AS ++YLH    
Sbjct: 73  IGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ---YPWSQRVSFAKDIASGMAYLH---S 126

Query: 409 RQIIHRDVKACNILLDAEFNAKLGDF-------------------------EATIPAGTM 443
             IIHRD+ + N L+    N  + DF                         +     G  
Sbjct: 127 MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186

Query: 444 GYLAPEYVYSGVP-SEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDA 502
            ++APE + +G    EK DV+SFG+V  E+    +   +         +  R     L+ 
Sbjct: 187 YWMAPE-MINGRSYDEKVDVFSFGIVLCEIIGRVNADPD---------YLPRTMDFGLNV 236

Query: 503 ADFRLRGKFNRKEM-----ERMLMVGLSCVHPNHEKRPSVKEAARILK 545
             F        +            + + C   + EKRPS  +    L+
Sbjct: 237 RGFL------DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLE 278

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  154 bits (391), Expect = 2e-42
 Identities = 67/309 (21%), Positives = 103/309 (33%), Gaps = 55/309 (17%)

Query: 277 TDIKQATLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATM 336
           T  KQ  +     + +G+G    V+ G    G  VAVK F         R    TE    
Sbjct: 34  TIAKQIQMV----KQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWFR---ETEIYQT 85

Query: 337 AGCLRHKNLVQLQGWCCEGN----ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNI 392
              +RH+N++       +G     +L L+ +Y  NGSL   L + +     L  +  L +
Sbjct: 86  VL-MRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT-----LDAKSMLKL 139

Query: 393 VLGVASALSYLHEECERQ-----IIHRDVKACNILLDAEFNAKLGDF------------- 434
                S L +LH E         I HRD+K+ NIL+       + D              
Sbjct: 140 AYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEV 199

Query: 435 --EATIPAGTMGYLAPEYVYSGVP-------SEKTDVYSFGVVALEVAAGKSPVDNDGCV 485
                   GT  Y+ PE V                D+YSFG++  EVA            
Sbjct: 200 DIPPNTRVGTKRYMPPE-VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY 258

Query: 486 IV---DWVWNLRKKGKLLDAADF-RLRGKFNRKEMERMLMVGLS-----CVHPNHEKRPS 536
            +   D V +      + +     +LR  F  +      +  +      C   N   R +
Sbjct: 259 QLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLT 318

Query: 537 VKEAARILK 545
                + L 
Sbjct: 319 ALRVKKTLA 327

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  153 bits (388), Expect = 3e-42
 Identities = 63/248 (25%), Positives = 91/248 (36%), Gaps = 55/248 (22%)

Query: 266 TVQRVPMRLALTDIKQATLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECA 325
           ++QR       T  +  TL       VG+G    V++GS   G  VAVK F   +     
Sbjct: 1   SMQR-------TVARDITLL----ECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKS-- 46

Query: 326 RNPFTTEFATMAGC-LRHKNLVQLQGWCCEGN----ELVLVYEYLPNGSLDKILHNNSSS 380
              +  E        LRH+N++              +L L+  Y   GSL   L   +  
Sbjct: 47  ---WFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-- 101

Query: 381 SIVLSWEKRLNIVLGVASALSYLHEECERQ-----IIHRDVKACNILLDAEFNAKLGDF- 434
              L     L IVL +AS L++LH E         I HRD+K+ NIL+       + D  
Sbjct: 102 ---LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLG 158

Query: 435 --------------EATIPAGTMGYLAPEYVYSGVP-------SEKTDVYSFGVVALEVA 473
                               GT  Y+APE V             ++ D+++FG+V  EVA
Sbjct: 159 LAVMHSQSTNQLDVGNNPRVGTKRYMAPE-VLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217

Query: 474 AGKSPVDN 481
                   
Sbjct: 218 RRMVSNGI 225

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  148 bits (374), Expect = 6e-40
 Identities = 71/310 (22%), Positives = 114/310 (36%), Gaps = 60/310 (19%)

Query: 277 TDIKQATLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATM 336
           T  +   L       +G+G    V++G    G  VAVK F         R     E    
Sbjct: 39  TIARTIVLQ----ESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFRE---AEIYQT 90

Query: 337 AGCLRHKNLVQLQGWCCEGN----ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNI 392
              LRH+N++       + N    +L LV +Y  +GSL   L+  +     ++ E  + +
Sbjct: 91  VM-LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKL 144

Query: 393 VLGVASALSYLHEECERQ-----IIHRDVKACNILLDAEFNAKLGDF------------- 434
            L  AS L++LH E         I HRD+K+ NIL+       + D              
Sbjct: 145 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI 204

Query: 435 --EATIPAGTMGYLAPE-----YVYSGVPS-EKTDVYSFGVVALEVAAGKSPVDNDGCVI 486
                   GT  Y+APE            S ++ D+Y+ G+V  E+A   S         
Sbjct: 205 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264

Query: 487 V---DWVWNLRKKGKLLDA-ADFRLR-----GKFNRKEMERM--LMVGLSCVHPNHEKRP 535
           +   D V +     ++     + +LR        + + +  M  +M    C + N   R 
Sbjct: 265 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR--ECWYANGAARL 322

Query: 536 SVKEAARILK 545
           +   A RI K
Sbjct: 323 T---ALRIKK 329

>3ipv_A Lectin alpha chain; galactose binding, SEED lectin, hemagglutinin, legume lectin fungal, sugar binding protein; 2.04A {Spatholobus parviflorus} PDB: 3ipv_B 3usu_B* 3usu_A* Length = 251

 Score =  129 bits (325), Expect = 3e-34
 Identities = 53/199 (26%), Positives = 80/199 (40%), Gaps = 10/199 (5%)

Query: 1   FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVL-SP 59
             D  T   ASF+  F F+I    +    DG AF +   A +  +  G++GL    +   
Sbjct: 59  IWDSATGLVASFATSFRFTIYAPNIATIADGLAFFLAPVASAPDSGGGFLGLFDSAVSGS 118

Query: 60  QDSFFAVEFDTSFDPSLGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYR 119
                AVEFDT  +    D    HIG D++S+ S  +V        L +G      I Y 
Sbjct: 119 TYQTVAVEFDTYENTVFTDPPYTHIGFDVNSISSIKTVK-----WSLANGEAAKVLITYN 173

Query: 120 DSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGSAIY---TVDRWR 176
            ++KL+     Y      S ++   +DLS    +++ VGFSAA G          V  W 
Sbjct: 174 SAVKLLVASLVYPS-SKTSFILADIVDLSSVLPEWVRVGFSAATGASGGKIETHDVFSWS 232

Query: 177 FKTFESYPSGNPIDVIDEG 195
           F +  +         +D G
Sbjct: 233 FASKLAGXXTKDSSFLDGG 251

>1v6i_A Agglutinin, PNA, galactose-binding lectin; open quaternary association, orthorhombic, carbohydrate specificity, protein crystallography; HET: GAL GLC; 2.15A {Arachis hypogaea} SCOP: b.29.1.1 PDB: 1bzw_A* 1v6j_A* 1v6k_A* 1v6l_A* 1v6m_A 1v6n_A 1v6o_A 2dva_A* 1cq9_A 1ciw_A* 1qf3_A* 1rir_A* 1rit_A* 2dh1_A 1cr7_A* 2dv9_A* 2dvb_A* 2dvd_A* 2dvf_A 2dvg_A* ... Length = 232

 Score =  127 bits (319), Expect = 2e-33
 Identities = 45/181 (24%), Positives = 65/181 (35%), Gaps = 9/181 (4%)

Query: 1   FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPG-PVLSP 59
                T   ASF   FSF +         DG  F I          +   G  G      
Sbjct: 54  IWSSATGNVASFLTSFSFEMKDIKDYDPADGIIFFIAPEDTQIPAGSIGGGTLGVSDTKG 113

Query: 60  QDSFFAVEFDTSFDPSLGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYR 119
              F  VEFDT  +    D   +H+GID++SV S  +V       +  SG  +   + Y 
Sbjct: 114 AGHFVGVEFDTYSNSEYNDPPTDHVGIDVNSVDSVKTVPW-----NSVSGAVVKVTVIYD 168

Query: 120 DSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGS-AIYTVDRWRFK 178
            S K + V             I   +DL  +  + +  GFSA+   G   I+ +  W F 
Sbjct: 169 SSTKTLSVAVTND--NGDITTIAQVVDLKAKLPERVKFGFSASGSLGGRQIHLIRSWSFT 226

Query: 179 T 179
           +
Sbjct: 227 S 227

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  127 bits (320), Expect = 6e-33
 Identities = 56/294 (19%), Positives = 102/294 (34%), Gaps = 61/294 (20%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F++   +G G   +V+K      G   A+KR +KP            E    A   +H +
Sbjct: 13  FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72

Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           +V+      E + +++  EY   GSL   +  N          +  +++L V   L Y+H
Sbjct: 73  VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132

Query: 405 EECERQIIHRDVKACNILLD-------------------AEFNAKLGDF-------EATI 438
                 ++H D+K  NI +                     +   K+GD           +
Sbjct: 133 ---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV 189

Query: 439 PAGTMGYLAPEYVYSGVP-SEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKG 497
             G   +LA E +        K D+++  +  +  A  +    N      D    +R+  
Sbjct: 190 EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG-----DQWHEIRQ-- 242

Query: 498 KLLDAADFRLRGKFNR------KEMERMLMVGLSCVHPNHEKRPSVKEAARILK 545
                      G+  R      +E   +L      +HP+ E+RPS      ++K
Sbjct: 243 -----------GRLPRIPQVLSQEFTELLK---VMIHPDPERRPSAMA---LVK 279

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  127 bits (322), Expect = 2e-32
 Identities = 52/204 (25%), Positives = 84/204 (41%), Gaps = 23/204 (11%)

Query: 290 RIVGEGASATVYKGSLPSGG-AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
             +G G    V+ G L +    VAVK   +       +  F  E   +     H N+V+L
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSC-RETLPPDLKAKFLQEARILKQ-YSHPNIVRL 177

Query: 349 QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE 408
            G C +   + +V E +  G     L    +    L  +  L +V   A+ + YL     
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR---LRVKTLLQMVGDAAAGMEYLE---S 231

Query: 409 RQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYL-----APEYVYSGV 455
           +  IHRD+ A N L+  +   K+ DF             +G +  +     APE +  G 
Sbjct: 232 KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGR 291

Query: 456 PSEKTDVYSFGVVALEVAA-GKSP 478
            S ++DV+SFG++  E  + G SP
Sbjct: 292 YSSESDVWSFGILLWETFSLGASP 315

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  125 bits (315), Expect = 3e-32
 Identities = 66/269 (24%), Positives = 108/269 (40%), Gaps = 36/269 (13%)

Query: 288 KNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLV 346
            +  +G G+  TVYKG    +   VA    +     +  R  F  E   + G L+H N+V
Sbjct: 30  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKG-LQHPNIV 88

Query: 347 QLQG----WCCEGNELVLVYEYLPNGSLDKIL--HNNSSSSIVLSWEKRLNIVLGVASAL 400
           +              +VLV E + +G+L   L         ++ SW ++      +   L
Sbjct: 89  RFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQ------ILKGL 142

Query: 401 SYLHEECERQIIHRDVKACNILLDAEF-NAKLGDF---------EATIPAGTMGYLAPEY 450
            +LH      IIHRD+K  NI +     + K+GD           A    GT  ++APE 
Sbjct: 143 QFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEM 201

Query: 451 VYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGK 510
                  E  DVY+FG+  LE+A  + P     C     ++     G    + D     K
Sbjct: 202 YEEKY-DESVDVYAFGMCMLEMATSEYPYSE--CQNAAQIYRRVTSGVKPASFD-----K 253

Query: 511 FNRKEMERMLMVGLSCVHPNHEKRPSVKE 539
               E++ ++     C+  N ++R S+K+
Sbjct: 254 VAIPEVKEIIE---GCIRQNKDERYSIKD 279

>2bqp_A Protein (PEA lectin); D-glucopyranose complex, sugar binding protein; HET: GLC; 1.90A {Pisum sativum} SCOP: b.29.1.1 Length = 234

 Score =  122 bits (308), Expect = 5e-32
 Identities = 45/185 (24%), Positives = 72/185 (38%), Gaps = 11/185 (5%)

Query: 1   FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPG-PVLSP 59
             D +T   A+F   F+F I         DGF F I           GY+G+        
Sbjct: 52  IWDRETGNVANFVTSFTFVINAPNSYNVADGFTFFIAPVDTKPQTGGGYLGVFNSAEYDK 111

Query: 60  QDSFFAVEFDTSFDPSLGDIN-GNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEY 118
                AVEFDT ++ +    N   HIGID++S+ S  +         L++G      I +
Sbjct: 112 TTQTVAVEFDTFYNAAWDPSNRDRHIGIDVNSIKSVNTKS-----WKLQNGEEANVVIAF 166

Query: 119 RDSLKLIRVWAGYS----QIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGSAIYTVDR 174
             +  ++ V   Y     +    S  +   + L     +++ +GFSA  G   A + V  
Sbjct: 167 NAATNVLTVSLTYPNNSLEEEVTSYTLSDVVSLKDVVPEWVRIGFSATTGAEYAAHEVLS 226

Query: 175 WRFKT 179
           W F +
Sbjct: 227 WSFHS 231

>1hql_A Lectin; xenograft antigen, sugar BI protein; HET: GLA MBG NAG; 2.20A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1gnz_A* Length = 257

 Score =  123 bits (309), Expect = 5e-32
 Identities = 47/192 (24%), Positives = 82/192 (42%), Gaps = 9/192 (4%)

Query: 1   FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGP---VL 57
             D KT + ASF   F+F +  +      DG AF +        +   Y+GL        
Sbjct: 60  LWDNKTESVASFYTEFTFFLKITG-NGPADGLAFFLAPPDSDVKDAGEYLGLFNKSTATQ 118

Query: 58  SPQDSFFAVEFDTSFDPSLGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIE 117
             ++   AVEFDT  +P+  + +  HIGI+++S++S  +        D+ SG+  T  I 
Sbjct: 119 PSKNQVVAVEFDTWTNPNFPEPSYRHIGINVNSIVSVATKRWED--SDIFSGKIATARIS 176

Query: 118 YRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGSAI-YTVDRWR 176
           Y  S +++ V   Y        ++   +D+ +   + + VG SA+ G    +   +  WR
Sbjct: 177 YDGSAEILTVVLSYP--DGSDYILSHSVDMRQNLPESVRVGISASTGNNQFLTVYILSWR 234

Query: 177 FKTFESYPSGNP 188
           F +     S   
Sbjct: 235 FSSNLQSTSVKA 246

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  124 bits (313), Expect = 8e-32
 Identities = 66/281 (23%), Positives = 119/281 (42%), Gaps = 45/281 (16%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHK 343
           F   + +G G  + VY+   L  G  VA+K+ +  + +   AR     E   +   L H 
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQ-LNHP 92

Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
           N+++      E NEL +V E    G L +++ +      ++         + + SAL ++
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM 152

Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTMGYLAPEYVY 452
           H    R+++HRD+K  N+ + A    KLGD             A    GT  Y++PE   
Sbjct: 153 HS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE-RI 208

Query: 453 SGVP-SEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKF 511
                + K+D++S G +  E+AA +SP   D   +     +L KK +         +  +
Sbjct: 209 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY----SLCKKIE---------QCDY 255

Query: 512 NR-------KEMERMLMVGLSCVHPNHEKRPSVKEAARILK 545
                    +E+ +++     C++P+ EKRP V     +  
Sbjct: 256 PPLPSDHYSEELRQLVN---MCINPDPEKRPDVTY---VYD 290

>1g7y_A Stem/LEAF lectin DB58; jelly roll fold, sugar binding protein; HET: NAG FUC FUL; 2.50A {Vigna unguiculata subsp} SCOP: b.29.1.1 PDB: 1lul_A 1lu1_A* 1bjq_A* 1lu2_A* Length = 253

 Score =  122 bits (307), Expect = 9e-32
 Identities = 46/196 (23%), Positives = 83/196 (42%), Gaps = 12/196 (6%)

Query: 1   FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVL-SP 59
             D  T   AS++  F+ +I      +  DG AF +        +++G++G+    +   
Sbjct: 56  IYDKSTGAVASWATSFTANIFAPNKSSSADGIAFALVPVGSEPKSNSGFLGVFDSDVYDN 115

Query: 60  QDSFFAVEFDTSFDPSLGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYR 119
                AVEFDT F  +  D    HIGID++S+ S  +         L +G++    I Y 
Sbjct: 116 SAQTVAVEFDT-FSNTDWDPTSRHIGIDVNSIKSIRTASW-----GLANGQNAEILITYN 169

Query: 120 DSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGSAIYT---VDRWR 176
            +  L+     +   R  S ++  ++D++ +  +Y+ +GFSA  G          V  W 
Sbjct: 170 AATSLLVASLVHPS-RRTSYIVSERVDITNELPEYVSIGFSATTGLSEGYTETHDVLSWS 228

Query: 177 FK-TFESYPSGNPIDV 191
           F        +  P+D+
Sbjct: 229 FASKLPDDSTTEPLDI 244

>1fny_A BARK lectin, BARK agglutinin I,polypeptide A; legume lectin, jelly roll, sugar binding protein; 1.81A {Robinia pseudoacacia} SCOP: b.29.1.1 PDB: 1fnz_A* Length = 237

 Score =  121 bits (303), Expect = 2e-31
 Identities = 47/183 (25%), Positives = 72/183 (39%), Gaps = 11/183 (6%)

Query: 1   FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVL-SP 59
             D  T   ASF   F+F I         DG AF +        +  G +G+      + 
Sbjct: 58  IWDSTTGNVASFVTSFTFIIQAPNPATTADGLAFFLAPVDTQPLDLGGMLGIFKDGYFNK 117

Query: 60  QDSFFAVEFDTSFDPSLGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYR 119
            +   AVEFDT F     D  G H+GI+++S+ S  +V       +  +G     +I Y 
Sbjct: 118 SNQIVAVEFDT-FSNGDWDPKGRHLGINVNSIESIKTVPW-----NWTNGEVANVFISYE 171

Query: 120 DSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGSAIYT---VDRWR 176
            S K +     Y      S +I A +D+     +++  GFSA  G          V  W 
Sbjct: 172 ASTKSLTASLVYPS-LETSFIIDAIVDVKIVLPEWVRFGFSATTGIDKGYVQTNDVLSWS 230

Query: 177 FKT 179
           F++
Sbjct: 231 FES 233

>3zyr_A Lectin; sugar binding protein, N-glycan; HET: NAG BMA MAN GOL; 1.65A {Platypodium elegans} PDB: 3zvx_A* 1ukg_A* 1q8o_A* 1q8q_A* 1q8s_A* 1q8v_A* 1q8p_A* 2auy_A* 2gme_A 2gmm_A* 2gmp_A* 2gn3_A* 2gn7_A* 2gnb_A* 2gnd_A* 2gnm_A* 2gnt_A 2phf_A* 2phr_A* 2pht_A* ... Length = 261

 Score =  121 bits (304), Expect = 3e-31
 Identities = 54/199 (27%), Positives = 88/199 (44%), Gaps = 15/199 (7%)

Query: 1   FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSF--GNDNGYMGLPGP--- 55
             +  TN  A+   +FSF +   PL    DG AF I     +   G+  G +GL  P   
Sbjct: 67  LWEKSTNRVANLQTQFSFFLSS-PLSNPADGIAFFIAPPDTTIPSGSAGGLLGLFNPRTA 125

Query: 56  VLSPQDSFFAVEFDTSFDPS--LGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHIT 113
           +    +   AVEFDT F  +    D N  HIGID++S+ S   V       + + G+ + 
Sbjct: 126 LNESANQVLAVEFDTFFAQNSNTWDPNYQHIGIDVNSIRSSKVVR-----WERREGKTLN 180

Query: 114 TWIEYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGSAIYTVD 173
             + Y  S + I V A Y         +   +DL+    +++ VGFSAA+G+    + ++
Sbjct: 181 VLVTYNPSTRTIDVVATYP--DGQRYQLSHVVDLTTILPEWVRVGFSAASGEQFQTHNLE 238

Query: 174 RWRFKTFESYPSGNPIDVI 192
            W F +   Y +    + +
Sbjct: 239 SWSFTSTLLYTAQKEDEYL 257

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  122 bits (309), Expect = 3e-31
 Identities = 61/286 (21%), Positives = 103/286 (36%), Gaps = 52/286 (18%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           +   + +GEG  + V     L  G   A+KR       +  R     E         H N
Sbjct: 31  YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE--QQDREEAQREADMHR-LFNHPN 87

Query: 345 LVQLQGWCCE----GNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASAL 400
           +++L  +C       +E  L+  +   G+L   +         L+ ++ L ++LG+   L
Sbjct: 88  ILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGL 147

Query: 401 SYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA-------------------- 440
             +H    +   HRD+K  NILL  E    L D  +   A                    
Sbjct: 148 EAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204

Query: 441 GTMGYLAPEYV--YSGVP-SEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKG 497
            T+ Y APE     S     E+TDV+S G V   +  G+ P D              +KG
Sbjct: 205 CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVF-----------QKG 253

Query: 498 KLLDAADFRLRGKFNRKEMERM--LMVGL--SCVHPNHEKRPSVKE 539
             +  A   ++ + +  +  R    +  L  S +  +  +RP +  
Sbjct: 254 DSVALA---VQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPL 296

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  122 bits (309), Expect = 5e-31
 Identities = 62/280 (22%), Positives = 110/280 (39%), Gaps = 49/280 (17%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           + + + +GEG+        S   G    +K           R     E A +A  ++H N
Sbjct: 26  YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLAN-MKHPN 84

Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           +VQ +    E   L +V +Y   G L K +  N+   ++   ++ L+  + +  AL ++H
Sbjct: 85  IVQYRESFEENGSLYIVMDYCEGGDLFKRI--NAQKGVLFQEDQILDWFVQICLALKHVH 142

Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTMGYLAPEYVYS 453
           +   R+I+HRD+K+ NI L  +   +LGDF            A    GT  YL+PE +  
Sbjct: 143 D---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPE-ICE 198

Query: 454 GVP-SEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFR-LRGKF 511
             P + K+D+++ G V  E+   K   +                   +     + + G F
Sbjct: 199 NKPYNNKSDIWALGCVLYELCTLKHAFE----------------AGSMKNLVLKIISGSF 242

Query: 512 NR------KEMERMLMVGLSCVHPNHEKRPSVKEAARILK 545
                    ++  ++         N   RPSV     IL+
Sbjct: 243 PPVSLHYSYDLRSLVS---QLFKRNPRDRPSVNS---ILE 276

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  122 bits (307), Expect = 5e-31
 Identities = 65/268 (24%), Positives = 98/268 (36%), Gaps = 39/268 (14%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F +   +G G+   V+K  S   G   AVKR   P R    R     E  +     +H  
Sbjct: 59  FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPC 118

Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
            V+L+    EG  L L  E     SL +      +S   L   +    +     AL++LH
Sbjct: 119 CVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGAS---LPEAQVWGYLRDTLLALAHLH 174

Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF----------EATIPAGTMGYLAPEYVYSG 454
               + ++H DVK  NI L      KLGDF             +  G   Y+APE +  G
Sbjct: 175 S---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPE-LLQG 230

Query: 455 VPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNR- 513
                 DV+S G+  LEVA              +    LR+           L  +F   
Sbjct: 231 SYGTAADVFSLGLTILEVACNMELPHGG-----EGWQQLRQG---------YLPPEFTAG 276

Query: 514 --KEMERMLMVGLSCVHPNHEKRPSVKE 539
              E+  +L+     + P+ + R + + 
Sbjct: 277 LSSELRSVLV---MMLEPDPKLRATAEA 301

>1fx5_A UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HOMO-dimer, fucose specific lectin, SUG binding protein; HET: NAG FUC BMA MAN; 2.20A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1jxn_A* Length = 242

 Score =  120 bits (301), Expect = 6e-31
 Identities = 48/183 (26%), Positives = 65/183 (35%), Gaps = 8/183 (4%)

Query: 1   FLDPKTNTTASFSCRFSFSIIPSP-LCAFGDGFAFLITSNADSFGNDNGYMGLPGPV-LS 58
             +  T   ASF   FSF +  S    A  DG  F +           GY GL       
Sbjct: 57  IWNCNTGELASFITSFSFFMETSANPKAATDGLTFFLAPPDSPLRRAGGYFGLFNDTKCD 116

Query: 59  PQDSFFAVEFDTSFDPS-LGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIE 117
                 AVEFDT   P    D    HIGID++ V S  +                   I 
Sbjct: 117 SSYQTVAVEFDTIGSPVNFWDPGFPHIGIDVNCVKSINAERW---NKRYGLNNVANVEII 173

Query: 118 YRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQG-SAIYTVDRWR 176
           Y  S K +     Y      S  + + +DL +   +++ VGFS +   G  A + V  W 
Sbjct: 174 YEASSKTLTASLTYPS-DQTSISVTSIVDLKEILPEWVSVGFSGSTYIGRQATHEVLNWY 232

Query: 177 FKT 179
           F +
Sbjct: 233 FTS 235

>1fat_A Phytohemagglutinin-L; glycoprotein, plant defense protein, lectin; HET: NAG; 2.80A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1g8w_A* Length = 252

 Score =  120 bits (301), Expect = 7e-31
 Identities = 49/195 (25%), Positives = 77/195 (39%), Gaps = 12/195 (6%)

Query: 1   FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQ 60
             D  T T ASF+  F+F+I         DG AF +        +  G++GL     +  
Sbjct: 57  IWDNTTGTVASFATSFTFNIQVPNNAGPADGLAFALVPVGSQPKDKGGFLGLFDGS-NSN 115

Query: 61  DSFFAVEFDTSFDPSLGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRD 120
               AVEFDT ++    D    HIGID++S+ S  +        D  +G +    I Y  
Sbjct: 116 FHTVAVEFDTLYNKDW-DPTERHIGIDVNSIRSIKTTRW-----DFVNGENAEVLITYDS 169

Query: 121 SLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGSAIYT---VDRWRF 177
           S  L+     Y   +  S ++   +DL     +++ VGFSA  G          V  W F
Sbjct: 170 STNLLVASLVYPS-QKTSFIVSDTVDLKSVLPEWVSVGFSATTGINKGNVETNDVLSWSF 228

Query: 178 K-TFESYPSGNPIDV 191
                   +   +++
Sbjct: 229 ASKLSDETTSEGLNL 243

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  121 bits (305), Expect = 1e-30
 Identities = 50/211 (23%), Positives = 92/211 (43%), Gaps = 34/211 (16%)

Query: 290 RIVGEGASATVYKGSLPSGG-----AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           +++G GA  TVYKG     G      VA+K   +      A      E   MA  + + +
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMAS-VDNPH 78

Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           + +L G  C  + + L+ + +P G L   +  +  +   +  +  LN  + +A  ++YL 
Sbjct: 79  VCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLE 134

Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF----------------EATIPAGTMGYLAP 448
           +   R+++HRD+ A N+L+    + K+ DF                   +P   M   A 
Sbjct: 135 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM---AL 188

Query: 449 EYVYSGVPSEKTDVYSFGVVALEVAA-GKSP 478
           E +   + + ++DV+S+GV   E+   G  P
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  120 bits (302), Expect = 1e-30
 Identities = 62/277 (22%), Positives = 105/277 (37%), Gaps = 43/277 (15%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           +     +G G+     K      G  +  K  +  +  E  +    +E   +   L+H N
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE-LKHPN 66

Query: 345 LVQLQGWCCE--GNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
           +V+      +     L +V EY   G L  ++   +     L  E  L ++  +  AL  
Sbjct: 67  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 126

Query: 403 LHE--ECERQIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTMGYLAPE 449
            H   +    ++HRD+K  N+ LD + N KLGDF            A    GT  Y++PE
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPE 186

Query: 450 YVYSGVP-SEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLR 508
              + +  +EK+D++S G +  E+ A   P              L  K +          
Sbjct: 187 -QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS------QKELAGKIR---------E 230

Query: 509 GKFNR------KEMERMLMVGLSCVHPNHEKRPSVKE 539
           GKF R       E+  ++      ++     RPSV+E
Sbjct: 231 GKFRRIPYRYSDELNEIIT---RMLNLKDYHRPSVEE 264

>1gsl_A Griffonia simplicifolia lectin 4; glycoprotein, manganese; HET: FUC GAL MAG NAG BMA; 2.00A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1lec_A* 1led_A* Length = 243

 Score =  119 bits (298), Expect = 2e-30
 Identities = 48/181 (26%), Positives = 74/181 (40%), Gaps = 9/181 (4%)

Query: 2   LDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQD 61
           L   T   ASF   F+F ++ +      DG AF +     S  +  G++GL     +   
Sbjct: 62  LWDSTGKAASFYTSFTF-LLKNYGAPTADGLAFFLAPVDSSVKDYGGFLGLFRHETAADP 120

Query: 62  S---FFAVEFDTSFDPSLGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEY 118
           S     AVEFDT  +    D    HIGID++S++S  +    +   D       T  I Y
Sbjct: 121 SKNQVVAVEFDTWINKDWNDPPYPHIGIDVNSIVSVATTRWEND--DAYGSSIATAHITY 178

Query: 119 RDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGSAIYTVDRWRFK 178
               K++ V   Y        ++   +DL+K     + +GFSA  G     Y +  W F 
Sbjct: 179 DARSKILTVLLSYEH--GRDYILSHVVDLAKVLPQKVRIGFSAGVGYDEVTY-ILSWHFF 235

Query: 179 T 179
           +
Sbjct: 236 S 236

>1dbn_A MAL, protein (leukoagglutinin); plant lectin, carbohydrate binding, sialyllactose, sugar BIN protein; HET: NAG SIA GAL BGC; 2.75A {Maackia amurensis} SCOP: b.29.1.1 Length = 239

 Score =  117 bits (293), Expect = 6e-30
 Identities = 52/186 (27%), Positives = 76/186 (40%), Gaps = 13/186 (6%)

Query: 1   FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSF--GNDNGYMGLPGPVL- 57
                T + ASFS  F+F +         DG AF +         G+ + Y+GL      
Sbjct: 58  IWGNTTGSVASFSTSFTFVVKAPNPDITSDGLAFYLAPPDSQIPSGSVSKYLGLFNNSNS 117

Query: 58  SPQDSFFAVEFDTSFDPSLG--DINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTW 115
              +   AVEFDT F  S    D N  HIGID++ + S  +V       D  +G      
Sbjct: 118 DSSNQIVAVEFDTYFAHSYDPWDPNYRHIGIDVNGIESIKTVQ-----WDWINGGVAFAT 172

Query: 116 IEYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGSAIYT--VD 173
           I Y    K +     Y      +  + A +DL +   +++ VGFSAA G  + + T  V 
Sbjct: 173 ITYLAPNKTLIASLVYPS-NQTTFSVAASVDLKEILPEWVRVGFSAATGYPTEVETHDVL 231

Query: 174 RWRFKT 179
            W F +
Sbjct: 232 SWSFTS 237

>1sbf_A Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {Glycine max} SCOP: b.29.1.1 PDB: 1sbd_A* 1sbe_A* 1g9f_A* 2sba_A* Length = 253

 Score =  117 bits (293), Expect = 9e-30
 Identities = 51/189 (26%), Positives = 78/189 (41%), Gaps = 11/189 (5%)

Query: 1   FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQ 60
             D +T + ASF+  F+F+          DG AF +           GY+GL     S  
Sbjct: 59  IWDKETGSVASFAASFNFTFYAPDTKRLADGLAFFLAPIDTKPQTHAGYLGLFNENES-G 117

Query: 61  DSFFAVEFDTSFDPSLGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRD 120
           D   AVEFDT  +    D    HIGI+++S+ S  +        DL + +     I Y  
Sbjct: 118 DQVVAVEFDTFRNS--WDPPNPHIGINVNSIRSIKTTS-----WDLANNKVAKVLITYDA 170

Query: 121 SLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGSA--IYTVDRWRFK 178
           S  L+     Y   +  S ++   +DL     +++ +GFSAA G       + V  W F 
Sbjct: 171 STSLLVASLVYPS-QRTSNILSDVVDLKTSLPEWVRIGFSAATGLDIPGESHDVLSWSFA 229

Query: 179 TFESYPSGN 187
           +   + S N
Sbjct: 230 SNLPHASSN 238

>2fmd_A Lectin, agglutinin, BMA; legume lectin, beta sandwich, protein-carbohydrate complex, sugar binding protein; HET: MAN; 1.90A {Bowringia mildbraedii} Length = 240

 Score =  116 bits (291), Expect = 1e-29
 Identities = 46/189 (24%), Positives = 79/189 (41%), Gaps = 10/189 (5%)

Query: 2   LDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDN-GYMGLPGP--VLS 58
           L   ++  ASF   F+FSI             F+ + +           +GL G      
Sbjct: 59  LWQSSSLVASFETTFTFSISQGSSTPADALTFFIASPDTKIPSGSGGRLLGLFGSSNNAG 118

Query: 59  PQDSFFAVEFDTSFDPSLGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEY 118
             +   +VEFDT  +  +GD N  HIGID++S+ S  +        D ++G+  T  I Y
Sbjct: 119 SDNGVVSVEFDTYPNTDIGDPNYRHIGIDVNSIRSKAASKW-----DWQNGKTATAHISY 173

Query: 119 RDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGSAIYTVDRWRFK 178
             + K + V + Y        ++   ++L+    B++ VGFSA  GQ +    +  W F+
Sbjct: 174 NSASKRLSVVSSYP--NSSPVVVSFDVELNNVBPBWVRVGFSATTGQYTQTNNILAWSFR 231

Query: 179 TFESYPSGN 187
           +       N
Sbjct: 232 SSLMGYQAN 240

>2eig_A Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG binding protein; HET: NAG; 2.00A {Lotus tetragonolobus} Length = 234

 Score =  115 bits (288), Expect = 3e-29
 Identities = 47/183 (25%), Positives = 73/183 (39%), Gaps = 12/183 (6%)

Query: 1   FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSF--GNDNGYMGLPGPVLS 58
             D  T   ASF   FSF +         DG  F +          +  GY+G+     S
Sbjct: 51  IWDSATGNVASFITSFSFIVSNVQRYPPTDGVVFFLAPWGTEIPPNSQGGYLGITDSSNS 110

Query: 59  PQDSFFAVEFDTSFDPS-LGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIE 117
            Q+ F AVEFD+  +      +  +HIGID++S++S  +V+      +  SG      I 
Sbjct: 111 -QNQFVAVEFDSHPNVWDPKSLRSSHIGIDVNSIMSLKAVN-----WNRVSGSLEKATII 164

Query: 118 YRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAA-NGQGSAIYTVDRWR 176
           Y    K++ V   +         I  +IDL     + + VGFSA         + +  W 
Sbjct: 165 YDSDTKILTVVMTHQN--GQITTISQEIDLKTVLPEKVSVGFSATTWNPERERHDIYSWS 222

Query: 177 FKT 179
           F +
Sbjct: 223 FTS 225

>1wbf_A Protein (agglutinin); lectin (agglutinin), legume lectin, protein crystallography, group specificity, saccharide free form; HET: NAG; 2.30A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 2d3s_A* 2dtw_A* 1wbl_A* 2dty_A* 2du0_A* 2du1_A* 2e51_A* 2e53_A* 2zmk_A* 2zml_A* 2zmn_A* 2e7t_A* 2e7q_A* Length = 242

 Score =  115 bits (288), Expect = 3e-29
 Identities = 60/187 (32%), Positives = 77/187 (41%), Gaps = 18/187 (9%)

Query: 1   FLDPKTNTTASFSCRFSFSII-PSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSP 59
             D  T   ASF  RFSFSI  P P     DG  F I       G   GY G+  P    
Sbjct: 58  VWDSTTGNVASFETRFSFSIRQPFPRPHPADGLVFFIAPPNTQTGEGGGYFGIYNP--LS 115

Query: 60  QDSFFAVEFDTSFDPSLGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYR 119
              F AVEFDT  +    D    HIGID++SVIS  +V        L +G      I+Y 
Sbjct: 116 PYPFVAVEFDTFRNT--WDPQIPHIGIDVNSVISTKTVP-----FTLDNGGIANVVIKYD 168

Query: 120 DSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGSA-------IYTV 172
            S K++ V   +         I   +DL +   + ++VGFSAA G  S         + +
Sbjct: 169 ASTKILHVVLVFPS-LGTIYTIADIVDLKQVLPESVNVGFSAATGDPSGKQRNATETHDI 227

Query: 173 DRWRFKT 179
             W F  
Sbjct: 228 LSWSFSA 234

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  117 bits (294), Expect = 4e-29
 Identities = 63/208 (30%), Positives = 95/208 (45%), Gaps = 27/208 (12%)

Query: 290 RIVGEGASATVYKGSLPSGG----AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           +I+G G S  V  G L   G     VA+K   K    E  R  F +E + M     H N+
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL-KAGYTERQRRDFLSEASIMGQ-FDHPNI 112

Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
           ++L+G    G   ++V EY+ NGSLD  L  +       +  + + ++ GV + + YL  
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ---FTIMQLVGMLRGVGAGMRYLS- 168

Query: 406 ECERQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGTMGYL-----APEYV 451
             +   +HRD+ A N+L+D+    K+ DF                T G +     APE +
Sbjct: 169 --DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAI 226

Query: 452 YSGVPSEKTDVYSFGVVALEVAA-GKSP 478
                S  +DV+SFGVV  EV A G+ P
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVLAYGERP 254

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  116 bits (292), Expect = 4e-29
 Identities = 54/218 (24%), Positives = 86/218 (39%), Gaps = 28/218 (12%)

Query: 279 IKQATLGFNKNRIVGEGASATVYKGSLPSGG---AVAVKRFEKPNRVECARNPFTTEFAT 335
           +K+  L      + G G   +V +G          VA+K   K    +        E   
Sbjct: 6   LKRDNLLIADIEL-GCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQI 63

Query: 336 MAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLG 395
           M   L +  +V+L G  C+   L+LV E    G L K L         +       ++  
Sbjct: 64  MHQ-LDNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQ 118

Query: 396 VASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGTMGYL 446
           V+  + YL    E+  +HRD+ A N+LL     AK+ DF         ++   A + G  
Sbjct: 119 VSMGMKYL---EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 175

Query: 447 -----APEYVYSGVPSEKTDVYSFGVVALEVAA-GKSP 478
                APE +     S ++DV+S+GV   E  + G+ P
Sbjct: 176 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 213

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  117 bits (294), Expect = 5e-29
 Identities = 70/311 (22%), Positives = 110/311 (35%), Gaps = 61/311 (19%)

Query: 290 RIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           R++ EG  A VY+   + SG   A+KR       E        E   M     H N+VQ 
Sbjct: 34  RVLAEGGFAFVYEAQDVGSGREYALKRLLSNE--EEKNRAIIQEVCFMKKLSGHPNIVQF 91

Query: 349 QGWCC-------EGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALS 401
                        G    L+   L  G L + L     S   LS +  L I      A+ 
Sbjct: 92  CSAASIGKEESDTGQAEFLLLTELCKGQLVEFL-KKMESRGPLSCDTVLKIFYQTCRAVQ 150

Query: 402 YLHEECERQIIHRDVKACNILLDAEFNAKLGDF-EATIPA-------------------- 440
           ++H   +  IIHRD+K  N+LL  +   KL DF  AT  +                    
Sbjct: 151 HMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEIT 209

Query: 441 --GTMGYLAPE--YVYSGVP-SEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRK 495
              T  Y  PE   +YS  P  EK D+++ G +   +   + P ++   + +        
Sbjct: 210 RNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI-------- 261

Query: 496 KGKLLDAADFRLRGKFNRKEMERM--LMVGL--SCVHPNHEKRPSVKEAARILKGEAPLP 551
                      + GK++    +    +   L  + +  N E+R S+ E    L+  A   
Sbjct: 262 -----------VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310

Query: 552 LLPVKKPTVNI 562
            +  K P   +
Sbjct: 311 NVNPKSPITEL 321

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  115 bits (291), Expect = 5e-29
 Identities = 59/311 (18%), Positives = 105/311 (33%), Gaps = 75/311 (24%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F +  ++G G    V+K      G    +KR +  N  E A      E   +A  L H N
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--EKAER----EVKALAK-LDHVN 65

Query: 345 LVQL----------------QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEK 388
           +V                       +   L +  E+   G+L++ +         L    
Sbjct: 66  IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK--LDKVL 123

Query: 389 RLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF----------EATI 438
            L +   +   + Y+H    +++I+RD+K  NI L      K+GDF          + T 
Sbjct: 124 ALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTR 180

Query: 439 PAGTMGYLAPEYVYSGVP-SEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKG 497
             GT+ Y++PE   S     ++ D+Y+ G++  E+                  +   + G
Sbjct: 181 SKGTLRYMSPE-QISSQDYGKEVDLYALGLILAELLHVCDTAFE-----TSKFFTDLRDG 234

Query: 498 KL-----LDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEAPLPL 552
            +                     ++++L           E RP+  E   IL+       
Sbjct: 235 IISDIFDKKEKTL----------LQKLL-------SKKPEDRPNTSE---ILR----TLT 270

Query: 553 LPVKKPTVNIR 563
           +  K P  N R
Sbjct: 271 VWKKSPEKNER 281

>1gzc_A Erythrina crista-galli lectin; carbohydrate, sugar binding protein, saccharide, protein-carbohydrate interactions, lactose, glycoprotein; HET: LAT; 1.58A {Erythrina crista-galli} SCOP: b.29.1.1 PDB: 1gz9_A* 1fyu_A* 1ax0_A* 1ax1_A* 1ax2_A* 1axy_A* 1axz_A* 1lte_A* 1sfy_A* 1v00_A* 1uzz_A 1uzy_A* 3n35_A* 3n36_A* 3n3h_A* Length = 239

 Score =  114 bits (286), Expect = 6e-29
 Identities = 51/184 (27%), Positives = 69/184 (37%), Gaps = 12/184 (6%)

Query: 1   FLDPKTNTTASFSCRFSFSII-PSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVL-S 58
             D  T T ASF  RFSFSI  P       DG  F +           GY+G+       
Sbjct: 59  MWDSTTGTVASFETRFSFSIEQPYTRPLPADGLVFFMGPTKSKPAQGYGYLGVFNNSKQD 118

Query: 59  PQDSFFAVEFDTSFDPSLGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEY 118
                 AVEFDT F          HIGID++S+ S  +         L +G+     I+Y
Sbjct: 119 NSYQTLAVEFDT-FSNPWDPPQVPHIGIDVNSIRSIKTQP-----FQLDNGQVANVVIKY 172

Query: 119 RDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGSAIYT---VDRW 175
               K++ V   Y         I   +D+ +   D++ VG S A G          V  W
Sbjct: 173 DAPSKILHVVLVYPS-SGAIYTIAEIVDVKQVLPDWVDVGLSGATGAQRDAAETHDVYSW 231

Query: 176 RFKT 179
            F+ 
Sbjct: 232 SFQA 235

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  116 bits (292), Expect = 8e-29
 Identities = 75/325 (23%), Positives = 126/325 (38%), Gaps = 72/325 (22%)

Query: 290 RIVGEGASATVYKGSLPSGG-----AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           +++G G   TV+KG     G      V +K   +      +    T     +   L H +
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI-EDKSGRQSFQAVTDHMLAIGS-LDHAH 76

Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           +V+L G  C G+ L LV +YLP GSL   +  +  +   L  +  LN  + +A  + YL 
Sbjct: 77  IVRLLG-LCPGSSLQLVTQYLPLGSLLDHVRQHRGA---LGPQLLLNWGVQIAKGMYYLE 132

Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF----------------EATIPAGTMGYLAP 448
           E     ++HR++ A N+LL +    ++ DF                EA  P   M   A 
Sbjct: 133 E---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM---AL 186

Query: 449 EYVYSGVPSEKTDVYSFGVVALEVAA-GKSP---VDNDGCVIVDWVWNLRKKGKLLDAAD 504
           E ++ G  + ++DV+S+GV   E+   G  P   +          V +L +KG       
Sbjct: 187 ESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE------VPDLLEKG------- 233

Query: 505 FRLRGKFNRKEMER---------MLMVGLSCVHPNHEKRPSVKEAARILKG--EAPLPLL 553
            R         + +         M+M  + C   +   RP+ KE A         P   L
Sbjct: 234 ER---------LAQPQICTIDVYMVM--VKCWMIDENIRPTFKELANEFTRMARDPPRYL 282

Query: 554 PVKKPTVNIRSVFPEASELIDSGGD 578
            +K+ +    +  PE   L +   +
Sbjct: 283 VIKRESGPGIAPGPEPHGLTNKKLE 307

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  115 bits (291), Expect = 1e-28
 Identities = 50/211 (23%), Positives = 92/211 (43%), Gaps = 34/211 (16%)

Query: 290 RIVGEGASATVYKGSLPSGG-----AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           +++G GA  TVYKG     G      VA+K   +      A      E   MA  + + +
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMAS-VDNPH 78

Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           + +L G  C  + + L+ + +P G L   +  +  +   +  +  LN  + +A  ++YL 
Sbjct: 79  VCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLE 134

Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF----------------EATIPAGTMGYLAP 448
           +   R+++HRD+ A N+L+    + K+ DF                   +P   M   A 
Sbjct: 135 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM---AL 188

Query: 449 EYVYSGVPSEKTDVYSFGVVALEVAA-GKSP 478
           E +   + + ++DV+S+GV   E+   G  P
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>1n47_A Isolectin B4; cancer antigen, vicia villosa lectin, glycoprotein TN-bindin protein, carbohydrate recognition, sugar binding protein; HET: NAG FUC TNR; 2.70A {Vicia villosa} SCOP: b.29.1.1 Length = 233

 Score =  113 bits (283), Expect = 1e-28
 Identities = 48/177 (27%), Positives = 69/177 (38%), Gaps = 12/177 (6%)

Query: 7   NTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGL-PGPVLSPQDSFFA 65
            T ASF+  FSF +      A  DG AF +           G++GL             A
Sbjct: 62  TTLASFTTSFSFVMAAPAAAAVADGLAFFLAPPDTQPQARGGFLGLFADRAHDASYQTVA 121

Query: 66  VEFDTSFDPSLGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRDSLKLI 125
           VEFDT  +    D N  HIGID + + S  +        D+  G      I Y+ S K +
Sbjct: 122 VEFDTYSNA--WDPNYTHIGIDTNGIESKKTTP-----FDMVYGEKANIVITYQASTKAL 174

Query: 126 RVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGSAIYT---VDRWRFKT 179
                +      S  + A++DL     +Y+ VGFSA  G  + +     +  W F  
Sbjct: 175 AASLVFPV-SQTSYAVSARVDLRDILPEYVRVGFSATTGLNAGVVETHDIVSWSFAV 230

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  115 bits (290), Expect = 1e-28
 Identities = 61/215 (28%), Positives = 95/215 (44%), Gaps = 30/215 (13%)

Query: 290 RIVGEGASATVYKGSLPSGGA---VAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLV 346
            ++GEG    V K  +   G     A+KR  K    +     F  E   +     H N++
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLGHHPNII 89

Query: 347 QLQGWCCEGNELVLVYEYLPNGSLDKILHNN------------SSSSIVLSWEKRLNIVL 394
            L G C     L L  EY P+G+L   L  +            +S++  LS ++ L+   
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149

Query: 395 GVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-----EATIPAGTMGYL--- 446
            VA  + YL    ++Q IHRD+ A NIL+   + AK+ DF     +      TMG L   
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR 206

Query: 447 --APEYVYSGVPSEKTDVYSFGVVALEVAA-GKSP 478
             A E +   V +  +DV+S+GV+  E+ + G +P
Sbjct: 207 WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  116 bits (292), Expect = 2e-28
 Identities = 55/208 (26%), Positives = 95/208 (45%), Gaps = 27/208 (12%)

Query: 290 RIVGEGASATVYKGSLPSGG----AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           ++VG G    V  G L        +VA+K   K    E  R  F  E + M     H N+
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTEKQRRDFLGEASIMGQ-FDHPNI 108

Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
           ++L+G   +   +++V EY+ NGSLD  L  + +     +  + + ++ G+AS + YL  
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIASGMKYLS- 164

Query: 406 ECERQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGTMGYL-----APEYV 451
             +   +HRD+ A NIL+++    K+ DF                  G +     +PE +
Sbjct: 165 --DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222

Query: 452 YSGVPSEKTDVYSFGVVALEVAA-GKSP 478
                +  +DV+S+G+V  EV + G+ P
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERP 250

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  113 bits (285), Expect = 8e-28
 Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 28/209 (13%)

Query: 290 RIVGEGASATVYKGSLPSGGA-----VAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           +++G G    VYKG L +        VA+K   K    E  R  F  E   M     H N
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVDFLGEAGIMGQ-FSHHN 107

Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           +++L+G   +   ++++ EY+ NG+LDK L          S  + + ++ G+A+ + YL 
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE---FSVLQLVGMLRGIAAGMKYLA 164

Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGTMGYL-----APEY 450
                  +HRD+ A NIL+++    K+ DF                + G +     APE 
Sbjct: 165 ---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 221

Query: 451 VYSGVPSEKTDVYSFGVVALEVAA-GKSP 478
           +     +  +DV+SFG+V  EV   G+ P
Sbjct: 222 ISYRKFTSASDVWSFGIVMWEVMTYGERP 250

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  115 bits (290), Expect = 9e-28
 Identities = 65/280 (23%), Positives = 105/280 (37%), Gaps = 59/280 (21%)

Query: 290 RIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQ 349
             +G+G    V+ G+      VA+K   KP  +      F  E   M   LRH+ LVQL 
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMS--PEAFLQEAQVMKK-LRHEKLVQLY 245

Query: 350 GWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECER 409
                   + +V EY+  GSL   L   +     L   + +++   +AS ++Y+      
Sbjct: 246 A-VVSEEPIYIVTEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVER---M 299

Query: 410 QIIHRDVKACNILLDAEFNAKLGDF---------------EATIPAGTMGYLAPEYVYSG 454
             +HRD++A NIL+      K+ DF                A  P   + + APE    G
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP---IKWTAPEAALYG 356

Query: 455 VPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNR 513
             + K+DV+SFG++  E+   G+ P               R+    ++   +R       
Sbjct: 357 RFTIKSDVWSFGILLTELTTKGRVPY---------PGMVNREVLDQVE-RGYR------- 399

Query: 514 KEMER---------MLMVGLSCVHPNHEKRPSVKEAARIL 544
             M            LM    C     E+RP+ +     L
Sbjct: 400 --MPCPPECPESLHDLM--CQCWRKEPEERPTFEYLQAFL 435

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  114 bits (286), Expect = 1e-27
 Identities = 66/280 (23%), Positives = 106/280 (37%), Gaps = 47/280 (16%)

Query: 290 RIVGEGASATVYKGSLPSGG----AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
            ++G G    VY G+L          AVK            + F TE   M     H N+
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKD-FSHPNV 152

Query: 346 VQLQGWCCEGNELVL-VYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           + L G C       L V  Y+ +G L   + N + +    + +  +   L VA  + +L 
Sbjct: 153 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN---PTVKDLIGFGLQVAKGMKFLA 209

Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF----------EATIPAGTMGYL-----APE 449
               ++ +HRD+ A N +LD +F  K+ DF            ++   T   L     A E
Sbjct: 210 S---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 266

Query: 450 YVYSGVPSEKTDVYSFGVVALEVAA-GKSP---VDNDGCVIVDWVWNLRKKGKLLDAADF 505
            + +   + K+DV+SFGV+  E+   G  P   V+         +     +G+ L   + 
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD------ITVYLLQGRRLLQPE- 319

Query: 506 RLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK 545
                    +    +M  L C HP  E RPS  E    + 
Sbjct: 320 ------YCPDPLYEVM--LKCWHPKAEMRPSFSELVSRIS 351

>1avb_A Arcelin-1; lectin-like glycoprotein, plant defense, insecticidal activi lectin; HET: NAG; 1.90A {Phaseolus vulgaris} SCOP: b.29.1.1 Length = 226

 Score =  110 bits (275), Expect = 1e-27
 Identities = 44/183 (24%), Positives = 62/183 (33%), Gaps = 17/183 (9%)

Query: 1   FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVL-SP 59
             D   +  ASFS  F+F I    +     G AF +            Y+GL        
Sbjct: 54  INDRTIDNLASFSTNFTFRINAKNIENSAYGLAFALVPVGSRPKLKGRYLGLFNTTNYDR 113

Query: 60  QDSFFAVEFDTSFDPSLGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYR 119
                AV FDT           N I ID++   S   +   S      +G      I Y 
Sbjct: 114 DAHTVAVVFDT---------VSNRIEIDVN---SIRPIATESCNFGHNNGEKAEVRITYD 161

Query: 120 DSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGSAIYT---VDRWR 176
                +RV   Y         + A + L K+ +D++ VGFSA +G          V  W 
Sbjct: 162 SPKNDLRVSLLYPS-SEEKCHVSATVPLEKEVEDWVSVGFSATSGSKKETTETHNVLSWS 220

Query: 177 FKT 179
           F +
Sbjct: 221 FSS 223

>1f9k_A Acidic lectin; legume lectin, glycosylated protein, H-antigenic specificity agglutinin, sugar binding protein; HET: NAG MAN AMG; 3.00A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 1fay_A* Length = 238

 Score =  109 bits (273), Expect = 3e-27
 Identities = 51/185 (27%), Positives = 79/185 (42%), Gaps = 16/185 (8%)

Query: 1   FLDPKTNTTASFSCRFSFSII-PSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSP 59
             D  T   ASF  RFSF+I  P       DG  F +       G D G +G+  P    
Sbjct: 58  IWDSTTGNVASFETRFSFNITQPYAYPEPADGLTFFMVPPNSPQGEDGGNLGVFKP--PE 115

Query: 60  QDSFFAVEFDTSFDPSLGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYR 119
            D+ FAVEFDT  +    D    HIGID++S++S  ++        L++G      I+Y 
Sbjct: 116 GDNAFAVEFDTFQNT--WDPQVPHIGIDVNSIVSSKTLH-----FQLENGGVANVVIKYD 168

Query: 120 DSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQF--KDYMHVGFSAANGQGSAIY---TVDR 174
              K++ V   +         +   +DL ++F   ++++VG SA  G          +  
Sbjct: 169 SPTKILNVVLAFHS-VGTVYTLSNIVDLKQEFPNSEWVNVGLSATTGYQKNAVETHEIIS 227

Query: 175 WRFKT 179
           W F +
Sbjct: 228 WSFTS 232

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  110 bits (277), Expect = 3e-27
 Identities = 60/202 (29%), Positives = 86/202 (42%), Gaps = 23/202 (11%)

Query: 290 RIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQ 349
           + +G G    V+ G   +   VA+K   +   +      F  E   M   L H  LVQL 
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMS--EEDFIEEAEVM-MKLSHPKLVQLY 69

Query: 350 GWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECER 409
           G C E   + LV E++ +G L   L          + E  L + L V   ++YL    E 
Sbjct: 70  GVCLEQAPICLVTEFMEHGCLSDYLRTQRGL---FAAETLLGMCLDVCEGMAYL---EEA 123

Query: 410 QIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGTM---GYLAPEYVYSGVPS 457
            +IHRD+ A N L+      K+ DF         + T   GT     + +PE       S
Sbjct: 124 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 183

Query: 458 EKTDVYSFGVVALEVAA-GKSP 478
            K+DV+SFGV+  EV + GK P
Sbjct: 184 SKSDVWSFGVLMWEVFSEGKIP 205

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  114 bits (287), Expect = 3e-27
 Identities = 59/206 (28%), Positives = 90/206 (43%), Gaps = 29/206 (14%)

Query: 290 RIVGEGASATVYKGSL-PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
             +G G    VY+G        VAVK   K + +E     F  E A M   ++H NLVQL
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTME--VEEFLKEAAVMKE-IKHPNLVQL 281

Query: 349 QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE 408
            G C       ++ E++  G+L   L   +     +S    L +   ++SA+ YL    +
Sbjct: 282 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAMEYLE---K 336

Query: 409 RQIIHRDVKACNILLDAEFNAKLGDF---------------EATIPAGTMGYLAPEYVYS 453
           +  IHR++ A N L+      K+ DF                A  P   + + APE +  
Sbjct: 337 KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP---IKWTAPESLAY 393

Query: 454 GVPSEKTDVYSFGVVALEVAA-GKSP 478
              S K+DV++FGV+  E+A  G SP
Sbjct: 394 NKFSIKSDVWAFGVLLWEIATYGMSP 419

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  110 bits (278), Expect = 3e-27
 Identities = 68/283 (24%), Positives = 106/283 (37%), Gaps = 53/283 (18%)

Query: 290 RIVGEGASATVYKGSLPSGG----AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
            ++G G    VY G+L          AVK            + F TE   M     H N+
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKD-FSHPNV 88

Query: 346 VQLQGWCCEGNELVL-VYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           + L G C       L V  Y+ +G L   + N + +    + +  +   L VA  + YL 
Sbjct: 89  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN---PTVKDLIGFGLQVAKGMKYLA 145

Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF------------------EATIPAGTMGYL 446
               ++ +HRD+ A N +LD +F  K+ DF                   A +P   M   
Sbjct: 146 S---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM--- 199

Query: 447 APEYVYSGVPSEKTDVYSFGVVALEVAA-GKSP---VDNDGCVIVDWVWNLRKKGKLLDA 502
           A E + +   + K+DV+SFGV+  E+   G  P   V+         +     +G+ L  
Sbjct: 200 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD------ITVYLLQGRRLLQ 253

Query: 503 ADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK 545
            +          +    +M  L C HP  E RPS  E    + 
Sbjct: 254 PE-------YCPDPLYEVM--LKCWHPKAEMRPSFSELVSRIS 287

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  110 bits (278), Expect = 3e-27
 Identities = 60/209 (28%), Positives = 90/209 (43%), Gaps = 27/209 (12%)

Query: 288 KNRIVGEGASATVYKGSLPSGGA---VAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           +++ +G G   TV KG          VAVK  +        ++    E   M   L +  
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ-LDNPY 79

Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           +V++ G  CE    +LV E    G L+K L  N      +  +  + +V  V+  + YL 
Sbjct: 80  IVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYL- 133

Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGTMGYL-----APEY 450
            E E   +HRD+ A N+LL  +  AK+ DF         E    A T G       APE 
Sbjct: 134 -E-ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 191

Query: 451 VYSGVPSEKTDVYSFGVVALEVAA-GKSP 478
           +     S K+DV+SFGV+  E  + G+ P
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  110 bits (278), Expect = 3e-27
 Identities = 52/215 (24%), Positives = 90/215 (41%), Gaps = 28/215 (13%)

Query: 290 RIVGEGASATVYKGS-LPSGGAVAVKRFEKPNRVECARNP-FTTEF---ATMAGCLRHKN 344
             +G G  +TVY          VA+K       +           F      +  L H+N
Sbjct: 17  DKLGGGGMSTVYLAEDTILNIKVAIKAI----FIPPREKEETLKRFEREVHNSSQLSHQN 72

Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           +V +     E +   LV EY+   +L + + ++      LS +  +N    +   + + H
Sbjct: 73  IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP----LSVDTAINFTNQILDGIKHAH 128

Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF-------EATIPA-----GTMGYLAPEYVY 452
           +    +I+HRD+K  NIL+D+    K+ DF       E ++       GT+ Y +PE   
Sbjct: 129 D---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAK 185

Query: 453 SGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIV 487
                E TD+YS G+V  E+  G+ P + +  V +
Sbjct: 186 GEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI 220

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  114 bits (288), Expect = 3e-27
 Identities = 55/205 (26%), Positives = 86/205 (41%), Gaps = 29/205 (14%)

Query: 290 RIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQ 349
             +G+G    V+ G+      VA+K   KP  +      F  E   M   LRH+ LVQL 
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMS--PEAFLQEAQVMKK-LRHEKLVQLY 328

Query: 350 GWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECER 409
                   + +V EY+  GSL   L   +     L   + +++   +AS ++Y+      
Sbjct: 329 A-VVSEEPIYIVTEYMSKGSLLDFLKGETGKY--LRLPQLVDMAAQIASGMAYVER---M 382

Query: 410 QIIHRDVKACNILLDAEFNAKLGDF---------------EATIPAGTMGYLAPEYVYSG 454
             +HRD++A NIL+      K+ DF                A  P       APE    G
Sbjct: 383 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT---APEAALYG 439

Query: 455 VPSEKTDVYSFGVVALEVAA-GKSP 478
             + K+DV+SFG++  E+   G+ P
Sbjct: 440 RFTIKSDVWSFGILLTELTTKGRVP 464

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  115 bits (288), Expect = 4e-27
 Identities = 53/218 (24%), Positives = 86/218 (39%), Gaps = 28/218 (12%)

Query: 279 IKQATLGFNKNRIVGEGASATVYKGSLPSGGA---VAVKRFEKPNRVECARNPFTTEFAT 335
           +K+  L      + G G   +V +G          VA+K   K    +        E   
Sbjct: 332 LKRDNLLIADIEL-GCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQI 389

Query: 336 MAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLG 395
           M   L +  +V+L G  C+   L+LV E    G L K L         +       ++  
Sbjct: 390 MHQ-LDNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQ 444

Query: 396 VASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGTMGYL 446
           V+  + YL    E+  +HR++ A N+LL     AK+ DF         ++   A + G  
Sbjct: 445 VSMGMKYL---EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 501

Query: 447 -----APEYVYSGVPSEKTDVYSFGVVALEVAA-GKSP 478
                APE +     S ++DV+S+GV   E  + G+ P
Sbjct: 502 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  111 bits (279), Expect = 4e-27
 Identities = 60/203 (29%), Positives = 86/203 (42%), Gaps = 20/203 (9%)

Query: 292 VGEGASATVYKGS-LPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQG 350
           +G GA  +V K    PSG  +AVKR  +    E  +     +   +        +VQ  G
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRI-RSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88

Query: 351 WCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRL-NIVLGVASALSYLHEECER 409
                 +  +  E + + S DK      S    +  E+ L  I L    AL++L E    
Sbjct: 89  ALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--L 145

Query: 410 QIIHRDVKACNILLDAEFNAKLGDF----------EATIPAGTMGYLAPEYVYSGVP--- 456
           +IIHRD+K  NILLD   N KL DF            T  AG   Y+APE +        
Sbjct: 146 KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQG 205

Query: 457 -SEKTDVYSFGVVALEVAAGKSP 478
              ++DV+S G+   E+A G+ P
Sbjct: 206 YDVRSDVWSLGITLYELATGRFP 228

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  110 bits (276), Expect = 5e-27
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 29/208 (13%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKR--FEKPNRVECARNPFTTEFATMAGCLRH 342
           + +   +G+GAS TVY    + +G  VA+++   ++  + E   N    E   M    ++
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN----EILVMREN-KN 76

Query: 343 KNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVL-GVASALS 401
            N+V        G+EL +V EYL  GSL  ++            E ++  V      AL 
Sbjct: 77  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD------EGQIAAVCRECLQALE 130

Query: 402 YLHEECERQIIHRDVKACNILLDAEFNAKLGDF------EATIP-----AGTMGYLAPEY 450
           +LH     Q+IHRD+K+ NILL  + + KL DF                 GT  ++APE 
Sbjct: 131 FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 187

Query: 451 VYSGVPSEKTDVYSFGVVALEVAAGKSP 478
           V       K D++S G++A+E+  G+ P
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  109 bits (275), Expect = 6e-27
 Identities = 57/206 (27%), Positives = 88/206 (42%), Gaps = 26/206 (12%)

Query: 290 RIVGEGASATVYKGSLPSGG----AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           R +GEG    V++G   S      AVA+K   K    +  R  F  E  TM     H ++
Sbjct: 21  RCIGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFLQEALTMRQ-FDHPHI 78

Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
           V+L G     N + ++ E    G L   L     S   L     +     +++AL+YL  
Sbjct: 79  VKLIG-VITENPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYLES 134

Query: 406 ECERQIIHRDVKACNILLDAEFNAKLGDF-------EATIPAGTMGYL-----APEYVYS 453
              ++ +HRD+ A N+L+ +    KLGDF       ++T    + G L     APE +  
Sbjct: 135 ---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 191

Query: 454 GVPSEKTDVYSFGVVALEVAA-GKSP 478
              +  +DV+ FGV   E+   G  P
Sbjct: 192 RRFTSASDVWMFGVCMWEILMHGVKP 217

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  114 bits (286), Expect = 9e-27
 Identities = 57/206 (27%), Positives = 88/206 (42%), Gaps = 26/206 (12%)

Query: 290 RIVGEGASATVYKGSLPSGG----AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           R +GEG    V++G   S      AVA+K   K    +  R  F  E  TM     H ++
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTC-KNCTSDSVREKFLQEALTMRQ-FDHPHI 453

Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
           V+L G     N + ++ E    G L   L     S   L     +     +++AL+YL  
Sbjct: 454 VKLIG-VITENPVWIIMELCTLGELRSFLQVRKFS---LDLASLILYAYQLSTALAYLES 509

Query: 406 ECERQIIHRDVKACNILLDAEFNAKLGDF-------EATIPAGTMGYL-----APEYVYS 453
              ++ +HRD+ A N+L+ +    KLGDF       ++T    + G L     APE +  
Sbjct: 510 ---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 566

Query: 454 GVPSEKTDVYSFGVVALEVAA-GKSP 478
              +  +DV+ FGV   E+   G  P
Sbjct: 567 RRFTSASDVWMFGVCMWEILMHGVKP 592

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  109 bits (275), Expect = 9e-27
 Identities = 60/204 (29%), Positives = 91/204 (44%), Gaps = 29/204 (14%)

Query: 290 RIVGEGASATVYKGSLPSGG-----AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           R +GEG    V        G      VAVK   KP            E   +   L H+N
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIADLKKEIEILRN-LYHEN 84

Query: 345 LVQLQGWCCE--GNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
           +V+ +G C E  GN + L+ E+LP+GSL + L  N +    ++ +++L   + +   + Y
Sbjct: 85  IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAVQICKGMDY 141

Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT--IPAGTMGY------------LAP 448
           L     RQ +HRD+ A N+L+++E   K+GDF  T  I      Y             AP
Sbjct: 142 LGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAP 198

Query: 449 EYVYSGVPSEKTDVYSFGVVALEV 472
           E +        +DV+SFGV   E+
Sbjct: 199 ECLMQSKFYIASDVWSFGVTLHEL 222

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  108 bits (272), Expect = 1e-26
 Identities = 58/202 (28%), Positives = 87/202 (43%), Gaps = 23/202 (11%)

Query: 290 RIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQ 349
           + +G G    V  G       VAVK   K   +    + F  E  TM   L H  LV+  
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMS--EDEFFQEAQTM-MKLSHPKLVKFY 69

Query: 350 GWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECER 409
           G C +   + +V EY+ NG L   L ++      L   + L +   V   +++L      
Sbjct: 70  GVCSKEYPIYIVTEYISNGCLLNYLRSHGKG---LEPSQLLEMCYDVCEGMAFLE---SH 123

Query: 410 QIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGTM---GYLAPEYVYSGVPS 457
           Q IHRD+ A N L+D +   K+ DF         +     GT     + APE  +    S
Sbjct: 124 QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYS 183

Query: 458 EKTDVYSFGVVALEVAA-GKSP 478
            K+DV++FG++  EV + GK P
Sbjct: 184 SKSDVWAFGILMWEVFSLGKMP 205

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  110 bits (276), Expect = 1e-26
 Identities = 55/201 (27%), Positives = 90/201 (44%), Gaps = 26/201 (12%)

Query: 292 VGEGASATVYKGSL-PSGGAVAVKRFEKPNRVECARNPFT---TEFATMAGCLRHKNLVQ 347
           +G G    V+K S  PSG  +A K       +E           E   +  C     +V 
Sbjct: 41  LGAGNGGVVFKVSHKPSGLVMARKLI----HLEIKPAIRNQIIRELQVLHEC-NSPYIVG 95

Query: 348 LQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRL-NIVLGVASALSYLHEE 406
             G      E+ +  E++  GSLD++L            E+ L  + + V   L+YL E+
Sbjct: 96  FYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP-----EQILGKVSIAVIKGLTYLREK 150

Query: 407 CERQIIHRDVKACNILLDAEFNAKLGDF------EATIP---AGTMGYLAPEYVYSGVPS 457
              +I+HRDVK  NIL+++    KL DF        ++     GT  Y++PE +     S
Sbjct: 151 --HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYS 208

Query: 458 EKTDVYSFGVVALEVAAGKSP 478
            ++D++S G+  +E+A G+ P
Sbjct: 209 VQSDIWSMGLSLVEMAVGRYP 229

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  110 bits (277), Expect = 2e-26
 Identities = 63/368 (17%), Positives = 109/368 (29%), Gaps = 72/368 (19%)

Query: 286 FNKNRIVGEGAS--ATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRH 342
           +    ++G+G     TV      P+G  V V+R                E         H
Sbjct: 27  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF-NH 85

Query: 343 KNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVL-GVASALS 401
            N+V  +      NEL +V  ++  GS   ++  +    +    E  +  +L GV  AL 
Sbjct: 86  PNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMN---ELAIAYILQGVLKALD 142

Query: 402 YLHEECERQIIHRDVKACNILLDAEFNAKLGDF------------------EATIPAGTM 443
           Y+H       +HR VKA +IL+  +    L                             +
Sbjct: 143 YIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199

Query: 444 GYLAPEYVYSGVP--SEKTDVYSFGVVALEVAAGKSP-------------VDNDGCVIVD 488
            +L+PE +   +     K+D+YS G+ A E+A G  P             ++     ++D
Sbjct: 200 PWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259

Query: 489 WVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGL--------------------SCVH 528
                 ++  +  +      G  +                                 C+ 
Sbjct: 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQ 319

Query: 529 PNHEKRPSVKE--------AARILKGEAPLPLLPVKKPTVNIRSVFPEASELIDSGGDHS 580
            N + RPS             +    EA   LL    P  N      +    I     + 
Sbjct: 320 RNPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFEGSQSQDHSGIFGLVTNL 379

Query: 581 PGFDDSLW 588
              +   W
Sbjct: 380 EELEVDDW 387

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  109 bits (274), Expect = 2e-26
 Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 29/208 (13%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKR--FEKPNRVECARNPFTTEFATMAGCLRH 342
            +    +GEG++  V       SG  VAVK     K  R E   N    E   M    +H
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFN----EVVIMRDY-QH 101

Query: 343 KNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVL-GVASALS 401
            N+V++      G EL ++ E+L  G+L  I+     +      E+++  V   V  AL+
Sbjct: 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLN------EEQIATVCEAVLQALA 155

Query: 402 YLHEECERQIIHRDVKACNILLDAEFNAKLGDF------EATIP-----AGTMGYLAPEY 450
           YLH +    +IHRD+K+ +ILL  +   KL DF         +P      GT  ++APE 
Sbjct: 156 YLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEV 212

Query: 451 VYSGVPSEKTDVYSFGVVALEVAAGKSP 478
           +   + + + D++S G++ +E+  G+ P
Sbjct: 213 ISRSLYATEVDIWSLGIMVIEMVDGEPP 240

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  111 bits (279), Expect = 2e-26
 Identities = 56/279 (20%), Positives = 96/279 (34%), Gaps = 47/279 (16%)

Query: 286 FNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           F    ++G GA  T+    +     VAVKR         A      E   +     H N+
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP-ECFSFADR----EVQLLRESDEHPNV 80

Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
           ++      +     +  E     +L + +     +       + + ++    S L++LH 
Sbjct: 81  IRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFA---HLGLEPITLLQQTTSGLAHLH- 135

Query: 406 ECERQIIHRDVKACNILL-----DAEFNAKLGDF--------------EATIPAGTMGYL 446
                I+HRD+K  NIL+       +  A + DF                +   GT G++
Sbjct: 136 --SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193

Query: 447 APEYV---YSGVPSEKTDVYSFGVVALEV-AAGKSPVDNDGCVIVDWVWNLRKKGKLLDA 502
           APE +       P+   D++S G V   V + G  P             N+      LD 
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA----NILLGACSLDC 249

Query: 503 ADFRLRGKFNRKEM-ERMLMVGLSCVHPNHEKRPSVKEA 540
                      +E+ E+M+         + +KRPS K  
Sbjct: 250 LHPEKHEDVIARELIEKMI-------AMDPQKRPSAKHV 281

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  111 bits (280), Expect = 2e-26
 Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 23/202 (11%)

Query: 290 RIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQ 349
           + +G G    V+  +      VAVK   KP  +      F  E   M   L+H  LV+L 
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMS--VEAFLAEANVM-KTLQHDKLVKLH 249

Query: 350 GWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECER 409
                   + ++ E++  GSL   L ++  S       K ++    +A  ++++ +   R
Sbjct: 250 A-VVTKEPIYIITEFMAKGSLLDFLKSDEGSK--QPLPKLIDFSAQIAEGMAFIEQ---R 303

Query: 410 QIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGTMG---YLAPEYVYSGVPS 457
             IHRD++A NIL+ A    K+ DF         E T   G      + APE +  G  +
Sbjct: 304 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 363

Query: 458 EKTDVYSFGVVALEVAA-GKSP 478
            K+DV+SFG++ +E+   G+ P
Sbjct: 364 IKSDVWSFGILLMEIVTYGRIP 385

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  111 bits (280), Expect = 2e-26
 Identities = 61/199 (30%), Positives = 90/199 (45%), Gaps = 21/199 (10%)

Query: 290 RIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQ 349
           + +G+G    V  G    G  VAVK   K +        F  E + M   LRH NLVQL 
Sbjct: 199 QTIGKGEFGDVMLGDY-RGNKVAVKCI-KND---ATAQAFLAEASVMTQ-LRHSNLVQLL 252

Query: 350 GWCCEGNELV-LVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE 408
           G   E    + +V EY+  GSL   L +   S   L  +  L   L V  A+ YL     
Sbjct: 253 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYLEG--- 307

Query: 409 RQIIHRDVKACNILLDAEFNAKLGDF-----EATIPAGT---MGYLAPEYVYSGVPSEKT 460
              +HRD+ A N+L+  +  AK+ DF      ++        + + APE +     S K+
Sbjct: 308 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKS 367

Query: 461 DVYSFGVVALEVAA-GKSP 478
           DV+SFG++  E+ + G+ P
Sbjct: 368 DVWSFGILLWEIYSFGRVP 386

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  108 bits (272), Expect = 2e-26
 Identities = 74/320 (23%), Positives = 113/320 (35%), Gaps = 72/320 (22%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F +  ++G+GA   V K  +       A+K+       E   +   +E   +A  L H+ 
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLAS-LNHQY 63

Query: 345 LVQLQG-WCCEGNE------------LVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRL 390
           +V+    W    N             L +  EY  NG+L D I   N +      W    
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW---- 119

Query: 391 NIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF---------------- 434
            +   +  ALSY+H    + IIHRD+K  NI +D   N K+GDF                
Sbjct: 120 RLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176

Query: 435 ---------EATIPAGTMGYLAPEYVYSGVPS--EKTDVYSFGVVALEVAAGKSPVDNDG 483
                      T   GT  Y+A E V  G     EK D+YS G++  E+    S      
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERV 235

Query: 484 CVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARI 543
            ++      LR             + K  +K +  ++         +  KRP  +    +
Sbjct: 236 NILK----KLRSVSIEFPPDFDDNKMKVEKKIIRLLIDH-------DPNKRPGART---L 281

Query: 544 LKGEAPLPLLPVKKPTVNIR 563
           L        LPVK     I+
Sbjct: 282 LN----SGWLPVKHQDEVIK 297

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  108 bits (271), Expect = 3e-26
 Identities = 61/297 (20%), Positives = 101/297 (34%), Gaps = 61/297 (20%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F   + +G G    V++  +       A+KR   PNR E AR     E   +A  L H  
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR-ELAREKVMREVKALA-KLEHPG 64

Query: 345 LVQLQGWCCEGNE------------LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNI 392
           +V+      E N             L +  +     +L   ++   +          L+I
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEE-RERSVCLHI 123

Query: 393 VLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF------------------ 434
            L +A A+ +LH    + ++HRD+K  NI    +   K+GDF                  
Sbjct: 124 FLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180

Query: 435 -----EATIPAGTMGYLAPEYVYSGVP-SEKTDVYSFGVVALEVAAGKSPVDNDGCVIVD 488
                  T   GT  Y++PE    G   S K D++S G++  E+    S           
Sbjct: 181 MPAYARHTGQVGTKLYMSPE-QIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVR---- 235

Query: 489 WVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK 545
                 +  K      F  +       ++ ML        P+  +RP       I++
Sbjct: 236 -TLTDVRNLKF--PPLFTQKYPCEYVMVQDML-------SPSPMERPEAIN---IIE 279

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  108 bits (271), Expect = 3e-26
 Identities = 57/209 (27%), Positives = 91/209 (43%), Gaps = 30/209 (14%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTT---EFATMAGCLR 341
           F K   +G+G+   V+KG    +   VA+K  +    +E A +       E   ++ C  
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID----LEEAEDEIEDIQQEITVLSQC-D 78

Query: 342 HKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVL-GVASAL 400
              + +  G   +  +L ++ EYL  GS   +L            E ++  +L  +   L
Sbjct: 79  SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLD------ETQIATILREILKGL 132

Query: 401 SYLHEECERQIIHRDVKACNILLDAEFNAKLGDF------EATIP-----AGTMGYLAPE 449
            YLH E   + IHRD+KA N+LL      KL DF        T        GT  ++APE
Sbjct: 133 DYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE 189

Query: 450 YVYSGVPSEKTDVYSFGVVALEVAAGKSP 478
            +       K D++S G+ A+E+A G+ P
Sbjct: 190 VIKQSAYDSKADIWSLGITAIELARGEPP 218

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  107 bits (270), Expect = 4e-26
 Identities = 58/280 (20%), Positives = 102/280 (36%), Gaps = 47/280 (16%)

Query: 290 RIVGEGASATVYKGSLPSGG----AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           R++G+G    VY G            A+K              F  E   M G L H N+
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL-SRITEMQQVEAFLREGLLMRG-LNHPNV 84

Query: 346 VQLQGWCCEGNELVL-VYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           + L G       L   +  Y+ +G L + + +   +    + +  ++  L VA  + YL 
Sbjct: 85  LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN---PTVKDLISFGLQVARGMEYLA 141

Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGTMGYL------APE 449
           E   ++ +HRD+ A N +LD  F  K+ DF         E                 A E
Sbjct: 142 E---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALE 198

Query: 450 YVYSGVPSEKTDVYSFGVVALEVAA-GKSP---VDNDGCVIVDWVWNLRKKGKLLDAADF 505
            + +   + K+DV+SFGV+  E+   G  P   +D         + +   +G+ L   + 
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD------LTHFLAQGRRLPQPE- 251

Query: 506 RLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK 545
                    +    +M    C   +   RP+ +     ++
Sbjct: 252 ------YCPDSLYQVM--QQCWEADPAVRPTFRVLVGEVE 283

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  107 bits (269), Expect = 4e-26
 Identities = 56/206 (27%), Positives = 87/206 (42%), Gaps = 26/206 (12%)

Query: 290 RIVGEGASATVYKGSLPSGGA----VAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           RI+GEG    VY+G   +       VAVK   K +     +  F +E   M   L H ++
Sbjct: 18  RILGEGFFGEVYEGVYTNHKGEKINVAVKTC-KKDCTLDNKEKFMSEAVIMKN-LDHPHI 75

Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
           V+L G   E     ++ E  P G L   L  N +S   L     +   L +  A++YL  
Sbjct: 76  VKLIG-IIEEEPTWIIMELYPYGELGHYLERNKNS---LKVLTLVLYSLQICKAMAYLES 131

Query: 406 ECERQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGTM---GYLAPEYVYS 453
                 +HRD+   NIL+ +    KLGDF         +    + T     +++PE +  
Sbjct: 132 ---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF 188

Query: 454 GVPSEKTDVYSFGVVALEVAA-GKSP 478
              +  +DV+ F V   E+ + GK P
Sbjct: 189 RRFTTASDVWMFAVCMWEILSFGKQP 214

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  108 bits (271), Expect = 4e-26
 Identities = 72/286 (25%), Positives = 114/286 (39%), Gaps = 49/286 (17%)

Query: 289 NRIVGEGASATVYKGSLPSGG------AVAVKRFEKPNRVECARNPFTTEFATMAGCLRH 342
           +R +G+G+   VY+G             VA+K           R  F  E + M      
Sbjct: 30  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-NEAASMRERIEFLNEASVMKE-FNC 87

Query: 343 KNLVQLQGWCCEGNELVLVYEYLPNGSLDKIL------HNNSSSSIVLSWEKRLNIVLGV 396
            ++V+L G   +G   +++ E +  G L   L        N+      S  K + +   +
Sbjct: 88  HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 147

Query: 397 ASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYL-- 446
           A  ++YL+     + +HRD+ A N ++  +F  K+GDF              G  G L  
Sbjct: 148 ADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 204

Query: 447 ---APEYVYSGVPSEKTDVYSFGVVALEVAA-GKSP---VDNDGCVIVDWVWNLRKKGKL 499
              +PE +  GV +  +DV+SFGVV  E+A   + P   + N+       V     +G L
Sbjct: 205 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ------VLRFVMEGGL 258

Query: 500 LDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK 545
           LD  D       N  +M   LM    C   N + RPS  E    +K
Sbjct: 259 LDKPD-------NCPDMLFELM--RMCWQYNPKMRPSFLEIISSIK 295

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  106 bits (268), Expect = 5e-26
 Identities = 55/202 (27%), Positives = 87/202 (43%), Gaps = 23/202 (11%)

Query: 290 RIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQ 349
           + +G G    V  G       VA+K   K   +    + F  E   M   L H+ LVQL 
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMS--EDEFIEEAKVM-MNLSHEKLVQLY 85

Query: 350 GWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECER 409
           G C +   + ++ EY+ NG L   L            ++ L +   V  A+ YL     +
Sbjct: 86  GVCTKQRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLE---SK 139

Query: 410 QIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGTM---GYLAPEYVYSGVPS 457
           Q +HRD+ A N L++ +   K+ DF         E T   G+     +  PE +     S
Sbjct: 140 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 199

Query: 458 EKTDVYSFGVVALEVAA-GKSP 478
            K+D+++FGV+  E+ + GK P
Sbjct: 200 SKSDIWAFGVLMWEIYSLGKMP 221

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  107 bits (270), Expect = 5e-26
 Identities = 52/211 (24%), Positives = 80/211 (37%), Gaps = 30/211 (14%)

Query: 290 RIVGEGASATVYKGSLPSGG-AVAVKRFEKPNRVECARNP-----FTTEFATMAGCLRHK 343
           R+VG G    VY+         VA+K          + +P        E A  AG L+  
Sbjct: 40  RLVGRGGMGDVYEAEDTVRERIVALKLM----SETLSSDPVFRTRMQRE-ARTAGRLQEP 94

Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
           ++V +  +     +L +    +    L  +L         L+  + + IV  + SAL   
Sbjct: 95  HVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP----LAPPRAVAIVRQIGSALDAA 150

Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF-------EATIPA-----GTMGYLAPEYV 451
           H        HRDVK  NIL+ A+  A L DF       +  +       GT+ Y+APE  
Sbjct: 151 HA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERF 207

Query: 452 YSGVPSEKTDVYSFGVVALEVAAGKSPVDND 482
                + + D+Y+   V  E   G  P   D
Sbjct: 208 SESHATYRADIYALTCVLYECLTGSPPYQGD 238

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  107 bits (269), Expect = 5e-26
 Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 33/218 (15%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKR--FEKPN-RVECARNPFTTEFATMAGCLR 341
           +    ++G GA+A V      P    VA+KR   EK    ++        E   M+ C  
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLK----EIQAMSQC-H 71

Query: 342 HKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSW---EKRLNIVL-GVA 397
           H N+V         +EL LV + L  GS+  I+ +  +     S    E  +  +L  V 
Sbjct: 72  HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131

Query: 398 SALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--EATIPA--------------G 441
             L YLH+      IHRDVKA NILL  + + ++ DF   A +                G
Sbjct: 132 EGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188

Query: 442 TMGYLAPEYVYSGVP-SEKTDVYSFGVVALEVAAGKSP 478
           T  ++APE +        K D++SFG+ A+E+A G +P
Sbjct: 189 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  106 bits (268), Expect = 5e-26
 Identities = 55/211 (26%), Positives = 87/211 (41%), Gaps = 27/211 (12%)

Query: 292 VGEGASATVYKGS-LPSGGAVAVKRFEKPNRVECARNPFT---TEFATMAGCLRHKNLVQ 347
           +G GA   V K   +PSG  +AVKR     R             +       +     V 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRI----RATVNSQEQKRLLMDLDISMRTVDCPFTVT 70

Query: 348 LQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRL-NIVLGVASALSYLHEE 406
             G      ++ +  E + + SLDK           +  E  L  I + +  AL +LH +
Sbjct: 71  FYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIP-EDILGKIAVSIVKALEHLHSK 128

Query: 407 CERQIIHRDVKACNILLDAEFNAKLGDF------EATIP----AGTMGYLAPEYVYSGVP 456
               +IHRDVK  N+L++A    K+ DF         +     AG   Y+APE +   + 
Sbjct: 129 --LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELN 186

Query: 457 ----SEKTDVYSFGVVALEVAAGKSPVDNDG 483
               S K+D++S G+  +E+A  + P D+ G
Sbjct: 187 QKGYSVKSDIWSLGITMIELAILRFPYDSWG 217

>1qnw_A Chitin binding lectin, UEA-II; carbohydrate binding; HET: NAG; 2.35A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1dzq_A* 1qoo_A* 1qos_A* 1qot_A* Length = 242

 Score =  106 bits (264), Expect = 6e-26
 Identities = 52/186 (27%), Positives = 74/186 (39%), Gaps = 14/186 (7%)

Query: 1   FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNG--YMGL-PGPVL 57
             D  T   ASF+  FSF +         DG AF +        + +     GL      
Sbjct: 58  IWDSITGKVASFATSFSFVVKADK-SDGVDGLAFFLAPANSQIPSGSSAGMFGLFSSSDS 116

Query: 58  SPQDSFFAVEFDTSFDPSL--GDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTW 115
              +   AVEFDT F  +    D +  HIGID++S+ S  +V       D ++G      
Sbjct: 117 KSSNQIIAVEFDTYFGKAYNPWDPDFKHIGIDVNSIKSIKTVK-----WDWRNGEVADVV 171

Query: 116 IEYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGSAIYT--VD 173
           I YR   K + V   Y      S +I A +DL     +++ VGFS   G  +   T  V 
Sbjct: 172 ITYRAPTKSLTVCLSYPS-DGTSNIITASVDLKAILPEWVSVGFSGGVGNAAEFETHDVL 230

Query: 174 RWRFKT 179
            W F +
Sbjct: 231 SWYFTS 236

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  107 bits (270), Expect = 6e-26
 Identities = 73/297 (24%), Positives = 118/297 (39%), Gaps = 53/297 (17%)

Query: 290 RIVGEGASATVYKGSL-----PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           R +GEG    V           +G  VAVK   K +     R+ +  E   +   L H++
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL-KADAGPQHRSGWKQEIDILRT-LYHEH 94

Query: 345 LVQLQGWCCEGNE--LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
           +++ +G C +     L LV EY+P GSL   L  +S     +   + L     +   ++Y
Sbjct: 95  IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-----IGLAQLLLFAQQICEGMAY 149

Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT--IPAGTMGY------------LAP 448
           LH    +  IHRD+ A N+LLD +   K+GDF     +P G   Y             AP
Sbjct: 150 LHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAP 206

Query: 449 EYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLR 508
           E +        +DV+SFGV   E+        +     ++ +   + +  +L   +   R
Sbjct: 207 ECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLER 266

Query: 509 GKFNRKEMER---------MLMVGLSCVHPNHEKRPSVKEAARIL-------KGEAP 549
           G+  R  + R          LM   +C       RP+ +    IL       +G+AP
Sbjct: 267 GE--R--LPRPDKCPAEVYHLM--KNCWETEASFRPTFENLIPILKTVHEKYQGQAP 317

>1ioa_A Arcelin-5A, ARC5A; lectin-like proteins, plant defense proteins, lectin; HET: NAG FUC; 2.70A {Phaseolus vulgaris} SCOP: b.29.1.1 Length = 240

 Score =  105 bits (263), Expect = 6e-26
 Identities = 38/189 (20%), Positives = 66/189 (34%), Gaps = 17/189 (8%)

Query: 5   KTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLP-GPVLSPQDSF 63
            +N  ASF+  F+F I          G AF +            ++G+       P    
Sbjct: 60  DSNNVASFNTNFTFIIRAKNQSISAYGLAFALVPVNSPPQKKQEFLGIFNTNNPEPNART 119

Query: 64  FAVEFDTSFDPSLGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRDSLK 123
            AV F+T  +    D + N I   ++    F             +G      I Y  S  
Sbjct: 120 VAVVFNTFKNR--IDFDKNFIKPYVNENCDF----------HKYNGEKTDVQITYDSSNN 167

Query: 124 LIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANG---QGSAIYTVDRWRFKTF 180
            +RV+  ++        + A + L K+  +++ VGFS  +G     +  + V  W F + 
Sbjct: 168 DLRVFLHFTV-SQVKCSVSATVHLEKEVDEWVSVGFSPTSGLTEDTTETHDVLSWSFSSK 226

Query: 181 ESYPSGNPI 189
                 N +
Sbjct: 227 FRNKLSNIL 235

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  106 bits (267), Expect = 6e-26
 Identities = 58/205 (28%), Positives = 90/205 (43%), Gaps = 29/205 (14%)

Query: 290 RIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQ 349
             +G G    V+ G       VAVK   K   +    + F  E   M   L+H+ LV+L 
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMS--PDAFLAEANLM-KQLQHQRLVRLY 74

Query: 350 GWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECER 409
                   + ++ EY+ NGSL   L   S     L+  K L++   +A  ++++ E   R
Sbjct: 75  A-VVTQEPIYIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEE---R 128

Query: 410 QIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGT------MGYLAPEYVYSG 454
             IHRD++A NIL+    + K+ DF         E T   G           APE +  G
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT---APEAINYG 185

Query: 455 VPSEKTDVYSFGVVALEVAA-GKSP 478
             + K+DV+SFG++  E+   G+ P
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIP 210

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  105 bits (265), Expect = 1e-25
 Identities = 61/202 (30%), Positives = 88/202 (43%), Gaps = 27/202 (13%)

Query: 290 RIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQ 349
           + +G+G    V  G    G  VAVK   K +        F  E + M   LRH NLVQL 
Sbjct: 27  QTIGKGEFGDVMLGDY-RGNKVAVKCI-KND---ATAQAFLAEASVM-TQLRHSNLVQLL 80

Query: 350 GWCCEGNELV-LVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE 408
           G   E    + +V EY+  GSL   L +   S   L  +  L   L V  A+ YL     
Sbjct: 81  GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYLEG--- 135

Query: 409 RQIIHRDVKACNILLDAEFNAKLGDF-----EATIPAGT------MGYLAPEYVYSGVPS 457
              +HRD+ A N+L+  +  AK+ DF      ++               APE +     S
Sbjct: 136 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT---APEALREKKFS 192

Query: 458 EKTDVYSFGVVALEVAA-GKSP 478
            K+DV+SFG++  E+ + G+ P
Sbjct: 193 TKSDVWSFGILLWEIYSFGRVP 214

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  106 bits (267), Expect = 1e-25
 Identities = 62/282 (21%), Positives = 110/282 (39%), Gaps = 53/282 (18%)

Query: 289 NRIVGEGASATVYKGSLPSGG----AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
            +I+GEG   +V +G+L         VAVK  +  N  +     F +E A M     H N
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKD-FSHPN 97

Query: 345 LVQLQGWCCEGN-----ELVLVYEYLPNGSLDKIL--HNNSSSSIVLSWEKRLNIVLGVA 397
           +++L G C E +     + +++  ++  G L   L      +    +  +  L  ++ +A
Sbjct: 98  VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157

Query: 398 SALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF----------------EATIPAG 441
             + YL     R  +HRD+ A N +L  +    + DF                 A +P  
Sbjct: 158 LGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 214

Query: 442 TMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSP---VDNDGCVIVDWVWNLRKKG 497
            +   A E +   V + K+DV++FGV   E+A  G +P   V N        +++    G
Sbjct: 215 WI---AIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE------MYDYLLHG 265

Query: 498 KLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKE 539
             L   +       +  +    +M   SC   +   RP+   
Sbjct: 266 HRLKQPE-------DCLDELYEIM--YSCWRTDPLDRPTFSV 298

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  107 bits (268), Expect = 1e-25
 Identities = 55/211 (26%), Positives = 83/211 (39%), Gaps = 33/211 (15%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
                 VG G+   V++     +G   AVK+      +E  R     E    AG      
Sbjct: 60  MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR----LEVFRV---EELVACAGL-SSPR 111

Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           +V L G   EG  + +  E L  GSL +++         L  ++ L  +      L YLH
Sbjct: 112 IVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGC----LPEDRALYYLGQALEGLEYLH 167

Query: 405 EECERQIIHRDVKACNILLDAE-FNAKLGDF-----------EATIPA-----GTMGYLA 447
               R+I+H DVKA N+LL ++   A L DF             ++       GT  ++A
Sbjct: 168 ---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMA 224

Query: 448 PEYVYSGVPSEKTDVYSFGVVALEVAAGKSP 478
           PE V       K D++S   + L +  G  P
Sbjct: 225 PEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  106 bits (267), Expect = 1e-25
 Identities = 56/280 (20%), Positives = 98/280 (35%), Gaps = 48/280 (17%)

Query: 289 NRIVGEGASATVYKGSLPSGG----AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
            R++G+G   +V +  L         VAVK  +           F  E A M     H +
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKE-FDHPH 86

Query: 345 LVQLQGWCCEG------NELVLVYEYLPNGSLDKIL--HNNSSSSIVLSWEKRLNIVLGV 396
           + +L G              +++  ++ +G L   L       +   L  +  +  ++ +
Sbjct: 87  VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146

Query: 397 ASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYL-- 446
           A  + YL     R  IHRD+ A N +L  +    + DF              G    L  
Sbjct: 147 ACGMEYLSS---RNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPV 203

Query: 447 ---APEYVYSGVPSEKTDVYSFGVVALEVAA-GKSP---VDNDGCVIVDWVWNLRKKGKL 499
              A E +   + +  +DV++FGV   E+   G++P   ++N        ++N    G  
Sbjct: 204 KWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE------IYNYLIGGNR 257

Query: 500 LDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKE 539
           L              E    LM    C   + ++RPS   
Sbjct: 258 LKQPP-------ECMEEVYDLM--YQCWSADPKQRPSFTC 288

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  105 bits (264), Expect = 2e-25
 Identities = 56/214 (26%), Positives = 87/214 (40%), Gaps = 34/214 (15%)

Query: 290 RIVGEGASATVYKGSLPSGGA--------VAVKRFEKPNRVECARNPFTTEFATMAGCLR 341
             +G+G    ++KG     G         V +K          + + F    + M+  L 
Sbjct: 14  ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVL-DKAHRNYSES-FFEAASMMSK-LS 70

Query: 342 HKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALS 401
           HK+LV   G C  G+E +LV E++  GSLD  L  N +    ++   +L +   +A+A+ 
Sbjct: 71  HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC---INILWKLEVAKQLAAAMH 127

Query: 402 YLHEECERQIIHRDVKACNILLDAEFN--------AKLGDFEATIPAGTMGYL------- 446
           +L    E  +IH +V A NILL  E +         KL D   +I       L       
Sbjct: 128 FLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWV 184

Query: 447 APE-YVYSGVPSEKTDVYSFGVVALEVAA-GKSP 478
            PE        +  TD +SFG    E+ + G  P
Sbjct: 185 PPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  105 bits (265), Expect = 2e-25
 Identities = 61/211 (28%), Positives = 95/211 (45%), Gaps = 35/211 (16%)

Query: 286 FNKNRIVGEGASATVYKGS-LPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F+    +GEG+  +VYK     +G  VA+K+    + ++        E + M  C    +
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIK----EISIMQQC-DSPH 85

Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLN------IVLGVAS 398
           +V+  G   +  +L +V EY   GS+  I+             K L       I+     
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLR---------NKTLTEDEIATILQSTLK 136

Query: 399 ALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF------EATIP-----AGTMGYLA 447
            L YLH     + IHRD+KA NILL+ E +AKL DF        T+       GT  ++A
Sbjct: 137 GLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMA 193

Query: 448 PEYVYSGVPSEKTDVYSFGVVALEVAAGKSP 478
           PE +     +   D++S G+ A+E+A GK P
Sbjct: 194 PEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  105 bits (264), Expect = 3e-25
 Identities = 56/218 (25%), Positives = 98/218 (44%), Gaps = 42/218 (19%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKR--FEKPNRVECARNPFTTEFATMAGCLRH 342
           +     +G+GA   VYK  +  +G   A K    +    +E     +  E   +A C  H
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELE----DYIVEIEILATC-DH 75

Query: 343 KNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLN------IVLGV 396
             +V+L G      +L ++ E+ P G++D         +I+L  ++ L       +   +
Sbjct: 76  PYIVKLLGAYYHDGKLWIMIEFCPGGAVD---------AIMLELDRGLTEPQIQVVCRQM 126

Query: 397 ASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF------EATIP-----AGTMGY 445
             AL++LH +   +IIHRD+KA N+L+  E + +L DF        T+       GT  +
Sbjct: 127 LEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYW 183

Query: 446 LAPEYVYSGVPSE-----KTDVYSFGVVALEVAAGKSP 478
           +APE V      +     K D++S G+  +E+A  + P
Sbjct: 184 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  109 bits (273), Expect = 3e-25
 Identities = 68/291 (23%), Positives = 102/291 (35%), Gaps = 40/291 (13%)

Query: 290 RIVGEGASATVYKGS-LPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
             +G G    V +     +G  VA+K+  +    +     +  E   M   L H N+V  
Sbjct: 20  ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRER-WCLEIQIMKK-LNHPNVVSA 77

Query: 349 ------QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
                        +  +L  EY   G L K L+   +    L       ++  ++SAL Y
Sbjct: 78  REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCG-LKEGPIRTLLSDISSALRY 136

Query: 403 LHEECERQIIHRDVKACNILLDAEFNA---KLGDF----------EATIPAGTMGYLAPE 449
           LHE    +IIHRD+K  NI+L         K+ D             T   GT+ YLAPE
Sbjct: 137 LHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPE 193

Query: 450 YVYSGVP-SEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLR 508
            +      +   D +SFG +A E   G  P   +    V W   +R+K          L 
Sbjct: 194 -LLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW-QPVQWHGKVREKSNEHIVVYDDLT 251

Query: 509 GKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEAPLPLLPVKKPT 559
           G      +            PNH       +  R L+    L     ++ T
Sbjct: 252 GAVKFSSV---------LPTPNHLSGILAGKLERWLQC--MLMWHQRQRGT 291

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  105 bits (263), Expect = 3e-25
 Identities = 70/290 (24%), Positives = 103/290 (35%), Gaps = 59/290 (20%)

Query: 290 RIVGEGASATVYKGSL--PSGGA--VAVKRFEKPNRV--ECARNPFTTEFATMAGCLRHK 343
             +G+G+   V +G    PSG    VAVK   KP+ +    A + F  E   M   L H+
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCL-KPDVLSQPEAMDDFIREVNAMHS-LDHR 81

Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
           NL++L G       + +V E  P GSL   L  +                + VA  + YL
Sbjct: 82  NLIRLYG-VVLTPPMKMVTELAPLGSLLDRLRKHQGH---FLLGTLSRYAVQVAEGMGYL 137

Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF--EATIPAGTMGY------------LAPE 449
                ++ IHRD+ A N+LL      K+GDF     +P     Y             APE
Sbjct: 138 ES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 194

Query: 450 YVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLR 508
            + +   S  +D + FGV   E+   G+ P             N  +    +D    R  
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG---------LNGSQILHKIDKEGER-- 243

Query: 509 GKFNRKEMER---------MLMVGLSCVHPNHEKRPSVKEAARILKGEAP 549
                  + R          +M  + C     E RP+       L    P
Sbjct: 244 -------LPRPEDCPQDIYNVM--VQCWAHKPEDRPTFVALRDFLLEAQP 284

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  104 bits (262), Expect = 4e-25
 Identities = 57/204 (27%), Positives = 87/204 (42%), Gaps = 30/204 (14%)

Query: 290 RIVGEGASATVYKGSLPSGGA-----VAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           + +G+G   +V               VAVK+  + +  E  R+ F  E   +   L+H N
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHLRD-FEREIEILKS-LQHDN 72

Query: 345 LVQLQGWCCEGNE--LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
           +V+ +G C       L L+ EYLP GSL   L  +      +   K L     +   + Y
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEY 129

Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT--IPAGTMGY------------LAP 448
           L     ++ IHRD+   NIL++ E   K+GDF  T  +P     +             AP
Sbjct: 130 LGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAP 186

Query: 449 EYVYSGVPSEKTDVYSFGVVALEV 472
           E +     S  +DV+SFGVV  E+
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYEL 210

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  104 bits (262), Expect = 4e-25
 Identities = 57/212 (26%), Positives = 89/212 (41%), Gaps = 32/212 (15%)

Query: 287 NKNRIVGEGASATVYKG-SLPSGGAVAVK--RFEKPNRVECARNPFTTEFATMAGCLRHK 343
               ++G+G    VY G  L +   +A+K          +    P   E A     L+HK
Sbjct: 25  GDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQ----PLHEEIALHKH-LKHK 79

Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRL--NIVLGVASALS 401
           N+VQ  G   E   + +  E +P GSL  +L +       L   ++        +   L 
Sbjct: 80  NIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGP---LKDNEQTIGFYTKQILEGLK 136

Query: 402 YLHEECERQIIHRDVKACNILLDAEF-NAKLGDF------------EATIPAGTMGYLAP 448
           YLH   + QI+HRD+K  N+L++      K+ DF              T   GT+ Y+AP
Sbjct: 137 YLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF-TGTLQYMAP 192

Query: 449 EYVYSGVP--SEKTDVYSFGVVALEVAAGKSP 478
           E +  G     +  D++S G   +E+A GK P
Sbjct: 193 EIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  104 bits (262), Expect = 4e-25
 Identities = 60/206 (29%), Positives = 88/206 (42%), Gaps = 29/206 (14%)

Query: 290 RIVGEGASATVYKGSLPSGG-AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
             +G G    VY+G        VAVK   K + +E     F  E A M   ++H NLVQL
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTME--VEEFLKEAAVM-KEIKHPNLVQL 74

Query: 349 QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE 408
            G C       ++ E++  G+L   L   +     +S    L +   ++SA+ YL    +
Sbjct: 75  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAMEYLE---K 129

Query: 409 RQIIHRDVKACNILLDAEFNAKLGDF---------------EATIPAGTMGYLAPEYVYS 453
           +  IHRD+ A N L+      K+ DF                A  P       APE +  
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT---APESLAY 186

Query: 454 GVPSEKTDVYSFGVVALEVAA-GKSP 478
              S K+DV++FGV+  E+A  G SP
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSP 212

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  105 bits (263), Expect = 4e-25
 Identities = 63/224 (28%), Positives = 92/224 (41%), Gaps = 40/224 (17%)

Query: 290 RIVGEGASATVYKGS---LPSGGAVAVKRFEKPNRVECARNP-FTTEF---ATMAGCLRH 342
            I+G G  + V+            VAVK      R + AR+P F   F   A  A  L H
Sbjct: 18  EILGFGGMSEVHLARDLRD--HRDVAVKVL----RADLARDPSFYLRFRREAQNAAALNH 71

Query: 343 KNLVQL--QGWCCEGNELVLVY---EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVA 397
             +V +   G   E     L Y   EY+   +L  I+H        ++ ++ + ++    
Sbjct: 72  PAIVAVYDTGEA-ETPAGPLPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADAC 126

Query: 398 SALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-------EATIPA-------GTM 443
            AL++ H+     IIHRDVK  NI++ A    K+ DF       ++           GT 
Sbjct: 127 QALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183

Query: 444 GYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIV 487
            YL+PE         ++DVYS G V  EV  G+ P   D  V V
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV 227

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  104 bits (261), Expect = 5e-25
 Identities = 57/221 (25%), Positives = 87/221 (39%), Gaps = 37/221 (16%)

Query: 290 RIVGEGASATVYKGSLPSGG------AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHK 343
             +GE     VYKG L          AVA+K   K       R  F  E    A  L+H 
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL-KDKAEGPLREEFRHEAMLRAR-LQHP 72

Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIV------------LSWEKRLN 391
           N+V L G   +   L +++ Y  +G L + L   S  S V            L     ++
Sbjct: 73  NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132

Query: 392 IVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTM 443
           +V  +A+ + YL       ++H+D+   N+L+  + N K+ D                  
Sbjct: 133 LVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 189

Query: 444 GYL-----APEYVYSGVPSEKTDVYSFGVVALEVAA-GKSP 478
             L     APE +  G  S  +D++S+GVV  EV + G  P
Sbjct: 190 SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  105 bits (263), Expect = 5e-25
 Identities = 65/287 (22%), Positives = 104/287 (36%), Gaps = 49/287 (17%)

Query: 290 RIVGEGASATVYKGSLPSGG-----AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
             +G+G   +V        G      VAVK+  + +  +  R+ F  E   +   L    
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQL-QHSGPDQQRD-FQREIQILKA-LHSDF 85

Query: 345 LVQLQGWCCEGNE--LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
           +V+ +G         L LV EYLP+G L   L  + +    L   + L     +   + Y
Sbjct: 86  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR---LDASRLLLYSSQICKGMEY 142

Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT--IPAGTMGY------------LAP 448
           L     R+ +HRD+ A NIL+++E + K+ DF     +P     Y             AP
Sbjct: 143 LGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAP 199

Query: 449 EYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRL 507
           E +   + S ++DV+SFGVV  E+                   +      +    A  RL
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSA------EFLRMMGCERDVPALSRL 253

Query: 508 RGKFNRKE-MER---------MLMVGLSCVHPNHEKRPSVKEAARIL 544
                  + +            LM    C  P+ + RPS       L
Sbjct: 254 LELLEEGQRLPAPPACPAEVHELM--KLCWAPSPQDRPSFSALGPQL 298

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  104 bits (262), Expect = 6e-25
 Identities = 58/204 (28%), Positives = 87/204 (42%), Gaps = 30/204 (14%)

Query: 290 RIVGEGASATVYKGSLPSGG-----AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           + +G+G   +V               VAVK+  + +  E  R+ F  E   +   L+H N
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHLRD-FEREIEILKS-LQHDN 103

Query: 345 LVQLQGWCCEGNE--LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
           +V+ +G C       L L+ EYLP GSL   L  +      +   K L     +   + Y
Sbjct: 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEY 160

Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT--IPAGTMGY------------LAP 448
           L     ++ IHRD+   NIL++ E   K+GDF  T  +P     Y             AP
Sbjct: 161 LGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAP 217

Query: 449 EYVYSGVPSEKTDVYSFGVVALEV 472
           E +     S  +DV+SFGVV  E+
Sbjct: 218 ESLTESKFSVASDVWSFGVVLYEL 241

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  104 bits (261), Expect = 7e-25
 Identities = 51/207 (24%), Positives = 83/207 (40%), Gaps = 31/207 (14%)

Query: 292 VGEGASATVYKGS-LPSGGAVAVKRFEKPNRVECARNPFT---TEFATMAGCLRHKNLVQ 347
           +G G    V+K     +G  +AVK+     R    +        +   +        +VQ
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQM----RRSGNKEENKRILMDLDVVLKSHDCPYIVQ 88

Query: 348 LQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRL-NIVLGVASALSYLHEE 406
             G      ++ +  E +     +K+          +  E+ L  + + +  AL YL E+
Sbjct: 89  CFGTFITNTDVFIAMELM-GTCAEKLKKRMQG---PIP-ERILGKMTVAIVKALYYLKEK 143

Query: 407 CERQIIHRDVKACNILLDAEFNAKLGDF----------EATIPAGTMGYLAPEYVYSGVP 456
               +IHRDVK  NILLD     KL DF               AG   Y+APE +    P
Sbjct: 144 --HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDP 201

Query: 457 SE-----KTDVYSFGVVALEVAAGKSP 478
           ++     + DV+S G+  +E+A G+ P
Sbjct: 202 TKPDYDIRADVWSLGISLVELATGQFP 228

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  104 bits (261), Expect = 8e-25
 Identities = 57/219 (26%), Positives = 93/219 (42%), Gaps = 33/219 (15%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           +  + I+G+GA+A V++G    +G   A+K F   + +    +    EF  +   L HKN
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR-PVDVQMREFEVLKK-LNHKN 68

Query: 345 LVQLQG--WCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
           +V+L            VL+ E+ P GSL  +L   S++   L   + L ++  V   +++
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAY-GLPESEFLIVLRDVVGGMNH 127

Query: 403 LHEECERQIIHRDVKACNILL----DAEFNAKLGDF----------EATIPAGTMGYLAP 448
           L E     I+HR++K  NI+     D +   KL DF          +     GT  YL P
Sbjct: 128 LRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184

Query: 449 EYVYSGVP---------SEKTDVYSFGVVALEVAAGKSP 478
           + +Y                 D++S GV     A G  P
Sbjct: 185 D-MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ... Length = 237

 Score =  102 bits (254), Expect = 8e-25
 Identities = 35/137 (25%), Positives = 57/137 (41%), Gaps = 7/137 (5%)

Query: 61  DSFFAVEFDTSFDPSLGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRD 120
           D+  AVE DT  +  +GD +  HIGIDI SV S  +        ++++G+  T  I Y  
Sbjct: 2   DTIVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKTAKW-----NMQNGKVGTAHIIYNS 56

Query: 121 SLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGSAIYTVDRWRFKTF 180
             K +     Y      S  +   +DL     +++ VG SA+ G      T+  W F + 
Sbjct: 57  VDKRLSAVVSYP--NADSATVSYDVDLDNVLPEWVRVGLSASTGLYKETNTILSWSFTSK 114

Query: 181 ESYPSGNPIDVIDEGDC 197
               S +  + +     
Sbjct: 115 LKSNSTHETNALHFMFN 131

>1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ... Length = 237

 Score = 41.0 bits (95), Expect = 5e-04
 Identities = 17/50 (34%), Positives = 24/50 (48%), Gaps = 3/50 (6%)

Query: 5   KTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSF--GNDNGYMGL 52
            +   ASF   F+F +I SP     DG AF I++   S   G+    +GL
Sbjct: 184 SSAVVASFEATFTF-LIKSPDSHPADGIAFFISNIDSSIPSGSTGRLLGL 232

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  105 bits (263), Expect = 9e-25
 Identities = 69/305 (22%), Positives = 100/305 (32%), Gaps = 59/305 (19%)

Query: 290 RIVGEGASATVYKGSLPSGG------AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHK 343
           R +G GA   VY+G +           VAVK        E     F  E   ++    H+
Sbjct: 77  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISK-FNHQ 134

Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNN---SSSSIVLSWEKRLNIVLGVASAL 400
           N+V+  G   +     ++ E +  G L   L       S    L+    L++   +A   
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194

Query: 401 SYLHEECERQIIHRDVKACNILLDAE---FNAKLGDF--------EATIPAGTMGYL--- 446
            YL    E   IHRD+ A N LL        AK+GDF              G    L   
Sbjct: 195 QYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK 251

Query: 447 --APEYVYSGVPSEKTDVYSFGVVALEVAA-GKSP---VDNDGCVIVDWVWNLRKKGKLL 500
              PE    G+ + KTD +SFGV+  E+ + G  P     N        V      G  +
Sbjct: 252 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE------VLEFVTSGGRM 305

Query: 501 DAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKE----------AARILKGEAPL 550
           D          N       +M    C     E RP+                ++    P+
Sbjct: 306 DPPK-------NCPGPVYRIM--TQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPI 356

Query: 551 PLLPV 555
              P+
Sbjct: 357 EYGPL 361

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  104 bits (261), Expect = 1e-24
 Identities = 71/312 (22%), Positives = 106/312 (33%), Gaps = 49/312 (15%)

Query: 290 RIVGEGASATVYKGSL------PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHK 343
           R +G GA   VY+G +      PS   VAVK        E     F  E   ++    H+
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISK-FNHQ 93

Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNS---SSSIVLSWEKRLNIVLGVASAL 400
           N+V+  G   +     ++ E +  G L   L       S    L+    L++   +A   
Sbjct: 94  NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153

Query: 401 SYLHEECERQIIHRDVKACNILLDAE---FNAKLGDF--------EATIPAGTMGYL--- 446
            YL    E   IHRD+ A N LL        AK+GDF         +    G    L   
Sbjct: 154 QYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 210

Query: 447 --APEYVYSGVPSEKTDVYSFGVVALEVAA-GKSP---VDNDGCVIVDWVWNLRKKGKLL 500
              PE    G+ + KTD +SFGV+  E+ + G  P     N        V      G  +
Sbjct: 211 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE------VLEFVTSGGRM 264

Query: 501 DAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEAPLPLLPVKKPTV 560
           D          N       +M    C     E RP+       ++     P +      +
Sbjct: 265 DPPK-------NCPGPVYRIM--TQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPI 315

Query: 561 NIRSVFPEASEL 572
               +  E  ++
Sbjct: 316 EYGPLVEEEEKV 327

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  103 bits (259), Expect = 1e-24
 Identities = 51/292 (17%), Positives = 97/292 (33%), Gaps = 68/292 (23%)

Query: 286 FNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           ++  + +G G S+ V++         A+K            + +  E A +   L+  + 
Sbjct: 30  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK-LQQHSD 88

Query: 346 --VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
             ++L  +      + +V E   N  L+  L    S    +   +R +    +  A+  +
Sbjct: 89  KIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS----IDPWERKSYWKNMLEAVHTI 143

Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF-------------EATIPAGTMGYLAPE- 449
           H   +  I+H D+K  N L+  +   KL DF                   GT+ Y+ PE 
Sbjct: 144 H---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 199

Query: 450 -----YVYSGVP-----SEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKL 499
                            S K+DV+S G +   +  GK+P       I++ +  L      
Sbjct: 200 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ----IINQISKLHAIIDP 255

Query: 500 -----------LDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEA 540
                       D  D           ++  L         + ++R S+ E 
Sbjct: 256 NHEIEFPDIPEKDLQDV----------LKCCLKR-------DPKQRISIPEL 290

>2ltn_A PEA lectin, alpha chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1bqp_A* 1hkd_A 1ofs_A* 1rin_A* 1lof_C* 1len_A 1lem_A 1les_A* 2lal_A 1loe_A 1loa_A* 1loc_A* 1lod_A* 1lob_A 1lof_A* 1log_A* 1lgc_A* 1lgb_A* 2b7y_A* Length = 181

 Score = 99.7 bits (248), Expect = 2e-24
 Identities = 34/134 (25%), Positives = 52/134 (38%), Gaps = 7/134 (5%)

Query: 1   FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVL-SP 59
             D +T   A+F   F+F I         DGF F I           GY+G+        
Sbjct: 52  IWDRETGNVANFVTSFTFVINAPNSYNVADGFTFFIAPVDTKPQTGGGYLGVFNSAEYDK 111

Query: 60  QDSFFAVEFDTSFDPSLGDIN-GNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEY 118
                AVEFDT ++ +    N   HIGID++S+ S  +         L++G      I +
Sbjct: 112 TTQTVAVEFDTFYNAAWDPSNRDRHIGIDVNSIKSVNTKS-----WKLQNGEEANVVIAF 166

Query: 119 RDSLKLIRVWAGYS 132
             +  ++ V   Y 
Sbjct: 167 NAATNVLTVSLTYP 180

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  103 bits (259), Expect = 2e-24
 Identities = 67/287 (23%), Positives = 112/287 (39%), Gaps = 56/287 (19%)

Query: 290 RIVGEGASATVYKGSLPSGG--------AVAVKRFEKPNRVECARNPFTTEFATMAGCLR 341
           + +GEGA   V                  VAVK   K +  E   +   +E   M    +
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGK 99

Query: 342 HKNLVQLQGWCCEGNELVLVYEYLPNGSL------------DKILHNNSSSSIVLSWEKR 389
           HKN++ L G C +   L ++ EY   G+L            +     N      ++++  
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159

Query: 390 LNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAG 441
           ++    +A  + YL     ++ IHRD+ A N+L+      K+ DF               
Sbjct: 160 VSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216

Query: 442 TMGYL-----APEYVYSGVPSEKTDVYSFGVVALEVAA-GKSP---VDNDGCVIVDWVWN 492
           T G L     APE ++  V + ++DV+SFGV+  E+   G SP   +  +       ++ 
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE------LFK 270

Query: 493 LRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKE 539
           L K+G  +D          N      M+M    C H    +RP+ K+
Sbjct: 271 LLKEGHRMDKPA-------NCTNELYMMM--RDCWHAVPSQRPTFKQ 308

>1qmo_E Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1 Length = 133

 Score = 97.5 bits (242), Expect = 3e-24
 Identities = 38/127 (29%), Positives = 58/127 (45%), Gaps = 8/127 (6%)

Query: 63  FFAVEFDTSFDPSLGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRDSL 122
             AVEFDT  +P  GD N  HIGID++S+ S V+        D ++G+  T  I Y    
Sbjct: 3   VVAVEFDTYLNPDYGDPNYIHIGIDVNSIRSKVTAKW-----DWQNGKIATAHISYNSVS 57

Query: 123 KLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGSAIYTVDRWRFK-TFE 181
           K + V + Y+        +   I+L     +++ VG SA+ GQ     TV  W F  +  
Sbjct: 58  KRLSVTSYYA--GSKPATLSYDIELHTVLPEWVRVGLSASTGQDKERNTVHSWSFTSSLW 115

Query: 182 SYPSGNP 188
           +  +   
Sbjct: 116 TNVAKKE 122

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  103 bits (258), Expect = 4e-24
 Identities = 54/223 (24%), Positives = 89/223 (39%), Gaps = 38/223 (17%)

Query: 290 RIVGEGASATVYKGSL--------PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLR 341
           + +GEG    V                  VAVK   K +  E   +   +E   M    +
Sbjct: 87  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGK 145

Query: 342 HKNLVQLQGWCCEGNELVLVYEYLPNGSL------------DKILHNNSSSSIVLSWEKR 389
           HKN++ L G C +   L ++ EY   G+L            +     N      ++++  
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205

Query: 390 LNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAG 441
           ++    +A  + YL     ++ IHRD+ A N+L+      K+ DF               
Sbjct: 206 VSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 262

Query: 442 TMGYL-----APEYVYSGVPSEKTDVYSFGVVALEVAA-GKSP 478
           T G L     APE ++  V + ++DV+SFGV+  E+   G SP
Sbjct: 263 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  102 bits (257), Expect = 4e-24
 Identities = 51/292 (17%), Positives = 97/292 (33%), Gaps = 68/292 (23%)

Query: 286 FNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           ++  + +G G S+ V++         A+K            + +  E A +   L+  + 
Sbjct: 11  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK-LQQHSD 69

Query: 346 --VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
             ++L  +      + +V E   N  L+  L    S    +   +R +    +  A+  +
Sbjct: 70  KIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS----IDPWERKSYWKNMLEAVHTI 124

Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF-------------EATIPAGTMGYLAPE- 449
           H   +  I+H D+K  N L+  +   KL DF                   GT+ Y+ PE 
Sbjct: 125 H---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180

Query: 450 ----------YVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKL 499
                            S K+DV+S G +   +  GK+P       I++ +  L      
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ----IINQISKLHAIIDP 236

Query: 500 -----------LDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEA 540
                       D  D           ++  L         + ++R S+ E 
Sbjct: 237 NHEIEFPDIPEKDLQDV----------LKCCLKR-------DPKQRISIPEL 271

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  102 bits (257), Expect = 6e-24
 Identities = 50/292 (17%), Positives = 97/292 (33%), Gaps = 70/292 (23%)

Query: 286 FNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           ++  + +G G S+ V++         A+K            + +  E A +   L+  + 
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK-LQQHSD 116

Query: 346 --VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
             ++L  +      + +V E   N  L+  L    S    +   +R +    +  A+  +
Sbjct: 117 KIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS----IDPWERKSYWKNMLEAVHTI 171

Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF-------------EATIPAGTMGYLAPEY 450
           H   +  I+H D+K  N L+  +   KL DF                   G + Y+ PE 
Sbjct: 172 H---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE- 226

Query: 451 VYSGVP------------SEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGK 498
               +             S K+DV+S G +   +  GK+P       I++ +  L     
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ----IINQISKLHAIID 282

Query: 499 L-----------LDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKE 539
                        D  D           ++  L         + ++R S+ E
Sbjct: 283 PNHEIEFPDIPEKDLQDV----------LKCCLKR-------DPKQRISIPE 317

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  100 bits (252), Expect = 8e-24
 Identities = 64/305 (20%), Positives = 116/305 (38%), Gaps = 63/305 (20%)

Query: 275 ALTDIKQATLG-FNKNRIVGEGASATVYKG-SLPSGGAVAVK-----RFEKPNRVECARN 327
           +L       +  F    ++G+G+ A VY+  S+ +G  VA+K        K   V+  +N
Sbjct: 1   SLATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQN 60

Query: 328 PFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWE 387
               E       L+H ++++L  +  + N + LV E   NG +++ L N           
Sbjct: 61  ----EVKIHC-QLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRV--------- 106

Query: 388 KRLN------IVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--EATIP 439
           K  +       +  + + + YLH      I+HRD+   N+LL    N K+ DF     + 
Sbjct: 107 KPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163

Query: 440 A---------GTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWV 490
                     GT  Y++PE         ++DV+S G +   +  G+ P D D       V
Sbjct: 164 MPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDT------V 217

Query: 491 WNLRKKGKLLDAADFRLRGKFN---RKEMERMLMVGLSCVHPNHEKRPSVKEAAR---IL 544
            N   K      AD+ +    +   +  + ++L         N   R S+        + 
Sbjct: 218 KNTLNKVV---LADYEMPSFLSIEAKDLIHQLL-------RRNPADRLSLSSVLDHPFMS 267

Query: 545 KGEAP 549
           +  + 
Sbjct: 268 RNSST 272

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  102 bits (257), Expect = 8e-24
 Identities = 69/288 (23%), Positives = 114/288 (39%), Gaps = 56/288 (19%)

Query: 289 NRIVGEGASATVYKGSLP--------SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCL 340
            + +GEGA   V                  VAVK   K +  E   +   +E   M    
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLISEMEMMKMIG 132

Query: 341 RHKNLVQLQGWCCEGNELVLVYEYLPNGSL------------DKILHNNSSSSIVLSWEK 388
           +HKN++ L G C +   L ++ EY   G+L            +   + + +    LS + 
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192

Query: 389 RLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPA 440
            ++    VA  + YL     ++ IHRD+ A N+L+  +   K+ DF              
Sbjct: 193 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 249

Query: 441 GTMGYL-----APEYVYSGVPSEKTDVYSFGVVALEVAA-GKSP---VDNDGCVIVDWVW 491
            T G L     APE ++  + + ++DV+SFGV+  E+   G SP   V  +       ++
Sbjct: 250 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE------LF 303

Query: 492 NLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKE 539
            L K+G  +D          N      M+M    C H    +RP+ K+
Sbjct: 304 KLLKEGHRMDKPS-------NCTNELYMMM--RDCWHAVPSQRPTFKQ 342

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  101 bits (254), Expect = 9e-24
 Identities = 54/219 (24%), Positives = 93/219 (42%), Gaps = 34/219 (15%)

Query: 290 RIVGEGASATVYKGSLPSGG------AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHK 343
           + +G GA   V + +    G       VAVK   K       +    +E   M+   +H+
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML-KSTAHADEKEALMSELKIMSHLGQHE 110

Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSL----------DKILHNNSSSSIVLSWEKRLNIV 393
           N+V L G C  G  ++++ EY   G L           +     + ++   S    L+  
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170

Query: 394 LGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGY 445
             VA  +++L     +  IHRDV A N+LL     AK+GDF        ++         
Sbjct: 171 SQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 227

Query: 446 L-----APEYVYSGVPSEKTDVYSFGVVALEVAA-GKSP 478
           L     APE ++  V + ++DV+S+G++  E+ + G +P
Sbjct: 228 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  101 bits (254), Expect = 9e-24
 Identities = 67/290 (23%), Positives = 109/290 (37%), Gaps = 55/290 (18%)

Query: 290 RIVGEGASATVYKGSLPSGG------AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHK 343
             +GEGA   V+     +         VAVK        E AR  F  E   +   L+H+
Sbjct: 47  WELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEASESARQDFQREAELLTM-LQHQ 103

Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKIL-----------HNNSSSSIVLSWEKRLNI 392
           ++V+  G C EG  L++V+EY+ +G L++ L                +   L   + L +
Sbjct: 104 HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163

Query: 393 VLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMG 444
              VA+ + YL        +HRD+   N L+      K+GDF              G   
Sbjct: 164 ASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 220

Query: 445 YL-----APEYVYSGVPSEKTDVYSFGVVALEVAA-GKSP---VDNDGCVIVDWVWNLRK 495
            L      PE +     + ++DV+SFGVV  E+   GK P   + N          +   
Sbjct: 221 MLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE------AIDCIT 274

Query: 496 KGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK 545
           +G+ L+                  +M    C     ++R S+K+    L+
Sbjct: 275 QGRELERPR-------ACPPEVYAIM--RGCWQREPQQRHSIKDVHARLQ 315

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  102 bits (256), Expect = 1e-23
 Identities = 57/219 (26%), Positives = 93/219 (42%), Gaps = 33/219 (15%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           +  + I+G+GA+A V++G    +G   A+K F   + +    +    EF  +   L HKN
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR-PVDVQMREFEVLKK-LNHKN 68

Query: 345 LVQLQGW--CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
           +V+L            VL+ E+ P GSL  +L   S++   L   + L ++  V   +++
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAY-GLPESEFLIVLRDVVGGMNH 127

Query: 403 LHEECERQIIHRDVKACNILL----DAEFNAKLGDF----------EATIPAGTMGYLAP 448
           L E     I+HR++K  NI+     D +   KL DF          +     GT  YL P
Sbjct: 128 LRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184

Query: 449 EYVYSGVP---------SEKTDVYSFGVVALEVAAGKSP 478
           + +Y                 D++S GV     A G  P
Sbjct: 185 D-MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  101 bits (254), Expect = 1e-23
 Identities = 52/228 (22%), Positives = 88/228 (38%), Gaps = 43/228 (18%)

Query: 290 RIVGEGASATVYKGSLPSGGA------VAVKRFEKPNRVECARNPFTTEFATMAGCLRHK 343
           +++G GA   V   +            VAVK   K       R    +E   M     H+
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKML-KEKADSSEREALMSELKMMTQLGSHE 109

Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSL-------------------DKILHNNSSSSIVL 384
           N+V L G C     + L++EY   G L                   ++          VL
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169

Query: 385 SWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--------EA 436
           ++E  L     VA  + +L     +  +HRD+ A N+L+      K+ DF        ++
Sbjct: 170 TFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226

Query: 437 TIPAGTMGYL-----APEYVYSGVPSEKTDVYSFGVVALEVAA-GKSP 478
                    L     APE ++ G+ + K+DV+S+G++  E+ + G +P
Sbjct: 227 NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  101 bits (253), Expect = 1e-23
 Identities = 57/211 (27%), Positives = 87/211 (41%), Gaps = 32/211 (15%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFE-KPNRVECARNPFTTEFATMAGCLRHK 343
           F+  R +G G+   VY    + +   VA+K+      +          E   +    RH 
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHP 114

Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLN------IVLGVA 397
           N +Q +G     +   LV EY    + D          ++   +K L       +  G  
Sbjct: 115 NTIQYRGCYLREHTAWLVMEYCLGSASD----------LLEVHKKPLQEVEIAAVTHGAL 164

Query: 398 SALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--EATIP-----AGTMGYLAPEY 450
             L+YLH      +IHRDVKA NILL      KLGDF   + +       GT  ++APE 
Sbjct: 165 QGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEV 221

Query: 451 VYSGVPSE---KTDVYSFGVVALEVAAGKSP 478
           + +    +   K DV+S G+  +E+A  K P
Sbjct: 222 ILAMDEGQYDGKVDVWSLGITCIELAERKPP 252

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  100 bits (251), Expect = 3e-23
 Identities = 28/292 (9%), Positives = 64/292 (21%), Gaps = 46/292 (15%)

Query: 290 RIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
             +  G  + V+    +      A+K F        +      E    A  L  ++  + 
Sbjct: 68  EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEA 127

Query: 349 QGWC--------------------------CEGNELVLVYEYLP--NGSLDKILHNNSSS 380
           +                                   +L+          L   L      
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVF 187

Query: 381 SIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF------ 434
                      +   +    + L     + ++H      N+ +  +    LGD       
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKV 244

Query: 435 --EATIPAGTMGYLAPEYVYSG--VPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWV 490
                  +  + Y   E++ +     +   + +  G+    V     P       I    
Sbjct: 245 GTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSW 304

Query: 491 WNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR 542
              R   ++               +  + L+           +R    EA  
Sbjct: 305 --KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDR--RRRLLPLEAME 352

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 99.2 bits (248), Expect = 3e-23
 Identities = 60/221 (27%), Positives = 98/221 (44%), Gaps = 38/221 (17%)

Query: 290 RIVGEGASATVYKGSLPSGG------AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHK 343
           R +GEGA   V+     +         VAVK  + P     AR  F  E   +   L+H+
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTN-LQHE 77

Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIV------------LSWEKRLN 391
           ++V+  G C +G+ L++V+EY+ +G L+K L  +   +++            L   + L+
Sbjct: 78  HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137

Query: 392 IVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTM 443
           I   +AS + YL     +  +HRD+   N L+ A    K+GDF              G  
Sbjct: 138 IASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 194

Query: 444 GYL-----APEYVYSGVPSEKTDVYSFGVVALEVAA-GKSP 478
             L      PE +     + ++DV+SFGV+  E+   GK P
Sbjct: 195 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 99.6 bits (249), Expect = 4e-23
 Identities = 56/223 (25%), Positives = 88/223 (39%), Gaps = 38/223 (17%)

Query: 290 RIVGEGASATVYKG---SLPSGGA---VAVKRFEKPNRVECARNPFTTEFATMAGCLRHK 343
           + +G GA   V +     L    A   VAVK   KP+     R    +E   ++    H 
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-KPSAHLTEREALMSELKVLSYLGNHM 87

Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSL--------------DKILHNNSSSSIVLSWEKR 389
           N+V L G C  G   +++ EY   G L                         + L  E  
Sbjct: 88  NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147

Query: 390 LNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAG 441
           L+    VA  +++L     +  IHRD+ A NILL      K+ DF        ++     
Sbjct: 148 LSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204

Query: 442 TMGYL-----APEYVYSGVPSEKTDVYSFGVVALEVAA-GKSP 478
               L     APE +++ V + ++DV+S+G+   E+ + G SP
Sbjct: 205 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 98.8 bits (247), Expect = 4e-23
 Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 39/214 (18%)

Query: 290 RIVGEGASATVYKG-SLPSGGAVAVK-----RFEKPNRVECARNPFTTEFATMAGCLRHK 343
           R +G+G    VY      S   +A+K     + EK       R     E    +  LRH 
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR----EVEIQS-HLRHP 69

Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLN------IVLGVA 397
           N+++L G+  +   + L+ EY P G++ + L              + +       +  +A
Sbjct: 70  NILRLYGYFHDATRVYLILEYAPLGTVYRELQK----------LSKFDEQRTATYITELA 119

Query: 398 SALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--EATIPA-------GTMGYLAP 448
           +ALSY H    +++IHRD+K  N+LL +    K+ DF      P+       GT+ YL P
Sbjct: 120 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPP 176

Query: 449 EYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDND 482
           E +   +  EK D++S GV+  E   GK P + +
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 210

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 99.3 bits (248), Expect = 4e-23
 Identities = 54/222 (24%), Positives = 85/222 (38%), Gaps = 37/222 (16%)

Query: 290 RIVGEGASATVYKGSL------PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHK 343
           + +G GA   V +          +   VAVK   K            +E   +     H 
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRALMSELKILIHIGHHL 91

Query: 344 NLVQLQGWCC-EGNELVLVYEYLPNGSL------------DKILHNNSSSSIVLSWEKRL 390
           N+V L G C   G  L+++ E+   G+L               +         L+ E  +
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151

Query: 391 NIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGT 442
                VA  + +L     R+ IHRD+ A NILL  +   K+ DF        +       
Sbjct: 152 CYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 208

Query: 443 MGYL-----APEYVYSGVPSEKTDVYSFGVVALEVAA-GKSP 478
              L     APE ++  V + ++DV+SFGV+  E+ + G SP
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  101 bits (252), Expect = 4e-23
 Identities = 62/303 (20%), Positives = 107/303 (35%), Gaps = 74/303 (24%)

Query: 286 FNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
               +I+G G+S TV       G  VAVKR    +  + A      E   +     H N+
Sbjct: 17  VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI-DFCDIALM----EIKLLTESDDHPNV 71

Query: 346 VQLQGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKR--LNIVLGVASALSY 402
           ++          L +  E   N +L D +   N S   +   ++   ++++  +AS +++
Sbjct: 72  IRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130

Query: 403 LHEECERQIIHRDVKACNILLDAE-------------FNAKLGDF--------------- 434
           LH     +IIHRD+K  NIL+                    + DF               
Sbjct: 131 LH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187

Query: 435 EATIPAGTMGYLAPEYVYSGVP-------SEKTDVYSFGVVALEV-AAGKSPVDNDGCVI 486
               P+GT G+ APE +            +   D++S G V   + + GK P  +     
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK---- 243

Query: 487 VDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLS---------CVHPNHEKRPSV 537
                  R+           +RG F+  EM+ +    L           +  +  KRP+ 
Sbjct: 244 -----YSRESNI--------IRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTA 290

Query: 538 KEA 540
            + 
Sbjct: 291 MKV 293

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 97.8 bits (244), Expect = 1e-22
 Identities = 55/218 (25%), Positives = 95/218 (43%), Gaps = 35/218 (16%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFE-KPNRVECARNPFTTEFATMAGCLRHK 343
           F    +VG G    VYKG  + +G   A+K  +   +  E        E   +     H+
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEE----EIKQEINMLKKYSHHR 81

Query: 344 NLVQLQG------WCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVL-GV 396
           N+    G           ++L LV E+   GS+  ++ N   +++    E+ +  +   +
Sbjct: 82  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLK---EEWIAYICREI 138

Query: 397 ASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF------EATIP-----AGTMGY 445
              LS+LH+    ++IHRD+K  N+LL      KL DF      + T+       GT  +
Sbjct: 139 LRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYW 195

Query: 446 LAPEYVYSGVPSE-----KTDVYSFGVVALEVAAGKSP 478
           +APE +      +     K+D++S G+ A+E+A G  P
Sbjct: 196 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 98.5 bits (245), Expect = 2e-22
 Identities = 41/243 (16%), Positives = 77/243 (31%), Gaps = 39/243 (16%)

Query: 268 QRVPMRLALTDIKQATLGFNKNRIVGEGASATVYKG------SLPSGGAVAVKRFEKPNR 321
            ++P     T+ +  +     + ++GEGA A VY+          +     +K  +  N 
Sbjct: 49  CKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP 108

Query: 322 VECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSL-DKILHNNSSS 380
            E       T+             ++        N  VLV E    G+L + I    ++ 
Sbjct: 109 WEFYI---GTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTP 165

Query: 381 SIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILL-----------DAEFNA 429
             V+     ++  + +   +  +H   + +IIH D+K  N +L           D     
Sbjct: 166 EKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGL 222

Query: 430 KLGDF-------------EATIPAGTMGYLAPEYVYSGVP-SEKTDVYSFGVVALEVAAG 475
            L D                T    T G+   E + S  P + + D +        +  G
Sbjct: 223 ALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVE-MLSNKPWNYQIDYFGVAATVYCMLFG 281

Query: 476 KSP 478
              
Sbjct: 282 TYM 284

>1dhk_B Bean lectin-like inhibitor, porcine pancreatic alpha-amylase; CO (hydrolase-inhibitor), complex (hydrolase-inhibitor) comple; HET: NAG; 1.85A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1viw_B* Length = 223

 Score = 95.2 bits (236), Expect = 2e-22
 Identities = 37/182 (20%), Positives = 60/182 (32%), Gaps = 33/182 (18%)

Query: 1   FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQ 60
             D  T   ASF   F+ +I          G  F++         D              
Sbjct: 51  IRDSTTGNVASFDTNFTMNIRTHRQANSAVGLDFVLVPVQPESKGD-------------- 96

Query: 61  DSFFAVEFDTSFDPSLGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRD 120
                VEFDT           + I ID+++        ++   +    G++    I Y  
Sbjct: 97  --TVTVEFDTFL---------SRISIDVNNNDI----KSVPWDVHDYDGQNAEVRITYNS 141

Query: 121 SLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGSA---IYTVDRWRF 177
           S K+  V          S  +   ++L K+  D++ VGFSA +G        + V  W F
Sbjct: 142 STKVFSVSLSNPS-TGKSNNVSTTVELEKEVYDWVSVGFSATSGAYQWSYETHDVLSWSF 200

Query: 178 KT 179
            +
Sbjct: 201 SS 202

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 97.3 bits (243), Expect = 2e-22
 Identities = 66/302 (21%), Positives = 112/302 (37%), Gaps = 81/302 (26%)

Query: 290 RIVGEGASATVYKGSLPSGG------AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHK 343
           + +GEG    V K +            VAVK   K N          +EF  +   + H 
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML-KENASPSELRDLLSEFNVLKQ-VNHP 86

Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSL--------------------DKILHNNSSSSIV 383
           ++++L G C +   L+L+ EY   GSL                          +      
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146

Query: 384 LSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--------E 435
           L+    ++    ++  + YL    E +++HRD+ A NIL+      K+ DF        E
Sbjct: 147 LTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203

Query: 436 ATIPAGTMGYL-----APEYVYSGVPSEKTDVYSFGVVALEVAA-GKSP---VDNDGCVI 486
            +    + G +     A E ++  + + ++DV+SFGV+  E+   G +P   +  +    
Sbjct: 204 DSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER--- 260

Query: 487 VDWVWNLRKKGKLLDAADFRLRGKFNRKEMER---------MLMVGLSCVHPNHEKRPSV 537
              ++NL K G              +R  MER          LM  L C     +KRP  
Sbjct: 261 ---LFNLLKTG--------------HR--MERPDNCSEEMYRLM--LQCWKQEPDKRPVF 299

Query: 538 KE 539
            +
Sbjct: 300 AD 301

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 97.4 bits (243), Expect = 3e-22
 Identities = 55/281 (19%), Positives = 102/281 (36%), Gaps = 62/281 (22%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVK-----RFEKPNRVECARNPFTTEFATMAGC 339
           + + R +G+G  A  ++     +    A K        KP+     R   + E +     
Sbjct: 43  YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPH----QREKMSMEISIHRS- 97

Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLN------I 392
           L H+++V   G+  + + + +V E     SL +                K L        
Sbjct: 98  LAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR-----------KALTEPEARYY 146

Query: 393 VLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--EATIPA---------G 441
           +  +     YLH     ++IHRD+K  N+ L+ +   K+GDF     +           G
Sbjct: 147 LRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCG 203

Query: 442 TMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLD 501
           T  Y+APE +     S + DV+S G +   +  GK P +         +     + K   
Sbjct: 204 TPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC------LKETYLRIK--- 254

Query: 502 AADFRLRGKFN---RKEMERMLMVGLSCVHPNHEKRPSVKE 539
             ++ +    N      +++ML         +   RP++ E
Sbjct: 255 KNEYSIPKHINPVAASLIQKMLQ-------TDPTARPTINE 288

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 96.5 bits (241), Expect = 3e-22
 Identities = 54/281 (19%), Positives = 102/281 (36%), Gaps = 62/281 (22%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVK-----RFEKPNRVECARNPFTTEFATMAGC 339
           + + R +G+G  A  ++     +    A K        KP+     R   + E +     
Sbjct: 17  YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPH----QREKMSMEISIHR-S 71

Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLN------I 392
           L H+++V   G+  + + + +V E     SL +                K L        
Sbjct: 72  LAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR-----------KALTEPEARYY 120

Query: 393 VLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--EATIPA---------G 441
           +  +     YLH     ++IHRD+K  N+ L+ +   K+GDF     +           G
Sbjct: 121 LRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCG 177

Query: 442 TMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLD 501
           T  Y+APE +     S + DV+S G +   +  GK P +         +     +   + 
Sbjct: 178 TPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC------LKETYLR---IK 228

Query: 502 AADFRLRGKFN---RKEMERMLMVGLSCVHPNHEKRPSVKE 539
             ++ +    N      +++ML         +   RP++ E
Sbjct: 229 KNEYSIPKHINPVAASLIQKML-------QTDPTARPTINE 262

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 96.1 bits (240), Expect = 3e-22
 Identities = 58/225 (25%), Positives = 95/225 (42%), Gaps = 40/225 (17%)

Query: 280 KQATLG-FNKNRIVGEGASATVYKG-SLPSGGAVAVK-----RFEKPNRVECARNPFTTE 332
           ++ T+  F+  R +G+G    VY      +   +A+K     + EK       R     E
Sbjct: 9   RKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRR----E 64

Query: 333 FATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLN- 391
               +  LRH N++++  +  +   + L+ E+ P G L K L              R + 
Sbjct: 65  IEIQS-HLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQK----------HGRFDE 113

Query: 392 -----IVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--EATIPA---- 440
                 +  +A AL Y HE   R++IHRD+K  N+L+  +   K+ DF      P+    
Sbjct: 114 QRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR 170

Query: 441 ---GTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDND 482
              GT+ YL PE +      EK D++  GV+  E   G  P D+ 
Sbjct: 171 TMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP 215

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 97.4 bits (243), Expect = 3e-22
 Identities = 59/229 (25%), Positives = 96/229 (41%), Gaps = 45/229 (19%)

Query: 290 RIVGEGASATVYKGSLPSGG------AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHK 343
           R +GEGA   V++   P          VAVK   K       +  F  E A MA    + 
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASADMQADFQREAALMAE-FDNP 110

Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIV-------------------- 383
           N+V+L G C  G  + L++EY+  G L++ L + S  ++                     
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170

Query: 384 LSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--------E 435
           LS  ++L I   VA+ ++YL    ER+ +HRD+   N L+      K+ DF         
Sbjct: 171 LSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227

Query: 436 ATIPAGTMGYL-----APEYVYSGVPSEKTDVYSFGVVALEVAA-GKSP 478
               A     +      PE ++    + ++DV+++GVV  E+ + G  P
Sbjct: 228 DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =   99 bits (249), Expect = 4e-22
 Identities = 43/208 (20%), Positives = 76/208 (36%), Gaps = 29/208 (13%)

Query: 290 RIVGEGASATVYKG---SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLV 346
             +  G    +Y     ++ +G  V +K     +    A+     E       + H ++V
Sbjct: 86  GCIAHGGLGWIYLALDRNV-NGRPVVLKGL-VHSGDAEAQAMAMAE-RQFLAEVVHPSIV 142

Query: 347 QL--QGWCCEGNELVLVY---EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALS 401
           Q+       + +   + Y   EY+   SL +           L   + +  +L +  ALS
Sbjct: 143 QIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK------LPVAEAIAYLLEILPALS 196

Query: 402 YLHEECERQIIHRDVKACNILLDAEFNAKLGDF-------EATIPAGTMGYLAPEYVYSG 454
           YLH      +++ D+K  NI+L  E   KL D              GT G+ APE +   
Sbjct: 197 YLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGYLYGTPGFQAPE-IVRT 251

Query: 455 VPSEKTDVYSFGVVALEVAAGKSPVDND 482
            P+  TD+Y+ G     +       +  
Sbjct: 252 GPTVATDIYTVGRTLAALTLDLPTRNGR 279

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 97.1 bits (242), Expect = 4e-22
 Identities = 46/237 (19%), Positives = 88/237 (37%), Gaps = 39/237 (16%)

Query: 280 KQATLG-FNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAG 338
           K   +  +   R + +G    +           A+K++EK    +      +        
Sbjct: 26  KDKYINDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIK 84

Query: 339 C--------------LRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHN----NSSS 380
                          ++++  +  +G     +E+ ++YEY+ N S+ K        + + 
Sbjct: 85  SKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY 144

Query: 381 SIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF------ 434
           +  +  +    I+  V ++ SY+H E  + I HRDVK  NIL+D     KL DF      
Sbjct: 145 TCFIPIQVIKCIIKSVLNSFSYIHNE--KNICHRDVKPSNILMDKNGRVKLSDFGESEYM 202

Query: 435 ---EATIPAGTMGYLAPEYV-----YSGVPSEKTDVYSFGVVALEVAAGKSPVDNDG 483
              +     GT  ++ PE+      Y+G    K D++S G+    +     P     
Sbjct: 203 VDKKIKGSRGTYEFMPPEFFSNESSYNG---AKVDIWSLGICLYVMFYNVVPFSLKI 256

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 96.7 bits (240), Expect = 1e-21
 Identities = 28/240 (11%), Positives = 72/240 (30%), Gaps = 50/240 (20%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPN------------------RVECAR 326
             +  ++G+       +     +G +  V                          +   +
Sbjct: 80  LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139

Query: 327 NPFTTE----FATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLP-------NGSLDKILH 375
           N    +    F      ++     ++     +  ++ ++  +           +  ++L 
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199

Query: 376 NNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF- 434
           ++SS+   L    RL + L V   L+ LH      ++H  ++  +I+LD      L  F 
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFE 256

Query: 435 ------EATIPAGTMGYLAPEYV----------YSGVPSEKTDVYSFGVVALEVAAGKSP 478
                  + +     G+  PE            +  + +   D ++ G+    +     P
Sbjct: 257 HLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 93.8 bits (233), Expect = 4e-21
 Identities = 44/214 (20%), Positives = 77/214 (35%), Gaps = 46/214 (21%)

Query: 356 NELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRD 415
             L +  +     +L   ++   S          L+I + +A A+ +LH    + ++HRD
Sbjct: 134 VYLYIQMQLCRKENLKDWMNRRCSLE-DREHGVCLHIFIQIAEAVEFLHS---KGLMHRD 189

Query: 416 VKACNILLDAEFNAKLGDF-----------------------EATIPAGTMGYLAPEYVY 452
           +K  NI    +   K+GDF                         T   GT  Y++PE   
Sbjct: 190 LKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE-QI 248

Query: 453 SGVP-SEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKF 511
            G   S K D++S G++  E+    S       +I D    +R   K      F  +   
Sbjct: 249 HGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITD----VR-NLKF--PLLFTQKYPQ 301

Query: 512 NRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK 545
               ++ ML        P+  +RP   +   I++
Sbjct: 302 EHMMVQDML-------SPSPTERPEATD---IIE 325

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 92.4 bits (229), Expect = 2e-20
 Identities = 45/312 (14%), Positives = 91/312 (29%), Gaps = 68/312 (21%)

Query: 277 TDIKQATLGFNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFAT 335
           +++ +      +  ++G+       +     +G +  V       R          E   
Sbjct: 66  SELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVL 125

Query: 336 MAGCLR-------------------------HKNLVQLQGWCCEGNELVLVYEY-LPNGS 369
               LR                          K +++++    +   L   + Y     +
Sbjct: 126 RLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSN 185

Query: 370 LDKI---LHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAE 426
           L      L ++SS+   L    RL + L V   L+ LH      ++H  ++  +I+LD  
Sbjct: 186 LQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQR 242

Query: 427 FNAKLGDF-------EATIPAGTMGYLAPEYVYSGVP-----------SEKTDVYSFGVV 468
               L  F          + + + G+  PE                  +   D ++ G+V
Sbjct: 243 GGVFLTGFEHLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302

Query: 469 ALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVH 528
              +     P+  D                 L  +++  R   N  +  R L+ G     
Sbjct: 303 IYWIWCADLPITKDA---------------ALGGSEWIFRSCKNIPQPVRALLEGFLRYP 347

Query: 529 PNHEKRPSVKEA 540
              E R    +A
Sbjct: 348 K--EDRLLPLQA 357

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 86.2 bits (214), Expect = 1e-18
 Identities = 52/204 (25%), Positives = 82/204 (40%), Gaps = 33/204 (16%)

Query: 290 RIVGEGASATVYKGS-LPSGGAVAVKRFEK-------PNRVECARNPFTTEFATMAGCLR 341
            I+G G S+ V +    P+    AVK  +           V+  R     E   +     
Sbjct: 23  EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82

Query: 342 HKNLVQLQGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVASAL 400
           H N++QL+          LV++ +  G L D +    +     LS ++   I+  +   +
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT-----LSEKETRKIMRALLEVI 137

Query: 401 SYLHEECERQIIHRDVKACNILLDAEFNAKLGDF----------EATIPAGTMGYLAPEY 450
             LH+     I+HRD+K  NILLD + N KL DF          +     GT  YLAPE 
Sbjct: 138 CALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 194

Query: 451 VYSGVPSEKT------DVYSFGVV 468
           +   +           D++S GV+
Sbjct: 195 IECSMNDNHPGYGKEVDMWSTGVI 218

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 85.8 bits (213), Expect = 2e-18
 Identities = 72/303 (23%), Positives = 124/303 (40%), Gaps = 66/303 (21%)

Query: 290 RIVGEGASATVYKGS-LPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           + +G+G  A V     + +G  VA+K  +K      +      E   M   L H N+V+L
Sbjct: 21  KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMK-ILNHPNIVKL 79

Query: 349 QGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLN----------IVLGVA 397
                    L L+ EY   G + D ++ +            R+           IV    
Sbjct: 80  FEVIETEKTLYLIMEYASGGEVFDYLVAH-----------GRMKEKEARSKFRQIV---- 124

Query: 398 SALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFE-ATIPA---------GTMGYLA 447
           SA+ Y H+   ++I+HRD+KA N+LLDA+ N K+ DF  +             G   Y A
Sbjct: 125 SAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAA 181

Query: 448 PEYVYSGVPSE--KTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADF 505
           PE ++ G   +  + DV+S GV+   + +G  P D         +  LR++        +
Sbjct: 182 PE-LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN------LKELRERVL---RGKY 231

Query: 506 RLRGKFN---RKEMERMLMVGLSCVHPNHEKRPSVKEAAR---ILKGEAPLPLLPVKKPT 559
           R+    +      ++R L++       N  KR ++++  +   I  G     L P  +P 
Sbjct: 232 RIPFYMSTDCENLLKRFLVL-------NPIKRGTLEQIMKDRWINAGHEEDELKPFVEPE 284

Query: 560 VNI 562
           ++I
Sbjct: 285 LDI 287

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 84.4 bits (209), Expect = 3e-18
 Identities = 19/199 (9%), Positives = 51/199 (25%), Gaps = 38/199 (19%)

Query: 292 VGEGASATVYKG---SLPSGGAVAVKRFEKPNRVECARNP-FTTEF---ATMAGCLRHKN 344
            G       ++    +L     VA+         +         E          +    
Sbjct: 39  HGGVPPLQFWQALDTAL--DRQVALTFV----DPQGVLPDDVLQETLSRTLRLSRIDKPG 92

Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           + ++          ++V E++  GSL ++   +       S    +  +  +A+A    H
Sbjct: 93  VARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAH 146

Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGTMGYLAPEYVYSGVPSEKTDVYS 464
                 +         + +  + +  L              +          + + D+  
Sbjct: 147 R---AGVALSIDHPSRVRVSIDGDVVLAYP---------ATMPDA-------NPQDDIRG 187

Query: 465 FGVVALEVAAGKSPVDNDG 483
            G     +   + P+   G
Sbjct: 188 IGASLYALLVNRWPLPEAG 206

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 83.8 bits (208), Expect = 4e-18
 Identities = 49/194 (25%), Positives = 84/194 (43%), Gaps = 22/194 (11%)

Query: 290 RIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           R +G GA   V+      SG    +K   K +R +        E   +   L H N++++
Sbjct: 28  RKLGSGAFGDVHLVEERSSGLERVIKTINK-DRSQVPMEQIEAEIEVLK-SLDHPNIIKI 85

Query: 349 QGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC 407
                + + + +V E    G L ++I+   +     LS      ++  + +AL+Y H   
Sbjct: 86  FEVFEDYHNMYIVMETCEGGELLERIVSAQARGK-ALSEGYVAELMKQMMNALAYFHS-- 142

Query: 408 ERQIIHRDVKACNILL---DAEFNAKLGDF----------EATIPAGTMGYLAPEYVYSG 454
            + ++H+D+K  NIL          K+ DF           +T  AGT  Y+APE V+  
Sbjct: 143 -QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPE-VFKR 200

Query: 455 VPSEKTDVYSFGVV 468
             + K D++S GVV
Sbjct: 201 DVTFKCDIWSAGVV 214

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 86.3 bits (214), Expect = 5e-18
 Identities = 56/205 (27%), Positives = 87/205 (42%), Gaps = 27/205 (13%)

Query: 290 RIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           + +G GA   V       +    A+K   K +    + +    E A +   L H N+++L
Sbjct: 43  KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLK-LLDHPNIMKL 101

Query: 349 QGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKR-LNIVLGVASALSYLHEE 406
             +  +     LV E    G L D+I+H    +      E     I+  V S ++YLH+ 
Sbjct: 102 YDFFEDKRNYYLVMECYKGGELFDEIIHRMKFN------EVDAAVIIKQVLSGVTYLHK- 154

Query: 407 CERQIIHRDVKACNILL---DAEFNAKLGDF----------EATIPAGTMGYLAPEYVYS 453
               I+HRD+K  N+LL   + +   K+ DF          +     GT  Y+APE V  
Sbjct: 155 --HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPE-VLR 211

Query: 454 GVPSEKTDVYSFGVVALEVAAGKSP 478
               EK DV+S GV+   + AG  P
Sbjct: 212 KKYDEKCDVWSIGVILFILLAGYPP 236

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 83.4 bits (207), Expect = 6e-18
 Identities = 53/195 (27%), Positives = 84/195 (43%), Gaps = 27/195 (13%)

Query: 290 RIVGEGASATVYKGS-LPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
            ++G+G+   V K     +    AVK   K +      +    E   +   L H N+++L
Sbjct: 28  CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK-KLDHPNIMKL 86

Query: 349 QGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKR-LNIVLGVASALSYLHEE 406
                + +   +V E    G L D+I+     S      E     I+  V S ++Y+H+ 
Sbjct: 87  FEILEDSSSFYIVGELYTGGELFDEIIKRKRFS------EHDAARIIKQVFSGITYMHK- 139

Query: 407 CERQIIHRDVKACNILL---DAEFNAKLGDF----------EATIPAGTMGYLAPEYVYS 453
               I+HRD+K  NILL   + + + K+ DF          +     GT  Y+APE V  
Sbjct: 140 --HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPE-VLR 196

Query: 454 GVPSEKTDVYSFGVV 468
           G   EK DV+S GV+
Sbjct: 197 GTYDEKCDVWSAGVI 211

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 84.8 bits (210), Expect = 6e-18
 Identities = 61/247 (24%), Positives = 100/247 (40%), Gaps = 39/247 (15%)

Query: 251 KKKRHDGRSKEDHVCTVQRVPMRLALTDIKQATLGFNKN----RIVGEGASATVYKGS-L 305
            KK +D + K       Q +     L D   A   F +      ++G G S+ V +    
Sbjct: 58  AKKLNDAQPKGTENLYFQSMGPEDELPDWAAAK-EFYQKYDPKDVIGRGVSSVVRRCVHR 116

Query: 306 PSGGAVAVKRFEK------PNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELV 359
            +G   AVK  E       P ++E  R     E   +     H +++ L       + + 
Sbjct: 117 ATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMF 176

Query: 360 LVYEYLPNGSL-DKILHNNSSSSIVLSWEKR-LNIVLGVASALSYLHEECERQIIHRDVK 417
           LV++ +  G L D +    + S      EK   +I+  +  A+S+LH      I+HRD+K
Sbjct: 177 LVFDLMRKGELFDYLTEKVALS------EKETRSIMRSLLEAVSFLHA---NNIVHRDLK 227

Query: 418 ACNILLDAEFNAKLGDF----------EATIPAGTMGYLAPEYVYSGVP------SEKTD 461
             NILLD     +L DF          +     GT GYLAPE +   +        ++ D
Sbjct: 228 PENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVD 287

Query: 462 VYSFGVV 468
           +++ GV+
Sbjct: 288 LWACGVI 294

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 83.4 bits (207), Expect = 1e-17
 Identities = 53/195 (27%), Positives = 85/195 (43%), Gaps = 29/195 (14%)

Query: 290 RIVGEGASATVYKGS-LPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
            ++G GA + V+      +G   A+K  +K        +    E A +   ++H+N+V L
Sbjct: 15  EVLGSGAFSEVFLVKQRLTGKLFALKCIKK--SPAFRDSSLENEIAVLKK-IKHENIVTL 71

Query: 349 QGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKR-LNIVLGVASALSYLHEE 406
           +          LV + +  G L D+IL     +      EK    ++  V SA+ YLH  
Sbjct: 72  EDIYESTTHYYLVMQLVSGGELFDRILERGVYT------EKDASLVIQQVLSAVKYLH-- 123

Query: 407 CERQIIHRDVKACNILL---DAEFNAKLGDF---------EATIPAGTMGYLAPEYVYSG 454
            E  I+HRD+K  N+L    +      + DF           +   GT GY+APE V + 
Sbjct: 124 -ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPE-VLAQ 181

Query: 455 VP-SEKTDVYSFGVV 468
            P S+  D +S GV+
Sbjct: 182 KPYSKAVDCWSIGVI 196

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 81.9 bits (203), Expect = 2e-17
 Identities = 63/238 (26%), Positives = 92/238 (38%), Gaps = 56/238 (23%)

Query: 290 RIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           + +GEGA   V    +  +  AVAVK  +    V+C  N    E       L H+N+V+ 
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN-IKKEICINK-MLNHENVVKF 70

Query: 349 QGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLN----------IVLGVA 397
            G   EGN   L  EY   G L D+I  +             +           ++    
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPD-----------IGMPEPDAQRFFHQLM---- 115

Query: 398 SALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-EATIPA------------GTMG 444
           + + YLH      I HRD+K  N+LLD   N K+ DF  AT+              GT+ 
Sbjct: 116 AGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172

Query: 445 YLAPEYV----YSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGK 498
           Y+APE +    +     E  DV+S G+V   + AG+ P D                 +
Sbjct: 173 YVAPELLKRREFHA---EPVDVWSCGIVLTAMLAGELPWDQPSDSCQ----EYSDWKE 223

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 82.7 bits (205), Expect = 2e-17
 Identities = 48/225 (21%), Positives = 89/225 (39%), Gaps = 39/225 (17%)

Query: 267 VQRVPMRLALTDIKQATLGFNKN----RIVGEGASATVYKG-SLPSGGAVAVKRFEKPNR 321
           +Q V +   +  + + ++ F         +G G+ +   +     +    AVK  +K ++
Sbjct: 1   MQTVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK-SK 59

Query: 322 VECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSL-DKILHNNSSS 380
            +        E   +    +H N++ L+    +G  + +V E +  G L DKIL     S
Sbjct: 60  RDPTE-----EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFS 114

Query: 381 SIVLSWEKR-LNIVLGVASALSYLHEECERQIIHRDVKACNILL-DAEFNA---KLGDF- 434
                 E+    ++  +   + YLH    + ++HRD+K  NIL  D   N    ++ DF 
Sbjct: 115 ------EREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFG 165

Query: 435 ----------EATIPAGTMGYLAPEYVYSGVP-SEKTDVYSFGVV 468
                         P  T  ++APE V          D++S GV+
Sbjct: 166 FAKQLRAENGLLMTPCYTANFVAPE-VLERQGYDAACDIWSLGVL 209

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 81.4 bits (202), Expect = 3e-17
 Identities = 45/154 (29%), Positives = 74/154 (48%), Gaps = 16/154 (10%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARN--PFTT--EFATMAGCL 340
           F K   +GEG    VYK  +  +G  VA+K+     R++      P T   E + +   L
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKI----RLDTETEGVPSTAIREISLLKE-L 59

Query: 341 RHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASAL 400
            H N+V+L       N+L LV+E+L    L K +  ++ + I L   K    +  +   L
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSY--LFQLLQGL 116

Query: 401 SYLHEECERQIIHRDVKACNILLDAEFNAKLGDF 434
           ++ H     +++HRD+K  N+L++ E   KL DF
Sbjct: 117 AFCHS---HRVLHRDLKPQNLLINTEGAIKLADF 147

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 83.6 bits (207), Expect = 4e-17
 Identities = 57/207 (27%), Positives = 91/207 (43%), Gaps = 30/207 (14%)

Query: 290 RIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNP--FTTEFATMAGCLRHKNLV 346
           R++G+G+   V       +G   AVK   K  +V+   +      E   +   L H N++
Sbjct: 32  RVLGKGSFGEVILCKDKITGQECAVKVISK-RQVKQKTDKESLLREVQLLK-QLDHPNIM 89

Query: 347 QLQGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKR-LNIVLGVASALSYLH 404
           +L  +  +     LV E    G L D+I+     S      E     I+  V S ++Y+H
Sbjct: 90  KLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFS------EVDAARIIRQVLSGITYMH 143

Query: 405 EECERQIIHRDVKACNILL---DAEFNAKLGDF----------EATIPAGTMGYLAPEYV 451
           +    +I+HRD+K  N+LL     + N ++ DF          +     GT  Y+APE V
Sbjct: 144 K---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE-V 199

Query: 452 YSGVPSEKTDVYSFGVVALEVAAGKSP 478
             G   EK DV+S GV+   + +G  P
Sbjct: 200 LHGTYDEKCDVWSTGVILYILLSGCPP 226

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 81.6 bits (202), Expect = 4e-17
 Identities = 60/302 (19%), Positives = 102/302 (33%), Gaps = 69/302 (22%)

Query: 290 RIVGEGASATVYKGS-LPSGGAVAVKRFEKPNRVECARNPFTT----EFATMA---GCLR 341
            ++G+G   TV+ G  L     VA+K   +   +  +    +     E A +        
Sbjct: 37  PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96

Query: 342 HKNLVQLQGWCCEGNELVLVYEYLPNGS--LDKILHNNSSSSIVLSWEKRLNIVLG---- 395
           H  +++L  W       +LV E         D I                L         
Sbjct: 97  HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK-----------GPLGEGPSRCFF 145

Query: 396 --VASALSYLHEECERQIIHRDVKACNILLDAEFNA-KLGDF--EATIP-------AGTM 443
             V +A+ + H    R ++HRD+K  NIL+D      KL DF   A +         GT 
Sbjct: 146 GQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTR 202

Query: 444 GYLAPEYV----YSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKL 499
            Y  PE++    Y         V+S G++  ++  G  P + D               + 
Sbjct: 203 VYSPPEWISRHQYHA---LPATVWSLGILLYDMVCGDIPFERD---------------QE 244

Query: 500 LDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR---ILKGEAPLPLLPVK 556
           +  A+       +  +   ++     C+ P    RPS++E      +      +PL P K
Sbjct: 245 ILEAELHFPAHVS-PDCCALIR---RCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSK 300

Query: 557 KP 558
             
Sbjct: 301 GG 302

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 81.6 bits (202), Expect = 4e-17
 Identities = 63/238 (26%), Positives = 92/238 (38%), Gaps = 56/238 (23%)

Query: 290 RIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           + +GEGA   V    +  +  AVAVK  +    V+C  N    E       L H+N+V+ 
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN-IKKEICINK-MLNHENVVKF 70

Query: 349 QGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLN----------IVLGVA 397
            G   EGN   L  EY   G L D+I  +             +           ++    
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPD-----------IGMPEPDAQRFFHQLM---- 115

Query: 398 SALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-EATIPA------------GTMG 444
           + + YLH      I HRD+K  N+LLD   N K+ DF  AT+              GT+ 
Sbjct: 116 AGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172

Query: 445 YLAPEYV----YSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGK 498
           Y+APE +    +     E  DV+S G+V   + AG+ P D                 +
Sbjct: 173 YVAPELLKRREFHA---EPVDVWSCGIVLTAMLAGELPWDQPSDSCQ----EYSDWKE 223

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 81.2 bits (201), Expect = 6e-17
 Identities = 57/289 (19%), Positives = 97/289 (33%), Gaps = 78/289 (26%)

Query: 290 RIVGEGASATVYKG-SLPSGGAVAVKRFEKP--NRVECARNPFTTEFATMAGCLRHKNLV 346
            ++GEG+   V +     +    AVK  +K    R+         E   +   LRHKN++
Sbjct: 11  DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLR-RLRHKNVI 69

Query: 347 QL-QGWCCE-GNELVLVYEYLPNGS---LDKILHNNSSSSIVLSWEKRLN---------- 391
           QL      E   ++ +V EY   G    LD +              KR            
Sbjct: 70  QLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE------------KRFPVCQAHGYFCQ 117

Query: 392 IVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--EATIPAGTMG----- 444
           ++      L YLH    + I+H+D+K  N+LL      K+        +           
Sbjct: 118 LI----DGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT 170

Query: 445 ------YLAPEYV-----YSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNL 493
                 +  PE       +SG    K D++S GV    +  G  P + D       ++ L
Sbjct: 171 SQGSPAFQPPEIANGLDTFSGF---KVDIWSAGVTLYNITTGLYPFEGDN------IYKL 221

Query: 494 RKKGKLLDAADFRLRGKFN---RKEMERMLMVGLSCVHPNHEKRPSVKE 539
            +    +    + + G         ++ ML            KR S+++
Sbjct: 222 FEN---IGKGSYAIPGDCGPPLSDLLKGML-------EYEPAKRFSIRQ 260

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 82.8 bits (205), Expect = 7e-17
 Identities = 54/207 (26%), Positives = 84/207 (40%), Gaps = 38/207 (18%)

Query: 290 RIVGEGASATVYKG-SLPSGGAVAVKRFEK-----------PNRVECARNPFTTEFATMA 337
           R +G GA   V            A+K  +K              +E        E + + 
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101

Query: 338 GCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKR-LNIVLG 395
             L H N+++L     +     LV E+   G L ++I++ +         E    NI+  
Sbjct: 102 -SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFD------ECDAANIMKQ 154

Query: 396 VASALSYLHEECERQIIHRDVKACNILL---DAEFNAKLGDF----------EATIPAGT 442
           + S + YLH+     I+HRD+K  NILL   ++  N K+ DF          +     GT
Sbjct: 155 ILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGT 211

Query: 443 MGYLAPEYVYSGVPSEKTDVYSFGVVA 469
             Y+APE V     +EK DV+S GV+ 
Sbjct: 212 AYYIAPE-VLKKKYNEKCDVWSCGVIM 237

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 81.7 bits (202), Expect = 1e-16
 Identities = 53/196 (27%), Positives = 84/196 (42%), Gaps = 27/196 (13%)

Query: 290 RIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
            ++G+G+   V K     +    AVK   K +      +    E   +   L H N+++L
Sbjct: 28  CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK-KLDHPNIMKL 86

Query: 349 QGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKR-LNIVLGVASALSYLHEE 406
                + +   +V E    G L D+I+     S      E     I+  V S ++Y+H+ 
Sbjct: 87  FEILEDSSSFYIVGELYTGGELFDEIIKRKRFS------EHDAARIIKQVFSGITYMHK- 139

Query: 407 CERQIIHRDVKACNILL---DAEFNAKLGDF----------EATIPAGTMGYLAPEYVYS 453
               I+HRD+K  NILL   + + + K+ DF          +     GT  Y+APE V  
Sbjct: 140 --HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPE-VLR 196

Query: 454 GVPSEKTDVYSFGVVA 469
           G   EK DV+S GV+ 
Sbjct: 197 GTYDEKCDVWSAGVIL 212

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 79.5 bits (197), Expect = 1e-16
 Identities = 45/156 (28%), Positives = 73/156 (46%), Gaps = 22/156 (14%)

Query: 286 FNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARN--PFTT--EFATMAGCLR 341
           ++    +GEG    VYK     G   A+K+     R+E      P TT  E + +   L+
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNNYGETFALKKI----RLEKEDEGIPSTTIREISILKE-LK 58

Query: 342 HKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNS---SSSIVLSWEKRLNIVLGVAS 398
           H N+V+L         LVLV+E+L    L K+L        S    S+  +L       +
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQL------LN 111

Query: 399 ALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF 434
            ++Y H+   R+++HRD+K  N+L++ E   K+ DF
Sbjct: 112 GIAYCHD---RRVLHRDLKPQNLLINREGELKIADF 144

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 79.7 bits (197), Expect = 2e-16
 Identities = 53/222 (23%), Positives = 83/222 (37%), Gaps = 47/222 (21%)

Query: 290 RIVGEGASATVYKGS-LPSGGAVAVKRFEKPNRVECARNPFTT----EFATMAGCLRHK- 343
            ++G G   +VY G  +     VA+K  EK    +    P  T    E   +   +    
Sbjct: 49  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK-KVSSGF 107

Query: 344 -NLVQLQGWCCEGNELVLVYEY-LPNGSL-DKILHNNSSSSIVLSWEKRLNIVLG----- 395
             +++L  W    +  VL+ E   P   L D I                L   L      
Sbjct: 108 SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-----------GALQEELARSFFW 156

Query: 396 -VASALSYLHEECERQIIHRDVKACNILLDAE-FNAKLGDF--EATIP-------AGTMG 444
            V  A+ + H      ++HRD+K  NIL+D      KL DF   A +         GT  
Sbjct: 157 QVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV 213

Query: 445 YLAPEYV----YSGVPSEKTDVYSFGVVALEVAAGKSPVDND 482
           Y  PE++    Y G  +    V+S G++  ++  G  P ++D
Sbjct: 214 YSPPEWIRYHRYHGRSA---AVWSLGILLYDMVCGDIPFEHD 252

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 80.1 bits (198), Expect = 2e-16
 Identities = 51/196 (26%), Positives = 84/196 (42%), Gaps = 32/196 (16%)

Query: 290 RIVGEGASATVYKGS-LPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
             +G GA++ VY+     +    A+K  +K    +  R     E   +   L H N+++L
Sbjct: 59  SELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRT----EIGVLLR-LSHPNIIKL 113

Query: 349 QGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKR-LNIVLGVASALSYLHEE 406
           +       E+ LV E +  G L D+I+     S      E+   + V  +  A++YLH  
Sbjct: 114 KEIFETPTEISLVLELVTGGELFDRIVEKGYYS------ERDAADAVKQILEAVAYLH-- 165

Query: 407 CERQIIHRDVKACNILL---DAEFNAKLGDF----------EATIPAGTMGYLAPEYVYS 453
            E  I+HRD+K  N+L      +   K+ DF                GT GY APE +  
Sbjct: 166 -ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPE-ILR 223

Query: 454 GVP-SEKTDVYSFGVV 468
           G     + D++S G++
Sbjct: 224 GCAYGPEVDMWSVGII 239

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 80.9 bits (200), Expect = 2e-16
 Identities = 51/204 (25%), Positives = 81/204 (39%), Gaps = 36/204 (17%)

Query: 290 RIVGEGASATVYKG-SLPSGGAVAVKRFEK------PNRVECARNPFTTEFATMAGCLRH 342
           + +G GA   V       +   VA++   K        R         TE   +   L H
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKK-LNH 199

Query: 343 KNLVQLQGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVASALS 401
             +++++ +  +  +  +V E +  G L DK++ N       L           +  A+ 
Sbjct: 200 PCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKR-----LKEATCKLYFYQMLLAVQ 253

Query: 402 YLHEECERQIIHRDVKACNILL---DAEFNAKLGDF-------EATIP---AGTMGYLAP 448
           YLHE     IIHRD+K  N+LL   + +   K+ DF       E ++     GT  YLAP
Sbjct: 254 YLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 310

Query: 449 EYVYSGVP----SEKTDVYSFGVV 468
           E V   V     +   D +S GV+
Sbjct: 311 E-VLVSVGTAGYNRAVDCWSLGVI 333

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 78.7 bits (195), Expect = 2e-16
 Identities = 42/157 (26%), Positives = 70/157 (44%), Gaps = 23/157 (14%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARN--PFTT--EFATMAGCL 340
           + K   +GEG   TV+K  +  +   VA+KR     R++      P +   E   +   L
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRV----RLDDDDEGVPSSALREICLLKE-L 58

Query: 341 RHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNS---SSSIVLSWEKRLNIVLGVA 397
           +HKN+V+L        +L LV+E+     L K   + +      IV S+  +L       
Sbjct: 59  KHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQL------L 111

Query: 398 SALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF 434
             L + H    R ++HRD+K  N+L++     KL +F
Sbjct: 112 KGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANF 145

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 80.4 bits (199), Expect = 3e-16
 Identities = 45/197 (22%), Positives = 77/197 (39%), Gaps = 29/197 (14%)

Query: 290 RIVGEGASATVYKGS-LPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
             +G+GA + V +   + +G   A                   E       L+H N+V+L
Sbjct: 17  EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRL-LKHPNIVRL 75

Query: 349 QGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKR-LNIVLGVASALSYLHEE 406
                E     L+++ +  G L + I+     S      E    + +  +  A+ + H  
Sbjct: 76  HDSISEEGHHYLIFDLVTGGELFEDIVAREYYS------EADASHCIQQILEAVLHCH-- 127

Query: 407 CERQIIHRDVKACNILL-DAEFNA--KLGDF-----------EATIPAGTMGYLAPEYVY 452
            +  ++HR++K  N+LL      A  KL DF                AGT GYL+PE V 
Sbjct: 128 -QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPE-VL 185

Query: 453 SGVP-SEKTDVYSFGVV 468
              P  +  D+++ GV+
Sbjct: 186 RKDPYGKPVDLWACGVI 202

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 79.2 bits (196), Expect = 3e-16
 Identities = 50/202 (24%), Positives = 83/202 (41%), Gaps = 33/202 (16%)

Query: 290 RIVGEGASATVYKG-SLPSGGAVAVK----RFEKPNRVECARNPFTTEFATMAGCLRHKN 344
             +G G  A V K     +G   A K    R  + +R   +R     E + +   + H N
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR-QVLHHN 76

Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRL-NIVLGVASALSY 402
           ++ L        ++VL+ E +  G L D +    S S      E+   + +  +   ++Y
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFDFLAQKESLS------EEEATSFIKQILDGVNY 130

Query: 403 LHEECERQIIHRDVKACNILL-DAEFNA---KLGDF----------EATIPAGTMGYLAP 448
           LH    ++I H D+K  NI+L D        KL DF          E     GT  ++AP
Sbjct: 131 LH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187

Query: 449 EYVYSGVP-SEKTDVYSFGVVA 469
           E + +  P   + D++S GV+ 
Sbjct: 188 E-IVNYEPLGLEADMWSIGVIT 208

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 78.8 bits (195), Expect = 3e-16
 Identities = 44/156 (28%), Positives = 70/156 (44%), Gaps = 22/156 (14%)

Query: 286 FNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARN--PFTT--EFATMAGCLR 341
           + K   VGEG    VYK     G  VA+KR     R++      P T   E + +   L 
Sbjct: 23  YQKLEKVGEGTYGVVYKAKDSQGRIVALKRI----RLDAEDEGIPSTAIREISLLKE-LH 77

Query: 342 HKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNS---SSSIVLSWEKRLNIVLGVAS 398
           H N+V L         L LV+E++    L K+L  N      S +  +  +L        
Sbjct: 78  HPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQL------LR 130

Query: 399 ALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF 434
            +++ H+    +I+HRD+K  N+L++++   KL DF
Sbjct: 131 GVAHCHQ---HRILHRDLKPQNLLINSDGALKLADF 163

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 78.0 bits (193), Expect = 4e-16
 Identities = 65/284 (22%), Positives = 106/284 (37%), Gaps = 76/284 (26%)

Query: 290 RIVGEGASATVYKGS-LPSGGAVAVKRFEK--------PNRVECARNPFTTEFATMAGCL 340
             +G G    V  G    +G  VAVK   +          +++        E   +    
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIK-------REIQNLKL-F 68

Query: 341 RHKNLVQL-QGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLG--- 395
           RH ++++L Q       +  +V EY+  G L D I  +            R+  +     
Sbjct: 69  RHPHIIKLYQVISTP-TDFFMVMEYVSGGELFDYICKH-----------GRVEEMEARRL 116

Query: 396 ---VASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--EATIPAGTM------- 443
              + SA+ Y H      ++HRD+K  N+LLDA  NAK+ DF     +  G         
Sbjct: 117 FQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGS 173

Query: 444 -GYLAPEYV----YSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGK 498
             Y APE +    Y+G    + D++S GV+   +  G  P D++          L KK  
Sbjct: 174 PNYAAPEVISGRLYAG---PEVDIWSCGVILYALLCGTLPFDDEHVP------TLFKK-- 222

Query: 499 LLDAADFRLRGKFN---RKEMERMLMVGLSCVHPNHEKRPSVKE 539
            +    F +    N      +  ML V       +  KR ++K+
Sbjct: 223 -IRGGVFYIPEYLNRSVATLLMHMLQV-------DPLKRATIKD 258

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 78.8 bits (195), Expect = 4e-16
 Identities = 48/196 (24%), Positives = 82/196 (41%), Gaps = 23/196 (11%)

Query: 290 RIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           + +G G  A V +  S  +G   A K  +K  R +  R     E A +        ++ L
Sbjct: 35  KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINL 94

Query: 349 QGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC 407
                  +E++L+ EY   G +    L   +     +S    + ++  +   + YLH   
Sbjct: 95  HEVYENTSEIILILEYAAGGEIFSLCLPELAEM---VSENDVIRLIKQILEGVYYLH--- 148

Query: 408 ERQIIHRDVKACNILL---DAEFNAKLGDF----------EATIPAGTMGYLAPEYVYSG 454
           +  I+H D+K  NILL       + K+ DF          E     GT  YLAPE + + 
Sbjct: 149 QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPE-ILNY 207

Query: 455 VP-SEKTDVYSFGVVA 469
            P +  TD+++ G++A
Sbjct: 208 DPITTATDMWNIGIIA 223

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 79.4 bits (196), Expect = 4e-16
 Identities = 49/238 (20%), Positives = 92/238 (38%), Gaps = 30/238 (12%)

Query: 251 KKKRHDGRSKEDHVCTVQRVPMRLALTDIKQATLGFNKN----RIVGEGASATVYKG-SL 305
            + ++DG    D+    + +  +     ++               +G GA   V++    
Sbjct: 14  VRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEK 73

Query: 306 PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYL 365
            +G     K    P  ++  +     E + M   L H  L+ L     +  E+VL+ E+L
Sbjct: 74  ATGRVFVAKFINTPYPLD--KYTVKNEISIMN-QLHHPKLINLHDAFEDKYEMVLILEFL 130

Query: 366 PNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLD 424
             G L D+I   +      +S  + +N +      L ++H   E  I+H D+K  NI+ +
Sbjct: 131 SGGELFDRIAAEDYK----MSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCE 183

Query: 425 AEFNA--KLGDF----------EATIPAGTMGYLAPEYV-YSGVPSEKTDVYSFGVVA 469
            +  +  K+ DF             +   T  + APE V    V    TD+++ GV+ 
Sbjct: 184 TKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPV-GFYTDMWAIGVLG 240

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 78.5 bits (194), Expect = 5e-16
 Identities = 51/198 (25%), Positives = 80/198 (40%), Gaps = 31/198 (15%)

Query: 288 KNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLV 346
           K++ +GEG+ +   K     S  A AVK   K       +     E   +  C  H N+V
Sbjct: 15  KDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK-----EITALKLCEGHPNIV 69

Query: 347 QLQGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKR-LNIVLGVASALSYLH 404
           +L     +     LV E L  G L ++I      S      E     I+  + SA+S++H
Sbjct: 70  KLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFS------ETEASYIMRKLVSAVSHMH 123

Query: 405 EECERQIIHRDVKACNILL---DAEFNAKLGDF-----------EATIPAGTMGYLAPEY 450
              +  ++HRD+K  N+L    +     K+ DF               P  T+ Y APE 
Sbjct: 124 ---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPEL 180

Query: 451 VYSGVPSEKTDVYSFGVV 468
           +      E  D++S GV+
Sbjct: 181 LNQNGYDESCDLWSLGVI 198

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 77.6 bits (192), Expect = 5e-16
 Identities = 48/195 (24%), Positives = 77/195 (39%), Gaps = 29/195 (14%)

Query: 290 RIVGEGASATVYKGS-LPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
             +G G+   V       +    A K+  K   VE   + F  E   M   L H N+++L
Sbjct: 15  NTIGRGSWGEVKIAVQKGTRIRRAAKKIPK-YFVE-DVDRFKQEIEIMK-SLDHPNIIRL 71

Query: 349 QGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKR-LNIVLGVASALSYLHEE 406
                +  ++ LV E    G L ++++H           E     I+  V SA++Y H+ 
Sbjct: 72  YETFEDNTDIYLVMELCTGGELFERVVHKRVFR------ESDAARIMKDVLSAVAYCHK- 124

Query: 407 CERQIIHRDVKACNILL---DAEFNAKLGDF----------EATIPAGTMGYLAPEYVYS 453
               + HRD+K  N L      +   KL DF                GT  Y++P+ V  
Sbjct: 125 --LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQ-VLE 181

Query: 454 GVPSEKTDVYSFGVV 468
           G+   + D +S GV+
Sbjct: 182 GLYGPECDEWSAGVM 196

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 78.5 bits (194), Expect = 6e-16
 Identities = 41/194 (21%), Positives = 71/194 (36%), Gaps = 31/194 (15%)

Query: 293 GEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           G G +  V +     +G   A+K      +          E           ++V +   
Sbjct: 38  GLGVNGKVLECFHRRTGQKCALKLLYDSPKAR-------QEVDHHWQASGGPHIVCILDV 90

Query: 352 CCEGNE----LVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEE 406
               +     L+++ E +  G L  +I      +    +  +   I+  + +A+ +LH  
Sbjct: 91  YENMHHGKRCLLIIMECMEGGELFSRIQERGDQA---FTEREAAEIMRDIGTAIQFLHS- 146

Query: 407 CERQIIHRDVKACNILL-DAEFNA--KLGDF---------EATIPAGTMGYLAPEYVYSG 454
               I HRDVK  N+L    E +A  KL DF             P  T  Y+APE +   
Sbjct: 147 --HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPE 204

Query: 455 VPSEKTDVYSFGVV 468
              +  D++S GV+
Sbjct: 205 KYDKSCDMWSLGVI 218

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 77.6 bits (192), Expect = 6e-16
 Identities = 47/195 (24%), Positives = 79/195 (40%), Gaps = 26/195 (13%)

Query: 290 RIVGEGASATVYKGS-LPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
             +G+GA + V +     +G   A K                 E       L+H N+V+L
Sbjct: 12  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK-LQHPNIVRL 70

Query: 349 QGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC 407
                E +   LV++ +  G L + I+          S     + +  +  +++Y H   
Sbjct: 71  HDSIQEESFHYLVFDLVTGGELFEDIVAREF-----YSEADASHCIQQILESIAYCHS-- 123

Query: 408 ERQIIHRDVKACNILLDAEFNA---KLGDF----------EATIPAGTMGYLAPEYVYSG 454
              I+HR++K  N+LL ++      KL DF               AGT GYL+PE V   
Sbjct: 124 -NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE-VLKK 181

Query: 455 VP-SEKTDVYSFGVV 468
            P S+  D+++ GV+
Sbjct: 182 DPYSKPVDIWACGVI 196

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 79.0 bits (195), Expect = 6e-16
 Identities = 55/199 (27%), Positives = 89/199 (44%), Gaps = 26/199 (13%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
            +K  I+G G    V+K     +G  +A K  +     +  +     E + M   L H N
Sbjct: 91  VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD--KEEVKNEISVMN-QLDHAN 147

Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
           L+QL       N++VLV EY+  G L D+I+  + +    L+    +  +  +   + ++
Sbjct: 148 LIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYN----LTELDTILFMKQICEGIRHM 203

Query: 404 HEECERQIIHRDVKACNILLDAEFNA--KLGDF----------EATIPAGTMGYLAPEYV 451
           H+     I+H D+K  NIL         K+ DF          +  +  GT  +LAPE V
Sbjct: 204 HQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVV 260

Query: 452 -YSGVPSEKTDVYSFGVVA 469
            Y  V S  TD++S GV+A
Sbjct: 261 NYDFV-SFPTDMWSVGVIA 278

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 78.5 bits (194), Expect = 6e-16
 Identities = 49/202 (24%), Positives = 82/202 (40%), Gaps = 33/202 (16%)

Query: 290 RIVGEGASATVYKG-SLPSGGAVAVK----RFEKPNRVECARNPFTTEFATMAGCLRHKN 344
             +G G  A V K     +G   A K    R  + +R    R     E + +   + H N
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR-QVLHPN 76

Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRL-NIVLGVASALSY 402
           ++ L        ++VL+ E +  G L D +    S S      E+   + +  +   ++Y
Sbjct: 77  IITLHDVYENRTDVVLILELVSGGELFDFLAQKESLS------EEEATSFIKQILDGVNY 130

Query: 403 LHEECERQIIHRDVKACNILL----DAEFNAKLGDF----------EATIPAGTMGYLAP 448
           LH    ++I H D+K  NI+L        + KL DF          E     GT  ++AP
Sbjct: 131 LH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187

Query: 449 EYVYSGVP-SEKTDVYSFGVVA 469
           E + +  P   + D++S GV+ 
Sbjct: 188 E-IVNYEPLGLEADMWSIGVIT 208

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 78.1 bits (193), Expect = 6e-16
 Identities = 43/161 (26%), Positives = 75/161 (46%), Gaps = 27/161 (16%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARN--PFTT--EFATMAGCL 340
           + +   +GEG    VYK     +   VA+KR     R+E      P T   E + +   L
Sbjct: 36  YRRITKLGEGTYGEVYKAIDTVTNETVAIKRI----RLEHEEEGVPGTAIREVSLLKE-L 90

Query: 341 RHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNS--SSSIVLSWEKRLNIVLGVAS 398
           +H+N+++L+      + L L++EY  N  L K +  N   S  ++ S+  +L       +
Sbjct: 91  QHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQL------IN 143

Query: 399 ALSYLHEECERQIIHRDVKACNILLDAEFNA-----KLGDF 434
            +++ H    R+ +HRD+K  N+LL     +     K+GDF
Sbjct: 144 GVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDF 181

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 77.6 bits (192), Expect = 9e-16
 Identities = 45/178 (25%), Positives = 69/178 (38%), Gaps = 24/178 (13%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTT--EFATMAGCLRH 342
           + K   +GEG+   V+K  +  +G  VA+K+F +               E   +   L+H
Sbjct: 5   YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVI--KKIALREIRMLKQ-LKH 61

Query: 343 KNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
            NLV L         L LV+EY  + ++   L         +      +I      A+++
Sbjct: 62  PNLVNLLEVFRRKRRLHLVFEYCDH-TVLHEL---DRYQRGVPEHLVKSITWQTLQAVNF 117

Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDF----EATIPAGTMG-------YLAPE 449
            H+      IHRDVK  NIL+      KL DF      T P+           Y +PE
Sbjct: 118 CHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPE 172

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 76.8 bits (190), Expect = 1e-15
 Identities = 49/201 (24%), Positives = 81/201 (40%), Gaps = 31/201 (15%)

Query: 290 RIVGEGASATVYKG-SLPSGGAVAVK----RFEKPNRVECARNPFTTEFATMAGCLRHKN 344
             +G G  A V K     +G   A K    R    +R   +R     E   +   +RH N
Sbjct: 11  EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR-EIRHPN 69

Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
           ++ L        ++VL+ E +  G L D +    S     L+ ++    +  +   + YL
Sbjct: 70  IITLHDIFENKTDVVLILELVSGGELFDFLAEKES-----LTEDEATQFLKQILDGVHYL 124

Query: 404 HEECERQIIHRDVKACNILL---DAEFNA-KLGDF----------EATIPAGTMGYLAPE 449
           H    ++I H D+K  NI+L   +      KL DF          E     GT  ++APE
Sbjct: 125 H---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE 181

Query: 450 YVYSGVP-SEKTDVYSFGVVA 469
            + +  P   + D++S GV+ 
Sbjct: 182 -IVNYEPLGLEADMWSIGVIT 201

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 77.3 bits (191), Expect = 1e-15
 Identities = 47/157 (29%), Positives = 70/157 (44%), Gaps = 24/157 (15%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVK--RFEKPNRVECARNPFTT--EFATMAGCL 340
           + K   +GEG  ATVYKG S  +   VA+K  R E          P T   E + +   L
Sbjct: 4   YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA-----PCTAIREVSLLKD-L 57

Query: 341 RHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNS---SSSIVLSWEKRLNIVLGVA 397
           +H N+V L         L LV+EYL    L + L +     +   V  +  +L       
Sbjct: 58  KHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQL------L 110

Query: 398 SALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF 434
             L+Y H    ++++HRD+K  N+L++     KL DF
Sbjct: 111 RGLAYCHR---QKVLHRDLKPQNLLINERGELKLADF 144

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 77.3 bits (191), Expect = 1e-15
 Identities = 57/205 (27%), Positives = 84/205 (40%), Gaps = 40/205 (19%)

Query: 293 GEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGW 351
           GEGA A V    +L +    AVK  EK  +    R+    E   +  C  H+N+++L  +
Sbjct: 22  GEGAHARVQTCINLITSQEYAVKIIEK--QPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79

Query: 352 CCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKR-LNIVLGVASALSYLHEECER 409
             E +   LV+E +  GS+   I      +      E     +V  VASAL +LH    +
Sbjct: 80  FEEEDRFYLVFEKMRGGSILSHIHKRRHFN------ELEASVVVQDVASALDFLH---NK 130

Query: 410 QIIHRDVKACNILL---DAEFNAKLGDF------------------EATIPAGTMGYLAP 448
            I HRD+K  NIL    +     K+ DF                  E   P G+  Y+AP
Sbjct: 131 GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190

Query: 449 EYVYSGVPSEKT-----DVYSFGVV 468
           E V +            D++S GV+
Sbjct: 191 EVVEAFSEEASIYDKRCDLWSLGVI 215

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 77.2 bits (191), Expect = 1e-15
 Identities = 44/156 (28%), Positives = 71/156 (45%), Gaps = 18/156 (11%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARN-PFTT--EFATMAGCLR 341
           + K   +GEG  ATVYK     +   VA+K+ +  +R E       T   E   +   L 
Sbjct: 12  YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE-LS 70

Query: 342 HKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNS---SSSIVLSWEKRLNIVLGVAS 398
           H N++ L       + + LV++++    L+ I+ +NS   + S + ++            
Sbjct: 71  HPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMT------LQ 123

Query: 399 ALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF 434
            L YLH+     I+HRD+K  N+LLD     KL DF
Sbjct: 124 GLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADF 156

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 76.9 bits (190), Expect = 2e-15
 Identities = 39/197 (19%), Positives = 75/197 (38%), Gaps = 31/197 (15%)

Query: 290 RIVGEGASATVYKG-SLPSGGAVAVKRFEK-PNRVECARNPFTTEFATMAGCLRHKNLVQ 347
             +G G    V++     S      K  +         +     E + +    RH+N++ 
Sbjct: 11  EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKK----EISILN-IARHRNILH 65

Query: 348 LQGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKR-LNIVLGVASALSYLHE 405
           L        ELV+++E++    + ++I  +    +     E+  ++ V  V  AL +LH 
Sbjct: 66  LHESFESMEELVMIFEFISGLDIFERINTSAFELN-----EREIVSYVHQVCEALQFLH- 119

Query: 406 ECERQIIHRDVKACNILLDAEFNA--KLGDF----------EATIPAGTMGYLAPEYVYS 453
                I H D++  NI+     ++  K+ +F             +      Y APE V+ 
Sbjct: 120 --SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPE-VHQ 176

Query: 454 GVP-SEKTDVYSFGVVA 469
               S  TD++S G + 
Sbjct: 177 HDVVSTATDMWSLGTLV 193

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 76.9 bits (190), Expect = 2e-15
 Identities = 39/152 (25%), Positives = 67/152 (44%), Gaps = 13/152 (8%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTT--EFATMAGCLRH 342
           +    +VGEG+   V K  +  +G  VA+K+F + +  +          E   +   LRH
Sbjct: 27  YENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMV--KKIAMREIKLLKQ-LRH 83

Query: 343 KNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
           +NLV L   C +     LV+E++ + ++   L         L ++     +  + + + +
Sbjct: 84  ENLVNLLEVCKKKKRWYLVFEFVDH-TILDDL---ELFPNGLDYQVVQKYLFQIINGIGF 139

Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDF 434
            H      IIHRD+K  NIL+      KL DF
Sbjct: 140 CHS---HNIIHRDIKPENILVSQSGVVKLCDF 168

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 78.7 bits (194), Expect = 2e-15
 Identities = 55/238 (23%), Positives = 95/238 (39%), Gaps = 30/238 (12%)

Query: 250 IKKKRHDGRSKEDHVCTVQRVPMRLALTDIKQATLG--FNKNRIVGEGASATVYKG-SLP 306
           I + +    S  D+              +IK   +   ++ +  +G GA   V++     
Sbjct: 121 IVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERA 180

Query: 307 SGGAVAVK--RFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEY 364
           +G   A K       +  E  R     E  TM+  LRH  LV L     + NE+V++YE+
Sbjct: 181 TGNNFAAKFVMTPHESDKETVRK----EIQTMS-VLRHPTLVNLHDAFEDDNEMVMIYEF 235

Query: 365 LPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILL 423
           +  G L +K+   ++     +S ++ +  +  V   L ++H   E   +H D+K  NI+ 
Sbjct: 236 MSGGELFEKVADEHNK----MSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMF 288

Query: 424 --DAEFNAKLGDF----------EATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVA 469
                   KL DF             +  GT  + APE          TD++S GV++
Sbjct: 289 TTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 76.6 bits (189), Expect = 3e-15
 Identities = 47/198 (23%), Positives = 80/198 (40%), Gaps = 24/198 (12%)

Query: 290 RIVGEGASATVYKGS-LPSGGAVAVKRFEK---PNRVECARNPFTTEFATMAGCLRHKNL 345
            ++G+G  + V +     +G   AVK  +     +    +      E +     L+H ++
Sbjct: 30  EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM-LKHPHI 88

Query: 346 VQLQGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           V+L         L +V+E++    L  +I+   + +  V S     + +  +  AL Y H
Sbjct: 89  VELLETYSSDGMLYMVFEFMDGADLCFEIVK-RADAGFVYSEAVASHYMRQILEALRYCH 147

Query: 405 EECERQIIHRDVKACNILL---DAEFNAKLGDF-----------EATIPAGTMGYLAPEY 450
              +  IIHRDVK   +LL   +     KLG F            A    GT  ++APE 
Sbjct: 148 ---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEV 204

Query: 451 VYSGVPSEKTDVYSFGVV 468
           V      +  DV+  GV+
Sbjct: 205 VKREPYGKPVDVWGCGVI 222

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 76.4 bits (188), Expect = 3e-15
 Identities = 57/253 (22%), Positives = 82/253 (32%), Gaps = 73/253 (28%)

Query: 290 RIVGEGASATVYKG-SLPSGGAVAVKRFEK-------PNRVECARNPFTTEFATMAGCLR 341
             +G+G+   V       +    A+K   K       P  VE  +     E   M   L 
Sbjct: 32  GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKT----EVRLMK-KLH 86

Query: 342 HKNLVQLQGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRL---------- 390
           H N+ +L     +   + LV E    G L DK+      S+   + +             
Sbjct: 87  HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146

Query: 391 -------------------------NIVLGVASALSYLHEECERQIIHRDVKACNILLDA 425
                                    NI+  + SAL YLH    + I HRD+K  N L   
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFST 203

Query: 426 EFNA--KLGDF---------------EATIPAGTMGYLAPEYVYSGVP---SEKTDVYSF 465
             +   KL DF                 T  AGT  ++APE V +        K D +S 
Sbjct: 204 NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE-VLNTTNESYGPKCDAWSA 262

Query: 466 GVVALEVAAGKSP 478
           GV+   +  G  P
Sbjct: 263 GVLLHLLLMGAVP 275

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 76.2 bits (188), Expect = 4e-15
 Identities = 48/196 (24%), Positives = 80/196 (40%), Gaps = 28/196 (14%)

Query: 290 RIVGEGASATVYKGS-LPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
             +G+GA + V +     +G   A K                 E       L+H N+V+L
Sbjct: 35  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK-LQHPNIVRL 93

Query: 349 QGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKR-LNIVLGVASALSYLHEE 406
                E +   LV++ +  G L + I+     S      E    + +  +  +++Y H  
Sbjct: 94  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYS------EADASHCIQQILESIAYCHS- 146

Query: 407 CERQIIHRDVKACNILLDAEFNA---KLGDF----------EATIPAGTMGYLAPEYVYS 453
               I+HR++K  N+LL ++      KL DF               AGT GYL+PE V  
Sbjct: 147 --NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE-VLK 203

Query: 454 GVP-SEKTDVYSFGVV 468
             P S+  D+++ GV+
Sbjct: 204 KDPYSKPVDIWACGVI 219

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 74.9 bits (185), Expect = 7e-15
 Identities = 47/156 (30%), Positives = 76/156 (48%), Gaps = 17/156 (10%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVK--RFEKPNRVECARNPFTT--EFATMAGCL 340
           F +   +G G  ATVYKG +  +G  VA+K  + +          P T   E + M   L
Sbjct: 7   FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT-----PSTAIREISLMKE-L 60

Query: 341 RHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRL--NIVLGVAS 398
           +H+N+V+L       N+L LV+E++ N  L K + + +  +     E  L       +  
Sbjct: 61  KHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119

Query: 399 ALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF 434
            L++ HE    +I+HRD+K  N+L++     KLGDF
Sbjct: 120 GLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDF 152

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 76.4 bits (188), Expect = 7e-15
 Identities = 70/281 (24%), Positives = 107/281 (38%), Gaps = 70/281 (24%)

Query: 290 RIVGEGASATVYKGS-LPSGGAVAVK-----RFEKPNRVECARNPFTTEFATMAGCLRHK 343
             +G G    V  G    +G  VAVK     +    + V   R     E   +    RH 
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIR----REIQNLK-LFRHP 76

Query: 344 NLVQL-QGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVA---- 397
           ++++L Q      +++ +V EY+  G L D I  N            RL+          
Sbjct: 77  HIIKLYQVISTP-SDIFMVMEYVSGGELFDYICKN-----------GRLDEKESRRLFQQ 124

Query: 398 --SALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--EATIPAGTM--------GY 445
             S + Y H      ++HRD+K  N+LLDA  NAK+ DF     +  G           Y
Sbjct: 125 ILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNY 181

Query: 446 LAPEYV----YSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLD 501
            APE +    Y+G    + D++S GV+   +  G  P D+D       V  L KK   + 
Sbjct: 182 AAPEVISGRLYAGP---EVDIWSSGVILYALLCGTLPFDDDH------VPTLFKK---IC 229

Query: 502 AADFRLRGKFN---RKEMERMLMVGLSCVHPNHEKRPSVKE 539
              F      N      ++ ML V       +  KR ++K+
Sbjct: 230 DGIFYTPQYLNPSVISLLKHMLQV-------DPMKRATIKD 263

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 74.6 bits (184), Expect = 9e-15
 Identities = 48/202 (23%), Positives = 82/202 (40%), Gaps = 33/202 (16%)

Query: 290 RIVGEGASATVYKG-SLPSGGAVAVK----RFEKPNRVECARNPFTTEFATMAGCLRHKN 344
             +G G  A V K     +G   A K    R  K +R   +R     E + +   ++H N
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK-EIQHPN 75

Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKR-LNIVLGVASALSY 402
           ++ L        +++L+ E +  G L D +    S +      E+     +  + + + Y
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKESLT------EEEATEFLKQILNGVYY 129

Query: 403 LHEECERQIIHRDVKACNILL---DAEFNA-KLGDF----------EATIPAGTMGYLAP 448
           LH     QI H D+K  NI+L   +      K+ DF          E     GT  ++AP
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186

Query: 449 EYVYSGVP-SEKTDVYSFGVVA 469
           E + +  P   + D++S GV+ 
Sbjct: 187 E-IVNYEPLGLEADMWSIGVIT 207

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 74.6 bits (184), Expect = 9e-15
 Identities = 51/204 (25%), Positives = 78/204 (38%), Gaps = 36/204 (17%)

Query: 290 RIVGEGASATVYKGS-LPSGGAVAVKRFEK------PNRVECARNPFTTEFATMAGCLRH 342
           + +G GA   V       +   VA+K   K        R         TE   +   L H
Sbjct: 16  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK-LNH 74

Query: 343 KNLVQLQGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVASALS 401
             +++++ +  +  +  +V E +  G L DK++ N       L           +  A+ 
Sbjct: 75  PCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKR-----LKEATCKLYFYQMLLAVQ 128

Query: 402 YLHEECERQIIHRDVKACNILL---DAEFNAKLGDF----------EATIPAGTMGYLAP 448
           YLHE     IIHRD+K  N+LL   + +   K+ DF                GT  YLAP
Sbjct: 129 YLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 185

Query: 449 EYVYSGVP----SEKTDVYSFGVV 468
           E V   V     +   D +S GV+
Sbjct: 186 E-VLVSVGTAGYNRAVDCWSLGVI 208

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 75.1 bits (185), Expect = 1e-14
 Identities = 34/96 (35%), Positives = 47/96 (48%), Gaps = 16/96 (16%)

Query: 396 VASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF----------EATIPAGTMGY 445
           +  AL YL     ++IIHRD+K  NILLD   +  + DF          + T  AGT  Y
Sbjct: 124 LVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPY 180

Query: 446 LAPEYVYSGVPSEKT---DVYSFGVVALEVAAGKSP 478
           +APE   S   +  +   D +S GV A E+  G+ P
Sbjct: 181 MAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 74.8 bits (184), Expect = 1e-14
 Identities = 46/198 (23%), Positives = 76/198 (38%), Gaps = 32/198 (16%)

Query: 290 RIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           +++G G +  V +  +  +    A+K  +       AR     E        +  ++V++
Sbjct: 68  QVLGLGINGKVLQIFNKRTQEKFALKMLQD---CPKARR----EVELHWRASQCPHIVRI 120

Query: 349 QGWC----CEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
                        L++V E L  G L  +I      +    +  +   I+  +  A+ YL
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA---FTEREASEIMKSIGEAIQYL 177

Query: 404 HEECERQIIHRDVKACNILL-DAEFNA--KLGDF----------EATIPAGTMGYLAPEY 450
           H      I HRDVK  N+L      NA  KL DF            T P  T  Y+APE 
Sbjct: 178 HS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 234

Query: 451 VYSGVPSEKTDVYSFGVV 468
           +      +  D++S GV+
Sbjct: 235 LGPEKYDKSCDMWSLGVI 252

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 73.6 bits (181), Expect = 3e-14
 Identities = 51/206 (24%), Positives = 80/206 (38%), Gaps = 43/206 (20%)

Query: 290 RIVGEGASATVYKGS-LPSGGAVAVK-----RFEKPNRVECARNP-FTTEFATMAGCLRH 342
             +G GA   V+          V VK     +  +   +E  +    T E A ++  + H
Sbjct: 30  SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR-VEH 88

Query: 343 KNLVQLQGWCCEGNELVLVYEYLPNGS--LDKILHNNSSSSIVLSWEKRLNIVLG----- 395
            N++++           LV E   +G      I  +            RL+  L      
Sbjct: 89  ANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRH-----------PRLDEPLASYIFR 137

Query: 396 -VASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--EATIP--------AGTMG 444
            + SA+ YL     + IIHRD+K  NI++  +F  KL DF   A +          GT+ 
Sbjct: 138 QLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIE 194

Query: 445 YLAPEYVYSGVPSE--KTDVYSFGVV 468
           Y APE V  G P    + +++S GV 
Sbjct: 195 YCAPE-VLMGNPYRGPELEMWSLGVT 219

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 71.4 bits (176), Expect = 1e-13
 Identities = 44/160 (27%), Positives = 63/160 (39%), Gaps = 17/160 (10%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARN-PFTT--EFATM--AGC 339
           +     +G GA  TVYK     SG  VA+K    PN        P +T  E A +     
Sbjct: 11  YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEA 70

Query: 340 LRHKNLVQLQ-----GWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVL 394
             H N+V+L             ++ LV+E++    L   L       +     K L  + 
Sbjct: 71  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDL--MR 127

Query: 395 GVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF 434
                L +LH      I+HRD+K  NIL+ +    KL DF
Sbjct: 128 QFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADF 164

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 71.6 bits (176), Expect = 1e-13
 Identities = 61/287 (21%), Positives = 100/287 (34%), Gaps = 78/287 (27%)

Query: 290 RIVGEGASATVYKG-SLPSGGAVAVKRFEK----PNRVECARNPFTTEFATMAGCLRHKN 344
           + +G G            +   VAVK  E+       V+  R     E       LRH N
Sbjct: 26  KDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ--R-----EIINHR-SLRHPN 77

Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLN----------IV 393
           +V+ +        L ++ EY   G L ++I +             R +          ++
Sbjct: 78  IVRFKEVILTPTHLAIIMEYASGGELYERICNA-----------GRFSEDEARFFFQQLL 126

Query: 394 LGVASALSYLHEECERQIIHRDVKACNILLDAEF--NAKLGDF-------EATIPA---G 441
               S +SY H     QI HRD+K  N LLD       K+ DF         + P    G
Sbjct: 127 ----SGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 179

Query: 442 TMGYLAPEYV----YSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKG 497
           T  Y+APE +    Y G   +  DV+S GV    +  G  P ++      +   + RK  
Sbjct: 180 TPAYIAPEVLLRQEYDG---KIADVWSCGVTLYVMLVGAYPFEDP-----EEPRDYRKTI 231

Query: 498 KLLDAADFRLRGKFN-----RKEMERMLMVGLSCVHPNHEKRPSVKE 539
           + + +  + +             + R+ +        +   R S+ E
Sbjct: 232 QRILSVKYSIPDDIRISPECCHLISRIFVA-------DPATRISIPE 271

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 65/284 (22%), Positives = 114/284 (40%), Gaps = 77/284 (27%)

Query: 290 RIVGEGASATVYKGS-LPSGGAVAVKRFEK--------PNRVECARNPFTTEFATMAGCL 340
             +GEG+   V   +   +   VA+K   +          RVE        E + +   L
Sbjct: 15  ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE-------REISYLK-LL 66

Query: 341 RHKNLVQL-QGWCCEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVA- 397
           RH ++++L         ++V+V EY   G L D I+             KR+    G   
Sbjct: 67  RHPHIIKLYDVITTP-TDIVMVIEYA-GGELFDYIVEK-----------KRMTEDEGRRF 113

Query: 398 -----SALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--EATIPAGTM------- 443
                 A+ Y H     +I+HRD+K  N+LLD   N K+ DF     +  G         
Sbjct: 114 FQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGS 170

Query: 444 -GYLAPEYV----YSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGK 498
             Y APE +    Y+G    + DV+S G+V   +  G+ P D++       + NL KK  
Sbjct: 171 PNYAAPEVINGKLYAG---PEVDVWSCGIVLYVMLVGRLPFDDEF------IPNLFKK-- 219

Query: 499 LLDAADFRLRGKFN---RKEMERMLMVGLSCVHPNHEKRPSVKE 539
            +++  + +    +   +  + RM++        +  +R +++E
Sbjct: 220 -VNSCVYVMPDFLSPGAQSLIRRMIVA-------DPMQRITIQE 255

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 44/228 (19%), Positives = 79/228 (34%), Gaps = 66/228 (28%)

Query: 290 RIVGEGASATVYKG-SLPSGGAVAVKRFEK-------------PNRVECARNPFTTEFAT 335
             +G+G+   V    +       A+K   K             P R          +   
Sbjct: 19  DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78

Query: 336 MAG----------CLRHKNLVQL-QGW-CCEGNELVLVYEYLPNGSLDKILHNNSSSSIV 383
                         L H N+V+L +       + L +V+E +  G + ++          
Sbjct: 79  PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL------- 131

Query: 384 LSWEKRLNIVLG------VASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--- 434
               K L+          +   + YLH    ++IIHRD+K  N+L+  + + K+ DF   
Sbjct: 132 ----KPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVS 184

Query: 435 --------EATIPAGTMGYLAPEYV------YSGVPSEKTDVYSFGVV 468
                     +   GT  ++APE +      +SG   +  DV++ GV 
Sbjct: 185 NEFKGSDALLSNTVGTPAFMAPESLSETRKIFSG---KALDVWAMGVT 229

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 70.3 bits (173), Expect = 2e-13
 Identities = 42/162 (25%), Positives = 66/162 (40%), Gaps = 23/162 (14%)

Query: 286 FNKNRIVGEGASATVYKG--SLPSGGAVAVKRFEKPNRVECARN--PFTT--EFATMAGC 339
           +     +GEGA   V+K       G  VA+KR     RV+      P +T  E A +   
Sbjct: 13  YECVAEIGEGAYGKVFKARDLKNGGRFVALKRV----RVQTGEEGMPLSTIREVAVLRHL 68

Query: 340 --LRHKNLVQLQ-----GWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNI 392
               H N+V+L             +L LV+E++    L   L       +     K +  
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDM-- 125

Query: 393 VLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF 434
           +  +   L +LH     +++HRD+K  NIL+ +    KL DF
Sbjct: 126 MFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADF 164

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 69.2 bits (170), Expect = 4e-13
 Identities = 55/219 (25%), Positives = 90/219 (41%), Gaps = 45/219 (20%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKP-----NRVECARNPFTTEFATMAGC 339
           F   +I+GEG+ +TV     L +    A+K  EK      N+V         E   M+  
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT----RERDVMS-R 86

Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLG---- 395
           L H   V+L     +  +L     Y  NG L K +                +        
Sbjct: 87  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK----------IGSFDETCTRFYT 136

Query: 396 --VASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF----EATIPA--------- 440
             + SAL YLH    + IIHRD+K  NILL+ + + ++ DF      +  +         
Sbjct: 137 AEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV 193

Query: 441 GTMGYLAPEYVYSGVPSEKT-DVYSFGVVALEVAAGKSP 478
           GT  Y++PE + +   + K+ D+++ G +  ++ AG  P
Sbjct: 194 GTAQYVSPE-LLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 70.7 bits (173), Expect = 6e-13
 Identities = 32/136 (23%), Positives = 56/136 (41%), Gaps = 39/136 (28%)

Query: 396 VASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGTMGYL 446
           +   L ++H    R +++RD+K  NILLD   + ++ D          +     GT GY+
Sbjct: 301 IILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYM 357

Query: 447 APEYVYSGVPSEKT-DVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADF 505
           APE +  GV  + + D +S G +  ++  G SP                          F
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP--------------------------F 391

Query: 506 RLRGKFNRKEMERMLM 521
           R     ++ E++RM +
Sbjct: 392 RQHKTKDKHEIDRMTL 407

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 69.4 bits (170), Expect = 8e-13
 Identities = 35/164 (21%), Positives = 59/164 (35%), Gaps = 37/164 (22%)

Query: 292 VGEGASATVYKG---SLPSGGAVAVKRFEKPNRVECARNPFTT--EFATMAGCLRHKNLV 346
           VG G    VYK            A+K+ E            +   E A +   L+H N++
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI------SMSACREIALLR-ELKHPNVI 81

Query: 347 QLQGWCCEGNE--LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVA------- 397
            LQ       +  + L+++Y  +  L  I+  + +S        +  + L          
Sbjct: 82  SLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASK-----ANKKPVQLPRGMVKSLLY 135

Query: 398 ---SALSYLHEECERQIIHRDVKACNILLDAEFNA----KLGDF 434
                + YLH      ++HRD+K  NIL+  E       K+ D 
Sbjct: 136 QILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADM 176

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 67.6 bits (166), Expect = 2e-12
 Identities = 41/165 (24%), Positives = 71/165 (43%), Gaps = 31/165 (18%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARN--PFTT--EFATMAGCL 340
           + K   +G+G    V+K     +G  VA+K+      +E  +   P T   E   +   L
Sbjct: 19  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKV----LMENEKEGFPITALREIKILQL-L 73

Query: 341 RHKNLVQLQGWCCE--------GNELVLVYEYLPNGSLDKILHNNS---SSSIVLSWEKR 389
           +H+N+V L   C             + LV+++  +  L  +L N     + S +    + 
Sbjct: 74  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQM 132

Query: 390 LNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF 434
           L       + L Y+H     +I+HRD+KA N+L+  +   KL DF
Sbjct: 133 LL------NGLYYIHR---NKILHRDMKAANVLITRDGVLKLADF 168

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 66.6 bits (163), Expect = 6e-12
 Identities = 49/215 (22%), Positives = 84/215 (39%), Gaps = 41/215 (19%)

Query: 286 FNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           +   +++G G+   V++  L     VA+K+  +  R +        E   M   ++H N+
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFK------NRELQIMRI-VKHPNV 94

Query: 346 VQL------QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASA 399
           V L       G   +   L LV EY+P  ++ +   + +     +        +  +  +
Sbjct: 95  VDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRS 153

Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNA-KLGDF---EATIPAGTMG-------YLAP 448
           L+Y+H      I HRD+K  N+LLD      KL DF   +  I             Y AP
Sbjct: 154 LAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAP 210

Query: 449 E-------YVYSGVPSEKTDVYSFGVVALEVAAGK 476
           E       Y      +   D++S G V  E+  G+
Sbjct: 211 ELIFGATNY------TTNIDIWSTGCVMAELMQGQ 239

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 65.0 bits (159), Expect = 1e-11
 Identities = 40/188 (21%), Positives = 68/188 (36%), Gaps = 33/188 (17%)

Query: 290 RIVGEGASATVYKGS-LPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           +++G G +  V +     +    A+K  +   +          E        +  ++V++
Sbjct: 24  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR-------REVELHWRASQCPHIVRI 76

Query: 349 QGWC----CEGNELVLVYEYLPNGSL-DKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
                        L++V E L  G L  +I      +    +  +   I+  +  A+ YL
Sbjct: 77  VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA---FTEREASEIMKSIGEAIQYL 133

Query: 404 HEECERQIIHRDVKACNILL-DAEFNA--KLGDFEATIPAGTMGYLAPEYVYSGVPSEKT 460
           H      I HRDVK  N+L      NA  KL DF      G     A E        +  
Sbjct: 134 HS---INIAHRDVKPENLLYTSKRPNAILKLTDF------G----FAKE-TTGEKYDKSC 179

Query: 461 DVYSFGVV 468
           D++S GV+
Sbjct: 180 DMWSLGVI 187

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 65.5 bits (160), Expect = 2e-11
 Identities = 44/176 (25%), Positives = 74/176 (42%), Gaps = 19/176 (10%)

Query: 267 VQRVPMRLALTDIKQATLGFNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECA 325
           V  V         +   + +   +++G G+   VY+     SG  VA+K+  +  R    
Sbjct: 37  VTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-FKN 95

Query: 326 RNPFTTEFATMAGCLRHKNLVQL------QGWCCEGNELVLVYEYLPNGSLDKILHNNSS 379
           R     E   M   L H N+V+L       G   +   L LV +Y+P  ++ ++  + S 
Sbjct: 96  R-----ELQIM-RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSR 148

Query: 380 SSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNA-KLGDF 434
           +   L        +  +  +L+Y+H      I HRD+K  N+LLD +    KL DF
Sbjct: 149 AKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDF 201

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 65.6 bits (160), Expect = 2e-11
 Identities = 38/139 (27%), Positives = 62/139 (44%), Gaps = 18/139 (12%)

Query: 358 LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLG-VASALSYLHEECERQIIHRDV 416
           L LV   +  G +   ++N    +     E R       + S L +LH+   R II+RD+
Sbjct: 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQ-EPRAIFYTAQIVSGLEHLHQ---RNIIYRDL 315

Query: 417 KACNILLDAEFNAKLGDF---------EATIP--AGTMGYLAPEYVYSGVPSEKT-DVYS 464
           K  N+LLD + N ++ D          +      AGT G++APE +  G   + + D ++
Sbjct: 316 KPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPE-LLLGEEYDFSVDYFA 374

Query: 465 FGVVALEVAAGKSPVDNDG 483
            GV   E+ A + P    G
Sbjct: 375 LGVTLYEMIAARGPFRARG 393

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 64.2 bits (157), Expect = 3e-11
 Identities = 33/99 (33%), Positives = 47/99 (47%), Gaps = 16/99 (16%)

Query: 396 VASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF----EATIPA-------GTMG 444
           + SAL YLH    R +++RD+K  N++LD + + K+ DF    E            GT  
Sbjct: 114 IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 170

Query: 445 YLAPEYVYSGVPSEKT-DVYSFGVVALEVAAGKSPVDND 482
           YLAPE V       +  D +  GVV  E+  G+ P  N 
Sbjct: 171 YLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 208

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 63.8 bits (156), Expect = 5e-11
 Identities = 36/99 (36%), Positives = 48/99 (48%), Gaps = 16/99 (16%)

Query: 396 VASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF----EATIPA-------GTMG 444
           +ASAL YLH      I++RD+K  NILLD++ +  L DF    E            GT  
Sbjct: 148 IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPE 204

Query: 445 YLAPEYVYSGVPSEKT-DVYSFGVVALEVAAGKSPVDND 482
           YLAPE V    P ++T D +  G V  E+  G  P  + 
Sbjct: 205 YLAPE-VLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 242

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 63.6 bits (155), Expect = 6e-11
 Identities = 33/99 (33%), Positives = 48/99 (48%), Gaps = 15/99 (15%)

Query: 396 VASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF----EATIPA-------GTMG 444
           + SAL YLH E  + +++RD+K  N++LD + + K+ DF    E            GT  
Sbjct: 257 IVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPE 314

Query: 445 YLAPEYVYSGVPSEKT-DVYSFGVVALEVAAGKSPVDND 482
           YLAPE V       +  D +  GVV  E+  G+ P  N 
Sbjct: 315 YLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 352

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 63.0 bits (153), Expect = 7e-11
 Identities = 47/185 (25%), Positives = 70/185 (37%), Gaps = 28/185 (15%)

Query: 375 HNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF 434
                    L+ E  +     VA  + +L     R+ IHRD+ A NILL  +   K+ DF
Sbjct: 181 APEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDF 237

Query: 435 --------EATIPAGTMGYL-----APEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVD 480
                   +          L     APE ++  V + ++DV+SFGV+  E+ + G SP  
Sbjct: 238 GLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY- 296

Query: 481 NDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEA 540
             G  I +      K+G        R+R            M  L C H    +RP+  E 
Sbjct: 297 -PGVKIDEEFCRRLKEG-------TRMRAPDYTTPEMYQTM--LDCWHGEPSQRPTFSEL 346

Query: 541 ARILK 545
              L 
Sbjct: 347 VEHLG 351

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 54.2 bits (130), Expect = 6e-08
 Identities = 31/193 (16%), Positives = 56/193 (29%), Gaps = 22/193 (11%)

Query: 290 RIVGEGASATVYKGSL------PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHK 343
           + +G GA   V +          +   VAVK   K            +E   +     H 
Sbjct: 28  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRALMSELKILIHIGHHL 86

Query: 344 NLVQLQGWCC-EGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
           N+V L G C   G  L+++ E+   G+L   L +            R   V        +
Sbjct: 87  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK-----------RNEFVPYKTKGARF 135

Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGTMGYLAPEYVYSGVPSEKTDV 462
              +     I  D+K     + +  ++    F        +                  +
Sbjct: 136 RQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHL 195

Query: 463 YSFGVVALEVAAG 475
             +   + +VA G
Sbjct: 196 ICY---SFQVAKG 205

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 64.0 bits (156), Expect = 7e-11
 Identities = 28/98 (28%), Positives = 44/98 (44%), Gaps = 15/98 (15%)

Query: 396 VASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF----------EATIPAGTMGY 445
           +   L  LH     +I++RD+K  NILLD   + ++ D                 GT+GY
Sbjct: 295 ICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGY 351

Query: 446 LAPEYVYSGVPSEKT-DVYSFGVVALEVAAGKSPVDND 482
           +APE V        + D ++ G +  E+ AG+SP    
Sbjct: 352 MAPE-VVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 388

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 62.6 bits (153), Expect = 9e-11
 Identities = 36/95 (37%), Positives = 50/95 (52%), Gaps = 16/95 (16%)

Query: 396 VASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF----EATIPA-------GTMG 444
           +A AL +LH      II+RD+K  NILLD E + KL DF    E+           GT+ 
Sbjct: 135 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVE 191

Query: 445 YLAPEYVYSGVPSEKT-DVYSFGVVALEVAAGKSP 478
           Y+APE V +     ++ D +SFGV+  E+  G  P
Sbjct: 192 YMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 62.6 bits (153), Expect = 9e-11
 Identities = 32/99 (32%), Positives = 54/99 (54%), Gaps = 16/99 (16%)

Query: 396 VASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF----EATIPA-------GTMG 444
           +A  L +L     + II+RD+K  N++LD+E + K+ DF    E            GT  
Sbjct: 130 IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPD 186

Query: 445 YLAPEYVYSGVPSEKT-DVYSFGVVALEVAAGKSPVDND 482
           Y+APE + +  P  K+ D ++FGV+  E+ AG++P + +
Sbjct: 187 YIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 224

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 62.6 bits (153), Expect = 1e-10
 Identities = 28/99 (28%), Positives = 49/99 (49%), Gaps = 16/99 (16%)

Query: 396 VASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF----EATIPA-------GTMG 444
           ++ AL +LH+   + II+RD+K  NI+L+ + + KL DF    E+           GT+ 
Sbjct: 130 ISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIE 186

Query: 445 YLAPEYVYSGVPSEKT-DVYSFGVVALEVAAGKSPVDND 482
           Y+APE +       +  D +S G +  ++  G  P   +
Sbjct: 187 YMAPE-ILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGE 224

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 62.6 bits (153), Expect = 1e-10
 Identities = 32/99 (32%), Positives = 50/99 (50%), Gaps = 16/99 (16%)

Query: 396 VASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF----EATIPA-------GTMG 444
           + SAL +LH+   + II+RD+K  N+LLD E + KL DF    E            GT  
Sbjct: 133 IISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPD 189

Query: 445 YLAPEYVYSGVPSEKT-DVYSFGVVALEVAAGKSPVDND 482
           Y+APE +   +      D ++ GV+  E+  G +P + +
Sbjct: 190 YIAPE-ILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE 227

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 63.1 bits (153), Expect = 1e-10
 Identities = 32/99 (32%), Positives = 54/99 (54%), Gaps = 16/99 (16%)

Query: 396 VASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF----EATIPA-------GTMG 444
           +A  L +L     + II+RD+K  N++LD+E + K+ DF    E            GT  
Sbjct: 451 IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPD 507

Query: 445 YLAPEYVYSGVPSEKT-DVYSFGVVALEVAAGKSPVDND 482
           Y+APE + +  P  K+ D ++FGV+  E+ AG++P + +
Sbjct: 508 YIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 545

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 62.5 bits (152), Expect = 1e-10
 Identities = 25/100 (25%), Positives = 47/100 (47%), Gaps = 20/100 (20%)

Query: 396 VASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF------------EATIPAGTM 443
           +  A+  +H+      +HRD+K  NIL+D   + +L DF            ++++  GT 
Sbjct: 184 MVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTP 240

Query: 444 GYLAPEYVYSGVPSEKT-----DVYSFGVVALEVAAGKSP 478
            Y++PE + +    +       D +S GV   E+  G++P
Sbjct: 241 DYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 62.2 bits (152), Expect = 1e-10
 Identities = 37/95 (38%), Positives = 54/95 (56%), Gaps = 16/95 (16%)

Query: 396 VASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF----EATIPA-------GTMG 444
           ++ AL+YLHE   R II+RD+K  N+LLD+E + KL D+    E   P        GT  
Sbjct: 119 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPN 175

Query: 445 YLAPEYVYSGVPSEKT-DVYSFGVVALEVAAGKSP 478
           Y+APE +  G     + D ++ GV+  E+ AG+SP
Sbjct: 176 YIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSP 209

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 62.4 bits (152), Expect = 1e-10
 Identities = 28/102 (27%), Positives = 44/102 (43%), Gaps = 22/102 (21%)

Query: 396 VASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF------------EATIPAGTM 443
           +  A+  +H       +HRD+K  NILLD   + +L DF             + +  GT 
Sbjct: 171 IVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTP 227

Query: 444 GYLAPEYVYSGVPSEKTDVY-------SFGVVALEVAAGKSP 478
            YL+PE + +      T  Y       + GV A E+  G++P
Sbjct: 228 DYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 62.0 bits (151), Expect = 2e-10
 Identities = 64/308 (20%), Positives = 110/308 (35%), Gaps = 79/308 (25%)

Query: 290 RIVGEGASATVYKGS-LPSGGAVAVKRFEKP--NRVECARNPFTT--EFATMAGCLRHKN 344
           + +G GA   V           VA+K+  +P  N+    R       E   M  C+ HKN
Sbjct: 31  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKR----AYRELVLMK-CVNHKN 85

Query: 345 LVQL------QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVAS 398
           ++ L      Q    E  ++ +V E +   +L +++         L  E+   ++  +  
Sbjct: 86  IIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQME------LDHERMSYLLYQMLC 138

Query: 399 ALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFE---ATIPAGTMG-------YLAP 448
            + +LH      IIHRD+K  NI++ ++   K+ DF        +  M        Y AP
Sbjct: 139 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 195

Query: 449 EYVYSGVPSEKTDVYSFGVVALEVAAGK--------------------SPVDNDGCVI-- 486
           E +      E  D++S G +  E+  G                     +P       +  
Sbjct: 196 EVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 255

Query: 487 --VDWVWNLRKK-----GKLLDAADFRLRGKFNRKE-------MERMLMVGLSCVHPNHE 532
               +V N  K       KL     F    + N+ +       + +ML++       +  
Sbjct: 256 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVI-------DAS 308

Query: 533 KRPSVKEA 540
           KR SV EA
Sbjct: 309 KRISVDEA 316

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 62.0 bits (151), Expect = 2e-10
 Identities = 37/95 (38%), Positives = 54/95 (56%), Gaps = 16/95 (16%)

Query: 396 VASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF----EATIPA-------GTMG 444
           ++ AL+YLHE   R II+RD+K  N+LLD+E + KL D+    E   P        GT  
Sbjct: 162 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPN 218

Query: 445 YLAPEYVYSGVPSEKT-DVYSFGVVALEVAAGKSP 478
           Y+APE +  G     + D ++ GV+  E+ AG+SP
Sbjct: 219 YIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSP 252

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 62.0 bits (151), Expect = 2e-10
 Identities = 58/252 (23%), Positives = 94/252 (37%), Gaps = 43/252 (17%)

Query: 250 IKKKRHDGRSKEDHVCTVQRV-PMRLALTDIKQATLGFNKNRIVGEGASATVY----KGS 304
           ++K ++       +  T+ ++  +R+   D       +   +++G GA   V     K +
Sbjct: 41  LRKNKNIDNFLSRYKDTINKIRDLRMKAED-------YEVVKVIGRGAFGEVQLVRHKST 93

Query: 305 LPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEY 364
                  A+K   K   ++ + + F  E   +        +VQL     +   L +V EY
Sbjct: 94  ---RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEY 150

Query: 365 LPNGSLDKILHNNSSSSIVLSWEKRLNIVLG-VASALSYLHEECERQIIHRDVKACNILL 423
           +P G L  ++ N          EK        V  AL  +H       IHRDVK  N+LL
Sbjct: 151 MPGGDLVNLMSNYDVP------EKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLL 201

Query: 424 DAEFNAKLGDF------------EATIPAGTMGYLAPEYVYSGVPSEKT-----DVYSFG 466
           D   + KL DF                  GT  Y++PE V      +       D +S G
Sbjct: 202 DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPE-VLKSQGGDGYYGRECDWWSVG 260

Query: 467 VVALEVAAGKSP 478
           V   E+  G +P
Sbjct: 261 VFLYEMLVGDTP 272

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 61.5 bits (150), Expect = 2e-10
 Identities = 32/99 (32%), Positives = 49/99 (49%), Gaps = 16/99 (16%)

Query: 396 VASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF----EATIPA-------GTMG 444
           +   L +LH    + I++RD+K  NILLD + + K+ DF    E  +         GT  
Sbjct: 127 IILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPD 183

Query: 445 YLAPEYVYSGVPSEKT-DVYSFGVVALEVAAGKSPVDND 482
           Y+APE +  G     + D +SFGV+  E+  G+SP    
Sbjct: 184 YIAPE-ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ 221

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 61.1 bits (147), Expect = 3e-10
 Identities = 38/253 (15%), Positives = 73/253 (28%), Gaps = 73/253 (28%)

Query: 282 ATLGFNKNRIVGEGASATVYKGSLPSGGAVAVK--RFEKPNRVECARNPFTTEFA----- 334
            T    +   +GEG    V++        VA+K    E P+ V  +      E       
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIAD-HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 335 -------TMAGCLRHKNLVQLQGWCC------------------------------EGNE 357
                  +   C R +  + L    C                              + ++
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 358 LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVK 417
           L +V E+   G   + +        + S     +I+  + ++L+        +  HRD+ 
Sbjct: 137 LFIVLEFEFGGIDLEQMRTK-----LSSLATAKSILHQLTASLAVAEASL--RFEHRDLH 189

Query: 418 ACNILLDAEFNAKLGDFEATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKS 477
             N+LL      KL                       +  + + + S G+    +    S
Sbjct: 190 WGNVLLKKTSLKKLHYT--------------------LNGKSSTIPSCGLQVSIIDYTLS 229

Query: 478 PVDNDG-CVIVDW 489
            ++ DG  V  D 
Sbjct: 230 RLERDGIVVFCDV 242

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 61.2 bits (149), Expect = 3e-10
 Identities = 33/97 (34%), Positives = 47/97 (48%), Gaps = 17/97 (17%)

Query: 396 VASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF----EATIPA--------GTM 443
           +  AL +LH+     II+RD+K  NILLD+  +  L DF    E             GT+
Sbjct: 168 IVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTI 224

Query: 444 GYLAPEYV-YSGVPSEKT-DVYSFGVVALEVAAGKSP 478
            Y+AP+ V       +K  D +S GV+  E+  G SP
Sbjct: 225 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 60.0 bits (146), Expect = 6e-10
 Identities = 50/215 (23%), Positives = 87/215 (40%), Gaps = 34/215 (15%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKR-FEKP---NRVECARNPFTTEFATMAGCL 340
           F   R+ G+G   TV  G    +G +VA+K+  + P   NR          +       L
Sbjct: 25  FQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNR--------ELQIMQDLAVL 76

Query: 341 RHKNLVQLQ-----GWCCEGNE--LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIV 393
            H N+VQLQ         +  +  L +V EY+P+ +L +   N     +          +
Sbjct: 77  HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFL 135

Query: 394 LGVASALSYLHEECERQIIHRDVKACNILLDAEFNA-KLGDF---EATIPAGTMG----- 444
             +  ++  LH      + HRD+K  N+L++      KL DF   +   P+         
Sbjct: 136 FQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICS 194

Query: 445 --YLAPEYVY-SGVPSEKTDVYSFGVVALEVAAGK 476
             Y APE ++ +   +   D++S G +  E+  G+
Sbjct: 195 RYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 59.5 bits (145), Expect = 8e-10
 Identities = 37/92 (40%), Positives = 49/92 (53%), Gaps = 13/92 (14%)

Query: 396 VASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF----EATIPA----GTMGYLA 447
           V  AL YLH    + II+RD+K  NILLD   + K+ DF              GT  Y+A
Sbjct: 115 VCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIA 171

Query: 448 PEYVYSGVPSEKT-DVYSFGVVALEVAAGKSP 478
           PE V S  P  K+ D +SFG++  E+ AG +P
Sbjct: 172 PE-VVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 59.6 bits (145), Expect = 8e-10
 Identities = 49/213 (23%), Positives = 84/213 (39%), Gaps = 38/213 (17%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKP-----NRVECARNPFTTEFATMAGC 339
           F++ + +G G+   V       SG   A+K  +K       ++E   N    E   +   
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN----EKRILQ-A 97

Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLG---- 395
           +    LV+L+    + + L +V EY+  G +   L              R +        
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR----------IGRFSEPHARFYA 147

Query: 396 --VASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGY 445
             +     YLH      +I+RD+K  N+L+D +   ++ DF              GT   
Sbjct: 148 AQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEA 204

Query: 446 LAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSP 478
           LAPE + S   ++  D ++ GV+  E+AAG  P
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 59.6 bits (145), Expect = 1e-09
 Identities = 47/211 (22%), Positives = 75/211 (35%), Gaps = 31/211 (14%)

Query: 290 RIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTE-FAT-------MAGCLR 341
           R +  G+   V  G    G  VA+KR           N  +             +     
Sbjct: 28  RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87

Query: 342 HKNLVQLQ-----GWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGV 396
           H N++ L+           ++L LV E +    L +++H      IV+S +     +  +
Sbjct: 88  HPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIH---DQRIVISPQHIQYFMYHI 143

Query: 397 ASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF----------EATIPAGTMGYL 446
              L  LHE     ++HRD+   NILL    +  + DF            T       Y 
Sbjct: 144 LLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYR 200

Query: 447 APEYVYSGVP-SEKTDVYSFGVVALEVAAGK 476
           APE V      ++  D++S G V  E+   K
Sbjct: 201 APELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 59.1 bits (143), Expect = 2e-09
 Identities = 65/308 (21%), Positives = 112/308 (36%), Gaps = 79/308 (25%)

Query: 290 RIVGEGASATVYKGS-LPSGGAVAVKRFEKP--NRVECARNPFTT--EFATMAGCLRHKN 344
           + +G GA   V           VA+K+  +P  N+    R       E   M  C+ HKN
Sbjct: 68  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR----AYRELVLMK-CVNHKN 122

Query: 345 LVQL------QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVAS 398
           ++ L      Q    E  ++ LV E +   +L +++         L  E+   ++  +  
Sbjct: 123 IISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQME------LDHERMSYLLYQMLC 175

Query: 399 ALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-----EATIPA-----GTMGYLAP 448
            + +LH      IIHRD+K  NI++ ++   K+ DF       T         T  Y AP
Sbjct: 176 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 232

Query: 449 EYVYSGVPSEKTDVYSFGVVALEVAAGK--------------------SPVDNDGCVI-- 486
           E +      E  D++S G +  E+   K                    +P       +  
Sbjct: 233 EVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 292

Query: 487 --VDWVWNLRKK-----GKLLDAADFRLRGKFNRKE-------MERMLMVGLSCVHPNHE 532
              ++V N  K       KL   + F    + N+ +       + +ML++       +  
Sbjct: 293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI-------DPA 345

Query: 533 KRPSVKEA 540
           KR SV +A
Sbjct: 346 KRISVDDA 353

>1gv9_A P58/ergic-53; lectin, carbohydrate binding; 1.46A {Rattus norvegicus} SCOP: b.29.1.13 PDB: 1r1z_A 3a4u_A 3lcp_A Length = 260

 Score = 57.2 bits (137), Expect = 3e-09
 Identities = 30/188 (15%), Positives = 50/188 (26%), Gaps = 21/188 (11%)

Query: 6   TNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQDSFFA 65
                ++    +F +         DG A   T N    G   G   +   V         
Sbjct: 82  KAAFENWEVEVTFRV-TGRGRIGADGLAIWYTENQGLDGPVFGSADMWNGV--------G 132

Query: 66  VEFDTS-------FDPSLGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEY 118
           + FD+            +   N   I  D  +  +  ++ +  R         +   I Y
Sbjct: 133 IFFDSFDNDGKKNNPAIVVVGNNGQINYDHQNDGATQALASCQRDFR-NKPYPVRAKITY 191

Query: 119 RDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGSAIYTVDRWRFK 178
               K + V          +         +       H G SAA G  +  + V    F 
Sbjct: 192 YQ--KTLTVMINNGFTPDKNDYEFCAKVENMVIPTQGHFGISAATGGLADDHDV--LSFL 247

Query: 179 TFESYPSG 186
           TF+    G
Sbjct: 248 TFQLTEPG 255

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 57.7 bits (140), Expect = 4e-09
 Identities = 48/207 (23%), Positives = 87/207 (42%), Gaps = 34/207 (16%)

Query: 290 RIVGEGASATVYKGS-LPSGGAVAVKRFEKP--NRVECARNPFTT--EFATMAGCLRHKN 344
           + VG GA   V       +G  VA+K+  +P  + +   R       E   +   +RH+N
Sbjct: 31  QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR----AYRELRLLK-HMRHEN 85

Query: 345 LVQL------QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVAS 398
           ++ L           +  +  LV  ++    L K++ +       L  ++   +V  +  
Sbjct: 86  VIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEK-----LGEDRIQFLVYQMLK 139

Query: 399 ALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEY 450
            L Y+H      IIHRD+K  N+ ++ +   K+ DF        E T    T  Y APE 
Sbjct: 140 GLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEV 196

Query: 451 VYSGVP-SEKTDVYSFGVVALEVAAGK 476
           + + +  ++  D++S G +  E+  GK
Sbjct: 197 ILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 56.5 bits (137), Expect = 8e-09
 Identities = 50/207 (24%), Positives = 85/207 (41%), Gaps = 35/207 (16%)

Query: 290 RIVGEGASATVYKGS-LPSGGAVAVKRFEKP--NRVECARNPFTT--EFATMAGCLRHKN 344
             VG GA  +V       SG  VA+K+  +P  + +   R       E   +   ++H+N
Sbjct: 30  THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKR----AYRELLLLK-HMQHEN 84

Query: 345 LVQL------QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVAS 398
           ++ L              +  LV  ++    L KI+          S EK   +V  +  
Sbjct: 85  VIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLK------FSEEKIQYLVYQMLK 137

Query: 399 ALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEY 450
            L Y+H      ++HRD+K  N+ ++ +   K+ DF        E T    T  Y APE 
Sbjct: 138 GLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEV 194

Query: 451 VYSGVP-SEKTDVYSFGVVALEVAAGK 476
           + S +  ++  D++S G +  E+  GK
Sbjct: 195 ILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 55.2 bits (133), Expect = 3e-08
 Identities = 31/155 (20%), Positives = 66/155 (42%), Gaps = 23/155 (14%)

Query: 290 RIVGEGASATVYKGS-LPSGGAVAVKRFEKP--NRVECARNPFTT--EFATMAGCLRHKN 344
            ++G G+   V +         VA+K+  +   + ++C R       E A +   L H +
Sbjct: 59  HLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKR----ILREIAILN-RLNHDH 113

Query: 345 LVQLQ-----GWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASA 399
           +V++          + +EL +V E   +    K+      + + L+      ++  +   
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFR----TPVYLTELHIKTLLYNLLVG 168

Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF 434
           + Y+H      I+HRD+K  N L++ + + K+ DF
Sbjct: 169 VKYVHS---AGILHRDLKPANCLVNQDCSVKVCDF 200

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 53.8 bits (130), Expect = 7e-08
 Identities = 44/216 (20%), Positives = 74/216 (34%), Gaps = 54/216 (25%)

Query: 290 RIVGEGASATVYKGS-LPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           R +G G  + V++   + +   V VK  +   + +  R     E   +       N++ L
Sbjct: 42  RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR-----EIKILENLRGGPNIITL 96

Query: 349 QG--WCCEGNELVLVYEYLPNGSLDKILHNNSSSSI------VLSWEKRLNIVLGVASAL 400
                        LV+E++ N    ++    +   I      +L              AL
Sbjct: 97  ADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILK-------------AL 143

Query: 401 SYLHEECERQIIHRDVKACNILLDAEFNA-KLGDF---EATIPAGTMG-------YLAPE 449
            Y H      I+HRDVK  N+++D E    +L D+   E   P            +  PE
Sbjct: 144 DYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE 200

Query: 450 -------YVYSGVPSEKTDVYSFGVVALEVAAGKSP 478
                  Y YS       D++S G +   +   K P
Sbjct: 201 LLVDYQMYDYS------LDMWSLGCMLASMIFRKEP 230

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 54.0 bits (130), Expect = 7e-08
 Identities = 36/155 (23%), Positives = 68/155 (43%), Gaps = 23/155 (14%)

Query: 290 RIVGEGASATVYKGS-LPSGGAVAVKRFEKP--NRVECARNPFTT--EFATMAGCLRHKN 344
            ++G G+   VY      +   VA+K+  +   + ++C R       E   +   L+   
Sbjct: 32  HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKR----ILREITILN-RLKSDY 86

Query: 345 LVQLQ-----GWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASA 399
           +++L          + +EL +V E   +  L K+      + I L+ E    I+  +   
Sbjct: 87  IIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFK----TPIFLTEEHIKTILYNLLLG 141

Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF 434
            +++HE     IIHRD+K  N LL+ + + K+ DF
Sbjct: 142 ENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDF 173

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 52.7 bits (127), Expect = 1e-07
 Identities = 49/207 (23%), Positives = 88/207 (42%), Gaps = 34/207 (16%)

Query: 290 RIVGEGASATVYKGS-LPSGGAVAVKRFEKP--NRVECARNPFTT--EFATMAGCLRHKN 344
             VG GA  +V       +G  VAVK+  +P  + +   R    T  E   +   ++H+N
Sbjct: 35  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR----TYRELRLLK-HMKHEN 89

Query: 345 LVQL------QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVAS 398
           ++ L           E N++ LV   +    L+ I+         L+ +    ++  +  
Sbjct: 90  VIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQK-----LTDDHVQFLIYQILR 143

Query: 399 ALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEY 450
            L Y+H      IIHRD+K  N+ ++ +   K+ DF        E T    T  Y APE 
Sbjct: 144 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRWYRAPEI 200

Query: 451 VYSGVP-SEKTDVYSFGVVALEVAAGK 476
           + + +  ++  D++S G +  E+  G+
Sbjct: 201 MLNWMHYNQTVDIWSVGCIMAELLTGR 227

>2dur_A VIP36;, vesicular integral-membrane protein VIP36; beta sandwich, carbohydrate binding protein, cargo receptor, transport; HET: MAN; 1.65A {Canis lupus familiaris} PDB: 2dup_A 2duq_A* 2duo_A* 2e6v_A* Length = 253

 Score = 51.8 bits (123), Expect = 1e-07
 Identities = 25/194 (12%), Positives = 56/194 (28%), Gaps = 26/194 (13%)

Query: 5   KTNTTASFSCRFSFSII-PSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQDSF 63
           +      +     F +         GDG A   T +            +PGPV   +D+F
Sbjct: 57  QPCFLKDWEMHVHFKVHGTGKKNLHGDGIALWYTRDR----------LVPGPVFGSKDNF 106

Query: 64  --FAVEFDTSFDPSLGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRDS 121
              A+  DT  +    +    +I + +++        +     D +         ++R+ 
Sbjct: 107 HGLAIFLDTYPNDETTERVFPYISVMVNN-----GSLSYDHSKDGRWTELAGCTADFRNR 161

Query: 122 LKLIRVWAGYSQ--------IRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGSAIYTVD 173
                +   YS+        +   +           +     + G SA  G  S  + + 
Sbjct: 162 DHDTFLAVRYSRGRLTVMTDLEDKNEWKNCIDITGVRLPTGYYFGASAGTGDLSDNHDII 221

Query: 174 RWRFKTFESYPSGN 187
             +        + +
Sbjct: 222 SMKLFQLMVEHTPD 235

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 53.0 bits (127), Expect = 1e-07
 Identities = 50/283 (17%), Positives = 81/283 (28%), Gaps = 101/283 (35%)

Query: 354 EGNELVLVYEYLPNG-SLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQII 412
            G  + +V+E L  G  L K +  ++   + L   K+  I+  V   L YLH +C  +II
Sbjct: 116 NGTHICMVFEVL--GHHLLKWIIKSNYQGLPLPCVKK--IIQQVLQGLDYLHTKC--RII 169

Query: 413 HRDVKACNILLDAE---------------------------------------------- 426
           H D+K  NILL                                                 
Sbjct: 170 HTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKN 229

Query: 427 ---FNAKLGDFEATIPAG--------TMGYLAPEYVYSGVP-SEKTDVYSFGVVALEVAA 474
                 K+ D                T  Y + E V  G   +   D++S   +A E+A 
Sbjct: 230 AEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLE-VLIGSGYNTPADIWSTACMAFELAT 288

Query: 475 GK---SPVDNDGCVIVD----------------WV--WNLRKK-----GKLLDAADFRLR 508
           G     P   +     +                 +      K+     G L      +  
Sbjct: 289 GDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPW 348

Query: 509 G---------KFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR 542
           G         +++++E        L  +    EKR +  E  R
Sbjct: 349 GLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391

>1qmo_A Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1 Length = 113

 Score = 48.4 bits (115), Expect = 3e-07
 Identities = 13/51 (25%), Positives = 17/51 (33%)

Query: 2   LDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGL 52
           L   +    SF    +F I         DG AF I           G++GL
Sbjct: 58  LWEDSAVLTSFDTIINFEISTPYTSRIADGLAFFIAPPDSVISYHGGFLGL 108

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 51.4 bits (122), Expect = 7e-07
 Identities = 49/370 (13%), Positives = 114/370 (30%), Gaps = 104/370 (28%)

Query: 89  SSVISFVSVDALSRGIDLKSGRHITTWIEYRDSLKLIRVWAGYS------QIRPPSPLII 142
             V  F+S    +      S  H +  +   +   L+  +          ++   +P  +
Sbjct: 275 KQVTDFLSAATTTH----ISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRL 330

Query: 143 AQIDLSKQFKDYMHVGFSAANGQGSAIYTVDRWRFKTFESYPS--GNPIDVIDEGDCLTC 200
           + I  ++  +D +               T D W+    +   +   + ++V++  +    
Sbjct: 331 SII--AESIRDGLA--------------TWDNWKHVNCDKLTTIIESSLNVLEPAEYRKM 374

Query: 201 Y------PEDAGYNGSYSDVDKRKAKIAETALEV--GGLVTFVFTVVAIVGIISCFLIKK 252
           +      P                A I    L +    ++         V ++   L K 
Sbjct: 375 FDRLSVFPPS--------------AHIPTILLSLIWFDVIKSD------VMVVVNKLHKY 414

Query: 253 KRHDGRSKEDHVCTVQRVPMRLALTDIKQATLGFNKNRIVGEGASATVYKG--SLPSGGA 310
              + + KE    ++  + + L +    +  L      IV        Y    +  S   
Sbjct: 415 SLVEKQPKE-STISIPSIYLELKVKLENEYAL---HRSIVDH------YNIPKTFDSDDL 464

Query: 311 VA--------------VKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGN 356
           +               +K  E P R+   R  F  +F  +   +RH +      W   G+
Sbjct: 465 IPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVF-LDFRFLEQKIRHDST----AWNASGS 519

Query: 357 ELVLV-----YE-YL------PNGSLDKILHN--NSSSSIVLSWEKRLNIV-LGVASALS 401
            L  +     Y+ Y+          ++ IL        +++ S  K  +++ + + +   
Sbjct: 520 ILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICS--KYTDLLRIALMAEDE 577

Query: 402 YLHEECERQI 411
            + EE  +Q+
Sbjct: 578 AIFEEAHKQV 587

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 50.1 bits (120), Expect = 1e-06
 Identities = 46/231 (19%), Positives = 81/231 (35%), Gaps = 48/231 (20%)

Query: 290 RIVGEGASATVYKGS-LPSGGAVAVKR-----------------------------FEKP 319
           + +G G+   V +   + SG   A+K+                             F   
Sbjct: 13  KTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTT 72

Query: 320 NRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNE--LVLVYEYLPNGSLDKILHNN 377
              E        +   + G     N               L ++ EY+P+ +L K+L + 
Sbjct: 73  GDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSF 131

Query: 378 SSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNA-KLGDF-- 434
             S   +        +  +  A+ ++H      I HRD+K  N+L++++ N  KL DF  
Sbjct: 132 IRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSKDNTLKLCDFGS 188

Query: 435 -EATIPAGTMG-------YLAPEYVYSGV-PSEKTDVYSFGVVALEVAAGK 476
            +  IP+           Y APE +      +   D++S G V  E+  GK
Sbjct: 189 AKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 48.9 bits (117), Expect = 3e-06
 Identities = 46/218 (21%), Positives = 81/218 (37%), Gaps = 41/218 (18%)

Query: 290 RIVGEGASATVYKGS-LPSGGAVAVK------RFEKPNRVE-----CARNPFTTEFATMA 337
           R +G G  +TV+    + +   VA+K       + +    E        +   T+  +M 
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84

Query: 338 GCLRHKNLVQLQGW----CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIV 393
                 ++++L          G  +V+V+E L   +L  ++       I L + K+  I 
Sbjct: 85  ----ANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQ--IS 137

Query: 394 LGVASALSYLHEECERQIIHRDVKACNILLDAE------FNAKLGDF-EATIPAGTMG-- 444
             +   L Y+H  C   IIH D+K  N+L++           K+ D   A          
Sbjct: 138 KQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS 195

Query: 445 -----YLAPEYVYSGVP-SEKTDVYSFGVVALEVAAGK 476
                Y +PE V  G P     D++S   +  E+  G 
Sbjct: 196 IQTREYRSPE-VLLGAPWGCGADIWSTACLIFELITGD 232

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 47.4 bits (113), Expect = 9e-06
 Identities = 40/160 (25%), Positives = 67/160 (41%), Gaps = 36/160 (22%)

Query: 290 RIVGEGASATVYKGS-LPSGGAVAVKRFEKP--NRVECARNPFTTEFATMAGCLR----- 341
           + +G+GA   V+K     +G  VAVK+      N  +  R              R     
Sbjct: 15  KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQR------------TFREIMIL 62

Query: 342 -----HKNLVQLQGWCC--EGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVL 394
                H+N+V L          ++ LV++Y+    L  ++  N     +L    +  +V 
Sbjct: 63  TELSGHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRAN-----ILEPVHKQYVVY 116

Query: 395 GVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF 434
            +   + YLH      ++HRD+K  NILL+AE + K+ DF
Sbjct: 117 QLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADF 153

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 46.9 bits (112), Expect = 1e-05
 Identities = 36/156 (23%), Positives = 65/156 (41%), Gaps = 27/156 (17%)

Query: 290 RIVGEGASATVYKGS-LPSGGAVAVKR---FEKPNRVECARNPFTT--EFATMAGCLRHK 343
             +GEGA   V       +   VA+K+   FE  ++  C R    T  E   +    RH+
Sbjct: 33  SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQR----TLREIKILL-RFRHE 85

Query: 344 NLVQLQ-----GWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVAS 398
           N++ +          +  ++ +V + +    L K+L         LS +     +  +  
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH-----LSNDHICYFLYQILR 139

Query: 399 ALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF 434
            L Y+H      ++HRD+K  N+LL+   + K+ DF
Sbjct: 140 GLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDF 172

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 46.5 bits (111), Expect = 2e-05
 Identities = 35/156 (22%), Positives = 68/156 (43%), Gaps = 27/156 (17%)

Query: 290 RIVGEGASATVYKGS-LPSGGAVAVKR---FEKPNRVECARNPFTT--EFATMAGCLRHK 343
            ++GEGA   V   +  P+G  VA+K+   F+    +   R    T  E   +    +H+
Sbjct: 17  SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALR----TLREIKILK-HFKHE 69

Query: 344 NLVQLQ-----GWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVAS 398
           N++ +            NE+ ++ E +    L +++        +LS +     +     
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQ-----MLSDDHIQYFIYQTLR 123

Query: 399 ALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF 434
           A+  LH      +IHRD+K  N+L+++  + K+ DF
Sbjct: 124 AVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDF 156

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 46.1 bits (110), Expect = 2e-05
 Identities = 34/165 (20%), Positives = 59/165 (35%), Gaps = 36/165 (21%)

Query: 290 RIVGEGASATVYKGS-LPSGGAVAVKR--FEKPNRVECARNPFTT--EFATMAGCLRHKN 344
           + +G G +  V+          VA+K+      +             E   +   L H N
Sbjct: 17  KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKH----ALREIKIIR-RLDHDN 69

Query: 345 LVQL--------------QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRL 390
           +V++               G   E N + +V EY+    L  +L         L  E   
Sbjct: 70  IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGP-----LLEEHAR 123

Query: 391 NIVLGVASALSYLHEECERQIIHRDVKACNILLDAEF-NAKLGDF 434
             +  +   L Y+H      ++HRD+K  N+ ++ E    K+GDF
Sbjct: 124 LFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDF 165

>2ltn_B PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1hkd_B 1rin_B* 1ofs_B* 1bqp_B* 1loe_B 1loa_B* 1loc_B* 1lod_B* 1lob_B 1lof_B* 1log_B* 1lof_D* 1les_B* 2b7y_B* 1lgc_B* 1lgb_B* 1len_B 1lem_B 2lal_B Length = 52

 Score = 37.9 bits (88), Expect = 3e-04
 Identities = 11/40 (27%), Positives = 18/40 (45%)

Query: 138 SPLIIAQIDLSKQFKDYMHVGFSAANGQGSAIYTVDRWRF 177
           S  +   + L     +++ +GFSA  G   A + V  W F
Sbjct: 3   SYTLSDVVSLKDVVPEWVRIGFSATTGAEYAAHEVLSWSF 42

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	596
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3ipv_A	251	Lectin alpha chain; galactose binding, SEED lectin	100.0
3ujo_A	281	Legume lectin; carbohydrate-binding, galactose, ad	100.0
3zyr_A	261	Lectin; sugar binding protein, N-glycan; HET: NAG	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
1fny_A	237	BARK lectin, BARK agglutinin I,polypeptide A; legu	100.0
1fx5_A	242	UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HO	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
1dbn_A	239	MAL, protein (leukoagglutinin); plant lectin, carb	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
1gzc_A	239	Erythrina crista-galli lectin; carbohydrate, sugar	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
1v6i_A	232	Agglutinin, PNA, galactose-binding lectin; open qu	100.0
2eig_A	234	Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG bin	100.0
1g7y_A	253	Stem/LEAF lectin DB58; jelly roll fold, sugar bind	100.0
1sbf_A	253	Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {G	100.0
1hql_A	257	Lectin; xenograft antigen, sugar BI protein; HET:	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
1qnw_A	242	Chitin binding lectin, UEA-II; carbohydrate bindin	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
1fat_A	252	Phytohemagglutinin-L; glycoprotein, plant defense	100.0
2bqp_A	234	Protein (PEA lectin); D-glucopyranose complex, sug	100.0
1gsl_A	243	Griffonia simplicifolia lectin 4; glycoprotein, ma	100.0
1wbf_A	242	Protein (agglutinin); lectin (agglutinin), legume	100.0
1f9k_A	238	Acidic lectin; legume lectin, glycosylated protein	100.0
1n47_A	233	Isolectin B4; cancer antigen, vicia villosa lectin	100.0
2fmd_A	240	Lectin, agglutinin, BMA; legume lectin, beta sandw	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
1avb_A	226	Arcelin-1; lectin-like glycoprotein, plant defense	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
1ioa_A	240	Arcelin-5A, ARC5A; lectin-like proteins, plant def	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1dhk_B	223	Bean lectin-like inhibitor, porcine pancreatic alp	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
1qmo_E	133	Mannose binding lectin, FRIL; crosslink, hematopoi	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2ltn_A	181	PEA lectin, alpha chain; 1.70A {Pisum sativum} SCO	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
1nls_A	237	Concanavalin A; lectin, agglutinin; 0.94A {Canaval	100.0
2dur_A	253	VIP36;, vesicular integral-membrane protein VIP36;	99.96
1gv9_A	260	P58/ergic-53; lectin, carbohydrate binding; 1.46A	99.96
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.94
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.92
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.87
2a6y_A	256	EMP47P (FORM1); beta sandwich, carbohydrate bindin	99.84
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.73
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.61
1qmo_A	113	Mannose binding lectin, FRIL; crosslink, hematopoi	99.55
2ltn_B	52	PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP	99.52
2a6z_A	222	EMP47P (FORM2); beta sandwich, carbohydrate bindin	99.3
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.2
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.02
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.82
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.64
2a6v_A	226	EMP46P; beta sandwich, carbohydrate binding protei	98.48
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.3
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.17
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.17
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	97.96
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.77
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	97.75
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.64
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.49
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.43
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.38
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.32
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.84
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.64
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.43
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.13
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.06
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.06
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	95.74
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	95.55
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	95.22
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	95.17
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.93
3mes_A	424	Choline kinase; malaria, structural genomics, stru	91.36
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	88.31
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	82.13
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	81.13

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.1e-53  Score=443.16  Aligned_cols=248  Identities=26%  Similarity=0.413  Sum_probs=202.5

Q ss_pred             CCCccceeecCCceEEEEEEcC------CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeE
Q 047719          285 GFNKNRIVGEGASATVYKGSLP------SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNEL  358 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~  358 (596)
                      +|...++||+|+||+||+|++.      ++..||||+++..  .....++|.+|+..|.+ ++|||||+++|+|.+.+.+
T Consensus        42 d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~-l~HpnIV~l~g~~~~~~~~  118 (329)
T 4aoj_A           42 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTM-LQHQHIVRFFGVCTEGRPL  118 (329)
T ss_dssp             GEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTT-CCCTTBCCEEEEECSSSSE
T ss_pred             HeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHh-CCCCCCCcEEEEEEECCEE
Confidence            4556789999999999999864      3678999999643  34456789999966655 8999999999999999999


Q ss_pred             EEEEecCCCCCHHHHhhhCCCC-----------CcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCC
Q 047719          359 VLVYEYLPNGSLDKILHNNSSS-----------SIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEF  427 (596)
Q Consensus       359 ~lV~E~~~~gsL~~~l~~~~~~-----------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~  427 (596)
                      |||||||++|+|.++|+.....           ..+++|.+++.|+.|||+||+|||+   ++|+||||||+||||++++
T Consensus       119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~  195 (329)
T 4aoj_A          119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGL  195 (329)
T ss_dssp             EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTT
T ss_pred             EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCC
Confidence            9999999999999999865321           2369999999999999999999999   8999999999999999999


Q ss_pred             ceEEccCCCcc-------------cCCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHH
Q 047719          428 NAKLGDFEATI-------------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNL  493 (596)
Q Consensus       428 ~~kl~Dfg~~~-------------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~  493 (596)
                      .+||+|||++.             ..||+.|||||++.+..++.++|||||||+||||+| |+.||......  +.+ ..
T Consensus       196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~--~~~-~~  272 (329)
T 4aoj_A          196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT--EAI-DC  272 (329)
T ss_dssp             EEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH--HHH-HH
T ss_pred             cEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH--HHH-HH
Confidence            99999999864             248899999999999999999999999999999999 99999875321  111 11


Q ss_pred             HhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCC
Q 047719          494 RKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEAPL  550 (596)
Q Consensus       494 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~~~~  550 (596)
                      ...+...         ..+......+.+|+.+||+.||++||||+||++.|+.....
T Consensus       273 i~~g~~~---------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          273 ITQGREL---------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             HHHTCCC---------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHcCCCC---------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence            1222111         12223345678889999999999999999999999876543

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.1e-53  Score=439.21  Aligned_cols=244  Identities=25%  Similarity=0.363  Sum_probs=200.6

Q ss_pred             CccceeecCCceEEEEEEcC------CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEE
Q 047719          287 NKNRIVGEGASATVYKGSLP------SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVL  360 (596)
Q Consensus       287 ~~~~~LG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~l  360 (596)
                      ...+.||+|+||+||+|.+.      +++.||||+++... .....++|.+|+..+.+ ++|||||+++|+|.+.+.++|
T Consensus        29 ~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~-l~HpNIV~l~g~~~~~~~~~l  106 (308)
T 4gt4_A           29 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRAR-LQHPNVVCLLGVVTKDQPLSM  106 (308)
T ss_dssp             EEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHH-CCCTTBCCEEEEECSSSSCEE
T ss_pred             eEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHh-CCCCCCCCcceEEEECCEEEE
Confidence            44578999999999999863      36789999996432 23345679999976655 899999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhCCCC------------CcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCc
Q 047719          361 VYEYLPNGSLDKILHNNSSS------------SIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFN  428 (596)
Q Consensus       361 V~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~  428 (596)
                      |||||++|+|.++|......            ...++|.+++.|+.|||+||+|||+   ++||||||||+||||++++.
T Consensus       107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~~  183 (308)
T 4gt4_A          107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLN  183 (308)
T ss_dssp             EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGC
T ss_pred             EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEECCCCC
Confidence            99999999999999764311            2359999999999999999999999   89999999999999999999


Q ss_pred             eEEccCCCcc-------------cCCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHH
Q 047719          429 AKLGDFEATI-------------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLR  494 (596)
Q Consensus       429 ~kl~Dfg~~~-------------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~  494 (596)
                      +||+|||++.             ..||+.|||||++.++.++.++|||||||+||||+| |+.||.+....  +.. ...
T Consensus       184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~--~~~-~~i  260 (308)
T 4gt4_A          184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--DVV-EMI  260 (308)
T ss_dssp             EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH--HHH-HHH
T ss_pred             EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH--HHH-HHH
Confidence            9999999864             247899999999999999999999999999999999 89999875431  111 222


Q ss_pred             hcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          495 KKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       495 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                      ..+...         ..+.+....+.+|+..||+.||++||||+||++.|+..
T Consensus       261 ~~~~~~---------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          261 RNRQVL---------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             HTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             HcCCCC---------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            222221         12223445678899999999999999999999999854

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=7.1e-54  Score=438.68  Aligned_cols=247  Identities=26%  Similarity=0.442  Sum_probs=202.0

Q ss_pred             cCCCccceeecCCceEEEEEEcC------CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCe
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP------SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNE  357 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~  357 (596)
                      ++|...+.||+|+||+||+|++.      ++..||||+++..  .....++|.+|+..|.+ ++|||||+++|+|.+++.
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~-l~HpnIV~l~g~~~~~~~   89 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTN-LQHEHIVKFYGVCVEGDP   89 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTT-CCCTTBCCEEEEECSSSS
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHh-CCCCCCccEEEEEeeCCE
Confidence            35667799999999999999863      3678999999643  34456789999966655 899999999999999999


Q ss_pred             EEEEEecCCCCCHHHHhhhCC---------CCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCc
Q 047719          358 LVLVYEYLPNGSLDKILHNNS---------SSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFN  428 (596)
Q Consensus       358 ~~lV~E~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~  428 (596)
                      +|||||||++|+|.++|+...         .....++|.+++.++.|||+||+|||+   ++|+||||||+||||++++.
T Consensus        90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~  166 (299)
T 4asz_A           90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLL  166 (299)
T ss_dssp             EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGC
T ss_pred             EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCc
Confidence            999999999999999998642         223469999999999999999999999   89999999999999999999


Q ss_pred             eEEccCCCcc-------------cCCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHH
Q 047719          429 AKLGDFEATI-------------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLR  494 (596)
Q Consensus       429 ~kl~Dfg~~~-------------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~  494 (596)
                      +||+|||++.             ..||+.|||||.+.++.++.++|||||||+||||+| |+.||.+....  +.. ...
T Consensus       167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~--~~~-~~i  243 (299)
T 4asz_A          167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--EVI-ECI  243 (299)
T ss_dssp             EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHH-HHH
T ss_pred             EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHH-HHH
Confidence            9999999863             237899999999999999999999999999999999 99999875431  111 122


Q ss_pred             hcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Q 047719          495 KKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEA  548 (596)
Q Consensus       495 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~~  548 (596)
                      ..+...         ..+......+.+|+.+||+.||++||||+||++.|+...
T Consensus       244 ~~~~~~---------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~  288 (299)
T 4asz_A          244 TQGRVL---------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA  288 (299)
T ss_dssp             HHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HcCCCC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            222211         122233456788999999999999999999999998643

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.5e-52  Score=429.30  Aligned_cols=247  Identities=28%  Similarity=0.410  Sum_probs=199.3

Q ss_pred             cCCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      +++...+.||+|+||+||+|++.+  .||||+++.........++|.+|+..+.+ ++|||||+++|+|.+ +.+|||||
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~-l~HpNIV~l~g~~~~-~~~~iVmE  111 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRK-TRHVNILLFMGYMTK-DNLAIVTQ  111 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTT-CCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHh-CCCCCEeeEEEEEEC-CeEEEEEE
Confidence            356677899999999999998753  69999997655555566789999966654 999999999999865 56899999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc-----
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI-----  438 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~-----  438 (596)
                      ||++|+|.++|+...   ..++|.+++.|+.|||+||+|||+   ++||||||||+||||++++.+||+|||++.     
T Consensus       112 y~~gGsL~~~l~~~~---~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~  185 (307)
T 3omv_A          112 WCEGSSLYKHLHVQE---TKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW  185 (307)
T ss_dssp             CCSSCBHHHHHHTSC---CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred             cCCCCCHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence            999999999998653   259999999999999999999999   899999999999999999999999999864     


Q ss_pred             --------cCCCcccCCcccccc---CCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccc
Q 047719          439 --------PAGTMGYLAPEYVYS---GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRL  507 (596)
Q Consensus       439 --------~~gt~~y~aPE~~~~---~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  507 (596)
                              .+||+.|||||++..   +.|+.++|||||||+||||+||+.||.+....  ..+......+..    .+.+
T Consensus       186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~--~~~~~~~~~~~~----~p~~  259 (307)
T 3omv_A          186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR--DQIIFMVGRGYA----SPDL  259 (307)
T ss_dssp             --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--HHHHHHHHTTCC----CCCS
T ss_pred             CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH--HHHHHHHhcCCC----CCCc
Confidence                    258999999999864   46899999999999999999999999864321  111122222111    1111


Q ss_pred             cCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          508 RGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       508 ~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                       ...+.+....+.+|+.+||+.||++||||.||++.|+..
T Consensus       260 -~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l  298 (307)
T 3omv_A          260 -SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL  298 (307)
T ss_dssp             -TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred             -ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence             112223345677889999999999999999999888754

>3ipv_A Lectin alpha chain; galactose binding, SEED lectin, hemagglutinin, legume lectin fungal, sugar binding protein; 2.04A {Spatholobus parviflorus} PDB: 3ipv_B 3usu_B* 3usu_A*

Probab=100.00  E-value=1.4e-51  Score=404.20  Aligned_cols=176  Identities=29%  Similarity=0.446  Sum_probs=161.1

Q ss_pred             CCCCCCCcccceEEEEEEEEecCCCCCCCCeEEEEEecCCCCCCCCCCccCCCCCC-CCCCCceEEEEeeCccCCCCCCC
Q 047719            1 FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPV-LSPQDSFFAVEFDTSFDPSLGDI   79 (596)
Q Consensus         1 ~~~~~~~~~asF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~~~~~~~~~lG~~~~~-~~~~~~~~AVEfDt~~~~~~~d~   79 (596)
                      |||++||++|||+|+|+|.|.+++...+||||||||+|.+..++..||||||+|.+ +...+|+|||||||++|.+|+||
T Consensus        59 l~d~~tg~vaSFsT~F~F~I~~~~~~~~gdGlAF~lap~~~~~~~~gg~LGL~n~~~~~~~n~~vAVEFDT~~n~~~~Dp  138 (251)
T 3ipv_A           59 IWDSATGLVASFATSFRFTIYAPNIATIADGLAFFLAPVASAPDSGGGFLGLFDSAVSGSTYQTVAVEFDTYENTVFTDP  138 (251)
T ss_dssp             CBCTTTCCBCEEEEEEEEECCCSSTTSCCEEEEEEEEETTCCCCCCGGGTTTCSSSSCCTTSCCEEEEEECSCCGGGTCC
T ss_pred             eecCCCCceeeEEEEEEEEEeCCCCCCCCCceEEEEecCCCCCCCCCceeeeccccCCCccCcEEEEEEecccccccCCC
Confidence            79999999999999999999988778899999999999877555689999999987 43489999999999999988899


Q ss_pred             CCCeeEEecCCccccccccCCCCCcccCCCceEEEEEEEcCCccEEEEEEeeCCCCCCCCeEEEeecCcccCCCceEEEE
Q 047719           80 NGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGF  159 (596)
Q Consensus        80 ~~~Hvgid~ns~~s~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~l~~~vdl~~~l~~~~~vGF  159 (596)
                      ++|||||||||++|+++.++     .|.+|+.++|||+||+.+++|+|+|.+... +..|+|++.|||+++|||||||||
T Consensus       139 ~~nHVGIdvNsi~S~~t~~~-----~l~~G~~~~v~I~Yd~~tk~L~V~l~~~~~-~~~~~ls~~vdL~~~l~e~v~VGF  212 (251)
T 3ipv_A          139 PYTHIGFDVNSISSIKTVKW-----SLANGEAAKVLITYNSAVKLLVASLVYPSS-KTSFILADIVDLSSVLPEWVRVGF  212 (251)
T ss_dssp             SSCEEEEEESSSSCSEEEEC-----CCCTTCEEEEEEEEETTTTEEEEEEECTTT-CCEEEEEEECCHHHHSCSEEEEEE
T ss_pred             CCCeEEEEcCCCccccccee-----EecCCCEEEEEEEEeCCCCEEEEEEecCCC-CccceEEEEechHHhCCCcEEEEE
Confidence            99999999999999998874     688999999999999999999999998543 567899999999999999999999


Q ss_pred             EeecCCc---cceeeeeeeeeeccCC
Q 047719          160 SAANGQG---SAIYTVDRWRFKTFES  182 (596)
Q Consensus       160 sastg~~---~~~~~i~~Wsf~~~~~  182 (596)
                      |||||..   .|.|+|++|+|++...
T Consensus       213 SAsTG~~~~~~e~h~IlsWsF~s~l~  238 (251)
T 3ipv_A          213 SAATGASGGKIETHDVFSWSFASKLA  238 (251)
T ss_dssp             EEEECSSTTCCCCCEEEEEEEEEEEC
T ss_pred             EEecCCCccccceeEEEEEEEEEECC
Confidence            9999998   8999999999998753

>3ujo_A Legume lectin; carbohydrate-binding, galactose, adenine binding protein; HET: ADE GAL; 2.00A {Dolichos lablab} PDB: 3ujq_A* 3uk9_A* 3ul2_A* 1fat_A* 1g8w_A*

Probab=100.00  E-value=8.1e-51  Score=402.93  Aligned_cols=175  Identities=27%  Similarity=0.422  Sum_probs=159.6

Q ss_pred             CCCCCCCcccceEEEEEEEEecCCCCCCCCeEEEEEecCCCCCCCCCCccCCCCCC-CCCCCceEEEEeeCccCCCCCCC
Q 047719            1 FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPV-LSPQDSFFAVEFDTSFDPSLGDI   79 (596)
Q Consensus         1 ~~~~~~~~~asF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~~~~~~~~~lG~~~~~-~~~~~~~~AVEfDt~~~~~~~d~   79 (596)
                      |||++||++|||+|+|+|.|.+++...+||||||||+|.+..++.+||||||+|.+ +...+|+|||||||++|++| ||
T Consensus        79 l~d~~tg~vaSFsTsFsF~I~~~~~~~~gdGlAF~laP~~~~p~~~gg~LGL~n~~~~~~~n~~vAVEFDT~~N~e~-Dp  157 (281)
T 3ujo_A           79 IWDNTTGTVASWATSFTFNLQAPNAASPADGLAFALVPVGSQPKDKGGFLGLFDSKNYASSNQTVAVEFDTFYNGGW-DP  157 (281)
T ss_dssp             CBCSSSCCBEEEEEEEEEECCCSSTTSCCEEEEEEEEETTCCCCCCGGGTTTCSCSSCCTTSCCEEEEECCSCCCSS-CC
T ss_pred             cccCCCCCceeEEEEEEEEEecCCCCCCCCceEEEEecCCCCCCCCcceeeeccccCCCccCcEEEEEEeccccccC-CC
Confidence            79999999999999999999988777899999999999877666789999999987 43489999999999999886 99


Q ss_pred             CCCeeEEecCCccccccccCCCCCcccCCCceEEEEEEEcCCccEEEEEEeeCCCCCCCCeEEEeecCcccCCCceEEEE
Q 047719           80 NGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGF  159 (596)
Q Consensus        80 ~~~Hvgid~ns~~s~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~l~~~vdl~~~l~~~~~vGF  159 (596)
                      ++|||||||||++|+++.++     .+.+|+.++|||+||+.+++|+|++++... +.+|+|++.|||+++|||||||||
T Consensus       158 ~~nHVGIDvNSi~S~~t~~~-----~l~~G~~~~vwI~Yd~~tk~L~V~l~~~~~-~~~~~lS~~vDL~~~L~e~v~VGF  231 (281)
T 3ujo_A          158 TERHIGIDVNSIKSIKTTSW-----DFANGENAEVLITYDSSTNLLVASLVHPSQ-KTSFIVSERVDLTSVLPEWVSVGF  231 (281)
T ss_dssp             SSSEEEEEESSSCCSCEEEC-----CCCSSCCEEEEEEECTTTCEEEEEEECTTT-CCCEEEEEECCSTTTSCSEEEEEE
T ss_pred             CCCeEEEEcCCCCccccccc-----cccCCCEEEEEEEEeCCCCEEEEEEecCCC-CCCceEEEEechHHhccCcEEEEE
Confidence            99999999999999999875     577999999999999999999999998543 458899999999999999999999


Q ss_pred             EeecCC---ccceeeeeeeeeeccCC
Q 047719          160 SAANGQ---GSAIYTVDRWRFKTFES  182 (596)
Q Consensus       160 sastg~---~~~~~~i~~Wsf~~~~~  182 (596)
                      |||||.   ..|.|+|++|||++...
T Consensus       232 SAsTG~~~~~~e~H~IlsWSFss~l~  257 (281)
T 3ujo_A          232 SATTGLSKGYVETNEVLSWSFASKLS  257 (281)
T ss_dssp             EEEECSSTTSCCCCEEEEEEEEEEEC
T ss_pred             EeecCCCCcccceeEEEEEEEEEEcC
Confidence            999996   58999999999998753

>3zyr_A Lectin; sugar binding protein, N-glycan; HET: NAG BMA MAN GOL; 1.65A {Platypodium elegans} SCOP: b.29.1.1 PDB: 3zvx_A* 1ukg_A* 1q8o_A* 1q8q_A* 1q8s_A* 1q8v_A* 1q8p_A* 2auy_A* 2gme_A 2gmm_A* 2gmp_A* 2gn3_A* 2gn7_A* 2gnb_A* 2gnd_A* 2gnm_A* 2gnt_A 2phf_A* 2phr_A* 2pht_A* ...

Probab=100.00  E-value=2.2e-50  Score=396.83  Aligned_cols=173  Identities=29%  Similarity=0.459  Sum_probs=157.5

Q ss_pred             CCCCCCCcccceEEEEEEEEecCCCCCCCCeEEEEEecCCC--CCCCCCCccCCCCCC-CCC--CCceEEEEeeCc---c
Q 047719            1 FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNAD--SFGNDNGYMGLPGPV-LSP--QDSFFAVEFDTS---F   72 (596)
Q Consensus         1 ~~~~~~~~~asF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~--~~~~~~~~lG~~~~~-~~~--~~~~~AVEfDt~---~   72 (596)
                      |||++||++|||+|+|+|.|.++ ...+||||||||+|.+.  |.+.+||||||+|.+ +++  .||+|||||||+   +
T Consensus        67 l~d~~tg~vaSFsT~F~F~I~~~-~~~~gdGlAF~lap~~~~~p~~~~g~~LGL~n~~~~g~~~~n~~vAVEFDT~~~~~  145 (261)
T 3zyr_A           67 LWEKSTNRVANLQTQFSFFLSSP-LSNPADGIAFFIAPPDTTIPSGSAGGLLGLFNPRTALNESANQVLAVEFDTFFAQN  145 (261)
T ss_dssp             CBCTTTCCBEEEEEEEEEEEECS-SSSCCCEEEEEEECTTCCCCTTCCGGGTTTCCTTTTTCGGGCCCEEEEEECCCCTT
T ss_pred             eecCCCCCceeEEEEEEEEEecC-CCCCCccEEEEEccCCCCCCCCCCCceeeeecccccCCCccCcEEEEEEecccccc
Confidence            79999999999999999999986 67789999999999876  567889999999987 433  589999999999   9


Q ss_pred             CCCCCCCCCCeeEEecCCccccccccCCCCCcccCCCceEEEEEEEcCCccEEEEEEeeCCCCCCCCeEEEeecCcccCC
Q 047719           73 DPSLGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFK  152 (596)
Q Consensus        73 ~~~~~d~~~~Hvgid~ns~~s~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~l~~~vdl~~~l~  152 (596)
                      |.+| ||++|||||||||++|+++.++     .+.+|+.++|||+||+.+++|+|++.+...+  +|+|++.|||+++||
T Consensus       146 n~~~-Dp~~nHVGIdvNsi~S~~s~~~-----~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~~--~~~ls~~vdL~~~l~  217 (261)
T 3zyr_A          146 SNTW-DPNYQHIGIDVNSIRSSKVVRW-----ERREGKTLNVLVTYNPSTRTIDVVATYPDGQ--RYQLSHVVDLTTILP  217 (261)
T ss_dssp             TCTT-SCSSCEEEEEESSSSCSEEEEC-----CCCTTCCEEEEEEEETTTTEEEEEEECTTCC--EEEEEEECCGGGTSC
T ss_pred             CcCC-CCCCCeEEEEcCCCCccccccc-----cccCCceEEEEEEEcCCCCEEEEEEEcCCCC--CeEEEEEechHHhCc
Confidence            9886 9999999999999999999875     6779999999999999999999999985433  889999999999999


Q ss_pred             CceEEEEEeecCCccceeeeeeeeeeccCC
Q 047719          153 DYMHVGFSAANGQGSAIYTVDRWRFKTFES  182 (596)
Q Consensus       153 ~~~~vGFsastg~~~~~~~i~~Wsf~~~~~  182 (596)
                      |+||||||||||...|.|+|++|||++...
T Consensus       218 e~v~VGFSAsTG~~~e~h~IlsWsF~s~l~  247 (261)
T 3zyr_A          218 EWVRVGFSAASGEQFQTHNLESWSFTSTLL  247 (261)
T ss_dssp             SEEEEEEEEEESSSCCEEEEEEEEEEEEEC
T ss_pred             CcEEEEEEecCCCccceEEEEEEEEEEEcC
Confidence            999999999999999999999999998753

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=4e-51  Score=425.00  Aligned_cols=241  Identities=23%  Similarity=0.344  Sum_probs=197.4

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      ++|...+.||+|+||+||+|... +|+.||||++.+........+.+.+|+..+.+ ++|||||++++++.+++.+||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~-l~HpnIV~~~~~~~~~~~~yiVm  102 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLAN-MKHPNIVQYRESFEENGSLYIVM  102 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHH-CCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHH-CCCCCCCcEEEEEEECCEEEEEE
Confidence            46888899999999999999864 58999999998765555566789999977765 89999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc---
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP---  439 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~---  439 (596)
                      |||++|+|.++|....  ...+++.+++.++.||+.||+|||+   ++|+||||||+||||+.++.+||+|||++..   
T Consensus       103 Ey~~gg~L~~~i~~~~--~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  177 (350)
T 4b9d_A          103 DYCEGGDLFKRINAQK--GVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS  177 (350)
T ss_dssp             ECCTTCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred             eCCCCCcHHHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence            9999999999997654  2357899999999999999999999   9999999999999999999999999998753   


Q ss_pred             --------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcC
Q 047719          440 --------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKF  511 (596)
Q Consensus       440 --------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  511 (596)
                              +||+.|||||++.+..|+.++|||||||+||||+||+.||.+...  .+....... +..     +.+...+
T Consensus       178 ~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~--~~~~~~i~~-~~~-----~~~~~~~  249 (350)
T 4b9d_A          178 TVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM--KNLVLKIIS-GSF-----PPVSLHY  249 (350)
T ss_dssp             HHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHH-TCC-----CCCCTTS
T ss_pred             CcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHHHHHHc-CCC-----CCCCccC
Confidence                    499999999999999999999999999999999999999987532  222222221 111     1111222


Q ss_pred             CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          512 NRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       512 ~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                          ...+.+|+.+||+.||++|||++|+++
T Consensus       250 ----s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          250 ----SYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             ----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                345678889999999999999999986

>1fny_A BARK lectin, BARK agglutinin I,polypeptide A; legume lectin, jelly roll, sugar binding protein; 1.81A {Robinia pseudoacacia} SCOP: b.29.1.1 PDB: 1fnz_A*

Probab=100.00  E-value=5.3e-50  Score=391.51  Aligned_cols=174  Identities=26%  Similarity=0.375  Sum_probs=157.4

Q ss_pred             CCCCCCCcccceEEEEEEEEecCCCCCCCCeEEEEEecCCCCCCCCCCccCCCCCCCCC-CCceEEEEeeCccCCCCCCC
Q 047719            1 FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSP-QDSFFAVEFDTSFDPSLGDI   79 (596)
Q Consensus         1 ~~~~~~~~~asF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~~~~~~~~~lG~~~~~~~~-~~~~~AVEfDt~~~~~~~d~   79 (596)
                      |||++||+++||+|+|+|.|.+++...+||||||||+|...+++.+||||||+|.++++ .+|+|||||||++|.+ +||
T Consensus        58 l~d~~tg~vaSFsT~F~F~I~~~~~~~~gdGlAF~l~p~~~~~~~~g~~LGl~n~~~~~~~~~~vAVEFDT~~n~~-~Dp  136 (237)
T 1fny_A           58 IWDSTTGNVASFVTSFTFIIQAPNPATTADGLAFFLAPVDTQPLDLGGMLGIFKDGYFNKSNQIVAVEFDTFSNGD-WDP  136 (237)
T ss_dssp             CBCTTTCCBCEEEEEEEEECCCSSTTSCCEEEEEEEEETTCCCCCCGGGTTTCC---CCTTSCCEEEEEECSCCTT-TCC
T ss_pred             cccCCCCCccceEEEEEEEEeCCCCCCCCCCEEEEeccCCCCCCCCCCcccccccCCCCccccEEEEEeecccCcc-cCC
Confidence            69999999999999999999987777789999999999877667889999999977334 8999999999999988 699


Q ss_pred             CCCeeEEecCCccccccccCCCCCcccCCCceEEEEEEEcCCccEEEEEEeeCCCCCCCCeEEEeecCcccCCCceEEEE
Q 047719           80 NGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGF  159 (596)
Q Consensus        80 ~~~Hvgid~ns~~s~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~l~~~vdl~~~l~~~~~vGF  159 (596)
                      ++|||||||||+.|+++.++     +|.+|+.++|||+||+.+++|+|+|.+.. .|..|+|+..|||+.+|||+|||||
T Consensus       137 ~~nHVGIdvNsi~S~~~~~~-----~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~~~ls~~vdL~~~l~e~v~VGF  210 (237)
T 1fny_A          137 KGRHLGINVNSIESIKTVPW-----NWTNGEVANVFISYEASTKSLTASLVYPS-LETSFIIDAIVDVKIVLPEWVRFGF  210 (237)
T ss_dssp             SSSEEEEEESSSSCSEEEEC-----CCCTTCCEEEEEEEEGGGTEEEEEEEETT-TTEEEEEEEECCHHHHSCSEEEEEE
T ss_pred             CCCceEEecCCccccccccc-----cccCCCEEEEEEEEeCCCcEEEEEEecCC-CCCcceEEEEechHHhCCCcEEEEE
Confidence            99999999999999998875     58899999999999999999999998854 3567899999999999999999999


Q ss_pred             EeecCCc---cceeeeeeeeeeccC
Q 047719          160 SAANGQG---SAIYTVDRWRFKTFE  181 (596)
Q Consensus       160 sastg~~---~~~~~i~~Wsf~~~~  181 (596)
                      ||+||..   .|.|+|++|+|+++.
T Consensus       211 SAsTG~~~~~~~~h~IlsWsF~s~l  235 (237)
T 1fny_A          211 SATTGIDKGYVQTNDVLSWSFESNL  235 (237)
T ss_dssp             EEEECSSTTCCCCCEEEEEEEEEEE
T ss_pred             EEeeCCCCcccceeEEEEEEEEEec
Confidence            9999998   999999999998763

>1fx5_A UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HOMO-dimer, fucose specific lectin, SUG binding protein; HET: NAG FUC BMA MAN; 2.20A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1jxn_A*

Probab=100.00  E-value=9.3e-50  Score=391.01  Aligned_cols=175  Identities=28%  Similarity=0.339  Sum_probs=159.6

Q ss_pred             CCCCCCCcccceEEEEEEEEecC-CCCCCCCeEEEEEecCCCCCCCCCCccCCCCCCCCC-CCceEEEEeeCccCCCC-C
Q 047719            1 FLDPKTNTTASFSCRFSFSIIPS-PLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSP-QDSFFAVEFDTSFDPSL-G   77 (596)
Q Consensus         1 ~~~~~~~~~asF~t~F~f~i~~~-~~~~~g~G~aF~l~~~~~~~~~~~~~lG~~~~~~~~-~~~~~AVEfDt~~~~~~-~   77 (596)
                      |||+.||+++||+|+|+|.|.++ +...+||||||||+|...+++.+||||||+|.++++ .+|+|||||||++|.++ +
T Consensus        57 l~~~~tg~vaSFsT~F~F~I~~~~~~~~~gdGlAF~l~p~~~~~~~~g~~LGl~n~~~~~~~n~~vAVEFDT~~N~~~~~  136 (242)
T 1fx5_A           57 IWNCNTGELASFITSFSFFMETSANPKAATDGLTFFLAPPDSPLRRAGGYFGLFNDTKCDSSYQTVAVEFDTIGSPVNFW  136 (242)
T ss_dssp             CEETTTTEECEEEEEEEEEEEESSCGGGCCCEEEEEEECTTCCCCBCGGGTTTBSSSCCCGGGCCEEEEEECCCTTTSTT
T ss_pred             eecCCCCCccceEEEEEEEEecCCCCCCCCCcEEEEEecCCCCCCCCCCcccccccCCCCccCcEEEEEeccccCccccc
Confidence            69999999999999999999987 566789999999999877677889999999977444 79999999999999997 8


Q ss_pred             CCCCCeeEEecCCccccccccCCCCCcccCCC--ceEEEEEEEcCCccEEEEEEeeCCCCCCCCeEEEeecCcccCCCce
Q 047719           78 DINGNHIGIDISSVISFVSVDALSRGIDLKSG--RHITTWIEYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYM  155 (596)
Q Consensus        78 d~~~~Hvgid~ns~~s~~~~~~~~~~~~l~~g--~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~l~~~vdl~~~l~~~~  155 (596)
                      ||++|||||||||+.|++++++     +|.+|  +.++|||+||+.+++|+|+|.+... +.+|+|+..|||+.+|||+|
T Consensus       137 Dp~~nHVGIdvNs~~S~~~~~~-----~l~~G~~~~~~v~I~Yd~~~~~L~V~l~~~~~-~~~~~ls~~vdL~~~l~e~v  210 (242)
T 1fx5_A          137 DPGFPHIGIDVNCVKSINAERW-----NKRYGLNNVANVEIIYEASSKTLTASLTYPSD-QTSISVTSIVDLKEILPEWV  210 (242)
T ss_dssp             SCSSCEEEEEESSSSCSEEEEC-----CCCCSGGGCEEEEEEEETTTTEEEEEEEETTT-TEEEEEEEECCGGGTSCSEE
T ss_pred             CCCCCeEEEecCCccccceecc-----cccCCCceeEEEEEEEeCCCCEEEEEEecCCC-CccceeeEEechHHhCCccE
Confidence            9999999999999999998875     58899  9999999999999999999998542 55789999999999999999


Q ss_pred             EEEEEeec--CCccceeeeeeeeeeccCC
Q 047719          156 HVGFSAAN--GQGSAIYTVDRWRFKTFES  182 (596)
Q Consensus       156 ~vGFsast--g~~~~~~~i~~Wsf~~~~~  182 (596)
                      ||||||+|  |.. |.|+|++|+|++...
T Consensus       211 ~VGFSAsT~~G~~-~~h~IlsWsF~s~l~  238 (242)
T 1fx5_A          211 SVGFSGSTYIGRQ-ATHEVLNWYFTSTFI  238 (242)
T ss_dssp             EEEEEEEEETTSC-EEEEEEEEEEEEESS
T ss_pred             EEEEEecccCCCc-ceeEEEEEEeEeecc
Confidence            99999999  999 999999999998754

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=5.7e-50  Score=411.50  Aligned_cols=249  Identities=24%  Similarity=0.288  Sum_probs=189.9

Q ss_pred             CCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCC----eEEE
Q 047719          285 GFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGN----ELVL  360 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~----~~~l  360 (596)
                      .+...+.||+|+||+||+|++ +|+.||||+++....   ....+..|+..+ ..++|||||+++|+|.+++    .+||
T Consensus         4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~---~~~~~e~Ei~~~-~~l~HpNIv~l~g~~~~~~~~~~~~~l   78 (303)
T 3hmm_A            4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE---RSWFREAEIYQT-VMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH---HHHHHHHHHHTS-TTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch---hhHHHHHHHHHH-hcCCCCCCCcEEEEEEecCCCceEEEE
Confidence            356678999999999999998 689999999954221   111223344333 3489999999999998764    6899


Q ss_pred             EEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhcc-----CCCeEEccCCCCceeecCCCceEEccCC
Q 047719          361 VYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC-----ERQIIHRDVKACNILLDAEFNAKLGDFE  435 (596)
Q Consensus       361 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~-----~~~ivHrDlkp~NiLl~~~~~~kl~Dfg  435 (596)
                      |||||++|+|.++|+...     ++|..+++++.|+++||+|||+.+     .++|+||||||+||||+.++++||+|||
T Consensus        79 V~Ey~~~gsL~~~l~~~~-----l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFG  153 (303)
T 3hmm_A           79 VSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  153 (303)
T ss_dssp             EEECCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             EecCCCCCcHHHHHHhCC-----CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCC
Confidence            999999999999998753     899999999999999999999732     2499999999999999999999999999


Q ss_pred             Ccc---------------cCCCcccCCccccccC------CCCCccceeehhHHHHHHHhCCCCCCCCCh----------
Q 047719          436 ATI---------------PAGTMGYLAPEYVYSG------VPSEKTDVYSFGVVALEVAAGKSPVDNDGC----------  484 (596)
Q Consensus       436 ~~~---------------~~gt~~y~aPE~~~~~------~~t~~sDV~SfGvll~El~tG~~p~~~~~~----------  484 (596)
                      ++.               .+||+.|||||++.+.      .++.++|||||||+||||+||++|+.....          
T Consensus       154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~  233 (303)
T 3hmm_A          154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP  233 (303)
T ss_dssp             TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred             CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccc
Confidence            853               2589999999998754      367899999999999999999877643211          


Q ss_pred             --hHHHHHHHHHhcCCchhhccccccC-cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          485 --VIVDWVWNLRKKGKLLDAADFRLRG-KFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       485 --~~~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                        ...+.+........    .++.+.. ..+.+....+.+|+.+||+.||++||||.||++.|+..
T Consensus       234 ~~~~~~~~~~~~~~~~----~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l  295 (303)
T 3hmm_A          234 SDPSVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  295 (303)
T ss_dssp             SSCCHHHHHHHHTTSC----CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccchHHHHHHHHhccc----CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence              01111111111111    1111111 11235667788999999999999999999999999754

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=5e-50  Score=407.67  Aligned_cols=237  Identities=26%  Similarity=0.362  Sum_probs=190.9

Q ss_pred             CccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeee----CCeEEEE
Q 047719          287 NKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE----GNELVLV  361 (596)
Q Consensus       287 ~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~----~~~~~lV  361 (596)
                      ...++||+|+||+||+|... ++..||||++..........+.|.+|+..+.+ ++|||||+++++|..    ...+|||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~-l~HpnIV~~~~~~~~~~~~~~~~~lv  107 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKG-LQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHT-CCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHh-CCCCCCCcEEEEEeeccCCCcEEEEE
Confidence            44578999999999999865 48899999997655555556779999966655 999999999999865    3468999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCC--eEEccCCCCceeecC-CCceEEccCCCcc
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQ--IIHRDVKACNILLDA-EFNAKLGDFEATI  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~--ivHrDlkp~NiLl~~-~~~~kl~Dfg~~~  438 (596)
                      ||||++|+|.++|....    .+++..+..++.||+.||+|||+   ++  |+||||||+||||+. ++.+||+|||++.
T Consensus       108 mEy~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~  180 (290)
T 3fpq_A          108 TELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence            99999999999998754    48999999999999999999998   66  999999999999985 7999999999864


Q ss_pred             ---------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccC
Q 047719          439 ---------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRG  509 (596)
Q Consensus       439 ---------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  509 (596)
                               .+||+.|||||++. +.|+.++|||||||+||||+||+.||.+.... .. +......+...    .....
T Consensus       181 ~~~~~~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~-~~-~~~~i~~~~~~----~~~~~  253 (290)
T 3fpq_A          181 LKRASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA-AQ-IYRRVTSGVKP----ASFDK  253 (290)
T ss_dssp             GCCTTSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-HH-HHHHHTTTCCC----GGGGG
T ss_pred             eCCCCccCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH-HH-HHHHHHcCCCC----CCCCc
Confidence                     35999999999886 46999999999999999999999999764321 11 11122222111    11111


Q ss_pred             cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          510 KFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       510 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ..+    ..+.+|+.+||+.||++|||++|+++
T Consensus       254 ~~~----~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          254 VAI----PEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             CCC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence            222    34677889999999999999999976

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.5e-50  Score=423.16  Aligned_cols=250  Identities=25%  Similarity=0.354  Sum_probs=202.0

Q ss_pred             HhcCCCccceeecCCceEEEEEEcCC------CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeC
Q 047719          282 ATLGFNKNRIVGEGASATVYKGSLPS------GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG  355 (596)
Q Consensus       282 at~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~  355 (596)
                      ..++|...+.||+|+||+||+|.+..      ++.||||++..... ....++|.+|+..|.+..+|||||+++|+|.+.
T Consensus        62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~-~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~  140 (353)
T 4ase_A           62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKP  140 (353)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC-hHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence            34678888999999999999997532      35799999975432 334567999998887744569999999999775


Q ss_pred             -CeEEEEEecCCCCCHHHHhhhCCC------------CCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCcee
Q 047719          356 -NELVLVYEYLPNGSLDKILHNNSS------------SSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNIL  422 (596)
Q Consensus       356 -~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiL  422 (596)
                       +.+|||||||++|+|.++|+....            ....++|.+++.++.|||+||+|||+   ++||||||||+|||
T Consensus       141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~~NIL  217 (353)
T 4ase_A          141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNIL  217 (353)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEE
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCcccee
Confidence             578999999999999999986432            12358999999999999999999999   89999999999999


Q ss_pred             ecCCCceEEccCCCccc-------------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHH
Q 047719          423 LDAEFNAKLGDFEATIP-------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVD  488 (596)
Q Consensus       423 l~~~~~~kl~Dfg~~~~-------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~  488 (596)
                      |++++.+||+|||++..             .||+.|||||++.++.|+.++|||||||+||||+| |+.||.+....  +
T Consensus       218 l~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~--~  295 (353)
T 4ase_A          218 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--E  295 (353)
T ss_dssp             ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS--H
T ss_pred             eCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH--H
Confidence            99999999999998752             37889999999999999999999999999999998 99999864321  1


Q ss_pred             HHHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          489 WVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       489 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                      .+......+...         ..+......+.+++..||+.||++||||.||++.|+.
T Consensus       296 ~~~~~i~~g~~~---------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~  344 (353)
T 4ase_A          296 EFCRRLKEGTRM---------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  344 (353)
T ss_dssp             HHHHHHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHHHcCCCC---------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence            122222222211         1122233567788899999999999999999998864

>1dbn_A MAL, protein (leukoagglutinin); plant lectin, carbohydrate binding, sialyllactose, sugar BIN protein; HET: NAG SIA GAL BGC; 2.75A {Maackia amurensis} SCOP: b.29.1.1

Probab=100.00  E-value=1.4e-49  Score=389.37  Aligned_cols=173  Identities=29%  Similarity=0.399  Sum_probs=158.0

Q ss_pred             CCCCCCCcccceEEEEEEEEecCCCCCCCCeEEEEEecCCC--CCCCCCCccCCCCCCCCC-CCceEEEEeeCccC---C
Q 047719            1 FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNAD--SFGNDNGYMGLPGPVLSP-QDSFFAVEFDTSFD---P   74 (596)
Q Consensus         1 ~~~~~~~~~asF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~--~~~~~~~~lG~~~~~~~~-~~~~~AVEfDt~~~---~   74 (596)
                      |||++||+++||+|+|+|.|.+++...+||||||||+|.+.  |.+..||||||+|.++++ .+|+|||||||++|   .
T Consensus        58 l~~~~tg~vaSFsT~F~F~I~~~~~~~~gdGlAF~l~p~~~~~p~~~~g~~LGl~n~~~~~~~~~~vAVEFDT~~n~~~~  137 (239)
T 1dbn_A           58 IWGNTTGSVASFSTSFTFVVKAPNPDITSDGLAFYLAPPDSQIPSGSVSKYLGLFNNSNSDSSNQIVAVEFDTYFAHSYD  137 (239)
T ss_dssp             CBCTTTCCBCEEEEEEEEECCCSSTTSCCEEEEEEEECTTCCCCSSSCGGGTTSCSSSCCCTTSCCEEEEEECCCCTTTC
T ss_pred             cccCCCCCccceEEEEEEEEeCCCCCCCCCCEEEEEecCCCCCCcCCCCCcccccccCCCCccccEEEEEEeccccCccc
Confidence            69999999999999999999987777789999999999865  567889999999976433 79999999999999   7


Q ss_pred             CCCCCCCCeeEEecCCccccccccCCCCCcccCCCceEEEEEEEcCCccEEEEEEeeCCCCCCCCeEEEeecCcccCCCc
Q 047719           75 SLGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDY  154 (596)
Q Consensus        75 ~~~d~~~~Hvgid~ns~~s~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~l~~~vdl~~~l~~~  154 (596)
                      + +||++|||||||||++|+++.++     +|.+|+.++|||+||+.+++|+|+|.+.. .+..|+|+..|||+.+|||+
T Consensus       138 ~-~Dp~~nHVGIdvNs~~S~~~~~~-----~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~~~ls~~vdL~~~l~e~  210 (239)
T 1dbn_A          138 P-WDPNYRHIGIDVNGIESIKTVQW-----DWINGGVAFATITYLAPNKTLIASLVYPS-NQTTFSVAASVDLKEILPEW  210 (239)
T ss_dssp             T-TSCSSCEEEEEESSSSCSEEEEC-----CCCTTCCEEEEEEEEGGGTEEEEEEEETT-TTEEEEEEEECCHHHHSCSE
T ss_pred             c-cCCCCCcEEEecCCccccceEcc-----cccCCCEEEEEEEEeCCCcEEEEEEccCC-CCCcceEEEEechHHhCCcc
Confidence            7 69999999999999999998875     58899999999999999999999998854 35678999999999999999


Q ss_pred             eEEEEEeecCCc--cceeeeeeeeeecc
Q 047719          155 MHVGFSAANGQG--SAIYTVDRWRFKTF  180 (596)
Q Consensus       155 ~~vGFsastg~~--~~~~~i~~Wsf~~~  180 (596)
                      ||||||||||..  .|.|+|++|+|+++
T Consensus       211 v~VGFSAsTG~~~~~~~h~IlsWsF~s~  238 (239)
T 1dbn_A          211 VRVGFSAATGYPTEVETHDVLSWSFTST  238 (239)
T ss_dssp             EEEEEEEEECSGGGCCCCEEEEEEEEEE
T ss_pred             EEEEEEeccCCCccceeeEEEEEEeEec
Confidence            999999999999  99999999999874

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=3.3e-49  Score=409.92  Aligned_cols=242  Identities=27%  Similarity=0.355  Sum_probs=199.4

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      ..|...+.||+|+||+||+|... +|+.||||++....  ....+.+.+|+..|.. ++|||||++++++.+.+.+||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~--~~~~~~~~~Ei~il~~-l~HpnIV~l~~~~~~~~~~~ivm  150 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRD-YQHENVVEMYNSYLVGDELWVVM  150 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG--CSSGGGGHHHHHHHHH-CCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCc--hhHHHHHHHHHHHHHh-CCCCCCCcEEEEEEECCEEEEEE
Confidence            34777889999999999999875 58999999996543  2345568899977765 89999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc----
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI----  438 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~----  438 (596)
                      |||++|+|.+++...     .+++.++..++.||+.||+|||+   ++|+||||||+||||+.++.+||+|||++.    
T Consensus       151 Ey~~gg~L~~~l~~~-----~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  222 (346)
T 4fih_A          151 EFLEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK  222 (346)
T ss_dssp             CCCTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             eCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCC
Confidence            999999999999864     38999999999999999999999   999999999999999999999999999763    


Q ss_pred             -------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcC
Q 047719          439 -------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKF  511 (596)
Q Consensus       439 -------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  511 (596)
                             .+||+.|||||++.+..|+.++|||||||+||||++|+.||.+....  +.........      .+.+  ..
T Consensus       223 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--~~~~~i~~~~------~~~~--~~  292 (346)
T 4fih_A          223 EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKMIRDNL------PPRL--KN  292 (346)
T ss_dssp             SSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHSS------CCCC--SC
T ss_pred             CCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHHHHHHcCC------CCCC--Cc
Confidence                   35999999999999999999999999999999999999999875421  1111111110      0111  11


Q ss_pred             CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhc
Q 047719          512 NRKEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKG  546 (596)
Q Consensus       512 ~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~~  546 (596)
                      .......+.+|+.+||+.||++|||++|+++  +++.
T Consensus       293 ~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~  329 (346)
T 4fih_A          293 LHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK  329 (346)
T ss_dssp             GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred             cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcC
Confidence            1122345678889999999999999999987  4544

>1gzc_A Erythrina crista-galli lectin; carbohydrate, sugar binding protein, saccharide, protein-carbohydrate interactions, lactose, glycoprotein; HET: LAT; 1.58A {Erythrina crista-galli} SCOP: b.29.1.1 PDB: 1gz9_A* 1fyu_A* 1ax0_A* 1ax1_A* 1ax2_A* 1axy_A* 1axz_A* 1lte_A* 1sfy_A* 1v00_A* 1uzz_A 1uzy_A* 3n35_A* 3n36_A* 3n3h_A*

Probab=100.00  E-value=2.9e-49  Score=387.23  Aligned_cols=174  Identities=29%  Similarity=0.408  Sum_probs=157.8

Q ss_pred             CCCCCCCcccceEEEEEEEEecCC-CCCCCCeEEEEEecCCCCCCCCCCccCCCCCCCCC-CCceEEEEeeCccCCCCCC
Q 047719            1 FLDPKTNTTASFSCRFSFSIIPSP-LCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSP-QDSFFAVEFDTSFDPSLGD   78 (596)
Q Consensus         1 ~~~~~~~~~asF~t~F~f~i~~~~-~~~~g~G~aF~l~~~~~~~~~~~~~lG~~~~~~~~-~~~~~AVEfDt~~~~~~~d   78 (596)
                      |||+.||+++||+|+|+|.|.+++ ...+||||||||+|...+++.+||||||+|.++++ .+|+|||||||++|. |+|
T Consensus        59 l~~~~tg~vaSFsT~F~F~I~~~~~~~~~gdGlAF~l~p~~~~~~~~g~~LGl~n~~~~~~~~~~vAVEFDT~~n~-~dD  137 (239)
T 1gzc_A           59 MWDSTTGTVASFETRFSFSIEQPYTRPLPADGLVFFMGPTKSKPAQGYGYLGVFNNSKQDNSYQTLAVEFDTFSNP-WDP  137 (239)
T ss_dssp             CBCTTTCCBCEEEEEEEEECCCCCSSSCCCEEEEEEEECSSCCCCCCGGGTTTCSSSSCCGGGCCEEEEEECSCCT-TSC
T ss_pred             cccCCCCCccceEEEEEEEEeCCCCCCCCCCcEEEEEecCCCCCCCCCCcccccccCCCCccccEEEEEEeccccc-CCC
Confidence            699999999999999999999876 67789999999999877677889999999977444 799999999999998 777


Q ss_pred             CCCCeeEEecCCccccccccCCCCCcccCCCceEEEEEEEcCCccEEEEEEeeCCCCCCCCeEEEeecCcccCCCceEEE
Q 047719           79 INGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVG  158 (596)
Q Consensus        79 ~~~~Hvgid~ns~~s~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~l~~~vdl~~~l~~~~~vG  158 (596)
                      |++||||||+||+.|+++.++     +|.+|+.++|||+||+.+++|+|+|.+.. .+..|+|+..|||+.+|||+||||
T Consensus       138 p~~nHVGIdvns~~S~~~~~~-----~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~~~ls~~vdL~~~l~e~v~VG  211 (239)
T 1gzc_A          138 PQVPHIGIDVNSIRSIKTQPF-----QLDNGQVANVVIKYDAPSKILHVVLVYPS-SGAIYTIAEIVDVKQVLPDWVDVG  211 (239)
T ss_dssp             SSSSEEEEEESSSSCSEEEEC-----CCCTTCEEEEEEEEETTTTEEEEEEECTT-TCCEEEEEEECCHHHHSCSEEEEE
T ss_pred             CCCCeEEEecCCccccccccc-----cccCCCEEEEEEEEeCCCcEEEEEEecCC-CCccceEEEEechHHhCCCceEEE
Confidence            999999999999999998775     58899999999999999999999998854 356789999999999999999999


Q ss_pred             EEeecCC---ccceeeeeeeeeeccC
Q 047719          159 FSAANGQ---GSAIYTVDRWRFKTFE  181 (596)
Q Consensus       159 Fsastg~---~~~~~~i~~Wsf~~~~  181 (596)
                      |||+||.   ..|.|+|++|+|+++.
T Consensus       212 FSAsTG~~~~~~~~h~IlsWsF~s~l  237 (239)
T 1gzc_A          212 LSGATGAQRDAAETHDVYSWSFQASL  237 (239)
T ss_dssp             EEEEECSSTTCCCCCEEEEEEEEEEE
T ss_pred             EEeccCCCccccceEEEEEEEeEEec
Confidence            9999997   4899999999998763

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.7e-49  Score=410.88  Aligned_cols=237  Identities=24%  Similarity=0.232  Sum_probs=194.9

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      ..|...++||+|+||+||+|+.. +|+.||||+++....       ..+|+..+ +.++|||||++++++.+++.+||||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il-~~l~HpnIV~l~~~~~~~~~~~ivm  129 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVAC-AGLSSPRIVPLYGAVREGPWVNIFM  129 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTT-TTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHH-HhCCCCCCCcEEEEEEECCEEEEEE
Confidence            45677789999999999999865 589999999965321       24687555 4599999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCC-ceEEccCCCcc---
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEF-NAKLGDFEATI---  438 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~-~~kl~Dfg~~~---  438 (596)
                      |||++|+|.++|+...    .+++.++..++.||+.||+|||+   ++|+||||||+||||+.++ .+||+|||++.   
T Consensus       130 Ey~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~  202 (336)
T 4g3f_A          130 ELLEGGSLGQLIKQMG----CLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQ  202 (336)
T ss_dssp             CCCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-
T ss_pred             eccCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEcc
Confidence            9999999999998754    49999999999999999999999   8999999999999999987 69999999763   


Q ss_pred             -------------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCCh-hHHHHHHHHHhcCCchhhcc
Q 047719          439 -------------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGC-VIVDWVWNLRKKGKLLDAAD  504 (596)
Q Consensus       439 -------------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~-~~~~~~~~~~~~~~~~~~~d  504 (596)
                                   .+||+.|||||++.+..|+.++|||||||+||||+||+.||.+... .+..   ........     
T Consensus       203 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~---~i~~~~~~-----  274 (336)
T 4g3f_A          203 PDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL---KIASEPPP-----  274 (336)
T ss_dssp             -----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHH---HHHHSCCG-----
T ss_pred             CCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH---HHHcCCCC-----
Confidence                         2599999999999999999999999999999999999999976432 1111   11111100     


Q ss_pred             ccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          505 FRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       505 ~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                         ...++......+.+++.+||+.||++|||+.|+++.|..
T Consensus       275 ---~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~  313 (336)
T 4g3f_A          275 ---IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK  313 (336)
T ss_dssp             ---GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence               011222334567788899999999999999999887753

>1v6i_A Agglutinin, PNA, galactose-binding lectin; open quaternary association, orthorhombic, carbohydrate specificity, protein crystallography; HET: GAL GLC; 2.15A {Arachis hypogaea} SCOP: b.29.1.1 PDB: 1bzw_A* 1v6j_A* 1v6k_A* 1v6l_A* 1v6m_A 1v6n_A 1v6o_A 2dva_A* 1cq9_A 1ciw_A* 1qf3_A* 1rir_A* 1rit_A* 2dh1_A 1cr7_A* 2dv9_A* 2dvb_A* 2dvd_A* 2dvf_A 2dvg_A* ...

Probab=100.00  E-value=4.4e-49  Score=383.83  Aligned_cols=171  Identities=27%  Similarity=0.410  Sum_probs=157.2

Q ss_pred             CCCCCCCcccceEEEEEEEEecCCCCCCCCeEEEEEecCCC--CCCC-CCCccCCCCCCCCCCCceEEEEeeCccCCCCC
Q 047719            1 FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNAD--SFGN-DNGYMGLPGPVLSPQDSFFAVEFDTSFDPSLG   77 (596)
Q Consensus         1 ~~~~~~~~~asF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~--~~~~-~~~~lG~~~~~~~~~~~~~AVEfDt~~~~~~~   77 (596)
                      |||++||+++||+|+|+|.|.+++...+||||||||+|.+.  |.++ +||||||+|.  ...+|+|||||||++|.+++
T Consensus        54 l~~~~tg~vaSFsT~F~F~I~~~~~~~~gdGlAF~l~p~~~~~p~~~~~g~~LGl~n~--~~~~~~vAVEFDT~~n~~~~  131 (232)
T 1v6i_A           54 IWSSATGNVASFLTSFSFEMKDIKDYDPADGIIFFIAPEDTQIPAGSIGGGTLGVSDT--KGAGHFVGVEFDTYSNSEYN  131 (232)
T ss_dssp             CBCTTTCCBCEEEEEEEEEEECCSSSBCCCEEEEEEEETTCCCCTTCCCGGGTTTSCT--TSEEEEEEEEEECSCCGGGT
T ss_pred             eecCCCCCccceEEEEEEEEecCCCCCCCCCEEEEEecCCCCCCCCcCCCcccccccC--CCcccEEEEEeecccccccC
Confidence            69999999999999999999988777789999999999874  5667 8999999986  34789999999999999989


Q ss_pred             CCCCCeeEEecCCccccccccCCCCCcccCCCceEEEEEEEcCCccEEEEEEeeCCCCCCCCeEEEeecCcccCCCceEE
Q 047719           78 DINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHV  157 (596)
Q Consensus        78 d~~~~Hvgid~ns~~s~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~l~~~vdl~~~l~~~~~v  157 (596)
                      ||++|||||||||++|+++.++     +|.+|+.++|||+||+.+++|+|+|++ . +|.+|+|+..|||+++|||+|||
T Consensus       132 Dp~~nHVGIdvns~~S~~~~~~-----~l~~G~~~~v~I~Yd~~~~~L~V~l~~-~-~~~~~~ls~~vdL~~~l~e~v~V  204 (232)
T 1v6i_A          132 DPPTDHVGIDVNSVDSVKTVPW-----NSVSGAVVKVTVIYDSSTKTLSVAVTN-D-NGDITTIAQVVDLKAKLPERVKF  204 (232)
T ss_dssp             CCSSCEEEEEEEESSCSEEEEC-----CCCTTCEEEEEEEEETTTTEEEEEEEC-T-TSCEEEEEEECCHHHHSCSEEEE
T ss_pred             CCCCCeEEEEcCCccccccccc-----cccCCCEEEEEEEEeCCCcEEEEEEec-C-CCCcceEEEEechHHhCCccEEE
Confidence            9999999999999999998875     588999999999999999999999998 3 56789999999999999999999


Q ss_pred             EEEeecCC--ccceeeeeeeeeeccC
Q 047719          158 GFSAANGQ--GSAIYTVDRWRFKTFE  181 (596)
Q Consensus       158 GFsastg~--~~~~~~i~~Wsf~~~~  181 (596)
                      ||| |||.  ..|.|+|++|+|+++.
T Consensus       205 GFS-sTG~~~~~~~h~IlsWsF~s~l  229 (232)
T 1v6i_A          205 GFS-ASGSLGGRQIHLIRSWSFTSTL  229 (232)
T ss_dssp             EEE-EECCSSBCCEEEEEEEEEEEEE
T ss_pred             EEE-ecCCCccccEEEEEEEEEEeec
Confidence            999 9998  5899999999999864

>2eig_A Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG binding protein; HET: NAG; 2.00A {Lotus tetragonolobus}

Probab=100.00  E-value=3.3e-48  Score=377.71  Aligned_cols=171  Identities=28%  Similarity=0.412  Sum_probs=157.2

Q ss_pred             CCCCCCCcccceEEEEEEEEecCCCCCCCCeEEEEEecCCC--CCCCCCCccCCCCCCCCCCCceEEEEeeCccCCCCCC
Q 047719            1 FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNAD--SFGNDNGYMGLPGPVLSPQDSFFAVEFDTSFDPSLGD   78 (596)
Q Consensus         1 ~~~~~~~~~asF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~--~~~~~~~~lG~~~~~~~~~~~~~AVEfDt~~~~~~~d   78 (596)
                      |||++||+++||+|+|+|.|.+++...+||||||||+|.+.  +.+..||||||+|.+ ...+|+|||||||++|.  +|
T Consensus        51 l~~~~tg~vaSFsT~F~F~I~~~~~~~~gdGlAF~l~p~~~~~p~~~~g~~LGl~n~~-~~~~~~vAVEFDT~~N~--~D  127 (234)
T 2eig_A           51 IWDSATGNVASFITSFSFIVSNVQRYPPTDGVVFFLAPWGTEIPPNSQGGYLGITDSS-NSQNQFVAVEFDSHPNV--WD  127 (234)
T ss_dssp             CBCTTTCCBCEEEEEEEEEEEECTTSCCCCEEEEEEEETTCCCCTTCCGGGTTTCCTT-CSCCCCEEEEEECSCCT--TS
T ss_pred             eecCCCCCccceEEEEEEEEeCCCCCCCCCcEEEEEecCCCCCCcCCCCCccccccCC-CccccEEEEEeccccCc--cC
Confidence            69999999999999999999988777889999999999875  667899999999876 44799999999999998  69


Q ss_pred             CCC---CeeEEecCCccccccccCCCCCcccCCCceEEEEEEEcCCccEEEEEEeeCCCCCCCCeEEEeecCcccCCCce
Q 047719           79 ING---NHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYM  155 (596)
Q Consensus        79 ~~~---~Hvgid~ns~~s~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~l~~~vdl~~~l~~~~  155 (596)
                      |++   ||||||+||++|+++.++     +|.+|+.++|||+||+.+++|+|+|.+ . +|..|+|+..|||+.+|||+|
T Consensus       128 p~~~~~nHVGIdvNsi~S~~~~~~-----~l~~g~~~~v~I~Yd~~~~~L~V~l~~-~-~~~~~~ls~~vdL~~~l~e~v  200 (234)
T 2eig_A          128 PKSLRSSHIGIDVNSIMSLKAVNW-----NRVSGSLEKATIIYDSDTKILTVVMTH-Q-NGQITTISQEIDLKTVLPEKV  200 (234)
T ss_dssp             CTTTCSSEEEEEESSSSCSEEEEC-----CCCTTCCEEEEEEEETTTTEEEEEEEE-T-TSCEEEEEEECCHHHHSCSEE
T ss_pred             CCCCCCCceEEecCCccccceecc-----cccCCCEEEEEEEEeCCCcEEEEEEec-C-CCCcceEeEeechHHhcCCce
Confidence            999   999999999999998875     588999999999999999999999998 3 467799999999999999999


Q ss_pred             EEEEEeec--CCccceeeeeeeeeeccCC
Q 047719          156 HVGFSAAN--GQGSAIYTVDRWRFKTFES  182 (596)
Q Consensus       156 ~vGFsast--g~~~~~~~i~~Wsf~~~~~  182 (596)
                      ||||||+|  |.. +.|+|++|+|++...
T Consensus       201 ~VGFSAsT~~G~~-~~h~IlsWsF~s~l~  228 (234)
T 2eig_A          201 SVGFSATTWNPER-ERHDIYSWSFTSTLK  228 (234)
T ss_dssp             EEEEEEEECSSCC-EEEEEEEEEEEEECC
T ss_pred             EEEEEeeecCCCc-ceeEEEEEEEEecCC
Confidence            99999999  988 999999999998753

>1g7y_A Stem/LEAF lectin DB58; jelly roll fold, sugar binding protein; HET: NAG FUC FUL; 2.50A {Vigna unguiculata subsp} SCOP: b.29.1.1 PDB: 1lul_A 1lu1_A* 1bjq_A* 1lu2_A*

Probab=100.00  E-value=1.5e-48  Score=385.03  Aligned_cols=174  Identities=25%  Similarity=0.405  Sum_probs=159.3

Q ss_pred             CCCCCCCcccceEEEEEEEEecCCCCCCCCeEEEEEecCCCCCCCCCCccCCCCCCCCC-CCceEEEEeeCccCCCCCCC
Q 047719            1 FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSP-QDSFFAVEFDTSFDPSLGDI   79 (596)
Q Consensus         1 ~~~~~~~~~asF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~~~~~~~~~lG~~~~~~~~-~~~~~AVEfDt~~~~~~~d~   79 (596)
                      |||+.||+++||+|+|+|.|.+++...+||||||||+|.+.+++++||||||+|.++++ .+|+|||||||++|.+ +||
T Consensus        56 l~d~~tg~vaSFsT~F~F~I~~~~~~~~gdGlAF~l~p~~~~~~~~g~~LGl~n~~~~~~~n~~vAVEFDT~~N~~-~Dp  134 (253)
T 1g7y_A           56 IYDKSTGAVASWATSFTANIFAPNKSSSADGIAFALVPVGSEPKSNSGFLGVFDSDVYDNSAQTVAVEFDTFSNTD-WDP  134 (253)
T ss_dssp             CBCTTTCCBCEEEEEEEEECCCSSGGGCCCEEEEEEEETTCCCCCCGGGTTTCSCSSCCGGGCCEEEEEECSCCTT-TCC
T ss_pred             eecCCCCCccceEEEEEEEEecCCCCCCCCcEEEEEecCCCCCCCCCCcccccccCCCCccCceEEEEecceeccC-cCC
Confidence            69999999999999999999987667789999999999877677889999999977434 7999999999999998 699


Q ss_pred             CCCeeEEecCCccccccccCCCCCcccCCCceEEEEEEEcCCccEEEEEEeeCCCCCCCCeEEEeecCcccCCCceEEEE
Q 047719           80 NGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGF  159 (596)
Q Consensus        80 ~~~Hvgid~ns~~s~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~l~~~vdl~~~l~~~~~vGF  159 (596)
                      ++||||||+||+.|.++.++     +|.+|+.++|||+||+.+++|+|++.+.. .|.+|+|+..|||+.+|||+|||||
T Consensus       135 ~~nHVGIdvns~~S~~t~~~-----~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~~~ls~~vdL~~~l~e~~~VGF  208 (253)
T 1g7y_A          135 TSRHIGIDVNSIKSIRTASW-----GLANGQNAEILITYNAATSLLVASLVHPS-RRTSYIVSERVDITNELPEYVSIGF  208 (253)
T ss_dssp             SSCEEEEEESSSSCSEEEEC-----CCCTTSEEEEEEEEETTTTEEEEEEEETT-TTEEEEEEEECCHHHHSCSEEEEEE
T ss_pred             CCCcEeeccCCccccceecc-----ccCCCCeEEEEEEEeCCCCEEEEEEecCC-CCCcceEEEEechHHhCCCceEEEE
Confidence            99999999999999998875     58899999999999999999999998854 3567899999999999999999999


Q ss_pred             EeecCCc---cceeeeeeeeeeccC
Q 047719          160 SAANGQG---SAIYTVDRWRFKTFE  181 (596)
Q Consensus       160 sastg~~---~~~~~i~~Wsf~~~~  181 (596)
                      |||||..   .+.|+|++|+|++..
T Consensus       209 SAsTG~~~~~~~~H~IlsWsF~s~l  233 (253)
T 1g7y_A          209 SATTGLSEGYTETHDVLSWSFASKL  233 (253)
T ss_dssp             EEECCSSSSCCCCCEEEEEEEEEEE
T ss_pred             EeCcCCCCcccceeEEEEEEEEeeC
Confidence            9999999   999999999999874

>1sbf_A Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {Glycine max} SCOP: b.29.1.1 PDB: 1sbd_A* 1sbe_A* 1g9f_A* 2sba_A*

Probab=100.00  E-value=2.6e-48  Score=382.78  Aligned_cols=172  Identities=28%  Similarity=0.439  Sum_probs=158.3

Q ss_pred             CCCCCCCcccceEEEEEEEEecCCCCCCCCeEEEEEecCCCCCCCCCCccCCCCCCCCCCCceEEEEeeCccCCCCCCCC
Q 047719            1 FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQDSFFAVEFDTSFDPSLGDIN   80 (596)
Q Consensus         1 ~~~~~~~~~asF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~~~~~~~~~lG~~~~~~~~~~~~~AVEfDt~~~~~~~d~~   80 (596)
                      |||++||+++||+|+|+|.|.+++...+||||||||+|...+++++||||||+|.. ...+|+|||||||++|.  +||+
T Consensus        59 l~d~~tg~vaSFsT~F~F~I~~~~~~~~gdGlAF~l~p~~~~~~~~g~~LGL~n~~-~~~n~~vAVEFDT~~N~--~Dp~  135 (253)
T 1sbf_A           59 IWDKETGSVASFAASFNFTFYAPDTKRLADGLAFFLAPIDTKPQTHAGYLGLFNEN-ESGDQVVAVEFDTFRNS--WDPP  135 (253)
T ss_dssp             CBCTTTCCBCEEEEEEEEEEECSSTTSCCEEEEEEEEETTCCCCCCGGGTTTCCTT-SCCCSCEEEEEECSCCT--TCCS
T ss_pred             cccCCCCcccceEEEEEEEEeCCCCCCCCCcEEEEEecCCCCCCCCCCccccccCC-CcccceEEEEeccccCC--CCCC
Confidence            69999999999999999999988777789999999999877667889999999876 45899999999999998  7999


Q ss_pred             CCeeEEecCCccccccccCCCCCcccCCCceEEEEEEEcCCccEEEEEEeeCCCCCCCCeEEEeecCcccCCCceEEEEE
Q 047719           81 GNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFS  160 (596)
Q Consensus        81 ~~Hvgid~ns~~s~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~l~~~vdl~~~l~~~~~vGFs  160 (596)
                      +||||||+||+.|+++.++     +|.+|+.++|||+||+.+++|+|++.+.. .|..|+|+..|||+.+|||+||||||
T Consensus       136 ~nHVGIdvNs~~S~~t~~~-----~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~~~ls~~vdL~~~l~e~~~VGFS  209 (253)
T 1sbf_A          136 NPHIGINVNSIRSIKTTSW-----DLANNKVAKVLITYDASTSLLVASLVYPS-QRTSNILSDVVDLKTSLPEWVRIGFS  209 (253)
T ss_dssp             SSEEEEEESSSSCSEEEEC-----CCCTTCCEEEEEEEETTTTEEEEEEEETT-TTEEEEEEEECCHHHHSCSEEEEEEE
T ss_pred             CCcEEEEcCCccccceecc-----cccCCCeeEEEEEEeCCCcEEEEEEecCC-CCCcceEEEEechHHhCCCceEEEEE
Confidence            9999999999999998875     58899999999999999999999999854 35578999999999999999999999


Q ss_pred             eecCCc--cceeeeeeeeeeccC
Q 047719          161 AANGQG--SAIYTVDRWRFKTFE  181 (596)
Q Consensus       161 astg~~--~~~~~i~~Wsf~~~~  181 (596)
                      ||||..  .+.|+|++|+|++..
T Consensus       210 AsTG~~~~~~~H~IlsWsF~s~l  232 (253)
T 1sbf_A          210 AATGLDIPGESHDVLSWSFASNL  232 (253)
T ss_dssp             EEECSSSCCCEEEEEEEEEEEEE
T ss_pred             eccCCCccceeeEEEEEEeEeec
Confidence            999999  999999999999875

>1hql_A Lectin; xenograft antigen, sugar BI protein; HET: GLA MBG NAG; 2.20A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1gnz_A*

Probab=100.00  E-value=3.5e-48  Score=383.21  Aligned_cols=177  Identities=26%  Similarity=0.419  Sum_probs=158.9

Q ss_pred             CCCCCCCcccceEEEEEEEEecCCCCCCCCeEEEEEecCCCCCCCCCCccCCCCCCC--CC-CCceEEEEeeCccCCCCC
Q 047719            1 FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVL--SP-QDSFFAVEFDTSFDPSLG   77 (596)
Q Consensus         1 ~~~~~~~~~asF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~~~~~~~~~lG~~~~~~--~~-~~~~~AVEfDt~~~~~~~   77 (596)
                      |||+.||+++||+|+|+|.|.++ ...+||||||||+|...+++++||||||+|.++  ++ .+|+|||||||++|.+|.
T Consensus        60 l~d~~tg~vasFsT~F~F~I~~~-~~~~gdGlAF~l~p~~~~~~~~g~~LGl~n~~~~~~~~~n~~vAVEFDT~~N~~~~  138 (257)
T 1hql_A           60 LWDNKTESVASFYTEFTFFLKIT-GNGPADGLAFFLAPPDSDVKDAGEYLGLFNKSTATQPSKNQVVAVEFDTWTNPNFP  138 (257)
T ss_dssp             CCCSTTCCCCEEEEEEEEEEEEC-SSCCCCEEEEEEECTTCCCCCCGGGTTTSCTTTTTCGGGCCCEEEEEECSCCSSSC
T ss_pred             cccCCCCCeeceEEEEEEEEecC-CCCCCCcEEEEEecCCCCCCCCCccccccccccccCCccCceEEEEeccccccccc
Confidence            69999999999999999999987 677899999999998777778899999998873  33 689999999999999988


Q ss_pred             CCCCCeeEEecCCccccccccCCCCCcc-cCCCceEEEEEEEcCCccEEEEEEeeCCCCCCCCeEEEeecCcccCCCceE
Q 047719           78 DINGNHIGIDISSVISFVSVDALSRGID-LKSGRHITTWIEYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMH  156 (596)
Q Consensus        78 d~~~~Hvgid~ns~~s~~~~~~~~~~~~-l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~l~~~vdl~~~l~~~~~  156 (596)
                      ||++||||||+||+.|+++.++.   +. |.+|+.++|||+||+.+++|+|++.+...  ..|+|+..|||+.+|||+||
T Consensus       139 Dp~~nHVGIdvNs~~S~~s~~~~---~~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~ls~~vdL~~~l~e~~~  213 (257)
T 1hql_A          139 EPSYRHIGINVNSIVSVATKRWE---DSDIFSGKIATARISYDGSAEILTVVLSYPDG--SDYILSHSVDMRQNLPESVR  213 (257)
T ss_dssp             CCSSCEEEEEESSSSCSEEEECC---HHHHTSCSCEEEEEEEETTTTEEEEEEEETTT--EEEEEEEECCGGGTSCSEEE
T ss_pred             CCCCCceeeeeCCccccceeccC---cccccCCceEEEEEEEeCCCCEEEEEEecCCC--CceeeEEeechHHhcCCceE
Confidence            99999999999999999988862   33 55699999999999999999999998543  46899999999999999999


Q ss_pred             EEEEeecC-CccceeeeeeeeeeccCCC
Q 047719          157 VGFSAANG-QGSAIYTVDRWRFKTFESY  183 (596)
Q Consensus       157 vGFsastg-~~~~~~~i~~Wsf~~~~~~  183 (596)
                      |||||||| ...+.|+|++|+|++..+.
T Consensus       214 vGFSAsTG~~~~~~H~IlsWsF~s~~~~  241 (257)
T 1hql_A          214 VGISASTGNNQFLTVYILSWRFSSNLQS  241 (257)
T ss_dssp             EEEEEECCSCCCEEEEEEEEEEEEEC--
T ss_pred             EEEEeccCCCccceeEEEEEEeEecCCC
Confidence            99999999 8999999999999987643

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=3.9e-48  Score=411.61  Aligned_cols=242  Identities=26%  Similarity=0.357  Sum_probs=200.3

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      ..|...+.||+|+||.||+|... +|+.||||++....  ....+.+.+|+..|.. ++|||||++++++.+.+.+||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~--~~~~~~~~~Ei~il~~-l~HpnIV~l~~~~~~~~~~~iVm  227 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRD-YQHENVVEMYNSYLVGDELWVVM  227 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT--CSSGGGHHHHHHHHHH-CCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHh-CCCCCCCceEEEEEECCEEEEEE
Confidence            45888899999999999999865 58999999997543  3345668899977765 89999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc----
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI----  438 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~----  438 (596)
                      |||++|+|.+++....     +++.++..++.||+.||+|||+   ++|+||||||+||||+.++.+||+|||++.    
T Consensus       228 Ey~~gG~L~~~i~~~~-----l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~  299 (423)
T 4fie_A          228 EFLEGGALTDIVTHTR-----MNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK  299 (423)
T ss_dssp             ECCTTEEHHHHHHHSC-----CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCS
T ss_pred             eCCCCCcHHHHHhccC-----CCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCC
Confidence            9999999999998653     8999999999999999999999   999999999999999999999999999763    


Q ss_pred             -------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcC
Q 047719          439 -------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKF  511 (596)
Q Consensus       439 -------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  511 (596)
                             .+||+.|||||++.+..|+.++|||||||+||||++|+.||.+....  +.........      .+.+.  .
T Consensus       300 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--~~~~~i~~~~------~~~~~--~  369 (423)
T 4fie_A          300 EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKMIRDNL------PPRLK--N  369 (423)
T ss_dssp             SCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHSC------CCCCS--C
T ss_pred             CCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHHHHHHcCC------CCCCc--c
Confidence                   35899999999999999999999999999999999999999865421  1111111111      11111  1


Q ss_pred             CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhc
Q 047719          512 NRKEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKG  546 (596)
Q Consensus       512 ~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~~  546 (596)
                      .......+.+|+.+||+.||++|||++|+++  +|+.
T Consensus       370 ~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~  406 (423)
T 4fie_A          370 LHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK  406 (423)
T ss_dssp             TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred             cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcC
Confidence            1122345678889999999999999999987  5554

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=5.6e-49  Score=402.08  Aligned_cols=238  Identities=26%  Similarity=0.275  Sum_probs=191.9

Q ss_pred             cCCCccceeecCCceEEEEEEcC----CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP----SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELV  359 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~  359 (596)
                      ++|...+.||+|+||+||+|+..    .++.||||++++..........+.+|+..+ +.++|||||++++++.+++.+|
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il-~~l~HpnIv~l~~~~~~~~~~~  102 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDIL-VEVNHPFIVKLHYAFQTEGKLY  102 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCC-CCCCCTTEECEEEEEEETTEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHH-HHCCCCCCCeEEEEEEECCEEE
Confidence            35888899999999999999752    367899999976554444556788898555 4599999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc-
Q 047719          360 LVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI-  438 (596)
Q Consensus       360 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~-  438 (596)
                      ||||||++|+|.++|....    .+++.++..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||++. 
T Consensus       103 ivmEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~  175 (304)
T 3ubd_A          103 LILDFLRGGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE  175 (304)
T ss_dssp             EEECCCTTCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred             EEEEcCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEeccccccee
Confidence            9999999999999998754    48999999999999999999999   999999999999999999999999999763 


Q ss_pred             ----------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhcccccc
Q 047719          439 ----------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLR  508 (596)
Q Consensus       439 ----------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  508 (596)
                                .+||+.|||||++.+..|+.++|||||||+||||+||+.||.+....  +....... +..      .  
T Consensus       176 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~--~~~~~i~~-~~~------~--  244 (304)
T 3ubd_A          176 SIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK--ETMTMILK-AKL------G--  244 (304)
T ss_dssp             -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHH-CCC------C--
T ss_pred             ccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH--HHHHHHHc-CCC------C--
Confidence                      35999999999999999999999999999999999999999875431  11111111 111      1  


Q ss_pred             CcCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHH
Q 047719          509 GKFNRKEMERMLMVGLSCVHPNHEKRPS-----VKEAAR  542 (596)
Q Consensus       509 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs-----~~ev~~  542 (596)
                        ++......+.+|+.+||+.||++|||     ++|+++
T Consensus       245 --~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          245 --MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             --CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             --CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence              11222345678889999999999998     466654

>1qnw_A Chitin binding lectin, UEA-II; carbohydrate binding; HET: NAG; 2.35A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1dzq_A* 1qoo_A* 1qos_A* 1qot_A*

Probab=100.00  E-value=3e-48  Score=380.33  Aligned_cols=172  Identities=31%  Similarity=0.473  Sum_probs=157.2

Q ss_pred             CCCCCCCcccceEEEEEEEEecCCCCCCCCeEEEEEecCCC--CCCCCCCccCCCCCCCCC-CCceEEEEeeCc----cC
Q 047719            1 FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNAD--SFGNDNGYMGLPGPVLSP-QDSFFAVEFDTS----FD   73 (596)
Q Consensus         1 ~~~~~~~~~asF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~--~~~~~~~~lG~~~~~~~~-~~~~~AVEfDt~----~~   73 (596)
                      |||+.||+++||+|+|+|.|.++ ...+||||||||+|.+.  |.+..||||||+|.++++ .+|+|||||||+    +|
T Consensus        58 l~~~~tg~vasFsT~F~F~I~~~-~~~~gdGlAF~l~p~~~~~p~~~~g~~LGl~n~~~~~~~~~~vAVEFDT~~~~~~N  136 (242)
T 1qnw_A           58 IWDSITGKVASFATSFSFVVKAD-KSDGVDGLAFFLAPANSQIPSGSSAGMFGLFSSSDSKSSNQIIAVEFDTYFGKAYN  136 (242)
T ss_dssp             CBCTTTCCBCEEEEEEEEECCBS-SSCCCCEEEEEEEETTCCCCTTCCGGGTTTCSSSSCCTTSCCEEEEEECCCCTTTC
T ss_pred             eecCCCCCcccEEEEEEEEEecC-CCCCCCCEEEEEecCCCCCCcCCCCCcccccccCCCCccccEEEEEeecccccccC
Confidence            69999999999999999999987 67789999999999875  667899999999977444 799999999999    99


Q ss_pred             CCCCCCCCCeeEEecCCccccccccCCCCCcccCCCceEEEEEEEcCCccEEEEEEeeCCCCCCCCeEEEeecCcccCCC
Q 047719           74 PSLGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKD  153 (596)
Q Consensus        74 ~~~~d~~~~Hvgid~ns~~s~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~l~~~vdl~~~l~~  153 (596)
                      .  +||++||||||+||+.|+++.++     +|.+|+.++|||+||+.+++|+|+|.+.. .|..|+|+..|||+.+|||
T Consensus       137 ~--~Dp~~nHVGIdvNs~~S~~~~~~-----~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~~~ls~~vdL~~~l~e  208 (242)
T 1qnw_A          137 P--WDPDFKHIGIDVNSIKSIKTVKW-----DWRNGEVADVVITYRAPTKSLTVCLSYPS-DGTSNIITASVDLKAILPE  208 (242)
T ss_dssp             T--TSCSSCEEEEEESSSSCSEEEEC-----CCCTTCCEEEEEEEEGGGTEEEEEEECTT-TCCEEEEEEECCHHHHSCS
T ss_pred             C--CCCCCCcEEEecCCccccceecc-----cccCCCEEEEEEEEeCCCcEEEEEEecCC-CCcceeEEEeechHHhcCC
Confidence            7  69999999999999999998875     58899999999999999999999998854 3567899999999999999


Q ss_pred             ceEEEEEeecCCc--cceeeeeeeeeeccC
Q 047719          154 YMHVGFSAANGQG--SAIYTVDRWRFKTFE  181 (596)
Q Consensus       154 ~~~vGFsastg~~--~~~~~i~~Wsf~~~~  181 (596)
                      +|||||||+||..  .|.|+|++|+|++..
T Consensus       209 ~v~VGFSAsTG~~~~~~~h~IlsWsF~s~l  238 (242)
T 1qnw_A          209 WVSVGFSGGVGNAAEFETHDVLSWYFTSNL  238 (242)
T ss_dssp             EEEEEEEEEESCGGGCBCCEEEEEEEEEEC
T ss_pred             ceEEEEEeccCCCccceEEEEEEEEeEeec
Confidence            9999999999999  999999999999874

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=5.5e-48  Score=389.44  Aligned_cols=241  Identities=24%  Similarity=0.320  Sum_probs=191.1

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchh-cccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVE-CARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~-~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      ++|...+.||+|+||+||+|... +|+.||||++.+..... .....+.+|+..+.. ++|||||++++++.+++.+|+|
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~-l~HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRL-LRHPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHH-CCCTTBCCEEEEEECSSEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHH-CCCCCCCeEEEEEEECCEEEEE
Confidence            57999999999999999999875 58999999997654332 334568899977655 8999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc---
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI---  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---  438 (596)
                      |||+ +|+|.+++....    .+++.++..++.||+.||+|||+   ++|+||||||+||||+.++.+||+|||++.   
T Consensus        92 mEy~-~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~  163 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQRD----KMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT  163 (275)
T ss_dssp             EECC-CEEHHHHHHHSC----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC----
T ss_pred             EeCC-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecC
Confidence            9999 689999998754    49999999999999999999999   999999999999999999999999999874   


Q ss_pred             -------cCCCcccCCccccccCCC-CCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCc
Q 047719          439 -------PAGTMGYLAPEYVYSGVP-SEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGK  510 (596)
Q Consensus       439 -------~~gt~~y~aPE~~~~~~~-t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  510 (596)
                             .+||+.|||||++.+..+ +.++||||+||+||||+||+.||.+...  ........ .+..      .+...
T Consensus       164 ~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~--~~~~~~i~-~~~~------~~p~~  234 (275)
T 3hyh_A          164 DGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI--PVLFKNIS-NGVY------TLPKF  234 (275)
T ss_dssp             -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHH-HTCC------CCCTT
T ss_pred             CCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHH-cCCC------CCCCC
Confidence                   359999999999988776 6899999999999999999999987532  12221211 1111      11122


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhc
Q 047719          511 FNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKG  546 (596)
Q Consensus       511 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~~  546 (596)
                      +    ...+.+|+.+|++.||++|||++|+++  +++.
T Consensus       235 ~----s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          235 L----SPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             S----CHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             C----CHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence            2    345677889999999999999999987  5653

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=8.6e-49  Score=400.96  Aligned_cols=237  Identities=25%  Similarity=0.305  Sum_probs=197.3

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      ++|...+.||+|+||+||+|... +|+.||||++.+.... ....+.+.+|+..+. .++|||||++++++.+++.+|||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~-~l~HpnIv~l~~~~~~~~~~yiv  110 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS-RLDHPFFVKLYFTFQDDEKLYFG  110 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHT-TCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHH-hCCCCCCCeEEEEEEeCCEEEEE
Confidence            35888999999999999999865 5899999999754322 234456889996665 59999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc---
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI---  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---  438 (596)
                      ||||++|+|.++|....    .+++.++..++.||+.||+|||+   ++|+||||||+||||+.++.+||+|||++.   
T Consensus       111 mEy~~gG~L~~~i~~~~----~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~  183 (311)
T 4aw0_A          111 LSYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLS  183 (311)
T ss_dssp             ECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecC
Confidence            99999999999998754    48999999999999999999999   999999999999999999999999999763   


Q ss_pred             ----------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhcccccc
Q 047719          439 ----------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLR  508 (596)
Q Consensus       439 ----------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  508 (596)
                                .+||+.|||||++.+..|+.++||||+||+||||+||+.||.+....  +...... .+..      .+.
T Consensus       184 ~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--~~~~~i~-~~~~------~~p  254 (311)
T 4aw0_A          184 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG--LIFAKII-KLEY------DFP  254 (311)
T ss_dssp             TTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHH-HTCC------CCC
T ss_pred             CCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHH-cCCC------CCC
Confidence                      25999999999999999999999999999999999999999875421  1111111 1111      111


Q ss_pred             CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 047719          509 GKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAA  541 (596)
Q Consensus       509 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~  541 (596)
                      ..+    ...+.+|+.+|++.||++|||++|++
T Consensus       255 ~~~----s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          255 EKF----FPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             TTC----CHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             ccc----CHHHHHHHHHHccCCHhHCcChHHHc
Confidence            222    34567888999999999999999864

>1fat_A Phytohemagglutinin-L; glycoprotein, plant defense protein, lectin; HET: NAG; 2.80A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1g8w_A*

Probab=100.00  E-value=3.3e-48  Score=382.33  Aligned_cols=173  Identities=28%  Similarity=0.428  Sum_probs=158.9

Q ss_pred             CCCCCCCcccceEEEEEEEEecCCCCCCCCeEEEEEecCCCCCCCCCCccCCCCCCCCCCCceEEEEeeCccCCCCCCCC
Q 047719            1 FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQDSFFAVEFDTSFDPSLGDIN   80 (596)
Q Consensus         1 ~~~~~~~~~asF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~~~~~~~~~lG~~~~~~~~~~~~~AVEfDt~~~~~~~d~~   80 (596)
                      |||+.||+++||+|+|+|.|.+++...+||||||||+|...+++++||||||+|.+ ...+|+|||||||++|.+ +||+
T Consensus        57 l~d~~tg~vaSFsT~F~F~I~~~~~~~~gdGlAF~l~p~~~~~~~~g~~LGl~n~~-~~~~~~vAVEFDT~~N~~-~Dp~  134 (252)
T 1fat_A           57 IWDNTTGTVASFATSFTFNIQVPNNAGPADGLAFALVPVGSQPKDKGGFLGLFDGS-NSNFHTVAVEFDTLYNKD-WDPT  134 (252)
T ss_dssp             CEETTTTEEEEEEEEEEEECCCCSSCBCCEEEEEEEEETTCCCCCSGGGTTTCCSS-CCCCCCEEEEEECSCCTT-TCCS
T ss_pred             cccCCCCcccceEEEEEEEEeCCCCCCCCCcEEEEEccCCCCCCCCCccccccccC-CccCcEEEEEeecccCCC-CCCC
Confidence            69999999999999999999987667789999999999877677889999999876 448999999999999988 6999


Q ss_pred             CCeeEEecCCccccccccCCCCCcccCCCceEEEEEEEcCCccEEEEEEeeCCCCCCCCeEEEeecCcccCCCceEEEEE
Q 047719           81 GNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFS  160 (596)
Q Consensus        81 ~~Hvgid~ns~~s~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~l~~~vdl~~~l~~~~~vGFs  160 (596)
                      +||||||+||+.|.++.++     +|.+|+.++|||+||+.+++|+|++.+.. .|.+|+|+..|||+.+|||+||||||
T Consensus       135 ~nHVGIdvNs~~S~~~~~~-----~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~~~ls~~vdL~~~l~e~~~VGFS  208 (252)
T 1fat_A          135 ERHIGIDVNSIRSIKTTRW-----DFVNGENAEVLITYDSSTNLLVASLVYPS-QKTSFIVSDTVDLKSVLPEWVSVGFS  208 (252)
T ss_dssp             SCEEEEEESSSSCSEEEEC-----CCCTTCEEEEEEEEETTTTEEEEEEEETT-TTEEEEEEEECCHHHHSCSEEEEEEE
T ss_pred             CCeEEEecCCccccceecc-----cccCCCEEEEEEEEeCCCCEEEEEEecCC-CCCcceEEEEechHHhCCCceEEEEE
Confidence            9999999999999998875     58899999999999999999999999854 35578999999999999999999999


Q ss_pred             eecCCc---cceeeeeeeeeeccC
Q 047719          161 AANGQG---SAIYTVDRWRFKTFE  181 (596)
Q Consensus       161 astg~~---~~~~~i~~Wsf~~~~  181 (596)
                      |+||..   .+.|+|++|+|++..
T Consensus       209 AsTG~~~~~~~~H~IlsWsF~s~l  232 (252)
T 1fat_A          209 ATTGINKGNVETNDVLSWSFASKL  232 (252)
T ss_dssp             EEECSSTTBCCCCEEEEEEEEEEE
T ss_pred             eccCCCCcccceEEEEEEEEEeeC
Confidence            999999   999999999999874

>2bqp_A Protein (PEA lectin); D-glucopyranose complex, sugar binding protein; HET: GLC; 1.90A {Pisum sativum} SCOP: b.29.1.1

Probab=100.00  E-value=1.2e-47  Score=375.78  Aligned_cols=174  Identities=26%  Similarity=0.415  Sum_probs=157.7

Q ss_pred             CCCCCCCcccceEEEEEEEEecCCCCCCCCeEEEEEecCCCCCCCCCCccCCCCCCCCC-CCceEEEEeeCccCCCCCCC
Q 047719            1 FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSP-QDSFFAVEFDTSFDPSLGDI   79 (596)
Q Consensus         1 ~~~~~~~~~asF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~~~~~~~~~lG~~~~~~~~-~~~~~AVEfDt~~~~~~~d~   79 (596)
                      |||+.||+++||+|+|+|.|.+++...+||||||+|+|.+..++++|+||||+|.++++ .+|+|||||||++|.+ +||
T Consensus        52 l~~~~~~~~~sFst~F~F~I~~~~~~~~gdGlAF~l~p~~~~p~~~g~~LGl~n~~~~~~~~~~vAVEFDT~~N~~-~Dp  130 (234)
T 2bqp_A           52 IWDRETGNVANFVTSFTFVINAPNSYNVADGFTFFIAPVDTKPQTGGGYLGVFNSAEYDKTTQTVAVEFDTFYNAA-WDP  130 (234)
T ss_dssp             CBCTTTCCBCEEEEEEEEEEECSSTTSCCCEEEEEEEETTCCCCCCGGGTTTCSCSSCCGGGCCEEEEEECSCCTT-TSC
T ss_pred             cccCCCCceeeEEEEEEEEEeCCCCCCCCCcEEEEEecCCCCCCCCCCccccccccCCCCCCcEEEEEEecccCcc-cCC
Confidence            69999999999999999999988777889999999999877455889999999987444 7999999999999988 699


Q ss_pred             C--CCeeEEecCCccccccccCCCCCcccCCCceEEEEEEEcCCccEEEEEEeeCC-C---CCCCCeEEEeecCcccCCC
Q 047719           80 N--GNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRDSLKLIRVWAGYSQ-I---RPPSPLIIAQIDLSKQFKD  153 (596)
Q Consensus        80 ~--~~Hvgid~ns~~s~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~-~---~~~~p~l~~~vdl~~~l~~  153 (596)
                      +  +|||||||||+.|+++.++     ++.+|+.++|||+||+.+++|+|++.+.. .   +|.+|+|+..|||+.+||+
T Consensus       131 ~~~~nHVgIdvns~~S~~s~~~-----~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~~p~~~~ls~~vdL~~~l~~  205 (234)
T 2bqp_A          131 SNRDRHIGIDVNSIKSVNTKSW-----KLQNGEEANVVIAFNAATNVLTVSLTYPNNSLEEEVTSYTLSDVVSLKDVVPE  205 (234)
T ss_dssp             TTCCCEEEEEESSSSCSEEEEC-----CCCTTCEEEEEEEEETTTTEEEEEEEECC------CEEEEEEEECCGGGTSCS
T ss_pred             CCCCCceeEeeCCccccceEee-----EEcCCCEEEEEEEEeCCCCEEEEEEecCCCCcccCCCcceEEEEechHHhCCC
Confidence            9  9999999999999988775     57899999999999999999999998843 3   4678899999999999999


Q ss_pred             ceEEEEEeecCCccceeeeeeeeeecc
Q 047719          154 YMHVGFSAANGQGSAIYTVDRWRFKTF  180 (596)
Q Consensus       154 ~~~vGFsastg~~~~~~~i~~Wsf~~~  180 (596)
                      +||||||||||...+.|+|++|+|+++
T Consensus       206 ~~yvGFSAsTG~~~~~H~IlsWsF~s~  232 (234)
T 2bqp_A          206 WVRIGFSATTGAEYAAHEVLSWSFHSE  232 (234)
T ss_dssp             EEEEEEEEECSSSCCEEEEEEEEEEEE
T ss_pred             ceEEEEEeccCCCcccEEEEEEEEEee
Confidence            999999999999999999999999875

>1gsl_A Griffonia simplicifolia lectin 4; glycoprotein, manganese; HET: FUC GAL MAG NAG BMA; 2.00A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1lec_A* 1led_A*

Probab=100.00  E-value=5.6e-48  Score=379.07  Aligned_cols=172  Identities=27%  Similarity=0.414  Sum_probs=156.6

Q ss_pred             CCCCCCCcccceEEEEEEEEecCCCCCCCCeEEEEEecCCCCCCCCCCccCCCCCCC--CC-CCceEEEEeeCccCCCCC
Q 047719            1 FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVL--SP-QDSFFAVEFDTSFDPSLG   77 (596)
Q Consensus         1 ~~~~~~~~~asF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~~~~~~~~~lG~~~~~~--~~-~~~~~AVEfDt~~~~~~~   77 (596)
                      ||| +||+++||+|+|+|.|.++ ...+||||||||+|...+++++||||||+|.++  +. .+|+|||||||++|.+|+
T Consensus        62 l~~-~tg~vasFsT~F~F~I~~~-~~~~gdGlAF~l~p~~~~~~~~g~~LGl~n~~~~~~~~~n~~vAVEFDT~~N~~~~  139 (243)
T 1gsl_A           62 LWD-STGKAASFYTSFTFLLKNY-GAPTADGLAFFLAPVDSSVKDYGGFLGLFRHETAADPSKNQVVAVEFDTWINKDWN  139 (243)
T ss_dssp             CBC-TTSCBCEEEEEEEEEEEES-SSSCBCEEEEEEEETTCCCCCCGGGTTTSCTTTTTCGGGCCCEEEEEECSCCGGGT
T ss_pred             ccC-CCCCcCceEEEEEEEEecC-CCCCCCCEEEEEecCCCCCCCCCCcccccccccccCCccCcEEEEEeccccccccC
Confidence            699 9999999999999999987 667899999999998777778899999998873  44 789999999999999888


Q ss_pred             CCCCCeeEEecCCccccccccCCCCCcccCC---CceEEEEEEEcCCccEEEEEEeeCCCCCCCCeEEEeecCcccCCCc
Q 047719           78 DINGNHIGIDISSVISFVSVDALSRGIDLKS---GRHITTWIEYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDY  154 (596)
Q Consensus        78 d~~~~Hvgid~ns~~s~~~~~~~~~~~~l~~---g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~l~~~vdl~~~l~~~  154 (596)
                      ||++||||||+||+.|+++.++     +|.+   |+.++|||+||+.+++|+|+|.+...  ..|+|+..|||+.+||++
T Consensus       140 Dp~~nHvGIdvns~~S~~~~~~-----~l~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~ls~~vdL~~~l~~~  212 (243)
T 1gsl_A          140 DPPYPHIGIDVNSIVSVATTRW-----ENDDAYGSSIATAHITYDARSKILTVLLSYEHG--RDYILSHVVDLAKVLPQK  212 (243)
T ss_dssp             CCSSCEEEEEESSSSCSEEEEC-----CHHHHTSCCEEEEEEEEETTTTEEEEEEEETTS--CEEEEEEECCHHHHSCSE
T ss_pred             CCCCCceeeccCCccccceeee-----EEeccCCCcEEEEEEEEeCCCCEEEEEEecCCC--CceeEEEEechHHhCCCc
Confidence            9999999999999999998875     4777   99999999999999999999998543  468999999999999999


Q ss_pred             eEEEEEeecCCccceeeeeeeeeeccCC
Q 047719          155 MHVGFSAANGQGSAIYTVDRWRFKTFES  182 (596)
Q Consensus       155 ~~vGFsastg~~~~~~~i~~Wsf~~~~~  182 (596)
                      |||||||||| ..+.|+|++|+|++...
T Consensus       213 ~~vGFSAsTG-~~~~h~IlsWsF~s~l~  239 (243)
T 1gsl_A          213 VRIGFSAGVG-YDEVTYILSWHFFSTLD  239 (243)
T ss_dssp             EEEEEEEEEC-BSEEEEEEEEEEEEECT
T ss_pred             eEEEEEeccC-CcceeEEEEEEEEeecc
Confidence            9999999999 99999999999998753

>1wbf_A Protein (agglutinin); lectin (agglutinin), legume lectin, protein crystallography, group specificity, saccharide free form; HET: NAG; 2.30A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 2d3s_A* 2dtw_A* 1wbl_A* 2dty_A* 2du0_A* 2du1_A* 2e51_A* 2e53_A* 2zmk_A* 2zml_A* 2zmn_A* 2e7t_A* 2e7q_A*

Probab=100.00  E-value=8.4e-48  Score=377.17  Aligned_cols=172  Identities=34%  Similarity=0.492  Sum_probs=156.9

Q ss_pred             CCCCCCCcccceEEEEEEEEecC-CCCCCCCeEEEEEecCCCCCCCCCCccCCCCCCCCCCCceEEEEeeCccCCCCCCC
Q 047719            1 FLDPKTNTTASFSCRFSFSIIPS-PLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQDSFFAVEFDTSFDPSLGDI   79 (596)
Q Consensus         1 ~~~~~~~~~asF~t~F~f~i~~~-~~~~~g~G~aF~l~~~~~~~~~~~~~lG~~~~~~~~~~~~~AVEfDt~~~~~~~d~   79 (596)
                      |||+.||+++||+|+|+|.|.++ +...+||||||||+|...+++.+||||||+|.+  ..+|+|||||||++|.  +||
T Consensus        58 l~d~~tg~vaSFsT~F~F~I~~~~~~~~~gdGlAF~l~p~~~~~~~~g~~LGl~n~~--~~~~~vAVEFDT~~N~--~Dp  133 (242)
T 1wbf_A           58 VWDSTTGNVASFETRFSFSIRQPFPRPHPADGLVFFIAPPNTQTGEGGGYFGIYNPL--SPYPFVAVEFDTFRNT--WDP  133 (242)
T ss_dssp             CBCTTTCCBCEEEEEEEEECCCSCCSSCCCEEEEEEEECSSCCCCCCGGGTTTCCTT--SCCCCEEEEEECSCCT--TCC
T ss_pred             cccCCCCCeeeEEEEEEEEEeCCCCCCCCCCcEEEEEecCCCCCCCCCCccccccCC--CcCcEEEEEeccccCC--CCC
Confidence            69999999999999999999977 567789999999999877777889999999875  5789999999999998  799


Q ss_pred             CCCeeEEecCCccccccccCCCCCcccCCCceEEEEEEEcCCccEEEEEEeeCCCCCCCCeEEEeecCcccCCCceEEEE
Q 047719           80 NGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGF  159 (596)
Q Consensus        80 ~~~Hvgid~ns~~s~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~l~~~vdl~~~l~~~~~vGF  159 (596)
                      ++||||||+||+.|.++.++     +|.+|+.++|||+||+.+++|+|++.+... +..|+|+..|||+.+|||+|||||
T Consensus       134 ~~nHVGIdvNs~~S~~~~~~-----~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~-~~~~~ls~~vdL~~~l~e~v~VGF  207 (242)
T 1wbf_A          134 QIPHIGIDVNSVISTKTVPF-----TLDNGGIANVVIKYDASTKILHVVLVFPSL-GTIYTIADIVDLKQVLPESVNVGF  207 (242)
T ss_dssp             SSSEEEEEESSSSCSEEEEC-----CCCTTSCEEEEEEEETTTTEEEEEEEETTT-TEEEEEEEECCHHHHSCSEEEEEE
T ss_pred             CCCeEEEECCCccccceeee-----EecCCCEEEEEEEEeCCCCEEEEEEccCCC-CCcceEEEEechHHhcCCceEEEE
Confidence            99999999999999988774     688999999999999999999999998542 457899999999999999999999


Q ss_pred             Eeec----CCc---cceeeeeeeeeeccCC
Q 047719          160 SAAN----GQG---SAIYTVDRWRFKTFES  182 (596)
Q Consensus       160 sast----g~~---~~~~~i~~Wsf~~~~~  182 (596)
                      ||||    |..   .|.|+|++|+|++...
T Consensus       208 SAsTg~~~G~~~~~~~~h~IlsWsF~s~l~  237 (242)
T 1wbf_A          208 SAATGDPSGKQRNATETHDILSWSFSASLP  237 (242)
T ss_dssp             EEEECCGGGCCTTCCCCCEEEEEEEEEECC
T ss_pred             EEeecCcCCccccccceEEEEEEEeEecCC
Confidence            9999    888   8999999999998753

>1f9k_A Acidic lectin; legume lectin, glycosylated protein, H-antigenic specificity agglutinin, sugar binding protein; HET: NAG MAN AMG; 3.00A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 1fay_A*

Probab=100.00  E-value=1.8e-47  Score=374.69  Aligned_cols=171  Identities=29%  Similarity=0.472  Sum_probs=156.9

Q ss_pred             CCCCCCCcccceEEEEEEEEecC-CCCCCCCeEEEEEecCCCCCCCCCCccCCCCCCCCCCCceEEEEeeCccCCCCCCC
Q 047719            1 FLDPKTNTTASFSCRFSFSIIPS-PLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQDSFFAVEFDTSFDPSLGDI   79 (596)
Q Consensus         1 ~~~~~~~~~asF~t~F~f~i~~~-~~~~~g~G~aF~l~~~~~~~~~~~~~lG~~~~~~~~~~~~~AVEfDt~~~~~~~d~   79 (596)
                      |||+.||+++||+|+|+|.|.++ +...+||||||||+|.+.+++++||||||+|.+ .. +|+|||||||++|.  +||
T Consensus        58 l~d~~~g~vasFsT~F~F~I~~~~~~~~~gdGlAF~l~p~~~~~~~~g~~LGl~n~~-~~-~~~vAVEFDT~~N~--~Dp  133 (238)
T 1f9k_A           58 IWDSTTGNVASFETRFSFNITQPYAYPEPADGLTFFMVPPNSPQGEDGGNLGVFKPP-EG-DNAFAVEFDTFQNT--WDP  133 (238)
T ss_dssp             CBCTTTCCBCEEEEEEEEEEECCCSSSCCCEEEEEEEECTTCCCCCSGGGTTTCCSS-CC-SCCEEEEEECSCCT--TCC
T ss_pred             eecCCCCCeeeEEEEEEEEEecCCCCCCCCCcEEEEEccCCCCCCCCCCcccccccC-CC-CcEEEEEEecccCC--CCC
Confidence            69999999999999999999987 667789999999999877677889999999876 44 99999999999998  799


Q ss_pred             CCCeeEEecCCccccccccCCCCCcccCCCceEEEEEEEcCCccEEEEEEeeCCCCCCCCeEEEeecCcccCCC--ceEE
Q 047719           80 NGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKD--YMHV  157 (596)
Q Consensus        80 ~~~Hvgid~ns~~s~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~l~~~vdl~~~l~~--~~~v  157 (596)
                      ++|||||||||+.|.++.++     +|.+|+.++|||+||+.+++|+|++.+.. .+..|+|+..|||+.+|||  +|||
T Consensus       134 ~~nHVgIdvns~~S~~s~~~-----~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~~~ls~~vdL~~~l~~~~~~~v  207 (238)
T 1f9k_A          134 QVPHIGIDVNSIVSSKTLHF-----QLENGGVANVVIKYDSPTKILNVVLAFHS-VGTVYTLSNIVDLKQEFPNSEWVNV  207 (238)
T ss_dssp             SSSEEEEEESSSSCSEEEEC-----CCCTTCCEEEEEEEETTTTEEEEEEEETT-TTEEEEEEEECCHHHHSTTCSEEEE
T ss_pred             CCCeEEEecCCccccceEee-----cccCCCEEEEEEEEeCCCCEEEEEEecCC-CCCceeEEEEechHHhCCCCceEEE
Confidence            99999999999999988774     68899999999999999999999998854 3557899999999999999  9999


Q ss_pred             EEEeecCCc---cceeeeeeeeeeccC
Q 047719          158 GFSAANGQG---SAIYTVDRWRFKTFE  181 (596)
Q Consensus       158 GFsastg~~---~~~~~i~~Wsf~~~~  181 (596)
                      |||||||..   .+.|+|++|+|++..
T Consensus       208 GFSAsTG~~~~~~~~h~IlsWsF~s~~  234 (238)
T 1f9k_A          208 GLSATTGYQKNAVETHEIISWSFTSSL  234 (238)
T ss_dssp             EEEEEECSSTTCCCEEEEEEEEEEEEC
T ss_pred             EEEeCcCCCCcccceEEEEEeEeEeec
Confidence            999999999   999999999999874

>1n47_A Isolectin B4; cancer antigen, vicia villosa lectin, glycoprotein TN-bindin protein, carbohydrate recognition, sugar binding protein; HET: NAG FUC TNR; 2.70A {Vicia villosa} SCOP: b.29.1.1

Probab=100.00  E-value=2.5e-47  Score=372.55  Aligned_cols=170  Identities=29%  Similarity=0.400  Sum_probs=153.9

Q ss_pred             CCCCCCCcccceEEEEEEEEecCCCCCCCCeEEEEEecCCCCCCCCCCccCCCCCCCCC-CCceEEEEeeCccCCCCCCC
Q 047719            1 FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSP-QDSFFAVEFDTSFDPSLGDI   79 (596)
Q Consensus         1 ~~~~~~~~~asF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~~~~~~~~~lG~~~~~~~~-~~~~~AVEfDt~~~~~~~d~   79 (596)
                      |||++|  ++||+|+|+|.|.+++...+||||||||+|....+++.||||||+|.++++ .+|+|||||||++|.  +||
T Consensus        58 l~d~~~--~~sFsT~F~F~I~~~~~~~~gdGlAF~l~p~~~~p~~~g~~LGl~n~~~~~~~n~~vAVEFDT~~N~--~Dp  133 (233)
T 1n47_A           58 IHDNTT--LASFTTSFSFVMAAPAAAAVADGLAFFLAPPDTQPQARGGFLGLFADRAHDASYQTVAVEFDTYSNA--WDP  133 (233)
T ss_dssp             CBCSSC--BCEEEEEEEEECCCSSTTSCCEEEEEEEECTTCCCCCCGGGTTTCSSSSCCGGGCCEEEEEECSCCT--TSC
T ss_pred             ccCCCC--cCCEEEEEEEEEeCCCCCCCCCcEEEEEecCCCCCCCCCCcccccccCCCCccCceEEEEeccccCC--CCC
Confidence            688877  999999999999987777789999999999877556889999999987444 799999999999998  699


Q ss_pred             CCCeeEEecCCccccccccCCCCCcccCCCceEEEEEEEcCCccEEEEEEeeCCCCCCCCeEEEeecCcccCCCceEEEE
Q 047719           80 NGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGF  159 (596)
Q Consensus        80 ~~~Hvgid~ns~~s~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~l~~~vdl~~~l~~~~~vGF  159 (596)
                      ++||||||+||+.|.++.++     +|.+|+.++|||+||+.+++|+|++.+... +..|+|+..|||+.+|||+|||||
T Consensus       134 ~~nHvGIdvns~~S~~~~~~-----~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~-~~~~~ls~~vdL~~~l~~~~~vGF  207 (233)
T 1n47_A          134 NYTHIGIDTNGIESKKTTPF-----DMVYGEKANIVITYQASTKALAASLVFPVS-QTSYAVSARVDLRDILPEYVRVGF  207 (233)
T ss_dssp             SSCEEEEEESSSSCSEEEEC-----CCCTTSCEEEEEEEETTTTEEEEEEEETTT-TEEEEEEEECCGGGTSCSEEEEEE
T ss_pred             CCCcEEEccCCccccccccc-----cccCCCEEEEEEEEeCCCCEEEEEEecCCC-CCcceEEEEechHHhCCCceEEEE
Confidence            99999999999999998774     688999999999999999999999998543 357899999999999999999999


Q ss_pred             EeecCCc---cceeeeeeeeeecc
Q 047719          160 SAANGQG---SAIYTVDRWRFKTF  180 (596)
Q Consensus       160 sastg~~---~~~~~i~~Wsf~~~  180 (596)
                      |||||..   .+.|+|++|+|+++
T Consensus       208 SAsTG~~~~~~~~h~IlsWsF~s~  231 (233)
T 1n47_A          208 SATTGLNAGVVETHDIVSWSFAVS  231 (233)
T ss_dssp             EEEECSSTTCCCCCEEEEEEEEEE
T ss_pred             EeccCCCccccceeEEEEEEEEee
Confidence            9999998   99999999999875

>2fmd_A Lectin, agglutinin, BMA; legume lectin, beta sandwich, protein-carbohydrate complex, sugar binding protein; HET: MAN; 1.90A {Bowringia mildbraedii}

Probab=100.00  E-value=5.3e-47  Score=372.18  Aligned_cols=172  Identities=27%  Similarity=0.441  Sum_probs=155.8

Q ss_pred             CCCCCCCcccceEEEEEEEEecCCCCCCCCeEEEEEecCCC-CCC-CCCCccCCCCCCC-CC-CCceEEEEeeCccCCCC
Q 047719            1 FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNAD-SFG-NDNGYMGLPGPVL-SP-QDSFFAVEFDTSFDPSL   76 (596)
Q Consensus         1 ~~~~~~~~~asF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~-~~~-~~~~~lG~~~~~~-~~-~~~~~AVEfDt~~~~~~   76 (596)
                      |||+ ||+++||+|+|+|.|.++ ...+||||||+|+|... +.+ ++|+||||+|.++ ++ .+|+|||||||++|.++
T Consensus        59 l~~~-~g~~~sFst~F~F~I~~~-~~~~gdGlAF~l~p~~~~p~~g~~g~~LGl~n~~~~~~~~n~~vAVEfDT~~N~~~  136 (240)
T 2fmd_A           59 LWQS-SSLVASFETTFTFSISQG-SSTPADALTFFIASPDTKIPSGSGGRLLGLFGSSNNAGSDNGVVSVEFDTYPNTDI  136 (240)
T ss_dssp             CCCT-TCSEEEEEEEEEEECCBS-SSSCCCEEEEEEECTTCCCCTTCCGGGTTTCSCCC----CCCEEEEEEECSCCGGG
T ss_pred             eeCC-CCCcCcEEEEEEEEEecC-CCCCCCcEEEEEecCCCCCCccCCCCcccccccCcCCCCcCcEEEEEecccccccc
Confidence            6999 999999999999999987 67789999999999877 443 8899999998873 44 79999999999999988


Q ss_pred             CCCCCCeeEEecCCccccccccCCCCCcccCCCceEEEEEEEcCCccEEEEEEeeCCCCCCCCeEEEeecCcccCCCceE
Q 047719           77 GDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMH  156 (596)
Q Consensus        77 ~d~~~~Hvgid~ns~~s~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~l~~~vdl~~~l~~~~~  156 (596)
                      +||++||||||+||+.|+.+.++     ++.+|+.++|||+||+.+++|+|++.+...  ..|+|+..|||+.+||++||
T Consensus       137 ~Dp~~nHvgIdvns~~S~~s~~~-----~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~ls~~vdL~~~l~~~~y  209 (240)
T 2fmd_A          137 GDPNYRHIGIDVNSIRSKAASKW-----DWQNGKTATAHISYNSASKRLSVVSSYPNS--SPVVVSFDVELNNVBPBWVR  209 (240)
T ss_dssp             TCCSSCEEEEEESSSSCSEEEEC-----CCCSSCEEEEEEEEETTTTEEEEEEECTTS--CCEEEEEECCGGGTSCSEEE
T ss_pred             CCCCCCceeeccccccccceeEE-----EeeCCCEEEEEEEEeCCCCEEEEEEecCCC--CceEEEEEechHHhCCCceE
Confidence            89999999999999999988774     578999999999999999999999988543  57899999999999999999


Q ss_pred             EEEEeecCCccceeeeeeeeeeccC
Q 047719          157 VGFSAANGQGSAIYTVDRWRFKTFE  181 (596)
Q Consensus       157 vGFsastg~~~~~~~i~~Wsf~~~~  181 (596)
                      |||||+||...+.|+|++|+|++..
T Consensus       210 vGFSAsTG~~~~~H~IlsWsF~s~~  234 (240)
T 2fmd_A          210 VGFSATTGQYTQTNNILAWSFRSSL  234 (240)
T ss_dssp             EEEEEECCSSCBCCEEEEEEEEEEE
T ss_pred             EEEEeccCCccccEEEEEEEeEecC
Confidence            9999999999999999999999864

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.8e-47  Score=391.68  Aligned_cols=238  Identities=23%  Similarity=0.348  Sum_probs=186.6

Q ss_pred             CCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCC-------
Q 047719          285 GFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGN-------  356 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~-------  356 (596)
                      +|...+.||+|+||+||+|... +|+.||||+++.... +...+.+.+|+..|.+ ++|||||++++++.+.+       
T Consensus         6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~E~~il~~-l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR-ELAREKVMREVKALAK-LEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSS-HHHHHHHHHHHHHHTT-CCCTTBCCEEEEEEEEC-------
T ss_pred             hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCC-HHHHHHHHHHHHHHHh-CCCCCCCeEEEEEEecCccccccc
Confidence            5788899999999999999865 589999999975442 3345678899966655 89999999999987644       


Q ss_pred             -----eEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEE
Q 047719          357 -----ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKL  431 (596)
Q Consensus       357 -----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl  431 (596)
                           .+|+|||||++|+|.+++..... ....++..++.++.||++||+|||+   ++|+||||||+||||+.++.+||
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl  159 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKV  159 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEE
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEE
Confidence                 37999999999999999987543 2246778889999999999999999   89999999999999999999999


Q ss_pred             ccCCCccc-----------------------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHH
Q 047719          432 GDFEATIP-----------------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVD  488 (596)
Q Consensus       432 ~Dfg~~~~-----------------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~  488 (596)
                      +|||++..                       +||+.|||||++.+..|+.++|||||||+||||++   ||....... .
T Consensus       160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~-~  235 (299)
T 4g31_A          160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERV-R  235 (299)
T ss_dssp             CCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH-H
T ss_pred             ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHH-H
Confidence            99998642                       59999999999999999999999999999999996   776421111 1


Q ss_pred             HHHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          489 WVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       489 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      .... .......         ....+......+|+.+||+.||++|||+.|+++
T Consensus       236 ~~~~-~~~~~~p---------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          236 TLTD-VRNLKFP---------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             HHHH-HHTTCCC---------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHH-HhcCCCC---------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            1111 1111110         011122344567889999999999999999987

>1avb_A Arcelin-1; lectin-like glycoprotein, plant defense, insecticidal activi lectin; HET: NAG; 1.90A {Phaseolus vulgaris} SCOP: b.29.1.1

Probab=100.00  E-value=1.4e-46  Score=365.16  Aligned_cols=167  Identities=26%  Similarity=0.361  Sum_probs=151.2

Q ss_pred             CCCCCCCcccceEEEEEEEEecCCCCCCCCeEEEEEecCCCCCCCCCCccCCCCCCCCC-CCceEEEEeeCccCCCCCCC
Q 047719            1 FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSP-QDSFFAVEFDTSFDPSLGDI   79 (596)
Q Consensus         1 ~~~~~~~~~asF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~~~~~~~~~lG~~~~~~~~-~~~~~AVEfDt~~~~~~~d~   79 (596)
                      |||++||+++||+|+|+|.|.+++...+||||||||+|.+..++.+||||||+|..+++ .+|+|||||||+        
T Consensus        54 l~~~~~g~vaSFsT~F~F~I~~~~~~~~gdGlAF~l~p~~~~p~~~g~~LGl~n~~~~~~~~~~vAVEFDT~--------  125 (226)
T 1avb_A           54 INDRTIDNLASFSTNFTFRINAKNIENSAYGLAFALVPVGSRPKLKGRYLGLFNTTNYDRDAHTVAVVFDTV--------  125 (226)
T ss_dssp             CEEGGGTEEEEEEEEEEEEEEESSTTSCCEEEEEEEEETTCCCCCCGGGTTTCSCSSCCGGGCCEEEEEETT--------
T ss_pred             eecCCCCCcccEEEEEEEEEeCCCCCCCCCcEEEEEecCCCCCCCCCCcccccccCCCCCcccEEEEEecCc--------
Confidence            69999999999999999999988777889999999999877455889999999987444 799999999998        


Q ss_pred             CCCeeEEecCCccccccccCCCCCcccCCCceEEEEEEEcCCccEEEEEEeeCCCCCCCCeEEEeecCcccCCCceEEEE
Q 047719           80 NGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGF  159 (596)
Q Consensus        80 ~~~Hvgid~ns~~s~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~l~~~vdl~~~l~~~~~vGF  159 (596)
                       +|||||||||+.|++++++   +..|.+|+.++|||+||+.+++|+|++.+... +.+|+|+..|||+++|||+|||||
T Consensus       126 -~nHVGIdvNs~~S~~t~~~---~~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~-~~~~~ls~~vdL~~~l~e~~~VGF  200 (226)
T 1avb_A          126 -SNRIEIDVNSIRPIATESC---NFGHNNGEKAEVRITYDSPKNDLRVSLLYPSS-EEKCHVSATVPLEKEVEDWVSVGF  200 (226)
T ss_dssp             -TTEEEEEESSSSCSEEEEC---CSGGGTTCEEEEEEEEEGGGTEEEEEEEETTT-TEEEEEEEECCHHHHSCSEEEEEE
T ss_pred             -CCccceeecCcccCccccC---CccccCCCeEEEEEEEeCCCcEEEEEEeecCC-CccceEEEEechHHhCCCceEEEE
Confidence             5999999999999999886   56788999999999999999999999988532 337899999999999999999999


Q ss_pred             EeecCCc---cceeeeeeeeeecc
Q 047719          160 SAANGQG---SAIYTVDRWRFKTF  180 (596)
Q Consensus       160 sastg~~---~~~~~i~~Wsf~~~  180 (596)
                      ||+||..   .|.|+|++|+|+++
T Consensus       201 SAsTG~~~~~~~~h~IlsWsF~s~  224 (226)
T 1avb_A          201 SATSGSKKETTETHNVLSWSFSSN  224 (226)
T ss_dssp             EEEECSSGGGCEEEEEEEEEEEEE
T ss_pred             EeccCCCCcccceeEEEEEEEEee
Confidence            9999999   99999999999875

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.2e-45  Score=382.42  Aligned_cols=279  Identities=40%  Similarity=0.707  Sum_probs=241.2

Q ss_pred             ccccCHHHHHHHhcCCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecc
Q 047719          271 PMRLALTDIKQATLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQG  350 (596)
Q Consensus       271 ~~~~~~~el~~at~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g  350 (596)
                      ..++++.++...+++|...+.||+|+||.||+|...+++.||||++..... ......+.+|+..+ +.++||||+++++
T Consensus        17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l-~~l~h~~iv~~~~   94 (326)
T 3uim_A           17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERT-QGGELQFQTEVEMI-SMAVHRNLLRLRG   94 (326)
T ss_dssp             CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGG-GTCCCTTBCCCCE
T ss_pred             cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccC-chHHHHHHHHHHHH-HhccCCCccceEE
Confidence            457889999999999999999999999999999987899999999965432 23344688898555 5589999999999


Q ss_pred             eeeeCCeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceE
Q 047719          351 WCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAK  430 (596)
Q Consensus       351 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~k  430 (596)
                      +|......++||||+++|+|.+++.........++|..++.++.|++.||+|||+.+..+|+||||||+|||++.++.+|
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k  174 (326)
T 3uim_A           95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV  174 (326)
T ss_dssp             EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred             EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence            99999999999999999999999988765556799999999999999999999993333999999999999999999999


Q ss_pred             EccCCCccc------------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCC------CChhHHHHHHH
Q 047719          431 LGDFEATIP------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDN------DGCVIVDWVWN  492 (596)
Q Consensus       431 l~Dfg~~~~------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~------~~~~~~~~~~~  492 (596)
                      |+|||++..            .||..|+|||.+.+..++.++|||||||++|||++|+.||+.      ......+|+..
T Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  254 (326)
T 3uim_A          175 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG  254 (326)
T ss_dssp             ECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred             eccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence            999998642            389999999999988899999999999999999999999952      23356677766


Q ss_pred             HHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCC
Q 047719          493 LRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEAPLP  551 (596)
Q Consensus       493 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~~~~p  551 (596)
                      ...........+..+...+..+....+.+++.+||+.||++|||++||++.|++.....
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~  313 (326)
T 3uim_A          255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAE  313 (326)
T ss_dssp             TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSS
T ss_pred             HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhh
Confidence            66677777777777888888999999999999999999999999999999999765433

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.9e-45  Score=388.40  Aligned_cols=255  Identities=20%  Similarity=0.252  Sum_probs=197.7

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeee------CC
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE------GN  356 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~------~~  356 (596)
                      +.|...+.||+|+||+||+|... +|+.||||++++........+.+.+|+..|.. ++|||||++++++..      .+
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKH-FKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHH-CCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHh-cCCCCcceEeeeeecccccccCC
Confidence            45888899999999999999865 59999999997655444455678899977765 899999999998764      36


Q ss_pred             eEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCC
Q 047719          357 ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEA  436 (596)
Q Consensus       357 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~  436 (596)
                      .+|||||||+ |+|.+++....    .+++.++..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~~~----~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGl  204 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHSSQ----PLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGM  204 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTSSS----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEEEeCCC-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecce
Confidence            7999999995 78999997653    59999999999999999999999   9999999999999999999999999998


Q ss_pred             cc---------------cCCCcccCCccccccC-CCCCccceeehhHHHHHHHhCCCCCCCCCh-hHHHHHHHHHhcCCc
Q 047719          437 TI---------------PAGTMGYLAPEYVYSG-VPSEKTDVYSFGVVALEVAAGKSPVDNDGC-VIVDWVWNLRKKGKL  499 (596)
Q Consensus       437 ~~---------------~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~El~tG~~p~~~~~~-~~~~~~~~~~~~~~~  499 (596)
                      +.               .+||+.|||||++.+. .++.++||||+||++|||++|+.||.+... .....+.........
T Consensus       205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~  284 (398)
T 4b99_A          205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP  284 (398)
T ss_dssp             CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCG
T ss_pred             eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            63               3699999999998875 569999999999999999999999987543 111111111111100


Q ss_pred             hhh--c--------cccc--cCcCCH-----HHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhcC
Q 047719          500 LDA--A--------DFRL--RGKFNR-----KEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKGE  547 (596)
Q Consensus       500 ~~~--~--------d~~l--~~~~~~-----~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~~~  547 (596)
                      ...  .        ...+  ....+.     .....+.+|+.+|++.||++|||++|+++  +++..
T Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  351 (398)
T 4b99_A          285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY  351 (398)
T ss_dssp             GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred             HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence            000  0        0000  000010     11245678899999999999999999987  56544

>1ioa_A Arcelin-5A, ARC5A; lectin-like proteins, plant defense proteins, lectin; HET: NAG FUC; 2.70A {Phaseolus vulgaris} SCOP: b.29.1.1

Probab=100.00  E-value=2.8e-45  Score=358.83  Aligned_cols=166  Identities=22%  Similarity=0.330  Sum_probs=149.1

Q ss_pred             CCCCCCCcccceEEEEEEEEecCCCCCCCCeEEEEEecCCCCCCCCCCccCCCCCCCCC-CCceEEEEeeCccCCCCCCC
Q 047719            1 FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSP-QDSFFAVEFDTSFDPSLGDI   79 (596)
Q Consensus         1 ~~~~~~~~~asF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~~~~~~~~~lG~~~~~~~~-~~~~~AVEfDt~~~~~~~d~   79 (596)
                      |||+.  +++||+|+|+|.|.+++...+||||||||+|.+..++.+||||||+|..+++ .+|+|||||||+        
T Consensus        58 l~d~~--~vaSFsT~F~F~I~~~~~~~~gdGlAF~l~p~~~~p~~~g~~LGL~n~~~~~~~~~~vAVEFDT~--------  127 (240)
T 1ioa_A           58 IKDSN--NVASFNTNFTFIIRAKNQSISAYGLAFALVPVNSPPQKKQEFLGIFNTNNPEPNARTVAVVFNTF--------  127 (240)
T ss_dssp             CBCSS--CBEEEEEEEEEECCBSCTTSCCEEEEEEEEETTCCCCCCGGGTTTCCCSSCCGGGCCEEEEEETT--------
T ss_pred             ccCCC--ccccEEEEEEEEEeCCCCCCCCCcEEEEEecCCCCCCCCCCcccccccCCCCCcCcEEEEEecCc--------
Confidence            68876  8999999999999988777889999999999877445889999999977444 799999999998        


Q ss_pred             CCCeeEEecCCccccccccCCCCCcccCCCceEEEEEEEcCCccEEEEEEeeCCCCCCCCeEEEeecCcccCCCceEEEE
Q 047719           80 NGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGF  159 (596)
Q Consensus        80 ~~~Hvgid~ns~~s~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~l~~~vdl~~~l~~~~~vGF  159 (596)
                       +|||||||||+.|++++++   +..|.+|+.++|||+||+.+++|+|++.+.. .+.+|+|+..|||+++|||+|||||
T Consensus       128 -~nHVGIdvNs~~S~~t~~~---~~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~~~ls~~vdL~~~l~e~v~VGF  202 (240)
T 1ioa_A          128 -KNRIDFDKNFIKPYVNENC---DFHKYNGEKTDVQITYDSSNNDLRVFLHFTV-SQVKCSVSATVHLEKEVDEWVSVGF  202 (240)
T ss_dssp             -TTEEEEEESSSSCSEEEEC---CHHHHCSSCEEEEEEEETTTTEEEEEEEETT-TCCEEEEEEECCGGGTSCSEEEEEE
T ss_pred             -CCceeeeeCCccccccccC---CccccCCCEEEEEEEEeCCCcEEEEEEecCC-CCccceeEEEechHHhCCCceEEEE
Confidence             5999999999999999886   4677799999999999999999999999854 2347899999999999999999999


Q ss_pred             EeecCCc---cceeeeeeeeeeccC
Q 047719          160 SAANGQG---SAIYTVDRWRFKTFE  181 (596)
Q Consensus       160 sastg~~---~~~~~i~~Wsf~~~~  181 (596)
                      ||+||..   .|.|+|++|+|++..
T Consensus       203 SAsTG~~~~~~~~H~IlsWsF~s~~  227 (240)
T 1ioa_A          203 SPTSGLTEDTTETHDVLSWSFSSKF  227 (240)
T ss_dssp             EEEECSSTTTCBCCEEEEEEEEEEE
T ss_pred             EeccCCCCcccceeEEEEEEEEeeC
Confidence            9999999   999999999999864

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=6.2e-45  Score=376.65  Aligned_cols=270  Identities=37%  Similarity=0.650  Sum_probs=232.5

Q ss_pred             ccCHHHHHHHhcCCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeeccee
Q 047719          273 RLALTDIKQATLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWC  352 (596)
Q Consensus       273 ~~~~~el~~at~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~  352 (596)
                      ++.+.++..++++|...+.||+|+||.||+|...+++.||||++....  ....+.+.+|+..+ +.++||||++++++|
T Consensus        28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l-~~l~h~~iv~~~~~~  104 (321)
T 2qkw_B           28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES--SQGIEEFETEIETL-SFCRHPHLVSLIGFC  104 (321)
T ss_dssp             --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC--SSHHHHHHHHHHGG-GSCCCTTBCCEEEEC
T ss_pred             eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC--hHHHHHHHHHHHHH-HhCCCCCEeeEEEEE
Confidence            445566777889999999999999999999998889999999986432  23455688898555 458999999999999


Q ss_pred             eeCCeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEc
Q 047719          353 CEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLG  432 (596)
Q Consensus       353 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~  432 (596)
                      .+.+..++||||+++|+|.+++.........++|..++.++.||+.||+|||+   .+++||||||+|||++.++.+||+
T Consensus       105 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~  181 (321)
T 2qkw_B          105 DERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKIT  181 (321)
T ss_dssp             CCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEEC
T ss_pred             cCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEe
Confidence            99999999999999999999998765444569999999999999999999999   899999999999999999999999


Q ss_pred             cCCCccc-------------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCC----hhHHHHHHHHHh
Q 047719          433 DFEATIP-------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDG----CVIVDWVWNLRK  495 (596)
Q Consensus       433 Dfg~~~~-------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~----~~~~~~~~~~~~  495 (596)
                      |||++..             .||..|+|||.+.+..++.++|||||||++|||++|+.||....    .....|......
T Consensus       182 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  261 (321)
T 2qkw_B          182 DFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN  261 (321)
T ss_dssp             CCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT
T ss_pred             ecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc
Confidence            9997642             37889999999999999999999999999999999999997532    245566666666


Q ss_pred             cCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Q 047719          496 KGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEA  548 (596)
Q Consensus       496 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~~  548 (596)
                      .+.+....++.+......+....+.+++.+||+.||++|||++|+++.|+...
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l  314 (321)
T 2qkw_B          262 NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL  314 (321)
T ss_dssp             TTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            66677777777777788889999999999999999999999999999998643

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.7e-44  Score=377.76  Aligned_cols=188  Identities=26%  Similarity=0.370  Sum_probs=165.5

Q ss_pred             HHhcCCCccceeecCCceEEEEEEcC----CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCC
Q 047719          281 QATLGFNKNRIVGEGASATVYKGSLP----SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGN  356 (596)
Q Consensus       281 ~at~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~  356 (596)
                      ...+.|...+.||+|+||+||+|+.+    .++.||||++.+..    ....+.+|+..+....+|||||++++++.+.+
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~   93 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKND   93 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence            34577999999999999999999742    36789999986432    23457889977777558999999999999999


Q ss_pred             eEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCC-CceEEccCC
Q 047719          357 ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAE-FNAKLGDFE  435 (596)
Q Consensus       357 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~-~~~kl~Dfg  435 (596)
                      .+|||||||++|+|.+++.       .+++.++..++.||+.||+|||+   ++|+||||||+|||++.+ +.+||+|||
T Consensus        94 ~~~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFG  163 (361)
T 4f9c_A           94 HVVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFG  163 (361)
T ss_dssp             EEEEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             EEEEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCC
Confidence            9999999999999999994       28899999999999999999999   999999999999999887 799999999


Q ss_pred             Ccc---------------------------------------cCCCcccCCccccccC-CCCCccceeehhHHHHHHHhC
Q 047719          436 ATI---------------------------------------PAGTMGYLAPEYVYSG-VPSEKTDVYSFGVVALEVAAG  475 (596)
Q Consensus       436 ~~~---------------------------------------~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~El~tG  475 (596)
                      ++.                                       .+||+.|||||++.+. .++.++||||+||++|||++|
T Consensus       164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G  243 (361)
T 4f9c_A          164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSG  243 (361)
T ss_dssp             TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred             CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHC
Confidence            873                                       2599999999999875 589999999999999999999


Q ss_pred             CCCCCCC
Q 047719          476 KSPVDND  482 (596)
Q Consensus       476 ~~p~~~~  482 (596)
                      +.||...
T Consensus       244 ~~Pf~~~  250 (361)
T 4f9c_A          244 RYPFYKA  250 (361)
T ss_dssp             CSSSSCC
T ss_pred             CCCCCCC
Confidence            9999654

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=7.8e-44  Score=395.24  Aligned_cols=241  Identities=19%  Similarity=0.243  Sum_probs=191.6

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcc-cchHHHHH--HHHHhccCCCceeeecceeeeCCeEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECA-RNPFTTEF--ATMAGCLRHKNLVQLQGWCCEGNELV  359 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~-~~~~~~E~--~~l~~~l~H~niv~l~g~~~~~~~~~  359 (596)
                      ++|...++||+|+||+||+++.. +|+.||||++.+....... .....+|.  ..+.+.++|||||++++++.+.+.+|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            46888999999999999999875 5899999999754322222 22233332  23445579999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc-
Q 047719          360 LVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI-  438 (596)
Q Consensus       360 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~-  438 (596)
                      ||||||++|+|.++|....    .+++..+..++.||+.||+|||+   ++||||||||+||||+.+|.+||+|||++. 
T Consensus       269 lVmEy~~GGdL~~~l~~~~----~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~~  341 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACD  341 (689)
T ss_dssp             EEECCCCSCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceeee
Confidence            9999999999999998754    48999999999999999999999   999999999999999999999999999863 


Q ss_pred             --------cCCCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCCh-hHHHHHHHHHhcCCchhhcccccc
Q 047719          439 --------PAGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGC-VIVDWVWNLRKKGKLLDAADFRLR  508 (596)
Q Consensus       439 --------~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~  508 (596)
                              .+||+.|||||++.. ..|+.++|||||||+||||++|+.||.+... .... +........          
T Consensus       342 ~~~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~-i~~~i~~~~----------  410 (689)
T 3v5w_A          342 FSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTMA----------  410 (689)
T ss_dssp             CSSCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHH-HHHHHHHCC----------
T ss_pred             cCCCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHhhcCCC----------
Confidence                    469999999999975 5799999999999999999999999975322 1111 111111111          


Q ss_pred             CcCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHH
Q 047719          509 GKFNRKEMERMLMVGLSCVHPNHEKRPS-----VKEAAR  542 (596)
Q Consensus       509 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs-----~~ev~~  542 (596)
                      ..++......+.+|+..|++.||++|++     ++||.+
T Consensus       411 ~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          411 VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence            1122223345678889999999999998     677765

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=3.3e-43  Score=391.04  Aligned_cols=241  Identities=24%  Similarity=0.312  Sum_probs=197.4

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      ++|...+.||+|+||.||+|... +|+.||||++......  ..+.+.+|+..|.. ++|||||++++++.+.+.+||||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~--~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~~~~~~iv~  233 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES--DKETVRKEIQTMSV-LRHPTLVNLHDAFEDDNEMVMIY  233 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH--HHHHHHHHHHHHHH-TCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchh--hHHHHHHHHHHHHh-CCCCCCCeEEEEEEECCEEEEEE
Confidence            46888999999999999999865 5899999999764432  34567889966655 99999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCC--CceEEccCCCccc-
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAE--FNAKLGDFEATIP-  439 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~--~~~kl~Dfg~~~~-  439 (596)
                      |||++|+|.++|....   ..+++.++..++.||++||+|||+   ++|+||||||+|||++.+  +.+||+|||++.. 
T Consensus       234 E~~~gg~L~~~i~~~~---~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~  307 (573)
T 3uto_A          234 EFMSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  307 (573)
T ss_dssp             ECCCCCBHHHHHTCTT---SCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred             eecCCCcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence            9999999999997543   248999999999999999999999   999999999999999864  8999999998743 


Q ss_pred             ---------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCc
Q 047719          440 ---------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGK  510 (596)
Q Consensus       440 ---------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  510 (596)
                               +||+.|||||++.+..|+.++|||||||+||||++|+.||.+....  +....... ... . ........
T Consensus       308 ~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~--~~~~~i~~-~~~-~-~~~~~~~~  382 (573)
T 3uto_A          308 DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD--ETLRNVKS-CDW-N-MDDSAFSG  382 (573)
T ss_dssp             CTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHHHT-TCC-C-CCSGGGTT
T ss_pred             cCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHHHHHHh-CCC-C-CCcccccC
Confidence                     5999999999999999999999999999999999999999875431  11111111 110 0 00111112


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          511 FNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       511 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      +    ...+.+|+.+||+.||++|||++|+++
T Consensus       383 ~----s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          383 I----SEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             S----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             C----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            2    345678889999999999999999987

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=3.1e-43  Score=362.51  Aligned_cols=255  Identities=31%  Similarity=0.418  Sum_probs=204.3

Q ss_pred             HHHhcCCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEE
Q 047719          280 KQATLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELV  359 (596)
Q Consensus       280 ~~at~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~  359 (596)
                      .....+|...+.||+|+||.||+|.. .|+.||||++..........+++.+|+..+.+ ++||||+++++++.+.+..+
T Consensus        33 ~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~-l~hp~iv~~~~~~~~~~~~~  110 (309)
T 3p86_A           33 DIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKR-LRHPNIVLFMGAVTQPPNLS  110 (309)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHH-CCCTTBCCEEEEECSTTCCE
T ss_pred             cCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHh-CCCCCEeeEEEEEEECCceE
Confidence            33456788889999999999999987 68899999997655444555678899976665 89999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCC--eEEccCCCCceeecCCCceEEccCCCc
Q 047719          360 LVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQ--IIHRDVKACNILLDAEFNAKLGDFEAT  437 (596)
Q Consensus       360 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~--ivHrDlkp~NiLl~~~~~~kl~Dfg~~  437 (596)
                      +||||+++|+|.+++..... ...+++..++.++.||+.||+|||+   .+  |+||||||+|||++.++.+||+|||++
T Consensus       111 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a  186 (309)
T 3p86_A          111 IVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS  186 (309)
T ss_dssp             EEEECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred             EEEecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence            99999999999999986431 2248999999999999999999999   78  999999999999999999999999976


Q ss_pred             c-----------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhcccc
Q 047719          438 I-----------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFR  506 (596)
Q Consensus       438 ~-----------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~  506 (596)
                      .           ..||..|+|||.+.+..++.++|||||||++|||++|+.||......  +...........       
T Consensus       187 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~--~~~~~~~~~~~~-------  257 (309)
T 3p86_A          187 RLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA--QVVAAVGFKCKR-------  257 (309)
T ss_dssp             ---------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH--HHHHHHHHSCCC-------
T ss_pred             ccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhcCCC-------
Confidence            3           35899999999999999999999999999999999999999865431  111111111111       


Q ss_pred             ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCC
Q 047719          507 LRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEAPLP  551 (596)
Q Consensus       507 l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~~~~p  551 (596)
                        ...+......+.+++..||+.||++|||++++++.|+......
T Consensus       258 --~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~  300 (309)
T 3p86_A          258 --LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA  300 (309)
T ss_dssp             --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred             --CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence              1112223345778889999999999999999999998765433

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1e-41  Score=349.67  Aligned_cols=269  Identities=35%  Similarity=0.587  Sum_probs=219.9

Q ss_pred             ccccCHHHHHHHhcCCCcc------ceeecCCceEEEEEEcCCCCEEEEEEeecCCc--hhcccchHHHHHHHHHhccCC
Q 047719          271 PMRLALTDIKQATLGFNKN------RIVGEGASATVYKGSLPSGGAVAVKRFEKPNR--VECARNPFTTEFATMAGCLRH  342 (596)
Q Consensus       271 ~~~~~~~el~~at~~f~~~------~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~--~~~~~~~~~~E~~~l~~~l~H  342 (596)
                      ...+++.++..++++|...      +.||+|+||.||+|.. +++.||||++.....  .+...+.+.+|+..+.. ++|
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h   89 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAK-CQH   89 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHH-CCC
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHh-cCC
Confidence            3568999999999999988      8999999999999987 688999999864321  22334568889866655 899


Q ss_pred             CceeeecceeeeCCeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCcee
Q 047719          343 KNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNIL  422 (596)
Q Consensus       343 ~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiL  422 (596)
                      |||+++++++.+.+..++||||+++|+|.+++..... ...++|..++.++.||+.||+|||+   .+++||||||+|||
T Consensus        90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil  165 (307)
T 2nru_A           90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANIL  165 (307)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG-CCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEE
T ss_pred             CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEE
Confidence            9999999999999999999999999999999975432 2358999999999999999999999   89999999999999


Q ss_pred             ecCCCceEEccCCCcc-------------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCCh--hHH
Q 047719          423 LDAEFNAKLGDFEATI-------------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGC--VIV  487 (596)
Q Consensus       423 l~~~~~~kl~Dfg~~~-------------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~--~~~  487 (596)
                      ++.++.+||+|||.+.             ..||..|+|||.+.+ .++.++|||||||++|||++|+.||.....  .+.
T Consensus       166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~  244 (307)
T 2nru_A          166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL  244 (307)
T ss_dssp             ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTT
T ss_pred             EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHH
Confidence            9999999999999753             247899999998764 589999999999999999999999976432  222


Q ss_pred             HHHHHHHhcC-CchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          488 DWVWNLRKKG-KLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       488 ~~~~~~~~~~-~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                      .+........ .+.+..+..+ ...+......+.+++..||+.||++|||++++++.|+..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l  304 (307)
T 2nru_A          245 DIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM  304 (307)
T ss_dssp             HHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             HHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            3322222222 2222333322 345667788899999999999999999999999999864

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=3.1e-42  Score=354.40  Aligned_cols=245  Identities=24%  Similarity=0.371  Sum_probs=199.5

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      ++|...++||+|+||+||++... ++..||+|++...  .....+.+.+|+..+. .++||||+++++++.+.+..++||
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~~~~~~~~lv~   86 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEETQRTFLKEVKVMR-CLEHPNVLKFIGVLYKDKRLNFIT   86 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC--CHHHHHHHHHHHHHHT-TCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC--CHHHHHHHHHHHHHHH-hCCCcCcccEEEEEecCCeeEEEE
Confidence            45777899999999999999875 5899999998542  3345567889996664 489999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc----
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI----  438 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~----  438 (596)
                      ||+++|+|.+++....   ..++|.+++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||.+.    
T Consensus        87 e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  160 (310)
T 3s95_A           87 EYIKGGTLRGIIKSMD---SQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVD  160 (310)
T ss_dssp             ECCTTCBHHHHHHHCC---TTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred             EecCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence            9999999999998743   248999999999999999999999   899999999999999999999999999763    


Q ss_pred             ---------------------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcC
Q 047719          439 ---------------------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKG  497 (596)
Q Consensus       439 ---------------------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~  497 (596)
                                           ..||+.|+|||.+.+..++.++|||||||++|||++|..|+.........      ...
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~------~~~  234 (310)
T 3s95_A          161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD------FGL  234 (310)
T ss_dssp             -------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT------SSB
T ss_pred             ccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH------Hhh
Confidence                                 35899999999999999999999999999999999999998653210000      000


Q ss_pred             CchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          498 KLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       498 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                      ......+..    .+......+.+++..||+.||++|||++++++.|+..
T Consensus       235 ~~~~~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l  280 (310)
T 3s95_A          235 NVRGFLDRY----CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL  280 (310)
T ss_dssp             CHHHHHHHT----CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hhhcccccc----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            000001111    1112224577888999999999999999999998764

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2e-41  Score=346.93  Aligned_cols=239  Identities=28%  Similarity=0.388  Sum_probs=197.0

Q ss_pred             hcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      .++|...+.||+|+||+||+|... +++.||||++....  ....+.+.+|+..+.. ++||||+++++++...+..++|
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~-l~hp~iv~~~~~~~~~~~~~lv   95 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRE-NKNPNIVNYLDSYLVGDELWVV   95 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGG--CSCHHHHHHHHHHHHH-CCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccc--ccHHHHHHHHHHHHhc-CCCCCCCeEeEEEEECCEEEEE
Confidence            457888999999999999999864 58999999996432  2234567888866655 8999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc---
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI---  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---  438 (596)
                      |||+++|+|.+++....     +++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++.   
T Consensus        96 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  167 (297)
T 3fxz_A           96 MEYLAGGSLTDVVTETC-----MDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  167 (297)
T ss_dssp             EECCTTCBHHHHHHHSC-----CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EECCCCCCHHHHHhhcC-----CCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecC
Confidence            99999999999998753     8899999999999999999999   899999999999999999999999999753   


Q ss_pred             --------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCc
Q 047719          439 --------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGK  510 (596)
Q Consensus       439 --------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  510 (596)
                              ..||+.|+|||.+.+..++.++|||||||++|||++|+.||.......  ...........    .    ..
T Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~----~----~~  237 (297)
T 3fxz_A          168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--ALYLIATNGTP----E----LQ  237 (297)
T ss_dssp             STTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHHHCSC----C----CS
T ss_pred             CcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhCCCC----C----CC
Confidence                    358999999999999999999999999999999999999997654321  11111111110    0    01


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          511 FNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       511 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      .+......+.+++.+||+.||++|||++|+++
T Consensus       238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          238 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            11223345778889999999999999999987

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=4.4e-42  Score=362.98  Aligned_cols=248  Identities=25%  Similarity=0.369  Sum_probs=201.0

Q ss_pred             cCCCccceeecCCceEEEEEEcC--------CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeC
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP--------SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG  355 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~--------~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~  355 (596)
                      ++|...+.||+|+||.||+|...        ++..||||+++... .......+.+|+..+....+||||++++++|.+.
T Consensus        81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            56778899999999999999742        34579999996542 3334567889997776633899999999999999


Q ss_pred             CeEEEEEecCCCCCHHHHhhhCCCC------------CcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceee
Q 047719          356 NELVLVYEYLPNGSLDKILHNNSSS------------SIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILL  423 (596)
Q Consensus       356 ~~~~lV~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl  423 (596)
                      +.+|+||||+++|+|.+++......            ...+++.+++.++.||+.||+|||+   .+|+||||||+|||+
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEE
Confidence            9999999999999999999875421            2358999999999999999999999   899999999999999


Q ss_pred             cCCCceEEccCCCccc-------------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHH
Q 047719          424 DAEFNAKLGDFEATIP-------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDW  489 (596)
Q Consensus       424 ~~~~~~kl~Dfg~~~~-------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~  489 (596)
                      +.++.+||+|||++..             .+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.......  .
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~--~  314 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--L  314 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--H
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--H
Confidence            9999999999997642             25678999999999999999999999999999999 999998653211  1


Q ss_pred             HHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          490 VWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       490 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                      . .....+.         ....+......+.+++..||+.||++||+++|+++.|+..
T Consensus       315 ~-~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i  362 (370)
T 2psq_A          315 F-KLLKEGH---------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  362 (370)
T ss_dssp             H-HHHHTTC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             H-HHHhcCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            1 1111111         1112223345677888999999999999999999999753

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=5.3e-41  Score=347.69  Aligned_cols=251  Identities=26%  Similarity=0.339  Sum_probs=203.7

Q ss_pred             ccccCHHHHHHHhcC----------CCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhc
Q 047719          271 PMRLALTDIKQATLG----------FNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGC  339 (596)
Q Consensus       271 ~~~~~~~el~~at~~----------f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~  339 (596)
                      +..+++++++.+++.          |...+.||+|+||.||+|... +|+.||||++....  ....+.+.+|+..+. .
T Consensus        22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~-~   98 (321)
T 2c30_A           22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMR-D   98 (321)
T ss_dssp             ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--CCSHHHHHHHHHHHT-T
T ss_pred             CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc--hhHHHHHHHHHHHHH-h
Confidence            346788999988875          566779999999999999876 69999999996432  234456888986664 5


Q ss_pred             cCCCceeeecceeeeCCeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCC
Q 047719          340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKAC  419 (596)
Q Consensus       340 l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~  419 (596)
                      ++||||+++++++...+..++||||+++|+|.+++...     .+++..+..++.||+.||+|||+   .+|+||||||+
T Consensus        99 l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~  170 (321)
T 2c30_A           99 YQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV-----RLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSD  170 (321)
T ss_dssp             CCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGG
T ss_pred             CCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHH
Confidence            89999999999999999999999999999999999754     38999999999999999999999   89999999999


Q ss_pred             ceeecCCCceEEccCCCcc-----------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHH
Q 047719          420 NILLDAEFNAKLGDFEATI-----------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVD  488 (596)
Q Consensus       420 NiLl~~~~~~kl~Dfg~~~-----------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~  488 (596)
                      |||++.++.+||+|||++.           ..||+.|+|||.+.+..++.++|||||||++|||++|+.||......  +
T Consensus       171 NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~--~  248 (321)
T 2c30_A          171 SILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV--Q  248 (321)
T ss_dssp             GEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--H
T ss_pred             HEEECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--H
Confidence            9999999999999999753           25899999999999999999999999999999999999999765321  1


Q ss_pred             HHHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          489 WVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       489 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      .........      .+.+.  ........+.+++.+||+.||++|||++|+++
T Consensus       249 ~~~~~~~~~------~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          249 AMKRLRDSP------PPKLK--NSHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             HHHHHHHSS------CCCCT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHhcCC------CCCcC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            111111111      01110  01112345677888999999999999999987

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2e-42  Score=356.56  Aligned_cols=237  Identities=25%  Similarity=0.294  Sum_probs=194.2

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      ++|...++||+|+||+||+|... +|+.||||++............+..|+..+.+..+|+||++++++|.+.+..++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            56888999999999999999876 68999999986554444455567777777777679999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc----
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI----  438 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~----  438 (596)
                      ||+ +++|.+++....   ..++|..++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++.    
T Consensus       137 e~~-~~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~  209 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAWG---ASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT  209 (311)
T ss_dssp             ECC-CCBHHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred             ecc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence            999 679999997653   259999999999999999999999   899999999999999999999999999753    


Q ss_pred             ------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCC
Q 047719          439 ------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFN  512 (596)
Q Consensus       439 ------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  512 (596)
                            ..||+.|+|||.+.+ .++.++|||||||++|||++|..|+.....      +.....+...    +....   
T Consensus       210 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~------~~~~~~~~~~----~~~~~---  275 (311)
T 3p1a_A          210 AGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG------WQQLRQGYLP----PEFTA---  275 (311)
T ss_dssp             -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH------HHHHTTTCCC----HHHHT---
T ss_pred             CCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHhccCCC----ccccc---
Confidence                  248999999998875 799999999999999999999776654211      1111111111    11111   


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          513 RKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       513 ~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                       .....+.+++.+|++.||++|||++|+++
T Consensus       276 -~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          276 -GLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             -TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -CCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence             22356778889999999999999999986

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=4.8e-42  Score=363.10  Aligned_cols=244  Identities=25%  Similarity=0.403  Sum_probs=194.8

Q ss_pred             cCCCccceeecCCceEEEEEEcC----CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP----SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELV  359 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~  359 (596)
                      .+|...+.||+|+||.||+|...    ++..||||+++... .....++|.+|+..+. .++||||++++++|.+.+..+
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~  122 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMG-QFDHPNIIRLEGVVTKSKPVM  122 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHT-TCCCTTBCCEEEEECSSSSCE
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHH-hCCCCCCCeEEEEEeeCCceE
Confidence            46888899999999999999864    46789999996532 3344567899996665 489999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc
Q 047719          360 LVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP  439 (596)
Q Consensus       360 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~  439 (596)
                      +||||+++|+|.+++....   ..+++.+++.++.||++||+|||+   .+|+||||||+|||++.++.+||+|||++..
T Consensus       123 lv~e~~~~~sL~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  196 (373)
T 2qol_A          123 IVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRV  196 (373)
T ss_dssp             EEEECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred             EEEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence            9999999999999998653   358999999999999999999999   8999999999999999999999999997643


Q ss_pred             C--------------CCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhcc
Q 047719          440 A--------------GTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAAD  504 (596)
Q Consensus       440 ~--------------gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d  504 (596)
                      .              ++..|+|||.+.+..++.++|||||||++|||++ |+.||......  +.. .....+       
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~--~~~-~~i~~~-------  266 (373)
T 2qol_A          197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ--DVI-KAVDEG-------  266 (373)
T ss_dssp             -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH--HHH-HHHHTT-------
T ss_pred             cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--HHH-HHHHcC-------
Confidence            1              3567999999999999999999999999999998 99999765321  111 111111       


Q ss_pred             ccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          505 FRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       505 ~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                        .....+......+.+++..||+.||++||++++|++.|+..
T Consensus       267 --~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~  307 (373)
T 2qol_A          267 --YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL  307 (373)
T ss_dssp             --EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence              11112223345678889999999999999999999998764

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=6.5e-42  Score=355.12  Aligned_cols=245  Identities=28%  Similarity=0.419  Sum_probs=199.1

Q ss_pred             CCCccceeecCCceEEEEEEcC----CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEE
Q 047719          285 GFNKNRIVGEGASATVYKGSLP----SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVL  360 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~----~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~l  360 (596)
                      .|...+.||+|+||.||+|...    .+..||||+++... .....+.+.+|+..+. .++||||+++++++.+.+..++
T Consensus        50 ~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           50 RIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMG-QFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHT-TCCCTTBCCEEEEECGGGCCEE
T ss_pred             HeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHH-hCCCCCCCcEEEEEEeCCccEE
Confidence            4666799999999999999874    24469999996432 3334567889996664 4899999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc-
Q 047719          361 VYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP-  439 (596)
Q Consensus       361 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~-  439 (596)
                      ||||+++|+|.+++....   ..+++.+++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++.. 
T Consensus       128 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  201 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTHD---GQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL  201 (325)
T ss_dssp             EEECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             EeeCCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence            999999999999997653   248999999999999999999999   8999999999999999999999999998643 


Q ss_pred             -------------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhccc
Q 047719          440 -------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADF  505 (596)
Q Consensus       440 -------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~  505 (596)
                                   .+|..|+|||.+.+..++.++|||||||++|||++ |+.||......  +..... ..+.       
T Consensus       202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~~~-~~~~-------  271 (325)
T 3kul_A          202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR--DVISSV-EEGY-------  271 (325)
T ss_dssp             C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--HHHHHH-HTTC-------
T ss_pred             ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH--HHHHHH-HcCC-------
Confidence                         24567999999998899999999999999999999 99999765321  111111 1111       


Q ss_pred             cccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Q 047719          506 RLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEAP  549 (596)
Q Consensus       506 ~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~~~  549 (596)
                        ....+......+.+++..||+.||++|||++++++.|+....
T Consensus       272 --~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~  313 (325)
T 3kul_A          272 --RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR  313 (325)
T ss_dssp             --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence              111122334567788899999999999999999999987543

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=3.1e-41  Score=350.66  Aligned_cols=239  Identities=25%  Similarity=0.320  Sum_probs=198.4

Q ss_pred             hcCCCccceeecCCceEEEEEEc-CCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          283 TLGFNKNRIVGEGASATVYKGSL-PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      ..+|...+.||+|+||.||+|.. .+|+.||||++.+........+.+.+|+..+.. ++||||+++++++...+..|+|
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~-l~hpnIv~l~~~~~~~~~~~lv   92 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKI-LNHPNIVKLFEVIETEKTLYLI   92 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHH-CCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHh-CCCCCEeeEEEEEEECCEEEEE
Confidence            35688889999999999999986 469999999997654444455678899966655 8999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc---
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI---  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---  438 (596)
                      |||+++|+|.+++....    .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++.   
T Consensus        93 ~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  165 (328)
T 3fe3_A           93 MEYASGGEVFDYLVAHG----RMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFT  165 (328)
T ss_dssp             ECCCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred             EECCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence            99999999999997654    48999999999999999999999   899999999999999999999999999764   


Q ss_pred             -------cCCCcccCCccccccCCCC-CccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCc
Q 047719          439 -------PAGTMGYLAPEYVYSGVPS-EKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGK  510 (596)
Q Consensus       439 -------~~gt~~y~aPE~~~~~~~t-~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  510 (596)
                             ..||+.|+|||.+.+..+. .++|||||||++|||++|+.||.+...  .+....... +..      ..   
T Consensus       166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~i~~-~~~------~~---  233 (328)
T 3fe3_A          166 VGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL--KELRERVLR-GKY------RI---  233 (328)
T ss_dssp             SSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHH-CCC------CC---
T ss_pred             CCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH--HHHHHHHHh-CCC------CC---
Confidence                   3589999999999887764 899999999999999999999987542  111111111 111      11   


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          511 FNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       511 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                       +......+.+++.+|++.||++|||++|+++
T Consensus       234 -p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          234 -PFYMSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             -CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             -CCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence             1112345677888999999999999999987

>1dhk_B Bean lectin-like inhibitor, porcine pancreatic alpha-amylase; CO (hydrolase-inhibitor), complex (hydrolase-inhibitor) comple; HET: NAG; 1.85A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1viw_B*

Probab=100.00  E-value=2.9e-41  Score=326.00  Aligned_cols=152  Identities=25%  Similarity=0.322  Sum_probs=131.0

Q ss_pred             CCCCCCCcccceEEEEEEEEecCCCCCCCCeEEEEEecCCCCCCCCCCccCCCCCCCCCCCceEEEEeeCccCCCCCCCC
Q 047719            1 FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQDSFFAVEFDTSFDPSLGDIN   80 (596)
Q Consensus         1 ~~~~~~~~~asF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~~~~~~~~~lG~~~~~~~~~~~~~AVEfDt~~~~~~~d~~   80 (596)
                      |||+.+|+++||+|+|+|.|.+++...+||||||||+|.+..++                +++|||||||+         
T Consensus        51 l~~~~~g~vaSFsT~F~F~I~~~~~~~~gdGlAF~l~p~~~~p~----------------~~~vAVEFDT~---------  105 (223)
T 1dhk_B           51 IRDSTTGNVASFDTNFTMNIRTHRQANSAVGLDFVLVPVQPESK----------------GDTVTVEFDTF---------  105 (223)
T ss_dssp             SEETTTTEECEEEEEEEEEEECCC---CCSEEEEEEEEC----------------------CCEEEEEETT---------
T ss_pred             eecCCCCCccceEEEEEEEEeCCCCCCCCCceEEEEecCCCCCC----------------ccEEEEEecCC---------
Confidence            69999999999999999999988777789999999999754211                34899999998         


Q ss_pred             CCeeEEecCCccccccccCCCCCcccCCCceEEEEEEEcCCccEEEEEEeeCCCCCCCCeEEEeecCcccCCCceEEEEE
Q 047719           81 GNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFS  160 (596)
Q Consensus        81 ~~Hvgid~ns~~s~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~l~~~vdl~~~l~~~~~vGFs  160 (596)
                      +||||||+||+ |+++.++   +..|.+|+.++|||+||+.+++|+|++.+.. .+.+|+|+..|||+++|||+||||||
T Consensus       106 ~nHVGIdvNsi-S~~~~~~---~~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~~~ls~~vdLs~~l~e~~~VGFS  180 (223)
T 1dhk_B          106 LSRISIDVNNN-DIKSVPW---DVHDYDGQNAEVRITYNSSTKVFSVSLSNPS-TGKSNNVSTTVELEKEVYDWVSVGFS  180 (223)
T ss_dssp             TTEEEEEETTE-EEEEEEC---CGGGTTTSCEEEEEEEETTTTEEEEEEECTT-TCCEEEEEEECCCCSGGGSEEEEEEE
T ss_pred             CCcccccCCcc-ccccccC---CccccCCCEEEEEEEEeCCCCEEEEEEecCC-CCccceEEEEechHHhCCCceEEEEE
Confidence            59999999999 9998886   5678899999999999999999999998853 23478999999999999999999999


Q ss_pred             eecCCc---cceeeeeeeeeeccCC
Q 047719          161 AANGQG---SAIYTVDRWRFKTFES  182 (596)
Q Consensus       161 astg~~---~~~~~i~~Wsf~~~~~  182 (596)
                      |+||..   .+.|+|++|+|++..+
T Consensus       181 AsTG~~~~~~~~H~IlsWsF~s~~~  205 (223)
T 1dhk_B          181 ATSGAYQWSYETHDVLSWSFSSKFI  205 (223)
T ss_dssp             EEECSGGGSCCEEEEEEEEEEEEC-
T ss_pred             eccCCCccccceEEEEEEEEEeccc
Confidence            999999   9999999999998753

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2.1e-41  Score=350.68  Aligned_cols=247  Identities=26%  Similarity=0.335  Sum_probs=193.7

Q ss_pred             hcCCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCC----eE
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGN----EL  358 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~----~~  358 (596)
                      .++|...++||+|+||+||+|+.. ++.||||++....   .....+..|+..+ ..++|||||++++++....    .+
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~---~~~~~~~~E~~~l-~~l~hpniv~~~~~~~~~~~~~~~~   97 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD---KQSWQNEYEVYSL-PGMKHENILQFIGAEKRGTSVDVDL   97 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG---HHHHHHHHHHHTS-TTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc---hHHHHHHHHHHHH-hcCCCCCchhhcceeccCCCCCceE
Confidence            356788899999999999999874 7899999995432   2233455677544 4589999999999998744    47


Q ss_pred             EEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCC----------CeEEccCCCCceeecCCCc
Q 047719          359 VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECER----------QIIHRDVKACNILLDAEFN  428 (596)
Q Consensus       359 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~----------~ivHrDlkp~NiLl~~~~~  428 (596)
                      ++||||+++|+|.+++....     ++|..++.++.||+.||+|||+   .          +|+||||||+|||++.++.
T Consensus        98 ~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~  169 (322)
T 3soc_A           98 WLITAFHEKGSLSDFLKANV-----VSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLT  169 (322)
T ss_dssp             EEEEECCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCC
T ss_pred             EEEEecCCCCCHHHHHHhcC-----CCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCe
Confidence            99999999999999998753     8999999999999999999998   6          9999999999999999999


Q ss_pred             eEEccCCCcc-------------cCCCcccCCccccccC-----CCCCccceeehhHHHHHHHhCCCCCCCCCh------
Q 047719          429 AKLGDFEATI-------------PAGTMGYLAPEYVYSG-----VPSEKTDVYSFGVVALEVAAGKSPVDNDGC------  484 (596)
Q Consensus       429 ~kl~Dfg~~~-------------~~gt~~y~aPE~~~~~-----~~t~~sDV~SfGvll~El~tG~~p~~~~~~------  484 (596)
                      +||+|||++.             ..||+.|+|||.+.+.     .++.++|||||||++|||++|+.||.....      
T Consensus       170 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~  249 (322)
T 3soc_A          170 ACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF  249 (322)
T ss_dssp             EEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTT
T ss_pred             EEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccch
Confidence            9999999763             3589999999998763     456789999999999999999999975321      


Q ss_pred             --------hHHHHHHHHHhcCCchhhccccccCc-CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          485 --------VIVDWVWNLRKKGKLLDAADFRLRGK-FNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       485 --------~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                              ...++........ .    .+.+... ........+.+++.+||+.||++|||++||++.|+..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~-~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l  316 (322)
T 3soc_A          250 EEEIGQHPSLEDMQEVVVHKK-K----RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM  316 (322)
T ss_dssp             HHHHCSSCCHHHHHHHHTTSC-C----CCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hhhhccCCchhhhhhhhhccc-C----CCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                    1111111111111 1    0111111 1224556788999999999999999999999999753

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=3.6e-42  Score=364.53  Aligned_cols=245  Identities=24%  Similarity=0.313  Sum_probs=200.4

Q ss_pred             hcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      .++|...+.||+|+||.||+|... +++.||||+++... .......|.+|+..+. .++|||||+++++|...+..++|
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~-~l~hpniv~~~~~~~~~~~~~lv  190 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL-PPDLKAKFLQEARILK-QYSHPNIVRLIGVCTQKQPIYIV  190 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS-CHHHHTTTTHHHHHHT-TCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC-CHHHHHHHHHHHHHHH-hCCCCCEEEEEEEEecCCCcEEE
Confidence            346777899999999999999876 68999999986432 2334456888986665 48999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcccC-
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA-  440 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~~-  440 (596)
                      |||+++|+|.+++....   ..+++..++.++.||+.||+|||+   .+++||||||+|||++.++.+||+|||++... 
T Consensus       191 ~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~  264 (377)
T 3cbl_A          191 MELVQGGDFLTFLRTEG---ARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEA  264 (377)
T ss_dssp             EECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred             EEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence            99999999999998643   248999999999999999999999   89999999999999999999999999986421 


Q ss_pred             ------------CCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhccccc
Q 047719          441 ------------GTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRL  507 (596)
Q Consensus       441 ------------gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  507 (596)
                                  ++..|+|||.+..+.++.++|||||||++|||++ |+.||.......   +......+..        
T Consensus       265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~---~~~~~~~~~~--------  333 (377)
T 3cbl_A          265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ---TREFVEKGGR--------  333 (377)
T ss_dssp             TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH---HHHHHHTTCC--------
T ss_pred             CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHcCCC--------
Confidence                        3567999999998899999999999999999999 999998754321   1112222211        


Q ss_pred             cCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          508 RGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       508 ~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                       ...+......+.+++..||+.||++|||++++++.|+..
T Consensus       334 -~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  372 (377)
T 3cbl_A          334 -LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI  372 (377)
T ss_dssp             -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence             111222334677888999999999999999999999753

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.1e-41  Score=340.86  Aligned_cols=242  Identities=28%  Similarity=0.362  Sum_probs=200.0

Q ss_pred             cCCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      ++|...+.||+|+||.||+|...+++.||||++.....   ..+++.+|+..+.+ ++||||+++++++.+.+..++|||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~e   85 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM---SEEDFIEEAEVMMK-LSHPKLVQLYGVCLEQAPICLVFE   85 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB---CHHHHHHHHHHHHT-CCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc---CHHHHHHHHHHHHh-CCCCCEeeEEEEEecCCceEEEEE
Confidence            45777899999999999999988889999999965332   33568889866655 899999999999999999999999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc----
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP----  439 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~----  439 (596)
                      |+++|+|.+++....   ..+++..++.++.|++.||+|||+   .+++||||||+|||++.++.+||+|||.+..    
T Consensus        86 ~~~~~~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  159 (269)
T 4hcu_A           86 FMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD  159 (269)
T ss_dssp             CCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred             eCCCCcHHHHHHhcC---cccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEecccccccccccc
Confidence            999999999997653   258999999999999999999999   8999999999999999999999999997642    


Q ss_pred             --------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhccccccCc
Q 047719          440 --------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGK  510 (596)
Q Consensus       440 --------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  510 (596)
                              .+|..|+|||.+....++.++|||||||++|||++ |+.||......  +.........          ...
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~--~~~~~~~~~~----------~~~  227 (269)
T 4hcu_A          160 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVVEDISTGF----------RLY  227 (269)
T ss_dssp             HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTTC----------CCC
T ss_pred             ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH--HHHHHHhcCc----------cCC
Confidence                    35667999999998999999999999999999999 99999875431  1111111110          111


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          511 FNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       511 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                      .+......+.+++..||+.||++|||++|+++.|+..
T Consensus       228 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l  264 (269)
T 4hcu_A          228 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI  264 (269)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence            1112234577888999999999999999999998753

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=8.5e-41  Score=341.45  Aligned_cols=249  Identities=26%  Similarity=0.323  Sum_probs=192.2

Q ss_pred             hcCCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHh-ccCCCceeeecceeeeC----Ce
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAG-CLRHKNLVQLQGWCCEG----NE  357 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~-~l~H~niv~l~g~~~~~----~~  357 (596)
                      .++|...+.||+|+||+||+|.. +++.||||++...     ....+..|.+.+.. .++||||+++++++...    ..
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~   80 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ   80 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence            35688889999999999999987 6889999998542     22334555544333 27999999999997653    46


Q ss_pred             EEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhcc-----CCCeEEccCCCCceeecCCCceEEc
Q 047719          358 LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC-----ERQIIHRDVKACNILLDAEFNAKLG  432 (596)
Q Consensus       358 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~-----~~~ivHrDlkp~NiLl~~~~~~kl~  432 (596)
                      .++||||+++|+|.++++..     .+++..++.++.||+.||+|||...     .++|+||||||+|||++.++.+||+
T Consensus        81 ~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~  155 (301)
T 3q4u_A           81 LWLITHYHEMGSLYDYLQLT-----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIA  155 (301)
T ss_dssp             EEEEECCCTTCBHHHHHTTC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred             eEEehhhccCCCHHHHHhhc-----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEe
Confidence            89999999999999999654     4899999999999999999999210     2899999999999999999999999


Q ss_pred             cCCCcc---------------cCCCcccCCccccccC------CCCCccceeehhHHHHHHHhC----------CCCCCC
Q 047719          433 DFEATI---------------PAGTMGYLAPEYVYSG------VPSEKTDVYSFGVVALEVAAG----------KSPVDN  481 (596)
Q Consensus       433 Dfg~~~---------------~~gt~~y~aPE~~~~~------~~t~~sDV~SfGvll~El~tG----------~~p~~~  481 (596)
                      |||++.               ..||+.|+|||.+.+.      .++.++|||||||++|||++|          +.||..
T Consensus       156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~  235 (301)
T 3q4u_A          156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD  235 (301)
T ss_dssp             CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence            999752               2689999999999876      455799999999999999999          888864


Q ss_pred             CCh---hHHHHHHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          482 DGC---VIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       482 ~~~---~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                      ...   ...................    ...........+.+++..||+.||++|||++||++.|+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~  299 (301)
T 3q4u_A          236 VVPNDPSFEDMRKVVCVDQQRPNIP----NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK  299 (301)
T ss_dssp             TSCSSCCHHHHHHHHTTSCCCCCCC----GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred             cCCCCcchhhhhHHHhccCCCCCCC----hhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence            211   1111111111111111110    111233567788999999999999999999999999975

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.4e-41  Score=368.98  Aligned_cols=245  Identities=23%  Similarity=0.384  Sum_probs=201.5

Q ss_pred             HhcCCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          282 ATLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       282 at~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      ..++|...+.||+|+||.||+|.+.++..||||+++...   ...+.|.+|+..+. .++|||||++++++. ....++|
T Consensus       186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~-~l~h~~iv~l~~~~~-~~~~~lv  260 (454)
T 1qcf_A          186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMK-TLQHDKLVKLHAVVT-KEPIYII  260 (454)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS---BCHHHHHHHHHHHT-TCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC---ccHHHHHHHHHHHh-hCCCCCEeeEEEEEe-CCccEEE
Confidence            455678889999999999999999888899999996432   34567899996665 489999999999986 6679999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc--
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP--  439 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~--  439 (596)
                      |||+++|+|.+++....  ...+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||++..  
T Consensus       261 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  335 (454)
T 1qcf_A          261 TEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIE  335 (454)
T ss_dssp             ECCCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred             EeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence            99999999999997542  1247899999999999999999999   8999999999999999999999999998753  


Q ss_pred             ----------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhcccccc
Q 047719          440 ----------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLR  508 (596)
Q Consensus       440 ----------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  508 (596)
                                .+|..|+|||.+..+.++.++|||||||+||||++ |+.||......  +...... .+.         .
T Consensus       336 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~--~~~~~i~-~~~---------~  403 (454)
T 1qcf_A          336 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIRALE-RGY---------R  403 (454)
T ss_dssp             CHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHHHHHH-HTC---------C
T ss_pred             CCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHHHH-cCC---------C
Confidence                      24678999999999999999999999999999999 99999865321  1111111 111         1


Q ss_pred             CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Q 047719          509 GKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEA  548 (596)
Q Consensus       509 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~~  548 (596)
                      ...+......+.+++..||+.||++|||+++|++.|+...
T Consensus       404 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~  443 (454)
T 1qcf_A          404 MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY  443 (454)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence            1112223456788899999999999999999999998764

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=4.2e-41  Score=364.68  Aligned_cols=241  Identities=29%  Similarity=0.386  Sum_probs=199.4

Q ss_pred             hcCCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCC-eEEEE
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGN-ELVLV  361 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~-~~~lV  361 (596)
                      .++|...+.||+|+||.||+|.+. |+.||||+++...    ..+.|.+|+..+.+ ++|||||+++++|.+.. .+++|
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~----~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~~iv  265 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQ-LRHSNLVQLLGVIVEEKGGLYIV  265 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT----TSHHHHHHHHHHHT-CCCTTBCCEEEEEECTTSCEEEE
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch----HHHHHHHHHHHHHh-ccCCCEEEEEEEEEcCCCceEEE
Confidence            346777899999999999999884 7899999996432    45678999977655 89999999999987765 79999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc--
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP--  439 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~--  439 (596)
                      ||||++|+|.+++....  ...+++..++.++.||+.||+|||+   .+++||||||+|||++.++.+||+|||++..  
T Consensus       266 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  340 (450)
T 1k9a_A          266 TEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  340 (450)
T ss_dssp             EECCTTCBHHHHHHHHC--TTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence            99999999999998754  2347899999999999999999999   8999999999999999999999999998642  


Q ss_pred             ------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCCh-hHHHHHHHHHhcCCchhhccccccCcC
Q 047719          440 ------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGC-VIVDWVWNLRKKGKLLDAADFRLRGKF  511 (596)
Q Consensus       440 ------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~~~~  511 (596)
                            .++..|+|||.+.+..++.++|||||||+||||++ |+.||..... .+..    ....+.         +...
T Consensus       341 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~----~i~~~~---------~~~~  407 (450)
T 1k9a_A          341 STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP----RVEKGY---------KMDA  407 (450)
T ss_dssp             ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHH----HHHTTC---------CCCC
T ss_pred             ccccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH----HHHcCC---------CCCC
Confidence                  36788999999999999999999999999999999 9999976432 1111    111111         1112


Q ss_pred             CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          512 NRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       512 ~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                      +......+.+++..||+.||++|||++++++.|+..
T Consensus       408 p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i  443 (450)
T 1k9a_A          408 PDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI  443 (450)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            223345677888999999999999999999998753

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=3.4e-41  Score=338.94  Aligned_cols=244  Identities=27%  Similarity=0.356  Sum_probs=201.0

Q ss_pred             hcCCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      .++|...+.||+|+||.||+|...++..||||++.....   ...++.+|+..+.+ ++||||+++++++.+....++||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~   82 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM---SEDEFFQEAQTMMK-LSHPKLVKFYGVCSKEYPIYIVT   82 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB---CHHHHHHHHHHHHH-CCCTTBCCEEEEECSSSSEEEEE
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC---cHHHHHHHHHHHHh-CCCCCEeeEEEEEccCCceEEEE
Confidence            356778899999999999999988888999999964332   34568889977665 89999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc---
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP---  439 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~---  439 (596)
                      ||+++++|.+++....   ..+++..++.++.|++.||+|||+   .+++||||||+|||++.++.+||+|||.+..   
T Consensus        83 e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  156 (268)
T 3sxs_A           83 EYISNGCLLNYLRSHG---KGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD  156 (268)
T ss_dssp             ECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred             EccCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecch
Confidence            9999999999998653   248999999999999999999999   8999999999999999999999999997642   


Q ss_pred             ---------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhccccccC
Q 047719          440 ---------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRG  509 (596)
Q Consensus       440 ---------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  509 (596)
                               .+|..|+|||.+.+..++.++||||||+++|||++ |+.||......  +...........          
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~~~~~----------  224 (268)
T 3sxs_A          157 DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS--EVVLKVSQGHRL----------  224 (268)
T ss_dssp             TCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHHHHHHTTCCC----------
T ss_pred             hhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH--HHHHHHHcCCCC----------
Confidence                     25567999999998889999999999999999999 99999765331  111111111110          


Q ss_pred             cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Q 047719          510 KFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEA  548 (596)
Q Consensus       510 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~~  548 (596)
                      ..+......+.+++..||+.||++|||++|+++.|+...
T Consensus       225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~  263 (268)
T 3sxs_A          225 YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR  263 (268)
T ss_dssp             CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred             CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            011112245778889999999999999999999998754

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.9e-42  Score=363.96  Aligned_cols=247  Identities=24%  Similarity=0.319  Sum_probs=198.8

Q ss_pred             cCCCccceeecCCceEEEEEEcC------CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCe
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP------SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNE  357 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~  357 (596)
                      ++|...+.||+|+||.||+|.+.      ++..||||++.... .......+.+|+..+.+ ++|||||++++++.+...
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~-l~hpnIv~~~~~~~~~~~  148 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISK-FNHQNIVRCIGVSLQSLP  148 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC-CHHHHHHHHHHHHHHHH-CCCTTBCCEEEEECSSSS
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc-ChhhHHHHHHHHHHHHh-CCCCCCCeEEEEEecCCC
Confidence            45778899999999999999843      36689999996432 33345568889866655 899999999999999999


Q ss_pred             EEEEEecCCCCCHHHHhhhCCC---CCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCC---ceEE
Q 047719          358 LVLVYEYLPNGSLDKILHNNSS---SSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEF---NAKL  431 (596)
Q Consensus       358 ~~lV~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~---~~kl  431 (596)
                      .++||||+++|+|.+++.....   ....+++.+++.++.||+.||+|||+   .+|+||||||+|||++.++   .+||
T Consensus       149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL  225 (367)
T 3l9p_A          149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKI  225 (367)
T ss_dssp             CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEE
Confidence            9999999999999999986532   22358999999999999999999999   8999999999999999554   5999


Q ss_pred             ccCCCcc-------------cCCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcC
Q 047719          432 GDFEATI-------------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKG  497 (596)
Q Consensus       432 ~Dfg~~~-------------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~  497 (596)
                      +|||++.             ..||+.|+|||.+.+..++.++|||||||++|||++ |+.||......  +..... ..+
T Consensus       226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~--~~~~~i-~~~  302 (367)
T 3l9p_A          226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--EVLEFV-TSG  302 (367)
T ss_dssp             CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHHHHH-HTT
T ss_pred             CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHH-HcC
Confidence            9998763             246889999999999999999999999999999998 99999875431  111111 111


Q ss_pred             CchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          498 KLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       498 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                      ..         ...+......+.+|+..||+.||++|||+.+|++.|+..
T Consensus       303 ~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          303 GR---------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             CC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CC---------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            11         111122234577888999999999999999999998754

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.8e-40  Score=344.02  Aligned_cols=240  Identities=26%  Similarity=0.314  Sum_probs=192.2

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      ++|...+.||+|+||.||+|... +++.||||++..... ....+.+.+|+..+.. ++||||+++++++.+.+..|+||
T Consensus         7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~-l~hpnIv~~~~~~~~~~~~~lv~   84 (323)
T 3tki_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKM-LNHENVVKFYGHRREGNIQYLFL   84 (323)
T ss_dssp             TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHH-CCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHh-CCCCCCCeEEEEEecCCeEEEEE
Confidence            46888899999999999999865 689999999964432 2234568888866654 89999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc----
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI----  438 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~----  438 (596)
                      ||+++|+|.+++....    .+++..++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++.    
T Consensus        85 e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  157 (323)
T 3tki_A           85 EYCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRY  157 (323)
T ss_dssp             ECCTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             EcCCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceecc
Confidence            9999999999997653    48999999999999999999999   899999999999999999999999999763    


Q ss_pred             ---------cCCCcccCCccccccCCC-CCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhcccccc
Q 047719          439 ---------PAGTMGYLAPEYVYSGVP-SEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLR  508 (596)
Q Consensus       439 ---------~~gt~~y~aPE~~~~~~~-t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  508 (596)
                               ..||+.|+|||.+.+..+ +.++|||||||++|||++|+.||.........+. ..........       
T Consensus       158 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~-~~~~~~~~~~-------  229 (323)
T 3tki_A          158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS-DWKEKKTYLN-------  229 (323)
T ss_dssp             TTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHH-HHHTTCTTST-------
T ss_pred             CCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHH-HHhcccccCC-------
Confidence                     358999999999987665 7899999999999999999999976433211111 1111111000       


Q ss_pred             CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          509 GKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       509 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                        ........+.+|+.+|++.||++|||++|+++
T Consensus       230 --~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          230 --PWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             --TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --ccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence              00122345667889999999999999999976

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.1e-41  Score=357.22  Aligned_cols=258  Identities=24%  Similarity=0.339  Sum_probs=205.2

Q ss_pred             CHHHHHHHhcCCCccceeecCCceEEEEEEc------CCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeee
Q 047719          275 ALTDIKQATLGFNKNRIVGEGASATVYKGSL------PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL  348 (596)
Q Consensus       275 ~~~el~~at~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l  348 (596)
                      ...+.+...++|...+.||+|+||.||+|.+      .+++.||||+++... .......+.+|+..+.+..+|||||++
T Consensus        13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            4455556678899999999999999999973      246789999996533 233445688999888774489999999


Q ss_pred             cceeeeCC-eEEEEEecCCCCCHHHHhhhCCCC-----------------------------------------------
Q 047719          349 QGWCCEGN-ELVLVYEYLPNGSLDKILHNNSSS-----------------------------------------------  380 (596)
Q Consensus       349 ~g~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~-----------------------------------------------  380 (596)
                      +++|.+.+ ..++||||+++|+|.+++......                                               
T Consensus        92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence            99998765 499999999999999999875421                                               


Q ss_pred             ---------------CcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc------
Q 047719          381 ---------------SIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP------  439 (596)
Q Consensus       381 ---------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~------  439 (596)
                                     ...+++..++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++..      
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  248 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD  248 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence                           1128999999999999999999999   8999999999999999999999999997642      


Q ss_pred             -------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcC
Q 047719          440 -------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKF  511 (596)
Q Consensus       440 -------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  511 (596)
                             .||..|+|||.+.+..++.++|||||||++|||++ |+.||......-  .+......+...         ..
T Consensus       249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~~~~~~~~---------~~  317 (359)
T 3vhe_A          249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRRLKEGTRM---------RA  317 (359)
T ss_dssp             CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--HHHHHHHHTCCC---------CC
T ss_pred             chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH--HHHHHHHcCCCC---------CC
Confidence                   36778999999999999999999999999999998 999997643211  111111111111         11


Q ss_pred             CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          512 NRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       512 ~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                      +......+.+++..||+.||++|||++|+++.|+..
T Consensus       318 ~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  353 (359)
T 3vhe_A          318 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  353 (359)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence            112234577888999999999999999999999753

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=3e-41  Score=366.06  Aligned_cols=245  Identities=24%  Similarity=0.366  Sum_probs=200.7

Q ss_pred             hcCCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      .++|...+.||+|+||.||+|.+.++..||||+++...   ...++|.+|+..+.+ ++||||+++++++.+ +..++||
T Consensus       183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~-l~hp~iv~~~~~~~~-~~~~iv~  257 (452)
T 1fmk_A          183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKK-LRHEKLVQLYAVVSE-EPIYIVT  257 (452)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS---SCHHHHHHHHHHHHH-CCCTTBCCEEEEECS-SSCEEEE
T ss_pred             hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC---CCHHHHHHHHHHHHh-CCCCCEeeEEEEEcC-CceEEEe
Confidence            45677789999999999999999888889999996433   234578999977765 899999999999876 6789999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc---
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP---  439 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~---  439 (596)
                      ||+++|+|.+++....  ...+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||++..   
T Consensus       258 e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  332 (452)
T 1fmk_A          258 EYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIED  332 (452)
T ss_dssp             CCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred             hhhcCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence            9999999999997532  1248999999999999999999999   8999999999999999999999999998753   


Q ss_pred             ---------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhccccccC
Q 047719          440 ---------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRG  509 (596)
Q Consensus       440 ---------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  509 (596)
                               .++..|+|||.+..+.++.++|||||||++|||++ |+.||......  +..... ..+.         +.
T Consensus       333 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~--~~~~~i-~~~~---------~~  400 (452)
T 1fmk_A          333 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVLDQV-ERGY---------RM  400 (452)
T ss_dssp             ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHH-HTTC---------CC
T ss_pred             CceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHHH-HcCC---------CC
Confidence                     24678999999999999999999999999999999 99999865321  111111 1111         11


Q ss_pred             cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Q 047719          510 KFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEAP  549 (596)
Q Consensus       510 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~~~  549 (596)
                      ..+......+.+++..||+.||++|||++++++.|+....
T Consensus       401 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~  440 (452)
T 1fmk_A          401 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  440 (452)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence            1222334567788999999999999999999999987653

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.9e-40  Score=338.95  Aligned_cols=250  Identities=24%  Similarity=0.337  Sum_probs=201.5

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCc-hhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNR-VECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      ++|...+.||+|+||.||++... ++..||+|++..... .....+.+.+|+..+. .++||||+++++++.+.+..++|
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~-~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSS-QLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHT-TCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHh-cCCCCCCceEEEeeeeCCeEEEE
Confidence            45778899999999999999864 588999999865432 2234456888886654 48999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc--
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP--  439 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~--  439 (596)
                      |||+++|+|.+++....    .+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||.+..  
T Consensus        90 ~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  162 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESHG----PLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS  162 (294)
T ss_dssp             EECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred             EeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence            99999999999998754    48999999999999999999999   8999999999999999999999999997642  


Q ss_pred             ----------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccC
Q 047719          440 ----------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRG  509 (596)
Q Consensus       440 ----------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  509 (596)
                                .||+.|+|||.+.+..++.++|||||||++|||++|+.||......  .......... ... .......
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~--~~~~~~~~~~-~~~-~~~~~~~  238 (294)
T 4eqm_A          163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV--SIAIKHIQDS-VPN-VTTDVRK  238 (294)
T ss_dssp             ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH--HHHHHHHSSC-CCC-HHHHSCT
T ss_pred             cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHhhcc-CCC-cchhccc
Confidence                      4899999999999999999999999999999999999999875421  1111111111 111 0111112


Q ss_pred             cCCHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHhcCCC
Q 047719          510 KFNRKEMERMLMVGLSCVHPNHEKRP-SVKEAARILKGEAP  549 (596)
Q Consensus       510 ~~~~~~~~~l~~l~~~C~~~dp~~RP-s~~ev~~~L~~~~~  549 (596)
                          +....+.+++.+|++.||++|| +++++.+.|+....
T Consensus       239 ----~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~  275 (294)
T 4eqm_A          239 ----DIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH  275 (294)
T ss_dssp             ----TSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred             ----CCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence                2335677888999999999999 89999999986543

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=4.5e-40  Score=343.10  Aligned_cols=238  Identities=25%  Similarity=0.282  Sum_probs=195.9

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCc-hhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNR-VECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      ++|...+.||+|+||+||++... +|+.||||++++... .......+.+|+..+. .++||||+++++++...+.+|+|
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~-~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ-NTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHH-SCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHH-hCCCCcCcceEEEEEeCCEEEEE
Confidence            46888899999999999999875 589999999975432 2233456778886665 48999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc--
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP--  439 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~--  439 (596)
                      |||+++|+|.+++....    .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++..  
T Consensus        84 ~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  156 (337)
T 1o6l_A           84 MEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             EECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             EeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence            99999999999998653    48899999999999999999999   8999999999999999999999999997642  


Q ss_pred             ---------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCc
Q 047719          440 ---------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGK  510 (596)
Q Consensus       440 ---------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  510 (596)
                               .||+.|+|||.+.+..++.++|||||||++|||++|+.||......  ........ ..      ..    
T Consensus       157 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~i~~-~~------~~----  223 (337)
T 1o6l_A          157 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--RLFELILM-EE------IR----  223 (337)
T ss_dssp             CTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHH-CC------CC----
T ss_pred             cCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH--HHHHHHHc-CC------CC----
Confidence                     4789999999999999999999999999999999999999765421  11111111 11      11    


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 047719          511 FNRKEMERMLMVGLSCVHPNHEKRP-----SVKEAAR  542 (596)
Q Consensus       511 ~~~~~~~~l~~l~~~C~~~dp~~RP-----s~~ev~~  542 (596)
                      ++......+.+++..|++.||++||     +++|+++
T Consensus       224 ~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          224 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence            1122234567788899999999999     8999876

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=3.7e-40  Score=350.66  Aligned_cols=242  Identities=26%  Similarity=0.323  Sum_probs=195.5

Q ss_pred             cCCCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      ++|...++||+|+||+||+++... ++.||||++++.... ......+..|...+.+..+|||||++++++.+.+.+|+|
T Consensus        52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV  131 (396)
T 4dc2_A           52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV  131 (396)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence            468888999999999999998764 788999999764332 233455778887776656999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc--
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP--  439 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~--  439 (596)
                      |||+++|+|..++....    .+++..+..++.||+.||+|||+   .+|+||||||+||||+.++.+||+|||++..  
T Consensus       132 ~E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~~  204 (396)
T 4dc2_A          132 IEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  204 (396)
T ss_dssp             EECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEcCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence            99999999999998754    48999999999999999999999   8999999999999999999999999997642  


Q ss_pred             ---------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCCh------hHHHHHHHHHhcCCchhhcc
Q 047719          440 ---------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGC------VIVDWVWNLRKKGKLLDAAD  504 (596)
Q Consensus       440 ---------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~------~~~~~~~~~~~~~~~~~~~d  504 (596)
                               +||+.|+|||.+.+..++.++|||||||++|||++|+.||.....      ...+.+.........     
T Consensus       205 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-----  279 (396)
T 4dc2_A          205 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-----  279 (396)
T ss_dssp             CTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC-----
T ss_pred             cCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc-----
Confidence                     589999999999999999999999999999999999999964321      011112222111111     


Q ss_pred             ccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHH
Q 047719          505 FRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSV------KEAAR  542 (596)
Q Consensus       505 ~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~------~ev~~  542 (596)
                           .++......+.+|+..||+.||++||++      +|+++
T Consensus       280 -----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~  318 (396)
T 4dc2_A          280 -----RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  318 (396)
T ss_dssp             -----CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred             -----CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence                 1222233457788899999999999985      56654

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=3.5e-41  Score=338.46  Aligned_cols=246  Identities=18%  Similarity=0.313  Sum_probs=199.1

Q ss_pred             cCCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeC--CeEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG--NELVLV  361 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~--~~~~lV  361 (596)
                      ++|...+.||+|+||.||+|.. +++.||||++..........+.+.+|+..+ +.++||||+++++++.+.  ...++|
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l-~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRL-RIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGG-CCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHH-HhcCCCchhheEEEEccCCCCCeEee
Confidence            4577889999999999999998 488999999976554455556788898555 558999999999999887  788999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCC--eEEccCCCCceeecCCCceEEccCCCc--
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQ--IIHRDVKACNILLDAEFNAKLGDFEAT--  437 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~--ivHrDlkp~NiLl~~~~~~kl~Dfg~~--  437 (596)
                      |||+++|+|.+++....  ...+++..++.++.||+.||+|||+   .+  ++||||||+|||++.++.++|+||+..  
T Consensus        88 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~  162 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEGT--NFVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFS  162 (271)
T ss_dssp             EECCTTCBHHHHHHSCS--SCCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred             ecccCCCcHHHHHhhcc--cCCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceee
Confidence            99999999999998754  2358999999999999999999998   77  999999999999999999999988654  


Q ss_pred             ----ccCCCcccCCccccccCCCCC---ccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCc
Q 047719          438 ----IPAGTMGYLAPEYVYSGVPSE---KTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGK  510 (596)
Q Consensus       438 ----~~~gt~~y~aPE~~~~~~~t~---~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  510 (596)
                          ...||+.|+|||.+.+..++.   ++|||||||++|||++|+.||......  +...........         ..
T Consensus       163 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~~~~---------~~  231 (271)
T 3kmu_A          163 FQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM--EIGMKVALEGLR---------PT  231 (271)
T ss_dssp             TSCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH--HHHHHHHHSCCC---------CC
T ss_pred             ecccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH--HHHHHHHhcCCC---------CC
Confidence                235899999999998765444   899999999999999999999865321  111122222111         11


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          511 FNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       511 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                      .+......+.+++..||+.||++|||++|+++.|+..
T Consensus       232 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l  268 (271)
T 3kmu_A          232 IPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM  268 (271)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence            1222334677888999999999999999999999754

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.8e-41  Score=370.44  Aligned_cols=245  Identities=27%  Similarity=0.360  Sum_probs=203.0

Q ss_pred             hcCCCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      ..+|...+.||+|+||.||+|.+.. +..||||+++...   ...++|.+|+..+.+ ++|||||+++++|.+...++||
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~-l~hpniv~l~~~~~~~~~~~lv  294 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKE-IKHPNLVQLLGVCTREPPFYII  294 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS---SCHHHHHHHHHHHHH-CCCTTBCCEEEEECSSSSCEEE
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc---cchHHHHHHHHHHHh-cCCCCEeeEEEEEecCCcEEEE
Confidence            4557788999999999999998765 8899999996432   235678999977765 8999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc--
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP--  439 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~--  439 (596)
                      ||||++|+|.++|.....  ..+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||++..  
T Consensus       295 ~E~~~~g~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  369 (495)
T 1opk_A          295 TEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMT  369 (495)
T ss_dssp             EECCTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred             EEccCCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceecc
Confidence            999999999999987542  358999999999999999999999   8999999999999999999999999998643  


Q ss_pred             ----------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhcccccc
Q 047719          440 ----------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLR  508 (596)
Q Consensus       440 ----------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  508 (596)
                                .++..|+|||.+....++.++|||||||+||||++ |+.||.......   +......+         .+
T Consensus       370 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~---~~~~~~~~---------~~  437 (495)
T 1opk_A          370 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYELLEKD---------YR  437 (495)
T ss_dssp             TCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHHHHTT---------CC
T ss_pred             CCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHcC---------CC
Confidence                      24568999999999999999999999999999999 999998653211   11111111         11


Q ss_pred             CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Q 047719          509 GKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEA  548 (596)
Q Consensus       509 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~~  548 (596)
                      ...+......+.+|+.+||+.||++|||++++++.|+...
T Consensus       438 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          438 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence            1222233456778889999999999999999999998754

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=4.8e-41  Score=350.02  Aligned_cols=253  Identities=26%  Similarity=0.406  Sum_probs=205.2

Q ss_pred             HHHhcCCCccceeecCCceEEEEEEcC------CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceee
Q 047719          280 KQATLGFNKNRIVGEGASATVYKGSLP------SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCC  353 (596)
Q Consensus       280 ~~at~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~  353 (596)
                      ....++|...+.||+|+||.||+|...      +++.||||+++... .......+.+|+..+.. ++||||++++++|.
T Consensus        43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~-l~hp~iv~~~~~~~  120 (343)
T 1luf_A           43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAE-FDNPNIVKLLGVCA  120 (343)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHT-CCCTTBCCEEEEEC
T ss_pred             EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHh-CCCCCEEEEEEEEc
Confidence            344677888999999999999999864      34789999996543 23345578889866655 89999999999999


Q ss_pred             eCCeEEEEEecCCCCCHHHHhhhCCCC--------------------CcccCHHHHHHHHHHHHHHHHHHHhccCCCeEE
Q 047719          354 EGNELVLVYEYLPNGSLDKILHNNSSS--------------------SIVLSWEKRLNIVLGVASALSYLHEECERQIIH  413 (596)
Q Consensus       354 ~~~~~~lV~E~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH  413 (596)
                      +.+..++||||+++|+|.+++......                    ...+++.+++.++.||++||+|||+   .+|+|
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH  197 (343)
T 1luf_A          121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVH  197 (343)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCC
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeec
Confidence            999999999999999999999874321                    1468999999999999999999999   89999


Q ss_pred             ccCCCCceeecCCCceEEccCCCcc-------------cCCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCC
Q 047719          414 RDVKACNILLDAEFNAKLGDFEATI-------------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPV  479 (596)
Q Consensus       414 rDlkp~NiLl~~~~~~kl~Dfg~~~-------------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~  479 (596)
                      |||||+|||++.++.+||+|||++.             ..+|..|+|||.+.+..++.++|||||||++|||++ |+.||
T Consensus       198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  277 (343)
T 1luf_A          198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY  277 (343)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence            9999999999999999999999753             246788999999999999999999999999999999 99999


Q ss_pred             CCCChhHHHHHHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Q 047719          480 DNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEAP  549 (596)
Q Consensus       480 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~~~  549 (596)
                      ......  +.. .....+...         ..+......+.+++..||+.||++||++.++++.|+....
T Consensus       278 ~~~~~~--~~~-~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~  335 (343)
T 1luf_A          278 YGMAHE--EVI-YYVRDGNIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  335 (343)
T ss_dssp             TTSCHH--HHH-HHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             CCCChH--HHH-HHHhCCCcC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence            765321  111 111222211         1112233467788899999999999999999999987543

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.8e-41  Score=355.81  Aligned_cols=250  Identities=25%  Similarity=0.365  Sum_probs=202.3

Q ss_pred             hcCCCccceeecCCceEEEEEEcC--------CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeee
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLP--------SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE  354 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~--------~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~  354 (596)
                      .++|...+.||+|+||.||+|...        .+..||||++.... .......+.+|+..+....+|||||+++++|.+
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  146 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ  146 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc-CHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence            356778899999999999999742        24579999996542 333456788999777664499999999999999


Q ss_pred             CCeEEEEEecCCCCCHHHHhhhCCCC------------CcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCcee
Q 047719          355 GNELVLVYEYLPNGSLDKILHNNSSS------------SIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNIL  422 (596)
Q Consensus       355 ~~~~~lV~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiL  422 (596)
                      .+..++||||+++|+|.+++......            ...+++.+++.++.||+.||+|||+   .+|+||||||+|||
T Consensus       147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIl  223 (382)
T 3tt0_A          147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVL  223 (382)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEE
T ss_pred             CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceEE
Confidence            99999999999999999999875421            2358999999999999999999999   89999999999999


Q ss_pred             ecCCCceEEccCCCccc-------------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHH
Q 047719          423 LDAEFNAKLGDFEATIP-------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVD  488 (596)
Q Consensus       423 l~~~~~~kl~Dfg~~~~-------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~  488 (596)
                      ++.++.+||+|||++..             .+|..|+|||.+.+..++.++|||||||++|||++ |+.||......  +
T Consensus       224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~--~  301 (382)
T 3tt0_A          224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--E  301 (382)
T ss_dssp             ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--H
T ss_pred             EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--H
Confidence            99999999999998642             25678999999999999999999999999999999 99999865321  1


Q ss_pred             HHHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Q 047719          489 WVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEA  548 (596)
Q Consensus       489 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~~  548 (596)
                      .. .....+...         ..+......+.+++..||+.||++|||++|+++.|+...
T Consensus       302 ~~-~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  351 (382)
T 3tt0_A          302 LF-KLLKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  351 (382)
T ss_dssp             HH-HHHHTTCCC---------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HH-HHHHcCCCC---------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            11 222222111         111122346778889999999999999999999997653

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=4.2e-41  Score=349.14  Aligned_cols=243  Identities=24%  Similarity=0.394  Sum_probs=192.2

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCC----EEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGG----AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNEL  358 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~----~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~  358 (596)
                      .+|...++||+|+||+||+|... +++    .||+|.+.... ......++.+|+..+.+ ++||||++++++|.+.. .
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~-~   91 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMAS-VDNPHVCRLLGICLTST-V   91 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHH-CCBTTBCCEEEEEESSS-E
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHh-CCCCCEeEEEEEEecCC-e
Confidence            45778899999999999999864 344    36888875322 23445678899966655 89999999999998754 8


Q ss_pred             EEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc
Q 047719          359 VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI  438 (596)
Q Consensus       359 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~  438 (596)
                      ++|+||+++|+|.+++....   ..+++..++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++.
T Consensus        92 ~~v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~  165 (327)
T 3poz_A           92 QLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAK  165 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHST---TSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred             EEEEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCccee
Confidence            89999999999999998754   258999999999999999999999   899999999999999999999999999753


Q ss_pred             c-------------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhcc
Q 047719          439 P-------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAAD  504 (596)
Q Consensus       439 ~-------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d  504 (596)
                      .             .+|..|+|||.+.+..++.++|||||||++|||++ |+.||.........   .....+.      
T Consensus       166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~---~~~~~~~------  236 (327)
T 3poz_A          166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---SILEKGE------  236 (327)
T ss_dssp             HHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---HHHHTTC------
T ss_pred             EccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHH---HHHHcCC------
Confidence            2             35778999999999999999999999999999999 99999865332111   1111111      


Q ss_pred             ccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          505 FRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       505 ~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                         ....+......+..++.+||+.||++||+++|+++.|+..
T Consensus       237 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~  276 (327)
T 3poz_A          237 ---RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  276 (327)
T ss_dssp             ---CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred             ---CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence               1111222345677888999999999999999999988754

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=7.8e-41  Score=339.08  Aligned_cols=242  Identities=25%  Similarity=0.358  Sum_probs=196.9

Q ss_pred             hcCCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      .++|...+.||+|+||.||++...++..||||++.....   ...++.+|+..+.. ++||||+++++++.+.+..++||
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~   98 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMN-LSHEKLVQLYGVCTKQRPIFIIT   98 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB---CHHHHHHHHHHHHT-CCCTTBCCEEEEECSSSSEEEEE
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC---CHHHHHHHHHHHhc-CCCCCEeeEEEEEecCCCeEEEE
Confidence            446777899999999999999998888999999965332   33568889866655 89999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc---
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP---  439 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~---  439 (596)
                      ||+++|+|.+++....   ..+++..++.++.|++.||+|||+   .+++||||||+|||++.++.+||+|||.+..   
T Consensus        99 e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  172 (283)
T 3gen_A           99 EYMANGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD  172 (283)
T ss_dssp             CCCTTCBHHHHHHCGG---GCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred             eccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEccccccccccc
Confidence            9999999999998632   248999999999999999999999   8999999999999999999999999997642   


Q ss_pred             ---------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhccccccC
Q 047719          440 ---------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRG  509 (596)
Q Consensus       440 ---------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  509 (596)
                               .+|..|+|||.+.+..++.++||||||+++|||++ |+.||......  +...... .+.         ..
T Consensus       173 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~-~~~---------~~  240 (283)
T 3gen_A          173 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ETAEHIA-QGL---------RL  240 (283)
T ss_dssp             HHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHHHHHH-TTC---------CC
T ss_pred             cccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh--HHHHHHh-ccc---------CC
Confidence                     35678999999998899999999999999999998 99999865431  1111111 110         01


Q ss_pred             cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          510 KFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       510 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                      ..+......+.+++..||+.||++|||++|+++.|+.
T Consensus       241 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~  277 (283)
T 3gen_A          241 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  277 (283)
T ss_dssp             CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence            1111123467788899999999999999999998874

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.6e-40  Score=336.64  Aligned_cols=251  Identities=22%  Similarity=0.289  Sum_probs=195.7

Q ss_pred             cCCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      ++|...+.||+|+||.||+|...+|+.||||++............+.+|+..+. .++||||+++++++...+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e   80 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILK-ELKHSNIVKLYDVIHTKKRLVLVFE   80 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGG-GCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHH-hcCCCCEeeeeeEEccCCeEEEEEE
Confidence            357788999999999999999877999999999765544445567888986554 5899999999999999999999999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc-----
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI-----  438 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~-----  438 (596)
                      |+++ +|.+++....   ..+++..+..++.||++||+|||+   .+|+||||||+|||++.++.+||+|||.+.     
T Consensus        81 ~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  153 (288)
T 1ob3_A           81 HLDQ-DLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIP  153 (288)
T ss_dssp             CCSE-EHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred             ecCC-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence            9975 9999997653   248899999999999999999999   899999999999999999999999999653     


Q ss_pred             ------cCCCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCChh-HHHHHHHHHhcCCchh--------h
Q 047719          439 ------PAGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV-IVDWVWNLRKKGKLLD--------A  502 (596)
Q Consensus       439 ------~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~-~~~~~~~~~~~~~~~~--------~  502 (596)
                            ..||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...... ................        .
T Consensus       154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T 1ob3_A          154 VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK  233 (288)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccc
Confidence                  247899999999876 45899999999999999999999999875431 1111111111110000        0


Q ss_pred             cccccc-------CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          503 ADFRLR-------GKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       503 ~d~~l~-------~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      .++...       ..........+.+++.+|++.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            000000       0011123356678889999999999999999876

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.5e-41  Score=345.02  Aligned_cols=252  Identities=26%  Similarity=0.367  Sum_probs=197.1

Q ss_pred             cCCCccceeecCCceEEEEEEc-----CCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeC--C
Q 047719          284 LGFNKNRIVGEGASATVYKGSL-----PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG--N  356 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~-----~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~--~  356 (596)
                      ++|...+.||+|+||.||++.+     .+++.||||++...  .....+.+.+|+..+.+ ++||||++++++|...  .
T Consensus        10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~   86 (295)
T 3ugc_A           10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKS-LQHDNIVKYKGVCYSAGRR   86 (295)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHT-CCCTTBCCEEEEECHHHHT
T ss_pred             HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHh-CCCCCEeeEEEEEecCCCC
Confidence            4577789999999999999984     25789999999643  23345578899966655 8999999999998654  4


Q ss_pred             eEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCC
Q 047719          357 ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEA  436 (596)
Q Consensus       357 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~  436 (596)
                      ..++||||+++|+|.+++....   ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+
T Consensus        87 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~  160 (295)
T 3ugc_A           87 NLKLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGL  160 (295)
T ss_dssp             SCEEEEECCTTCBHHHHHHHCG---GGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred             ceEEEEEeCCCCCHHHHHHhcc---cccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCcc
Confidence            6899999999999999998753   248999999999999999999999   8999999999999999999999999998


Q ss_pred             ccc--------------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcC-----
Q 047719          437 TIP--------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKG-----  497 (596)
Q Consensus       437 ~~~--------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~-----  497 (596)
                      +..              .++..|+|||.+.+..++.++|||||||++|||++|..|+..........   .....     
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~---~~~~~~~~~~  237 (295)
T 3ugc_A          161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM---IGNDKQGQMI  237 (295)
T ss_dssp             CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHH---HCTTCCTHHH
T ss_pred             cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhh---hcCccccchh
Confidence            753              25566999999999999999999999999999999999986532111110   00000     


Q ss_pred             --CchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          498 --KLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       498 --~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                        .+.+..........+......+.+++..||+.||++|||++|+++.|+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l  289 (295)
T 3ugc_A          238 VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI  289 (295)
T ss_dssp             HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence              00001111111122223345678889999999999999999999998753

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.3e-40  Score=341.31  Aligned_cols=251  Identities=23%  Similarity=0.274  Sum_probs=194.3

Q ss_pred             cCCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      ++|...+.||+|+||+||+|...+|+.||||++............+.+|+..+.+ ++||||+++++++.+....++|||
T Consensus        21 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~-l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKE-LHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             CEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHH-CCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             hhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHH-cCCCCEeeeeeEEccCCEEEEEEc
Confidence            4677889999999999999998889999999997554444445678889866655 899999999999999999999999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc----
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP----  439 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~----  439 (596)
                      |++ |+|.+++....   ..+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||.+..    
T Consensus       100 ~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  172 (311)
T 3niz_A          100 FME-KDLKKVLDENK---TGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIP  172 (311)
T ss_dssp             CCS-EEHHHHHHTCT---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred             CCC-CCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence            998 48988887653   248999999999999999999999   8999999999999999999999999997642    


Q ss_pred             -------CCCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCCh-hHHHHHHHHHhcCCchhhcc------
Q 047719          440 -------AGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGC-VIVDWVWNLRKKGKLLDAAD------  504 (596)
Q Consensus       440 -------~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~-~~~~~~~~~~~~~~~~~~~d------  504 (596)
                             .||..|+|||.+.+ ..++.++|||||||++|||++|+.||..... ....................      
T Consensus       173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  252 (311)
T 3niz_A          173 VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPL  252 (311)
T ss_dssp             CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHH
T ss_pred             cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccch
Confidence                   47899999999876 5689999999999999999999999976432 22222222211111100000      


Q ss_pred             -----ccccCcC-----CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          505 -----FRLRGKF-----NRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       505 -----~~l~~~~-----~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                           .......     .......+.+++..|++.||++|||++|+++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             HHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                 0000000     0112246778899999999999999999987

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.2e-40  Score=344.31  Aligned_cols=253  Identities=22%  Similarity=0.329  Sum_probs=192.7

Q ss_pred             HHHhcCCCccceeecCCceEEEEEEcCCCC----EEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeC
Q 047719          280 KQATLGFNKNRIVGEGASATVYKGSLPSGG----AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG  355 (596)
Q Consensus       280 ~~at~~f~~~~~LG~G~fG~Vy~~~~~~g~----~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~  355 (596)
                      ....++|...+.||+|+||.||+|......    .||||++..........+.+.+|+..+.. ++||||+++++++...
T Consensus        19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~~   97 (323)
T 3qup_A           19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKE-FDHPHVAKLVGVSLRS   97 (323)
T ss_dssp             BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTT-CCCTTBCCCCEEEECC
T ss_pred             ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHH-CCCCceehhhceeecc
Confidence            334567899999999999999999876532    79999997654444556678899966654 8999999999999887


Q ss_pred             CeE------EEEEecCCCCCHHHHhhhCC--CCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCC
Q 047719          356 NEL------VLVYEYLPNGSLDKILHNNS--SSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEF  427 (596)
Q Consensus       356 ~~~------~lV~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~  427 (596)
                      ...      ++||||+++|+|.+++....  .....+++..++.++.||+.||+|||+   .+|+||||||+|||++.++
T Consensus        98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~  174 (323)
T 3qup_A           98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDM  174 (323)
T ss_dssp             -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTS
T ss_pred             ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCC
Confidence            655      99999999999999996532  122358999999999999999999999   8999999999999999999


Q ss_pred             ceEEccCCCccc-------------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChh-HHHHHHH
Q 047719          428 NAKLGDFEATIP-------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCV-IVDWVWN  492 (596)
Q Consensus       428 ~~kl~Dfg~~~~-------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~-~~~~~~~  492 (596)
                      .+||+|||.+..             .++..|+|||.+.+..++.++|||||||++|||++ |+.||...... ...   .
T Consensus       175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~---~  251 (323)
T 3qup_A          175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYN---Y  251 (323)
T ss_dssp             CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH---H
T ss_pred             CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHH---H
Confidence            999999998643             25678999999999999999999999999999999 99999865331 111   1


Q ss_pred             HHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Q 047719          493 LRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEAP  549 (596)
Q Consensus       493 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~~~  549 (596)
                      . ..+..         ...+......+.+++..||+.||++|||+.++++.|+....
T Consensus       252 ~-~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~  298 (323)
T 3qup_A          252 L-IGGNR---------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG  298 (323)
T ss_dssp             H-HTTCC---------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             H-hcCCC---------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            1 11110         11122233567888999999999999999999999986543

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=6.1e-41  Score=344.64  Aligned_cols=248  Identities=24%  Similarity=0.385  Sum_probs=200.4

Q ss_pred             hcCCCccceeecCCceEEEEEEc------CCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCC
Q 047719          283 TLGFNKNRIVGEGASATVYKGSL------PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGN  356 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~  356 (596)
                      .++|...+.||+|+||.||++..      .++..||||++.... .....+.+.+|+..+. .++||||+++++++.+.+
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~~~~~   99 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLK-QVNHPHVIKLYGACSQDG   99 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHT-TCCCTTBCCEEEEECSSS
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHh-hCCCCceeeEEEEEecCC
Confidence            45678889999999999999975      235789999996433 2334566888986665 489999999999999999


Q ss_pred             eEEEEEecCCCCCHHHHhhhCCC--------------------CCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccC
Q 047719          357 ELVLVYEYLPNGSLDKILHNNSS--------------------SSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDV  416 (596)
Q Consensus       357 ~~~lV~E~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDl  416 (596)
                      ..++||||+++|+|.+++.....                    ....+++.+++.++.||++||+|||+   .+|+||||
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~di  176 (314)
T 2ivs_A          100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDL  176 (314)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCC
T ss_pred             ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCccccc
Confidence            99999999999999999987542                    12348999999999999999999999   89999999


Q ss_pred             CCCceeecCCCceEEccCCCccc-------------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCC
Q 047719          417 KACNILLDAEFNAKLGDFEATIP-------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDND  482 (596)
Q Consensus       417 kp~NiLl~~~~~~kl~Dfg~~~~-------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~  482 (596)
                      ||+|||++.++.+||+|||++..             .+|..|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus       177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  256 (314)
T 2ivs_A          177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI  256 (314)
T ss_dssp             SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999997642             35678999999998889999999999999999999 99999765


Q ss_pred             ChhHHHHHHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          483 GCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       483 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                      ....   +......+..         ...+......+.+++..||+.||++||++.|+++.|+..
T Consensus       257 ~~~~---~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~  309 (314)
T 2ivs_A          257 PPER---LFNLLKTGHR---------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM  309 (314)
T ss_dssp             CGGG---HHHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CHHH---HHHHhhcCCc---------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            3311   1111111111         111222335677888999999999999999999998753

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=9.1e-41  Score=336.19  Aligned_cols=242  Identities=27%  Similarity=0.419  Sum_probs=191.2

Q ss_pred             cCCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCch--hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRV--ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~--~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      .+|...+.||+|+||.||+|.. .++.||||++......  ....+.+.+|+..+.. ++||||+++++++.+.+..++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAM-LKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHH-CCCTTBCCEEEEECCC--CEEE
T ss_pred             hheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHh-cCCCCEeeEEEEEecCCceEEE
Confidence            4677889999999999999987 4889999998654322  2234567888866554 8999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCC---eEEccCCCCceeecC--------CCceE
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQ---IIHRDVKACNILLDA--------EFNAK  430 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~---ivHrDlkp~NiLl~~--------~~~~k  430 (596)
                      |||+++++|.+++...     .+++..++.++.|++.||+|||+   .+   ++||||||+|||++.        ++.+|
T Consensus        85 ~e~~~~~~L~~~~~~~-----~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~k  156 (271)
T 3dtc_A           85 MEFARGGPLNRVLSGK-----RIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKILK  156 (271)
T ss_dssp             EECCTTEEHHHHHTSS-----CCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEE
T ss_pred             EEcCCCCCHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcceE
Confidence            9999999999999643     48999999999999999999999   66   999999999999986        67899


Q ss_pred             EccCCCcc---------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchh
Q 047719          431 LGDFEATI---------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLD  501 (596)
Q Consensus       431 l~Dfg~~~---------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~  501 (596)
                      |+|||.+.         ..||..|+|||.+.+..++.++||||||+++|||++|+.||........  ........    
T Consensus       157 l~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~~~~----  230 (271)
T 3dtc_A          157 ITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV--AYGVAMNK----  230 (271)
T ss_dssp             ECCCCC-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH--HHHHHTSC----
T ss_pred             EccCCcccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHhhhcCC----
Confidence            99999864         3589999999999999999999999999999999999999987543211  11111111    


Q ss_pred             hccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          502 AADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       502 ~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                           .....+......+.+++..||+.||++|||++|+++.|+.
T Consensus       231 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~  270 (271)
T 3dtc_A          231 -----LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT  270 (271)
T ss_dssp             -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred             -----CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence                 1111122233567788899999999999999999999974

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.7e-40  Score=349.47  Aligned_cols=243  Identities=25%  Similarity=0.283  Sum_probs=196.2

Q ss_pred             hcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhc----ccchHHHHHHHHHhccCCCceeeecceeeeCCe
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVEC----ARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNE  357 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~----~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~  357 (596)
                      .+.|...+.||+|+||.||++... +|+.||||++.+......    ..+.+.+|+..+. .++||||+++++++.+...
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~-~l~hpnIv~l~~~~~~~~~   89 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR-QVLHPNIITLHDVYENRTD   89 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHT-TCCCTTBCCEEEEEECSSE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHH-hCCCcCCCcEEEEEEeCCE
Confidence            356888899999999999999875 589999999976443221    2456888986664 4899999999999999999


Q ss_pred             EEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCC----ceEEcc
Q 047719          358 LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEF----NAKLGD  433 (596)
Q Consensus       358 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~----~~kl~D  433 (596)
                      .++||||+++|+|.+++....    .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++    .+||+|
T Consensus        90 ~~lv~e~~~gg~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~D  162 (361)
T 2yab_A           90 VVLILELVSGGELFDFLAQKE----SLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLID  162 (361)
T ss_dssp             EEEEEECCCSCBHHHHHTTCS----CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred             EEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEe
Confidence            999999999999999997643    48999999999999999999999   8999999999999998876    799999


Q ss_pred             CCCcc----------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhc
Q 047719          434 FEATI----------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAA  503 (596)
Q Consensus       434 fg~~~----------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  503 (596)
                      ||++.          ..||+.|+|||.+.+..++.++|||||||++|||++|+.||.+....  +...... .... . .
T Consensus       163 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~--~~~~~i~-~~~~-~-~  237 (361)
T 2yab_A          163 FGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETLANIT-AVSY-D-F  237 (361)
T ss_dssp             CSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHHH-TTCC-C-C
T ss_pred             cCCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHH-hcCC-C-C
Confidence            99763          35899999999999989999999999999999999999999875321  1111111 1110 0 0


Q ss_pred             cccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          504 DFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       504 d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      +......    ....+.+++..|++.||++|||++|+++
T Consensus       238 ~~~~~~~----~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          238 DEEFFSQ----TSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             CHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CchhccC----CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            0000111    2345678889999999999999999875

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.6e-40  Score=344.89  Aligned_cols=242  Identities=21%  Similarity=0.251  Sum_probs=196.0

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchh----cccchHHHHHHHHHhccCCCceeeecceeeeCCeE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVE----CARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNEL  358 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~----~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~  358 (596)
                      +.|...+.||+|+||.||++... +|..||||++.......    .....+.+|+..+.. ++||||+++++++.+....
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE-IQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHH-CCCTTBCCEEEEEECSSEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHh-CCCCCCCcEEEEEEeCCEE
Confidence            45788899999999999999875 58999999997543322    134568899966655 8999999999999999999


Q ss_pred             EEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCC----ceEEccC
Q 047719          359 VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEF----NAKLGDF  434 (596)
Q Consensus       359 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~----~~kl~Df  434 (596)
                      ++||||+++|+|.+++....    .+++..++.++.||+.||.|||+   .+|+||||||+|||++.++    .+||+||
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df  162 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDF  162 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTSS----CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEEcCCCCCHHHHHHhcC----CcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence            99999999999999997643    48999999999999999999999   8999999999999999887    8999999


Q ss_pred             CCcc----------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhcc
Q 047719          435 EATI----------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAAD  504 (596)
Q Consensus       435 g~~~----------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d  504 (596)
                      |++.          ..||+.|+|||.+....++.++|||||||++|||++|+.||......  +...........  . .
T Consensus       163 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~~~~~~~~--~-~  237 (326)
T 2y0a_A          163 GLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETLANVSAVNYE--F-E  237 (326)
T ss_dssp             TTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHHHHTCCC--C-C
T ss_pred             CCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH--HHHHHHHhcCCC--c-C
Confidence            9763          24899999999999899999999999999999999999999765321  111111111100  0 0


Q ss_pred             ccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          505 FRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       505 ~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      .....    .....+.+++..|++.||++|||++|+++
T Consensus       238 ~~~~~----~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          238 DEYFS----NTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             HHHHT----TSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ccccc----cCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            00001    12345678889999999999999999987

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.9e-41  Score=363.75  Aligned_cols=254  Identities=20%  Similarity=0.248  Sum_probs=200.4

Q ss_pred             cCHHHHHHHhcCCCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecce
Q 047719          274 LALTDIKQATLGFNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGW  351 (596)
Q Consensus       274 ~~~~el~~at~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~  351 (596)
                      ..+.+++..+++|...++||+|+||+||+|.... ++.||||++.+.... ......+.+|...+.. ++||||++++++
T Consensus        64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~-~~hp~Iv~l~~~  142 (437)
T 4aw2_A           64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN-GDSKWITTLHYA  142 (437)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHH-SCTTTBCCEEEE
T ss_pred             chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHh-CCCCCEEEEEEE
Confidence            3456666778899999999999999999998765 788999999753322 2233457888866654 899999999999


Q ss_pred             eeeCCeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEE
Q 047719          352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKL  431 (596)
Q Consensus       352 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl  431 (596)
                      |.+.+.+|||||||++|+|.+++....   ..+++..+..++.||+.||+|||+   .+|+||||||+||||+.++.+||
T Consensus       143 ~~~~~~~~lV~Ey~~gg~L~~~l~~~~---~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL  216 (437)
T 4aw2_A          143 FQDDNNLYLVMDYYVGGDLLTLLSKFE---DRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRL  216 (437)
T ss_dssp             EECSSEEEEEECCCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEE
T ss_pred             EeeCCEEEEEEecCCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEE
Confidence            999999999999999999999998642   248999999999999999999999   89999999999999999999999


Q ss_pred             ccCCCcc------------cCCCcccCCccccc-----cCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHH
Q 047719          432 GDFEATI------------PAGTMGYLAPEYVY-----SGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLR  494 (596)
Q Consensus       432 ~Dfg~~~------------~~gt~~y~aPE~~~-----~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~  494 (596)
                      +|||++.            .+||+.|+|||++.     .+.++.++|||||||++|||++|+.||......  +......
T Consensus       217 ~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~--~~~~~i~  294 (437)
T 4aw2_A          217 ADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV--ETYGKIM  294 (437)
T ss_dssp             CCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHH
T ss_pred             cchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh--HHHHhhh
Confidence            9999762            36899999999987     467899999999999999999999999875421  1111111


Q ss_pred             hcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCC--CCCHHHHHH
Q 047719          495 KKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEK--RPSVKEAAR  542 (596)
Q Consensus       495 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~--RPs~~ev~~  542 (596)
                      ....  ...-+.....+    ...+.+|+.+|+..+|++  ||+++|+++
T Consensus       295 ~~~~--~~~~p~~~~~~----s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          295 NHKE--RFQFPTQVTDV----SENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             THHH--HCCCCSSCCCS----CHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             hccc--cccCCcccccC----CHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence            1000  00000000112    345667777888877777  999999987

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=3.3e-40  Score=346.07  Aligned_cols=245  Identities=24%  Similarity=0.280  Sum_probs=195.4

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCch---hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRV---ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELV  359 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~---~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~  359 (596)
                      +.|...+.||+|+||.||++... +++.||||++......   ....+.+.+|+..+.. ++||||+++++++.+.+..|
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM-LKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHH-CCCTTBCCEEEEEEETTEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHh-CCCCCCCcEEEEEEeCCEEE
Confidence            45788899999999999999865 5899999998643221   1134568889866655 89999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCc---eEEccCCC
Q 047719          360 LVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFN---AKLGDFEA  436 (596)
Q Consensus       360 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~---~kl~Dfg~  436 (596)
                      +||||+++|+|.+++.........+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            9999999999999887543223458999999999999999999999   89999999999999987655   99999997


Q ss_pred             cc-----------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccc
Q 047719          437 TI-----------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADF  505 (596)
Q Consensus       437 ~~-----------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~  505 (596)
                      +.           ..||+.|+|||.+.+..++.++|||||||++|||++|+.||......+..    ....+...  ..+
T Consensus       180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~----~i~~~~~~--~~~  253 (351)
T 3c0i_A          180 AIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFE----GIIKGKYK--MNP  253 (351)
T ss_dssp             CEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHH----HHHHTCCC--CCH
T ss_pred             eeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHH----HHHcCCCC--CCc
Confidence            53           25899999999999989999999999999999999999999875322111    11111110  000


Q ss_pred             cccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          506 RLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       506 ~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      .....    ....+.+++.+||+.||++|||+.|+++
T Consensus       254 ~~~~~----~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          254 RQWSH----ISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             HHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccc----CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            00011    2346778889999999999999999986

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=3.1e-40  Score=350.86  Aligned_cols=254  Identities=21%  Similarity=0.288  Sum_probs=196.0

Q ss_pred             hcCCCccceeecC--CceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEE
Q 047719          283 TLGFNKNRIVGEG--ASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELV  359 (596)
Q Consensus       283 t~~f~~~~~LG~G--~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~  359 (596)
                      ..+|...++||+|  +||.||++... +|+.||||++............+.+|+..+.. ++|||||++++++.+.+..|
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~  102 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKL-FNHPNIVPYRATFIADNELW  102 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHH-CCCTTBCCEEEEEEETTEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHh-CCCCCCCcEeEEEEECCEEE
Confidence            3457888999999  99999999876 58999999997654444455667788866554 89999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc-
Q 047719          360 LVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI-  438 (596)
Q Consensus       360 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~-  438 (596)
                      +|||||++|+|.+++.....  ..+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||.+. 
T Consensus       103 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~  177 (389)
T 3gni_B          103 VVTSFMAYGSAKDLICTHFM--DGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLS  177 (389)
T ss_dssp             EEEECCTTCBHHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             EEEEccCCCCHHHHHhhhcc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEccccccee
Confidence            99999999999999987532  248999999999999999999999   899999999999999999999999997542 


Q ss_pred             -----------------cCCCcccCCcccccc--CCCCCccceeehhHHHHHHHhCCCCCCCCChh--HHHHHHHHHh--
Q 047719          439 -----------------PAGTMGYLAPEYVYS--GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV--IVDWVWNLRK--  495 (596)
Q Consensus       439 -----------------~~gt~~y~aPE~~~~--~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~--~~~~~~~~~~--  495 (596)
                                       ..||..|+|||.+.+  ..++.++|||||||++|||++|+.||.+....  +.........  
T Consensus       178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  257 (389)
T 3gni_B          178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL  257 (389)
T ss_dssp             CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------
T ss_pred             eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcc
Confidence                             257888999999987  57899999999999999999999999764321  1100000000  


Q ss_pred             --c-----CC-------------chhhc---cc------cccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          496 --K-----GK-------------LLDAA---DF------RLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       496 --~-----~~-------------~~~~~---d~------~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                        .     ..             ..+..   ..      .............+.+|+.+||+.||++|||++|+++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~  333 (389)
T 3gni_B          258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN  333 (389)
T ss_dssp             ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence              0     00             00000   00      0000112223456888999999999999999999986

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=3e-40  Score=346.60  Aligned_cols=240  Identities=24%  Similarity=0.274  Sum_probs=196.1

Q ss_pred             hcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCc-hhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEE
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNR-VECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVL  360 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~l  360 (596)
                      .++|...++||+|+||+||+++.. +++.||||++++... .......+.+|...+....+||||+++++++.+.+.+|+
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            467888999999999999999865 489999999975422 223344567787677664589999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc-
Q 047719          361 VYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP-  439 (596)
Q Consensus       361 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~-  439 (596)
                      ||||+++|+|.+++....    .+++..+..++.||+.||+|||+   .+|+||||||+||||+.++.+||+|||++.. 
T Consensus       102 v~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~~  174 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQKSR----RFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG  174 (353)
T ss_dssp             EEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             EEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceeec
Confidence            999999999999998754    48999999999999999999999   8999999999999999999999999997642 


Q ss_pred             ----------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccC
Q 047719          440 ----------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRG  509 (596)
Q Consensus       440 ----------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  509 (596)
                                +||+.|+|||.+.+..++.++|||||||++|||++|+.||......  +....... +..          
T Consensus       175 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--~~~~~i~~-~~~----------  241 (353)
T 3txo_A          175 ICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED--DLFEAILN-DEV----------  241 (353)
T ss_dssp             CC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHH-CCC----------
T ss_pred             ccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH--HHHHHHHc-CCC----------
Confidence                      4899999999999888999999999999999999999999875431  11111111 111          


Q ss_pred             cCCHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHH
Q 047719          510 KFNRKEMERMLMVGLSCVHPNHEKRPSV------KEAAR  542 (596)
Q Consensus       510 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~------~ev~~  542 (596)
                      .++......+.+++..|++.||++||++      +|+++
T Consensus       242 ~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          242 VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence            1112233456778889999999999998      67765

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.1e-40  Score=339.52  Aligned_cols=246  Identities=28%  Similarity=0.443  Sum_probs=196.1

Q ss_pred             cCCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      ++|...+.||+|+||.||++.. .++.||||++...    ...+.+.+|+..+.+ ++||||+++++++.+  ..++|||
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~----~~~~~~~~E~~~l~~-l~hp~iv~~~~~~~~--~~~lv~e   79 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE----SERKAFIVELRQLSR-VNHPNIVKLYGACLN--PVCLVME   79 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST----THHHHHHHHHHHHHH-CCCTTBCCEEEBCTT--TTEEEEE
T ss_pred             hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh----hHHHHHHHHHHHHhc-CCCCCcCeEEEEEcC--CcEEEEE
Confidence            3577789999999999999987 4788999998532    234568899976655 899999999999874  4799999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCc-eEEccCCCcc----
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFN-AKLGDFEATI----  438 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~-~kl~Dfg~~~----  438 (596)
                      |+++|+|.+++..... ...+++..++.++.|+++||+|||+...++|+||||||+|||++.++. +||+|||.+.    
T Consensus        80 ~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~  158 (307)
T 2eva_A           80 YAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT  158 (307)
T ss_dssp             CCTTCBHHHHHHCSSS-EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred             cCCCCCHHHHHhccCC-CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence            9999999999986542 224788999999999999999999854468999999999999998886 7999999763    


Q ss_pred             ----cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHH
Q 047719          439 ----PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRK  514 (596)
Q Consensus       439 ----~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  514 (596)
                          ..||..|+|||.+.+..++.++|||||||++|||++|+.||...........+.......      +.....+   
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~------~~~~~~~---  229 (307)
T 2eva_A          159 HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR------PPLIKNL---  229 (307)
T ss_dssp             ------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCC------CCCBTTC---
T ss_pred             ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCC------CCccccc---
Confidence                358999999999999999999999999999999999999998644333222222222111      1111222   


Q ss_pred             HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Q 047719          515 EMERMLMVGLSCVHPNHEKRPSVKEAARILKGEA  548 (596)
Q Consensus       515 ~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~~  548 (596)
                       ...+.+++.+||+.||++|||++++++.|+...
T Consensus       230 -~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  262 (307)
T 2eva_A          230 -PKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM  262 (307)
T ss_dssp             -CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred             -CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence             345778889999999999999999999987643

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.8e-40  Score=349.63  Aligned_cols=243  Identities=22%  Similarity=0.264  Sum_probs=197.9

Q ss_pred             hcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      .++|...+.||+|+||.||++... +|..||||++..........+.+.+|+..+.. ++||||+++++++.+.+..|+|
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~-l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK-LQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHH-CCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHh-CCCCCCCeEEEEEEeCCEEEEE
Confidence            456888999999999999999865 58999999997655444455678889966655 8999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCC---CceEEccCCCcc
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAE---FNAKLGDFEATI  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~---~~~kl~Dfg~~~  438 (596)
                      |||+++|+|.+++....    .+++..+..++.||+.||+|||+   .+|+||||||+|||++.+   +.+||+|||++.
T Consensus       107 ~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~  179 (362)
T 2bdw_A          107 FDLVTGGELFEDIVARE----FYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAI  179 (362)
T ss_dssp             ECCCCSCBHHHHHTTCS----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred             EecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence            99999999999997643    48999999999999999999999   899999999999999865   459999999764


Q ss_pred             ----------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhcccccc
Q 047719          439 ----------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLR  508 (596)
Q Consensus       439 ----------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  508 (596)
                                ..||+.|+|||.+.+..++.++|||||||++|||++|+.||......  ...... ..+... ...    
T Consensus       180 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~--~~~~~i-~~~~~~-~~~----  251 (362)
T 2bdw_A          180 EVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--RLYAQI-KAGAYD-YPS----  251 (362)
T ss_dssp             CCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHH-HHTCCC-CCT----
T ss_pred             EecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHH-HhCCCC-CCc----
Confidence                      35899999999999989999999999999999999999999765431  111111 111110 000    


Q ss_pred             CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          509 GKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       509 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                       .........+.+++.+||+.||++||++.|+++
T Consensus       252 -~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          252 -PEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             -TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             -ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence             000112345678889999999999999999976

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-39  Score=336.85  Aligned_cols=259  Identities=24%  Similarity=0.284  Sum_probs=204.5

Q ss_pred             cCCCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCC--eEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGN--ELVL  360 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~--~~~l  360 (596)
                      +.|...++||+|+||.||+|.... ++.||||++..... ......+.+|+..+.+ ++||||+++++++....  ..++
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~~~l   86 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKK-LNHKNIVKLFAIEEETTTRHKVL   86 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHH-CCCTTBCCEEEEEECTTTCCEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHh-cCCCCcceEEEEeecCCCceEEE
Confidence            457788999999999999998764 89999999964322 2334567888866655 89999999999998765  7899


Q ss_pred             EEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceee----cCCCceEEccCCC
Q 047719          361 VYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILL----DAEFNAKLGDFEA  436 (596)
Q Consensus       361 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl----~~~~~~kl~Dfg~  436 (596)
                      ||||+++|+|.+++..... ...+++..++.++.||+.||+|||+   .+|+||||||+|||+    +.++.+||+|||+
T Consensus        87 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~  162 (319)
T 4euu_A           87 IMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (319)
T ss_dssp             EEECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred             EEeCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence            9999999999999986532 2238999999999999999999999   899999999999999    8888899999997


Q ss_pred             ccc----------CCCcccCCccccc--------cCCCCCccceeehhHHHHHHHhCCCCCCCCCh--hHHHHHHHHHhc
Q 047719          437 TIP----------AGTMGYLAPEYVY--------SGVPSEKTDVYSFGVVALEVAAGKSPVDNDGC--VIVDWVWNLRKK  496 (596)
Q Consensus       437 ~~~----------~gt~~y~aPE~~~--------~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~--~~~~~~~~~~~~  496 (596)
                      +..          .||..|+|||.+.        ...++.++|||||||++|||++|+.||.....  ...+........
T Consensus       163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (319)
T 4euu_A          163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (319)
T ss_dssp             CEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred             ceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence            642          4899999999886        46789999999999999999999999964321  112222222221


Q ss_pred             CC---chhh-------c----cccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Q 047719          497 GK---LLDA-------A----DFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEA  548 (596)
Q Consensus       497 ~~---~~~~-------~----d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~~  548 (596)
                      ..   ....       .    ...............+..++..|++.||++|||++|+++....+.
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~  308 (319)
T 4euu_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (319)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred             CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence            11   0000       0    111223456777888899999999999999999999999887654

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=3.1e-40  Score=356.78  Aligned_cols=244  Identities=21%  Similarity=0.229  Sum_probs=198.1

Q ss_pred             HhcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEE
Q 047719          282 ATLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVL  360 (596)
Q Consensus       282 at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~l  360 (596)
                      -.++|...+.||+|+||.||++... +|+.||+|++..........+.+.+|+..+.. ++|||||++++++.+.+..|+
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~-l~hpnIv~l~~~~~~~~~~~l   87 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRL-LKHPNIVRLHDSISEEGHHYL   87 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHH-CCBTTBCCEEEEEECSSEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHh-CCCcCCCeEEEEEEECCEEEE
Confidence            3456888999999999999999764 58899999998765555556678899966655 899999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeec---CCCceEEccCCCc
Q 047719          361 VYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLD---AEFNAKLGDFEAT  437 (596)
Q Consensus       361 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~---~~~~~kl~Dfg~~  437 (596)
                      ||||+++|+|.+++....    .+++..+..++.||+.||+|||+   .+|+||||||+|||++   .++.+||+|||++
T Consensus        88 v~E~~~gg~L~~~i~~~~----~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a  160 (444)
T 3soa_A           88 IFDLVTGGELFEDIVARE----YYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLA  160 (444)
T ss_dssp             EECCCBCCBHHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSC
T ss_pred             EEEeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCcee
Confidence            999999999999998754    48999999999999999999999   8999999999999998   4578999999976


Q ss_pred             c-----------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhcccc
Q 047719          438 I-----------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFR  506 (596)
Q Consensus       438 ~-----------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~  506 (596)
                      .           ..||+.|+|||.+.+..++.++|||||||++|||++|+.||......  +.. .....+.. ..    
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~--~~~-~~i~~~~~-~~----  232 (444)
T 3soa_A          161 IEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH--RLY-QQIKAGAY-DF----  232 (444)
T ss_dssp             BCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHH-HHHHHTCC-CC----
T ss_pred             EEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH--HHH-HHHHhCCC-CC----
Confidence            3           35899999999999989999999999999999999999999765421  111 11111111 00    


Q ss_pred             ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          507 LRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       507 l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                       ...........+.+++..|++.||++|||+.|+++
T Consensus       233 -~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          233 -PSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             -CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             -CccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence             00011122345778889999999999999999987

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=5.4e-40  Score=333.56  Aligned_cols=245  Identities=26%  Similarity=0.412  Sum_probs=196.2

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhc-----ccchHHHHHHHHHhccCCCceeeecceeeeCCe
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVEC-----ARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNE  357 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~-----~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~  357 (596)
                      ++|...+.||+|+||.||+|... +++.||||++........     ..+.+.+|+..+. .++||||+++++++.+.. 
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS-NLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHT-TCCCTTBCCEEEEETTTT-
T ss_pred             ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHH-hCCCCCchhhheeecCCC-
Confidence            56788899999999999999875 589999999864332211     1256888986665 489999999999997765 


Q ss_pred             EEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCC--eEEccCCCCceeecCCCc-----eE
Q 047719          358 LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQ--IIHRDVKACNILLDAEFN-----AK  430 (596)
Q Consensus       358 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~--ivHrDlkp~NiLl~~~~~-----~k  430 (596)
                       ++||||+++|+|.+++....   ..+++..++.++.|++.||+|||+   .+  ++||||||+|||++.++.     +|
T Consensus        97 -~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~k  169 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDKA---HPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAK  169 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred             -eEEEEecCCCCHHHHHhccc---CCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEE
Confidence             79999999999999997653   358999999999999999999999   78  999999999999988776     99


Q ss_pred             EccCCCcc--------cCCCcccCCccccc--cCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCch
Q 047719          431 LGDFEATI--------PAGTMGYLAPEYVY--SGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLL  500 (596)
Q Consensus       431 l~Dfg~~~--------~~gt~~y~aPE~~~--~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~  500 (596)
                      |+|||.+.        ..||..|+|||.+.  ...++.++|||||||++|||++|+.||...................  
T Consensus       170 l~Dfg~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--  247 (287)
T 4f0f_A          170 VADFGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL--  247 (287)
T ss_dssp             ECCCTTCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCC--
T ss_pred             eCCCCccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCC--
Confidence            99999764        35899999999984  4567899999999999999999999998654332222222222211  


Q ss_pred             hhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          501 DAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       501 ~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                             ....+......+.+++..||+.||++|||++|+++.|+.
T Consensus       248 -------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          248 -------RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             -------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             -------CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence                   111222334567888899999999999999999999975

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.4e-40  Score=344.67  Aligned_cols=240  Identities=21%  Similarity=0.264  Sum_probs=194.0

Q ss_pred             hcCCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCC--CceeeecceeeeCCeEEE
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRH--KNLVQLQGWCCEGNELVL  360 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H--~niv~l~g~~~~~~~~~l  360 (596)
                      .+.|...+.||+|+||.||++...+++.||||++............+.+|+..+.. ++|  +||+++++++.+....++
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~-l~~~~~~iv~~~~~~~~~~~~~l   86 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK-LQQHSDKIIRLYDYEITDQYIYM   86 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHH-HTTTCTTBCCEEEEEECSSEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHh-hhhcCCceEEEeeeEeeCCEEEE
Confidence            34578889999999999999998889999999997655545555678899977765 665  999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc--
Q 047719          361 VYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI--  438 (596)
Q Consensus       361 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~--  438 (596)
                      ||| +.+|+|.+++....    .+++.++..++.||+.||+|||+   .+|+||||||+|||++ ++.+||+|||++.  
T Consensus        87 v~e-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~  157 (343)
T 3dbq_A           87 VME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQM  157 (343)
T ss_dssp             EEC-CCSEEHHHHHHHSC----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred             EEe-CCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence            999 56889999998754    48999999999999999999999   8999999999999997 5789999999764  


Q ss_pred             -----------cCCCcccCCcccccc-----------CCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhc
Q 047719          439 -----------PAGTMGYLAPEYVYS-----------GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKK  496 (596)
Q Consensus       439 -----------~~gt~~y~aPE~~~~-----------~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~  496 (596)
                                 ..||+.|+|||.+.+           ..++.++|||||||++|||++|+.||.......... ....  
T Consensus       158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-~~~~--  234 (343)
T 3dbq_A          158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL-HAII--  234 (343)
T ss_dssp             ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH-HHHH--
T ss_pred             CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHH-HHHh--
Confidence                       248999999999864           678999999999999999999999997643322111 1111  


Q ss_pred             CCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          497 GKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       497 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                             +......++......+.+++..||+.||++|||+.|+++
T Consensus       235 -------~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~  273 (343)
T 3dbq_A          235 -------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  273 (343)
T ss_dssp             -------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -------cCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence                   111111222222345678889999999999999999987

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.8e-40  Score=343.38  Aligned_cols=239  Identities=23%  Similarity=0.327  Sum_probs=190.3

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCC------
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGN------  356 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~------  356 (596)
                      ++|...+.||+|+||.||+|... +|+.||||++.... .....+.+.+|+..+. .++|||||+++++|.+..      
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~-~l~hpniv~~~~~~~~~~~~~~~~   83 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALA-KLEHPGIVRYFNAWLETPPEKWQE   83 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHT-SCCCTTBCCEEEEEEECCSCHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHH-hCCCCCEeeEEEEEEEeccchhhh
Confidence            46788899999999999999876 68999999997543 2334567889996665 489999999999986643      


Q ss_pred             ---------------------------------------------------eEEEEEecCCCCCHHHHhhhCCCCCcccC
Q 047719          357 ---------------------------------------------------ELVLVYEYLPNGSLDKILHNNSSSSIVLS  385 (596)
Q Consensus       357 ---------------------------------------------------~~~lV~E~~~~gsL~~~l~~~~~~~~~l~  385 (596)
                                                                         ..++||||+++|+|.+++..... ....+
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~  162 (332)
T 3qd2_B           84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDRE  162 (332)
T ss_dssp             HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSC
T ss_pred             hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchh
Confidence                                                               38999999999999999987643 33467


Q ss_pred             HHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc-----------------------cCCC
Q 047719          386 WEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI-----------------------PAGT  442 (596)
Q Consensus       386 ~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~-----------------------~~gt  442 (596)
                      +..++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++.                       ..||
T Consensus       163 ~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt  239 (332)
T 3qd2_B          163 HGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT  239 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred             hHHHHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence            88899999999999999999   899999999999999999999999999753                       2489


Q ss_pred             cccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHHHHHHHHHH
Q 047719          443 MGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMV  522 (596)
Q Consensus       443 ~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l  522 (596)
                      +.|+|||.+.+..++.++|||||||++|||++|..|+...    .. ...........         .........+.++
T Consensus       240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~----~~-~~~~~~~~~~~---------~~~~~~~~~~~~l  305 (332)
T 3qd2_B          240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER----VR-IITDVRNLKFP---------LLFTQKYPQEHMM  305 (332)
T ss_dssp             GGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH----HH-HHHHHHTTCCC---------HHHHHHCHHHHHH
T ss_pred             cCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH----HH-HHHHhhccCCC---------cccccCChhHHHH
Confidence            9999999999999999999999999999999987764321    11 11111111110         1112333556788


Q ss_pred             HHHcCCCCCCCCCCHHHHHH
Q 047719          523 GLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       523 ~~~C~~~dp~~RPs~~ev~~  542 (596)
                      +..||+.||++|||++|+++
T Consensus       306 i~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          306 VQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHHHCSSGGGSCCHHHHHH
T ss_pred             HHHHccCCCCcCCCHHHHhh
Confidence            89999999999999999986

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-40  Score=346.09  Aligned_cols=252  Identities=24%  Similarity=0.363  Sum_probs=200.0

Q ss_pred             HhcCCCccceeecCCceEEEEEEc------CCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeC
Q 047719          282 ATLGFNKNRIVGEGASATVYKGSL------PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG  355 (596)
Q Consensus       282 at~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~  355 (596)
                      ..++|...+.||+|+||.||+|..      .++..||||++.... .......+.+|+..+.+..+||||+++++++...
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  121 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLS  121 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence            456788899999999999999985      235689999996432 2334567889997776633999999999999999


Q ss_pred             CeEEEEEecCCCCCHHHHhhhCCCC-------------------CcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccC
Q 047719          356 NELVLVYEYLPNGSLDKILHNNSSS-------------------SIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDV  416 (596)
Q Consensus       356 ~~~~lV~E~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDl  416 (596)
                      +..++||||+++|+|.+++......                   ...+++..++.++.||+.||+|||+   .+|+||||
T Consensus       122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Di  198 (344)
T 1rjb_A          122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDL  198 (344)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTC
T ss_pred             CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCC
Confidence            9999999999999999999865421                   1248999999999999999999999   89999999


Q ss_pred             CCCceeecCCCceEEccCCCccc-------------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCC
Q 047719          417 KACNILLDAEFNAKLGDFEATIP-------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDND  482 (596)
Q Consensus       417 kp~NiLl~~~~~~kl~Dfg~~~~-------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~  482 (596)
                      ||+|||++.++.+||+|||++..             .||+.|+|||.+.+..++.++|||||||++|||+| |+.||...
T Consensus       199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  278 (344)
T 1rjb_A          199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI  278 (344)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence            99999999999999999998642             25678999999999999999999999999999998 99999765


Q ss_pred             ChhHHHHHHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Q 047719          483 GCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEA  548 (596)
Q Consensus       483 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~~  548 (596)
                      ....  ........+.         ....+......+.+++..||+.||++|||+.++++.|+...
T Consensus       279 ~~~~--~~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~  333 (344)
T 1rjb_A          279 PVDA--NFYKLIQNGF---------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL  333 (344)
T ss_dssp             CCSH--HHHHHHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             CcHH--HHHHHHhcCC---------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence            3211  1111112111         11111223356778889999999999999999999998654

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=7.7e-40  Score=333.65  Aligned_cols=251  Identities=23%  Similarity=0.276  Sum_probs=192.7

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      ++|...+.||+|+||+||+|... +++.||||++............+.+|+..+. .++||||+++++++.+.+..++||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~   80 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLK-ELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHT-TCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHh-cCCCCCEeeEEeEEEeCCEEEEEE
Confidence            46778899999999999999875 5889999999765554445567888986664 489999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc---
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP---  439 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~---  439 (596)
                      ||+++ +|.+++....   ..+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||.+..   
T Consensus        81 e~~~~-~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  153 (292)
T 3o0g_A           81 EFCDQ-DLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGI  153 (292)
T ss_dssp             ECCSE-EHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred             ecCCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence            99975 6666665532   248999999999999999999999   8999999999999999999999999997642   


Q ss_pred             --------CCCcccCCccccccCC-CCCccceeehhHHHHHHHhCCCCCCCCCh--hHHHHHHHHHhcCCch------hh
Q 047719          440 --------AGTMGYLAPEYVYSGV-PSEKTDVYSFGVVALEVAAGKSPVDNDGC--VIVDWVWNLRKKGKLL------DA  502 (596)
Q Consensus       440 --------~gt~~y~aPE~~~~~~-~t~~sDV~SfGvll~El~tG~~p~~~~~~--~~~~~~~~~~~~~~~~------~~  502 (596)
                              .||..|+|||.+.+.. ++.++|||||||++|||++|..|+.....  .....+..........      ..
T Consensus       154 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  233 (292)
T 3o0g_A          154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL  233 (292)
T ss_dssp             CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred             ccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccc
Confidence                    4788999999998765 79999999999999999998887543322  1111111111111000      00


Q ss_pred             ccc---------cccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          503 ADF---------RLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       503 ~d~---------~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      .+.         .............+.+++..|++.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            000         0000111123456678889999999999999999987

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.2e-39  Score=345.56  Aligned_cols=240  Identities=27%  Similarity=0.318  Sum_probs=194.6

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      ++|...+.||+|+||.||++... +++.||||++.+.... ......+.+|+..+.. ++|||||++++++.+...+|+|
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~-l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQG-LEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHT-CCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHh-CCCCCCCcEEEEEEeCCEEEEE
Confidence            45788899999999999999865 4889999999654322 2334567888866655 8999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc---
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI---  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---  438 (596)
                      |||+++|+|.+++....    .+++..+..++.||+.||.|||+   .+|+||||||+||||+.++.+||+|||++.   
T Consensus        94 ~e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~  166 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQNV----HFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP  166 (384)
T ss_dssp             ECCCTTEEHHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence            99999999999998653    48999999999999999999999   899999999999999999999999999763   


Q ss_pred             -------cCCCcccCCcccccc---CCCCCccceeehhHHHHHHHhCCCCCCCCCh-hHHHHHHHHHhcCCchhhccccc
Q 047719          439 -------PAGTMGYLAPEYVYS---GVPSEKTDVYSFGVVALEVAAGKSPVDNDGC-VIVDWVWNLRKKGKLLDAADFRL  507 (596)
Q Consensus       439 -------~~gt~~y~aPE~~~~---~~~t~~sDV~SfGvll~El~tG~~p~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l  507 (596)
                             ..||+.|+|||.+..   ..++.++|||||||++|||++|+.||..... ........... ..         
T Consensus       167 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~-~~---------  236 (384)
T 4fr4_A          167 RETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET-TV---------  236 (384)
T ss_dssp             TTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH-CC---------
T ss_pred             CCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh-cc---------
Confidence                   358999999999874   4589999999999999999999999975432 12221111111 11         


Q ss_pred             cCcCCHHHHHHHHHHHHHcCCCCCCCCCC-HHHHHH
Q 047719          508 RGKFNRKEMERMLMVGLSCVHPNHEKRPS-VKEAAR  542 (596)
Q Consensus       508 ~~~~~~~~~~~l~~l~~~C~~~dp~~RPs-~~ev~~  542 (596)
                       ..++......+.+|+..||+.||++||+ ++++.+
T Consensus       237 -~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          237 -VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             -CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             -cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence             1112223356778889999999999998 777764

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=3.2e-40  Score=340.14  Aligned_cols=249  Identities=23%  Similarity=0.275  Sum_probs=195.9

Q ss_pred             hcCCCccceeecCCceEEEEEEc-CCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeee----CCe
Q 047719          283 TLGFNKNRIVGEGASATVYKGSL-PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE----GNE  357 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~----~~~  357 (596)
                      .++|...+.||+|+||.||++.. .+++.||||++....  ....+.+.+|+..+. .++||||+++++++..    ...
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~~~  104 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE--QQDREEAQREADMHR-LFNHPNILRLVAYCLRERGAKHE  104 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS--HHHHHHHHHHHHHHH-TCCCTTBCCCCEEEEEEETTEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC--HHHHHHHHHHHHHHh-hcCCCCeeeEEEEEEeccCCCce
Confidence            45688889999999999999986 468999999986532  234556888886665 4899999999999873    347


Q ss_pred             EEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCc
Q 047719          358 LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT  437 (596)
Q Consensus       358 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~  437 (596)
                      .++||||+++|+|.+++.........+++..++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||.+
T Consensus       105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~  181 (317)
T 2buj_A          105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSM  181 (317)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred             eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence            899999999999999998643223468999999999999999999999   89999999999999999999999999975


Q ss_pred             cc--------------------CCCcccCCccccccCC---CCCccceeehhHHHHHHHhCCCCCCCC---ChhHHHHHH
Q 047719          438 IP--------------------AGTMGYLAPEYVYSGV---PSEKTDVYSFGVVALEVAAGKSPVDND---GCVIVDWVW  491 (596)
Q Consensus       438 ~~--------------------~gt~~y~aPE~~~~~~---~t~~sDV~SfGvll~El~tG~~p~~~~---~~~~~~~~~  491 (596)
                      ..                    .||..|+|||.+....   ++.++|||||||++|||++|+.||...   ......   
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~---  258 (317)
T 2buj_A          182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL---  258 (317)
T ss_dssp             EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHH---
T ss_pred             hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhH---
Confidence            42                    2589999999987543   689999999999999999999998531   101110   


Q ss_pred             HHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCC
Q 047719          492 NLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEAPL  550 (596)
Q Consensus       492 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~~~~  550 (596)
                       ....         .............+.+++..||+.||++|||++++++.|+...+.
T Consensus       259 -~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  307 (317)
T 2buj_A          259 -AVQN---------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP  307 (317)
T ss_dssp             -HHHC---------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred             -Hhhc---------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence             0011         011111112235677888999999999999999999999976643

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-39  Score=335.98  Aligned_cols=238  Identities=23%  Similarity=0.301  Sum_probs=195.0

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchh-cccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVE-CARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~-~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      ++|...+.||+|+||.||++... +|+.||||++.+..... ...+.+.+|...+ +.++||||+++++++.+...+|+|
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l-~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLML-SIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHH-HSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHH-hhCCCCCCceEeEEEEeCCEEEEE
Confidence            46788899999999999999875 58999999997543222 2334566777555 558999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc---
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI---  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---  438 (596)
                      |||+++|+|.+++....    .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++.   
T Consensus        85 ~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~  157 (318)
T 1fot_A           85 MDYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP  157 (318)
T ss_dssp             ECCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred             EeCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecC
Confidence            99999999999998754    48899999999999999999999   899999999999999999999999999763   


Q ss_pred             -----cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCH
Q 047719          439 -----PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNR  513 (596)
Q Consensus       439 -----~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  513 (596)
                           ..||+.|+|||.+.+..++.++|||||||++|||++|+.||......  ......... .      ......+  
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~i~~~-~------~~~p~~~--  226 (318)
T 1fot_A          158 DVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM--KTYEKILNA-E------LRFPPFF--  226 (318)
T ss_dssp             SCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHHC-C------CCCCTTS--
T ss_pred             CccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHHhC-C------CCCCCCC--
Confidence                 35899999999999999999999999999999999999999765321  111111111 1      1111222  


Q ss_pred             HHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 047719          514 KEMERMLMVGLSCVHPNHEKRP-----SVKEAAR  542 (596)
Q Consensus       514 ~~~~~l~~l~~~C~~~dp~~RP-----s~~ev~~  542 (596)
                        ...+.+++..|++.||++||     +++|+++
T Consensus       227 --~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          227 --NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             --CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             --CHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence              34567788899999999999     8888875

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.5e-40  Score=336.47  Aligned_cols=242  Identities=22%  Similarity=0.346  Sum_probs=196.4

Q ss_pred             hcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      +.+|...+.||+|+||.||+|... +++.||||++...........++.+|+..+....+||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            456888899999999999999876 6899999999865554555667888987777755999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecC----------------
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDA----------------  425 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~----------------  425 (596)
                      |||+++|+|.+++.........+++..++.++.||+.||+|||+   .+|+||||||+|||++.                
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC-----------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            99999999999998643222358999999999999999999999   89999999999999984                


Q ss_pred             ---CCceEEccCCCcc-------cCCCcccCCccccccC-CCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHH
Q 047719          426 ---EFNAKLGDFEATI-------PAGTMGYLAPEYVYSG-VPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLR  494 (596)
Q Consensus       426 ---~~~~kl~Dfg~~~-------~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~  494 (596)
                         ...+||+|||.+.       ..||..|+|||.+.+. .++.++|||||||++|||++|.+|+.....      +...
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~------~~~~  240 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ------WHEI  240 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCSCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH------HHHH
T ss_pred             cCCceEEEEcccccccccCCccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH------HHHH
Confidence               4479999999754       3489999999999865 667899999999999999999987654321      1111


Q ss_pred             hcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          495 KKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       495 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ..+..     +.+...+    ...+.+++..||+.||++|||++|+++
T Consensus       241 ~~~~~-----~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          241 RQGRL-----PRIPQVL----SQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             HTTCC-----CCCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HcCCC-----CCCCccc----CHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence            22211     1111222    345778888999999999999999876

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=8.6e-41  Score=357.30  Aligned_cols=249  Identities=25%  Similarity=0.290  Sum_probs=198.5

Q ss_pred             HHHHHHHhcCCCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceee
Q 047719          276 LTDIKQATLGFNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCC  353 (596)
Q Consensus       276 ~~el~~at~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~  353 (596)
                      +.+++...++|...++||+|+||+||++.... ++.||||++.+.... ......+.+|+..+. .++|||||+++++|.
T Consensus        61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~-~l~hp~Iv~l~~~~~  139 (410)
T 3v8s_A           61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA-FANSPWVVQLFYAFQ  139 (410)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHH-HCCCTTBCCEEEEEE
T ss_pred             HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHH-hCCCCCCCeEEEEEE
Confidence            34555667889999999999999999998764 889999999753322 223445777875554 589999999999999


Q ss_pred             eCCeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEcc
Q 047719          354 EGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGD  433 (596)
Q Consensus       354 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~D  433 (596)
                      +...+||||||+++|+|.+++....     +++..+..++.||+.||+|||+   .+|+||||||+||||+.++.+||+|
T Consensus       140 ~~~~~~lV~E~~~gg~L~~~l~~~~-----~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~D  211 (410)
T 3v8s_A          140 DDRYLYMVMEYMPGGDLVNLMSNYD-----VPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLAD  211 (410)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHHCC-----CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECC
T ss_pred             ECCEEEEEEeCCCCCcHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEec
Confidence            9999999999999999999998643     8899999999999999999999   8999999999999999999999999


Q ss_pred             CCCcc------------cCCCcccCCccccccCC----CCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcC
Q 047719          434 FEATI------------PAGTMGYLAPEYVYSGV----PSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKG  497 (596)
Q Consensus       434 fg~~~------------~~gt~~y~aPE~~~~~~----~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~  497 (596)
                      ||++.            .+||+.|+|||.+....    ++.++|||||||++|||++|+.||......  +.........
T Consensus       212 FG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--~~~~~i~~~~  289 (410)
T 3v8s_A          212 FGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--GTYSKIMNHK  289 (410)
T ss_dssp             CTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHTHH
T ss_pred             cceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh--hHHHHHHhcc
Confidence            99762            35899999999998654    789999999999999999999999865421  1111111100


Q ss_pred             CchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCC--CCCHHHHHH
Q 047719          498 KLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEK--RPSVKEAAR  542 (596)
Q Consensus       498 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~--RPs~~ev~~  542 (596)
                      .   .........+    ...+.+|+..|++.+|++  ||+++||++
T Consensus       290 ~---~~~~p~~~~~----s~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          290 N---SLTFPDDNDI----SKEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             H---HCCCCTTCCC----CHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             c---cccCCCcccc----cHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence            0   0000001112    345677888999989988  999999987

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=9.9e-41  Score=345.97  Aligned_cols=244  Identities=28%  Similarity=0.389  Sum_probs=193.4

Q ss_pred             cCCCccceeecCCceEEEEEEcCC-CCE----EEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPS-GGA----VAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNEL  358 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~----vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~  358 (596)
                      .+|...+.||+|+||.||+|.... ++.    ||+|.+.... .......+.+|+..+.+ ++||||++++++|. .+..
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~-~~~~   89 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGS-LDHAHIVRLLGLCP-GSSL   89 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHT-CCCTTBCCEEEEEC-BSSE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhc-CCCCCcCeEEEEEc-CCcc
Confidence            357778999999999999998643 444    7888875332 23344567788866654 89999999999986 5679


Q ss_pred             EEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc
Q 047719          359 VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI  438 (596)
Q Consensus       359 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~  438 (596)
                      ++||||+++|+|.+++....   ..+++..++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++.
T Consensus        90 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~  163 (325)
T 3kex_A           90 QLVTQYLPLGSLLDHVRQHR---GALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVAD  163 (325)
T ss_dssp             EEEEECCTTCBSHHHHHSSG---GGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred             EEEEEeCCCCCHHHHHHHcc---ccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCccc
Confidence            99999999999999998652   358899999999999999999999   899999999999999999999999999864


Q ss_pred             c-------------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhcc
Q 047719          439 P-------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAAD  504 (596)
Q Consensus       439 ~-------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d  504 (596)
                      .             .||..|+|||.+.++.++.++|||||||++|||++ |+.||........   ......+...    
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~~~~~~~~----  236 (325)
T 3kex_A          164 LLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV---PDLLEKGERL----  236 (325)
T ss_dssp             GSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH---HHHHHTTCBC----
T ss_pred             ccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH---HHHHHcCCCC----
Confidence            2             36678999999999999999999999999999999 9999986533211   1111111111    


Q ss_pred             ccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Q 047719          505 FRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEA  548 (596)
Q Consensus       505 ~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~~  548 (596)
                           ..+......+.+++..||+.||++||+++|+++.|+...
T Consensus       237 -----~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~  275 (325)
T 3kex_A          237 -----AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA  275 (325)
T ss_dssp             -----CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred             -----CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                 111112234667888999999999999999999997654

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.7e-40  Score=338.06  Aligned_cols=239  Identities=22%  Similarity=0.298  Sum_probs=187.1

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchh------------------------cccchHHHHHHHHHh
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVE------------------------CARNPFTTEFATMAG  338 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~------------------------~~~~~~~~E~~~l~~  338 (596)
                      ++|...+.||+|+||.||+|... +++.||||++.......                        ...+.+.+|+..+..
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   92 (298)
T 2zv2_A           13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK   92 (298)
T ss_dssp             TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred             cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence            46888899999999999999865 58899999997543211                        123568889966655


Q ss_pred             ccCCCceeeecceeee--CCeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccC
Q 047719          339 CLRHKNLVQLQGWCCE--GNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDV  416 (596)
Q Consensus       339 ~l~H~niv~l~g~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDl  416 (596)
                       ++||||+++++++.+  ....++||||+++++|.+++...     .+++..++.++.||+.||+|||+   .+|+||||
T Consensus        93 -l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dl  163 (298)
T 2zv2_A           93 -LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK-----PLSEDQARFYFQDLIKGIEYLHY---QKIIHRDI  163 (298)
T ss_dssp             -CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCC
T ss_pred             -CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCC
Confidence             899999999999987  56899999999999999876432     48999999999999999999999   89999999


Q ss_pred             CCCceeecCCCceEEccCCCcc-----------cCCCcccCCccccccCC---CCCccceeehhHHHHHHHhCCCCCCCC
Q 047719          417 KACNILLDAEFNAKLGDFEATI-----------PAGTMGYLAPEYVYSGV---PSEKTDVYSFGVVALEVAAGKSPVDND  482 (596)
Q Consensus       417 kp~NiLl~~~~~~kl~Dfg~~~-----------~~gt~~y~aPE~~~~~~---~t~~sDV~SfGvll~El~tG~~p~~~~  482 (596)
                      ||+|||++.++.+||+|||++.           ..||+.|+|||.+.+..   ++.++|||||||++|||++|+.||...
T Consensus       164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  243 (298)
T 2zv2_A          164 KPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE  243 (298)
T ss_dssp             CGGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CHHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence            9999999999999999999753           35899999999997755   378899999999999999999999865


Q ss_pred             ChhHHHHHHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          483 GCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       483 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ...  .+...... ...    .......+    ...+.+++.+||+.||++|||++|+++
T Consensus       244 ~~~--~~~~~~~~-~~~----~~~~~~~~----~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          244 RIM--CLHSKIKS-QAL----EFPDQPDI----AEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             SHH--HHHHHHHH-CCC----CCCSSSCC----CHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             cHH--HHHHHHhc-ccC----CCCCcccc----CHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            321  11111111 111    00011122    345778889999999999999999865

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=6.2e-41  Score=338.89  Aligned_cols=249  Identities=23%  Similarity=0.315  Sum_probs=200.4

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeee--CCeEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE--GNELVL  360 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~--~~~~~l  360 (596)
                      ++|...+.||+|+||.||++... +++.||+|++..........+.+.+|+..+.+ ++||||+++++++..  ....++
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE-LKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHH-CCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHh-cCCCCCCeEEEEEecCCCceEEE
Confidence            46788899999999999999875 58999999997655444556678889866665 899999999998854  568999


Q ss_pred             EEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCC-----eEEccCCCCceeecCCCceEEccCC
Q 047719          361 VYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQ-----IIHRDVKACNILLDAEFNAKLGDFE  435 (596)
Q Consensus       361 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~-----ivHrDlkp~NiLl~~~~~~kl~Dfg  435 (596)
                      ||||+++|+|.+++.........+++..++.++.|++.||+|||+   .+     ++||||||+|||++.++.+||+|||
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            999999999999998654333458999999999999999999999   66     9999999999999999999999999


Q ss_pred             Cccc-----------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhcc
Q 047719          436 ATIP-----------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAAD  504 (596)
Q Consensus       436 ~~~~-----------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d  504 (596)
                      .+..           .||..|+|||.+.+..++.++||||||+++|||++|+.||......  +.. .....+...    
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~-~~i~~~~~~----  234 (279)
T 2w5a_A          162 LARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK--ELA-GKIREGKFR----  234 (279)
T ss_dssp             HHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHH-HHHHHTCCC----
T ss_pred             hheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH--HHH-HHHhhcccc----
Confidence            7532           4789999999999989999999999999999999999999875431  111 111122111    


Q ss_pred             ccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Q 047719          505 FRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEA  548 (596)
Q Consensus       505 ~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~~  548 (596)
                           ..+......+.+++.+||+.||++||+++|+++.+....
T Consensus       235 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~  273 (279)
T 2w5a_A          235 -----RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE  273 (279)
T ss_dssp             -----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred             -----cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence                 111122356778889999999999999999998765443

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2.7e-40  Score=348.27  Aligned_cols=254  Identities=17%  Similarity=0.199  Sum_probs=194.4

Q ss_pred             HhcCCCccceeecCCceEEEEEEcCC------CCEEEEEEeecCCchhcc---------cchHHHHHHHHHhccCCCcee
Q 047719          282 ATLGFNKNRIVGEGASATVYKGSLPS------GGAVAVKRFEKPNRVECA---------RNPFTTEFATMAGCLRHKNLV  346 (596)
Q Consensus       282 at~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vAvK~l~~~~~~~~~---------~~~~~~E~~~l~~~l~H~niv  346 (596)
                      ..++|...+.||+|+||.||+|.+..      ++.||||++.........         ...+..|+..+ ..++|+||+
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~-~~l~h~~iv  111 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT-RKLKYLGVP  111 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHH-TTCSCCCSC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHH-hhccCCCCC
Confidence            34578889999999999999998754      478999998754321111         11233343233 457899999


Q ss_pred             eecceeeeC----CeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCcee
Q 047719          347 QLQGWCCEG----NELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNIL  422 (596)
Q Consensus       347 ~l~g~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiL  422 (596)
                      ++++++...    ...+|||||+ +++|.+++....   ..+++..++.++.||+.||+|||+   .+|+||||||+|||
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nil  184 (364)
T 3op5_A          112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA---KRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLL  184 (364)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEE
T ss_pred             eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEE
Confidence            999998875    4589999999 999999998753   359999999999999999999999   89999999999999


Q ss_pred             ec--CCCceEEccCCCccc------------------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCC
Q 047719          423 LD--AEFNAKLGDFEATIP------------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDND  482 (596)
Q Consensus       423 l~--~~~~~kl~Dfg~~~~------------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~  482 (596)
                      ++  .++.+||+|||++..                  .||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus       185 l~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~  264 (364)
T 3op5_A          185 LNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDN  264 (364)
T ss_dssp             EESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             EecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence            99  889999999997632                  2899999999999999999999999999999999999999853


Q ss_pred             C--hhHHHHHHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          483 G--CVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       483 ~--~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                      .  .....+..... ...+.+..+..+...   .....+.+++..||+.||++||+++++++.|+..
T Consensus       265 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~  327 (364)
T 3op5_A          265 LKDPKYVRDSKIRY-RENIASLMDKCFPAA---NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQG  327 (364)
T ss_dssp             TTCHHHHHHHHHHH-HHCHHHHHHHHSCTT---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             ccCHHHHHHHHHHh-hhhHHHHHHHhcccc---cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence            2  12222221111 112333333322211   1234567788899999999999999999988653

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.7e-40  Score=331.75  Aligned_cols=242  Identities=28%  Similarity=0.349  Sum_probs=199.8

Q ss_pred             cCCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      ++|...+.||+|+||.||++...+++.||+|++.....   ..+.+.+|+..+.. ++||||+++++++.+.+..++|||
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~e   83 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM---SEEDFIEEAEVMMK-LSHPKLVQLYGVCLEQAPICLVTE   83 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB---CHHHHHHHHHHHHT-CCCTTBCCEEEEECSSSSCEEEEC
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC---CHHHHHHHHHHHHh-CCCCCEeeEEEEEccCCCeEEEEe
Confidence            45777899999999999999988888999999965432   33568889866655 899999999999999999999999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc----
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP----  439 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~----  439 (596)
                      |+++++|.+++....   ..+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||.+..    
T Consensus        84 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  157 (267)
T 3t9t_A           84 FMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD  157 (267)
T ss_dssp             CCTTCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred             CCCCCcHHHHHhhCc---ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEcccccccccccc
Confidence            999999999998753   248899999999999999999999   8999999999999999999999999997642    


Q ss_pred             --------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhccccccCc
Q 047719          440 --------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGK  510 (596)
Q Consensus       440 --------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  510 (596)
                              .++..|+|||.+....++.++||||||+++|||++ |+.||......  +..........          ..
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~i~~~~~----------~~  225 (267)
T 3t9t_A          158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVVEDISTGFR----------LY  225 (267)
T ss_dssp             HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTTCC----------CC
T ss_pred             cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH--HHHHHHhcCCc----------CC
Confidence                    35678999999998899999999999999999999 89999865321  11111111110          01


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          511 FNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       511 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                      .+......+.+++.+||+.||++||+++++++.|+..
T Consensus       226 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l  262 (267)
T 3t9t_A          226 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI  262 (267)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            1112234577888999999999999999999998753

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.5e-40  Score=368.03  Aligned_cols=246  Identities=24%  Similarity=0.356  Sum_probs=201.6

Q ss_pred             HhcCCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          282 ATLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       282 at~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      ..++|...+.||+|+||.||+|.+.++..||||+++...   ...++|.+|+..|.+ ++|+|||+++++|.+ +..+||
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~-l~hpniv~~~~~~~~-~~~~lv  339 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKK-LRHEKLVQLYAVVSE-EPIYIV  339 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS---SCHHHHHHHHHHHHH-CCCTTBCCEEEEECS-SSCEEE
T ss_pred             chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC---CCHHHHHHHHHHHHh-CCCCCEeeEEEEEee-ccceEe
Confidence            345677889999999999999999888889999996533   234578999977765 899999999999876 679999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc--
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP--  439 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~--  439 (596)
                      ||||++|+|.++|....  ...+++.+++.++.||+.||+|||+   ++|+||||||+||||+.++.+||+|||++..  
T Consensus       340 ~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  414 (535)
T 2h8h_A          340 TEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIE  414 (535)
T ss_dssp             ECCCTTEEHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred             eehhcCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence            99999999999997532  1248899999999999999999999   8999999999999999999999999998753  


Q ss_pred             ----------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhcccccc
Q 047719          440 ----------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLR  508 (596)
Q Consensus       440 ----------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  508 (596)
                                .++..|+|||.+..+.++.++|||||||+||||++ |+.||......  +..... ..+..         
T Consensus       415 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~--~~~~~i-~~~~~---------  482 (535)
T 2h8h_A          415 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVLDQV-ERGYR---------  482 (535)
T ss_dssp             CHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH--HHHHHH-HTTCC---------
T ss_pred             CCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHH-HcCCC---------
Confidence                      24678999999999999999999999999999999 99999865321  111111 12111         


Q ss_pred             CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Q 047719          509 GKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEAP  549 (596)
Q Consensus       509 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~~~  549 (596)
                      ...+......+.+|+..||+.||++|||+++|++.|+....
T Consensus       483 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  523 (535)
T 2h8h_A          483 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  523 (535)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence            11122334567788899999999999999999999987643

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2.3e-40  Score=340.12  Aligned_cols=250  Identities=25%  Similarity=0.367  Sum_probs=200.6

Q ss_pred             hcCCCccceeecCCceEEEEEEc------CCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCC
Q 047719          283 TLGFNKNRIVGEGASATVYKGSL------PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGN  356 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~  356 (596)
                      .++|...+.||+|+||.||+|..      .++..||||++..... ....+.+.+|+..+.+..+||||+++++++...+
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  100 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh-HHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence            45678889999999999999974      2467899999975432 2344678899977766339999999999999999


Q ss_pred             eEEEEEecCCCCCHHHHhhhCCCC--------------CcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCcee
Q 047719          357 ELVLVYEYLPNGSLDKILHNNSSS--------------SIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNIL  422 (596)
Q Consensus       357 ~~~lV~E~~~~gsL~~~l~~~~~~--------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiL  422 (596)
                      ..++||||+++|+|.+++......              ...+++..++.++.||+.||+|||+   .+++||||||+|||
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil  177 (313)
T 1t46_A          101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNIL  177 (313)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEE
T ss_pred             CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEE
Confidence            999999999999999999875421              2248999999999999999999999   89999999999999


Q ss_pred             ecCCCceEEccCCCccc-------------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHH
Q 047719          423 LDAEFNAKLGDFEATIP-------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVD  488 (596)
Q Consensus       423 l~~~~~~kl~Dfg~~~~-------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~  488 (596)
                      ++.++.+||+|||.+..             .||..|+|||.+.+..++.++|||||||++|||++ |+.||........ 
T Consensus       178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-  256 (313)
T 1t46_A          178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-  256 (313)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH-
T ss_pred             EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH-
Confidence            99999999999997643             24567999999999999999999999999999999 9999976532111 


Q ss_pred             HHHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          489 WVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       489 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                       .........         ....+......+.+++.+||+.||++|||++|+++.|+..
T Consensus       257 -~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  305 (313)
T 1t46_A          257 -FYKMIKEGF---------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (313)
T ss_dssp             -HHHHHHHTC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -HHHHhccCC---------CCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence             111111111         1111122335677888999999999999999999999753

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.9e-39  Score=334.56  Aligned_cols=251  Identities=24%  Similarity=0.333  Sum_probs=193.8

Q ss_pred             HhcCCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHh-ccCCCceeeecceeeeC----C
Q 047719          282 ATLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAG-CLRHKNLVQLQGWCCEG----N  356 (596)
Q Consensus       282 at~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~-~l~H~niv~l~g~~~~~----~  356 (596)
                      ..++|...+.||+|+||.||+|... ++.||||++....     ...+..|.+.+.. .++||||+++++++...    .
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~  108 (337)
T 3mdy_A           35 IAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE-----EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT  108 (337)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred             cccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc-----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence            4467899999999999999999874 8999999985322     2233444433332 25899999999999887    7


Q ss_pred             eEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhcc-----CCCeEEccCCCCceeecCCCceEE
Q 047719          357 ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC-----ERQIIHRDVKACNILLDAEFNAKL  431 (596)
Q Consensus       357 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~-----~~~ivHrDlkp~NiLl~~~~~~kl  431 (596)
                      ..++||||+++|+|.+++...     .+++..++.++.|++.||+|||+.+     ..+|+||||||+|||++.++.+||
T Consensus       109 ~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl  183 (337)
T 3mdy_A          109 QLYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI  183 (337)
T ss_dssp             EEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred             ceEEEEeccCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence            899999999999999999765     3899999999999999999999821     129999999999999999999999


Q ss_pred             ccCCCcc---------------cCCCcccCCccccccCCCCCc------cceeehhHHHHHHHhC----------CCCCC
Q 047719          432 GDFEATI---------------PAGTMGYLAPEYVYSGVPSEK------TDVYSFGVVALEVAAG----------KSPVD  480 (596)
Q Consensus       432 ~Dfg~~~---------------~~gt~~y~aPE~~~~~~~t~~------sDV~SfGvll~El~tG----------~~p~~  480 (596)
                      +|||++.               ..||..|+|||.+.+...+.+      +|||||||++|||++|          +.||.
T Consensus       184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~  263 (337)
T 3mdy_A          184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH  263 (337)
T ss_dssp             CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence            9999762               358999999999987766665      9999999999999999          66665


Q ss_pred             CCCh---hHHHHHHHHHhcCCchhhccccccCc-CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Q 047719          481 NDGC---VIVDWVWNLRKKGKLLDAADFRLRGK-FNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEA  548 (596)
Q Consensus       481 ~~~~---~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~~  548 (596)
                      ....   ..... .........    .+..... ...+....+.+++.+||+.||++|||+.|+++.|+...
T Consensus       264 ~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~  330 (337)
T 3mdy_A          264 DLVPSDPSYEDM-REIVCIKKL----RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS  330 (337)
T ss_dssp             TTSCSSCCHHHH-HHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hhcCCCCchhhh-HHHHhhhcc----CccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHH
Confidence            4211   11111 111111111    1111111 12256778899999999999999999999999998643

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=2.6e-40  Score=335.29  Aligned_cols=242  Identities=24%  Similarity=0.341  Sum_probs=190.9

Q ss_pred             hcCCCccceeecCCceEEEEEEcCC----CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeE
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLPS----GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNEL  358 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~  358 (596)
                      .++|...+.||+|+||.||+|....    +..||||++.... .....+.+.+|+..+.+ ++||||+++++++. .+..
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~-~~~~   90 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQ-FDHPHIVKLIGVIT-ENPV   90 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHT-CCCTTBCCEEEEEC-SSSC
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHh-CCCCccceEEEEEc-cCcc
Confidence            3467788999999999999998643    4579999986432 23345568889866655 89999999999984 5678


Q ss_pred             EEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc
Q 047719          359 VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI  438 (596)
Q Consensus       359 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~  438 (596)
                      ++||||+++|+|.+++....   ..+++..++.++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++.
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  164 (281)
T 1mp8_A           91 WIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSR  164 (281)
T ss_dssp             EEEEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred             EEEEecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECcccccc
Confidence            99999999999999998653   248999999999999999999999   899999999999999999999999999764


Q ss_pred             c------------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCCh-hHHHHHHHHHhcCCchhhcc
Q 047719          439 P------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGC-VIVDWVWNLRKKGKLLDAAD  504 (596)
Q Consensus       439 ~------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~-~~~~~~~~~~~~~~~~~~~d  504 (596)
                      .            .+|+.|+|||.+....++.++|||||||++|||++ |+.||..... ....   .. ..+..     
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~---~i-~~~~~-----  235 (281)
T 1mp8_A          165 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG---RI-ENGER-----  235 (281)
T ss_dssp             --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH---HH-HTTCC-----
T ss_pred             ccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHH---HH-HcCCC-----
Confidence            3            25678999999998999999999999999999997 9999986432 1211   11 11111     


Q ss_pred             ccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          505 FRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       505 ~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                          ...+......+.+++..||+.||++|||+.|+++.|+.
T Consensus       236 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~  273 (281)
T 1mp8_A          236 ----LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST  273 (281)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ----CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence                11122233567788899999999999999999999875

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.4e-40  Score=341.69  Aligned_cols=245  Identities=19%  Similarity=0.208  Sum_probs=197.8

Q ss_pred             hcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      .++|...+.||+|+||.||++... +++.||+|.+....   .....+.+|+..+.. ++||||+++++++.+.+..++|
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~E~~~l~~-l~hpnIv~~~~~~~~~~~~~lv   79 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNI-ARHRNILHLHESFESMEELVMI   79 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHH-SCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc---ccHHHHHHHHHHHHh-CCCCCCCeEeEEEecCCEEEEE
Confidence            356888899999999999999875 48899999986432   234457888866654 8999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecC--CCceEEccCCCccc
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDA--EFNAKLGDFEATIP  439 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~--~~~~kl~Dfg~~~~  439 (596)
                      |||+++|+|.+++....   ..+++.+++.++.||+.||+|||+   .+|+||||||+|||++.  ++.+||+|||++..
T Consensus        80 ~e~~~g~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~  153 (321)
T 1tki_A           80 FEFISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ  153 (321)
T ss_dssp             ECCCCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred             EEeCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeE
Confidence            99999999999997643   258999999999999999999999   89999999999999987  78999999998743


Q ss_pred             ----------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccC
Q 047719          440 ----------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRG  509 (596)
Q Consensus       440 ----------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  509 (596)
                                .||+.|+|||.+.+..++.++|||||||++|||++|+.||......  +............   +.....
T Consensus       154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~~~~~---~~~~~~  228 (321)
T 1tki_A          154 LKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ--QIIENIMNAEYTF---DEEAFK  228 (321)
T ss_dssp             CCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHHTCCCC---CHHHHT
T ss_pred             CCCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH--HHHHHHHcCCCCC---Chhhhc
Confidence                      3889999999999888999999999999999999999999875321  1121221111000   000001


Q ss_pred             cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhc
Q 047719          510 KFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKG  546 (596)
Q Consensus       510 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~~  546 (596)
                      .    ....+.+++.+|++.||++|||+.|+++  +++.
T Consensus       229 ~----~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  263 (321)
T 1tki_A          229 E----ISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             T----SCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             c----CCHHHHHHHHHHcCCChhHCcCHHHHhcChhhcc
Confidence            1    2345778889999999999999999988  5544

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=8.8e-40  Score=342.07  Aligned_cols=242  Identities=27%  Similarity=0.326  Sum_probs=194.9

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      ++|...+.||+|+||.||+++.. +++.||||++.+.... ......+.+|...+....+||||+++++++.+.+.+|+|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            45788899999999999999875 4889999999754322 223445777887776655999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc--
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP--  439 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~--  439 (596)
                      |||+++|+|.+++....    .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++..  
T Consensus        89 ~e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~  161 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  161 (345)
T ss_dssp             ECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred             EeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEecccccccc
Confidence            99999999999998653    48999999999999999999999   8999999999999999999999999997642  


Q ss_pred             ---------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCCh------hHHHHHHHHHhcCCchhhcc
Q 047719          440 ---------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGC------VIVDWVWNLRKKGKLLDAAD  504 (596)
Q Consensus       440 ---------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~------~~~~~~~~~~~~~~~~~~~d  504 (596)
                               .||+.|+|||.+.+..++.++|||||||++|||++|+.||...+.      ...+...........     
T Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~-----  236 (345)
T 3a8x_A          162 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-----  236 (345)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC-----
T ss_pred             CCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC-----
Confidence                     589999999999999999999999999999999999999965211      011111111111111     


Q ss_pred             ccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHH
Q 047719          505 FRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSV------KEAAR  542 (596)
Q Consensus       505 ~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~------~ev~~  542 (596)
                           .++......+.+++.+|++.||++||++      +|+++
T Consensus       237 -----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~  275 (345)
T 3a8x_A          237 -----RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  275 (345)
T ss_dssp             -----CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred             -----CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence                 1122233457788899999999999995      56654

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=3.4e-40  Score=335.22  Aligned_cols=245  Identities=26%  Similarity=0.354  Sum_probs=195.0

Q ss_pred             cCCCccceeecCCceEEEEEEcCC-C-------CEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeC
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPS-G-------GAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG  355 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~-g-------~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~  355 (596)
                      ++|...+.||+|+||.||+|.... +       ..||+|++...  .....+.+.+|+..+.. ++||||+++++++.+.
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~~   84 (289)
T 4fvq_A            8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA--HRNYSESFFEAASMMSK-LSHKHLVLNYGVCVCG   84 (289)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG--GGGGHHHHHHHHHHHHT-SCCTTBCCEEEEECCT
T ss_pred             hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc--cHHHHHHHHHHHHHHHh-CCCCCEeEEEEEEEeC
Confidence            457778999999999999997653 3       46999999543  23345668889866655 8999999999999999


Q ss_pred             CeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCc-------
Q 047719          356 NELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFN-------  428 (596)
Q Consensus       356 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~-------  428 (596)
                      +..++||||+++|+|.+++....   ..+++..++.++.||+.||+|||+   .+|+||||||+|||++.++.       
T Consensus        85 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~  158 (289)
T 4fvq_A           85 DENILVQEFVKFGSLDTYLKKNK---NCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPP  158 (289)
T ss_dssp             TCCEEEEECCTTCBHHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred             CCCEEEEECCCCCCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCcccccccc
Confidence            99999999999999999998753   248999999999999999999999   89999999999999998887       


Q ss_pred             -eEEccCCCccc-------CCCcccCCcccccc-CCCCCccceeehhHHHHHHHhC-CCCCCCCChhHHHHHHHHHhcCC
Q 047719          429 -AKLGDFEATIP-------AGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAG-KSPVDNDGCVIVDWVWNLRKKGK  498 (596)
Q Consensus       429 -~kl~Dfg~~~~-------~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG-~~p~~~~~~~~~~~~~~~~~~~~  498 (596)
                       +||+|||.+..       .||..|+|||.+.+ ..++.++|||||||++|||++| .+|+........  .........
T Consensus       159 ~~kl~Dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~--~~~~~~~~~  236 (289)
T 4fvq_A          159 FIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK--LQFYEDRHQ  236 (289)
T ss_dssp             EEEECCCCSCTTTSCHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH--HHHHHTTCC
T ss_pred             eeeeccCcccccccCccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH--HHHhhccCC
Confidence             99999998754       37889999999987 6789999999999999999995 455554332111  111111111


Q ss_pred             chhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCC
Q 047719          499 LLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEAPLP  551 (596)
Q Consensus       499 ~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~~~~p  551 (596)
                              +....    ...+.+++..||+.||++|||++|+++.|+....+.
T Consensus       237 --------~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~  277 (289)
T 4fvq_A          237 --------LPAPK----AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD  277 (289)
T ss_dssp             --------CCCCS----SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred             --------CCCCC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence                    11111    234677888999999999999999999999776533

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=5.5e-40  Score=349.39  Aligned_cols=239  Identities=20%  Similarity=0.254  Sum_probs=193.0

Q ss_pred             cCCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccC--CCceeeecceeeeCCeEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLR--HKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~--H~niv~l~g~~~~~~~~~lV  361 (596)
                      ..|...+.||+|+||.||++...+++.||||++............+.+|+..+.. ++  |+||+++++++...+.+|+|
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~-l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK-LQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHH-HTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHH-cccCCCeEEEEEEEEecCCEEEEE
Confidence            3488889999999999999998889999999997655444556678999977766 54  69999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc---
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI---  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---  438 (596)
                      || +.+++|.+++....    .+++.++..++.||+.||+|||+   .+|+||||||+|||++ ++.+||+|||++.   
T Consensus       135 ~E-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~  205 (390)
T 2zmd_A          135 ME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ  205 (390)
T ss_dssp             EE-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred             Ee-cCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence            99 56889999998754    48899999999999999999999   8999999999999995 5899999999764   


Q ss_pred             ----------cCCCcccCCcccccc-----------CCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcC
Q 047719          439 ----------PAGTMGYLAPEYVYS-----------GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKG  497 (596)
Q Consensus       439 ----------~~gt~~y~aPE~~~~-----------~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~  497 (596)
                                ..||+.|+|||++.+           ..++.++|||||||++|||++|+.||........ .......  
T Consensus       206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~-~~~~~~~--  282 (390)
T 2zmd_A          206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-KLHAIID--  282 (390)
T ss_dssp             --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-HHHHHHC--
T ss_pred             CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHH-HHHHHhC--
Confidence                      248999999999865           4689999999999999999999999976432211 1111111  


Q ss_pred             CchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          498 KLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       498 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                             ......++......+.+++..||+.||++|||++|+++
T Consensus       283 -------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  320 (390)
T 2zmd_A          283 -------PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  320 (390)
T ss_dssp             -------TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -------ccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence                   11111111112345778889999999999999999987

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.9e-39  Score=335.20  Aligned_cols=254  Identities=24%  Similarity=0.327  Sum_probs=182.7

Q ss_pred             hcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      ..+|...+.||+|+||.||+|... +|+.||||++.... .......+.+|+..+. .++||||+++++++...+..++|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~~~~~~~~lv   81 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMK-ELKHENIVRLYDVIHTENKLTLV   81 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHT-TCCBTTBCCEEEEECCTTEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHH-hcCCCCcceEEEEEEECCeEEEE
Confidence            456888899999999999999875 48899999997543 2334456888986664 58999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCC--CCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc-
Q 047719          362 YEYLPNGSLDKILHNNS--SSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI-  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~-  438 (596)
                      |||++ |+|.+++....  .....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||.+. 
T Consensus        82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~  157 (317)
T 2pmi_A           82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARA  157 (317)
T ss_dssp             EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEE
T ss_pred             EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCcccee
Confidence            99998 69999997542  122358999999999999999999999   899999999999999999999999999763 


Q ss_pred             ----------cCCCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCChh-HHHHHHHHHhcCC--chh---
Q 047719          439 ----------PAGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV-IVDWVWNLRKKGK--LLD---  501 (596)
Q Consensus       439 ----------~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~-~~~~~~~~~~~~~--~~~---  501 (596)
                                ..||..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ....+........  ...   
T Consensus       158 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  237 (317)
T 2pmi_A          158 FGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT  237 (317)
T ss_dssp             TTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred             cCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence                      247899999999876 46899999999999999999999999875431 1111211111100  000   


Q ss_pred             -h--cccc------------ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          502 -A--ADFR------------LRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       502 -~--~d~~------------l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                       .  ..+.            +...........+.+++.+|++.||++|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence             0  0000            000001112346788899999999999999999876

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=8.6e-40  Score=340.76  Aligned_cols=242  Identities=21%  Similarity=0.295  Sum_probs=195.3

Q ss_pred             cCCCccceeecCCceEEEEEEc-CCCCEEEEEEeecCCchh-cccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSL-PSGGAVAVKRFEKPNRVE-CARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~-~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      .+|...+.||+|+||.||+|.. .+++.||||++.+..... .....+.+|+..+ +.++||||+++++++...+..++|
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l-~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYL-KLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHH-TTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHH-HhCCCCCCCeEEEEEEeCCEEEEE
Confidence            4678889999999999999986 468999999996532222 2344678888555 559999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc---
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI---  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---  438 (596)
                      |||+ +|+|.+++....    .+++.++..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++.   
T Consensus        88 ~E~~-~g~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~  159 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEKK----RMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT  159 (336)
T ss_dssp             ECCC-CEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred             EECC-CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence            9999 789999997654    48999999999999999999999   899999999999999999999999999764   


Q ss_pred             -------cCCCcccCCccccccCCC-CCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCc
Q 047719          439 -------PAGTMGYLAPEYVYSGVP-SEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGK  510 (596)
Q Consensus       439 -------~~gt~~y~aPE~~~~~~~-t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  510 (596)
                             ..||+.|+|||.+.+..+ +.++|||||||++|||++|+.||.....            ..+....... ...
T Consensus       160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~------------~~~~~~i~~~-~~~  226 (336)
T 3h4j_B          160 DGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFI------------PNLFKKVNSC-VYV  226 (336)
T ss_dssp             TSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSS------------TTCBCCCCSS-CCC
T ss_pred             CCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccH------------HHHHHHHHcC-CCC
Confidence                   358999999999987765 7899999999999999999999976421            0111111100 011


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhcC
Q 047719          511 FNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKGE  547 (596)
Q Consensus       511 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~~~  547 (596)
                      .+......+.+++.+|++.||++|||++|+++  +++..
T Consensus       227 ~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  265 (336)
T 3h4j_B          227 MPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN  265 (336)
T ss_dssp             CCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred             CcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence            12223345678889999999999999999987  55543

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=3.6e-40  Score=342.96  Aligned_cols=249  Identities=24%  Similarity=0.361  Sum_probs=199.9

Q ss_pred             hcCCCccceeecCCceEEEEEEcC--------CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeee
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLP--------SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE  354 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~--------~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~  354 (596)
                      .++|...+.||+|+||.||+|...        ++..||||++.... .......+.+|+..+....+||||++++++|.+
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            457888899999999999999753        46789999996433 233456688898777663399999999999999


Q ss_pred             CCeEEEEEecCCCCCHHHHhhhCCCC------------CcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCcee
Q 047719          355 GNELVLVYEYLPNGSLDKILHNNSSS------------SIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNIL  422 (596)
Q Consensus       355 ~~~~~lV~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiL  422 (596)
                      .+..++||||+++|+|.+++......            ...+++..++.++.||+.||+|||+   .+|+||||||+|||
T Consensus       113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIl  189 (334)
T 2pvf_A          113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVL  189 (334)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEE
T ss_pred             CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEE
Confidence            99999999999999999999875421            2248999999999999999999999   89999999999999


Q ss_pred             ecCCCceEEccCCCccc-------------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHH
Q 047719          423 LDAEFNAKLGDFEATIP-------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVD  488 (596)
Q Consensus       423 l~~~~~~kl~Dfg~~~~-------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~  488 (596)
                      ++.++.+||+|||++..             .+|..|+|||.+.+..++.++|||||||++|||++ |+.||......  +
T Consensus       190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~  267 (334)
T 2pvf_A          190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--E  267 (334)
T ss_dssp             ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--H
T ss_pred             EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH--H
Confidence            99999999999997642             35678999999998889999999999999999999 99999765321  1


Q ss_pred             HHHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          489 WVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       489 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                      ..... ..+..         ...+......+.+++..||+.||++|||++|+++.|+..
T Consensus       268 ~~~~~-~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l  316 (334)
T 2pvf_A          268 LFKLL-KEGHR---------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  316 (334)
T ss_dssp             HHHHH-HHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHH-hcCCC---------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            11111 11111         111122334677888999999999999999999998764

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=6e-40  Score=334.12  Aligned_cols=249  Identities=28%  Similarity=0.440  Sum_probs=195.1

Q ss_pred             hcCCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      ..+|...+.||+|+||.||+|...  ..||||+++.........+.+.+|+..+. .++||||+++++++ .....++||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~-~~~~~~lv~   98 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLR-KTRHVNILLFMGYS-TAPQLAIVT   98 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHT-TCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHH-hCCCCcEEEEEeec-cCCccEEEE
Confidence            456888899999999999999864  35999999765555555677889996654 59999999999965 456789999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc----
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI----  438 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~----  438 (596)
                      ||+++++|.+++....   ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++.    
T Consensus        99 e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  172 (289)
T 3og7_A           99 QWCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR  172 (289)
T ss_dssp             ECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred             EecCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceecccccc
Confidence            9999999999997543   358999999999999999999999   899999999999999999999999999763    


Q ss_pred             ---------cCCCcccCCccccc---cCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhcccc
Q 047719          439 ---------PAGTMGYLAPEYVY---SGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFR  506 (596)
Q Consensus       439 ---------~~gt~~y~aPE~~~---~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~  506 (596)
                               ..||..|+|||.+.   ...++.++|||||||++|||++|+.||......  +.+......+......   
T Consensus       173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~---  247 (289)
T 3og7_A          173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--DQIIEMVGRGSLSPDL---  247 (289)
T ss_dssp             -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH--HHHHHHHHHTSCCCCT---
T ss_pred             ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH--HHHHHHhcccccCcch---
Confidence                     24799999999986   567889999999999999999999999764321  1111222222211110   


Q ss_pred             ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Q 047719          507 LRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEA  548 (596)
Q Consensus       507 l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~~  548 (596)
                        ..........+.+++..||+.||++|||++++++.|+...
T Consensus       248 --~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          248 --SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             --TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             --hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence              0111223356788889999999999999999999998654

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=3.6e-40  Score=344.88  Aligned_cols=242  Identities=22%  Similarity=0.285  Sum_probs=196.5

Q ss_pred             HHHhcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCCe
Q 047719          280 KQATLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNE  357 (596)
Q Consensus       280 ~~at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~  357 (596)
                      ....++|...+.||+|+||.||+|... +|+.||||++++.... ......+..|...+....+||||+++++++.+.+.
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            345578899999999999999999875 4889999999753221 22344567787677665699999999999999999


Q ss_pred             EEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCc
Q 047719          358 LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT  437 (596)
Q Consensus       358 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~  437 (596)
                      +|+||||+++|+|.+++....    .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a  165 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMC  165 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhh
Confidence            999999999999999998643    48999999999999999999999   89999999999999999999999999976


Q ss_pred             c-----------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhcccc
Q 047719          438 I-----------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFR  506 (596)
Q Consensus       438 ~-----------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~  506 (596)
                      .           .+||+.|+|||.+.+..++.++|||||||++|||++|+.||......  +....... ..      ..
T Consensus       166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~i~~-~~------~~  236 (345)
T 1xjd_A          166 KENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--ELFHSIRM-DN------PF  236 (345)
T ss_dssp             BCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHH-CC------CC
T ss_pred             hhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHh-CC------CC
Confidence            4           24899999999999999999999999999999999999999865431  11111111 11      11


Q ss_pred             ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHH-HHH
Q 047719          507 LRGKFNRKEMERMLMVGLSCVHPNHEKRPSVK-EAA  541 (596)
Q Consensus       507 l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~-ev~  541 (596)
                          ++......+.+++..|++.||++||++. ++.
T Consensus       237 ----~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          237 ----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             ----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             ----CCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence                1112234567888999999999999997 665

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=6.2e-40  Score=337.11  Aligned_cols=253  Identities=25%  Similarity=0.349  Sum_probs=196.6

Q ss_pred             cCCCccceeecCCceEEEEEEc-CCCCEEEEEEeecCCc-hhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSL-PSGGAVAVKRFEKPNR-VECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~-~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      .+|...+.||+|+||.||+|.. .+|+.||||++..... .......+.+|+..+.. ++||||+++++++...+..++|
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQ-LNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHT-CCCTTBCCEEEEEEETTEEEEE
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHh-CCCCCEeeEEEEEEcCCcEEEE
Confidence            4688889999999999999986 4689999999965322 23345568889866655 8999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc---
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI---  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---  438 (596)
                      |||+++|+|.+++.........+++..++.++.||+.||.|||+   .+++||||||+|||++.++.+||+|||++.   
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            99999999999997532223458999999999999999999999   899999999999999999999999999753   


Q ss_pred             --------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCc
Q 047719          439 --------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGK  510 (596)
Q Consensus       439 --------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  510 (596)
                              ..||..|+|||.+.+..++.++|||||||++|||++|+.||............... .......    ... 
T Consensus       188 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~----~~~-  261 (310)
T 2wqm_A          188 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE-QCDYPPL----PSD-  261 (310)
T ss_dssp             -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHH-TTCSCCC----CTT-
T ss_pred             CCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhh-cccCCCC----ccc-
Confidence                    24788999999999999999999999999999999999999764333222222221 1111100    011 


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Q 047719          511 FNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEAP  549 (596)
Q Consensus       511 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~~~  549 (596)
                         .....+.+++.+||+.||++|||++++++.|+...+
T Consensus       262 ---~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~  297 (310)
T 2wqm_A          262 ---HYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA  297 (310)
T ss_dssp             ---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---ccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence               223457788899999999999999999999987543

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.7e-39  Score=333.82  Aligned_cols=251  Identities=22%  Similarity=0.247  Sum_probs=194.7

Q ss_pred             cCCCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      ++|...+.||+|+||.||+|.... |+.||||++............+.+|+..+.+ ++||||+++++++.+.+..++||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~   81 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQ-LKHPNLVNLLEVFRRKRRLHLVF   81 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHH-CCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHh-CCCCCccchhheeecCCeEEEEE
Confidence            467888999999999999998754 8999999997655444445667889866655 89999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc---
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP---  439 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~---  439 (596)
                      ||+++++|.+++....    .+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||.+..   
T Consensus        82 e~~~~~~l~~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  154 (311)
T 4agu_A           82 EYCDHTVLHELDRYQR----GVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTG  154 (311)
T ss_dssp             ECCSEEHHHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             EeCCCchHHHHHhhhc----CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence            9999999999987653    48999999999999999999999   8999999999999999999999999997642   


Q ss_pred             --------CCCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCChhH-HHHHHHHH-----------hcCC
Q 047719          440 --------AGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVI-VDWVWNLR-----------KKGK  498 (596)
Q Consensus       440 --------~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~-~~~~~~~~-----------~~~~  498 (596)
                              .||..|+|||.+.+ ..++.++|||||||++|||++|+.||......- ...+....           ....
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (311)
T 4agu_A          155 PSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ  234 (311)
T ss_dssp             -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred             cccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence                    47889999999876 678999999999999999999999998754311 11111110           0000


Q ss_pred             chhhcccc-ccCcCC-----HHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          499 LLDAADFR-LRGKFN-----RKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       499 ~~~~~d~~-l~~~~~-----~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ........ ......     ......+.+++..||+.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            00000000 000000     112345778999999999999999999986

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.1e-39  Score=330.66  Aligned_cols=248  Identities=21%  Similarity=0.257  Sum_probs=199.8

Q ss_pred             hcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      .++|...+.||+|+||.||+|... +++.||+|++............+.+|+..+.+ ++||||+++++++.+.+..++|
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~~v   83 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK-LQHPNIVRLHDSIQEESFHYLV   83 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHH-CCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHH-cCCCCcCeEEEEEEcCCEEEEE
Confidence            457888899999999999999865 48899999997654444455668888866655 8999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCc---eEEccCCCcc
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFN---AKLGDFEATI  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~---~kl~Dfg~~~  438 (596)
                      |||+++++|.+++....    .+++..+..++.|++.||+|||+   .+++||||||+|||++.++.   +||+|||.+.
T Consensus        84 ~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~  156 (284)
T 3kk8_A           84 FDLVTGGELFEDIVARE----FYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAI  156 (284)
T ss_dssp             ECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence            99999999999997653    48999999999999999999999   89999999999999987655   9999999763


Q ss_pred             ----------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhcccccc
Q 047719          439 ----------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLR  508 (596)
Q Consensus       439 ----------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  508 (596)
                                ..||+.|+|||.+.+..++.++||||||+++|||++|+.||......  ....... .+... .     .
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~-~~~~~-~-----~  227 (284)
T 3kk8_A          157 EVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--RLYAQIK-AGAYD-Y-----P  227 (284)
T ss_dssp             ECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHH-HTCCC-C-----C
T ss_pred             EcccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh--HHHHHHH-hcccc-C-----C
Confidence                      35889999999999999999999999999999999999999765432  1111111 11110 0     0


Q ss_pred             CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhcC
Q 047719          509 GKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKGE  547 (596)
Q Consensus       509 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~~~  547 (596)
                      ..........+.+++..|++.||++|||++|+++  +++..
T Consensus       228 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (284)
T 3kk8_A          228 SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR  268 (284)
T ss_dssp             TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSC
T ss_pred             chhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCC
Confidence            0000122345678889999999999999999987  55543

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.2e-40  Score=338.49  Aligned_cols=243  Identities=27%  Similarity=0.369  Sum_probs=200.9

Q ss_pred             HhcCCCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEE
Q 047719          282 ATLGFNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVL  360 (596)
Q Consensus       282 at~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~l  360 (596)
                      ...+|...+.||+|+||.||+|.... +..||||++....   ...+.+.+|+..+.. ++||||+++++++.+.+..++
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~-l~h~~i~~~~~~~~~~~~~~~   86 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKE-IKHPNLVQLLGVCTREPPFYI   86 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHH-CCCTTBCCEEEEECSSSSEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHh-CCCCCEeeEEEEEccCCCEEE
Confidence            45678888999999999999998765 8889999996432   234568889866655 899999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcccC
Q 047719          361 VYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA  440 (596)
Q Consensus       361 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~~  440 (596)
                      ||||+++++|.+++....  ...+++..++.++.||+.||+|||+   .+++||||||+||+++.++.+||+|||.+...
T Consensus        87 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~  161 (288)
T 3kfa_A           87 ITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLM  161 (288)
T ss_dssp             EEECCTTEEHHHHHHHCC--TTTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred             EEEcCCCCcHHHHHHhcc--cCCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceec
Confidence            999999999999998754  2358999999999999999999999   89999999999999999999999999976532


Q ss_pred             ------------CCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChh-HHHHHHHHHhcCCchhhcccc
Q 047719          441 ------------GTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCV-IVDWVWNLRKKGKLLDAADFR  506 (596)
Q Consensus       441 ------------gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~-~~~~~~~~~~~~~~~~~~d~~  506 (596)
                                  +|..|+|||.+.+..++.++||||||+++|||++ |+.||...... ..+    .....         
T Consensus       162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~----~~~~~---------  228 (288)
T 3kfa_A          162 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE----LLEKD---------  228 (288)
T ss_dssp             CSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH----HHHTT---------
T ss_pred             cCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH----HHhcc---------
Confidence                        4667999999999999999999999999999999 99999765321 111    11111         


Q ss_pred             ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          507 LRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       507 l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                      .....+......+.+++..|++.||++|||++++++.|+.
T Consensus       229 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~  268 (288)
T 3kfa_A          229 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET  268 (288)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHH
Confidence            1111122233567888899999999999999999999875

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=2.2e-40  Score=342.22  Aligned_cols=252  Identities=25%  Similarity=0.339  Sum_probs=197.6

Q ss_pred             CCccceeecCCceEEEEEEcC-----CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeC--CeE
Q 047719          286 FNKNRIVGEGASATVYKGSLP-----SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG--NEL  358 (596)
Q Consensus       286 f~~~~~LG~G~fG~Vy~~~~~-----~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~--~~~  358 (596)
                      |...+.||+|+||.||++.+.     +++.||||++.... .......+.+|+..+.. ++||||+++++++.+.  ..+
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~~  110 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-GPQHRSGWKQEIDILRT-LYHEHIIKYKGCCEDAGAASL  110 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHH-CCCTTBCCEEEEEEETTTTEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc-ChHHHHHHHHHHHHHHh-CCCcchhhEEEEEecCCCceE
Confidence            477899999999999988642     47889999997542 23345668899966655 8999999999999884  679


Q ss_pred             EEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc
Q 047719          359 VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI  438 (596)
Q Consensus       359 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~  438 (596)
                      ++||||+++|+|.+++....     +++..++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||.+.
T Consensus       111 ~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~  182 (318)
T 3lxp_A          111 QLVMEYVPLGSLRDYLPRHS-----IGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAK  182 (318)
T ss_dssp             EEEECCCTTCBHHHHGGGSC-----CCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             EEEEecccCCcHHHHHhhCC-----CCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCccccc
Confidence            99999999999999998653     8999999999999999999999   899999999999999999999999998764


Q ss_pred             c--------------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHH---HHHHhcCCchh
Q 047719          439 P--------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWV---WNLRKKGKLLD  501 (596)
Q Consensus       439 ~--------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~---~~~~~~~~~~~  501 (596)
                      .              .+|..|+|||.+.+..++.++|||||||++|||++|+.||.........+.   ........+.+
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (318)
T 3lxp_A          183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE  262 (318)
T ss_dssp             ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHH
T ss_pred             cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHH
Confidence            2              366779999999998899999999999999999999999875321111100   00000001111


Q ss_pred             hccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          502 AADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       502 ~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                      ..........+......+.+++.+||+.||++|||++|+++.|+..
T Consensus       263 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l  308 (318)
T 3lxp_A          263 LLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV  308 (318)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            1111112222333446788889999999999999999999998753

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=3.2e-39  Score=338.36  Aligned_cols=240  Identities=22%  Similarity=0.300  Sum_probs=186.6

Q ss_pred             hcCCCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      .+.|...+.||+|+||.||+|.... ++.||||++....    ..+.+.+|+..+.+ ++||||++++++|.+.+..++|
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~lv  126 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLR-LSHPNIIKLKEIFETPTEISLV  126 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHH-CCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHh-CCCCCCcceeeeEecCCeEEEE
Confidence            4568888999999999999998764 7899999996532    23457788866655 8999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecC---CCceEEccCCCcc
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDA---EFNAKLGDFEATI  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~---~~~~kl~Dfg~~~  438 (596)
                      |||+++|+|.+++....    .+++.+++.++.||+.||.|||+   .+|+||||||+|||++.   ++.+||+|||++.
T Consensus       127 ~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~  199 (349)
T 2w4o_A          127 LELVTGGELFDRIVEKG----YYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSK  199 (349)
T ss_dssp             ECCCCSCBHHHHHTTCS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC---
T ss_pred             EEeCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCcccc
Confidence            99999999999997653    48999999999999999999999   89999999999999975   8999999999764


Q ss_pred             ----------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhcccccc
Q 047719          439 ----------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLR  508 (596)
Q Consensus       439 ----------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  508 (596)
                                ..||+.|+|||.+.+..++.++|||||||++|||++|+.||.......  ............      ..
T Consensus       200 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~~i~~~~~~------~~  271 (349)
T 2w4o_A          200 IVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ--FMFRRILNCEYY------FI  271 (349)
T ss_dssp             -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH--HHHHHHHTTCCC------CC
T ss_pred             ccCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH--HHHHHHHhCCCc------cC
Confidence                      248999999999999899999999999999999999999997643221  111111111110      00


Q ss_pred             CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          509 GKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       509 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      .....+....+.+++.+|++.||++|||+.|+++
T Consensus       272 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          272 SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1111223346778889999999999999999987

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=5e-40  Score=341.04  Aligned_cols=252  Identities=21%  Similarity=0.252  Sum_probs=201.7

Q ss_pred             HHHHHHhcCCCcc-ceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeee
Q 047719          277 TDIKQATLGFNKN-RIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE  354 (596)
Q Consensus       277 ~el~~at~~f~~~-~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~  354 (596)
                      ...+.-.+.|... +.||+|+||.||+|... +++.||||++............+.+|+..+....+||||+++++++.+
T Consensus        21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~  100 (327)
T 3lm5_A           21 QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN  100 (327)
T ss_dssp             BCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             HHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence            3344445556655 88999999999999865 589999999976544444566788999777775578999999999999


Q ss_pred             CCeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecC---CCceEE
Q 047719          355 GNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDA---EFNAKL  431 (596)
Q Consensus       355 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~---~~~~kl  431 (596)
                      .+..++||||+++|+|.+++....  ...+++..++.++.||+.||+|||+   .+|+||||||+|||++.   ++.+||
T Consensus       101 ~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~kL  175 (327)
T 3lm5_A          101 TSEIILILEYAAGGEIFSLCLPEL--AEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKI  175 (327)
T ss_dssp             SSEEEEEEECCTTEEGGGGGSSCC---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCEEE
T ss_pred             CCeEEEEEEecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcEEE
Confidence            999999999999999999996543  2358999999999999999999999   89999999999999988   789999


Q ss_pred             ccCCCccc----------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchh
Q 047719          432 GDFEATIP----------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLD  501 (596)
Q Consensus       432 ~Dfg~~~~----------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~  501 (596)
                      +|||++..          .||+.|+|||.+.+..++.++|||||||++|||++|+.||.......  .........    
T Consensus       176 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~i~~~~----  249 (327)
T 3lm5_A          176 VDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE--TYLNISQVN----  249 (327)
T ss_dssp             CCGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHTC----
T ss_pred             eeCccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH--HHHHHHhcc----
Confidence            99997642          58999999999999999999999999999999999999998754311  111111110    


Q ss_pred             hccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          502 AADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       502 ~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                         ..............+.+++..|++.||++|||++|+++
T Consensus       250 ---~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          250 ---VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             ---CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ---cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence               00111111123355778889999999999999999976

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=4.5e-40  Score=335.23  Aligned_cols=242  Identities=26%  Similarity=0.330  Sum_probs=194.3

Q ss_pred             cCCCccc-eeecCCceEEEEEEc--C-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEE
Q 047719          284 LGFNKNR-IVGEGASATVYKGSL--P-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELV  359 (596)
Q Consensus       284 ~~f~~~~-~LG~G~fG~Vy~~~~--~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~  359 (596)
                      ..|...+ .||+|+||.||+|.+  . .++.||||++..........+++.+|+..+.. ++||||+++++++ +.+..+
T Consensus        16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ-LDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHT-CCCTTBCCEEEEE-ESSSEE
T ss_pred             hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHh-CCCCCEEEEEEEE-CCCCcE
Confidence            4455566 899999999999954  2 36789999997554334445678899966655 8999999999999 667899


Q ss_pred             EEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc
Q 047719          360 LVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP  439 (596)
Q Consensus       360 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~  439 (596)
                      +||||+++++|.+++....    .+++..++.++.||+.||+|||+   .+++||||||+|||++.++.+||+|||.+..
T Consensus        94 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  166 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKA  166 (291)
T ss_dssp             EEEECCTTEEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEeCCCCCHHHHHHhCc----CCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence            9999999999999998754    48999999999999999999999   8999999999999999999999999997642


Q ss_pred             --------------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhcc
Q 047719          440 --------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAAD  504 (596)
Q Consensus       440 --------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d  504 (596)
                                    .+|..|+|||.+.+..++.++||||||+++|||++ |+.||.......   +......+..     
T Consensus       167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~~~~~-----  238 (291)
T 1xbb_A          167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VTAMLEKGER-----  238 (291)
T ss_dssp             CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHHHTTCC-----
T ss_pred             eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHHcCCC-----
Confidence                          24578999999988889999999999999999999 999998754321   1111122211     


Q ss_pred             ccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          505 FRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       505 ~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                          ...+......+.+++..||+.||++||++.++++.|+.
T Consensus       239 ----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~  276 (291)
T 1xbb_A          239 ----MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  276 (291)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             ----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence                11122334567788899999999999999999999875

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2.4e-40  Score=340.88  Aligned_cols=239  Identities=25%  Similarity=0.344  Sum_probs=192.3

Q ss_pred             CCCc-cceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          285 GFNK-NRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       285 ~f~~-~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      .|.. .+.||+|+||.||++... +++.||||++....  ......+.+|+..+.+..+||||+++++++.+.+..++||
T Consensus        13 ~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             SCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS--SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            4555 478999999999999865 58999999996542  2345578899988877678999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCc---eEEccCCCccc
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFN---AKLGDFEATIP  439 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~---~kl~Dfg~~~~  439 (596)
                      ||+++|+|.+++....    .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.   +||+|||++..
T Consensus        91 e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~  163 (316)
T 2ac3_A           91 EKMRGGSILSHIHKRR----HFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG  163 (316)
T ss_dssp             ECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred             EcCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence            9999999999998753    48999999999999999999999   89999999999999998776   99999987532


Q ss_pred             ------------------CCCcccCCcccccc-----CCCCCccceeehhHHHHHHHhCCCCCCCCChhH----------
Q 047719          440 ------------------AGTMGYLAPEYVYS-----GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVI----------  486 (596)
Q Consensus       440 ------------------~gt~~y~aPE~~~~-----~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~----------  486 (596)
                                        .||..|+|||.+..     ..++.++|||||||++|||++|+.||.......          
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  243 (316)
T 2ac3_A          164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP  243 (316)
T ss_dssp             ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred             cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence                              38999999999875     557899999999999999999999997642110          


Q ss_pred             --HHHHHHHHhcCCchhhccccccCcCCH----HHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          487 --VDWVWNLRKKGKLLDAADFRLRGKFNR----KEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       487 --~~~~~~~~~~~~~~~~~d~~l~~~~~~----~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                        ..........+..          .++.    .....+.+++.+|++.||++|||++|+++
T Consensus       244 ~~~~~~~~~i~~~~~----------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          244 ACQNMLFESIQEGKY----------EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             HHHHHHHHHHHHCCC----------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hHHHHHHHHHhccCc----------ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence              0111111111111          1111    12346778899999999999999999987

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.6e-40  Score=340.65  Aligned_cols=243  Identities=25%  Similarity=0.398  Sum_probs=195.2

Q ss_pred             CCCccceeecCCceEEEEEEcCC-----CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEE
Q 047719          285 GFNKNRIVGEGASATVYKGSLPS-----GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELV  359 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~~-----g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~  359 (596)
                      .|...+.||+|+||.||+|....     +..||||++.... .......+.+|+..+.. ++||||+++++++.+.+..+
T Consensus        45 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~  122 (333)
T 1mqb_A           45 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQ-FSHHNIIRLEGVISKYKPMM  122 (333)
T ss_dssp             TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHT-CCCTTBCCEEEEECSSSSEE
T ss_pred             HhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHh-CCCCCCCcEEEEEecCCCcE
Confidence            34556899999999999997643     2359999996433 23345568889866655 89999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc
Q 047719          360 LVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP  439 (596)
Q Consensus       360 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~  439 (596)
                      +||||+++|+|.+++....   ..+++..++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||.+..
T Consensus       123 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  196 (333)
T 1mqb_A          123 IITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRV  196 (333)
T ss_dssp             EEEECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             EEEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchh
Confidence            9999999999999998653   258999999999999999999999   8999999999999999999999999997643


Q ss_pred             --------------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhcc
Q 047719          440 --------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAAD  504 (596)
Q Consensus       440 --------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d  504 (596)
                                    .+|..|+|||.+.+..++.++|||||||++|||++ |+.||......  +.. .....+..     
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~--~~~-~~~~~~~~-----  268 (333)
T 1mqb_A          197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--EVM-KAINDGFR-----  268 (333)
T ss_dssp             --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHH-HHHHTTCC-----
T ss_pred             hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH--HHH-HHHHCCCc-----
Confidence                          24667999999999999999999999999999999 99999765321  111 11111110     


Q ss_pred             ccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          505 FRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       505 ~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                          ...+......+.+++.+||+.||++||++.++++.|+..
T Consensus       269 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  307 (333)
T 1mqb_A          269 ----LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL  307 (333)
T ss_dssp             ----CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             ----CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                111122335677888999999999999999999998754

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.6e-39  Score=343.71  Aligned_cols=252  Identities=24%  Similarity=0.318  Sum_probs=187.0

Q ss_pred             HhcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCC--eE
Q 047719          282 ATLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGN--EL  358 (596)
Q Consensus       282 at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~--~~  358 (596)
                      ..++|...+.||+|+||.||+|... +|+.||||++.+..........+.+|+..+.....||||+++++++...+  .+
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~   86 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV   86 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence            4567888999999999999999764 58999999996554444455678889877776445999999999997544  79


Q ss_pred             EEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc
Q 047719          359 VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI  438 (596)
Q Consensus       359 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~  438 (596)
                      |+|||||+ |+|.+++...     .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++.
T Consensus        87 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~  157 (388)
T 3oz6_A           87 YLVFDYME-TDLHAVIRAN-----ILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSR  157 (388)
T ss_dssp             EEEEECCS-EEHHHHHHHT-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEecccC-cCHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence            99999997 6999999864     38899999999999999999999   899999999999999999999999999764


Q ss_pred             --------------------------------cCCCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCChh
Q 047719          439 --------------------------------PAGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV  485 (596)
Q Consensus       439 --------------------------------~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~  485 (596)
                                                      ..||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.+....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~  237 (388)
T 3oz6_A          158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM  237 (388)
T ss_dssp             ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence                                            258999999999876 67899999999999999999999999875431


Q ss_pred             -HHHHHHHHHhcCCchhhc---------------------cccccCcC------------CHHHHHHHHHHHHHcCCCCC
Q 047719          486 -IVDWVWNLRKKGKLLDAA---------------------DFRLRGKF------------NRKEMERMLMVGLSCVHPNH  531 (596)
Q Consensus       486 -~~~~~~~~~~~~~~~~~~---------------------d~~l~~~~------------~~~~~~~l~~l~~~C~~~dp  531 (596)
                       ...-+.............                     .......+            .......+.+|+.+||+.||
T Consensus       238 ~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP  317 (388)
T 3oz6_A          238 NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNP  317 (388)
T ss_dssp             HHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSG
T ss_pred             HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCc
Confidence             111111111100000000                     00000000            00113457788999999999


Q ss_pred             CCCCCHHHHHH
Q 047719          532 EKRPSVKEAAR  542 (596)
Q Consensus       532 ~~RPs~~ev~~  542 (596)
                      ++|||++|+++
T Consensus       318 ~~R~t~~e~l~  328 (388)
T 3oz6_A          318 NKRISANDALK  328 (388)
T ss_dssp             GGSCCHHHHTT
T ss_pred             ccCCCHHHHhC
Confidence            99999999987

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=3.6e-39  Score=338.06  Aligned_cols=238  Identities=23%  Similarity=0.255  Sum_probs=196.2

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      ++|...+.||+|+||.||++... +|+.||||++.+.... ......+.+|+..+ +.++||||+++++++.+...+|+|
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l-~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRIL-QAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHH-TTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHH-HhCCCCCCCeEEEEEEcCCEEEEE
Confidence            46778899999999999999875 5899999999654322 23345677888555 458999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc---
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI---  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---  438 (596)
                      |||+++|+|.+++....    .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++.   
T Consensus       120 ~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~  192 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK  192 (350)
T ss_dssp             EECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceecc
Confidence            99999999999998754    48999999999999999999999   899999999999999999999999999864   


Q ss_pred             -----cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCH
Q 047719          439 -----PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNR  513 (596)
Q Consensus       439 -----~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  513 (596)
                           ..||+.|+|||.+.+..++.++|||||||++|||++|+.||......  +...... .+..      .+    +.
T Consensus       193 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~i~-~~~~------~~----p~  259 (350)
T 1rdq_E          193 GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI--QIYEKIV-SGKV------RF----PS  259 (350)
T ss_dssp             SCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHH-HCCC------CC----CT
T ss_pred             CCcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH--HHHHHHH-cCCC------CC----CC
Confidence                 35899999999999999999999999999999999999999865321  1111111 1111      11    11


Q ss_pred             HHHHHHHHHHHHcCCCCCCCCCC-----HHHHHH
Q 047719          514 KEMERMLMVGLSCVHPNHEKRPS-----VKEAAR  542 (596)
Q Consensus       514 ~~~~~l~~l~~~C~~~dp~~RPs-----~~ev~~  542 (596)
                      .....+.+++..|++.||++||+     ++|+++
T Consensus       260 ~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          260 HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence            22345778889999999999998     888875

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=3.5e-40  Score=339.45  Aligned_cols=253  Identities=24%  Similarity=0.363  Sum_probs=196.4

Q ss_pred             HHHHHhcCCCccceeecCCceEEEEEEcCC----CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceee
Q 047719          278 DIKQATLGFNKNRIVGEGASATVYKGSLPS----GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCC  353 (596)
Q Consensus       278 el~~at~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~  353 (596)
                      ++....++|...+.||+|+||.||+|....    +..||||++............+.+|+..+.+ ++||||+++++++.
T Consensus        28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~  106 (313)
T 3brb_A           28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKD-FSHPNVIRLLGVCI  106 (313)
T ss_dssp             TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHT-CCCTTBCCCCEEEE
T ss_pred             hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhc-CCCCCeeeeeEEEe
Confidence            344455678888999999999999997532    4479999997554444455678899866655 89999999999998


Q ss_pred             eCCe-----EEEEEecCCCCCHHHHhhhCC--CCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCC
Q 047719          354 EGNE-----LVLVYEYLPNGSLDKILHNNS--SSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAE  426 (596)
Q Consensus       354 ~~~~-----~~lV~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~  426 (596)
                      +...     .++||||+++|+|.+++....  .....+++..++.++.||++||.|||+   .+|+||||||+|||++.+
T Consensus       107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~  183 (313)
T 3brb_A          107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDD  183 (313)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTT
T ss_pred             eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCC
Confidence            7653     599999999999999996432  123469999999999999999999999   899999999999999999


Q ss_pred             CceEEccCCCccc-------------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChh-HHHHHH
Q 047719          427 FNAKLGDFEATIP-------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCV-IVDWVW  491 (596)
Q Consensus       427 ~~~kl~Dfg~~~~-------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~-~~~~~~  491 (596)
                      +.+||+|||.+..             .++..|+|||.+.+..++.++|||||||++|||++ |+.||...... ...   
T Consensus       184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~---  260 (313)
T 3brb_A          184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYD---  260 (313)
T ss_dssp             SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH---
T ss_pred             CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHH---
Confidence            9999999997642             25678999999999999999999999999999999 89999765331 111   


Q ss_pred             HHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          492 NLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       492 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                      .. ..+..         ...+......+.+++..||+.||++|||++++++.|+..
T Consensus       261 ~~-~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l  306 (313)
T 3brb_A          261 YL-LHGHR---------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL  306 (313)
T ss_dssp             HH-HTTCC---------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HH-HcCCC---------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            11 11111         111122335677888999999999999999999998754

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=4.8e-40  Score=370.50  Aligned_cols=236  Identities=27%  Similarity=0.341  Sum_probs=193.4

Q ss_pred             ceeecCCceEEEEEEcC---CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecCC
Q 047719          290 RIVGEGASATVYKGSLP---SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLP  366 (596)
Q Consensus       290 ~~LG~G~fG~Vy~~~~~---~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~~  366 (596)
                      +.||+|+||.||+|.+.   .++.||||+++.........+++.+|+..+.+ ++|||||+++++|. .+..++|||||+
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~-l~hpnIv~l~~~~~-~~~~~lv~E~~~  452 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ-LDNPYIVRMIGICE-AESWMLVMEMAE  452 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHH-CCCTTBCCEEEEEE-SSSEEEEEECCT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHh-CCCCCEeeEEEEEe-cCCEEEEEEccC
Confidence            57999999999999543   36789999997544444455679999977765 89999999999996 456899999999


Q ss_pred             CCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc-------
Q 047719          367 NGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP-------  439 (596)
Q Consensus       367 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~-------  439 (596)
                      +|+|.+++....    .+++..++.++.||+.||+|||+   .+|+||||||+||||+.++.+||+|||++..       
T Consensus       453 ~g~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~  525 (635)
T 4fl3_A          453 LGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY  525 (635)
T ss_dssp             TEEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred             CCCHHHHHhhCC----CCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence            999999998654    48999999999999999999999   8999999999999999999999999997532       


Q ss_pred             -------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcC
Q 047719          440 -------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKF  511 (596)
Q Consensus       440 -------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  511 (596)
                             .+|..|+|||++....++.++|||||||+||||++ |+.||.......   +......+..         ...
T Consensus       526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~~~~i~~~~~---------~~~  593 (635)
T 4fl3_A          526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VTAMLEKGER---------MGC  593 (635)
T ss_dssp             ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHHHTTCC---------CCC
T ss_pred             cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHcCCC---------CCC
Confidence                   25678999999999999999999999999999998 999998754321   1122222211         112


Q ss_pred             CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          512 NRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       512 ~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                      +......+.+|+..||+.||++||++++|++.|+.
T Consensus       594 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~  628 (635)
T 4fl3_A          594 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  628 (635)
T ss_dssp             CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            22334567888899999999999999999999874

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.4e-40  Score=345.51  Aligned_cols=252  Identities=25%  Similarity=0.367  Sum_probs=200.6

Q ss_pred             HHHHhcCCCccceeecCCceEEEEEEcCC-C-----CEEEEEEeecCCchhcccchHHHHHHHHHhcc-CCCceeeecce
Q 047719          279 IKQATLGFNKNRIVGEGASATVYKGSLPS-G-----GAVAVKRFEKPNRVECARNPFTTEFATMAGCL-RHKNLVQLQGW  351 (596)
Q Consensus       279 l~~at~~f~~~~~LG~G~fG~Vy~~~~~~-g-----~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l-~H~niv~l~g~  351 (596)
                      .+...++|...+.||+|+||.||+|.... +     ..||+|++..... ......+.+|+..+.. + +||||++++++
T Consensus        41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~-l~~h~~iv~~~~~  118 (333)
T 2i1m_A           41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH-ADEKEALMSELKIMSH-LGQHENIVNLLGA  118 (333)
T ss_dssp             GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCC-HHHHHHHHHHHHHHHH-HCCCTTBCCEEEE
T ss_pred             ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccC-hHHHHHHHHHHHHHHh-hcCCCCeeeEEEE
Confidence            34456778889999999999999998643 2     4799999965432 2345568899977766 6 89999999999


Q ss_pred             eeeCCeEEEEEecCCCCCHHHHhhhCCC----------CCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCce
Q 047719          352 CCEGNELVLVYEYLPNGSLDKILHNNSS----------SSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNI  421 (596)
Q Consensus       352 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~Ni  421 (596)
                      |.+.+..++||||+++|+|.+++.....          ....+++..++.++.||+.||+|||+   .+|+||||||+||
T Consensus       119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NI  195 (333)
T 2i1m_A          119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNV  195 (333)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGC
T ss_pred             EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceE
Confidence            9999999999999999999999975321          02347999999999999999999999   8999999999999


Q ss_pred             eecCCCceEEccCCCccc-------------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHH
Q 047719          422 LLDAEFNAKLGDFEATIP-------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIV  487 (596)
Q Consensus       422 Ll~~~~~~kl~Dfg~~~~-------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~  487 (596)
                      |++.++.+||+|||++..             .||..|+|||.+.+..++.++|||||||++|||++ |..||....... 
T Consensus       196 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-  274 (333)
T 2i1m_A          196 LLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS-  274 (333)
T ss_dssp             EEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH-
T ss_pred             EECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH-
Confidence            999999999999997642             24668999999999999999999999999999999 999997643211 


Q ss_pred             HHHHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          488 DWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       488 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                       ........+..         ...+......+.+++..||+.||++|||++|+++.|+.
T Consensus       275 -~~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~  323 (333)
T 2i1m_A          275 -KFYKLVKDGYQ---------MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE  323 (333)
T ss_dssp             -HHHHHHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -HHHHHHhcCCC---------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHH
Confidence             11111111110         01111123467788899999999999999999999875

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.4e-39  Score=341.82  Aligned_cols=202  Identities=24%  Similarity=0.253  Sum_probs=173.4

Q ss_pred             cccCHHHHHHHhcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccC-----CCce
Q 047719          272 MRLALTDIKQATLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLR-----HKNL  345 (596)
Q Consensus       272 ~~~~~~el~~at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~-----H~ni  345 (596)
                      ..+++.+.....++|...++||+|+||.||+|... +++.||||++...   ......+..|+..+.. ++     ||||
T Consensus        23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~-l~~~~~~h~~i   98 (360)
T 3llt_A           23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKK-IQNDDINNNNI   98 (360)
T ss_dssp             GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHH-TCCCSTTGGGB
T ss_pred             eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHH-hcccCCCCCCe
Confidence            44555555566788999999999999999999874 5889999999532   2233446667755554 54     9999


Q ss_pred             eeecceeeeCCeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecC
Q 047719          346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDA  425 (596)
Q Consensus       346 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~  425 (596)
                      +++++++...+..++||||+ +++|.+++.....  ..+++..+..++.||+.||+|||+   .+|+||||||+|||++.
T Consensus        99 v~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~  172 (360)
T 3llt_A           99 VKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNY--NGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDD  172 (360)
T ss_dssp             CCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESC
T ss_pred             ecccceeeECCeeEEEEcCC-CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEcc
Confidence            99999999999999999999 9999999987642  248999999999999999999999   89999999999999975


Q ss_pred             -------------------------CCceEEccCCCcc--------cCCCcccCCccccccCCCCCccceeehhHHHHHH
Q 047719          426 -------------------------EFNAKLGDFEATI--------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEV  472 (596)
Q Consensus       426 -------------------------~~~~kl~Dfg~~~--------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El  472 (596)
                                               ++.+||+|||++.        ..||+.|+|||.+.+..++.++|||||||++|||
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el  252 (360)
T 3llt_A          173 PYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL  252 (360)
T ss_dssp             TTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred             ccccccccchhcccccccccccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHH
Confidence                                     7899999999864        3589999999999999999999999999999999


Q ss_pred             HhCCCCCCCCC
Q 047719          473 AAGKSPVDNDG  483 (596)
Q Consensus       473 ~tG~~p~~~~~  483 (596)
                      ++|+.||....
T Consensus       253 l~g~~pf~~~~  263 (360)
T 3llt_A          253 YTGSLLFRTHE  263 (360)
T ss_dssp             HHSSCSCCCSS
T ss_pred             HHCCCCCCCCc
Confidence            99999998654

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.7e-39  Score=337.25  Aligned_cols=245  Identities=18%  Similarity=0.182  Sum_probs=196.2

Q ss_pred             cCCCccceeecCCceEEEEEEc-CCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSL-PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      .+|...+.||+|+||.||+|.. .+++.||||++....    ....+.+|+..+...-+||||+++++++...+..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~   84 (330)
T 2izr_A            9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS----RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL   84 (330)
T ss_dssp             TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC----SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred             CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc----chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence            5688889999999999999985 468899999986432    23468889977766339999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCc-----eEEccCCCc
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFN-----AKLGDFEAT  437 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~-----~kl~Dfg~~  437 (596)
                      ||+ +++|.+++....   ..+++..++.++.||+.||+|||+   .+|+||||||+|||++.++.     +||+|||++
T Consensus        85 e~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a  157 (330)
T 2izr_A           85 ELL-GPSLEDLFDLCD---RTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA  157 (330)
T ss_dssp             ECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred             EeC-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence            999 999999998652   258999999999999999999999   89999999999999999887     999999976


Q ss_pred             c------------------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCCh-hHHHHHHHHHhcCC
Q 047719          438 I------------------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGC-VIVDWVWNLRKKGK  498 (596)
Q Consensus       438 ~------------------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~-~~~~~~~~~~~~~~  498 (596)
                      .                  ..||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ...+........ .
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~-~  236 (330)
T 2izr_A          158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDT-K  236 (330)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHH-H
T ss_pred             eeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhh-h
Confidence            3                  2488999999999999999999999999999999999999986432 222211111100 0


Q ss_pred             chhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          499 LLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       499 ~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                      . ......+...+    . .+.+++..||+.||.+||+++++.+.|+.
T Consensus       237 ~-~~~~~~~~~~~----p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~  278 (330)
T 2izr_A          237 R-ATPIEVLCENF----P-EMATYLRYVRRLDFFEKPDYDYLRKLFTD  278 (330)
T ss_dssp             H-HSCHHHHTTTC----H-HHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred             c-cCCHHHHhccC----h-HHHHHHHHHHhCCCCCCCCHHHHHHHHHH
Confidence            0 00000011111    1 67888899999999999999999998864

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2.7e-39  Score=332.17  Aligned_cols=255  Identities=26%  Similarity=0.274  Sum_probs=192.0

Q ss_pred             HhcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCch---hcccchHHHHHHHHHh--ccCCCceeeecceeeeC
Q 047719          282 ATLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRV---ECARNPFTTEFATMAG--CLRHKNLVQLQGWCCEG  355 (596)
Q Consensus       282 at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~---~~~~~~~~~E~~~l~~--~l~H~niv~l~g~~~~~  355 (596)
                      .+++|...+.||+|+||+||+|... +++.||||++......   ......+.+|+..+..  .++||||++++++|...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            4678999999999999999999864 5899999998643321   1122356667654443  24599999999999876


Q ss_pred             C-----eEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceE
Q 047719          356 N-----ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAK  430 (596)
Q Consensus       356 ~-----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~k  430 (596)
                      .     ..++||||+. |+|.+++.....  ..+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+|
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~k  160 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP--PGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVK  160 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCT--TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCEE
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEE
Confidence            5     5899999997 699999987642  348999999999999999999999   8999999999999999999999


Q ss_pred             EccCCCcc----------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChh-HHHHHHHHHhcCCc
Q 047719          431 LGDFEATI----------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV-IVDWVWNLRKKGKL  499 (596)
Q Consensus       431 l~Dfg~~~----------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~-~~~~~~~~~~~~~~  499 (596)
                      |+|||.+.          ..||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ..............
T Consensus       161 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  240 (308)
T 3g33_A          161 LADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE  240 (308)
T ss_dssp             ECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             EeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            99999764          24789999999999999999999999999999999999999875431 11111111111100


Q ss_pred             hhh------cccccc--Cc-----CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          500 LDA------ADFRLR--GK-----FNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       500 ~~~------~d~~l~--~~-----~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ...      ......  ..     ...+....+.+++.+|++.||++|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             TTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            000      000000  00     00122356778889999999999999999876

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.6e-39  Score=341.06  Aligned_cols=240  Identities=21%  Similarity=0.265  Sum_probs=195.8

Q ss_pred             hcCCCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEE
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVL  360 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~l  360 (596)
                      ..+|...+.||+|+||+||++.... ++.||||++++.... ......+..|...+....+||||+++++++.+.+.+|+
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            4578889999999999999998765 789999999754321 22344567787666554589999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc-
Q 047719          361 VYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP-  439 (596)
Q Consensus       361 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~-  439 (596)
                      ||||+++|+|.+++....    .+++..++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++.. 
T Consensus        99 v~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~  171 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  171 (353)
T ss_dssp             EEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence            999999999999998653    48999999999999999999999   8999999999999999999999999997642 


Q ss_pred             ----------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccC
Q 047719          440 ----------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRG  509 (596)
Q Consensus       440 ----------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  509 (596)
                                +||+.|+|||.+.+..++.++|||||||++|||++|+.||......  +....... ...          
T Consensus       172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--~~~~~i~~-~~~----------  238 (353)
T 2i0e_A          172 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--ELFQSIME-HNV----------  238 (353)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHH-CCC----------
T ss_pred             ccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH--HHHHHHHh-CCC----------
Confidence                      4899999999999999999999999999999999999999865431  11111111 111          


Q ss_pred             cCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHH
Q 047719          510 KFNRKEMERMLMVGLSCVHPNHEKRPS-----VKEAAR  542 (596)
Q Consensus       510 ~~~~~~~~~l~~l~~~C~~~dp~~RPs-----~~ev~~  542 (596)
                      .++......+.+++..|++.||++||+     ++++++
T Consensus       239 ~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          239 AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            112223356778889999999999995     567654

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.9e-40  Score=368.09  Aligned_cols=235  Identities=23%  Similarity=0.329  Sum_probs=192.5

Q ss_pred             eeecCCceEEEEEEcC---CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecCCC
Q 047719          291 IVGEGASATVYKGSLP---SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPN  367 (596)
Q Consensus       291 ~LG~G~fG~Vy~~~~~---~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  367 (596)
                      .||+|+||.||+|.+.   ++..||||+++... .....+++.+|+..+.+ ++|||||+++++|.. +.+++||||+++
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~-l~hpniv~l~~~~~~-~~~~lv~E~~~~  419 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQ-LDNPYIVRLIGVCQA-EALMLVMEMAGG  419 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTT-CCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHh-CCCCCEeeEEEEecc-CCeEEEEEeCCC
Confidence            7999999999999764   35679999996542 23345678999966654 899999999999976 569999999999


Q ss_pred             CCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcccC-------
Q 047719          368 GSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPA-------  440 (596)
Q Consensus       368 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~~-------  440 (596)
                      |+|.+++....   ..+++..++.++.||+.||+|||+   .+|+||||||+||||+.++.+||+|||++...       
T Consensus       420 g~L~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~  493 (613)
T 2ozo_A          420 GPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY  493 (613)
T ss_dssp             CBHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC------
T ss_pred             CcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCcee
Confidence            99999997643   358999999999999999999999   89999999999999999999999999987532       


Q ss_pred             -------CCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCC
Q 047719          441 -------GTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFN  512 (596)
Q Consensus       441 -------gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  512 (596)
                             +|..|+|||.+....++.++|||||||+||||++ |+.||......-   +......+..         ...+
T Consensus       494 ~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~~~~i~~~~~---------~~~p  561 (613)
T 2ozo_A          494 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMAFIEQGKR---------MECP  561 (613)
T ss_dssp             --------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH---HHHHHHTTCC---------CCCC
T ss_pred             eeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHHHHHcCCC---------CCCC
Confidence                   3468999999999999999999999999999998 999998753311   1111222211         1222


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          513 RKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       513 ~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                      ......+.+|+..||+.||++||++++|++.|+.
T Consensus       562 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~  595 (613)
T 2ozo_A          562 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA  595 (613)
T ss_dssp             TTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHH
T ss_pred             CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            2334567888999999999999999999998875

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=4.3e-39  Score=328.30  Aligned_cols=247  Identities=17%  Similarity=0.186  Sum_probs=197.8

Q ss_pred             cCCCccceeecCCceEEEEEEc-CCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSL-PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      ++|...+.||+|+||.||+|.. .+++.||||++....    ....+.+|+..+....+|+|++++++++.+....++||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   85 (298)
T 1csn_A           10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   85 (298)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC----ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence            4688889999999999999985 468999999986432    33457888877777558999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCc-----eEEccCCCc
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFN-----AKLGDFEAT  437 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~-----~kl~Dfg~~  437 (596)
                      ||+ +++|.+++....   ..+++..++.++.||+.||+|||+   .+|+||||||+|||++.++.     +||+|||++
T Consensus        86 e~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~  158 (298)
T 1csn_A           86 DLL-GPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV  158 (298)
T ss_dssp             ECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred             Eec-CCCHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence            999 999999998753   248999999999999999999999   89999999999999987776     999999975


Q ss_pred             c------------------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChh-HHHHHHHHHhcCC
Q 047719          438 I------------------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV-IVDWVWNLRKKGK  498 (596)
Q Consensus       438 ~------------------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~-~~~~~~~~~~~~~  498 (596)
                      .                  ..||..|+|||.+.+..++.++|||||||++|||++|+.||...... .............
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  238 (298)
T 1csn_A          159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ  238 (298)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred             cccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc
Confidence            3                  24889999999999999999999999999999999999999864321 1111111111000


Q ss_pred             chhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          499 LLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       499 ~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                        ......+...+    ...+.+++..||+.||++||++++|++.|+..
T Consensus       239 --~~~~~~~~~~~----~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~  281 (298)
T 1csn_A          239 --STPLRELCAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKV  281 (298)
T ss_dssp             --HSCHHHHTTTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             --CccHHHHHhhC----cHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence              00000111122    35677888999999999999999999998754

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=3.1e-39  Score=326.82  Aligned_cols=243  Identities=26%  Similarity=0.410  Sum_probs=197.1

Q ss_pred             hcCCCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCchh-cccchHHHHHHHHHhccCCCceeeecceeeeCCeEEE
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRVE-CARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVL  360 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~-~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~l  360 (596)
                      .++|...+.||+|+||.||+|.... +..||||++....... .....+.+|+..+ +.++||||+++++++.+....++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ-SHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHH-TTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHH-HcCCCCCCcchhheEecCCEEEE
Confidence            4568888999999999999997654 7799999986533222 2344577788555 55899999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc--
Q 047719          361 VYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI--  438 (596)
Q Consensus       361 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~--  438 (596)
                      ||||+++|+|.+++....    .+++..++.++.||+.||+|||+   .+++||||||+|||++.++.+||+|||.+.  
T Consensus        87 v~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~  159 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHA  159 (279)
T ss_dssp             EECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred             EEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccC
Confidence            999999999999998653    48999999999999999999999   899999999999999999999999999653  


Q ss_pred             -------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcC
Q 047719          439 -------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKF  511 (596)
Q Consensus       439 -------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  511 (596)
                             ..||..|+|||.+.+..++.++||||||+++|||++|+.||......  +....... .      ..    ..
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~-~------~~----~~  226 (279)
T 3fdn_A          160 PSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ--ETYKRISR-V------EF----TF  226 (279)
T ss_dssp             --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHH-T------CC----CC
T ss_pred             CcccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH--HHHHHHHh-C------CC----CC
Confidence                   35889999999999999999999999999999999999999865321  11111111 1      01    11


Q ss_pred             CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhc
Q 047719          512 NRKEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKG  546 (596)
Q Consensus       512 ~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~~  546 (596)
                      +......+.+++..|++.||++|||++|+++  +++.
T Consensus       227 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~  263 (279)
T 3fdn_A          227 PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA  263 (279)
T ss_dssp             CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHH
T ss_pred             CCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccC
Confidence            1122345678889999999999999999987  4443

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.1e-39  Score=338.47  Aligned_cols=245  Identities=24%  Similarity=0.312  Sum_probs=178.2

Q ss_pred             cceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecCCC
Q 047719          289 NRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPN  367 (596)
Q Consensus       289 ~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  367 (596)
                      .+.||+|+||.||++... +++.||||++.+.     ....+.+|+..+....+||||+++++++.+....|+||||+++
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~   90 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNG   90 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCC
Confidence            478999999999999875 5899999999642     2345677887776644599999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCC---ceEEccCCCcc------
Q 047719          368 GSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEF---NAKLGDFEATI------  438 (596)
Q Consensus       368 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~---~~kl~Dfg~~~------  438 (596)
                      |+|.+++....    .+++.++..++.||+.||+|||+   .+|+||||||+|||++.++   .+||+|||++.      
T Consensus        91 ~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~  163 (325)
T 3kn6_A           91 GELFERIKKKK----HFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN  163 (325)
T ss_dssp             CBHHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--
T ss_pred             CcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC
Confidence            99999998754    48999999999999999999999   8999999999999997765   89999999764      


Q ss_pred             -----cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChh-----HHHHHHHHHhcCCchhhcccccc
Q 047719          439 -----PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV-----IVDWVWNLRKKGKLLDAADFRLR  508 (596)
Q Consensus       439 -----~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~d~~l~  508 (596)
                           ..||..|+|||.+.+..++.++|||||||++|||++|+.||......     ..+ .......+..      ...
T Consensus       164 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~-~~~~i~~~~~------~~~  236 (325)
T 3kn6_A          164 QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVE-IMKKIKKGDF------SFE  236 (325)
T ss_dssp             --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHH-HHHHHTTTCC------CCC
T ss_pred             CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHH-HHHHHHcCCC------CCC
Confidence                 24789999999999999999999999999999999999999764321     111 1111111111      001


Q ss_pred             CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhcCCCCCC
Q 047719          509 GKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKGEAPLPL  552 (596)
Q Consensus       509 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~~~~~~p~  552 (596)
                      ..........+.+|+..|++.||++|||++|+++  +++.....+.
T Consensus       237 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~~~  282 (325)
T 3kn6_A          237 GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSS  282 (325)
T ss_dssp             SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCCCC
T ss_pred             cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccCCC
Confidence            1101122456778889999999999999999975  4555444433

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.7e-39  Score=339.55  Aligned_cols=244  Identities=21%  Similarity=0.307  Sum_probs=194.5

Q ss_pred             hcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      .++|...+.||+|+||.||++... +++.||||++.+...      ...+|++.+.+..+||||+++++++.+....|+|
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv   94 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV   94 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence            456888899999999999999875 588999999965422      2356777777756899999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCC----CceEEccCCCc
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAE----FNAKLGDFEAT  437 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~----~~~kl~Dfg~~  437 (596)
                      |||+++|+|.+++....    .+++..+..++.||+.||+|||+   .+|+||||||+|||+..+    +.+||+|||++
T Consensus        95 ~E~~~gg~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a  167 (342)
T 2qr7_A           95 TELMKGGELLDKILRQK----FFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFA  167 (342)
T ss_dssp             ECCCCSCBHHHHHHTCT----TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTC
T ss_pred             EeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCc
Confidence            99999999999998653    48999999999999999999999   899999999999998543    35999999975


Q ss_pred             c-----------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCCh-hHHHHHHHHHhcCCchhhccc
Q 047719          438 I-----------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGC-VIVDWVWNLRKKGKLLDAADF  505 (596)
Q Consensus       438 ~-----------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~-~~~~~~~~~~~~~~~~~~~d~  505 (596)
                      .           ..||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ...+..... ..+..      
T Consensus       168 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i-~~~~~------  240 (342)
T 2qr7_A          168 KQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARI-GSGKF------  240 (342)
T ss_dssp             EECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHH-HHCCC------
T ss_pred             ccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHH-ccCCc------
Confidence            3           3578999999999888889999999999999999999999976322 122222222 22211      


Q ss_pred             cccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhc
Q 047719          506 RLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKG  546 (596)
Q Consensus       506 ~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~~  546 (596)
                      .+...+.......+.+++..|++.||++|||+.|+++  ++..
T Consensus       241 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  283 (342)
T 2qr7_A          241 SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH  283 (342)
T ss_dssp             CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred             ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence            1111111223356778889999999999999999987  5544

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=4.9e-40  Score=332.48  Aligned_cols=242  Identities=27%  Similarity=0.403  Sum_probs=196.6

Q ss_pred             cCCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      ++|...+.||+|+||.||+|...++..||||++....   ...+.+.+|+..+.. ++||||+++++++. .+..++|||
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~-l~h~~i~~~~~~~~-~~~~~~v~e   87 (279)
T 1qpc_A           13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAEANLMKQ-LQHQRLVRLYAVVT-QEPIYIITE   87 (279)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS---SCHHHHHHHHHHHHH-CCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred             HhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc---ccHHHHHHHHHHHHh-CCCcCcceEEEEEc-CCCcEEEEe
Confidence            4677789999999999999998888899999996432   234568889866655 89999999999986 456899999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc----
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP----  439 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~----  439 (596)
                      |+++++|.+++....  ...+++..++.++.|++.||+|||+   .+++||||||+|||++.++.+||+|||.+..    
T Consensus        88 ~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  162 (279)
T 1qpc_A           88 YMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (279)
T ss_dssp             CCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             cCCCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence            999999999997532  1248999999999999999999999   8999999999999999999999999997642    


Q ss_pred             --------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhccccccCc
Q 047719          440 --------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGK  510 (596)
Q Consensus       440 --------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  510 (596)
                              .++..|+|||.+.+..++.++|||||||++|||++ |+.||......  +...... .+.         ...
T Consensus       163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~~-~~~---------~~~  230 (279)
T 1qpc_A          163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVIQNLE-RGY---------RMV  230 (279)
T ss_dssp             CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHH-TTC---------CCC
T ss_pred             ccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH--HHHHHHh-ccc---------CCC
Confidence                    25678999999998889999999999999999999 99999765321  1111111 111         011


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          511 FNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       511 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                      .+......+.+++..|++.||++|||++++++.|+..
T Consensus       231 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  267 (279)
T 1qpc_A          231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (279)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence            1122235677888999999999999999999988754

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.1e-39  Score=338.12  Aligned_cols=247  Identities=26%  Similarity=0.395  Sum_probs=197.3

Q ss_pred             cCCCccceeecCCceEEEEEEcCC-CCE--EEEEEeecCCchhcccchHHHHHHHHHhcc-CCCceeeecceeeeCCeEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPS-GGA--VAVKRFEKPNRVECARNPFTTEFATMAGCL-RHKNLVQLQGWCCEGNELV  359 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~--vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l-~H~niv~l~g~~~~~~~~~  359 (596)
                      ++|...+.||+|+||.||+|.... +..  ||||++... ........+.+|+..+.+ + +||||+++++++.+.+..+
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~-l~~hp~iv~~~~~~~~~~~~~  102 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCK-LGHHPNIINLLGACEHRGYLY  102 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTT-CCCCTTBCCEEEEEEETTEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc-cchHHHHHHHHHHHHHHh-ccCCCchhhhceeeeeCCceE
Confidence            467888999999999999998653 554  599998643 233455678899976665 6 9999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhhCC------------CCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCC
Q 047719          360 LVYEYLPNGSLDKILHNNS------------SSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEF  427 (596)
Q Consensus       360 lV~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~  427 (596)
                      +||||+++|+|.+++....            .....+++..++.++.||+.||+|||+   .+|+||||||+|||++.++
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~  179 (327)
T 1fvr_A          103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENY  179 (327)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGG
T ss_pred             EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCC
Confidence            9999999999999998653            223468999999999999999999999   8999999999999999999


Q ss_pred             ceEEccCCCccc----------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhc
Q 047719          428 NAKLGDFEATIP----------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKK  496 (596)
Q Consensus       428 ~~kl~Dfg~~~~----------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~  496 (596)
                      .+||+|||++..          .++..|+|||.+....++.++|||||||++|||++ |+.||......  +.. .....
T Consensus       180 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~--~~~-~~~~~  256 (327)
T 1fvr_A          180 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--ELY-EKLPQ  256 (327)
T ss_dssp             CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHH-HHGGG
T ss_pred             eEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH--HHH-HHhhc
Confidence            999999997642          36788999999988889999999999999999998 99999765321  111 11111


Q ss_pred             CCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          497 GKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       497 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                      +.         ....+......+.+++.+||+.||++|||++|+++.|+..
T Consensus       257 ~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  298 (327)
T 1fvr_A          257 GY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  298 (327)
T ss_dssp             TC---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CC---------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            11         1111122335677888999999999999999999988753

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=4e-40  Score=336.86  Aligned_cols=255  Identities=24%  Similarity=0.338  Sum_probs=193.9

Q ss_pred             cCCCccceeecCCceEEEEEEc-----CCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeC--C
Q 047719          284 LGFNKNRIVGEGASATVYKGSL-----PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG--N  356 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~-----~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~--~  356 (596)
                      +.|...+.||+|+||.||++.+     .+++.||||++.... .......+.+|+..+.. ++||||+++++++...  .
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~-l~h~~i~~~~~~~~~~~~~   98 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRN-LYHENIVKYKGICTEDGGN   98 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHT-CCCTTBCCEEEEEEC---C
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHh-CCCCCeeeeeeEEecCCCc
Confidence            3467789999999999999983     358899999996433 23344668889866655 8999999999999877  6


Q ss_pred             eEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCC
Q 047719          357 ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEA  436 (596)
Q Consensus       357 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~  436 (596)
                      ..++||||+++|+|.+++....   ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||.
T Consensus        99 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~  172 (302)
T 4e5w_A           99 GIKLIMEFLPSGSLKEYLPKNK---NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGL  172 (302)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred             eEEEEEEeCCCCcHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECcccc
Confidence            6899999999999999996543   248999999999999999999999   8999999999999999999999999997


Q ss_pred             ccc--------------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHH---hcCCc
Q 047719          437 TIP--------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLR---KKGKL  499 (596)
Q Consensus       437 ~~~--------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~---~~~~~  499 (596)
                      +..              .||..|+|||.+.+..++.++|||||||++|||++|+.|+...............   .....
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  252 (302)
T 4e5w_A          173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL  252 (302)
T ss_dssp             CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHH
T ss_pred             cccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHH
Confidence            632              3667799999999999999999999999999999999986532110000000000   00000


Q ss_pred             hhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          500 LDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       500 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                      ............+......+.+++..||+.||++|||++++++.|+.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  299 (302)
T 4e5w_A          253 VNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA  299 (302)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence            00111111112222334567889999999999999999999999974

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.1e-39  Score=338.57  Aligned_cols=245  Identities=24%  Similarity=0.386  Sum_probs=194.9

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCE----EEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGA----VAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNEL  358 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~----vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~  358 (596)
                      .+|...++||+|+||.||+|... +++.    ||+|.+.... .......+.+|+..+. .++||||++++++|.... .
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~~~~~-~   91 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMA-SVDNPHVCRLLGICLTST-V   91 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHT-TCCBTTBCCCCEEEESSS-E
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHH-hCCCCCeeEEEEEEecCC-c
Confidence            46888899999999999999864 3544    5777775322 2334567888986664 589999999999998765 8


Q ss_pred             EEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc
Q 047719          359 VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI  438 (596)
Q Consensus       359 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~  438 (596)
                      ++|+||+++|+|.+++....   ..+++..++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++.
T Consensus        92 ~~v~~~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~  165 (327)
T 3lzb_A           92 QLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAK  165 (327)
T ss_dssp             EEEECCCSSCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred             eEEEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCccee
Confidence            89999999999999998753   248999999999999999999999   899999999999999999999999999874


Q ss_pred             c-------------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhcc
Q 047719          439 P-------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAAD  504 (596)
Q Consensus       439 ~-------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d  504 (596)
                      .             .+|..|+|||.+.+..++.++|||||||++|||++ |+.||.........   .....+.      
T Consensus       166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~---~~~~~~~------  236 (327)
T 3lzb_A          166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---SILEKGE------  236 (327)
T ss_dssp             --------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---HHHHTTC------
T ss_pred             EccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH---HHHHcCC------
Confidence            3             25678999999999999999999999999999999 99999875432111   1111111      


Q ss_pred             ccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Q 047719          505 FRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEAP  549 (596)
Q Consensus       505 ~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~~~  549 (596)
                         ....+......+.+++..||+.||++||+++|+++.|+....
T Consensus       237 ---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  278 (327)
T 3lzb_A          237 ---RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             ---CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred             ---CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence               111122233457788899999999999999999999987543

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2.9e-39  Score=344.90  Aligned_cols=249  Identities=19%  Similarity=0.239  Sum_probs=190.6

Q ss_pred             CCCcc-ceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeee----CCeE
Q 047719          285 GFNKN-RIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE----GNEL  358 (596)
Q Consensus       285 ~f~~~-~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~----~~~~  358 (596)
                      +|... ++||+|+||+||++... +++.||||++..       ...+.+|+..+.+..+||||+++++++..    ...+
T Consensus        62 ~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~  134 (400)
T 1nxk_A           62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL  134 (400)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-------chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence            44444 68999999999999865 588999999953       23467788777677899999999999876    5679


Q ss_pred             EEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecC---CCceEEccCC
Q 047719          359 VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDA---EFNAKLGDFE  435 (596)
Q Consensus       359 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~---~~~~kl~Dfg  435 (596)
                      ||||||+++|+|.+++....  ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.   ++.+||+|||
T Consensus       135 ~lv~E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG  209 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFG  209 (400)
T ss_dssp             EEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             EEEEEeCCCCcHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEecc
Confidence            99999999999999998653  2358999999999999999999999   89999999999999998   7899999999


Q ss_pred             Ccc----------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhH-HHHHHHHHhcCCchhhcc
Q 047719          436 ATI----------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVI-VDWVWNLRKKGKLLDAAD  504 (596)
Q Consensus       436 ~~~----------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~-~~~~~~~~~~~~~~~~~d  504 (596)
                      ++.          ..||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..........+..     
T Consensus       210 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~-----  284 (400)
T 1nxk_A          210 FAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY-----  284 (400)
T ss_dssp             TCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCC-----
T ss_pred             cccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcc-----
Confidence            764          357999999999999999999999999999999999999997643210 0000011111110     


Q ss_pred             ccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhcCCCCC
Q 047719          505 FRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKGEAPLP  551 (596)
Q Consensus       505 ~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~~~~~~p  551 (596)
                       .............+.+|+..||+.||++|||++|+++  ++......+
T Consensus       285 -~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~  332 (400)
T 1nxk_A          285 -EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP  332 (400)
T ss_dssp             -CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTTTSC
T ss_pred             -cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCCCCC
Confidence             0000001122345778889999999999999999988  455444333

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=3.7e-39  Score=334.72  Aligned_cols=238  Identities=23%  Similarity=0.293  Sum_probs=189.1

Q ss_pred             cCCCccceeecCCceEEEEEEc----CCCCEEEEEEeecCCch--hcccchHHHHHHHHHhccCCCceeeecceeeeCCe
Q 047719          284 LGFNKNRIVGEGASATVYKGSL----PSGGAVAVKRFEKPNRV--ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNE  357 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~----~~g~~vAvK~l~~~~~~--~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~  357 (596)
                      ++|...+.||+|+||.||++..    .+++.||||++++....  ......+.+|+..+.. ++||||+++++++...+.
T Consensus        17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~-l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEE-VKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHH-CCCTTBCCEEEEEECSSC
T ss_pred             HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHh-CCCCCccceeEEEEcCCE
Confidence            4688889999999999999986    46889999999754321  2234457788866655 899999999999999999


Q ss_pred             EEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCc
Q 047719          358 LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT  437 (596)
Q Consensus       358 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~  437 (596)
                      .|+||||+++|+|.+++....    .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~  168 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLEREG----IFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLC  168 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred             EEEEEeCCCCCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence            999999999999999998653    48899999999999999999999   89999999999999999999999999975


Q ss_pred             c-----------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhcccc
Q 047719          438 I-----------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFR  506 (596)
Q Consensus       438 ~-----------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~  506 (596)
                      .           ..||+.|+|||.+.+..++.++|||||||++|||++|+.||......  +........ .      ..
T Consensus       169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~~~-~------~~  239 (327)
T 3a62_A          169 KESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK--KTIDKILKC-K------LN  239 (327)
T ss_dssp             ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHT-C------CC
T ss_pred             cccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHhC-C------CC
Confidence            3           24899999999999989999999999999999999999999865421  111111111 1      01


Q ss_pred             ccCcCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 047719          507 LRGKFNRKEMERMLMVGLSCVHPNHEKRP-----SVKEAAR  542 (596)
Q Consensus       507 l~~~~~~~~~~~l~~l~~~C~~~dp~~RP-----s~~ev~~  542 (596)
                          ++......+.+++.+||+.||++||     +++|+++
T Consensus       240 ----~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          240 ----LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             ----CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             ----CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence                1112234567888899999999999     7778776

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-39  Score=345.16  Aligned_cols=242  Identities=21%  Similarity=0.269  Sum_probs=196.2

Q ss_pred             hcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      .+.|...+.||+|+||.||+|... +|+.||+|++.....  .....+.+|+..+. .++||||+++++++.+....++|
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~E~~il~-~l~hpnIv~~~~~~~~~~~~~lv  126 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP--LDKYTVKNEISIMN-QLHHPKLINLHDAFEDKYEMVLI  126 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH--HHHHHHHHHHHHHT-TCCSTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch--hhHHHHHHHHHHHH-hCCCcCCCeEEEEEEeCCEEEEE
Confidence            356888899999999999999875 588999999965432  23446788986664 58999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecC--CCceEEccCCCccc
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDA--EFNAKLGDFEATIP  439 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~--~~~~kl~Dfg~~~~  439 (596)
                      |||+++|+|.+++....   ..+++..++.++.||+.||+|||+   .+|+||||||+|||++.  ++.+||+|||++..
T Consensus       127 ~E~~~gg~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~  200 (387)
T 1kob_A          127 LEFLSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATK  200 (387)
T ss_dssp             EECCCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred             EEcCCCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEeccccee
Confidence            99999999999997543   248999999999999999999999   89999999999999974  47799999997642


Q ss_pred             ----------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccC
Q 047719          440 ----------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRG  509 (596)
Q Consensus       440 ----------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  509 (596)
                                .||+.|+|||.+.+..++.++|||||||++|||++|+.||......  +......... .      ....
T Consensus       201 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--~~~~~i~~~~-~------~~~~  271 (387)
T 1kob_A          201 LNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL--ETLQNVKRCD-W------EFDE  271 (387)
T ss_dssp             CCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHHHHCC-C------CCCS
T ss_pred             cCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH--HHHHHHHhCC-C------CCCc
Confidence                      4899999999999999999999999999999999999999875421  1111111111 0      0111


Q ss_pred             cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          510 KFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       510 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      .........+.+++..||+.||++|||++|+++
T Consensus       272 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          272 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             cccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence            111122346778889999999999999999987

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-39  Score=331.42  Aligned_cols=242  Identities=23%  Similarity=0.325  Sum_probs=195.1

Q ss_pred             CCCccc-eeecCCceEEEEEEcC---CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEE
Q 047719          285 GFNKNR-IVGEGASATVYKGSLP---SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVL  360 (596)
Q Consensus       285 ~f~~~~-~LG~G~fG~Vy~~~~~---~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~l  360 (596)
                      +|...+ .||+|+||.||+|...   ++..||||+++... .....+.+.+|+..+.. ++||||+++++++ +.+..++
T Consensus        10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~-l~h~~i~~~~~~~-~~~~~~l   86 (287)
T 1u59_A           10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQ-LDNPYIVRLIGVC-QAEALML   86 (287)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHH-CCCTTBCCEEEEE-ESSSEEE
T ss_pred             HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHh-CCCCCEeEEEEEe-cCCCcEE
Confidence            344444 8999999999999753   47789999997542 23345678899977665 8999999999999 5667999


Q ss_pred             EEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc-
Q 047719          361 VYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP-  439 (596)
Q Consensus       361 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~-  439 (596)
                      ||||+++++|.+++....   ..+++..++.++.|++.||.|||+   .+++||||||+|||++.++.+||+|||.+.. 
T Consensus        87 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~  160 (287)
T 1u59_A           87 VMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKAL  160 (287)
T ss_dssp             EEECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEeCCCCCHHHHHHhCC---ccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence            999999999999997543   358999999999999999999999   8999999999999999999999999997642 


Q ss_pred             -------------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhccc
Q 047719          440 -------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADF  505 (596)
Q Consensus       440 -------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~  505 (596)
                                   .+|..|+|||.+.+..++.++|||||||++|||++ |+.||......  +.. .....+..      
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~-~~i~~~~~------  231 (287)
T 1u59_A          161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVM-AFIEQGKR------  231 (287)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHH-HHHHTTCC------
T ss_pred             ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--HHH-HHHhcCCc------
Confidence                         24678999999988889999999999999999999 99999765331  111 11111111      


Q ss_pred             cccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          506 RLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       506 ~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                         ...+......+.+++..||+.||++||++.++++.|+..
T Consensus       232 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  270 (287)
T 1u59_A          232 ---MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  270 (287)
T ss_dssp             ---CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence               112223345677888999999999999999999988753

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.3e-40  Score=352.08  Aligned_cols=253  Identities=22%  Similarity=0.252  Sum_probs=199.6

Q ss_pred             cCHHHHHHHhcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecce
Q 047719          274 LALTDIKQATLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGW  351 (596)
Q Consensus       274 ~~~~el~~at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~  351 (596)
                      +.+.+++...++|...++||+|+||+||+++.. +|+.||||++.+.... ......+.+|...+.. ++||||++++++
T Consensus        51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~-~~hp~Iv~l~~~  129 (412)
T 2vd5_A           51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVN-GDRRWITQLHFA  129 (412)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHH-SCTTTBCCEEEE
T ss_pred             hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHh-cCCCCeeeEEEE
Confidence            445566667789999999999999999999875 5899999999753322 2334567788866655 899999999999


Q ss_pred             eeeCCeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEE
Q 047719          352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKL  431 (596)
Q Consensus       352 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl  431 (596)
                      +.+.+.+||||||+++|+|.+++....   ..+++..+..++.||+.||+|||+   .+|+||||||+||||+.++.+||
T Consensus       130 ~~~~~~~~lVmE~~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL  203 (412)
T 2vd5_A          130 FQDENYLYLVMEYYVGGDLLTLLSKFG---ERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRL  203 (412)
T ss_dssp             EECSSEEEEEECCCCSCBHHHHHHHHS---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEE
T ss_pred             EeeCCEEEEEEcCCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEE
Confidence            999999999999999999999998642   248999999999999999999999   89999999999999999999999


Q ss_pred             ccCCCcc------------cCCCcccCCccccc-------cCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHH
Q 047719          432 GDFEATI------------PAGTMGYLAPEYVY-------SGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWN  492 (596)
Q Consensus       432 ~Dfg~~~------------~~gt~~y~aPE~~~-------~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~  492 (596)
                      +|||++.            .+||+.|+|||.+.       ...++.++|||||||++|||++|+.||......  +....
T Consensus       204 ~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--~~~~~  281 (412)
T 2vd5_A          204 ADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA--ETYGK  281 (412)
T ss_dssp             CCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHH
T ss_pred             eechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH--HHHHH
Confidence            9999752            36899999999987       356899999999999999999999999875431  11111


Q ss_pred             HHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCC---CCHHHHHH
Q 047719          493 LRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKR---PSVKEAAR  542 (596)
Q Consensus       493 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~R---Ps~~ev~~  542 (596)
                      ......  ....+..    .......+.+++.+|++ +|++|   |+++|+++
T Consensus       282 i~~~~~--~~~~p~~----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          282 IVHYKE--HLSLPLV----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             HHTHHH--HCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             HHhccc--CcCCCcc----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            111000  0000111    11223466778889999 99998   58999876

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.1e-39  Score=341.72  Aligned_cols=240  Identities=28%  Similarity=0.389  Sum_probs=193.7

Q ss_pred             cCCCccceeecCCceEEEEEEc-CCCCEEEEEEeecCCc-hhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSL-PSGGAVAVKRFEKPNR-VECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~-~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      ..|...+.||+|+||.||+|.. .+++.||||++..... .....+.+.+|+..+.+ ++||||+++++++.+.+..++|
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~-l~hpniv~~~~~~~~~~~~~lv  132 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK-LRHPNTIQYRGCYLREHTAWLV  132 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHH-CCCTTBCCEEEEEEETTEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHh-CCCCCEeeEEEEEEECCeEEEE
Confidence            3477789999999999999985 4688999999975432 23344568899966655 8999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc---
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI---  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---  438 (596)
                      |||+. |+|.+++....   ..+++..+..++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||++.   
T Consensus       133 ~e~~~-g~l~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~  205 (348)
T 1u5q_A          133 MEYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA  205 (348)
T ss_dssp             EECCS-EEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred             EecCC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence            99997 68988886542   258999999999999999999999   899999999999999999999999999864   


Q ss_pred             ----cCCCcccCCccccc---cCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcC
Q 047719          439 ----PAGTMGYLAPEYVY---SGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKF  511 (596)
Q Consensus       439 ----~~gt~~y~aPE~~~---~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  511 (596)
                          ..||+.|+|||.+.   .+.++.++|||||||++|||++|+.||.....  .+........... .    .....+
T Consensus       206 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~--~~~~~~~~~~~~~-~----~~~~~~  278 (348)
T 1u5q_A          206 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSALYHIAQNESP-A----LQSGHW  278 (348)
T ss_dssp             SBCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHSCCC-C----CCCTTS
T ss_pred             CCCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHhcCCC-C----CCCCCC
Confidence                35899999999985   56789999999999999999999999976532  1222222222110 0    001122


Q ss_pred             CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          512 NRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       512 ~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                          ...+.+++..||+.||++|||++++++
T Consensus       279 ----~~~l~~li~~~l~~dP~~Rps~~~ll~  305 (348)
T 1u5q_A          279 ----SEYFRNFVDSCLQKIPQDRPTSEVLLK  305 (348)
T ss_dssp             ----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ----CHHHHHHHHHHcccChhhCcCHHHHhh
Confidence                245677888999999999999999987

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.8e-39  Score=328.64  Aligned_cols=243  Identities=22%  Similarity=0.233  Sum_probs=192.9

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      +.|...+.||+|+||.||++... ++..||+|++.... .....+.+.+|+..+.+ ++||||+++++++.+....++||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~-l~hp~iv~~~~~~~~~~~~~lv~   99 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR-SQVPMEQIEAEIEVLKS-LDHPNIIKIFEVFEDYHNMYIVM   99 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG-CCSCHHHHHHHHHHHHT-CCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc-cchhHHHHHHHHHHHHh-CCCchHHhHHHheecCCeEEEEE
Confidence            45778899999999999999865 58899999997543 22345678889866655 89999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceee---cCCCceEEccCCCccc
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILL---DAEFNAKLGDFEATIP  439 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl---~~~~~~kl~Dfg~~~~  439 (596)
                      ||+++|+|.+++.........+++..++.++.||+.||+|||+   .+|+||||||+|||+   +.++.+||+|||.+..
T Consensus       100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~  176 (285)
T 3is5_A          100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL  176 (285)
T ss_dssp             CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred             EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence            9999999999996542222358999999999999999999999   899999999999999   4568899999997642


Q ss_pred             ----------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccC
Q 047719          440 ----------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRG  509 (596)
Q Consensus       440 ----------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  509 (596)
                                .||..|+|||.+. +.++.++|||||||++|||++|+.||.......  ..............    ...
T Consensus       177 ~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~--~~~~~~~~~~~~~~----~~~  249 (285)
T 3is5_A          177 FKSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE--VQQKATYKEPNYAV----ECR  249 (285)
T ss_dssp             ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHCCCCCCC------C
T ss_pred             cCCcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH--HHhhhccCCccccc----ccC
Confidence                      4889999999875 568999999999999999999999998754221  11111111100000    001


Q ss_pred             cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          510 KFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       510 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      .+    ...+.+++..|++.||++|||++|+++
T Consensus       250 ~~----~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          250 PL----TPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             CC----CHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             cC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            12    245668889999999999999999975

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.7e-39  Score=337.21  Aligned_cols=256  Identities=22%  Similarity=0.207  Sum_probs=198.7

Q ss_pred             HHHHHhcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCc---hhcccchHHHHHHHHHhccCCCceeeecceee
Q 047719          278 DIKQATLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNR---VECARNPFTTEFATMAGCLRHKNLVQLQGWCC  353 (596)
Q Consensus       278 el~~at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~  353 (596)
                      ++....++|...+.||+|+||.||+|... ++..||||++.+...   .......+.+|+..+.. ++||||+++++++.
T Consensus        20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~hpniv~~~~~~~   98 (345)
T 3hko_A           20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK-LHHPNIARLYEVYE   98 (345)
T ss_dssp             CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHH-CCCTTBCCEEEEEE
T ss_pred             hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHh-CCCCCcceeehhhc
Confidence            35566778999999999999999999865 588999999864321   22344578889966655 89999999999999


Q ss_pred             eCCeEEEEEecCCCCCHHHHhhhCCC------------------------------------CCcccCHHHHHHHHHHHH
Q 047719          354 EGNELVLVYEYLPNGSLDKILHNNSS------------------------------------SSIVLSWEKRLNIVLGVA  397 (596)
Q Consensus       354 ~~~~~~lV~E~~~~gsL~~~l~~~~~------------------------------------~~~~l~~~~~~~i~~~ia  397 (596)
                      +.+..++||||+++|+|.+++.....                                    ....+++..++.++.||+
T Consensus        99 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~  178 (345)
T 3hko_A           99 DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF  178 (345)
T ss_dssp             CSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHH
T ss_pred             cCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHH
Confidence            99999999999999999999952100                                    012346778889999999


Q ss_pred             HHHHHHHhccCCCeEEccCCCCceeecCCC--ceEEccCCCcc---------------cCCCcccCCcccccc--CCCCC
Q 047719          398 SALSYLHEECERQIIHRDVKACNILLDAEF--NAKLGDFEATI---------------PAGTMGYLAPEYVYS--GVPSE  458 (596)
Q Consensus       398 ~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~--~~kl~Dfg~~~---------------~~gt~~y~aPE~~~~--~~~t~  458 (596)
                      .||+|||+   .+|+||||||+|||++.++  .+||+|||++.               ..||+.|+|||.+.+  ..++.
T Consensus       179 ~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  255 (345)
T 3hko_A          179 SALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP  255 (345)
T ss_dssp             HHHHHHHH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCT
T ss_pred             HHHHHHHH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCc
Confidence            99999999   8999999999999998776  89999999763               248899999999875  67899


Q ss_pred             ccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHH
Q 047719          459 KTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVK  538 (596)
Q Consensus       459 ~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~  538 (596)
                      ++|||||||++|||++|+.||......  +..............  +. .    ......+.+++..|++.||++||++.
T Consensus       256 ~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~--~~-~----~~~~~~~~~li~~~l~~~p~~Rps~~  326 (345)
T 3hko_A          256 KCDAWSAGVLLHLLLMGAVPFPGVNDA--DTISQVLNKKLCFEN--PN-Y----NVLSPLARDLLSNLLNRNVDERFDAM  326 (345)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCCCCTTS--GG-G----GGSCHHHHHHHHHHSCSCTTTSCCHH
T ss_pred             HHHHHHHHHHHHHHHHCCCCCCCCChH--HHHHHHHhcccccCC--cc-c----ccCCHHHHHHHHHHcCCChhHCCCHH
Confidence            999999999999999999999865431  122222222111110  00 0    11234567888999999999999999


Q ss_pred             HHHH--HHhc
Q 047719          539 EAAR--ILKG  546 (596)
Q Consensus       539 ev~~--~L~~  546 (596)
                      |+++  +++.
T Consensus       327 ~~l~hp~~~~  336 (345)
T 3hko_A          327 RALQHPWISQ  336 (345)
T ss_dssp             HHHHSHHHHT
T ss_pred             HHhcChhhcc
Confidence            9987  4543

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=4.6e-40  Score=338.41  Aligned_cols=258  Identities=24%  Similarity=0.343  Sum_probs=203.8

Q ss_pred             CHHHHHHHhcCCCccceeecCCceEEEEEEc------CCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeee
Q 047719          275 ALTDIKQATLGFNKNRIVGEGASATVYKGSL------PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL  348 (596)
Q Consensus       275 ~~~el~~at~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l  348 (596)
                      ...+.....++|...+.||+|+||.||+|..      .+++.||||++..... ......+.+|+..+....+||||+++
T Consensus        18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCC-cHHHHHHHHHHHHHHhcccCCCeeeE
Confidence            3444555567899999999999999999973      3467899999965432 23445688899777764489999999


Q ss_pred             cceeeeCC-eEEEEEecCCCCCHHHHhhhCCCC------------CcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEcc
Q 047719          349 QGWCCEGN-ELVLVYEYLPNGSLDKILHNNSSS------------SIVLSWEKRLNIVLGVASALSYLHEECERQIIHRD  415 (596)
Q Consensus       349 ~g~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrD  415 (596)
                      +++|...+ ..++||||+++|+|.+++......            ...+++..++.++.||+.||.|||+   .+|+|||
T Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~d  173 (316)
T 2xir_A           97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRD  173 (316)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSC
T ss_pred             EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCccccc
Confidence            99988765 599999999999999999875431            1238899999999999999999999   8999999


Q ss_pred             CCCCceeecCCCceEEccCCCccc-------------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCC
Q 047719          416 VKACNILLDAEFNAKLGDFEATIP-------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDN  481 (596)
Q Consensus       416 lkp~NiLl~~~~~~kl~Dfg~~~~-------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~  481 (596)
                      |||+|||++.++.+||+|||.+..             .||+.|+|||.+.+..++.++|||||||++|||++ |+.||..
T Consensus       174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~  253 (316)
T 2xir_A          174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  253 (316)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence            999999999999999999997642             25678999999999999999999999999999998 9999976


Q ss_pred             CChhHHHHHHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          482 DGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       482 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                      .....  ........+...     ..    +......+.+++..||+.||++|||++|+++.|+..
T Consensus       254 ~~~~~--~~~~~~~~~~~~-----~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  308 (316)
T 2xir_A          254 VKIDE--EFCRRLKEGTRM-----RA----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  308 (316)
T ss_dssp             CCCSH--HHHHHHHHTCCC-----CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cchhH--HHHHHhccCccC-----CC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            43211  111111111111     11    112234577888999999999999999999998753

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.3e-39  Score=344.16  Aligned_cols=236  Identities=24%  Similarity=0.286  Sum_probs=186.4

Q ss_pred             cCCCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      ++|...+.||+|+||+||+++... ++.||||++.+.... ......+..|...+.+.++|||||++++++.+.+.+|+|
T Consensus        38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv  117 (373)
T 2r5t_A           38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV  117 (373)
T ss_dssp             GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence            467888999999999999998764 889999999764332 223344566665555668999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc---
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI---  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---  438 (596)
                      |||+++|+|.+++....    .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++.   
T Consensus       118 ~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          118 LDYINGGELFYHLQRER----CFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             EECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred             EeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence            99999999999998653    48899999999999999999999   899999999999999999999999999764   


Q ss_pred             --------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCc
Q 047719          439 --------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGK  510 (596)
Q Consensus       439 --------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  510 (596)
                              .+||+.|+|||.+.+..++.++|||||||++|||++|+.||......  +........ .      ..+...
T Consensus       191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--~~~~~i~~~-~------~~~~~~  261 (373)
T 2r5t_A          191 EHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA--EMYDNILNK-P------LQLKPN  261 (373)
T ss_dssp             CCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH--HHHHHHHHS-C------CCCCSS
T ss_pred             cCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHhc-c------cCCCCC
Confidence                    25899999999999999999999999999999999999999865421  111111111 1      111122


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHH
Q 047719          511 FNRKEMERMLMVGLSCVHPNHEKRPSVKE  539 (596)
Q Consensus       511 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~e  539 (596)
                      +    ...+.+++..|++.||++||++.+
T Consensus       262 ~----~~~~~~li~~lL~~dp~~R~~~~~  286 (373)
T 2r5t_A          262 I----TNSARHLLEGLLQKDRTKRLGAKD  286 (373)
T ss_dssp             S----CHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred             C----CHHHHHHHHHHcccCHHhCCCCCC
Confidence            2    345677888999999999999753

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=5.3e-40  Score=340.53  Aligned_cols=255  Identities=24%  Similarity=0.308  Sum_probs=198.8

Q ss_pred             cCCCccceeecCCceEEEEEEc-----CCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceee--eCC
Q 047719          284 LGFNKNRIVGEGASATVYKGSL-----PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCC--EGN  356 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~-----~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~--~~~  356 (596)
                      ++|...+.||+|+||.||++.+     .+++.||||++....  ....+.+.+|+..+.+ ++|+||+++++++.  +..
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~-l~h~~i~~~~~~~~~~~~~   99 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG--PDQQRDFQREIQILKA-LHSDFIVKYRGVSYGPGRQ   99 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC--HHHHHHHHHHHHHHHT-CCCTTBCCEEEEEECSSSC
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC--HHHHHHHHHHHHHHHh-cCCCceeEEEEEEecCCCc
Confidence            4677789999999999999983     357899999996432  3344568889866655 89999999999887  456


Q ss_pred             eEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCC
Q 047719          357 ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEA  436 (596)
Q Consensus       357 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~  436 (596)
                      ..++||||+++++|.+++....   ..+++..++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||.
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~  173 (327)
T 3lxl_A          100 SLRLVMEYLPSGCLRDFLQRHR---ARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGL  173 (327)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGG
T ss_pred             eEEEEEeecCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEccccc
Confidence            7999999999999999998643   248999999999999999999999   8999999999999999999999999997


Q ss_pred             ccc--------------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhc---CCc
Q 047719          437 TIP--------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKK---GKL  499 (596)
Q Consensus       437 ~~~--------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~---~~~  499 (596)
                      +..              .||..|+|||.+.+..++.++|||||||++|||++|+.||.................   ..+
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  253 (327)
T 3lxl_A          174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL  253 (327)
T ss_dssp             CEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHH
T ss_pred             ceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHH
Confidence            642              366779999999988899999999999999999999999865322111000000000   001


Q ss_pred             hhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          500 LDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       500 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                      .+..........+......+.+++..||+.||++|||++|+++.|+..
T Consensus       254 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  301 (327)
T 3lxl_A          254 LELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML  301 (327)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC
T ss_pred             HHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            111111112222333446678889999999999999999999999865

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.1e-39  Score=335.33  Aligned_cols=242  Identities=24%  Similarity=0.279  Sum_probs=196.3

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchh----cccchHHHHHHHHHhccCCCceeeecceeeeCCeE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVE----CARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNEL  358 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~----~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~  358 (596)
                      +.|...+.||+|+||.||++... +|+.||||++.......    .....+.+|+..+.. ++||||+++++++.+....
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ-VLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHH-CCCTTBCCEEEEEECSSEE
T ss_pred             ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHh-CCCCCcceEEEEEecCCEE
Confidence            45788899999999999999875 58899999997543322    134568889866655 8999999999999999999


Q ss_pred             EEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCC----ceEEccC
Q 047719          359 VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEF----NAKLGDF  434 (596)
Q Consensus       359 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~----~~kl~Df  434 (596)
                      ++||||+++++|.+++....    .+++..++.++.|++.||+|||+   .+++||||||+|||++.++    .+||+||
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Df  163 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQKE----SLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTCS----CEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccC
Confidence            99999999999999998643    48999999999999999999999   8999999999999999887    7999999


Q ss_pred             CCcc----------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhcc
Q 047719          435 EATI----------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAAD  504 (596)
Q Consensus       435 g~~~----------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d  504 (596)
                      |.+.          ..||+.|+|||.+.+..++.++|||||||++|||++|+.||......  +......... .  ..+
T Consensus       164 g~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~-~--~~~  238 (321)
T 2a2a_A          164 GLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETLANITSVS-Y--DFD  238 (321)
T ss_dssp             TTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHHHTTC-C--CCC
T ss_pred             ccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHhcc-c--ccC
Confidence            9763          24889999999999999999999999999999999999999765321  1111111110 0  000


Q ss_pred             ccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          505 FRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       505 ~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ......+    ...+.+++..|++.||++|||++|+++
T Consensus       239 ~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          239 EEFFSHT----SELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             HHHHTTC----CHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             hhhhccc----CHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            1111112    245778889999999999999999987

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=4.1e-39  Score=336.67  Aligned_cols=252  Identities=18%  Similarity=0.182  Sum_probs=189.8

Q ss_pred             cCCCccceeecCCceEEEEEEcC----CCCEEEEEEeecCCchh---------cccchHHHHHHHHHhccCCCceeeecc
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP----SGGAVAVKRFEKPNRVE---------CARNPFTTEFATMAGCLRHKNLVQLQG  350 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vAvK~l~~~~~~~---------~~~~~~~~E~~~l~~~l~H~niv~l~g  350 (596)
                      ++|...+.||+|+||.||+|...    .+..||||++.......         .....+.+|+..+. .++||||+++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~-~l~h~ni~~~~~  115 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK-QLDYLGIPLFYG  115 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHH-TCSCCCCCCEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhc-cccccCcceeec
Confidence            56888899999999999999875    46789999987543211         12233556664554 489999999999


Q ss_pred             eeee----CCeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCC
Q 047719          351 WCCE----GNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAE  426 (596)
Q Consensus       351 ~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~  426 (596)
                      ++..    ....|+||||+ +++|.+++....    .+++.+++.++.||+.||+|||+   .+|+||||||+|||++.+
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~  187 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG----TFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYK  187 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG----BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESS
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccC
Confidence            9988    77899999999 999999998653    58999999999999999999999   899999999999999988


Q ss_pred             C--ceEEccCCCcc------------------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCCh--
Q 047719          427 F--NAKLGDFEATI------------------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGC--  484 (596)
Q Consensus       427 ~--~~kl~Dfg~~~------------------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~--  484 (596)
                      +  .+||+|||++.                  ..||..|+|||.+.+..++.++|||||||++|||++|+.||.....  
T Consensus       188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~  267 (345)
T 2v62_A          188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP  267 (345)
T ss_dssp             STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred             CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence            7  99999999763                  2489999999999999999999999999999999999999964221  


Q ss_pred             hHHHHHHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Q 047719          485 VIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEA  548 (596)
Q Consensus       485 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~~  548 (596)
                      ............ ...........   .......+.+++..||+.||++||++++|++.|+...
T Consensus       268 ~~~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  327 (345)
T 2v62_A          268 VAVQTAKTNLLD-ELPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG  327 (345)
T ss_dssp             HHHHHHHHHHHH-TTTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred             HHHHHHHHhhcc-cccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence            111111111111 11111100000   0022346778888999999999999999999998654

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=3.7e-40  Score=340.42  Aligned_cols=256  Identities=25%  Similarity=0.368  Sum_probs=204.1

Q ss_pred             HHHHHHhcCCCccceeecCCceEEEEEEcC------CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecc
Q 047719          277 TDIKQATLGFNKNRIVGEGASATVYKGSLP------SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQG  350 (596)
Q Consensus       277 ~el~~at~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g  350 (596)
                      ++.+...++|...+.||+|+||.||+|...      .+..||||++..... ......+.+|+..+. .++||||+++++
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~-~l~h~~i~~~~~   95 (322)
T 1p4o_A           18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS-MRERIEFLNEASVMK-EFNCHHVVRLLG   95 (322)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC-HHHHHHHHHHHHHGG-GCCCTTBCCEEE
T ss_pred             hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccC-HHHHHHHHHHHHHHH-hcCCCCEeeeEE
Confidence            344455677889999999999999999754      367899999964332 234456888985554 589999999999


Q ss_pred             eeeeCCeEEEEEecCCCCCHHHHhhhCCC------CCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeec
Q 047719          351 WCCEGNELVLVYEYLPNGSLDKILHNNSS------SSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLD  424 (596)
Q Consensus       351 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~  424 (596)
                      ++.+.+..++||||+++|+|.+++.....      ....+++..++.++.||+.||+|||+   .+|+||||||+|||++
T Consensus        96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~  172 (322)
T 1p4o_A           96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVA  172 (322)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEEC
T ss_pred             EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEc
Confidence            99999999999999999999999975321      11347899999999999999999999   8999999999999999


Q ss_pred             CCCceEEccCCCccc-------------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHH
Q 047719          425 AEFNAKLGDFEATIP-------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWV  490 (596)
Q Consensus       425 ~~~~~kl~Dfg~~~~-------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~  490 (596)
                      .++.+||+|||++..             .+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......  +..
T Consensus       173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~  250 (322)
T 1p4o_A          173 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE--QVL  250 (322)
T ss_dssp             TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH--HHH
T ss_pred             CCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH--HHH
Confidence            999999999998642             24678999999999999999999999999999999 89999765321  111


Q ss_pred             HHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Q 047719          491 WNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEAP  549 (596)
Q Consensus       491 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~~~  549 (596)
                       .....+...         ..+......+.+++..||+.||++|||+.|+++.|+....
T Consensus       251 -~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          251 -RFVMEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             -HHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             -HHHHcCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence             111122111         1111233457788899999999999999999999987543

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.4e-40  Score=346.26  Aligned_cols=241  Identities=27%  Similarity=0.404  Sum_probs=188.2

Q ss_pred             CCccceeecCCceEEEEEEcCC----CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeee-CCeEEE
Q 047719          286 FNKNRIVGEGASATVYKGSLPS----GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE-GNELVL  360 (596)
Q Consensus       286 f~~~~~LG~G~fG~Vy~~~~~~----g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~-~~~~~l  360 (596)
                      |...+.||+|+||.||+|.+.+    +..||||.++... .......+.+|+..+ +.++||||++++++|.+ .+..++
T Consensus        91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il-~~l~hpnIv~~~~~~~~~~~~~~l  168 (373)
T 3c1x_A           91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIM-KDFSHPNVLSLLGICLRSEGSPLV  168 (373)
T ss_dssp             EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-CSHHHHHHHHHHTTS-TTCCCTTBCCCCEEECCCSSCCEE
T ss_pred             eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-CHHHHHHHHHHHHHH-HhCCCCCcceEEEEEEcCCCCeEE
Confidence            5566899999999999997632    2368999986432 223456788898555 45899999999998765 457899


Q ss_pred             EEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc-
Q 047719          361 VYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP-  439 (596)
Q Consensus       361 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~-  439 (596)
                      ||||+++|+|.+++....   ..+++..++.++.||++||+|||+   .+|+||||||+|||++.++.+||+|||++.. 
T Consensus       169 v~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~  242 (373)
T 3c1x_A          169 VLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDM  242 (373)
T ss_dssp             EEECCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             EEECCCCCCHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeeccccccc
Confidence            999999999999997643   247899999999999999999999   8999999999999999999999999997642 


Q ss_pred             --------------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCCh-hHHHHHHHHHhcCCchhhc
Q 047719          440 --------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGC-VIVDWVWNLRKKGKLLDAA  503 (596)
Q Consensus       440 --------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~-~~~~~~~~~~~~~~~~~~~  503 (596)
                                    .+|..|+|||.+.+..++.++|||||||++|||++ |.+||..... .....   . ..+...   
T Consensus       243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~---~-~~~~~~---  315 (373)
T 3c1x_A          243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY---L-LQGRRL---  315 (373)
T ss_dssp             ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHH---H-HTTCCC---
T ss_pred             cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHH---H-HcCCCC---
Confidence                          25678999999999999999999999999999999 7788875432 12111   1 111110   


Q ss_pred             cccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          504 DFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       504 d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                            ..+......+.+++..||+.||++|||++|+++.|+..
T Consensus       316 ------~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i  353 (373)
T 3c1x_A          316 ------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  353 (373)
T ss_dssp             ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                  11112234677888999999999999999999999754

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=3.9e-39  Score=348.87  Aligned_cols=240  Identities=25%  Similarity=0.269  Sum_probs=189.0

Q ss_pred             hcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCc-hhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEE
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNR-VECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVL  360 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~l  360 (596)
                      .++|...+.||+|+||.||++... +|+.||||++.+... .......+.+|+..+ +.++||||++++++|.+.+.+|+
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~~iv~l~~~~~~~~~~~l  225 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVL-QNSRHPFLTALKYSFQTHDRLCF  225 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CC-CCCSCTTSCCEEEEEEETTEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHH-HhCCCCeEeeEEEEEeeCCEEEE
Confidence            356888899999999999999864 589999999965321 222334567777444 55899999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc--
Q 047719          361 VYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI--  438 (596)
Q Consensus       361 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~--  438 (596)
                      ||||+++|+|.+++....    .+++..+..++.||+.||+|||+.  .+|+||||||+||||+.++.+||+|||++.  
T Consensus       226 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~--~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~  299 (446)
T 4ejn_A          226 VMEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEG  299 (446)
T ss_dssp             EECCCSSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHH--TCCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred             EEeeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhhc--CCEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence            999999999999998654    489999999999999999999963  689999999999999999999999999764  


Q ss_pred             ---------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccC
Q 047719          439 ---------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRG  509 (596)
Q Consensus       439 ---------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  509 (596)
                               ..||+.|+|||++.+..++.++|||||||++|||++|+.||......  ......... .      ..   
T Consensus       300 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~i~~~-~------~~---  367 (446)
T 4ejn_A          300 IKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFELILME-E------IR---  367 (446)
T ss_dssp             CC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHC-C------CC---
T ss_pred             cCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH--HHHHHHHhC-C------CC---
Confidence                     24899999999999999999999999999999999999999765431  111111111 1      11   


Q ss_pred             cCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 047719          510 KFNRKEMERMLMVGLSCVHPNHEKRP-----SVKEAAR  542 (596)
Q Consensus       510 ~~~~~~~~~l~~l~~~C~~~dp~~RP-----s~~ev~~  542 (596)
                       ++......+.+++..||+.||++||     +++|+++
T Consensus       368 -~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          368 -FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             -CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             -CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence             1112234577888999999999999     9999986

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.6e-39  Score=336.12  Aligned_cols=251  Identities=25%  Similarity=0.346  Sum_probs=187.0

Q ss_pred             hcCCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHH-HhccCCCceeeecceeee-----CC
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATM-AGCLRHKNLVQLQGWCCE-----GN  356 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l-~~~l~H~niv~l~g~~~~-----~~  356 (596)
                      .++|...+.||+|+||.||+|+. +++.||||++....     ...+..|.+.+ ...++|+||+++++++..     ..
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~   85 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM   85 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence            35678889999999999999987 68999999996432     22333343222 234899999999985542     33


Q ss_pred             eEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhcc------CCCeEEccCCCCceeecCCCceE
Q 047719          357 ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC------ERQIIHRDVKACNILLDAEFNAK  430 (596)
Q Consensus       357 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~------~~~ivHrDlkp~NiLl~~~~~~k  430 (596)
                      ..++||||+++|+|.+++....     .++..++.++.||++||+|||+.+      ..+|+||||||+|||++.++.+|
T Consensus        86 ~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  160 (336)
T 3g2f_A           86 EYLLVMEYYPNGSLXKYLSLHT-----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV  160 (336)
T ss_dssp             EEEEEECCCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred             eEEEEEecCCCCcHHHHHhhcc-----cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEE
Confidence            6799999999999999998654     689999999999999999999821      11999999999999999999999


Q ss_pred             EccCCCcc-------------------cCCCcccCCcccccc-------CCCCCccceeehhHHHHHHHhCCCCCCCCCh
Q 047719          431 LGDFEATI-------------------PAGTMGYLAPEYVYS-------GVPSEKTDVYSFGVVALEVAAGKSPVDNDGC  484 (596)
Q Consensus       431 l~Dfg~~~-------------------~~gt~~y~aPE~~~~-------~~~t~~sDV~SfGvll~El~tG~~p~~~~~~  484 (596)
                      |+|||++.                   ..||..|+|||.+.+       ..++.++|||||||++|||++|+.|+.....
T Consensus       161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~  240 (336)
T 3g2f_A          161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES  240 (336)
T ss_dssp             ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred             EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence            99999873                   248999999999976       3567799999999999999999776533211


Q ss_pred             ----------------hHHHHHHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          485 ----------------VIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       485 ----------------~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                                      ...++............. ..  ...........+.+++.+||+.||++|||++|+++.|+..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l  316 (336)
T 3g2f_A          241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKF-PE--AWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL  316 (336)
T ss_dssp             CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCC-CT--TCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             hhHHHHhhhcccCCCchHHHHHhhhcccccCCCC-Cc--ccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence                            001111111111100000 00  0011223566789999999999999999999999998764

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=7.2e-40  Score=332.73  Aligned_cols=245  Identities=24%  Similarity=0.302  Sum_probs=187.8

Q ss_pred             hcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      .++|...+.||+|+||.||++... +|+.||||++....... ...++..|...+.+.++||||+++++++.+.+..++|
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv   84 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQ-EQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC   84 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcH-HHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence            356888899999999999999864 68899999996543333 2334455555666779999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCC-CeEEccCCCCceeecCCCceEEccCCCcc--
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECER-QIIHRDVKACNILLDAEFNAKLGDFEATI--  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~-~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~--  438 (596)
                      |||++ |+|.+++.........+++..++.++.|++.||+|||+   . +++||||||+|||++.++.+||+|||.+.  
T Consensus        85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            99997 59988886532223459999999999999999999999   6 99999999999999999999999999764  


Q ss_pred             --------cCCCcccCCcccc----ccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhcccc
Q 047719          439 --------PAGTMGYLAPEYV----YSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFR  506 (596)
Q Consensus       439 --------~~gt~~y~aPE~~----~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~  506 (596)
                              ..||+.|+|||.+    ....++.++|||||||++|||++|+.||........... ........      .
T Consensus       161 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~------~  233 (290)
T 3fme_A          161 VDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLK-QVVEEPSP------Q  233 (290)
T ss_dssp             ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHH-HHHHSCCC------C
T ss_pred             cccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHH-HHhccCCC------C
Confidence                    2589999999996    456789999999999999999999999986433222211 11111110      0


Q ss_pred             ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          507 LRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       507 l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ..   .......+.+++..|++.||++|||++|+++
T Consensus       234 ~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          234 LP---ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             CC---TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             cc---cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            00   1122345778889999999999999999987

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.7e-39  Score=338.42  Aligned_cols=233  Identities=22%  Similarity=0.293  Sum_probs=193.0

Q ss_pred             hcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchh------cccchHHHHHHHHHhccCCCceeeecceeeeC
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVE------CARNPFTTEFATMAGCLRHKNLVQLQGWCCEG  355 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~------~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~  355 (596)
                      .++|...+.||+|+||.||+|... +++.||||++.......      .....+.+|+..+.. ++||||+++++++.+.
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR-VEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTT-CCCTTBCCEEEEEECS
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHh-CCCCCEeeEEEEEeeC
Confidence            457888999999999999999854 58899999997653221      134467788866654 8999999999999999


Q ss_pred             CeEEEEEecCCCC-CHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccC
Q 047719          356 NELVLVYEYLPNG-SLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF  434 (596)
Q Consensus       356 ~~~~lV~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Df  434 (596)
                      +..++||||+.+| +|.+++....    .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+||
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Df  174 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRHP----RLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDF  174 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTCC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCC
T ss_pred             CEEEEEEEeCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeec
Confidence            9999999999777 9999998754    48999999999999999999999   89999999999999999999999999


Q ss_pred             CCccc----------CCCcccCCccccccCCC-CCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhc
Q 047719          435 EATIP----------AGTMGYLAPEYVYSGVP-SEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAA  503 (596)
Q Consensus       435 g~~~~----------~gt~~y~aPE~~~~~~~-t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  503 (596)
                      |++..          .||+.|+|||.+.+..+ +.++|||||||++|||++|+.||.....                 ..
T Consensus       175 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----------------~~  237 (335)
T 3dls_A          175 GSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-----------------TV  237 (335)
T ss_dssp             TTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-----------------GT
T ss_pred             ccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-----------------HH
Confidence            97642          48999999999988776 8899999999999999999999975311                 00


Q ss_pred             cccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          504 DFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       504 d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ......  +......+.+++..|++.||++|||++|+++
T Consensus       238 ~~~~~~--~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  274 (335)
T 3dls_A          238 EAAIHP--PYLVSKELMSLVSGLLQPVPERRTTLEKLVT  274 (335)
T ss_dssp             TTCCCC--SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hhccCC--CcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            000000  1112345778888999999999999999988

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.5e-39  Score=344.02  Aligned_cols=240  Identities=26%  Similarity=0.251  Sum_probs=188.7

Q ss_pred             ccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecCC
Q 047719          288 KNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLP  366 (596)
Q Consensus       288 ~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~~  366 (596)
                      ..+.||+|+||.||+|... +|+.||||+++....  ...+.+.+|+..+. .++||||++++++|.+.+..+|||||++
T Consensus        93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~-~l~hpnIv~~~~~~~~~~~~~lv~E~~~  169 (373)
T 2x4f_A           93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM--KDKEEVKNEISVMN-QLDHANLIQLYDAFESKNDIVLVMEYVD  169 (373)
T ss_dssp             EEEECC-----CEEEEEETTTCCEEEEEEEECCSH--HHHHHHHHHHHHHT-TCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             cceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc--ccHHHHHHHHHHHH-hCCCCCCCeEEEEEEECCEEEEEEeCCC
Confidence            3578999999999999864 589999999975432  34457889996665 4899999999999999999999999999


Q ss_pred             CCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceee--cCCCceEEccCCCcc------
Q 047719          367 NGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILL--DAEFNAKLGDFEATI------  438 (596)
Q Consensus       367 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl--~~~~~~kl~Dfg~~~------  438 (596)
                      +|+|.+++....   ..+++..++.++.||+.||+|||+   .+|+||||||+|||+  +.++.+||+|||++.      
T Consensus       170 ~~~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~  243 (373)
T 2x4f_A          170 GGELFDRIIDES---YNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE  243 (373)
T ss_dssp             TCEEHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred             CCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence            999999997643   358999999999999999999999   899999999999999  567899999999764      


Q ss_pred             ----cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHH
Q 047719          439 ----PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRK  514 (596)
Q Consensus       439 ----~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  514 (596)
                          ..||+.|+|||.+....++.++|||||||++|||++|+.||......  +...........  . .......    
T Consensus       244 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--~~~~~i~~~~~~--~-~~~~~~~----  314 (373)
T 2x4f_A          244 KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA--ETLNNILACRWD--L-EDEEFQD----  314 (373)
T ss_dssp             BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHHTCCC--S-CSGGGTT----
T ss_pred             ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhccCC--C-Chhhhcc----
Confidence                24899999999999889999999999999999999999999875421  111122111100  0 0000111    


Q ss_pred             HHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHh
Q 047719          515 EMERMLMVGLSCVHPNHEKRPSVKEAAR--ILK  545 (596)
Q Consensus       515 ~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~  545 (596)
                      ....+.+++.+|++.||++|||++|+++  +++
T Consensus       315 ~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~  347 (373)
T 2x4f_A          315 ISEEAKEFISKLLIKEKSWRISASEALKHPWLS  347 (373)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred             CCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcC
Confidence            2346778889999999999999999987  554

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=9.4e-40  Score=330.43  Aligned_cols=241  Identities=30%  Similarity=0.385  Sum_probs=192.7

Q ss_pred             cCCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeC-CeEEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG-NELVLVY  362 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~-~~~~lV~  362 (596)
                      ++|...+.||+|+||.||++.. .|+.||||++....    ..+.+.+|+..+. .++||||+++++++.+. +..++||
T Consensus        21 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~----~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~~lv~   94 (278)
T 1byg_A           21 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA----TAQAFLAEASVMT-QLRHSNLVQLLGVIVEEKGGLYIVT   94 (278)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC------HHHHHTHHHHT-TCCCTTBCCEEEEECCC--CCEEEE
T ss_pred             hhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh----HHHHHHHHHHHHH-hCCCCCEeeEEEEEEcCCCceEEEE
Confidence            4677889999999999999987 58899999986432    3456888986664 58999999999997654 4789999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc---
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP---  439 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~---  439 (596)
                      ||+++|+|.+++....  ...+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||.+..   
T Consensus        95 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  169 (278)
T 1byg_A           95 EYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  169 (278)
T ss_dssp             CCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             ecCCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence            9999999999997643  2237899999999999999999999   8999999999999999999999999997643   


Q ss_pred             -----CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCH
Q 047719          440 -----AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNR  513 (596)
Q Consensus       440 -----~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  513 (596)
                           .++..|+|||.+.+..++.++||||||+++|||++ |+.||......  +.. .....+.         ....+.
T Consensus       170 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~~~-~~~~~~~---------~~~~~~  237 (278)
T 1byg_A          170 TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVV-PRVEKGY---------KMDAPD  237 (278)
T ss_dssp             ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GHH-HHHTTTC---------CCCCCT
T ss_pred             cccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--HHH-HHHhcCC---------CCCCcc
Confidence                 46788999999999999999999999999999998 99999764321  111 1111111         111122


Q ss_pred             HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          514 KEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       514 ~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                      .....+.+++..||+.||++|||+.|+++.|+..
T Consensus       238 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i  271 (278)
T 1byg_A          238 GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  271 (278)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence            2335677888999999999999999999998753

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.7e-39  Score=332.69  Aligned_cols=255  Identities=22%  Similarity=0.303  Sum_probs=192.4

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      ++|...+.||+|+||.||+|... +++.||||++..... ......+.+|+..+ +.++||||+++++++...+..++||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l-~~l~h~~iv~~~~~~~~~~~~~lv~   79 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLL-KDLKHANIVTLHDIIHTEKSLTLVF   79 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHH-SCCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc-cccchhHHHHHHHH-HhcCCCCCCeeeeEEeeCCEEEEEe
Confidence            45778899999999999999875 588999999964332 22233455687555 5589999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc---
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP---  439 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~---  439 (596)
                      ||++ |+|.+++....   ..+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||.+..   
T Consensus        80 e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  152 (324)
T 3mtl_A           80 EYLD-KDLKQYLDDCG---NIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSI  152 (324)
T ss_dssp             ECCS-EEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC--
T ss_pred             cccc-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccC
Confidence            9997 59999998753   258999999999999999999999   8999999999999999999999999997542   


Q ss_pred             --------CCCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCCh-hHHHHHHHHHhcCCchh---hccc-
Q 047719          440 --------AGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGC-VIVDWVWNLRKKGKLLD---AADF-  505 (596)
Q Consensus       440 --------~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~-~~~~~~~~~~~~~~~~~---~~d~-  505 (596)
                              .||..|+|||.+.+ ..++.++|||||||++|||++|+.||..... .....+...........   .... 
T Consensus       153 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  232 (324)
T 3mtl_A          153 PTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE  232 (324)
T ss_dssp             ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCH
T ss_pred             CccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcch
Confidence                    46899999999876 5689999999999999999999999987543 12222222211111000   0000 


Q ss_pred             --------cccC----cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhcC
Q 047719          506 --------RLRG----KFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKGE  547 (596)
Q Consensus       506 --------~l~~----~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~~~  547 (596)
                              ....    .........+.+++..|++.||++|||++|+++  ++...
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  288 (324)
T 3mtl_A          233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL  288 (324)
T ss_dssp             HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred             hhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence                    0000    000112345678899999999999999999988  45443

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=4.2e-39  Score=327.67  Aligned_cols=238  Identities=25%  Similarity=0.354  Sum_probs=190.5

Q ss_pred             CCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeee----CCeEEE
Q 047719          286 FNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE----GNELVL  360 (596)
Q Consensus       286 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~----~~~~~l  360 (596)
                      |...+.||+|+||.||+|... ++..||+|++............+.+|+..+. .++||||+++++++..    ...+++
T Consensus        28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~~~~~l  106 (290)
T 1t4h_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLK-GLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHT-TCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHH-hCCCCCeeeeeeeeccccCCCceEEE
Confidence            556678999999999999865 4789999999765444455667888885554 5899999999999875    456899


Q ss_pred             EEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCC--eEEccCCCCceeec-CCCceEEccCCCc
Q 047719          361 VYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQ--IIHRDVKACNILLD-AEFNAKLGDFEAT  437 (596)
Q Consensus       361 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~--ivHrDlkp~NiLl~-~~~~~kl~Dfg~~  437 (596)
                      ||||+++|+|.+++....    .+++..++.++.||+.||+|||+   .+  ++||||||+|||++ .++.+||+|||++
T Consensus       107 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~  179 (290)
T 1t4h_A          107 VTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA  179 (290)
T ss_dssp             EEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             EEEecCCCCHHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence            999999999999998743    48899999999999999999999   67  99999999999998 7899999999976


Q ss_pred             c---------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhcccccc
Q 047719          438 I---------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLR  508 (596)
Q Consensus       438 ~---------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  508 (596)
                      .         ..||+.|+|||.+. +.++.++|||||||++|||++|+.||...... ....... ..+....    ...
T Consensus       180 ~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~-~~~~~~~----~~~  252 (290)
T 1t4h_A          180 TLKRASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA-AQIYRRV-TSGVKPA----SFD  252 (290)
T ss_dssp             GGCCTTSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-HHHHHHH-TTTCCCG----GGG
T ss_pred             ccccccccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH-HHHHHHH-hccCCcc----ccC
Confidence            3         34899999999876 56999999999999999999999999764321 1111111 1111111    111


Q ss_pred             CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          509 GKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       509 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ...    ...+.+++..||+.||++|||++|+++
T Consensus       253 ~~~----~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          253 KVA----IPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             GCC----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCC----CHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            112    245778889999999999999999986

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=3.3e-39  Score=326.89  Aligned_cols=242  Identities=22%  Similarity=0.278  Sum_probs=196.2

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchh----cccchHHHHHHHHHhccCCCceeeecceeeeCCeE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVE----CARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNEL  358 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~----~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~  358 (596)
                      ++|...+.||+|+||.||++... +++.||||++.......    ...+.+.+|+..+.. ++||||+++++++.+....
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE-IRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHH-CCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHh-CCCCCeeehhheecCCCeE
Confidence            45788899999999999999876 58999999997543322    134568889866655 8999999999999999999


Q ss_pred             EEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCC----ceEEccC
Q 047719          359 VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEF----NAKLGDF  434 (596)
Q Consensus       359 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~----~~kl~Df  434 (596)
                      ++||||+++++|.+++....    .+++..++.++.||+.||.|||+   .+++||||||+||+++.++    .+||+||
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~df  156 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAEKE----SLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDF  156 (283)
T ss_dssp             EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEeecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEec
Confidence            99999999999999997643    48999999999999999999999   8999999999999998877    8999999


Q ss_pred             CCccc----------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhcc
Q 047719          435 EATIP----------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAAD  504 (596)
Q Consensus       435 g~~~~----------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d  504 (596)
                      |.+..          .||+.|+|||.+....++.++||||||+++|||++|+.||......  +....... ...  ...
T Consensus       157 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~-~~~--~~~  231 (283)
T 3bhy_A          157 GIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ--ETLTNISA-VNY--DFD  231 (283)
T ss_dssp             TTCEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHT-TCC--CCC
T ss_pred             ccceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH--HHHHHhHh-ccc--CCc
Confidence            97642          4789999999999899999999999999999999999999875321  11111111 100  000


Q ss_pred             ccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          505 FRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       505 ~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ......    ....+.+++.+|++.||++|||+.|+++
T Consensus       232 ~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          232 EEYFSN----TSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             HHHHTT----CCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             chhccc----CCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence            001111    2345778889999999999999999987

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.5e-39  Score=342.36  Aligned_cols=240  Identities=23%  Similarity=0.243  Sum_probs=189.1

Q ss_pred             hcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      .++|...+.||+|+||.||++... +++.||||++....   .....+.+|+..+.. ++||||+++++++.+.+..++|
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~-l~hpniv~~~~~~~~~~~~~lv   94 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA---AIDENVQREIINHRS-LRHPNIVRFKEVILTPTHLAII   94 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST---TSCHHHHHHHHHHHH-CCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc---cccHHHHHHHHHHHh-CCCCCCCcEEEEEeeCCEEEEE
Confidence            456888899999999999999876 58999999996533   223457888866655 8999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCc--eEEccCCCcc-
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFN--AKLGDFEATI-  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~--~kl~Dfg~~~-  438 (596)
                      |||+++|+|.+++....    .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.  +||+|||++. 
T Consensus        95 ~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~  167 (361)
T 3uc3_A           95 MEYASGGELYERICNAG----RFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKS  167 (361)
T ss_dssp             EECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred             EEeCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence            99999999999997653    48999999999999999999999   89999999999999988765  9999999764 


Q ss_pred             ---------cCCCcccCCccccccCCCCCc-cceeehhHHHHHHHhCCCCCCCCCh--hHHHHHHHHHhcCCchhhcccc
Q 047719          439 ---------PAGTMGYLAPEYVYSGVPSEK-TDVYSFGVVALEVAAGKSPVDNDGC--VIVDWVWNLRKKGKLLDAADFR  506 (596)
Q Consensus       439 ---------~~gt~~y~aPE~~~~~~~t~~-sDV~SfGvll~El~tG~~p~~~~~~--~~~~~~~~~~~~~~~~~~~d~~  506 (596)
                               ..||+.|+|||.+.+..++.+ +|||||||++|||++|+.||.....  ..............       .
T Consensus       168 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~-------~  240 (361)
T 3uc3_A          168 SVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY-------S  240 (361)
T ss_dssp             -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCC-------C
T ss_pred             ccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCC-------C
Confidence                     348999999999988777655 8999999999999999999976422  12222211111110       0


Q ss_pred             ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          507 LRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       507 l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ..  ........+.+|+.+||+.||++|||++|+++
T Consensus       241 ~~--~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          241 IP--DDIRISPECCHLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             CC--TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             CC--CcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence            00  00012345678889999999999999999987

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=2.3e-39  Score=328.08  Aligned_cols=242  Identities=26%  Similarity=0.323  Sum_probs=194.7

Q ss_pred             hcCCCccceeecCCceEEEEEEcCC----CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeE
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLPS----GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNEL  358 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~  358 (596)
                      .++|...+.||+|+||.||+|....    +..||||.+..... ....+.+.+|+..+.. ++||||+++++++.+ +..
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~-l~h~~i~~~~~~~~~-~~~   87 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCT-LDNKEKFMSEAVIMKN-LDHPHIVKLIGIIEE-EPT   87 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSC-HHHHHHHHHHHHHHHH-HCCTTBCCEEEEECS-SSC
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccC-chHHHHHHHHHHHHHh-CCCCCcceEEEEEcC-CCC
Confidence            4568888999999999999997532    33699999965432 2345678889866655 899999999999865 457


Q ss_pred             EEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc
Q 047719          359 VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI  438 (596)
Q Consensus       359 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~  438 (596)
                      ++||||+++++|.+++....   ..+++..++.++.|++.||+|||+   .+++||||||+|||++.++.+||+|||.+.
T Consensus        88 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  161 (281)
T 3cc6_A           88 WIIMELYPYGELGHYLERNK---NSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSR  161 (281)
T ss_dssp             EEEEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred             EEEEecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCc
Confidence            89999999999999997643   248999999999999999999999   899999999999999999999999999764


Q ss_pred             c------------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCCh-hHHHHHHHHHhcCCchhhcc
Q 047719          439 P------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGC-VIVDWVWNLRKKGKLLDAAD  504 (596)
Q Consensus       439 ~------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~-~~~~~~~~~~~~~~~~~~~d  504 (596)
                      .            .+|..|+|||.+.+..++.++|||||||++|||++ |+.||..... .....   . ..+...    
T Consensus       162 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~---~-~~~~~~----  233 (281)
T 3cc6_A          162 YIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGV---L-EKGDRL----  233 (281)
T ss_dssp             CC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHH---H-HHTCCC----
T ss_pred             ccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHH---H-hcCCCC----
Confidence            2            35678999999998999999999999999999998 9999975432 22111   1 111110    


Q ss_pred             ccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          505 FRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       505 ~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                           ..+......+.+++..||+.||++|||+.|+++.|+.
T Consensus       234 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~  270 (281)
T 3cc6_A          234 -----PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSD  270 (281)
T ss_dssp             -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -----CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHH
Confidence                 1111223457788899999999999999999999875

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=4.2e-39  Score=328.85  Aligned_cols=243  Identities=27%  Similarity=0.390  Sum_probs=191.6

Q ss_pred             cCCCccceeecCCceEEEEEEcCC----CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeee-CCeE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPS----GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE-GNEL  358 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~-~~~~  358 (596)
                      ..|...+.||+|+||.||+|...+    ...||+|.+.... .......+.+|+..+.+ ++||||++++++|.+ .+..
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~-~~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~  102 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKD-FSHPNVLSLLGICLRSEGSP  102 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC-SHHHHHHHHHHHHHHHT-CCCTTBCCCCEEECCSSSCC
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC-CHHHHHHHHHHHHHHHh-CCCCCEeeeeeEEEcCCCce
Confidence            456778999999999999998643    2358999986432 22344568889866654 899999999998654 5678


Q ss_pred             EEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc
Q 047719          359 VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI  438 (596)
Q Consensus       359 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~  438 (596)
                      ++||||+++|+|.+++....   ..+++..++.++.|++.||+|||+   .+++||||||+|||++.++.+||+|||.+.
T Consensus       103 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~  176 (298)
T 3f66_A          103 LVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLAR  176 (298)
T ss_dssp             EEEEECCTTCBHHHHHHCTT---CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGC
T ss_pred             EEEEeCCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECcccccc
Confidence            99999999999999997643   348899999999999999999999   899999999999999999999999999764


Q ss_pred             c---------------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCCh-hHHHHHHHHHhcCCchh
Q 047719          439 P---------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGC-VIVDWVWNLRKKGKLLD  501 (596)
Q Consensus       439 ~---------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~-~~~~~~~~~~~~~~~~~  501 (596)
                      .               .||..|+|||.+.+..++.++|||||||++|||++ |.+||..... ....   .... +..  
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~---~~~~-~~~--  250 (298)
T 3f66_A          177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV---YLLQ-GRR--  250 (298)
T ss_dssp             CCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHH---HHHT-TCC--
T ss_pred             cccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHH---HHhc-CCC--
Confidence            2               25678999999999999999999999999999999 6666665332 1111   1111 110  


Q ss_pred             hccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          502 AADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       502 ~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                             ...+......+.+++..||+.||++|||++|+++.|+..
T Consensus       251 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~  289 (298)
T 3f66_A          251 -------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  289 (298)
T ss_dssp             -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                   001111234577888999999999999999999999764

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=3.2e-39  Score=332.41  Aligned_cols=242  Identities=24%  Similarity=0.315  Sum_probs=190.1

Q ss_pred             cCCCccceeecCCceEEEEEEc-CCCCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCC----e
Q 047719          284 LGFNKNRIVGEGASATVYKGSL-PSGGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGN----E  357 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~----~  357 (596)
                      ++|...+.||+|+||.||++.. .+++.||||++...... ......+.+|+..+ ..++||||+++++++....    .
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l-~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNA-AALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTC-CCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHH-HcCCCCCcceEEEeeeccCCCCcc
Confidence            4688889999999999999986 46889999999754322 22334677887544 5589999999999987654    3


Q ss_pred             EEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCc
Q 047719          358 LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT  437 (596)
Q Consensus       358 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~  437 (596)
                      .|+||||+++|+|.+++....    .+++.+++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a  163 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIA  163 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred             cEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence            499999999999999998654    48999999999999999999999   89999999999999999999999999976


Q ss_pred             cc--------------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhc
Q 047719          438 IP--------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAA  503 (596)
Q Consensus       438 ~~--------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  503 (596)
                      ..              .||..|+|||.+.+..++.++|||||||++|||++|+.||......  +.............. 
T Consensus       164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~--~~~~~~~~~~~~~~~-  240 (311)
T 3ork_A          164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV--SVAYQHVREDPIPPS-  240 (311)
T ss_dssp             ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHCCCCCHH-
T ss_pred             ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHhcCCCCCcc-
Confidence            42              3799999999999999999999999999999999999999875432  222222222111100 


Q ss_pred             cccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          504 DFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       504 d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                        .....    ....+.+++.+||+.||++||+..++++
T Consensus       241 --~~~~~----~~~~l~~li~~~l~~dP~~R~~~~~~l~  273 (311)
T 3ork_A          241 --ARHEG----LSADLDAVVLKALAKNPENRYQTAAEMR  273 (311)
T ss_dssp             --HHSTT----CCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred             --cccCC----CCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence              00111    2345678889999999999997665543

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2.5e-39  Score=327.49  Aligned_cols=240  Identities=23%  Similarity=0.383  Sum_probs=194.9

Q ss_pred             hcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeee-------
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE-------  354 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~-------  354 (596)
                      ..+|...+.||+|+||.||+|... +++.||||++....      ..+.+|+..+.. ++||||+++++++..       
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~~~   82 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAK-LDHVNIVHYNGCWDGFDYDPET   82 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHH-CCCTTBCCEEEEEEEEEEC---
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHh-CCCCCEEEEeeeEeccccCccc
Confidence            346888899999999999999876 68999999996432      346788866655 899999999998864       


Q ss_pred             ---------CCeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecC
Q 047719          355 ---------GNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDA  425 (596)
Q Consensus       355 ---------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~  425 (596)
                               ....++||||+++|+|.+++....  ...+++..++.++.||+.||.|||+   .+++||||||+|||++.
T Consensus        83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~  157 (284)
T 2a19_B           83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVD  157 (284)
T ss_dssp             ------CCEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEE
T ss_pred             ccccccccCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcC
Confidence                     456899999999999999997653  2358999999999999999999999   89999999999999999


Q ss_pred             CCceEEccCCCcc----------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHh
Q 047719          426 EFNAKLGDFEATI----------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRK  495 (596)
Q Consensus       426 ~~~~kl~Dfg~~~----------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~  495 (596)
                      ++.+||+|||.+.          ..||+.|+|||.+.+..++.++|||||||++|||++|..|+....    .+ .....
T Consensus       158 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----~~-~~~~~  232 (284)
T 2a19_B          158 TKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS----KF-FTDLR  232 (284)
T ss_dssp             TTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH----HH-HHHHH
T ss_pred             CCCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH----HH-HHHhh
Confidence            9999999999653          348899999999999999999999999999999999998864311    11 11111


Q ss_pred             cCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCC
Q 047719          496 KGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEAPLP  551 (596)
Q Consensus       496 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~~~~p  551 (596)
                      .+.        +...++    ..+.+++.+||+.||++|||+.|+++.|+.....+
T Consensus       233 ~~~--------~~~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~  276 (284)
T 2a19_B          233 DGI--------ISDIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP  276 (284)
T ss_dssp             TTC--------CCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred             ccc--------ccccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence            111        112233    34667888999999999999999999998665433

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=6.3e-39  Score=324.15  Aligned_cols=239  Identities=24%  Similarity=0.349  Sum_probs=176.8

Q ss_pred             cCCCccceeecCCceEEEEEEc-CCCCEEEEEEeecCCchh-cccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSL-PSGGAVAVKRFEKPNRVE-CARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~-~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      ++|...+.||+|+||.||+|.. .+|+.||||++....... .....+.+|+..+ +.++||||+++++++.+.+..++|
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIH-CQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHH-TTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHH-HhCCCCCeEeEEEEEccCCeEEEE
Confidence            4688889999999999999986 468999999996433222 2235678888555 558999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc---
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI---  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---  438 (596)
                      |||+++++|.+++....   ..+++..++.++.|+++||+|||+   .+++||||||+|||++.++.+||+|||.+.   
T Consensus        90 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~  163 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRV---KPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLK  163 (278)
T ss_dssp             EECCTTEEHHHHHHTCS---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EecCCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence            99999999999998653   358999999999999999999999   899999999999999999999999999764   


Q ss_pred             --------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCc
Q 047719          439 --------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGK  510 (596)
Q Consensus       439 --------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  510 (596)
                              ..||+.|+|||.+.+..++.++|||||||++|||++|+.||......-      ......   ..+...   
T Consensus       164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~---~~~~~~---  231 (278)
T 3cok_A          164 MPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN------TLNKVV---LADYEM---  231 (278)
T ss_dssp             ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------CC---SSCCCC---
T ss_pred             CCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH------HHHHHh---hcccCC---
Confidence                    247889999999998889999999999999999999999997643210      000000   001111   


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          511 FNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       511 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                       +......+.+++.+|++.||++|||++++++
T Consensus       232 -~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          232 -PSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             -CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             -ccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence             1122345678889999999999999999876

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.5e-38  Score=350.36  Aligned_cols=244  Identities=21%  Similarity=0.256  Sum_probs=197.6

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchh-cccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVE-CARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~-~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      ++|...++||+|+||+||+++.. +|+.||||++.+..... .....+.+|+..+.. ++||||+++++++.+...+|+|
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~-l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAK-VHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHH-CCCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHh-cCCCCEeeEEEEEeeCCEEEEE
Confidence            56777889999999999999875 58999999997543222 234567888866655 8999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc---
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI---  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---  438 (596)
                      |||+++|+|.+++.........+++..++.++.||+.||+|||+   .+|+||||||+||||+.++.+||+|||++.   
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            99999999999998755434469999999999999999999999   899999999999999999999999999763   


Q ss_pred             --------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCCh--hHHHHHHHHHhcCCchhhcccccc
Q 047719          439 --------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGC--VIVDWVWNLRKKGKLLDAADFRLR  508 (596)
Q Consensus       439 --------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~--~~~~~~~~~~~~~~~~~~~d~~l~  508 (596)
                              ..||+.|+|||.+.+..++.++|||||||++|||++|+.||.....  ............ .          
T Consensus       341 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~-~----------  409 (543)
T 3c4z_A          341 AGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ-A----------  409 (543)
T ss_dssp             TTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC-C----------
T ss_pred             CCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc-c----------
Confidence                    2689999999999999999999999999999999999999976432  111111111111 1          


Q ss_pred             CcCCHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHH
Q 047719          509 GKFNRKEMERMLMVGLSCVHPNHEKRPSV-----KEAAR  542 (596)
Q Consensus       509 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~-----~ev~~  542 (596)
                      ..++......+.+++..|++.||++||++     +++++
T Consensus       410 ~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          410 VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence            11122233566778889999999999975     56654

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=5.7e-40  Score=340.27  Aligned_cols=248  Identities=24%  Similarity=0.336  Sum_probs=196.7

Q ss_pred             hcCCCccceeecCCceEEEEEEcC------CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCC
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLP------SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGN  356 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~  356 (596)
                      .++|...+.||+|+||.||+|...      ++..||||++.... .......+.+|+..+.+ ++||||+++++++.+..
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~  106 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISK-FNHQNIVRCIGVSLQSL  106 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC-CHHHHHHHHHHHHHHHH-CCCTTBCCEEEEECSSS
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc-chhhHHHHHHHHHHHhh-CCCCCCCeEEEEEcCCC
Confidence            457888999999999999999842      46789999996432 23345578889866655 89999999999999999


Q ss_pred             eEEEEEecCCCCCHHHHhhhCCCC---CcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecC---CCceE
Q 047719          357 ELVLVYEYLPNGSLDKILHNNSSS---SIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDA---EFNAK  430 (596)
Q Consensus       357 ~~~lV~E~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~---~~~~k  430 (596)
                      ..++||||+++|+|.+++......   ...+++..++.++.||+.||.|||+   .+++||||||+|||++.   +..+|
T Consensus       107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~k  183 (327)
T 2yfx_A          107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAK  183 (327)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEE
Confidence            999999999999999999875421   2358999999999999999999999   89999999999999984   45699


Q ss_pred             EccCCCcc-------------cCCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhc
Q 047719          431 LGDFEATI-------------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKK  496 (596)
Q Consensus       431 l~Dfg~~~-------------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~  496 (596)
                      |+|||.+.             ..||..|+|||.+.+..++.++|||||||++|||++ |+.||......  +.. .....
T Consensus       184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~-~~~~~  260 (327)
T 2yfx_A          184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--EVL-EFVTS  260 (327)
T ss_dssp             ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHH-HHHHT
T ss_pred             ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH--HHH-HHHhc
Confidence            99998653             246788999999999999999999999999999998 99999765321  111 11111


Q ss_pred             CCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          497 GKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       497 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                      +...         ..+......+.+++..||+.||++||++.++++.|+..
T Consensus       261 ~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          261 GGRM---------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             TCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCC---------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            1111         11112234677888999999999999999999988754

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=8.6e-39  Score=347.67  Aligned_cols=249  Identities=22%  Similarity=0.242  Sum_probs=191.8

Q ss_pred             hcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeC------
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG------  355 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~------  355 (596)
                      .++|...+.||+|+||.||+|... +++.||||++.+..........+.+|+..+.. ++|||||++++++...      
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~-l~hpnIv~l~~~~~~~~~~~~~  139 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKC-VNHKNIISLLNVFTPQKTLEEF  139 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHH-CCCTTBCCCSEEECSCCSTTTC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHh-CCCCCCCcEEEEEccCCccccC
Confidence            356888899999999999999765 58899999997654444556678899866655 8999999999998654      


Q ss_pred             CeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCC
Q 047719          356 NELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFE  435 (596)
Q Consensus       356 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg  435 (596)
                      ...|||||||++ +|.+.+..      .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||
T Consensus       140 ~~~~lv~E~~~~-~l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG  209 (464)
T 3ttj_A          140 QDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG  209 (464)
T ss_dssp             CEEEEEEECCSE-EHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred             CeEEEEEeCCCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEE
Confidence            468999999976 57777743      28899999999999999999999   899999999999999999999999999


Q ss_pred             Ccc----------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChh-HHHHHHHHHhcC------C
Q 047719          436 ATI----------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV-IVDWVWNLRKKG------K  498 (596)
Q Consensus       436 ~~~----------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~-~~~~~~~~~~~~------~  498 (596)
                      ++.          ..||+.|+|||.+.+..++.++|||||||++|||++|+.||.+.+.. ...-+.......      .
T Consensus       210 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~  289 (464)
T 3ttj_A          210 LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  289 (464)
T ss_dssp             CC-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred             eeeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            764          35899999999999999999999999999999999999999875421 110010100000      0


Q ss_pred             c-------------------hhhcccccc---CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          499 L-------------------LDAADFRLR---GKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       499 ~-------------------~~~~d~~l~---~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      +                   .......+.   ..........+.+|+.+|++.||++|||++|+++
T Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             SCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0                   000000000   0001122467889999999999999999999987

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=2.6e-39  Score=336.03  Aligned_cols=251  Identities=24%  Similarity=0.341  Sum_probs=196.6

Q ss_pred             cCCCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      ++|...+.||+|+||.||++.... |+.||||++............+.+|+..+.. ++||||+++++++.+.+..++||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQ-LRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHH-CCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhh-CCCCCEeeEEEEeecCCEEEEEE
Confidence            457778999999999999998754 8999999997655444445567788866655 89999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc----
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI----  438 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~----  438 (596)
                      ||+++++|.+++....    .+++..+..++.||+.||+|||+   .+++||||||+|||++.++.+||+|||.+.    
T Consensus       104 e~~~~~~l~~~~~~~~----~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  176 (331)
T 4aaa_A          104 EFVDHTILDDLELFPN----GLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA  176 (331)
T ss_dssp             ECCSEEHHHHHHHSTT----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             ecCCcchHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence            9999999998876543    48999999999999999999999   899999999999999999999999999763    


Q ss_pred             -------cCCCcccCCccccccC-CCCCccceeehhHHHHHHHhCCCCCCCCChhH-HHHHHH-----------HHhcCC
Q 047719          439 -------PAGTMGYLAPEYVYSG-VPSEKTDVYSFGVVALEVAAGKSPVDNDGCVI-VDWVWN-----------LRKKGK  498 (596)
Q Consensus       439 -------~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~-~~~~~~-----------~~~~~~  498 (596)
                             ..||..|+|||.+.+. .++.++|||||||++|||++|+.||....... ......           ......
T Consensus       177 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (331)
T 4aaa_A          177 PGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP  256 (331)
T ss_dssp             -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred             CccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcc
Confidence                   2478999999999875 78999999999999999999999998754311 110100           000000


Q ss_pred             -chhhccccccCcCC-----HHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          499 -LLDAADFRLRGKFN-----RKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       499 -~~~~~d~~l~~~~~-----~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                       ......+......+     ......+.+++.+||+.||++|||++|+++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence             00000011111111     122456788999999999999999999876

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.1e-38  Score=331.99  Aligned_cols=252  Identities=24%  Similarity=0.330  Sum_probs=197.5

Q ss_pred             HHHhcCCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhc-cCCCceeeecceeeeCC--
Q 047719          280 KQATLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGC-LRHKNLVQLQGWCCEGN--  356 (596)
Q Consensus       280 ~~at~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~-l~H~niv~l~g~~~~~~--  356 (596)
                      ....++|...+.||+|+||.||+|.. +++.||||++...     ....+.+|.+.+... ++||||+++++++....  
T Consensus        38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~  111 (342)
T 1b6c_B           38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGT  111 (342)
T ss_dssp             HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred             ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence            34456799999999999999999987 5899999999532     234566777555443 79999999999998876  


Q ss_pred             --eEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhcc-----CCCeEEccCCCCceeecCCCce
Q 047719          357 --ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC-----ERQIIHRDVKACNILLDAEFNA  429 (596)
Q Consensus       357 --~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~-----~~~ivHrDlkp~NiLl~~~~~~  429 (596)
                        ..++||||+++|+|.+++...     .+++..++.++.|++.||+|||...     ..+|+||||||+|||++.++.+
T Consensus       112 ~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~  186 (342)
T 1b6c_B          112 WTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC  186 (342)
T ss_dssp             CCCEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCE
T ss_pred             cceeEEEEeecCCCcHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCE
Confidence              899999999999999999864     3899999999999999999999210     1899999999999999999999


Q ss_pred             EEccCCCcc---------------cCCCcccCCccccccCC------CCCccceeehhHHHHHHHhC----------CCC
Q 047719          430 KLGDFEATI---------------PAGTMGYLAPEYVYSGV------PSEKTDVYSFGVVALEVAAG----------KSP  478 (596)
Q Consensus       430 kl~Dfg~~~---------------~~gt~~y~aPE~~~~~~------~t~~sDV~SfGvll~El~tG----------~~p  478 (596)
                      ||+|||++.               ..||..|+|||.+.+..      ++.++|||||||++|||++|          +.|
T Consensus       187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p  266 (342)
T 1b6c_B          187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP  266 (342)
T ss_dssp             EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence            999999752               25889999999987652      34789999999999999999          778


Q ss_pred             CCCCCh---hHHHHHHHHHhcCCchhhccccccCc-CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          479 VDNDGC---VIVDWVWNLRKKGKLLDAADFRLRGK-FNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       479 ~~~~~~---~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                      |.....   ....+..... ....    .+.+... ...+....+.+|+.+||+.||++|||++||++.|+..
T Consensus       267 ~~~~~~~~~~~~~~~~~~~-~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i  334 (342)
T 1b6c_B          267 YYDLVPSDPSVEEMRKVVC-EQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  334 (342)
T ss_dssp             TTTTSCSSCCHHHHHHHHT-TSCC----CCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccccCcCcccHHHHHHHHH-HHHh----CCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence            765321   2222222111 1111    1111111 1235677889999999999999999999999999754

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=9.5e-40  Score=338.67  Aligned_cols=245  Identities=26%  Similarity=0.312  Sum_probs=179.7

Q ss_pred             hcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceee--------
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCC--------  353 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~--------  353 (596)
                      ..+|...++||+|+||.||++... +++.||||++....  ......+.+|+..+.+..+||||+++++++.        
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~  104 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE--EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT  104 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS--HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc--hHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence            446788899999999999999865 58999999985432  2344567888877766335999999999984        


Q ss_pred             eCCeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCC--eEEccCCCCceeecCCCceEE
Q 047719          354 EGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQ--IIHRDVKACNILLDAEFNAKL  431 (596)
Q Consensus       354 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~--ivHrDlkp~NiLl~~~~~~kl  431 (596)
                      .....++||||+. |+|.+++..... ...+++..++.++.||+.||+|||+   .+  |+||||||+|||++.++.+||
T Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~kl  179 (337)
T 3ll6_A          105 GQAEFLLLTELCK-GQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIKL  179 (337)
T ss_dssp             SSEEEEEEEECCS-EEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEEB
T ss_pred             CCceEEEEEEecC-CCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEEE
Confidence            3456899999995 799999875321 2258999999999999999999999   77  999999999999999999999


Q ss_pred             ccCCCccc-----------------------CCCcccCCcccc---ccCCCCCccceeehhHHHHHHHhCCCCCCCCChh
Q 047719          432 GDFEATIP-----------------------AGTMGYLAPEYV---YSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV  485 (596)
Q Consensus       432 ~Dfg~~~~-----------------------~gt~~y~aPE~~---~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~  485 (596)
                      +|||++..                       .||+.|+|||.+   .+..++.++|||||||++|||++|+.||......
T Consensus       180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~  259 (337)
T 3ll6_A          180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL  259 (337)
T ss_dssp             CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred             ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence            99998643                       378899999998   4667899999999999999999999999753211


Q ss_pred             HHHHHHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Q 047719          486 IVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEAP  549 (596)
Q Consensus       486 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~~~  549 (596)
                        ...    .. .    ........    ....+..++..||+.||++|||++|+++.|+....
T Consensus       260 --~~~----~~-~----~~~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~  308 (337)
T 3ll6_A          260 --RIV----NG-K----YSIPPHDT----QYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA  308 (337)
T ss_dssp             -----------------CCCCTTCC----SSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --Hhh----cC-c----ccCCcccc----cchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence              000    00 0    00000111    12346678899999999999999999999976543

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=6.4e-39  Score=328.46  Aligned_cols=237  Identities=26%  Similarity=0.377  Sum_probs=195.9

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      ..|...+.||+|+||.||+|... +++.||||++..... ....+.+.+|+..+.. ++||||+++++++.+....++||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~   99 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQ-CDSPYVTKYYGSYLKDTKLWIIM   99 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC-STTHHHHHHHHHHHHH-CCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc-HHHHHHHHHHHHHHHh-CCCCCEeEEEEEEecCCeEEEEE
Confidence            45788899999999999999764 588999999975432 2345668888866655 89999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc----
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI----  438 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~----  438 (596)
                      ||+++++|.+++...     .+++..++.++.|++.||.|||+   .+++||||||+|||++.++.+||+|||.+.    
T Consensus       100 e~~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  171 (303)
T 3a7i_A          100 EYLGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD  171 (303)
T ss_dssp             ECCTTEEHHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred             EeCCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCc
Confidence            999999999999753     48999999999999999999999   899999999999999999999999999763    


Q ss_pred             -------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcC
Q 047719          439 -------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKF  511 (596)
Q Consensus       439 -------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  511 (596)
                             ..||..|+|||.+.+..++.++|||||||++|||++|+.||.......  ...... ...     .+.+...+
T Consensus       172 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~-~~~-----~~~~~~~~  243 (303)
T 3a7i_A          172 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK--VLFLIP-KNN-----PPTLEGNY  243 (303)
T ss_dssp             TBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHH-HSC-----CCCCCSSC
T ss_pred             cccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH--HHHHhh-cCC-----CCCCcccc
Confidence                   247889999999999999999999999999999999999997653211  111111 111     11122223


Q ss_pred             CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          512 NRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       512 ~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      +    ..+.+++..||+.||++|||++|+++
T Consensus       244 ~----~~l~~li~~~l~~dp~~Rps~~~ll~  270 (303)
T 3a7i_A          244 S----KPLKEFVEACLNKEPSFRPTAKELLK  270 (303)
T ss_dssp             C----HHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             C----HHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            3    45778889999999999999999987

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.4e-39  Score=335.88  Aligned_cols=242  Identities=24%  Similarity=0.257  Sum_probs=192.8

Q ss_pred             cCCCccceeecCCceEEEEEEc----CCCCEEEEEEeecCCc--hhcccchHHHHHHHHHhccCCCceeeecceeeeCCe
Q 047719          284 LGFNKNRIVGEGASATVYKGSL----PSGGAVAVKRFEKPNR--VECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNE  357 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~----~~g~~vAvK~l~~~~~--~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~  357 (596)
                      .+|...+.||+|+||.||++..    .+++.||||++++...  .......+.+|+..+....+||||+++++++.....
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            4688889999999999999986    3689999999864322  112334566787666663479999999999999999


Q ss_pred             EEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCc
Q 047719          358 LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT  437 (596)
Q Consensus       358 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~  437 (596)
                      .+|||||+++|+|.+++....    .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus       134 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~a  206 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLS  206 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             EEEEeecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence            999999999999999998653    48999999999999999999999   89999999999999999999999999975


Q ss_pred             c------------cCCCcccCCcccccc--CCCCCccceeehhHHHHHHHhCCCCCCCCCh--hHHHHHHHHHhcCCchh
Q 047719          438 I------------PAGTMGYLAPEYVYS--GVPSEKTDVYSFGVVALEVAAGKSPVDNDGC--VIVDWVWNLRKKGKLLD  501 (596)
Q Consensus       438 ~------------~~gt~~y~aPE~~~~--~~~t~~sDV~SfGvll~El~tG~~p~~~~~~--~~~~~~~~~~~~~~~~~  501 (596)
                      .            ..||+.|+|||.+.+  ..++.++|||||||++|||++|+.||.....  .............    
T Consensus       207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~----  282 (355)
T 1vzo_A          207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE----  282 (355)
T ss_dssp             EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC----
T ss_pred             eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccC----
Confidence            3            248999999999985  3578999999999999999999999975321  2222221111110    


Q ss_pred             hccccccCcCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHH
Q 047719          502 AADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRP-----SVKEAARI  543 (596)
Q Consensus       502 ~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RP-----s~~ev~~~  543 (596)
                             ..++......+.+++.+||+.||++||     +++|+++.
T Consensus       283 -------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h  322 (355)
T 1vzo_A          283 -------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  322 (355)
T ss_dssp             -------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             -------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence                   112223335577888999999999999     99999873

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=7.7e-39  Score=336.26  Aligned_cols=251  Identities=24%  Similarity=0.332  Sum_probs=196.4

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      ++|...+.||+|+||.||++... ++..||+|++.... .......+.+|+..+. .++||||+++++++...+..++||
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~  110 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLH-ECNSPYIVGFYGAFYSDGEISICM  110 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGG-GCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHH-HCCCCCEEEEeEEEEECCEEEEEE
Confidence            45788899999999999999876 58899999997543 2334556888885554 489999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc----
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI----  438 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~----  438 (596)
                      ||+++|+|.+++....    .+++..+..++.|++.||+|||+.  .+|+||||||+|||++.++.+||+|||++.    
T Consensus       111 e~~~~~~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  184 (360)
T 3eqc_A          111 EHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  184 (360)
T ss_dssp             CCCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             ECCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence            9999999999998754    488999999999999999999982  289999999999999999999999999763    


Q ss_pred             -----cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcC----------------
Q 047719          439 -----PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKG----------------  497 (596)
Q Consensus       439 -----~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~----------------  497 (596)
                           ..||..|+|||.+.+..++.++|||||||++|||++|+.||.................+                
T Consensus       185 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (360)
T 3eqc_A          185 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL  264 (360)
T ss_dssp             HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------
T ss_pred             ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcc
Confidence                 36899999999999999999999999999999999999999865432211111000000                


Q ss_pred             -----------Cchhhcccc----ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          498 -----------KLLDAADFR----LRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       498 -----------~~~~~~d~~----l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                                 ...+..+..    ............+.+++..|++.||++|||++|+++
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          265 NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             ---------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             cccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                       000000000    000001112345778889999999999999999987

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=7.1e-39  Score=323.61  Aligned_cols=240  Identities=20%  Similarity=0.239  Sum_probs=193.5

Q ss_pred             hcCCCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      .+.|...+.||+|+||.||+|.... +..||+|++....  ....+.+.+|+..+.. ++||||+++++++.+....++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~E~~~l~~-l~h~~i~~~~~~~~~~~~~~lv   84 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF--VEDVDRFKQEIEIMKS-LDHPNIIRLYETFEDNTDIYLV   84 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG--CSCHHHHHHHHHHHHT-CCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhc--cchHHHHHHHHHHHHh-CCCCCEeeEEEEEecCCeEEEE
Confidence            3468888999999999999998764 7799999996532  2334568889866655 8999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceee---cCCCceEEccCCCcc
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILL---DAEFNAKLGDFEATI  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl---~~~~~~kl~Dfg~~~  438 (596)
                      |||+++++|.+++....    .+++..++.++.|++.||+|||+   .+++||||||+|||+   +.++.+||+|||.+.
T Consensus        85 ~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~  157 (277)
T 3f3z_A           85 MELCTGGELFERVVHKR----VFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA  157 (277)
T ss_dssp             EECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EeccCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccce
Confidence            99999999999998654    48999999999999999999999   899999999999999   788999999999763


Q ss_pred             ----------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhcccccc
Q 047719          439 ----------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLR  508 (596)
Q Consensus       439 ----------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  508 (596)
                                ..||+.|+|||.+.+ .++.++||||||+++|||++|+.||......  +...... .+.... .. ...
T Consensus       158 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~-~~~~~~-~~-~~~  231 (277)
T 3f3z_A          158 RFKPGKMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDS--EVMLKIR-EGTFTF-PE-KDW  231 (277)
T ss_dssp             ECCTTSCBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHH-HCCCCC-CH-HHH
T ss_pred             eccCccchhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHH--HHHHHHH-hCCCCC-Cc-hhh
Confidence                      358999999998865 4899999999999999999999999875431  1111111 111100 00 000


Q ss_pred             CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          509 GKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       509 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      .    .....+.+++..|++.||++|||+.++++
T Consensus       232 ~----~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          232 L----NVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             T----TSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             h----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0    12346778889999999999999999976

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.5e-39  Score=327.54  Aligned_cols=242  Identities=22%  Similarity=0.307  Sum_probs=191.2

Q ss_pred             CCCccceeecCCceEEEEEEcCC-C---CEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeE-E
Q 047719          285 GFNKNRIVGEGASATVYKGSLPS-G---GAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNEL-V  359 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~~-g---~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~-~  359 (596)
                      .|...++||+|+||.||+|...+ +   ..||+|++.... .....+.+.+|+..+.. ++||||+++++++.+.+.. +
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~~   99 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-EMQQVEAFLREGLLMRG-LNHPNVLALIGIMLPPEGLPH   99 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC-SHHHHHHHHHHHHHHHT-CCCTTBCCCCEEECCSSSCCE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc-cHHHHHHHHHHHHHHHh-CCCCCeeeEEEEEecCCCCcE
Confidence            34556899999999999997533 2   379999986432 22345678889866655 8999999999999876665 9


Q ss_pred             EEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc
Q 047719          360 LVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP  439 (596)
Q Consensus       360 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~  439 (596)
                      +||||+.+|+|.+++....   ..+++..++.++.|++.||+|||+   .+++||||||+|||++.++.+||+|||.+..
T Consensus       100 ~v~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~  173 (298)
T 3pls_A          100 VLLPYMCHGDLLQFIRSPQ---RNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARD  173 (298)
T ss_dssp             EEECCCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCT
T ss_pred             EEEecccCCCHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCccc
Confidence            9999999999999998643   358899999999999999999999   8999999999999999999999999998742


Q ss_pred             ---------------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCC-CCCCCh-hHHHHHHHHHhcCCchhh
Q 047719          440 ---------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSP-VDNDGC-VIVDWVWNLRKKGKLLDA  502 (596)
Q Consensus       440 ---------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p-~~~~~~-~~~~~~~~~~~~~~~~~~  502 (596)
                                     .+|..|+|||.+.+..++.++|||||||++|||++|..| +..... .....    ......   
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~----~~~~~~---  246 (298)
T 3pls_A          174 ILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHF----LAQGRR---  246 (298)
T ss_dssp             TTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHH----HHTTCC---
T ss_pred             ccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHH----hhcCCC---
Confidence                           357789999999999999999999999999999995544 544322 11111    111110   


Q ss_pred             ccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          503 ADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       503 ~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                            ...+......+.+++..|++.||++|||++++++.|+..
T Consensus       247 ------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~  285 (298)
T 3pls_A          247 ------LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI  285 (298)
T ss_dssp             ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                  111112234677888999999999999999999988754

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=6.3e-39  Score=325.39  Aligned_cols=243  Identities=24%  Similarity=0.359  Sum_probs=197.8

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      ++|...+.||+|+||.||+|... ++..||||++...... ......+.+|+..+.. ++||||+++++++.+.+..++|
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSH-LRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHT-CCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhc-CCCCCEeeEEEEEEcCCEEEEE
Confidence            46788899999999999999875 4778999999643222 2234567888866554 8999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc---
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI---  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---  438 (596)
                      |||+++|+|.+++....    .+++..++.++.||+.||.|||+   .+++||||||+||+++.++.+||+|||.+.   
T Consensus        93 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~  165 (284)
T 2vgo_A           93 LEFAPRGELYKELQKHG----RFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAP  165 (284)
T ss_dssp             ECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred             EEeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence            99999999999998753    48999999999999999999999   899999999999999999999999999753   


Q ss_pred             ------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCC
Q 047719          439 ------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFN  512 (596)
Q Consensus       439 ------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  512 (596)
                            ..||..|+|||.+.+..++.++||||||+++|||++|+.||......  +...... ..      +......  
T Consensus       166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~-~~------~~~~~~~--  234 (284)
T 2vgo_A          166 SLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT--ETHRRIV-NV------DLKFPPF--  234 (284)
T ss_dssp             SSCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHH-TT------CCCCCTT--
T ss_pred             ccccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh--HHHHHHh-cc------ccCCCCc--
Confidence                  35889999999999989999999999999999999999999865321  1111111 11      1111122  


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhcC
Q 047719          513 RKEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKGE  547 (596)
Q Consensus       513 ~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~~~  547 (596)
                        ....+.+++..|++.||++||+++++++  +++..
T Consensus       235 --~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~  269 (284)
T 2vgo_A          235 --LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN  269 (284)
T ss_dssp             --SCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred             --CCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence              2345678889999999999999999987  55543

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=6.4e-39  Score=333.02  Aligned_cols=253  Identities=22%  Similarity=0.288  Sum_probs=188.2

Q ss_pred             HHhcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEE
Q 047719          281 QATLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELV  359 (596)
Q Consensus       281 ~at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~  359 (596)
                      ...++|...+.||+|+||+||+|... +++.||||++............+.+|+..+. .++||||+++++++.+....+
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~  109 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLK-ELQHRNIIELKSVIHHNHRLH  109 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGG-GCCCTTBCCEEEEEEETTEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHH-HcCCCCcceEEEEEecCCEEE
Confidence            34567889999999999999999754 5889999999765544444556778885554 489999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeec-----CCCceEEccC
Q 047719          360 LVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLD-----AEFNAKLGDF  434 (596)
Q Consensus       360 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~-----~~~~~kl~Df  434 (596)
                      +||||++ |+|.+++....    .+++..+..++.||+.||+|||+   .+|+||||||+|||++     .++.+||+||
T Consensus       110 lv~e~~~-~~L~~~~~~~~----~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Df  181 (329)
T 3gbz_A          110 LIFEYAE-NDLKKYMDKNP----DVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDF  181 (329)
T ss_dssp             EEEECCS-EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCT
T ss_pred             EEEecCC-CCHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcC
Confidence            9999997 59999998764    48999999999999999999999   8999999999999994     5556999999


Q ss_pred             CCcc-----------cCCCcccCCccccccC-CCCCccceeehhHHHHHHHhCCCCCCCCChhH-HHHHHHHHhcCCchh
Q 047719          435 EATI-----------PAGTMGYLAPEYVYSG-VPSEKTDVYSFGVVALEVAAGKSPVDNDGCVI-VDWVWNLRKKGKLLD  501 (596)
Q Consensus       435 g~~~-----------~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~-~~~~~~~~~~~~~~~  501 (596)
                      |.+.           ..||..|+|||.+.+. .++.++|||||||++|||++|+.||....... ..-............
T Consensus       182 g~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  261 (329)
T 3gbz_A          182 GLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT  261 (329)
T ss_dssp             THHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             CCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhh
Confidence            9753           2468999999999874 58999999999999999999999998754311 111111111000000


Q ss_pred             h------cc-----ccccCc-----CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          502 A------AD-----FRLRGK-----FNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       502 ~------~d-----~~l~~~-----~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      .      .+     +.....     ........+.+++..|++.||++|||++|+++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          262 WPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             STTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            0      00     000000     00012256678899999999999999999987

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=8.8e-39  Score=335.02  Aligned_cols=245  Identities=19%  Similarity=0.156  Sum_probs=192.8

Q ss_pred             cCCCccceeecCCceEEEEEEcCC---------CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceee-------
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPS---------GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQ-------  347 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~---------g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~-------  347 (596)
                      ++|...+.||+|+||.||+|....         ++.||||++...       ..+.+|+..+.. ++||||++       
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~-l~h~niv~~~~~~~~  113 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQR-AAKPLQVNKWKKLYS  113 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHH-HCCHHHHHHHHHHTT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHH-hcccchhhhhhhhcc
Confidence            568888999999999999998764         789999998643       357888866655 89999988       


Q ss_pred             --------ecceeee-CCeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCC
Q 047719          348 --------LQGWCCE-GNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKA  418 (596)
Q Consensus       348 --------l~g~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp  418 (596)
                              +++++.. ....++||||+ +++|.+++....  ...+++..++.++.||+.||+|||+   .+|+||||||
T Consensus       114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp  187 (352)
T 2jii_A          114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTA  187 (352)
T ss_dssp             CTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCG
T ss_pred             CCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCH
Confidence                    5667766 67899999999 999999998752  2359999999999999999999999   8999999999


Q ss_pred             CceeecCCC--ceEEccCCCccc------------------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCC
Q 047719          419 CNILLDAEF--NAKLGDFEATIP------------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSP  478 (596)
Q Consensus       419 ~NiLl~~~~--~~kl~Dfg~~~~------------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p  478 (596)
                      +|||++.++  .+||+|||++..                  .||+.|+|||.+.+..++.++|||||||++|||++|+.|
T Consensus       188 ~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p  267 (352)
T 2jii_A          188 ENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP  267 (352)
T ss_dssp             GGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred             HHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            999999998  999999997632                  588999999999998999999999999999999999999


Q ss_pred             CCCCCh---hHHHHHHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          479 VDNDGC---VIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       479 ~~~~~~---~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                      |.....   .+...........  ....+.....   ......+.+++..||+.||++||+++++++.|+..
T Consensus       268 f~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  334 (352)
T 2jii_A          268 WTNCLPNTEDIMKQKQKFVDKP--GPFVGPCGHW---IRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEAL  334 (352)
T ss_dssp             TGGGTTCHHHHHHHHHHHHHSC--CCEECTTSCE---ECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             cccCCcCHHHHHHHHHhccCCh--hhhhhhcccc---CCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHH
Confidence            976431   1111111111111  1111110000   01125677888899999999999999999988754

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=2.2e-38  Score=322.52  Aligned_cols=241  Identities=25%  Similarity=0.379  Sum_probs=190.6

Q ss_pred             CCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          285 GFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      .|....+||+|+||.||+|... ++..||||++....  ....+.+.+|+..+. .++||||+++++++.+.+..++|||
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e   99 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHK-HLKHKNIVQYLGSFSENGFIKIFME   99 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHH-TCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHH-hCCCCCEeeEeeEEEeCCcEEEEEE
Confidence            3555679999999999999864 58899999996532  234456888886665 4899999999999999999999999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecC-CCceEEccCCCcc----
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDA-EFNAKLGDFEATI----  438 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~-~~~~kl~Dfg~~~----  438 (596)
                      |+++++|.+++..... ...+++..+..++.||+.||+|||+   .+++||||||+|||++. ++.+||+|||.+.    
T Consensus       100 ~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~  175 (295)
T 2clq_A          100 QVPGGSLSALLRSKWG-PLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG  175 (295)
T ss_dssp             CCSEEEHHHHHHHTTC-CCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred             eCCCCCHHHHHHhhcc-CCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence            9999999999987532 3357789999999999999999999   89999999999999988 8999999999763    


Q ss_pred             -------cCCCcccCCccccccCC--CCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccC
Q 047719          439 -------PAGTMGYLAPEYVYSGV--PSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRG  509 (596)
Q Consensus       439 -------~~gt~~y~aPE~~~~~~--~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  509 (596)
                             ..||..|+|||.+....  ++.++|||||||++|||++|+.||........... ......         ...
T Consensus       176 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~---------~~~  245 (295)
T 2clq_A          176 INPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF-KVGMFK---------VHP  245 (295)
T ss_dssp             -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHH-HHHHHC---------CCC
T ss_pred             CCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHH-hhcccc---------ccc
Confidence                   24788999999987643  88999999999999999999999975332211111 110000         111


Q ss_pred             cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          510 KFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       510 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ..+......+.+++..||+.||++||+++++++
T Consensus       246 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          246 EIPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            122223356778889999999999999999976

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.2e-38  Score=323.87  Aligned_cols=249  Identities=22%  Similarity=0.240  Sum_probs=196.5

Q ss_pred             hcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchh-cccchHHHHHHHHHhccCCCceeeecceeeeCCeEEE
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVE-CARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVL  360 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~-~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~l  360 (596)
                      .++|...+.||+|+||.||++... +++.||||++....... .....+.+|+..+ +.++||||+++++++...+..++
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l-~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTA-GRLQEPHVVPIHDFGEIDGQLYV  111 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHH-TTCCCTTBCCEEEEEEETTEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHH-hhcCCCCeeEEEEEEeeCCeEEE
Confidence            457888999999999999999865 58899999986543222 2335678888555 45899999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc--
Q 047719          361 VYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI--  438 (596)
Q Consensus       361 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~--  438 (596)
                      ||||+++++|.+++....    .+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||.+.  
T Consensus       112 v~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~  184 (309)
T 2h34_A          112 DMRLINGVDLAAMLRRQG----PLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASAT  184 (309)
T ss_dssp             EEECCCCEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred             EEEecCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence            999999999999998653    48999999999999999999999   899999999999999999999999999753  


Q ss_pred             ----------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhcccccc
Q 047719          439 ----------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLR  508 (596)
Q Consensus       439 ----------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  508 (596)
                                ..||..|+|||.+.+..++.++||||||+++|||++|+.||......   ........... .   +   
T Consensus       185 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~-~---~---  254 (309)
T 2h34_A          185 TDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS---VMGAHINQAIP-R---P---  254 (309)
T ss_dssp             ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH---HHHHHHHSCCC-C---G---
T ss_pred             cccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH---HHHHHhccCCC-C---c---
Confidence                      24788999999999999999999999999999999999999875322   11111111110 0   0   


Q ss_pred             CcCCHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHhcCCC
Q 047719          509 GKFNRKEMERMLMVGLSCVHPNHEKRP-SVKEAARILKGEAP  549 (596)
Q Consensus       509 ~~~~~~~~~~l~~l~~~C~~~dp~~RP-s~~ev~~~L~~~~~  549 (596)
                      ..........+.+++.+||+.||++|| +++++++.|+....
T Consensus       255 ~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~  296 (309)
T 2h34_A          255 STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA  296 (309)
T ss_dssp             GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred             cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence            011112234567788999999999999 99999999986544

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-38  Score=334.30  Aligned_cols=254  Identities=20%  Similarity=0.268  Sum_probs=191.3

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCC------
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGN------  356 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~------  356 (596)
                      ..|...+.||+|+||.||+|... +|+.||||++..........+.+.+|+..+.. ++||||+++++++....      
T Consensus        25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~-l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKH-MRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHH-CCBTTBCCCSEEECSCSSTTTCC
T ss_pred             ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHh-CCCcCCCCceeeEecCCccccCc
Confidence            56788899999999999999864 58999999996554444455678899966655 89999999999998653      


Q ss_pred             eEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCC
Q 047719          357 ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEA  436 (596)
Q Consensus       357 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~  436 (596)
                      ..|+||||+ +++|.+++...     .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  174 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGL  174 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeec
Confidence            469999999 88999999864     38899999999999999999999   8999999999999999999999999997


Q ss_pred             cc--------cCCCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCChh-HHHHHHHHHhcCCc-------
Q 047719          437 TI--------PAGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV-IVDWVWNLRKKGKL-------  499 (596)
Q Consensus       437 ~~--------~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~-~~~~~~~~~~~~~~-------  499 (596)
                      +.        ..||..|+|||.+.+ ..++.++|||||||++|||++|+.||.+.... ..............       
T Consensus       175 a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~  254 (367)
T 1cm8_A          175 ARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ  254 (367)
T ss_dssp             CEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred             ccccccccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence            64        358899999999887 68999999999999999999999999875421 11111111000000       


Q ss_pred             -----------hhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhcCC
Q 047719          500 -----------LDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKGEA  548 (596)
Q Consensus       500 -----------~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~~~~  548 (596)
                                 .......+. .........+.+|+.+|++.||++|||++|+++  +++...
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~  315 (367)
T 1cm8_A          255 SDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  315 (367)
T ss_dssp             CHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             hHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence                       000000000 011122356778889999999999999999988  555443

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.2e-38  Score=346.18  Aligned_cols=182  Identities=22%  Similarity=0.320  Sum_probs=149.9

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeC-----Ce
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG-----NE  357 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~-----~~  357 (596)
                      ++|...+.||+|+||.||+|... +++.||||++.+........+.+.+|+..+.. ++|||||++++++...     ..
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNR-LNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHH-CCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHh-CCCCCCCceEEEEecCCcccCce
Confidence            56888899999999999999765 58999999997654444455678899977665 8999999999998543     57


Q ss_pred             EEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCc
Q 047719          358 LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT  437 (596)
Q Consensus       358 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~  437 (596)
                      +|+||||+ +|+|.+++....    .+++..+..++.||+.||+|||+   .+|+||||||+||||+.++.+||+|||++
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla  203 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRTPV----YLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLA  203 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHSSC----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEecc-ccchhhhcccCC----CCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccc
Confidence            99999998 579999997653    48999999999999999999999   89999999999999999999999999987


Q ss_pred             cc--------------------------------------CCCcccCCcccc-ccCCCCCccceeehhHHHHHHHh
Q 047719          438 IP--------------------------------------AGTMGYLAPEYV-YSGVPSEKTDVYSFGVVALEVAA  474 (596)
Q Consensus       438 ~~--------------------------------------~gt~~y~aPE~~-~~~~~t~~sDV~SfGvll~El~t  474 (596)
                      ..                                      +||+.|+|||++ ....++.++|||||||+||||++
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt  279 (458)
T 3rp9_A          204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN  279 (458)
T ss_dssp             BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred             hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence            43                                      358899999986 45679999999999999999999

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.1e-39  Score=334.69  Aligned_cols=251  Identities=26%  Similarity=0.363  Sum_probs=195.2

Q ss_pred             cCCCccceeecCCceEEEEEEc-----CCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCC--
Q 047719          284 LGFNKNRIVGEGASATVYKGSL-----PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGN--  356 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~-----~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~--  356 (596)
                      .+|...+.||+|+||.||++.+     .+++.||||++...  .....+.+.+|+..+.. ++||||+++++++...+  
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~  117 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKS-LQHDNIVKYKGVCYSAGRR  117 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHT-CCCTTBCCEEEEECC----
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHh-CCCCCeeeEEEEEEecCCC
Confidence            4577789999999999999983     35889999999643  23345578899966655 89999999999987654  


Q ss_pred             eEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCC
Q 047719          357 ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEA  436 (596)
Q Consensus       357 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~  436 (596)
                      ..++||||+++++|.+++....   ..+++..++.++.||+.||+|||+   .+++||||||+|||++.++.+||+|||+
T Consensus       118 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~  191 (326)
T 2w1i_A          118 NLKLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGL  191 (326)
T ss_dssp             CCEEEECCCTTCBHHHHHHHST---TSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred             ceEEEEECCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcc
Confidence            6899999999999999998753   248999999999999999999999   8999999999999999999999999997


Q ss_pred             ccc--------------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcC-----
Q 047719          437 TIP--------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKG-----  497 (596)
Q Consensus       437 ~~~--------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~-----  497 (596)
                      +..              .++..|+|||.+.+..++.++|||||||++|||++|+.|+........+.    ....     
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~----~~~~~~~~~  267 (326)
T 2w1i_A          192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM----IGNDKQGQM  267 (326)
T ss_dssp             CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHH----HCTTCCTHH
T ss_pred             hhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHh----hccccchhh
Confidence            642              25567999999998889999999999999999999999886421111100    0000     


Q ss_pred             ---CchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          498 ---KLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       498 ---~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                         .+.+..........+......+.+++..||+.||++|||++|+++.|+..
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l  320 (326)
T 2w1i_A          268 IVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI  320 (326)
T ss_dssp             HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             hHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence               00011111111112223345678889999999999999999999998753

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.7e-38  Score=333.81  Aligned_cols=262  Identities=21%  Similarity=0.242  Sum_probs=200.0

Q ss_pred             ccCHHHHHHHhcCCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhc---------ccchHHHHHHHHHhccCCC
Q 047719          273 RLALTDIKQATLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVEC---------ARNPFTTEFATMAGCLRHK  343 (596)
Q Consensus       273 ~~~~~el~~at~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~---------~~~~~~~E~~~l~~~l~H~  343 (596)
                      +..+.++....++|...+.||+|+||.||+|...+|..||||++........         ..+.+.+|+..+.+ ++||
T Consensus        11 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~   89 (362)
T 3pg1_A           11 RDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNH-FHHP   89 (362)
T ss_dssp             HHHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHH-CCCT
T ss_pred             HHHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHh-CCCc
Confidence            4456788899999999999999999999999988899999999864322211         12568889866655 8999


Q ss_pred             ceeeecceeee-----CCeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCC
Q 047719          344 NLVQLQGWCCE-----GNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKA  418 (596)
Q Consensus       344 niv~l~g~~~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp  418 (596)
                      ||+++++++..     ....|+||||++ |+|.+++....   ..+++..+..++.||+.||+|||+   .+|+||||||
T Consensus        90 ~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp  162 (362)
T 3pg1_A           90 NILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR---IVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHP  162 (362)
T ss_dssp             TBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCG
T ss_pred             CccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCCh
Confidence            99999999854     346899999997 68999887543   358999999999999999999999   8999999999


Q ss_pred             CceeecCCCceEEccCCCcc----------cCCCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCChh-H
Q 047719          419 CNILLDAEFNAKLGDFEATI----------PAGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV-I  486 (596)
Q Consensus       419 ~NiLl~~~~~~kl~Dfg~~~----------~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~-~  486 (596)
                      +|||++.++.+||+|||.+.          ..||..|+|||.+.+ ..++.++|||||||++|||++|+.||...... .
T Consensus       163 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~  242 (362)
T 3pg1_A          163 GNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ  242 (362)
T ss_dssp             GGEEECTTCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             HHEEEcCCCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence            99999999999999999864          247889999999877 67899999999999999999999999875421 1


Q ss_pred             HHHHHHHHhcCCchhh-----------cccccc-------CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          487 VDWVWNLRKKGKLLDA-----------ADFRLR-------GKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       487 ~~~~~~~~~~~~~~~~-----------~d~~l~-------~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ...+..........+.           ......       ..........+.+++..|++.||++|||++|+++
T Consensus       243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          243 LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence            1111111111111000           000000       0001112345778899999999999999999987

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=3.2e-38  Score=338.95  Aligned_cols=243  Identities=23%  Similarity=0.271  Sum_probs=187.4

Q ss_pred             HHhcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCc------hhcccchHHHHHHHHHhccCCCceeeecceee
Q 047719          281 QATLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNR------VECARNPFTTEFATMAGCLRHKNLVQLQGWCC  353 (596)
Q Consensus       281 ~at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~------~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~  353 (596)
                      ...++|...+.||+|+||.||+|... +++.||||++.+...      .......+.+|+..+.+ ++|||||++++++.
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~hpniv~l~~~~~  210 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKK-LNHPCIIKIKNFFD  210 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHH-CCCTTBCCCCEEEE
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHh-CCCCCEeeEEEEEe
Confidence            34568899999999999999999765 488999999975321      12233458889966665 89999999999975


Q ss_pred             eCCeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCC---CceE
Q 047719          354 EGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAE---FNAK  430 (596)
Q Consensus       354 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~---~~~k  430 (596)
                       .+..++||||+++|+|.+++....    .+++..+..++.||+.||+|||+   .+|+||||||+|||++.+   ..+|
T Consensus       211 -~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~k  282 (419)
T 3i6u_A          211 -AEDYYIVLELMEGGELFDKVVGNK----RLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIK  282 (419)
T ss_dssp             -SSEEEEEEECCTTCBGGGGTSSSC----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEE
T ss_pred             -cCceEEEEEcCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEE
Confidence             566899999999999999997653    48999999999999999999999   899999999999999754   4599


Q ss_pred             EccCCCccc----------CCCcccCCcccccc---CCCCCccceeehhHHHHHHHhCCCCCCCCCh--hHHHHHHHHHh
Q 047719          431 LGDFEATIP----------AGTMGYLAPEYVYS---GVPSEKTDVYSFGVVALEVAAGKSPVDNDGC--VIVDWVWNLRK  495 (596)
Q Consensus       431 l~Dfg~~~~----------~gt~~y~aPE~~~~---~~~t~~sDV~SfGvll~El~tG~~p~~~~~~--~~~~~~~~~~~  495 (596)
                      |+|||++..          .||+.|+|||.+..   ..++.++|||||||++|||++|+.||.....  .+.+.    ..
T Consensus       283 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~----i~  358 (419)
T 3i6u_A          283 ITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ----IT  358 (419)
T ss_dssp             ECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHH----HH
T ss_pred             EeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHH----Hh
Confidence            999998743          48999999999853   6788999999999999999999999976422  11111    11


Q ss_pred             cCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          496 KGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       496 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      .+....  .+....    .....+.+++.+|++.||++|||++|+++
T Consensus       359 ~~~~~~--~~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          359 SGKYNF--IPEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             TTCCCC--CHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             cCCCCC--Cchhhc----ccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            111100  000001    12356778889999999999999999987

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.4e-38  Score=339.08  Aligned_cols=258  Identities=24%  Similarity=0.274  Sum_probs=202.2

Q ss_pred             cCCCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCC--eEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGN--ELVL  360 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~--~~~l  360 (596)
                      +.|...++||+|+||.||+|.... |+.||||++..... ......+.+|+..+.+ ++||||+++++++....  ..++
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~-l~hpnIv~~~~~~~~~~~~~~~l   86 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKK-LNHKNIVKLFAIEEETTTRHKVL   86 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHH-CCCTTBCCEEEEEECTTTCCEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHh-cCCCCCCeEEEeeccCCCCeeEE
Confidence            457788999999999999998764 89999999964322 2334567788866655 89999999999998765  7899


Q ss_pred             EEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceee----cCCCceEEccCCC
Q 047719          361 VYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILL----DAEFNAKLGDFEA  436 (596)
Q Consensus       361 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl----~~~~~~kl~Dfg~  436 (596)
                      ||||+++|+|.+++..... ...+++..++.++.||+.||+|||+   .+|+||||||+|||+    +.++.+||+|||.
T Consensus        87 v~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~  162 (396)
T 4eut_A           87 IMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (396)
T ss_dssp             EECCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred             EEecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence            9999999999999986432 2238999999999999999999999   899999999999999    7888899999997


Q ss_pred             cc----------cCCCcccCCcccccc--------CCCCCccceeehhHHHHHHHhCCCCCCCCCh--hHHHHHHHHHhc
Q 047719          437 TI----------PAGTMGYLAPEYVYS--------GVPSEKTDVYSFGVVALEVAAGKSPVDNDGC--VIVDWVWNLRKK  496 (596)
Q Consensus       437 ~~----------~~gt~~y~aPE~~~~--------~~~t~~sDV~SfGvll~El~tG~~p~~~~~~--~~~~~~~~~~~~  496 (596)
                      +.          ..||..|+|||.+..        ..++.++|||||||++|||++|+.||.....  ...+........
T Consensus       163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  242 (396)
T 4eut_A          163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (396)
T ss_dssp             CEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred             ceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence            63          348999999999865        4678899999999999999999999964321  112222222222


Q ss_pred             CCchhh--c------------cccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          497 GKLLDA--A------------DFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       497 ~~~~~~--~------------d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                      ......  .            +..............+..++..|++.||++||+++|+++.++..
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i  307 (396)
T 4eut_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (396)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence            110000  0            11112244567788888999999999999999999998877653

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.4e-38  Score=346.22  Aligned_cols=244  Identities=23%  Similarity=0.353  Sum_probs=198.2

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchh-cccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVE-CARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~-~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      .+|...+.||+|+||.||+|... +|+.||||++.+..... .....+.+|+..+ +.++||||+++++++...+..|+|
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l-~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNL-KLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHH-TTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHH-HhCCCCCCCcEEEEEEECCEEEEE
Confidence            45778899999999999999875 68999999996533222 2344678888665 459999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc---
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI---  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---  438 (596)
                      |||+++|+|.+++....    .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++.   
T Consensus        95 ~E~~~gg~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~  167 (476)
T 2y94_A           95 MEYVSGGELFDYICKNG----RLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS  167 (476)
T ss_dssp             EECCSSEEHHHHTTSSS----SCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             EeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence            99999999999997643    48999999999999999999999   899999999999999999999999999763   


Q ss_pred             -------cCCCcccCCccccccCCC-CCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCc
Q 047719          439 -------PAGTMGYLAPEYVYSGVP-SEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGK  510 (596)
Q Consensus       439 -------~~gt~~y~aPE~~~~~~~-t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  510 (596)
                             ..||+.|+|||.+.+..+ +.++|||||||++|||++|+.||......  ...... ..+..      .....
T Consensus       168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~--~~~~~i-~~~~~------~~p~~  238 (476)
T 2y94_A          168 DGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP--TLFKKI-CDGIF------YTPQY  238 (476)
T ss_dssp             TTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH--HHHHHH-HTTCC------CCCTT
T ss_pred             ccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH--HHHHHH-hcCCc------CCCcc
Confidence                   358999999999988765 78999999999999999999999865321  111111 11111      01111


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhcCC
Q 047719          511 FNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKGEA  548 (596)
Q Consensus       511 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~~~~  548 (596)
                      +    ...+.+++..|++.||++|||++|+++  +++...
T Consensus       239 ~----s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~  274 (476)
T 2y94_A          239 L----NPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDL  274 (476)
T ss_dssp             C----CHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTTC
T ss_pred             C----CHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhcC
Confidence            2    245678889999999999999999987  666543

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=3.3e-38  Score=318.17  Aligned_cols=240  Identities=26%  Similarity=0.314  Sum_probs=192.9

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      ++|...+.||+|+||.||+|... +++.||||++..... ......+.+|+..+. .++||||+++++++.+.+..++||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~   84 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINK-MLNHENVVKFYGHRREGNIQYLFL   84 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHH-TCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHH-hcCCCCceeeeeEEEcCCEEEEEE
Confidence            46788899999999999999875 589999999964332 223456788885554 489999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc----
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI----  438 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~----  438 (596)
                      ||+++++|.+++....    .+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||.+.    
T Consensus        85 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  157 (276)
T 2yex_A           85 EYCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRY  157 (276)
T ss_dssp             ECCTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             EecCCCcHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence            9999999999997543    48999999999999999999999   899999999999999999999999999763    


Q ss_pred             ---------cCCCcccCCccccccCCC-CCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhcccccc
Q 047719          439 ---------PAGTMGYLAPEYVYSGVP-SEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLR  508 (596)
Q Consensus       439 ---------~~gt~~y~aPE~~~~~~~-t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  508 (596)
                               ..||..|+|||.+.+..+ +.++|||||||++|||++|+.||.........+. .........     ...
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~-----~~~  231 (276)
T 2yex_A          158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS-DWKEKKTYL-----NPW  231 (276)
T ss_dssp             TTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHH-HHHTTCTTS-----TTG
T ss_pred             CcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHH-Hhhhccccc-----Cch
Confidence                     247899999999987664 7899999999999999999999976533211111 111111000     001


Q ss_pred             CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          509 GKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       509 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      .    .....+.+++..|++.||++|||++|+++
T Consensus       232 ~----~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          232 K----KIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             G----GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             h----hcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence            1    12345677889999999999999999876

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=5.9e-40  Score=347.39  Aligned_cols=238  Identities=15%  Similarity=0.163  Sum_probs=182.8

Q ss_pred             hcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCc-hhcccchHHHHHHHH--HhccCCCceeeec-------ce
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNR-VECARNPFTTEFATM--AGCLRHKNLVQLQ-------GW  351 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~~E~~~l--~~~l~H~niv~l~-------g~  351 (596)
                      .+.|...+.||+|+||.||+|... +|+.||||++..... .....+.+.+|+..+  .+.++|||||+++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            456777899999999999999974 589999999975422 223445678888422  2336899999998       44


Q ss_pred             eeeCC-----------------eEEEEEecCCCCCHHHHhhhCCC---CCcccCHHHHHHHHHHHHHHHHHHHhccCCCe
Q 047719          352 CCEGN-----------------ELVLVYEYLPNGSLDKILHNNSS---SSIVLSWEKRLNIVLGVASALSYLHEECERQI  411 (596)
Q Consensus       352 ~~~~~-----------------~~~lV~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~i  411 (596)
                      +...+                 ..||||||+ +|+|.+++.....   ....++|..++.++.||+.||+|||+   .+|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCe
Confidence            44432                 289999999 6899999986421   12345678999999999999999999   899


Q ss_pred             EEccCCCCceeecCCCceEEccCCCccc--------CCCcccCCccccccC-----------CCCCccceeehhHHHHHH
Q 047719          412 IHRDVKACNILLDAEFNAKLGDFEATIP--------AGTMGYLAPEYVYSG-----------VPSEKTDVYSFGVVALEV  472 (596)
Q Consensus       412 vHrDlkp~NiLl~~~~~~kl~Dfg~~~~--------~gt~~y~aPE~~~~~-----------~~t~~sDV~SfGvll~El  472 (596)
                      +||||||+|||++.++.+||+|||++..        .| ..|+|||.+.+.           .++.++|||||||++|||
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el  306 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI  306 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence            9999999999999999999999998643        46 899999999887           899999999999999999


Q ss_pred             HhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          473 AAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       473 ~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ++|+.||.....           . ......... ...+    ...+.+++.+||+.||++|||+.|+++
T Consensus       307 ltg~~Pf~~~~~-----------~-~~~~~~~~~-~~~~----~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          307 WCADLPITKDAA-----------L-GGSEWIFRS-CKNI----PQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHSSCCC------------------CCSGGGGSS-CCCC----CHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHCCCCCccccc-----------c-cchhhhhhh-ccCC----CHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            999999975321           0 011111110 1222    245778889999999999999999986

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=5.1e-38  Score=324.74  Aligned_cols=256  Identities=25%  Similarity=0.268  Sum_probs=196.7

Q ss_pred             HHhcCCCccceeecCCceEEEEEEc--CCCCEEEEEEeecCCchhcccchHHHHHHHHHh--ccCCCceeeecceee---
Q 047719          281 QATLGFNKNRIVGEGASATVYKGSL--PSGGAVAVKRFEKPNRVECARNPFTTEFATMAG--CLRHKNLVQLQGWCC---  353 (596)
Q Consensus       281 ~at~~f~~~~~LG~G~fG~Vy~~~~--~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~--~l~H~niv~l~g~~~---  353 (596)
                      .+.++|...+.||+|+||.||+|..  .+|+.||||++............+.+|+..+..  .++||||++++++|.   
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            3457788999999999999999987  357899999997544333344567777755543  248999999999987   


Q ss_pred             --eCCeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEE
Q 047719          354 --EGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKL  431 (596)
Q Consensus       354 --~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl  431 (596)
                        .....++||||+. |+|.+++.....  ..+++..++.++.||+.||+|||+   .+++||||||+|||++.++.+||
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl  161 (326)
T 1blx_A           88 TDRETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKL  161 (326)
T ss_dssp             CSSEEEEEEEEECCS-CBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEE
T ss_pred             cCCCceEEEEEecCC-CCHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEE
Confidence              5567999999998 699999987642  248999999999999999999999   89999999999999999999999


Q ss_pred             ccCCCccc----------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChh-HHHHHHHHHhcCCch
Q 047719          432 GDFEATIP----------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV-IVDWVWNLRKKGKLL  500 (596)
Q Consensus       432 ~Dfg~~~~----------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~-~~~~~~~~~~~~~~~  500 (596)
                      +|||.+..          .||..|+|||.+.+..++.++|||||||++|||++|+.||...... ....+..........
T Consensus       162 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  241 (326)
T 1blx_A          162 ADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE  241 (326)
T ss_dssp             CSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             ecCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcc
Confidence            99997642          4789999999999999999999999999999999999999875431 111111111110000


Q ss_pred             hhc------c-------ccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          501 DAA------D-------FRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       501 ~~~------d-------~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ...      .       ......+.......+.+++.+||+.||++|||+.|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            000      0       00000111223356778889999999999999999985

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.5e-38  Score=325.96  Aligned_cols=247  Identities=23%  Similarity=0.325  Sum_probs=198.0

Q ss_pred             hcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      .++|...+.||+|+||.||++... +|+.||||++.....  .....+.+|+..+.. ++||||+++++++.+....++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv   84 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKK-IKHENIVTLEDIYESTTHYYLV   84 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHH-CCCTTBCCEEEEEECSSEEEEE
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHh-CCCCCeeehhhhcccCCEEEEE
Confidence            346788899999999999999875 589999999975332  234567888866655 8999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceee---cCCCceEEccCCCcc
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILL---DAEFNAKLGDFEATI  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl---~~~~~~kl~Dfg~~~  438 (596)
                      |||+++++|.+++....    .+++..+..++.|++.||.|||+   .+++||||||+|||+   +.++.+||+|||.+.
T Consensus        85 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~  157 (304)
T 2jam_A           85 MQLVSGGELFDRILERG----VYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSK  157 (304)
T ss_dssp             ECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTC
T ss_pred             EEcCCCccHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcce
Confidence            99999999999997653    48899999999999999999999   899999999999999   788999999999764


Q ss_pred             c---------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccC
Q 047719          439 P---------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRG  509 (596)
Q Consensus       439 ~---------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  509 (596)
                      .         .||..|+|||.+.+..++.++|||||||++|||++|+.||......  +...... .+..      ....
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~i~-~~~~------~~~~  228 (304)
T 2jam_A          158 MEQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES--KLFEKIK-EGYY------EFES  228 (304)
T ss_dssp             CCCCBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHH-HCCC------CCCT
T ss_pred             ecCCCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHH-cCCC------CCCc
Confidence            3         3889999999999999999999999999999999999999765321  1111111 1111      0011


Q ss_pred             cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhcCC
Q 047719          510 KFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKGEA  548 (596)
Q Consensus       510 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~~~~  548 (596)
                      .........+.+++..|++.||++|||++|+++  ++++..
T Consensus       229 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (304)
T 2jam_A          229 PFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT  269 (304)
T ss_dssp             TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred             cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence            111223356778889999999999999999987  666544

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=3.8e-38  Score=321.24  Aligned_cols=243  Identities=21%  Similarity=0.343  Sum_probs=197.9

Q ss_pred             cCCCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      ++|...+.||+|+||.||++.... ++.||+|++...... ....+.+.+|+..+. .++||||+++++++.+.+..++|
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR-SLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHH-TCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHH-hCCCCCEeeeeeeeccCCEEEEE
Confidence            467788999999999999998764 789999998654322 234456788886665 48999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc--
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP--  439 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~--  439 (596)
                      |||+++++|.+++....    .+++.+++.++.|++.||+|||+   .+++||||||+|||++.++.+||+|||.+..  
T Consensus        94 ~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  166 (294)
T 2rku_A           94 LELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  166 (294)
T ss_dssp             EECCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence            99999999999997653    48999999999999999999999   8999999999999999999999999997632  


Q ss_pred             ---------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCc
Q 047719          440 ---------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGK  510 (596)
Q Consensus       440 ---------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  510 (596)
                               .||..|+|||.+.+..++.++||||||+++|||++|+.||.....  .+....... ..      ..+...
T Consensus       167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~-~~------~~~~~~  237 (294)
T 2rku_A          167 YDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL--KETYLRIKK-NE------YSIPKH  237 (294)
T ss_dssp             STTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHHHHT-TC------CCCCTT
T ss_pred             cCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHhh-cc------CCCccc
Confidence                     478899999999988899999999999999999999999986532  111111111 11      111112


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhcC
Q 047719          511 FNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKGE  547 (596)
Q Consensus       511 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~~~  547 (596)
                      +    ...+.+++.+|++.||++|||++|+++  ++...
T Consensus       238 ~----~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~  272 (294)
T 2rku_A          238 I----NPVAASLIQKMLQTDPTARPTINELLNDEFFTSG  272 (294)
T ss_dssp             S----CHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred             c----CHHHHHHHHHHcccChhhCcCHHHHhhChheecC
Confidence            2    245677888999999999999999987  45443

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=8.9e-38  Score=319.86  Aligned_cols=247  Identities=21%  Similarity=0.293  Sum_probs=192.6

Q ss_pred             hcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCch--hcccchHHHHHHHHHhccCCCceeeecceee--eCCe
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRV--ECARNPFTTEFATMAGCLRHKNLVQLQGWCC--EGNE  357 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~--~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~--~~~~  357 (596)
                      .++|...+.||+|+||.||++... +++.||||++......  ......+.+|+..+. .++||||+++++++.  +...
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~~   82 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLR-RLRHKNVIQLVDVLYNEEKQK   82 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHT-TCCCTTBCCEEEEEECC---C
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHH-hcCCCCeeEEEEEEEcCCCCe
Confidence            357889999999999999999875 5889999999643221  233456888986654 589999999999984  4568


Q ss_pred             EEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCc
Q 047719          358 LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT  437 (596)
Q Consensus       358 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~  437 (596)
                      .++||||++++ |.+++....  ...+++..++.++.||+.||.|||+   .+++||||||+|||++.++.+||+|||.+
T Consensus        83 ~~lv~e~~~~~-l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~  156 (305)
T 2wtk_C           83 MYMVMEYCVCG-MQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVA  156 (305)
T ss_dssp             EEEEEECCSEE-HHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEehhccCC-HHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeeccccc
Confidence            99999999876 888887654  2358999999999999999999999   89999999999999999999999999876


Q ss_pred             cc-------------CCCcccCCccccccCC--CCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhh
Q 047719          438 IP-------------AGTMGYLAPEYVYSGV--PSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDA  502 (596)
Q Consensus       438 ~~-------------~gt~~y~aPE~~~~~~--~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~  502 (596)
                      ..             .||..|+|||.+.+..  ++.++|||||||++|||++|+.||.....  .+...... .+.    
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~i~-~~~----  229 (305)
T 2wtk_C          157 EALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI--YKLFENIG-KGS----  229 (305)
T ss_dssp             EECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHH-HCC----
T ss_pred             cccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH--HHHHHHHh-cCC----
Confidence            32             3789999999987644  37899999999999999999999986532  11111111 111    


Q ss_pred             ccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhcCCC
Q 047719          503 ADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKGEAP  549 (596)
Q Consensus       503 ~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~~~~~  549 (596)
                        ..+...+    ...+.+++.+|++.||++|||++|+++  +++...+
T Consensus       230 --~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  272 (305)
T 2wtk_C          230 --YAIPGDC----GPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP  272 (305)
T ss_dssp             --CCCCSSS----CHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred             --CCCCCcc----CHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence              1111222    345678889999999999999999997  5665443

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.3e-38  Score=349.09  Aligned_cols=241  Identities=24%  Similarity=0.296  Sum_probs=189.3

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      +.|...+.||+|+||.||+|... ++..||||++.+..........+.+|+..+ +.++|||||+++++|.+....|+||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l-~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVL-KLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHH-TTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHH-HhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            45788899999999999999875 588999999976554444566788898665 5599999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCC---CceEEccCCCcc-
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAE---FNAKLGDFEATI-  438 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~---~~~kl~Dfg~~~-  438 (596)
                      ||+++|+|.+++....    .+++..+..++.||+.||+|||+   .+|+||||||+|||++.+   +.+||+|||++. 
T Consensus       116 e~~~~g~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~  188 (494)
T 3lij_A          116 ECYKGGELFDEIIHRM----KFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV  188 (494)
T ss_dssp             ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             ecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence            9999999999997653    48999999999999999999999   899999999999999764   559999999763 


Q ss_pred             ---------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccC
Q 047719          439 ---------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRG  509 (596)
Q Consensus       439 ---------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  509 (596)
                               ..||+.|+|||.+. +.++.++|||||||++|||++|+.||......  +....... +... . ......
T Consensus       189 ~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~-~~~~-~-~~~~~~  262 (494)
T 3lij_A          189 FENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ--EILRKVEK-GKYT-F-DSPEWK  262 (494)
T ss_dssp             CBTTBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHH-TCCC-C-CSGGGT
T ss_pred             CCCCccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHh-CCCC-C-Cchhcc
Confidence                     35899999999876 56999999999999999999999999875431  11212211 1110 0 000001


Q ss_pred             cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          510 KFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       510 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                          .....+.+++..||+.||++|||++|+++
T Consensus       263 ----~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          263 ----NVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             ----TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ----cCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence                12345678889999999999999999986

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=4.9e-38  Score=332.01  Aligned_cols=250  Identities=21%  Similarity=0.273  Sum_probs=192.4

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCC------
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGN------  356 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~------  356 (596)
                      ++|...+.||+|+||.||+|... +++.||||++............+.+|+..+.. ++||||+++++++....      
T Consensus        25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~-l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKC-VNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHH-CCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHh-cCCCCccceEEeecccccccccc
Confidence            56888899999999999999765 58899999997654444455678889866655 89999999999997665      


Q ss_pred             eEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCC
Q 047719          357 ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEA  436 (596)
Q Consensus       357 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~  436 (596)
                      ..|+||||++ |+|.+++..      .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+
T Consensus       104 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  173 (371)
T 2xrw_A          104 DVYIVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL  173 (371)
T ss_dssp             EEEEEEECCS-EEHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred             ceEEEEEcCC-CCHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeec
Confidence            7899999997 589888863      38899999999999999999999   8999999999999999999999999997


Q ss_pred             ccc----------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhc-CCc------
Q 047719          437 TIP----------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKK-GKL------  499 (596)
Q Consensus       437 ~~~----------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~-~~~------  499 (596)
                      +..          .||..|+|||.+.+..++.++|||||||++|||++|+.||.+.... ..+. ..... +..      
T Consensus       174 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~-~i~~~~~~~~~~~~~  251 (371)
T 2xrw_A          174 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI-DQWN-KVIEQLGTPCPEFMK  251 (371)
T ss_dssp             ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHH-HHHC-CCCCCHHHHT
T ss_pred             ccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH-HHHH-HHHHHhCCCCHHHHH
Confidence            642          4789999999999999999999999999999999999999875421 1111 11100 000      


Q ss_pred             ---------------------hhhcccccc---CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhc
Q 047719          500 ---------------------LDAADFRLR---GKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKG  546 (596)
Q Consensus       500 ---------------------~~~~d~~l~---~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~~  546 (596)
                                           .........   ..........+.+|+.+|++.||++|||++|+++  +++.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  324 (371)
T 2xrw_A          252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV  324 (371)
T ss_dssp             TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence                                 000000000   0011223567889999999999999999999987  5543

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=3.9e-38  Score=331.79  Aligned_cols=241  Identities=17%  Similarity=0.152  Sum_probs=190.3

Q ss_pred             HHHhcCCCccceeecCCceEEEEEE------cCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccC---CCceeeecc
Q 047719          280 KQATLGFNKNRIVGEGASATVYKGS------LPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLR---HKNLVQLQG  350 (596)
Q Consensus       280 ~~at~~f~~~~~LG~G~fG~Vy~~~------~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~---H~niv~l~g  350 (596)
                      +...+.|...++||+|+||.||+|.      ...++.||||++....     ..++..|+..+.. ++   |+||+++++
T Consensus        61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~-l~~~~~~~iv~~~~  134 (365)
T 3e7e_A           61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMER-LKPSMQHMFMKFYS  134 (365)
T ss_dssp             ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHH-SCGGGGGGBCCEEE
T ss_pred             EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHH-hhhhhhhhhhhhhe
Confidence            3445678888999999999999994      3458899999996432     3346666655443 55   999999999


Q ss_pred             eeeeCCeEEEEEecCCCCCHHHHhhhCCC-CCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecC----
Q 047719          351 WCCEGNELVLVYEYLPNGSLDKILHNNSS-SSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDA----  425 (596)
Q Consensus       351 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~----  425 (596)
                      ++...+..||||||+++|+|.+++..... ....++|..++.++.||+.||+|||+   .+|+||||||+||||+.    
T Consensus       135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~  211 (365)
T 3e7e_A          135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLE  211 (365)
T ss_dssp             EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTC
T ss_pred             eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccC
Confidence            99999999999999999999999975321 13459999999999999999999999   89999999999999998    


Q ss_pred             -------CCceEEccCCCcc-------------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChh
Q 047719          426 -------EFNAKLGDFEATI-------------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV  485 (596)
Q Consensus       426 -------~~~~kl~Dfg~~~-------------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~  485 (596)
                             ++.+||+|||++.             ..||..|+|||++.+..++.++|||||||++|||++|+.||..... 
T Consensus       212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-  290 (365)
T 3e7e_A          212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG-  290 (365)
T ss_dssp             C------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEET-
T ss_pred             ccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCC-
Confidence                   8999999999873             2489999999999999999999999999999999999999864311 


Q ss_pred             HHHHHHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhc
Q 047719          486 IVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKR-PSVKEAARILKG  546 (596)
Q Consensus       486 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~R-Ps~~ev~~~L~~  546 (596)
                                 +.  ......+......   +.+..++..|++.+|.+| |+++++.+.|+.
T Consensus       291 -----------~~--~~~~~~~~~~~~~---~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~  336 (365)
T 3e7e_A          291 -----------GE--CKPEGLFRRLPHL---DMWNEFFHVMLNIPDCHHLPSLDLLRQKLKK  336 (365)
T ss_dssp             -----------TE--EEECSCCTTCSSH---HHHHHHHHHHHCCCCTTCCCCHHHHHHHHHH
T ss_pred             -----------Cc--eeechhccccCcH---HHHHHHHHHHcCCCCCCcchHHHHHHHHHHH
Confidence                       00  0011111111222   344556678889999988 578888777764

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=5.5e-39  Score=354.99  Aligned_cols=244  Identities=21%  Similarity=0.266  Sum_probs=197.5

Q ss_pred             hcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEE
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVL  360 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~l  360 (596)
                      .++|...++||+|+||.||++... +|+.||||++.+.... ......+.+|+..+.. ++|||||++++++.+.+.+|+
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~-l~hp~Iv~l~~~~~~~~~l~l  261 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEK-VNSRFVVSLAYAYETKDALCL  261 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHH-CCCTTBCCEEEEEECSSEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHH-cCCCCEeeEEEEEeeCCEEEE
Confidence            355888899999999999999875 5899999999754322 2234457788866655 899999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc--
Q 047719          361 VYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI--  438 (596)
Q Consensus       361 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~--  438 (596)
                      ||||+++|+|.+++....  ...+++..+..++.||+.||+|||+   .+|+||||||+||||+.++.+||+|||++.  
T Consensus       262 VmEy~~gg~L~~~l~~~~--~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~  336 (576)
T 2acx_A          262 VLTLMNGGDLKFHIYHMG--QAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHV  336 (576)
T ss_dssp             EECCCCSCBHHHHHHSSS--SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEcCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceec
Confidence            999999999999998654  2348999999999999999999999   899999999999999999999999999763  


Q ss_pred             --------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChh-HHHHHHHHHhcCCchhhccccccC
Q 047719          439 --------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV-IVDWVWNLRKKGKLLDAADFRLRG  509 (596)
Q Consensus       439 --------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~-~~~~~~~~~~~~~~~~~~d~~l~~  509 (596)
                              ..||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ....+.......          ..
T Consensus       337 ~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~----------~~  406 (576)
T 2acx_A          337 PEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV----------PE  406 (576)
T ss_dssp             CTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC----------CC
T ss_pred             ccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc----------cc
Confidence                    35899999999999989999999999999999999999999864321 111111111111          01


Q ss_pred             cCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 047719          510 KFNRKEMERMLMVGLSCVHPNHEKRP-----SVKEAAR  542 (596)
Q Consensus       510 ~~~~~~~~~l~~l~~~C~~~dp~~RP-----s~~ev~~  542 (596)
                      .++......+.+|+..|++.||++||     +++|+++
T Consensus       407 ~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          407 EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence            12222335677888999999999999     7888875

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=5.8e-38  Score=330.76  Aligned_cols=248  Identities=23%  Similarity=0.330  Sum_probs=196.5

Q ss_pred             HHHHhcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCch------hcccchHHHHHHHHHhccCCCceeeecce
Q 047719          279 IKQATLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRV------ECARNPFTTEFATMAGCLRHKNLVQLQGW  351 (596)
Q Consensus       279 l~~at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~------~~~~~~~~~E~~~l~~~l~H~niv~l~g~  351 (596)
                      ......+|...+.||+|+||.||+|... +|+.||||++......      ....+.+.+|+..+....+||||++++++
T Consensus        89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  168 (365)
T 2y7j_A           89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS  168 (365)
T ss_dssp             HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence            3445567889999999999999999875 6999999998654311      11234577888677663489999999999


Q ss_pred             eeeCCeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEE
Q 047719          352 CCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKL  431 (596)
Q Consensus       352 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl  431 (596)
                      +......++||||+++++|.+++....    .+++..+..++.||+.||.|||+   .+++||||||+|||++.++.+||
T Consensus       169 ~~~~~~~~lv~e~~~g~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ikl  241 (365)
T 2y7j_A          169 YESSSFMFLVFDLMRKGELFDYLTEKV----ALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRL  241 (365)
T ss_dssp             EEBSSEEEEEECCCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEE
T ss_pred             EeeCCEEEEEEEeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEE
Confidence            999999999999999999999998643    48999999999999999999999   89999999999999999999999


Q ss_pred             ccCCCcc----------cCCCcccCCcccccc------CCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHh
Q 047719          432 GDFEATI----------PAGTMGYLAPEYVYS------GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRK  495 (596)
Q Consensus       432 ~Dfg~~~----------~~gt~~y~aPE~~~~------~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~  495 (596)
                      +|||++.          ..||+.|+|||.+.+      ..++.++|||||||++|||++|+.||......  ...... .
T Consensus       242 ~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~--~~~~~i-~  318 (365)
T 2y7j_A          242 SDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI--LMLRMI-M  318 (365)
T ss_dssp             CCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHH-H
T ss_pred             EecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH--HHHHHH-H
Confidence            9999653          358999999998863      35789999999999999999999999765321  111111 1


Q ss_pred             cCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          496 KGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       496 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      .+... ...+. ...    ....+.+++.+|++.||++|||++|+++
T Consensus       319 ~~~~~-~~~~~-~~~----~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          319 EGQYQ-FSSPE-WDD----RSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             HTCCC-CCHHH-HSS----SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hCCCC-CCCcc-ccc----CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            11110 00000 011    1245778889999999999999999986

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=4.2e-38  Score=327.71  Aligned_cols=243  Identities=21%  Similarity=0.337  Sum_probs=198.1

Q ss_pred             cCCCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCc-hhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNR-VECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~-~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      .+|...+.||+|+||.||++...+ ++.||+|++..... .....+.+.+|+..+. .++|+||+++++++.+.+..++|
T Consensus        41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR-SLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHH-TCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHH-hCCCCCCCeEEEEEecCCeEEEE
Confidence            467778999999999999998764 78999999865432 2234456788886555 48999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc---
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI---  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---  438 (596)
                      |||+++++|.+++....    .+++.+++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||.+.   
T Consensus       120 ~e~~~~~~L~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  192 (335)
T 2owb_A          120 LELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  192 (335)
T ss_dssp             ECCCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EecCCCCCHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence            99999999999997653    48999999999999999999999   899999999999999999999999999764   


Q ss_pred             --------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCc
Q 047719          439 --------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGK  510 (596)
Q Consensus       439 --------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  510 (596)
                              ..||..|+|||.+.+..++.++|||||||++|||++|+.||.....  .+........ .      ..+...
T Consensus       193 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~~~~~-~------~~~~~~  263 (335)
T 2owb_A          193 YDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL--KETYLRIKKN-E------YSIPKH  263 (335)
T ss_dssp             STTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHHHHHT-C------CCCCTT
T ss_pred             cCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH--HHHHHHHhcC-C------CCCCcc
Confidence                    2478899999999998899999999999999999999999986532  1111111111 1      111122


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhcC
Q 047719          511 FNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKGE  547 (596)
Q Consensus       511 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~~~  547 (596)
                      +    ...+.+++.+||+.||++|||++|+++  ++...
T Consensus       264 ~----~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~  298 (335)
T 2owb_A          264 I----NPVAASLIQKMLQTDPTARPTINELLNDEFFTSG  298 (335)
T ss_dssp             S----CHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred             C----CHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence            2    245677888999999999999999987  55543

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.5e-38  Score=347.98  Aligned_cols=246  Identities=23%  Similarity=0.265  Sum_probs=197.8

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      +.|...+.||+|+||+||++... +++.||||++.+..........+.+|+..+.+ ++|||||++++++.+....|+||
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~-l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKK-LDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHH-CCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHh-CCCCCcCeEEEEEEcCCEEEEEE
Confidence            46888899999999999999875 58999999996543333445678899976665 89999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeec---CCCceEEccCCCcc-
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLD---AEFNAKLGDFEATI-  438 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~---~~~~~kl~Dfg~~~-  438 (596)
                      ||+++|+|.+++....    .+++..+..++.||+.||.|||+   .+|+||||||+|||++   .++.+||+|||++. 
T Consensus       101 e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  173 (486)
T 3mwu_A          101 ELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (486)
T ss_dssp             CCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred             EcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence            9999999999997653    48999999999999999999999   8999999999999995   45679999999764 


Q ss_pred             ---------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccC
Q 047719          439 ---------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRG  509 (596)
Q Consensus       439 ---------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  509 (596)
                               ..||+.|+|||.+.+ .++.++|||||||++|||++|+.||......  +....... +....      ..
T Consensus       174 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~-~~~~~------~~  243 (486)
T 3mwu_A          174 FQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY--DILKRVET-GKYAF------DL  243 (486)
T ss_dssp             BCCC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHH-TCCCS------CS
T ss_pred             CCCCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHh-CCCCC------CC
Confidence                     358999999999875 5999999999999999999999999875431  11112111 11100      00


Q ss_pred             cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhcC
Q 047719          510 KFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKGE  547 (596)
Q Consensus       510 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~~~  547 (596)
                      .........+.+++..||+.||++|||+.|+++  +++..
T Consensus       244 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~  283 (486)
T 3mwu_A          244 PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY  283 (486)
T ss_dssp             GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHT
T ss_pred             cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccC
Confidence            001122345678889999999999999999988  45543

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=4e-38  Score=329.67  Aligned_cols=251  Identities=21%  Similarity=0.269  Sum_probs=193.2

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeee--------
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE--------  354 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~--------  354 (596)
                      .+|...+.||+|+||.||+|... +|+.||||++............+.+|+..+.. ++||||+++++++..        
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQL-LKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHH-CCCTTBCCEEEEEEEC-------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHh-ccCCCcccHhheeeccccccccC
Confidence            46888899999999999999874 68999999997655444455678889966655 899999999999987        


Q ss_pred             CCeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccC
Q 047719          355 GNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF  434 (596)
Q Consensus       355 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Df  434 (596)
                      .+..++||||+++ +|.+.+....   ..+++.++..++.||+.||+|||+   .+|+||||||+|||++.++.+||+||
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Df  168 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVL---VKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADF  168 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCC
T ss_pred             CceEEEEEeccCC-CHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccc
Confidence            4568999999975 8888887543   248999999999999999999999   89999999999999999999999999


Q ss_pred             CCcc---------------cCCCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCChh-HHHHHHHHHhcC
Q 047719          435 EATI---------------PAGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV-IVDWVWNLRKKG  497 (596)
Q Consensus       435 g~~~---------------~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~-~~~~~~~~~~~~  497 (596)
                      |++.               ..||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...... ....+.......
T Consensus       169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  248 (351)
T 3mi9_A          169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI  248 (351)
T ss_dssp             TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            9753               246889999999876 45899999999999999999999999875432 112122211111


Q ss_pred             Cc--hhhcc-ccc--------cCcCC-HHH------HHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          498 KL--LDAAD-FRL--------RGKFN-RKE------MERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       498 ~~--~~~~d-~~l--------~~~~~-~~~------~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ..  ....+ ...        ..... .+.      ...+.+|+.+|++.||++|||++|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            00  00000 000        00000 011      234778999999999999999999987

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.2e-38  Score=330.04  Aligned_cols=256  Identities=24%  Similarity=0.310  Sum_probs=189.5

Q ss_pred             HHHHhcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchh---cccchHHHHHHHHHhccCCCceeeecceeee
Q 047719          279 IKQATLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVE---CARNPFTTEFATMAGCLRHKNLVQLQGWCCE  354 (596)
Q Consensus       279 l~~at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~---~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~  354 (596)
                      +....++|...+.||+|+||.||+|... +|+.||||++.......   .....+.+|+..+.. ++||||+++++++..
T Consensus         5 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~   83 (346)
T 1ua2_A            5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE-LSHPNIIGLLDAFGH   83 (346)
T ss_dssp             --------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHH-CCCTTBCCEEEEECC
T ss_pred             hHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhh-CCCCCCCeEEEEEee
Confidence            3444567999999999999999999876 48999999986433221   223467889866655 899999999999999


Q ss_pred             CCeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccC
Q 047719          355 GNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF  434 (596)
Q Consensus       355 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Df  434 (596)
                      .+..++||||+++ +|.+++....   ..+++..+..++.|+++||+|||+   .+|+||||||+|||++.++.+||+||
T Consensus        84 ~~~~~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Df  156 (346)
T 1ua2_A           84 KSNISLVFDFMET-DLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADF  156 (346)
T ss_dssp             TTCCEEEEECCSE-EHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred             CCceEEEEEcCCC-CHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEec
Confidence            9999999999986 8999987653   358889999999999999999999   89999999999999999999999999


Q ss_pred             CCcc-----------cCCCcccCCccccccC-CCCCccceeehhHHHHHHHhCCCCCCCCChh-HHHHHHHHHhcCCchh
Q 047719          435 EATI-----------PAGTMGYLAPEYVYSG-VPSEKTDVYSFGVVALEVAAGKSPVDNDGCV-IVDWVWNLRKKGKLLD  501 (596)
Q Consensus       435 g~~~-----------~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~El~tG~~p~~~~~~~-~~~~~~~~~~~~~~~~  501 (596)
                      |++.           ..||+.|+|||.+.+. .++.++|||||||++|||++|.+||...... ....+...........
T Consensus       157 g~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~  236 (346)
T 1ua2_A          157 GLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQ  236 (346)
T ss_dssp             GGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             ccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhh
Confidence            9764           2478899999998764 5899999999999999999999999875431 1111111111110000


Q ss_pred             hc------c---ccccCcCC-----HHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          502 AA------D---FRLRGKFN-----RKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       502 ~~------d---~~l~~~~~-----~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ..      +   .......+     ......+.+++..|++.||++|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  291 (346)
T 1ua2_A          237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  291 (346)
T ss_dssp             SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence            00      0   00000011     122356788999999999999999999987

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=5.9e-38  Score=319.33  Aligned_cols=245  Identities=20%  Similarity=0.236  Sum_probs=189.7

Q ss_pred             HhcCCCccceeecCCceEEEEEEc-CCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeeccee-eeCCeEE
Q 047719          282 ATLGFNKNRIVGEGASATVYKGSL-PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWC-CEGNELV  359 (596)
Q Consensus       282 at~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~-~~~~~~~  359 (596)
                      ..++|...+.||+|+||.||+|.. .+++.||||++....    ....+.+|+..+.. ++|++++..++++ ......+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~l~~-l~~~~~i~~~~~~~~~~~~~~   81 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKM-MQGGVGIPTIRWCGAEGDYNV   81 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------CCCHHHHHHHHHH-HTTSTTCCCEEEEEEETTEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc----cchHHHHHHHHHHH-hcCCCCCCeeeeecCCCCceE
Confidence            346799999999999999999986 468899999875432    23457888866655 7777766666655 6677889


Q ss_pred             EEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceee---cCCCceEEccCCC
Q 047719          360 LVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILL---DAEFNAKLGDFEA  436 (596)
Q Consensus       360 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl---~~~~~~kl~Dfg~  436 (596)
                      +||||+ +++|.+++....   ..+++..++.++.||+.||+|||+   .+|+||||||+|||+   +.++.+||+|||.
T Consensus        82 lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~  154 (296)
T 4hgt_A           82 MVMELL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGL  154 (296)
T ss_dssp             EEEECC-CCBHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTT
T ss_pred             EEEEcc-CCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCcc
Confidence            999999 999999998543   248999999999999999999999   899999999999999   7889999999997


Q ss_pred             cc------------------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCCh----hHHHHHHHHH
Q 047719          437 TI------------------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGC----VIVDWVWNLR  494 (596)
Q Consensus       437 ~~------------------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~----~~~~~~~~~~  494 (596)
                      +.                  ..||..|+|||.+.+..++.++|||||||++|||++|+.||.....    ..........
T Consensus       155 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  234 (296)
T 4hgt_A          155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK  234 (296)
T ss_dssp             CEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH
T ss_pred             ceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccc
Confidence            63                  2588999999999999999999999999999999999999976321    1111111110


Q ss_pred             hcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          495 KKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       495 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                      ....     .......+    ...+.+++..||+.||++|||++++++.|+..
T Consensus       235 ~~~~-----~~~~~~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~  278 (296)
T 4hgt_A          235 MSTP-----IEVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  278 (296)
T ss_dssp             HHSC-----HHHHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred             ccch-----hhhhhccC----CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence            0000     00011122    24677888999999999999999999998754

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.4e-39  Score=330.85  Aligned_cols=253  Identities=25%  Similarity=0.394  Sum_probs=198.5

Q ss_pred             cCHHHHHHHhcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeeccee
Q 047719          274 LALTDIKQATLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWC  352 (596)
Q Consensus       274 ~~~~el~~at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~  352 (596)
                      +.+.++....+.|...+.||+|+||.||+|... +++.||||++....   .....+.+|+..+.+..+||||+++++++
T Consensus        14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   90 (326)
T 2x7f_A           14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAF   90 (326)
T ss_dssp             --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---STTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred             ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc---ccHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence            344455566778999999999999999999874 68999999996432   23456888987776644899999999999


Q ss_pred             ee------CCeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCC
Q 047719          353 CE------GNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAE  426 (596)
Q Consensus       353 ~~------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~  426 (596)
                      ..      ....++||||+++|+|.+++....  ...+++..++.++.||+.||+|||+   .+++||||||+|||++.+
T Consensus        91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~  165 (326)
T 2x7f_A           91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTEN  165 (326)
T ss_dssp             EECC--CCCCEEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTT
T ss_pred             eeccCccccceEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCC
Confidence            87      468999999999999999998753  2358899999999999999999999   899999999999999999


Q ss_pred             CceEEccCCCccc-----------CCCcccCCccccc-----cCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHH
Q 047719          427 FNAKLGDFEATIP-----------AGTMGYLAPEYVY-----SGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWV  490 (596)
Q Consensus       427 ~~~kl~Dfg~~~~-----------~gt~~y~aPE~~~-----~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~  490 (596)
                      +.+||+|||++..           .||..|+|||.+.     ...++.++|||||||++|||++|+.||.......  ..
T Consensus       166 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~  243 (326)
T 2x7f_A          166 AEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR--AL  243 (326)
T ss_dssp             CCEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH--HH
T ss_pred             CCEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH--HH
Confidence            9999999997642           4789999999987     5678999999999999999999999997654211  11


Q ss_pred             HHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHh
Q 047719          491 WNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILK  545 (596)
Q Consensus       491 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~  545 (596)
                      ....... ....    ....+    ...+.+++..||+.||++||+++++++  +++
T Consensus       244 ~~~~~~~-~~~~----~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~  291 (326)
T 2x7f_A          244 FLIPRNP-APRL----KSKKW----SKKFQSFIESCLVKNHSQRPATEQLMKHPFIR  291 (326)
T ss_dssp             HHHHHSC-CCCC----SCSCS----CHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHH
T ss_pred             HHhhcCc-cccC----Ccccc----CHHHHHHHHHHhccChhhCCCHHHHhhChHHh
Confidence            1111111 0000    01122    245678888999999999999999987  454

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=4.1e-39  Score=340.08  Aligned_cols=248  Identities=11%  Similarity=0.017  Sum_probs=174.3

Q ss_pred             hcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCc-hhcccchHHHHHHHH--HhccCCCceeeecc-------e
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNR-VECARNPFTTEFATM--AGCLRHKNLVQLQG-------W  351 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~~E~~~l--~~~l~H~niv~l~g-------~  351 (596)
                      ...|...+.||+|+||.||+|... +|+.||||++..... .......+.+|+..+  ++. +||||++++.       +
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~  139 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA  139 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence            345778899999999999999865 688999999986543 223344566664322  233 7999888553       3


Q ss_pred             eeeC-----------------CeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHH------HHHHHHHHHHHHHHHhccC
Q 047719          352 CCEG-----------------NELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKR------LNIVLGVASALSYLHEECE  408 (596)
Q Consensus       352 ~~~~-----------------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~~ia~gL~~LH~~~~  408 (596)
                      +...                 ..+||||||++ |+|.+++.....   .+.+..+      +.++.||++||+|||+   
T Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---  212 (371)
T 3q60_A          140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANLQS---  212 (371)
T ss_dssp             EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHHHH---
T ss_pred             eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHHHH---
Confidence            3322                 34899999999 899999986421   2455556      7888999999999999   


Q ss_pred             CCeEEccCCCCceeecCCCceEEccCCCcc--------cCCCcccCCcccccc--CCCCCccceeehhHHHHHHHhCCCC
Q 047719          409 RQIIHRDVKACNILLDAEFNAKLGDFEATI--------PAGTMGYLAPEYVYS--GVPSEKTDVYSFGVVALEVAAGKSP  478 (596)
Q Consensus       409 ~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~--------~~gt~~y~aPE~~~~--~~~t~~sDV~SfGvll~El~tG~~p  478 (596)
                      .+|+||||||+|||++.++.+||+|||++.        ..+|+.|+|||.+.+  ..++.++|||||||+||||++|+.|
T Consensus       213 ~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P  292 (371)
T 3q60_A          213 KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP  292 (371)
T ss_dssp             TTEEETTCSGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred             CCCccCcCCHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence            899999999999999999999999999864        346789999999987  6799999999999999999999999


Q ss_pred             CCCCChhHHHHHHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          479 VDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       479 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      |........    ..+........................+.+++.+||+.||++|||+.|+++
T Consensus       293 f~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          293 FGLVTPGIK----GSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             TTBCCTTCT----TCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCcCcccc----cchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            976421100    000000000000111111111123456778889999999999999999875

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=6.5e-38  Score=341.64  Aligned_cols=246  Identities=19%  Similarity=0.223  Sum_probs=193.2

Q ss_pred             cCCCccceeecCCceEEEEEEc-CCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSL-PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      ++|...++||+|+||.||+|.. .+++.||||++....    ...++..|+..+..+-+|+++..+..++.+....+|||
T Consensus         7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm   82 (483)
T 3sv0_A            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM   82 (483)
T ss_dssp             TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC----SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc----ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence            5788899999999999999986 458999999886432    23457888877766334466777777778888999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceee---cCCCceEEccCCCcc-
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILL---DAEFNAKLGDFEATI-  438 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl---~~~~~~kl~Dfg~~~-  438 (596)
                      ||+ +++|.+++....   ..+++.+++.++.||+.||+|||+   .+|+||||||+||||   +.++.+||+|||++. 
T Consensus        83 e~~-g~sL~~ll~~~~---~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~  155 (483)
T 3sv0_A           83 DLL-GPSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK  155 (483)
T ss_dssp             ECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             ECC-CCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence            999 999999998643   249999999999999999999999   899999999999999   688999999999752 


Q ss_pred             -----------------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCCh-hHHHHHHHHHhcCCch
Q 047719          439 -----------------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGC-VIVDWVWNLRKKGKLL  500 (596)
Q Consensus       439 -----------------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~-~~~~~~~~~~~~~~~~  500 (596)
                                       ..||..|+|||.+.+..++.++|||||||+||||++|+.||..... ............ ...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~-~~~  234 (483)
T 3sv0_A          156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK-KVA  234 (483)
T ss_dssp             CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHH-HHH
T ss_pred             ccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhc-ccc
Confidence                             3588999999999999999999999999999999999999986432 111111111110 000


Q ss_pred             hhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          501 DAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       501 ~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                      ... ..+...+    ...+.+++..||+.+|++||++++|++.|+.
T Consensus       235 ~~~-~~l~~~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~  275 (483)
T 3sv0_A          235 TSI-EALCRGY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRD  275 (483)
T ss_dssp             SCH-HHHHTTS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred             ccH-HHHhcCC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence            000 0111122    2467788899999999999999999998864

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.6e-38  Score=335.48  Aligned_cols=253  Identities=20%  Similarity=0.243  Sum_probs=187.0

Q ss_pred             HHHHhcCCCccceeecCCceEEEEEEc-CCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeC--
Q 047719          279 IKQATLGFNKNRIVGEGASATVYKGSL-PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG--  355 (596)
Q Consensus       279 l~~at~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~--  355 (596)
                      ++...++|...+.||+|+||.||+|.. .+|+.||||++.....      ...+|+..+ +.++|||||++++++...  
T Consensus         2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------~~~~E~~il-~~l~hpnIv~l~~~~~~~~~   74 (383)
T 3eb0_A            2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------YKNRELDIM-KVLDHVNIIKLVDYFYTTGD   74 (383)
T ss_dssp             ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHH-TTCCCTTBCCEEEEEEEC--
T ss_pred             CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc------hHHHHHHHH-HHcCCCCccchhheeeecCc
Confidence            345567899999999999999999976 4689999999864321      123677555 458999999999998543  


Q ss_pred             ------------------------------------CeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHH
Q 047719          356 ------------------------------------NELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASA  399 (596)
Q Consensus       356 ------------------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~g  399 (596)
                                                          ..+++||||++ |+|.+.+.........+++..+..++.||++|
T Consensus        75 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~a  153 (383)
T 3eb0_A           75 EEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRA  153 (383)
T ss_dssp             -----------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHH
Confidence                                                34899999998 58888876522223459999999999999999


Q ss_pred             HHHHHhccCCCeEEccCCCCceeec-CCCceEEccCCCcc----------cCCCcccCCccccccC-CCCCccceeehhH
Q 047719          400 LSYLHEECERQIIHRDVKACNILLD-AEFNAKLGDFEATI----------PAGTMGYLAPEYVYSG-VPSEKTDVYSFGV  467 (596)
Q Consensus       400 L~~LH~~~~~~ivHrDlkp~NiLl~-~~~~~kl~Dfg~~~----------~~gt~~y~aPE~~~~~-~~t~~sDV~SfGv  467 (596)
                      |+|||+   .+|+||||||+|||++ .++.+||+|||.+.          ..||..|+|||.+.+. .++.++|||||||
T Consensus       154 L~~LH~---~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~  230 (383)
T 3eb0_A          154 VGFIHS---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGC  230 (383)
T ss_dssp             HHHHHT---TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred             HHHHHH---CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHH
Confidence            999999   8999999999999998 68899999999864          2478899999998765 5899999999999


Q ss_pred             HHHHHHhCCCCCCCCChh-HHHHHHHHHhcCCc----------hhh-----ccccccCcCCHHHHHHHHHHHHHcCCCCC
Q 047719          468 VALEVAAGKSPVDNDGCV-IVDWVWNLRKKGKL----------LDA-----ADFRLRGKFNRKEMERMLMVGLSCVHPNH  531 (596)
Q Consensus       468 ll~El~tG~~p~~~~~~~-~~~~~~~~~~~~~~----------~~~-----~d~~l~~~~~~~~~~~l~~l~~~C~~~dp  531 (596)
                      ++|||++|+.||.+.... ..............          .+.     ........++......+.+|+.+|++.||
T Consensus       231 il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  310 (383)
T 3eb0_A          231 VFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP  310 (383)
T ss_dssp             HHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred             HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence            999999999999875431 11111111111000          000     00000111222234567889999999999


Q ss_pred             CCCCCHHHHHH
Q 047719          532 EKRPSVKEAAR  542 (596)
Q Consensus       532 ~~RPs~~ev~~  542 (596)
                      ++|||+.|+++
T Consensus       311 ~~R~t~~e~l~  321 (383)
T 3eb0_A          311 DLRINPYEAMA  321 (383)
T ss_dssp             GGSCCHHHHHT
T ss_pred             hhCCCHHHHhc
Confidence            99999999986

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=6.6e-39  Score=330.39  Aligned_cols=248  Identities=22%  Similarity=0.344  Sum_probs=195.8

Q ss_pred             HHhcCCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEE
Q 047719          281 QATLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVL  360 (596)
Q Consensus       281 ~at~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~l  360 (596)
                      ...++|...+.||+|+||.||+|....  .||+|++..........+.+.+|+..+ +.++|+||+++++++......++
T Consensus        30 i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l-~~l~h~~iv~~~~~~~~~~~~~i  106 (319)
T 2y4i_B           30 IPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAY-RQTRHENVVLFMGACMSPPHLAI  106 (319)
T ss_dssp             SCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGG-TTCCCTTBCCCCEEEECSSCEEE
T ss_pred             CCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHH-hcCCCCCEeEEEEEEecCCceEE
Confidence            345678888999999999999998743  599999976544444556677888555 45899999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc-
Q 047719          361 VYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP-  439 (596)
Q Consensus       361 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~-  439 (596)
                      ||||+++++|.+++....   ..+++..++.++.||+.||+|||+   .+++||||||+|||++ ++.+||+|||++.. 
T Consensus       107 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~  179 (319)
T 2y4i_B          107 ITSLCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSIS  179 (319)
T ss_dssp             ECBCCCSEEHHHHTTSSC---CCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred             EeecccCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence            999999999999997643   358899999999999999999999   8999999999999998 67999999997432 


Q ss_pred             ---------------CCCcccCCcccccc---------CCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHh
Q 047719          440 ---------------AGTMGYLAPEYVYS---------GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRK  495 (596)
Q Consensus       440 ---------------~gt~~y~aPE~~~~---------~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~  495 (596)
                                     .||..|+|||.+..         ..++.++|||||||++|||++|+.||.......  ..+....
T Consensus       180 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~~~  257 (319)
T 2y4i_B          180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA--IIWQMGT  257 (319)
T ss_dssp             --------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH--HHHHHHT
T ss_pred             ccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHhcc
Confidence                           37889999999864         457899999999999999999999998754321  1222211


Q ss_pred             cCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Q 047719          496 KGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEAP  549 (596)
Q Consensus       496 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~~~  549 (596)
                       +......    ...+    ...+.+++..||+.||++|||++++++.|+....
T Consensus       258 -~~~~~~~----~~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~  302 (319)
T 2y4i_B          258 -GMKPNLS----QIGM----GKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK  302 (319)
T ss_dssp             -TCCCCCC----CSSC----CTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred             -CCCCCCC----cCCC----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence             1111110    0112    2346788899999999999999999999987543

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=5.3e-38  Score=323.26  Aligned_cols=250  Identities=20%  Similarity=0.248  Sum_probs=198.3

Q ss_pred             HHHHHHhcCCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccC--CCceeeecceeee
Q 047719          277 TDIKQATLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLR--HKNLVQLQGWCCE  354 (596)
Q Consensus       277 ~el~~at~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~--H~niv~l~g~~~~  354 (596)
                      ..+....+.|...+.||+|+||.||++...+++.||||++............+.+|+..+.+ ++  |+||+++++++..
T Consensus        21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~-l~~~~~~iv~~~~~~~~   99 (313)
T 3cek_A           21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK-LQQHSDKIIRLYDYEIT   99 (313)
T ss_dssp             CEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHH-HGGGCTTBCCEEEEEEC
T ss_pred             eeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHh-ccccCCceEEEEEEeec
Confidence            33344456788899999999999999998889999999997655444556678889877766 55  6999999999999


Q ss_pred             CCeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccC
Q 047719          355 GNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF  434 (596)
Q Consensus       355 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Df  434 (596)
                      ....++||| +.+++|.+++....    .+++..++.++.||++||.|||+   .+++||||||+|||+++ +.+||+||
T Consensus       100 ~~~~~lv~e-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL~Df  170 (313)
T 3cek_A          100 DQYIYMVME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKLIDF  170 (313)
T ss_dssp             SSEEEEEEC-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEECCC
T ss_pred             CCEEEEEEe-cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEEeec
Confidence            999999999 56889999998754    48999999999999999999999   89999999999999965 89999999


Q ss_pred             CCccc-------------CCCcccCCcccccc-----------CCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHH
Q 047719          435 EATIP-------------AGTMGYLAPEYVYS-----------GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWV  490 (596)
Q Consensus       435 g~~~~-------------~gt~~y~aPE~~~~-----------~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~  490 (596)
                      |++..             .||..|+|||.+..           ..++.++|||||||++|||++|+.||......... .
T Consensus       171 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-~  249 (313)
T 3cek_A          171 GIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK-L  249 (313)
T ss_dssp             SSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH-H
T ss_pred             cccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHH-H
Confidence            97642             47899999999865           46889999999999999999999999764332211 1


Q ss_pred             HHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhc
Q 047719          491 WNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKG  546 (596)
Q Consensus       491 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~~  546 (596)
                      ......         .....++......+.+++.+||+.||++||+++|+++  +++.
T Consensus       250 ~~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~  298 (313)
T 3cek_A          250 HAIIDP---------NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI  298 (313)
T ss_dssp             HHHHCT---------TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHC
T ss_pred             HHHHhc---------ccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccC
Confidence            111111         1111111112345778888999999999999999987  4443

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.6e-38  Score=333.71  Aligned_cols=253  Identities=20%  Similarity=0.262  Sum_probs=182.9

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeC------C
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG------N  356 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~------~  356 (596)
                      .+|...+.||+|+||.||+|... +|+.||||++............+.+|+..+.. ++||||+++++++...      .
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~-l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKH-MKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHH-CCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHh-CCCCCCCcEEEEEecCCccccCC
Confidence            56888899999999999999754 58899999997544444455678889966655 8999999999998754      5


Q ss_pred             eEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCC
Q 047719          357 ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEA  436 (596)
Q Consensus       357 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~  436 (596)
                      ..|+|+||+ +++|.+++...     .+++..+..++.||++||+|||+   .+|+||||||+|||++.++.+||+|||+
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~  178 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL  178 (367)
T ss_dssp             CCEEEEECC-CEECC-----C-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC---
T ss_pred             eEEEEeccc-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeeccc
Confidence            689999999 68999998753     48999999999999999999999   8999999999999999999999999997


Q ss_pred             ccc--------CCCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCCh-hHHHHHHHHHhcCCchhhcc--
Q 047719          437 TIP--------AGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGC-VIVDWVWNLRKKGKLLDAAD--  504 (596)
Q Consensus       437 ~~~--------~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~-~~~~~~~~~~~~~~~~~~~d--  504 (596)
                      +..        .||..|+|||.+.+ ..++.++|||||||++|||++|+.||.+... .....+......... +...  
T Consensus       179 a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~-~~~~~~  257 (367)
T 2fst_X          179 ARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA-ELLKKI  257 (367)
T ss_dssp             ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH-HHHTTC
T ss_pred             cccccccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH-HHHHHh
Confidence            643        58999999999877 6789999999999999999999999987543 111111111111000 0000  


Q ss_pred             ---------ccc--cCcCCH-----HHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhcC
Q 047719          505 ---------FRL--RGKFNR-----KEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKGE  547 (596)
Q Consensus       505 ---------~~l--~~~~~~-----~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~~~  547 (596)
                               ..+  ......     .....+.+|+.+|++.||++|||++|+++  +++..
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~  318 (367)
T 2fst_X          258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  318 (367)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             hhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhc
Confidence                     000  000000     11245778889999999999999999987  44443

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=3.6e-38  Score=357.47  Aligned_cols=241  Identities=21%  Similarity=0.250  Sum_probs=198.0

Q ss_pred             HhcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCc-hhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEE
Q 047719          282 ATLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNR-VECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELV  359 (596)
Q Consensus       282 at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~  359 (596)
                      ...+|...++||+|+||+||++... +++.||||++++... .......+..|...+....+|+||+++++++.+.+.+|
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            3457888999999999999999875 488899999975422 22344557778767766558999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc-
Q 047719          360 LVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI-  438 (596)
Q Consensus       360 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~-  438 (596)
                      |||||+++|+|.+++....    .+++..++.++.||+.||+|||+   .+|+||||||+||||+.++.+||+|||++. 
T Consensus       419 lV~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~  491 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  491 (674)
T ss_dssp             EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred             EEEeCcCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeec
Confidence            9999999999999998754    48999999999999999999999   899999999999999999999999999764 


Q ss_pred             ----------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhcccccc
Q 047719          439 ----------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLR  508 (596)
Q Consensus       439 ----------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  508 (596)
                                ..||+.|+|||++.+..++.++|||||||+||||++|+.||......  +....... ..          
T Consensus       492 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~--~~~~~i~~-~~----------  558 (674)
T 3pfq_A          492 NIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--ELFQSIME-HN----------  558 (674)
T ss_dssp             CCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHS-SC----------
T ss_pred             cccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH--HHHHHHHh-CC----------
Confidence                      35899999999999999999999999999999999999999875431  11111111 11          


Q ss_pred             CcCCHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHH
Q 047719          509 GKFNRKEMERMLMVGLSCVHPNHEKRPSV-----KEAAR  542 (596)
Q Consensus       509 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~-----~ev~~  542 (596)
                      ..++......+.+|+..||+.||++||++     +||.+
T Consensus       559 ~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          559 VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence            11222334567788899999999999997     67654

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=7.8e-38  Score=336.91  Aligned_cols=191  Identities=20%  Similarity=0.251  Sum_probs=164.0

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhc-----cCCCceeeecceeeeCCe
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGC-----LRHKNLVQLQGWCCEGNE  357 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~-----l~H~niv~l~g~~~~~~~  357 (596)
                      .+|...++||+|+||.||+|... +++.||||++....   .....+.+|+..+...     ..|+||+++++++.....
T Consensus        97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  173 (429)
T 3kvw_A           97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK---RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH  173 (429)
T ss_dssp             TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred             CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc---chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence            45888899999999999999765 48899999996432   2233456666544431     268899999999999999


Q ss_pred             EEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCc--eEEccCC
Q 047719          358 LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFN--AKLGDFE  435 (596)
Q Consensus       358 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~--~kl~Dfg  435 (596)
                      .++||||+. ++|.+++.....  ..+++..+..++.||+.||+|||+   .+|+||||||+||||+.++.  +||+|||
T Consensus       174 ~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG  247 (429)
T 3kvw_A          174 ICMTFELLS-MNLYELIKKNKF--QGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFG  247 (429)
T ss_dssp             EEEEECCCC-CBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred             EEEEEeccC-CCHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeecc
Confidence            999999996 699999987642  348999999999999999999999   89999999999999999987  9999999


Q ss_pred             Ccc--------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCC
Q 047719          436 ATI--------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDG  483 (596)
Q Consensus       436 ~~~--------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~  483 (596)
                      ++.        ..||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       248 ~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~  303 (429)
T 3kvw_A          248 SSCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED  303 (429)
T ss_dssp             TCEETTCCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cceecCCcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence            863        358999999999999999999999999999999999999998754

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=7.6e-38  Score=315.68  Aligned_cols=243  Identities=22%  Similarity=0.349  Sum_probs=191.9

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      ++|...+.||+|+||.||+|... +|+.||||++...... ......+.+|+..+.. ++||||+++++++...+..++|
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKL-FRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHT-CCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhc-CCCCCEeEEEEEEecCCeEEEE
Confidence            46778899999999999999876 6899999999653221 2234567888866654 8999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc--
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP--  439 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~--  439 (596)
                      |||+++++|.+++....    .+++..+..++.||+.||+|||+   .+++||||||+|||++.++.+||+|||.+..  
T Consensus        90 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~  162 (276)
T 2h6d_A           90 MEYVSGGELFDYICKHG----RVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS  162 (276)
T ss_dssp             EECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred             EeccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccC
Confidence            99999999999998653    48899999999999999999999   8999999999999999999999999997643  


Q ss_pred             --------CCCcccCCccccccCCC-CCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCc
Q 047719          440 --------AGTMGYLAPEYVYSGVP-SEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGK  510 (596)
Q Consensus       440 --------~gt~~y~aPE~~~~~~~-t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  510 (596)
                              .||..|+|||.+.+..+ +.++||||||+++|||++|+.||......  ...... ..+..      .....
T Consensus       163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~-~~~~~------~~~~~  233 (276)
T 2h6d_A          163 DGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP--TLFKKI-RGGVF------YIPEY  233 (276)
T ss_dssp             C-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHH-HHCCC------CCCTT
T ss_pred             CCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH--HHHHHh-hcCcc------cCchh
Confidence                    47889999999987665 68999999999999999999999765321  111111 11110      11112


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhcC
Q 047719          511 FNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKGE  547 (596)
Q Consensus       511 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~~~  547 (596)
                      +    ...+.+++.+|++.||++|||++|+++  +++..
T Consensus       234 ~----~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          234 L----NRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD  268 (276)
T ss_dssp             S----CHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             c----CHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence            2    345677889999999999999999987  45543

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.2e-37  Score=335.88  Aligned_cols=188  Identities=22%  Similarity=0.303  Sum_probs=162.2

Q ss_pred             hcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeC-----C
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG-----N  356 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~-----~  356 (596)
                      .++|...+.||+|+||.||+|... +++.||||++..........+.+.+|+..+.. ++|+||+++++++...     .
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~-l~h~nIv~l~~~~~~~~~~~~~  103 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNR-LKSDYIIRLYDLIIPDDLLKFD  103 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHH-CCCTTBCCEEEECCCSCTTTCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHH-cCCCCcceEEEEEecCCCCcCC
Confidence            356888899999999999999865 48899999997654444455678899966655 8999999999999876     5


Q ss_pred             eEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCC
Q 047719          357 ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEA  436 (596)
Q Consensus       357 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~  436 (596)
                      .+|+||||+. |+|.+++....    .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+
T Consensus       104 ~~~lv~e~~~-~~L~~~~~~~~----~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGl  175 (432)
T 3n9x_A          104 ELYIVLEIAD-SDLKKLFKTPI----FLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGL  175 (432)
T ss_dssp             CEEEEEECCS-EEHHHHHHSSC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEEecCC-cCHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCC
Confidence            7999999986 59999998653    48999999999999999999999   8999999999999999999999999997


Q ss_pred             cc---------------------------------cCCCcccCCcccc-ccCCCCCccceeehhHHHHHHHhCCCCC
Q 047719          437 TI---------------------------------PAGTMGYLAPEYV-YSGVPSEKTDVYSFGVVALEVAAGKSPV  479 (596)
Q Consensus       437 ~~---------------------------------~~gt~~y~aPE~~-~~~~~t~~sDV~SfGvll~El~tG~~p~  479 (596)
                      +.                                 ..||+.|+|||++ ....++.++|||||||++|||++|..|+
T Consensus       176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             CEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            53                                 2478999999986 4567999999999999999999854443

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=3.2e-38  Score=327.01  Aligned_cols=247  Identities=27%  Similarity=0.327  Sum_probs=178.4

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      ++|...+.||+|+||.||+|... +|+.||||++..... .....++..|+..+.+.++||||+++++++...+..++||
T Consensus        22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            56778899999999999999875 588999999975432 2334456777766777799999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCC-CCCcccCHHHHHHHHHHHHHHHHHHHhccCC-CeEEccCCCCceeecCCCceEEccCCCccc-
Q 047719          363 EYLPNGSLDKILHNNS-SSSIVLSWEKRLNIVLGVASALSYLHEECER-QIIHRDVKACNILLDAEFNAKLGDFEATIP-  439 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~-~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~-  439 (596)
                      ||+++ +|.+++.... .....+++..+..++.|++.||.|||+   . +++||||||+|||++.++.+||+|||++.. 
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            99985 8888876311 112358999999999999999999999   7 999999999999999999999999997643 


Q ss_pred             ---------CCCcccCCcccc----ccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhcccc
Q 047719          440 ---------AGTMGYLAPEYV----YSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFR  506 (596)
Q Consensus       440 ---------~gt~~y~aPE~~----~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~  506 (596)
                               .||..|+|||.+    .+..++.++|||||||++|||++|+.||....... +    ..  ........+.
T Consensus       177 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~----~~--~~~~~~~~~~  249 (327)
T 3aln_A          177 VDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-D----QL--TQVVKGDPPQ  249 (327)
T ss_dssp             -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------CCCCCSCCCC
T ss_pred             ccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-H----HH--HHHhcCCCCC
Confidence                     588999999998    45678999999999999999999999997642110 0    00  0111111111


Q ss_pred             ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          507 LRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       507 l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      +...........+.+++.+||+.||++|||++++++
T Consensus       250 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          250 LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            111111123356778889999999999999999976

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.1e-37  Score=342.72  Aligned_cols=247  Identities=26%  Similarity=0.307  Sum_probs=193.9

Q ss_pred             hcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchh-----------cccchHHHHHHHHHhccCCCceeeecc
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVE-----------CARNPFTTEFATMAGCLRHKNLVQLQG  350 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~-----------~~~~~~~~E~~~l~~~l~H~niv~l~g  350 (596)
                      .+.|...+.||+|+||+||+|... +++.||||++.+.....           ...+.+.+|+..+.. ++||||+++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~hpniv~~~~  113 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS-LDHPNIIKLFD  113 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHT-CCCTTBCCEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHh-CCCCCCCeEEE
Confidence            457888899999999999999875 47899999997543221           234568889866655 89999999999


Q ss_pred             eeeeCCeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCC---
Q 047719          351 WCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEF---  427 (596)
Q Consensus       351 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~---  427 (596)
                      ++.+....|+||||+++|+|.+++....    .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++   
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~  186 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINRH----KFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLL  186 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCS
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCc
Confidence            9999999999999999999999997653    48999999999999999999999   8999999999999998775   


Q ss_pred             ceEEccCCCcc----------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcC
Q 047719          428 NAKLGDFEATI----------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKG  497 (596)
Q Consensus       428 ~~kl~Dfg~~~----------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~  497 (596)
                      .+||+|||++.          ..||+.|+|||.+. +.++.++|||||||++|||++|+.||......  +...... .+
T Consensus       187 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~-~~  262 (504)
T 3q5i_A          187 NIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ--DIIKKVE-KG  262 (504)
T ss_dssp             SEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHH-HC
T ss_pred             cEEEEECCCCEEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHH-cC
Confidence            69999999763          35899999999886 56899999999999999999999999875431  1121221 11


Q ss_pred             CchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhcC
Q 047719          498 KLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKGE  547 (596)
Q Consensus       498 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~~~  547 (596)
                      ....  +......    ....+.+++..|++.||++|||++|+++  +++..
T Consensus       263 ~~~~--~~~~~~~----~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~  308 (504)
T 3q5i_A          263 KYYF--DFNDWKN----ISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY  308 (504)
T ss_dssp             CCCC--CHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHT
T ss_pred             CCCC--CccccCC----CCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhc
Confidence            1100  0000011    2245778889999999999999999987  55543

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.5e-37  Score=322.23  Aligned_cols=249  Identities=20%  Similarity=0.230  Sum_probs=192.9

Q ss_pred             cCCCccceeecCCceEEEEEEc--CCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCC------ceeeecceeeeC
Q 047719          284 LGFNKNRIVGEGASATVYKGSL--PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHK------NLVQLQGWCCEG  355 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~--~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~------niv~l~g~~~~~  355 (596)
                      ++|...+.||+|+||.||++..  .+++.||||++...   ......+.+|+..+.. ++|+      +++++++++...
T Consensus        14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~-l~~~~~~~~~~i~~~~~~~~~~   89 (339)
T 1z57_A           14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEH-LNTTDPNSTFRCVQMLEWFEHH   89 (339)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHH-HHHHCTTCTTCBCCEEEEEEET
T ss_pred             CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHH-hhhcCCCCceeeEeeecccccC
Confidence            4688889999999999999975  35889999999542   2234456777755544 5544      599999999999


Q ss_pred             CeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecC----------
Q 047719          356 NELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDA----------  425 (596)
Q Consensus       356 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~----------  425 (596)
                      +..++||||+ +++|.+++....  ...+++..+..++.||+.||+|||+   .+|+||||||+|||++.          
T Consensus        90 ~~~~lv~e~~-~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~  163 (339)
T 1z57_A           90 GHICIVFELL-GLSTYDFIKENG--FLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPK  163 (339)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC--
T ss_pred             CcEEEEEcCC-CCCHHHHHHhcC--CCCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCc
Confidence            9999999999 889999998764  2358899999999999999999999   89999999999999987          


Q ss_pred             ---------CCceEEccCCCcc--------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhH-H
Q 047719          426 ---------EFNAKLGDFEATI--------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVI-V  487 (596)
Q Consensus       426 ---------~~~~kl~Dfg~~~--------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~-~  487 (596)
                               ++.+||+|||.+.        ..||..|+|||.+.+..++.++|||||||++|||++|+.||....... .
T Consensus       164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  243 (339)
T 1z57_A          164 IKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL  243 (339)
T ss_dssp             --CEEEEESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH
T ss_pred             cccccccccCCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence                     6789999999764        358999999999999899999999999999999999999998754321 1


Q ss_pred             HHHHHHHhcCC--------chh---------------------hcccc-ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCH
Q 047719          488 DWVWNLRKKGK--------LLD---------------------AADFR-LRGKFNRKEMERMLMVGLSCVHPNHEKRPSV  537 (596)
Q Consensus       488 ~~~~~~~~~~~--------~~~---------------------~~d~~-l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~  537 (596)
                      ..+........        ...                     ..... ............+.+++.+|++.||++|||+
T Consensus       244 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~  323 (339)
T 1z57_A          244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITL  323 (339)
T ss_dssp             HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred             HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCH
Confidence            11111110000        000                     00000 0011223456778899999999999999999


Q ss_pred             HHHHH
Q 047719          538 KEAAR  542 (596)
Q Consensus       538 ~ev~~  542 (596)
                      +|+++
T Consensus       324 ~ell~  328 (339)
T 1z57_A          324 REALK  328 (339)
T ss_dssp             HHHTT
T ss_pred             HHHhc
Confidence            99975

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=4.1e-38  Score=321.31  Aligned_cols=244  Identities=24%  Similarity=0.289  Sum_probs=195.1

Q ss_pred             hcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCch-------hcccchHHHHHHHHHhccCCCceeeecceeee
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRV-------ECARNPFTTEFATMAGCLRHKNLVQLQGWCCE  354 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~-------~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~  354 (596)
                      .++|...+.||+|+||.||+|... +|+.||||++......       ....+.+.+|+..+.+...||||+++++++..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            457888899999999999999875 5889999999754311       12345677888777663359999999999999


Q ss_pred             CCeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccC
Q 047719          355 GNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF  434 (596)
Q Consensus       355 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Df  434 (596)
                      .+..++||||+++++|.+++....    .+++..++.++.||+.||.|||+   .+++||||||+||+++.++.+||+||
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~df  168 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDF  168 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCC
T ss_pred             CCeEEEEEeccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEecc
Confidence            999999999999999999998653    48999999999999999999999   89999999999999999999999999


Q ss_pred             CCcc----------cCCCcccCCccccc------cCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCC
Q 047719          435 EATI----------PAGTMGYLAPEYVY------SGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGK  498 (596)
Q Consensus       435 g~~~----------~~gt~~y~aPE~~~------~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~  498 (596)
                      |.+.          ..||..|+|||.+.      ...++.++||||||+++|||++|+.||......  ........ +.
T Consensus       169 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~-~~  245 (298)
T 1phk_A          169 GFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM--LMLRMIMS-GN  245 (298)
T ss_dssp             TTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHH-TC
T ss_pred             cchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH--HHHHHHhc-CC
Confidence            9763          24789999999885      456889999999999999999999999765321  11111111 11


Q ss_pred             chhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          499 LLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       499 ~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ..      ............+.+++.+|++.||++|||+.|+++
T Consensus       246 ~~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          246 YQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             CC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             cc------cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            10      000011123356778889999999999999999876

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.7e-38  Score=347.26  Aligned_cols=245  Identities=24%  Similarity=0.299  Sum_probs=196.9

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      +.|...+.||+|+||.||++... +|+.||||++.+.... ......+.+|+..+. .++|||||++++++.+.+..++|
T Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~-~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK-QLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHT-TCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHH-hCCCCCCCcEEEEEEeCCEEEEE
Confidence            45778899999999999999875 5899999999754332 234556888986665 48999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceee---cCCCceEEccCCCcc
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILL---DAEFNAKLGDFEATI  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl---~~~~~~kl~Dfg~~~  438 (596)
                      |||+++|+|.+++....    .+++..+..++.||+.||+|||+   .+|+||||||+|||+   +.++.+||+|||++.
T Consensus       105 ~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  177 (484)
T 3nyv_A          105 GEVYTGGELFDEIISRK----RFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLST  177 (484)
T ss_dssp             ECCCCSCBHHHHHHTCS----CCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred             EecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence            99999999999998654    48999999999999999999999   899999999999999   567899999999753


Q ss_pred             ----------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhcccccc
Q 047719          439 ----------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLR  508 (596)
Q Consensus       439 ----------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  508 (596)
                                ..||+.|+|||.+.+ .++.++|||||||++|||++|+.||......  +...... .+....      .
T Consensus       178 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~-~~~~~~------~  247 (484)
T 3nyv_A          178 HFEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY--DILKKVE-KGKYTF------E  247 (484)
T ss_dssp             HBCCCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHH-HCCCCC------C
T ss_pred             EcccccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHH-cCCCCC------C
Confidence                      258999999998865 6999999999999999999999999875431  1111121 111100      0


Q ss_pred             CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhc
Q 047719          509 GKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKG  546 (596)
Q Consensus       509 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~~  546 (596)
                      ..........+.+++..|++.||++|||++|+++  +++.
T Consensus       248 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~  287 (484)
T 3nyv_A          248 LPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQT  287 (484)
T ss_dssp             SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHH
T ss_pred             CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcc
Confidence            0001122345778889999999999999999987  4543

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.1e-37  Score=320.70  Aligned_cols=244  Identities=25%  Similarity=0.341  Sum_probs=192.8

Q ss_pred             HhcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEE
Q 047719          282 ATLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVL  360 (596)
Q Consensus       282 at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~l  360 (596)
                      ..+.|...+.||+|+||.||+|... +|+.||||++....    ....+.+|+..+.. ++||||+++++++...+..++
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~l  101 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQ-CDSPHVVKYYGSYFKNTDLWI  101 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS----CCHHHHHHHHHHHT-CCCTTBCCEEEEEEETTEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH----HHHHHHHHHHHHHh-CCCCCCccEEEEEEeCCEEEE
Confidence            4567888999999999999999875 48999999996432    34568889866655 899999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc--
Q 047719          361 VYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI--  438 (596)
Q Consensus       361 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~--  438 (596)
                      ||||+++++|.+++....   ..+++..++.++.||+.||.|||+   .+++||||||+||+++.++.+||+|||.+.  
T Consensus       102 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  175 (314)
T 3com_A          102 VMEYCGAGSVSDIIRLRN---KTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQL  175 (314)
T ss_dssp             EEECCTTEEHHHHHHHHT---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EeecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhh
Confidence            999999999999997432   248999999999999999999999   899999999999999999999999999763  


Q ss_pred             ---------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccC
Q 047719          439 ---------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRG  509 (596)
Q Consensus       439 ---------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  509 (596)
                               ..||..|+|||.+.+..++.++|||||||++|||++|+.||........  .........      +..  
T Consensus       176 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~------~~~--  245 (314)
T 3com_A          176 TDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA--IFMIPTNPP------PTF--  245 (314)
T ss_dssp             BTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHHHHSCC------CCC--
T ss_pred             hhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHhcCCC------ccc--
Confidence                     2478899999999998999999999999999999999999986543211  111111110      000  


Q ss_pred             cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhc
Q 047719          510 KFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKG  546 (596)
Q Consensus       510 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~~  546 (596)
                      ..+......+.+++..||+.||++|||+.++++  +++.
T Consensus       246 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~  284 (314)
T 3com_A          246 RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRS  284 (314)
T ss_dssp             SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHT
T ss_pred             CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhc
Confidence            011112345778889999999999999999986  5543

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.9e-37  Score=315.76  Aligned_cols=244  Identities=20%  Similarity=0.239  Sum_probs=192.2

Q ss_pred             hcCCCccceeecCCceEEEEEEc-CCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeeccee-eeCCeEEE
Q 047719          283 TLGFNKNRIVGEGASATVYKGSL-PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWC-CEGNELVL  360 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~-~~~~~~~l  360 (596)
                      .++|...+.||+|+||.||+|.. .+++.||||++....    ....+.+|+..+.. ++|++++..++++ .+....++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~l~~-l~~~~~i~~~~~~~~~~~~~~l   82 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKM-MQGGVGIPTIRWCGAEGDYNVM   82 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS----SCCHHHHHHHHHHH-HTTSTTCCCEEEEEEETTEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc----chhHHHHHHHHHHH-hhcCCCCCccccccCCCCceEE
Confidence            45788899999999999999986 468999999986432    23457888866655 7777766666555 56778899


Q ss_pred             EEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceee---cCCCceEEccCCCc
Q 047719          361 VYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILL---DAEFNAKLGDFEAT  437 (596)
Q Consensus       361 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl---~~~~~~kl~Dfg~~  437 (596)
                      ||||+ +++|.+++....   ..+++..++.++.||+.||+|||+   .+|+||||||+|||+   +.++.+||+|||.+
T Consensus        83 v~e~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~  155 (296)
T 3uzp_A           83 VMELL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA  155 (296)
T ss_dssp             EEECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred             EEEec-CCCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCc
Confidence            99999 999999998543   248999999999999999999999   899999999999999   58899999999875


Q ss_pred             c------------------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCCh----hHHHHHHHHHh
Q 047719          438 I------------------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGC----VIVDWVWNLRK  495 (596)
Q Consensus       438 ~------------------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~----~~~~~~~~~~~  495 (596)
                      .                  ..||..|+|||.+.+..++.++|||||||++|||++|+.||.....    .....+.....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  235 (296)
T 3uzp_A          156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM  235 (296)
T ss_dssp             EECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccccc
Confidence            3                  2588999999999999999999999999999999999999976321    11111111110


Q ss_pred             cCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          496 KGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       496 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                      ...     ...+...++    ..+.+++..||+.||++|||++++++.|+..
T Consensus       236 ~~~-----~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~  278 (296)
T 3uzp_A          236 STP-----IEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  278 (296)
T ss_dssp             HSC-----HHHHTTTSC----HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred             CCc-----hHHHHhhCC----HHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence            000     001112222    4577888999999999999999999999754

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=4.9e-38  Score=321.33  Aligned_cols=241  Identities=25%  Similarity=0.319  Sum_probs=191.8

Q ss_pred             hcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      .+.|...+.||+|+||.||+|... ++..||+|++...  .......+.+|+..+.. ++||||+++++++...+..++|
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv   94 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEILAT-CDHPYIVKLLGAYYHDGKLWIM   94 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHH-CCCTTBCCEEEEEECC-CEEEE
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC--CHHHHHHHHHHHHHHhc-CCCCCEeeeeeeeeeCCeEEEE
Confidence            356788899999999999999876 4889999998543  23345678889866655 8999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc---
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI---  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---  438 (596)
                      |||+++++|.+++....   ..+++..++.++.||+.||.|||+   .+++||||||+|||++.++.+||+|||++.   
T Consensus        95 ~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  168 (302)
T 2j7t_A           95 IEFCPGGAVDAIMLELD---RGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL  168 (302)
T ss_dssp             EECCTTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHH
T ss_pred             EEeCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCcccc
Confidence            99999999999997642   248999999999999999999999   899999999999999999999999998642   


Q ss_pred             --------cCCCcccCCccccc-----cCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccc
Q 047719          439 --------PAGTMGYLAPEYVY-----SGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADF  505 (596)
Q Consensus       439 --------~~gt~~y~aPE~~~-----~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~  505 (596)
                              ..||..|+|||.+.     ...++.++|||||||++|||++|+.||......  ............ ..   
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~-~~---  242 (302)
T 2j7t_A          169 KTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM--RVLLKIAKSDPP-TL---  242 (302)
T ss_dssp             HHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHSCCC-CC---
T ss_pred             ccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH--HHHHHHhccCCc-cc---
Confidence                    35899999999984     567899999999999999999999999865321  111122111110 00   


Q ss_pred             cccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          506 RLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       506 ~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                          ..+......+.+++..||+.||++|||++++++
T Consensus       243 ----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          243 ----LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             ----SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             ----CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                011122345778889999999999999999865

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2.3e-37  Score=323.60  Aligned_cols=254  Identities=20%  Similarity=0.254  Sum_probs=194.2

Q ss_pred             hcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeC-----C
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG-----N  356 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~-----~  356 (596)
                      .++|...+.||+|+||.||+|... +|+.||||++.... .......+.+|+..+.. ++||||+++++++...     .
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~~~   87 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKH-FKHENIITIFNIQRPDSFENFN   87 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHH-CCCTTBCCEEEECCCSCSTTCC
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHh-CcCCCcCCeeeeecccccCccc
Confidence            457888899999999999999875 58899999996432 22334567889866655 8999999999988764     6


Q ss_pred             eEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCC
Q 047719          357 ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEA  436 (596)
Q Consensus       357 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~  436 (596)
                      ..++||||+. |+|.+++...     .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||.
T Consensus        88 ~~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~  158 (353)
T 2b9h_A           88 EVYIIQELMQ-TDLHRVISTQ-----MLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGL  158 (353)
T ss_dssp             CEEEEECCCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEEeccC-ccHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEeccc
Confidence            7999999997 6999999864     38999999999999999999999   8999999999999999999999999997


Q ss_pred             ccc---------------------CCCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCChh-HHHHHHHH
Q 047719          437 TIP---------------------AGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV-IVDWVWNL  493 (596)
Q Consensus       437 ~~~---------------------~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~-~~~~~~~~  493 (596)
                      +..                     .||..|+|||.+.. ..++.++|||||||++|||++|+.||...... ........
T Consensus       159 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~  238 (353)
T 2b9h_A          159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGI  238 (353)
T ss_dssp             CEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred             ccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Confidence            642                     46889999998765 67899999999999999999999999875421 11111111


Q ss_pred             HhcCCchhh----ccc-------cc--cCc-----CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhcC
Q 047719          494 RKKGKLLDA----ADF-------RL--RGK-----FNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKGE  547 (596)
Q Consensus       494 ~~~~~~~~~----~d~-------~l--~~~-----~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~~~  547 (596)
                      .........    ...       .+  ...     ........+.+++.+|++.||++|||++|+++  +++..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  312 (353)
T 2b9h_A          239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTY  312 (353)
T ss_dssp             HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             hCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence            111000000    000       00  000     00122345678889999999999999999987  55543

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=7e-39  Score=325.62  Aligned_cols=247  Identities=26%  Similarity=0.327  Sum_probs=190.0

Q ss_pred             cCCCccceeecCCceEEEEEEcC--CCC--EEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCCeE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP--SGG--AVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNEL  358 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~--~g~--~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~  358 (596)
                      ++|...+.||+|+||.||+|.+.  ++.  .||||+++..... ....+.+.+|+..+.+ ++||||+++++++.... .
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS-LDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHH-CCCTTBCCEEEEECSSS-C
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHh-CCCCCcccEEEEEccCC-c
Confidence            46788899999999999999753  233  6899998654322 2345678889866655 89999999999998765 8


Q ss_pred             EEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc
Q 047719          359 VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI  438 (596)
Q Consensus       359 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~  438 (596)
                      ++||||+++|+|.+++....   ..+++..++.++.|++.||.|||+   .+++||||||+|||++.++.+||+|||++.
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~  169 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMR  169 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             eeeEecccCCCHHHHHHhcc---CCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEccccccc
Confidence            99999999999999998642   248999999999999999999999   899999999999999999999999999754


Q ss_pred             c--------------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhc
Q 047719          439 P--------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAA  503 (596)
Q Consensus       439 ~--------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  503 (596)
                      .              .+|..|+|||.+.+..++.++||||||+++|||++ |+.||......  +...........    
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~~~~~----  243 (291)
T 1u46_A          170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--QILHKIDKEGER----  243 (291)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTSCCC----
T ss_pred             cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH--HHHHHHHccCCC----
Confidence            2              35668999999998889999999999999999999 99999865321  222222221111    


Q ss_pred             cccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Q 047719          504 DFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEAP  549 (596)
Q Consensus       504 d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~~~  549 (596)
                           ...+......+.+++..||+.||++|||+.++++.|+...+
T Consensus       244 -----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          244 -----LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             -----CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence                 01112233567788899999999999999999999986553

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.6e-37  Score=328.08  Aligned_cols=247  Identities=21%  Similarity=0.276  Sum_probs=192.4

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeE----
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNEL----  358 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~----  358 (596)
                      ++|...+.||+|+||.||+|... +|+.||||++......+.....+.+|+..+.. ++||||+++++++...+..    
T Consensus        42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKH-MQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHH-CCCTTBCCCSEEECSCSSSTTCC
T ss_pred             ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHh-cCCCCchhhhhheeccCCcccce
Confidence            46778899999999999999765 58899999997655444455678889866655 8999999999999877654    


Q ss_pred             --EEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCC
Q 047719          359 --VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEA  436 (596)
Q Consensus       359 --~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~  436 (596)
                        ++||||+. ++|.+++..      .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||.
T Consensus       121 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~  190 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMGM------EFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGL  190 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred             eEEEEEcccc-ccHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCc
Confidence              99999997 689888843      38999999999999999999999   8999999999999999999999999998


Q ss_pred             cc--------cCCCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCChh-HHHHHHHHHhcCCchhh----
Q 047719          437 TI--------PAGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV-IVDWVWNLRKKGKLLDA----  502 (596)
Q Consensus       437 ~~--------~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~-~~~~~~~~~~~~~~~~~----  502 (596)
                      +.        ..||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...... ............. .+.    
T Consensus       191 a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~  269 (371)
T 4exu_A          191 ARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG-TEFVQKL  269 (371)
T ss_dssp             C--------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC-HHHHTTC
T ss_pred             ccccccCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc-HHHHHHh
Confidence            64        358999999999987 68899999999999999999999999875421 1111111000000 000    


Q ss_pred             -----------ccccccC---cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          503 -----------ADFRLRG---KFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       503 -----------~d~~l~~---~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                                 .......   .........+.+|+..|++.||++|||++|+++
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          270 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             SCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence                       0000000   000112356788899999999999999999987

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.6e-37  Score=321.10  Aligned_cols=241  Identities=24%  Similarity=0.280  Sum_probs=187.5

Q ss_pred             hcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCc------hhcccchHHHHHHHHHhccCCCceeeecceeeeC
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNR------VECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG  355 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~------~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~  355 (596)
                      .++|...+.||+|+||.||+|... +++.||||++.....      .......+.+|+..+.. ++||||+++++++...
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK-LNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHH-CCCTTBCCEEEEEESS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHh-CCCCCCceEeeEEcCC
Confidence            356888999999999999999865 478999999864321      11233457889866655 8999999999998765


Q ss_pred             CeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCc---eEEc
Q 047719          356 NELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFN---AKLG  432 (596)
Q Consensus       356 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~---~kl~  432 (596)
                      . .++||||+++|+|.+++....    .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.   +||+
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~  159 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVGNK----RLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKIT  159 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHSTTC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred             c-eEEEEecCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEEc
Confidence            5 899999999999999997643    48999999999999999999999   89999999999999987654   9999


Q ss_pred             cCCCccc----------CCCcccCCccccc---cCCCCCccceeehhHHHHHHHhCCCCCCCCCh--hHHHHHHHHHhcC
Q 047719          433 DFEATIP----------AGTMGYLAPEYVY---SGVPSEKTDVYSFGVVALEVAAGKSPVDNDGC--VIVDWVWNLRKKG  497 (596)
Q Consensus       433 Dfg~~~~----------~gt~~y~aPE~~~---~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~--~~~~~~~~~~~~~  497 (596)
                      |||.+..          .||..|+|||.+.   ...++.++|||||||++|||++|+.||.....  .+...+    ..+
T Consensus       160 Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~----~~~  235 (322)
T 2ycf_A          160 DFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI----TSG  235 (322)
T ss_dssp             CCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHH----HHT
T ss_pred             cCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHH----HhC
Confidence            9998743          3889999999874   46789999999999999999999999976422  122111    111


Q ss_pred             CchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          498 KLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       498 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ....  .+....    .....+.+++.+|++.||++||+++++++
T Consensus       236 ~~~~--~~~~~~----~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          236 KYNF--IPEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             CCCC--CHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cccc--Cchhhh----hcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            1100  000011    12356778889999999999999999875

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.4e-38  Score=325.08  Aligned_cols=250  Identities=28%  Similarity=0.364  Sum_probs=180.5

Q ss_pred             HhcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEE
Q 047719          282 ATLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVL  360 (596)
Q Consensus       282 at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~l  360 (596)
                      ..++|...+.||+|+||.||+|... +++.||||++..... .....++.+|+..+ +.++||||+++++++...+..++
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~~~~~~l   90 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAM-SQCHHPNIVSYYTSFVVKDELWL   90 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CC-CCCCCTTBCCEEEEEESSSCEEE
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHH-hhcCCCCEeeEEEEEeecCCcEE
Confidence            3567888999999999999999865 588999999864322 23445677888555 45899999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhC----CCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCC
Q 047719          361 VYEYLPNGSLDKILHNN----SSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEA  436 (596)
Q Consensus       361 V~E~~~~gsL~~~l~~~----~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~  436 (596)
                      ||||+++++|.+++...    ......+++..++.++.||+.||+|||+   .+++||||||+|||++.++.+||+|||.
T Consensus        91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~  167 (303)
T 2vwi_A           91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGV  167 (303)
T ss_dssp             EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred             EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence            99999999999999741    1112358999999999999999999999   8999999999999999999999999986


Q ss_pred             cc----------------cCCCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcC-C
Q 047719          437 TI----------------PAGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKG-K  498 (596)
Q Consensus       437 ~~----------------~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~-~  498 (596)
                      +.                ..||..|+|||.+.. ..++.++|||||||++|||++|+.||......-.  ........ .
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~  245 (303)
T 2vwi_A          168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV--LMLTLQNDPP  245 (303)
T ss_dssp             HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH--HHHHHTSSCC
T ss_pred             hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH--HHHHhccCCC
Confidence            42                248899999999876 5689999999999999999999999986533111  11111111 0


Q ss_pred             -ch-hhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          499 -LL-DAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       499 -~~-~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                       .. ...+......+    ...+.+++.+||+.||++|||++|+++
T Consensus       246 ~~~~~~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          246 SLETGVQDKEMLKKY----GKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             CTTC-----CCCCCC----CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ccccccccchhhhhh----hHHHHHHHHHHccCChhhCcCHHHHhh
Confidence             00 00111111222    245678889999999999999999976

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.2e-37  Score=330.42  Aligned_cols=249  Identities=23%  Similarity=0.254  Sum_probs=192.1

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccC--------CCceeeecceee-
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLR--------HKNLVQLQGWCC-  353 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~--------H~niv~l~g~~~-  353 (596)
                      ++|...++||+|+||.||+|... +++.||||++...   ......+.+|+..+.. ++        |+||+++++++. 
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~-l~~~~~~~~~~~~iv~~~~~~~~  112 (397)
T 1wak_A           37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKS-VRNSDPNDPNREMVVQLLDDFKI  112 (397)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHH-HHHSCTTCGGGGGBCCEEEEEEE
T ss_pred             CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHH-HhhcCCCCCCcceeeeeecceee
Confidence            56888899999999999999754 5889999999642   2234567788866655 43        889999999988 


Q ss_pred             ---eCCeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCC-CeEEccCCCCceeecCCC--
Q 047719          354 ---EGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECER-QIIHRDVKACNILLDAEF--  427 (596)
Q Consensus       354 ---~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~-~ivHrDlkp~NiLl~~~~--  427 (596)
                         .....++||||+ +++|.+++....  ...+++..++.++.||+.||+|||+   + +|+||||||+|||++.++  
T Consensus       113 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~~~  186 (397)
T 1wak_A          113 SGVNGTHICMVFEVL-GHHLLKWIIKSN--YQGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNEQY  186 (397)
T ss_dssp             EETTEEEEEEEECCC-CCBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCHHH
T ss_pred             cCCCCceEEEEEecc-CccHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccchh
Confidence               556899999999 667777776543  2358999999999999999999999   7 999999999999999775  


Q ss_pred             -----------------------------------------------ceEEccCCCcc--------cCCCcccCCccccc
Q 047719          428 -----------------------------------------------NAKLGDFEATI--------PAGTMGYLAPEYVY  452 (596)
Q Consensus       428 -----------------------------------------------~~kl~Dfg~~~--------~~gt~~y~aPE~~~  452 (596)
                                                                     .+||+|||.+.        ..||..|+|||++.
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~  266 (397)
T 1wak_A          187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLI  266 (397)
T ss_dssp             HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHH
T ss_pred             hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhc
Confidence                                                           79999999764        35899999999999


Q ss_pred             cCCCCCccceeehhHHHHHHHhCCCCCCCCCh-------hHHHHHHHHHhc--------CCch-----------hhccc-
Q 047719          453 SGVPSEKTDVYSFGVVALEVAAGKSPVDNDGC-------VIVDWVWNLRKK--------GKLL-----------DAADF-  505 (596)
Q Consensus       453 ~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~-------~~~~~~~~~~~~--------~~~~-----------~~~d~-  505 (596)
                      +..++.++|||||||+||||++|+.||.....       ............        +...           ...+. 
T Consensus       267 ~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (397)
T 1wak_A          267 GSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLK  346 (397)
T ss_dssp             TSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCC
T ss_pred             CCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccC
Confidence            99999999999999999999999999975421       011111111100        0000           00000 


Q ss_pred             --------cccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          506 --------RLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       506 --------~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                              .-....+.+....+.+|+.+||+.||++|||++|+++
T Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          347 PWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             CcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence                    0011245667788999999999999999999999976

>1qmo_E Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1

Probab=100.00  E-value=4.2e-38  Score=276.89  Aligned_cols=114  Identities=33%  Similarity=0.510  Sum_probs=106.5

Q ss_pred             CceEEEEeeCccCCCCCCCCCCeeEEecCCccccccccCCCCCcccCCCceEEEEEEEcCCccEEEEEEeeCCCCCCCCe
Q 047719           61 DSFFAVEFDTSFDPSLGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRDSLKLIRVWAGYSQIRPPSPL  140 (596)
Q Consensus        61 ~~~~AVEfDt~~~~~~~d~~~~Hvgid~ns~~s~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~  140 (596)
                      ||+|||||||++|.+++||++|||||||||+.|.++.++     +|.+|+.++|||+||+.+++|+|++++...+  +|+
T Consensus         1 n~~vAVEFDT~~N~e~~Dp~~nHVGIdvNsi~S~~s~~~-----~l~sG~~~~v~I~Yd~~~~~L~V~l~~~~~~--~p~   73 (133)
T 1qmo_E            1 SNVVAVEFDTYLNPDYGDPNYIHIGIDVNSIRSKVTAKW-----DWQNGKIATAHISYNSVSKRLSVTSYYAGSK--PAT   73 (133)
T ss_dssp             CCCEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEEC-----CCCTTSCEEEEEEEETTTTEEEEEEECSSSC--CEE
T ss_pred             CCEEEEEEeCCcCccccCCCCCeeEEecccccccceeee-----EEcCCCEEEEEEEEeCCCcEEEEEEccCCCc--cce
Confidence            689999999999999889999999999999999998875     5889999999999999999999999885433  799


Q ss_pred             EEEeecCcccCCCceEEEEEeecCCccceeeeeeeeeeccC
Q 047719          141 IIAQIDLSKQFKDYMHVGFSAANGQGSAIYTVDRWRFKTFE  181 (596)
Q Consensus       141 l~~~vdl~~~l~~~~~vGFsastg~~~~~~~i~~Wsf~~~~  181 (596)
                      |+..+||+++|||+||||||||||...|.|+|++|+|++..
T Consensus        74 ls~~vdLs~~l~e~v~VGFSAsTG~~~~~h~IlsWsF~s~l  114 (133)
T 1qmo_E           74 LSYDIELHTVLPEWVRVGLSASTGQDKERNTVHSWSFTSSL  114 (133)
T ss_dssp             EEEECCGGGTSCSEEEEEEEEECSSSCCEEEEEEEEEEEEE
T ss_pred             EEEeechHHhccccEEEEEEeccCCCcceeEEEEEEEEeeC
Confidence            99999999999999999999999999999999999999875

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1e-37  Score=327.24  Aligned_cols=263  Identities=22%  Similarity=0.258  Sum_probs=185.3

Q ss_pred             HHHHHHHhcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeee
Q 047719          276 LTDIKQATLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE  354 (596)
Q Consensus       276 ~~el~~at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~  354 (596)
                      -.+.....++|...+.||+|+||.||+|... +|+.||||++....   .....+..++..+.. ++||||+++++++..
T Consensus        15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~l~~-l~h~niv~~~~~~~~   90 (360)
T 3e3p_A           15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP---RFRNRELQIMQDLAV-LHHPNIVQLQSYFYT   90 (360)
T ss_dssp             SHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT---TCCCHHHHHHHHHHH-HCCTTBCCEEEEEEE
T ss_pred             hhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc---cccHHHHHHHHHHHh-cCCCCcccHHHhhhc
Confidence            3456677889999999999999999999875 58999999986432   223445666655544 899999999999976


Q ss_pred             CCe-------EEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHH--hccCCCeEEccCCCCceeecC
Q 047719          355 GNE-------LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH--EECERQIIHRDVKACNILLDA  425 (596)
Q Consensus       355 ~~~-------~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH--~~~~~~ivHrDlkp~NiLl~~  425 (596)
                      .+.       .++||||+++ +|...+.........+++..+..++.|++.||.|||  +   .+|+||||||+|||++.
T Consensus        91 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~  166 (360)
T 3e3p_A           91 LGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNE  166 (360)
T ss_dssp             ECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEET
T ss_pred             cccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeC
Confidence            443       8999999986 666555432222345889999999999999999999  7   89999999999999997


Q ss_pred             -CCceEEccCCCccc----------CCCcccCCccccccC-CCCCccceeehhHHHHHHHhCCCCCCCCChh-HHHHHHH
Q 047719          426 -EFNAKLGDFEATIP----------AGTMGYLAPEYVYSG-VPSEKTDVYSFGVVALEVAAGKSPVDNDGCV-IVDWVWN  492 (596)
Q Consensus       426 -~~~~kl~Dfg~~~~----------~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~El~tG~~p~~~~~~~-~~~~~~~  492 (596)
                       ++.+||+|||++..          .||..|+|||.+.+. .++.++|||||||++|||++|+.||...... .......
T Consensus       167 ~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~  246 (360)
T 3e3p_A          167 ADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVR  246 (360)
T ss_dssp             TTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             CCCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHH
Confidence             89999999998642          478999999998764 4899999999999999999999999875431 1111111


Q ss_pred             HHhcC------------Cchhhccc------cccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhc
Q 047719          493 LRKKG------------KLLDAADF------RLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKG  546 (596)
Q Consensus       493 ~~~~~------------~~~~~~d~------~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~~  546 (596)
                      .....            ......+.      .............+.+|+..|++.||++|||+.|+++  +++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  320 (360)
T 3e3p_A          247 VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDE  320 (360)
T ss_dssp             HHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGG
T ss_pred             HcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccc
Confidence            10000            00000000      0001111123567889999999999999999999987  4544

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=4.3e-38  Score=327.89  Aligned_cols=252  Identities=18%  Similarity=0.226  Sum_probs=176.5

Q ss_pred             hcCCCc-cceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeee----CC
Q 047719          283 TLGFNK-NRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE----GN  356 (596)
Q Consensus       283 t~~f~~-~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~----~~  356 (596)
                      .++|.. .++||+|+||.||+|... +++.||||++...       ....+|+..+.+.++||||+++++++..    ..
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~   99 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-------PKARQEVDHHWQASGGPHIVCILDVYENMHHGKR   99 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-------HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence            456777 457999999999999876 5899999999542       1234455555566899999999999876    45


Q ss_pred             eEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecC---CCceEEcc
Q 047719          357 ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDA---EFNAKLGD  433 (596)
Q Consensus       357 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~---~~~~kl~D  433 (596)
                      ..++||||+++|+|.+++....  ...+++.+++.++.||+.||+|||+   .+|+||||||+|||++.   ++.+||+|
T Consensus       100 ~~~lv~e~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~D  174 (336)
T 3fhr_A          100 CLLIIMECMEGGELFSRIQERG--DQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTD  174 (336)
T ss_dssp             EEEEEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred             eEEEEEeccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEec
Confidence            6899999999999999998754  2358999999999999999999999   89999999999999976   45599999


Q ss_pred             CCCcc---------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHH-HHHHHHhcCCchhhc
Q 047719          434 FEATI---------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVD-WVWNLRKKGKLLDAA  503 (596)
Q Consensus       434 fg~~~---------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~  503 (596)
                      ||.+.         ..||+.|+|||.+....++.++|||||||++|||++|+.||......... .........      
T Consensus       175 fg~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------  248 (336)
T 3fhr_A          175 FGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLG------  248 (336)
T ss_dssp             CTTCEEC----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred             cccceeccccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcc------
Confidence            99764         34789999999998888999999999999999999999999764321110 000000000      


Q ss_pred             cccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhcCCCCCC
Q 047719          504 DFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKGEAPLPL  552 (596)
Q Consensus       504 d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~~~~~~p~  552 (596)
                      ...............+.+++..|++.||++|||++|+++  +++.....+.
T Consensus       249 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~  299 (336)
T 3fhr_A          249 QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQ  299 (336)
T ss_dssp             --CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGGSCC
T ss_pred             ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccccCCC
Confidence            000111111123356778889999999999999999998  6665544443

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.3e-37  Score=327.67  Aligned_cols=253  Identities=19%  Similarity=0.256  Sum_probs=193.3

Q ss_pred             hcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeC-----C
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG-----N  356 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~-----~  356 (596)
                      ..+|...+.||+|+||.||++... ++..||||++.... .......+.+|+..+.+ ++||||+++++++...     .
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~~~  103 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLR-FRHENIIGINDIIRAPTIEQMK  103 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHH-CCCTTBCCCCEEECCSSTTTCC
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHh-cCCCCCccceeEEecCCccccc
Confidence            356888899999999999999865 58899999996432 23344568889966665 8999999999998765     3


Q ss_pred             eEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCC
Q 047719          357 ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEA  436 (596)
Q Consensus       357 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~  436 (596)
                      ..|+||||+. |+|.+++....     +++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||.
T Consensus       104 ~~~iv~e~~~-~~L~~~l~~~~-----~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~  174 (364)
T 3qyz_A          104 DVYIVQDLME-TDLYKLLKTQH-----LSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGL  174 (364)
T ss_dssp             CEEEEEECCS-EEHHHHHHHCC-----CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEEcccC-cCHHHHHHhCC-----CCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcc
Confidence            6899999997 59999998653     8999999999999999999999   8999999999999999999999999997


Q ss_pred             cc--------------cCCCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCCh-hHHHHHHHHHhcCCch
Q 047719          437 TI--------------PAGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGC-VIVDWVWNLRKKGKLL  500 (596)
Q Consensus       437 ~~--------------~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~-~~~~~~~~~~~~~~~~  500 (596)
                      +.              ..||+.|+|||.+.+ ..++.++|||||||++|||++|+.||..... .....+..........
T Consensus       175 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  254 (364)
T 3qyz_A          175 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE  254 (364)
T ss_dssp             CEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHH
T ss_pred             eEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            53              258999999998765 4589999999999999999999999986532 1211111111111000


Q ss_pred             hh-----------c-cccccCcCC-----HHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhc
Q 047719          501 DA-----------A-DFRLRGKFN-----RKEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKG  546 (596)
Q Consensus       501 ~~-----------~-d~~l~~~~~-----~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~~  546 (596)
                      ..           . ........+     ......+.+|+.+|++.||++|||++|+++  +++.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~  319 (364)
T 3qyz_A          255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ  319 (364)
T ss_dssp             HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTT
T ss_pred             HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhh
Confidence            00           0 000000000     112345778899999999999999999987  4443

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.1e-37  Score=320.94  Aligned_cols=244  Identities=18%  Similarity=0.223  Sum_probs=188.8

Q ss_pred             cCCCccceeecCCceEEEEEEc-CCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeee--CCeEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSL-PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE--GNELVL  360 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~--~~~~~l  360 (596)
                      ++|...+.||+|+||.||+|.. .+++.||||++...     ....+.+|+..+...-.||||+++++++..  ....++
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l  110 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL  110 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence            4577889999999999999975 46899999999632     235678898777663349999999999988  667999


Q ss_pred             EEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCC-ceEEccCCCcc-
Q 047719          361 VYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEF-NAKLGDFEATI-  438 (596)
Q Consensus       361 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~-~~kl~Dfg~~~-  438 (596)
                      ||||+++++|.+++..       +++..+..++.||+.||+|||+   .+|+||||||+|||++.++ .+||+|||++. 
T Consensus       111 v~e~~~~~~l~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~  180 (330)
T 3nsz_A          111 VFEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF  180 (330)
T ss_dssp             EEECCCCCCHHHHGGG-------CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEeccCchhHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceE
Confidence            9999999999999853       7889999999999999999999   8999999999999999776 89999999864 


Q ss_pred             ---------cCCCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHH--HHHHhcCCchhhc---
Q 047719          439 ---------PAGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWV--WNLRKKGKLLDAA---  503 (596)
Q Consensus       439 ---------~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~--~~~~~~~~~~~~~---  503 (596)
                               ..||..|+|||.+.+ ..++.++|||||||++|||++|+.||...........  ..........+..   
T Consensus       181 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  260 (330)
T 3nsz_A          181 YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY  260 (330)
T ss_dssp             CCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred             cCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHh
Confidence                     247889999999877 6789999999999999999999999965332111100  0000000000000   


Q ss_pred             --------------------cccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          504 --------------------DFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       504 --------------------d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                                          ...............+.+++..|++.||++|||++|+++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                                000001111113456788899999999999999999987

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=5.6e-38  Score=327.69  Aligned_cols=251  Identities=22%  Similarity=0.306  Sum_probs=194.9

Q ss_pred             cCCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhccc---------------chHHHHHHHHHhccCCCceeee
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECAR---------------NPFTTEFATMAGCLRHKNLVQL  348 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~---------------~~~~~E~~~l~~~l~H~niv~l  348 (596)
                      ++|...+.||+|+||.||+|.. +++.||||++..........               ..+.+|+..+.+ ++||||+++
T Consensus        31 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~~i~~~  108 (348)
T 2pml_X           31 NDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITD-IKNEYCLTC  108 (348)
T ss_dssp             TTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTT-CCCTTBCCC
T ss_pred             CceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHh-CCCCCcceE
Confidence            5788889999999999999998 89999999996432221111               678899866654 899999999


Q ss_pred             cceeeeCCeEEEEEecCCCCCHHHH------hhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCcee
Q 047719          349 QGWCCEGNELVLVYEYLPNGSLDKI------LHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNIL  422 (596)
Q Consensus       349 ~g~~~~~~~~~lV~E~~~~gsL~~~------l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiL  422 (596)
                      ++++.+.+..++||||+++|+|.++      +....  ...+++..++.++.||+.||+|||+.  .+++||||||+|||
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dl~p~Nil  184 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY--TCFIPIQVIKCIIKSVLNSFSYIHNE--KNICHRDVKPSNIL  184 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS--CCCCCHHHHHHHHHHHHHHHHHHHHT--SCEECCCCCGGGEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc--ccCCCHHHHHHHHHHHHHHHHHHhcc--CCEeecCCChHhEE
Confidence            9999999999999999999999999      55422  34599999999999999999999973  79999999999999


Q ss_pred             ecCCCceEEccCCCccc---------CCCcccCCccccccC-CCCC-ccceeehhHHHHHHHhCCCCCCCCChhHHHHHH
Q 047719          423 LDAEFNAKLGDFEATIP---------AGTMGYLAPEYVYSG-VPSE-KTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVW  491 (596)
Q Consensus       423 l~~~~~~kl~Dfg~~~~---------~gt~~y~aPE~~~~~-~~t~-~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~  491 (596)
                      ++.++.+||+|||.+..         .||..|+|||.+.+. .++. ++|||||||++|||++|+.||...... .+.. 
T Consensus       185 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~-  262 (348)
T 2pml_X          185 MDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL-VELF-  262 (348)
T ss_dssp             ECTTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS-HHHH-
T ss_pred             EcCCCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHH-
Confidence            99999999999997643         588999999999877 5666 999999999999999999999865331 1111 


Q ss_pred             HHHhcCCchhhccc-----cc----cCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          492 NLRKKGKLLDAADF-----RL----RGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       492 ~~~~~~~~~~~~d~-----~l----~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      .....+......+.     ..    ...........+.+++.+||+.||++|||++|+++
T Consensus       263 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          263 NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             HHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            11111111000000     00    00000223356778889999999999999999987

>2ltn_A PEA lectin, alpha chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1bqp_A* 1hkd_A 1ofs_A* 1rin_A* 1lof_C* 1len_A 1lem_A 1les_A* 2lal_A 1loe_A 1loa_A* 1loc_A* 1lod_A* 1lob_A 1lof_A* 1log_A* 1lgc_A* 1lgb_A* 2b7y_A*

Probab=100.00  E-value=2.4e-37  Score=288.78  Aligned_cols=126  Identities=27%  Similarity=0.430  Sum_probs=114.8

Q ss_pred             CCCCCCCcccceEEEEEEEEecCCCCCCCCeEEEEEecCCCCCCCCCCccCCCCCCCCC-CCceEEEEeeCccCCCCCCC
Q 047719            1 FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSP-QDSFFAVEFDTSFDPSLGDI   79 (596)
Q Consensus         1 ~~~~~~~~~asF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~~~~~~~~~lG~~~~~~~~-~~~~~AVEfDt~~~~~~~d~   79 (596)
                      |||+.||+++||+|+|+|.|.+++...+||||||||+|.+..++.+||||||+|.++++ .+|+|||||||++|.+ +||
T Consensus        52 l~d~~tg~vaSFsT~F~F~I~~~~~~~~gdGlAF~l~p~~~~p~~~g~~LGL~n~~~~~~~n~~vAVEFDT~~n~~-~Dp  130 (181)
T 2ltn_A           52 IWDRETGNVANFVTSFTFVINAPNSYNVADGFTFFIAPVDTKPQTGGGYLGVFNSAEYDKTTQTVAVEFDTFYNAA-WDP  130 (181)
T ss_dssp             CBCTTTCCBCEEEEEEEEEEECSSTTSCCCEEEEEEEETTCCCCCCGGGTTTCSCSSCCTTSCCEEEEEECSCCTT-TSC
T ss_pred             eecCCCCCccceEEEEEEEEecCCCCCCCCceEEEEecCCCCCCCCCccccccccCCCCccccEEEEEeccccccc-cCC
Confidence            79999999999999999999988777789999999999877445889999999987444 7999999999999998 699


Q ss_pred             C--CCeeEEecCCccccccccCCCCCcccCCCceEEEEEEEcCCccEEEEEEeeC
Q 047719           80 N--GNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRDSLKLIRVWAGYS  132 (596)
Q Consensus        80 ~--~~Hvgid~ns~~s~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~  132 (596)
                      +  +|||||||||+.|++++++     +|.+|+.++|||+||+.+++|+|+|+++
T Consensus       131 ~~~~nHVGIdvNs~~S~~t~~~-----~l~~G~~~~v~I~Yd~~~~~L~V~l~~~  180 (181)
T 2ltn_A          131 SNRDRHIGIDVNSIKSVNTKSW-----KLQNGEEANVVIAFNAATNVLTVSLTYP  180 (181)
T ss_dssp             TTCCCEEEEEESSSSCSEEEEC-----CCCTTCCEEEEEEEETTTTEEEEEEEEC
T ss_pred             CCCCCEEEEEcCCccccceecc-----ccCCCCEEEEEEEEECCCCEEEEEEecC
Confidence            9  9999999999999999875     5789999999999999999999999874

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=8.7e-38  Score=335.65  Aligned_cols=247  Identities=23%  Similarity=0.319  Sum_probs=183.8

Q ss_pred             CCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeC------Ce
Q 047719          285 GFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG------NE  357 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~------~~  357 (596)
                      .|...+.||+|+||.||+|... +|+.||||++....      ....+|+..+. .++|+|||+++++|...      ..
T Consensus        55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~il~-~l~hpniv~l~~~~~~~~~~~~~~~  127 (420)
T 1j1b_A           55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMR-KLDHCNIVRLRYFFYSSGEKKDEVY  127 (420)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT------TSCCHHHHHHH-TCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred             eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc------hhHHHHHHHHH-HcCCCCccceeeEEeccCCCCccee
Confidence            4777899999999999999875 58999999986432      12336775555 48999999999998642      23


Q ss_pred             EEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCC-CceEEccCCC
Q 047719          358 LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAE-FNAKLGDFEA  436 (596)
Q Consensus       358 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~-~~~kl~Dfg~  436 (596)
                      +++||||+++ +|.+.+.........+++..+..++.||++||+|||+   .+|+||||||+||||+.+ +.+||+|||+
T Consensus       128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~  203 (420)
T 1j1b_A          128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGS  203 (420)
T ss_dssp             EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchh
Confidence            7899999985 6777665322223458999999999999999999999   899999999999999965 6789999998


Q ss_pred             cc----------cCCCcccCCccccccC-CCCCccceeehhHHHHHHHhCCCCCCCCCh--hHHHHHHHHHh--------
Q 047719          437 TI----------PAGTMGYLAPEYVYSG-VPSEKTDVYSFGVVALEVAAGKSPVDNDGC--VIVDWVWNLRK--------  495 (596)
Q Consensus       437 ~~----------~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~El~tG~~p~~~~~~--~~~~~~~~~~~--------  495 (596)
                      +.          ..||..|+|||++.+. .++.++|||||||++|||++|+.||.+...  .+...+..+..        
T Consensus       204 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~  283 (420)
T 1j1b_A          204 AKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE  283 (420)
T ss_dssp             CEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred             hhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            74          2478999999998764 789999999999999999999999987542  11111111000        


Q ss_pred             -cCCchhhccccccC-----cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          496 -KGKLLDAADFRLRG-----KFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       496 -~~~~~~~~d~~l~~-----~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                       .....+...+.+..     .+.......+.+|+.+||+.||++|||+.|+++
T Consensus       284 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence             00000000000000     011122356788999999999999999999986

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.7e-37  Score=316.55  Aligned_cols=239  Identities=26%  Similarity=0.388  Sum_probs=187.3

Q ss_pred             hcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeee-------
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE-------  354 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~-------  354 (596)
                      ..+|...+.||+|+||.||+|... +++.||||++...   ......+.+|+..+. .++||||+++++++.+       
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~~~~   80 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLA-SLNHQYVVRYYAAWLERRNFVKP   80 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHT-TCCCTTBCCEEEEEEECCCCCC-
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHH-hcCchHHHHHHHHHHhhcchhhh
Confidence            456888899999999999999864 6899999999532   234456888886554 5899999999998865       


Q ss_pred             ------CCeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCc
Q 047719          355 ------GNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFN  428 (596)
Q Consensus       355 ------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~  428 (596)
                            ....++||||+++|+|.+++....   ..+++..++.++.||+.||+|||+   .+++||||||+|||++.++.
T Consensus        81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~  154 (303)
T 1zy4_A           81 MTAVKKKSTLFIQMEYCENGTLYDLIHSEN---LNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRN  154 (303)
T ss_dssp             -----CEEEEEEEEECCCSCBHHHHHHHSC---GGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSC
T ss_pred             hcccccCCceEEEEecCCCCCHHHhhhccc---cccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCC
Confidence                  457899999999999999998653   357889999999999999999999   89999999999999999999


Q ss_pred             eEEccCCCccc-------------------------CCCcccCCccccccC-CCCCccceeehhHHHHHHHhCCCCCCCC
Q 047719          429 AKLGDFEATIP-------------------------AGTMGYLAPEYVYSG-VPSEKTDVYSFGVVALEVAAGKSPVDND  482 (596)
Q Consensus       429 ~kl~Dfg~~~~-------------------------~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~El~tG~~p~~~~  482 (596)
                      +||+|||.+..                         .||..|+|||.+.+. .++.++|||||||++|||++   |+...
T Consensus       155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~  231 (303)
T 1zy4_A          155 VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG  231 (303)
T ss_dssp             EEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred             EEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc
Confidence            99999997642                         378889999999764 78999999999999999998   55432


Q ss_pred             ChhHHHHHHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          483 GCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       483 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      . ......... ...      .......++......+.+++..|++.||++|||++++++
T Consensus       232 ~-~~~~~~~~~-~~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          232 M-ERVNILKKL-RSV------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             H-HHHHHHHHH-HST------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             h-hHHHHHHhc-ccc------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            1 111111111 111      111122233344456778899999999999999999986

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=3e-37  Score=323.43  Aligned_cols=248  Identities=21%  Similarity=0.287  Sum_probs=192.0

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCe-----
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNE-----  357 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~-----  357 (596)
                      .+|...+.||+|+||.||+|... +|+.||||++............+.+|+..+.. ++||||+++++++.....     
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKH-MQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHH-CCCTTBCCCSEEECSCSSGGGCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHh-cCCCCcccHhheEecccccccce
Confidence            46778899999999999999865 58999999997654444445678889866655 899999999999987654     


Q ss_pred             -EEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCC
Q 047719          358 -LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEA  436 (596)
Q Consensus       358 -~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~  436 (596)
                       .|+||||+. ++|.+++..      .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||.
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~  172 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL------KFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGL  172 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred             eEEEEecccc-CCHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeeccc
Confidence             599999997 688888743      38999999999999999999999   8999999999999999999999999998


Q ss_pred             ccc--------CCCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCChh-HHHHHHHHHhcCC------c-
Q 047719          437 TIP--------AGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV-IVDWVWNLRKKGK------L-  499 (596)
Q Consensus       437 ~~~--------~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~-~~~~~~~~~~~~~------~-  499 (596)
                      +..        .||..|+|||.+.+ ..++.++|||||||++|||++|+.||...... .............      + 
T Consensus       173 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  252 (353)
T 3coi_A          173 ARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN  252 (353)
T ss_dssp             TTC--------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCS
T ss_pred             ccCCCCCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHh
Confidence            653        57899999999877 67899999999999999999999999865421 1111111100000      0 


Q ss_pred             -------hhhcccccc---CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          500 -------LDAADFRLR---GKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       500 -------~~~~d~~l~---~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                             .........   ..........+.+++.+|++.||++|||++|+++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          253 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             CHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                   000000000   0111223456788889999999999999999986

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=8.5e-38  Score=317.71  Aligned_cols=242  Identities=23%  Similarity=0.285  Sum_probs=195.0

Q ss_pred             hcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      .++|...+.||+|+||.||++... +++.||||++............+.+|+..+.+ ++||||+++++++.+.+..++|
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv   99 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKK-LDHPNIMKLFEILEDSSSFYIV   99 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHT-CCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHh-ccCCCccEEEEEEeCCCeEEEE
Confidence            457888999999999999999875 58899999997654444455678899966655 8999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCC---CceEEccCCCcc
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAE---FNAKLGDFEATI  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~---~~~kl~Dfg~~~  438 (596)
                      |||+++++|.+++....    .+++..++.++.||+.||.|||+   .+++||||||+|||++.+   +.+||+|||.+.
T Consensus       100 ~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~  172 (287)
T 2wei_A          100 GELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (287)
T ss_dssp             ECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred             EEccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence            99999999999987653    48999999999999999999999   899999999999999764   479999999764


Q ss_pred             c----------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhcccccc
Q 047719          439 P----------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLR  508 (596)
Q Consensus       439 ~----------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  508 (596)
                      .          .||..|+|||.+.+ .++.++||||||+++|||++|+.||......  +...... .+....  +....
T Consensus       173 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~-~~~~~~--~~~~~  246 (287)
T 2wei_A          173 CFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY--DILKRVE-TGKYAF--DLPQW  246 (287)
T ss_dssp             TBCCCSSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHH-HCCCCC--CSGGG
T ss_pred             eecCCCccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH--HHHHHHH-cCCCCC--Cchhh
Confidence            3          26778999998865 5899999999999999999999999875432  1111221 111100  00001


Q ss_pred             CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          509 GKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       509 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ..+    ...+.+++.+|++.||++|||++|+++
T Consensus       247 ~~~----~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          247 RTI----SDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hhc----CHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            122    345778889999999999999999987

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=9.4e-37  Score=323.38  Aligned_cols=196  Identities=23%  Similarity=0.262  Sum_probs=163.4

Q ss_pred             HHhcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCC-----ceeeecceeee
Q 047719          281 QATLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHK-----NLVQLQGWCCE  354 (596)
Q Consensus       281 ~at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~-----niv~l~g~~~~  354 (596)
                      ...++|...+.||+|+||+||+|... +++.||||+++...   ....++..|+..+...-+|+     +|+++++++..
T Consensus        51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~  127 (382)
T 2vx3_A           51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK---AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF  127 (382)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH---HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred             EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH---HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence            34568889999999999999999865 57899999996422   22344566665544422344     59999999999


Q ss_pred             CCeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeec--CCCceEEc
Q 047719          355 GNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLD--AEFNAKLG  432 (596)
Q Consensus       355 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~--~~~~~kl~  432 (596)
                      .+..+|||||++ |+|.+++.....  ..+++..+..++.||+.||.|||+. ..+|+||||||+|||++  .++.+||+
T Consensus       128 ~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~  203 (382)
T 2vx3_A          128 RNHLCLVFEMLS-YNLYDLLRNTNF--RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIV  203 (382)
T ss_dssp             TTEEEEEEECCC-CBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred             CCceEEEEecCC-CCHHHHHhhcCc--CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEE
Confidence            999999999996 599999987642  3489999999999999999999941 27899999999999994  47889999


Q ss_pred             cCCCcc--------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCC
Q 047719          433 DFEATI--------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDG  483 (596)
Q Consensus       433 Dfg~~~--------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~  483 (596)
                      |||++.        ..||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus       204 DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~  262 (382)
T 2vx3_A          204 DFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN  262 (382)
T ss_dssp             CCTTCEETTCCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             eccCceecccccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            999764        358999999999999999999999999999999999999998754

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=6.3e-38  Score=354.47  Aligned_cols=244  Identities=24%  Similarity=0.334  Sum_probs=196.5

Q ss_pred             HhcCCCccceeecCCceEEEEEEcCC----CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCe
Q 047719          282 ATLGFNKNRIVGEGASATVYKGSLPS----GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNE  357 (596)
Q Consensus       282 at~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~  357 (596)
                      ....|...+.||+|+||.||+|.+..    +..||||++.... .....+.+.+|+..+.+ ++||||+++++++. .+.
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~-l~HpnIv~l~~~~~-~~~  464 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-SDSVREKFLQEALTMRQ-FDHPHIVKLIGVIT-ENP  464 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT-CHHHHHHHHHHHHHHHH-CCCTTBCCEEEEEC-SSS
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC-CHHHHHHHHHHHHHHHh-CCCCCCCeEEEEEe-cCc
Confidence            34567778999999999999998643    4579999986432 23344678889866655 89999999999985 456


Q ss_pred             EEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCc
Q 047719          358 LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT  437 (596)
Q Consensus       358 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~  437 (596)
                      .++||||+++|+|.+++....   ..+++..++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus       465 ~~lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a  538 (656)
T 2j0j_A          465 VWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLS  538 (656)
T ss_dssp             CEEEEECCTTCBHHHHHHHTT---TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred             eEEEEEcCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCC
Confidence            899999999999999998653   248999999999999999999999   89999999999999999999999999987


Q ss_pred             cc------------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhcc
Q 047719          438 IP------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAAD  504 (596)
Q Consensus       438 ~~------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d  504 (596)
                      ..            .+|+.|+|||.+....++.++|||||||++|||++ |..||.+....  +....... +..     
T Consensus       539 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~--~~~~~i~~-~~~-----  610 (656)
T 2j0j_A          539 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRIEN-GER-----  610 (656)
T ss_dssp             CSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHH-TCC-----
T ss_pred             eecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHc-CCC-----
Confidence            53            25678999999998999999999999999999997 99999865321  11111111 111     


Q ss_pred             ccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          505 FRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       505 ~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                          ...+......+.+++..||+.||++|||+.++++.|+.
T Consensus       611 ----~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~  648 (656)
T 2j0j_A          611 ----LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST  648 (656)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ----CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence                11122233567788899999999999999999998875

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.2e-37  Score=331.87  Aligned_cols=247  Identities=21%  Similarity=0.326  Sum_probs=183.5

Q ss_pred             cCCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCe------
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNE------  357 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~------  357 (596)
                      ..|...++||+|+||.||+|....+..||+|++......      ..+|+..+. .++||||+++++++...+.      
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~------~~~E~~il~-~l~h~niv~l~~~~~~~~~~~~~~~  112 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF------KNRELQIMR-IVKHPNVVDLKAFFYSNGDKKDEVF  112 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS------CCHHHHHHH-TCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch------HHHHHHHHH-hCCCCCcceEEEEEEecCCCCCceE
Confidence            357788999999999999999877777999998643211      235775554 5899999999999965443      


Q ss_pred             EEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeec-CCCceEEccCCC
Q 047719          358 LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLD-AEFNAKLGDFEA  436 (596)
Q Consensus       358 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~-~~~~~kl~Dfg~  436 (596)
                      +++||||++++ |.+.+.........+++..+..++.||+.||+|||+   .+|+||||||+|||++ .++.+||+|||+
T Consensus       113 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~  188 (394)
T 4e7w_A          113 LNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGS  188 (394)
T ss_dssp             EEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence            89999999874 444433211112358999999999999999999999   8999999999999999 789999999998


Q ss_pred             cc----------cCCCcccCCccccccC-CCCCccceeehhHHHHHHHhCCCCCCCCChh--HHHHHHHHHhcCC-----
Q 047719          437 TI----------PAGTMGYLAPEYVYSG-VPSEKTDVYSFGVVALEVAAGKSPVDNDGCV--IVDWVWNLRKKGK-----  498 (596)
Q Consensus       437 ~~----------~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~El~tG~~p~~~~~~~--~~~~~~~~~~~~~-----  498 (596)
                      +.          ..||..|+|||.+.+. .++.++|||||||++|||++|+.||.+....  +.... .......     
T Consensus       189 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~-~~~g~p~~~~~~  267 (394)
T 4e7w_A          189 AKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEII-KVLGTPSREQIK  267 (394)
T ss_dssp             CEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-HHHCCCCHHHHH
T ss_pred             cccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-HHhCCCCHHHHH
Confidence            64          2478899999998764 5899999999999999999999999875431  11111 1110000     


Q ss_pred             -----chhh-----ccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          499 -----LLDA-----ADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       499 -----~~~~-----~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                           ..+.     ........+.......+.+|+.+||+.||++|||+.|+++
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence                 0000     0000001111123356788999999999999999999987

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.6e-37  Score=318.00  Aligned_cols=250  Identities=18%  Similarity=0.205  Sum_probs=186.4

Q ss_pred             cCCCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceee---------
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCC---------  353 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~---------  353 (596)
                      .+|...+.||+|+||.||+|.... ++.||||++....  ....+.+.+|+..+.. ++||||+++++++.         
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~~~~   87 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD--PQSVKHALREIKIIRR-LDHDNIVKVFEILGPSGSQLTDD   87 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS--HHHHHHHHHHHHHHHT-CCCTTBCCEEEEECTTSCBCCC-
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC--hHHHHHHHHHHHHHHh-cCCCCeeEEEEeccccccccccc
Confidence            467788999999999999998764 8899999996432  3345678889866655 89999999998873         


Q ss_pred             -----eCCeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeec-CCC
Q 047719          354 -----EGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLD-AEF  427 (596)
Q Consensus       354 -----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~-~~~  427 (596)
                           +....++||||++ |+|.+++...     .+++..++.++.||+.||+|||+   .+|+||||||+|||++ +++
T Consensus        88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~  158 (320)
T 2i6l_A           88 VGSLTELNSVYIVQEYME-TDLANVLEQG-----PLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDL  158 (320)
T ss_dssp             ---CCSCSEEEEEEECCS-EEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTT
T ss_pred             cccccccCceeEEeeccC-CCHHHHhhcC-----CccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCC
Confidence                 4568999999997 6999999753     38899999999999999999999   8999999999999997 567


Q ss_pred             ceEEccCCCccc--------------CCCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHH
Q 047719          428 NAKLGDFEATIP--------------AGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWN  492 (596)
Q Consensus       428 ~~kl~Dfg~~~~--------------~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~  492 (596)
                      .+||+|||.+..              .+|..|+|||.+.. ..++.++|||||||++|||++|+.||......  +....
T Consensus       159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--~~~~~  236 (320)
T 2i6l_A          159 VLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL--EQMQL  236 (320)
T ss_dssp             EEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHH
T ss_pred             eEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH--HHHHH
Confidence            999999997653              25788999998875 67899999999999999999999999875431  11111


Q ss_pred             HHhcC-Cch------------hhcccccc-Cc-----CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhcC
Q 047719          493 LRKKG-KLL------------DAADFRLR-GK-----FNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKGE  547 (596)
Q Consensus       493 ~~~~~-~~~------------~~~d~~l~-~~-----~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~~~  547 (596)
                      ..... ...            ........ ..     ........+.+++.+|++.||++|||++|+++  +++..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  312 (320)
T 2i6l_A          237 ILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY  312 (320)
T ss_dssp             HHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred             HHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccc
Confidence            11100 000            00000000 00     00112356788899999999999999999987  66643

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.9e-37  Score=334.38  Aligned_cols=240  Identities=23%  Similarity=0.274  Sum_probs=182.5

Q ss_pred             CCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecC
Q 047719          286 FNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYL  365 (596)
Q Consensus       286 f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~  365 (596)
                      |...++||+|+||+||.+...+|+.||||++....     ...+.+|+..+....+|||||++++++.+.+..|+||||+
T Consensus        17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~   91 (434)
T 2rio_A           17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC   91 (434)
T ss_dssp             EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence            34468899999999987666679999999986421     2346788877766569999999999999999999999999


Q ss_pred             CCCCHHHHhhhCCCCCcc---cCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCC-------------Cce
Q 047719          366 PNGSLDKILHNNSSSSIV---LSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAE-------------FNA  429 (596)
Q Consensus       366 ~~gsL~~~l~~~~~~~~~---l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~-------------~~~  429 (596)
                      . |+|.+++.........   ..+..++.++.||+.||+|||+   .+|+||||||+|||++.+             +.+
T Consensus        92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEE
Confidence            5 6999999875432211   1334567899999999999999   899999999999999754             489


Q ss_pred             EEccCCCcc---------------cCCCcccCCcccccc-------CCCCCccceeehhHHHHHHHh-CCCCCCCCChhH
Q 047719          430 KLGDFEATI---------------PAGTMGYLAPEYVYS-------GVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVI  486 (596)
Q Consensus       430 kl~Dfg~~~---------------~~gt~~y~aPE~~~~-------~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~  486 (596)
                      ||+|||++.               ..||+.|+|||.+.+       ..++.++|||||||++|||++ |+.||.......
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~  247 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE  247 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence            999999753               258999999999865       678999999999999999999 999997643221


Q ss_pred             HHHHHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          487 VDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       487 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ....   ......     ..............+.+++.+|++.||++|||+.|+++
T Consensus       248 ~~i~---~~~~~~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          248 SNII---RGIFSL-----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             HHHH---HTCCCC-----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHh---cCCCCc-----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            1111   000010     01111223456678889999999999999999999976

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.9e-37  Score=329.85  Aligned_cols=248  Identities=20%  Similarity=0.261  Sum_probs=177.5

Q ss_pred             CCc-cceeecCCceEEEEEEcC---CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeee--CCeEE
Q 047719          286 FNK-NRIVGEGASATVYKGSLP---SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE--GNELV  359 (596)
Q Consensus       286 f~~-~~~LG~G~fG~Vy~~~~~---~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~--~~~~~  359 (596)
                      |.. +++||+|+||.||+|...   ++..||||++....    ....+.+|+..+.. ++|||||++++++..  ....+
T Consensus        22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~E~~~l~~-l~hpniv~~~~~~~~~~~~~~~   96 (405)
T 3rgf_A           22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG----ISMSACREIALLRE-LKHPNVISLQKVFLSHADRKVW   96 (405)
T ss_dssp             EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS----CCHHHHHHHHHHHH-CCCTTBCCCCEEEEETTTTEEE
T ss_pred             hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC----CCHHHHHHHHHHHh-cCCCCeeeEeeEEecCCCCeEE
Confidence            443 468999999999999865   47889999996432    23457889866655 899999999999954  67899


Q ss_pred             EEEecCCCCCHHHHhhhCC-----CCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceee----cCCCceE
Q 047719          360 LVYEYLPNGSLDKILHNNS-----SSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILL----DAEFNAK  430 (596)
Q Consensus       360 lV~E~~~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl----~~~~~~k  430 (596)
                      +||||+. |+|.+++....     .....+++..++.++.||+.||+|||+   .+|+||||||+||||    +.++.+|
T Consensus        97 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~k  172 (405)
T 3rgf_A           97 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVK  172 (405)
T ss_dssp             EEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred             EEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEE
Confidence            9999996 58888886321     112348999999999999999999999   899999999999999    7789999


Q ss_pred             EccCCCcc--------------cCCCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCChh----------
Q 047719          431 LGDFEATI--------------PAGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV----------  485 (596)
Q Consensus       431 l~Dfg~~~--------------~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~----------  485 (596)
                      |+|||++.              ..||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......          
T Consensus       173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~  252 (405)
T 3rgf_A          173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD  252 (405)
T ss_dssp             ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred             EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence            99999764              247899999999987 45899999999999999999999999754321          


Q ss_pred             HHHHHHHHHhcCCchhhccc---------------cccCcCCH---------HHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 047719          486 IVDWVWNLRKKGKLLDAADF---------------RLRGKFNR---------KEMERMLMVGLSCVHPNHEKRPSVKEAA  541 (596)
Q Consensus       486 ~~~~~~~~~~~~~~~~~~d~---------------~l~~~~~~---------~~~~~l~~l~~~C~~~dp~~RPs~~ev~  541 (596)
                      ....+.............+.               ........         .....+.+|+..||+.||++|||++|++
T Consensus       253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L  332 (405)
T 3rgf_A          253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM  332 (405)
T ss_dssp             HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence            11111111111000000000               00000000         0134567889999999999999999998


Q ss_pred             H
Q 047719          542 R  542 (596)
Q Consensus       542 ~  542 (596)
                      +
T Consensus       333 ~  333 (405)
T 3rgf_A          333 Q  333 (405)
T ss_dssp             T
T ss_pred             c
Confidence            8

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.3e-36  Score=320.31  Aligned_cols=253  Identities=19%  Similarity=0.233  Sum_probs=192.6

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccC-----------CCceeeecce
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLR-----------HKNLVQLQGW  351 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~-----------H~niv~l~g~  351 (596)
                      .+|...+.||+|+||.||+|... +++.||||++....   .....+.+|+..+.. ++           |+||++++++
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~-l~~~~~~~~~~~~~~~i~~~~~~   94 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQR-VNDADNTKEDSMGANHILKLLDH   94 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHH-HHHTCCSHHHHHHHTTBCCCCEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc---cchhhhhHHHHHHHH-hhcccccchhccccchHHHHHHH
Confidence            46888899999999999999864 58899999996422   233456777755544 43           8999999999


Q ss_pred             eeeCC----eEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCC-CeEEccCCCCceeec--
Q 047719          352 CCEGN----ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECER-QIIHRDVKACNILLD--  424 (596)
Q Consensus       352 ~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~-~ivHrDlkp~NiLl~--  424 (596)
                      +...+    ..++||||+ +++|.+++.....  ..+++..+..++.||+.||+|||+   + +|+||||||+|||++  
T Consensus        95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~  168 (373)
T 1q8y_A           95 FNHKGPNGVHVVMVFEVL-GENLLALIKKYEH--RGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIV  168 (373)
T ss_dssp             EEEEETTEEEEEEEECCC-CEEHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEE
T ss_pred             hhccCCCCceEEEEEecC-CCCHHHHHHHhhc--cCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEecc
Confidence            98754    789999999 8999999987542  248999999999999999999999   7 999999999999994  


Q ss_pred             ----CCCceEEccCCCcc--------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChh----HHH
Q 047719          425 ----AEFNAKLGDFEATI--------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV----IVD  488 (596)
Q Consensus       425 ----~~~~~kl~Dfg~~~--------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~----~~~  488 (596)
                          ..+.+||+|||++.        ..||..|+|||.+.+..++.++|||||||++|||++|+.||......    ..+
T Consensus       169 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  248 (373)
T 1q8y_A          169 DSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  248 (373)
T ss_dssp             ETTTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             CCCcCcceEEEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence                44589999999763        35899999999999999999999999999999999999999864311    001


Q ss_pred             HHHHHHh-cCCchh---------------------hcc---------ccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCH
Q 047719          489 WVWNLRK-KGKLLD---------------------AAD---------FRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSV  537 (596)
Q Consensus       489 ~~~~~~~-~~~~~~---------------------~~d---------~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~  537 (596)
                      .+..... .+....                     ...         ......++......+.+|+..||+.||++|||+
T Consensus       249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  328 (373)
T 1q8y_A          249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA  328 (373)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred             HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence            1111100 000000                     000         000123456777889999999999999999999


Q ss_pred             HHHHH--HHhc
Q 047719          538 KEAAR--ILKG  546 (596)
Q Consensus       538 ~ev~~--~L~~  546 (596)
                      +|+++  +++.
T Consensus       329 ~ell~hp~f~~  339 (373)
T 1q8y_A          329 GGLVNHPWLKD  339 (373)
T ss_dssp             HHHHTCGGGTT
T ss_pred             HHHhhChhhhc
Confidence            99987  4544

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-37  Score=319.24  Aligned_cols=238  Identities=24%  Similarity=0.338  Sum_probs=182.8

Q ss_pred             HHHHHhcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchh----cccchHHHHHHHHHhcc----CCCceeee
Q 047719          278 DIKQATLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVE----CARNPFTTEFATMAGCL----RHKNLVQL  348 (596)
Q Consensus       278 el~~at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~----~~~~~~~~E~~~l~~~l----~H~niv~l  348 (596)
                      +.....++|...+.||+|+||.||+|... +++.||||++.......    .....+.+|+..+.+ +    +|+||+++
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~-l~~~~~h~~i~~~  103 (312)
T 2iwi_A           25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK-VGAGGGHPGVIRL  103 (312)
T ss_dssp             --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHH-HHSSCCCSSBCCE
T ss_pred             chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHh-hcccCCCCCeeeE
Confidence            34455678999999999999999999865 58899999996543211    123345667755554 4    89999999


Q ss_pred             cceeeeCCeEEEEEec-CCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeec-CC
Q 047719          349 QGWCCEGNELVLVYEY-LPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLD-AE  426 (596)
Q Consensus       349 ~g~~~~~~~~~lV~E~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~-~~  426 (596)
                      ++++...+..++|+|| +.+++|.+++....    .+++..++.++.||+.||+|||+   .+++||||||+|||++ .+
T Consensus       104 ~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~  176 (312)
T 2iwi_A          104 LDWFETQEGFMLVLERPLPAQDLFDYITEKG----PLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRR  176 (312)
T ss_dssp             EEEC-----CEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTT
T ss_pred             EEEEecCCeEEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCC
Confidence            9999999999999999 78999999998753    48999999999999999999999   8999999999999999 88


Q ss_pred             CceEEccCCCcc---------cCCCcccCCccccccCCC-CCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhc
Q 047719          427 FNAKLGDFEATI---------PAGTMGYLAPEYVYSGVP-SEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKK  496 (596)
Q Consensus       427 ~~~kl~Dfg~~~---------~~gt~~y~aPE~~~~~~~-t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~  496 (596)
                      +.+||+|||.+.         ..||..|+|||.+.+..+ +.++|||||||++|||++|+.||.....        ... 
T Consensus       177 ~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~-  247 (312)
T 2iwi_A          177 GCAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE--------ILE-  247 (312)
T ss_dssp             TEEEECCCSSCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------HHH-
T ss_pred             CeEEEEEcchhhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH--------Hhh-
Confidence            999999999754         348899999999887665 4589999999999999999999975311        001 


Q ss_pred             CCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          497 GKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       497 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ..      ..    ++......+.+++.+||+.||++|||++|+++
T Consensus       248 ~~------~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          248 AE------LH----FPAHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             TC------CC----CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             hc------cC----CcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00      01    11122345678889999999999999999987

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.4e-36  Score=317.22  Aligned_cols=249  Identities=18%  Similarity=0.192  Sum_probs=190.7

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CC-CEEEEEEeecCCchhcccchHHHHHHHHHhccCCCc------eeeecceeeeC
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SG-GAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN------LVQLQGWCCEG  355 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g-~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~n------iv~l~g~~~~~  355 (596)
                      ++|...+.||+|+||.||++... ++ ..||||+++..   ......+.+|+..+.. ++|++      ++.+++++...
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~-l~~~~~~~~~~~~~~~~~~~~~   94 (355)
T 2eu9_A           19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKK-IKEKDKENKFLCVLMSDWFNFH   94 (355)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHH-HHHHCTTSCSCBCCEEEEEEET
T ss_pred             ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHH-HhhcCCCCceeEEEeeeeeeeC
Confidence            56888899999999999999864 34 68999999642   2234456777755544 66555      99999999999


Q ss_pred             CeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceee------------
Q 047719          356 NELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILL------------  423 (596)
Q Consensus       356 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl------------  423 (596)
                      +..++||||+ +++|.+++....  ...+++.+++.++.||+.||+|||+   .+|+||||||+|||+            
T Consensus        95 ~~~~lv~e~~-~~~l~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~  168 (355)
T 2eu9_A           95 GHMCIAFELL-GKNTFEFLKENN--FQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEH  168 (355)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC
T ss_pred             CeEEEEEecc-CCChHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeccccccccccc
Confidence            9999999999 678888887653  2358999999999999999999999   899999999999999            


Q ss_pred             -------cCCCceEEccCCCcc--------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChh-HH
Q 047719          424 -------DAEFNAKLGDFEATI--------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV-IV  487 (596)
Q Consensus       424 -------~~~~~~kl~Dfg~~~--------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~-~~  487 (596)
                             +.++.+||+|||++.        ..||..|+|||.+.+..++.++|||||||++|||++|+.||...... ..
T Consensus       169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  248 (355)
T 2eu9_A          169 KSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL  248 (355)
T ss_dssp             -CCCEEEESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             ccccccccCCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence                   678899999999764        35899999999999999999999999999999999999999875431 11


Q ss_pred             HHHHHHHhcC--------Cchhhc---------------------cc-cccCcCCHHHHHHHHHHHHHcCCCCCCCCCCH
Q 047719          488 DWVWNLRKKG--------KLLDAA---------------------DF-RLRGKFNRKEMERMLMVGLSCVHPNHEKRPSV  537 (596)
Q Consensus       488 ~~~~~~~~~~--------~~~~~~---------------------d~-~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~  537 (596)
                      ..+.......        ......                     .+ .............+.+|+.+||+.||++|||+
T Consensus       249 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~  328 (355)
T 2eu9_A          249 VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITL  328 (355)
T ss_dssp             HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred             HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCH
Confidence            1111111000        000000                     00 00001122345678899999999999999999


Q ss_pred             HHHHH
Q 047719          538 KEAAR  542 (596)
Q Consensus       538 ~ev~~  542 (596)
                      +|+++
T Consensus       329 ~e~l~  333 (355)
T 2eu9_A          329 AEALL  333 (355)
T ss_dssp             HHHTT
T ss_pred             HHHhc
Confidence            99975

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.2e-37  Score=322.28  Aligned_cols=234  Identities=22%  Similarity=0.330  Sum_probs=190.6

Q ss_pred             HhcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchh----cccchHHHHHHHHHhccC--CCceeeecceeee
Q 047719          282 ATLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVE----CARNPFTTEFATMAGCLR--HKNLVQLQGWCCE  354 (596)
Q Consensus       282 at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~----~~~~~~~~E~~~l~~~l~--H~niv~l~g~~~~  354 (596)
                      ...+|...+.||+|+||.||+|... +++.||||++.......    .....+.+|+..+.. ++  |+||+++++++..
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~~~~~~i~~~~~~~~~  119 (320)
T 3a99_A           41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK-VSSGFSGVIRLLDWFER  119 (320)
T ss_dssp             CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHH-HCSSSCSBCCEEEEEEC
T ss_pred             ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHh-hccCCCCceEEEEEEec
Confidence            3456888899999999999999754 58899999997543322    123456678866655 54  6999999999999


Q ss_pred             CCeEEEEEecCCC-CCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeec-CCCceEEc
Q 047719          355 GNELVLVYEYLPN-GSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLD-AEFNAKLG  432 (596)
Q Consensus       355 ~~~~~lV~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~-~~~~~kl~  432 (596)
                      .+..++|+||+.+ ++|.+++....    .+++..++.++.||+.||+|||+   .+|+||||||+|||++ .++.+||+
T Consensus       120 ~~~~~lv~e~~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL~  192 (320)
T 3a99_A          120 PDSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLI  192 (320)
T ss_dssp             SSEEEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEEC
T ss_pred             CCcEEEEEEcCCCCccHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEEe
Confidence            9999999999976 89999998753    48999999999999999999999   8999999999999999 78999999


Q ss_pred             cCCCcc---------cCCCcccCCccccccCCC-CCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhh
Q 047719          433 DFEATI---------PAGTMGYLAPEYVYSGVP-SEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDA  502 (596)
Q Consensus       433 Dfg~~~---------~~gt~~y~aPE~~~~~~~-t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~  502 (596)
                      |||++.         ..||..|+|||.+.+..+ +.++|||||||++|||++|+.||.....        ... ...   
T Consensus       193 Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--------~~~-~~~---  260 (320)
T 3a99_A          193 DFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--------IIR-GQV---  260 (320)
T ss_dssp             CCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------HHH-CCC---
T ss_pred             eCccccccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh--------hhc-ccc---
Confidence            999754         358899999999987665 7889999999999999999999975321        111 110   


Q ss_pred             ccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          503 ADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       503 ~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                         .....+    ...+.+++.+||+.||++|||++|+++
T Consensus       261 ---~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          261 ---FFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             ---CCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---cccccC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               111222    245678889999999999999999987

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=6e-37  Score=315.42  Aligned_cols=243  Identities=23%  Similarity=0.312  Sum_probs=179.0

Q ss_pred             hcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      .++|...+.||+|+||.||+|... +|+.||||++....... ...++..|+..+.+.++||||+++++++.+.+..++|
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv  102 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKE-ENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA  102 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHH-HHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccch-HHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence            346777899999999999999875 58999999997654333 2334555555666778999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCC-CeEEccCCCCceeecCCCceEEccCCCcc--
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECER-QIIHRDVKACNILLDAEFNAKLGDFEATI--  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~-~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~--  438 (596)
                      |||+ ++.+..++....   ..+++..++.++.||+.||.|||+   . +++||||||+|||++.++.+||+|||.+.  
T Consensus       103 ~e~~-~~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  175 (318)
T 2dyl_A          103 MELM-GTCAEKLKKRMQ---GPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRL  175 (318)
T ss_dssp             ECCC-SEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred             Eecc-CCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence            9999 455655554322   248999999999999999999998   5 89999999999999999999999999763  


Q ss_pred             --------cCCCcccCCccccc-----cCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccc
Q 047719          439 --------PAGTMGYLAPEYVY-----SGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADF  505 (596)
Q Consensus       439 --------~~gt~~y~aPE~~~-----~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~  505 (596)
                              ..||..|+|||.+.     ...++.++|||||||++|||++|+.||....... +.......... ...   
T Consensus       176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~-~~~---  250 (318)
T 2dyl_A          176 VDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF-EVLTKVLQEEP-PLL---  250 (318)
T ss_dssp             -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH-HHHHHHHHSCC-CCC---
T ss_pred             cCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH-HHHHHHhccCC-CCC---
Confidence                    24889999999984     4578999999999999999999999998643221 11112211111 000   


Q ss_pred             cccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          506 RLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       506 ~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      .....+    ...+.+++..||+.||++||+++|+++
T Consensus       251 ~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          251 PGHMGF----SGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             CSSSCC----CHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CccCCC----CHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            000112    245677888999999999999999976

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.8e-36  Score=308.60  Aligned_cols=225  Identities=11%  Similarity=0.109  Sum_probs=178.9

Q ss_pred             cCCCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      ..|...+.||+|+||.||+|.... ++.||||++...... ......+.+|+..+.+ ++||||+++++++.+.+..|+|
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~-l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSR-IDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHT-CCCTTBCCEEEEEEETTEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhc-CCCCCcceeeEEEEECCcEEEE
Confidence            468888999999999999998754 899999999754332 2334678888866654 8999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcccCC
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG  441 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~~g  441 (596)
                      |||+++++|.+++...      ....+...++.||+.||+|||+   .+|+||||||+|||++.++.+||+++       
T Consensus       110 ~e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~-------  173 (286)
T 3uqc_A          110 AEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYP-------  173 (286)
T ss_dssp             EECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSC-------
T ss_pred             EEecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEec-------
Confidence            9999999999999643      3455788999999999999999   89999999999999999999999854       


Q ss_pred             CcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccC------cCCHHH
Q 047719          442 TMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRG------KFNRKE  515 (596)
Q Consensus       442 t~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~------~~~~~~  515 (596)
                        +|++|       ++.++|||||||++|||++|+.||......            ............      ......
T Consensus       174 --~~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T 3uqc_A          174 --ATMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVR------------SGLAPAERDTAGQPIEPADIDRDI  232 (286)
T ss_dssp             --CCCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBC------------CCSEECCBCTTSCBCCHHHHCTTS
T ss_pred             --cccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcc------------hhhHHHHHHhccCCCChhhcccCC
Confidence              35544       789999999999999999999999864310            000000000000      011122


Q ss_pred             HHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          516 MERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       516 ~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                      ...+.+++.+||+.||++| |+.|+++.|+..
T Consensus       233 ~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~  263 (286)
T 3uqc_A          233 PFQISAVAARSVQGDGGIR-SASTLLNLMQQA  263 (286)
T ss_dssp             CHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHcccCCccC-CHHHHHHHHHHH
Confidence            3457788899999999999 999999999864

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.3e-36  Score=324.38  Aligned_cols=238  Identities=22%  Similarity=0.264  Sum_probs=182.0

Q ss_pred             hcCCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      ..+|...++||+|+||+||.....+++.||||++....     ...+.+|+..+....+|||||++++++.+....||||
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~   97 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC-----FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI   97 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT-----EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence            44578889999999999655444578999999996432     2335678877766448999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecC-----CCceEEccCCCc
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDA-----EFNAKLGDFEAT  437 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~-----~~~~kl~Dfg~~  437 (596)
                      ||+. |+|.+++.....   .+.+..++.++.||++||+|||+   .+|+||||||+|||++.     ...+||+|||++
T Consensus        98 E~~~-g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a  170 (432)
T 3p23_A           98 ELCA-ATLQEYVEQKDF---AHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC  170 (432)
T ss_dssp             ECCS-EEHHHHHHSSSC---CCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred             ECCC-CCHHHHHHhcCC---CccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence            9996 699999986542   24445667899999999999999   89999999999999943     346889999975


Q ss_pred             c--------------cCCCcccCCccccc---cCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCc
Q 047719          438 I--------------PAGTMGYLAPEYVY---SGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKL  499 (596)
Q Consensus       438 ~--------------~~gt~~y~aPE~~~---~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~  499 (596)
                      .              ..||+.|+|||.+.   ...++.++|||||||++|||++ |..||.........   ........
T Consensus       171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~---~~~~~~~~  247 (432)
T 3p23_A          171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN---ILLGACSL  247 (432)
T ss_dssp             ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH---HHTTCCCC
T ss_pred             eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH---HHhccCCc
Confidence            3              24899999999997   4567889999999999999999 99999654322111   11111110


Q ss_pred             hhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          500 LDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       500 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                       ..      ..........+.+|+.+||+.||++|||++||++
T Consensus       248 -~~------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          248 -DC------LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             -TT------SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -cc------cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence             00      0111234455778999999999999999999984

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.3e-35  Score=303.56  Aligned_cols=238  Identities=18%  Similarity=0.223  Sum_probs=182.9

Q ss_pred             cCCCcc-ceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeee----CCe
Q 047719          284 LGFNKN-RIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE----GNE  357 (596)
Q Consensus       284 ~~f~~~-~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~----~~~  357 (596)
                      .+|... ++||+|+||.||++... +++.||||++..       ...+.+|+..+.+..+||||+++++++..    ...
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~   89 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   89 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence            345554 78999999999999864 588999999953       23467788777677899999999999987    678


Q ss_pred             EEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecC---CCceEEccC
Q 047719          358 LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDA---EFNAKLGDF  434 (596)
Q Consensus       358 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~---~~~~kl~Df  434 (596)
                      .++||||+++|+|.+++....  ...+++..++.++.|++.||+|||+   .+|+||||||+|||++.   ++.+||+||
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Df  164 (299)
T 3m2w_A           90 LLIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDF  164 (299)
T ss_dssp             EEEEECCCCSCBHHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred             EEEEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEecc
Confidence            999999999999999998754  2358999999999999999999999   89999999999999998   789999999


Q ss_pred             CCcccCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCC--
Q 047719          435 EATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFN--  512 (596)
Q Consensus       435 g~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~--  512 (596)
                      |++....           +..++.++|||||||++|||++|+.||.......        ............ ....+  
T Consensus       165 g~a~~~~-----------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~--------~~~~~~~~~~~~-~~~~~~~  224 (299)
T 3m2w_A          165 GFAKETT-----------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA--------ISPGMKTRIRMG-QYEFPNP  224 (299)
T ss_dssp             TTCEECT-----------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC---------------CCSCCSSCTT-CCSSCHH
T ss_pred             ccccccc-----------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchh--------hhHHHHHHHhhc-cccCCch
Confidence            9875432           3557889999999999999999999997642110        000000000000 00111  


Q ss_pred             --HHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhcCCCCCCC
Q 047719          513 --RKEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKGEAPLPLL  553 (596)
Q Consensus       513 --~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~~~~~~p~~  553 (596)
                        ......+.+++..||+.||++|||++|+++  ++......+..
T Consensus       225 ~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~~~  269 (299)
T 3m2w_A          225 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQT  269 (299)
T ss_dssp             HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSCCC
T ss_pred             hcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCCCC
Confidence              112356778889999999999999999988  56554444433

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=4.2e-36  Score=335.52  Aligned_cols=249  Identities=25%  Similarity=0.304  Sum_probs=189.9

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeee------CC
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE------GN  356 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~------~~  356 (596)
                      .+|...+.||+|+||.||+|... +|+.||||++.... .......+.+|+..+.. ++||||+++++++..      .+
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~-L~HpnIV~l~~v~~~~~~~~~~~   91 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL-SPKNRERWCLEIQIMKK-LNHPNVVSAREVPDGLQKLAPND   91 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC-CHHHHHHHHHHHHHHHH-CCBTTBCCEEECCTTTCCCCTTS
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC-CHHHHHHHHHHHHHHHh-CCCCCCCceeeeecccccccCCC
Confidence            67999999999999999999875 58899999986432 33445678889966655 899999999998765      67


Q ss_pred             eEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCc---eEEcc
Q 047719          357 ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFN---AKLGD  433 (596)
Q Consensus       357 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~---~kl~D  433 (596)
                      ..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.   +||+|
T Consensus        92 ~~~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~D  167 (676)
T 3qa8_A           92 LPLLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIID  167 (676)
T ss_dssp             SCCCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred             eEEEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEcc
Confidence            78999999999999999987542 2358889999999999999999999   89999999999999997665   99999


Q ss_pred             CCCccc----------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCC-----
Q 047719          434 FEATIP----------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGK-----  498 (596)
Q Consensus       434 fg~~~~----------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~-----  498 (596)
                      ||.+..          .||..|+|||.+.+..++.++|||||||++|||++|+.||..... ...|.........     
T Consensus       168 FG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~-~~~~~~~i~~~~~~~~~~  246 (676)
T 3qa8_A          168 LGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ-PVQWHGKVREKSNEHIVV  246 (676)
T ss_dssp             CCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH-HHHSSTTCC------CCS
T ss_pred             cccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc-hhhhhhhhhcccchhhhh
Confidence            997643          588999999999999999999999999999999999999976422 1122111100000     


Q ss_pred             ---chhhccc----cccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHH
Q 047719          499 ---LLDAADF----RLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKE  539 (596)
Q Consensus       499 ---~~~~~d~----~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~e  539 (596)
                         .......    .............+.+++..|++.||++|||++|
T Consensus       247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e  294 (676)
T 3qa8_A          247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ  294 (676)
T ss_dssp             CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred             hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence               0000000    0112234456678889999999999999999865

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.7e-35  Score=336.89  Aligned_cols=230  Identities=23%  Similarity=0.265  Sum_probs=182.3

Q ss_pred             cCCCccceeecCCceEEEEEEcC--CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCe----
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP--SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNE----  357 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~----  357 (596)
                      ++|...+.||+|+||.||+|...  +|+.||||++.... .......+.+|+..+. .++|||||+++++|...+.    
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~~~~~~~~~~  157 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLA-EVVHPSIVQIFNFVEHTDRHGDP  157 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC-CHHHHHHHHHHHGGGG-GCCCTTBCCEEEEEEEECTTSCE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC-CHHHHHHHHHHHHHHH-hcCCCCcCeEeeeEeecCCCCCc
Confidence            56888899999999999999875  58899999986432 2234456788885554 5899999999999987665    


Q ss_pred             -EEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCC
Q 047719          358 -LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEA  436 (596)
Q Consensus       358 -~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~  436 (596)
                       .||||||+++++|.+++..      .++|.+++.++.||+.||.|||+   .+|+||||||+|||++.+ .+||+|||+
T Consensus       158 ~~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~  227 (681)
T 2pzi_A          158 VGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGA  227 (681)
T ss_dssp             EEEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTT
T ss_pred             eeEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEeccc
Confidence             7999999999999988754      48999999999999999999999   899999999999999986 899999997


Q ss_pred             cc-------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccC
Q 047719          437 TI-------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRG  509 (596)
Q Consensus       437 ~~-------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  509 (596)
                      +.       ..||+.|+|||++.++. +.++|||||||++|||++|..|+.....            ..+.       ..
T Consensus       228 a~~~~~~~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~------------~~~~-------~~  287 (681)
T 2pzi_A          228 VSRINSFGYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYV------------DGLP-------ED  287 (681)
T ss_dssp             CEETTCCSCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEEC------------SSCC-------TT
T ss_pred             chhcccCCccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccc------------cccc-------cc
Confidence            64       35899999999987654 8999999999999999999988764210            0000       00


Q ss_pred             cCCHHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHHh
Q 047719          510 KFNRKEMERMLMVGLSCVHPNHEKRPS-VKEAARILK  545 (596)
Q Consensus       510 ~~~~~~~~~l~~l~~~C~~~dp~~RPs-~~ev~~~L~  545 (596)
                      .........+..++.+||+.||++||+ ++++.+.|.
T Consensus       288 ~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~  324 (681)
T 2pzi_A          288 DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT  324 (681)
T ss_dssp             CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence            001122356778899999999999995 555655554

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.3e-35  Score=318.01  Aligned_cols=238  Identities=18%  Similarity=0.189  Sum_probs=173.1

Q ss_pred             HhcCCCccceeecCCceEEEEEEc-CCCCEEEEEEeecCCc-hhcccchHHHHHHHHHhccCC-Cceeeecce-------
Q 047719          282 ATLGFNKNRIVGEGASATVYKGSL-PSGGAVAVKRFEKPNR-VECARNPFTTEFATMAGCLRH-KNLVQLQGW-------  351 (596)
Q Consensus       282 at~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~-~~~~~~~~~~E~~~l~~~l~H-~niv~l~g~-------  351 (596)
                      .+..|...++||+|+||.||+|.. .+|+.||||++..... .....+.+.+|+..+. .++| +|......+       
T Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~-~l~~~~~~~~~~~~~~~~~~~  154 (413)
T 3dzo_A           76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLR-LLRGIKNQKQAKVHLRFIFPF  154 (413)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGG-GSTTCCSHHHHHHHTCBCCCC
T ss_pred             CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHH-hhccCCCHHHHHHhcccccch
Confidence            344577789999999999999985 4699999999873322 2234566788885554 4766 322111111       


Q ss_pred             --------------eee-----CCeEEEEEecCCCCCHHHHhhhC---CCCCcccCHHHHHHHHHHHHHHHHHHHhccCC
Q 047719          352 --------------CCE-----GNELVLVYEYLPNGSLDKILHNN---SSSSIVLSWEKRLNIVLGVASALSYLHEECER  409 (596)
Q Consensus       352 --------------~~~-----~~~~~lV~E~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~  409 (596)
                                    +..     ....+++|+++ +++|.+++...   ......++|..++.++.||++||+|||+   +
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~  230 (413)
T 3dzo_A          155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---Y  230 (413)
T ss_dssp             EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---T
T ss_pred             hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---C
Confidence                          111     22467778766 67999998521   1223468899999999999999999999   8


Q ss_pred             CeEEccCCCCceeecCCCceEEccCCCcc--------cCCCcccCCcccc----------ccCCCCCccceeehhHHHHH
Q 047719          410 QIIHRDVKACNILLDAEFNAKLGDFEATI--------PAGTMGYLAPEYV----------YSGVPSEKTDVYSFGVVALE  471 (596)
Q Consensus       410 ~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~--------~~gt~~y~aPE~~----------~~~~~t~~sDV~SfGvll~E  471 (596)
                      +|+||||||+||||+.++.+||+|||++.        ..| +.|+|||++          ....++.++|||||||++||
T Consensus       231 ~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e  309 (413)
T 3dzo_A          231 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW  309 (413)
T ss_dssp             TEECSCCCGGGEEECTTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred             CcccCCcccceEEEecCCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence            99999999999999999999999999854        357 899999999          55568899999999999999


Q ss_pred             HHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          472 VAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       472 l~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      |++|+.||......           ........  ....++    ..+.+|+..||+.||++||++.++++
T Consensus       310 lltg~~Pf~~~~~~-----------~~~~~~~~--~~~~~~----~~~~~li~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          310 IWCADLPNTDDAAL-----------GGSEWIFR--SCKNIP----QPVRALLEGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             HHHSSCCCCTTGGG-----------SCSGGGGS--SCCCCC----HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHCCCCCCCcchh-----------hhHHHHHh--hcccCC----HHHHHHHHHHccCChhhCcCHHHHHh
Confidence            99999999764210           00111111  011233    55778889999999999999776643

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=3.4e-35  Score=305.60  Aligned_cols=233  Identities=14%  Similarity=0.127  Sum_probs=175.6

Q ss_pred             cCCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCc------hhcccchHHHHHHHHHhccC---------CCceeee
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNR------VECARNPFTTEFATMAGCLR---------HKNLVQL  348 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~------~~~~~~~~~~E~~~l~~~l~---------H~niv~l  348 (596)
                      ++|...+.||+|+||+||+|.. +|+.||||++.....      .....+.+.+|+..+.. ++         |+|||++
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           20 EKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKE-LSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHH-HHHGGGCSSSBCCCBCCE
T ss_pred             ccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHH-HHHhhccccccCCchhhh
Confidence            4577789999999999999987 789999999976432      12223567888866554 43         5555555


Q ss_pred             cc-----------------eeee-------------CCeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHH
Q 047719          349 QG-----------------WCCE-------------GNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVAS  398 (596)
Q Consensus       349 ~g-----------------~~~~-------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~  398 (596)
                      .+                 ++.+             .+.+||||||+++|++.+.+...     .+++..+..++.||+.
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~-----~~~~~~~~~i~~qi~~  172 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK-----LSSLATAKSILHQLTA  172 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTT-----CCCHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhc-----CCCHHHHHHHHHHHHH
Confidence            44                 4443             67899999999999877777442     3899999999999999


Q ss_pred             HHHHHH-hccCCCeEEccCCCCceeecCCC--------------------ceEEccCCCccc------CCCcccCCcccc
Q 047719          399 ALSYLH-EECERQIIHRDVKACNILLDAEF--------------------NAKLGDFEATIP------AGTMGYLAPEYV  451 (596)
Q Consensus       399 gL~~LH-~~~~~~ivHrDlkp~NiLl~~~~--------------------~~kl~Dfg~~~~------~gt~~y~aPE~~  451 (596)
                      ||+||| +   .+|+||||||+||||+.++                    .+||+|||++..      .||+.|+|||.+
T Consensus       173 aL~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~~~~gt~~y~aPE~~  249 (336)
T 2vuw_A          173 SLAVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLF  249 (336)
T ss_dssp             HHHHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETTEEECCCCTTCSGGG
T ss_pred             HHHHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCCcEEEeecccChhhh
Confidence            999999 7   8999999999999999887                    899999998753      589999999999


Q ss_pred             ccCCCCCccceeehhHH-HHHHHhCCCCCCCCChhHHHHHHHH----HhcCCchhhccccccCcCCHHHHHHHHHHHHHc
Q 047719          452 YSGVPSEKTDVYSFGVV-ALEVAAGKSPVDNDGCVIVDWVWNL----RKKGKLLDAADFRLRGKFNRKEMERMLMVGLSC  526 (596)
Q Consensus       452 ~~~~~t~~sDV~SfGvl-l~El~tG~~p~~~~~~~~~~~~~~~----~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C  526 (596)
                      .+.. +.++||||||++ .+++++|..||...     .|....    .......    ..............+.+|+.+|
T Consensus       250 ~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~-----~~~~~~~~~~~~~~~~~----~~~~~~~~~~~s~~~~dli~~~  319 (336)
T 2vuw_A          250 TGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV-----LWLHYLTDKMLKQMTFK----TKCNTPAMKQIKRKIQEFHRTM  319 (336)
T ss_dssp             CCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH-----HHHHHHHHHHHHTCCCS----SCCCSHHHHHHHHHHHHHHHHG
T ss_pred             cCCC-ccceehhhhhCCCCcccccccCCCcch-----hhhhHHHHhhhhhhccC----cccchhhhhhcCHHHHHHHHHH
Confidence            8665 899999998777 77888899998531     121111    1111100    0111112335667889999999


Q ss_pred             CCCCCCCCCCHHHHH
Q 047719          527 VHPNHEKRPSVKEAA  541 (596)
Q Consensus       527 ~~~dp~~RPs~~ev~  541 (596)
                      ++.|     |++|++
T Consensus       320 L~~d-----sa~e~l  329 (336)
T 2vuw_A          320 LNFS-----SATDLL  329 (336)
T ss_dssp             GGSS-----SHHHHH
T ss_pred             hccC-----CHHHHH
Confidence            9976     888887

>1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ...

Probab=100.00  E-value=7.7e-34  Score=276.36  Aligned_cols=116  Identities=29%  Similarity=0.414  Sum_probs=107.8

Q ss_pred             CCceEEEEeeCccCCCCCCCCCCeeEEecCCccccccccCCCCCcccCCCceEEEEEEEcCCccEEEEEEeeCCCCCCCC
Q 047719           60 QDSFFAVEFDTSFDPSLGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRDSLKLIRVWAGYSQIRPPSP  139 (596)
Q Consensus        60 ~~~~~AVEfDt~~~~~~~d~~~~Hvgid~ns~~s~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p  139 (596)
                      +||+|||||||++|.+|+||++|||||||||+.|++++++     +|.+|+.++|||+||+.+++|+|++.+...  .+|
T Consensus         1 ~n~~vAVEFDT~~n~~~~Dp~~nHVGIdvNs~~S~~~~~~-----~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~   73 (237)
T 1nls_A            1 ADTIVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKTAKW-----NMQNGKVGTAHIIYNSVDKRLSAVVSYPNA--DSA   73 (237)
T ss_dssp             CCCEEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEEC-----CCCTTCEEEEEEEEETTTTEEEEEEECTTS--CCE
T ss_pred             CCCEEEEEEeCCCCcccCCCCCCeeeEecCCccccccccc-----cccCCCEEEEEEEEeCCCCEEEEEEecCCC--Ccc
Confidence            4789999999999999889999999999999999999875     588999999999999999999999987543  679


Q ss_pred             eEEEeecCcccCCCceEEEEEeecCCccceeeeeeeeeeccCC
Q 047719          140 LIIAQIDLSKQFKDYMHVGFSAANGQGSAIYTVDRWRFKTFES  182 (596)
Q Consensus       140 ~l~~~vdl~~~l~~~~~vGFsastg~~~~~~~i~~Wsf~~~~~  182 (596)
                      +|++.|||+++|+|+||||||||||...|.|+|++|+|++...
T Consensus        74 ~ls~~vdLs~~l~e~~~VGFSAsTG~~~~~h~IlsWsF~s~~~  116 (237)
T 1nls_A           74 TVSYDVDLDNVLPEWVRVGLSASTGLYKETNTILSWSFTSKLK  116 (237)
T ss_dssp             EEEEECCGGGTSCSEEEEEEEEECSSSCCCCEEEEEEEEEEEE
T ss_pred             eEEEeeChHHhCccccEEEEEeccCCcceeeeeEEEEEEeccc
Confidence            9999999999999999999999999999999999999998753

>2dur_A VIP36;, vesicular integral-membrane protein VIP36; beta sandwich, carbohydrate binding protein, cargo receptor, transport; HET: MAN; 1.65A {Canis lupus familiaris} PDB: 2dup_A 2duq_A* 2duo_A* 2e6v_A*

Probab=99.96  E-value=8.7e-29  Score=245.72  Aligned_cols=163  Identities=13%  Similarity=0.079  Sum_probs=119.9

Q ss_pred             CCCCCCCcccceEEEEEEEEecCCC-CCCCCeEEEEEecCCCCCCCCCCccCCCCCCCCCCCceEEEEeeCccCCCCCCC
Q 047719            1 FLDPKTNTTASFSCRFSFSIIPSPL-CAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQDSFFAVEFDTSFDPSLGDI   79 (596)
Q Consensus         1 ~~~~~~~~~asF~t~F~f~i~~~~~-~~~g~G~aF~l~~~~~~~~~~~~~lG~~~~~~~~~~~~~AVEfDt~~~~~~~d~   79 (596)
                      +|.+..-.++||+|+|+|.|.++.. ..+||||||+|+|....   .|++||+.+     .++.|||||||+.|.++.| 
T Consensus        53 ~w~~~pi~~~sF~t~F~F~I~~~~~~~~~gdGlAF~l~~~~~~---~G~~lG~~~-----~~~gvAVefDT~~n~~~~~-  123 (253)
T 2dur_A           53 IWNHQPCFLKDWEMHVHFKVHGTGKKNLHGDGIALWYTRDRLV---PGPVFGSKD-----NFHGLAIFLDTYPNDETTE-  123 (253)
T ss_dssp             EEESSCBCCSSEEEEEEEEEECCCCTTCCCCEEEEEEESCCSC---EETBTEECS-----SCEEEEEEEECSCCCTTCC-
T ss_pred             EEeCCCCccCcEEEEEEEEEecCCCCCcCCCcEEEEEECCCCC---CCcccCcCC-----CCCEEEEEEECCCCCCCCC-
Confidence            3666666789999999999998765 56899999999986543   578999633     4678999999999975433 


Q ss_pred             CCCeeEEecCCccccccccCC-----------CCCcccC-CCceEEEEEEEcCCccEEEEEEeeCCCCCCCCeEEEeecC
Q 047719           80 NGNHIGIDISSVISFVSVDAL-----------SRGIDLK-SGRHITTWIEYRDSLKLIRVWAGYSQIRPPSPLIIAQIDL  147 (596)
Q Consensus        80 ~~~Hvgid~ns~~s~~~~~~~-----------~~~~~l~-~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~l~~~vdl  147 (596)
                         |+++|||++.+..+..+.           .....++ .|+.++|||+||+.  +|+|++.+....+..+  ...++ 
T Consensus       124 ---~~~~~I~~~~n~gs~~~d~~~dg~~~~~~~c~~~~~n~g~~~~v~I~Y~~~--~L~V~l~~~~~~~~~~--~~~~~-  195 (253)
T 2dur_A          124 ---RVFPYISVMVNNGSLSYDHSKDGRWTELAGCTADFRNRDHDTFLAVRYSRG--RLTVMTDLEDKNEWKN--CIDIT-  195 (253)
T ss_dssp             ---SCSSEEEEEEEESCCCCCGGGTTGGGCCEEEECCCBTCSSCEEEEEEEETT--EEEEEEECSSSSCCEE--EEEEC-
T ss_pred             ---CCCcEEEEEecCCceeeeccCCCcccccccccHhhccCCCCeEEEEEEECC--EEEEEEeCCCCCCceE--EEEeC-
Confidence               555555555444333321           0011343 48899999999976  8999998744333333  33455 


Q ss_pred             cccCCCceEEEEEeecCCccceeeeeeeeeecc
Q 047719          148 SKQFKDYMHVGFSAANGQGSAIYTVDRWRFKTF  180 (596)
Q Consensus       148 ~~~l~~~~~vGFsastg~~~~~~~i~~Wsf~~~  180 (596)
                      ..+||++|||||||+||...+.|+|++|+|.+-
T Consensus       196 ~v~Lp~~~yvGfSAaTG~~~~~h~Ilswsf~sl  228 (253)
T 2dur_A          196 GVRLPTGYYFGASAGTGDLSDNHDIISMKLFQL  228 (253)
T ss_dssp             CEECCSSBEEEEEEEESSSCCEEEEEEEEEEEC
T ss_pred             CcccCCCcEEEEEeccCCCcceEEEEEEEEEec
Confidence            446999999999999999999999999999864

>1gv9_A P58/ergic-53; lectin, carbohydrate binding; 1.46A {Rattus norvegicus} SCOP: b.29.1.13 PDB: 1r1z_A 3a4u_A 3lcp_A

Probab=99.96  E-value=1.1e-28  Score=245.49  Aligned_cols=165  Identities=15%  Similarity=0.102  Sum_probs=124.9

Q ss_pred             CCCCCCCcccceEEEEEEEEecCCCCCCCCeEEEEEecCCCCCCCCCCccCCCCCCCCCCCceEEEEeeCccCCCCC-CC
Q 047719            1 FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQDSFFAVEFDTSFDPSLG-DI   79 (596)
Q Consensus         1 ~~~~~~~~~asF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~~~~~~~~~lG~~~~~~~~~~~~~AVEfDt~~~~~~~-d~   79 (596)
                      +|++....++||+|+|+|.|..++ ..+||||||+|+|...   ..|++||+.+     .++.|||||||+.|.++. +|
T Consensus        77 ~w~~~p~~~~sF~t~F~F~I~~~~-~~~gdGlAF~l~~~~~---~~g~~~G~~~-----~~~gvaVefDT~~N~~~~~~p  147 (260)
T 1gv9_A           77 VWTKTKAAFENWEVEVTFRVTGRG-RIGADGLAIWYTENQG---LDGPVFGSAD-----MWNGVGIFFDSFDNDGKKNNP  147 (260)
T ss_dssp             EEESSCBCCSSEEEEEEEEEECSS-SCCCCEEEEEEESSCC---CEEEETTECS-----CCEEEEEEEECCCC-----CC
T ss_pred             EEECCCccccCEEEEEEEEEecCC-CCCCCeEEEEEecCCC---CCCCccCCCC-----CCCEEEEEEECCCCCCCCCCC
Confidence            477777889999999999998764 3679999999998644   2578888732     467899999999997431 23


Q ss_pred             ------CCCeeEEecCC-ccccccccCCCCCcccC-CCceEEEEEEEcCCccEEEEEEeeCC-CCCCCCeEEEeecCccc
Q 047719           80 ------NGNHIGIDISS-VISFVSVDALSRGIDLK-SGRHITTWIEYRDSLKLIRVWAGYSQ-IRPPSPLIIAQIDLSKQ  150 (596)
Q Consensus        80 ------~~~Hvgid~ns-~~s~~~~~~~~~~~~l~-~g~~~~~~I~Y~~~~~~l~v~~~~~~-~~~~~p~l~~~vdl~~~  150 (596)
                            |++|+|||+|+ +.|......   ...+. +|..++|||+||+.  +|+|.+.+.. .......++..+| ..+
T Consensus       148 ~I~~~indg~~~~d~~~d~~s~~~~~c---~~~~~n~g~~~~~~I~Y~~~--~L~V~l~~~~~~~~~~~~~~~~vd-~~~  221 (260)
T 1gv9_A          148 AIVVVGNNGQINYDHQNDGATQALASC---QRDFRNKPYPVRAKITYYQK--TLTVMINNGFTPDKNDYEFCAKVE-NMV  221 (260)
T ss_dssp             EEEEEEEESCCCCCHHHHHHHHCSEEE---CCCCBSCSSCEEEEEEEETT--EEEEEEECSSCCCTTCCEEEEEET-TCC
T ss_pred             ceEEEeCCCceEeecCCCcccceeecc---ChhhccCCCcEEEEEEEECC--EEEEEEeeccCCCCCcceEEEEEc-ccc
Confidence                  46788888875 544433322   12343 58999999999987  7999998742 1112346888899 678


Q ss_pred             CCCceEEEEEeecCCccceeeeeeeeeecc
Q 047719          151 FKDYMHVGFSAANGQGSAIYTVDRWRFKTF  180 (596)
Q Consensus       151 l~~~~~vGFsastg~~~~~~~i~~Wsf~~~  180 (596)
                      ||+++||||||+||...+.|+|++|+|..-
T Consensus       222 LP~~~~vGfSAaTG~~~e~hdIlsw~~~~l  251 (260)
T 1gv9_A          222 IPTQGHFGISAATGGLADDHDVLSFLTFQL  251 (260)
T ss_dssp             CCSSBEEEEEEECCSSCCEEEEEEEEEEEE
T ss_pred             cCCCcEEEEEEeCCCCcceEEEEEEEEEEe
Confidence            999999999999999999999999999753

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.94  E-value=2.4e-28  Score=271.42  Aligned_cols=176  Identities=18%  Similarity=0.121  Sum_probs=125.1

Q ss_pred             eeecCCceEEEEEEc-CCCCEEEEEEeecCC--------chhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          291 IVGEGASATVYKGSL-PSGGAVAVKRFEKPN--------RVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       291 ~LG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~--------~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      .++.|++|.+..++. --|+.+|||++.+..        ..+...++|.+|++.|.+...|+||+++++++.+++..|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            355667776665532 248889999997542        12344567999998888766899999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc--
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP--  439 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~--  439 (596)
                      |||++|++|.++|....    +++..   +|+.||+.||+|||+   ++||||||||+||||+.++.+||+|||++..  
T Consensus       321 MEyv~G~~L~d~i~~~~----~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~  390 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAGE----EIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTP  390 (569)
T ss_dssp             EECCCSEEHHHHHHTTC----CCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred             EecCCCCcHHHHHHhCC----CCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence            99999999999998764    35543   588999999999999   9999999999999999999999999998643  


Q ss_pred             ---------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCC
Q 047719          440 ---------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKS  477 (596)
Q Consensus       440 ---------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~  477 (596)
                               +||+.|||||++.+ .+..++|+||+|++++++.++..
T Consensus       391 ~~~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~  436 (569)
T 4azs_A          391 QDCSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS  436 (569)
T ss_dssp             ---CCSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred             CCCccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence                     38899999998865 56788999999999888766543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.92  E-value=9.4e-26  Score=249.13  Aligned_cols=175  Identities=14%  Similarity=0.148  Sum_probs=139.9

Q ss_pred             CccceeecCCceEEEEEEcCCCCEEEEEEeecCCch------hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEE
Q 047719          287 NKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRV------ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVL  360 (596)
Q Consensus       287 ~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~------~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~l  360 (596)
                      ...++||+|+||.||+|.. .+..+|+|+.......      ....+.+.+|+..+.+ ++||||+++..++...+..||
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~-l~h~nIv~~~~~~~~~~~~~l  416 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLAL-VKDFGIPAPYIFDVDLDNKRI  416 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHH-GGGGTCCCCCEEEEETTTTEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHh-cCCCCcCceEEEEEeCCccEE
Confidence            3457899999999999955 6788999987532211      1123457899977665 899999987777778888899


Q ss_pred             EEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc-
Q 047719          361 VYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP-  439 (596)
Q Consensus       361 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~-  439 (596)
                      ||||+++++|.+++..            ++.++.|+++||+|||+   ++|+||||||+|||++.  .+||+|||++.. 
T Consensus       417 VmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~  479 (540)
T 3en9_A          417 MMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKIS  479 (540)
T ss_dssp             EEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEEC
T ss_pred             EEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEEC
Confidence            9999999999999975            45899999999999999   89999999999999999  999999998642 


Q ss_pred             -----------------CCCcccCCcccccc--CCCCCccceeehhHHHHHHHhCCCCCC
Q 047719          440 -----------------AGTMGYLAPEYVYS--GVPSEKTDVYSFGVVALEVAAGKSPVD  480 (596)
Q Consensus       440 -----------------~gt~~y~aPE~~~~--~~~t~~sDV~SfGvll~El~tG~~p~~  480 (596)
                                       .||+.|||||++..  ..|+..+|+|+..+-.++-+.++.+|.
T Consensus       480 ~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          480 NLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             CCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence                             47899999999976  568888999999999999988887764

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.87  E-value=1.1e-22  Score=206.38  Aligned_cols=156  Identities=16%  Similarity=0.155  Sum_probs=121.8

Q ss_pred             HHHHHHHhcCCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchh----------------cccchHHHHHHHHHhc
Q 047719          276 LTDIKQATLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVE----------------CARNPFTTEFATMAGC  339 (596)
Q Consensus       276 ~~el~~at~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~----------------~~~~~~~~E~~~l~~~  339 (596)
                      +..+.....-|...+.||+|+||.||+|...+|+.||||+++......                .....+.+|+..+.. 
T Consensus        82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~-  160 (282)
T 1zar_A           82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQK-  160 (282)
T ss_dssp             HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHH-
T ss_pred             HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHh-
Confidence            344555556677789999999999999998779999999996432111                123458889977766 


Q ss_pred             cCCCceeeecceeeeCCeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCC
Q 047719          340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKAC  419 (596)
Q Consensus       340 l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~  419 (596)
                      ++  | +++.+++.. +..|+||||+++|+|.+ +..          .....++.|++.||.|||+   .+|+||||||+
T Consensus       161 l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~  222 (282)
T 1zar_A          161 LQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQY  222 (282)
T ss_dssp             TT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTT
T ss_pred             cc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHH
Confidence            66  5 777775544 55699999999999998 522          1234699999999999999   89999999999


Q ss_pred             ceeecCCCceEEccCCCcccCCCcccCCcccccc
Q 047719          420 NILLDAEFNAKLGDFEATIPAGTMGYLAPEYVYS  453 (596)
Q Consensus       420 NiLl~~~~~~kl~Dfg~~~~~gt~~y~aPE~~~~  453 (596)
                      |||++ ++.+||+|||++..  +..|+|||++..
T Consensus       223 NILl~-~~~vkl~DFG~a~~--~~~~~a~e~l~r  253 (282)
T 1zar_A          223 NVLVS-EEGIWIIDFPQSVE--VGEEGWREILER  253 (282)
T ss_dssp             SEEEE-TTEEEECCCTTCEE--TTSTTHHHHHHH
T ss_pred             HEEEE-CCcEEEEECCCCeE--CCCCCHHHHHHH
Confidence            99999 99999999999864  556899998753

>2a6y_A EMP47P (FORM1); beta sandwich, carbohydrate binding protein, cargo receptor, structural genomics, NPPSFA; 1.42A {Saccharomyces cerevisiae} SCOP: b.29.1.13

Probab=99.84  E-value=6.9e-21  Score=188.44  Aligned_cols=157  Identities=13%  Similarity=0.152  Sum_probs=117.6

Q ss_pred             CCCCCCCc-ccceEEEEEEEEecCCCCCCCCeEEEEEecCCCCCCCCCCccCCCCCCCCCCCceEEEEeeCccCCCCCCC
Q 047719            1 FLDPKTNT-TASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQDSFFAVEFDTSFDPSLGDI   79 (596)
Q Consensus         1 ~~~~~~~~-~asF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~~~~~~~~~lG~~~~~~~~~~~~~AVEfDt~~~~~~~d~   79 (596)
                      +|++.+.+ .++|+|+|+|.|..+. ..+||||||++++....+ ..|+.+|..+.     ..-+||||||+.|.   .|
T Consensus        58 iW~~~p~~~~~~f~~~f~FrI~g~~-~~~gdGlAfwlt~~~~~~-~~g~~~G~~~~-----f~GlaV~fDT~~n~---~p  127 (256)
T 2a6y_A           58 LWLKQGFDLKDSFTMEWTFRSVGYS-GQTDGGISFWFVQDSNIP-RDKQLYNGPVN-----YDGLQLLVDNNGPL---GP  127 (256)
T ss_dssp             EEESSCEEESSCEEEEEEEEEESCC-SCCSCEEEEEEEECSSSC-CCCTBTTBCTT-----CEEEEEEEESCSTT---CS
T ss_pred             EeeCCCCcccCCEEEEEEEEEecCC-CCCCCeEEEEEeCCCCcc-cCCcccCcCCC-----CCEEEEEEECCCCC---Cc
Confidence            58889997 9999999999998664 337999999999865421 56778887542     34589999999873   33


Q ss_pred             C------CCeeEEecCCccccccccCCCCCccc-CCCceEEEEEEEc-CCccEEEEEEeeCCCCCCCCeEEEeecCccc-
Q 047719           80 N------GNHIGIDISSVISFVSVDALSRGIDL-KSGRHITTWIEYR-DSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQ-  150 (596)
Q Consensus        80 ~------~~Hvgid~ns~~s~~~~~~~~~~~~l-~~g~~~~~~I~Y~-~~~~~l~v~~~~~~~~~~~p~l~~~vdl~~~-  150 (596)
                      .      +.|+++|.+++.+......   .... .+|...++||+|+ +..+.|+|.+.+      +    .-+++..+ 
T Consensus       128 ~i~~~~Ndg~~~~d~~~~~~~~~~~c---~~~~rn~~~~~~v~I~Y~~~~~~~L~V~i~~------~----~c~~~~~v~  194 (256)
T 2a6y_A          128 TLRGQLNDGQKPVDKTKIYDQSFASC---LMGYQDSSVPSTIRVTYDLEDDNLLKVQVDN------K----VCFQTRKVR  194 (256)
T ss_dssp             EEEEEEEESSSCCCGGGHHHHCSEEE---ECCCTTCSSCEEEEEEEEGGGTSEEEEEETT------E----EEEEESCEE
T ss_pred             eEEEEECCCceecccCCCcccceecc---eeecccCCCcEEEEEEEecCCCcEEEEEEcC------E----EEEEECcEE
Confidence            3      6788888876434333221   1122 3788999999999 878899999854      1    12334444 


Q ss_pred             CCCce-EEEEEeecC---Cccceeeeeeeeeecc
Q 047719          151 FKDYM-HVGFSAANG---QGSAIYTVDRWRFKTF  180 (596)
Q Consensus       151 l~~~~-~vGFsastg---~~~~~~~i~~Wsf~~~  180 (596)
                      ||+++ ||||||+||   ...+.|.|++|+|...
T Consensus       195 LP~~~~~~GfSAaTG~~~~~~d~hdIls~~~~~~  228 (256)
T 2a6y_A          195 FPSGSYRIGVTAQNGAVNNNAESFEIFKMQFFNG  228 (256)
T ss_dssp             CCSEEEEEEEEEECCSGGGCCCEEEEEEEEEEES
T ss_pred             eCCCCeEEEEEEeCCCCCCCcceEEEEEEEEEec
Confidence            89998 699999999   8889999999999874

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.73  E-value=5.4e-18  Score=169.38  Aligned_cols=138  Identities=17%  Similarity=0.179  Sum_probs=102.1

Q ss_pred             CCccceeecCCceEEEEEEc-CCCCE--EEEEEeecCCchh----------------------cccchHHHHHHHHHhcc
Q 047719          286 FNKNRIVGEGASATVYKGSL-PSGGA--VAVKRFEKPNRVE----------------------CARNPFTTEFATMAGCL  340 (596)
Q Consensus       286 f~~~~~LG~G~fG~Vy~~~~-~~g~~--vAvK~l~~~~~~~----------------------~~~~~~~~E~~~l~~~l  340 (596)
                      |...+.||+|+||.||+|.. .+|+.  ||||+++......                      .....+.+|+..+.. +
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l  127 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER-A  127 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH-H
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH-H
Confidence            45678999999999999987 67888  9999975432110                      011256788866655 6


Q ss_pred             CCCce--eeecceeeeCCeEEEEEecCCC-C----CHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHH-hccCCCeE
Q 047719          341 RHKNL--VQLQGWCCEGNELVLVYEYLPN-G----SLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH-EECERQII  412 (596)
Q Consensus       341 ~H~ni--v~l~g~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH-~~~~~~iv  412 (596)
                      +|+++  ..++.+    ...+|||||+.+ |    +|.++...       .++.....++.|++.||.||| +   .+|+
T Consensus       128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~---~giv  193 (258)
T 1zth_A          128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQE---AELV  193 (258)
T ss_dssp             HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHT---SCEE
T ss_pred             HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHH---CCEE
Confidence            66653  223322    356899999942 4    67776543       223456789999999999999 7   8999


Q ss_pred             EccCCCCceeecCCCceEEccCCCcccC
Q 047719          413 HRDVKACNILLDAEFNAKLGDFEATIPA  440 (596)
Q Consensus       413 HrDlkp~NiLl~~~~~~kl~Dfg~~~~~  440 (596)
                      ||||||+|||++.  .++|+|||++...
T Consensus       194 HrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          194 HADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             CSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             eCCCCHHHEEEcC--cEEEEECcccccC
Confidence            9999999999998  9999999998654

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.61  E-value=4.6e-16  Score=162.63  Aligned_cols=143  Identities=11%  Similarity=0.080  Sum_probs=98.8

Q ss_pred             CCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhc------------ccchHHHHHHHHHhccCCCceeeeccee
Q 047719          285 GFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVEC------------ARNPFTTEFATMAGCLRHKNLVQLQGWC  352 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~------------~~~~~~~E~~~l~~~l~H~niv~l~g~~  352 (596)
                      -|...+.||+|+||.||+|...+|+.||||+++.....-.            .....+.+. .+.....|+|+++++...
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~-rl~A~kE~~nL~rL~~~g  174 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLS-RLAAIKEFAFMKALYEEG  174 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHH-HHHHHHHHHHHHHHHHTT
T ss_pred             EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHH-HHHHHHHHHHHHHHHhcC
Confidence            3888999999999999999998999999999753211100            000111222 111113455555554332


Q ss_pred             eeCC------eEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCC
Q 047719          353 CEGN------ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAE  426 (596)
Q Consensus       353 ~~~~------~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~  426 (596)
                      ....      ..+|||||+++++|.++...          .....+..||+.+|.|||+   .+||||||||.|||++++
T Consensus       175 v~vp~p~~~~~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl~~d  241 (397)
T 4gyi_A          175 FPVPEPIAQSRHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAK---HGLIHGDFNEFNILIREE  241 (397)
T ss_dssp             CSCCCEEEEETTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEEEE
T ss_pred             CCCCeeeeccCceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeCC
Confidence            2211      23699999999888765421          1234678999999999999   899999999999999887


Q ss_pred             C----------ceEEccCCCcccCC
Q 047719          427 F----------NAKLGDFEATIPAG  441 (596)
Q Consensus       427 ~----------~~kl~Dfg~~~~~g  441 (596)
                      +          .+.|+||+-+....
T Consensus       242 gd~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          242 KDAEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             ECSSCTTSEEEEEEECCCTTCEETT
T ss_pred             CCcccccccccceEEEEeCCcccCC
Confidence            6          38999998765443

>1qmo_A Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1

Probab=99.55  E-value=4.2e-15  Score=127.44  Aligned_cols=55  Identities=22%  Similarity=0.405  Sum_probs=49.1

Q ss_pred             CCCCCCCcccceEEEEEEEEecCCCCCCCCeEEEEEecCCCCCCCCCCccCCCCCC
Q 047719            1 FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPV   56 (596)
Q Consensus         1 ~~~~~~~~~asF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~~~~~~~~~lG~~~~~   56 (596)
                      |||+ ||++|||+|+|+|.|.+++...+||||||||+|+...++++||||||+|.+
T Consensus        58 l~d~-tg~vaSFsT~F~F~I~~~~~~~~gdGlAF~lap~~~~p~s~g~~LGL~n~~  112 (113)
T 1qmo_A           58 LWED-SAVLTSFDTIINFEISTPYTSRIADGLAFFIAPPDSVISYHGGFLGLFPNA  112 (113)
T ss_dssp             CCCT-TEEEEEEEEEEEEEEECSSSSCCCCEEEEEEECTTCCCCCCGGGTTTCSSC
T ss_pred             eeCC-CCCEEeeEEEEEEEEecCCCCCCCCeEEEEecCCCCCCCCCccccccccCC
Confidence            7999 999999999999999988777889999999999877444899999999864

>2ltn_B PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1hkd_B 1rin_B* 1ofs_B* 1bqp_B* 1loe_B 1loa_B* 1loc_B* 1lod_B* 1lob_B 1lof_B* 1log_B* 1lof_D* 1les_B* 2b7y_B* 1lgc_B* 1lgb_B* 1len_B 1lem_B 2lal_B

Probab=99.52  E-value=5.8e-15  Score=107.08  Aligned_cols=45  Identities=27%  Similarity=0.411  Sum_probs=42.1

Q ss_pred             CCeEEEeecCcccCCCceEEEEEeecCCccceeeeeeeeeeccCC
Q 047719          138 SPLIIAQIDLSKQFKDYMHVGFSAANGQGSAIYTVDRWRFKTFES  182 (596)
Q Consensus       138 ~p~l~~~vdl~~~l~~~~~vGFsastg~~~~~~~i~~Wsf~~~~~  182 (596)
                      +|+|+..|||+++|+|+|||||||+||...+.|+|++|+|+++.+
T Consensus         3 ~p~ls~~vdLs~~l~e~v~VGFSAsTG~~~~~h~IlsWsF~s~~~   47 (52)
T 2ltn_B            3 SYTLSDVVSLKDVVPEWVRIGFSATTGAEYAAHEVLSWSFHSELS   47 (52)
T ss_dssp             EEEEEEECCHHHHSCSEEEEEEEEECCSSCCEEEEEEEEEEEEEC
T ss_pred             eeeEEEEEcHHHhcCceEEEEEEeccCCcceeEEEEEeEEEeecc
Confidence            478999999999999999999999999999999999999998753

>2a6z_A EMP47P (FORM2); beta sandwich, carbohydrate binding protein, cargo receptor, structural genomics, NPPSFA; 1.00A {Saccharomyces cerevisiae} SCOP: b.29.1.13 PDB: 2a70_A 2a71_A

Probab=99.30  E-value=4.8e-12  Score=122.33  Aligned_cols=148  Identities=15%  Similarity=0.195  Sum_probs=91.2

Q ss_pred             ccceEEEEEEEEecCCCCCCCCeEEEEEecCCCCCCCCCCccCCCCCCCCCCCceEEEEeeCccCCCCCCCCCCeeEEec
Q 047719            9 TASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQDSFFAVEFDTSFDPSLGDINGNHIGIDI   88 (596)
Q Consensus         9 ~asF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~~~~~~~~~lG~~~~~~~~~~~~~AVEfDt~~~~~~~d~~~~Hvgid~   88 (596)
                      ..+|+++|+|.|..+. ..+||||||.++..... ...|..+|..+.-+|     +||+|||+.|.      .++|.+.+
T Consensus        60 ~~~weie~~Fri~g~~-~~~gdGlA~W~t~~~~~-~~~g~~~G~~~~f~G-----L~I~~Dt~~n~------~p~i~~~~  126 (222)
T 2a6z_A           60 KDSFTMEWTFRSVGYS-GQTDGGISFWFVQDSNI-PRDKQLYNGPVNYDG-----LQLLVDNNGPL------GPTLRGQL  126 (222)
T ss_dssp             CSCEEEEEEEEEESCC-SCCSCEEEEEEEECSSS-CCCCTBTTBCTTCEE-----EEEEEESCSTT------SSEEEEEE
T ss_pred             CCCEEEEEEEEEeCCC-CCCCCEEEEEEECCCcc-cCCCcccCCCCCCCE-----EEEEEECCCCC------CceEEEEE
Confidence            4589999999998653 34799999999976441 123444443222112     69999998773      24454433


Q ss_pred             CC-ccccc-----cccCCCCCccc-CCCceEEEEEEEc-CCccEEEEEEeeCCCCCCCCeEEEeecCcccCCCc-eEEEE
Q 047719           89 SS-VISFV-----SVDALSRGIDL-KSGRHITTWIEYR-DSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDY-MHVGF  159 (596)
Q Consensus        89 ns-~~s~~-----~~~~~~~~~~l-~~g~~~~~~I~Y~-~~~~~l~v~~~~~~~~~~~p~l~~~vdl~~~l~~~-~~vGF  159 (596)
                      |. ..+..     ...++.-.... ..+.+.+++|.|+ ...+.|+|.+..      +  +...++ .-.||+- .|+||
T Consensus       127 ndG~~~yd~~~~~~~~~~~C~~~~rn~~~~~~~rI~Y~~~~~~~l~v~id~------~--~C~~~~-~v~LP~~~~y~G~  197 (222)
T 2a6z_A          127 NDGQKPVDKTKIYDQSFASCLMGYQDSSVPSTIRVTYDLEDDNLLKVQVDN------K--VCFQTR-KVRFPSGSYRIGV  197 (222)
T ss_dssp             EESSSCCCGGGHHHHCSEEEECCCTTEEEEEEEEEEEEGGGTSEEEEEETT------E--EEEEES-CCCCCSSEEEEEE
T ss_pred             CCCCeeeccCCCccccccccceeccCCCCcEEEEEEEEcCCCcEEEEEEcC------e--EEEEeC-CeecCCCCcEEEE
Confidence            21 11111     11111001122 2466789999998 667788888733      1  222221 0125665 47999


Q ss_pred             EeecC---Cccceeeeeeeeee
Q 047719          160 SAANG---QGSAIYTVDRWRFK  178 (596)
Q Consensus       160 sastg---~~~~~~~i~~Wsf~  178 (596)
                      ||+||   ...+.|.|++|++.
T Consensus       198 SA~TG~l~~~~d~hdil~~~~~  219 (222)
T 2a6z_A          198 TAQNGAVNNNAESFEIFKMQFF  219 (222)
T ss_dssp             EEECCSGGGCCCEEEEEEEEEE
T ss_pred             EEcCCCCCCCCccEEEEEEEEE
Confidence            99999   88899999999885

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.20  E-value=1.1e-10  Score=115.97  Aligned_cols=147  Identities=12%  Similarity=0.021  Sum_probs=111.6

Q ss_pred             HHHHhcCCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeE
Q 047719          279 IKQATLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNEL  358 (596)
Q Consensus       279 l~~at~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~  358 (596)
                      +.....+|.....++.|+.+.||+... .++.+++|+......  .....+.+|...+...-.+..+.++++++...+..
T Consensus         9 l~~~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~--~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~   85 (263)
T 3tm0_A            9 LKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHHHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHHHhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccC--CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCce
Confidence            445556787778888899999999986 468999999853211  22345788886666533467788899999999999


Q ss_pred             EEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhc--------------------------------
Q 047719          359 VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEE--------------------------------  406 (596)
Q Consensus       359 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~--------------------------------  406 (596)
                      |+||||++|.+|.+.+...         .....++.+++++|+.||+.                                
T Consensus        86 ~lv~e~i~G~~l~~~~~~~---------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (263)
T 3tm0_A           86 NLLMSEADGVLCSEEYEDE---------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE  156 (263)
T ss_dssp             EEEEECCSSEEHHHHCCTT---------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGG
T ss_pred             EEEEEecCCeehhhccCCc---------ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccc
Confidence            9999999999998764211         12347888999999999981                                


Q ss_pred             ------------------------cCCCeEEccCCCCceeecCCCceEEccCCCc
Q 047719          407 ------------------------CERQIIHRDVKACNILLDAEFNAKLGDFEAT  437 (596)
Q Consensus       407 ------------------------~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~  437 (596)
                                              ....++|+|+++.|||++++..+.|.||+.+
T Consensus       157 ~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a  211 (263)
T 3tm0_A          157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS  211 (263)
T ss_dssp             GGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTC
T ss_pred             cccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhc
Confidence                                    0145899999999999987666779999765

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.02  E-value=7e-10  Score=109.44  Aligned_cols=137  Identities=19%  Similarity=0.111  Sum_probs=96.0

Q ss_pred             cCCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCc--eeeecceeeeCCeEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN--LVQLQGWCCEGNELVLV  361 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~n--iv~l~g~~~~~~~~~lV  361 (596)
                      .++....+.+.|..+.||+....+|..+++|.....     ....+..|...+.. +.+.+  +.+++++....+..++|
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~-l~~~~~~vP~~~~~~~~~~~~~~v   93 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG-----ALNELQDEAARLSW-LATTGVPCAAVLDVVTEAGRDWLL   93 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC-----TTSCHHHHHHHHHH-HHTTTCCBCCEEEEEECSSCEEEE
T ss_pred             CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc-----cchhhhHHHHHHHH-HHhCCCCCCeEEEeccCCCCCEEE
Confidence            344443333455669999998877888999997432     22456778766654 43334  45588888888889999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhcc----------------------------------
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC----------------------------------  407 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~----------------------------------  407 (596)
                      |||+++.+|.  ...       .+   ...++.++++.|+.||+..                                  
T Consensus        94 ~e~i~G~~l~--~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (264)
T 1nd4_A           94 LGEVPGQDLL--SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEE  161 (264)
T ss_dssp             EECCSSEETT--TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGG
T ss_pred             EEecCCcccC--cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhh
Confidence            9999998884  211       11   1256777888888888621                                  


Q ss_pred             ---------------------CCCeEEccCCCCceeecCCCceEEccCCCcc
Q 047719          408 ---------------------ERQIIHRDVKACNILLDAEFNAKLGDFEATI  438 (596)
Q Consensus       408 ---------------------~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~  438 (596)
                                           ...++|+|++|.|||++++..++|.||+.+.
T Consensus       162 ~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          162 HQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             GTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                                 1229999999999999887667799998753

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.82  E-value=1.1e-08  Score=106.48  Aligned_cols=141  Identities=16%  Similarity=0.188  Sum_probs=101.4

Q ss_pred             cceeecCCceEEEEEEcCCCCEEEEEEee--cCCchhcccchHHHHHHHHHhccC--CCceeeecceeeeC---CeEEEE
Q 047719          289 NRIVGEGASATVYKGSLPSGGAVAVKRFE--KPNRVECARNPFTTEFATMAGCLR--HKNLVQLQGWCCEG---NELVLV  361 (596)
Q Consensus       289 ~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~--~~~~~~~~~~~~~~E~~~l~~~l~--H~niv~l~g~~~~~---~~~~lV  361 (596)
                      .+.|+.|.++.||+.... +..+++|+..  .... ......+.+|...+.. +.  +..+.+++.++.+.   +..|+|
T Consensus        43 ~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~-~~~~~~~~~E~~~l~~-L~~~~vpvP~~~~~~~~~~~~g~~~~v  119 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKL-LPSAHAIEREYRVMDA-LAGTDVPVAKMYALCEDESVIGRAFYI  119 (359)
T ss_dssp             EEECCC-CCSCEEEEECS-SCEEEEECCCC-----------CHHHHHHHHHH-HTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred             EEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCC-CCcHHHHHHHHHHHHH-hhcCCCCCCcEEEECCCCCccCCeEEE
Confidence            467899999999999875 4678888874  2211 1223456778765554 44  45578888888776   458999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhcc----------------------------------
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC----------------------------------  407 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~----------------------------------  407 (596)
                      |||+++..+.+...      ..++..++..++.++++.|+.||+..                                  
T Consensus       120 me~v~G~~l~~~~~------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (359)
T 3dxp_A          120 MEFVSGRVLWDQSL------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES  193 (359)
T ss_dssp             EECCCCBCCCCTTC------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred             EEecCCeecCCCcc------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence            99999987754211      13678888999999999999999720                                  


Q ss_pred             ---------------------CCCeEEccCCCCceeecCCCc--eEEccCCCcc
Q 047719          408 ---------------------ERQIIHRDVKACNILLDAEFN--AKLGDFEATI  438 (596)
Q Consensus       408 ---------------------~~~ivHrDlkp~NiLl~~~~~--~kl~Dfg~~~  438 (596)
                                           ...++|+|+++.|||++.++.  +.|.||+.+.
T Consensus       194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~  247 (359)
T 3dxp_A          194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELST  247 (359)
T ss_dssp             CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCE
T ss_pred             ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccc
Confidence                                 257999999999999997753  6899998764

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.64  E-value=2.3e-08  Score=101.62  Aligned_cols=178  Identities=17%  Similarity=0.122  Sum_probs=116.4

Q ss_pred             cceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCc--eeeecceeeeCC---eEEEEEe
Q 047719          289 NRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN--LVQLQGWCCEGN---ELVLVYE  363 (596)
Q Consensus       289 ~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~n--iv~l~g~~~~~~---~~~lV~E  363 (596)
                      .+.++.|....||+..    ..+++|+....    .....+.+|...+.....+..  +.+++.......   ..|+|||
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~   96 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFT   96 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEE
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEc
Confidence            3568999999999863    56889986321    223457778766654223332  233444433332   3489999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhc-------------------------------------
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEE-------------------------------------  406 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~-------------------------------------  406 (596)
                      +++|.+|.+....      .++..++..++.+++..|+.||+.                                     
T Consensus        97 ~i~G~~l~~~~~~------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (304)
T 3sg8_A           97 KIKGVPLTPLLLN------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQM  170 (304)
T ss_dssp             CCCCEECCHHHHH------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHH
T ss_pred             ccCCeECCccccc------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccH
Confidence            9999888754432      266777888888888888888861                                     


Q ss_pred             ------------------cCCCeEEccCCCCceeecC--CCceEEccCCCcccC-------CCccc---CCcccccc---
Q 047719          407 ------------------CERQIIHRDVKACNILLDA--EFNAKLGDFEATIPA-------GTMGY---LAPEYVYS---  453 (596)
Q Consensus       407 ------------------~~~~ivHrDlkp~NiLl~~--~~~~kl~Dfg~~~~~-------gt~~y---~aPE~~~~---  453 (596)
                                        ....++|+|+++.||+++.  ...+.|.||+.+...       ....+   ..|+....   
T Consensus       171 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~  250 (304)
T 3sg8_A          171 KKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILN  250 (304)
T ss_dssp             HHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHH
T ss_pred             HHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHH
Confidence                              0145899999999999998  556889999765321       11111   23332211   


Q ss_pred             --CCCC---------CccceeehhHHHHHHHhCCCCCC
Q 047719          454 --GVPS---------EKTDVYSFGVVALEVAAGKSPVD  480 (596)
Q Consensus       454 --~~~t---------~~sDV~SfGvll~El~tG~~p~~  480 (596)
                        +...         ...+.|+++.++|++.+|..++-
T Consensus       251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence              1111         12589999999999999987653

>2a6v_A EMP46P; beta sandwich, carbohydrate binding protein, cargo receptor, structural genomics, NPPSFA; 1.52A {Saccharomyces cerevisiae} SCOP: b.29.1.13 PDB: 2a6w_A 2a6x_A

Probab=98.48  E-value=1.5e-06  Score=83.65  Aligned_cols=146  Identities=11%  Similarity=0.083  Sum_probs=85.3

Q ss_pred             cceEEEEEEEEecCCCCCCCCeEEEEEecCCCCCCCCCCccCCCCCCCCCCCceEEEEeeCccCCCCCCCCCCeeEE-ec
Q 047719           10 ASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQDSFFAVEFDTSFDPSLGDINGNHIGI-DI   88 (596)
Q Consensus        10 asF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~~~~~~~~~lG~~~~~~~~~~~~~AVEfDt~~~~~~~d~~~~Hvgi-d~   88 (596)
                      .+|+.+|+|.|..... .+||||||.++.....  ..|...|-...    .-.=+||.|||+.|.      ...|.+ --
T Consensus        64 ~~weiev~Fri~G~~~-~~gdGlA~Wyt~~~~~--~~g~vfGg~~d----~f~GlgI~~Dt~~n~------~p~i~~~~N  130 (226)
T 2a6v_A           64 DAMTIEWTFRSFGFRG-STKGGLAFWLKQGNEG--DSTELFGGSSK----KFNGLMILLRLDDKL------GESVTAYLN  130 (226)
T ss_dssp             SCEEEEEEEEEESCCS-CCSCEEEEEEECSCCC--CCCTBTTTBCS----SCEEEEEEEEEETTT------EEEEEEEEE
T ss_pred             CCeEEEEEEEEecCCC-CCCCEEEEEEECCCCC--CCcccccccCC----CccEEEEEEECCCCC------CceEEEEEC
Confidence            5799999999986643 2699999999964331  22333321000    111269999998762      122222 11


Q ss_pred             CCcccccc---ccCCCCCc-ccCCCceEEEEEEEc-CCccEEEEEEeeCCCCCCCCeEE-EeecCcccCCCce--EEEEE
Q 047719           89 SSVISFVS---VDALSRGI-DLKSGRHITTWIEYR-DSLKLIRVWAGYSQIRPPSPLII-AQIDLSKQFKDYM--HVGFS  160 (596)
Q Consensus        89 ns~~s~~~---~~~~~~~~-~l~~g~~~~~~I~Y~-~~~~~l~v~~~~~~~~~~~p~l~-~~vdl~~~l~~~~--~vGFs  160 (596)
                      ++..+...   ..++.=.. ....+.+.+++|.|+ ...+.|+|.+..      +.++. ..|    .||..-  |+|||
T Consensus       131 DGt~~yd~~~~~~~g~C~~~~rn~~~~t~~ri~Y~~~~~~~l~v~id~------~~Cf~~~~v----~LP~g~~~yfGiS  200 (226)
T 2a6v_A          131 DGTKDLDIESSPYFASCLFQYQDSMVPSTLRLTYNPLDNHLLKLQMDN------RVCFQTRKV----KFMGSSPFRIGTS  200 (226)
T ss_dssp             ESSSCCCTTTSCCSEEEECCCSSCSSCEEEEEEEEGGGTSEEEEEETT------EEEEEESCC----CGGGTSCBEEEEE
T ss_pred             CCCcccCCCCCcccceEeEeccCCCCCEEEEEEEEccCCCEEEEEEcC------CeeEEECCe----ecCCCCccEEEEE
Confidence            22222111   11110001 123456789999997 456789998842      11222 112    345544  99999


Q ss_pred             eecCCccceeeeeeeeee
Q 047719          161 AANGQGSAIYTVDRWRFK  178 (596)
Q Consensus       161 astg~~~~~~~i~~Wsf~  178 (596)
                      |+||...+.|.|++-.+.
T Consensus       201 AaTg~~~D~hdils~~~~  218 (226)
T 2a6v_A          201 AINDASKESFEILKMKLY  218 (226)
T ss_dssp             EECCTTCCEEEEEEEEEE
T ss_pred             EcCCCCcccEEEEEEEEE
Confidence            999999999999996654

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.17  E-value=1.5e-05  Score=78.83  Aligned_cols=143  Identities=17%  Similarity=0.142  Sum_probs=96.2

Q ss_pred             HhcCCCccceeecCCce-EEEEEEcCC-CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEE
Q 047719          282 ATLGFNKNRIVGEGASA-TVYKGSLPS-GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELV  359 (596)
Q Consensus       282 at~~f~~~~~LG~G~fG-~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~  359 (596)
                      ...+|.. +.+..|..| .||+..... +..+.+|+-...     ...++.+|...+...-.+--+-++++++.+.+..+
T Consensus        23 ~l~g~~~-~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~   96 (272)
T 4gkh_A           23 DLYGYRW-ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAW   96 (272)
T ss_dssp             HHTTCEE-EEEECSSSSCEEEEEECCTTCCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             cccCCeE-EEccCCCcCCeEEEEEecCCCeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEE
Confidence            3344443 345556555 699887654 567899986422     23346677755544323333567788899999999


Q ss_pred             EEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhcc--------------------------------
Q 047719          360 LVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC--------------------------------  407 (596)
Q Consensus       360 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~--------------------------------  407 (596)
                      +|||++++.++.+......        .....+..+++..|+-||+..                                
T Consensus        97 lvme~l~G~~~~~~~~~~~--------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (272)
T 4gkh_A           97 LLTTAIPGKTAFQVLEEYP--------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFD  168 (272)
T ss_dssp             EEEECCCSEEHHHHHHHCG--------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCC
T ss_pred             EEEEeeCCccccccccCCH--------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcc
Confidence            9999999988877654321        223345666777777777420                                


Q ss_pred             -----------------------CCCeEEccCCCCceeecCCCceEEccCCCcc
Q 047719          408 -----------------------ERQIIHRDVKACNILLDAEFNAKLGDFEATI  438 (596)
Q Consensus       408 -----------------------~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~  438 (596)
                                             ...++|+|+.+.|||++.++.+-|.||+.+.
T Consensus       169 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          169 DERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             GGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                                   1238999999999999988777899998753

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=97.96  E-value=5.4e-05  Score=76.69  Aligned_cols=135  Identities=16%  Similarity=0.110  Sum_probs=87.0

Q ss_pred             cceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCC---ceeeecceee-eCCeEEEEEec
Q 047719          289 NRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHK---NLVQLQGWCC-EGNELVLVYEY  364 (596)
Q Consensus       289 ~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~---niv~l~g~~~-~~~~~~lV~E~  364 (596)
                      .+.++.|....||+.    |+.+++|+...    ......+..|...+.. +.+.   .+.+.+.++. ..+..++||||
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~~----~~~~~~~~~E~~~L~~-L~~~~~v~VP~~~~~~~~~~g~~~~v~e~   94 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPKS----QQGADELNKEIQLLPL-LVGCVKVNIPQYVYIGKRSDGNPFVGYRK   94 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEESS----HHHHHHHHHHHHHHHH-HTTTCSSBCCCEEEEEECTTSCEEEEEEC
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecCC----chHHHHHHHHHHHHHH-HHhcCCCCCCCeEeecccCCCceEEEEec
Confidence            356888888999988    56788888521    1223457788866654 4432   2445555553 34567899999


Q ss_pred             CCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhc--------------------------------------
Q 047719          365 LPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEE--------------------------------------  406 (596)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~--------------------------------------  406 (596)
                      ++|.+|.+....      .++..++..++.++++.|+.||+.                                      
T Consensus        95 i~G~~l~~~~~~------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~  168 (306)
T 3tdw_A           95 VQGQILGEDGMA------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESL  168 (306)
T ss_dssp             CCSEECHHHHHT------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHH
T ss_pred             cCCeECchhhhh------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhh
Confidence            999887763221      133344444555555555555431                                      


Q ss_pred             -------------------cCCCeEEccCCCCceeecC---CCc-eEEccCCCcc
Q 047719          407 -------------------CERQIIHRDVKACNILLDA---EFN-AKLGDFEATI  438 (596)
Q Consensus       407 -------------------~~~~ivHrDlkp~NiLl~~---~~~-~kl~Dfg~~~  438 (596)
                                         ....++|+|+++.|||++.   ++. ..|.||+.+.
T Consensus       169 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~  223 (306)
T 3tdw_A          169 RDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA  223 (306)
T ss_dssp             HHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred             HHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence                               2245799999999999987   455 4899998654

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.77  E-value=4e-05  Score=79.17  Aligned_cols=82  Identities=7%  Similarity=-0.006  Sum_probs=50.4

Q ss_pred             cee-ecCCceEEEEEEcC-------CCCEEEEEEeecCCc-hhcccchHHHHHHHHHhccCC--CceeeecceeeeC---
Q 047719          290 RIV-GEGASATVYKGSLP-------SGGAVAVKRFEKPNR-VECARNPFTTEFATMAGCLRH--KNLVQLQGWCCEG---  355 (596)
Q Consensus       290 ~~L-G~G~fG~Vy~~~~~-------~g~~vAvK~l~~~~~-~~~~~~~~~~E~~~l~~~l~H--~niv~l~g~~~~~---  355 (596)
                      +.| +.|....+|+....       +++.+++|+...... .......+.+|...+...-.+  -.+.+++.++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            567 78888999998764       266788887642210 000124566776555442222  2455677776654   


Q ss_pred             CeEEEEEecCCCCCHH
Q 047719          356 NELVLVYEYLPNGSLD  371 (596)
Q Consensus       356 ~~~~lV~E~~~~gsL~  371 (596)
                      +..++||||+++..+.
T Consensus       106 g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             SSCEEEEECCCCBCCC
T ss_pred             CCceEEEEecCCCChh
Confidence            3568999999987654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.64  E-value=0.00028  Score=71.88  Aligned_cols=42  Identities=17%  Similarity=0.126  Sum_probs=33.2

Q ss_pred             HHHHHHHHHh----------ccCCCeEEccCCCCceeecCCCceEEccCCCc
Q 047719          396 VASALSYLHE----------ECERQIIHRDVKACNILLDAEFNAKLGDFEAT  437 (596)
Q Consensus       396 ia~gL~~LH~----------~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~  437 (596)
                      +..++.+|+.          .....++|+|+++.|||++.++.+.|.||+.+
T Consensus       199 ~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a  250 (346)
T 2q83_A          199 GLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTV  250 (346)
T ss_dssp             HHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTC
T ss_pred             HHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhc
Confidence            3445666763          13478999999999999988889999999865

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.49  E-value=0.00054  Score=71.78  Aligned_cols=78  Identities=17%  Similarity=0.074  Sum_probs=45.6

Q ss_pred             cceeecCCceEEEEEEcC-CCCEEEEEEeecCCc--h---hcccchHHHHHHHHHhccCC-Ccee-eecceeeeCCeEEE
Q 047719          289 NRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNR--V---ECARNPFTTEFATMAGCLRH-KNLV-QLQGWCCEGNELVL  360 (596)
Q Consensus       289 ~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~--~---~~~~~~~~~E~~~l~~~l~H-~niv-~l~g~~~~~~~~~l  360 (596)
                      .+.||.|.++.||++... +++.++||.......  .   ......+..|...+...-.+ +..+ +++.+  +....++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            367899999999999765 468899998643211  0   01233456676555432122 3333 44443  3445689


Q ss_pred             EEecCCCC
Q 047719          361 VYEYLPNG  368 (596)
Q Consensus       361 V~E~~~~g  368 (596)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.43  E-value=0.00071  Score=67.54  Aligned_cols=78  Identities=18%  Similarity=0.224  Sum_probs=50.8

Q ss_pred             CCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCC--ceeeecceeeeCCeEEEEEe
Q 047719          286 FNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHK--NLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       286 f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~--niv~l~g~~~~~~~~~lV~E  363 (596)
                      ....+.+|.|..+.||+.++.+|+.|.+|+-....  ......|..|...|..+-+..  -+.+++++.    .-++|||
T Consensus        17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e   90 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDA--PALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAME   90 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTC--CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEE
T ss_pred             eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCC--cchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEE
Confidence            34457789999999999999999999999864322  122334677876665422221  233344432    2378999


Q ss_pred             cCCCCC
Q 047719          364 YLPNGS  369 (596)
Q Consensus       364 ~~~~gs  369 (596)
                      |++.+.
T Consensus        91 ~l~~~~   96 (288)
T 3f7w_A           91 WVDERP   96 (288)
T ss_dssp             CCCCCC
T ss_pred             eecccC
Confidence            998765

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.38  E-value=0.00079  Score=71.22  Aligned_cols=68  Identities=10%  Similarity=0.107  Sum_probs=44.0

Q ss_pred             CCCeEEccCCCCceeecCCCceEEccCCCcccCC------------CcccCCccccccC---CCCCccceeehhHHHHHH
Q 047719          408 ERQIIHRDVKACNILLDAEFNAKLGDFEATIPAG------------TMGYLAPEYVYSG---VPSEKTDVYSFGVVALEV  472 (596)
Q Consensus       408 ~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~~g------------t~~y~aPE~~~~~---~~t~~sDV~SfGvll~El  472 (596)
                      ...++|+|+++.|||++.++ +++.||+.+....            ...|.+|+.....   ......++......+|+.
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL  309 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence            47899999999999998876 9999997654311            1234555544311   112234555777777777


Q ss_pred             HhCC
Q 047719          473 AAGK  476 (596)
Q Consensus       473 ~tG~  476 (596)
                      ++++
T Consensus       310 y~~~  313 (420)
T 2pyw_A          310 FNKR  313 (420)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            6653

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.32  E-value=0.0011  Score=67.36  Aligned_cols=140  Identities=17%  Similarity=0.119  Sum_probs=88.4

Q ss_pred             cceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccC--CCceeeecceeeeCCeEEEEEecCC
Q 047719          289 NRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLR--HKNLVQLQGWCCEGNELVLVYEYLP  366 (596)
Q Consensus       289 ~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~--H~niv~l~g~~~~~~~~~lV~E~~~  366 (596)
                      .+.|+.|....+|+... +++.+++|+....     ....+..|...|..+-.  ...+.+++.++...+..++||||++
T Consensus        41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~  114 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN  114 (312)
T ss_dssp             EEEECCSSSSEEEEEES-SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred             eEEeCCccceeeeEEEE-CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence            46789999999999986 5678889987432     23446677655544222  3567778888888889999999999


Q ss_pred             CCCHH-----------HHhhhCCC-CC-----------------cccCHHHHH---HHHH--H--------------HHH
Q 047719          367 NGSLD-----------KILHNNSS-SS-----------------IVLSWEKRL---NIVL--G--------------VAS  398 (596)
Q Consensus       367 ~gsL~-----------~~l~~~~~-~~-----------------~~l~~~~~~---~i~~--~--------------ia~  398 (596)
                      +..+.           ..|+.... ..                 -.-+|...+   ++..  +              +..
T Consensus       115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~  194 (312)
T 3jr1_A          115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ  194 (312)
T ss_dssp             CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred             CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence            87642           12333221 00                 012465332   1111  1              111


Q ss_pred             H-HHHHHh-ccCCCeEEccCCCCceeecCCCceEEccCC
Q 047719          399 A-LSYLHE-ECERQIIHRDVKACNILLDAEFNAKLGDFE  435 (596)
Q Consensus       399 g-L~~LH~-~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg  435 (596)
                      . ...|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus       195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            1 123321 2247899999999999999887 8899973

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.84  E-value=0.011  Score=59.62  Aligned_cols=160  Identities=15%  Similarity=0.170  Sum_probs=84.4

Q ss_pred             cCHHHHHHHhcCCCc-----cceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhc----cCCCc
Q 047719          274 LALTDIKQATLGFNK-----NRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGC----LRHKN  344 (596)
Q Consensus       274 ~~~~el~~at~~f~~-----~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~----l~H~n  344 (596)
                      ++.+++...-..|..     .+.|+.|....+|+....+| .+++|.....    .....+..|...+...    +.-|.
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~----~~~~~l~~e~~~l~~L~~~g~~vP~   81 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR----VEKNDLPFFLGLMQHLAAKGLSCPL   81 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC----CCHHHHHHHHHHHHHHHHCCCCCCc
Confidence            445556555555554     23466788889999987555 6889988532    1122344444333221    22233


Q ss_pred             eeeec-c--eeeeCCeEEEEEecCCCCCHHH--------------HhhhCC-C--CC-----cccCHHHHHHH-------
Q 047719          345 LVQLQ-G--WCCEGNELVLVYEYLPNGSLDK--------------ILHNNS-S--SS-----IVLSWEKRLNI-------  392 (596)
Q Consensus       345 iv~l~-g--~~~~~~~~~lV~E~~~~gsL~~--------------~l~~~~-~--~~-----~~l~~~~~~~i-------  392 (596)
                      ++... |  +....+..++++||+++..+..              .++... .  ..     ....|...+.-       
T Consensus        82 ~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~  161 (322)
T 2ppq_A           82 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE  161 (322)
T ss_dssp             BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred             ccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHh
Confidence            33221 1  1123466799999998764311              122110 0  00     01124332111       


Q ss_pred             -----HHHHHHHHHHHHhc----cCCCeEEccCCCCceeecCCCceEEccCCCcc
Q 047719          393 -----VLGVASALSYLHEE----CERQIIHRDVKACNILLDAEFNAKLGDFEATI  438 (596)
Q Consensus       393 -----~~~ia~gL~~LH~~----~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~  438 (596)
                           ...+...++.|++.    ....++|+|+.+.|||++.+..+.|.||+.+.
T Consensus       162 ~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          162 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence                 11244556666542    23579999999999999987666899997653

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.64  E-value=0.0073  Score=61.36  Aligned_cols=31  Identities=29%  Similarity=0.382  Sum_probs=26.5

Q ss_pred             CCCeEEccCCCCceeecCC----CceEEccCCCcc
Q 047719          408 ERQIIHRDVKACNILLDAE----FNAKLGDFEATI  438 (596)
Q Consensus       408 ~~~ivHrDlkp~NiLl~~~----~~~kl~Dfg~~~  438 (596)
                      ...++|+|+.+.|||++.+    ..+.|.||+.+.
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~  216 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAK  216 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcC
Confidence            3679999999999999875    679999997653

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.43  E-value=0.019  Score=57.44  Aligned_cols=29  Identities=24%  Similarity=0.111  Sum_probs=24.2

Q ss_pred             CCeEEccCCCCceeecCCCceEEccCCCcc
Q 047719          409 RQIIHRDVKACNILLDAEFNAKLGDFEATI  438 (596)
Q Consensus       409 ~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~  438 (596)
                      ..++|+|+.+.||+ ..++.+.+.||..+.
T Consensus       173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~  201 (301)
T 3dxq_A          173 LAACHCDPLCENFL-DTGERMWIVDWEYSG  201 (301)
T ss_dssp             CEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred             ceeeccCCCcCCEE-ECCCCEEEEeccccc
Confidence            45899999999999 566778999997653

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.13  E-value=0.0093  Score=63.17  Aligned_cols=72  Identities=15%  Similarity=0.181  Sum_probs=43.4

Q ss_pred             ceeecCCceEEEEEEcCC--------CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          290 RIVGEGASATVYKGSLPS--------GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       290 ~~LG~G~fG~Vy~~~~~~--------g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      +.|+.|-...+|+....+        +..+.+|+.... ..   ...+..|...+...-.+.-..++++.+.+    .+|
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v  150 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL  150 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEE
Confidence            567788889999998653        478999987321 11   13345676555432223223456665432    289


Q ss_pred             EecCCCCC
Q 047719          362 YEYLPNGS  369 (596)
Q Consensus       362 ~E~~~~gs  369 (596)
                      +||+++.+
T Consensus       151 ~e~l~G~~  158 (429)
T 1nw1_A          151 EEYIPSRP  158 (429)
T ss_dssp             ECCCCEEE
T ss_pred             EEEeCCcc
Confidence            99998643

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.06  E-value=0.042  Score=55.35  Aligned_cols=141  Identities=11%  Similarity=0.111  Sum_probs=74.8

Q ss_pred             ceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccC-C-Cceeeecce-----eeeCCeEEEEE
Q 047719          290 RIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLR-H-KNLVQLQGW-----CCEGNELVLVY  362 (596)
Q Consensus       290 ~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~-H-~niv~l~g~-----~~~~~~~~lV~  362 (596)
                      ..|+ |....||+....+|+.+++|.......   ....+..|...+.. +. + -.+.+++..     ....+..++||
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~---~~~~~~~E~~~~~~-L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~  106 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW---TADQILEEHQFALQ-LVNDEVPVAAPVAFNGQTLLNHQGFYFAVF  106 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS---CHHHHHHHHHHHHH-HHHTTCSBCCCCCBTTBSCEEETTEEEEEE
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC---CHHHHHHHHHHHHH-HHHcCCeecceeecCCcEEEEECCEEEEEE
Confidence            3466 778899998876777899999853211   12234445433322 21 1 113333332     22355678999


Q ss_pred             ecCCCCCHH-----H------H---hhhC----CC-CCcccCHHHH----HHH---------------HHHHHHHHHHHH
Q 047719          363 EYLPNGSLD-----K------I---LHNN----SS-SSIVLSWEKR----LNI---------------VLGVASALSYLH  404 (596)
Q Consensus       363 E~~~~gsL~-----~------~---l~~~----~~-~~~~l~~~~~----~~i---------------~~~ia~gL~~LH  404 (596)
                      ||+++..+.     .      .   ++..    .. ....+++...    ..+               ...+...++.+.
T Consensus       107 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~  186 (328)
T 1zyl_A          107 PSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVT  186 (328)
T ss_dssp             ECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHH
T ss_pred             EecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHH
Confidence            999875432     1      1   1111    00 0112232211    001               011112233333


Q ss_pred             hc----cCCCeEEccCCCCceeecCCCceEEccCCCc
Q 047719          405 EE----CERQIIHRDVKACNILLDAEFNAKLGDFEAT  437 (596)
Q Consensus       405 ~~----~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~  437 (596)
                      ..    ....++|+|+++.|||++ + .+.|.||+.+
T Consensus       187 ~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a  221 (328)
T 1zyl_A          187 AHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDA  221 (328)
T ss_dssp             HHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTC
T ss_pred             HHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCC
Confidence            21    235689999999999999 4 8999999765

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.06  E-value=0.014  Score=55.34  Aligned_cols=99  Identities=19%  Similarity=0.145  Sum_probs=65.6

Q ss_pred             CCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcccCCCcccCC
Q 047719          368 GSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIPAGTMGYLA  447 (596)
Q Consensus       368 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~~gt~~y~a  447 (596)
                      -||.+.|....   .++++.++|.++.|.+++|.-+-.. ... ..+=+.|..|+|..+|.+...+ ..+. .....+.|
T Consensus        33 vSL~eIL~~~~---~PlsEEqaWALc~Qc~~~L~~~~~~-~~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~-~~~~~~~~  105 (229)
T 2yle_A           33 LSLEEILRLYN---QPINEEQAWAVCYQCCGSLRAAARR-RQP-RHRVRSAAQIRVWRDGAVTLAP-AADD-AGEPPPVA  105 (229)
T ss_dssp             EEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT-TCC-CCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred             ccHHHHHHHcC---CCcCHHHHHHHHHHHHHHHHhhhhc-ccC-CceecCCcceEEecCCceeccc-cccc-ccccCCCC
Confidence            47999998754   4799999999999999998766211 011 1233446899999999998885 2221 22345678


Q ss_pred             ccccccCCCCCccceeehhHHHHHHHh
Q 047719          448 PEYVYSGVPSEKTDVYSFGVVALEVAA  474 (596)
Q Consensus       448 PE~~~~~~~t~~sDV~SfGvll~El~t  474 (596)
                      ||... ...+.+.=|||+|+++|..+-
T Consensus       106 pe~~~-~~~te~~~IysLG~tLY~ALD  131 (229)
T 2yle_A          106 GKLGY-SQCMETEVIESLGIIIYKALD  131 (229)
T ss_dssp             -CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred             hhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence            88763 345678899999999999987

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=95.74  E-value=0.018  Score=59.92  Aligned_cols=142  Identities=20%  Similarity=0.180  Sum_probs=76.0

Q ss_pred             ceeecCCceEEEEEEcCC--------CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          290 RIVGEGASATVYKGSLPS--------GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       290 ~~LG~G~fG~Vy~~~~~~--------g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      +.|..|-...+|+....+        ++.+.+|+...  . ........+|...+..+-.+.-..++++.+.+    .+|
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~--~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v  128 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA--I-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRL  128 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC--c-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccE
Confidence            456666677889988642        47899988522  1 11233455676555432223223455655543    299


Q ss_pred             EecCCCCCHHH--------------H---hhhCCC-CCcccC--HHHHHHHHHHHH-------------------HHHHH
Q 047719          362 YEYLPNGSLDK--------------I---LHNNSS-SSIVLS--WEKRLNIVLGVA-------------------SALSY  402 (596)
Q Consensus       362 ~E~~~~gsL~~--------------~---l~~~~~-~~~~l~--~~~~~~i~~~ia-------------------~gL~~  402 (596)
                      |||+++.+|..              .   |+.... ......  |.+..++..++.                   ..+..
T Consensus       129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  208 (379)
T 3feg_A          129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN  208 (379)
T ss_dssp             EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred             EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence            99999755431              1   121110 011122  344444443332                   12333


Q ss_pred             HHhc-----cCCCeEEccCCCCceeecCC----CceEEccCCCcc
Q 047719          403 LHEE-----CERQIIHRDVKACNILLDAE----FNAKLGDFEATI  438 (596)
Q Consensus       403 LH~~-----~~~~ivHrDlkp~NiLl~~~----~~~kl~Dfg~~~  438 (596)
                      |.+.     ....++|+|+.+.|||++.+    +.+.+.||..+.
T Consensus       209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            3321     23468999999999999876    789999997653

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=95.55  E-value=0.046  Score=58.29  Aligned_cols=73  Identities=15%  Similarity=0.121  Sum_probs=42.6

Q ss_pred             ceeecCCceEEEEEEcCC-CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCce-eeecceeeeCCeEEEEEecCCC
Q 047719          290 RIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL-VQLQGWCCEGNELVLVYEYLPN  367 (596)
Q Consensus       290 ~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~ni-v~l~g~~~~~~~~~lV~E~~~~  367 (596)
                      +.|+.|-...+|+....+ +..+++|+....  .. ..-...+|...+.. +...++ .++++.+.  +  .+||||+++
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~--~~-~~idR~~E~~vl~~-L~~~gl~P~ll~~~~--~--G~v~e~I~G  185 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPK--TD-EIINREREKKISCI-LYNKNIAKKIYVFFT--N--GRIEEFMDG  185 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC---CC-SCSCHHHHHHHHHH-HTTSSSBCCEEEEET--T--EEEEECCCS
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCC--hh-hhcCHHHHHHHHHH-HHhcCCCCCEEEEeC--C--eEEEEeeCC
Confidence            567788889999998765 478888876321  11 11122466655544 443334 45666652  2  259999987


Q ss_pred             CCH
Q 047719          368 GSL  370 (596)
Q Consensus       368 gsL  370 (596)
                      .+|
T Consensus       186 ~~l  188 (458)
T 2qg7_A          186 YAL  188 (458)
T ss_dssp             EEC
T ss_pred             ccC
Confidence            443

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=95.22  E-value=0.037  Score=57.05  Aligned_cols=28  Identities=29%  Similarity=0.380  Sum_probs=23.5

Q ss_pred             CCeEEccCCCCceeecCCCceEEccCCCc
Q 047719          409 RQIIHRDVKACNILLDAEFNAKLGDFEAT  437 (596)
Q Consensus       409 ~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~  437 (596)
                      ..++|+|+.+.|||++.+. +.|.||..+
T Consensus       212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a  239 (369)
T 3c5i_A          212 IVFCHNDLQENNIINTNKC-LRLIDFEYS  239 (369)
T ss_dssp             EEEECSCCCGGGEEECC-C-EEECCCTTC
T ss_pred             eEEEeCCCCcccEEecCCc-EEEEEecCC
Confidence            5689999999999998654 899999765

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=95.17  E-value=0.1  Score=53.16  Aligned_cols=29  Identities=24%  Similarity=0.376  Sum_probs=26.1

Q ss_pred             CCeEEccCCCCceeecCCCceEEccCCCc
Q 047719          409 RQIIHRDVKACNILLDAEFNAKLGDFEAT  437 (596)
Q Consensus       409 ~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~  437 (596)
                      ..++|+|+.+.||+++.++.+.|.||..+
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~  234 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEP  234 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSC
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCC
Confidence            57999999999999998888999999654

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=91.36  E-value=0.48  Score=49.76  Aligned_cols=29  Identities=24%  Similarity=0.410  Sum_probs=25.2

Q ss_pred             CCeEEccCCCCceeecCCCceEEccCCCcc
Q 047719          409 RQIIHRDVKACNILLDAEFNAKLGDFEATI  438 (596)
Q Consensus       409 ~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~  438 (596)
                      ..++|+|+.+.||+ +.++.+.+.||..+.
T Consensus       262 ~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~  290 (424)
T 3mes_A          262 LVFAHNDLQENNLL-QTQNNIRMIDYEYSA  290 (424)
T ss_dssp             EEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred             ceEECCCCCcccee-cCCCcEEEEecccCC
Confidence            46899999999999 888899999997653

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=88.31  E-value=0.44  Score=32.59  Aligned_cols=9  Identities=11%  Similarity=0.183  Sum_probs=3.6

Q ss_pred             hhhHHHHHH
Q 047719          227 EVGGLVTFV  235 (596)
Q Consensus       227 ~~~~~~~~~  235 (596)
                      +.++++..+
T Consensus        12 IA~gVVgGv   20 (44)
T 2l2t_A           12 IAAGVIGGL   20 (44)
T ss_dssp             HHHHHHHHH
T ss_pred             EEEeehHHH
Confidence            334444433

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=82.13  E-value=5.3  Score=41.22  Aligned_cols=29  Identities=34%  Similarity=0.396  Sum_probs=23.9

Q ss_pred             CeEEccCCCCceee------cCCCceEEccCCCcc
Q 047719          410 QIIHRDVKACNILL------DAEFNAKLGDFEATI  438 (596)
Q Consensus       410 ~ivHrDlkp~NiLl------~~~~~~kl~Dfg~~~  438 (596)
                      .++|+|+.+.|||+      +++..+++.||..+.
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            35799999999999      456789999997653

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=81.13  E-value=0.19  Score=53.57  Aligned_cols=61  Identities=8%  Similarity=-0.033  Sum_probs=17.2

Q ss_pred             cceeecCCceEEEEEEcCC-CCEEEE------EEeecCCchhcccchHHHHHHHHHhccCCCceeeecceee
Q 047719          289 NRIVGEGASATVYKGSLPS-GGAVAV------KRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCC  353 (596)
Q Consensus       289 ~~~LG~G~fG~Vy~~~~~~-g~~vAv------K~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~  353 (596)
                      .+.||   ||.||+|.+.. ..+|||      |..+......+....|.+|...+ +..+|+|+++.+++..
T Consensus       147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~-~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLK-ENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             TTTSS---BCCC---------CCBGGGC------------------------------------CBCCCEEE
T ss_pred             cccCC---chhhhcccccccCCchhhhhccCcccccccccccccccccccccccc-ccccccccCCCcceEE
Confidence            35566   99999998864 468999      77654344444555677777444 4589999999988754

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	596
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	4e-56
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	7e-52
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-50
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-50
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-50
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	8e-50
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-49
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	4e-49
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	5e-49
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	7e-49
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-48
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	3e-48
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-47
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-47
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-47
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	3e-47
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	8e-47
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-46
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-46
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-46
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-45
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-45
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	4e-45
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	7e-45
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-44
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	4e-43
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-42
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	8e-42
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-41
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	4e-41
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	6e-41
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	7e-41
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-40
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-40
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	7e-40
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-38
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-38
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-37
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	6e-37
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-36
d1hqla_	236	b.29.1.1 (A:) Legume lectin {Griffonia simplicifol	6e-36
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	4e-35
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-34
d1qnwa_	237	b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus	3e-34
d1gzca_	239	b.29.1.1 (A:) Legume lectin {Cockspur coral tree (	4e-34
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	5e-34
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-33
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	4e-33
d1g7ya_	253	b.29.1.1 (A:) Legume lectin {Horse gram (Dolichos	7e-33
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	8e-33
d1leda_	243	b.29.1.1 (A:) Legume lectin {West-central african	8e-33
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-32
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-32
d1v6ia_	232	b.29.1.1 (A:) Legume lectin {Peanut (Arachis hypog	2e-32
d1fx5a_	240	b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus	3e-32
d1g9fa_	251	b.29.1.1 (A:) Legume lectin {Soybean (Glycine max)	4e-32
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	4e-32
d1g8wa_	233	b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also ar	5e-32
g1qmo.1	230	b.29.1.1 (A:,E:) Legume lectin {Field bean (Dolich	9e-32
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-31
d1f9ka_	234	b.29.1.1 (A:) Legume lectin {Winged bean (Psophoca	3e-31
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	5e-31
d1avba_	226	b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also ar	5e-31
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-30
d1ukga_	241	b.29.1.1 (A:) Legume lectin {Bloodwood tree (Ptero	2e-30
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-29
d1fnya_	237	b.29.1.1 (A:) Legume lectin {Black locust (Robinia	1e-29
d2d3sa1	237	b.29.1.1 (A:1-237) Legume lectin {Winged bean (Pso	2e-29
d1nlsa_	237	b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia	2e-29
d1nlsa_	237	b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia	5e-06
d1n47a_	233	b.29.1.1 (A:) Legume lectin {Hairy vetch (Vicia vi	9e-29
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-28
g2ltn.1	229	b.29.1.1 (A:,B:) Legume lectin {Garden pea (Pisum	1e-28
d1dbna_	239	b.29.1.1 (A:) Legume lectin {Maackia amurensis, le	2e-28
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	8e-28
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-27
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-27
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	8e-27
d1ioaa_	228	b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also ar	8e-27
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	7e-26
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-24
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-22
d1dhkb_	204	b.29.1.1 (B:) Phytohemagglutinin-L, PHA-L, also ar	2e-22
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-17
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-15
d1gv9a_	228	b.29.1.13 (A:) Carbohydrate-recognition domain of	2e-15
d2a6va1	218	b.29.1.13 (A:9-226) Emp46p N-terminal domain {Bake	6e-05
d2a6za1	221	b.29.1.13 (A:7-227) Emp47p N-terminal domain {Bake	0.004

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 4e-56
 Identities = 65/276 (23%), Positives = 108/276 (39%), Gaps = 33/276 (11%)

Query: 286 FNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
               + +G G+  TVYKG       VAVK              F  E   +    RH N+
Sbjct: 10  ITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRK-TRHVNI 66

Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
           +   G      +L +V ++    SL   LH   +        K ++I    A  + YLH 
Sbjct: 67  LLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGMDYLHA 122

Query: 406 ECERQIIHRDVKACNILLDAEFNAKLGDF-------------EATIPAGTMGYLAPEYVY 452
              + IIHRD+K+ NI L  +   K+GDF             +    +G++ ++APE + 
Sbjct: 123 ---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179

Query: 453 ---SGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRG 509
                  S ++DVY+FG+V  E+  G+ P  N      D +  +  +G L          
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--RDQIIFMVGRGYLSPDLS----- 232

Query: 510 KFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK 545
           K      + M  +   C+    ++RP   +    ++
Sbjct: 233 KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 7e-52
 Identities = 64/296 (21%), Positives = 113/296 (38%), Gaps = 49/296 (16%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F K   +G G    V+K    PSG  +A K      +    RN    E   +        
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK-PAIRNQIIRELQVLH-ECNSPY 65

Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           +V   G      E+ +  E++  GSLD++L         +  +    + + V   L+YL 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR----IPEQILGKVSIAVIKGLTYLR 121

Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGTMGYLAPEYVYSGV 455
           E+   +I+HRDVK  NIL+++    KL DF          A    GT  Y++PE +    
Sbjct: 122 EKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTH 179

Query: 456 PSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLD-------------- 501
            S ++D++S G+  +E+A G+ P+       ++ ++  + +G   +              
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 239

Query: 502 --------AADFRLRGKFNRKEMERMLMVGLS---------CVHPNHEKRPSVKEA 540
                    A F L      +   ++     S         C+  N  +R  +K+ 
Sbjct: 240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (440), Expect = 1e-50
 Identities = 66/272 (24%), Positives = 102/272 (37%), Gaps = 33/272 (12%)

Query: 286 FNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
               + +G G    V+ G   +   VA+K   +    E     F  E   M   L H  L
Sbjct: 7   LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMM-KLSHPKL 62

Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
           VQL G C E   + LV+E++ +G L   L        + + E  L + L V   ++YL E
Sbjct: 63  VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEE 119

Query: 406 ECERQIIHRDVKACNILLDAEFNAKLGDF------------EATIPAGTMGYLAPEYVYS 453
            C   +IHRD+ A N L+      K+ DF             +T     + + +PE    
Sbjct: 120 AC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF 176

Query: 454 GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNR 513
              S K+DV+SFGV+  EV +                +  R   ++++      R    R
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKI-----------PYENRSNSEVVEDISTGFRLYKPR 225

Query: 514 KEMERMLMVGLSCVHPNHEKRPSVKEAARILK 545
                +  +   C     E RP+     R L 
Sbjct: 226 LASTHVYQIMNHCWKERPEDRPAFSRLLRQLA 257

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (440), Expect = 2e-50
 Identities = 62/272 (22%), Positives = 110/272 (40%), Gaps = 33/272 (12%)

Query: 286 FNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
                 +G G    V+ G       VAVK  ++ +    + + F  E   M   L+H+ L
Sbjct: 15  LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM---SPDAFLAEANLMK-QLQHQRL 70

Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
           V+L         + ++ EY+ NGSL   L   S   I L+  K L++   +A  ++++ E
Sbjct: 71  VRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEE 127

Query: 406 ECERQIIHRDVKACNILLDAEFNAKLGDF------------EATIPAGTMGYLAPEYVYS 453
              R  IHRD++A NIL+    + K+ DF                    + + APE +  
Sbjct: 128 ---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184

Query: 454 GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNR 513
           G  + K+DV+SFG++  E+          G    + + NL +  +++   +         
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPY-PGMTNPEVIQNLERGYRMVRPDNC-------- 235

Query: 514 KEMERMLMVGLSCVHPNHEKRPSVKEAARILK 545
              E +  +   C     E RP+      +L+
Sbjct: 236 --PEELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 3e-50
 Identities = 59/271 (21%), Positives = 106/271 (39%), Gaps = 29/271 (10%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           +     +G G+     K      G  +  K  +  +  E  +    +E   +   L+H N
Sbjct: 6   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR-ELKHPN 64

Query: 345 LVQLQGWCCE--GNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
           +V+      +     L +V EY   G L  ++   +     L  E  L ++  +  AL  
Sbjct: 65  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124

Query: 403 LHE--ECERQIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTMGYLAPE 449
            H   +    ++HRD+K  N+ LD + N KLGDF            A    GT  Y++PE
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPE 184

Query: 450 YVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRG 509
            +     +EK+D++S G +  E+ A   P                  GK+ +    R+  
Sbjct: 185 QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS--------QKELAGKIREGKFRRIPY 236

Query: 510 KFNRKEMERMLMVGLSCVHPNHEKRPSVKEA 540
           +++  E+  ++      ++     RPSV+E 
Sbjct: 237 RYS-DELNEIIT---RMLNLKDYHRPSVEEI 263

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 8e-50
 Identities = 64/295 (21%), Positives = 106/295 (35%), Gaps = 49/295 (16%)

Query: 290 RIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQ 349
             +G+G    V++G    G  VAVK F         R     E       LRH+N++   
Sbjct: 9   ESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFRE---AEIYQTVM-LRHENILGFI 63

Query: 350 GWCCEGN----ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
               + N    +L LV +Y  +GSL   L+  +     ++ E  + + L  AS L++LH 
Sbjct: 64  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHM 118

Query: 406 EC-----ERQIIHRDVKACNILLDAEFNAKLGDF---------------EATIPAGTMGY 445
           E      +  I HRD+K+ NIL+       + D                      GT  Y
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 178

Query: 446 LAPEYVYSGV------PSEKTDVYSFGVVALEVAAGKSPVDND--------GCVIVDWVW 491
           +APE +   +        ++ D+Y+ G+V  E+A   S               V  D   
Sbjct: 179 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238

Query: 492 NLRKKGKLLDAADFRLRGKFNRKE-MERMLMVGLSCVHPNHEKRPSVKEAARILK 545
              +K          +  ++   E +  M  +   C + N   R +     + L 
Sbjct: 239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (435), Expect = 2e-49
 Identities = 63/291 (21%), Positives = 112/291 (38%), Gaps = 47/291 (16%)

Query: 290 RIVGEGASATVYKGSL------PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHK 343
           + +G GA   V + +        +   VAVK   KP+     R    +E   ++    H 
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-KPSAHLTEREALMSELKVLSYLGNHM 87

Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSS--------------SIVLSWEKR 389
           N+V L G C  G   +++ EY   G L   L     S               + L  E  
Sbjct: 88  NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147

Query: 390 LNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFE-------------A 436
           L+    VA  +++L     +  IHRD+ A NILL      K+ DF               
Sbjct: 148 LSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204

Query: 437 TIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKK 496
                 + ++APE +++ V + ++DV+S+G+   E+ +  S     G  +    + + K+
Sbjct: 205 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY-PGMPVDSKFYKMIKE 263

Query: 497 GKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE 547
           G          R          M  +  +C   +  KRP+ K+  ++++ +
Sbjct: 264 G---------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (433), Expect = 4e-49
 Identities = 69/315 (21%), Positives = 119/315 (37%), Gaps = 45/315 (14%)

Query: 286 FNKNRIVGEGASATVYKGSLPSGG---AVAVKRFEKPNRVECARNPFTTEFATMAGCLRH 342
                ++GEG    V K  +   G     A+KR ++    +  R+ F  E   +     H
Sbjct: 12  IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD-FAGELEVLCKLGHH 70

Query: 343 KNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNN------------SSSSIVLSWEKRL 390
            N++ L G C     L L  EY P+G+L   L  +            +S++  LS ++ L
Sbjct: 71  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 130

Query: 391 NIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFE----------ATIPA 440
           +    VA  + YL    ++Q IHRD+ A NIL+   + AK+ DF            T+  
Sbjct: 131 HFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR 187

Query: 441 GTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLL 500
             + ++A E +   V +  +DV+S+GV+  E+ +                +      +L 
Sbjct: 188 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-----------PYCGMTCAELY 236

Query: 501 DAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEAPLPLLPVKKPTV 560
           +      R +      + +  +   C      +RPS  +    L       +L  +K  V
Sbjct: 237 EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN-----RMLEERKTYV 291

Query: 561 NIRSVFPEASELIDS 575
           N           ID 
Sbjct: 292 NTTLYEKFTYAGIDC 306

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 5e-49
 Identities = 73/269 (27%), Positives = 108/269 (40%), Gaps = 31/269 (11%)

Query: 286 FNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
               + +G+G    V  G    G  VAVK  +     +     F  E + M   LRH NL
Sbjct: 9   LKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQA----FLAEASVMT-QLRHSNL 62

Query: 346 VQLQGWCCEG-NELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           VQL G   E    L +V EY+  GSL   L +   S  VL  +  L   L V  A+ YL 
Sbjct: 63  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS--VLGGDCLLKFSLDVCEAMEYLE 120

Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGVP 456
                  +HRD+ A N+L+  +  AK+ DF                + + APE +     
Sbjct: 121 G---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKF 177

Query: 457 SEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEM 516
           S K+DV+SFG++  E+ +          + +  V    +KG  +DA D            
Sbjct: 178 STKSDVWSFGILLWEIYSFGRVPYPR--IPLKDVVPRVEKGYKMDAPD---------GCP 226

Query: 517 ERMLMVGLSCVHPNHEKRPSVKEAARILK 545
             +  V  +C H +   RPS  +    L+
Sbjct: 227 PAVYEVMKNCWHLDAAMRPSFLQLREQLE 255

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  169 bits (430), Expect = 7e-49
 Identities = 64/298 (21%), Positives = 116/298 (38%), Gaps = 50/298 (16%)

Query: 278 DIKQATLGFNKN---------RIVGEGASATVYKGSLPSGG----AVAVKRFEKPNRVEC 324
           D  +A   F K          +++G G    V  G L   G     VA+K   K    E 
Sbjct: 11  DPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTL-KSGYTEK 69

Query: 325 ARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVL 384
            R  F +E + M     H N++ L+G   +   ++++ E++ NGSLD  L  N       
Sbjct: 70  QRRDFLSEASIMG-QFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF--- 125

Query: 385 SWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF---------- 434
           +  + + ++ G+A+ + YL +      +HRD+ A NIL+++    K+ DF          
Sbjct: 126 TVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182

Query: 435 ------EATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALE-VAAGKSPVDNDGCVIV 487
                  A      + + APE +     +  +DV+S+G+V  E ++ G+ P         
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP--------- 233

Query: 488 DWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK 545
              +       +++A +   R          +  + L C   +   RP   +    L 
Sbjct: 234 ---YWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLD 288

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (427), Expect = 1e-48
 Identities = 62/285 (21%), Positives = 110/285 (38%), Gaps = 38/285 (13%)

Query: 286 FNKNRIVGEGASATVYKGSLPSGG-----AVAVKRFEKPNRVECARNPFTTEFATMAGCL 340
             + +++G G    VYKG L +        VA+K   K    E  R  F  E   M    
Sbjct: 9   VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVDFLGEAGIMG-QF 66

Query: 341 RHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASAL 400
            H N+++L+G   +   ++++ EY+ NG+LDK L          S  + + ++ G+A+ +
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGM 123

Query: 401 SYLHEECERQIIHRDVKACNILLDAEFNAKLGDFE--------------ATIPAGTMGYL 446
            YL        +HRD+ A NIL+++    K+ DF                +     + + 
Sbjct: 124 KYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180

Query: 447 APEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFR 506
           APE +     +  +DV+SFG+V  EV         +               +++ A +  
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE-----------LSNHEVMKAINDG 229

Query: 507 LRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEAPLP 551
            R          +  + + C      +RP   +   IL      P
Sbjct: 230 FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (423), Expect = 3e-48
 Identities = 60/273 (21%), Positives = 106/273 (38%), Gaps = 35/273 (12%)

Query: 286 FNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
               + +G G    V  G       VA+K  ++ +    + + F  E   M   L H+ L
Sbjct: 6   LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMM-NLSHEKL 61

Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
           VQL G C +   + ++ EY+ NG L   L            ++ L +   V  A+ YL  
Sbjct: 62  VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLE- 117

Query: 406 ECERQIIHRDVKACNILLDAEFNAKLGDF------------EATIPAGTMGYLAPEYVYS 453
              +Q +HRD+ A N L++ +   K+ DF             +      + +  PE +  
Sbjct: 118 --SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 175

Query: 454 GVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFN 512
              S K+D+++FGV+  E+ + GK P            +      +  +     LR    
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMP------------YERFTNSETAEHIAQGLRLYRP 223

Query: 513 RKEMERMLMVGLSCVHPNHEKRPSVKEAARILK 545
               E++  +  SC H   ++RP+ K     + 
Sbjct: 224 HLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  166 bits (422), Expect = 2e-47
 Identities = 68/292 (23%), Positives = 117/292 (40%), Gaps = 34/292 (11%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHK 343
           F+  R +G G+   VY    + +   VA+K+     +           E   +   LRH 
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ-KLRHP 75

Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
           N +Q +G     +   LV EY    + D +  +       L   +   +  G    L+YL
Sbjct: 76  NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAAVTHGALQGLAYL 131

Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF-------EATIPAGTMGYLAPEYVYS--- 453
           H      +IHRDVKA NILL      KLGDF        A    GT  ++APE + +   
Sbjct: 132 H---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDE 188

Query: 454 GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNR 513
           G    K DV+S G+  +E+A  K P+ N     +  ++++ +           L+     
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPPLFNMN--AMSALYHIAQNE------SPALQSGHWS 240

Query: 514 KEMERMLMVGLSCVHPNHEKRPSVKEAAR---ILKGEAPLPLLPVKKPTVNI 562
           +     +    SC+    + RP+ +   +   +L+   P  ++ + + T + 
Sbjct: 241 EYFRNFVD---SCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDA 289

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (422), Expect = 2e-47
 Identities = 63/301 (20%), Positives = 107/301 (35%), Gaps = 54/301 (17%)

Query: 286 FNKNRIVGEGASATVYKGSLPSGG------AVAVKRFEKPNRVECARNPFTTEFATMAGC 339
               +++G GA   V   +            VAVK   K       R    +E   M   
Sbjct: 39  LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML-KEKADSSEREALMSELKMMTQL 97

Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNN-------------------SSS 380
             H+N+V L G C     + L++EY   G L   L +                       
Sbjct: 98  GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157

Query: 381 SIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF------ 434
             VL++E  L     VA  + +L     +  +HRD+ A N+L+      K+ DF      
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDI 214

Query: 435 -------EATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALE-VAAGKSPVDNDGCVI 486
                          + ++APE ++ G+ + K+DV+S+G++  E  + G +P    G  +
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY--PGIPV 272

Query: 487 VDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG 546
               + L + G          +        E + ++  SC   +  KRPS       L  
Sbjct: 273 DANFYKLIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323

Query: 547 E 547
           +
Sbjct: 324 Q 324

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 2e-47
 Identities = 60/289 (20%), Positives = 107/289 (37%), Gaps = 34/289 (11%)

Query: 286 FNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
                 +G+G    V+ G+      VA+K  +       +   F  E   M   LRH+ L
Sbjct: 19  LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMK-KLRHEKL 74

Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
           VQL         + +V EY+  GSL   L   +   +     + +++   +AS ++Y+  
Sbjct: 75  VQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLR--LPQLVDMAAQIASGMAYVER 131

Query: 406 ECERQIIHRDVKACNILLDAEFNAKLGDF------------EATIPAGTMGYLAPEYVYS 453
                 +HRD++A NIL+      K+ DF                    + + APE    
Sbjct: 132 ---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 188

Query: 454 GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNR 513
           G  + K+DV+SFG++  E+                         ++LD  +   R     
Sbjct: 189 GRFTIKSDVWSFGILLTELTTKGRVPYPG-----------MVNREVLDQVERGYRMPCPP 237

Query: 514 KEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEAPLPLLPVKKPTVNI 562
           +  E +  +   C     E+RP+ +     L+ +      P  +P  N+
Sbjct: 238 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLE-DYFTSTEPQYQPGENL 285

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (417), Expect = 3e-47
 Identities = 63/267 (23%), Positives = 104/267 (38%), Gaps = 32/267 (11%)

Query: 289 NRIVGEGASATVYKGSLPSGG-AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQ 347
           +  +G G+  TVYKG        VA    +     +  R  F  E   +   L+H N+V+
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLK-GLQHPNIVR 72

Query: 348 LQGWCCE----GNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
                         +VLV E + +G+L   L        V+  +   +    +   L +L
Sbjct: 73  FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFL 128

Query: 404 HEECERQIIHRDVKACNILLDAE-FNAKLGDF---------EATIPAGTMGYLAPEYVYS 453
           H      IIHRD+K  NI +     + K+GD           A    GT  ++APE +Y 
Sbjct: 129 HTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPE-MYE 186

Query: 454 GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNR 513
               E  DVY+FG+  LE+A  + P     C     ++     G             F++
Sbjct: 187 EKYDESVDVYAFGMCMLEMATSEYPY--SECQNAAQIYRRVTSGV--------KPASFDK 236

Query: 514 KEMERMLMVGLSCVHPNHEKRPSVKEA 540
             +  +  +   C+  N ++R S+K+ 
Sbjct: 237 VAIPEVKEIIEGCIRQNKDERYSIKDL 263

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  164 bits (416), Expect = 8e-47
 Identities = 66/299 (22%), Positives = 110/299 (36%), Gaps = 55/299 (18%)

Query: 286 FNKNRIVGEGASATVYKGSLP------SGGAVAVKRFEKPNRVECARNPFTTEFATMAGC 339
               R +GEGA   V++   P          VAVK   K       +  F  E A MA  
Sbjct: 15  IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASADMQADFQREAALMA-E 72

Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSI----------------- 382
             + N+V+L G C  G  + L++EY+  G L++ L + S  ++                 
Sbjct: 73  FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132

Query: 383 ---VLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF----- 434
               LS  ++L I   VA+ ++YL E      +HRD+   N L+      K+ DF     
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRN 189

Query: 435 --------EATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVI 486
                        A  + ++ PE ++    + ++DV+++GVV  E+ +            
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA-- 247

Query: 487 VDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK 545
            + V    + G +L                  +  +   C       RPS     RIL+
Sbjct: 248 HEEVIYYVRDGNILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 297

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (410), Expect = 2e-46
 Identities = 63/266 (23%), Positives = 110/266 (41%), Gaps = 32/266 (12%)

Query: 286 FNKNRIVGEGASATVYKGSLPSGGA-VAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHK 343
           F   R +G+G    VY          +A+K   K         +    E    +  LRH 
Sbjct: 8   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS-HLRHP 66

Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
           N+++L G+  +   + L+ EY P G++ + L   S        ++    +  +A+ALSY 
Sbjct: 67  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYC 122

Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGTMGYLAPEYVYSG 454
           H    +++IHRD+K  N+LL +    K+ DF           T   GT+ YL PE +   
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGR 179

Query: 455 VPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRK 514
           +  EK D++S GV+  E   GK P + +           ++  K +   +F        +
Sbjct: 180 MHDEKVDLWSLGVLCYEFLVGKPPFEAN---------TYQETYKRISRVEFTFPDFVT-E 229

Query: 515 EMERMLMVGLSCVHPNHEKRPSVKEA 540
               ++      +  N  +RP ++E 
Sbjct: 230 GARDLIS---RLLKHNPSQRPMLREV 252

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  162 bits (411), Expect = 3e-46
 Identities = 61/273 (22%), Positives = 102/273 (37%), Gaps = 33/273 (12%)

Query: 286 FNKNRIVGEGASATVYKGSLPSGG-AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
                 +G G    VY+G        VAVK  ++          F  E A M   ++H N
Sbjct: 19  ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMK-EIKHPN 74

Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           LVQL G C       ++ E++  G+L   L   +     +S    L +   ++SA+ YL 
Sbjct: 75  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAMEYLE 132

Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF------------EATIPAGTMGYLAPEYVY 452
              ++  IHRD+ A N L+      K+ DF                    + + APE + 
Sbjct: 133 ---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 189

Query: 453 SGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFN 512
               S K+DV++FGV+  E+A                        ++ +  +   R +  
Sbjct: 190 YNKFSIKSDVWAFGVLLWEIATYGMSPYPG-----------IDLSQVYELLEKDYRMERP 238

Query: 513 RKEMERMLMVGLSCVHPNHEKRPSVKEAARILK 545
               E++  +  +C   N   RPS  E  +  +
Sbjct: 239 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (412), Expect = 3e-46
 Identities = 67/287 (23%), Positives = 111/287 (38%), Gaps = 39/287 (13%)

Query: 279 IKQATLGFNKNRIVGEGASATVYKGSLPSGG----AVAVKRFEKPNRVECARNPFTTEFA 334
           I  ++L  + N ++G G    VY G+L          AVK   +   +      F TE  
Sbjct: 22  IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-FLTEGI 80

Query: 335 TMAGCLRHKNLVQLQGWCCEG-NELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIV 393
            M     H N++ L G C       ++V  Y+ +G L   + N + +    + +  +   
Sbjct: 81  IMKD-FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN---PTVKDLIGFG 136

Query: 394 LGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF---------------EATI 438
           L VA  +        ++ +HRD+ A N +LD +F  K+ DF                 T 
Sbjct: 137 LQVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTG 193

Query: 439 PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGK 498
               + ++A E + +   + K+DV+SFGV+  E+    +P   D     D    L +  +
Sbjct: 194 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-TFDITVYLLQGRR 252

Query: 499 LLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK 545
           LL                + +  V L C HP  E RPS  E    + 
Sbjct: 253 LLQPEYC----------PDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (404), Expect = 2e-45
 Identities = 70/286 (24%), Positives = 108/286 (37%), Gaps = 42/286 (14%)

Query: 278 DIKQATLGFNKNRIVGEGASATVYKGSLPSGGA---VAVKRFEKPNRVECARNPFTTEFA 334
           D K  TL   +++ +G G   TV KG          VAVK  +        ++    E  
Sbjct: 4   DRKLLTL---EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEAN 60

Query: 335 TMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVL 394
            M   L +  +V++ G  CE    +LV E    G L+K L  N      +  +  + +V 
Sbjct: 61  VMQ-QLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRH----VKDKNIIELVH 114

Query: 395 GVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--------------EATIPA 440
            V+  + YL E      +HRD+ A N+LL  +  AK+ DF                T   
Sbjct: 115 QVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 171

Query: 441 GTMGYLAPEYVYSGVPSEKTDVYSFGVVALE-VAAGKSPVDNDGCVIVDWVWNLRKKGKL 499
             + + APE +     S K+DV+SFGV+  E  + G+ P           V  + +KG+ 
Sbjct: 172 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK---GSEVTAMLEKGE- 227

Query: 500 LDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK 545
                   R          M  +   C   + E RP        L+
Sbjct: 228 --------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (402), Expect = 3e-45
 Identities = 65/270 (24%), Positives = 100/270 (37%), Gaps = 34/270 (12%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           ++  + +GEGA   V    +  +  AVAVK  +    V+C  N    E       L H+N
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN-IKKEICINK-MLNHEN 64

Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           +V+  G   EGN   L  EY   G L   +  +      +           + + + YLH
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQLMAGVVYLH 120

Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF-------------EATIPAGTMGYLAPEYV 451
                 I HRD+K  N+LLD   N K+ DF                   GT+ Y+APE +
Sbjct: 121 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177

Query: 452 YSG-VPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGK 510
                 +E  DV+S G+V   + AG+ P D       ++     KK  L           
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI----- 232

Query: 511 FNRKEMERMLMVGLSCVHPNHEKRPSVKEA 540
                   +L      +  N   R ++ + 
Sbjct: 233 --DSAPLALLH---KILVENPSARITIPDI 257

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (403), Expect = 4e-45
 Identities = 58/276 (21%), Positives = 98/276 (35%), Gaps = 39/276 (14%)

Query: 288 KNRIVGEGASATVYKGSLPSGG---AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
            +  +G G   +V +G          VA+K   K    +        E   M   L +  
Sbjct: 13  ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMH-QLDNPY 70

Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           +V+L G  C+   L+LV E    G L K L         +       ++  V+  + YL 
Sbjct: 71  IVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLE 126

Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF--------------EATIPAGTMGYLAPEY 450
           E   +  +HRD+ A N+LL     AK+ DF                +     + + APE 
Sbjct: 127 E---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 183

Query: 451 VYSGVPSEKTDVYSFGVVALEV-AAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRG 509
           +     S ++DV+S+GV   E  + G+ P           V    ++GK         R 
Sbjct: 184 INFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK---GPEVMAFIEQGK---------RM 231

Query: 510 KFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK 545
           +   +    +  +   C     E RP      + ++
Sbjct: 232 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (402), Expect = 7e-45
 Identities = 72/283 (25%), Positives = 120/283 (42%), Gaps = 35/283 (12%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           + +   +G+GAS TVY    + +G  VA+++     + +        E   M    ++ N
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINEILVMR-ENKNPN 78

Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           +V        G+EL +V EYL  GSL  ++             +   +      AL +LH
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD-----EGQIAAVCRECLQALEFLH 133

Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTMGYLAPEYVYS 453
                Q+IHRD+K+ NILL  + + KL DF           + +   GT  ++APE V  
Sbjct: 134 S---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 190

Query: 454 GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNR 513
                K D++S G++A+E+  G+ P  N+    +  ++ +   G         L+     
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNEN--PLRALYLIATNGT------PELQNPEKL 242

Query: 514 KEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKGEAPLPLLP 554
             + R  +    C+  + EKR S KE  +   LK   PL  L 
Sbjct: 243 SAIFRDFL--NRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLT 283

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 2e-44
 Identities = 61/268 (22%), Positives = 102/268 (38%), Gaps = 36/268 (13%)

Query: 290 RIVGEGASATVYKGSLPSGGA-VAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
             +G+GA   VYK          A K  +  +  E     +  E   +A    H N+V+L
Sbjct: 18  GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELED--YMVEIDILA-SCDHPNIVKL 74

Query: 349 QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE 408
                  N L ++ E+   G++D ++         L+  +   +      AL+YLH+   
Sbjct: 75  LDAFYYENNLWILIEFCAGGAVDAVMLELERP---LTESQIQVVCKQTLDALNYLHD--- 128

Query: 409 RQIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTMGYLAPEYVYSGVP- 456
            +IIHRD+KA NIL   + + KL DF                 GT  ++APE V      
Sbjct: 129 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 188

Query: 457 ----SEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFN 512
                 K DV+S G+  +E+A  + P        +  +  + K      A   R    F 
Sbjct: 189 DRPYDYKADVWSLGITLIEMAEIEPPHHELN--PMRVLLKIAKSEPPTLAQPSRWSSNF- 245

Query: 513 RKEMERMLMVGLSCVHPNHEKRPSVKEA 540
           +  +++ L         N + R +  + 
Sbjct: 246 KDFLKKCL-------EKNVDARWTTSQL 266

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 4e-43
 Identities = 65/289 (22%), Positives = 112/289 (38%), Gaps = 48/289 (16%)

Query: 290 RIVGEGASATVYKGSLPS--------GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLR 341
           + +GEGA   V                  VAVK   K +  E   +   +E   M    +
Sbjct: 19  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLISEMEMMKMIGK 77

Query: 342 HKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSI------------VLSWEKR 389
           HKN++ L G C +   L ++ EY   G+L + L       +             LS +  
Sbjct: 78  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 137

Query: 390 LNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFE-------------A 436
           ++    VA  + YL     ++ IHRD+ A N+L+  +   K+ DF               
Sbjct: 138 VSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 194

Query: 437 TIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKK 496
           T     + ++APE ++  + + ++DV+SFGV+  E+            V V+ ++ L K+
Sbjct: 195 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG--VPVEELFKLLKE 252

Query: 497 GKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK 545
           G  +D                 + M+   C H    +RP+ K+    L 
Sbjct: 253 GHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 3e-42
 Identities = 56/284 (19%), Positives = 112/284 (39%), Gaps = 38/284 (13%)

Query: 286 FNKNRIVGEGASATVYKGSLPSGG-----AVAVKRFEKPNRVECARNPFTTEFATMAGCL 340
           F K +++G GA  TVYKG     G      VA+K   +    +  +     E   MA  +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE-ILDEAYVMA-SV 68

Query: 341 RHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASAL 400
            + ++ +L    C  + + L+ + +P G L   +  +  +      +  LN  + +A  +
Sbjct: 69  DNPHVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNI---GSQYLLNWCVQIAKGM 124

Query: 401 SYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-------------EATIPAGTMGYLA 447
           +YL    +R+++HRD+ A N+L+    + K+ DF              A      + ++A
Sbjct: 125 NYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181

Query: 448 PEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRL 507
            E +   + + ++DV+S+GV   E+    S             ++     ++    +   
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFGSK-----------PYDGIPASEISSILEKGE 230

Query: 508 RGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEAPLP 551
           R          + M+ + C   + + RP  +E        A  P
Sbjct: 231 RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 274

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  152 bits (384), Expect = 8e-42
 Identities = 61/292 (20%), Positives = 116/292 (39%), Gaps = 36/292 (12%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           ++ +  +G GA   V++     +G   A K    P+  +        E  TM+  LRH  
Sbjct: 28  YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKET--VRKEIQTMS-VLRHPT 84

Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           LV L     + NE+V++YE++  G L + + +  +    +S ++ +  +  V   L ++H
Sbjct: 85  LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK---MSEDEAVEYMRQVCKGLCHMH 141

Query: 405 EECERQIIHRDVKACNILLDAEFN--AKLGDF----------EATIPAGTMGYLAPEYVY 452
              E   +H D+K  NI+   + +   KL DF             +  GT  + APE   
Sbjct: 142 ---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAE 198

Query: 453 SGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFN 512
                  TD++S GV++  + +G SP   +         N  +  + + + D+ +     
Sbjct: 199 GKPVGYYTDMWSVGVLSYILLSGLSPFGGE---------NDDETLRNVKSCDWNMDDSAF 249

Query: 513 RKEMERMLMVGLSCVHPNHEKRPSVKEAAR---ILKGEAPL--PLLPVKKPT 559
               E         +  +   R ++ +A     +  G AP     +P  + T
Sbjct: 250 SGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYT 301

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 1e-41
 Identities = 65/292 (22%), Positives = 108/292 (36%), Gaps = 46/292 (15%)

Query: 286 FNKNRIVGEGASATVYKG------SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGC 339
               + +G GA   V +          +   VAVK   K            +E   +   
Sbjct: 15  LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRALMSELKILIHI 73

Query: 340 LRHKNLVQLQGWCCE-GNELVLVYEYLPNGSLDKILHNNSSSSI------------VLSW 386
             H N+V L G C + G  L+++ E+   G+L   L +  +  +             L+ 
Sbjct: 74  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133

Query: 387 EKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF------------ 434
           E  +     VA  + +L     R+ IHRD+ A NILL  +   K+ DF            
Sbjct: 134 EHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 190

Query: 435 -EATIPAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNL 493
                    + ++APE ++  V + ++DV+SFGV+  E+ +  +     G  I +     
Sbjct: 191 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-PGVKIDEEFCRR 249

Query: 494 RKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK 545
            K+G  + A D+             M    L C H    +RP+  E    L 
Sbjct: 250 LKEGTRMRAPDY---------TTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 292

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 4e-41
 Identities = 64/287 (22%), Positives = 113/287 (39%), Gaps = 41/287 (14%)

Query: 286 FNKNRIVGEGASATVYKGSL------PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGC 339
              +R +G+G+   VY+G             VA+K   +   +   R  F  E + M   
Sbjct: 22  ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR-ERIEFLNEASVMK-E 79

Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHN------NSSSSIVLSWEKRLNIV 393
               ++V+L G   +G   +++ E +  G L   L +      N+      S  K + + 
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 394 LGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF-------------EATIPA 440
             +A  ++YL      + +HRD+ A N ++  +F  K+GDF             +     
Sbjct: 140 GEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 441 GTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLL 500
             + +++PE +  GV +  +DV+SFGVV  E+A           +  + V     +G LL
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG--LSNEQVLRFVMEGGLL 254

Query: 501 DAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE 547
           D  D            + +  +   C   N + RPS  E    +K E
Sbjct: 255 DKPD---------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (373), Expect = 6e-41
 Identities = 60/269 (22%), Positives = 104/269 (38%), Gaps = 34/269 (12%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F   +I+GEG+ +TV     L +    A+K  EK + ++  + P+ T    +   L H  
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69

Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
            V+L     +  +L     Y  NG L K +    S                + SAL YLH
Sbjct: 70  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEYLH 125

Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDFE-------------ATIPAGTMGYLAPEYV 451
               + IIHRD+K  NILL+ + + ++ DF              A    GT  Y++PE +
Sbjct: 126 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182

Query: 452 YSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKF 511
                 + +D+++ G +  ++ AG  P            +    +  +      +L   F
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVAGLPP------------FRAGNEYLIFQKI-IKLEYDF 229

Query: 512 NRKEMERMLMVGLSCVHPNHEKRPSVKEA 540
             K   +   +    +  +  KR   +E 
Sbjct: 230 PEKFFPKARDLVEKLLVLDATKRLGCEEM 258

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  147 bits (372), Expect = 7e-41
 Identities = 61/279 (21%), Positives = 106/279 (37%), Gaps = 40/279 (14%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPN-------RVECARNPFTTEFATMA 337
           +    I+G G S+ V +    P+    AVK  +           V+  R     E   + 
Sbjct: 5   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64

Query: 338 GCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVA 397
               H N++QL+          LV++ +  G L   L    +    LS ++   I+  + 
Sbjct: 65  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT----LSEKETRKIMRALL 120

Query: 398 SALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF----------EATIPAGTMGYLA 447
             +  LH   +  I+HRD+K  NILLD + N KL DF          +     GT  YLA
Sbjct: 121 EVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLA 177

Query: 448 PEYVYSGVP------SEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLD 501
           PE +   +        ++ D++S GV+   + AG  P  +     +  +  +        
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK--QMLMLRMIMSGNYQFG 235

Query: 502 AADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEA 540
           + ++       +  + R L           +KR + +EA
Sbjct: 236 SPEWDDYSDTVKDLVSRFL-------VVQPQKRYTAEEA 267

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  148 bits (375), Expect = 2e-40
 Identities = 56/279 (20%), Positives = 108/279 (38%), Gaps = 33/279 (11%)

Query: 277 TDIKQATL--GFNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEF 333
            ++KQ ++   ++    +G GA   V++     +G     K    P  ++  +     E 
Sbjct: 20  VEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD--KYTVKNEI 77

Query: 334 ATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIV 393
           + M   L H  L+ L     +  E+VL+ E+L  G L   +         +S  + +N +
Sbjct: 78  SIMNQ-LHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK---MSEAEVINYM 133

Query: 394 LGVASALSYLHEECERQIIHRDVKACNILLDAEFNA--KLGDF----------EATIPAG 441
                 L ++H   E  I+H D+K  NI+ + +  +  K+ DF             +   
Sbjct: 134 RQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTA 190

Query: 442 TMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLD 501
           T  + APE V        TD+++ GV+   + +G SP   +     D +  L+   +   
Sbjct: 191 TAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE-----DDLETLQNVKRCDW 245

Query: 502 AADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEA 540
             D       +  E +  +    + +     KR +V +A
Sbjct: 246 EFDEDAFSSVS-PEAKDFIK---NLLQKEPRKRLTVHDA 280

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 2e-40
 Identities = 61/280 (21%), Positives = 95/280 (33%), Gaps = 39/280 (13%)

Query: 286 FNKNRIVGEGASATVYKGSLPS----GGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCL 340
                 +G+G+   V +G   +      +VAVK  +        A + F  E   M   L
Sbjct: 10  LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH-SL 68

Query: 341 RHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASAL 400
            H+NL++L G       + +V E  P GSL   L  +                + VA  +
Sbjct: 69  DHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGH---FLLGTLSRYAVQVAEGM 124

Query: 401 SYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--------------EATIPAGTMGYL 446
            YL  +     IHRD+ A N+LL      K+GDF                        + 
Sbjct: 125 GYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181

Query: 447 APEYVYSGVPSEKTDVYSFGVVALE-VAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADF 505
           APE + +   S  +D + FGV   E    G+ P           +  + K+G+ L     
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN--GSQILHKIDKEGERLP---- 235

Query: 506 RLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK 545
                      + +  V + C     E RP+       L 
Sbjct: 236 -----RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 7e-40
 Identities = 62/273 (22%), Positives = 103/273 (37%), Gaps = 38/273 (13%)

Query: 290 RIVGEGASATVYKGSLPSGG----AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL 345
           R +GEG    V++G   S      AVA+K  +     +  R  F  E  TM     H ++
Sbjct: 13  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS-DSVREKFLQEALTMR-QFDHPHI 70

Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
           V+L G   E   + ++ E    G L   L     S   L     +     +++AL+YL  
Sbjct: 71  VKLIGVITENP-VWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYLES 126

Query: 406 ECERQIIHRDVKACNILLDAEFNAKLGDF------------EATIPAGTMGYLAPEYVYS 453
              ++ +HRD+ A N+L+ +    KLGDF            +A+     + ++APE +  
Sbjct: 127 ---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 183

Query: 454 GVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFN 512
              +  +DV+ FGV   E+   G  P    G    D +  +    +L             
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHGVKP--FQGVKNNDVIGRIENGERL----------PMP 231

Query: 513 RKEMERMLMVGLSCVHPNHEKRPSVKEAARILK 545
                 +  +   C   +  +RP   E    L 
Sbjct: 232 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS 264

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 1e-38
 Identities = 54/293 (18%), Positives = 105/293 (35%), Gaps = 39/293 (13%)

Query: 289 NRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQ 347
           ++++G G +  V +  +  +    A+K  +   +          E        +  ++V+
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR-------REVELHWRASQCPHIVR 69

Query: 348 LQGWC----CEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
           +             L++V E L  G L   + +    +   +  +   I+  +  A+ YL
Sbjct: 70  IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA--FTEREASEIMKSIGEAIQYL 127

Query: 404 HEECERQIIHRDVKACNILLDAEFN---AKLGDF----------EATIPAGTMGYLAPEY 450
           H      I HRDVK  N+L  ++      KL DF            T P  T  Y+APE 
Sbjct: 128 HS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 184

Query: 451 VYSGVPSEKTDVYSFGVVALEVAAGKSP-VDNDGCVIVDWVWNLRKKGKLLDAADFRLRG 509
           +      +  D++S GV+   +  G  P   N G  I   +    + G+      +    
Sbjct: 185 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ------YEFPN 238

Query: 510 KFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKGEAPLPLLPVKKPTV 560
               +  E + M+  + +     +R ++ E      +     +P  P+    V
Sbjct: 239 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRV 291

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  141 bits (356), Expect = 2e-38
 Identities = 60/297 (20%), Positives = 111/297 (37%), Gaps = 34/297 (11%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           ++   ++G GA + V       +   VA+K   K   +E        E A +   ++H N
Sbjct: 11  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAK-KALEGKEGSMENEIAVLH-KIKHPN 68

Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           +V L      G  L L+ + +  G L   +          +      ++  V  A+ YLH
Sbjct: 69  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF----YTERDASRLIFQVLDAVKYLH 124

Query: 405 EECERQIIHRDVKACNILL---DAEFNAKLGDF----------EATIPAGTMGYLAPEYV 451
           +     I+HRD+K  N+L    D +    + DF            +   GT GY+APE +
Sbjct: 125 DLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVL 181

Query: 452 YSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKF 511
                S+  D +S GV+A  +  G  P  ++          + K       A++     +
Sbjct: 182 AQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN--DAKLFEQILK-------AEYEFDSPY 232

Query: 512 NRKEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKGEAPLPLLPVKKPTVNIRSVF 566
                +         +  + EKR + ++A +   + G+  L     +  +  I+  F
Sbjct: 233 WDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKKNF 289

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 3e-37
 Identities = 48/264 (18%), Positives = 97/264 (36%), Gaps = 32/264 (12%)

Query: 290 RIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
             +G G    V++     S      K  +     +        E + +    RH+N++ L
Sbjct: 11  EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL---VKKEISILN-IARHRNILHL 66

Query: 349 QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE 408
                   ELV+++E++    + + ++ ++     L+  + ++ V  V  AL +LH    
Sbjct: 67  HESFESMEELVMIFEFISGLDIFERINTSAFE---LNEREIVSYVHQVCEALQFLH---S 120

Query: 409 RQIIHRDVKACNILLDAEFNA--KLGDF----------EATIPAGTMGYLAPEYVYSGVP 456
             I H D++  NI+     ++  K+ +F             +      Y APE     V 
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV 180

Query: 457 SEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEM 516
           S  TD++S G +   + +G +P   +       + N+       D   F+         +
Sbjct: 181 STATDMWSLGTLVYVLLSGINPFLAET--NQQIIENIMNAEYTFDEEAFKEISIEAMDFV 238

Query: 517 ERMLMVGLSCVHPNHEKRPSVKEA 540
           +R+L           + R +  EA
Sbjct: 239 DRLL-------VKERKSRMTASEA 255

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (347), Expect = 6e-37
 Identities = 60/300 (20%), Positives = 106/300 (35%), Gaps = 46/300 (15%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHK 343
           F  ++++G+G+   V+      +    A+K  +K   + +        E   ++    H 
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63

Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
            L  +         L  V EYL  G L   + +           +       +   L +L
Sbjct: 64  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK----FDLSRATFYAAEIILGLQFL 119

Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTMGYLAPEYVY 452
                + I++RD+K  NILLD + + K+ DF           +     GT  Y+APE + 
Sbjct: 120 ---HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILL 176

Query: 453 SGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFN 512
               +   D +SFGV+  E+  G+SP         + +++  +                 
Sbjct: 177 GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD---EEELFHSIRMDNPFYPRWL------- 226

Query: 513 RKEMERMLMVGLSCVHPNHEKRPSVKEAAR------------ILKGEAPLPLLP-VKKPT 559
            KE + +L+          EKR  V+   R            + + E   P  P VK P 
Sbjct: 227 EKEAKDLLV---KLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPKVKSPF 283

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  137 bits (347), Expect = 1e-36
 Identities = 57/337 (16%), Positives = 105/337 (31%), Gaps = 55/337 (16%)

Query: 286 FNKNRIVGEGASATVYKGSLPSGGA-VAVKRFEKPNRVECARNPFTTEFATMAGCLR--- 341
           F+ +RI+G G    VY       G   A+K  +K                 M   +    
Sbjct: 6   FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65

Query: 342 HKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALS 401
              +V +       ++L  + + +  G L   L  +       S          +   L 
Sbjct: 66  CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF----SEADMRFYAAEIILGLE 121

Query: 402 YLHEECERQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGTMGYLAPEYVY 452
           ++H    R +++RD+K  NILLD   + ++ D          +     GT GY+APE + 
Sbjct: 122 HMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQ 178

Query: 453 SGVP-SEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKF 511
            GV      D +S G +  ++  G SP           +  +     +     F      
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF------ 232

Query: 512 NRKEMERMLMVGLSCVHPNHEKRPSVKEA----------------ARILKGEAPLPLLPV 555
              E+  +L      +  +  +R                        +   + P PL+P 
Sbjct: 233 -SPELRSLLE---GLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPP 288

Query: 556 KKP--------TVNIRSVFPEASELIDSGGDHSPGFD 584
           +            +      +  +L+DS  +    F 
Sbjct: 289 RGEVNAADAFDIGSFDEEDTKGIKLLDSDQELYRNFP 325

>d1hqla_ b.29.1.1 (A:) Legume lectin {Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]} Length = 236

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]

 Score =  132 bits (333), Expect = 6e-36
 Identities = 46/183 (25%), Positives = 80/183 (43%), Gaps = 9/183 (4%)

Query: 1   FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGP---VL 57
             D KT + ASF   F+F  +        DG AF +        +   Y+GL        
Sbjct: 57  LWDNKTESVASFYTEFTF-FLKITGNGPADGLAFFLAPPDSDVKDAGEYLGLFNKSTATQ 115

Query: 58  SPQDSFFAVEFDTSFDPSLGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIE 117
             ++   AVEFDT  +P+  + +  HIGI+++S++S  +        D+ SG+  T  I 
Sbjct: 116 PSKNQVVAVEFDTWTNPNFPEPSYRHIGINVNSIVSVATKRWEDS--DIFSGKIATARIS 173

Query: 118 YRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGSAI-YTVDRWR 176
           Y  S +++ V   Y        ++   +D+ +   + + VG SA+ G    +   +  WR
Sbjct: 174 YDGSAEILTVVLSYP--DGSDYILSHSVDMRQNLPESVRVGISASTGNNQFLTVYILSWR 231

Query: 177 FKT 179
           F +
Sbjct: 232 FSS 234

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  131 bits (331), Expect = 4e-35
 Identities = 60/271 (22%), Positives = 100/271 (36%), Gaps = 37/271 (13%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPN-RVECARNPFTTEFATMAGCLRHK 343
           +    I+G G  + V+    L     VAVK       R       F  E    A  L H 
Sbjct: 9   YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA-ALNHP 67

Query: 344 NLVQLQGWCCE----GNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASA 399
            +V +          G    +V EY+   +L  I+H        ++ ++ + ++     A
Sbjct: 68  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADACQA 123

Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--------------EATIPAGTMGY 445
           L++     +  IIHRDVK  NI++ A    K+ DF              +     GT  Y
Sbjct: 124 LNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 180

Query: 446 LAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADF 505
           L+PE         ++DVYS G V  EV  G+ P   D    V   +   ++  +      
Sbjct: 181 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS--PVSVAYQHVREDPIPP---- 234

Query: 506 RLRGKFNRKEMERMLMVGLSCVHPNHEKRPS 536
             R +    +++ +++     +  N E R  
Sbjct: 235 SARHEGLSADLDAVVL---KALAKNPENRYQ 262

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 3e-34
 Identities = 61/284 (21%), Positives = 98/284 (34%), Gaps = 39/284 (13%)

Query: 290 RIVGEGASATVYKG--SLPSGGAVAVKRFEKPNRVECARNPFTTEFATM--AGCLRHKNL 345
             +GEGA   V+K       G  VA+KR       E        E A +       H N+
Sbjct: 13  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72

Query: 346 VQLQGWCCEG-----NELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASAL 400
           V+L   C         +L LV+E++       +          +  E   +++  +   L
Sbjct: 73  VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG---VPTETIKDMMFQLLRGL 129

Query: 401 SYLHEECERQIIHRDVKACNILLDAEFNAKLGDF----------EATIPAGTMGYLAPEY 450
            +LH      ++HRD+K  NIL+ +    KL DF            T    T+ Y APE 
Sbjct: 130 DFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV 186

Query: 451 VYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV-----IVDWVWNLRKKGKLLDAADF 505
           +     +   D++S G +  E+   K        V     I+D +    ++    D A  
Sbjct: 187 LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 246

Query: 506 RLRGKFNRKEMERMLMVGLS---------CVHPNHEKRPSVKEA 540
           R        +     +  +          C+  N  KR S   A
Sbjct: 247 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1qnwa_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-II [TaxId: 3902]} Length = 237

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Furze (Ulex europaeus), UEA-II [TaxId: 3902]

 Score =  127 bits (321), Expect = 3e-34
 Identities = 51/185 (27%), Positives = 73/185 (39%), Gaps = 12/185 (6%)

Query: 1   FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQ 60
             D  T   ASF+  FSF +             FL  +N+      +  M         +
Sbjct: 56  IWDSITGKVASFATSFSFVVKADKSDGVDGLAFFLAPANSQIPSGSSAGMFGLFSSSDSK 115

Query: 61  DS--FFAVEFDTSFDPSLG--DINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWI 116
            S    AVEFDT F  +    D +  HIGID++S+ S  +V       D ++G      I
Sbjct: 116 SSNQIIAVEFDTYFGKAYNPWDPDFKHIGIDVNSIKSIKTVKW-----DWRNGEVADVVI 170

Query: 117 EYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGSAIYT--VDR 174
            YR   K + V   Y      S +I A +DL     +++ VGFS   G  +   T  V  
Sbjct: 171 TYRAPTKSLTVCLSYPS-DGTSNIITASVDLKAILPEWVSVGFSGGVGNAAEFETHDVLS 229

Query: 175 WRFKT 179
           W F +
Sbjct: 230 WYFTS 234

>d1gzca_ b.29.1.1 (A:) Legume lectin {Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]} Length = 239

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]

 Score =  127 bits (320), Expect = 4e-34
 Identities = 51/184 (27%), Positives = 71/184 (38%), Gaps = 12/184 (6%)

Query: 1   FLDPKTNTTASFSCRFSFSII-PSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVL-S 58
             D  T T ASF  RFSFSI  P       DG  F +           GY+G+       
Sbjct: 59  MWDSTTGTVASFETRFSFSIEQPYTRPLPADGLVFFMGPTKSKPAQGYGYLGVFNNSKQD 118

Query: 59  PQDSFFAVEFDTSFDPSLGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEY 118
                 AVEFDT F          HIGID++S+ S  +         L +G+     I+Y
Sbjct: 119 NSYQTLAVEFDT-FSNPWDPPQVPHIGIDVNSIRSIKTQP-----FQLDNGQVANVVIKY 172

Query: 119 RDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANG---QGSAIYTVDRW 175
               K++ V   Y         I   +D+ +   D++ VG S A G     +  + V  W
Sbjct: 173 DAPSKILHVVLVYPS-SGAIYTIAEIVDVKQVLPDWVDVGLSGATGAQRDAAETHDVYSW 231

Query: 176 RFKT 179
            F+ 
Sbjct: 232 SFQA 235

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 5e-34
 Identities = 53/268 (19%), Positives = 90/268 (33%), Gaps = 42/268 (15%)

Query: 290 RIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLR-----HK 343
            ++G G   +VY G  +     VA+K  EK    +    P  T        L+       
Sbjct: 10  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69

Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
            +++L  W    +  VL+ E                +   L  E   +    V  A+ + 
Sbjct: 70  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHC 126

Query: 404 HEECERQIIHRDVKACNILLDAE-FNAKLGDF---------EATIPAGTMGYLAPEYV-Y 452
                  ++HRD+K  NIL+D      KL DF           T   GT  Y  PE++ Y
Sbjct: 127 ---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRY 183

Query: 453 SGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFN 512
                    V+S G++  ++  G  P ++D  +I   V+  ++     +           
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSS--ECQHL------- 234

Query: 513 RKEMERMLMVGLSCVHPNHEKRPSVKEA 540
              +   L             RP+ +E 
Sbjct: 235 ---IRWCL-------ALRPSDRPTFEEI 252

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (318), Expect = 3e-33
 Identities = 57/284 (20%), Positives = 104/284 (36%), Gaps = 36/284 (12%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           F K   +GEG    VYK  +  +G  VA+K+       E   +    E + +   L H N
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK-ELNHPN 62

Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           +V+L       N+L LV+E+L       +  +  +    +      + +  +   L++  
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG---IPLPLIKSYLFQLLQGLAFC- 118

Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTMGYLAPE-YVY 452
                +++HRD+K  N+L++ E   KL DF             T    T+ Y APE  + 
Sbjct: 119 --HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176

Query: 453 SGVPSEKTDVYSFGVVALEVAAGKSPVDNDGC-------VIVDWVWNLRKKGKLLDAADF 505
               S   D++S G +  E+   ++    D                +      +    D+
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236

Query: 506 RLRGKFNRKEMERMLMVGLS---------CVHPNHEKRPSVKEA 540
           +       ++    ++  L           +H +  KR S K A
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  127 bits (319), Expect = 4e-33
 Identities = 47/202 (23%), Positives = 87/202 (43%), Gaps = 16/202 (7%)

Query: 290 RIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           R +G G+   V+   S  +G   A+K  +K   V   +   T +   M   + H  ++++
Sbjct: 10  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69

Query: 349 QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE 408
            G   +  ++ ++ +Y+  G L  +L  +      ++      +          L     
Sbjct: 70  WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV-------CLALEYLHS 122

Query: 409 RQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGVPSEKT 460
           + II+RD+K  NILLD   + K+ DF              GT  Y+APE V +   ++  
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSI 182

Query: 461 DVYSFGVVALEVAAGKSPVDND 482
           D +SFG++  E+ AG +P  + 
Sbjct: 183 DWWSFGILIYEMLAGYTPFYDS 204

>d1g7ya_ b.29.1.1 (A:) Legume lectin {Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]} Length = 253

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]

 Score =  124 bits (312), Expect = 7e-33
 Identities = 46/196 (23%), Positives = 84/196 (42%), Gaps = 12/196 (6%)

Query: 1   FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGL-PGPVLSP 59
             D  T   AS++  F+ +I      +  DG AF +        +++G++G+    V   
Sbjct: 56  IYDKSTGAVASWATSFTANIFAPNKSSSADGIAFALVPVGSEPKSNSGFLGVFDSDVYDN 115

Query: 60  QDSFFAVEFDTSFDPSLGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYR 119
                AVEFDT  +    D    HIGID++S+ S  +         L +G++    I Y 
Sbjct: 116 SAQTVAVEFDTFSNTD-WDPTSRHIGIDVNSIKSIRTAS-----WGLANGQNAEILITYN 169

Query: 120 DSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQG---SAIYTVDRWR 176
            +  L+     +   R  S ++  ++D++ +  +Y+ +GFSA  G     +  + V  W 
Sbjct: 170 AATSLLVASLVHPS-RRTSYIVSERVDITNELPEYVSIGFSATTGLSEGYTETHDVLSWS 228

Query: 177 FK-TFESYPSGNPIDV 191
           F        +  P+D+
Sbjct: 229 FASKLPDDSTTEPLDI 244

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 8e-33
 Identities = 52/274 (18%), Positives = 103/274 (37%), Gaps = 36/274 (13%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEK----PNRVECARNPFTTEFATMAGCL 340
           ++    +G G  A V K     +G   A K  +K     +R   +R     E + +   +
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK-EI 70

Query: 341 RHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASAL 400
           +H N++ L        +++L+ E +  G L   L    S    L+ E+    +  + + +
Sbjct: 71  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES----LTEEEATEFLKQILNGV 126

Query: 401 SYLHEECERQIIHRDVKACNILLDAE----FNAKLGDF----------EATIPAGTMGYL 446
              +     QI H D+K  NI+L          K+ DF          E     GT  ++
Sbjct: 127 ---YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 183

Query: 447 APEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFR 506
           APE V       + D++S GV+   + +G SP   D           ++    + A ++ 
Sbjct: 184 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD---------TKQETLANVSAVNYE 234

Query: 507 LRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEA 540
              ++               +  + +KR +++++
Sbjct: 235 FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 268

>d1leda_ b.29.1.1 (A:) Legume lectin {West-central african legume (Griffonia simplicifolia) [TaxId: 3850]} Length = 243

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: West-central african legume (Griffonia simplicifolia) [TaxId: 3850]

 Score =  124 bits (311), Expect = 8e-33
 Identities = 48/180 (26%), Positives = 74/180 (41%), Gaps = 9/180 (5%)

Query: 1   FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQ 60
           FL   T   ASF   F+F ++ +      DG AF +     S  +  G++GL     +  
Sbjct: 61  FLWDSTGKAASFYTSFTF-LLKNYGAPTADGLAFFLAPVDSSVKDYGGFLGLFRHETAAD 119

Query: 61  DS---FFAVEFDTSFDPSLGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIE 117
            S     AVEFDT  +    D    HIGID++S++S  +    +   D       T  I 
Sbjct: 120 PSKNQVVAVEFDTWINKDWNDPPYPHIGIDVNSIVSVATTRWEND--DAYGSSIATAHIT 177

Query: 118 YRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGSAIYTVDRWRF 177
           Y    K++ V   Y        ++   +DL+K     + +GFSA  G    +  +  W F
Sbjct: 178 YDARSKILTVLLSYE--HGRDYILSHVVDLAKVLPQKVRIGFSAGVG-YDEVTYILSWHF 234

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  124 bits (313), Expect = 1e-32
 Identities = 55/279 (19%), Positives = 101/279 (36%), Gaps = 36/279 (12%)

Query: 290 RIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQ 349
             +GEG    VYK     G   A+K+       E   +    E + +   L+H N+V+L 
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILK-ELKHSNIVKLY 66

Query: 350 GWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECER 409
                   LVLV+E+L       +          L      + +L + + ++Y H+   R
Sbjct: 67  DVIHTKKRLVLVFEHLDQDLKKLLDVCEGG----LESVTAKSFLLQLLNGIAYCHD---R 119

Query: 410 QIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTMGYLAPEYVY-SGVPS 457
           +++HRD+K  N+L++ E   K+ DF           + T    T+ Y AP+ +  S   S
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYS 179

Query: 458 EKTDVYSFGVVALEVAAGKSPVDNDGC-------VIVDWVWNLRKKGKLLDAADFRLRGK 510
              D++S G +  E+  G                  +    N +    + +   +     
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239

Query: 511 FNRKEMERMLMVGLS---------CVHPNHEKRPSVKEA 540
                     + GL           +  +  +R + K+A
Sbjct: 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 1e-32
 Identities = 63/305 (20%), Positives = 103/305 (33%), Gaps = 42/305 (13%)

Query: 290 RIVGEGASATVYKGSLPSGGA-VAVKRFEKPNRVE---CARNPFTTEFATMAGCLRHKNL 345
             +GEG  ATVYK    +    VA+K+ +  +R E           E   +   L H N+
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQ-ELSHPNI 62

Query: 346 VQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHE 405
           + L       + + LV++++       I  N+     VL+       +L     L YLH+
Sbjct: 63  IGLLDAFGHKSNISLVFDFMETDLEVIIKDNSL----VLTPSHIKAYMLMTLQGLEYLHQ 118

Query: 406 ECERQIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTMGYLAPEYVYSG 454
                I+HRD+K  N+LLD     KL DF             T    T  Y APE ++  
Sbjct: 119 HW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGA 175

Query: 455 VP-SEKTDVYSFGVVALEVAAGKSPV--DNDGCVIVDWVWNLRKKGKLLDAADFRLRGKF 511
                  D+++ G +  E+      +  D+D   +      L    +        L    
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235

Query: 512 NRKEMERMLMVGL-------------SCVHPNHEKRPSVKEAAR--ILKGEAPLPLLPVK 556
             K    + +  +                  N   R +  +A +        P P    +
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS-NRPGPTPGCQ 294

Query: 557 KPTVN 561
            P  N
Sbjct: 295 LPRPN 299

>d1v6ia_ b.29.1.1 (A:) Legume lectin {Peanut (Arachis hypogaea) [TaxId: 3818]} Length = 232

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Peanut (Arachis hypogaea) [TaxId: 3818]

 Score =  122 bits (308), Expect = 2e-32
 Identities = 46/182 (25%), Positives = 66/182 (36%), Gaps = 11/182 (6%)

Query: 1   FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVL--S 58
                T   ASF   FSF +         DG  F I    D+        G    V    
Sbjct: 54  IWSSATGNVASFLTSFSFEMKDIKDYDPADGIIFFIAPE-DTQIPAGSIGGGTLGVSDTK 112

Query: 59  PQDSFFAVEFDTSFDPSLGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEY 118
               F  VEFDT  +    D   +H+GID++SV S  +V       +  SG  +   + Y
Sbjct: 113 GAGHFVGVEFDTYSNSEYNDPPTDHVGIDVNSVDSVKTVPW-----NSVSGAVVKVTVIY 167

Query: 119 RDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGS-AIYTVDRWRF 177
             S K + V             I   +DL  +  + +  GFSA+   G   I+ +  W F
Sbjct: 168 DSSTKTLSVAVTN--DNGDITTIAQVVDLKAKLPERVKFGFSASGSLGGRQIHLIRSWSF 225

Query: 178 KT 179
            +
Sbjct: 226 TS 227

>d1fx5a_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-I [TaxId: 3902]} Length = 240

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Furze (Ulex europaeus), UEA-I [TaxId: 3902]

 Score =  122 bits (307), Expect = 3e-32
 Identities = 47/183 (25%), Positives = 64/183 (34%), Gaps = 8/183 (4%)

Query: 1   FLDPKTNTTASFSCRFSFSIIPSPLCAF-GDGFAFLITSNADSFGNDNGYMGLPGPV-LS 58
             +  T   ASF   FSF +  S       DG  F +           GY GL       
Sbjct: 57  IWNCNTGELASFITSFSFFMETSANPKAATDGLTFFLAPPDSPLRRAGGYFGLFNDTKCD 116

Query: 59  PQDSFFAVEFDTSFDPS-LGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIE 117
                 AVEFDT   P    D    HIGID++ V S  +                   I 
Sbjct: 117 SSYQTVAVEFDTIGSPVNFWDPGFPHIGIDVNCVKSINAERW---NKRYGLNNVANVEII 173

Query: 118 YRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQG-SAIYTVDRWR 176
           Y  S K +     Y      S  + + +DL +   +++ VGFS +   G  A + V  W 
Sbjct: 174 YEASSKTLTASLTYPS-DQTSISVTSIVDLKEILPEWVSVGFSGSTYIGRQATHEVLNWY 232

Query: 177 FKT 179
           F +
Sbjct: 233 FTS 235

>d1g9fa_ b.29.1.1 (A:) Legume lectin {Soybean (Glycine max) [TaxId: 3847]} Length = 251

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Soybean (Glycine max) [TaxId: 3847]

 Score =  122 bits (307), Expect = 4e-32
 Identities = 50/189 (26%), Positives = 77/189 (40%), Gaps = 11/189 (5%)

Query: 1   FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQ 60
             D +T + ASF+  F+F+          DG AF +           GY+GL        
Sbjct: 59  IWDKETGSVASFAASFNFTFYAPDTKRLADGLAFFLAPIDTKPQTHAGYLGLFNEN-ESG 117

Query: 61  DSFFAVEFDTSFDPSLGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRD 120
           D   AVEFDT  +    D    HIGI+++S+ S       +   DL + +     I Y  
Sbjct: 118 DQVVAVEFDTFRNS--WDPPNPHIGINVNSIRS-----IKTTSWDLANNKVAKVLITYDA 170

Query: 121 SLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGSA--IYTVDRWRFK 178
           S  L+     Y   +  S ++   +DL     +++ +GFSAA G       + V  W F 
Sbjct: 171 STSLLVASLVYPS-QRTSNILSDVVDLKTSLPEWVRIGFSAATGLDIPGESHDVLSWSFA 229

Query: 179 TFESYPSGN 187
           +   + S N
Sbjct: 230 SNLPHASSN 238

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 4e-32
 Identities = 54/293 (18%), Positives = 97/293 (33%), Gaps = 48/293 (16%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           +     +GEGA   V       +   VA+K+   P   +        E   +    RH+N
Sbjct: 10  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILL-RFRHEN 67

Query: 345 LVQLQGWC----CEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASAL 400
           ++ +         E  + V +  +L    L K+L         LS +     +  +   L
Sbjct: 68  IIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-----LSNDHICYFLYQILRGL 122

Query: 401 SYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--------------EATIPAGTMGYL 446
            Y+H      ++HRD+K  N+LL+   + K+ DF                T    T  Y 
Sbjct: 123 KYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 179

Query: 447 APEYVYSGVP-SEKTDVYSFGVVALEVAAGKSPVDNDGC---------VIVDWVWNLRKK 496
           APE + +    ++  D++S G +  E+ + +                 ++          
Sbjct: 180 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239

Query: 497 GKLLDAADFRLRGKFNRKEMERMLMVGLS---------CVHPNHEKRPSVKEA 540
              L A ++ L      K     L               +  N  KR  V++A
Sbjct: 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292

>d1g8wa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 233

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score =  121 bits (304), Expect = 5e-32
 Identities = 49/182 (26%), Positives = 74/182 (40%), Gaps = 11/182 (6%)

Query: 1   FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQ 60
             D  T T ASF+  F+F+I         DG AF +        +  G++GL     +  
Sbjct: 57  IWDNTTGTVASFATSFTFNIQVPNNAGPADGLAFALVPVGSQPKDKGGFLGLFDGS-NSN 115

Query: 61  DSFFAVEFDTSFDPSLGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRD 120
               AVEFDT ++    D    HIGID++S+ S  +        D  +G +    I Y  
Sbjct: 116 FHTVAVEFDTLYNKD-WDPTERHIGIDVNSIRSIKTTRW-----DFVNGENAEVLITYDS 169

Query: 121 SLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGSA---IYTVDRWRF 177
           S  L+     Y   +  S ++   +DL     +++ VGFSA  G          V  W F
Sbjct: 170 STNLLVASLVYPS-QKTSFIVSDTVDLKSVLPEWVSVGFSATTGINKGNVETNDVLSWSF 228

Query: 178 KT 179
            +
Sbjct: 229 AS 230

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  121 bits (304), Expect = 2e-31
 Identities = 44/280 (15%), Positives = 90/280 (32%), Gaps = 40/280 (14%)

Query: 290 RIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           R +GEG+   +++G +L +   VA+K   + +     R+    E+ T         +  +
Sbjct: 11  RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRD----EYRTYKLLAGCTGIPNV 66

Query: 349 QGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECE 408
             +  EG   VLV + L     D +           S +        + + +  +HE   
Sbjct: 67  YYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK----FSVKTVAMAAKQMLARVQSIHE--- 119

Query: 409 RQIIHRDVKACNILLDAEFN-----AKLGDF------------------EATIPAGTMGY 445
           + +++RD+K  N L+    +       + DF                  E    +GT  Y
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179

Query: 446 LAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADF 505
           ++         S + D+ + G V +    G  P    G           + G+   +   
Sbjct: 180 MSINTHLGREQSRRDDLEALGHVFMYFLRGSLP--WQGLKAATNKQKYERIGEKKQSTPL 237

Query: 506 RLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK 545
           R       +E  + +       +   +  P       +  
Sbjct: 238 RELCAGFPEEFYKYMH---YARNLAFDATPDYDYLQGLFS 274

>d1f9ka_ b.29.1.1 (A:) Legume lectin {Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]} Length = 234

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]

 Score =  119 bits (299), Expect = 3e-31
 Identities = 51/185 (27%), Positives = 80/185 (43%), Gaps = 16/185 (8%)

Query: 1   FLDPKTNTTASFSCRFSFSII-PSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSP 59
             D  T   ASF  RFSF+I  P       DG  F +       G D G +G+  P    
Sbjct: 58  IWDSTTGNVASFETRFSFNITQPYAYPEPADGLTFFMVPPNSPQGEDGGNLGVFKP--PE 115

Query: 60  QDSFFAVEFDTSFDPSLGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYR 119
            D+ FAVEFDT  +    D    HIGID++S++S  ++        L++G      I+Y 
Sbjct: 116 GDNAFAVEFDTFQNT--WDPQVPHIGIDVNSIVSSKTLH-----FQLENGGVANVVIKYD 168

Query: 120 DSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQF--KDYMHVGFSAANG---QGSAIYTVDR 174
              K++ V   +         +   +DL ++F   ++++VG SA  G        + +  
Sbjct: 169 SPTKILNVVLAFHS-VGTVYTLSNIVDLKQEFPNSEWVNVGLSATTGYQKNAVETHEIIS 227

Query: 175 WRFKT 179
           W F +
Sbjct: 228 WSFTS 232

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (305), Expect = 5e-31
 Identities = 59/290 (20%), Positives = 100/290 (34%), Gaps = 46/290 (15%)

Query: 286 FNKNRIVGEGASATVYKGSLPSGGA-VAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           +   +++G G+   VY+  L   G  VA+K+  +  R          E   M   L H N
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMR-KLDHCN 74

Query: 345 LVQLQGWCCEGNE------LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVAS 398
           +V+L+ +     E      L LV +Y+P        H + +    L        +  +  
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ-TLPVIYVKLYMYQLFR 133

Query: 399 ALSYLHEECERQIIHRDVKACNILLDAE-FNAKLGDF----------EATIPAGTMGYLA 447
           +L+Y+H      I HRD+K  N+LLD +    KL DF                 +  Y A
Sbjct: 134 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRA 190

Query: 448 PEYVYSGVP-SEKTDVYSFGVVALEVAAGKSPVDND-------------GCVIVDWVWNL 493
           PE ++     +   DV+S G V  E+  G+     D             G    + +  +
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250

Query: 494 RK---KGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEA 540
                + K            F  +     + +    +      R +  EA
Sbjct: 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300

>d1avba_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 226

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score =  118 bits (297), Expect = 5e-31
 Identities = 41/182 (22%), Positives = 63/182 (34%), Gaps = 15/182 (8%)

Query: 1   FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQ 60
             D   +  ASFS  F+F I    +     G AF +            Y+GL        
Sbjct: 54  INDRTIDNLASFSTNFTFRINAKNIENSAYGLAFALVPVGSRPKLKGRYLGLFNTT---- 109

Query: 61  DSFFAVEFDTSFDPSLGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRD 120
                 + D      + D   N I ID++S+     +   S      +G      I Y  
Sbjct: 110 ----NYDRDAHTVAVVFDTVSNRIEIDVNSI---RPIATESCNFGHNNGEKAEVRITYDS 162

Query: 121 SLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGS---AIYTVDRWRF 177
               +RV   Y         + A + L K+ +D++ VGFSA +G        + V  W F
Sbjct: 163 PKNDLRVSLLYPS-SEEKCHVSATVPLEKEVEDWVSVGFSATSGSKKETTETHNVLSWSF 221

Query: 178 KT 179
            +
Sbjct: 222 SS 223

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  119 bits (298), Expect = 1e-30
 Identities = 51/283 (18%), Positives = 88/283 (31%), Gaps = 40/283 (14%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           +   R +G G+   +Y G  + +G  VA+K      +          E       ++   
Sbjct: 9   YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYK-MMQGGV 63

Query: 345 LVQLQGWCC-EGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
            +    WC  EG+  V+V E L     D     +       S +  L +   + S + Y+
Sbjct: 64  GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK----FSLKTVLLLADQMISRIEYI 119

Query: 404 HEECERQIIHRDVKACNILL---------------------DAEFNAKLGDFEATIPAGT 442
           H    +  IHRDVK  N L+                     DA  +  +   E     GT
Sbjct: 120 HS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176

Query: 443 MGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDA 502
             Y +         S + D+ S G V +    G  P            +    + K+   
Sbjct: 177 ARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 236

Query: 503 ADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK 545
            +   +G     E    L     C     + +P      ++ +
Sbjct: 237 IEVLCKG--YPSEFATYLN---FCRSLRFDDKPDYSYLRQLFR 274

>d1ukga_ b.29.1.1 (A:) Legume lectin {Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]} Length = 241

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]

 Score =  117 bits (294), Expect = 2e-30
 Identities = 43/185 (23%), Positives = 78/185 (42%), Gaps = 13/185 (7%)

Query: 1   FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNAD----SFGNDNGYMGLPGPV 56
             +  ++  A+F  +FSFS+             F+   +      S G   G        
Sbjct: 58  LWEKSSSRVANFQSQFSFSLKSPLSNGADGIAFFIAPPDTTIPSGSGGGLLGLFAPGTAQ 117

Query: 57  LSPQDSFFAVEFDTSFDPSLGDI--NGNHIGIDISSVISFVSVDALSRGIDLKSGRHITT 114
            +  +   AVEFDT +         N  HIGID++S+ S  +V       D + G+ +  
Sbjct: 118 NTSANQVIAVEFDTFYAQDSNTWDPNYPHIGIDVNSIRSVKTVK-----WDRRDGQSLNV 172

Query: 115 WIEYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGSAIYTVDR 174
            + +  S + + V A YS        +  ++D+     +++ VGFSAA+G+    +T++ 
Sbjct: 173 LVTFNPSTRNLDVVATYS--DGTRYEVSYEVDVRSVLPEWVRVGFSAASGEQYQTHTLES 230

Query: 175 WRFKT 179
           W F +
Sbjct: 231 WSFTS 235

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (295), Expect = 1e-29
 Identities = 53/289 (18%), Positives = 103/289 (35%), Gaps = 44/289 (15%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           +   + VG GA   V       +G  VA+K+  +P + E        E   +   +RH+N
Sbjct: 20  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLK-HMRHEN 78

Query: 345 LVQLQGWCCEGN------ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVAS 398
           ++ L              +  LV  ++       + H        L  ++   +V  +  
Sbjct: 79  VIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK------LGEDRIQFLVYQMLK 132

Query: 399 ALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEY 450
            L Y+H      IIHRD+K  N+ ++ +   K+ DF        E T    T  Y APE 
Sbjct: 133 GLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEV 189

Query: 451 VYSGVP-SEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDW----------VWNLRKKGKL 499
           + + +  ++  D++S G +  E+  GK+       +                 +++    
Sbjct: 190 ILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 249

Query: 500 LDAADFRLRGKFNRKEMERMLMVG--------LSCVHPNHEKRPSVKEA 540
                 +   +  +K+   +L              +  + E+R +  EA
Sbjct: 250 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298

>d1fnya_ b.29.1.1 (A:) Legume lectin {Black locust (Robinia pseudoacacia) [TaxId: 35938]} Length = 237

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Black locust (Robinia pseudoacacia) [TaxId: 35938]

 Score =  115 bits (288), Expect = 1e-29
 Identities = 46/183 (25%), Positives = 72/183 (39%), Gaps = 11/183 (6%)

Query: 1   FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGL-PGPVLSP 59
             D  T   ASF   F+F I         DG AF +        +  G +G+      + 
Sbjct: 58  IWDSTTGNVASFVTSFTFIIQAPNPATTADGLAFFLAPVDTQPLDLGGMLGIFKDGYFNK 117

Query: 60  QDSFFAVEFDTSFDPSLGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYR 119
            +   AVEFDT  +    D  G H+GI+++S+ S  +V       +  +G     +I Y 
Sbjct: 118 SNQIVAVEFDTFSNGD-WDPKGRHLGINVNSIESIKTVPW-----NWTNGEVANVFISYE 171

Query: 120 DSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGSAIYT---VDRWR 176
            S K +     Y      S +I A +D+     +++  GFSA  G          V  W 
Sbjct: 172 ASTKSLTASLVYPS-LETSFIIDAIVDVKIVLPEWVRFGFSATTGIDKGYVQTNDVLSWS 230

Query: 177 FKT 179
           F++
Sbjct: 231 FES 233

>d2d3sa1 b.29.1.1 (A:1-237) Legume lectin {Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]} Length = 237

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]

 Score =  114 bits (285), Expect = 2e-29
 Identities = 60/187 (32%), Positives = 76/187 (40%), Gaps = 18/187 (9%)

Query: 1   FLDPKTNTTASFSCRFSFSII-PSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSP 59
             D  T   ASF  RFSFSI  P P     DG  F I       G   GY G+  P    
Sbjct: 57  VWDSTTGNVASFETRFSFSIRQPFPRPHPADGLVFFIAPPNTQTGEGGGYFGIYNP--LS 114

Query: 60  QDSFFAVEFDTSFDPSLGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYR 119
              F AVEFDT  +    D    HIGID++SVIS  +V        L +G      I+Y 
Sbjct: 115 PYPFVAVEFDTFRNT--WDPQIPHIGIDVNSVISTKTVP-----FTLDNGGIANVVIKYD 167

Query: 120 DSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGSAIYT-------V 172
            S K++ V   +         I   +DL +   + ++VGFSAA G  S           +
Sbjct: 168 ASTKILHVVLVFPS-LGTIYTIADIVDLKQVLPESVNVGFSAATGDPSGKQRNATETHDI 226

Query: 173 DRWRFKT 179
             W F  
Sbjct: 227 LSWSFSA 233

>d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]} Length = 237

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Concanavalin A
species: Jack bean (Canavalia ensiformis) [TaxId: 3823]

 Score =  114 bits (286), Expect = 2e-29
 Identities = 35/131 (26%), Positives = 56/131 (42%), Gaps = 9/131 (6%)

Query: 61  DSFFAVEFDTSFDPSLGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRD 120
           D+  AVE DT  +  +GD +  HIGIDI SV S  +        ++++G+  T  I Y  
Sbjct: 2   DTIVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKTAK-----WNMQNGKVGTAHIIYNS 56

Query: 121 SLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGSAIYTVDRWRFKTF 180
             K +     Y      S  +   +DL     +++ VG SA+ G      T+  W F + 
Sbjct: 57  VDKRLSAVVSYP--NADSATVSYDVDLDNVLPEWVRVGLSASTGLYKETNTILSWSFTS- 113

Query: 181 ESYPSGNPIDV 191
               S +  + 
Sbjct: 114 -KLKSNSTHET 123

>d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]} Length = 237

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Concanavalin A
species: Jack bean (Canavalia ensiformis) [TaxId: 3823]

 Score = 45.7 bits (108), Expect = 5e-06
 Identities = 16/53 (30%), Positives = 23/53 (43%), Gaps = 3/53 (5%)

Query: 2   LDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSF--GNDNGYMGL 52
           +   +   ASF   F+F I   P     DG AF I++   S   G+    +GL
Sbjct: 181 IWESSAVVASFEATFTFLIKS-PDSHPADGIAFFISNIDSSIPSGSTGRLLGL 232

>d1n47a_ b.29.1.1 (A:) Legume lectin {Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]} Length = 233

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]

 Score =  112 bits (281), Expect = 9e-29
 Identities = 47/174 (27%), Positives = 68/174 (39%), Gaps = 12/174 (6%)

Query: 10  ASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLP-GPVLSPQDSFFAVEF 68
           ASF+  FSF +      A  DG AF +           G++GL             AVEF
Sbjct: 65  ASFTTSFSFVMAAPAAAAVADGLAFFLAPPDTQPQARGGFLGLFADRAHDASYQTVAVEF 124

Query: 69  DTSFDPSLGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRDSLKLIRVW 128
           DT  +    D N  HIGID + + S  +        D+  G      I Y+ S K +   
Sbjct: 125 DTYSNA--WDPNYTHIGIDTNGIESKKTTP-----FDMVYGEKANIVITYQASTKALAAS 177

Query: 129 AGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGSAIYT---VDRWRFKT 179
             +      S  + A++DL     +Y+ VGFSA  G  + +     +  W F  
Sbjct: 178 LVFPV-SQTSYAVSARVDLRDILPEYVRVGFSATTGLNAGVVETHDIVSWSFAV 230

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (285), Expect = 1e-28
 Identities = 50/299 (16%), Positives = 99/299 (33%), Gaps = 52/299 (17%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           + K   +G+G    V+K     +G  VA+K+    N  E        E   +   L+H+N
Sbjct: 12  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQ-LLKHEN 70

Query: 345 LVQLQGWCCEG--------NELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGV 396
           +V L   C             + LV+++  +     + +         +  +   ++  +
Sbjct: 71  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK----FTLSEIKRVMQML 126

Query: 397 ASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF---------------EATIPAG 441
              L+ L+     +I+HRD+KA N+L+  +   KL DF                 T    
Sbjct: 127 ---LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183

Query: 442 TMGYLAPEYVYSGVP-SEKTDVYSFGVVALEVAAGKSPVDNDGCV------------IVD 488
           T+ Y  PE +          D++  G +  E+      +  +               I  
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243

Query: 489 WVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVG-------LSCVHPNHEKRPSVKEA 540
            VW      +L +  +     K   K+  +  +            +  +  +R    +A
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

>d1dbna_ b.29.1.1 (A:) Legume lectin {Maackia amurensis, leukoagglutinin [TaxId: 37501]} Length = 239

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Maackia amurensis, leukoagglutinin [TaxId: 37501]

 Score =  111 bits (279), Expect = 2e-28
 Identities = 51/186 (27%), Positives = 75/186 (40%), Gaps = 13/186 (6%)

Query: 1   FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGN--DNGYMGLPGPV-L 57
                T + ASFS  F+F +         DG AF +        +   + Y+GL      
Sbjct: 58  IWGNTTGSVASFSTSFTFVVKAPNPDITSDGLAFYLAPPDSQIPSGSVSKYLGLFNNSNS 117

Query: 58  SPQDSFFAVEFDTSFDPSL--GDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTW 115
              +   AVEFDT F  S    D N  HIGID++ + S  +V       D  +G      
Sbjct: 118 DSSNQIVAVEFDTYFAHSYDPWDPNYRHIGIDVNGIESIKTVQW-----DWINGGVAFAT 172

Query: 116 IEYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGSAIYTVD-- 173
           I Y    K +     Y      +  + A +DL +   +++ VGFSAA G  + + T D  
Sbjct: 173 ITYLAPNKTLIASLVYPS-NQTTFSVAASVDLKEILPEWVRVGFSAATGYPTEVETHDVL 231

Query: 174 RWRFKT 179
            W F +
Sbjct: 232 SWSFTS 237

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (280), Expect = 8e-28
 Identities = 50/206 (24%), Positives = 78/206 (37%), Gaps = 21/206 (10%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHK 343
           F+  +++G+G    V       +G   A+K   K   + +       TE   +    RH 
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ-NTRHP 65

Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
            L  L+      + L  V EY   G L   L        V + E+       + SAL   
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE----RVFTEERARFYGAEIVSAL--- 118

Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTMGYLAPEYVY 452
                R +++RD+K  N++LD + + K+ DF                 GT  YLAPE + 
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178

Query: 453 SGVPSEKTDVYSFGVVALEVAAGKSP 478
                   D +  GVV  E+  G+ P
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLP 204

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  112 bits (280), Expect = 1e-27
 Identities = 49/207 (23%), Positives = 81/207 (39%), Gaps = 18/207 (8%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHK 343
           F++ + +G G+   V       SG   A+K  +K   V          E   +   +   
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ-AVNFP 101

Query: 344 NLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYL 403
            LV+L+    + + L +V EY+  G +   L          S          +     YL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYL 157

Query: 404 HEECERQIIHRDVKACNILLDAEFNAKLGDF--------EATIPAGTMGYLAPEYVYSGV 455
           H      +I+RD+K  N+L+D +   ++ DF              GT   LAPE + S  
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKG 214

Query: 456 PSEKTDVYSFGVVALEVAAGKSPVDND 482
            ++  D ++ GV+  E+AAG  P   D
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFAD 241

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (274), Expect = 2e-27
 Identities = 55/285 (19%), Positives = 105/285 (36%), Gaps = 38/285 (13%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           + K   +GEG   TV+K  +  +   VA+KR    +  E   +    E   +   L+HKN
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLK-ELKHKN 62

Query: 345 LVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLH 404
           +V+L        +L LV+E+            N         E   + +  +   L + H
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD----PEIVKSFLFQLLKGLGFCH 118

Query: 405 EECERQIIHRDVKACNILLDAEFNAKLGDF-----------EATIPAGTMGYLAPEYVY- 452
               R ++HRD+K  N+L++     KL +F             +    T+ Y  P+ ++ 
Sbjct: 119 S---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175

Query: 453 SGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVI--------VDWVWNLRKKGKLLDAAD 504
           + + S   D++S G +  E+A    P+     V         +       +   +    D
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235

Query: 505 FRLRGKFNRKEMERMLMVGLS---------CVHPNHEKRPSVKEA 540
           ++    +        ++  L+          +  N  +R S +EA
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  109 bits (272), Expect = 8e-27
 Identities = 50/295 (16%), Positives = 102/295 (34%), Gaps = 55/295 (18%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           +   R +G G  + V++  ++ +   V VK  +   + +  R     E   +       N
Sbjct: 37  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR-----EIKILENLRGGPN 91

Query: 345 LVQLQGWCCEGNE--LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
           ++ L     +       LV+E++ N    ++          L+       +  +  AL Y
Sbjct: 92  IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDY 144

Query: 403 LHEECERQIIHRDVKACNILLDAEFN-AKLGDF----------EATIPAGTMGYLAPEYV 451
            H      I+HRDVK  N+++D E    +L D+          E  +   +  +  PE +
Sbjct: 145 CHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 201

Query: 452 YSGVP-SEKTDVYSFGVVALEVAAGKSPVDNDGCVI-----------VDWVWNLRKKGKL 499
                     D++S G +   +   K P  +                 + +++   K  +
Sbjct: 202 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261

Query: 500 LDAADFR-LRGKFNRKEMERMLMVGL-------------SCVHPNHEKRPSVKEA 540
                F  + G+ +RK  ER +                   +  +H+ R + +EA
Sbjct: 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316

>d1ioaa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]} Length = 228

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]

 Score =  106 bits (266), Expect = 8e-27
 Identities = 37/178 (20%), Positives = 64/178 (35%), Gaps = 17/178 (9%)

Query: 6   TNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLP-GPVLSPQDSFF 64
           +N  ASF+  F+F I          G AF +            ++G+       P     
Sbjct: 61  SNNVASFNTNFTFIIRAKNQSISAYGLAFALVPVNSPPQKKQEFLGIFNTNNPEPNARTV 120

Query: 65  AVEFDTSFDPSLGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRDSLKL 124
           AV F+T  +    D + N I   ++    F             +G      I Y  S   
Sbjct: 121 AVVFNTFKNR--IDFDKNFIKPYVNENCDF----------HKYNGEKTDVQITYDSSNND 168

Query: 125 IRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGS---AIYTVDRWRFKT 179
           +RV+  ++ +      + A + L K+  +++ VGFS  +G        + V  W F +
Sbjct: 169 LRVFLHFT-VSQVKCSVSATVHLEKEVDEWVSVGFSPTSGLTEDTTETHDVLSWSFSS 225

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (266), Expect = 7e-26
 Identities = 57/297 (19%), Positives = 95/297 (31%), Gaps = 57/297 (19%)

Query: 290 RIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQL 348
           + +G GA   V           VA+K+  +P + +        E   M  C+ HKN++ L
Sbjct: 23  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMK-CVNHKNIISL 81

Query: 349 QGWCC------EGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
                      E  ++ LV E +       I             E+   ++  +   + +
Sbjct: 82  LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-------HERMSYLLYQMLCGIKH 134

Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDF----------EATIPAGTMGYLAPEYVY 452
           LH      IIHRD+K  NI++ ++   K+ DF            T    T  Y APE + 
Sbjct: 135 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 191

Query: 453 SGVPSEKTDVYSFGVVALEVAAGKSPVDND------------------------GCVIVD 488
                E  D++S G +  E+   K                                 + +
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251

Query: 489 WVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGL-----SCVHPNHEKRPSVKEA 540
           +V N  K   L     F         E  ++            +  +  KR SV +A
Sbjct: 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (255), Expect = 1e-24
 Identities = 59/282 (20%), Positives = 102/282 (36%), Gaps = 38/282 (13%)

Query: 286 FNKNRIVGEGASATVYKG----SLPSGGAVAVKRFEKPNRVECARNP--FTTEFATMAGC 339
           F   +++G GA   V+         +G   A+K  +K   V+ A+      TE   +   
Sbjct: 26  FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 85

Query: 340 LRHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASA 399
            +   LV L        +L L+ +Y+  G L   L      +            + V   
Sbjct: 86  RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQ-------IYVGEI 138

Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF------------EATIPAGTMGYLA 447
           +  L    +  II+RD+K  NILLD+  +  L DF             A    GT+ Y+A
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMA 198

Query: 448 PEYVYSGV--PSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADF 505
           P+ V  G     +  D +S GV+  E+  G SP   DG    +    + ++         
Sbjct: 199 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG--EKNSQAEISRR-------IL 249

Query: 506 RLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKE--AARILK 545
           +    + ++       +    +  + +KR       A  I +
Sbjct: 250 KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.3 bits (241), Expect = 1e-22
 Identities = 49/288 (17%), Positives = 98/288 (34%), Gaps = 42/288 (14%)

Query: 286 FNKNRIVGEGASATVYKG-SLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKN 344
           +     VG GA  +V       +G  VAVK+  +P +          E   +   ++H+N
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK-HMKHEN 78

Query: 345 LVQLQGWCCEGNEL-----VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASA 399
           ++ L         L     V +  +L    L+ I+         L+ +    ++  +   
Sbjct: 79  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-----LTDDHVQFLIYQILRG 133

Query: 400 LSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF---------EATIPAGTMGYLAPEY 450
           L Y+H      IIHRD+K  N+ ++ +   K+ DF              A          
Sbjct: 134 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM 190

Query: 451 VYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGC---------VIVDWVWNLRKKGKLLD 501
           +     ++  D++S G +  E+  G++                ++      L KK     
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250

Query: 502 AADFRLRGKFNRKEMERMLMVGLS---------CVHPNHEKRPSVKEA 540
           A ++        K     + +G +          +  + +KR +  +A
Sbjct: 251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298

>d1dhkb_ b.29.1.1 (B:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 204

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 93.3 bits (231), Expect = 2e-22
 Identities = 38/182 (20%), Positives = 56/182 (30%), Gaps = 33/182 (18%)

Query: 1   FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQ 60
             D  T   ASF   F+ +I          G  F++         D              
Sbjct: 51  IRDSTTGNVASFDTNFTMNIRTHRQANSAVGLDFVLVPVQPESKGD-------------- 96

Query: 61  DSFFAVEFDTSFDPSLGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRD 120
                VEFDT       D+N N I                   +    G++    I Y  
Sbjct: 97  --TVTVEFDTFLSRISIDVNNNDIKSV-------------PWDVHDYDGQNAEVRITYNS 141

Query: 121 SLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGSA---IYTVDRWRF 177
           S K+  V          S  +   ++L K+  D++ VGFSA +G        + V  W F
Sbjct: 142 STKVFSVSLSNPS-TGKSNNVSTTVELEKEVYDWVSVGFSATSGAYQWSYETHDVLSWSF 200

Query: 178 KT 179
            +
Sbjct: 201 SS 202

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 81.6 bits (200), Expect = 2e-17
 Identities = 56/357 (15%), Positives = 99/357 (27%), Gaps = 76/357 (21%)

Query: 290 RIVGEGASATVYKG-SLPSGGAVAVKRFEK-PNRVECARNPFTT------EFATMAGCLR 341
           R +G G  +TV+    + +   VA+K         E A +             T    + 
Sbjct: 19  RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 342 HKNLVQLQGWCCE----GNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVA 397
             ++++L          G  +V+V+E L    L  I                  I   + 
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGI---PLIYVKQISKQLL 135

Query: 398 SALSYLHEECERQIIHRDVKACNILLDAE--------------FNAKLGDFEATIPAGTM 443
             L Y+H      IIH D+K  N+L++                 NA   D   T    T 
Sbjct: 136 LGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 193

Query: 444 GYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDND-------------------GC 484
            Y +PE +         D++S   +  E+  G    + D                   G 
Sbjct: 194 EYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGE 253

Query: 485 VIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGL----------------SCVH 528
           +    + N +      ++          +      ++                     + 
Sbjct: 254 LPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQ 313

Query: 529 PNHEKRPSVKEAARILKGEAPLPLLPVKKPTVNIRSVFPEASELIDSGGDHSPGFDD 585
            +  KR                   P  K T+ +  +     EL  SG D    F++
Sbjct: 314 LDPRKRADAGGLVN----------HPWLKDTLGMEEIRVPDRELYGSGSDIPGWFEE 360

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 72.9 bits (178), Expect = 2e-15
 Identities = 26/152 (17%), Positives = 54/152 (35%), Gaps = 18/152 (11%)

Query: 290 RIVGEGASATVYKGSLPSGGAVAVK-------RFEKPNRVECARNPFTTEFATMAGCLRH 342
           +++GEG  + V+       G   VK        F+K        +   +  A  +     
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 343 KNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSY 402
           + L +LQG          VY +  N  L +++       + +       ++  +   ++ 
Sbjct: 66  RALQKLQGLAV-----PKVYAWEGNAVLMELIDAKELYRVRVENPDE--VLDMILEEVAK 118

Query: 403 LHEECERQIIHRDVKACNILLDAEFNAKLGDF 434
            +      I+H D+   N+L+  E    + DF
Sbjct: 119 FYHRG---IVHGDLSQYNVLVS-EEGIWIIDF 146

>d1gv9a_ b.29.1.13 (A:) Carbohydrate-recognition domain of P58/ERGIC-53 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 228

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Lectin leg-like
domain: Carbohydrate-recognition domain of P58/ERGIC-53
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 73.6 bits (180), Expect = 2e-15
 Identities = 27/187 (14%), Positives = 46/187 (24%), Gaps = 19/187 (10%)

Query: 3   DPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQDS 62
                   ++    +F  +        DG A   T N    G   G             +
Sbjct: 54  TKTKAAFENWEVEVTF-RVTGRGRIGADGLAIWYTENQGLDGPVFGSAD--------MWN 104

Query: 63  FFAVEFDTSFDPSLGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHI------TTWI 116
              + FD+  +   G  N   I +  ++               L S +            
Sbjct: 105 GVGIFFDSFDND--GKKNNPAIVVVGNNGQINYDHQNDGATQALASCQRDFRNKPYPVRA 162

Query: 117 EYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGSAIYTVDRWR 176
           +     K + V          +         +       H G SAA G  +  + V    
Sbjct: 163 KITYYQKTLTVMINNGFTPDKNDYEFCAKVENMVIPTQGHFGISAATGGLADDHDV--LS 220

Query: 177 FKTFESY 183
           F TF+  
Sbjct: 221 FLTFQLT 227

>d2a6va1 b.29.1.13 (A:9-226) Emp46p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 218

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Lectin leg-like
domain: Emp46p N-terminal domain
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 42.3 bits (99), Expect = 6e-05
 Identities = 23/188 (12%), Positives = 53/188 (28%), Gaps = 36/188 (19%)

Query: 1   FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQ 60
           +L P+ +   + +  ++F        +   G AF +    +                   
Sbjct: 50  WLKPEYSIKDAMTIEWTFRSF-GFRGSTKGGLAFWLKQGNEGDST--------ELFGGSS 100

Query: 61  DSF--FAVEFDTSFDPSLGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEY 118
             F    +           D  G  +   ++        D         S    +   +Y
Sbjct: 101 KKFNGLMILLRLD------DKLGESVTAYLN--------DGTKDLDIESSPYFASCLFQY 146

Query: 119 RDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFK---------DYMHVGFSAANGQGSAI 169
           +DS+    +   Y+ +   + L+  Q+D    F+             +G SA N      
Sbjct: 147 QDSMVPSTLRLTYNPLD--NHLLKLQMDNRVCFQTRKVKFMGSSPFRIGTSAINDASKES 204

Query: 170 YTVDRWRF 177
           + + + + 
Sbjct: 205 FEILKMKL 212

>d2a6za1 b.29.1.13 (A:7-227) Emp47p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 221

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Lectin leg-like
domain: Emp47p N-terminal domain
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 36.9 bits (85), Expect = 0.004
 Identities = 23/191 (12%), Positives = 56/191 (29%), Gaps = 31/191 (16%)

Query: 1   FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQ 60
           +L    +   SF+  ++F  +         G +F            +  +     + +  
Sbjct: 51  WLKQGFDLKDSFTMEWTFRSV-GYSGQTDGGISFWFV--------QDSNIPRDKQLYNGP 101

Query: 61  DSF--FAVEFDT---SFDPSLGDINGNHIGIDISSVI--SFVSVDALSRGIDLKSGRHIT 113
            ++    +  D          G +N     +D + +   SF S     +     S    T
Sbjct: 102 VNYDGLQLLVDNNGPLGPTLRGQLNDGQKPVDKTKIYDQSFASCLMGYQD----SSVPST 157

Query: 114 TWIEY-RDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANGQGSAIYTV 172
             + Y  +   L++V     Q+         ++           +G +A NG  +     
Sbjct: 158 IRVTYDLEDDNLLKV-----QVDNKVCFQTRKVRFPSG---SYRIGVTAQNGAVNN--NA 207

Query: 173 DRWRFKTFESY 183
           + +     + +
Sbjct: 208 ESFEIFKMQFF 218

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	596
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1hqla_	236	Legume lectin {Griffonia simplicifolia, lectin I-b	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1leda_	243	Legume lectin {West-central african legume (Griffo	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1fx5a_	240	Legume lectin {Furze (Ulex europaeus), UEA-I [TaxI	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1gzca_	239	Legume lectin {Cockspur coral tree (Erythrina cris	100.0
d1qnwa_	237	Legume lectin {Furze (Ulex europaeus), UEA-II [Tax	100.0
d2d3sa1	237	Legume lectin {Winged bean (Psophocarpus tetragono	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1g9fa_	251	Legume lectin {Soybean (Glycine max) [TaxId: 3847]	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1f9ka_	234	Legume lectin {Winged bean (Psophocarpus tetragono	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1g7ya_	253	Legume lectin {Horse gram (Dolichos biflorus), dif	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1g8wa_	233	Phytohemagglutinin-L, PHA-L, also arcelin {Kidney	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
g1qmo.1	230	Legume lectin {Field bean (Dolichos lablab), Fril	100.0
d1dbna_	239	Legume lectin {Maackia amurensis, leukoagglutinin	100.0
d1fnya_	237	Legume lectin {Black locust (Robinia pseudoacacia)	100.0
d1n47a_	233	Legume lectin {Hairy vetch (Vicia villosa), isolec	100.0
d1v6ia_	232	Legume lectin {Peanut (Arachis hypogaea) [TaxId: 3	100.0
d1ukga_	241	Legume lectin {Bloodwood tree (Pterocarpus angolen	100.0
g2ltn.1	229	Legume lectin {Garden pea (Pisum sativum) [TaxId:	100.0
d1ioaa_	228	Phytohemagglutinin-L, PHA-L, also arcelin {Kidney	100.0
d1avba_	226	Phytohemagglutinin-L, PHA-L, also arcelin {Kidney	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1dhkb_	204	Phytohemagglutinin-L, PHA-L, also arcelin {Kidney	99.97
d1nlsa_	237	Concanavalin A {Jack bean (Canavalia ensiformis) [	99.97
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.86
d1gv9a_	228	Carbohydrate-recognition domain of P58/ERGIC-53 {R	99.82
d2a6va1	218	Emp46p N-terminal domain {Baker's yeast (Saccharom	99.44
d2a6za1	221	Emp47p N-terminal domain {Baker's yeast (Saccharom	99.42
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.34
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.58
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	96.92
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	95.77
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	94.61
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	94.06

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6e-51  Score=415.57  Aligned_cols=254  Identities=24%  Similarity=0.388  Sum_probs=201.9

Q ss_pred             cCHHHHHHHhcCCC---------ccceeecCCceEEEEEEcCC-C---CEEEEEEeecCCchhcccchHHHHHHHHHhcc
Q 047719          274 LALTDIKQATLGFN---------KNRIVGEGASATVYKGSLPS-G---GAVAVKRFEKPNRVECARNPFTTEFATMAGCL  340 (596)
Q Consensus       274 ~~~~el~~at~~f~---------~~~~LG~G~fG~Vy~~~~~~-g---~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l  340 (596)
                      ++++|+.+++.+|.         ..++||+|+||+||+|.+.. +   ..||||++.... .+...++|.+|+..+.+ +
T Consensus         7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~-l   84 (299)
T d1jpaa_           7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQ-F   84 (299)
T ss_dssp             GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTT-C
T ss_pred             CCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHh-C
Confidence            45667777766553         35799999999999998753 3   258999986433 33455679999966655 8


Q ss_pred             CCCceeeecceeeeCCeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCc
Q 047719          341 RHKNLVQLQGWCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACN  420 (596)
Q Consensus       341 ~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~N  420 (596)
                      +|||||+++|+|.+.+.+++|||||++|+|.+++....   ..++|.+++.++.||++||+|||+   ++|+||||||+|
T Consensus        85 ~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~---~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~N  158 (299)
T d1jpaa_          85 DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARN  158 (299)
T ss_dssp             CCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGG
T ss_pred             CCCCCccEEEEEeeCCEEEEEEEecCCCcceeeecccc---CCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccce
Confidence            99999999999999999999999999999999998653   258999999999999999999999   899999999999


Q ss_pred             eeecCCCceEEccCCCccc----------------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCC
Q 047719          421 ILLDAEFNAKLGDFEATIP----------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDG  483 (596)
Q Consensus       421 iLl~~~~~~kl~Dfg~~~~----------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~  483 (596)
                      |||+.++.+||+|||++..                .||+.|||||.+.++.++.++|||||||+||||+| |+.||.+..
T Consensus       159 ILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~  238 (299)
T d1jpaa_         159 ILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT  238 (299)
T ss_dssp             EEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             EEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC
Confidence            9999999999999997642                36788999999999999999999999999999998 899998653


Q ss_pred             hhHHHHHHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          484 CVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       484 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                      ..  +...... .+.         +...+.+....+.+|+.+||+.||++||||+||++.|+..
T Consensus       239 ~~--~~~~~i~-~~~---------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~  290 (299)
T d1jpaa_         239 NQ--DVINAIE-QDY---------RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM  290 (299)
T ss_dssp             HH--HHHHHHH-TTC---------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             HH--HHHHHHH-cCC---------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            21  1121221 111         1112223345677889999999999999999999998754

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-51  Score=406.56  Aligned_cols=242  Identities=28%  Similarity=0.366  Sum_probs=197.0

Q ss_pred             cCCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      ++|...+.||+|+||+||+|.+.+++.||||+++...   ...++|.+|+..+.+ ++|||||+++|+|.+.+..++|||
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~---~~~~~~~~E~~~l~~-l~HpnIv~~~g~~~~~~~~~lv~E   80 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA---MSEEDFIEEAEVMMK-LSHPKLVQLYGVCLEQAPICLVFE   80 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS---SCHHHHHHHHHHHHH-CCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc---CcHHHHHHHHHHHHh-cCCCCcccccceeccCCceEEEEE
Confidence            3577789999999999999999888899999996432   334679999977765 899999999999999999999999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc----
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP----  439 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~----  439 (596)
                      |+++|+|.+++....   ..++|..++.++.|||+||+|||+   ++|+||||||+|||+++++.+||+|||++..    
T Consensus        81 ~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  154 (263)
T d1sm2a_          81 FMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD  154 (263)
T ss_dssp             CCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC--------
T ss_pred             ecCCCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCC
Confidence            999999999997653   358999999999999999999999   8999999999999999999999999997642    


Q ss_pred             --------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhccccccCc
Q 047719          440 --------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGK  510 (596)
Q Consensus       440 --------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  510 (596)
                              .||..|+|||.+.+..++.++|||||||++|||+| |++|+.....  .+....... +..         ..
T Consensus       155 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~--~~~~~~i~~-~~~---------~~  222 (263)
T d1sm2a_         155 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--SEVVEDIST-GFR---------LY  222 (263)
T ss_dssp             ----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH--HHHHHHHHH-TCC---------CC
T ss_pred             CceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH--HHHHHHHHh-cCC---------CC
Confidence                    47889999999999999999999999999999999 5666654322  111212211 111         11


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          511 FNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       511 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                      .+......+.+++..||+.||++||||+||++.|+..
T Consensus       223 ~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i  259 (263)
T d1sm2a_         223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI  259 (263)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence            1122235678899999999999999999999999753

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-50  Score=405.69  Aligned_cols=248  Identities=27%  Similarity=0.405  Sum_probs=199.6

Q ss_pred             cCCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      ++|...+.||+|+||+||+|+++  ..||||+++.........+.|.+|+..+.+ ++|||||+++|++.+ +.++||||
T Consensus         8 ~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~-l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           8 GQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRK-TRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTT-CCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             ccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHh-CCCCCEeeeeEEEec-cEEEEEEe
Confidence            46788899999999999999874  369999997665555566789999966655 899999999998865 56899999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc-----
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI-----  438 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~-----  438 (596)
                      ||++|+|.++|....   ..++|..++.++.||++||+|||+   ++|+||||||+||||+.++.+||+|||++.     
T Consensus        84 y~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~  157 (276)
T d1uwha_          84 WCEGSSLYHHLHIIE---TKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW  157 (276)
T ss_dssp             CCCEEEHHHHHHTSC---CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred             cCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence            999999999997653   259999999999999999999999   899999999999999999999999999863     


Q ss_pred             --------cCCCcccCCcccccc---CCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccc
Q 047719          439 --------PAGTMGYLAPEYVYS---GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRL  507 (596)
Q Consensus       439 --------~~gt~~y~aPE~~~~---~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  507 (596)
                              ..||+.|||||++.+   +.++.++|||||||+||||+||+.||.+.....  .+......+....    .+
T Consensus       158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~--~~~~~~~~~~~~p----~~  231 (276)
T d1uwha_         158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIFMVGRGYLSP----DL  231 (276)
T ss_dssp             --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--HHHHHHHHTSCCC----CG
T ss_pred             CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH--HHHHHHhcCCCCC----cc
Confidence                    248999999999864   458999999999999999999999998643211  1112222221110    00


Q ss_pred             cCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Q 047719          508 RGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEA  548 (596)
Q Consensus       508 ~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~~  548 (596)
                       ...+......+.+|+.+||+.||++||||+||++.|+...
T Consensus       232 -~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~  271 (276)
T d1uwha_         232 -SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA  271 (276)
T ss_dssp             -GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence             1112223356778889999999999999999999987543

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-50  Score=403.91  Aligned_cols=236  Identities=27%  Similarity=0.356  Sum_probs=192.2

Q ss_pred             ceeecCCceEEEEEEcCC---CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEecCC
Q 047719          290 RIVGEGASATVYKGSLPS---GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEYLP  366 (596)
Q Consensus       290 ~~LG~G~fG~Vy~~~~~~---g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~~~  366 (596)
                      ++||+|+||+||+|.+.+   ++.||||+++.........++|.+|+..+.+ ++|||||+++|+|.. +..+|||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~-l~HpnIv~~~g~~~~-~~~~lvmE~~~   90 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ-LDNPYIVRMIGICEA-ESWMLVMEMAE   90 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHT-CCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHh-CCCCCCceEEEEecc-CCEEEEEEcCC
Confidence            579999999999997643   4679999997544444445679999977755 899999999999864 56799999999


Q ss_pred             CCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc-------
Q 047719          367 NGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP-------  439 (596)
Q Consensus       367 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~-------  439 (596)
                      +|+|.+++....    .++|..++.++.||+.||+|||+   ++|+||||||+||||+.++.+||+|||++..       
T Consensus        91 ~g~L~~~l~~~~----~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~  163 (277)
T d1xbba_          91 LGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY  163 (277)
T ss_dssp             TEEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred             CCcHHHHHhhcc----CCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence            999999998754    49999999999999999999999   8999999999999999999999999998642       


Q ss_pred             -------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcC
Q 047719          440 -------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKF  511 (596)
Q Consensus       440 -------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  511 (596)
                             .||+.|||||.+.++.++.++|||||||++|||+| |+.||.+....  + +......+...         ..
T Consensus       164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~--~-~~~~i~~~~~~---------~~  231 (277)
T d1xbba_         164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--E-VTAMLEKGERM---------GC  231 (277)
T ss_dssp             EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--H-HHHHHHTTCCC---------CC
T ss_pred             cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH--H-HHHHHHcCCCC---------CC
Confidence                   47899999999999999999999999999999998 89999875431  1 11222222211         12


Q ss_pred             CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          512 NRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       512 ~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                      +......+.+|+.+||+.||++||||++|++.|+.
T Consensus       232 p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         232 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence            22233567788999999999999999999988864

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-50  Score=403.64  Aligned_cols=241  Identities=26%  Similarity=0.387  Sum_probs=195.3

Q ss_pred             cCCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      ++|...+.||+|+||+||+|.+++++.||||+++...   ...++|.+|+..+.+ ++|||||+++|+|.+ +.+++|||
T Consensus        13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~-l~HpnIv~~~g~~~~-~~~~iv~E   87 (272)
T d1qpca_          13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAEANLMKQ-LQHQRLVRLYAVVTQ-EPIYIITE   87 (272)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS---SCHHHHHHHHHHHHH-CCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc---CCHHHHHHHHHHHHh-CCCCCEeEEEeeecc-CCeEEEEE
Confidence            4577789999999999999999888899999996432   334579999977765 899999999998865 56799999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc----
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP----  439 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~----  439 (596)
                      |+++|+|.+++....  ...++|..++.++.||++||+|||+   ++|+||||||+||||++++.+||+|||++..    
T Consensus        88 y~~~g~L~~~~~~~~--~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~  162 (272)
T d1qpca_          88 YMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (272)
T ss_dssp             CCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             eCCCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCC
Confidence            999999999886543  2358999999999999999999999   8999999999999999999999999998642    


Q ss_pred             --------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCC-CCCCChhHHHHHHHHHhcCCchhhccccccCc
Q 047719          440 --------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSP-VDNDGCVIVDWVWNLRKKGKLLDAADFRLRGK  510 (596)
Q Consensus       440 --------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p-~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  510 (596)
                              .||+.|||||.+.++.++.++|||||||++|||+||..| +.....  .+..... ..+.         +..
T Consensus       163 ~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~--~~~~~~i-~~~~---------~~~  230 (272)
T d1qpca_         163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--PEVIQNL-ERGY---------RMV  230 (272)
T ss_dssp             CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHH-HTTC---------CCC
T ss_pred             ccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH--HHHHHHH-HhcC---------CCC
Confidence                    478899999999999999999999999999999996554 444322  1111111 1111         111


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          511 FNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       511 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                      .+......+.+|+.+||+.||++||||+||++.|+.
T Consensus       231 ~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~  266 (272)
T d1qpca_         231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED  266 (272)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence            122233467788899999999999999999998874

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.9e-50  Score=409.44  Aligned_cols=246  Identities=26%  Similarity=0.332  Sum_probs=201.6

Q ss_pred             hcCCCccceeecCCceEEEEEEcCC-CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLPS-GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      .++|...+.||+|+||+||+|.+.. ++.||||+++...   ...++|.+|+..+.+ ++|||||+++|+|.+.+.+++|
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~---~~~~~~~~E~~il~~-l~HpnIv~~~~~~~~~~~~~iv   91 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKE-IKHPNLVQLLGVCTREPPFYII   91 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC---SCHHHHHHHHHHHHH-CCCTTBCCEEEEECSSSSCEEE
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc---chHHHHHHHHHHHHh-CCCCCEecCCccEeeCCeeEEE
Confidence            4567788999999999999998764 8899999986432   234578999977765 8999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc--
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP--  439 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~--  439 (596)
                      ||||++|+|.+++....  ...++|..++.++.||++||+|||+   ++|+||||||+||||++++.+||+|||++..  
T Consensus        92 ~E~~~~g~l~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~  166 (287)
T d1opja_          92 TEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT  166 (287)
T ss_dssp             EECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred             eecccCcchHHHhhhcc--ccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecC
Confidence            99999999999998754  3458999999999999999999999   8999999999999999999999999998753  


Q ss_pred             ----------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccC
Q 047719          440 ----------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRG  509 (596)
Q Consensus       440 ----------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  509 (596)
                                .||..|||||.+.++.++.++|||||||++|||++|..|+..... ... +......+         ...
T Consensus       167 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-~~~-~~~~i~~~---------~~~  235 (287)
T d1opja_         167 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQ-VYELLEKD---------YRM  235 (287)
T ss_dssp             SSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-HHH-HHHHHHTT---------CCC
T ss_pred             CCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch-HHH-HHHHHhcC---------CCC
Confidence                      267889999999999999999999999999999997666543221 111 11222221         112


Q ss_pred             cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Q 047719          510 KFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEA  548 (596)
Q Consensus       510 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~~  548 (596)
                      ..+......+.+|+..||+.||++||||+||++.|+...
T Consensus       236 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~  274 (287)
T d1opja_         236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  274 (287)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            222233456788999999999999999999999997643

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-50  Score=403.34  Aligned_cols=246  Identities=23%  Similarity=0.340  Sum_probs=190.7

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeee--CCeEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE--GNELVL  360 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~--~~~~~l  360 (596)
                      ++|...+.||+|+||+||+|... +|+.||||++......+...+.+.+|+..+ +.++|||||++++++.+  .+.+|+
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il-~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLL-RELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHT-TSCCCTTBCCEEEEEEC----CEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHH-HHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            46888899999999999999765 589999999976655555566788999655 55999999999999865  456899


Q ss_pred             EEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhcc--CCCeEEccCCCCceeecCCCceEEccCCCcc
Q 047719          361 VYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC--ERQIIHRDVKACNILLDAEFNAKLGDFEATI  438 (596)
Q Consensus       361 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~--~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~  438 (596)
                      |||||++|+|.+++.........+++..++.++.||+.||+|||+..  ..+|+||||||+||||+.++.+||+|||++.
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence            99999999999999754322346999999999999999999999831  1359999999999999999999999998653


Q ss_pred             -----------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccc
Q 047719          439 -----------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRL  507 (596)
Q Consensus       439 -----------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  507 (596)
                                 ..||+.|||||.+.+..++.++|||||||++|||+||+.||......  +.. .....+...     .+
T Consensus       163 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~--~~~-~~i~~~~~~-----~~  234 (269)
T d2java1         163 ILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK--ELA-GKIREGKFR-----RI  234 (269)
T ss_dssp             HC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHH-HHHHHTCCC-----CC
T ss_pred             ecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH--HHH-HHHHcCCCC-----CC
Confidence                       35899999999999999999999999999999999999999865431  111 111222211     11


Q ss_pred             cCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          508 RGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       508 ~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ...+    ...+.+|+.+||+.||++|||++|+++
T Consensus       235 ~~~~----s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         235 PYRY----SDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             CTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             Cccc----CHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            1223    345778889999999999999999865

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-49  Score=392.70  Aligned_cols=241  Identities=24%  Similarity=0.354  Sum_probs=202.8

Q ss_pred             cCCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      ++|+..++||+|+||+||+|++++++.||||++++...   ..++|.+|+..+.+ ++|||||+++|+|.+++.+++|||
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~---~~~~~~~Ev~~~~~-l~HpnIv~~~g~~~~~~~~~iv~E   79 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMN-LSHEKLVQLYGVCTKQRPIFIITE   79 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS---CHHHHHHHHHHHHT-CCCTTBCCEEEEECCSSSEEEEEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC---CHHHHHHHHHHHHh-cCCCceeeEEEEEeeCCceEEEEE
Confidence            57888999999999999999998888999999975432   34579999966655 899999999999999999999999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc-----
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI-----  438 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~-----  438 (596)
                      |+++|+|.+++....   ..+++..+++++.||++||+|||+   .+|+||||||+|||+++++.+||+|||++.     
T Consensus        80 y~~~g~l~~~~~~~~---~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~  153 (258)
T d1k2pa_          80 YMANGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD  153 (258)
T ss_dssp             CCTTEEHHHHHHSGG---GCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS
T ss_pred             ccCCCcHHHhhhccc---cCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCC
Confidence            999999999987653   258899999999999999999999   899999999999999999999999999864     


Q ss_pred             -------cCCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhccccccCc
Q 047719          439 -------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGK  510 (596)
Q Consensus       439 -------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  510 (596)
                             ..||..|+|||.+....++.++|||||||++|||+| |+.||......  +..... ..+..         ..
T Consensus       154 ~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~--~~~~~i-~~~~~---------~~  221 (258)
T d1k2pa_         154 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ETAEHI-AQGLR---------LY  221 (258)
T ss_dssp             SCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--HHHHHH-HTTCC---------CC
T ss_pred             CceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH--HHHHHH-HhCCC---------CC
Confidence                   247889999999999999999999999999999998 89999875432  222222 22211         11


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          511 FNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       511 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                      .+......+.+++..||+.||++|||++|+++.|..
T Consensus       222 ~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             CcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence            122233567888999999999999999999998853

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-49  Score=401.37  Aligned_cols=247  Identities=24%  Similarity=0.373  Sum_probs=198.4

Q ss_pred             cCCCccceeecCCceEEEEEEcCCC-----CEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPSG-----GAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNEL  358 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~g-----~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~  358 (596)
                      ..|+..++||+|+||+||+|.++.+     ..||||+++.... +....+|.+|+..+.+ ++|||||+++|+|.+.+..
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~E~~il~~-l~H~nIv~~~g~~~~~~~~   84 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT-EKQRVDFLGEAGIMGQ-FSHHNIIRLEGVISKYKPM   84 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHT-CCCTTBCCEEEEECSSSSE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccC-hHHHHHHHHHHHHHHh-cCCCCEeeeeEEEecCCce
Confidence            3577789999999999999987542     3699999965432 3345578999966655 8999999999999999999


Q ss_pred             EEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc
Q 047719          359 VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI  438 (596)
Q Consensus       359 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~  438 (596)
                      ++|||||.+|+|.+++....   ..++|.+++.++.||+.||+|||+   ++|+||||||+||||+.++.+||+|||++.
T Consensus        85 ~~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~  158 (283)
T d1mqba_          85 MIITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSR  158 (283)
T ss_dssp             EEEEECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             EEEEEecccCcchhhhhccc---ccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhh
Confidence            99999999999999987654   259999999999999999999999   899999999999999999999999999864


Q ss_pred             c--------------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhcc
Q 047719          439 P--------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAAD  504 (596)
Q Consensus       439 ~--------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d  504 (596)
                      .              .||+.|||||.+.++.++.++|||||||++|||++|..|+..... ..+.. .....+       
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~-~~~~~-~~i~~~-------  229 (283)
T d1mqba_         159 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-NHEVM-KAINDG-------  229 (283)
T ss_dssp             ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-HHHHH-HHHHTT-------
T ss_pred             cccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC-HHHHH-HHHhcc-------
Confidence            2              378899999999999999999999999999999996555443221 11111 111221       


Q ss_pred             ccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Q 047719          505 FRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEAP  549 (596)
Q Consensus       505 ~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~~~  549 (596)
                        .+...+.+....+.+|+.+||+.||++||||.||++.|+....
T Consensus       230 --~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~  272 (283)
T d1mqba_         230 --FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  272 (283)
T ss_dssp             --CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             --CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence              1222233344668889999999999999999999999976543

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-49  Score=399.78  Aligned_cols=241  Identities=23%  Similarity=0.333  Sum_probs=195.5

Q ss_pred             CCCccc-eeecCCceEEEEEEcC---CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEE
Q 047719          285 GFNKNR-IVGEGASATVYKGSLP---SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVL  360 (596)
Q Consensus       285 ~f~~~~-~LG~G~fG~Vy~~~~~---~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~l  360 (596)
                      +|...+ +||+|+||+||+|.++   ++..||||+++... .....++|.+|+..+.+ ++|||||+++|+|.. +.+||
T Consensus         9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~-l~HpnIv~l~g~~~~-~~~~l   85 (285)
T d1u59a_           9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQ-LDNPYIVRLIGVCQA-EALML   85 (285)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHH-CCCTTBCCEEEEEES-SSEEE
T ss_pred             CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHh-CCCCCEeeEeeeecc-CeEEE
Confidence            344445 4999999999999764   24579999997543 33455679999977765 899999999999864 56899


Q ss_pred             EEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc-
Q 047719          361 VYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP-  439 (596)
Q Consensus       361 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~-  439 (596)
                      |||||++|+|.+++....   ..+++.+++.++.||++||+|||+   ++|+||||||+||||+.++.+||+|||++.. 
T Consensus        86 vmE~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~  159 (285)
T d1u59a_          86 VMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKAL  159 (285)
T ss_dssp             EEECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEeCCCCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhcc
Confidence            999999999999986543   258999999999999999999999   8999999999999999999999999997642 


Q ss_pred             -------------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhccc
Q 047719          440 -------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAADF  505 (596)
Q Consensus       440 -------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~  505 (596)
                                   .||+.|||||.+..+.++.++|||||||++|||+| |+.||.+....  +.. .....+...     
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~--~~~-~~i~~~~~~-----  231 (285)
T d1u59a_         160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVM-AFIEQGKRM-----  231 (285)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHH-HHHHTTCCC-----
T ss_pred             cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH--HHH-HHHHcCCCC-----
Confidence                         37889999999999999999999999999999998 99999865321  111 222222211     


Q ss_pred             cccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          506 RLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       506 ~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                          ..+......+.+|+.+||+.||++||||.+|++.|+.
T Consensus       232 ----~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~  268 (285)
T d1u59a_         232 ----ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA  268 (285)
T ss_dssp             ----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             ----CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence                1222333567788999999999999999999998864

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-49  Score=393.61  Aligned_cols=238  Identities=27%  Similarity=0.415  Sum_probs=197.9

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      ++|...+.||+|+||+||+|... +++.||||++.+.... ......+.+|+..+. .++|||||++++++.+++.+|+|
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~-~l~hpnIv~~~~~~~~~~~~~iv   84 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS-HLRHPNILRLYGYFHDATRVYLI   84 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHH-TCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHH-hcCCCCCCeEEEEEEECCEEEEE
Confidence            35788899999999999999875 5889999999754322 234456788986665 48999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc--
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP--  439 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~--  439 (596)
                      ||||++|+|.+++....    .+++..+..++.||++||+|||+   ++|+||||||+|||++.++.+||+|||++..  
T Consensus        85 mEy~~~g~L~~~l~~~~----~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~  157 (263)
T d2j4za1          85 LEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP  157 (263)
T ss_dssp             EECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCC
T ss_pred             EeecCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecC
Confidence            99999999999998654    48999999999999999999999   8999999999999999999999999998643  


Q ss_pred             -------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCC
Q 047719          440 -------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFN  512 (596)
Q Consensus       440 -------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  512 (596)
                             .||+.|||||.+.+..++.++|||||||+||||++|+.||......  +.. .......      ..    ++
T Consensus       158 ~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--~~~-~~i~~~~------~~----~p  224 (263)
T d2j4za1         158 SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ--ETY-KRISRVE------FT----FP  224 (263)
T ss_dssp             CCCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HHH-HHHHTTC------CC----CC
T ss_pred             CCcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH--HHH-HHHHcCC------CC----CC
Confidence                   4899999999999999999999999999999999999999865321  111 1111111      11    11


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          513 RKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       513 ~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ......+.+++.+||+.||++|||++|+++
T Consensus       225 ~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         225 DFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence            222345677888999999999999999986

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-48  Score=390.92  Aligned_cols=240  Identities=26%  Similarity=0.318  Sum_probs=192.3

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      ++|+..+.||+|+||+||+|... +|+.||||++..... ....+.+.+|+..+.+ ++|||||++++++.+.+..||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~-l~HpnIv~~~~~~~~~~~~~ivm   82 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKM-LNHENVVKFYGHRREGNIQYLFL   82 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHT-CCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHh-CCCCCEeeEeeeeccCceeEEEE
Confidence            45788899999999999999865 589999999975433 2344578999966654 99999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc----
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI----  438 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~----  438 (596)
                      ||+++|+|.++|....    .+++.++..++.||++||+|||+   ++|+||||||+|||+++++.+||+|||++.    
T Consensus        83 Ey~~gg~L~~~l~~~~----~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~  155 (271)
T d1nvra_          83 EYCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRY  155 (271)
T ss_dssp             ECCTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             eccCCCcHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeecc
Confidence            9999999999997543    59999999999999999999999   899999999999999999999999999764    


Q ss_pred             ---------cCCCcccCCccccccCCC-CCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhcccccc
Q 047719          439 ---------PAGTMGYLAPEYVYSGVP-SEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLR  508 (596)
Q Consensus       439 ---------~~gt~~y~aPE~~~~~~~-t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  508 (596)
                               .+||+.|||||.+.+..+ +.++|||||||+||||++|+.||.........+. ..........     ..
T Consensus       156 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~-~~~~~~~~~~-----~~  229 (271)
T d1nvra_         156 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS-DWKEKKTYLN-----PW  229 (271)
T ss_dssp             TTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHH-HHHTTCTTST-----TG
T ss_pred             CCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHH-HHhcCCCCCC-----cc
Confidence                     258999999999988765 6789999999999999999999976433211111 1111111100     00


Q ss_pred             CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          509 GKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       509 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ..+    ...+.+|+.+||+.||++|||++|+++
T Consensus       230 ~~~----s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         230 KKI----DSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             GGS----CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccC----CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            112    245667888999999999999999865

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-49  Score=405.81  Aligned_cols=247  Identities=25%  Similarity=0.372  Sum_probs=198.3

Q ss_pred             cCCCccceeecCCceEEEEEEcCC-C-----CEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCe
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPS-G-----GAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNE  357 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~-g-----~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~  357 (596)
                      ++|...++||+|+||+||+|+... +     ..||||++.... .......+.+|+..+.+..+|||||+++++|.+.+.
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence            467788999999999999998643 2     369999986433 234556789999888775599999999999999999


Q ss_pred             EEEEEecCCCCCHHHHhhhCCCC-------------------CcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCC
Q 047719          358 LVLVYEYLPNGSLDKILHNNSSS-------------------SIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKA  418 (596)
Q Consensus       358 ~~lV~E~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp  418 (596)
                      +|||||||++|+|.++|+.....                   ...++|..++.++.||++||+|||+   ++|+||||||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlKp  192 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAA  192 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSG
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCch
Confidence            99999999999999999865321                   1358999999999999999999999   8999999999


Q ss_pred             CceeecCCCceEEccCCCccc-------------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCCh
Q 047719          419 CNILLDAEFNAKLGDFEATIP-------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGC  484 (596)
Q Consensus       419 ~NiLl~~~~~~kl~Dfg~~~~-------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~  484 (596)
                      +|||++.++.+||+|||++..             .||+.|||||.+.++.++.++|||||||+||||+| |+.||.+...
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~  272 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  272 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999998642             36889999999999999999999999999999998 8999986432


Q ss_pred             hHHHHHHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 047719          485 VIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILK  545 (596)
Q Consensus       485 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~  545 (596)
                      ..  -+......+.         +...+......+.+|+.+||+.||++||||+||++.|.
T Consensus       273 ~~--~~~~~~~~~~---------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         273 DA--NFYKLIQNGF---------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             SH--HHHHHHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HH--HHHHHHhcCC---------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            11  1112222221         11122223456788899999999999999999999985

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-48  Score=391.95  Aligned_cols=238  Identities=28%  Similarity=0.402  Sum_probs=197.6

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      +.|...+.||+|+||+||+|... +|+.||||++....  ....+.+.+|+..+.. ++|||||++++++.+.+.+||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~-l~HpnIv~~~~~~~~~~~~~ivm   96 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRE-NKNPNIVNYLDSYLVGDELWVVM   96 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGG--CSCHHHHHHHHHHHHH-CCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEeccc--ChHHHHHHHHHHHHHh-CCCCCEeeEeEEEEECCEEEEEE
Confidence            46888999999999999999864 58999999996533  2334568899966655 99999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc----
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI----  438 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~----  438 (596)
                      |||++|+|.+++..+     .+++.++..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||++.    
T Consensus        97 Ey~~gg~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~  168 (293)
T d1yhwa1          97 EYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (293)
T ss_dssp             ECCTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeecc
Confidence            999999999998765     38999999999999999999999   899999999999999999999999999764    


Q ss_pred             -------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcC
Q 047719          439 -------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKF  511 (596)
Q Consensus       439 -------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  511 (596)
                             ..||+.|||||.+.+..++.++|||||||++|||++|+.||.+....  +...........    ..    ..
T Consensus       169 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~~~~~~~~~----~~----~~  238 (293)
T d1yhwa1         169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--RALYLIATNGTP----EL----QN  238 (293)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHHCSC----CC----SS
T ss_pred             ccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH--HHHHHHHhCCCC----CC----CC
Confidence                   24899999999999999999999999999999999999999765432  112222221110    01    11


Q ss_pred             CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          512 NRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       512 ~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      +......+.+++.+||+.||++|||++|+++
T Consensus       239 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1222345778889999999999999999976

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-49  Score=396.33  Aligned_cols=245  Identities=24%  Similarity=0.335  Sum_probs=198.5

Q ss_pred             cCCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      ++|...+.||+|+||+||+|.+++++.||||+++...   ...+.|.+|+..+.+ ++|||||+++|+|.+ ++.++|||
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~---~~~~~~~~E~~~l~~-l~h~nIv~~~g~~~~-~~~~lv~E   91 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKK-LRHEKLVQLYAVVSE-EPIYIVTE   91 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS---SCHHHHHHHHHHHHH-CCCTTBCCEEEEECS-SSCEEEEC
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc---CCHHHHHHHHHHHHh-cccCCEeEEEEEEec-CCeEEEEE
Confidence            4678889999999999999999888899999996432   334679999977655 999999999999855 56899999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc----
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP----  439 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~----  439 (596)
                      |+++|+|..++....  ...++|.+++.++.||+.||+|||+   ++|+||||||+||||+.++.+||+|||++..    
T Consensus        92 y~~~g~l~~~~~~~~--~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~  166 (285)
T d1fmka3          92 YMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN  166 (285)
T ss_dssp             CCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred             ecCCCchhhhhhhcc--cccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCC
Confidence            999999999997643  2249999999999999999999999   8999999999999999999999999998642    


Q ss_pred             --------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcC
Q 047719          440 --------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKF  511 (596)
Q Consensus       440 --------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  511 (596)
                              .||+.|+|||.+..+.++.++|||||||++|||+||..|+..... ..+...... .+.         ....
T Consensus       167 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~-~~~~~~~i~-~~~---------~~~~  235 (285)
T d1fmka3         167 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-NREVLDQVE-RGY---------RMPC  235 (285)
T ss_dssp             ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-HHHHHHHHH-TTC---------CCCC
T ss_pred             CceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC-HHHHHHHHH-hcC---------CCCC
Confidence                    478999999999999999999999999999999996655543221 111221111 111         1112


Q ss_pred             CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Q 047719          512 NRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEAP  549 (596)
Q Consensus       512 ~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~~~  549 (596)
                      +....+.+.+++.+||+.||++||||++|+++|+....
T Consensus       236 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~  273 (285)
T d1fmka3         236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  273 (285)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence            22334567888999999999999999999999987543

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-48  Score=388.38  Aligned_cols=237  Identities=25%  Similarity=0.352  Sum_probs=189.7

Q ss_pred             CccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeee----CCeEEEE
Q 047719          287 NKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE----GNELVLV  361 (596)
Q Consensus       287 ~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~----~~~~~lV  361 (596)
                      ...+.||+|+||+||+|... ++..||+|++..........+.+.+|++.+. .++|||||++++++..    ...+|+|
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~-~l~HpnIv~~~~~~~~~~~~~~~~~iv   90 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLK-GLQHPNIVRFYDSWESTVKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHT-TCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHH-hCCCCCeeeEEEEEeeccccCCEEEEE
Confidence            44568999999999999875 5889999999765444455667899996665 5999999999999865    3568999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCC--eEEccCCCCceeec-CCCceEEccCCCcc
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQ--IIHRDVKACNILLD-AEFNAKLGDFEATI  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~--ivHrDlkp~NiLl~-~~~~~kl~Dfg~~~  438 (596)
                      |||+++|+|.+++....    .+++..+..++.||++||+|||+   ++  |+||||||+||||+ .++.+||+|||++.
T Consensus        91 mE~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~  163 (270)
T d1t4ha_          91 TELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  163 (270)
T ss_dssp             EECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EeCCCCCcHHHHHhccc----cccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence            99999999999998754    48999999999999999999998   66  99999999999996 47899999999864


Q ss_pred             ---------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccC
Q 047719          439 ---------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRG  509 (596)
Q Consensus       439 ---------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  509 (596)
                               ..||+.|||||.+.+ .++.++|||||||++|||++|+.||...... .. +......+...    .....
T Consensus       164 ~~~~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~-~~-~~~~i~~~~~~----~~~~~  236 (270)
T d1t4ha_         164 LKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-AQ-IYRRVTSGVKP----ASFDK  236 (270)
T ss_dssp             GCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-HH-HHHHHTTTCCC----GGGGG
T ss_pred             eccCCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH-HH-HHHHHHcCCCC----cccCc
Confidence                     259999999998865 6999999999999999999999999764321 11 11111211111    11111


Q ss_pred             cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          510 KFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       510 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ..+    ..+.+|+.+||+.||++|||++|+++
T Consensus       237 ~~~----~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         237 VAI----PEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             CCC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cCC----HHHHHHHHHHccCCHhHCcCHHHHhC
Confidence            222    34677889999999999999999976

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-47  Score=388.68  Aligned_cols=239  Identities=24%  Similarity=0.295  Sum_probs=195.4

Q ss_pred             CCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          285 GFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      .|...+.||+|+||+||+|... +|..||||+++...  ....+.+.+|+..+.+ ++|||||++++++.+.+.++||||
T Consensus        13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~-l~HpnIv~l~~~~~~~~~~~lvmE   89 (288)
T d2jfla1          13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILAS-CDHPNIVKLLDAFYYENNLWILIE   89 (288)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHH-CCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHh-CCCCCCCeEEEEEeeCCeEEEEEe
Confidence            4777899999999999999865 58899999997543  3445678999977755 899999999999999999999999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc-----
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI-----  438 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~-----  438 (596)
                      ||++|+|.+++.+..   ..+++.++..++.||++||.|||+   ++|+||||||+|||++.++.+||+|||++.     
T Consensus        90 y~~~g~L~~~~~~~~---~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~  163 (288)
T d2jfla1          90 FCAGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT  163 (288)
T ss_dssp             CCTTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH
T ss_pred             cCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCC
Confidence            999999999987543   258999999999999999999999   899999999999999999999999999863     


Q ss_pred             ------cCCCcccCCccccc-----cCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccc
Q 047719          439 ------PAGTMGYLAPEYVY-----SGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRL  507 (596)
Q Consensus       439 ------~~gt~~y~aPE~~~-----~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  507 (596)
                            ..||+.|||||.+.     ...++.++|||||||++|||+||+.||.+....  +......... ..     . 
T Consensus       164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~--~~~~~i~~~~-~~-----~-  234 (288)
T d2jfla1         164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM--RVLLKIAKSE-PP-----T-  234 (288)
T ss_dssp             HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG--GHHHHHHHSC-CC-----C-
T ss_pred             cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH--HHHHHHHcCC-CC-----C-
Confidence                  35999999999984     456899999999999999999999999765321  1111111111 00     0 


Q ss_pred             cCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          508 RGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       508 ~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                       ...+......+.+|+.+||+.||++|||++|+++
T Consensus       235 -~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         235 -LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             -CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -CCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             0111122346778889999999999999999876

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-48  Score=397.55  Aligned_cols=255  Identities=24%  Similarity=0.348  Sum_probs=198.8

Q ss_pred             hcCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      .++|...+.||+|+||+||+|... +|+.||||+++... .......+.+|+..+ +.++|||||+++++|.+.+++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il-~~l~HpnIv~l~~~~~~~~~~~iV   82 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVL-HECNSPYIVGFYGAFYSDGEISIC   82 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGG-GGCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHH-HhCCCCCCCcEEEEEEECCEEEEE
Confidence            467888899999999999999865 58899999997543 233445788999655 559999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc---
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI---  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---  438 (596)
                      ||||++|+|.+++.+..    .+++..+..++.||++||.|||+.  ++|+||||||+||||+.++.+||+|||++.   
T Consensus        83 mEy~~gg~L~~~l~~~~----~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~  156 (322)
T d1s9ja_          83 MEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  156 (322)
T ss_dssp             EECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred             EEcCCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence            99999999999998654    489999999999999999999972  489999999999999999999999999864   


Q ss_pred             ------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCc-------------
Q 047719          439 ------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKL-------------  499 (596)
Q Consensus       439 ------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~-------------  499 (596)
                            .+||+.|||||++.+..|+.++||||+||++|||++|+.||.................+..             
T Consensus       157 ~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (322)
T d1s9ja_         157 DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP  236 (322)
T ss_dssp             HHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred             CCccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence                  3699999999999999999999999999999999999999976533211111000000000             


Q ss_pred             --------------hhhccccc---cCcCC-HHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHh
Q 047719          500 --------------LDAADFRL---RGKFN-RKEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILK  545 (596)
Q Consensus       500 --------------~~~~d~~l---~~~~~-~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~  545 (596)
                                    .+..+...   ....+ ......+.+++.+|++.||++|||++|+++  +++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~  302 (322)
T d1s9ja_         237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK  302 (322)
T ss_dssp             ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             ccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhC
Confidence                          00000000   00000 011245678889999999999999999987  454

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3e-48  Score=396.10  Aligned_cols=256  Identities=26%  Similarity=0.409  Sum_probs=208.0

Q ss_pred             HHHHHHHhcCCCccceeecCCceEEEEEEcC------CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeec
Q 047719          276 LTDIKQATLGFNKNRIVGEGASATVYKGSLP------SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQ  349 (596)
Q Consensus       276 ~~el~~at~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~  349 (596)
                      +.+++...++|+..+.||+|+||+||+|+..      +++.||||+++... .....++|.+|+..+.+ ++||||++++
T Consensus         5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~-l~h~niv~~~   82 (301)
T d1lufa_           5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAE-FDNPNIVKLL   82 (301)
T ss_dssp             HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHT-CCCTTBCCEE
T ss_pred             hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHh-cCCCCcccce
Confidence            4455556778999999999999999999753      35689999996533 33445679999977765 8999999999


Q ss_pred             ceeeeCCeEEEEEecCCCCCHHHHhhhCCC--------------------CCcccCHHHHHHHHHHHHHHHHHHHhccCC
Q 047719          350 GWCCEGNELVLVYEYLPNGSLDKILHNNSS--------------------SSIVLSWEKRLNIVLGVASALSYLHEECER  409 (596)
Q Consensus       350 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~  409 (596)
                      ++|.+....++||||+++|+|.++|+....                    ....++|..++.++.||+.||+|||+   +
T Consensus        83 ~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~  159 (301)
T d1lufa_          83 GVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---R  159 (301)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---T
T ss_pred             eeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---C
Confidence            999999999999999999999999975431                    12348999999999999999999999   9


Q ss_pred             CeEEccCCCCceeecCCCceEEccCCCcc-------------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCC
Q 047719          410 QIIHRDVKACNILLDAEFNAKLGDFEATI-------------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGK  476 (596)
Q Consensus       410 ~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~-------------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~  476 (596)
                      +++||||||+|||||.++.+||+|||++.             ..||+.|+|||.+.+..++.++|||||||++|||++|.
T Consensus       160 ~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~  239 (301)
T d1lufa_         160 KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG  239 (301)
T ss_dssp             TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred             CeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccC
Confidence            99999999999999999999999999753             34778999999999999999999999999999999985


Q ss_pred             -CCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Q 047719          477 -SPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEA  548 (596)
Q Consensus       477 -~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~~  548 (596)
                       +||.....  .+..... ..+...         ..+......+.+|+..||+.||++||||.||+++|++..
T Consensus       240 ~~p~~~~~~--~e~~~~v-~~~~~~---------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         240 LQPYYGMAH--EEVIYYV-RDGNIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             CCTTTTSCH--HHHHHHH-HTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCCCCCCH--HHHHHHH-HcCCCC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence             67766432  1222222 222221         112223346788999999999999999999999998653

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.2e-47  Score=392.38  Aligned_cols=244  Identities=27%  Similarity=0.373  Sum_probs=198.1

Q ss_pred             CCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCc-hhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          285 GFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNR-VECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      .|+..+.||+|+||+||+|... +|+.||||++..... .....+.+.+|+..+. .++|||||++++++.+++.+|+||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~-~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ-KLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHT-TCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHH-HCCCCCEeeEEEEEEECCEEEEEE
Confidence            4788899999999999999864 588999999976443 2334567889996665 499999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc---
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP---  439 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~---  439 (596)
                      |||++|+|..++....    .+++.++..++.||++||.|||+   ++|+||||||+||||+.++.+||+|||++..   
T Consensus        95 E~~~~g~l~~~~~~~~----~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~  167 (309)
T d1u5ra_          95 EYCLGSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (309)
T ss_dssp             ECCSEEHHHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             EecCCCchHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence            9999999988776543    48999999999999999999999   8999999999999999999999999998753   


Q ss_pred             ----CCCcccCCcccccc---CCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCC
Q 047719          440 ----AGTMGYLAPEYVYS---GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFN  512 (596)
Q Consensus       440 ----~gt~~y~aPE~~~~---~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  512 (596)
                          .||+.|||||++.+   +.|+.++|||||||++|||++|+.||.+....  +......... ....    ....+ 
T Consensus       168 ~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~--~~~~~i~~~~-~~~~----~~~~~-  239 (309)
T d1u5ra_         168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYHIAQNE-SPAL----QSGHW-  239 (309)
T ss_dssp             BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHSC-CCCC----SCTTS-
T ss_pred             CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHhCC-CCCC----CCCCC-
Confidence                59999999999864   46899999999999999999999999765321  1122222111 1000    11122 


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhcC
Q 047719          513 RKEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKGE  547 (596)
Q Consensus       513 ~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~~~  547 (596)
                         ...+.+|+.+||+.||++|||++|+++  ++...
T Consensus       240 ---s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~  273 (309)
T d1u5ra_         240 ---SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (309)
T ss_dssp             ---CHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             ---CHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence               345778889999999999999999987  56543

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-48  Score=385.62  Aligned_cols=238  Identities=31%  Similarity=0.408  Sum_probs=193.4

Q ss_pred             CCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeee-CCeEEEEEe
Q 047719          285 GFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE-GNELVLVYE  363 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~-~~~~~lV~E  363 (596)
                      +|...+.||+|+||.||+|.+ .|..||||+++++.    ..++|.+|+..+. .++|||||+++|+|.+ .+.+++|||
T Consensus         8 ~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~----~~~~~~~E~~~l~-~l~HpnIv~~~g~~~~~~~~~~lv~e   81 (262)
T d1byga_           8 ELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA----TAQAFLAEASVMT-QLRHSNLVQLLGVIVEEKGGLYIVTE   81 (262)
T ss_dssp             GEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC------HHHHHTHHHHT-TCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred             HeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH----HHHHHHHHHHHHH-hCCCCCEeeEEEEEEecCCcEEEEEe
Confidence            466778999999999999998 57899999996432    3456899996665 5899999999999865 456899999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc----
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP----  439 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~----  439 (596)
                      |+++|+|.++|....  ...++|..+++++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++..    
T Consensus        82 y~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~  156 (262)
T d1byga_          82 YMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  156 (262)
T ss_dssp             CCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             ccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCC
Confidence            999999999997643  2358999999999999999999999   8999999999999999999999999998753    


Q ss_pred             ----CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCCh-hHHHHHHHHHhcCCchhhccccccCcCCH
Q 047719          440 ----AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGC-VIVDWVWNLRKKGKLLDAADFRLRGKFNR  513 (596)
Q Consensus       440 ----~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  513 (596)
                          .+|..|+|||.+.++.++.++|||||||++|||+| |+.|+..... .+..++    ..+         .+.+.+.
T Consensus       157 ~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i----~~~---------~~~~~~~  223 (262)
T d1byga_         157 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV----EKG---------YKMDAPD  223 (262)
T ss_dssp             -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH----TTT---------CCCCCCT
T ss_pred             CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHH----HcC---------CCCCCCc
Confidence                47889999999999999999999999999999998 7888876432 222222    111         1122223


Q ss_pred             HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          514 KEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       514 ~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                      .....+.+|+.+||+.||++||||.++++.|+.
T Consensus       224 ~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~  256 (262)
T d1byga_         224 GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH  256 (262)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             cCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence            333567788999999999999999999999975

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-47  Score=386.87  Aligned_cols=238  Identities=25%  Similarity=0.317  Sum_probs=197.3

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      ++|...+.||+|+||+||+|... +|+.||||++.+.... +...+.+.+|+..+.+ ++|||||++++++.+++.+|+|
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~-l~HpnIv~l~~~~~~~~~~~iv   86 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR-LDHPFFVKLYFTFQDDEKLYFG   86 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHH-CCSTTBCCEEEEEECSSEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHH-cCCCCeeEEEEEEEECCEEEEE
Confidence            35888899999999999999864 5899999999754322 2344568889866655 8999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc---
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI---  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---  438 (596)
                      |||+++|+|.+++....    .+++..+..++.|++.||+|||+   ++|+||||||+|||+++++.+||+|||++.   
T Consensus        87 mEy~~gg~L~~~~~~~~----~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~  159 (288)
T d1uu3a_          87 LSYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLS  159 (288)
T ss_dssp             ECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEccCCCCHHHhhhccC----CCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecc
Confidence            99999999999998754    48999999999999999999999   899999999999999999999999999763   


Q ss_pred             ----------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhcccccc
Q 047719          439 ----------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLR  508 (596)
Q Consensus       439 ----------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  508 (596)
                                ..||+.|||||++.+..++.++|||||||+||||++|+.||.......   +.........      .  
T Consensus       160 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~~~i~~~~~------~--  228 (288)
T d1uu3a_         160 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL---IFQKIIKLEY------D--  228 (288)
T ss_dssp             ----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHTTCC------C--
T ss_pred             cCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH---HHHHHHcCCC------C--
Confidence                      248999999999999999999999999999999999999998754211   1111111111      1  


Q ss_pred             CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          509 GKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       509 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                        ++......+.+|+.+||+.||++|||++|+++
T Consensus       229 --~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         229 --FPEKFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             --CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             --CCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence              11222345678889999999999999998743

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.4e-47  Score=388.92  Aligned_cols=245  Identities=22%  Similarity=0.317  Sum_probs=189.5

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      +.|...+.||+|+||+||+|... +|+.||||++.+.... .....+.+|+..+.. ++|||||++++++.+++.+||||
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~~~~~~lvm   86 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHK-IKHPNIVALDDIYESGGHLYLIM   86 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHT-CCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh-hHHHHHHHHHHHHHh-CCCCCCCcEEEEEEECCEEEEEE
Confidence            45888899999999999999865 5889999999754332 234567889966655 89999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeec---CCCceEEccCCCcc-
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLD---AEFNAKLGDFEATI-  438 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~---~~~~~kl~Dfg~~~-  438 (596)
                      |||++|+|.++|....    .+++.++..++.||+.||+|||+   ++|+||||||+|||+.   +++.+||+|||++. 
T Consensus        87 E~~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~  159 (307)
T d1a06a_          87 QLVSGGELFDRIVEKG----FYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM  159 (307)
T ss_dssp             CCCCSCBHHHHHHTCS----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred             eccCCCcHHHhhhccc----CCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEE
Confidence            9999999999998653    49999999999999999999999   9999999999999994   57899999999764 


Q ss_pred             ---------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccC
Q 047719          439 ---------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRG  509 (596)
Q Consensus       439 ---------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  509 (596)
                               .+||+.|||||.+.+..++.++|||||||++|||++|+.||.+....  +....... ...      ....
T Consensus       160 ~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--~~~~~i~~-~~~------~~~~  230 (307)
T d1a06a_         160 EDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA--KLFEQILK-AEY------EFDS  230 (307)
T ss_dssp             -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHT-TCC------CCCT
T ss_pred             ccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH--HHHHHHhc-cCC------CCCC
Confidence                     25899999999999999999999999999999999999999875421  11111111 111      1111


Q ss_pred             cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhc
Q 047719          510 KFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKG  546 (596)
Q Consensus       510 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~~  546 (596)
                      .........+.+|+.+||+.||++|||++|+++  ++++
T Consensus       231 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  269 (307)
T d1a06a_         231 PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG  269 (307)
T ss_dssp             TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred             ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence            111223345778889999999999999999987  4544

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-47  Score=387.20  Aligned_cols=248  Identities=25%  Similarity=0.367  Sum_probs=197.7

Q ss_pred             cCCCccceeecCCceEEEEEEcCC-CC--EEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPS-GG--AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVL  360 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~--~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~l  360 (596)
                      ++|+..++||+|+||+||+|.+.+ |.  .||||++.... .....++|.+|+..+.+..+|||||+++|+|.+.+.+++
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i   88 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   88 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence            467778999999999999998764 33  57888886432 334566799999777664489999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhCC------------CCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCc
Q 047719          361 VYEYLPNGSLDKILHNNS------------SSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFN  428 (596)
Q Consensus       361 V~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~  428 (596)
                      ||||+++|+|.++|+...            .....++|..++.++.||+.||.|||+   ++|+||||||+|||++.++.
T Consensus        89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~  165 (309)
T d1fvra_          89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYV  165 (309)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGC
T ss_pred             EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCc
Confidence            999999999999997642            123469999999999999999999999   89999999999999999999


Q ss_pred             eEEccCCCcc----------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCC-CCCCCCChhHHHHHHHHHhcC
Q 047719          429 AKLGDFEATI----------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGK-SPVDNDGCVIVDWVWNLRKKG  497 (596)
Q Consensus       429 ~kl~Dfg~~~----------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~-~p~~~~~~~~~~~~~~~~~~~  497 (596)
                      +||+|||++.          ..||..|+|||.+..+.++.++|||||||++|||++|. +||.....  .+.. .....+
T Consensus       166 ~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~--~~~~-~~i~~~  242 (309)
T d1fvra_         166 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--AELY-EKLPQG  242 (309)
T ss_dssp             EEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHH-HHGGGT
T ss_pred             eEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH--HHHH-HHHHhc
Confidence            9999999863          24899999999999999999999999999999999965 56765432  1111 111111


Q ss_pred             CchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          498 KLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       498 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                      .         +...+......+.+|+.+||+.||++||||+||++.|+..
T Consensus       243 ~---------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i  283 (309)
T d1fvra_         243 Y---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  283 (309)
T ss_dssp             C---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             C---------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            1         1122223345678888999999999999999999988754

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-47  Score=388.79  Aligned_cols=241  Identities=25%  Similarity=0.400  Sum_probs=194.5

Q ss_pred             CCCccceeecCCceEEEEEEcCC-CC----EEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEE
Q 047719          285 GFNKNRIVGEGASATVYKGSLPS-GG----AVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELV  359 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~~-g~----~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~  359 (596)
                      +|+..++||+|+||+||+|.+.. |+    .||||+++.. ......++|.+|+..+.+ ++|||||+++|+|.++ ..+
T Consensus        10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~-l~HpnIv~l~g~~~~~-~~~   86 (317)
T d1xkka_          10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMAS-VDNPHVCRLLGICLTS-TVQ   86 (317)
T ss_dssp             TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHH-CCCTTBCCEEEEEESS-SEE
T ss_pred             HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc-cCHHHHHHHHHHHHHHHh-CCCCCEeeEEEEEecC-Cee
Confidence            58888999999999999998653 43    5899988643 233456679999977765 8999999999999865 578


Q ss_pred             EEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc
Q 047719          360 LVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP  439 (596)
Q Consensus       360 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~  439 (596)
                      +++||+.+|+|.+++....   ..++|..++.++.||++||+|||+   ++|+||||||+||||+.++.+||+|||++..
T Consensus        87 ~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~  160 (317)
T d1xkka_          87 LITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKL  160 (317)
T ss_dssp             EEEECCTTCBHHHHHHHTS---SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred             EEEEeccCCcccccccccc---cCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeecccccee
Confidence            8899999999999988753   358999999999999999999999   8999999999999999999999999997532


Q ss_pred             -------------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChh-HHHHHHHHHhcCCchhhcc
Q 047719          440 -------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCV-IVDWVWNLRKKGKLLDAAD  504 (596)
Q Consensus       440 -------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~-~~~~~~~~~~~~~~~~~~d  504 (596)
                                   .||+.|||||.+.++.++.++|||||||+||||+| |+.||...... +..    ....+.      
T Consensus       161 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~----~i~~~~------  230 (317)
T d1xkka_         161 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS----ILEKGE------  230 (317)
T ss_dssp             TTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHH----HHHHTC------
T ss_pred             cccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHH----HHHcCC------
Confidence                         47899999999999999999999999999999999 89999865332 211    111221      


Q ss_pred             ccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          505 FRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       505 ~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                         +...+......+.+|+.+||+.||++|||++||++.|+..
T Consensus       231 ---~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~  270 (317)
T d1xkka_         231 ---RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  270 (317)
T ss_dssp             ---CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence               1122223345678899999999999999999999987643

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-46  Score=383.13  Aligned_cols=242  Identities=21%  Similarity=0.252  Sum_probs=196.9

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchh----cccchHHHHHHHHHhccCCCceeeecceeeeCCeE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVE----CARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNEL  358 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~----~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~  358 (596)
                      +.|...+.||+|+||+||+|... +|+.||||++++.....    ...+.+.+|+..+.+ ++|||||++++++.+.+.+
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~-l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE-IQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHH-CCCTTBCCEEEEEECSSEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHh-CCCCCCCcEEEEEEECCEE
Confidence            46888899999999999999874 58999999997543322    234568899976655 8999999999999999999


Q ss_pred             EEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCC----ceEEccC
Q 047719          359 VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEF----NAKLGDF  434 (596)
Q Consensus       359 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~----~~kl~Df  434 (596)
                      |||||||++|+|.++|....    .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++    .+||+||
T Consensus        89 ~iv~E~~~gg~L~~~i~~~~----~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~Df  161 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDF  161 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEEcCCCccccchhcccc----ccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecch
Confidence            99999999999999998754    49999999999999999999999   8999999999999998776    5999999


Q ss_pred             CCcc----------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhcc
Q 047719          435 EATI----------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAAD  504 (596)
Q Consensus       435 g~~~----------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d  504 (596)
                      |++.          ..||+.|+|||.+.+..++.++|||||||++|||++|+.||.+....  +....... ....  ..
T Consensus       162 G~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--~~~~~i~~-~~~~--~~  236 (293)
T d1jksa_         162 GLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETLANVSA-VNYE--FE  236 (293)
T ss_dssp             TTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHT-TCCC--CC
T ss_pred             hhhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH--HHHHHHHh-cCCC--CC
Confidence            9763          25889999999999999999999999999999999999999865321  11111111 1100  00


Q ss_pred             ccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          505 FRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       505 ~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      .....    .....+.+|+.+||+.||++|||++|+++
T Consensus       237 ~~~~~----~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         237 DEYFS----NTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             HHHHT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             chhcC----CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00111    12345678889999999999999999976

>d1hqla_ b.29.1.1 (A:) Legume lectin {Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]

Probab=100.00  E-value=7.3e-46  Score=361.57  Aligned_cols=175  Identities=26%  Similarity=0.438  Sum_probs=157.9

Q ss_pred             CCCCCCCcccceEEEEEEEEecCCCCCCCCeEEEEEecCCCCCCCCCCccCCCCCC-CCC--CCceEEEEeeCccCCCCC
Q 047719            1 FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPV-LSP--QDSFFAVEFDTSFDPSLG   77 (596)
Q Consensus         1 ~~~~~~~~~asF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~~~~~~~~~lG~~~~~-~~~--~~~~~AVEfDt~~~~~~~   77 (596)
                      |||+.||++|||+|+|+|.|.+. ...+||||||||+|...+++..|+|||+++.. ++.  .+++|||||||++|.+++
T Consensus        57 l~~~~t~~~asFsT~F~F~i~~~-~~~~gDGlAFvl~p~~~~~~~~G~~lGl~~~~~~~~~~~~~~vAVEFDT~~n~~~~  135 (236)
T d1hqla_          57 LWDNKTESVASFYTEFTFFLKIT-GNGPADGLAFFLAPPDSDVKDAGEYLGLFNKSTATQPSKNQVVAVEFDTWTNPNFP  135 (236)
T ss_dssp             CCCSTTCCCCEEEEEEEEEEEEC-SSCCCCEEEEEEECTTCCCCCCGGGTTTSCTTTTTCGGGCCCEEEEEECSCCSSSC
T ss_pred             eecCCCCceeEEEEEEEEEEeCC-CCCCCceEEEEEeCCCCCCCCCccccccccccccCCcccCceEEEEeeCccCCCCC
Confidence            79999999999999999999875 45679999999999877888899999999987 332  689999999999999999


Q ss_pred             CCCCCeeEEecCCccccccccCCCCCcccCCCceEEEEEEEcCCccEEEEEEeeCCCCCCCCeEEEeecCcccCCCceEE
Q 047719           78 DINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHV  157 (596)
Q Consensus        78 d~~~~Hvgid~ns~~s~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~l~~~vdl~~~l~~~~~v  157 (596)
                      ||++||||||+||+.|..+.++.  ..++.+|+.++|||+||+.+++|+|++.+.  ++.+|+|++.|||+++|+++|||
T Consensus       136 D~~~nHIgIdvns~~s~~~~~~~--~~~l~~G~~~~v~I~Yd~~~~~L~V~l~~~--~~~~~~ls~~vdL~~~l~~~v~v  211 (236)
T d1hqla_         136 EPSYRHIGINVNSIVSVATKRWE--DSDIFSGKIATARISYDGSAEILTVVLSYP--DGSDYILSHSVDMRQNLPESVRV  211 (236)
T ss_dssp             CCSSCEEEEEESSSSCSEEEECC--HHHHTSCSCEEEEEEEETTTTEEEEEEEET--TTEEEEEEEECCGGGTSCSEEEE
T ss_pred             CCCCCEEEEEcCCcccccccccc--cccccCCCEEEEEEEEeCCCcEEEEEEecC--CCCCeeEEEEeCHHHhCCCcEEE
Confidence            99999999999999998887763  467899999999999999999999999874  46678999999999999999999


Q ss_pred             EEEeecCCc-cceeeeeeeeeecc
Q 047719          158 GFSAANGQG-SAIYTVDRWRFKTF  180 (596)
Q Consensus       158 GFsastg~~-~~~~~i~~Wsf~~~  180 (596)
                      |||||||.. .+.|+|++|+|+++
T Consensus       212 GFSasTG~~~~~~h~I~sWsF~s~  235 (236)
T d1hqla_         212 GISASTGNNQFLTVYILSWRFSSN  235 (236)
T ss_dssp             EEEEECCSCCCEEEEEEEEEEEEE
T ss_pred             EEEeECCCCCceEEEEEEeEeEec
Confidence            999999975 57899999999975

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-47  Score=379.91  Aligned_cols=241  Identities=24%  Similarity=0.345  Sum_probs=192.6

Q ss_pred             cCCCccceeecCCceEEEEEEcCC----CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPS----GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELV  359 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~  359 (596)
                      ++|...+.||+|+||.||+|.+..    +..||||+++... .+...+.|.+|+..+.+ ++|||||+++|+|. .+.+|
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~E~~~l~~-l~HpnIv~l~~~~~-~~~~~   83 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQ-FDHPHIVKLIGVIT-ENPVW   83 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHT-CCCTTBCCEEEEEC-SSSCE
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc-CHHHHHHHHHHHHHHHh-CCCCCEeeEEEEEe-cCeEE
Confidence            457788999999999999998643    3468999985432 33445678999966655 89999999999996 46789


Q ss_pred             EEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc
Q 047719          360 LVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP  439 (596)
Q Consensus       360 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~  439 (596)
                      +||||+++|+|.+++....   ..+++..++.++.||++||+|||+   ++|+||||||+|||++.++.+||+|||++..
T Consensus        84 iv~E~~~~g~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~  157 (273)
T d1mp8a_          84 IIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY  157 (273)
T ss_dssp             EEEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred             EEEEeccCCcHHhhhhccC---CCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhhee
Confidence            9999999999999987653   258999999999999999999999   9999999999999999999999999997642


Q ss_pred             ------------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCCh-hHHHHHHHHHhcCCchhhccc
Q 047719          440 ------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGC-VIVDWVWNLRKKGKLLDAADF  505 (596)
Q Consensus       440 ------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~-~~~~~~~~~~~~~~~~~~~d~  505 (596)
                                  .||+.|+|||.+.++.++.++|||||||++|||+| |++||..... .+...    ...+...     
T Consensus       158 ~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~----i~~~~~~-----  228 (273)
T d1mp8a_         158 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR----IENGERL-----  228 (273)
T ss_dssp             -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH----HHTTCCC-----
T ss_pred             ccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHH----HHcCCCC-----
Confidence                        37889999999999999999999999999999998 8999986533 22211    1122111     


Q ss_pred             cccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          506 RLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       506 ~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                          ..+......+.+|+..||+.||++|||++||++.|+.
T Consensus       229 ----~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~  265 (273)
T d1mp8a_         229 ----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST  265 (273)
T ss_dssp             ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ----CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence                1222333567888999999999999999999998864

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-47  Score=386.21  Aligned_cols=248  Identities=25%  Similarity=0.345  Sum_probs=192.6

Q ss_pred             cCCCccceeecCCceEEEEEEcC------CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeC-C
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP------SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG-N  356 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~-~  356 (596)
                      ++|...+.||+|+||.||+|...      +++.||||+++.... ....+.+.+|+..+.+..+|+|||.+++++.+. .
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~-~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~   91 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   91 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC-cHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence            56788899999999999999753      246899999964332 334556888887888877899999999998765 4


Q ss_pred             eEEEEEecCCCCCHHHHhhhCCC------------CCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeec
Q 047719          357 ELVLVYEYLPNGSLDKILHNNSS------------SSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLD  424 (596)
Q Consensus       357 ~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~  424 (596)
                      .+++|||||++|+|.++|+....            ....++|.+++.++.||++||+|||+   ++|+||||||+||||+
T Consensus        92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NILl~  168 (299)
T d1ywna1          92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLS  168 (299)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEC
T ss_pred             eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCccceeEC
Confidence            68999999999999999976432            12358999999999999999999999   8999999999999999


Q ss_pred             CCCceEEccCCCcc-------------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhC-CCCCCCCChhHHHHH
Q 047719          425 AEFNAKLGDFEATI-------------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAG-KSPVDNDGCVIVDWV  490 (596)
Q Consensus       425 ~~~~~kl~Dfg~~~-------------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG-~~p~~~~~~~~~~~~  490 (596)
                      .++.+||+|||++.             ..||+.|||||.+.++.++.++|||||||++|||+|| .+||......  +.+
T Consensus       169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~--~~~  246 (299)
T d1ywna1         169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEF  246 (299)
T ss_dssp             GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS--HHH
T ss_pred             CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH--HHH
Confidence            99999999999763             2488999999999999999999999999999999996 5678654321  112


Q ss_pred             HHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          491 WNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       491 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                      ......+...         ..+......+.+++.+||+.||++|||++||++.|+.
T Consensus       247 ~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~  293 (299)
T d1ywna1         247 CRRLKEGTRM---------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  293 (299)
T ss_dssp             HHHHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHhcCCCC---------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            2222222211         1122233467788999999999999999999999875

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.2e-46  Score=389.47  Aligned_cols=241  Identities=24%  Similarity=0.301  Sum_probs=196.8

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      ++|...+.||+|+||.||+|... +|+.||||++.....  ...+.+.+|+..+.+ ++|||||++++++.+.+.+||||
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~--~~~~~~~~E~~il~~-l~HpnIv~~~~~~~~~~~~~ivm  102 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE--SDKETVRKEIQTMSV-LRHPTLVNLHDAFEDDNEMVMIY  102 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH--HHHHHHHHHHHHHHH-TCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch--hhHHHHHHHHHHHHh-CCCCCCCcEEEEEEECCEEEEEE
Confidence            46888899999999999999864 589999999965433  334568899966655 89999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecC--CCceEEccCCCcc--
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDA--EFNAKLGDFEATI--  438 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~--~~~~kl~Dfg~~~--  438 (596)
                      |||++|+|.+++....   ..+++..+..++.||+.||+|||+   ++|+||||||+|||++.  ++.+||+|||++.  
T Consensus       103 E~~~gg~L~~~l~~~~---~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~  176 (350)
T d1koaa2         103 EFMSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  176 (350)
T ss_dssp             CCCCSCBHHHHHTCTT---SCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred             EcCCCCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence            9999999999996543   249999999999999999999999   99999999999999964  5789999999864  


Q ss_pred             --------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCc
Q 047719          439 --------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGK  510 (596)
Q Consensus       439 --------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  510 (596)
                              ..||+.|||||++.+..++.++|||||||++|||++|+.||.+...  .+...........   ........
T Consensus       177 ~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--~~~~~~i~~~~~~---~~~~~~~~  251 (350)
T d1koaa2         177 DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND--DETLRNVKSCDWN---MDDSAFSG  251 (350)
T ss_dssp             CTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHTCCC---SCCGGGGG
T ss_pred             ccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH--HHHHHHHHhCCCC---CCcccccC
Confidence                    3589999999999999999999999999999999999999986532  1222222111100   01111111


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          511 FNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       511 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      +    ...+.+|+.+||+.||++|||++|+++
T Consensus       252 ~----s~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         252 I----SEDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             C----CHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             C----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            2    245678889999999999999999987

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-46  Score=382.14  Aligned_cols=240  Identities=27%  Similarity=0.396  Sum_probs=192.4

Q ss_pred             cceeecCCceEEEEEEcCCC----CEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeee-CCeEEEEEe
Q 047719          289 NRIVGEGASATVYKGSLPSG----GAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE-GNELVLVYE  363 (596)
Q Consensus       289 ~~~LG~G~fG~Vy~~~~~~g----~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~-~~~~~lV~E  363 (596)
                      .++||+|+||+||+|.+.++    ..||||++++.. .....++|.+|+..+.+ ++|||||+++|+|.+ ++..++|||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~-l~HpnIv~~~g~~~~~~~~~~lv~E  109 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKD-FSHPNVLSLLGICLRSEGSPLVVLP  109 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCC-CHHHHHHHHHHHHHHHT-CCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHh-CCCCCEeEEeEEEEecCCceEEEEE
Confidence            47899999999999987542    258999996432 34455779999977755 899999999999876 468999999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc----
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP----  439 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~----  439 (596)
                      ||++|+|.+++....   ..+++..++.++.|++.||.|||+   .+|+||||||+||||++++.+||+|||++..    
T Consensus       110 ~~~~g~l~~~~~~~~---~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~  183 (311)
T d1r0pa_         110 YMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  183 (311)
T ss_dssp             CCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred             EeecCchhhhhcccc---ccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence            999999999998653   347889999999999999999999   8999999999999999999999999997642    


Q ss_pred             -----------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhcccccc
Q 047719          440 -----------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLR  508 (596)
Q Consensus       440 -----------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  508 (596)
                                 .||..|+|||.+..+.++.++|||||||++|||+||+.|+..... ..++.... ..+...        
T Consensus       184 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~-~~~~~~~i-~~g~~~--------  253 (311)
T d1r0pa_         184 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-TFDITVYL-LQGRRL--------  253 (311)
T ss_dssp             TCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHH-HTTCCC--------
T ss_pred             ccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC-HHHHHHHH-HcCCCC--------
Confidence                       378899999999999999999999999999999998877765321 11111111 122111        


Q ss_pred             CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          509 GKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       509 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                       ..+......+.+|+.+||+.||++||+|+||++.|+..
T Consensus       254 -~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i  291 (311)
T d1r0pa_         254 -LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  291 (311)
T ss_dssp             -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence             11122234677889999999999999999999999764

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-47  Score=385.89  Aligned_cols=248  Identities=25%  Similarity=0.367  Sum_probs=197.9

Q ss_pred             cCCCccceeecCCceEEEEEEcCC--------CCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeC
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPS--------GGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG  355 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~--------g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~  355 (596)
                      ++|...+.||+|+||.||+|+...        +..||||++++.. .+....++.+|+..+.+..+|||||+++++|.++
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            456778999999999999997532        2479999997543 3344567888987887766999999999999999


Q ss_pred             CeEEEEEecCCCCCHHHHhhhCCC------------CCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceee
Q 047719          356 NELVLVYEYLPNGSLDKILHNNSS------------SSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILL  423 (596)
Q Consensus       356 ~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl  423 (596)
                      +.+++||||+++|+|.++|.....            ....+++.+++.++.||+.||+|||+   .+|+||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceee
Confidence            999999999999999999976532            12458999999999999999999999   999999999999999


Q ss_pred             cCCCceEEccCCCcc-------------cCCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHH
Q 047719          424 DAEFNAKLGDFEATI-------------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDW  489 (596)
Q Consensus       424 ~~~~~~kl~Dfg~~~-------------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~  489 (596)
                      +.++.+||+|||++.             ..||+.|+|||.+.++.++.++|||||||++|||++ |++||......   .
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~---~  245 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---E  245 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---H
T ss_pred             cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH---H
Confidence            999999999998754             247889999999999999999999999999999998 78888765432   1


Q ss_pred             HHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q 047719          490 VWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGE  547 (596)
Q Consensus       490 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~  547 (596)
                      +......+...         ..+......+.+|+.+||+.||++|||+.||++.|++.
T Consensus       246 ~~~~i~~~~~~---------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i  294 (299)
T d1fgka_         246 LFKLLKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  294 (299)
T ss_dssp             HHHHHHTTCCC---------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHcCCCC---------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence            22222222211         11222334678899999999999999999999999764

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-47  Score=380.70  Aligned_cols=244  Identities=25%  Similarity=0.329  Sum_probs=189.7

Q ss_pred             cCCCccceeecCCceEEEEEEcCC--C--CEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCCeE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPS--G--GAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNEL  358 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~--g--~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~  358 (596)
                      ++|+..+.||+|+||.||+|++..  +  ..||||++.+.... ....++|.+|+..+.+ ++|||||+++|+|.+ ...
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~-l~H~nIv~~~g~~~~-~~~   85 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS-LDHRNLIRLYGVVLT-PPM   85 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHH-CCCTTBCCEEEEECS-SSC
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHh-CCCCCEEEEEEEEee-cch
Confidence            457778899999999999997532  3  37899998754332 2345679999966655 899999999999976 467


Q ss_pred             EEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc
Q 047719          359 VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI  438 (596)
Q Consensus       359 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~  438 (596)
                      ++||||+++|+|.+++....   ..+++..++.++.|||.||.|||+   ++|+||||||+||||+.++.+||+|||++.
T Consensus        86 ~lv~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~  159 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMR  159 (273)
T ss_dssp             EEEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             heeeeeecCcchhhhhhccc---CCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhh
Confidence            89999999999999887653   259999999999999999999999   899999999999999999999999999764


Q ss_pred             c--------------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcCCchhhc
Q 047719          439 P--------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDWVWNLRKKGKLLDAA  503 (596)
Q Consensus       439 ~--------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  503 (596)
                      .              .|+..|+|||.+.+..++.++|||||||++|||+| |+.||.+....  +........+...   
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~--~~~~~i~~~~~~~---  234 (273)
T d1u46a_         160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--QILHKIDKEGERL---  234 (273)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTSCCCC---
T ss_pred             hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH--HHHHHHHhCCCCC---
Confidence            3              36788999999999999999999999999999998 89999865321  2222222322111   


Q ss_pred             cccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          504 DFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       504 d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                            ..+......+.+|+.+||+.||++||||+||.++|+.
T Consensus       235 ------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~  271 (273)
T d1u46a_         235 ------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE  271 (273)
T ss_dssp             ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence                  1112223457788999999999999999999999974

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=5.8e-46  Score=386.63  Aligned_cols=245  Identities=22%  Similarity=0.285  Sum_probs=199.2

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      +.|...+.||+|+||.||+|... +|+.||||+++....  .....+.+|+..+. .++|||||++++++.+++.+||||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~Ei~il~-~l~HpnIv~~~~~~~~~~~~~ivm  105 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP--LDKYTVKNEISIMN-QLHHPKLINLHDAFEDKYEMVLIL  105 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH--HHHHHHHHHHHHHT-TCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch--hHHHHHHHHHHHHH-hCCCCCCCcEEEEEEECCEEEEEE
Confidence            46888999999999999999864 599999999975433  23456788996554 589999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeec--CCCceEEccCCCccc-
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLD--AEFNAKLGDFEATIP-  439 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~--~~~~~kl~Dfg~~~~-  439 (596)
                      |||++|+|.+++....   ..+++.++..++.||+.||+|||+   .+|+||||||+||||+  .++.+||+|||++.. 
T Consensus       106 E~~~gg~L~~~~~~~~---~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~  179 (352)
T d1koba_         106 EFLSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKL  179 (352)
T ss_dssp             ECCCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred             EcCCCChHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceec
Confidence            9999999999886543   359999999999999999999999   9999999999999998  578999999998743 


Q ss_pred             ---------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCc
Q 047719          440 ---------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGK  510 (596)
Q Consensus       440 ---------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  510 (596)
                               .||+.|||||.+.+..++.++|||||||+||||+||+.||.+....  +....... +..      .....
T Consensus       180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--~~~~~i~~-~~~------~~~~~  250 (352)
T d1koba_         180 NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL--ETLQNVKR-CDW------EFDED  250 (352)
T ss_dssp             CTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHHHH-CCC------CCCSS
T ss_pred             CCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHh-CCC------CCCcc
Confidence                     5899999999999999999999999999999999999999875431  11111111 111      11111


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhc
Q 047719          511 FNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKG  546 (596)
Q Consensus       511 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~~  546 (596)
                      ........+.+|+.+||+.||++|||++|+++  ++++
T Consensus       251 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~  288 (352)
T d1koba_         251 AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG  288 (352)
T ss_dssp             TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred             cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence            11223345678889999999999999999987  4554

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-46  Score=383.88  Aligned_cols=248  Identities=25%  Similarity=0.373  Sum_probs=200.2

Q ss_pred             cCCCccceeecCCceEEEEEEc------CCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCe
Q 047719          284 LGFNKNRIVGEGASATVYKGSL------PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNE  357 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~  357 (596)
                      ++|...++||+|+||.||+|++      ..+..||||+++.... .....+|.+|+..+....+|||||+++|+|.+...
T Consensus        23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC-HHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence            4677789999999999999974      2356899999975433 33455788999888775589999999999999999


Q ss_pred             EEEEEecCCCCCHHHHhhhCCC--------------CCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceee
Q 047719          358 LVLVYEYLPNGSLDKILHNNSS--------------SSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILL  423 (596)
Q Consensus       358 ~~lV~E~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl  423 (596)
                      .++|||||++|+|.++|+....              ....+++..++.++.||++||+|||+   ++++||||||+|||+
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NIl~  178 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILL  178 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred             EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccccccccc
Confidence            9999999999999999986532              12358999999999999999999999   899999999999999


Q ss_pred             cCCCceEEccCCCccc-------------CCCcccCCccccccCCCCCccceeehhHHHHHHHh-CCCCCCCCChhHHHH
Q 047719          424 DAEFNAKLGDFEATIP-------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAA-GKSPVDNDGCVIVDW  489 (596)
Q Consensus       424 ~~~~~~kl~Dfg~~~~-------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~t-G~~p~~~~~~~~~~~  489 (596)
                      +.++.+|++|||.+..             .||+.|+|||.+.++.++.++|||||||++|||+| |.+|+......  +.
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~--~~  256 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD--SK  256 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS--HH
T ss_pred             cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH--HH
Confidence            9999999999997642             37889999999999999999999999999999999 55556543221  11


Q ss_pred             HHHHHhcCCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          490 VWNLRKKGKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       490 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                      +......+         .+...+......+.+|+.+||+.||++||||+||+++|++
T Consensus       257 ~~~~i~~~---------~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~  304 (311)
T d1t46a_         257 FYKMIKEG---------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK  304 (311)
T ss_dssp             HHHHHHHT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHhcC---------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            11121221         1112222234567888999999999999999999999975

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-45  Score=380.82  Aligned_cols=238  Identities=25%  Similarity=0.294  Sum_probs=197.3

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      ++|...+.||+|+||+||+|... +|+.||||++++.... ......+.+|+..+. .++|||||++++++.+.+.+|+|
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~-~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ-NTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHH-SCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHH-hCCCCCEEEEEeeeccccccccc
Confidence            46888999999999999999864 6899999999754322 234456888986664 59999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc---
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI---  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---  438 (596)
                      ||||++|+|.+++....    .+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||++.   
T Consensus        84 ~ey~~gg~L~~~~~~~~----~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~  156 (337)
T d1o6la_          84 MEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             EECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             eeccCCCchhhhhhccc----CCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccc
Confidence            99999999999998754    48899999999999999999999   999999999999999999999999999864   


Q ss_pred             --------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCc
Q 047719          439 --------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGK  510 (596)
Q Consensus       439 --------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  510 (596)
                              .+||+.|||||++.+..++.++|||||||++|||++|+.||.+.+..  + +......+..      .+...
T Consensus       157 ~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~--~-~~~~i~~~~~------~~p~~  227 (337)
T d1o6la_         157 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--R-LFELILMEEI------RFPRT  227 (337)
T ss_dssp             CTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--H-HHHHHHHCCC------CCCTT
T ss_pred             cCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH--H-HHHHHhcCCC------CCCcc
Confidence                    24899999999999999999999999999999999999999876432  1 1111111111      11122


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHH
Q 047719          511 FNRKEMERMLMVGLSCVHPNHEKRPS-----VKEAAR  542 (596)
Q Consensus       511 ~~~~~~~~l~~l~~~C~~~dp~~RPs-----~~ev~~  542 (596)
                      +    ...+.+|+..|++.||++||+     ++|+++
T Consensus       228 ~----s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         228 L----SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             S----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             C----CHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence            3    345678889999999999995     778765

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-46  Score=378.38  Aligned_cols=247  Identities=25%  Similarity=0.331  Sum_probs=189.5

Q ss_pred             CCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHH-HhccCCCceeeecceeeeCC----eEE
Q 047719          285 GFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATM-AGCLRHKNLVQLQGWCCEGN----ELV  359 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l-~~~l~H~niv~l~g~~~~~~----~~~  359 (596)
                      .|...+.||+|+||.||+|++ +|+.||||+++...     ..++..|.+.+ ...++|||||+++|+|.+.+    .+|
T Consensus         4 ~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~-----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~   77 (303)
T d1vjya_           4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW   77 (303)
T ss_dssp             GEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence            455678999999999999997 68899999995322     22334443222 23479999999999998754    689


Q ss_pred             EEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhcc-----CCCeEEccCCCCceeecCCCceEEccC
Q 047719          360 LVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC-----ERQIIHRDVKACNILLDAEFNAKLGDF  434 (596)
Q Consensus       360 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~-----~~~ivHrDlkp~NiLl~~~~~~kl~Df  434 (596)
                      +|||||++|+|.++|++.     .++|..+++++.|+|.||+|||+..     .++|+||||||+||||+.++.+||+||
T Consensus        78 lv~Ey~~~g~L~~~l~~~-----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF  152 (303)
T d1vjya_          78 LVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  152 (303)
T ss_dssp             EEEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred             EEEecccCCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence            999999999999999875     3899999999999999999999732     369999999999999999999999999


Q ss_pred             CCcc---------------cCCCcccCCccccccCC------CCCccceeehhHHHHHHHhCCCCCCCCCh---------
Q 047719          435 EATI---------------PAGTMGYLAPEYVYSGV------PSEKTDVYSFGVVALEVAAGKSPVDNDGC---------  484 (596)
Q Consensus       435 g~~~---------------~~gt~~y~aPE~~~~~~------~t~~sDV~SfGvll~El~tG~~p~~~~~~---------  484 (596)
                      |++.               ..||+.|||||++....      ++.++|||||||+||||+||..|+.....         
T Consensus       153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~  232 (303)
T d1vjya_         153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV  232 (303)
T ss_dssp             TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred             CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcc
Confidence            9653               34899999999987542      57799999999999999999987743210         


Q ss_pred             ---hHHHHHHHHHhcCCchhhccccccCc-CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          485 ---VIVDWVWNLRKKGKLLDAADFRLRGK-FNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       485 ---~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                         ...+...........    ++.+... .+.+....+.+|+.+||+.||++||||.||++.|+.
T Consensus       233 ~~~~~~~~~~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~  294 (303)
T d1vjya_         233 PSDPSVEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ  294 (303)
T ss_dssp             CSSCCHHHHHHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred             cccchHHHHHHHHhcccc----CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence               111112222211111    1111111 123456678899999999999999999999998874

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1e-44  Score=371.96  Aligned_cols=238  Identities=23%  Similarity=0.298  Sum_probs=196.3

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      ++|...+.||+|+||+||+|+.. +|+.||||++++.... ....+.+.+|+..+ +.++|||||++++++.+.+.+|+|
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il-~~l~HpnIv~~~~~~~~~~~~~iv   82 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLML-SIVTHPFIIRMWGTFQDAQQIFMI   82 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHH-HSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHH-HhccCcChhheeeeEeeCCeeeeE
Confidence            45888899999999999999864 5899999999754322 23345678888555 459999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc---
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI---  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---  438 (596)
                      ||||++|+|..++....    .+++..+..++.||+.||+|||+   ++|+||||||+||||+.++.+||+|||++.   
T Consensus        83 mE~~~gg~l~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~  155 (316)
T d1fota_          83 MDYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP  155 (316)
T ss_dssp             ECCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred             eeecCCccccccccccc----cccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEec
Confidence            99999999999998765    47888999999999999999999   899999999999999999999999999864   


Q ss_pred             -----cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCH
Q 047719          439 -----PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNR  513 (596)
Q Consensus       439 -----~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  513 (596)
                           ..||+.|||||.+.+..++.++|||||||+||||++|+.||.+....  +...... .+.      ......+  
T Consensus       156 ~~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~~i~-~~~------~~~p~~~--  224 (316)
T d1fota_         156 DVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM--KTYEKIL-NAE------LRFPPFF--  224 (316)
T ss_dssp             SCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHH-HCC------CCCCTTS--
T ss_pred             cccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH--HHHHHHH-cCC------CCCCCCC--
Confidence                 45999999999999999999999999999999999999999875431  1111111 111      1111222  


Q ss_pred             HHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 047719          514 KEMERMLMVGLSCVHPNHEKRP-----SVKEAAR  542 (596)
Q Consensus       514 ~~~~~l~~l~~~C~~~dp~~RP-----s~~ev~~  542 (596)
                        ...+.+++.+|++.||++||     |++++++
T Consensus       225 --s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         225 --NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             --CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             --CHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence              24567788899999999996     8999876

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-46  Score=381.65  Aligned_cols=249  Identities=25%  Similarity=0.371  Sum_probs=201.9

Q ss_pred             cCCCccceeecCCceEEEEEEcC------CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCe
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP------SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNE  357 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~  357 (596)
                      ++|...+.||+|+||+||+|.+.      ++..||||++++.. .......|.+|+..+.+ ++|||||+++|+|.....
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~-l~h~nIv~~~~~~~~~~~   97 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKE-FNCHHVVRLLGVVSQGQP   97 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGG-CCCTTBCCEEEEECSSSS
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHH-cCCCCEeeeeeEEecCCc
Confidence            46677899999999999999763      25789999997543 33445578999966655 899999999999999999


Q ss_pred             EEEEEecCCCCCHHHHhhhCC------CCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEE
Q 047719          358 LVLVYEYLPNGSLDKILHNNS------SSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKL  431 (596)
Q Consensus       358 ~~lV~E~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl  431 (596)
                      .++|||||++|+|.+++....      .....++|..++.++.|+|+||.|||+   ++|+||||||+||||++++++||
T Consensus        98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl  174 (308)
T d1p4oa_          98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKI  174 (308)
T ss_dssp             CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEE
T ss_pred             eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEE
Confidence            999999999999999986532      112357999999999999999999999   89999999999999999999999


Q ss_pred             ccCCCccc-------------CCCcccCCccccccCCCCCccceeehhHHHHHHHhC-CCCCCCCChhHHHHHHHHHhcC
Q 047719          432 GDFEATIP-------------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAG-KSPVDNDGCVIVDWVWNLRKKG  497 (596)
Q Consensus       432 ~Dfg~~~~-------------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG-~~p~~~~~~~~~~~~~~~~~~~  497 (596)
                      +|||++..             .||+.|+|||.+.++.++.++|||||||++|||+|| +.||.....  .++..... .+
T Consensus       175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~--~~~~~~i~-~~  251 (308)
T d1p4oa_         175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--EQVLRFVM-EG  251 (308)
T ss_dssp             CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH--HHHHHHHH-TT
T ss_pred             eecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH--HHHHHHHH-hC
Confidence            99998642             378999999999999999999999999999999997 577765432  22222222 22


Q ss_pred             CchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Q 047719          498 KLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKGEAP  549 (596)
Q Consensus       498 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~~~~  549 (596)
                      ....         .+......+.+|+.+||+.||++||||++|++.|+....
T Consensus       252 ~~~~---------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         252 GLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             CCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             CCCC---------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            2211         112223568888999999999999999999999987644

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=2.8e-45  Score=369.60  Aligned_cols=246  Identities=25%  Similarity=0.301  Sum_probs=195.9

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCC----e
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGN----E  357 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~----~  357 (596)
                      +.|...+.||+|+||+||+|... +|+.||||++++.... ......+.+|+..+.. ++|||||++++++...+    .
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~-~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA-LNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHT-CCCTTBCCEEEEEEEECSSSEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHh-cCCCCCCcccceeeeccCCCce
Confidence            45888899999999999999864 6899999999754432 2334568899977655 99999999999988654    4


Q ss_pred             EEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCc
Q 047719          358 LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT  437 (596)
Q Consensus       358 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~  437 (596)
                      .||||||+++|+|.+++....    .+++.+++.++.||+.||+|||+   ++|+||||||+|||++.++..+|+|||..
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~----~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~  158 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIA  158 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred             EEEEEECCCCCEehhhhcccC----CCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhh
Confidence            899999999999999997754    48999999999999999999999   99999999999999999999999999854


Q ss_pred             c--------------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhc
Q 047719          438 I--------------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAA  503 (596)
Q Consensus       438 ~--------------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  503 (596)
                      .              ..||+.|||||.+.+..++.++|||||||++|||+||+.||.....  .+.............  
T Consensus       159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--~~~~~~~~~~~~~~~--  234 (277)
T d1o6ya_         159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP--VSVAYQHVREDPIPP--  234 (277)
T ss_dssp             EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHCCCCCG--
T ss_pred             hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH--HHHHHHHHhcCCCCC--
Confidence            2              2589999999999999999999999999999999999999986542  222222222221110  


Q ss_pred             cccccCcCCHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHhc
Q 047719          504 DFRLRGKFNRKEMERMLMVGLSCVHPNHEKRP-SVKEAARILKG  546 (596)
Q Consensus       504 d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RP-s~~ev~~~L~~  546 (596)
                       ......+    ...+.+++.+|++.||++|| |++++++.|.+
T Consensus       235 -~~~~~~~----s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         235 -SARHEGL----SADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             -GGTSSSC----CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             -chhccCC----CHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence             1111222    34567788899999999999 89999887764

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=4.8e-45  Score=381.52  Aligned_cols=242  Identities=20%  Similarity=0.256  Sum_probs=191.4

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchh-cccchHHHHHH--HHHhccCCCceeeecceeeeCCeEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVE-CARNPFTTEFA--TMAGCLRHKNLVQLQGWCCEGNELV  359 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~-~~~~~~~~E~~--~l~~~l~H~niv~l~g~~~~~~~~~  359 (596)
                      ++|...++||+|+||.||+|+.. +|+.||||++.+..... .....+.+|..  .+.+.++|||||++++++.+.+.+|
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            46888999999999999999865 58999999996533222 22233444432  3445578999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc-
Q 047719          360 LVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI-  438 (596)
Q Consensus       360 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~-  438 (596)
                      +|||||++|+|.++|....    .+++..+..++.||+.||+|||+   ++|+||||||+||||+.++.+||+|||++. 
T Consensus        84 ivmE~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~  156 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACD  156 (364)
T ss_dssp             EEECCCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred             EEEEecCCCcHHHHHHhcc----cccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeee
Confidence            9999999999999998754    48899999999999999999999   999999999999999999999999999764 


Q ss_pred             --------cCCCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccC
Q 047719          439 --------PAGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRG  509 (596)
Q Consensus       439 --------~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  509 (596)
                              ..||+.|||||.+.. ..++.++|||||||+||||+||+.||..........+.......      ......
T Consensus       157 ~~~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~------~~~~~~  230 (364)
T d1omwa3         157 FSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM------AVELPD  230 (364)
T ss_dssp             CSSSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSC------CCCCCS
T ss_pred             cCCCcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC------CCCCCC
Confidence                    359999999999975 56899999999999999999999999764321111111111110      011112


Q ss_pred             cCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHH
Q 047719          510 KFNRKEMERMLMVGLSCVHPNHEKRPS-----VKEAAR  542 (596)
Q Consensus       510 ~~~~~~~~~l~~l~~~C~~~dp~~RPs-----~~ev~~  542 (596)
                      .+    ...+.+|+.+||+.||++|||     ++|+++
T Consensus       231 ~~----s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         231 SF----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             SS----CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             CC----CHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence            23    345678889999999999999     688865

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-45  Score=378.15  Aligned_cols=239  Identities=21%  Similarity=0.271  Sum_probs=197.4

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCc-hhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNR-VECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      ++|...+.||+|+||+||+|... +|+.||||++++... .+...+.+..|+..+...++|||||++++++.+++.+|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            46888899999999999999875 588999999975332 2233445777876777679999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc---
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI---  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---  438 (596)
                      ||||++|+|.+++....    .+++.++..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||++.   
T Consensus        82 mEy~~~g~L~~~i~~~~----~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~  154 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENM  154 (320)
T ss_dssp             EECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EeecCCCcHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhcc
Confidence            99999999999998754    48899999999999999999999   899999999999999999999999999764   


Q ss_pred             --------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCc
Q 047719          439 --------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGK  510 (596)
Q Consensus       439 --------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  510 (596)
                              ..||+.|+|||.+.+..++.++|||||||++|||++|+.||.+.....   +......+.      +.....
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~---~~~~i~~~~------~~~p~~  225 (320)
T d1xjda_         155 LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---LFHSIRMDN------PFYPRW  225 (320)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHCC------CCCCTT
T ss_pred             cccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH---HHHHHHcCC------CCCCcc
Confidence                    358999999999999999999999999999999999999998754321   111111111      111112


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHH-HHHH
Q 047719          511 FNRKEMERMLMVGLSCVHPNHEKRPSVK-EAAR  542 (596)
Q Consensus       511 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~-ev~~  542 (596)
                      +    ...+.+|+.+||+.||++||+++ |+++
T Consensus       226 ~----s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         226 L----EKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             S----CHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             C----CHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence            2    34577888999999999999995 6753

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=3.7e-45  Score=368.27  Aligned_cols=243  Identities=24%  Similarity=0.303  Sum_probs=195.7

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchh-------cccchHHHHHHHHHhccCCCceeeecceeeeC
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVE-------CARNPFTTEFATMAGCLRHKNLVQLQGWCCEG  355 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~-------~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~  355 (596)
                      ++|+..+.||+|+||+||+|+.. +|+.||||++++.....       ...+.+.+|+..+.+.-.|||||++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            46888899999999999999864 68899999997654322       12335788997777633499999999999999


Q ss_pred             CeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCC
Q 047719          356 NELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFE  435 (596)
Q Consensus       356 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg  435 (596)
                      +.+|||||||++|+|.++|..+.    .+++.++..++.||++||+|||+   ++|+||||||+|||++.++.+||+|||
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG  155 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFG  155 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             cceEEEEEcCCCchHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccch
Confidence            99999999999999999998654    48999999999999999999999   899999999999999999999999999


Q ss_pred             Ccc----------cCCCcccCCcccccc------CCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCc
Q 047719          436 ATI----------PAGTMGYLAPEYVYS------GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKL  499 (596)
Q Consensus       436 ~~~----------~~gt~~y~aPE~~~~------~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~  499 (596)
                      ++.          ..||..|+|||.+.+      ..++.++||||+||++|||++|+.||.+.....   .......+..
T Consensus       156 ~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~---~~~~i~~~~~  232 (277)
T d1phka_         156 FSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML---MLRMIMSGNY  232 (277)
T ss_dssp             TCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHTCC
T ss_pred             heeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH---HHHHHHhCCC
Confidence            764          348899999998863      356899999999999999999999998764321   1111111111


Q ss_pred             hhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          500 LDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       500 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      .      ............+.+++.+||++||++|||++||++
T Consensus       233 ~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         233 Q------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             C------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             C------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            0      001111122346778889999999999999999865

>d1leda_ b.29.1.1 (A:) Legume lectin {West-central african legume (Griffonia simplicifolia) [TaxId: 3850]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: West-central african legume (Griffonia simplicifolia) [TaxId: 3850]

Probab=100.00  E-value=8.7e-45  Score=355.11  Aligned_cols=174  Identities=26%  Similarity=0.394  Sum_probs=155.8

Q ss_pred             CCCCCCCcccceEEEEEEEEecCCCCCCCCeEEEEEecCCCCCCCCCCccCCCCCC-CCC--CCceEEEEeeCccCCCCC
Q 047719            1 FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPV-LSP--QDSFFAVEFDTSFDPSLG   77 (596)
Q Consensus         1 ~~~~~~~~~asF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~~~~~~~~~lG~~~~~-~~~--~~~~~AVEfDt~~~~~~~   77 (596)
                      |||+ |+++|||+|+|+|.|.+. ...+||||||||+|.+.+.+..|+|||+++.. +++  .+++|||||||++|.+++
T Consensus        62 l~~~-t~~~asFsT~F~f~i~~~-~~~~gdGlAF~l~p~~~~~~~~g~~lGl~~~~~~~~~~~~~~vAVEFDT~~n~~~~  139 (243)
T d1leda_          62 LWDS-TGKAASFYTSFTFLLKNY-GAPTADGLAFFLAPVDSSVKDYGGFLGLFRHETAADPSKNQVVAVEFDTWINKDWN  139 (243)
T ss_dssp             CBCT-TSCBCEEEEEEEEEEEES-SSSCBCEEEEEEEETTCCCCCCGGGTTTCCTTTTTCGGGCCCEEEEEECSCCGGGT
T ss_pred             ecCC-CCcEeeEEEEEEEEcCCC-CCCCCCceEEEEcCCCCCCCCCccccccccccccCCCccCcEEEEEEeCccccccC
Confidence            6884 899999999999988765 45679999999999877788899999999887 333  689999999999999889


Q ss_pred             CCCCCeeEEecCCccccccccCCCCCcccCCCceEEEEEEEcCCccEEEEEEeeCCCCCCCCeEEEeecCcccCCCceEE
Q 047719           78 DINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHV  157 (596)
Q Consensus        78 d~~~~Hvgid~ns~~s~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~l~~~vdl~~~l~~~~~v  157 (596)
                      ||++||||||+|++.|..+.++.  ..++.+|+.++|||+||+.+++|+|++.+.  ++..|+|++.|||+++|+++|||
T Consensus       140 d~~~nHVgIdvns~~s~~~~~~~--~~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~--~~~~p~ls~~idL~~~l~~~vyv  215 (243)
T d1leda_         140 DPPYPHIGIDVNSIVSVATTRWE--NDDAYGSSIATAHITYDARSKILTVLLSYE--HGRDYILSHVVDLAKVLPQKVRI  215 (243)
T ss_dssp             CCSSCEEEEEESSSSCSEEEECC--HHHHTSCCEEEEEEEEETTTTEEEEEEEET--TSCEEEEEEECCHHHHSCSEEEE
T ss_pred             CCCCCceEEEecCcccccccccc--cCCcccCceeEEEEEEECCCCEEEEEEeeC--CCCCceEEEecCHHHhcCCcEEE
Confidence            99999999999999999888763  357899999999999999999999999874  56788999999999999999999


Q ss_pred             EEEeecCCccceeeeeeeeeeccC
Q 047719          158 GFSAANGQGSAIYTVDRWRFKTFE  181 (596)
Q Consensus       158 GFsastg~~~~~~~i~~Wsf~~~~  181 (596)
                      |||||||. .|.|+|++|+|+++.
T Consensus       216 GFSAsTG~-~~~h~I~sWsF~s~l  238 (243)
T d1leda_         216 GFSAGVGY-DEVTYILSWHFFSTL  238 (243)
T ss_dssp             EEEEEECB-SEEEEEEEEEEEEEC
T ss_pred             EEEcccCC-cceeeEEEEEEEeeC
Confidence            99999995 699999999999875

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.3e-44  Score=374.38  Aligned_cols=238  Identities=24%  Similarity=0.269  Sum_probs=196.9

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCch-hcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRV-ECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      ++|...+.||+|+||.||+|... +|+.||||++.+.... ....+.+.+|+..+ +.++|||||++++++.+....++|
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il-~~l~hpnIv~~~~~~~~~~~~~~v  119 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRIL-QAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHH-TTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHH-HHcCCCcEeecccccccccccccc
Confidence            36888899999999999999865 5999999999654322 23345688898665 458999999999999999999999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc---
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI---  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~---  438 (596)
                      |||+.+|+|.+++....    .+++..+..++.||+.||.|||+   .+|+||||||+||||+.++.+||+|||++.   
T Consensus       120 ~e~~~~g~l~~~l~~~~----~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~  192 (350)
T d1rdqe_         120 MEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK  192 (350)
T ss_dssp             EECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             cccccccchhhhHhhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeecc
Confidence            99999999999998754    48999999999999999999999   899999999999999999999999999864   


Q ss_pred             -----cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCcCCH
Q 047719          439 -----PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGKFNR  513 (596)
Q Consensus       439 -----~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  513 (596)
                           ..||+.|||||++.+..++.++|||||||+||||+||+.||.+...  ......... +.      ......+  
T Consensus       193 ~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~--~~~~~~i~~-~~------~~~p~~~--  261 (350)
T d1rdqe_         193 GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP--IQIYEKIVS-GK------VRFPSHF--  261 (350)
T ss_dssp             SCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHH-CC------CCCCTTC--
T ss_pred             cccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH--HHHHHHHhc-CC------CCCCccC--
Confidence                 3489999999999999999999999999999999999999987542  111112211 11      1111222  


Q ss_pred             HHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 047719          514 KEMERMLMVGLSCVHPNHEKRP-----SVKEAAR  542 (596)
Q Consensus       514 ~~~~~l~~l~~~C~~~dp~~RP-----s~~ev~~  542 (596)
                        ...+.+++.+|++.||++|+     |++++++
T Consensus       262 --s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         262 --SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             --CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             --CHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence              34567888899999999994     8999976

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-45  Score=370.54  Aligned_cols=249  Identities=22%  Similarity=0.265  Sum_probs=187.9

Q ss_pred             cceeecCCceEEEEEEcC-CCCEEEEEEeecCCchh---cccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEec
Q 047719          289 NRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVE---CARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYEY  364 (596)
Q Consensus       289 ~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~---~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E~  364 (596)
                      .++||+|+||+||+|... +|+.||||+++......   ...+.+.+|+..+.. ++|||||++++++..++.+||||||
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~-l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE-LSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHH-CCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHh-CCCCCEeEEEeeeccCCceeehhhh
Confidence            478999999999999875 58999999996543322   224568899966655 9999999999999999999999999


Q ss_pred             CCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc-----
Q 047719          365 LPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP-----  439 (596)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~-----  439 (596)
                      +.++++..++...    ..+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||.+..     
T Consensus        82 ~~~~~~~~~~~~~----~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~  154 (299)
T d1ua2a_          82 METDLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN  154 (299)
T ss_dssp             CSEEHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred             hcchHHhhhhhcc----cCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCc
Confidence            9988777666543    248888999999999999999999   9999999999999999999999999997632     


Q ss_pred             ------CCCcccCCccccccC-CCCCccceeehhHHHHHHHhCCCCCCCCChh-HHHHHHHHHhcCCchh---------h
Q 047719          440 ------AGTMGYLAPEYVYSG-VPSEKTDVYSFGVVALEVAAGKSPVDNDGCV-IVDWVWNLRKKGKLLD---------A  502 (596)
Q Consensus       440 ------~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~El~tG~~p~~~~~~~-~~~~~~~~~~~~~~~~---------~  502 (596)
                            .||+.|+|||.+... .++.++|||||||++|||++|+.||...... ....+...........         .
T Consensus       155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~  234 (299)
T d1ua2a_         155 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY  234 (299)
T ss_dssp             CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred             ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchh
Confidence                  489999999998754 5799999999999999999999999865431 1111111111110000         0


Q ss_pred             ccccccCcCCH-----HHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHh
Q 047719          503 ADFRLRGKFNR-----KEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILK  545 (596)
Q Consensus       503 ~d~~l~~~~~~-----~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~  545 (596)
                      .........+.     .....+.+|+.+|++.||++|||++|+++  +++
T Consensus       235 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~  284 (299)
T d1ua2a_         235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS  284 (299)
T ss_dssp             CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGT
T ss_pred             hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhC
Confidence            00000001111     12346788899999999999999999987  565

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-45  Score=377.54  Aligned_cols=252  Identities=19%  Similarity=0.238  Sum_probs=195.5

Q ss_pred             cCCCcc-ceeecCCceEEEEEEc-CCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeee----CCe
Q 047719          284 LGFNKN-RIVGEGASATVYKGSL-PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE----GNE  357 (596)
Q Consensus       284 ~~f~~~-~~LG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~----~~~  357 (596)
                      ++|... ++||+|+||+||+|.. .+++.||||++++.       ..+.+|+..+.+..+|||||++++++.+    ...
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~   83 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   83 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence            467654 5699999999999976 46899999999532       3467788777776799999999999875    467


Q ss_pred             EEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecC---CCceEEccC
Q 047719          358 LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDA---EFNAKLGDF  434 (596)
Q Consensus       358 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~---~~~~kl~Df  434 (596)
                      +|||||||++|+|.++|....  ...+++.++..++.||+.||+|||+   .+|+||||||+|||++.   ++.+||+||
T Consensus        84 ~~ivmEy~~gg~L~~~i~~~~--~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DF  158 (335)
T d2ozaa1          84 LLIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDF  158 (335)
T ss_dssp             EEEEEECCCSEEHHHHHHSCS--CCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred             EEEEEECCCCCcHHHHHHhcC--CCCcCHHHHHHHHHHHHHHHHHHHH---cCCcccccccccccccccccccccccccc
Confidence            899999999999999998653  2359999999999999999999999   99999999999999986   467999999


Q ss_pred             CCcc----------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChh-HHHHHHHHHhcCCchhhc
Q 047719          435 EATI----------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV-IVDWVWNLRKKGKLLDAA  503 (596)
Q Consensus       435 g~~~----------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~-~~~~~~~~~~~~~~~~~~  503 (596)
                      |++.          ..||+.|||||++.+..++.++|||||||+||||+||+.||.+.... ...........+      
T Consensus       159 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~------  232 (335)
T d2ozaa1         159 GFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG------  232 (335)
T ss_dssp             TTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSC------
T ss_pred             ceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcC------
Confidence            9764          35999999999999989999999999999999999999999764321 111110000000      


Q ss_pred             cccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhcCCCCCCC
Q 047719          504 DFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKGEAPLPLL  553 (596)
Q Consensus       504 d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~~~~~~p~~  553 (596)
                      ...............+.+|+.+|++.||++|||++|+++  ++......+..
T Consensus       233 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~~  284 (335)
T d2ozaa1         233 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQT  284 (335)
T ss_dssp             SSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTSSCCC
T ss_pred             CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCCCCCC
Confidence            000111111223456788899999999999999999988  45544444443

>d1fx5a_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-I [TaxId: 3902]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Furze (Ulex europaeus), UEA-I [TaxId: 3902]

Probab=100.00  E-value=6.1e-44  Score=349.91  Aligned_cols=177  Identities=27%  Similarity=0.309  Sum_probs=157.8

Q ss_pred             CCCCCCCcccceEEEEEEEEecC-CCCCCCCeEEEEEecCCCCCCCCCCccCCCCCCCCC-CCceEEEEeeCccCC-CCC
Q 047719            1 FLDPKTNTTASFSCRFSFSIIPS-PLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSP-QDSFFAVEFDTSFDP-SLG   77 (596)
Q Consensus         1 ~~~~~~~~~asF~t~F~f~i~~~-~~~~~g~G~aF~l~~~~~~~~~~~~~lG~~~~~~~~-~~~~~AVEfDt~~~~-~~~   77 (596)
                      |||+.+|+++||+|+|+|.|... ....+||||||||+|...+.+.+|+||||++..+++ .+++|||||||++|+ +++
T Consensus        57 l~~~~t~~~~sF~t~F~f~i~~~~~~~~ggdG~AFvl~p~~~~~~~~g~~lGl~~~~~~~~~~~~vAVEFDT~~n~~~~~  136 (240)
T d1fx5a_          57 IWNCNTGELASFITSFSFFMETSANPKAATDGLTFFLAPPDSPLRRAGGYFGLFNDTKCDSSYQTVAVEFDTIGSPVNFW  136 (240)
T ss_dssp             CEETTTTEECEEEEEEEEEEEESSCGGGCCCEEEEEEECTTCCCCBCGGGTTTBSSSCCCGGGCCEEEEEECCCTTTSTT
T ss_pred             eecCCCCceeeeEEEEEEEEeCCCCCCCCCCcEEEEECCCCCCCCCCCccccccccCCCCccCceEEEEeeccccccccC
Confidence            69999999999999999999755 345678999999999877888999999999887443 788999999999985 678


Q ss_pred             CCCCCeeEEecCCccccccccCCCCCcccCCCceEEEEEEEcCCccEEEEEEeeCCCCCCCCeEEEeecCcccCCCceEE
Q 047719           78 DINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHV  157 (596)
Q Consensus        78 d~~~~Hvgid~ns~~s~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~l~~~vdl~~~l~~~~~v  157 (596)
                      ||++||||||+||+.+..+.++   ...+.+|+.++|||+||+.+++|.|++.+.. ++..|+|+..|||+.+|+++|||
T Consensus       137 D~~~nHIgid~ns~~s~~~~~~---~~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~~~ls~~vdLs~~l~~~v~v  212 (240)
T d1fx5a_         137 DPGFPHIGIDVNCVKSINAERW---NKRYGLNNVANVEIIYEASSKTLTASLTYPS-DQTSISVTSIVDLKEILPEWVSV  212 (240)
T ss_dssp             SCSSCEEEEEESSSSCSEEEEC---CCCCSGGGCEEEEEEEETTTTEEEEEEEETT-TTEEEEEEEECCGGGTSCSEEEE
T ss_pred             CCCCCceEEccCCccccccccc---ccccCCCCeEEEEEEEcCCCCEEEEEEecCC-CceeeEEeEEEchHHhCCCcEEE
Confidence            9999999999999999887775   4578899999999999999999999998754 66788999999999999999999


Q ss_pred             EEEeecCC-ccceeeeeeeeeeccC
Q 047719          158 GFSAANGQ-GSAIYTVDRWRFKTFE  181 (596)
Q Consensus       158 GFsastg~-~~~~~~i~~Wsf~~~~  181 (596)
                      |||||||. ..|.|+|++|+|+++.
T Consensus       213 GFSasTG~~~~~~H~I~sWsFsst~  237 (240)
T d1fx5a_         213 GFSGSTYIGRQATHEVLNWYFTSTF  237 (240)
T ss_dssp             EEEEEEETTSCEEEEEEEEEEEEES
T ss_pred             EEEeECCCCCCceEEEEEEEeEEec
Confidence            99999995 5689999999999864

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-44  Score=368.82  Aligned_cols=244  Identities=19%  Similarity=0.211  Sum_probs=196.6

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      ++|...+.||+|+||+||+|... +|+.||||+++....   ....+.+|+..+.. ++|||||++++++.+.+.+||||
T Consensus         5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~---~~~~~~~Ei~il~~-l~HpnIv~~~~~~~~~~~~~lvm   80 (321)
T d1tkia_           5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT---DQVLVKKEISILNI-ARHRNILHLHESFESMEELVMIF   80 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH---HHHHHHHHHHHHHH-SCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc---cHHHHHHHHHHHHh-CCCCCCCeEEEEEEECCEEEEEE
Confidence            46788899999999999999865 588999999965432   23457889866654 99999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCC--CceEEccCCCccc-
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAE--FNAKLGDFEATIP-  439 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~--~~~kl~Dfg~~~~-  439 (596)
                      |||++|+|.++|....   ..+++.++..++.||++||+|||+   .+|+||||||+|||++.+  ..+||+|||++.. 
T Consensus        81 E~~~gg~L~~~i~~~~---~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~  154 (321)
T d1tkia_          81 EFISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL  154 (321)
T ss_dssp             CCCCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred             ecCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhcc
Confidence            9999999999997653   248999999999999999999999   999999999999999854  5899999998643 


Q ss_pred             ---------CCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhccccccCc
Q 047719          440 ---------AGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAADFRLRGK  510 (596)
Q Consensus       440 ---------~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  510 (596)
                               .||+.|+|||.+.+..++.++|||||||++|||++|+.||......  +...........   .+......
T Consensus       155 ~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~--~~~~~i~~~~~~---~~~~~~~~  229 (321)
T d1tkia_         155 KPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ--QIIENIMNAEYT---FDEEAFKE  229 (321)
T ss_dssp             CTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHHTCCC---CCHHHHTT
T ss_pred             ccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCCCC---CChhhccC
Confidence                     4889999999999999999999999999999999999999875431  111122111100   00000111


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhc
Q 047719          511 FNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKG  546 (596)
Q Consensus       511 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~~  546 (596)
                      +    ...+.+|+..|++.||++|||++|+++  +++.
T Consensus       230 ~----s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~  263 (321)
T d1tkia_         230 I----SIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             S----CHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             C----CHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence            2    245678889999999999999999987  5553

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-43  Score=359.98  Aligned_cols=256  Identities=23%  Similarity=0.308  Sum_probs=191.6

Q ss_pred             cCCCccceeecCCceEEEEEEc-CCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSL-PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      ++|...+.||+|+||+||+|.. .+|+.||||+++.....+.....+.+|+..+. .++|||||++++++.+...+|+||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~-~l~Hp~Iv~~~~~~~~~~~~~iv~   80 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK-ELNHPNIVKLLDVIHTENKLYLVF   80 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHT-TCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHH-hCCCCcEEEeccccccccceeEEE
Confidence            4688889999999999999986 46899999999765544455677899996664 599999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc----
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI----  438 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~----  438 (596)
                      ||+.+ ++.+++....  ...+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||.+.    
T Consensus        81 e~~~~-~~~~~~~~~~--~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~  154 (298)
T d1gz8a_          81 EFLHQ-DLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV  154 (298)
T ss_dssp             ECCSE-EHHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred             eecCC-chhhhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccC
Confidence            99975 5555554433  2359999999999999999999999   899999999999999999999999999652    


Q ss_pred             -------cCCCcccCCccccccCC-CCCccceeehhHHHHHHHhCCCCCCCCChhHH-HHHHHHHhcCCc------hhhc
Q 047719          439 -------PAGTMGYLAPEYVYSGV-PSEKTDVYSFGVVALEVAAGKSPVDNDGCVIV-DWVWNLRKKGKL------LDAA  503 (596)
Q Consensus       439 -------~~gt~~y~aPE~~~~~~-~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~-~~~~~~~~~~~~------~~~~  503 (596)
                             ..||+.|+|||.+.... ++.++|||||||++|||++|+.||.+....-. .-.........-      ....
T Consensus       155 ~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  234 (298)
T d1gz8a_         155 PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP  234 (298)
T ss_dssp             CSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             CcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccc
Confidence                   35899999999877654 58999999999999999999999986543111 001111111000      0000


Q ss_pred             ccc--cc--CcC-----CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhc
Q 047719          504 DFR--LR--GKF-----NRKEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKG  546 (596)
Q Consensus       504 d~~--l~--~~~-----~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~~  546 (596)
                      +..  ..  ...     .......+.+|+.+|++.||++|||++|+++  +++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~  288 (298)
T d1gz8a_         235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD  288 (298)
T ss_dssp             TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTT
T ss_pred             ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhcc
Confidence            000  00  000     0012246678889999999999999999988  4653

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.4e-43  Score=358.75  Aligned_cols=251  Identities=21%  Similarity=0.256  Sum_probs=195.9

Q ss_pred             cCCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEEe
Q 047719          284 LGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVYE  363 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~E  363 (596)
                      ++|...+.||+|+||+||+|..++|+.||||+++.....+...+.+.+|+..+. .++|||||++++++...+..++++|
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~-~l~hpnIv~~~~~~~~~~~~~i~~e   80 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILK-ELKHSNIVKLYDVIHTKKRLVLVFE   80 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGG-GCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHH-hCCCCcEEeeeeecccCCceeEEEE
Confidence            467788999999999999999888999999999766555555678899996654 5999999999999999999999999


Q ss_pred             cCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc-----
Q 047719          364 YLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI-----  438 (596)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~-----  438 (596)
                      |+.++.+..+.....    .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||.+.     
T Consensus        81 ~~~~~~~~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~  153 (286)
T d1ob3a_          81 HLDQDLKKLLDVCEG----GLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIP  153 (286)
T ss_dssp             CCSEEHHHHHHTSTT----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred             eehhhhHHHHHhhcC----CcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccC
Confidence            998877777765443    49999999999999999999999   899999999999999999999999999752     


Q ss_pred             ------cCCCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCChh-HHHHHHHHHhcCCchhhc-------
Q 047719          439 ------PAGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV-IVDWVWNLRKKGKLLDAA-------  503 (596)
Q Consensus       439 ------~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~-~~~~~~~~~~~~~~~~~~-------  503 (596)
                            ..|++.|+|||.+.. ..++.++|||||||++|||++|+.||.+.... ...-..............       
T Consensus       154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  233 (286)
T d1ob3a_         154 VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK  233 (286)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             ccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhh
Confidence                  247889999999875 45699999999999999999999999865321 111111111111000000       


Q ss_pred             -cc-------cccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          504 -DF-------RLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       504 -d~-------~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                       ..       .............+.+++.+|++.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             00       0000111122346778899999999999999999974

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-44  Score=360.40  Aligned_cols=232  Identities=22%  Similarity=0.335  Sum_probs=188.9

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchh----cccchHHHHHHHHHhccC--CCceeeecceeeeCC
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVE----CARNPFTTEFATMAGCLR--HKNLVQLQGWCCEGN  356 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~----~~~~~~~~E~~~l~~~l~--H~niv~l~g~~~~~~  356 (596)
                      ++|...++||+|+||+||+|... +|+.||||++.+.....    .....+.+|+..+.+ ++  |||||++++++.+.+
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~-l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK-VSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHH-HCSSSCSBCCEEEEEECSS
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHH-hccCCCCccEEEEEEeeCC
Confidence            46888899999999999999864 68999999997543222    122346788866655 54  999999999999999


Q ss_pred             eEEEEEecCCC-CCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCC-CceEEccC
Q 047719          357 ELVLVYEYLPN-GSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAE-FNAKLGDF  434 (596)
Q Consensus       357 ~~~lV~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~-~~~kl~Df  434 (596)
                      ..++||||+.+ +++.+++....    .+++.++..++.||++||+|||+   ++|+||||||+|||++.+ +.+||+||
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~~----~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DF  155 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDF  155 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             eEEEEEEeccCcchHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECcc
Confidence            99999999975 68888887653    48999999999999999999999   999999999999999855 79999999


Q ss_pred             CCcc---------cCCCcccCCccccccCCC-CCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCchhhcc
Q 047719          435 EATI---------PAGTMGYLAPEYVYSGVP-SEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLLDAAD  504 (596)
Q Consensus       435 g~~~---------~~gt~~y~aPE~~~~~~~-t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d  504 (596)
                      |++.         ..||+.|+|||++.+..+ +.++|||||||++|||++|+.||.....        ... +.      
T Consensus       156 G~a~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------i~~-~~------  220 (273)
T d1xwsa_         156 GSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--------IIR-GQ------  220 (273)
T ss_dssp             TTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------HHH-CC------
T ss_pred             ccceecccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH--------Hhh-cc------
Confidence            9763         358999999999987665 6779999999999999999999976321        111 11      


Q ss_pred             ccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          505 FRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       505 ~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ......++    ..+.+++.+|++.||++|||++|+++
T Consensus       221 ~~~~~~~s----~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         221 VFFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             CCCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cCCCCCCC----HHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            11222233    45677888999999999999999976

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-43  Score=358.51  Aligned_cols=254  Identities=24%  Similarity=0.247  Sum_probs=192.1

Q ss_pred             hcCCCccceeecCCceEEEEEEcC-C-CCEEEEEEeecCCchhcccchHHHHHHHHHh--ccCCCceeeecceeee----
Q 047719          283 TLGFNKNRIVGEGASATVYKGSLP-S-GGAVAVKRFEKPNRVECARNPFTTEFATMAG--CLRHKNLVQLQGWCCE----  354 (596)
Q Consensus       283 t~~f~~~~~LG~G~fG~Vy~~~~~-~-g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~--~l~H~niv~l~g~~~~----  354 (596)
                      .++|...+.||+|+||+||+|... + ++.||||+++.....+.....+.+|+..+..  ..+||||++++++|..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            467888999999999999999863 4 5679999997654444455567788765543  2489999999999863    


Q ss_pred             -CCeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEcc
Q 047719          355 -GNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGD  433 (596)
Q Consensus       355 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~D  433 (596)
                       ...++++|||+.++++........   ..+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~---~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~d  159 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLAD  159 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCT---TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECS
T ss_pred             cCceEEEEEEeccCCchhhhhhccC---CCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecc
Confidence             347899999998877765554332   358899999999999999999999   8999999999999999999999999


Q ss_pred             CCCcc----------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChh-HHHHHHHHHhcCCchhh
Q 047719          434 FEATI----------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV-IVDWVWNLRKKGKLLDA  502 (596)
Q Consensus       434 fg~~~----------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~-~~~~~~~~~~~~~~~~~  502 (596)
                      ||.+.          ..||+.|+|||.+.+..++.++||||+||++|||++|+.||.+.... ...-.............
T Consensus       160 fg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  239 (305)
T d1blxa_         160 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW  239 (305)
T ss_dssp             CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred             hhhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence            99754          35899999999999999999999999999999999999999875431 11111111110000000


Q ss_pred             ---------c----cccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          503 ---------A----DFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       503 ---------~----d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                               .    .......+.......+.+|+.+|++.||++|||++|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                     0    000000111122345677889999999999999999876

>d1gzca_ b.29.1.1 (A:) Legume lectin {Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]

Probab=100.00  E-value=6.5e-43  Score=342.37  Aligned_cols=174  Identities=28%  Similarity=0.407  Sum_probs=156.1

Q ss_pred             CCCCCCCcccceEEEEEEEEecC-CCCCCCCeEEEEEecCCCCCCCCCCccCCCCCC-CCCCCceEEEEeeCccCCCCCC
Q 047719            1 FLDPKTNTTASFSCRFSFSIIPS-PLCAFGDGFAFLITSNADSFGNDNGYMGLPGPV-LSPQDSFFAVEFDTSFDPSLGD   78 (596)
Q Consensus         1 ~~~~~~~~~asF~t~F~f~i~~~-~~~~~g~G~aF~l~~~~~~~~~~~~~lG~~~~~-~~~~~~~~AVEfDt~~~~~~~d   78 (596)
                      |||+.+++++||+|+|+|.|... +...+||||||+|+|.+.+.+..+++||+++.. .++.++.|||||||++| +++|
T Consensus        59 l~~~~~~~~~sFst~F~f~i~~~~~~~~g~dG~aF~l~p~~~~~~~~~g~lg~~~~~~~~~~~~~vaVEFDT~~n-~~~d  137 (239)
T d1gzca_          59 MWDSTTGTVASFETRFSFSIEQPYTRPLPADGLVFFMGPTKSKPAQGYGYLGVFNNSKQDNSYQTLAVEFDTFSN-PWDP  137 (239)
T ss_dssp             CBCTTTCCBCEEEEEEEEECCCCCSSSCCCEEEEEEEECSSCCCCCCGGGTTTCSSSSCCGGGCCEEEEEECSCC-TTSC
T ss_pred             ecCCCCCceeeEEEEEEEEEecCCCCCCCCCeEEEEECCCCCCCCCCcccccccccCCCCCccceEEEEEEcccc-CCCC
Confidence            69999999999999999999754 446689999999999888778889999998776 34478899999999999 5689


Q ss_pred             CCCCeeEEecCCccccccccCCCCCcccCCCceEEEEEEEcCCccEEEEEEeeCCCCCCCCeEEEeecCcccCCCceEEE
Q 047719           79 INGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVG  158 (596)
Q Consensus        79 ~~~~Hvgid~ns~~s~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~l~~~vdl~~~l~~~~~vG  158 (596)
                      |++||||||+|++.|..+.+     .++.+|+.++|||+||+.+++|+|++.+.. +|..|+|++.|||+++|+++||||
T Consensus       138 ~~~~HvgI~vn~~~s~~t~~-----~~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~~~ls~~vdL~~~l~~~vyvG  211 (239)
T d1gzca_         138 PQVPHIGIDVNSIRSIKTQP-----FQLDNGQVANVVIKYDAPSKILHVVLVYPS-SGAIYTIAEIVDVKQVLPDWVDVG  211 (239)
T ss_dssp             SSSSEEEEEESSSSCSEEEE-----CCCCTTCEEEEEEEEETTTTEEEEEEECTT-TCCEEEEEEECCHHHHSCSEEEEE
T ss_pred             CCCCEEEEEECCccccccCC-----ccccCCCEEEEEEEEeCCCcEEEEEEecCC-CCcceeeeeEechHHhcCCcEEEE
Confidence            99999999999999988876     478999999999999999999999998754 788899999999999999999999


Q ss_pred             EEeecCC---ccceeeeeeeeeeccC
Q 047719          159 FSAANGQ---GSAIYTVDRWRFKTFE  181 (596)
Q Consensus       159 Fsastg~---~~~~~~i~~Wsf~~~~  181 (596)
                      |||+||.   ..|.|+|++|||+++.
T Consensus       212 FSAsTG~~~~~~~~H~V~sWsF~s~l  237 (239)
T d1gzca_         212 LSGATGAQRDAAETHDVYSWSFQASL  237 (239)
T ss_dssp             EEEEECSSTTCCCCCEEEEEEEEEEE
T ss_pred             EEEEcCCCCCCceeeEEEEEEeEeeC
Confidence            9999994   5689999999999874

>d1qnwa_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-II [TaxId: 3902]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Furze (Ulex europaeus), UEA-II [TaxId: 3902]

Probab=100.00  E-value=2.5e-42  Score=337.99  Aligned_cols=174  Identities=30%  Similarity=0.470  Sum_probs=154.2

Q ss_pred             CCCCCCCcccceEEEEEEEEecCCCCCCCCeEEEEEecCCC--CCCCCCCccCCCCCCC-CCCCceEEEEeeCccCCCCC
Q 047719            1 FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNAD--SFGNDNGYMGLPGPVL-SPQDSFFAVEFDTSFDPSLG   77 (596)
Q Consensus         1 ~~~~~~~~~asF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~--~~~~~~~~lG~~~~~~-~~~~~~~AVEfDt~~~~~~~   77 (596)
                      |||+.+++++||+|+|+|.|.++ ...+||||||||+|...  +.++.++++|+.+..+ +..+++|||||||++|.+++
T Consensus        56 l~~~~~~~~~sF~t~F~f~i~~~-~~~ggdG~aF~l~p~~~~~~~~~~~~~~g~~~~~~~~~~~~~vAVEFDT~~n~~~~  134 (237)
T d1qnwa_          56 IWDSITGKVASFATSFSFVVKAD-KSDGVDGLAFFLAPANSQIPSGSSAGMFGLFSSSDSKSSNQIIAVEFDTYFGKAYN  134 (237)
T ss_dssp             CBCTTTCCBCEEEEEEEEECCBS-SSCCCCEEEEEEEETTCCCCTTCCGGGTTTCSSSSCCTTSCCEEEEEECCCCTTTC
T ss_pred             ecCCCCcceeeEEEEEEEEEecC-CCCCcceeEEEEeCCCCCCCCCCccccccccCCCCCCCcccEEEEEeeceecCCcC
Confidence            79999999999999999998765 45679999999999876  5677888999988763 34889999999999998754


Q ss_pred             --CCCCCeeEEecCCccccccccCCCCCcccCCCceEEEEEEEcCCccEEEEEEeeCCCCCCCCeEEEeecCcccCCCce
Q 047719           78 --DINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYM  155 (596)
Q Consensus        78 --d~~~~Hvgid~ns~~s~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~l~~~vdl~~~l~~~~  155 (596)
                        ||++||||||+|++.|..+.+     .++.+|+.++|||+||+.+++|+|++.+.. +|..|+|++.|||+++|+++|
T Consensus       135 ~~d~~~nHvgid~ns~~s~~~~~-----~~~~~G~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~p~ls~~vDLs~~l~~~v  208 (237)
T d1qnwa_         135 PWDPDFKHIGIDVNSIKSIKTVK-----WDWRNGEVADVVITYRAPTKSLTVCLSYPS-DGTSNIITASVDLKAILPEWV  208 (237)
T ss_dssp             TTSCSSCEEEEEESSSSCSEEEE-----CCCCTTCCEEEEEEEEGGGTEEEEEEECTT-TCCEEEEEEECCHHHHSCSEE
T ss_pred             CCCCCCCeEEEECCCCCcccccc-----cccCCCcEEEEEEEEcCCCcEEEEEEecCC-CCccceEEEEEChHHhCCCcE
Confidence              689999999999999988766     478899999999999999999999998754 788899999999999999999


Q ss_pred             EEEEEeecCCcc--ceeeeeeeeeeccC
Q 047719          156 HVGFSAANGQGS--AIYTVDRWRFKTFE  181 (596)
Q Consensus       156 ~vGFsastg~~~--~~~~i~~Wsf~~~~  181 (596)
                      |||||||||...  |.|+|++|+|+++.
T Consensus       209 yvGFSasTG~~~~~q~h~I~sWsF~s~l  236 (237)
T d1qnwa_         209 SVGFSGGVGNAAEFETHDVLSWYFTSNL  236 (237)
T ss_dssp             EEEEEEEESCGGGCBCCEEEEEEEEEEC
T ss_pred             EEEEEeECCCCCCccEeEEEEeEeEEec
Confidence            999999999765  89999999999863

>d2d3sa1 b.29.1.1 (A:1-237) Legume lectin {Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]

Probab=100.00  E-value=2.3e-42  Score=337.77  Aligned_cols=171  Identities=34%  Similarity=0.492  Sum_probs=153.1

Q ss_pred             CCCCCCCcccceEEEEEEEEecC-CCCCCCCeEEEEEecCCCCCCCCCCccCCCCCCCCCCCceEEEEeeCccCCCCCCC
Q 047719            1 FLDPKTNTTASFSCRFSFSIIPS-PLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQDSFFAVEFDTSFDPSLGDI   79 (596)
Q Consensus         1 ~~~~~~~~~asF~t~F~f~i~~~-~~~~~g~G~aF~l~~~~~~~~~~~~~lG~~~~~~~~~~~~~AVEfDt~~~~~~~d~   79 (596)
                      |||+++++++||+|+|+|.|... +...+||||||+|+|...+.+..|++||+++..  ..+++|||||||++|.  +||
T Consensus        57 l~~~~~~~~~sF~t~F~f~i~~~~~~~~g~dGlaFvl~p~~~~~~~~gg~lG~~~~~--~~~~~vaVEFDT~~n~--~d~  132 (237)
T d2d3sa1          57 VWDSTTGNVASFETRFSFSIRQPFPRPHPADGLVFFIAPPNTQTGEGGGYFGIYNPL--SPYPFVAVEFDTFRNT--WDP  132 (237)
T ss_dssp             CBCTTTCCBCEEEEEEEEECCCSCCSSCCCEEEEEEEECSSCCCCBCGGGTTTBCTT--SCCCCEEEEEECSCCT--TCC
T ss_pred             eecCCCCceeeEEEEEEEEeecCCCCCCCCCeEEEEeCCCCccCCccccccccccCC--CcCceEEEEEEeecCC--CCC
Confidence            79999999999999999999754 445678999999999877888899999998763  4578899999999997  699


Q ss_pred             CCCeeEEecCCccccccccCCCCCcccCCCceEEEEEEEcCCccEEEEEEeeCCCCCCCCeEEEeecCcccCCCceEEEE
Q 047719           80 NGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGF  159 (596)
Q Consensus        80 ~~~Hvgid~ns~~s~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~l~~~vdl~~~l~~~~~vGF  159 (596)
                      ++||||||+|++.|.++..     +.+.+|+.++|||+||+.+++|+|++.+.. ++..|+++..|||+.+|+++|||||
T Consensus       133 ~~nHvgI~vns~~s~~~~~-----~~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~~~ls~~vdL~~~l~~~vyvGF  206 (237)
T d2d3sa1         133 QIPHIGIDVNSVISTKTVP-----FTLDNGGIANVVIKYDASTKILHVVLVFPS-LGTIYTIADIVDLKQVLPESVNVGF  206 (237)
T ss_dssp             SSSEEEEEESSSSCSEEEE-----CCCCTTCEEEEEEEEETTTTEEEEEEEETT-TTEEEEEEEECCHHHHSCSEEEEEE
T ss_pred             CCCcEEEEcCCCccccccc-----eeecCCCEEEEEEEEECCCCEEEEEEEcCC-CCcccceeeEechHHhCCCcEEEEE
Confidence            9999999999999987765     478999999999999999999999998854 5677899999999999999999999


Q ss_pred             EeecCC-------ccceeeeeeeeeeccC
Q 047719          160 SAANGQ-------GSAIYTVDRWRFKTFE  181 (596)
Q Consensus       160 sastg~-------~~~~~~i~~Wsf~~~~  181 (596)
                      |||||.       ..|.|+|++|+|+++.
T Consensus       207 SasTG~~~~~~~~~~e~h~I~sWsFss~l  235 (237)
T d2d3sa1         207 SAATGDPSGKQRNATETHDILSWSFSASL  235 (237)
T ss_dssp             EEEECCGGGCCTTCCCCCEEEEEEEEEEC
T ss_pred             EeECCCCccCccccceeeEEEEeEeEeeC
Confidence            999995       4689999999999874

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-42  Score=356.23  Aligned_cols=254  Identities=20%  Similarity=0.260  Sum_probs=190.2

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCC------
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGN------  356 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~------  356 (596)
                      +.|...+.||+|+||+||+|... +|+.||||++++....+...+.+.+|+..|.. ++|||||+++++|...+      
T Consensus        18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~-l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKH-MRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHH-CCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHh-cCCCCeeEEEEEeccCccccccc
Confidence            46778899999999999999864 59999999997655555556678899977765 89999999999998655      


Q ss_pred             eEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCC
Q 047719          357 ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEA  436 (596)
Q Consensus       357 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~  436 (596)
                      .+|+||||+ +.+|..+++..     .+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+|++|||.
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~  167 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGL  167 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEEecc-cccHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccccccc
Confidence            579999999 56888887654     39999999999999999999999   9999999999999999999999999997


Q ss_pred             cc--------cCCCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHH-HHHHhcC--------C
Q 047719          437 TI--------PAGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWV-WNLRKKG--------K  498 (596)
Q Consensus       437 ~~--------~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~-~~~~~~~--------~  498 (596)
                      +.        ..||+.|+|||.+.+ ..++.++||||+||++|||++|+.||........-+. .......        .
T Consensus       168 a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (346)
T d1cm8a_         168 ARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ  247 (346)
T ss_dssp             CEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred             eeccCCccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhc
Confidence            64        458999999999876 4579999999999999999999999987543111110 0000000        0


Q ss_pred             ----------chhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhcCC
Q 047719          499 ----------LLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKGEA  548 (596)
Q Consensus       499 ----------~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~~~~  548 (596)
                                +.+.....+. .........+.+|+.+|++.||++|||++|+++  +++...
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         248 SDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             CHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             chhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence                      0000000000 011112245678889999999999999999988  466544

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-41  Score=350.14  Aligned_cols=251  Identities=19%  Similarity=0.221  Sum_probs=188.8

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeee--------
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE--------  354 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~--------  354 (596)
                      .+|...+.||+|+||+||+|... +|+.||||++......+....++.+|+..|.. ++|||++++++++..        
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~-l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQL-LKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHH-CCCTTBCCEEEEEEC--------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHH-hcCCCccceEeeeeccccccccc
Confidence            56888899999999999999864 69999999997665555566778999976655 899999999999865        


Q ss_pred             CCeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccC
Q 047719          355 GNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDF  434 (596)
Q Consensus       355 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Df  434 (596)
                      .+.+|+||||+.++.+..+.....    .++...+..++.||++||.|||+   ++|+||||||+|||++.++.+||+||
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~~~----~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~df  161 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNVLV----KFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADF  161 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCTTC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCC
T ss_pred             CceEEEEEeccCCCccchhhhccc----ccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeec
Confidence            346899999998877765554432    47889999999999999999999   89999999999999999999999999


Q ss_pred             CCcc---------------cCCCcccCCccccccC-CCCCccceeehhHHHHHHHhCCCCCCCCChhH-HHHHHHHHhcC
Q 047719          435 EATI---------------PAGTMGYLAPEYVYSG-VPSEKTDVYSFGVVALEVAAGKSPVDNDGCVI-VDWVWNLRKKG  497 (596)
Q Consensus       435 g~~~---------------~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~-~~~~~~~~~~~  497 (596)
                      |++.               ..||+.|+|||.+.+. .++.++|||||||++|||++|+.||.+..... ...........
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~  241 (318)
T d3blha1         162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI  241 (318)
T ss_dssp             TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            9763               2489999999998765 68999999999999999999999998654311 11111111110


Q ss_pred             C--chhhc---------cccccCcCCH-H------HHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          498 K--LLDAA---------DFRLRGKFNR-K------EMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       498 ~--~~~~~---------d~~l~~~~~~-~------~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      .  .....         .......... +      ....+.+|+.+|++.||++|||++|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            0  00000         0000000001 1      1234567899999999999999999987

>d1g9fa_ b.29.1.1 (A:) Legume lectin {Soybean (Glycine max) [TaxId: 3847]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Soybean (Glycine max) [TaxId: 3847]

Probab=100.00  E-value=1.4e-41  Score=335.18  Aligned_cols=175  Identities=27%  Similarity=0.428  Sum_probs=153.4

Q ss_pred             CCCCCCCcccceEEEEEEEEecCCCCCCCCeEEEEEecCCCCCCCCCCccCCCCCCCCCCCceEEEEeeCccCCCCCCCC
Q 047719            1 FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQDSFFAVEFDTSFDPSLGDIN   80 (596)
Q Consensus         1 ~~~~~~~~~asF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~~~~~~~~~lG~~~~~~~~~~~~~AVEfDt~~~~~~~d~~   80 (596)
                      |||+.+++++||+|+|+|.|...+...+||||||+|+|...+++..||+||+++.. ...++.|||||||++|.  +||+
T Consensus        59 l~~~~~~~~~sf~t~f~F~i~~~~~~~~gDGlAFvl~p~~~~~~~~~g~lG~~~~~-~~~~~~vaVEFDT~~n~--~D~~  135 (251)
T d1g9fa_          59 IWDKETGSVASFAASFNFTFYAPDTKRLADGLAFFLAPIDTKPQTHAGYLGLFNEN-ESGDQVVAVEFDTFRNS--WDPP  135 (251)
T ss_dssp             CBCC-CCCBCEEEEEEEEEEECSCC--CCEEEEEEEEETTCCCCCCGGGTTTCCTT-SCCCSCEEEEEECC-CT--TSCS
T ss_pred             ccCCCCccceeeEEEEEEEEecCCCCCCCCceEEEEecCCCCCCCccCccCccccc-CCCcceEEEEEecccCC--CCCC
Confidence            79999999999999999999988888899999999999888788899999998864 33578899999999997  6999


Q ss_pred             CCeeEEecCCccccccccCCCCCcccCCCceEEEEEEEcCCccEEEEEEeeCCCCCCCCeEEEeecCcccCCCceEEEEE
Q 047719           81 GNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFS  160 (596)
Q Consensus        81 ~~Hvgid~ns~~s~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~l~~~vdl~~~l~~~~~vGFs  160 (596)
                      +||||||+|++.|..+..     +++.+|+.++|||+||+.+++|.|++.+.. ++..|+++..|||+.+|+++||||||
T Consensus       136 ~~Hvgi~~n~~~s~~~~~-----~~l~~g~~~~v~I~Yd~~~~~L~v~l~~~~-~~~~~~l~~~vdL~~~l~~~~yvGFS  209 (251)
T d1g9fa_         136 NPHIGINVNSIRSIKTTS-----WDLANNKVAKVLITYDASTSLLVASLVYPS-QRTSNILSDVVDLKTSLPEWVRIGFS  209 (251)
T ss_dssp             SSEEEEEESSSSCSEEEE-----CCCCTTCCEEEEEEEETTTTEEEEEEEEGG-GTEEEEEEEECCC-CCSCSEEEEEEE
T ss_pred             CCcEeEEecCcccccccc-----eEecCCCEEEEEEEEECCccEEEEEEecCC-CCcceeEEEEecchhhCCCcEEEEEE
Confidence            999999999999988766     478999999999999999999999998754 77889999999999999999999999


Q ss_pred             eecCCcc--ceeeeeeeeeeccCCCC
Q 047719          161 AANGQGS--AIYTVDRWRFKTFESYP  184 (596)
Q Consensus       161 astg~~~--~~~~i~~Wsf~~~~~~~  184 (596)
                      ||||...  |.|+|++|+|+++.+++
T Consensus       210 AsTG~~~~~~~h~I~sWsF~s~~~~~  235 (251)
T d1g9fa_         210 AATGLDIPGESHDVLSWSFASNLPHA  235 (251)
T ss_dssp             EEECSSSCCCEEEEEEEEEEEEECC-
T ss_pred             eecCCCCCCceeEEEEeEeECCCCCC
Confidence            9999765  88999999999876544

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-41  Score=352.40  Aligned_cols=255  Identities=20%  Similarity=0.222  Sum_probs=188.0

Q ss_pred             cCCCccceeecCCceEEEEEEc-CCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCC----eE
Q 047719          284 LGFNKNRIVGEGASATVYKGSL-PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGN----EL  358 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~----~~  358 (596)
                      .+|...+.||+|+||+||+|.. .+|+.||||++.+... ....+.+.+|+..|.. ++||||+++++++....    ..
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~Ei~il~~-l~hp~iv~~~~~~~~~~~~~~~~   85 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH-QTYCQRTLREIKILLR-FRHENIIGINDIIRAPTIEQMKD   85 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTC-HHHHHHHHHHHHHHHH-CCCTTBCCCCEEECCSSTTTCCC
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcC-hHHHHHHHHHHHHHHH-cCCCCCCcEEEEEeeccccccce
Confidence            3577889999999999999975 4699999999975432 3344578899977765 89999999999987653    23


Q ss_pred             EEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCcc
Q 047719          359 VLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATI  438 (596)
Q Consensus       359 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~  438 (596)
                      +++++|+.+|+|.+++...     .+++..+..++.||+.||+|||+   ++|+||||||+||||+.++.+||+|||++.
T Consensus        86 ~~l~~~~~~g~L~~~l~~~-----~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~  157 (345)
T d1pmea_          86 VYLVTHLMGADLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLAR  157 (345)
T ss_dssp             EEEEEECCCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEeecCCchhhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCcee
Confidence            4445566799999999865     38999999999999999999999   899999999999999999999999999753


Q ss_pred             --------------cCCCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHH-HHHHHhcCCchhh
Q 047719          439 --------------PAGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDW-VWNLRKKGKLLDA  502 (596)
Q Consensus       439 --------------~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~-~~~~~~~~~~~~~  502 (596)
                                    ..||+.|+|||.+.. ..++.++||||+||++|||++|+.||......-..+ .............
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (345)
T d1pmea_         158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL  237 (345)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhh
Confidence                          248899999999854 567899999999999999999999998754311111 1111111000000


Q ss_pred             ------------ccccccCcCCH-----HHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhcCC
Q 047719          503 ------------ADFRLRGKFNR-----KEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKGEA  548 (596)
Q Consensus       503 ------------~d~~l~~~~~~-----~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~~~~  548 (596)
                                  .........+.     .....+.+|+.+|++.||++|||++|+++  +|+...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~  302 (345)
T d1pmea_         238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY  302 (345)
T ss_dssp             HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred             hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCC
Confidence                        00000000010     11235778899999999999999999987  355443

>d1f9ka_ b.29.1.1 (A:) Legume lectin {Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]

Probab=100.00  E-value=2.4e-41  Score=330.08  Aligned_cols=170  Identities=29%  Similarity=0.490  Sum_probs=150.8

Q ss_pred             CCCCCCCcccceEEEEEEEEecC-CCCCCCCeEEEEEecCCCCCCCCCCccCCCCCCCCCCCceEEEEeeCccCCCCCCC
Q 047719            1 FLDPKTNTTASFSCRFSFSIIPS-PLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQDSFFAVEFDTSFDPSLGDI   79 (596)
Q Consensus         1 ~~~~~~~~~asF~t~F~f~i~~~-~~~~~g~G~aF~l~~~~~~~~~~~~~lG~~~~~~~~~~~~~AVEfDt~~~~~~~d~   79 (596)
                      |||+.+++++||+|+|+|.|.+. ....+||||||+|+|...+.+..|+++|+++..  ..++.|||||||++|+  +||
T Consensus        58 l~~~~~~~~~sFsT~F~f~i~~~~~~~~g~dG~aF~i~p~~~~~~~~g~~~g~~~~~--~~~~~vaVEFDT~~n~--~Dp  133 (234)
T d1f9ka_          58 IWDSTTGNVASFETRFSFNITQPYAYPEPADGLTFFMVPPNSPQGEDGGNLGVFKPP--EGDNAFAVEFDTFQNT--WDP  133 (234)
T ss_dssp             CBCTTTCCBCEEEEEEEEEEECCCSSSCCCEEEEEEEECTTCCCCCSGGGTTTCCSS--CCSCCEEEEEECSCCT--TCC
T ss_pred             eeCCCCCcCcceEEEEEEEEECCCCCCCccceEEEEECCCCCCcccccccccccCCC--CccceEEEEEeccccC--CCC
Confidence            69999999999999999999865 445678999999999888888899999998763  3567899999999997  799


Q ss_pred             CCCeeEEecCCccccccccCCCCCcccCCCceEEEEEEEcCCccEEEEEEeeCCCCCCCCeEEEeecCcccCC--CceEE
Q 047719           80 NGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFK--DYMHV  157 (596)
Q Consensus        80 ~~~Hvgid~ns~~s~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~l~~~vdl~~~l~--~~~~v  157 (596)
                      ++||||||+|++.|.++.+     ++|.+|+.++|||+||+.+++|.|++.+.. ++..|+|++.|||+.+|+  |+|||
T Consensus       134 ~~nHvgi~~ns~~s~~~~~-----~~l~~G~~~~v~I~Yd~~~~~l~V~l~~~~-~~~~~~ls~~idL~~~l~~~~~v~v  207 (234)
T d1f9ka_         134 QVPHIGIDVNSIVSSKTLH-----FQLENGGVANVVIKYDSPTKILNVVLAFHS-VGTVYTLSNIVDLKQEFPNSEWVNV  207 (234)
T ss_dssp             SSSEEEEEESSSSCSEEEE-----CCCCTTCCEEEEEEEETTTTEEEEEEEETT-TTEEEEEEEECCHHHHSTTCSEEEE
T ss_pred             CCCcEeEecCCcccccccc-----ccccCCCEEEEEEEEcCCCcEEEEEEEeCC-CCccceEEEEEcHHHhcCCCCEEEE
Confidence            9999999999999887765     589999999999999999999999998854 566789999999999997  57999


Q ss_pred             EEEeecCC---ccceeeeeeeeeecc
Q 047719          158 GFSAANGQ---GSAIYTVDRWRFKTF  180 (596)
Q Consensus       158 GFsastg~---~~~~~~i~~Wsf~~~  180 (596)
                      |||||||.   ..|.|+|++|+|+++
T Consensus       208 GFSasTG~~~~~~~~h~I~sWsF~s~  233 (234)
T d1f9ka_         208 GLSATTGYQKNAVETHEIISWSFTSS  233 (234)
T ss_dssp             EEEEEECSSTTCCCEEEEEEEEEEEE
T ss_pred             EEEeecCCCCCceeeeEEEEEEeEEe
Confidence            99999994   568999999999975

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-41  Score=342.16  Aligned_cols=253  Identities=23%  Similarity=0.259  Sum_probs=196.8

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      ++|...+.||+|+||+||+|+.. +++.||||+++.....+.....+.+|+..+. .++|||||+++++|.+....++|+
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~-~l~h~niv~~~~~~~~~~~~~iv~   80 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLK-ELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHT-TCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHH-hcCcCCEEeeccccccccceeEEe
Confidence            36788899999999999999864 6889999999766554555667889996664 599999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCccc---
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEATIP---  439 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~~---  439 (596)
                      |++.+++|..++....    .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||.+..   
T Consensus        81 ~~~~~~~l~~~~~~~~----~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~  153 (292)
T d1unla_          81 EFCDQDLKKYFDSCNG----DLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGI  153 (292)
T ss_dssp             ECCSEEHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             eecccccccccccccc----ccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccC
Confidence            9999999988887654    48899999999999999999999   8999999999999999999999999997642   


Q ss_pred             --------CCCcccCCccccccCC-CCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHH---HHHhcCCc------hh
Q 047719          440 --------AGTMGYLAPEYVYSGV-PSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVW---NLRKKGKL------LD  501 (596)
Q Consensus       440 --------~gt~~y~aPE~~~~~~-~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~---~~~~~~~~------~~  501 (596)
                              .++..|+|||.+.... ++.++|||||||++|||++|+.||..... ..+...   ........      ..
T Consensus       154 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  232 (292)
T d1unla_         154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND-VDDQLKRIFRLLGTPTEEQWPSMTK  232 (292)
T ss_dssp             CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS-HHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred             CCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCC-HHHHHHHHHhhcCCCChhhhhhhhh
Confidence                    3667899999887654 69999999999999999999998754322 111111   11111100      00


Q ss_pred             hccc---------cccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHh
Q 047719          502 AADF---------RLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILK  545 (596)
Q Consensus       502 ~~d~---------~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~  545 (596)
                      ..+.         .............+.+|+.+|++.||++|||++|+++  +++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~  287 (292)
T d1unla_         233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS  287 (292)
T ss_dssp             STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGS
T ss_pred             cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhc
Confidence            0000         0001111222345678889999999999999999976  454

>d1g7ya_ b.29.1.1 (A:) Legume lectin {Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]

Probab=100.00  E-value=3.8e-41  Score=333.25  Aligned_cols=174  Identities=25%  Similarity=0.402  Sum_probs=157.3

Q ss_pred             CCCCCCCcccceEEEEEEEEecCCCCCCCCeEEEEEecCCCCCCCCCCccCCCCCC-CCCCCceEEEEeeCccCCCCCCC
Q 047719            1 FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPV-LSPQDSFFAVEFDTSFDPSLGDI   79 (596)
Q Consensus         1 ~~~~~~~~~asF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~~~~~~~~~lG~~~~~-~~~~~~~~AVEfDt~~~~~~~d~   79 (596)
                      |||+.+++++||+|+|+|.|.+.....+||||||+|+|.+..++..+|+||+++.. .++.++.+||||||++|.+ +||
T Consensus        56 l~~~~~~~~~sF~t~F~F~i~~~~~~~ggDGlAF~l~~~~~~~~~~~g~lgl~~~~~~~~~~~~vaVEFDT~~n~~-~d~  134 (253)
T d1g7ya_          56 IYDKSTGAVASWATSFTANIFAPNKSSSADGIAFALVPVGSEPKSNSGFLGVFDSDVYDNSAQTVAVEFDTFSNTD-WDP  134 (253)
T ss_dssp             CBCTTTCCBCEEEEEEEEECCCSSGGGCCCEEEEEEEETTCCCCCCGGGTTTCSCSSCCGGGCCEEEEEECSCCTT-TCC
T ss_pred             eecCCCCceeeEEEEEEEEEecCCCCCCCCceEEEEeCCCCCCCCCcccccccccCCCCCcCceEEEEEeceecCC-CCC
Confidence            79999999999999999999887777789999999999888778889999999876 3346788999999999987 499


Q ss_pred             CCCeeEEecCCccccccccCCCCCcccCCCceEEEEEEEcCCccEEEEEEeeCCCCCCCCeEEEeecCcccCCCceEEEE
Q 047719           80 NGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGF  159 (596)
Q Consensus        80 ~~~Hvgid~ns~~s~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~l~~~vdl~~~l~~~~~vGF  159 (596)
                      +++|||||+|++.|..+.+     ..+.+|+.++|||+||+.+++|.|++.+.. +|..|+++..+||+.+||++|||||
T Consensus       135 ~~~Hvgi~~ns~~s~~~~~-----~~~~~g~~~~v~I~Yd~~~~~L~v~l~~~~-~~~~~~ls~~vdL~~~l~~~~yvGF  208 (253)
T d1g7ya_         135 TSRHIGIDVNSIKSIRTAS-----WGLANGQNAEILITYNAATSLLVASLVHPS-RRTSYIVSERVDITNELPEYVSIGF  208 (253)
T ss_dssp             SSCEEEEEESSSSCSEEEE-----CCCCTTSEEEEEEEEETTTTEEEEEEEETT-TTEEEEEEEECCHHHHSCSEEEEEE
T ss_pred             CCCcEEEeeCCcccccccC-----CCccCCCEEEEEEEEeCCcEEEEEEEecCC-CCCceEEEEEechhhcCCCcEEEEE
Confidence            9999999999999988766     478999999999999999999999998743 7788999999999999999999999


Q ss_pred             EeecC---CccceeeeeeeeeeccC
Q 047719          160 SAANG---QGSAIYTVDRWRFKTFE  181 (596)
Q Consensus       160 sastg---~~~~~~~i~~Wsf~~~~  181 (596)
                      ||+||   ...+.|+|++|+|++..
T Consensus       209 SAsTG~~~~~~~~H~IlsWsF~s~l  233 (253)
T d1g7ya_         209 SATTGLSEGYTETHDVLSWSFASKL  233 (253)
T ss_dssp             EEECCSSSSCCCCCEEEEEEEEEEE
T ss_pred             EeEcCCCCCcccccEEEEEEeEEeC
Confidence            99999   45789999999999864

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-41  Score=350.55  Aligned_cols=251  Identities=24%  Similarity=0.304  Sum_probs=183.9

Q ss_pred             CCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeC------Ce
Q 047719          285 GFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG------NE  357 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~------~~  357 (596)
                      .|+..++||+|+||+||+|+.. +|+.||||++.+...      ...+|+..+.+ ++|+|||+++++|...      ..
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~-l~h~niv~~~~~~~~~~~~~~~~~   93 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRK-LDHCNIVRLRYFFYSSGEKKDEVY   93 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHH-CCCTTBCCEEEEEEEC--CCSCCE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHh-cCCCCCCcEEEEEEecCccCCceE
Confidence            4677789999999999999875 589999999965321      22468866655 8999999999998643      35


Q ss_pred             EEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCC-ceEEccCCC
Q 047719          358 LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEF-NAKLGDFEA  436 (596)
Q Consensus       358 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~-~~kl~Dfg~  436 (596)
                      ++||||||+++.+...... ......+++.++..++.||+.||+|||+   ++|+||||||+|||++.++ .+||+|||+
T Consensus        94 ~~lv~Ey~~~~~~~~l~~~-~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~  169 (350)
T d1q5ka_          94 LNLVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGS  169 (350)
T ss_dssp             EEEEEECCSEEHHHHHHHH-HHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTT
T ss_pred             EEEEEeccCCccHHHHHhh-hhccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccc
Confidence            8999999987544433321 1113359999999999999999999999   9999999999999999875 899999997


Q ss_pred             cc----------cCCCcccCCcccccc-CCCCCccceeehhHHHHHHHhCCCCCCCCChh--HHHHHHH----------H
Q 047719          437 TI----------PAGTMGYLAPEYVYS-GVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV--IVDWVWN----------L  493 (596)
Q Consensus       437 ~~----------~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~--~~~~~~~----------~  493 (596)
                      +.          ..||..|+|||.+.+ ..++.++||||+||++|||++|+.||......  +......          .
T Consensus       170 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~  249 (350)
T d1q5ka_         170 AKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE  249 (350)
T ss_dssp             CEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             hhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence            64          248899999998875 57899999999999999999999999865431  1111100          0


Q ss_pred             Hhc----CCchhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhc
Q 047719          494 RKK----GKLLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKG  546 (596)
Q Consensus       494 ~~~----~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~~  546 (596)
                      ...    ......................+.+|+.+|++.||++|||++|+++  +++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~  308 (350)
T d1q5ka_         250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE  308 (350)
T ss_dssp             HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred             hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence            000    0000000000000111123345778889999999999999999986  4543

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.8e-41  Score=340.56  Aligned_cols=246  Identities=20%  Similarity=0.207  Sum_probs=185.2

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCce-eeecceeeeCCeEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNL-VQLQGWCCEGNELVLV  361 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~ni-v~l~g~~~~~~~~~lV  361 (596)
                      +.|...+.||+|+||.||+|... +|+.||||++....    ...++..|++.+.. ++|+|+ +.+.++..+.+..++|
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~~~~E~~i~~~-l~~~~~i~~~~~~~~~~~~~~iv   81 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKM-MQGGVGIPTIRWCGAEGDYNVMV   81 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT----TSCCHHHHHHHHHH-STTSTTCCCEEEEEEETTEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc----cCHHHHHHHHHHHH-ccCCCcccEEEEEEecCCEEEEE
Confidence            35888899999999999999864 58899999986432    23457888866665 666654 5555666778889999


Q ss_pred             EecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeec---CCCceEEccCCCcc
Q 047719          362 YEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLD---AEFNAKLGDFEATI  438 (596)
Q Consensus       362 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~---~~~~~kl~Dfg~~~  438 (596)
                      |||+ +++|.+.+....   ..+++..++.++.|++.||+|||+   ++|+||||||+|||++   .+..+||+|||++.
T Consensus        82 me~~-~~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~  154 (299)
T d1ckia_          82 MELL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  154 (299)
T ss_dssp             EECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCE
T ss_pred             EEEc-CCchhhhhhhcc---CCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcce
Confidence            9999 557777766543   258999999999999999999999   9999999999999875   45679999999763


Q ss_pred             ------------------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHHHHHHhcCCch
Q 047719          439 ------------------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWVWNLRKKGKLL  500 (596)
Q Consensus       439 ------------------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~~~~~~~~~~~  500 (596)
                                        ..||+.|||||.+.+..++.++|||||||++|||+||+.||.........+.......... 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~-  233 (299)
T d1ckia_         155 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM-  233 (299)
T ss_dssp             ECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHH-
T ss_pred             eccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccC-
Confidence                              2489999999999999999999999999999999999999976432211111111000000 


Q ss_pred             hhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          501 DAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       501 ~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                      ....+.+...++    ..+.+++..||+.+|++||+++++.+.|+.
T Consensus       234 ~~~~~~~~~~~p----~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  275 (299)
T d1ckia_         234 STPIEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRN  275 (299)
T ss_dssp             HSCHHHHTTTSC----HHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred             CCChhHhccCCC----HHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence            000111122232    456778889999999999999999888764

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-41  Score=347.20  Aligned_cols=241  Identities=25%  Similarity=0.276  Sum_probs=190.9

Q ss_pred             cCCCccceeecCCceEEEEEEc----CCCCEEEEEEeecCCch--hcccchHHHHHHHHHhccCC-CceeeecceeeeCC
Q 047719          284 LGFNKNRIVGEGASATVYKGSL----PSGGAVAVKRFEKPNRV--ECARNPFTTEFATMAGCLRH-KNLVQLQGWCCEGN  356 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~----~~g~~vAvK~l~~~~~~--~~~~~~~~~E~~~l~~~l~H-~niv~l~g~~~~~~  356 (596)
                      ++|...+.||+|+||+||+|..    .+|+.||||++++....  ....+.+.+|+..+.+ ++| |||+++++++.+..
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~-l~h~pnIv~~~~~~~~~~  102 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH-IRQSPFLVTLHYAFQTET  102 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHH-HHTCTTBCCEEEEEEETT
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHh-ccCCCeEEEeeeeeccCC
Confidence            4588899999999999999964    24789999998654321  2234567889977766 655 89999999999999


Q ss_pred             eEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCC
Q 047719          357 ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEA  436 (596)
Q Consensus       357 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~  436 (596)
                      ..+++|||+.+|+|.+++....    .+.......++.||+.||+|||+   .+|+||||||+||||+.++.+||+|||+
T Consensus       103 ~~~~v~e~~~~~~L~~~i~~~~----~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~  175 (322)
T d1vzoa_         103 KLHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGL  175 (322)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred             ceeeeeecccccHHHHHHHhcc----cccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccc
Confidence            9999999999999999998765    36788899999999999999999   8999999999999999999999999997


Q ss_pred             cc------------cCCCcccCCccccccC--CCCCccceeehhHHHHHHHhCCCCCCCCCh-hHHHHHHHHHhcCCchh
Q 047719          437 TI------------PAGTMGYLAPEYVYSG--VPSEKTDVYSFGVVALEVAAGKSPVDNDGC-VIVDWVWNLRKKGKLLD  501 (596)
Q Consensus       437 ~~------------~~gt~~y~aPE~~~~~--~~t~~sDV~SfGvll~El~tG~~p~~~~~~-~~~~~~~~~~~~~~~~~  501 (596)
                      +.            ..|++.|+|||.+...  .++.++|||||||+||||++|+.||..... .....+.......    
T Consensus       176 a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~----  251 (322)
T d1vzoa_         176 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS----  251 (322)
T ss_dssp             EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC----
T ss_pred             hhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC----
Confidence            63            2488999999999764  468899999999999999999999976432 1111111111111    


Q ss_pred             hccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHH
Q 047719          502 AADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPS-----VKEAAR  542 (596)
Q Consensus       502 ~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs-----~~ev~~  542 (596)
                            ...++......+.+++.+||++||++|||     ++|+++
T Consensus       252 ------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         252 ------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             ------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             ------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence                  11122234456777889999999999994     788875

>d1g8wa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=1.6e-40  Score=324.19  Aligned_cols=173  Identities=28%  Similarity=0.431  Sum_probs=155.7

Q ss_pred             CCCCCCCcccceEEEEEEEEecCCCCCCCCeEEEEEecCCCCCCCCCCccCCCCCCCCCCCceEEEEeeCccCCCCCCCC
Q 047719            1 FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQDSFFAVEFDTSFDPSLGDIN   80 (596)
Q Consensus         1 ~~~~~~~~~asF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~~~~~~~~~lG~~~~~~~~~~~~~AVEfDt~~~~~~~d~~   80 (596)
                      |||+.++.++||+|+|+|.|.+.+...+||||||+|+|.+.+++..|++||+++.. ...++.|||||||++|.+ +||+
T Consensus        57 l~~~~~~~~~sF~t~f~f~i~~~~~~~~gDGlAF~l~~~~~~~g~~g~~lG~~~g~-~~~~~~vaVEFDT~~N~~-~d~~  134 (233)
T d1g8wa_          57 IWDNTTGTVASFATSFTFNIQVPNNAGPADGLAFALVPVGSQPKDKGGFLGLFDGS-NSNFHTVAVEFDTLYNKD-WDPT  134 (233)
T ss_dssp             CBCTTTCCBEEEEEEEEEECCCCSSCBCCEEEEEEEEETTCCCCCCGGGTTTCCSS-CCCCCCEEEEEECSCCTT-TCCS
T ss_pred             eecCCCCceeeEEEEEEEEEecCCCCCCCCeEEEEEecCCCCCCcccccCCccccC-CCcccEEEEEeecccCCC-CCCC
Confidence            69999999999999999999988777889999999999888888899999998764 336788999999999987 5999


Q ss_pred             CCeeEEecCCccccccccCCCCCcccCCCceEEEEEEEcCCccEEEEEEeeCCCCCCCCeEEEeecCcccCCCceEEEEE
Q 047719           81 GNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFS  160 (596)
Q Consensus        81 ~~Hvgid~ns~~s~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~l~~~vdl~~~l~~~~~vGFs  160 (596)
                      ++|||||+|++.|..+.+     .++.+|+.++|||+||+.+++|.|++.+.. ++..|+++..+||+.+||++||||||
T Consensus       135 ~~Hvgi~~n~~~s~~~~~-----~~~~~g~~~~~~I~yd~~~~~l~v~l~~~~-~~~~~~l~~~vdL~~~l~~~~yvGFS  208 (233)
T d1g8wa_         135 ERHIGIDVNSIRSIKTTR-----WDFVNGENAEVLITYDSSTNLLVASLVYPS-QKTSFIVSDTVDLKSVLPEWVSVGFS  208 (233)
T ss_dssp             SCEEEEEESSSSCSEEEE-----CCCCTTCCEEEEEEEETTTTEEEEEEEETT-TTEEEEEEEECCHHHHSCSEEEEEEE
T ss_pred             CCeEEEECCCcceeeecc-----ccccCCcEEEEEEEEeCCCcEEEEEEEeCC-CCCcEEEEEEechhHcCCCcEEEEEE
Confidence            999999999999887766     478899999999999999999999998854 67788999999999999999999999


Q ss_pred             eecCC---ccceeeeeeeeeeccC
Q 047719          161 AANGQ---GSAIYTVDRWRFKTFE  181 (596)
Q Consensus       161 astg~---~~~~~~i~~Wsf~~~~  181 (596)
                      |+||.   ..|.|+|++|+|+++.
T Consensus       209 AsTG~~~~~~~~h~I~sWsFss~l  232 (233)
T d1g8wa_         209 ATTGINKGNVETNDVLSWSFASKL  232 (233)
T ss_dssp             EEECSSTTBCCCCEEEEEEEEEEE
T ss_pred             EEcCCCCCCceeeEEEEEEEEEEc
Confidence            99994   4577999999999863

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-41  Score=347.98  Aligned_cols=256  Identities=20%  Similarity=0.233  Sum_probs=192.3

Q ss_pred             cCCCccceeecCCceEEEEEEc-CCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeC-----Ce
Q 047719          284 LGFNKNRIVGEGASATVYKGSL-PSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEG-----NE  357 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~-----~~  357 (596)
                      ++|...+.||+|+||+||+|.. .+|+.||||++++........+.+.+|+..+.. ++|||+|++++++...     ..
T Consensus        18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~-l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKH-MKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHH-CCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHh-cCCCCeeeEEEEEeeccccccCc
Confidence            4578889999999999999985 469999999997655554555678899976655 8999999999998643     34


Q ss_pred             EEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCCc
Q 047719          358 LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEAT  437 (596)
Q Consensus       358 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~  437 (596)
                      .++++||+.+|+|.+++..+     .+++.++..++.||+.||+|||+   ++|+||||||+|||++.++.+|++|||.+
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~-----~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a  168 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA  168 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred             eEEEEEeecCCchhhhcccc-----cccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchh
Confidence            56677788899999999654     39999999999999999999999   89999999999999999999999999876


Q ss_pred             cc--------CCCcccCCccccccC-CCCCccceeehhHHHHHHHhCCCCCCCCChhHH-HHHHHHHhcCCchhhcc---
Q 047719          438 IP--------AGTMGYLAPEYVYSG-VPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIV-DWVWNLRKKGKLLDAAD---  504 (596)
Q Consensus       438 ~~--------~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~-~~~~~~~~~~~~~~~~d---  504 (596)
                      ..        .||..|+|||.+.+. .++.++|||||||++|||++|+.||.+...... ..+........ .+...   
T Consensus       169 ~~~~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~-~~~~~~~~  247 (348)
T d2gfsa1         169 RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKIS  247 (348)
T ss_dssp             -CCTGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC-HHHHTTCC
T ss_pred             cccCcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC-hHHhhhcc
Confidence            43        478889999987765 568999999999999999999999987543211 11111110000 00000   


Q ss_pred             --------ccc--cCcCC-----HHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhcCCC
Q 047719          505 --------FRL--RGKFN-----RKEMERMLMVGLSCVHPNHEKRPSVKEAAR--ILKGEAP  549 (596)
Q Consensus       505 --------~~l--~~~~~-----~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~--~L~~~~~  549 (596)
                              ..+  .....     ......+.+|+.+|++.||++|||++|+++  +++....
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~  309 (348)
T d2gfsa1         248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  309 (348)
T ss_dssp             CHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             chhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence                    000  00000     012245678889999999999999999988  6665433

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=4.7e-40  Score=333.78  Aligned_cols=246  Identities=17%  Similarity=0.188  Sum_probs=193.1

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLVY  362 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV~  362 (596)
                      ++|...+.||+|+||+||+|+.. +|+.||||++....    ....+.+|++.+...-+|+|++.+++++.+....++||
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm   80 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   80 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc----CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence            46888899999999999999865 58899999986432    23456777766666445699999999999999999999


Q ss_pred             ecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecC-----CCceEEccCCCc
Q 047719          363 EYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDA-----EFNAKLGDFEAT  437 (596)
Q Consensus       363 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~-----~~~~kl~Dfg~~  437 (596)
                      ||+ +++|.+++....   ..+++.++..++.|++.||+|||+   ++|+||||||+|||++.     ++.+||+|||++
T Consensus        81 e~~-~~~l~~~~~~~~---~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a  153 (293)
T d1csna_          81 DLL-GPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV  153 (293)
T ss_dssp             ECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred             Eec-CCCHHHHHHhhc---cchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEccccee
Confidence            999 689999997654   258999999999999999999999   99999999999999974     578999999976


Q ss_pred             c------------------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChh-HHHHHHHHHhcCC
Q 047719          438 I------------------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV-IVDWVWNLRKKGK  498 (596)
Q Consensus       438 ~------------------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~-~~~~~~~~~~~~~  498 (596)
                      .                  ..||+.|||||.+.+..++.++|||||||++|||++|+.||...... .............
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~  233 (293)
T d1csna_         154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ  233 (293)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred             EEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC
Confidence            3                  24899999999999999999999999999999999999999764321 1111111111000


Q ss_pred             chhhccccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 047719          499 LLDAADFRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAARILKG  546 (596)
Q Consensus       499 ~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~~L~~  546 (596)
                        ......+...++    ..+.+++..|++.+|++||+++.+.+.|+.
T Consensus       234 --~~~~~~l~~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~  275 (293)
T d1csna_         234 --STPLRELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSK  275 (293)
T ss_dssp             --HSCHHHHTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred             --CCChHHhcCCCC----HHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence              000011122233    346677788999999999999988887754

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-40  Score=344.20  Aligned_cols=248  Identities=21%  Similarity=0.229  Sum_probs=188.1

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeee------CC
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE------GN  356 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~------~~  356 (596)
                      +.|...++||+|+||+||+|... +|+.||||++.+..........+.+|+..+.+ ++|||||++++++..      ..
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~-l~hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKC-VNHKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHH-CCCTTBCCCSEEECSCCSTTTCC
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHh-cCCCCeeEEEEEEecccccccCc
Confidence            46888899999999999999865 59999999998665544555678899966655 899999999999864      36


Q ss_pred             eEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceEEccCCC
Q 047719          357 ELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAKLGDFEA  436 (596)
Q Consensus       357 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~  436 (596)
                      .+|+||||+.++ +.+.+..      .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+|++|||.
T Consensus        96 ~~~iv~Ey~~~~-l~~~~~~------~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~  165 (355)
T d2b1pa1          96 DVYLVMELMDAN-LCQVIQM------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_dssp             EEEEEEECCSEE-HHHHHTS------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred             eeEEEEeccchH-HHHhhhc------CCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhh
Confidence            899999999765 4455532      38899999999999999999999   9999999999999999999999999986


Q ss_pred             cc----------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChhHHHH-HHH-------------
Q 047719          437 TI----------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDW-VWN-------------  492 (596)
Q Consensus       437 ~~----------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~-~~~-------------  492 (596)
                      +.          ..||+.|+|||.+.+..+++++||||+||++|||++|+.||.+.+...... +..             
T Consensus       166 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~  245 (355)
T d2b1pa1         166 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  245 (355)
T ss_dssp             ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred             hhccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh
Confidence            53          358999999999999999999999999999999999999998654311100 000             


Q ss_pred             ------HHhcC-Cc-----hhhcccccc---CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          493 ------LRKKG-KL-----LDAADFRLR---GKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       493 ------~~~~~-~~-----~~~~d~~l~---~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                            ..... ..     .........   ..........+.+|+.+|++.||++|||++|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                  00000 00     000000000   1112234567888999999999999999999986

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=4.5e-40  Score=339.35  Aligned_cols=244  Identities=18%  Similarity=0.214  Sum_probs=186.0

Q ss_pred             cCCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeee--CCeEEE
Q 047719          284 LGFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCE--GNELVL  360 (596)
Q Consensus       284 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~--~~~~~l  360 (596)
                      ++|...++||+|+||+||+|+.. +|+.||||+++..     ..+.+.+|+..|...-.||||+++++++..  ...+++
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~  109 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL  109 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence            46888899999999999999864 5899999999643     234678899777663359999999999874  356999


Q ss_pred             EEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCC-ceEEccCCCccc
Q 047719          361 VYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEF-NAKLGDFEATIP  439 (596)
Q Consensus       361 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~-~~kl~Dfg~~~~  439 (596)
                      ||||+.+++|..+.+       .+++..+..++.||+.||+|||+   ++|+||||||+|||++.++ .+||+|||++..
T Consensus       110 v~e~~~~~~L~~~~~-------~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~  179 (328)
T d3bqca1         110 VFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF  179 (328)
T ss_dssp             EEECCCSCBGGGTTT-------SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEE
T ss_pred             EEeecCCCcHHHHhc-------CCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeeccccccee
Confidence            999999999987642       38899999999999999999999   9999999999999998755 699999998642


Q ss_pred             ----------CCCcccCCccccccC-CCCCccceeehhHHHHHHHhCCCCCCCCChhHHHHH-----------HHHHhcC
Q 047719          440 ----------AGTMGYLAPEYVYSG-VPSEKTDVYSFGVVALEVAAGKSPVDNDGCVIVDWV-----------WNLRKKG  497 (596)
Q Consensus       440 ----------~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~El~tG~~p~~~~~~~~~~~~-----------~~~~~~~  497 (596)
                                .||..|+|||.+.+. .++.++||||+||++|||++|+.||.........+.           .......
T Consensus       180 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  259 (328)
T d3bqca1         180 YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY  259 (328)
T ss_dssp             CCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred             ccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence                      478999999998765 579999999999999999999999976543211110           0011110


Q ss_pred             Cch---hhcc-----------ccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 047719          498 KLL---DAAD-----------FRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAAR  542 (596)
Q Consensus       498 ~~~---~~~d-----------~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~~  542 (596)
                      ...   ...+           ..............+.+|+.+|++.||++|||++|+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000   0000           00000011112345678889999999999999999976

>d1dbna_ b.29.1.1 (A:) Legume lectin {Maackia amurensis, leukoagglutinin [TaxId: 37501]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Maackia amurensis, leukoagglutinin [TaxId: 37501]

Probab=100.00  E-value=1.1e-39  Score=320.54  Aligned_cols=174  Identities=30%  Similarity=0.409  Sum_probs=154.3

Q ss_pred             CCCCCCCcccceEEEEEEEEecCCCCCCCCeEEEEEecCCC--CCCCCCCccCCCCCCCC-CCCceEEEEeeCccCCCCC
Q 047719            1 FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNAD--SFGNDNGYMGLPGPVLS-PQDSFFAVEFDTSFDPSLG   77 (596)
Q Consensus         1 ~~~~~~~~~asF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~--~~~~~~~~lG~~~~~~~-~~~~~~AVEfDt~~~~~~~   77 (596)
                      |||+.+++++||+|+|+|.|.+.....+||||||+|+|.+.  +.+..|++||+++..+. ..++.+||||||++|.+++
T Consensus        58 l~~~~~~~~~sFst~F~F~i~~~~~~~~gdG~AF~l~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~aVEfDT~~n~~~~  137 (239)
T d1dbna_          58 IWGNTTGSVASFSTSFTFVVKAPNPDITSDGLAFYLAPPDSQIPSGSVSKYLGLFNNSNSDSSNQIVAVEFDTYFAHSYD  137 (239)
T ss_dssp             CBCTTTCCBCEEEEEEEEECCCSSTTSCCEEEEEEEECTTCCCCSSSCGGGTTSCSSSCCCTTSCCEEEEEECCCCTTTC
T ss_pred             ccCCCCccceEEEEEEEEEEECCCCCCCCCCEEEEEeCCCccCCcccCccccccccccCCCcccCeeeeEEeeeecCCCC
Confidence            69999999999999999999988777889999999999776  56678899999987633 3789999999999998763


Q ss_pred             --CCCCCeeEEecCCccccccccCCCCCcccCCCceEEEEEEEcCCccEEEEEEeeCCCCCCCCeEEEeecCcccCCCce
Q 047719           78 --DINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYM  155 (596)
Q Consensus        78 --d~~~~Hvgid~ns~~s~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~l~~~vdl~~~l~~~~  155 (596)
                        ||+.+|||||+|++.|..+...     .+.+|+.+.|||+||+.++.|.|++.+.. ++..|.|+..|||+.+|+++|
T Consensus       138 ~~d~~~~hvgid~n~~~s~~~~~~-----~~~~g~~~~~~i~y~~~~~~l~v~l~~~~-~~~~~~ls~~vdL~~~l~~~v  211 (239)
T d1dbna_         138 PWDPNYRHIGIDVNGIESIKTVQW-----DWINGGVAFATITYLAPNKTLIASLVYPS-NQTTFSVAASVDLKEILPEWV  211 (239)
T ss_dssp             TTSCSSCEEEEEESSSSCSEEEEC-----CCCTTCCEEEEEEEEGGGTEEEEEEEETT-TTEEEEEEEECCHHHHSCSEE
T ss_pred             CCCCCCceeeEEcCCccccccccc-----eEeCCceeEEEEEEcCCCCEEEEEEEecC-CCccEEEEEecchHHhcCCcE
Confidence              7899999999999998877653     56789999999999999999999998754 667789999999999999999


Q ss_pred             EEEEEeecCCc--cceeeeeeeeeecc
Q 047719          156 HVGFSAANGQG--SAIYTVDRWRFKTF  180 (596)
Q Consensus       156 ~vGFsastg~~--~~~~~i~~Wsf~~~  180 (596)
                      |||||||||..  .|.|+|++|||+++
T Consensus       212 yvGFSAsTG~~~~~~~H~I~sWsFss~  238 (239)
T d1dbna_         212 RVGFSAATGYPTEVETHDVLSWSFTST  238 (239)
T ss_dssp             EEEEEEEECSGGGCCCCEEEEEEEEEE
T ss_pred             EEEEEEeCCCCCCcceeEEEEEEeEEe
Confidence            99999999965  47899999999975

>d1fnya_ b.29.1.1 (A:) Legume lectin {Black locust (Robinia pseudoacacia) [TaxId: 35938]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Black locust (Robinia pseudoacacia) [TaxId: 35938]

Probab=100.00  E-value=1.6e-39  Score=319.07  Aligned_cols=174  Identities=26%  Similarity=0.390  Sum_probs=155.8

Q ss_pred             CCCCCCCcccceEEEEEEEEecCCCCCCCCeEEEEEecCCCCCCCCCCccCCCCCC-CCCCCceEEEEeeCccCCCCCCC
Q 047719            1 FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPV-LSPQDSFFAVEFDTSFDPSLGDI   79 (596)
Q Consensus         1 ~~~~~~~~~asF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~~~~~~~~~lG~~~~~-~~~~~~~~AVEfDt~~~~~~~d~   79 (596)
                      |||+.+++++||+|+|+|.|.......+||||||+|+|.+.+.+..||+||+++.. .+..++.+||||||++|.++ ||
T Consensus        58 l~~~~~~~~~sF~t~F~F~i~~~~~~~~gDG~AF~l~~~~~~~~~~gg~lg~~~~~~~~~~~~~~aVefDT~~n~~~-d~  136 (237)
T d1fnya_          58 IWDSTTGNVASFVTSFTFIIQAPNPATTADGLAFFLAPVDTQPLDLGGMLGIFKDGYFNKSNQIVAVEFDTFSNGDW-DP  136 (237)
T ss_dssp             CBCTTTCCBCEEEEEEEEECCCSSTTSCCEEEEEEEEETTCCCCCCGGGTTTCC---CCTTSCCEEEEEECSCCTTT-CC
T ss_pred             cccCCCCcceeeEEEEEEEEecCCCCCCCCeeEEEEcCCCCCcccccCcccccCCCCccCccceEEEEeccccccCC-CC
Confidence            69999999999999999999888778889999999999888778889999998876 34478899999999999874 99


Q ss_pred             CCCeeEEecCCccccccccCCCCCcccCCCceEEEEEEEcCCccEEEEEEeeCCCCCCCCeEEEeecCcccCCCceEEEE
Q 047719           80 NGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGF  159 (596)
Q Consensus        80 ~~~Hvgid~ns~~s~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~l~~~vdl~~~l~~~~~vGF  159 (596)
                      +++|||||+|++.|..+.+     .++.+|+.++|||+||+.+++|.|++.+.. ++..|+++..+||+.+||++|||||
T Consensus       137 ~~~Higi~~n~~~s~~~~~-----~~~~~g~~~~v~I~Y~~~~~~l~v~l~~~~-~~~~~~l~~~vdL~~~l~~~~yvGF  210 (237)
T d1fnya_         137 KGRHLGINVNSIESIKTVP-----WNWTNGEVANVFISYEASTKSLTASLVYPS-LETSFIIDAIVDVKIVLPEWVRFGF  210 (237)
T ss_dssp             SSSEEEEEESSSSCSEEEE-----CCCCTTCCEEEEEEEEGGGTEEEEEEEETT-TTEEEEEEEECCHHHHSCSEEEEEE
T ss_pred             CCceEEEecCCCccccccc-----ccccCCcEEEEEEEEeCCccEEEEEEEeCC-CCcceeEEEEechhhcCCCcEEEEE
Confidence            9999999999999987765     478899999999999999999999998854 5678899999999999999999999


Q ss_pred             EeecC---CccceeeeeeeeeeccC
Q 047719          160 SAANG---QGSAIYTVDRWRFKTFE  181 (596)
Q Consensus       160 sastg---~~~~~~~i~~Wsf~~~~  181 (596)
                      ||+||   ...|.|+|++|+|+++.
T Consensus       211 SAsTG~~s~~~e~H~I~sWsF~s~l  235 (237)
T d1fnya_         211 SATTGIDKGYVQTNDVLSWSFESNL  235 (237)
T ss_dssp             EEEECSSTTCCCCCEEEEEEEEEEE
T ss_pred             EEECCCCCCcccccEEEEeEeEEeC
Confidence            99999   45678999999999874

>d1n47a_ b.29.1.1 (A:) Legume lectin {Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]

Probab=100.00  E-value=4.7e-39  Score=314.36  Aligned_cols=171  Identities=29%  Similarity=0.398  Sum_probs=151.5

Q ss_pred             CCCCCCCcccceEEEEEEEEecCCCCCCCCeEEEEEecCCCCCCCCCCccCCCCCC-CCCCCceEEEEeeCccCCCCCCC
Q 047719            1 FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPV-LSPQDSFFAVEFDTSFDPSLGDI   79 (596)
Q Consensus         1 ~~~~~~~~~asF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~~~~~~~~~lG~~~~~-~~~~~~~~AVEfDt~~~~~~~d~   79 (596)
                      |||+.  .++||+|+|+|.|.+.....+||||||+|+|.+.+++..|++||+++.. .+..++.|||||||++|.  +||
T Consensus        58 l~~~~--~~~sF~t~f~f~i~~~~~~~~gDGlAF~l~~~~~~~~~~gg~lGl~~~~~~~~~~~~~aVefDT~~n~--~d~  133 (233)
T d1n47a_          58 IHDNT--TLASFTTSFSFVMAAPAAAAVADGLAFFLAPPDTQPQARGGFLGLFADRAHDASYQTVAVEFDTYSNA--WDP  133 (233)
T ss_dssp             CBCSS--CBCEEEEEEEEECCCSSTTSCCEEEEEEEECTTCCCCCCGGGTTTCSSSSCCGGGCCEEEEEECSCCT--TSC
T ss_pred             ccCCC--eeeeEEEEEEEEEeCCCCCCCCCceEEEECCCCCCCCCCCCccccccccCCCCcCceEEEEEEeeecC--CCC
Confidence            46543  5899999999999888788899999999999877788889999999776 334778899999999997  699


Q ss_pred             CCCeeEEecCCccccccccCCCCCcccCCCceEEEEEEEcCCccEEEEEEeeCCCCCCCCeEEEeecCcccCCCceEEEE
Q 047719           80 NGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGF  159 (596)
Q Consensus        80 ~~~Hvgid~ns~~s~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~l~~~vdl~~~l~~~~~vGF  159 (596)
                      ++||||||+|++.|..+.+     +.+.+|+.++|||+||+.+++|.|++.+.. ++..|.|+..|||+.+||++|||||
T Consensus       134 ~~~higi~~n~~~s~~~~~-----~~l~~g~~~~v~I~Y~~~~~~l~v~l~~~~-~~~~~~ls~~vdL~~~l~~~vyvGF  207 (233)
T d1n47a_         134 NYTHIGIDTNGIESKKTTP-----FDMVYGEKANIVITYQASTKALAASLVFPV-SQTSYAVSARVDLRDILPEYVRVGF  207 (233)
T ss_dssp             SSCEEEEEESSSSCSEEEE-----CCCCTTSCEEEEEEEETTTTEEEEEEEETT-TTEEEEEEEECCGGGTSCSEEEEEE
T ss_pred             CCCceeEccCCcccccccc-----ceecCCCEEEEEEEEcCCCeEEEEEEEeCC-CCccEEEEEEechHHhcCCcEEEEE
Confidence            9999999999999887766     478899999999999999999999998754 6778899999999999999999999


Q ss_pred             EeecC---CccceeeeeeeeeeccC
Q 047719          160 SAANG---QGSAIYTVDRWRFKTFE  181 (596)
Q Consensus       160 sastg---~~~~~~~i~~Wsf~~~~  181 (596)
                      ||+||   ...|.|+|++|+|+++.
T Consensus       208 SAsTG~~~~~~~~H~I~sWsFss~l  232 (233)
T d1n47a_         208 SATTGLNAGVVETHDIVSWSFAVSL  232 (233)
T ss_dssp             EEEECSSTTCCCCCEEEEEEEEEEE
T ss_pred             EEecCCCCCcccccEEEEEEeEEEc
Confidence            99999   45688999999999863

>d1v6ia_ b.29.1.1 (A:) Legume lectin {Peanut (Arachis hypogaea) [TaxId: 3818]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Peanut (Arachis hypogaea) [TaxId: 3818]

Probab=100.00  E-value=4.7e-39  Score=314.14  Aligned_cols=174  Identities=26%  Similarity=0.337  Sum_probs=147.8

Q ss_pred             CCCCCCCcccceEEEEEEEEecCCCCCCCCeEEEEEecCCCCCCCCCCccCCCCCC-CCCCCceEEEEeeCccCCCCCCC
Q 047719            1 FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPV-LSPQDSFFAVEFDTSFDPSLGDI   79 (596)
Q Consensus         1 ~~~~~~~~~asF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~~~~~~~~~lG~~~~~-~~~~~~~~AVEfDt~~~~~~~d~   79 (596)
                      |||+.+++++||+|+|+|.|.+.+...+||||||+|+|.+...+..++.+|+.+.. ..+.++.+||||||++|.+++||
T Consensus        54 l~~~~~~~~~sf~t~f~f~i~~~~~~~~gDG~AF~l~~~~~~~~~~~~~g~~~~~~~~~~~~~~~aVEfDT~~n~~~~d~  133 (232)
T d1v6ia_          54 IWSSATGNVASFLTSFSFEMKDIKDYDPADGIIFFIAPEDTQIPAGSIGGGTLGVSDTKGAGHFVGVEFDTYSNSEYNDP  133 (232)
T ss_dssp             CBCTTTCCBCEEEEEEEEEEECCSSSBCCCEEEEEEEETTCCCCTTCCCGGGTTTSCTTSEEEEEEEEEECSCCGGGTCC
T ss_pred             ccCCCCCccceeEEEEEEEeccCCCCCCCCeEEEEEECCCCCCCCCccCCcccccccCCCCCceEEEEEEeEecCCCCCC
Confidence            79999999999999999999988888899999999999876433322222222222 23367899999999999988899


Q ss_pred             CCCeeEEecCCccccccccCCCCCcccCCCceEEEEEEEcCCccEEEEEEeeCCCCCCCCeEEEeecCcccCCCceEEEE
Q 047719           80 NGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGF  159 (596)
Q Consensus        80 ~~~Hvgid~ns~~s~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~l~~~vdl~~~l~~~~~vGF  159 (596)
                      +++|||||+|++.+..+..     .++.+|+.++|||+||+.+++|.|++.+.  ++..|.++..|||+.+|+++|||||
T Consensus       134 ~~~Higid~n~~~s~~~~~-----~~~~~g~~~~v~I~Yd~~~~~L~V~~~~~--~~~~~~l~~~vdL~~~l~~~vyvGF  206 (232)
T d1v6ia_         134 PTDHVGIDVNSVDSVKTVP-----WNSVSGAVVKVTVIYDSSTKTLSVAVTND--NGDITTIAQVVDLKAKLPERVKFGF  206 (232)
T ss_dssp             SSCEEEEEEEESSCSEEEE-----CCCCTTCEEEEEEEEETTTTEEEEEEECT--TSCEEEEEEECCHHHHSCSEEEEEE
T ss_pred             CCccEeEeeCCcccccccc-----cccCCCCEEEEEEEEeCCceEEEEEEecC--CCCcceEEEEEchhhccCCcEEEEE
Confidence            9999999999998887755     47889999999999999999999998763  4667889999999999999999999


Q ss_pred             EeecCCc-cceeeeeeeeeeccC
Q 047719          160 SAANGQG-SAIYTVDRWRFKTFE  181 (596)
Q Consensus       160 sastg~~-~~~~~i~~Wsf~~~~  181 (596)
                      ||+||.. .|.|+|++|+|+++.
T Consensus       207 SAsTG~~~~~~H~I~sWsFss~l  229 (232)
T d1v6ia_         207 SASGSLGGRQIHLIRSWSFTSTL  229 (232)
T ss_dssp             EEECCSSBCCEEEEEEEEEEEEE
T ss_pred             EEECCCCCCcccEEEEeEeEEee
Confidence            9999975 589999999999864

>d1ukga_ b.29.1.1 (A:) Legume lectin {Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]

Probab=100.00  E-value=3.3e-37  Score=303.27  Aligned_cols=173  Identities=29%  Similarity=0.488  Sum_probs=151.3

Q ss_pred             CCCCCCCcccceEEEEEEEEecCCCCCCCCeEEEEEecCCC--CCCCCCCccCCCCCC-CC--CCCceEEEEeeCccCCC
Q 047719            1 FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNAD--SFGNDNGYMGLPGPV-LS--PQDSFFAVEFDTSFDPS   75 (596)
Q Consensus         1 ~~~~~~~~~asF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~--~~~~~~~~lG~~~~~-~~--~~~~~~AVEfDt~~~~~   75 (596)
                      |||+.+++++||+|+|+|.|..+ ....||||||+|++...  +.+.+|+++|+++.. .+  ..++.+||||||++|.+
T Consensus        58 l~~~~~~~~~sF~t~F~f~i~~~-~~~~~~g~~f~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~n~~vaVEfDt~~n~~  136 (241)
T d1ukga_          58 LWEKSSSRVANFQSQFSFSLKSP-LSNGADGIAFFIAPPDTTIPSGSGGGLLGLFAPGTAQNTSANQVIAVEFDTFYAQD  136 (241)
T ss_dssp             CEETTTTEEEEEEEEEEEEEECS-SSSCCCEEEEEEECTTCCCCTTCCGGGTTTSCGGGTTCGGGCCCEEEEEECCCCTT
T ss_pred             cccCCCCceeeeEEEEEEEEecC-CCCCCCceEEEEeCCCCCcccccCcccccccccccccCCccCcccceeccCEecCc
Confidence            68999999999999999999765 44578999999998655  566778888888765 22  26889999999999875


Q ss_pred             C--CCCCCCeeEEecCCccccccccCCCCCcccCCCceEEEEEEEcCCccEEEEEEeeCCCCCCCCeEEEeecCcccCCC
Q 047719           76 L--GDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKD  153 (596)
Q Consensus        76 ~--~d~~~~Hvgid~ns~~s~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~l~~~vdl~~~l~~  153 (596)
                      .  +||++||||||+|++.|.++..     .++.+|+.++|||+||+.+++|+|++.+.  ++..|.+++.|||+.+|++
T Consensus       137 ~~~~~~~~~Higid~n~~~s~~~~~-----~~~~~g~~~~v~I~Yd~~~~~L~v~~~~~--~~~~~~l~~~vdL~~~l~~  209 (241)
T d1ukga_         137 SNTWDPNYPHIGIDVNSIRSVKTVK-----WDRRDGQSLNVLVTFNPSTRNLDVVATYS--DGTRYEVSYEVDVRSVLPE  209 (241)
T ss_dssp             TCTTSCSSCEEEEEESSSSCSEEEE-----CCCCTTCCEEEEEEEETTTTEEEEEEEET--TCCEEEEEEECCGGGTSCS
T ss_pred             cCCCCCCCccEeeecCCcccccccc-----cccCCCcEEEEEEEEeCCCcEEEEEEccC--CCCceEEEEEEehHHhCCC
Confidence            4  4589999999999999987765     47889999999999999999999999774  5677899999999999999


Q ss_pred             ceEEEEEeecCCccceeeeeeeeeeccC
Q 047719          154 YMHVGFSAANGQGSAIYTVDRWRFKTFE  181 (596)
Q Consensus       154 ~~~vGFsastg~~~~~~~i~~Wsf~~~~  181 (596)
                      +||||||||||...+.|+|++|+|+++.
T Consensus       210 ~~yvGFSAsTG~~~~~H~IlsWsFss~l  237 (241)
T d1ukga_         210 WVRVGFSAASGEQYQTHTLESWSFTSTL  237 (241)
T ss_dssp             EEEEEEEEEESSSCCEEEEEEEEEEEEE
T ss_pred             cEEEEEEEecCCCCceeEEEEeEEEEEe
Confidence            9999999999999999999999999864

>d1ioaa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]

Probab=100.00  E-value=1e-36  Score=297.12  Aligned_cols=166  Identities=22%  Similarity=0.306  Sum_probs=144.9

Q ss_pred             CCCCCCCcccceEEEEEEEEecCCCCCCCCeEEEEEecCCCCCCCCCCccCCCCCCCCC-CCceEEEEeeCccCCCCCCC
Q 047719            1 FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSP-QDSFFAVEFDTSFDPSLGDI   79 (596)
Q Consensus         1 ~~~~~~~~~asF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~~~~~~~~~lG~~~~~~~~-~~~~~AVEfDt~~~~~~~d~   79 (596)
                      |||  +++++||+|+|+|.|.+++...+||||||+|+|.+.+++..|++||+++...++ .++.|||||||++|.  .|+
T Consensus        58 l~~--~~~~~sFst~F~f~i~~~~~~~~gDGlAF~l~~~~~~~~~~g~~lgl~~~~~~~~~~~~vave~dt~~n~--~~~  133 (228)
T d1ioaa_          58 IKD--SNNVASFNTNFTFIIRAKNQSISAYGLAFALVPVNSPPQKKQEFLGIFNTNNPEPNARTVAVVFNTFKNR--IDF  133 (228)
T ss_dssp             CBC--SSCBEEEEEEEEEECCBSCTTSCCEEEEEEEEETTCCCCCCGGGTTTCCCSSCCGGGCCEEEEEETTTTE--EEE
T ss_pred             ecC--CCceeeEEEEEEEEEecCCCCCCCCEEEEEEeCCCCCCCCCccccccccccCCCCcceeEEEEecCcccc--ccC
Confidence            455  578999999999999988888889999999999888888899999999876443 788999999999886  578


Q ss_pred             CCCeeEEecCCccccccccCCCCCcccCCCceEEEEEEEcCCccEEEEEEeeCCCCCCCCeEEEeecCcccCCCceEEEE
Q 047719           80 NGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGF  159 (596)
Q Consensus        80 ~~~Hvgid~ns~~s~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~l~~~vdl~~~l~~~~~vGF  159 (596)
                      +.+|+|+++++..          ...+.+|+.++|||+||+.+++|+|++.+.. ++..|+|+..+||+++|+++|||||
T Consensus       134 ~~~~~~~~~~~~~----------~~~~~~g~~~~v~I~Yd~~~~~l~V~l~~~~-~~~~~~ls~~vdL~~~l~~~vyvGF  202 (228)
T d1ioaa_         134 DKNFIKPYVNENC----------DFHKYNGEKTDVQITYDSSNNDLRVFLHFTV-SQVKCSVSATVHLEKEVDEWVSVGF  202 (228)
T ss_dssp             EESSSSCSEEEEC----------CHHHHCSSCEEEEEEEETTTTEEEEEEEETT-TCCEEEEEEECCGGGTSCSEEEEEE
T ss_pred             CCCccceeccccc----------ccccccCcEEEEEEEEcCCCCEEEEEEEeCC-CCceeeEEEEEchHHcCCCcEEEEE
Confidence            8888888876532          3467799999999999999999999998854 7788999999999999999999999


Q ss_pred             EeecC---CccceeeeeeeeeeccC
Q 047719          160 SAANG---QGSAIYTVDRWRFKTFE  181 (596)
Q Consensus       160 sastg---~~~~~~~i~~Wsf~~~~  181 (596)
                      |||||   ...|.|+|++|||+++.
T Consensus       203 SAsTG~~~~~~~~h~I~sWsFss~~  227 (228)
T d1ioaa_         203 SPTSGLTEDTTETHDVLSWSFSSKF  227 (228)
T ss_dssp             EEEECSSTTTCBCCEEEEEEEEEEE
T ss_pred             EeecCCCCCCceEEEEEEEEeEEec
Confidence            99999   55688999999999863

>d1avba_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=1e-35  Score=289.77  Aligned_cols=168  Identities=24%  Similarity=0.330  Sum_probs=151.7

Q ss_pred             CCCCCCCcccceEEEEEEEEecCCCCCCCCeEEEEEecCCCCCCCCCCccCCCCCCCCCCCceEEEEeeCccCCCCCCCC
Q 047719            1 FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQDSFFAVEFDTSFDPSLGDIN   80 (596)
Q Consensus         1 ~~~~~~~~~asF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~~~~~~~~~lG~~~~~~~~~~~~~AVEfDt~~~~~~~d~~   80 (596)
                      |||+.++.++||+|+|+|.|.+.....+||||||+|+|.+...+..|+++|+++.        ++|||||+.|...+|+.
T Consensus        54 l~~~~~~~~~sF~t~f~f~i~~~~~~~~gDG~aF~i~~~~~~~g~~gg~~gl~~~--------~~v~fdt~~~~~~~d~~  125 (226)
T d1avba_          54 INDRTIDNLASFSTNFTFRINAKNIENSAYGLAFALVPVGSRPKLKGRYLGLFNT--------TNYDRDAHTVAVVFDTV  125 (226)
T ss_dssp             CEEGGGTEEEEEEEEEEEEEEESSTTSCCEEEEEEEEETTCCCCCCGGGTTTCSC--------SSCCGGGCCEEEEEETT
T ss_pred             cccCCCCcccceEEEEEEEEecCCCCCCCceEEEEEccCCCCCCCccccCCcccc--------ccccccceeccccccCC
Confidence            6899999999999999999998888889999999999988878888999999865        37999999987667999


Q ss_pred             CCeeEEecCCccccccccCCCCCcccCCCceEEEEEEEcCCccEEEEEEeeCCCCCCCCeEEEeecCcccCCCceEEEEE
Q 047719           81 GNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFS  160 (596)
Q Consensus        81 ~~Hvgid~ns~~s~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~l~~~vdl~~~l~~~~~vGFs  160 (596)
                      .||||||+|+..+..+.+.   ...+.+|+.++|||+||+.+++|+|++.+.. ++..|.++..|||+.+||++||||||
T Consensus       126 ~nhi~i~~n~~~s~~~~~~---~~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~~~~~~~vdL~~~l~~~~y~GFS  201 (226)
T d1avba_         126 SNRIEIDVNSIRPIATESC---NFGHNNGEKAEVRITYDSPKNDLRVSLLYPS-SEEKCHVSATVPLEKEVEDWVSVGFS  201 (226)
T ss_dssp             TTEEEEEESSSSCSEEEEC---CSGGGTTCEEEEEEEEEGGGTEEEEEEEETT-TTEEEEEEEECCHHHHSCSEEEEEEE
T ss_pred             CCEEEEeCCCCcccccccc---ccccCCCeEEEEEEEEcCCCcEEEEEEEeCC-CCccEEEEEEecHHHccCCcEEEEEE
Confidence            9999999999998887765   4688999999999999999999999998865 67788899999999999999999999


Q ss_pred             eecCC---ccceeeeeeeeeecc
Q 047719          161 AANGQ---GSAIYTVDRWRFKTF  180 (596)
Q Consensus       161 astg~---~~~~~~i~~Wsf~~~  180 (596)
                      |+||.   ..|.|+|++|+|+++
T Consensus       202 AaTG~~s~~~~~H~IlsWsF~s~  224 (226)
T d1avba_         202 ATSGSKKETTETHNVLSWSFSSN  224 (226)
T ss_dssp             EEECSSGGGCEEEEEEEEEEEEE
T ss_pred             EEcCCCCCCeeeeEEEEEEeEEe
Confidence            99995   457899999999975

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.1e-34  Score=302.49  Aligned_cols=254  Identities=18%  Similarity=0.192  Sum_probs=181.8

Q ss_pred             CCCccceeecCCceEEEEEEcC-CCCEEEEEEeecCCchhcccchHHHHHHHHHhc----------cCCCceeeecceee
Q 047719          285 GFNKNRIVGEGASATVYKGSLP-SGGAVAVKRFEKPNRVECARNPFTTEFATMAGC----------LRHKNLVQLQGWCC  353 (596)
Q Consensus       285 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~----------l~H~niv~l~g~~~  353 (596)
                      .|...++||+|+||+||+|+.. +|+.||||++++...   ..+.+.+|+..+...          +.|+|||++++++.
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~---~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~   90 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV---YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   90 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH---HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc---chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence            3788899999999999999864 689999999965322   223456666544331          24789999999886


Q ss_pred             eC--CeEEEEEecCCCCCHH-HHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCc--
Q 047719          354 EG--NELVLVYEYLPNGSLD-KILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFN--  428 (596)
Q Consensus       354 ~~--~~~~lV~E~~~~gsL~-~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~--  428 (596)
                      ..  ...+++++++..+... .......  ...+++..+..++.||++||+|||+.  .+|+||||||+||||+.++.  
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~  166 (362)
T d1q8ya_          91 HKGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPE  166 (362)
T ss_dssp             EEETTEEEEEEEECCCCEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTT
T ss_pred             eccccceeeeeeeccccccccccccccc--ccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccCccc
Confidence            53  4667777776555433 3333222  33588899999999999999999973  78999999999999987653  


Q ss_pred             ----eEEccCCCcc--------cCCCcccCCccccccCCCCCccceeehhHHHHHHHhCCCCCCCCChh--------HHH
Q 047719          429 ----AKLGDFEATI--------PAGTMGYLAPEYVYSGVPSEKTDVYSFGVVALEVAAGKSPVDNDGCV--------IVD  488 (596)
Q Consensus       429 ----~kl~Dfg~~~--------~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~El~tG~~p~~~~~~~--------~~~  488 (596)
                          +|++|||.+.        ..||+.|+|||.+....++.++||||+||+++||++|+.||......        +..
T Consensus       167 ~~~~~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~  246 (362)
T d1q8ya_         167 NLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ  246 (362)
T ss_dssp             TEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred             ccceeeEeecccccccccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence                9999999764        35899999999999999999999999999999999999999754220        111


Q ss_pred             HHHHHH-------hcCCc-hhhcc-------------------ccccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 047719          489 WVWNLR-------KKGKL-LDAAD-------------------FRLRGKFNRKEMERMLMVGLSCVHPNHEKRPSVKEAA  541 (596)
Q Consensus       489 ~~~~~~-------~~~~~-~~~~d-------------------~~l~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ev~  541 (596)
                      .+..+.       ..... ....+                   ..............+.+|+.+|++.||++|||++|++
T Consensus       247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L  326 (362)
T d1q8ya_         247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV  326 (362)
T ss_dssp             HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred             HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence            111100       00000 00000                   0011234566778899999999999999999999998


Q ss_pred             H--HHh
Q 047719          542 R--ILK  545 (596)
Q Consensus       542 ~--~L~  545 (596)
                      +  +++
T Consensus       327 ~Hp~f~  332 (362)
T d1q8ya_         327 NHPWLK  332 (362)
T ss_dssp             TCGGGT
T ss_pred             cCcccC
Confidence            7  354

>d1dhkb_ b.29.1.1 (B:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.97  E-value=1e-31  Score=256.89  Aligned_cols=150  Identities=24%  Similarity=0.335  Sum_probs=121.2

Q ss_pred             CCCCCCCcccceEEEEEEEEecCCCCCCCCeEEEEEecCCCCCCCCCCccCCCCCCCCCCCceEEEEeeCccCCCCCCCC
Q 047719            1 FLDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQDSFFAVEFDTSFDPSLGDIN   80 (596)
Q Consensus         1 ~~~~~~~~~asF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~~~~~~~~~lG~~~~~~~~~~~~~AVEfDt~~~~~~~d~~   80 (596)
                      |||+.+++++||+|+|+|.|.+.+...+||||||+|+|...                ...++.+||||||++        
T Consensus        51 l~~~~~~~~~sF~t~F~f~i~~~~~~~~gdGlaf~~~~~~~----------------~~~~~~~~vefDt~~--------  106 (204)
T d1dhkb_          51 IRDSTTGNVASFDTNFTMNIRTHRQANSAVGLDFVLVPVQP----------------ESKGDTVTVEFDTFL--------  106 (204)
T ss_dssp             SEETTTTEECEEEEEEEEEEECCC---CCSEEEEEEEEC----------------------CCEEEEEETTT--------
T ss_pred             ccCCCCcccccEEEEEEEEEecCCCCCCCceEEEEecCCCC----------------CCCCcEeeEeeEccc--------
Confidence            69999999999999999999988877889999999998532                113467999999986        


Q ss_pred             CCeeEEecCCccccccccCCCCCcccCCCceEEEEEEEcCCccEEEEEEeeCCCCCCCCeEEEeecCcccCCCceEEEEE
Q 047719           81 GNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRDSLKLIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFS  160 (596)
Q Consensus        81 ~~Hvgid~ns~~s~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~l~~~vdl~~~l~~~~~vGFs  160 (596)
                       ||+++|+|+...... .   ....+.+|+.++|||+||+.+++|+|++.+.. ++..|.|+..+||+.+||++||||||
T Consensus       107 -n~~~~d~~~~~~~~~-~---~~~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~~~l~~~vdL~~~l~~~~yvGFS  180 (204)
T d1dhkb_         107 -SRISIDVNNNDIKSV-P---WDVHDYDGQNAEVRITYNSSTKVFSVSLSNPS-TGKSNNVSTTVELEKEVYDWVSVGFS  180 (204)
T ss_dssp             -TEEEEEETTEEEEEE-E---CCGGGTTTSCEEEEEEEETTTTEEEEEEECTT-TCCEEEEEEECCCCSGGGSEEEEEEE
T ss_pred             -ccccCcccccccccc-c---cccEecCCCEEEEEEEEcCCCEEEEEEEecCC-CCCceeEEEEecchhccCCcEEEEEE
Confidence             466777666443222 1   14678899999999999999999999998855 56678899999999999999999999


Q ss_pred             eecCCc---cceeeeeeeeeecc
Q 047719          161 AANGQG---SAIYTVDRWRFKTF  180 (596)
Q Consensus       161 astg~~---~~~~~i~~Wsf~~~  180 (596)
                      ||||..   .|.|+|++|||+++
T Consensus       181 AaTG~~~~~~e~H~IlsWsFss~  203 (204)
T d1dhkb_         181 ATSGAYQWSYETHDVLSWSFSSK  203 (204)
T ss_dssp             EEECSGGGSCCEEEEEEEEEEEE
T ss_pred             eecCCCCCCceeeEEEEEEEEec
Confidence            999964   57899999999974

>d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Concanavalin A
species: Jack bean (Canavalia ensiformis) [TaxId: 3823]

Probab=99.97  E-value=1.9e-31  Score=256.89  Aligned_cols=117  Identities=29%  Similarity=0.412  Sum_probs=108.1

Q ss_pred             CCceEEEEeeCccCCCCCCCCCCeeEEecCCccccccccCCCCCcccCCCceEEEEEEEcCCccEEEEEEeeCCCCCCCC
Q 047719           60 QDSFFAVEFDTSFDPSLGDINGNHIGIDISSVISFVSVDALSRGIDLKSGRHITTWIEYRDSLKLIRVWAGYSQIRPPSP  139 (596)
Q Consensus        60 ~~~~~AVEfDt~~~~~~~d~~~~Hvgid~ns~~s~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p  139 (596)
                      .|++|||||||++|.+++||++||||||+|++.|.++.+     +++.+|+.++|||+||+.+++|.|++.+.  ++..|
T Consensus         1 an~ivAVEFDT~~N~~~~Dp~~nHIgIdvns~~S~~~~~-----~~l~~G~~~~v~I~Yd~~~~~L~V~~~~~--~~~~~   73 (237)
T d1nlsa_           1 ADTIVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKTAK-----WNMQNGKVGTAHIIYNSVDKRLSAVVSYP--NADSA   73 (237)
T ss_dssp             CCCEEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEE-----CCCCTTCEEEEEEEEETTTTEEEEEEECT--TSCCE
T ss_pred             CCCEEEEEEECCcCCCCCCCCCCEEEEEeCCCCccceec-----ccccCCCEEEEEEEEecCCcEEEEEEecC--CCCCe
Confidence            479999999999999889999999999999999988766     48999999999999999999999999763  56788


Q ss_pred             eEEEeecCcccCCCceEEEEEeecCCccceeeeeeeeeeccCCC
Q 047719          140 LIIAQIDLSKQFKDYMHVGFSAANGQGSAIYTVDRWRFKTFESY  183 (596)
Q Consensus       140 ~l~~~vdl~~~l~~~~~vGFsastg~~~~~~~i~~Wsf~~~~~~  183 (596)
                      +|++.|||+.+|+++||||||||||...|.|+|++|+|+++...
T Consensus        74 ~ls~~vdL~~~l~~~vyvGFSAsTG~~~~~h~I~sWsFsS~~~~  117 (237)
T d1nlsa_          74 TVSYDVDLDNVLPEWVRVGLSASTGLYKETNTILSWSFTSKLKS  117 (237)
T ss_dssp             EEEEECCGGGTSCSEEEEEEEEECSSSCCCCEEEEEEEEEEEEE
T ss_pred             EEEEEEChHHhCCCcEEEEEEeecCCCccceEEEEEEEEeeccc
Confidence            99999999999999999999999999999999999999987544

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.86  E-value=1.7e-22  Score=190.47  Aligned_cols=161  Identities=19%  Similarity=0.242  Sum_probs=114.9

Q ss_pred             CccceeecCCceEEEEEEcCCCCEEEEEEeecCCchh----------------cccchHHHHHHHHHhccCCCceeeecc
Q 047719          287 NKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVE----------------CARNPFTTEFATMAGCLRHKNLVQLQG  350 (596)
Q Consensus       287 ~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~----------------~~~~~~~~E~~~l~~~l~H~niv~l~g  350 (596)
                      ..+++||+|+||+||+|...+|+.||||+++......                ........|...+.+ +.|.+++..++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~-l~~~~v~~~~~   81 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQK-LQGLAVPKVYA   81 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHH-TTTSSSCCEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHH-ccCCCcceEEE
Confidence            3568999999999999998889999999875321110                001123445555544 78999888775


Q ss_pred             eeeeCCeEEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhccCCCeEEccCCCCceeecCCCceE
Q 047719          351 WCCEGNELVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEECERQIIHRDVKACNILLDAEFNAK  430 (596)
Q Consensus       351 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NiLl~~~~~~k  430 (596)
                      +..    .+++|||+++..+.+           ++......++.|++++|+|||+   .+|+||||||+|||++++ .++
T Consensus        82 ~~~----~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~  142 (191)
T d1zara2          82 WEG----NAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIW  142 (191)
T ss_dssp             EET----TEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEE
T ss_pred             ecC----CEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEE
Confidence            532    379999998765433           2334456789999999999999   899999999999999965 589


Q ss_pred             EccCCCcccCCCcccCCcccc----------ccCCCCCccceeehhHHH
Q 047719          431 LGDFEATIPAGTMGYLAPEYV----------YSGVPSEKTDVYSFGVVA  469 (596)
Q Consensus       431 l~Dfg~~~~~gt~~y~aPE~~----------~~~~~t~~sDV~SfGvll  469 (596)
                      |+|||++...+.+.  +.+++          ....|+.++|+||..--+
T Consensus       143 liDFG~a~~~~~~~--~~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         143 IIDFPQSVEVGEEG--WREILERDVRNIITYFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             ECCCTTCEETTSTT--HHHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred             EEECCCcccCCCCC--cHHHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence            99999886554332  22222          135678899999875443

>d1gv9a_ b.29.1.13 (A:) Carbohydrate-recognition domain of P58/ERGIC-53 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Lectin leg-like
domain: Carbohydrate-recognition domain of P58/ERGIC-53
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.82  E-value=1.9e-20  Score=181.39  Aligned_cols=163  Identities=17%  Similarity=0.060  Sum_probs=104.5

Q ss_pred             CCCCCCcccceEEEEEEEEecCCCCCCCCeEEEEEecCCCCCCCCCCccCCCCCCCCCCCceEEEEeeCccCCCCCCCCC
Q 047719            2 LDPKTNTTASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQDSFFAVEFDTSFDPSLGDING   81 (596)
Q Consensus         2 ~~~~~~~~asF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~~~~~~~~~lG~~~~~~~~~~~~~AVEfDt~~~~~~~d~~~   81 (596)
                      |.+.--.+.+|+|+|+|.+... ...+||||||+|++....   .|+.+|..+     ..+-+||||||+.|.  ++++.
T Consensus        53 ~~~~p~~~~~F~~~f~f~~~~~-~~~ggdG~aF~i~~~~~~---~g~~~G~~~-----~~~glaVefDt~~n~--~~~~~  121 (228)
T d1gv9a_          53 WTKTKAAFENWEVEVTFRVTGR-GRIGADGLAIWYTENQGL---DGPVFGSAD-----MWNGVGIFFDSFDND--GKKNN  121 (228)
T ss_dssp             EESSCBCCSSEEEEEEEEEECS-SSCCCCEEEEEEESSCCC---EEEETTECS-----CCEEEEEEEECCCC-------C
T ss_pred             EeCCCccccCcEEEEEEeccCC-CCCCCCEEEEEEecCCCC---CCCccCcCC-----CCceEEEEEEccccc--CCCCC
Confidence            3344445679999999999764 456799999999986543   344444321     234589999999997  57888


Q ss_pred             CeeEEecCCccccc-cc------cCCCCCcc-cCCCceEEEEEEEcCCccEEEEEEeeCCCCCCC-CeEEEeecCcccCC
Q 047719           82 NHIGIDISSVISFV-SV------DALSRGID-LKSGRHITTWIEYRDSLKLIRVWAGYSQIRPPS-PLIIAQIDLSKQFK  152 (596)
Q Consensus        82 ~Hvgid~ns~~s~~-~~------~~~~~~~~-l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~-p~l~~~vdl~~~l~  152 (596)
                      +|+.+++|...... ..      ........ ..++..+++||+|+  .+.|+|++......... +.+...++ ...++
T Consensus       122 ~~~~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~--~~~l~v~i~~~~~~~~~~~~~~~~~~-~~~l~  198 (228)
T d1gv9a_         122 PAIVVVGNNGQINYDHQNDGATQALASCQRDFRNKPYPVRAKITYY--QKTLTVMINNGFTPDKNDYEFCAKVE-NMVIP  198 (228)
T ss_dssp             CEEEEEEEESCCCCCHHHHHHHHCSEEECCCCBSCSSCEEEEEEEE--TTEEEEEEECSSCCCTTCCEEEEEET-TCCCC
T ss_pred             CcEEEEecCCcceeeecCCCccccccceeeeecCCceEEEEEEEec--CCEEEEEEeccccCCCcceeEEEEec-ccccC
Confidence            88888776432111 10      01000111 12344566666665  56799988774433333 33344343 56789


Q ss_pred             CceEEEEEeecCCccceeeeeeeeee
Q 047719          153 DYMHVGFSAANGQGSAIYTVDRWRFK  178 (596)
Q Consensus       153 ~~~~vGFsastg~~~~~~~i~~Wsf~  178 (596)
                      +++||||||+||...+.|.|++|.+.
T Consensus       199 ~~~y~GFTAsTG~~~~~H~I~s~~~~  224 (228)
T d1gv9a_         199 TQGHFGISAATGGLADDHDVLSFLTF  224 (228)
T ss_dssp             SSBEEEEEEECCSSCCEEEEEEEEEE
T ss_pred             CCEEEEEEEeCCCCcCeEEEEEEEEE
Confidence            99999999999999999999999875

>d2a6va1 b.29.1.13 (A:9-226) Emp46p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Lectin leg-like
domain: Emp46p N-terminal domain
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.44  E-value=6.5e-13  Score=126.32  Aligned_cols=147  Identities=11%  Similarity=0.040  Sum_probs=92.4

Q ss_pred             cceEEEEEEEEecCCCCCCCCeEEEEEecCCCCCC--CCCCccCCCCCCCCCCCceEEEEeeCccCCCCCCCCCCeeEEe
Q 047719           10 ASFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFG--NDNGYMGLPGPVLSPQDSFFAVEFDTSFDPSLGDINGNHIGID   87 (596)
Q Consensus        10 asF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~~~~--~~~~~lG~~~~~~~~~~~~~AVEfDt~~~~~~~d~~~~Hvgid   87 (596)
                      .+|+++|+|.|... ...+||||||.+++.....+  ..+|..+.++        =+||||||+.|.      .+||.+.
T Consensus        59 ~~f~i~~~F~i~g~-~~~~~dG~afw~~~~~~~~~~~~~~G~~~~f~--------GlaV~fDt~~n~------~~~i~~~  123 (218)
T d2a6va1          59 DAMTIEWTFRSFGF-RGSTKGGLAFWLKQGNEGDSTELFGGSSKKFN--------GLMILLRLDDKL------GESVTAY  123 (218)
T ss_dssp             SCEEEEEEEEEESC-CSCCSCEEEEEEECSCCCCCCTBTTTBCSSCE--------EEEEEEEEETTT------EEEEEEE
T ss_pred             ccceEEEEEEEeCC-CCCCCCcEEEEEEcCCcccCCCcccccCCCcc--------eEEEEEECCCCC------CCeEEEE
Confidence            36999999999864 35579999999997544322  2223333322        279999998774      2677776


Q ss_pred             cCCccc---ccc-ccCCCCC-cccCCCceEEEEEEEcCCcc-EEEEEEeeCCCCCCCCeE-EEeecCcccCCCceEEEEE
Q 047719           88 ISSVIS---FVS-VDALSRG-IDLKSGRHITTWIEYRDSLK-LIRVWAGYSQIRPPSPLI-IAQIDLSKQFKDYMHVGFS  160 (596)
Q Consensus        88 ~ns~~s---~~~-~~~~~~~-~~l~~g~~~~~~I~Y~~~~~-~l~v~~~~~~~~~~~p~l-~~~vdl~~~l~~~~~vGFs  160 (596)
                      +|.=..   ..+ ..++.-. -...++...+++|.|+..+. .+.|.+..      +.++ ...|+|  ..++++|+|||
T Consensus       124 ~ndGs~~~~~~~d~~~g~c~~~~~~~~~~~~~~i~Y~~~~~~~l~v~id~------~~c~~t~~i~l--p~~~~~yfG~S  195 (218)
T d2a6va1         124 LNDGTKDLDIESSPYFASCLFQYQDSMVPSTLRLTYNPLDNHLLKLQMDN------RVCFQTRKVKF--MGSSPFRIGTS  195 (218)
T ss_dssp             EEESSSCCCTTTSCCSEEEECCCSSCSSCEEEEEEEEGGGTSEEEEEETT------EEEEEESCCCG--GGTSCBEEEEE
T ss_pred             eCCCCccccccCCcccceEEecccCCCCcEEEEEEEECcccceEEEEeCC------cEEEEECCeec--CCCCcEEEEEE
Confidence            552110   000 0110000 11335677899999987664 46776531      1111 122333  34677999999


Q ss_pred             eecCCccceeeeeeeeeec
Q 047719          161 AANGQGSAIYTVDRWRFKT  179 (596)
Q Consensus       161 astg~~~~~~~i~~Wsf~~  179 (596)
                      |+||...+.|.|++|.+..
T Consensus       196 A~Tg~~~d~~dIls~~~~~  214 (218)
T d2a6va1         196 AINDASKESFEILKMKLYD  214 (218)
T ss_dssp             EECCTTCCEEEEEEEEEES
T ss_pred             ECCCCCcCcEEEEEEEEEe
Confidence            9999999999999999864

>d2a6za1 b.29.1.13 (A:7-227) Emp47p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Lectin leg-like
domain: Emp47p N-terminal domain
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.42  E-value=5.8e-13  Score=127.06  Aligned_cols=146  Identities=13%  Similarity=0.043  Sum_probs=88.1

Q ss_pred             ceEEEEEEEEecCCCCCCCCeEEEEEecCCCCCCCCCCccCCCCCCCCCCCceEEEEeeCccCCCCCCCCCCeeEEecCC
Q 047719           11 SFSCRFSFSIIPSPLCAFGDGFAFLITSNADSFGNDNGYMGLPGPVLSPQDSFFAVEFDTSFDPSLGDINGNHIGIDISS   90 (596)
Q Consensus        11 sF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~~~~~~~~~lG~~~~~~~~~~~~~AVEfDt~~~~~~~d~~~~Hvgid~ns   90 (596)
                      +|+++|.|.|... ...+||||||++++.+. .+..|+++|..+.     ..-+||||||+.|..    ...|+.++.++
T Consensus        61 ~f~~~~~F~i~g~-~~~ggdG~af~~~~~~~-~~~~g~~~G~~~~-----~~GlaV~fDt~~n~~----~~~~~~~ndgt  129 (221)
T d2a6za1          61 SFTMEWTFRSVGY-SGQTDGGISFWFVQDSN-IPRDKQLYNGPVN-----YDGLQLLVDNNGPLG----PTLRGQLNDGQ  129 (221)
T ss_dssp             CEEEEEEEEEESC-CSCCSCEEEEEEEECSS-SCCCCTBTTBCTT-----CEEEEEEEESCSTTS----SEEEEEEEESS
T ss_pred             CeEEEEEEEEeCC-CCCCCCcEEEEEEcCCC-ccccccccccCCC-----CceEEEEEECCCCCC----CceEEEecCCC
Confidence            6999999999854 34579999999997543 2334555554222     234899999988741    12233444333


Q ss_pred             cccccc----ccCCCCCcc-cCCCceEEEEEEEcCCcc-EEEEEEeeCCCCCCCCeEEEeecCcccCCCceEEEEEeecC
Q 047719           91 VISFVS----VDALSRGID-LKSGRHITTWIEYRDSLK-LIRVWAGYSQIRPPSPLIIAQIDLSKQFKDYMHVGFSAANG  164 (596)
Q Consensus        91 ~~s~~~----~~~~~~~~~-l~~g~~~~~~I~Y~~~~~-~l~v~~~~~~~~~~~p~l~~~vdl~~~l~~~~~vGFsastg  164 (596)
                      .....+    ...+..... ..++...+++|.|+..++ .|.|.+...        +...++--.+-+++.|+||||+||
T Consensus       130 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~I~y~~~~~~~l~v~id~~--------~c~~~~~v~lp~~~~~fG~SA~TG  201 (221)
T d2a6za1         130 KPVDKTKIYDQSFASCLMGYQDSSVPSTIRVTYDLEDDNLLKVQVDNK--------VCFQTRKVRFPSGSYRIGVTAQNG  201 (221)
T ss_dssp             SCCCGGGHHHHCSEEEECCCTTEEEEEEEEEEEEGGGTSEEEEEETTE--------EEEEESCCCCCSSEEEEEEEEECC
T ss_pred             ccccccCCcccccceeeecccCCCCCEEEEEEEecCccceEEEEecCc--------EeEEECCeecCCCCEEEEEEEccC
Confidence            221111    111111122 235667799999987654 477776321        111222222335678999999999


Q ss_pred             Cccceeeeeee
Q 047719          165 QGSAIYTVDRW  175 (596)
Q Consensus       165 ~~~~~~~i~~W  175 (596)
                      ...+.|.+..+
T Consensus       202 ~~~~~hd~~~i  212 (221)
T d2a6za1         202 AVNNNAESFEI  212 (221)
T ss_dssp             SGGGCCCEEEE
T ss_pred             CccCCCceEEE
Confidence            99998887664

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.34  E-value=1.6e-06  Score=83.10  Aligned_cols=149  Identities=12%  Similarity=0.010  Sum_probs=96.1

Q ss_pred             HHHHHhcCCCccceeecCCceEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCe
Q 047719          278 DIKQATLGFNKNRIVGEGASATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNE  357 (596)
Q Consensus       278 el~~at~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~  357 (596)
                      |++..-.+|...+..+.++...||+... +++.+.+|+....  .......+.+|...+...-.+--+.+++.++..++.
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~--~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~   84 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSR--YKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW   84 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGG--GTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCC--cccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence            5566666666555444444578999875 5667888887432  222333466676554332223334566777888889


Q ss_pred             EEEEEecCCCCCHHHHhhhCCCCCcccCHHHHHHHHHHHHHHHHHHHhcc------------------------------
Q 047719          358 LVLVYEYLPNGSLDKILHNNSSSSIVLSWEKRLNIVLGVASALSYLHEEC------------------------------  407 (596)
Q Consensus       358 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~------------------------------  407 (596)
                      .++|||++++.++.+......         ....++.++++.|+.||+..                              
T Consensus        85 ~~lv~~~l~G~~~~~~~~~~~---------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (263)
T d1j7la_          85 SNLLMSEADGVLCSEEYEDEQ---------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC  155 (263)
T ss_dssp             EEEEEECCSSEEHHHHTTTCS---------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCG
T ss_pred             eEEEEEecccccccccccccc---------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhh
Confidence            999999999988866543211         12234555666666666421                              


Q ss_pred             --------------------------CCCeEEccCCCCceeecCCCceEEccCCCcc
Q 047719          408 --------------------------ERQIIHRDVKACNILLDAEFNAKLGDFEATI  438 (596)
Q Consensus       408 --------------------------~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~  438 (596)
                                                ...++|+|+.|.|||++++....|.||+.+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             GGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             hcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                      1237999999999999987777799997653

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.58  E-value=7.4e-05  Score=70.64  Aligned_cols=75  Identities=19%  Similarity=0.076  Sum_probs=48.0

Q ss_pred             eeecCCc-eEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhcc-CCCceeeecceeeeCCeEEEEEecCCCC
Q 047719          291 IVGEGAS-ATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGCL-RHKNLVQLQGWCCEGNELVLVYEYLPNG  368 (596)
Q Consensus       291 ~LG~G~f-G~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~g  368 (596)
                      .+..|.. +.||+...+++..+.+|......     ...+..|...+...- ..-.+.+++.++.+.+..++||||+++-
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~-----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~   91 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ   91 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccC-----HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence            3444543 68999998778888999864321     223455554433211 1223556777778888899999999876


Q ss_pred             CH
Q 047719          369 SL  370 (596)
Q Consensus       369 sL  370 (596)
                      ++
T Consensus        92 ~~   93 (255)
T d1nd4a_          92 DL   93 (255)
T ss_dssp             ET
T ss_pred             cc
Confidence            54

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=96.92  E-value=0.002  Score=64.98  Aligned_cols=78  Identities=14%  Similarity=0.042  Sum_probs=44.4

Q ss_pred             ceeecCCceEEEEEEcCC-CCEEEEEEeecCCc-----hhcccchHHHHHHHHHhccCC--CceeeecceeeeCCeEEEE
Q 047719          290 RIVGEGASATVYKGSLPS-GGAVAVKRFEKPNR-----VECARNPFTTEFATMAGCLRH--KNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       290 ~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~-----~~~~~~~~~~E~~~l~~~l~H--~niv~l~g~~~~~~~~~lV  361 (596)
                      +.||.|....||+....+ ++.|+||.-.....     ..........|...+...-.+  ..+.+++.+  +....++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence            468999999999998765 67899997532110     011222344565454432222  334455544  44456889


Q ss_pred             EecCCCCC
Q 047719          362 YEYLPNGS  369 (596)
Q Consensus       362 ~E~~~~gs  369 (596)
                      ||++++..
T Consensus       110 mE~L~~~~  117 (392)
T d2pula1         110 MEDLSHLK  117 (392)
T ss_dssp             ECCCTTSE
T ss_pred             EeccCCcc
Confidence            99997644

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=95.77  E-value=0.015  Score=56.49  Aligned_cols=68  Identities=10%  Similarity=0.016  Sum_probs=40.1

Q ss_pred             eEEEEEEcCCCCEEEEEEeecCCchhcccchHHHHHHHHHhc----cCCCceeeec--ceeeeCCeEEEEEecCCCC
Q 047719          298 ATVYKGSLPSGGAVAVKRFEKPNRVECARNPFTTEFATMAGC----LRHKNLVQLQ--GWCCEGNELVLVYEYLPNG  368 (596)
Q Consensus       298 G~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~----l~H~niv~l~--g~~~~~~~~~lV~E~~~~g  368 (596)
                      -.||+...++|..+++|..+....   ...++..|...+..+    +..+..+..-  ......+..+.++++++|.
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~~---s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPERW---TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCCC---CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            479999998999999999754322   223345555333321    2222222222  1234566789999999763

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=94.61  E-value=0.15  Score=48.56  Aligned_cols=31  Identities=23%  Similarity=0.207  Sum_probs=27.4

Q ss_pred             CCCeEEccCCCCceeecCCCceEEccCCCcc
Q 047719          408 ERQIIHRDVKACNILLDAEFNAKLGDFEATI  438 (596)
Q Consensus       408 ~~~ivHrDlkp~NiLl~~~~~~kl~Dfg~~~  438 (596)
                      ..++||+|+.+.||+++.+...-|.||+.+.
T Consensus       182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccccccCCcchhhhhcccccceeEecccccc
Confidence            4679999999999999998878899998763

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=94.06  E-value=0.048  Score=54.36  Aligned_cols=73  Identities=15%  Similarity=0.145  Sum_probs=42.2

Q ss_pred             ceeecCCceEEEEEEcCCC--------CEEEEEEeecCCchhcccchHHHHHHHHHhccCCCceeeecceeeeCCeEEEE
Q 047719          290 RIVGEGASATVYKGSLPSG--------GAVAVKRFEKPNRVECARNPFTTEFATMAGCLRHKNLVQLQGWCCEGNELVLV  361 (596)
Q Consensus       290 ~~LG~G~fG~Vy~~~~~~g--------~~vAvK~l~~~~~~~~~~~~~~~E~~~l~~~l~H~niv~l~g~~~~~~~~~lV  361 (596)
                      +.|+.|--=.+|+....++        ..|.+++.. ...   ......+|...+...-.+.-..++++++..    .+|
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~---~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I  119 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPE---TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL  119 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCC---CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccc---hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceE
Confidence            5677777788999976542        456666653 211   122344566554443334333466776643    689


Q ss_pred             EecCCCCCH
Q 047719          362 YEYLPNGSL  370 (596)
Q Consensus       362 ~E~~~~gsL  370 (596)
                      +||+++.+|
T Consensus       120 ~efi~g~~l  128 (395)
T d1nw1a_         120 EEYIPSRPL  128 (395)
T ss_dssp             ECCCCEEEC
T ss_pred             EEEeccccC
Confidence            999986443